id|nct_id|organization|name|phone|email
86816|NCT03231371|University of Michigan|Bryan Goldstein||Bryan.Goldstein@cchmc.org
86817|NCT03163134|University of Pittsburgh|Benita Valappil|412.864.1744|valappilb2@upmc.edu
86818|NCT03159143|University of Pittsburgh|Leonard Appleman, MD|412-648-6538|applemanlj@upmc.edu
86819|NCT03157232|Masimo|Tala Harake||studies@masimo.com
86820|NCT03134326|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com
86821|NCT03134313|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com
86822|NCT03125031|Masimo|Tala Harake||studies@masimo.com
86823|NCT03125018|Masimo|Tala Harake||studies@masimo.com
86824|NCT03125005|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com
86825|NCT03124979|Masimo|Tala Harake||studies@masimo.com
86826|NCT03124966|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com
86827|NCT03124927|Masimo Corporation|Vikram Ramakanth||clinicalresearchdept@masimo.com
86828|NCT03124901|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com
86829|NCT03124836|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com
86830|NCT03124823|Masimo|Tala Harake||studies@masimo.com
86831|NCT03124797|Masimo|Tala Harake||studies@masimo.com
86832|NCT03124771|Masimo|Tala Harake||studies@masimo.com
86833|NCT03124758|Masimo|Tala Harake||studies@masimo.com
86834|NCT03124693|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com
86835|NCT03119831|Department of Periodontology, School of Dentistry, National and Kapodistrian University of Athens, Greece|Dr. Anastasios M. Gkatzonis|6976486314 ext 0030|gkatzonis.tasos@gmail.com
86836|NCT03115853|Vanderbilt University Medical Center|James Muldowney, MD|615-936-1720|james.muldowney@vanderbilt.edu
86837|NCT03106870|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com
86838|NCT03106337|Massachusetts General Hospital|Antonia Stephen, MD||ASTEPHEN@PARTNERS.ORG
86839|NCT03091751|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com
86841|NCT03072719|GlaxoSmithKline|GSK Response Center|866-435-7343|
86842|NCT03070730|Beth Israel Deaconess Medical Center|Dr. Roy Freeman|617-632-8454|rfreeman@bidmc.harvard.edu
86843|NCT03065933|McLean Hospital|Elizabeth S. Liebson, M.D.|617-855-2284|eliebson@partners.org
86844|NCT03061513|Weill Cornell Medical College|Claire Henchcliffe|2127462584|clh2007@med.cornell.edu
86845|NCT03055221|United Therapeutics, Corp.|Leigh Peterson, PhD||lpeterson@unither.com
118762|NCT02815397|Northwestern University|Dr. R Karmali|312-695-6832|reem.karmali@northwestern.edu
86847|NCT03048383|University of Utah|Dr. P. Daniel Ward|801-581-8471|PDanielWard@hsc.utah.edu
86848|NCT03048006|Guerbet GmbH|Oliver Heine, MD, Radiology & Scientific Affairs Manager|+49 6196 76250|oliver.heine@guerbet-group.com
86849|NCT03047447|Bristlecone Health, Inc,|Dr. Kelly Gibas, Director or Clinical Trials|(763) 424-2474|kgibas@bristleconefitness.com
86850|NCT03043534|WakeForest|Dr Amy McMichael|336-716-3775|amcmicha@wakehealth.edu
86851|NCT03041298|Guerbet GmbH|Oliver Heine, MD, Radiology & Scientific Affairs Manager|+49 6196 76250|oliver.heine@guerbet-group.com
86852|NCT03039179|Istituto Ortopedico Rizzoli|Head of the Research Nursing Unit|0516366694 ext 0039|cristiana.forni@ior.it
86854|NCT03035955|WakeForest|Director of Clinical Trials|336-716-3775|
86855|NCT03028987|Stanford University School of Medicine, Dept. of Pediatrics|Cornelia Dekker, MD|6507244437|cdekker@stanford.edu
86856|NCT03026803|City of Hope|Jeffrey Longmate, Ph.D.|626-256-4673 ext 62478|jlongmate@coh.org
86857|NCT03023709|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu
86858|NCT03023683|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu
86859|NCT03023553|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu
86860|NCT03023488|Marmara University, School of Medicine, Department of Urology|Dr. Tarik Emre Sener|+905337620712|dr.emresener@gmail.com
86861|NCT03023176|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker.|650-724-4437|cdekker@stanford.edu
86862|NCT03023137|Hospital Federal dos Servidores do Estado|Dr. Silvia Hoirisch-Clapauch|5521999737500|sclapauch@gmail.com
86863|NCT03022435|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker.|650-724-4437|cdekker@stanford.edu
86864|NCT03022422|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu
86865|NCT03022396|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu
86866|NCT03020537|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu
86867|NCT03020498|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu
86868|NCT03020472|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu
86869|NCT03019783|Brigham and Women's Hospital|Dr. Joshua Beckman|617-732-5500|joshua.a.beckman@vanderbilt.edu
86870|NCT03002454|Winnipeg Regional Health Authority|Dr. Sandor Demeter|1 (204) 787-3375|sdemeter@hsc.mb.ca
86871|NCT03001674|Tufts Medical Center|Dr. Navin Kapur|617 636 0720|nkapur@tuftsmedicalcenter.org
86872|NCT03001258|BRAC|Anita Sharif Chowdhury/Research Fellow of BRAC Research and Evaluation Division|+88029846448 ext 3719|anita.sc@brac.net
86873|NCT03000088|Ajou University School of Medicine|Dr. Jiyoung Lee|82-31-219-5689 ext 667|leejiyoung0616@gmail.com
86874|NCT02997904|Piedmont Pharmaceuticals|Dr. Kathy Palma|336 544 0320 ext 202|kpalma@piedmontpharma.com
86875|NCT02990910|the Children’s Hospital of Fudan University|Dr.Wang Xuan|18017591058|744734170@qq.com
86876|NCT02988219|Warsaw Medical University|Dr. Karolina Dobronska|48 22 502 17 21|karolinapladzyk@gmail.com
86877|NCT02987374|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu
86878|NCT02986282|Warsaw Medical University|Dr Jacek Lewandowski|5992828 ext +48 22|jlewandowski@wum.edu.pl
86879|NCT02977572|INTENSIVE CARE UNIT. HOSPITAL GENERAL UNIVERSITARI CASTELLO|Dr. Alberto Belenguer Muncharaz|0034-964-725000|belengueralberto8@gmail.com
86880|NCT02974543|University of Michigan|Susan Shore, Professor of Otolaryngology|734 647-2116|sushore@umich.edu
86881|NCT02971670|Biomedizinische Forschungsgesellschaft mbH|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at
86882|NCT02964767|SinghRK|Dr. Ranjan K Singh|91+9431263911|dr_ranjankumarsingh@yahoo.com
86884|NCT02959840|Rutgers-Robert Wood Johnson Medical School|Dr. Shaul Cohen, M.D., Professor of Clinical Anesthesiology, Director of Obstetric Anesthesia|732-937-8841|cohensh@rwjms.rutgers.edu
86885|NCT02958995|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
86886|NCT02958956|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
86887|NCT02958345|Tulane University|Dr. Luis Balart|504-988-3047|lbalart@tulane.edu
86888|NCT02951767|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
86889|NCT02949141|Patan Academy of Health Science|Darlene R House, MD|+977 9810339799|dhouse@iupui.edu
86890|NCT02947984|Massachusetts General Hospital|Nina Sanford, MD||NSANFORD@PARTNERS.ORG
86891|NCT02941640|University Clinical Center Tuzla|Samir Delibegovic|+387 61 149 131|delibegovic.samir@gmail.com
86892|NCT02937506|Mount Carmel Health System|Anantha Padmanabhan, MD|614-234-1079|apadmanabhan@mchs.com
86893|NCT02934347|Glan Clwyd Hospital, Betsi Cadwaladr University Health Board|Dr Raj Reddy|01745 583910|Rajashekhar.Reddy@wales.nhs.uk
86894|NCT02920749|Department of Anaesthesiology and Intensive Therapy, University of Pecs|Dr. Timea Bocskai|36 72 507374|bocskai.timea@pte.hu
86895|NCT02919657|Medfit Rx|David Michael|9196109893|dmichael@medfitrx.net
86896|NCT02912650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
86897|NCT02910362|Arizona Eye Consultants|Sean McCafferty, MD|(520) 791-7401|sjmccafferty66@hotmail.com
86898|NCT02903238|Northwestern University Medical School|Dr. Apkar Vania Apkarian|(312) 503-0404|a-apkarian@northwestern.edu
86899|NCT02895347|GWU Medical Faculty Associates|Dr. Gaby Moawad|202-741-2500|jebert@mfa.gwu.edu
86900|NCT02891863|Boston Scientific CRM|Greg Voss|651-581-3068|gregory.voss@bsco.com
86901|NCT02889289|Washington DC VA Medical Center|Dr. Shane Chanpimol|202-745-8000 ext 55854|shane.chanpimol@va.gov
86902|NCT02886338|TMU|Fat-Moon, Suk|29307930 ext 7923|fmsuk@tmu.edu.tw
86903|NCT02884427|Universidad Andrés Bello|Professor Hernán Andrés de la Barra O., DC,PT,Mg|56226618402|quiropraxiayequilibrio@gmail.com
86904|NCT02882152|University of São Paulo|Dr. Joaquim Edson Vieira|+55 11 3061 8716|joaquimev@usp.br
86905|NCT02881658|The University of Hong Kong|Dr Cheung Ching Lung|(852)28315085|lung1212@hku.hk
86906|NCT02873429|University of Pittsburgh|Carol M. Greco, Associate Professor of Psychiatry|412-623-6873|grecocm@upmc.edu
86907|NCT02867150|Optimal Health and Weight Center|Dr. Ellyn Levine M.D.|(619) 567-6914|dr.levine@teamtsfl.com
86908|NCT02863198|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com
86909|NCT02862600|Heart Metabolics, Ltd.|Mark G. Midei, MD, Executive Director and Head of Cardiology|4103715357 ext 410|markgmidei@gmail.com
86910|NCT02862106|Institute of Immunology，PLA|Dr.Wu|02368752230 ext 86|wuyuzhang@yahoo.com
86911|NCT02856880|GlaxoSmithKline|GSK Response Center|866-435-7343|
86912|NCT02855411|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
86913|NCT02850159|Samsung Medical Center|Dr. Won Hyuk Chang|82234102818|wh.chang@samsung.com
86914|NCT02849678|University of Pittsburgh Medical Center Department of Anesthesiology|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu
118763|NCT02792062|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
86916|NCT02847169|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com
86917|NCT02844998|Ankara TRH|Dr. Muhammet Fatih Kilinc|+90 312 595 3700 ext 3724|mdfatihkilinc@yahoo.com
86918|NCT02840916|Kaohsiung Chang Gung Memorial Hospital|Dr. Wen-Long Hu|+886-7-731-7123 ext 2334|oolonghu@gmail.com
86919|NCT02839772|University of Hull|Jill Brooks. PhD student,|01491 839044|jb284@btinternet.com
86920|NCT02834624|University of Missouri-Columbia|Dr. Naomi Lauriello|573-882-2272|lauriellon@health.missouri.edu
86921|NCT02832375|GlaxoSmithKline|GSK Response Center|866-435-7343|
86922|NCT02829775|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
86923|NCT02829463|Third Xiangya Hospital of Central South University|Dr. Jinshen He|8613517470997|jinshen.he@hotmail.com
86924|NCT02828137|Inha University Hospital|Dr. Sung Woo Kwon|821031133363|kwonswdr@gmail.com
86925|NCT02826421|Alcon, A Novartis Division|Sr Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com
86926|NCT02823080|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com
86927|NCT02822885|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com
86928|NCT02822287|GlaxoSmithKline|GSK Response Center|866-435-7343|
86929|NCT02821403|The Hong Kong Polytechnic University|Dr. Tsz Wing Leung|27664268|jeffrey.TW.leung@polyu.edu.hk
86930|NCT02818244|Cleveland Clinic|Marc Gillinov MD|216 445-8841|GILLINOM@ccf.org
86932|NCT02815735|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com
86934|NCT02814227|University of Michigan|J. Todd Arnedt, PhD|734-615-8666|tarnedt@med.umich.edu
86935|NCT02813070|GE Healthcare|Paul Sherwin, M.D., PhD|+1-774-843-3888|PaulSherwin@ge.com
86936|NCT02809911|Regenesis Biomedical|Heather Vander Ploeg|602-4287041|Heather.VanderPloeg@regenesisbio.com
86937|NCT02809833|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
86938|NCT02808130|Ondokuz Mayıs University Dentalfaculty Periodontology Dep.|Assoc Prof Muge Lutfioglu|+905063073738|mugelutfioglu@hotmail.com
86939|NCT02806544|Vanderbilt University|Laila Agrawal|615-322-4967|laila.saied@vanderbilt.edu
86940|NCT02806505|Hoffmann-La Roche|Medical Communications|800-821-8590|global.trial_information@roche.com
86941|NCT02805907|MurciaSalud|Dr. Rubén Andújar-Espinosa|0034669500052|rubemed@hotmail.com
86942|NCT02802592|Johns Hopkins University School of Medicine|Dr. Kenneth Horvath|301-896-3100|
86943|NCT02801396|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO|904-443-1396|MBishop4@its.jnj.com
86945|NCT02799082|Biofrontera Bioscience GmbH|Dr. Beate Schmitz|+49 214 876 32 ext 41|b.schmitz@biofrontera.com
86946|NCT02799069|Biofrontera Bioscience GmbH|Dr. Beate Schmitz|+49 214 876 32 ext 41|b.schmitz@biofrontera.com
86947|NCT02796092|GITMI (University of Zaragoza)|Prof. Alicia Laborda|0034 976 76 15 49|alaborda@unizar.es
86948|NCT02792049|Brooke Army Medical Center|Dr. Michael D. April|(210) 916 - 0808|Michael.D.April@post.harvard.edu
86949|NCT02791659|Gastroenterology endoscopy center|Phonthep Angsuwatcharakon, MD|6622564265|borndeb@yahoo.com
86950|NCT02791269|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
86951|NCT02790281|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
86952|NCT02788357|University of Kentucky|Dr. Lumy Sawaki||lsawa2@uky.edu
86953|NCT02788097|Antalya IVF|Kevin Coetzee|090 242 345 4700|kevincoetzee61@yahoo.co.nz
118766|NCT02627794|Cedars-Sinai Medical Center|Dr. Martin L. Hopp|310-657-7704|marty@towerent.com
86955|NCT02786004|GE Healthcare|Beth Heckel|262-312-7269|beth.heckel@med.ge.com
86956|NCT02784925|WanFangH|Ming-Shun Wu|88629307930 ext 7923|mswu@tmu.edu.tw
86957|NCT02780622|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
86959|NCT02777125|University of Tennessee Health Sciences College of Medicine/Le Bonheur Children's Hospital|Mark Snider DO, Principal Investigator|9012875986|marksnider02@hotmail.com
86960|NCT02774278|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
86961|NCT02773758|GlaxoSmithKline|GSK Response Center|866-435-7343|
86962|NCT02772666|Mashhad University of Medical Sciences|Dr. Amirhossein Vejdani|+9151105411|amirhosein_vejdani@yahoo.com
86963|NCT02770625|ISU ABXIS Co., Ltd.|Taekseung Kim|+82.31.696.4715|kimts@isu.co.kr
86964|NCT02767843|California Center for Sleep Disorders|Jerrold Kram, MD|510.263.3300|info@californiasleepcenters.com
86965|NCT02767765|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
86967|NCT02766244|Texas Tech University Health Sciences Center|Dr. Sharmila Dissanaike|8067435609|sharmila.dissanaike@ttuhsc.edu
86968|NCT02765269|Xinhua Translational Institute for Cancer Pain, Shanghai|Gang Ding|021-69691540|
86970|NCT02761733|Felton Institute & Palo Alto University|Joyce Chu (Principal Investigator)|650-814-8376|jchu@paloaltou.edu
86971|NCT02761629|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
86972|NCT02760810|Johnson & Johnson Vision Care Inc.|Andrea Le, OD, MBA - Manager, Global Medical Affairs|904 4431866|ale3@ITS.JNJ.com
86974|NCT02759692|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO|904 443-1290|BPALL@its.jnj.com
86975|NCT02759471|CooperVision|Senior Manager Global Medical Scientific Affairs|1-925-621-3761|javega@coopervision.com
118768|NCT02553772|Allergan, Inc|Therapeutic Area Head,|1-877-277-8566|IR-CTRegistration@allergan.com
86977|NCT02756637|Abramson Cancer Center of the University of Pennsylvania|John Christodouleus|215-662-2428|John.Christodouleas@uphs.upenn.edu
86978|NCT02756624|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com
86979|NCT02756351|CytaCoat AB|Dr Jacob Odeberg|+46 (0) 70 2087571|jacob.odeberg@scilifelab.se
86981|NCT02755090|University of New Mexico|Sharla Biefeld Research Coordinator|505-272-9703|hsc-familyplanningresearch@salud.unm.edu
86982|NCT02753699|Debiopharm International, S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com
86983|NCT02753413|GlaxoSmithKline|GSK Response Center|866-435-7343|
86984|NCT02753075|GlaxoSmithKline|GSK Response Center|866-435-7343|
86985|NCT02752802|Osprey Medical, Inc|Michele Shepard, Vice President of Clinical Affairs|952-955-8236|mshepard@ospreymed.com
86986|NCT02751450|GlaxoSmithKline|GSK Response Center|866-435-7343|
86988|NCT02750813|Alcon, A Novartis Division|Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com
86989|NCT02750709|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com
86990|NCT02750345|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com
86991|NCT02750332|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com
86992|NCT02750267|Center for Diabetes Technology|Dr. Daniel R. Chernavvsky|4342431395|drc2v@virginia.edu
86993|NCT02748213|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
86994|NCT02746679|The First Affiliated Hospital of Sun Yat-sen University|Yuqing Chen|+86 020-87755766-8341|fangchenyq@163.com
86995|NCT02746406|Laborie|Clinical Researcher|9056121170 ext 1755|sbitzos@laborie.com
86996|NCT02746107|Carol Davila University of Medicine and Pharmacy Bucharest|Professor Cristian Baicus|+40788302355|cbaicus@gmail.com
86997|NCT02745626|University of Connecticut Health|Dr. Madhur Upadhyay, Director Orthodontic Clinic, Assistant Professor|860-679-3729|maupadhyay@uchc.edu
86998|NCT02743936|Brooke Army Medical Center|Dr. Michael D. April|210-916-0808|Michael.D.April@post.harvard.edu
86999|NCT02743780|Alcon, A Novartis Division|Translational Medicine Expert II, TM-Ophthalmic|1-888-451-3937|alcon.medinfo@alcon.com
87000|NCT02743702|University of Seville|Dr. Jose J. Jimenez-Rejano|+34667309369|jjjimenez@us.es
87001|NCT02743117|MedImmune, LLC|Raburn Mallory, MD|301-398-000|information.center@astrazeneca.com
87002|NCT02742987|Campus Bio-Medico University|Dr. Fabio Mangiacapra|003906225411612|f.mangiacapra@unicampus.it
87003|NCT02739698|University Hospital Reina Sofia, Cordoba, Spain|Angela Casado-Adam, MD|0034957010439|angeti@hotmail.com
87004|NCT02739594|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87005|NCT02737852|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annhita.ghassemi@churchdwight.com
87006|NCT02737631|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com
87007|NCT02737618|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com
87008|NCT02737592|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com
87009|NCT02736721|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87010|NCT02735200|Dammam University|Dr Dalal Bubshait|+966505848281|dbubshait@ud.edu.sa
87011|NCT02734355|Research Institute for Complex Problems of Cardiovascular Diseases, Russia|Dr. Sergey Mamchur|+73842643308|reception@kemcardio.ru
87012|NCT02734212|VISN 5 MIRECC|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov
87013|NCT02734056|Brigham|Bhavani Kodali|6175258449|kodali@zeus.bwh.harvard.edu
87014|NCT02732639|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
118771|NCT02502734|GlaxoSmithKline|GSK Response Center|866-435-7343|
87016|NCT02732327|Allergan|David Melnick, MD|201-427-8554|Melnick_David@Allergan.com
87017|NCT02732210|Amgen Inc.|Study Director|866-572-6436|
87018|NCT02731833|GlaxoSmithKline|GSK Response Center|866-435-7343|
87019|NCT02731313|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
87020|NCT02731300|Department of Physiology; Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.|Paradee Auvichayapat|66896222624|aparad@kku.ac.th
87021|NCT02731131|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87023|NCT02730260|Washington University School of Medicine|Dr. Walton Sumner|314-454-8164|wsumner@dom.wustl.edu
87024|NCT02726971|Department of Hysteroscopic Center, Fuxing Hospital, Capital Medical University, Beijing, China|Dr. YH Liu|8618301474064|emmagj@126.com
87025|NCT02726178|Sainte Justine university hospital center|Dr. Anne Monique Nuyt|514 3454931 ext 3971|anne-monique.nuyt@recherche-ste-justine.qc.ca
87026|NCT02726022|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87027|NCT02725788|3M|Laura Rutledge|651-733-5394|lfrutledge1@mmm.com
87028|NCT02724449|North Shore University Hospital|Mary Brennan, Assist Director WOCN|516-562-8252|mbrennan@northwell.edu
87029|NCT02723188|Tel Aviv University|Yair Bar-Haim|97236406393|yair1@post.tau.ac.il
87030|NCT02722564|St. Luke's University Health Network|Holly Stankewicz, D.O.|484-526-4000|holly.stankewicz@gmail.com
87031|NCT02721641|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com
87032|NCT02721277|University of Florida|Josef Neu, MD|352-273-8985|neuj@peds.ufl.edu
87033|NCT02720952|Diurnal Limited|Dr John Porter||info@diurnal.co.uk
87034|NCT02717754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87035|NCT02716779|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
87036|NCT02716298|CooperVision|Senior Manager Global Medical Scientific Affairs|925-621-3761|javega@coopervision.com
87037|NCT02713594|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu
87038|NCT02712333|Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn
87039|NCT02712099|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com
118773|NCT02446483|GlaxoSmithKline|GSK Response Center|866-435-7343|
87041|NCT02710292|Alcon Japan Ltd.|Clinical Manager|1-888-451-3937|alcon.medinfo@alcon.com
87042|NCT02709577|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3263|kwoessner@gidynamics.com
87043|NCT02709096|BioPharmX, Inc.|AnnaMarie Daniels|310-701-2080|amdaniels@biopharmx.com
87044|NCT02708524|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D. PRINCIPAL RESEARCH OPTOMETRIST|904-443-1474|KCANAVA2@its.jnj.com
87045|NCT02708355|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
87046|NCT02708277|The First Affiliated Hospital of Sun Yat-sen University|Yuqing Chen|+86 020-87755766-8341|fangchenyq@163.com
87047|NCT02708238|"Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II"|Annamaria Staiano|00390817462679|staiano@unina.it
87048|NCT02708212|Evergreen General Hospital|Dr. Chiliang Cheng|+886-3-4631230|chiliang.cheng@gmail.com
87049|NCT02707640|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
87050|NCT02707172|Kaohsiung Medical University|Dr. Ming-Tsang Wu|+886-7-3121101 ext 2315|e_encourage@yahoo.com
118774|NCT02322216|Alcon, a Novartis Company|Clinical Project Lead, GCRA-Pharma|1-888-451-3937|alcon.medinfo@alcon.com
87052|NCT02705807|GlaxoSmithKline|GSK Response Center|866-435-7343|
87053|NCT02705716|GlaxoSmithKline|GSK Response Center|866-435-7343|
87054|NCT02705365|Massachusetts General Hospital|Sanja Percac-Lima, MD, PhD|617-643-6980|spercaclima@partners.org
87055|NCT02701556|Valeant Pharmaceuticals|Denise Raimondo|(908)927-1885|denise.raimondo@valeant.com
87056|NCT02701387|UCLA School of Dentistry|Perry R. Klokkevold, DDS, MS, FACD|310-825-1927|pklokkevold@dentistry.ucla.edu
87057|NCT02701296|ST. FRANCIS HOSPITAL AND MEDICAL CENTER|Sanjay Sinha, MD||sanjaysinha@comcast.net
87058|NCT02701270|Danisco Sweeteners Oy|Kirsti Tiihonen|+358 10 431 050|kirsti.tiihonen@dupont.com
87059|NCT02699892|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87060|NCT02699684|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com
87061|NCT02699593|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO -Sr. Principal Research Optometrist|904 443-1290|BPALL@its.jnj.com
87062|NCT02698566|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87064|NCT02697890|TuftsUSDM|Y. Natalie Jeong|6176366531|natalie.jeong@tufts.edu
87066|NCT02695446|BioPharmX, Inc.|AnnaMarie Daniels|310-701-2080|amdaniels@biopharmx.com
87067|NCT02695290|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
87068|NCT02694718|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
87069|NCT02694536|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87070|NCT02694315|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179 ext +2|amr.riad@med.asu.edu.eg
87071|NCT02694198|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179 ext +2|amr.riad@med.asu.edu.eg
87072|NCT02693704|EPFL|Gilles Courtois|0041216932631|gilles.courtois@epfl.ch
87073|NCT02692859|jiangsuPCDCP|Kai Chu|18915999781|chukai19812007@163.com
87074|NCT02691507|Johnson & Johnson Consumer, Inc|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com
87075|NCT02691416|The Third Central Clinical College of Tianjin Medical University, Tianjin the Third Central Hospital|Dr.Haiyun Wang|13752211206|why819@126.com
87076|NCT02691143|Sport and Spine Rehab Clinical Research Foundation|Jena Slaski|240-766-0300 ext 838|jslaski@ssrehab.com
87078|NCT02689804|Columbia University|Carolyn L. Westhoff, MD|212-305-4805|clw3@columbia.edu
87079|NCT02687217|Lady Hardinge Medical College and associated Hospitals|Dr. Swati Sattavan|9891777424 ext 91|swatisattavan@gmail.com
87080|NCT02687126|Shahid Gangalal National Heart Centre|Santosh Sharma Parajuli|+9779806532132|santoshparajuli77@hotmail.com
118776|NCT02251717|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
87082|NCT02684942|Chulabhorn hospital|Saengrawee Thanthong|+662-576-6021|saengrawee81@gmail.com
87083|NCT02684630|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com
87084|NCT02684604|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179 ext +2|amr.riad@med.asu.edu.eg
87085|NCT02684396|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
87086|NCT02683954|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179 ext +2|amr.riad@med.asu.edu.eg
87087|NCT02682498|UC Irvine Health|Joseph Rinehart|714-456-5059|jrinehar@uci.edu
87088|NCT02681458|Islamic Azad University of Mashhad|Dr. Hassan Yazdanfar|00985136631004|hasanyazdanfar@yahoo.com
87089|NCT02679976|Johnson & Johnson Vision Care Inc.|Tom Karkkainen SR. PRINCIPAL RESEARCH OPTOMETRIST|904-443-3500 ext 3402|TKarkkai@its.jnj.com
87090|NCT02679469|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366|
87091|NCT02678923|The Medicines Company|Global Health Science Center|1-888-977-6326|medical.information@themedco.com
87092|NCT02678676|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
87093|NCT02678039|Dartmouth-Hitchcock|Mark P. Yeager, MD|603-650-5922|mark.p.yeager@hitchcock.org
87094|NCT02677779|AOU Careggi|Dr. Matteo Monami, Director Diabetic Foot Unit|00390557946563|matteo.monami@unifi.it
87095|NCT02677493|IL-YANG PHARM.|Clinical Research Manager|+82-70-7165-7316 ext 7316|hlpark@ilyang.co.kr
118777|NCT02202980|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
118778|NCT02132949|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87098|NCT02675543|University of Brescia|Francesco Semeraro|+30 030 3995308|francesco.semeraro@unibs.it
87099|NCT02674334|West Virginia University Department of Orthopaedics|Dr. George K Bal|304-293-1310|gbal@hsc.wvu.edu
87100|NCT02673944|Laborie|Clinical Researcher|905-612-1170 ext 1755|sbitzos@laborie.com
87101|NCT02672514|Herzzentrum Coswig|Dr. Jessica Vogler|+491749740710|j_vo@web.de
87102|NCT02670811|Centro de Investigación en Alimentación y Desarrollo, A.C.|Dr. Belinda Vallejo Galland|526622892400 ext 365|vallejo@ciad.mx
87103|NCT02670473|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com
87104|NCT02669095|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D., FAAO Principal Research Optometrist|904 443-1474|KCANAVA2@its.jnj.com
87105|NCT02669043|Massachusetts General Hospital|Dr.Cristina Cusin|617-726-6421|ccusin@partners.org
118779|NCT02100644|GlaxoSmithKline|GSK Response Center|866-435-7343|
87107|NCT02667704|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
87108|NCT02666560|University College London|Joanne Lindop|07909116145|joanne.lindop.12@ucl.ac.uk
87109|NCT02666222|Envoy Medical Corp.|Elizabeth Anderson, PhD|651-361-8080|landerson@envoymedical.com
87110|NCT02665260|Montefiore Medical center|Dr. Steven Cohen|718-920-8470|dermpharmeinstein@gmail.com
87111|NCT02664987|Mundipharma Pte Ltd|Valerie Leck|+65 6511 1165|info.rma@mundipharma.com.sg
87112|NCT02664610|University of Michigan|Lesli Skolarus|734-936-9075|lerusche@umich.edu
87113|NCT02664532|Tata Main Hospital|Dr.Deb Sanjay Nag|+91-7763807101|debsanjay@gmail.com
87114|NCT02664311|Beth Israel Deaconess Medical Center|Eleanor Greene|617-667-1836|ergreene@bidmc.harvard.edu
87115|NCT02663453|Thammasat University|Dr.Wilaiporn Techasatid|66890339442|wilaiporn66@gmail.com
87116|NCT02663232|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87117|NCT02662608|The University of Texas (UT) MD Anderson Cancer Center|Dr. Renata Ferrarotto, Asst Professor/Thoracic/Head & Neck Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org
87118|NCT02662556|AcelRx Pharmaceuticals, Inc.|Pamela P. Palmer, MD, PhD, Chief Medical Officer|650-216-3504|ppalmer@acelrx.com
87119|NCT02662387|Loma Linda University Children's Hospital|Dr. Janeth Ejike|9095584000 ext 44250|jejike@llu.edu
87120|NCT02658461|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87121|NCT02657629|HackensackUMC|Nicole Spillane MD|917-446-6656|nspillane@hackensackumc.org
87122|NCT02657538|Department of Preventive, Restorative and Pediatric Dentistry, University of Bern|PD Dr. Klaus Neuhaus|+41 (0)31 632 49 74|klaus.neuhaus@zmk.unibe.ch
87123|NCT02656485|AOBIOME|Masha Gaber|617-475-1605|mgaber@aobiome.com
87124|NCT02656160|Brigham and women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu
87125|NCT02653560|UT Southwestern Medical Center|Dr Wanpen Vongpatanasin|2146489078|wanpen.vongpatanasin@utsouthwestern.edu
87126|NCT02653495|Rockefeller University|Dr. Ursula Andreo|212-327-7894|uandreo@gmail.com
87127|NCT02652221|Cincinnati Children's Hospital Medical Center|Andrew T. Trout, MD|513-803-3004|andrew.trout@cchmc.org
87128|NCT02652208|Massachusetts General Hospital|Dr. Karen Sepucha|617-724-3350|ksepucha@partners.org
87129|NCT02651922|PASCOE Pharmazeutische Präparate GmbH|Dr. Inga Trompetter and Jennifer Lebert|0049-(0)641-7960-955|Jennifer.lebert@pascoe.de
87130|NCT02651467|GlaxoSmithKline|GSK Response Center|866-435-7343|
87131|NCT02650440|Coordination of Improvement of Higher Level Personnel – CAPES|Thais A. Rodrigues, MS, PT.|55 (61) 2022-6002|faleconosco@capes.gov.br
87132|NCT02650219|St Joseph Hospital Marseille|Dr Christine Serratrice|0041798731474|cserratrice@hotmail.fr
87133|NCT02649634|University of Calgary|Dr. Kristin von Ranson|403.220.7085|kvonrans@ucalgary.ca
87134|NCT02648438|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com
87135|NCT02648022|Va San Diego Healthcare System|Dr. Samuel B. Ho|858-552-8585 ext 3280|Samuel.Ho2@va.gov
87136|NCT02646449|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu
87137|NCT02645760|Khonkaen University|Rungthip Chalermsan|+66 835603675|chalermsanrungthip@gmail.com
87138|NCT02644356|Collinge and Associates, Inc.|William Collinge, PhD, MPH|541-632-3502|william@collinge.org
87139|NCT02643251|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com
87140|NCT02645123|University of Ioannina School of Medicine|Dr. Georgios Krekoukias|00306934609400|gkrekos@gmail.com
87141|NCT02644109|Nutrition and Food Technology Institute, University of Chile|Dr. Sandra Hirsch|+56229781495|shirsch@inta.uchile.cl
87142|NCT02644096|University of Copenhagen|Chief researcher Britta Hørdam|+ 45 22214383|britta@hordam.dk
87143|NCT02643615|The Ohio State University Wexner Medical Center|Dr. Sergio Bergese|6142933559|sergio.bergese@osumc.edu
87144|NCT02643225|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com
87145|NCT02643199|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com
87146|NCT02643004|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com
87147|NCT02642575|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com
87148|NCT02642536|VA|Dr. Gina Evans|713-440-4459|gina.evans@va.gov
118781|NCT01995513|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
87150|NCT02641912|GlaxoSmithKline|GSK Response Center|866-435-7343|
87151|NCT02641379|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
87152|NCT02641249|University of California|Dr. Kalpashri Kesavan|3108256304|KKesavan@mednet.ucla.edu
87154|NCT02640157|AbbVie|Global Medical Services|800-633-9110|
87155|NCT02639052|Lewis Katz School of Medicine at Temple University|Susan G. Fisher, M.S., Ph.D., Associate Dean and Director, Temple Clinical Research Institute|215-707-3577|susan.fisher@tuhs.temple.edu
87156|NCT02638493|University of North Carolina at Chapel Hill|Julie B. Dumond, PharmD, MS, BCPS, AAHIVP|919-966-5017|jdumond@unc.edu
87157|NCT02638129|Orexigen Therapeutics, Inc.|Global Head of Development|858-875-8600|MedInfo@Orexigen.com
87158|NCT02638051|Clifford Hospital|Prof. Clifford LK Pang, President of Clifford Hospital|(8620) 34710038|cpang@cliffordgroup.com
87159|NCT02637063|Oregon Center for Applied Science|Amelia J Birney (PI), Director of Research|541-342-7227 ext 541|abirney@orcasinc.com
87161|NCT02636595|AbbVie|Global Medical Services|800-633-9110|
87162|NCT02635828|The Ohio State Universtiy Wexner Medical Center|Director of Neuroanesthesia|6142933559|sergio.bergese@osumc.edu
87163|NCT02635425|Ain Shams university|Dr. Ahmad Hussieny Salama|00201223114626|ahmdhsf@hotmail.com
87164|NCT02634788|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com
87165|NCT02634073|GlaxoSmithKline|GSK Response Center|866-435-7343|
87166|NCT02633787|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
87167|NCT02633215|University of Kentucky|Dr. Lumy Sawaki||lsawa2@uky.edu
87168|NCT02632812|Galeno Desenvolvimento de Pesquisas Ltda.|Gilberto De Nucci, PhD, principal investigator|55.19.32516928|denucci@gilbertodenucci.com
87169|NCT02630563|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com
87170|NCT02629354|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
87171|NCT02628938|Riyadh Colleges of Dentistry and Pharmacy|Dr. Mohammad Rayyan|00966508821318|mohammadrayyan1979@gmail.com
87172|NCT02628418|Fondazione Salvatore Maugeri|Dr. Palmira Bernocchi|00390308253 ext 260|palmira.bernocchi@fsm.it
87173|NCT02628236|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|8452681943|Anna.Houlihan@sunpharma.com
87174|NCT02628106|West China Hospital of Sichuan University|Mr.Zhi-cheng Li|+86 13795581617|wangcaizi2@163.com
87175|NCT02627144|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87176|NCT02627001|San Antonio Military Medical Center|Dr. Michael D. April|(210) 916-0808|Michael.D.April@post.harvard.edu
87177|NCT02625844|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
87178|NCT02625298|Faculty of Dentistry, University of Belgrade|Dr. Dejan Markovic, professor at Clinic for Pediatric and Preventive Dentistry|+381600203041|dejan.markovic@stomf.bg.ac.rs
87179|NCT02625233|Johson & Johnson Vision Care Inc.|Kristy Canavan, O.D., FAAO Principal Research Optometrist|904 443-1474|KCANAVA2@its.jnj.com
87180|NCT02625220|Johnson & Johnson Vision Care Inc.|Benjamin Straker, BAppSc(Optom)(HonS) Principal Research Optometrist|904-443-3500 ext 1380|Bstraker@ITS.JNJ.com
87181|NCT02625207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
87182|NCT02624791|UVa Center for Behavioral Medicine Research|Project Coordinator|434-924-8656|tab2v@hscmail.mcc.virginia.edu
87183|NCT02622568|University of Texas Southwestern|Dr. Nnenna Agim|2144561631|Nnenna.Agim@childrens.com
87184|NCT02621034|Zahedan university of medical sciences|Seyed Roholla Havaei|+989215257093|marty_zl@yahoo.com
87185|NCT02619812|Mayo Clinic|Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu
87186|NCT02619799|Rangaraya medical college|Dr.Paleti Sophia|9948599758 ,08842343023|dr.sophia29@gmail.com
87187|NCT02619591|UMASS Memorial Department of Emergency Medicine|Executive Vice Chairman|508-421-1400|Romolo.Gaspari@umassmemorial.org
87188|NCT02618772|MUHC|Dr. Jennifer Turnbull|514-412-4400 ext 23039|jennifer.turnbull@mcgill.ca
87189|NCT02617888|Ft. Belvoir Community Hospital|Michael K. Cheezum, MD|571-231-2159|Michael.k.cheezum.mil@mail.mil
87190|NCT02617784|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87191|NCT02616523|University Clinical Center Ljubljana|dr. Lea Andjelković|0038615223810|lea.andjelkovic@gmail.com
87192|NCT02615717|University of Nebraska, Lincoln|Christina Hein, M.A.|7036184722|chein9@gmail.com
87193|NCT02614924|UHCW NHS Trust|Dr Ratidzo Danha|02476 964000 ext 25871|Ratidzo.Danha@uhcw.nhs.uk
87194|NCT02614586|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87195|NCT02614469|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-764-9611|michaels@helix.mgh.harvard.edu
87196|NCT02614222|The Cooper Health System|Dr. Ronak Desai|856-342-2000|desai-ronak@cooperhealth.edu
87197|NCT02613910|GlaxoSmithKline|GSK Response Center|866-435-7343|
87198|NCT02612077|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com
87199|NCT02612064|GlaxoSmithKline|GSK Response Center|866-435-7343|
87200|NCT02611765|Baylor College of Medicine|Jose Serpa-Alvarez|713 798-7910|jaserpaa@bcm.edu
87201|NCT02611154|Sports Medicine Research & Testing Laboratory|Dr. Geoffry Miller|801-994-9519|gmiller@smrtl.org
87203|NCT02609841|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
118784|NCT01929317|GlaxoSmithKline|GSK Response Center|866-435-7343|
87205|NCT02609178|Stomatological Hospital of FMMU|Pingting Lin, PhD|+86 15249049902|biu79@hotmail.com
87206|NCT02608489|Soonchunhyang University Hospital|Dr. JinKwon Chung|82-2-709-9354|schcornea@schmc.ac.kr
87207|NCT02606838|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com
87208|NCT02606734|Osprey Medical|Michele Shepard|952-955-5236|mshepard@ospreymed.com
87209|NCT02605928|Department of Medicine, Division of Rheumatology, Helsinki University Central Hospital and University of Helsinki, Finland|PhD MD Ritva Peltomaa||ritva.peltomaa@hus.fi
87210|NCT02604589|William Beaumont Hospital|Rose Callahan|248 551-5147|rose.callahan@beaumont.org
87211|NCT02604550|Emory University|John Xerogeanes, MD|404-778-7202|jxeroge@emory.edu
87212|NCT02604407|Shire|Study physician||ClinicalTransparency@shire.com
87213|NCT02604264|Fresenius Medical Care North America|Jeffrey L. Hymes, MD|615-567-4821|Jeffrey.HymesMD@fmc-na.com
87214|NCT02604017|AbbVie|Global Medical Services|800-633-9110|
87215|NCT02603666|Karolinska University Hospital, Huddinge, 141 86 Stockholm|Ferenc Karpati M.D., Ph.D., Senior Consultant|+46858580000 ext 81656|ferenc.karpati@karolinska.se
87216|NCT02602223|Oregon Health & Sciences University|Dr. Sivaraman Prakasam|503-346-4711|prakasam@ohsu.edu
87218|NCT02598934|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87219|NCT02598622|Indiana University|Dr. Chie Schin-Shih|317-944-8784|shih2@iu.edu
87220|NCT02598128|Alcresta Therapeutics, Inc.|Russell G. Clayton, D.O., Chief Medical Officer|215.813.5100|rclayton@alcresta.com
87221|NCT02597907|Kyungpook National University|Dr Younghoon Jeon|82534205871|jeon68@gmail.com
87222|NCT02597855|Yeungnam University College of Medicine|Dr. Min Sagong|82-53-620-4191|msagong@ynu.ac.kr
87223|NCT02597582|Taichung Veterans General Hospital|Shih-An Liu|+886-4-23592525 ext 5409|saliu@vghtc.gov.tw
87224|NCT02597543|UCSD|Paul Kim, MD|3104907217|pjk017@ucsd.edu
87225|NCT02596958|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87226|NCT02596945|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87227|NCT02596620|Chang Gung Memorial Hospital, Taiwan|Dr. Wei-Chen Tai|886-975056026|luketai1019@gmail.com
87228|NCT02596451|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com
87229|NCT02595502|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S., F.A.A.O - Senrior Principal Research Optometrist|904-443-1290|BPALL@its.jnj.com
87230|NCT02595450|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87231|NCT02594826|Fox Chase Cancer Center|Dr. Carolyn Fang|1-888-369-2427|carolyn.fang@fccc.edu
87232|NCT02592655|Marcus Migura|Marcus Migura|(619) 436-7323|mwmigura@gmail.com
87233|NCT02591537|Northwestern University|Dr. Robert Galiano, Associate Professor of Surgery|312.695.3908|
87234|NCT02591238|Peking Union Medical College Hospital.|Prof. Changwei Liu. Director of vascular surgery.|+86 1069152509|aresbill@outlook.com
87235|NCT02591056|Regulatory Insight, Inc.|Elvira Cawthon, Clinical Consultant|615-712-9743|elvira@reginsight.com
87236|NCT02590588|Boston Medical Center|Mark Sloan MD|617-638-2367|mark.sloan@bmc.org
87237|NCT02590562|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87238|NCT02588872|Rush University Medical Center|Mukesh Ahuja|312-432-2380|cole.research@rushortho.com
87239|NCT02588599|Arizona Institute of Footcare Physicians|Kerry Zang DPM|480-834-8804|kerryzang@aol.com
87240|NCT02587819|Biosceptre UK|Dr Shaun McNulty|01223496092|shaun.mcnulty@biosceptre.com
87241|NCT02587234|University of Kentucky|Lumy Sawaki, MD, PhD||lumy.sawaki@uky.edu
87242|NCT02587117|B.P. Koirala Institute of Health Sciences|Dr. Ramayan Prasad Kushwaha|977-9842207716|visitramayan007@yahoo.com
118785|NCT01901575|NYU Langone Medical Center|Avrimin M. Kogan, MD|(212) 263-5072|Avrimin.Kogan@nyumc.org
87245|NCT02585999|Boston Medical Center|Dr. Antonella Lavelanet|6174143745|Katharine.White@bmc.org
87246|NCT02585895|Amgen Inc.|Study Director|866-572-6436|
87247|NCT02584686|Department of Andrlolgy, Sexology & STDs, Cairo University|Prof. Dr. Hussein Ghanem, Chairman of Andrology Department|00201001176111|hmhghanem@gmail.com
87248|NCT02584673|The Cooper Health System|Irwin Gratz|856-968-8527|gratz-irwin@cooperhealth.edu
87249|NCT02582983|Hoffmann-La Roche|Medical Communications|800-821-8590|
87250|NCT02582970|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87251|NCT02581475|Shandong University Qilu Hospital|Dr. Yanqing Li|+86-531-82169236|liyanqing@sdu.edu.cn
87253|NCT02580799|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87254|NCT02580357|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br
87255|NCT02580318|St. Luke's University Health Network|Holly Stankewicz, D.O.|610-360-2725|holly.stankewicz@gmail.com
87256|NCT02580240|Subei People's Hospital|QQLv|18051063899|bonhomie2014@163.com
87257|NCT02578992|Tri-Service General Hospital|Dr. Wei-Hung Chan|+886-2-87927128|whcken@gmail.com
87258|NCT02578316|Eisai Inc.|Eisai Medical Services|888-|
87259|NCT02578199|YALE|Dr. Rachel Barnes|203-785-6395|rachel.barnes@yale.edu
87260|NCT02578186|Procter & Gamble|Andrew L. Carr, PhD|513-622-0928|carr.an@pg.com
87261|NCT02577510|CF|Gaurav Gupta|6139451601|gaurav00gupta@gmail.com
87262|NCT02577445|Livanova|Clinical Project Manager|0032498644704|renske.dezwaef@livanova.com
87263|NCT02577315|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
87264|NCT02576639|Novartis Pharmaceuticals|Study Director|862-778-8300|
87265|NCT02576535|NYU Langone Medical Center|Paul Huang|212-263-6414|Paul.Huang@nyumc.org
87266|NCT02576249|Mayo Clinic|Dr. Jacob Sellon|507-255-1141|sellon.jacob@mayo.edu
87267|NCT02576145|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
87268|NCT02576041|Allergology Unit, Azienda Ospedaliero-Universitaria Policlinico di Modena|Patrizia Pepe, MD|+39. 059 4225449|
87269|NCT02575911|Alcon, A Novartis Division|Global Brand Med Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com
87270|NCT02574845|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
87271|NCT02574260|Amgen, Inc.|Study Director|866-572-6436|
87272|NCT02573870|GlaxoSmithKline|GSK Response Center|866-435-7343|
87273|NCT02572752|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
87274|NCT02572609|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
87275|NCT02572427|University of Arkansas for Medical Sciences|Dr Richard Whit Hall|501-680-7894|HallRichardW@uams.edu
87276|NCT02571634|Womack Army Medical Center|Michael Bartoszek, MD|910-907-6000|michael.w.bartoszek.mil@mail.mil
87277|NCT02571153|Pontificia UCSP|Eduardo Toshiyuki Moro||eduardo_moro@terra.com.br
87278|NCT02570425|Sydney Medical School, University of Sydney & Woolcock Institute of Medical Research|Assoc Prof Sinthia Bosnic-Anticevich|+61 2 9114 0040|sinthia.bosnic-anticevich@sydney.edu.au
87279|NCT02570295|Swiss Federal Institute of Sport Magglingen SFISM|Dr. Thomas Wyss|+41 58 467 64 16|thomas.wyss@baspo.admin.ch
87281|NCT02570022|Henry Ford Hospital|Dr. Kelechi Okoroha|8324239895|krokoroha@gmail.com
87282|NCT02569996|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com
87283|NCT02569658|Rush University Medical Center|Yale Fillingham|3095310220|yale.fillingham@gmail.com
87284|NCT02568852|Haseki-156|Dr.Turgut Donmez|00905347400967|surgeont73@hotmail.com
87285|NCT02568384|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com
87286|NCT02568345|Central Hospital, Irmandade da Santa Casa de Misericórdia (ISCM)|Mauro Prado da Silva|+55 11 2176 7000|comissaocientifica@fcmsantacasasp.edu.br
87287|NCT02568254|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan BSc, OD, FAAOPrincipal Research Optometrist|904 443 3449|CColesb@ITS.JNJ.com
87288|NCT02567188|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87289|NCT02565628|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
87290|NCT02565381|Massachusetts General Hospital|Travis P. Baggett, MD, MPH (Principal Investigator)|617-643-9314|tbaggett@mgh.harvard.edu
87291|NCT02563834|Indiana University|Dr. Kieren J Mather|317-278-7826|kmather@iu.edu
87292|NCT02563093|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
87293|NCT02561572|Sheffield Teaching Hospitals NHS Foundation Trust|Dr Matthew Wiles|00441142712381|matthew.wiles@sth.nhs.uk
87294|NCT02559622|Novartis Pharmaceuticals|Study Director|862­-778-­8300|
87295|NCT02559414|New York University School of Medicine|Jeffrey Berger, MD|212 263 4004|Jeffrey.Berger@nyumc.org
87296|NCT02557698|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de
87297|NCT02557646|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87298|NCT02557555|Rutgers New Jersey Medical School|Assistant Professor|4133869415|ajantoni@gmail.com
87299|NCT02556307|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com
87300|NCT02555722|CooperVision Inc.|Senior Manager, Clinical Research|925-730-6754|PChamberlain@coopervision.com
87301|NCT02555618|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
87302|NCT02555228|MOHH Holdings|Dr Song Mingjun|86337635|mingjun.song0950c@gmail.com
87303|NCT02554981|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
87304|NCT02554877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
87305|NCT02553629|Leiden University Medical Center|Prof. Dr. A. Dahan|+31 71 526 2301|a.dahan@lumc.nl
87306|NCT02553512|Proteus Digital Health|Lorenzo DiCarlo MD, Vice-President of Clinical and Medical Affairs|+1 650 637 6199|ldicarlo@proteus.com
87307|NCT02553421|ivWatch, LLC|Jason Naramore|855-485-2824 ext 7019|jason.naramore@ivwatch.com
87308|NCT02552810|University of Valencia|Dr. Luigi Canullo|+39 347 6201976|luigicanullo@yahoo.com
87309|NCT02552303|University of Pennsylvania|Michael Perlis|(215) 746-3577|mperlis@upenn.edu
87310|NCT02551887|Indiana University|Dr. Gregory Zimet|317-274-8812|gzimet@iu.edu
87313|NCT02550197|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
87314|NCT02550132|Université du Québec à Trois-Rivières|Dr Martin Descarreaux DC, PhD|18193765011 ext 3791|martin.descarreaux@uqtr.ca
87315|NCT02549027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
87316|NCT02549014|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
87317|NCT02548156|GlaxoSmithKline|GSK Response Center|866-435-7343|
87318|NCT02547714|Novartis Pharmaceuticals|Study Director|862-778-8300|
87319|NCT02547454|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
87320|NCT02547064|Keimyung university|Hyun-Chang Kim|+821028862876|onidori1979@gmail.com
87321|NCT02545543|Seqirus|Seqirus Clinical Trial Disclosure Lead||Seqirus.ClinicalTrials@Seqirus.com
87322|NCT02545322|Department of Therapeutic Radiology and Oncology, Medical University of Graz|Peter Winkler, PhD (Head of Medical Physics)|+43 316 385 ext 83193|peter.winkler@medunigraz.at
87323|NCT02543918|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|
87324|NCT02543437|Stryker Japan|Yasuyuki Inatsugu, Associate manager of clinical affairs|81 3 6894 8394|yasuyuki.inatsugu@stryker.com
87325|NCT02542943|GlaxoSmithKline|GSK Response Center|866-435-7343|
87326|NCT02542761|Mayo Clinic|Kenton Kaufman, Ph.D.|507-266-0136|Kaufman.Kenton@mayo.edu
87327|NCT02542280|Ain Shams Maternity Hospital|Ahmed Bahaa|+20 1111700556|abahaa0503@yahoo.com
87330|NCT02540850|BioChain (Beijing) Science and Technology, Inc.|Dr. Lele Song|86-10-63401580|songlele@biochainbj.com
87331|NCT02540772|San Rafael University Hospital|Monica Triviño Mosquera|34958275700|monica.trivino@sjd.es
87332|NCT02540447|Mansoura Faculty of Medicine|Amr Mohamed Yassen Ali Badawy|+201001497044|amryassen@hotmail.com
87333|NCT02540434|Weill Cornell Medicine|Michele Steinkamp|2127462953|mls9004@med.cornell.edu
118790|NCT01838655|National Institutes of Health|Brian Brooks, MD, PhD, Principal Investigator, NEI|301-451-2238|brian.brooks@nih.gov
87335|NCT02540265|Recro Pharma, Inc.|Randall Mack|484-395-2470 ext 2406|rmack@recropharma.com
87336|NCT02540213|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87337|NCT02539992|Stryker European Operations BV|Dr. Eric Garling, Director Medical & Scientific Affairs Europe|+31 20 219 2660|eric.garling@stryker.com
87338|NCT02539134|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87339|NCT02539108|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
87340|NCT02537522|Johnson & Johnson Vision Care Inc.|Andrea Le, OD -Manager Global Medical Affairs|904 4431866|ale3@ITS.JNJ.com
87341|NCT02538107|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87342|NCT02537730|Coopervision Japan|Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com
87343|NCT02536781|Khon Kaen University|Faculty of Pharmaceutical Science|+66-43-362092|lsucharat@gmail.com
87344|NCT02536664|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87345|NCT02536313|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
87346|NCT02535741|Stryker European Operations BV|Doug McGurty|+44(0)1635 500690|doug.mcgurty@stryker.com
87347|NCT02535026|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87348|NCT02534324|Faculty of Medicine, Chulalongkorn University|Dr. Khrongwong Musikatavorn|+66818390511|Khrongwong.m@chulahospital.org
87349|NCT02534129|ProTechSure Scientific Inc.|L. Michael Glode, MD|303-526-9031|mike.glode@ucdenver.edu
87350|NCT02533466|GlaxoSmithKline|GSK Response Center|866-435-7343|
87351|NCT02533401|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87352|NCT02533258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
87353|NCT02532998|AstraZeneca AB|AZD9977 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com
87354|NCT02532374|Philip Morris Products S.A.|Loyse Felber Medlin|+41 (58) 242 2686|Loyse.FelberMedlin@pmi.com
87355|NCT02531867|Alexion|Medical Director|(781) 357-9900|clinicaltrials@alexion.com
87356|NCT02531646|Carestream Health, Inc.|Susan Pate, RN, MS, RAC, Senior Clinical Manager|585-627-6557|susan.pate@carestream.com
87357|NCT02531308|Northwestern University|Dr. R Karmali|312-695-0686|reem.karmali@northwestern.edu
87358|NCT02530671|University Kiel|Dr. Sonja Sälzer|00494315972810|saelzer@konspar.uni-kiel.de
87359|NCT02530450|UT Health Science Center in San Antonio|Dr. Maria Rayas, Assistant Professor in Pediatric Endocrinology and Diabetes|210-567-5283|rayas@uthscsa.edu
87360|NCT02529995|AstraZeneca|Global Clinical Lead, Serban Ghiorghiu|+44 1625 512243|
87361|NCT02528721|Exalenz Bioscience|VP of Clinical Affairs|972-8-9737502|melinaa@exalenz.com
87362|NCT02528331|Duke University|Richard Weiner, MD, PhD|919-681-8742|weine002@duke.edu
87363|NCT02528097|NYU Langone Medical Center|The Office of Clinical Trials|646.754.7431|clinicaltrials@nyumc.org
87364|NCT02527161|Stryker SP|Natascha Millard|+61 2 9467 1073|Natascha.Millard@stryker.com
87365|NCT02527148|Stryker South Pacific|Iffat Azeem|+61 2 9467 1166|Iffat.azeem@stryker.com
87366|NCT02526550|Siriraj Hospital|Prof.Kulkanya Chokephaibulkit|662 4195695|kulkanya.cho@mahidol.ac.th
87367|NCT02525536|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
87368|NCT02524665|GlaxoSmithKline|GSK Response Center|866-435-7343|
87369|NCT02524561|Brigham and Women's Hospital|Dr. Rulla Tamimi|617-525-0862|rulla.tamimi@channing.harvard.edu
87370|NCT02524418|University of Florida|Dr. Peter V. Draganov MD|352-273-9472|peter.draganov@medicine.ufl.edu
87371|NCT02524288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118791|NCT01831232|Fred Hutchinson Cancer Research Ctr|Dr, Mazyar Shadman|206-667-5467|mshadman@fredhutch.org
87373|NCT02522624|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu
87374|NCT02520414|Boston Scientific|Meaghan Wilk Clinical Project Manager|5086834113|meaghan.wilk@bsci.com
87376|NCT02519595|Children's Hospital of Michigan|Nirupama Kannikeswaran|313-745-5260|nkannike@dmc.org
87377|NCT02519387|Mundipharma Pharmaceuticals Sdn Bhd|Elayne Chan|+60 122162170|Elayne.Chan@mundipharma.com.my
87378|NCT02518048|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com
118793|NCT01769365|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121 ext 8233|pihsu@isca.vghks.gov.tw
87380|NCT02516163|Stryker SP|Holly Solomon|+61 2 9467 1072|Holly.Solomon@stryker.com
87381|NCT02516150|Massachusetts General Hospital|Courtney Balliro|617-726-1242|cballiro@partners.org
87382|NCT02516098|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
87383|NCT02515994|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D., F.A.A.O. Principle Research Optometrist|904-443-1474|KCANAVA2@its.jnj.com
87384|NCT02515279|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87385|NCT02515045|Carolina Eyecare Physicians, LLC|Helga P. Sandoval, MD, MSCR. Director of Research|8438813937|helga.sandoval@carolinaeyecare.com
87387|NCT02513095|Eagle Pharmaceuticals, Inc.|Adrian Hepner, MD, PhD, Chief Medical Officer|201 326 5300|ahepner@eagleus.com
87388|NCT02512900|MedImmune, LLC|Rene van der Merwe, Senior Director, Clinical Development, Respiratory, and Inflammation|301-398-0000|
87389|NCT02512783|Children's Hospitals and Clinics of Minnesota|Angela Doucette|6128137144|angela.doucette@childrensmn.org
87390|NCT02512679|Children's Hospital Los Angeles|Neena Kapoor, M.D.|343-361-2434|nkapoor@chla.usc.edu
87391|NCT02512393|The University of Texas Health Science Center at Houston|Hyochol Ahn, PhD, ARNP|713-500-2179|Hyochol.Ahn@uth.tmc.edu
87392|NCT02512224|The University of Tokyo Hospital|Dr. Sumito Ogawa|+81-3-5800-8830|suogawa-tky@umin.ac.jp
87393|NCT02511782|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-4762|Pooja.Khandelwal@cchmc.org
87394|NCT02510820|CooperVision|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com
87395|NCT02508103|University of North Carolina at Chapel Hill|Dr. Susan Girdler|919-966-2179|susan_girdler@med.unc.edu
87396|NCT02507752|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
87398|NCT02507375|Hoffmann-La Roche|Medical Communications|800-821-8590|
87399|NCT02506881|BIOCAD|Biryulin Andrey|+7812380 49 33 ext 925|biryulin@biocad.ru
87400|NCT02506309|Brno University Hospital|dr. Martin Huser|+420532233843|huser.martin@fnbrno.cz
87401|NCT02506257|AMC Amsterdam|Dr. IJE van Der Muelen|020 - 566 9111|TtT@amc.uva.nl
87402|NCT02504775|GlaxoSmithKline|GSK Response Center|866-435-7343|
87403|NCT02504723|Kaohsiung Veterans General Hospital|Dr. Wen-Chi Chen|886-7-3422121 ext 2139|wcchen@vghks.gov.tw
87404|NCT02504502|Geisinger Health System|Alanna Kulchak Rahm, PhD|570-214-5093|akrahm@geisinger.edu
87405|NCT02504320|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
87406|NCT02504073|Kantonsspital Baselland Standort Bruderholz|Alexandra Bellwald|0041797429755|alexandra.bellwald@ksbl.ch
87407|NCT02503982|Schneider Children's Medical Center of Israel|Dr. Liat Ashkenazi-Hoffnung|972-3-9253681|LiatA3@clalit.org.il
87408|NCT02503865|Republican Scientific Center for Emergency care at Nazarbayev University|Dr. Kuat Oshakbayev|+77013999141|okp.kuat@mail.ru
87409|NCT02503787|Medtronic Implantable Therapies|Helen Berrier|1-800-633-8766|medtronicneurotrials@medtronic.com
87410|NCT02503254|Philip Morris Products S.A.|Cam Tuan Tran|+41 (58) 242 2620|CamTuan.Tran@pmi.com
87411|NCT02503215|Nephrology Division, University of São Paulo|Dr Bruno Caldin da Silva|5511997620521|brunocaldin@hotmail.com
87413|NCT02502487|West China Hospital, Department of Anesthesiology|Dr. Guizhi Du, Associate professor|+86 18980602213|du_guizhi@yahoo.com
87414|NCT02501590|Head of The Pediatric Neurology and Developmental Unit|Aviva Mimouni-Bloch|97297709048|abloch@clalit.org.il
87415|NCT02500836|STATKING Clinical Services|Lori Christman, PhD|513-858-2989 ext 317|lori@statkingclinical.com
87416|NCT02500758|Universidad Complutense de Madrid|Dr. Ricardo Becerro de Bengoa Vallejo|914590409|ribebeva@enf.ucm.es
87417|NCT02500537|Medtronic|Michelle DiSalvo|774.284.6089|michelle.v.disalvo@medtronic.com
87418|NCT02500368|CooperVision Inc.|Sr. Manager Clinical Research|(925) 730-6754|PChamberlain@coopervision.com
87419|NCT02500056|Tartu University Hospital|Ceith Nikkolo|+37253319082|ceith.nikkolo@kliinikum.ee
87420|NCT02499692|The General Hospital of ShenYang Military|Dr Hanyaling|02428851876|hanyl@medmail.com.cn
87421|NCT02499575|Orthopedic Foot and Ankle Center|Dr. Christopher Hyer|614-895-8747|hyerofac@gmail.com
87422|NCT02498821|Bard Access Systems, Inc.|Gina Gilbert, BSN, RN|407-489-0835|Gina.Gilbert@crbard.com
87423|NCT02498678|Instituto da Criança do Hospital das Clínicas da Universidade de São Paulo|Dr. Ricardo Vieira Carlos|55-11-99911-6677|ricardovieirac@gmail.com
87424|NCT02498522|AinShamsU|Dr. Ahmed kotb|1008681999 ext +20|ahmedmkotp@hotmail.com
87425|NCT02497235|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com
87426|NCT02496533|Midwestern Regional Medical Center, Inc.|Jessica Kapustin, RN-C||Jessica.Kapustin@CTCA-Hope.com
87427|NCT02496221|GlaxoSmithKline|GSK Response Center|866-435-7343|
87428|NCT02496039|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com
87429|NCT02496000|Orange County Research Center|Joel M. Neutel, M. D.|714-541-5591|jmneutel@aol.com
87430|NCT02495948|Alcon, A Novartis Division|Global Medical Affairs Brand Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com
87431|NCT02495831|CROSS REsearch SA|Dr. Milko Radicioni|+41.91.63.00 ext 510|clinic@croalliance.com
87432|NCT02495623|Synthetic Biologics Inc|Christopher T. da Costa|301-417-4364 ext 304|cdacosta@syntheticbiologics.com
87433|NCT02494596|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87434|NCT02494440|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com
87435|NCT02494323|Bet-Loewenstein|Dr.Yaron Sacher|97297709918|ysacher@clalit.org.il
87437|NCT02493127|Massachusetts General Hospital|Taylor Pong, Research Coordinator|617-726-1569|tpong1@partners.org
87438|NCT02493088|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Jérôme SAINT-MARTIN, study director|+33 5 46 45 66 03|jerome.saint-martin@ch-larochelle.fr
87439|NCT02493036|Synthetic Biologics Inc|Christopher T. da Costa|301-417-4364 ext 304|cdacosta@syntheticbiologics.com
87440|NCT02492984|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
87441|NCT02492841|UNIVERSIDAD DE LOS ANDES|Dra. CLAUDIA BRIZUELA CORDERO|562226181166|clau@cibrizuela.com
87442|NCT02492451|Zeynep Kamil Research and Teaching Hospital|Selcuk Selcuk|+905321630488|md_sel@hotmail.com
87443|NCT02492165|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
87444|NCT02491944|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com
87445|NCT02491892|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87446|NCT02490670|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
87447|NCT02490475|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87448|NCT02490293|SeoulStmary's hospital|Tae-ho Hong|010-5206-5266|gshth@catholic.ac.kr
87449|NCT02489799|The Johns Hopkins University School of Medicine|Rebecca Aslakson, M.D., Ph.D.|410-955-9082|raslaks1@jhmi.edu
87450|NCT02488980|Penn State Hershey Infectious Diseases|Jose Stoute, MD|800-243-1455|noemail@no.com
87451|NCT02488317|Arbor Research Collaborative for Health|Dr. Francesca Tentori|7346654108|francesca.tentori@arborresearch.org
87452|NCT02488070|Stanford University|Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu
87453|NCT02488018|Addis Ababa University [Office telephone +251011-655-1927]|Abera Belay (PhD Candidate)|Mobile +251911840655|ab.berabelay@gmail.com
87455|NCT02486952|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87456|NCT02485483|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87457|NCT02485353|IndianaU|Hamid Sayar, MD|317-948-7576|ssayar@iu.edu
87458|NCT02485158|University of Chicago|Dr. Harriet de Wit|773-702-1537|hdew@uchicago.edu
87459|NCT02484911|First Affiliated Hospital of Harbin Medical University|Dr.Zhang|85555068|daxinmay@126.com
87460|NCT02484898|Medtronic CRHF|Medtronic SEEQ Performance Clinical Trial Leader|1-800-328-2518|medtronicCRMtrials@medtronic.com
87461|NCT02484729|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com
87462|NCT02483975|GlaxoSmithKline|GSK Response Center|866-435-7343|
87463|NCT02483611|University of Sao Paulo|Dra Waynice Neiva de Paula Garcia|551636021000 ext 2211|waynicegarcia@gmail.com
87464|NCT02482428|Novartis Pharmaceuticals|Study Director|862-778-8300|
87465|NCT02482129|Alcon, A Novartis Division|Ophthalmology & Medical Lead, Translational Medicine, NIBR|1-888-451-3937|alcon.medinfo@alcon.com
87466|NCT02481934|Hospital universitario 12 de octubre|Alejandra Leivas PhD|+34917792612 ext 4612|alejandraleial@gmail.com
87467|NCT02481219|Given Imaging (a Medtronic company)|Liron Bar Yaakov|+97249097946|liron.bar-yaakov@covidien.com
87468|NCT02480712|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
87469|NCT02480582|University of Leeds|Dr Graham Finlayson|0113 343 7601|g.s.finlayson@leeds.ac.uk
87470|NCT02480439|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
87471|NCT02480166|Stanford University Medical Center|Mindie H. Nguyen, MD, MAS|650-4985691|mindiehn@stanford.edu
87473|NCT02480010|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87474|NCT02479763|Montreal General Hospital|Dr. De QH Tran|514-934-1934 ext 43261|de_tran@hotmail.com
87475|NCT02479412|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com
87476|NCT02479139|Allergan, Inc|Therapeutic Area Head,|1-877-277-8566|IR-CTRegistration@allergan.com
87477|NCT02478671|Terumo Medical Corporation|Robert Gash, Director of Clinical Affairs|732-302-4931|robert.gash@terumomedical.com
118799|NCT01594411|CardioDx, Inc.|EJ Fernandez, MD, CCRP - Sr. Manager Clinical Affairs|650-383-3350|jkuo@cardiodx.com
87479|NCT02478372|Golden Jubilee National Hospital|David McDonald|07914861078|david.mcdonald@nhs.net
87480|NCT02477709|Afferent Pharmaceuticals, Inc.|Chief Medical Officer|650-286-1276|info@afferentpharma.com
87481|NCT02477605|Alcon, A Novartis Division|Brand Lead, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com
87482|NCT02477527|Midtown Medical Center|Edward W Braun, MD|8139353221|Dr.Braun@DrEdwardBraun.com
87483|NCT02477020|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87484|NCT02476617|AbbVie|Global Medical Services|800-633-9110|
87485|NCT02476422|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
87486|NCT02475980|University of New Mexico Health Sciences Center|Nancy Sokkary, MD|email|HSC-FamilyPlanningResearch@salud.unm.edu
87487|NCT02475564|Hospital de Clínicas de Porto Alegre, RS|Dr. Ricardo Francalacci Savaris|+55 51 33598653|rsavaris@hcpa.edu.br
87489|NCT02475278|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87490|NCT02475031|Indiana University School of Medicine - Anesthesia Division|Dr. Yar Yeap|317-274-0275|yyeap@iupui.edu
87491|NCT02474498|Piracicaba Dental School - University of Campinas|Prof.Dr. Enilson Antonio Sallum|+55 19 2106-5301|easallum@fop.unicamp.br
87492|NCT02473991|ain shams university maternity hospital|prof Dr khaled ebrahim abdalla|00201023220701|drkhaled_abdallah@med.asu.edu.eg
87493|NCT02473523|St. Jude Children's Research Hospital|Kirsten Ness, PT, PhD|901-595-5157|kiri.ness@stjude.org
87494|NCT02473510|MedImmune, LLC|Ashwin Swami, MD|+1 301 398 5000|information.center@astrazeneca.com
87495|NCT02473367|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
87496|NCT02472886|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
87497|NCT02472847|University of Illinois at Chicago|Dr. K. Luan Phan|312-355-5954|klphan@psych.uic.edu
87498|NCT02472756|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87500|NCT02472522|Tata Main Hospital, Jamshedpur, India|Specialist, Anaesthesia & Critical Care|91-9431166582|debsanjay@gmail.com
87501|NCT02472366|Hopital Lariboisiere|Professor Pascale Massin|0149 95 24 74|pascale.massin@lrb.aphp.FR
87502|NCT02471755|Guang'anmen Hospital of China Academy of Chinese Medical Sciences|Dr.Xiaoxu Liu|+86 10 8800 1124|liuxiaoxu_lxx@163.com
87503|NCT02471612|Tata Main Hospital|Dr.Deb Sanjay Nag|+91-7763807101|debsanjay@gmail.com
87504|NCT02470949|University of Florida|Michelle Cardel, PhD, RD|(352) 273-9703|mcardel@ufl.edu
87505|NCT02470494|Earlens Corporation|Dr. Suzanne Levy, Director of Clinical Research|650-739-4447|Suzanne.Levy@Earlens.com
87506|NCT02470429|Alcon, A Novartis Division|WW Medical Affairs Director, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com
87507|NCT02470403|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
87508|NCT02469961|Maimonides Medical Center|Piyush Gupta, Director of clinical affairs|718-283-7189|pgupta@maimonidesmed.org
87509|NCT02469597|Northwell Health- Cohen Children's Medical Center|Dr. Kristy Williamson|718-470-7640|kwilliam12@nshs.edu
87510|NCT02469298|GlaxoSmithKline|GSK Response Center|866-435-7343|
87511|NCT02469116|Washington University School of Medicine|David G. Mutch, M.D.|314-362-3181|mutchd@wustl.edu
87512|NCT02468414|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com
87513|NCT02468154|Istituto Ortopedico Rizzoli|Luisa Veronesi|0516366694 ext 0039|cristiana.forni@ior.it
87514|NCT02467777|Fox Valley Orthopaedic Institute|Vishal Mehta|6305841400|vmehta@fvortho.com
87515|NCT02467491|University of Florida|Dr. Vincenzo Valiani|352-2835906|vincio86@gmail.com; v.valiani@ufl.edu
87516|NCT02467075|University of Michigan, Department of Radiology|Matthew Davenport, MD|734-232-2095|matdaven@med.umich.edu
87517|NCT02466425|Shire|Study physician||ClinicalTransparency@shire.com
87518|NCT02466412|Philip Morris Products S.A.|Steffen Fredersdorf|+41 (58) 242 2182|Steffen.Fredersdorf@pmi.com
87519|NCT02465866|Charleston Laboratories, Inc|Chief Commercial Officer|561-748-2007|cliregulatory@charlestonlabs.com
87520|NCT02465632|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com
87521|NCT02465489|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com
87522|NCT02465073|Southwest Regional Wound Care Center|Randall Wolcott|806-793-8869|randy@randallwolcott.com
87523|NCT02463409|Vanderbilt University Medical Center|Dr. Ashley Shoemaker|615-343-8816 ext 615|ashley.h.shoemaker@vanderbilt.edu
87524|NCT02463331|Clinic Hospital of University of Sao Paulo|Lydia Teófilo de Moraes Falcão|55-81-996486935 ext 81|lydiatmf@yahoo.com.br
87525|NCT02463227|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s3.com
87526|NCT02463097|Medtronic Minimed|Thomas Thoub|8185763142|thomas.troub@medtronic.com
87527|NCT02462473|Janssen R&D US|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com
87528|NCT02462291|University of Verona|Massimo Venturelli - PI|+39 02503 14648|massimo.venturelli@univr.it
87529|NCT02461992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
87530|NCT02461693|University of Alabama at Birmingham|Dr. David Allison, PI|205-975-9169|dallison@uab.edu
87531|NCT02461290|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
87532|NCT02460822|University of Michigan|Dr. Lawrence C. An|734-763-6099|lcan@med.umich.edu
87533|NCT02460458|Hematology and Transfusion Medicine, L. Sacco University Hospital Department of Clinical & Community Sciences, University of Milan, Via Pace, 9 20122 Milan, Italy|Prof. Augusto B. Federici|+39-0250319895|augusto.federici@unimi.it
87534|NCT02458768|LG Life Sciences|Jonghee Jin|82-2-6924-3122|jonghee@lgls.com
87535|NCT02458365|Pro-Change Behavior Systems, Inc.|Deborah Levesque, Ph.D.|(401) 360-2975|dlevesque@prochange.com
87536|NCT02457728|St John of God Hospital Vienna|Bernhard Dauser, MD, PhD|+4321121 ext 5098|b.dauser@hotmail.com
87537|NCT02457611|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
87538|NCT02457247|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
87539|NCT02455050|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
87540|NCT02454959|Pearl Therapeutics, Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com
87542|NCT02454296|University of Hawaii|Reni Soon, MD|808-203-6548|rsoon@hawaii.edu
87543|NCT02454283|Laguna Pharmaceuticals|Chief Medical Officer|858-405-1429|hdittrich@imager.com
87544|NCT02454127|Tufts Medical Center|Michael Dansinger, MD|617-636-5000|mdansinger@tuftsmedicalcenter.org
87545|NCT02454101|AinShamsU|ahmed kotb|0100868199 ext +2|ahmedmkotp@hotmail.com
87546|NCT02453581|Qeensland Institute of Medical Research|Dr James McCarthy|+61 7 3845 3796|James.McCarthy@qimr.edu.au
87547|NCT02452944|Department of Anesthesiology, Gachon University Gil Hospital|Mi Geum Lee|82-32-460-3637|mikeum2@gilhospital.com
87548|NCT02451150|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
87549|NCT02450799|Alcon, A Novartis Division|Phase IV, Clinical and Regulatory Affairs, Alcon Japan|1-888-451-3937|alcon.medinfo@alcon.com
87550|NCT02450747|Johnson & Johnson Vision Care Inc.|Tom Karkkainen O.D., M.S., F.A.A.O- Sr. Research Principal Optometrist|904-443-3500 ext 3402|TKarkkai@its.jnj.com
118803|NCT01467427|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com
87552|NCT02449902|TherapeuticsMD|Shelli Graham, PhD|561-961-1900|Shelli.Graham@TherapeuticsMD.com
87553|NCT02449798|Bard Access Systems, Inc.|Gina Gilbert, BSN, RN|407-489-0935|Gina.Gilbert@crbard.com
87554|NCT02449356|Xiangya Hospital|Jiali Shao|+8684327413|zwyfeng@163.com
87555|NCT02449044|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
87556|NCT02448914|LobSor Pharmaceutical AB|Roger Bolsöy, CEO|+46 (0) 72 222 44 08|roger.bolsoy@lsmgroup.se
87557|NCT02448862|Gangnam Severance hospital, Seoul, Korea|Dr. Jae Chul Koh, MD|82-01087023931|aneskoh@yuhs.ac
87558|NCT02448563|Boston Medical Center|Ashley McCarthy, Clinical Research Manager|617-638-5906|ashley.mccarthy@bmc.org
87559|NCT02447458|Takeda|Takeda Study Registration Call Center|+1-877-825-3327|medicalinformation@tpna.com
87560|NCT02447432|GlaxoSmithKline|GSK Response Center|866-435-7343|
87561|NCT02447133|Topcon|Charles Reisman|201-599-5283|CREISMAN@topcon.com
87562|NCT02447029|Stanford University|Klaira Lerma, MPH|(650) 721-1562|klairalerma@stanford.edu
87564|NCT02446717|AbbVie|Global Medical Services|800-633-9110|
87565|NCT02446613|GlaxoSmithKline|GSK Response Center|866-435-7343|
87566|NCT02446496|GlaxoSmithKline|GSK Response Center|866-435-7343|
87568|NCT02446171|AstraZeneca AB|Ian Wogan|+1 301 398 0670|ClinicalTrialTransparency@astrazeneca.com
87569|NCT02446015|Alcon, A Novartis Division|WW Medical Affairs Director, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com
87570|NCT02445755|Stanford University School of Medicine|Vinod K. Bhutani, MD|(650) 723-5711|bhutani@stanford.edu
87571|NCT02445573|Guang’anmen hospital of China Academy of Chinese Medical Sciences|Dr. Huanfang Xu|+86 10 8800 1124|huanfang_xu@126.com
87572|NCT02445287|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com
87573|NCT02445196|Stanford University|Dr. C. Barr Taylor|415-987-1810|btaylor@stanford.edu
87574|NCT02444715|Luxembourg Institute of Science and Technology|Dr. Lübomira Spassova|+352 275 888 1|lubomira.spassova@list.lu
87575|NCT02444533|Mayo Clinic|Dr. Daniel Price|507-293-4395|Price.Daniel@mayo.edu
87576|NCT02444182|Kuwait University - Faculty of Dentistry|Dr. Abrar Alanzi|24636812|aalanzi@hsc.edu.kw
87577|NCT02443792|U of Cape Town|Dr. Justin Shenje|0027788938497|justintshenje@gmail.com
87578|NCT02442804|Brown University|John Bellone, Ph.D.|4012737100 ext 6168|john_bellone@brown.edu
87579|NCT02442700|Ramathibodi Hospital, Mahidol University|Asita Wongprikorn, MD|664236949|wongprikorn@yahoo.com
87580|NCT02442349|AstraZeneca|Global Clinical Lead, Serban Ghiorghiu|+44 1625 512243|
87581|NCT02442310|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com
118805|NCT01410097|Wake Forest University|Stephen B. Kritchevsky, PhD|336-713-8548|skritche@wakehealth.edu
87583|NCT02442271|AbbVie|Global Medical Services|800 633-9110|
87585|NCT02441179|Teleton Institute|Dr. Angela Navarrete-Opazo|+56 0226772075|angelaandrean@gmail.com
87586|NCT02441114|Seoul National University Hospital|Clinical Pharmacology and Therapeutics|82-2-2072-4081|rheesjin@gmail.com
87587|NCT02440659|Arbor Research Collaborative for Health|Francesca Tentori|734-665-4108|christina.pustulka@arborresearch.org
87588|NCT02440633|Otsuka Pharmaceutical Co., Ltd.|Study Director, Yoshitaka Kotobuki, Mr|+81-3-6361-7366|
87589|NCT02440308|Stanford Healthcare|Dr. Andrei Iagaru, Chief of the Division of Nuclear Medicine and Molecular Imaging|650-725-4711|aiagaru@stanford.edu
87590|NCT02439879|Universidad Popular Autonoma del Estado de Puebla|Dr. Hector Garcia Alcala|+522222299400 ext 7466|hector.garcia@upaep.mx
87591|NCT02439164|Beijing Tiantan Hospital|Dr. Nan Lin|861067096658|linnan127@163.com
87592|NCT02439138|Dana-Farber Cancer Institute|Jorge J. Castillo|617-632-6045|jorgej_castillo@dfci.harvard.edu
87593|NCT02438540|Nanjing university of TCM|Dr. Amir Firouzjaei|+989125397047|amirfi@yahoo.com
87594|NCT02438137|UMichigan|Tiffany Braley, M.D., M.S.|734-232-1147|tbraley@med.umich.edu
87595|NCT02437903|Baumann Cosmetic and Research Institute|Leslie Baumann, MD|(305) 531-5788|studies@derm.net
87596|NCT02437513|Protip Medical|Linda Nicolini CEO|0033388103068|l.nicolini@protipmedical.com
87597|NCT02437409|phenox GmbH|Clinical Affairs|+49 (0)234 36 919 ext 0|ARTESp@phenox.info
87598|NCT02437344|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu
87599|NCT02437305|Northwestern Univeristy|Dr. Roopal Kundu|312-926-4926|rkundu@nm.org
87600|NCT02437253|Los Angeles Biomedical Research Institute at Harbor-UCLA|Dr. Lynda Polgreen (PI)|310-222-1961|lpolgreen@labiomed.org
87601|NCT02436811|Universidade Federal do Paraná|Dr Luciana Reichert Assunção Zanon|554133604025|lurassuncao@yahoo.com.br
87602|NCT02436577|AstraZeneca AB|Brilinta Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com
87603|NCT02436330|University of Illinois College of Medicine at Peoria|Dr. Amy L. Christison|309-624-9188|alc@uic.edu
87604|NCT02436304|Alcon, A Novartis Division|Clinical Scientific Director, GCRA|1-888-451-3937|alcon.medinfo@alcon.com
87605|NCT02436031|Brigham and Women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu
87606|NCT02435966|Physios & Universidad Europea de Madrid|Gracia M. Gallego, M.Sc.|+34 609036607|gracia.maria.gallego@gmail.com
87607|NCT02435836|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
87608|NCT02434939|Makerere University ,College of Health Sciences, Department of Anesthesia and Critical care|Dr.Lubega Felix Anthony|+256777756571|falubega@chs.mak.ac.ug
87609|NCT02434523|Boston Medical Center|Dr. Jacob Pieter Noordzij|617-638-8124|Pieter.Noordzij@bmc.org
87611|NCT02433834|Pearl Therapeutics, Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com
87612|NCT02433366|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127 ext +1|clintriage.rdg@boehringer-ingelheim.com
87613|NCT02433340|AbbVie|Global Medical Services|800-633-9110|
87614|NCT02432105|Alcon, A Novartis Division|Clinical Scientific Director, GCRA - Global Clinical Development|1-888-451-3937|alcon.medinfo@alcon.com
87615|NCT02432040|University of the Philippines - Philippine General Hospital Section of Dermatology|Dr. Sharlene Chua|2418118|sharlene_chua@yahoo.com
87616|NCT02431754|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
87617|NCT02431741|Faculty Hospital Kralovske Czech Republic|Prof. Dr. Petr Arenberger|+420 267 16 11 11|avemedica@email.cz
87618|NCT02431598|Duke University Medical Center|Dr. Mustafa Bashir|919-684-8111|mustafa.bashir@duke.edu
87619|NCT02431455|Lahey Hospital and Medical Center|Haddon Pantel|3013566674|Haddon.Pantel@Lahey.org
87620|NCT02431299|Indiana University Purdue University Indianapolis|Dr. Alan B. McGuire|3179882725|abmcguir@iupui.edu
87621|NCT02430870|Takeda|Medical Director Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
87622|NCT02430532|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
87623|NCT02430389|Northwester University|Laura B. Hemmer, M.D.|312-695-0061|l-hemmer@northwestern.edu
87624|NCT02430090|Ankara Numune Training and Research Hospital|Dr. Müge Çakırca|+905054433177|mugeturkoglu81@hotmail.com
87625|NCT02429258|AstraZeneca, PLL|Sergey Zhuplatov MD, PhD|215-542-3222|sergey.zhuplatov@astrazeneca.com
87626|NCT02428478|Brigham and Women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu
87627|NCT02428413|Teleflex|Thomas Philbeck, PhD, MBA, Senior Director of Global Research and Scientific Services|210-581-7778|thomas.philbeck@teleflex.com
87628|NCT02428231|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
87629|NCT02427984|Medical technology laboratory, Rizzoli Orthopaedic Institute|Susanna Stea|00390516366861|stea@tecno.ior.it
87630|NCT02427750|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com
87631|NCT02427477|Johnson & Johnson Vision Care Inc.|John R. Buch, O.D., M.S., F.A.A.O.|904-443-3500 ext 1707|JBUCH@its.jnj.com
87632|NCT02427399|Fenway Health|Dr. Jennifer Potter|617-416-0986|jpotter@bidmc.harvard.edu
87633|NCT02425956|GE Healthcare|Research Manager|262-521-6819|Sandhya.Parameswaran@med.ge.com
87635|NCT02424591|NYU School of Medicine|John Ard, MD|212.263.5072|john.ard@nyumc.org
87636|NCT02424578|Iroko Pharmaceuticals|SVP Medical Affairs, Pharmacovigilance and Medical Information|2675463003 ext 3182|eoimagosie@iroko.com
87637|NCT02424565|GlaxoSmithKline|GSK Response Center|866-435-7343|
87638|NCT02424149|Hartford Hospital|Katie Propst, MD|860-972-4338|katie.propst@hhchealth.org
87639|NCT02423993|Endocrinology Research Centre, Moscow|Dr. Lyudmila Ibragimova|+7 9266180811|doc_mila@mail.ru
87640|NCT02423980|Xeris Pharmaceuticals, Inc.|Martin Cummins, VP Drug Development|512-498-2675|mcummins@xerispharma.com
87642|NCT02423577|President and Chief Scientific Officer|Russell Wilson, PhD|504-896-2789|rbw@autoimmune.com
87643|NCT02423447|Stanford University|Carlos Milla, MD|650-723-5193|cmilla@stanford.edu
87644|NCT02423408|Tonix Pharmaceuticals|Judith Gendreau, Senior Medical Director|858-433-5574|judy.gendreau@tonixpharma.com
87645|NCT02423317|Govt. Medical College, Haldwani.|Dr. Bikramjit Das|8937963828|bikramjit.anesth@gmail.com
87646|NCT02423291|Institute of Hematology “L. e A. Seràgnoli”, AOU Policlinico S.Orsola-Malpighi Via Massarenti, 9 - 40138 Bologna Italy|MD Vittorio Stefoni|+39 0512143680|vittorio.stefoni2@unibo.it
87647|NCT02421211|Janssen Research & Development|Trial Physician, Clinical Development||ClinicalTrialDisclosure@its.jnj.com
87648|NCT02421120|Hartford Hospital|Dr. Joseph L. Kuti, PharmD|860-972-3612|joseph.kuti@hhchealth.org
87650|NCT02420093|University of Michigan Health System|Patricia Connors, PT, DScPT, OMPT|734-763-6464|pattyconnors219@gmail.com
87651|NCT02420041|Naval Medical Center San Diego|LCDR Ian M Fowler, MD|619-532-8954|ian.m.fowler.mil@mail.mil
87653|NCT02419313|Yale-Department of Neurology|Bahman Jabbari M.D , Professor Emeritus- Neurology|914-482-8542|bahman.jabbari@yale.edu
87654|NCT02419001|Synthetic Biologics Inc.|Christopher T. da Costa|301-417-4364 ext 304|cdacosta@syntheticbiologics.com
87655|NCT02418676|State University of Maringá - Paraná - Brazil|Dra. Graciette Matioli|55 44 3011-3868|gmatioli@uem.br
87656|NCT02418468|Novartis Pharmaceuticals|Study Director|862-778-8300|
87657|NCT02418234|Hangzhou first people's hospital|Prof. Shenglin Ma|086057156007664|mashenglin@medmail.com.cn
87658|NCT02418026|Groupe Hospitalier de la Rochelle Ré Aunis|Mrs Sandrine Delavaux|+33 5 46 45 50 50|saniade@msn.com
87659|NCT02417961|AstraZeneca|Mitchell Goldman, Global Clinical Lead Benralizumab|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com
87660|NCT02417753|National Cancer Institute|Dr. Tim Greten|301-451-4723|gretentf@nih.gov
87661|NCT02417532|The Chris Moody Centre|Nick Birch|+44 1604 215440|nickbirch@doctors.org.uk
87662|NCT02417376|GCD Indore|Dr Divya Singh Hada|+918720898289|dr_dshada@yahoo.com
87663|NCT02417129|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
87664|NCT02416973|Regenesis Biomedical Inc.|Heather Vander Ploeg|602-428-7041|Heather.VanderPloeg@regenesisbio.com
87665|NCT02416180|GlaxoSmithKline|GSK Response Center|866-435-7343|
87666|NCT02415959|Abbott|Suntje Sander-Struckmeier|+49 (0) 511 6750 3254|suntje.sander@abbott.com
87667|NCT02415439|ReveraGen BioPharma, Inc.|Eric P. Hoffman, PhD|301-962-1578|eric.hoffman@reveragen.com
87668|NCT02414828|Aeras|Ann Ginsberg, Chief Medical Officer|301-547-2912|aginsberg@aeras.org
87669|NCT02414152|Northwell Health|Dr. Andrea Vambutas|718-470-7550|avambuta@northwell.edu
87670|NCT02413879|Prescient Surgical|Director of Clinical|6504895025|lclaude@prescientsurgical.com
87671|NCT02413593|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
87672|NCT02413333|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com
87673|NCT02413294|University of Michigan|Dr. Amanda Leggett|734-232-0538|leggetta@med.umich.edu
87674|NCT02413203|Univesrity of Pennsylvania|Garret A. FitzGerald|215-898-1185|garret@upenn.edu
87675|NCT02413034|Hospital del Mar|Daniel Pérez-Prieto|0034932483196|dperezprieto@hospitaldelmar.cat
87676|NCT02412657|MaisonneuveRH|Dr Veronique Brulotte|(514)252-3400|veronique.brulotte@umontreal.ca
87677|NCT02411929|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
87678|NCT02411747|Copenhagen Academy for Medical Education and Simulation, Rigshospitalet, Copenhagen University Hospital|Dr. Sarah Bube, director of the CYSTOSIM project|+4561339183|sarahbube@gmail.com
87679|NCT02411539|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
87680|NCT02411292|Division of Plastic Surgery, University of Utah|Dr. Christopher J. Pannucci, M.D., M.S.|801-581-7719|christopher.pannucci@hsc.utah.edu
87681|NCT02411201|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com
87682|NCT02410824|CooperVision Inc.|Sr. Manager Clinical Research|925-730-6754|pchamberlain@coopervision.com
87683|NCT02410291|Sunnybrook Health Sciences Centre|Krista Dawdy, Clinical Educator|416 480 6104|krista.dawdy@sunnybrook.ca
118809|NCT01377441|NYU School of Medicine|Lisa Doan, MD|212.263.5072|lisa.doan@nyumc.org
87686|NCT02406937|Sprim (Shanghai) Consulting Co., Ltd.|Dr. Charlie Zhang|+86 (21) 51097272|charlie.zhang@sprim.cn
87687|NCT02406586|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu
87688|NCT02406495|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com
87689|NCT02405429|University of Iowa|Edward F. Bell, MD|319-356-4006|edward-bell@uiowa.edu
87690|NCT02405390|Nicklaus Children's Hospital|Jose M. Vargas Loayza, M.D.|786-624-3588|jose.vargas-loayza@mch.com
87691|NCT02404649|Harvard School of Dental Medicine|Dr. Kevin Guze|6177210707|kevin_guze@hsdm.harvard.edu
87692|NCT02404545|Baptist Health South Florida - Miami Cancer Institute|Murugesan Manoharan MD, FRCS (Eng), FRACS (Urol)|305-595-2141|mmanoharan@baptisthealth.net
87693|NCT02404493|Johnson & Johnson Consumer, Inc|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com
87694|NCT02403830|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu
87695|NCT02403206|Alcon, A Novartis Division|Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com
87696|NCT02403180|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com
87697|NCT02402933|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
87698|NCT02402764|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hyo Sook Han|813-745-8960|hyo.han@moffitt.org
87699|NCT02402322|Universitat Autonoma de Barcelona|Dr. Pablo Oromendia|+34 665175467|p.oromendia@gmail.com
87700|NCT02402296|Al-Azhar University- Faculty of dental medicine (Girls branch)|Professor Hala Helmi Hazzaa|00201014129297|hala.hazzaa@yahoo.com
87761|NCT02383719|Convergent Engineering|Study Coordinator|3523784899 ext 113|carl@conveng.com
87701|NCT02402127|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com
87702|NCT02401867|Fenway Community Health|Sari Reisner, ScD|617-927-6017|sari.reisner@childrens.harvard.edu
87703|NCT02401555|Bio-Rad Laboratories|David Bhend|425 498 1758|david_bhend@bio-rad.com
87704|NCT02401529|King Fahd General Hospital|Dr Faris Ahmed Bahammam|00966554699544|dr_farisbahammam@yahoo.com
87705|NCT02401464|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87706|NCT02400996|Sir Ganga Ram Hospital, New Delhi, India|Md Tanveer Adil|0091-9830154566|tanveer.cmc@gmail.com
87707|NCT02400710|Center for Integrated Healthcare, Syracuse Veterans Affairs Medical Center|Kyle Possemato, Ph.D.|315-425-4400 ext 53551|kyle.possmato@va.gov
87708|NCT02400346|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com
87709|NCT02400333|AstraZeneca AB|Brilinta Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com
87710|NCT02399345|AbbVie|Global Medical Information|800-633-9110|
87711|NCT02399163|GlaxoSmithKline|GSK Response Center|866-435-7343|
87712|NCT02399111|Northwell Health System|Dr. Kambhampaty Krishnasastry|516-233-3643|kkrishna@northwell.edu
87713|NCT02397915|GlaxoSmithKline|GSK Response Center|866-435-7343|
87714|NCT02397655|Xuanwu hospital, Capital medical university|Dr. Yang Hua|86-10-83198923|dryanghua99@163.com
87715|NCT02397564|University of Louisville|W. James Tidwell|5025831749|wjamestidwell@gmail.com
87716|NCT02396537|University of Alabama at Birmingham|Dr. Christopher Pruitt|2056389587|cpruitt@peds.uab.edu
87717|NCT02396316|Bayer|Therapeutic Area Head||clinical-trials-contact@bayer.com
87718|NCT02396160|University of Queensland|Dr Niikee Schoendorfer|0413122076|n.schoendorfer@uq.edu.au
87719|NCT02396147|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
118810|NCT01352117|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
87721|NCT02395536|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|7635268168|lindsay.k.werder@medtronic.com
87722|NCT02395302|Tactile Medical|Clinical Research Manager|(612)355-5123|mbroich@tactilemedical.com
87723|NCT02395055|BIOCAD|Biryulin Andrey|+7812380 49 33 ext 925|biryulin@biocad.ru
87724|NCT02394925|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO Sr. Principal Research Optometrist|904 443-3402|TKarkkai@its.jnj.com
87725|NCT02394808|Johnson & Johnson Vision Care Inc.|Tawnya Wilson O.D. SR. MANAGER GLOBAL CLINICAL SALES EDU|443-1834|TWilson@ITS.JNJ.com
87726|NCT02394756|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan- PRINCIPAL RESEARCH OPTOMETRIST|1 904 443 3449|CColesb@ITS.JNJ.com
87727|NCT02394665|University of Miami|Fazilat Ishkanian MD, PhD|305-243-4200|f.ishkanian@med.miami.edu
87728|NCT02394457|Naval Medical Center San Diego|Steven Hanling, MD|619-532-8954|steven.r.hanling@mail.mil
87729|NCT02393950|Orion Corporation|Clinical Trials Information Desk|+358104261|clinicaltrials@orionpharma.com
87730|NCT02393677|Govt. Medical College, Haldwani.|Dr. Bikramjit Das|(05946)-228393|bikramjit_81@rediff.com
87731|NCT02393547|Mayo Clinic|Ryan T. Hurt, MD|507-266-1944|nicotineresearch@mayo.edu
87732|NCT02392767|Dr. Loges + Co. GmbH|Dr. Birgit Goyvaerts|0049-4171-707182|goyvaerts@loges.de
87733|NCT02392247|Virginia Commonwealth University|Dr.Bruce Spiess, Principal Investigator|804-828-2267|bruce.spiess@vcuhealth.org
87734|NCT02392208|University of Michigan|Dr. Bruce A. Mueller|734-763-6629|muellerb@med.umich.edu
87735|NCT02391714|Division of Family Planning, University of New Mexico|Sunderjeet Kaur|Email|skaur@salud.unm.edu
87736|NCT02391311|UAB|Pariya L Fazeli, PhD|205-996-0330|plfazeli@uab.edu
87737|NCT02391038|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87738|NCT02390167|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com
87739|NCT02389881|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87740|NCT02389452|Sanofi|Trial Transparency Team||Contact ­-US@Sanofi.com
87741|NCT02389374|Menzies School of Health Research|Benedikt Ley|889468643|benedikt.ley@menzies.edu.au
87742|NCT02389361|ASTES|Dr. DEFLANDRE Eric|0032477764241|eric.deflandre@gmail.com
87743|NCT02389088|University of California, San Diego|Dr. R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu
87744|NCT02388815|Abbott Diabetes Care|Jolyon Bugler, Snr Director Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com
87745|NCT02388763|Alcon, A Novartis Division|GMA Franchise Head - Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com
87746|NCT02387268|M.C.Carmel|Dr.Kobie Dickstein|048250055|kobiedi@clalit.org.il
87747|NCT02388347|MedImmune LLC|Rene van der Merwe||information.center@astrazeneca.com
87748|NCT02388295|AstraZeneca Pharmaceuticals LP|Jamie Mullen MD||Clinicaltrialtransparency@astrazeneca.net
87749|NCT02388191|Planned Parenthood League of Massachusetts|Principal Investigator|6176298603|jfortin@pplm.org
87750|NCT02388074|bioAffinity Technologies Inc.|Bijal Karia, PhD Director of Research|2107485287|bk@bioaffinitytech.com
87752|NCT02387983|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
87753|NCT02387801|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
87754|NCT02387710|Brigham and women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu
87755|NCT02387580|Medicines for Malaria Venture (MMV)|Fiona Macintyre PhD|+41 22 555 0319|Macintyref@mv.org
87756|NCT02387554|Bundang Seoul National University Hospital|Principal Investigator||mekka@snu.ac.kr
87757|NCT02387502|Govt. Medical College, Haldwani.|Dr. Geeta Bhandari|8958267145|bhandari_geetantl@rediff.com
87758|NCT02384538|AbbVie|Global Medical Services|800-633-9110|
87759|NCT02384070|Odessa Heart Institute / Permian Research Foundation|Fernando Boccalandro MD FACC FSCAI|432-3373117|Fboccalandro@echd.org
87760|NCT02383862|Regenstrief Institute|Research Coordintor|317-274-9288|tltalib@regenstrief.org
89185|NCT02080312|UCSD|Julie Bykowski|619-543-6766|jbykowski@ucsd.edu
87762|NCT02383420|Carestream Health, Inc.|Susan Pate, Senior Clinical Affairs Manager|585-627-6557|susan.pate@carestream.com
87763|NCT02382913|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
87764|NCT02382640|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87765|NCT02382133|Barnes-Jewish Hospital|Dr. Marilyn Schallom|314-286-0835|marilyn.schallom@bjc.org
87766|NCT02381678|Guangdong General Hospital|Dr. Huiming Guo (Chief in Cardiac Surgical Department)|86-13609089789|guohuiming@vip.tom.com
87767|NCT02381418|Abbott|Global Clinical Director|+31294477184|serge.vandewitte@abbott.com
87768|NCT02381288|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87769|NCT02380742|Loyola University|Brendan Martin, Biostatistician|708-216-8051|bmartin5@luc.edu
87770|NCT02380287|BIOCAD|Biryulin Andrey|+7812380 49 33 ext 925|biryulin@biocad.ru
87771|NCT02380261|Alcon, a Novartis company|Dir Clinical Operations - LACAR, GCRA|1-888-451-3937|alcon.medinfo@alcon.com
87772|NCT02380248|Alcon, A Novartis Division|Clinical Scientific Associate Director, GCRA-GDD|1-888-451-3937|alcon.medinfo@alcon.com
87773|NCT02379637|Novartis|Dr Marianna Armogida Director Clinical Research Innovation|+41223635182|marianna.armogida@novartis.com
87774|NCT02378961|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
87775|NCT02378506|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
87776|NCT02376998|University Magna Graecia of Catanzaro|Prof. Raffaele Serra|+3909613647380|rserra@unicz.it
87777|NCT02376530|SUNYBuffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu
87778|NCT02375724|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com
87779|NCT02375373|University of Florida|Volker Mai, PhD, MPH|352-273-9398|vmai@epi.ufl.edu
87780|NCT02375347|University of Florida|Volker Mai, PhD, MPH|3522739398|vmai@epi.ufl.edu
118811|NCT01312428|Stryker Orthopedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com
87782|NCT02374398|Eastern Maine Medical Center|Dr. Alexandru Seviciu|207-973-5918|aseviciu@emhs.org
87783|NCT02374346|Attikon Hospital|P. Matsota|00302105831000|matsota@yahoo.gr
87784|NCT02374164|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
87785|NCT02372344|AstraZeneca Pharmaceuticals|Stefan C Carlsson, MD, PhD, Global Clinical Lead|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com
87786|NCT02372097|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87787|NCT02372071|Hadassah Hospital located in Jerusalem, Israel|PROF. BAR-OZ BENJAMIN|02-6774919|baroz@hadassah.org.il
87788|NCT02372058|Albert Einstein Medical Center located in Philadelphia, Pennsylvania, USA|Dr. David L. Schutzman|215-456-6698|schutzmand@einstein.edu
87789|NCT02371876|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com
87790|NCT02371850|University of Maryland School of Pharmacy|Audra Stinchcomb, PharmD|410-706-2646|astinchc@rx.umaryland.edu
87791|NCT02371759|University of Belgrade, Faculty of Dental Medicine|DDS PhD Professor Dragica Stojic, DDS PhD Professor Bozidar Brkovic, DDS PhD Marija Milic|+ 381 11 2685 280 ext 244|brkovic73@yahoo.com
87792|NCT02370914|Stanford University|Dr. Paul Auerbach|(650) 725-9445|auerbach@stanford.edu
87793|NCT02370667|McMaster University|Dr. Monica Maly|905-525-9140 ext 27823|mmaly@mcmaster.ca
87794|NCT02370615|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87795|NCT02370602|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com
87796|NCT02370537|AstraZeneca AB|Stefan Carlsson||Stefan.C.Carlsson@astrazeneca.com
87797|NCT02370407|Johns Hopkins University|Dr. Lauren Thomaier|410-955-6710|lthomai1@jhmi.edu
87798|NCT02370121|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00 ext 34211|esperanzamartnezabundi@yahoo.com
87799|NCT02369796|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87800|NCT02369510|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|Daniel.Katz@MountSinai.org
118812|NCT01299610|GlaxoSmithKline|GSK Response Center|866-435-7343|
87802|NCT02368457|Oral and Maxillofacial Surgeon|Dr. Miriam Martos|+34932746179|miryam.martos@gmail.com
87803|NCT02368314|BIOCAD|Biryulin Andrey|+7812380 49 33 ext 925|biryulin@biocad.ru
87804|NCT02368093|Taichung Veterans General Hospital|Der-Yuan Chen|884-4-23592525 ext 3354|dychen@vghtc.gov.tw
87805|NCT02367885|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
87806|NCT02367872|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87807|NCT02367391|Penn State College of Medicine|Project Coordinator|7175310003 ext 289511|jyingst@phs.psu.edu
87808|NCT02367170|University of Florida|PhD in exercise physiology|352 2736105|UFCT-gov@ufl.edu
87809|NCT02367066|AstraZeneca|Dr. Stanko Skrtic, MD, PhD||ClinicalTrialTransparency@astrazeneca.com
87810|NCT02366936|Duke University Health System|Dr. William Malcolm|919-681-4913|william.malcolm@duke.edu
87811|NCT02366923|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com
87812|NCT02366910|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com
87813|NCT02366767|Stanford School of Medicine|Bruce Buckingham|650-725-9549|buckingham@stanford.edu
87814|NCT02366689|Farid Ayad|Dr. Farid Ayad|416-473-1189|ayad.farid@gmail.com
87815|NCT02366637|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
87816|NCT02366338|Mugla Sitki Kocman University|Ozcan Basaran|+902522120724|basaran_ozcan@yahoo.com
87817|NCT02365688|Duke University Medical Center, Department of Anesthesiology|Timothy Miller MB ChB, FRCA|(+1) 919 6819660|timothy.miller2@duke.edu
87818|NCT02365298|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan|904-443-3449|CColesb@ITS.JNJ.com
87819|NCT02364778|Icahn School Of Medicine at Mount Sinai|Dr. Annapoorna Kini||annapoorna.kini@mountsinai.org
87820|NCT02364700|New York University|Grace Kim PhD, OTR/L|121-998-5846|gjk207@nyu.edu
87821|NCT02364180|The University of Toledo|Shashi Bhatt, MD|419-383-3556|Shashi.Bhatt@utoledo.edu
87822|NCT02363907|Dexcom|Eileen Casal, RN, MSN|8588759774|ecasal@dexcom.com
87823|NCT02363478|Academic Department of Gastroenterology, “LAIKON” General Hospital|Dr. George P. Karamanolis|+30.213.2061307|georgekaramanolis@yahoo.co.uk
87825|NCT02362412|Astellas Pharma Inc.|Vice-President, Japan-Asia Clinical Development Administration||Astellas.resultsdisclosure@astellas.com
87826|NCT02362373|Columbia University|Anne Davis, MD|212-305-4951|ard4@cumc.columbia.edu
87827|NCT02362360|Coloplast|Head of Clinical Operations|0045 49111990|dkcfv@coloplast.com
87828|NCT02362321|CHU de Québec|Principal Investigator|418-649-0252|michel.prudhomme.chuq@gmail.com
87829|NCT02361736|Tianjin Medical University General Hospital|Dr. Yuanyuan Zhang|13821685913|doctorkelly@126.com
87830|NCT02361580|Massachusetts Generla Hospital|Taylor Pong, Research Coordinator||tpong1@partners.org
87831|NCT02360995|Loma Linda University School of Dentistry|Yiming Li, DDS|909-558-8069|yli@llu.edu
87832|NCT02360475|GlaxoSmithKline|GSK Response Center|866-435-7343|
87833|NCT02360124|University of Hong Kong|Prof. E.C.M. Lo|852-2859 0292|edward-lo@hku.hk
87834|NCT02360059|The University of Texas (UT) MD Anderson Cancer Center|Dr. David L. Ramirez, Assistant Professor, Breast Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org
87835|NCT02359955|Shanghai No. 9 People's Hospital|Dr. Haixin Qian|13501961651|drqian8167@126.com
87836|NCT02359903|BIOCAD|Biryulin Andrey|+7812380 49 33 ext 925|biryulin@biocad.ru
87837|NCT02359877|BIOCAD|Biryulin Andrey|+7812380 49 33 ext 925|biryulin@biocad.ru
87838|NCT02359435|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121 ext 8233|pihsu@vghks.gov.tw
87839|NCT02359045|AstraZeneca AB|Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com
87840|NCT02358876|Great Lakes NeuroTechnologies Inc|Biomedical Research Manager|2163615410|dheldman@glneurotech.com
87841|NCT02358668|The Chinese University of Hong Kong|Dr Andrea Luk|852-26324276|andrealuk@cuhk.edu.hk
87842|NCT02358044|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
87843|NCT02357940|Johnson & Johnson Consumer Inc.|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com
87844|NCT02357485|UCLA Medical Center|Peter Fodor, MD|3102039818|pbfodor@centurysurgery.com
87845|NCT02357342|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com
87846|NCT02357264|Maimonides Medical Center|Eitan Dickman, MD|718-283-6057|edickman@maimonidesmed.org
87847|NCT02356900|Duke University Medical School|Richard Moon, MD|919-684-6726|richard.moon@duke.edu
87848|NCT02356588|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com
87849|NCT02355977|Zhejiang University|Dr. Ying Wang|86-571-87217437|wyi1006@sina.com
87850|NCT02355275|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777 ext 838|jslaski@gmail.com
87851|NCT02355158|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com
87852|NCT02354924|Mackay Memorial Hospital_Taipei|Dr. Huey-Chuan Cheng|886-2-25433535|hccheng@ms2.mmh.org.tw
87853|NCT02354833|West Virginia University|Dr. Manuel C. Vallejo, Chair of Department of Anesthesiology|304-598-4929|mvallejo@wvumediciane.org
87854|NCT02354599|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87856|NCT02353754|Pacira Pharmaceuticals Inc.|James B. Jones, MD, PharmD|(973) 254-3560|jim.jones@pacira.com
87857|NCT02353572|University of Colorado|Choon-kee Lee, MD|7208489252|
87858|NCT02353468|University of Colorado|Choon-kee Lee, MD|7208489252|
87859|NCT02353442|São Carlos Fedetal University|Dayana Rosa|+55 16 33066695|dad_rosa@hotmail.com
87860|NCT02352779|University of Rochester Medical Center|Luke J. Peppone, PhD, MPH. Assistant Professor|585-275-7827|Luke_Peppone@urmc.rochester.edu
87861|NCT02352298|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|303-724-6761|satish.garg@ucdenver.edu
87862|NCT02351960|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87863|NCT02351934|Mayo Clinic|Ilya Danelich, Pharm.D., R.Ph.|507-255-5732|Danelich.Ilya@mayo.edu
87864|NCT02351817|Coloplast A/S|Medical Director|+45 4911 1395|dkbir@coloplast.com
87865|NCT02351505|The Ohio State University Comprehensive Cancer Center|Erin Bertino, MD|614-293-8054|Erin.Bertino@osumc.edu
87866|NCT02350881|Casa di Cura VIlla Berica|Dr Stefano Fieschi||stefanofieschi@gmail.com
87867|NCT02350569|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
87868|NCT02349711|Food Science and Human Nutrition Department, University of Florida|Dr. Bobbi Langkamp-Henken|352-294-3721|henken@ufl.edu
87869|NCT02349685|SeoulNUBH|Nayoung Kim|+ 82-31-787-7008|nayoungkim49@empas.com
87870|NCT02349542|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2260|susan.odum@orthocarolina.com
87871|NCT02349451|AbbVie|Global Medical Services|800-633-9110|
87872|NCT02349438|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan, PRINCIPAL RESEARCH OPTOMETRIST|904-443-3449|CColesb@ITS.JNJ.com
87873|NCT02349048|Janssen R&D BE|Associate Director, Medical Department||ClinicalTrialDisclosure@its.jnj.com
87874|NCT02348658|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
87875|NCT02347488|UCLA Department of Anesthesiology|Nir Nahum Hoftman, MD|310-267-8679|nhoftman@mednet.ucla.edu
87876|NCT02347176|MedImmune, LLC|Rene van der Merwe|301-398-4095|information.center@astrazeneca.com
87877|NCT02347085|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com
87878|NCT02347072|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-350-2600|creisner@pearltherapeutics.com
87879|NCT02346877|Amgen Inc.|Study Director|866-572-6436|
87880|NCT02346721|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
87881|NCT02345720|Johnson & Johnson Vision Care Inc.|Tom Karkkainen, OD, MS, FAAO|904-443-3500 ext 3402|TKarkkai@its.jnj.com
87882|NCT02345031|Autifony Therapeutics Ltd|Clinical Project Manager|+44 1438 906860|info@autifony.com
87883|NCT02344745|Keck School of Medicine|Begum Ozel, M.D.|323-226-3416|ozel@usc.edu
87884|NCT02344407|Division of Biostatistics, University of Minnesota|Greg Grandits|612-626-9033|grand001@umn.edu
87885|NCT02344342|University of Michgan Health Systems|Todd Koelling, MD|734-936-5265|tkoellin@med.umich.edu
87886|NCT02343380|University of Turin|Dr Simona Bo|0039116335543 ext 5541|simona.bo@unito.it
87887|NCT02343159|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
87888|NCT02343081|FLENI- mrc (FLENI Multi-specialty Research Center)|Dr. Alejandro Muggeri (Principal Investigator)|54-11-5777 3200 ext 2020|alemuggeri@hotmail.com.ar
87890|NCT02342704|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
87891|NCT02342561|The Orthopaedic Research Unit, Department of Orthopaedic Surgery and Trauma, Odense University Hospital, Denmark|Nikolaj Milandt, Undergraduate researcher|26616611 ext 0045|nikolaj.rongsted.milandt@rsyd.dk
87892|NCT02342535|Northwestern University|Dr. Namratha Kandula|312-503-6470|nkandula@nm.org
87893|NCT02342418|University of Michigan|Manjunath Pai, Associate Professor|7346470006|amitpai@med.umich.edu
87894|NCT02342288|West Virginia University|Dr. Sanford Emery|304-293-1170|semery@hsc.wvu.edu
87895|NCT02342223|VA Northern California Health Care System|Jared Jagdeo, MD, MS|917-837-9796|jrjagdeo@gmail.com
87896|NCT02342197|Kasr El-Aini Hospital|Nawara Mohamed|0223654060 ext 002|nawaram@kasrelaini.edu.eg
87897|NCT02341859|Coopervision Japan|Taku Muraoka, OD, Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com
87898|NCT02341482|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
87899|NCT02341144|Johns Hopkins All Children's Hospital|Nicole Chandler|7277674170 ext 727|nicole.chandler@jhmi.edu
87900|NCT02340338|Biomedizinische Forschungsgesellschaft mbH|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at
87901|NCT02340104|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
87902|NCT02340000|Albany Medical College|Paul Sorum, MD|5182627500|sorump@mail.amc.edu
87903|NCT02339831|Brigham and Women's Hospital|Wolfgang Fitz MD|617-732-9500|wfitz@partners.org
87904|NCT02339584|Enter Alcon, A Novartis Division|Clinical Scientific Associate Director, GCRA, GDD|1-888-451-3937|alcon.medinfo@alcon.com
87905|NCT02339246|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com
87906|NCT02339038|NIH Clinical Center|Masur, Henry|+1 301 496 9320|HMasur@cc.nih.gov
87907|NCT02338713|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87908|NCT02338336|Norwarta|Peggy Hagerty|267-240-4010|hagertymws@comcast.net
87909|NCT02338076|Rockefeller University|Dr. Emma Guttman|212-327-8333|skhattri@rockefeller.edu
87910|NCT02337959|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com
87911|NCT02337062|Acacia Pharma Ltd|Dr Gabriel Fox|44-(0)1223-875130|GabrielFox@acaciapharma.com
87912|NCT02336958|Helios Kliniken Schwerin|Dr. med. Ronald Seidel|0049 (0)385 5204251|ronald.seidel@helios-kliniken.de
87913|NCT02336763|UCLA|Mitchell Kamrava, MD|310-825-9775|mkamrava@mednet.ucla.edu
87914|NCT02336607|Astrazeneca|BP of Astrazeneca|+86 21 60302288|aztrial_results_posting@astrazeneca.com
87915|NCT02336438|Bassett Healthcare Network|Dr. Amy Freeth|607-547-3273|amy.freeth@bassett.org
87916|NCT02336425|Novartis Pharmaceuticals|Study Director|862-778-8300|
87917|NCT02336178|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
87918|NCT02335710|University of Tennessee|Richard D. Komistek, Ph. D.|8659742093|rkomiste@utk.edu
87919|NCT02335502|St. Jude Medical|Roni Diaz|+19723098601|RDiaz@sjm.com
87920|NCT02335489|St. Jude Medical|Roni Diaz|+1 972 309 8601|rdiaz@sjm.com
87921|NCT02334982|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com
87922|NCT02334813|University Hospital Essen, Germany|Prof. Dr. Ulrich Dührsen|+49 201 723 ext 2417|ulrich.duehrsen@uk-essen.de
87923|NCT02334787|Otsuka Pharmaceutical Co., LTD.|Study Director, Department of Clinical Management|+81-3-6361-7366|
87924|NCT02334267|Frenova Renal Research|Brigid Flanagan, MS, RN, CCRC|781-699-2970|Brigid.Flanagan@frenovarenalresearch.com
87925|NCT02332902|The University of Texas Health Science Center at Houston|Dr. Mary Kay Koenig||Mary.K.Koenig@uth.tmc.edu
87926|NCT02332798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
87928|NCT02331940|University of Crete|Director of Clinical Trials|2810394824 ext 0030|izolthi@gmail.com
87929|NCT02331589|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr
87930|NCT02331446|Federal Universisty of Pelotas|Msc. Matheus Pintanel Freitas||matheus.pintanel@hotmail.com
87931|NCT02331108|Albert Einstein Healthcare Network|Jonathan Roth, M.D.|2154567979|rothj@einstein.edu
87932|NCT02330588|Department of Pediatrics, University of Alberta|Dr. Geoff Ball|780-248-5490|gdball@ualberta.ca
87933|NCT02330523|The McGuire Institute|E. Todd Scheyer DDS, MS|713-783-544|etsperio@swbell.net
87934|NCT02330276|Va San Diego Healthcare System|Robert R. Henry, MD|8585528585 ext 3648|rrhenry@outlook.com
87935|NCT02330172|Seoul national university Bundang Hospital|Eunsu Choi|821032990658|potterydoll@hanmail.net
87936|NCT02329964|Korea University Anam Hospital|Seolju Park|+82-10-6314-6013|gursla2@naver.com
87937|NCT02329730|Shanghai Public Health Clinical Center|Shuihua Lu|021-37990333 ext 2582|tubercle@gmail.com
87938|NCT02329600|Faculty of Oral and Dental Medicine Cairo University|Dr. Noha Ayman Ghallab|+201005263365|noha.ghallab@dentistry.cu.edu.eg
87939|NCT02329431|UNC Chapel Hill|Kathleen Thomas|919-966-3387|kathleen_thomas@unc.edu
87940|NCT02329223|Novartis|Study Director|862-778-8300|
87941|NCT02329015|Long Island University|Marshall Hagins PhD, PT|3478048512|mhagins@liu.edu
87942|NCT02328937|Johnson & Johnson Vision Care Inc.|Tawnya Wilson - PRINCIPAL RESEARCH OPTOMETRIST|+1 904 443-1834|TWilson@ITS.JNJ.com
87943|NCT02328404|Hayat Pharmaceutical industries|DR. ALA' ABU RUQA'A|00962 6 4162607 ext 225|tbd@hayatpharma.com
87944|NCT02327429|University of Alberta|Catherine Chan|780-492-9939|cbchan@ualberta.ca
87945|NCT02327117|Isfahan University of Medical Sciences|Amin Nemati|00989131009918|nemati@med.mui.ac.ir
87946|NCT02326844|National Cancer Institute|Dr. Jung-Min Lee|301-443-7735|leej6@mail.nih.gov
87947|NCT02326649|UCSD|Christopher Davis|8589665855 ext 5668|cdavis@rchsd.org
87948|NCT02325856|Department of Nephrology, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan|Lim Paik-Seong|886-4-26581919|jamespslim@gmail.com
87949|NCT02325713|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
87950|NCT02325518|Alcon, A Novartis Division|Novartis Pharma KK|1-888-451-3937|alcon.medinfo@alcon.com
87951|NCT02324673|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com
87952|NCT02324660|Azienda Ospedaliera Universitaria di Ferrara|Gianluca Campo, PI of the study|0532237079 ext +39|cmpglc@unife.it
87953|NCT02322892|Beth Israel Deaconess Medical Center|Dr. Lars W. Andersen|6173886343|larswiuffandersen@gmail.com
87954|NCT02322879|BIDMC|Michael Ganetsky, MD|617-754-2323|mganetsk@bidmc.harvard.edu
87955|NCT02322788|AstraZeneca R&D Gothenburg, SE-431 83 Mölndal, Sweden|Göran Eckerwall, MD, PhD|+46 708467664|goran.eckerwall@astrazeneca.com
87956|NCT02322775|AstraZeneca Research and Development|Mitchell Goldman, Global Clinical Leader Benralizumab|301 398 0323 ext +1|Mitchell.Goldman@astrazeneca.com
87957|NCT02322749|AstraZeneca|Information Centre||Information.centre@astrazeneca.com
87958|NCT02322528|University of Rochester|Dr. James V. Aquavella|585-276-7439|rick_barrett@urmc.rochester.edu
118815|NCT01204255|Virginia Commonwealth University|Thomas J. Smith, MD|804-828-9723|tsmith5@mcvh-vcu.edu
87960|NCT02321527|The University of Texas (UT) MD Anderson Cancer Center|Dr. Basak Dogan/Diagnostic Radiology|713-792-7734|CR_Study_Registration@mdanderson.org
87961|NCT02321436|Ipsen|Medical Affairs Director, Neurology||clinical.trials@ipsen.com
87962|NCT02320838|Universidad de Castilla-La Mancha|Dr. Juan Avendaño Coy|+34 925268800 ext 5014|juan.avendano@uclm.es
87963|NCT02320721|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
87964|NCT02320695|Johnson & Johnson Consumer and Personal Products Worldwide|Christopher Nunez, PhD|973-385-7984|cnunez1@its.jnj.com
87965|NCT02320396|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
87966|NCT02320227|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com
87967|NCT02320214|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com
87968|NCT02319824|Fred Hutchinson Cancer Research Center|Seth Pollack|206-667-6629|spollack@fhcrc.org
87969|NCT02319668|GlaxoSmithKline|GSK Response Center|866-435-7343|
87970|NCT02319525|UAB|Dr. Jasvinder Singh, Principal Investigator|2059343235|jasvinder.md@gmail.com
87971|NCT02319486|Zhongshan Ophthalmic Center, Sun Yat-sen University|Huasheng Yang|+862087331539|yanghs64@126.com
87973|NCT02319148|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
87974|NCT02319031|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com
87975|NCT02318940|Universidad de Chile|Dr. Pietro Pietroboni Fuster|+56982261539|pietroboni@gmail.com
87976|NCT02318693|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
87977|NCT02318303|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com
87978|NCT02317809|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
87979|NCT02317510|Lutfiye NBGH|Dr. Turgut Donmez|00905347400967|surgeont73@hotmail.com
87981|NCT02316769|Vanderbilt University|Bret Alvis|6159365836|bret.d.alvis@vanderbilt.edu
87982|NCT02316678|University of Pennsylvania|James Lewis|215-573-5137|lewisjd@upenn.edu
87983|NCT02316613|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
87984|NCT02316470|Valneva Austria GmbH|Manager Clinical Research|+43120620 ext 0|info@valneva.com
87985|NCT02316366|Nationwide Children's Hospital|Dr. Renee Quarrie, fellow|2037136871|reneepetagae@gmail.com
87986|NCT02315989|Linkou Chang Gung Memorial Hospital|Hong, Ji-Hong M.D.|03-3281200 ext 2600|jihong@cgmh.org.tw
87987|NCT02315352|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
87988|NCT02314689|University of Mississippi Medical Center|Suvankar Majumdar MD|6019845220|smajumdar@umc.edu
87989|NCT02314637|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
87990|NCT02314546|Bassett Healthcare Network|David A. Ullman, MD, Senior Attending Anesthesiologist|607-547-3153|david.ullman@bassett.org
87991|NCT02314520|Penn State Health Milton S. Hershey Medical Center Dept of Neurosurgery|Dr. J. Christopher Zacko|717-531-1279|jzacko@pennstatehealth.psu.edu
87992|NCT02314260|kasr EL alini|Dr Ahmed Kamel|0201120022332|dr.ahmed.m.kamel@gmail.com
87993|NCT02314104|St. Barnabas Medical Center|Dr. Eric Liberman|917-696-1370|eliberma@montefiore.org
87994|NCT02313766|CaenUH|Pr Jean-Luc Hanouz|33 2 31 06 47 36|hanouz-jl@chu-caen.fr
87995|NCT02313558|Guanghua School of Stomatology, Sun Yat-sen University,|Dr. Hongchun Liu|0086-0-13826189071|hongchun751@sina.com
87996|NCT02313233|Kaohsiung Municipal TA- TUNG Hospital|Dr. Ching- Chia Li|886-7-291-1101|
87997|NCT02313155|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
87998|NCT02312739|Division of Family Planning, University of New Mexico|Sunderjeet Kaur|Email|HSC-familyplanningresearch@salud.unm.edu
87999|NCT02312726|University of New Mexico - Family Planning Research Division|Michel Paves, Research Specialist|505-272-9703|mdaliva@salud.unm.edu
88000|NCT02312154|Konkuk University|Yang Won Lee|8220305172|20130112@kuh.ac.kr
88001|NCT02311972|Duke University|Dr. Robin B. Dail|919-684-3786|robin.dail@duke.edu
88002|NCT02311907|Mayo Clinic|Charles L. Loprinzi M.D.|507/284-1623|cloprinzi@mayo.edu
88003|NCT02311881|GlaxoSmithKline|GSK Response Center|866-435-7343|
88004|NCT02311309|CHU de Caen|Dr Jean-Luc Hanouz|2 31 06 47 36 ext 33|hanouz-jl@chu-caen.fr
88005|NCT02310776|Northwestern Medicine|Ellen B. Mendelson, MD, FACR, Lee F. Rogers Professor of Medical Education in Radiology, Profess|3124720436|emendels@nm.org
88006|NCT02310750|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com
88007|NCT02310646|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com
88008|NCT02310581|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com
88009|NCT02310568|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88010|NCT02310126|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, O.D., M.S., F.A.A.O., Sr. Principal Research Optometrist|904-443-3500 ext 3402|TKarkkai@its.jnj.com
88011|NCT02309723|Tufts Medical Center|Dr.Yue Zhong, Project Director of Center for the Evaluation of Value and Risk in Health|6176361424|yzhong@tuftsmedicalcenter.org
88012|NCT02309294|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com
88013|NCT02309112|University of Oxford|Marcy McCall, Lead Researcher|+441865 289300|marcy.mccall@kellogg.ox.ac.uk
88014|NCT02308787|Terumo BCT|Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer-BBT|(303) 231-4357|Ray.Goodrich@terumobct.com
88015|NCT02308748|U.S. Food and Drug Administration|David G Strauss, MD, PhD|301-796-6323|david.strauss@fda.hhs.gov
88016|NCT02308371|University of North Carolina|Dr. Melissa Hines|901-652-6138|mhinesthomas@gmail.com
88017|NCT02308124|SNUH|Jung-Ick Byun|+8224406254|mr830611@gmail.com
88018|NCT02307838|Novartis Pharmaceuticals|Study Director|862-778-8300|
88019|NCT02307552|UC Irvine|Thomas Ahlering, MD|714 456-6068|tahlerin@uci.edu
88020|NCT02307526|James J. Peters VA Medical Center|Jill M. Wecht|7185849000 ext 3122|jm.wecht@va.gov
88021|NCT02307318|HealthEast Care System|Amy Fehrer|651-232-5363|afehrer@healtheast.org
88022|NCT02307266|Galderma|Gaëlle Charier|+33 4 93 95 70 68|gaelle.charier@galderma.com
88023|NCT02307188|Columbia University Medical Center|Abgelo Biviano|212-305-7646|ab542@columbia.edu
88024|NCT02307123|Tampere University Hospital|Toni Pakkanen, MD|358408227209|toni.pakkanen@icloud.com
88025|NCT02306928|Aarhus University Hospital, Department of infectious diseases|Dr. Kristina Öbrink-Hansen|+45 7845 2845|krisoebr@rm.dk
88026|NCT02306759|The Brooklyn Hospital Center|Director, Emergency Medicine Clinical Research Program|718-250-6250|bsin@tbh.org
88027|NCT02305446|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
88028|NCT02305329|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88029|NCT02305316|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88030|NCT02305277|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88031|NCT02305017|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88032|NCT02304926|FISABIO-University Hospital Dr Peset|Dr Antonio Hernández|961622492|hernandez_antmij@gva.es
88033|NCT02304432|McLean Hospital|Dr. Deborah Levy|617-855-2854|dlevy@mclean.harvard.edu
88034|NCT02303743|Hospital Germans Trias i Pujol|Dr. Vicente Lorenzo-Zúñiga García|+34-934978866 ext 8443|vlorenzo.germanstrias@gencat.cat
88035|NCT02303704|Ch. Pervaiz Elahi Institute of Cardiology, Multan, Pakistan.|Dr. Muhammad Sher-i-Murtaza|0333-6107570|sherm.cpeic@gmail.com
88036|NCT02302365|Terumo BCT|Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer-BBT|303-231-4357|ray.goodrich@terumobct.com
118818|NCT01169350|University of Washington|Dr. Janet F. Eary|206-598-6244|jeary@uw.edu
88038|NCT02301936|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
88039|NCT02301429|Medtronic Regional Clinical Center|Clinical Study manager|0039(0)22 241371|laura.manotta@medtronic.com
88040|NCT02301377|University of Michigan|Dr. Aarti Shakkottai|734-764-4123|aartik@med.umich.edu
88042|NCT02300311|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127 ext +1|clintriage.rdg@boehringer-ingelheim.com
88043|NCT02300129|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com
88044|NCT02300103|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
88045|NCT02300025|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com
88046|NCT02299869|CooperVision|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com
88047|NCT02299791|KaiserPermanente Center for Health Research|Rachel Gold|503-528-3902|rachel.gold@kpchr.org
88048|NCT02299635|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88049|NCT02299427|University of Alabama at Birmingham|David Schwebel|205-934-8745|schwebel@uab.edu
88050|NCT02299349|TriHealth Hatton Research Institute|Angela N Fellner PhD CCRP|513-862-2330|Angie_Fellner@trihealth.com
88051|NCT02299258|The First People’s Hospital of Yuhang District|Dr.Ding Shi|+8657189369162|shidingyuhang@163.com
88052|NCT02299076|VAL HEALTH, LLC|Daniel Astrachan|2033769388|dastrachan@valhealth.com
88053|NCT02298868|University of Virginia|Dr. Zachary Henry|434-243-2718|zhenry@virginia.edu
88054|NCT02298842|Terumo BCT|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com
88055|NCT02298361|OCHIN, Inc.|Jennifer E. DeVoe, MD, DPhil|503-943-2618|devoej@ohsu.edu
88056|NCT02298192|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
88057|NCT02297841|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com
88058|NCT02297308|Terumo Medical Corporation|Robert Gash, Director of Clinical Affairs|732-302-4931|robert.gash@terumomedical.com
88060|NCT02295774|Humanitas Research Hospital & Humanitas University|Alessandro Repici MD|00390282247493|alessandro.repici@hunimed.eu
88062|NCT02295020|LSUHSC-NO -Orthopaedic Department|Dr. Vinod Dasa|(504) 412-1700|vdasa@lsuhsc.edu
88063|NCT02294773|Midwest Fertility Specialists or St. Vincent Women's Hospital|Dr. Matt Will or Dr. Lauren Messinger|317-415-7528|laurenmessinger@gmail.com
88064|NCT02294734|GlaxoSmithKline|GSK Response Center|866-435-7343|
88065|NCT02294682|GlaxoSmithKline|GSK Response Center|866-435-7343|
88066|NCT02294604|Shuang Ho Hospital, Taipei Medical University|Dr. Ka-Wai Tam|886-2-22490088 ext 8860|kelvintam@h.tmu.edu.tw
118821|NCT01097304|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu
88068|NCT02294019|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88069|NCT02293538|Alcon Research, Ltd.|Global Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com
88070|NCT02292849|Weill Cornell Medical College|Patrick Raue, Ph.D.|206-543-3807|praue@uw.edu
88071|NCT02292433|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88072|NCT02292212|Asahi Kasei Medical Co., Ltd.|Masaharu Aritomi, Ph.D.||aritomi.mb@om.asahi-kasei.co.jp
88073|NCT02291718|Duke University Medical Center|Dr. Lynne Koweek|919-684-8111|lynne.koweek@duke.edu
88074|NCT02291679|Ironwood Pharmaceuticals, Inc.|Michael Hall, MD|(617) 621-7722|
88075|NCT02291510|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com
88076|NCT02291419|Cleveland Clinic|Dr. Venu Menon|216-445-5390|menonv@ccf.org
88077|NCT02290821|Novartis Consumer Health|Clinical Research Director Pain, CH Clinical Research & Development Lead|+41225672574|
88078|NCT02290509|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064 ext 153|ldunkle@proteinsciences.com
88079|NCT02289989|Rutgers Robert Wood Johnson Medical School|Amy Pappert, MD|732-235-7765|papperas@rwjms.rutgers.edu
88080|NCT02289963|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
88081|NCT02289755|Allena Pharmaceuticals|VP of Clinical Development|617-467-4577 ext 314|akausz@allenapharma.com
88082|NCT02289742|Alcon Research, Ltd.|Global Medical Affairs, Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com
88083|NCT02289469|SAI Interactive|Dr. Dane Boyington|(423) 521-2309|dane@thinkingmedia.com
88084|NCT02289105|Fostering Improvement in End-of-Life Decision Science Program|Dr. Scott Halpern|215-5739461|shalpern@exchange.upenn.edu
88085|NCT02289079|University of MInnesota|Dr. Jacob Hutchins|6126249990|hutc0079@umn.edu
88086|NCT02288364|Duke University Medical Center|Jay A. Baker, MD|919-684-7645|jay.baker@duke.edu
88087|NCT02288312|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88088|NCT02288273|AstraZeneca, PLL|Sergey Zhuplatov MD, PhD|215-542-3222|Sergey.Zhuplatov@astrazeneca.com
118822|NCT01032200|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu
88090|NCT02287779|Shire|Study Physician|1 866-842-5335|
88091|NCT02287623|University of Minnesota|Dr. Jacob Hutchins|612-624-9990|hutc0079@umn.edu
88092|NCT02287610|Horizon Pharma Ireland, Ltd.|Mike Marshall, PharmD|224-383-3000|clinicaltrials@horizonpharma.com
88093|NCT02287415|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88094|NCT02287402|Japan Development Center, Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited|Hitoshi Onouchi|+81-6-6204-5116|hitoshi.onouchi@takeda.com
88095|NCT02287376|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com
88096|NCT02287350|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com
88097|NCT02286518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
118823|NCT01006707|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu
88099|NCT02286102|Hospital for Special Surgery|Oheneba Boachie-Adjei, MD|212 606-1723|rosst@hss.edu
118824|NCT00976352|University of Florida|Dr. Barry Byrne, Professor and Associate Chair|352-273-6563|bbyrne@ufl.edu
88101|NCT02285270|University of Pennsylvania|Daniel Pryma|215-349-5272|daniel.pryma@uphs.upenn.edu
88102|NCT02284880|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88103|NCT02284867|Ain Shams university (AinShamsU)|Ahmed Mohammed Abass , Ass.lecturer in faculty of medicine|002-01066903903|ahmedmams@hotmail.com
88104|NCT02284854|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88105|NCT02284828|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88106|NCT02284555|Destiny Pharma|Director of Projects|+44 (0)1273 704440|medinfo@destinypharma.com
88107|NCT02284516|Shire|Study Physician|1 866-842-5335|
88108|NCT02284386|Pacira|James B. Jones, MD, PharmD|(973) 254-3560|jim.jones@pacira.com
88109|NCT02284347|Medtronic Xomed|Director of Clinical Trials|904-296-9600|dl.nuventstudy@medtronic.com
88110|NCT02284243|Recro Pharma|Randall Mack|484-395-2470 ext 2406|rmack@recropharma.com
88111|NCT02284165|Duke Clinical Resarch Institute|Janet Prvu Bettger, ScD|617-901-0277|janet.bettger@duke.edu
88112|NCT02283840|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88113|NCT02283827|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88114|NCT02283814|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88115|NCT02283788|BIAL – Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|francisco.rocha@bial.com
89304|NCT02058628|GlaxoSmithKline|GSK Response Center|866-435-7343|
118825|NCT00965146|Stryker Orthopaedics®|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com
88117|NCT02282982|AbbVie|Global Medical Services|800-633-9110|
88118|NCT02282813|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com
88119|NCT02282631|Institute of Health and Society, Newcastle University|Dr Samuel Ginja|+44191208 ext 4565|samuel.ginja@newcastle.ac.uk
88120|NCT02282605|Destiny Pharma|Director of Projects|+44 (0) 1273 704440|medinfo@destinypharma.com
88121|NCT02282527|Grifols Therapeutics Inc.|Henry Li|1-919-316-6042|henry.li@grifols.com
88122|NCT02281591|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88123|NCT02281526|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88124|NCT02281448|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88125|NCT02281422|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88127|NCT02281136|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Manager of Clinical Research|9147608796|Anna.Houlihan@sunpharma.com
88128|NCT02280811|National Cancer Institute|Dr. Christian Hinrichs|301-435-3027|hinrichs@nih.gov
88129|NCT02280655|Emory University|Dr. John D. Roback|404-712-1774|jroback@emory.edu
88130|NCT02280499|Smith & Nephew|Evita Leiber, Clinical Study Manager|+41 41 766 2205|evita.leiber@smith-nephew.com
88131|NCT02280473|Allergan plc|Michael Robinson|1-714-246-6415|Robinson_Michael@Allergan.com
88132|NCT02280187|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133 ext 6068|msbkclinicalresearch@medtronic.com
88133|NCT02280122|JWGUniversity|Prof. Dr. Peter Eickholz|+49696301 ext 5642|eickholz@med.uni-frankfurt.de
88134|NCT02279667|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88135|NCT02279420|USGI Medical|Senior Director of Clinical Research|9493693890|samlung@usgimedical.com
88136|NCT02279407|AstraZeneca|Stefan Carlsson||Stefan.C.Carlsson@astrazeneca.com
118827|NCT00891527|Boston Childrens Hospital|Kathy Jenkins MD MPH|6173557275|kathy.jenkins@cardio.chboston.org
88138|NCT02278783|Huntsman Cancer Institute|Theresa Werner|801-587-3486|theresa.werner@hci.utah.edu
88139|NCT02278640|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com
88140|NCT02278614|Laboratoires Théa|Director of Medical Operations|04 73 98 50 89|J.AUGER@laboratoires-thea.fr
88141|NCT02278484|Entellus Medical|Ellen O'Malley|763-463-1598 ext 952|eomalley@entellusmedical.com
88142|NCT02278146|Skyline Urology|Fredrick Wolk, MD|+1 310.602.5005|fred.wolk@skyuro.com
88143|NCT02277691|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88144|NCT02277626|Stanford University|Carlos Milla, MD|650-723-5193|cmilla@stanford.edu
88145|NCT02277249|University of California, Los Angeles|Clinical Instructor - Department of Obstetrics and Gynecology|3107942257|priyabatra@mednet.ucla.edu
88146|NCT02277119|Topcon|Charles Reisman|201-599-5283|CREISMAN@topcon.com
88147|NCT02277093|Washington University School of Medicine|Benjamin R. Tan|314-362-9915|btan@wustl.edu
88148|NCT02276560|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
88149|NCT02276274|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
88150|NCT02275767|Univ of Texas Health Sci Ctr San Antonjio, Dept of Periodontics|Brian L. Mealey DDS, MS|210-567-3567|mealey@uthscsa.edu
88151|NCT02275611|University of North Carolina at Chapel Hill|Dr. Cort A. Pedersen|(919) 966-4447|Cort_Pedersen@med.unc.edu
88152|NCT02275546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
88153|NCT02275481|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com
88154|NCT02275364|GlaxoSmithKline|GSK Response Center|866-435-7343|
88155|NCT02275156|Amgen Inc.|Study Director|866-572-6436|
88157|NCT02274948|Faculty of Medicine, University of Colombo|Prof V Pujitha Wickramasinghe|+94112688748 ext 170|pujithaw@yahoo.com
88158|NCT02274792|Amgen Inc.|Study Director|866-572-6436|
88160|NCT02274675|Universiti Teknologi Malaysia|Project Leader||cfyeong@utm.my
88161|NCT02274558|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com
88162|NCT02273908|Medical Affairs, Pfizer Japan Inc.|Study Director : Koichi Fujii, MD|81-3-5309-9370|koichi.fujii@pfizer.com
88163|NCT02273752|Emory University|R. Donald Harvey, PharmD|404-778-1900|donald.harvey@emory.edu
88164|NCT02273323|Unilever R&D Vlaardingen|Theo Mulder|+31 10 460 8315|theo.mulder@unilever.com
88165|NCT02273310|The Children's Hospital of Philadelphia/Perleman School of Medicine of The University of Pennsylvania|Lamia Barakat, Ph.D.|267-426-8135|barakat@email.chop.edu
88166|NCT02273167|Norgine Ltd|Lucy Clayton|+44-1895-826669|LClayton@norgine.com
88167|NCT02273141|Norgine Ltd|Lucy Clayton|+44-1895-826669|LClayton@norgine.com
88168|NCT02273115|University of Massachusetts - Baystate|Dr. Corina Schoen|4137543470 ext 413|Corina.SchoenMD@baystatehealth.org
88169|NCT02272725|Stanford University School of Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu
88170|NCT02271854|Novartis Consumer Health a GSK Consumer Healthcare company|Director Clinical Research pain category|+413635528|
88171|NCT02271698|Duke University Health System|Dr. Stuart Alan Grant|919-681-6437|stuart.grant@duke.edu
88172|NCT02271529|Cook Research Incorporated|Scott Snyder, Director, Clinical Affairs|765-463-7537|SSnyder@medinst.com
88173|NCT02271477|Ente Ospedaliero Cantonale|Dr. med. Andrea Saporito, Vice-Director of Anaesthesiology|091/811.89.78|andrea.saporito@eoc.ch
88174|NCT02270944|GlaxoSmithKline|GSK Response Center|866-435-7343|
88175|NCT02270684|University of Southern California|Dr Christopher Powers|3234422900|powers@usc.edu
88234|NCT02256488|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com
88176|NCT02270515|University of Illinois, Chicago|Dr. Denise M. Hynes, Professor, College of Medicine|312-355-0083|dhynes@uic.edu
88177|NCT02269709|University of Michigan|Frank W. DiPaola, MD|734-763-9650|dipaolaf@med.umich.edu
88178|NCT02269657|Children's Hospital of Philadelphia|Saba Pasha, PhD|215-590-1815|pashas@email.chop.edu
88179|NCT02269488|MedImmune, LLC, a wholly-owned subsidiary of AstraZeneca PLC|Raburn Mallory|+1 301-398-5799|malloryr@medimmune.com
88180|NCT02269475|CO RIA TA, R&D|Hideo Negi|+81 6 4803 3533 ext 4716|H.Negi@astrazeneca.com
88181|NCT02269098|Medstar Health Research Institute|Michelle F Magee, MD|202-877-0351|michelle.f.magee@medstar.net
88182|NCT02268877|Denver Health and Hospital Authority|Dr. John Kendall|(303)602-5187|John.Kendall@dhha.org
88183|NCT02268864|Janssen Research and Developement, Belgium|Trial Physician||ClinicalTrialDisclosure@its.jnj.com
88184|NCT02268396|Pearl Therapeutics Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com
88185|NCT02268058|McMaster Children's Hospital|Dr. Tina Petrelli|905-521-2100 ext 75162|petrelli@hhsc.ca
88186|NCT02267837|Shaughnessy Orthodontics|Dr. Timothy Shaughnessy|770-495-9590|staff@straightteethdoc.com
88187|NCT02267824|Shaughnessy Orthodontics|Dr. Timothy Shaughnessy|770-495-9590|staff@straightteethdoc.com
88188|NCT02267629|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor, Director of Rodriguez Translational Therapeutics Lab|650-723-6158|cr2163@stanford.edu
88189|NCT02267447|Ottawa Hospital Research Institute|Dr. Doug Manuel|613-798-5555 ext 19108|dmanuel@ohri.ca
88190|NCT02266810|Intersect ENT|James Stambaugh (VP, Clinical Affairs)|650-641-2103|jstambaugh@intersectent.com
88191|NCT02266797|NYU Langone Medical Center|Michael Gerling|(718) 630-8600|Michael.Gerling@nyumc.org
88192|NCT02266472|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127 ext +1|clintriage.rdg@boehringer-ingelheim.com
88193|NCT02266381|The First Affiliated Hospital of Guangzhou Medical University|Dr. Guohua Zeng|0086-20-34294163|gzgyzgh@vip.sina.com
88194|NCT02266277|University of Massachusetts Medical School|Dr. Sarah Cutrona|508-856-3086|sarah.cutrona@umassmed.edu
88195|NCT02265848|Center for Clinical Research / Carolinas Pain Institute|Dr. James North MD|3367656181|jhong@ccrpain.com
88196|NCT02265783|Medtronic|Michael Luna-Victoria|3033052463|michael.luna-victoria@medtronic.com
88197|NCT02265237|AbbVie|Global Medical Information|800-633-9110|
88198|NCT02264977|W.L. Gore & Associates|Jennifer Gorman|928-863-8483|jgorman@wlgore.com
88199|NCT02264821|CHU Brugmann|Dr Madeleine Wilwerth|003224773996|madeleine.wilwerth@chu-brugmann.be
88200|NCT02264249|Cleveland Clinic Florida|Dr. Alison Schneider|954-659-5646|schneia2@ccf.org
88201|NCT02263911|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
88202|NCT02263833|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
88203|NCT02263131|The Catholic University of Korea, Seoul St. Mary’s Hospital|Dr. Kang Jin Han|+82-10-4251-8375|kjhan@catholic.ac.kr
88204|NCT02263118|Ecole Polytechnique|Dr. Jose Tomas Prieto|+50252800643|jose-tomas.prieto@polytechnique.edu
88205|NCT02262754|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-­800­-718­-1021|ClinicalTrials.gov_Inquiries@pfizer.com
118828|NCT00866359|Celgene Corporation|Anne McClain|888-260-1599|ClinicalTrialDisclosure@Celgene.com
88207|NCT02262078|Mayo Clinic|Barry A. Borlaug, MD||Borlaug.Barry@mayo.edu
88208|NCT02262039|Yale University|Dr. Sanjay Kulkarni|203-785-6501|sanjay.kulkarni@yale.edu
88209|NCT02261948|Centro Cardiologoco Monzino|Piergiuseppe Agostoni|02 5800 ext 2772|piergiuseppe.agostoni@ccfm.it
88210|NCT02261818|Johns Hopkins University|Dr Jin Hui Joo|4105502282 ext 410|jjoo1@jhmi.edu
88211|NCT02261493|Allergan, Inc|Tanya Brandstetter|714-246-2567|brandstetter_tanya@Allergan.com
88212|NCT02261467|Allergan, Inc|Tanya Brandstetter|714-246-2567|brandstetter_tanya@Allergan.com
88213|NCT02261428|"Attikon General University Hospital of Athens"|Mr. Konstantinos Grigoriadis ICU Physical Therapist|00302105832489|grigoriakost@gmail.com
88214|NCT02260882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
88216|NCT02260492|Oriel Therapeutics, a Novartis Company|Malinda Longphre PhD, Director Clinical Reserach|9193131290 ext 114|mlongphre@orieltherapeutics.com
88217|NCT02260440|University of Pittsburgh Cancer Institute|James J. Lee, MD, PhD|412-648-6586|leejj@upmc.edu
88218|NCT02260401|University of Washington|Dr. Janna Friedly|206-744-3000|friedlyj@uw.edu
88219|NCT02259608|Radboud UMC|Rob Arts|0031 24 ext 36 67206|rob.jw.arts@radboudumc.nl
88220|NCT02259400|"AOU G. Martino Universitary Hospital of Messina"|Dr. Vincenzo Salvo|+39 0902212132|salvovincenzo@virgilio.it
88221|NCT02259348|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|901-595-2766|brandon.triplett@stjude.org
88222|NCT02258529|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
88223|NCT02258477|University of Colorado, Anschutz Health and Wellness Center|Dr. James Hill|303-724-9974|james.hill@ucdenver.edu
88224|NCT02258412|3M Health Care Business|Clinical Research Specialist|651-736-1578|mdavid@mmm.com
88225|NCT02258334|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
88226|NCT02257918|Louisiana State University Health Sciences Center|Stephanie N. Taylor, MD|(504) 658-2622|staylo2@lsuhsc.edu
88227|NCT02257684|Jazz Pharmaceuticals|Head of Clinical Development|650-496-3777|
88228|NCT02257385|GlaxoSmithKline|GSK Response Center|866-435-7343|
88229|NCT02257372|GlaxoSmithKline|GSK Response Center|866-435-7343|
88230|NCT02256982|Massachusetts General Hospital|Ted Hong, MD|617-726-6050|tshong1@partners.org
88231|NCT02256969|Massachusetts Eye and Ear Infirmary|Assistant Professor of Ophthalmology|617-573-6060 ext 6060|ophthalmologyclinicalresearch@meei.harvard.edu
88232|NCT02256891|Health Partners|Michael Walsh|(952) 831-8742|michael.walsh@tria.com
88233|NCT02256553|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118830|NCT00833989|GlaxoSmithKline|GSK Response Center|866-435-7343|
118831|NCT00753545|AstraZeneca|Elizabeth Lowe||ClinicalTrialTransparency@astrazeneca.com
88236|NCT02256358|Haeundae Paik Hospital, Inje University|Kihwa Lee|82-51-797-0426|tedy333@paik.ac.kr
88237|NCT02256345|UPenn|Julio Chirinos|2158235800|julio.chirinos@uphs.upenn.edu
88238|NCT02256072|Northwestern University Feinberg School of Medicine|Dr. Lee A. Lindquist|312-503-3916|LAL425@md.northwestern.edu
88239|NCT02255565|Dept. of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu
88240|NCT02255279|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com
88241|NCT02255149|University of Michigan|Dr. Hsun-Liang Chan|734-763-3325|hlchan@umich.edu
88243|NCT02254772|Stanford Univeristy Medical Center|Ronald Levy, MD, Professor of Medicine|650-725-6452|levy@stanford.edu
88244|NCT02254551|Sarah Cannon Development Innovations|Charles Davis, Sr Mgr Regulatory Strategy & Operations|615-524-4341|charles.davis2@scri-innovations.com
88245|NCT02254486|Norgine Ltd|Lucy Clayton|+44-1895-826669|lclayton@norgine.com
88246|NCT02254460|GlaxoSmithKline|GSK Response Center|866-435-7343|
88247|NCT02254252|Mashhad University of Medical Sciences|Pouya Nezafati|00989151578421|nezafatip871@mums.ac.ir
88248|NCT02253654|Amgen Inc.|Study Director|866-572-6436|
88249|NCT02253173|TherapeuticsMD|Sebastian Mirkin, MD, Chief Medical Officer|561-961-1900 ext 1952|sebastian.mirkin@therapeuticsmd.com
88250|NCT02253160|Terumo BCT|Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer - BBT|303-232-6800|Ray.Goodrich@terumobct.com
88251|NCT02252016|Merck Sharp & Dohme Corp.|Senior Vice President, Glocal Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
88252|NCT02252965|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
88253|NCT02252744|Western University of Health Sciences|Jasmine Wong Yumori OD FAAO|(909) 706-3886|jyumori@westernu.edu
88254|NCT02252718|Medical University of Warsaw|Katarzyna Wojtyniak|(+48) 223179536|wojtyniakkasia@gmail.com
88255|NCT02252445|Keimyung university|Assistant professor|+821028862876|onidori1979@gmail.com
88256|NCT02252354|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
88257|NCT02252133|Alcon Research, Ltd.|Senior Manager, Clinical Development, Japan|1-888-451-3937|alcon.medinfo@alcon.com
88258|NCT02251912|University of North Carolina at Chapel Hill|Dr. Cort Pedersen|919-923-3284|cort_pedersen@med.unc.edu
88259|NCT02251886|Herning Hospital|Finn Lauszus|+45 78434614|finlau@rm.dk
88260|NCT02251652|Icahn School of Medicine at Mount Sinai|Dr. Gary Goldenberg|212-241-9728|garygoldenbergmd@gmail.com
88261|NCT02251613|Alcon Japan, Ltd.|Hironari Sakaguchi, Phase IV Clinical & Regulatory Affairs, Japan|+81 3 6899 5054|Hironari.Sakaguchi@alcon.com
88262|NCT02251561|Alcon Japan, Ltd.|Director, Clinical & Regulatory Affairs, Division of Medical Affairs||alcon.medinfo@alcon.com
88263|NCT02250807|Janssen R&D BE|Trial Physician||ClinicalTrialDisclosure@its.jnj.com
88264|NCT02250703|University of Mississippi Medical Center|Madhankumar Sathyamoorthy. PI|6018157066|msathyamoorthy@umc.edu
88265|NCT02250274|Marshfield Clinic Research Foundation|Director of the Center for Clinical Epidemiology & Population Health|715-389-3444|belongia.edward@mcrf.mfldclin.edu
88266|NCT02249728|Prana Biotechnology|Dr Dianne Angus|+61 393494906|info@pranabio.com
88267|NCT02249104|Galderma Laboratories L.P.|Dr. Jay Mashburn|817 961 5027|jay.mashburn@galderma.com
88268|NCT02249052|Dr. Zachary E. Gerut|Dr. Zachary E. Gerut, Sponsor/Investigator|516 295-2100|zger@optonline.net
88269|NCT02248818|AstraZeneca LP|Joel Posner MD||ClinicalTrialTransparency@astrazeneca.com
88270|NCT02248766|Optometry Research Group (GIO) University of Valencia|Robert Montes-Mico, O.D., PhD|34-9635-44764|robert.montes@uv.es
88271|NCT02248727|Optometry Research Group (GIO) University of Valencia|Robert Montes-Mico, O.D., PhD|34-9635-44764|robert.montes@uv.es
88272|NCT02248675|VA Center of Excellence for Suicide Prevention|Wilfred R. Pigeon, PhD|(585) 393-7945|wilfred.pigeon2@va.gov
88273|NCT02248558|UNC Project-China|Weiming Tang|+86-15920567132|weimingtangscience@gmail.com
88274|NCT02248480|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
88275|NCT02248246|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com
88276|NCT02248103|Faculty of Oral and Dental Medicine Cairo University|Ass. Prof. Dr. Noha Ghallab|+201005263365|noha.ghallab@dentistry.cu.edu.eg
88277|NCT02247960|University of Rochester|Jean Joseph|585-341-7795|jean_joseph@urmc.rochester.edu
88278|NCT02247765|Medtronic|Michael Luna-Victoria|3034068955|michael.luna-victoria@medtronic.com
88279|NCT02247401|AbbVie|Global Medical Services|800-633-9110|
88280|NCT02247011|Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital,Chinese Academy of Medical Science|Dr. Weibo Xia|86-10-6915-5076|xiaweibo@medmail.com.cn
88281|NCT02246673|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com
88282|NCT02246582|Medtronic Diabtes|Smita Barua, Clinical Trial Manager|818.576.5534|smita.barua@medtronic.com
88283|NCT02246166|GlaxoSmithKline|GSK Response Center|866-435-7343|
88284|NCT02246114|The Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu
88285|NCT02246062|Faculdade de ciências médicas da Santa Casa de São Paulo|Dr Débora de Oliveira Cumino|+55 11 33617333|comissaocientifica@fcmsantacasasp.edu.br
88286|NCT02245412|Alexion|Alexion Medical Monitor|617-613-1071|Bert.Yao@Alexion.com
88287|NCT02245360|Abbott|Dmitri Kazei MD, PhD|+31 294477008|dmitri.kazei@abbott.com
88288|NCT02244840|Seoul National University Hospital|Professor|82-2-2072-2901|kjparkmd@plaza.snu.ac.kr
88289|NCT02244619|Kettering Health Network|Skip Hickman, RPH|(937) 762-1339|skip.hickman@ketteringhealth.org
88290|NCT02244580|Biontech Diagnostics GmbH|Dr. Michael Oed|+49 6131/ 6358030|michael.oed@theracode.de
88291|NCT02243943|LUMC|Prof Dr A. Dahan|+31 71 526 2301|a.dahan@lumc.nl
89305|NCT02058563|GlaxoSmithKline|GSK Response Center|866-435-7343|
88292|NCT02243293|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com
88293|NCT02243280|AbbVie|Global Medical Services|800-633-9110|
88294|NCT02243202|Janssen Research & Development, LLC|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com
88295|NCT02243176|ASTRAZENECA INVESTMENT (CHINA) CO., LTD.|Xia, Zhang|+86 21 6030 2288 ext 2035|Xia.Zhang@astrazeneca.com
88296|NCT02243046|Global Research Consultants|Dr. Franklin Garcia-Godoy|954-888-9102|fgarciagodoy@gmail.com
88297|NCT02243007|Massachusetts General Hospital|David P. Ryan, MD|6177240245|dpryan@mgh.harvard.edu
88298|NCT02242994|Children's National|Dr. Axel Krieger|2024761284|akrieger@childrensnational.org
88300|NCT02242630|Keesler Medical Center|Matthew B. Carroll|228-376-3629|matthew.carroll.1@us.af.mil
88301|NCT02242305|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88302|NCT02242019|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com
88303|NCT02241889|Oregon Health and Science University|Dr. Jessica Castle|503-494-7072|castleje@ohsu.edu
88304|NCT02241785|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
88305|NCT02241486|Loyola University Medical Center|Dr. Joseph R. Holtman|7082168563|jholtman@luc.edu
88306|NCT02241187|Memorial Sloan Kettering Cancer Center|Dr. Kenneth Yu, MD|646-888-4188|YuK1@mskcc.org
88307|NCT02240628|The University of Texas Health Science Center at Houston|Dr. Samia Khalil|713-500-6242|Samia.N.Khalil@uth.tmc.edu
88308|NCT02240589|Indiana University School of Medicine|Flora Hammond, MD|317-329-2106|flora.hammond@rhin.com
88309|NCT02240368|University of Foggia|Alberto Sciusco|0039 3290408320|alberto.sciusco@gmail.com
88310|NCT02240329|University of Florida|Erin Pearson Ph.D CCC/SLP|352-339-4100|epearson@ufl.edu
88311|NCT02239978|Salt Lake City VA|Dr. Daniel Peterson|6028242279|daniel.peterson1@asu.edu
88312|NCT02239926|Mayo Clinic|Dr. Yuri Saito Loftus|507-255-3680|saito.yuri@mayo.edu
88313|NCT02239744|Department of Environmental Health, School of Public Health, Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn
88314|NCT02239692|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
88315|NCT02239679|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|Anna.Houlihan@sunpharma.com
88316|NCT02239289|Université du Québec à Trois-Rivières|Martin Descarreaux|1-819-376-5011 ext 3791|martin.descarreaux@uqtr.ca
88317|NCT02238782|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com
88318|NCT02238379|Yale University|Dr. Helena Rutherford|203-737-3408|helena.rutherford@yale.edu
88319|NCT02238080|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
88320|NCT02238067|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
88321|NCT02238028|Fudan University|Dr. Haidong Kan|+86-021-54237908|kanh@fudan.edu.cn
88322|NCT02237118|Clinique Mutualiste du Medoc|Dr Anne Solanilla|+33 5 56 73 11 43|annasolanilla@yahoo.fr
88323|NCT02237092|Tver Regional Perinatal Center|Dr. Alexandr Ronenson|011-7-4822-776213|ronensonam@gmail.com
88324|NCT02236767|Hartford Hospital|Gretchen Diefenbach|860-545-7396|gretchen.diefenbach@hhchealth.org
88326|NCT02236598|Duke University Health System|Ranee Chatterjee Montgomery, M.D.||ranee.chatterjee@duke.edu
88327|NCT02236546|Vanderbilt-Ingram Cancer Center|Dr. Tom Yankeelov||thomas.yankeelov@utexas.edu
88328|NCT02236130|University of Mississippi Medical Center|Madhankumar Sathyamoorthy|6018157066|msathyamoorthy@umc.edu
88329|NCT02235831|Alcon Research, Ltd.|Sr. Global Brand Lead, GCRA, Vision Care|1-888-451-3937|
88330|NCT02235493|Alexion Pharmaceuticals|Senior Medical Director, Clinical Development|203-272-2596|clinicaltrials@alxn.com
88331|NCT02235454|Duke University|Sanjay Asrani|919-684-8656|sanjay.asrani@duke.edu
88332|NCT02235311|University of Missouri - Columbia|Ashley McCormick, PharmD, BCPS|573-771-7798|ausmusash@health.missouri.edu
88333|NCT02235285|The Department of Plastic Surgery, Winners Clinic|Dr. Cheol Hwan Kim|.+82.2.511.9446|winners511@naver.com
88334|NCT02235077|Duke Clinical Research Institute|Adrian Hernandez, MD|919 668 7515|adrian.hernandez@duke.edu
88335|NCT02235064|Cooper University Health System|Dr. Richard L Fischer|856-342-2491|fischer-richard@cooperhealth.edu
88336|NCT02234479|University of Maryland|Elizabeth Nichols, MD|410-328-2324|enichols1@umm.edu
88337|NCT02234427|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu
88338|NCT02234362|MGH Center for Women's Mental Health|Dr. Marlene Freeman|617-723-6403|mfreeman@partners.org
88339|NCT02234011|McLean Hospital, Biological Psychiatry Laboratory|Dr. Brian Brennan, MD|617-855-2911|bbrennan@partners.org
88340|NCT02233998|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com
88341|NCT02233985|Instituto Mexicano del Seguro Social|Dr. Gloria Patricia Sosa-Bustamante|01 52 4777174800 ext 31828|patriciasosab@hotmail.com
88342|NCT02233842|National Cancer Institute (NCI)|Dr. Stephanie Land|240-276-6946|stephanie.land@nih.gov
88343|NCT02233803|GlaxoSmithKline|GSK Response Center|866-435-7343|
88344|NCT02233647|University of Kentucky|William W. Stoops, Ph.D.|859-257-5388|william.stoops@uky.edu
88345|NCT02233309|University of Nebraska Children's Hospital & Medical Center|Jessica K. Goeller, DO|(402) 955-4303|JGoeller@childrensOmaha.org
88346|NCT02233296|CoLucid Pharmaceuticals, Inc|Head Clinical Operations|(857) 285-6489|clinicaltrials@colucid.com
88348|NCT02232880|Vanderbilt University|David Harrison||david.g.harrison@Vanderbilt.Edu
88349|NCT02232698|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com
88350|NCT02232126|University of Southern California|Dr. Susan Enguidanos|213-740-9822|enguidan@usc.edu
88351|NCT02231918|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88352|NCT02231177|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88353|NCT02231164|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88354|NCT02230995|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88355|NCT02230956|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
88356|NCT02230904|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
88357|NCT02230761|Topokine Therapeutics, Inc.|Chief Scientific Officer|617 203 2034|CSO@topokine.com
88358|NCT02230683|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com
88359|NCT02230670|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com
88360|NCT02230540|Rigshospitalet, Department of Urology|Per Bagi, MD|+45 3545 8310|Per.bagi@regionh.dk
88361|NCT02230085|Fisher & Paykel Healthcare|Clinical Research Scientist|+6495740123|cpaptrial@fphcare.co.nz
88362|NCT02229864|Abbott Vascular|Dana Haudek|928-925-4054|dana.haudek@av.abbott.com
88363|NCT02229539|Mayo Clinic|Robert C. Miller, MD, MS|904-953-1003|miller.robert@mayo.edu
88364|NCT02229513|Baylor University Medical Center|Dr. Janice Mitchell, PI|713-705-6240|janicemitchellmd@gmail.com
88366|NCT02229461|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
118835|NCT00666562|University of Wisconsin|Howard H. Bailey|608-263-8624|hhbailey@wisc.edu
88369|NCT02229318|The Children's Hospital of Philadelphia|Dr Christina Bergqvist, M.D., Study Principal Investigator|+1 215 590 1719|Bergqvist@Email.CHoP.Edu
88371|NCT02228980|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
88372|NCT02228720|Intersect ENT|James Stambaugh|6506412103|jstambaugh@intersectent.com
88373|NCT02228395|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88374|NCT02227810|Chang Gung memorial hospital|Dr Huang Chung-Chi|88632118800 ext 5233|yhchen@mail.cgu.edu.tw
88375|NCT02227485|Shiraz University of Medical Sciences|Dr. Mahsa Rostami-Chijan|+989111960300|mahsa_59_2007@yahoo.com
88376|NCT02227368|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD|+1 302-885-8976|Naeem.Khan@astrazeneca.com
88377|NCT02227121|Medtronic Cardiac Rhythm and Heart Failure|Griet Wouters|800-328-2518|MedtronicCRMtrials@medtronic.com
88378|NCT02227108|MedImmune LLC|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazenea.com
88379|NCT02226562|GlaxoSmithKline|GSK Response Center|866-435-7343|
88380|NCT02226549|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
88381|NCT02226198|AstraZeneca Plc|Robin Mukherjee|+46 31 776 1000|robin.mukherjee@astrazeneca.com
88382|NCT02226003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
88383|NCT02225860|Tufts Medical Center|Ronald D. Perrone|6176362372|rperrone@tuftsmedicalcenter.org
88384|NCT02224820|Dept of Transplant Surgery, Uppsala University Hospital|Dr. Tomas Lorant|+46 70 677 29 01|tomas.lorant@surgsci.uu.se
88385|NCT02224664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88386|NCT02224625|Bioscience Labs|C Beausoleil|406-587-5735|cbeausoleil@bioscience.com
88388|NCT02224404|Universitair Ziekenhuis Gent|Dr. Hilde Beele|09/332 22 87|Hilde.Beele@uzgent.be
88389|NCT02224053|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com
88390|NCT02223871|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com
88391|NCT02223754|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, O.D., M.S., F.A.A.O., Sr. Principal Research Optemtrist|904-443-3500 ext 3402|TKarkkai@its.jnj.com
88392|NCT02223715|Otsuka Pharmaceutical Co., LTD.|Study Director, Yoshitaka Kotobuki, Mr|+81-3-6361-7366|
88393|NCT02223650|Jaeb Center for Health Research|Ray Kraker, M.S.P.H., Director of PEDIG Coordinating Center|(813) 975-8690|rkraker@jaeb.org
88394|NCT02223429|Emory University|Dr. James Rilling|404-727-3062|jrillin@emory.edu
88395|NCT02223364|Mayo Clinic|Dr. Sandra L. Kopp|507-284-6637|Kopp.Sandra@mayo.edu
88396|NCT02223260|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88397|NCT02223065|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484 ext 762 484|Eva.Johnsson@astrazeneca.com
88398|NCT02222870|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
88399|NCT02222818|Medtronic Cardiac Rhythm and Heart Failure|CRTee Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com
88400|NCT02222558|TesoRx Pharma, LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500 ext 104|karl@tesorx.com
88401|NCT02222493|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88402|NCT02222246|Duke University|Dr. Paula Tanabe|919-613-6038|paula.tanabe@duke.edu
88403|NCT02222207|BAYER|Therapeutic Area Head||Clinical-Trial-Disclosure@bayer.com
88404|NCT02222181|Unesp|Fernanda Mariana de Oliveira|+551636640217|femoliveira12@gmail.com
88405|NCT02222129|USAF|Richard Knight, MD|+44 1638 528186|richard_b_knight@yahoo.com
88407|NCT02221648|Yale University School of Medicine|Bahman Jabbari M.D, , Professor of Neurology|203-737-2464|bahman.jabbari@yale.edu
88408|NCT02221557|Sunstar Americas, Inc.|Akane Takemura, R&D Senior Manager|847-794-4276|akane.takemura@us.sunstar.com
88409|NCT02220998|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
90628|NCT01876368|Novartis Pharmaceuticals|Study Director|862-778-8300|
88410|NCT02220920|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
88411|NCT02220764|Zahnärztliche Prothetik|Dr. Konstantinidis Ioannis|+49 351 458 4231|ioannis.konstantinidis@uniklinikum-dresden.de
88412|NCT02220205|Beth Israel Deaconess Medical Center|Siripanth Nippita|617-667-4165|snippita@bidmc.harvard.edu
88413|NCT02219997|Alcon Research, Ltd.|Global Brand Med Affairs Lead, VGR|1-888-451-3937|alcon.medinfo@alcon.com
88414|NCT02219932|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
88415|NCT02219685|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
88416|NCT02219516|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com
88417|NCT02219503|AbbVie|Global Medical Services|800-633-9110|
88418|NCT02219477|AbbVie|Global Medical Services|800-633-9110|
88419|NCT02219464|Vanderbilt University Medical Center|Cindy Pastern, RN BSN CCRP|615-343-0259|cindy.pastern@vanderbilt.edu
88420|NCT02219282|DorkuzEU|Semih Kucukguclu|902324125707|semih.kucukguclu@gmail.com
88421|NCT02219256|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88423|NCT02217280|Missouri Orthopaedic Institute|Dr. Christina Goldstein|573-884-9022|goldsteincl@health.missouri.edu
88424|NCT02218307|University of Miami|Dr. Roy Casiano|305-243-1870|rcasiano@miami.edu
88425|NCT02218268|University of Florida|Michael Haller|352-265-0111|hallemj@peds.ufl.edu
88426|NCT02218216|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com
88427|NCT02217982|Rocky Mountain MS Research Group|Tammy Hoyt|8014085711|thoyt@rmmsc.com
88428|NCT02217878|Collegium Medicum, Nicolaus Copernicus University|Prof. Jacek Kubica|+485854023|jkubica@cm.umk.pl
88429|NCT02216695|Derby Teaching Hospital NHS Trust|Nitin V Kolhe|01332788266|nitin.kolhe@nhs.net
88430|NCT02216591|Duke University School of Medicine|Dr. Sheri Towe|919-668-4030|sheri.towe@duke.edu
88431|NCT02216422|AbbVie|Global Medical Services|800-633-9110|
88432|NCT02216357|Cumberland Pharmaceuticals Inc.|Senior Manger, Clinical Operations|615-255-0068 ext 250|bkaelin@cumberlandpharma.com
88433|NCT02216097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88434|NCT02215954|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
88435|NCT02215252|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88436|NCT02214615|VAMC and Yale University|Stephen Waxman|203-937-3802|stephen.waxman@yale.edu
88437|NCT02214238|Fisher & Paykel Healthcare|Clinical Research Scientist|+6495740123|cpaptrial@fphcare.co.nz
88438|NCT02214225|Seqirus|Seqirus Clinical Trial Disclosure Lead||Seqirus.ClinicalTrials@Seqirus.com
88439|NCT02214186|Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo|M.D. Wallace Andrino da Silva|+551126616787|wallaceandrino@yahoo.com.br
88440|NCT02213900|Indiana University|Babar Khan, MD|317-274-9132|bakhan@iu.edu
88441|NCT02213666|Beth Israel Deaconess Medical Center|Elad Anter, MD|617-632-9209|eanter@bidmc.harvard.edu
88442|NCT02213510|UC San Diego School of Medicine|Ulrika Birgersdotter-Green, MD|858-657-5310|ubgreen@ucsd.edu
88443|NCT02213250|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|(001)8007181021|ClinicalTrials.gov_Inquiries@pfizer.com
88444|NCT02213198|UTHSCSA|Dr. Dawn Velligan|210-567-5508|velligand@uthscsa.edu
88445|NCT02213055|The Deirdre Imus Environmental Health Center at HackensackUMC|Project Manager, Environmental Research|551-996-8071|dimuscenter@hackensackumc.org
88446|NCT02212977|Duke University Medical Center|Dr. Charles Kim|9196847424|charles.kim@duke.edu
88448|NCT02212457|GlaxoSmithKline|GSK Response Center|866-435-7343|
88449|NCT02212301|Johnson & Johnson Vision Care Inc.|Tawnya Wilson OD|904-443-3500 ext 1834|TWilson@ITS.JNJ.com
88450|NCT02212197|Camurus AB|Clinical Trial Manager||info@camurus.com
88451|NCT02212106|bioCSL PTY LTD|Clinical Program Director||bioCSL.ClinicalTrials@biocsl.com.au
88452|NCT02212028|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu
88453|NCT02210208|Mölnlycke Health Care|Channing Wood|+1 470 375 0186|channing.wood@molnlycke.com
88454|NCT02210195|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu
88456|NCT02210052|Mayo Clinic|Dr. Tim J. Lamer, M.D.|507 778-8760|lamer.tim@mayo.edu
88457|NCT02209766|CO RIA TA, R&D|Hideo Negi|+81 6 4803 3533 ext 4716|H.Negi@astrazeneca.com
88458|NCT02209506|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88459|NCT02209454|Menarini Ricerche S.p.A.|Corporate Director of Clinical Research|0555680 ext 9990|acapriati@menarini-ricerche.it
88460|NCT02209181|McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.|Joseph Aquilina, MD, Senior Director, Clinical Research|(215) 273-8025|JAquilin@its.jnj.com
88461|NCT02209064|EpiEP|Pam Bunes CEO & Founder|+1 864 423 2526|pbunes@epiep.com
88462|NCT02208310|University of Michigan|Peter Higgins|7346472964|phiggins@umich.edu
88463|NCT02207907|GlaxoSmithKline|GSK Response Center|866-435-7343|
88464|NCT02207829|GlaxoSmithKline|GSK Response Center|866-435-7343|
88465|NCT02207608|University of Rome Tor Vergata|Prof. Enrico Finazzi Agro|+393296152920|efinazzi@tin.it
88466|NCT02207478|Shanghai Chest hospital|Dr. Jiayuan Sun|+86 18017321598|jysun1976@163.com
88467|NCT02207413|GlaxoSmithKline|GSK Response Center|866-435-7343|
88468|NCT02207400|GlaxoSmithKline|GSK Response Center|866-435-7343|
88469|NCT02206776|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|650-723-4095|ocdresearch@stanford.edu
88470|NCT02206607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88591|NCT02180893|NYU Langone Medical Center|Peter Neuberger|212 263 5821|Peter.Neuburger@nyumc.org
121200|NCT03010800|Oklahoma University Health Science Center|Dr. Robert Hurst|405-271-3930|Robert-Hurst@ouhsc.edu
88471|NCT02205814|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680 ext 9990|acapriati@menarini-ricerche.it
88472|NCT02205476|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88473|NCT02205333|MedImmune, LLC|Victoria Chiou|301-398-4330|chiouv@MedImmune.com
88474|NCT02204748|The University of Tennessee|Adrija Sharma, Ph. D.|8659742093|asharma1@utk.edu
88475|NCT02204657|University Malaya Medical Centre|Dr Sharmila SP|60379492299|sharmsp13@gmail.com
88476|NCT02204579|Shire|Study Physician|1 866-842-5335|
88477|NCT02204449|UHN Toronto|Dr. Sherry Grace|416.736.2100 ext 22364|sgrace@yorku.ca
88478|NCT02204410|Massachusetts General Hospital|Dr. Timothy Wilens|(617)643-3481|twilens@mgh.harvard.edu
88479|NCT02204371|GlaxoSmithKline|GSK Response Center|866-435-7343|
88480|NCT02204319|ProHealth Care|Linda LaBorde PT|262-928-5139|linda.laborde@phci.org
88481|NCT02204007|Cleveland Clinic Foundation|Dr. Carlos A Higuera, MD|2166361136|higuerc@ccf.org
88482|NCT02203916|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88483|NCT02203786|Centre for Addiction and Mental Health|Dr. Daniela Lobo, Qualified Investigator for Study, Clinician-Scientist|416-535-8501 ext 36568|Daniela.Lobo@camh.ca
88484|NCT02203747|Abbott Medical Optics|Carrie Garufis|714-566-3728|carrie.garufis@abbott.com
88485|NCT02203721|Abbott Medical Optics|Kendra Hileman, Ph.D., Director of Clinical Research and Development|714-247-8613|kendra.hileman@abbott.com
88486|NCT02203578|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu
88487|NCT02203565|Stanford University School of Medicine|Dr. Kathleen Horst|6507256009|kateh@stanford.edu
88488|NCT02203162|Montefiore Medical Center|Peter Dicpinigaitis, MD|718-904-2676|pdicpini@montefiore.org
88489|NCT02203149|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
88490|NCT02203032|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com
88491|NCT02202785|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88492|NCT02202759|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88493|NCT02202538|Parker Hannifin Corporation|Ryan Farris|(216) 896-3335|ryan.farris@parker.com
88494|NCT02202252|Diskapi Training and Research Hospital|Melih Akinci, MD, Associate Prof|90 312 5962080|melihakinci@yahoo.com
88495|NCT02202135|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com
88496|NCT02201953|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
88497|NCT02201940|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
88498|NCT02201901|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
88499|NCT02201784|Jawaharlal Nehru Medical College, AMU, Aligarh, India|Dr. Manazir Athar|+918868056469|drmanazirathar@gmail.com
88500|NCT02201524|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com
88501|NCT02201446|Department of Burn Surgery, Changhai Hospital, The Second Military Medical University, Shanghai, People’s Republic of China|Guo-sheng Wu|+86 18019359841|drwuguosheng@sina.cn
88502|NCT02201420|Navidea Biopharmaceuticals, Inc.|Dr. Frederick O. Cope, Chief Scientific Officer|614-793-7500 ext 140|fcope@navidea.com
88503|NCT02201056|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88504|NCT02200536|Damascus University|Assistant Professor Easter Joury|00963955650456|easterjoury@icloud.com
88505|NCT02200458|Christie Medical Holdings, Inc.|Clinical Affairs Manager|901-721-0330|christiemedinfo@christiedigital.com
88506|NCT02200328|Cleveland Clinic Florida|Dr.Alison Schneider|9546595646|schneia2@ccf.org
88507|NCT02199717|Hospital for Sick Children|Vanessa Bouskill NP|4168135871|vanessa.bouskill@sickkids.ca
88508|NCT02199574|Pacira Pharmaceuticals Inc.|James B. Jones, MD, PharmD|(973) 254-3560|jim.jones@pacira.com
88509|NCT02199509|National Institutes of Health|Dr. Mark Hallett||hallettm@ninds.nih.gov
88510|NCT02198963|Mercury Street Medical|Dr. John Pullman|(406) 723-1375|john.pullman@mecurystmed.com
88511|NCT02198833|Baylor College of Medcine|Rabih Darouiche, MD|713-794-8858|rabihd@bcm.edu
88512|NCT02198430|Real Fundación Victoria Eugenia|Dr. Rubén Cuesta-Barriuso|+34913146508|ruben.cuestab@gmail.com
88513|NCT02198235|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu
88514|NCT02198040|Universidad de Murcia|Rubén Cuesta-Barriuso, PhD|+34 913146508|ruben.cuestab@gmail.com
88515|NCT02197806|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
88516|NCT02197455|Yale Univ School of Medicine|Brett King, MD|2037854092|brett.king@yale.edu
88517|NCT02197273|OhioHealth|Deborah Napier|614-566-5575|Deborah.Napier@ohiohealth.com
88519|NCT02197234|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com
88520|NCT02197065|Hospital for Special Surgery|Anne R. Bass, MD|212-774-7043|bassa@hss.edu
88521|NCT02196766|Coopervision Japan|Taku Muraoka, OD, Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com
88522|NCT02196714|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com
88523|NCT02196675|Ethicon|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com
88524|NCT02196259|University of Michigan|Dr. Scott Peltier|734-647-8077|spelt@umich.edu
88525|NCT02196168|London Health Sciences centre|Dr.Eric Winquist|519-685-8500|Winquist@lhsc.on.ca
88526|NCT02196077|Pearl Therapeutics Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com
88528|NCT02195713|Theranova, LLC|Devyani Nanduri|415-926-8616|dnanduri@theranova.com
88529|NCT02195687|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
88530|NCT02195583|GlaxoSmithKline|GSK Response Center|866-435-7343|
88592|NCT02180828|Peking University|Shangrong Fan|860755-83923333 ext 5502|fanshangrong@163.com
121583|NCT01556100|Chang Gung Memorial Hospital|Dr. kun-Ju Lin|033281200 ext 2632|lin4857@adm.cgmh.org.tw
88531|NCT02195414|The General Hospital of Shenyang Military Region|Yaling Han, Study Chair of Clinical Trials|+86-024-28856123|hanyaling@263.net
88532|NCT02194621|RBHS-Rutgers School of Dental Medicine, Oral Biology Department|Daniel Fine, DMD|973-972-3728|finedh@sdm.rutgers.edu
88533|NCT02194088|Brigham and Women's Hospital|Edwards Robert|617-732-9486|rredwards@partners.org
88534|NCT02194062|Yale School of Medicine|Paul Neubauer|2037855430|paul.neubauer@yale.edu
88535|NCT02193828|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
88536|NCT02193815|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88537|NCT02193178|CooperVision, Inc.|Sr. Manager, Clinical Research|9257306754|pchamberlain@coopervision.com
88538|NCT02193165|Colgate Palmolive|William Devizio|732-878-7901|william_devizio@colpal.com
88539|NCT02193087|Takeda|Medical Director Clinical Science, Study Official|+1-877-825-3327|trialdisclosures@takeda.com
88540|NCT02193074|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
88541|NCT02192879|Duke University Medical Center|Elizabeth Malinzak, MD|919-681-9660|elizabeth.malinzak@duke.edu
88542|NCT02192814|UCB Pharma|UCB Clinical Trial Call Center|+1877 822 ext 9493|
88543|NCT02192684|Stanford Universtiy|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu
88544|NCT02192606|Brigham and Women's Hospital|Jon I. Einarsson|617-732-5500|jeinarsson@partners.org
88545|NCT02192164|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88546|NCT02191865|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127 ext +1|clintriage.rdg@boehringer-ingelheim.com
88547|NCT02191046|Thammasat university|Dr.Araya Satdhabudha|0813414900 ext 662|araya221@gmail.com
88548|NCT02191033|Yale University|Deepa Camenga, MD|203-737-8310|deepa.camenga@yale.edu
88549|NCT02190604|Novartis|Study Director|862-778-8300|
88550|NCT02190591|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com
88551|NCT02190435|William Beaumont Hospital|Denise Koueiter, MS|248-551-5166|denise.koueiter@beaumont.org
88552|NCT02189954|DorkuzEU|Anaesthesiology and Reanimation, Dr. Sule Ozbilgin|0905055252901|ozbilginsule@gmail.com
88553|NCT02189941|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com
88554|NCT02189915|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu
88555|NCT02189863|Alcon Research, Ltd.|Global Brand Lead, Global Medical Affairs, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com
88557|NCT02189759|University of Alabama at Birmingham|Manimaran Ramani|2054731425|mramani@peds.uab.edu
88558|NCT02189317|Emory University|John W Xerogeanes, MD|404-778-7202|jxeroge@emory.edu
88559|NCT02189252|AstraZeneca AB|Hong Yang, Study Statistician|+46-(0)317762397|hong.yang1@astrazeneca.com
88560|NCT02189161|Laser Surgery Care|Dr. Stephen E. Goldstone, MD|212-242-6500|segmd@prodigy.net
88561|NCT02189122|VANDERBILT UNIVERSITY MEDICAL CENTER|Nancy J. Brown, M.D.|6153438701|nancy.j.brown@vanderbilt.edu
88562|NCT02188849|Institute of Nutrition and Food Technology University of Chile|Sandra Hirsch MD|+56 229781485|shirsch@inta.uchile.cl
88563|NCT02188784|Duke Clinical Research Institute|Dr. Adrian Hernandez|919-668-7515|adrian.hernandez@duke.edu
88564|NCT02188589|Spirox|Chief Operating Officer|650-618-1440|mrosenthal@spiroxmed.com
88565|NCT02187809|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com
88566|NCT02187744|Pfizer, Inc.|Pfizer CT.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88567|NCT02187029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88568|NCT02187016|Silverstone Research Group|Pejjmon Amini, DMD|702-901-444|
88569|NCT02186808|Nobel Biocare|Head of Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com
88570|NCT02186665|Galderma|Michael Graeber|(817)961-5000|michael.graeber@galderma.com
88571|NCT02186587|University of Missouri - Department of Orthopaedic Surgery|Sonny B. Bal, MD, PI|573-882-6762|BalB@health.missouri.edu
88572|NCT02186223|Bio2 Medical, Inc.|Chief Medical Officer|720-833-5675|langel@bio2medical.com
88573|NCT02185729|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu
88574|NCT02185534|AstraZeneca|Brilinta Global Clinical Leader|+46 31 776 1000|ClinicalTrialTransparency@astrazeneca.com
88575|NCT02185339|Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine, Seoul St. Mary's Hospital|Dr. Sanghyun Hong|82-2-2258-2236|shhong7272@gmail.com
88576|NCT02185183|ENZO|Dr. Elazar Rabbani|2125830100|erabbani@enzo.com
88577|NCT02185131|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu
88578|NCT02185105|CooperVision, Inc|Sr. Manager, Clinical Research|9257306754|pchamberlain@coopervision.com
88579|NCT02184624|GlaxoSmithKline|GSK Response Center|866-435-7343|
88580|NCT02184494|Florida State University|Michael J. Ormsbee|6103313126|mormsbee@fsu.edu
88581|NCT02183675|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88582|NCT02183519|University of Florida Communicative Disorders|Karen Hegland, PhD|352-273-3710|kwheeler@ufl.edu
88583|NCT02182895|Brigham and Women's Hospital|Dr. Rajesh Garg, MD|617-732-5584|rgarg@partners.org
88584|NCT02181790|Icahn School of Medicine at Mount Sinai|Dr Mark Lebwohl|2122413288|giselle.singer@mssm.edu
88585|NCT02181530|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
88586|NCT02181517|Allergan, Inc|Clinical Trials Registry Team|1-800-347-4500|IR-CTRegistration@allergan.com
88587|NCT02181504|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
88589|NCT02181140|Interdisciplinary Endoscopy Department and Clinic University Hospital Hamburg-Eppendorf|Professor Dr. Thomas Rösch|+4940 7410 ext 50098|t.roesch@uke.de
88590|NCT02181127|Massachusetts General Hospital|Dr Steven J Russell|617-726-1848|sjrussell@partners.org
88593|NCT02180646|University of Missouri|Dr Jill Kanaley|573-882-2519|kanaleyj@missouri.edu
88594|NCT02180230|Nobel Biocare|Head of Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com
88595|NCT02180061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
121584|NCT01542541|BIDMC|Dr Alan Moss|6176673197|amoss@bidmc.harvard.edu
88597|NCT02179424|University of Hong Kong|Professor Lam Tai-Hing|39179287|hrmrlth@hku.hk
88598|NCT02179398|Geneva University Hospital|Dr. Laurence Lacroix|+41223725082|laurence.lacroix@hcuge.ch
88599|NCT02178995|Stanford University|Jesse Adams, MD|2069144771|jadamsuw@stanford.edu
88600|NCT02178787|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu
88601|NCT02178540|Novartis Pharmaceuticals|Study Director|862-778-8300|
88602|NCT02178059|AstraZeneca R&D|Göran Eckerwall, Medical Science Director|1-800-236-9933|Goran.Eckerwall@astrazeneca.com
88603|NCT02177266|Mayo Clinic|Dr. Jae K. Oh|507-284-6055|oh.jae@mayo.edu
88604|NCT02177201|Adnan Menders University, Anesthesiology and Reanimation Department|Dr. Sinan Yılmaz|+905055954374|dr_snnylmz@hotmail.com
88605|NCT02177032|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com
88606|NCT02176655|Clinvest/A Division of Banyan Group Inc.|Heather Manley|417-841-3664|hmanley@clinvest.com
88607|NCT02176525|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88608|NCT02176421|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com
88609|NCT02176356|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
88610|NCT02176343|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com
88611|NCT02175771|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com
88612|NCT02175745|Stanford University|Erik Mittra, MD, PhD|650-736-2859|emittra@stanford.edu
88613|NCT02175212|Hospital Universitario de la Princesa; Health Research Institute IIS from Hospital Universitario de la Princesa|Dr. Almudena Zapatero|+34 91 520 23 15|almudena.zapatero@salud.madrid.org
88614|NCT02175199|Alcon Research, Ltd.|Global Brand Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com
88615|NCT02175121|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88616|NCT02173769|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88617|NCT02173535|Johnson & Johnson Vision Care Inc.|Charis Lau, Pharm.D., O.D., FAAO|(904) 443-1293|MLau87@ITS.JNJ.com
88618|NCT02173392|Valeant Pharmaceuticals|Director of Clinical Trials|908|lindsey.mathew@valeant.com
88619|NCT02173054|Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University|Papapit Tuchinda|+662-419-4333|papapitt@gmail.com
88620|NCT02172755|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com
88621|NCT02172742|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com
88622|NCT02172625|Georgia State University|Dr. Gerald S. Zavorsky|404-413-1271|zavorsky@gsu.edu
88623|NCT02172040|Kitov Pharmaceuticals, Ltd.|J. Paul Waymack, M.D., Chief Medical Officer|(202) 965-2215|paul@kitovpharma.com
88624|NCT02171611|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88625|NCT02171247|Duke University Medical Center|Daniel T Boll, MD|919-684-2711|daniel.boll@duke.edu
88626|NCT02171234|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com
88627|NCT02171195|BIAL – Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|francisco.rocha@bial.com
88628|NCT02170779|VA Research and Development|Cinda Hugos, Physical Therapist|503-220-8262 ext 52338|hugosc@ohsu.edu
88629|NCT02170688|Duke University Medical Center|Lisa Ho, MD|919-684-7890|lisa.ho@duke.edu
88630|NCT02170662|Duke University Medical Center|Dr. Elise Olsen|919-668-5613|elise.olsen@dm.duke.edu
88631|NCT02170649|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|clinical.trials@bial.com
88632|NCT02170532|Duke University Medical Center|Neil MacIntyre, MD|(919) 681-2720|macin001@mc.duke.edu
88633|NCT02170519|Duke University Medical Center|Neil MacIntyre, MD|919-681-2720|neil.macintyre@dm.duke.edu
88634|NCT02170376|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88635|NCT02170220|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
88636|NCT02170207|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88637|NCT02170077|BIAL – Portela & Cª, SA|Head of Clinical Research|+351 22 9866100|clinical.trials@bial.com
88638|NCT02170064|BIAL - Portela & Cª, SA|Head of Clinical Research|+351-22 9866100|clinical.trials@bial.com
88639|NCT02169895|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88640|NCT02169479|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88641|NCT02169466|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|clinical.trials@bial.com
88642|NCT02169453|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88643|NCT02169440|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88644|NCT02169427|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88645|NCT02169414|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
88646|NCT02169336|Recro Pharma, Inc|Randall Mack|484-395-2400|rmack@recropharma.com
88647|NCT02169115|Charité- Dpt. of Dermatology and Allergy|Professor Martin Metz|+49 30 450 518 159|martin.metz@charite.de
88648|NCT02168491|Medical University Vienna, Austria|Prof. Dr. Michael Krebs|+ 43 1 40400 ext 43120|michael.krebs@meduniwien.ac.at
88649|NCT02168478|Medimetriks|Noah L. Rosenberg, MD, Chief Medical Officer|2019194083|Noahrosie@yahoo.com
91221|NCT01805089|DFCI|Dr. Wendy Chen|617-632-3800|wychen@partners.org
88650|NCT02168439|Children's Hospital of Pittsburgh of UPMC|Desiree Neville|4126927692|desiree.neville@chp.edu
88651|NCT02168387|Duke University Medical Center|Ira M. Cheifetz, MD, FCCM, FAARC|919-681-4080|ira.cheifetz@dm.duke.edu
88652|NCT02168361|Center for Hepatitis C|Dr. Brian Pearlman|4042651044|brianpearlman3@hotmail.com
88653|NCT02167893|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88654|NCT02167867|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com
88655|NCT02167815|Nemocnice Podlesí|MuDr Jan Stryja|+420 558 304 111|Jan.stryja@atlas.cz
88656|NCT02167139|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534|dh01.shin@samsung.com
88657|NCT02166697|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88658|NCT02165826|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
88659|NCT02165462|Universidad Católica San Antonio de Murcia|Rubén Cuesta-Barriuso, PhD|+34 913146508|ruben.cuestab@gmail.com
88660|NCT02165111|Johns Hopkins University|Dr. Ricardo J. Bello|4109557566|rbello@jhmi.edu
88661|NCT02165072|Texas Tech university Health Sciences Center, Lubbock, TX|Dr Kenneth Nugent|(806) 743-6847|Kenneth.nugent@ttuhsc.edu
88664|NCT02164396|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S.- Senior Principal Research Optometrist|904-443-3500 ext 190|BPALL@its.jnj.com
88666|NCT02163915|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88667|NCT02163733|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com
88668|NCT02163421|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88669|NCT02163395|Clinical Research|Intsitut Straumann AG|0041619651111|research@straumann.com
88671|NCT02162862|University of Pittsburgh Medical Center|Dr. Eva Szigethy|412-802-6696|szigethye@upmc.edu
88672|NCT02162758|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88673|NCT02162680|Duke University Medical Center|Julia Aucoin, DNS|1 919 613 6406|julia.aucoin@dm.duke.edu
88674|NCT02161549|MotusGI|Ravit Peled -Director of Clinical Trial|+972 (0)4 6214447 ext 203|ravit@motusgi.com
88675|NCT02161146|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
88676|NCT02161016|RTI Surgical|Robin Waite|386-418-8888|rwaite@rtix.com
88677|NCT02160990|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu
88678|NCT02160977|Peking University Third Hospital|Dr. Jia-Kuo Yu|86-10-82267392|yujiakuo@126.com
88679|NCT02160873|Florida State University|Dr. Michael J. Ormsbee|(850) 645-5000|mormsbee@fsu.edu
88680|NCT02160314|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com
88681|NCT02159950|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
88682|NCT02159859|Beaumont Health|Lama Hsaiky, Pharm.D. (Primary investigator)|313-593-7264|lama.hsaiky@beaumont.org
88683|NCT02159768|National University Hospital|Senior Consultant|+65 67724200|eugene_liu_hc@nuhs.edu.sg
88684|NCT02159547|Akdeniz University|Cenker EKEN|00905321593948|cenkereken@akdeniz.edu.tr
88685|NCT02159482|Duke University|Dr. Michael Morse|919-681-3480|morse004@mc.duke.edu
88687|NCT02159352|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
88688|NCT02159118|The University of Texas Health Science Center|Chatchawin Assanasen, MD|210-567-7456|assanasen@uthscsa.edu
88689|NCT02159040|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
88690|NCT02158728|Medtronic|Clinical Research Specialist L. Vainer|+31 43 3566752|lidwien.vainer@medtronic.com
88691|NCT02158572|Agile Therapeutics|Lisa Flood, Associate Director of Clinical Operations|609-683-1880|lflood@agiletherapeutics.com
88692|NCT02158442|Osprey Medical|Michele Shepard|952.955.8236|mshepard@ospreymed.com
88693|NCT02158273|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu
88694|NCT02158247|The Catholic University of Korea|Dr. Oh Saecheol|+88-42-220-9046|oscane0822@gmail.com
88695|NCT02158039|Mayo Clinic|Dr. Mark Topazian|507-284-7602|topazian.mark@mayo.edu
88696|NCT02157948|Amgen Inc.|Study Director|866-572-6436|
88698|NCT02157909|Alcon Research, Ltd.|Head Clinical Development, Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com
121645|NCT00415870|UCSD|Project Coordinator|858-534-9329|ldillon@ucsd.edu
88700|NCT02157623|Cleveland Clinic|Edward Maytin, MD, PhD|216-445-6676|maytine@ccf.org
88701|NCT02157376|AstraZeneca|Barry Traxler||barry.traxler@astrazeneca.com
88702|NCT02157298|AstraZeneca K.K.|Yuji Ageishi|+81-3-6268-2740|Yuji.Ageishi@astrazeneca.com
88703|NCT02157116|Duke University|Richard Riedel, MD|919-681-6932|richard.riedel@duke.edu
88704|NCT02156466|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
88705|NCT02156271|Duke University Medical Center|Dr. Andrew Krystal|919-681-8742|andrew.krystal@duke.edu
88706|NCT02156167|Cochlear|Christiane D’hondt, Clinical Research Specialist|+32 15 76 55 14|cdhondt@cochlear.com
88707|NCT02155985|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
88708|NCT02155881|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
88709|NCT02155543|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
88710|NCT02155335|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
121646|NCT00404768|GlaxoSmithKline|GSK Response Center|866-435-7343|
121647|NCT00390546|University of British Columbia|Dr. Shubhayan Sanatani|604-875-2345 ext 7955|ssanatani@cw.bc.ca
121648|NCT00375609|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000|
121649|NCT00304356|VA Houston|Daniel Musher|713-794-7386|daniel.musher@va.gov
121650|NCT00301808|Barbara Ann Karmanos Cancer Institute|Shrish Gadgeel, M.D.|(313) 576-8753|sgadgeel@med.umich.edu
121651|NCT00288574|NYSPI|BT Walsh, MD|646-774-8066|edru@nyspi.columbia.edu
88711|NCT02155322|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
88712|NCT02155283|Radiancy Ltd|Dr. Daniele Perl-Treves, Clinical Director|972-97757556|daniele@radiancy.com
88713|NCT02155010|Haeundae paik hospital, Inje University|Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com
88714|NCT02154906|UT Health Science Center San Antonio|Brian L. Mealey|210-567-3567|mealey@uthscsa.edu
88715|NCT02154425|Cares|UCB|+1877 822 ext 9493|
88716|NCT02154386|UT Health Science Center San Antonio (School of Dentistry)|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu
88717|NCT02154243|HSS|Dr. Haskins|(212) 606-1000|HaskinsS@hss.edu
88718|NCT02154139|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88719|NCT02154087|Smith & Nephew, Inc|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com
88720|NCT02154048|Duke University|Steve Melton, MD|919.668.2047|steve.melton@duke.edu
88721|NCT02153827|University of St. Augustine|Eric Chaconas|904-826-0084 ext 1275|echaconas@usa.edu
88722|NCT02153788|Duke University Medical Center|Andrew Krystal, MD|919-681-8742|andrew.krystal@duke.edu
88723|NCT02153736|Virginia Commonwealth University|Stacey Dusing, PT, PhD, PCS, Director Motor Development Lab|804-628-3632|scdusing@vcu.edu
88724|NCT02153489|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com
88725|NCT02153398|Biometrics Department, Science Affairs Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com
88726|NCT02153346|GlaxoSmithKline|GSK Response Center|866-435-7343|
88727|NCT02153099|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88728|NCT02153086|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88730|NCT02152566|Fisher & Paykel Healthcare|Dr Rachel Vicars|09 574 0123 ext 7759|rachel.vicars@fphcare.co.nz
88731|NCT02152371|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
88732|NCT02152007|TransDerm, Inc.|Roger Kaspar, PhD|831-420-1684|roger.kaspar@transderminc.com
88733|NCT02151994|BIAL-Portela & Ca, S.A.,|Head of Clinical Research|(+351)-22-9866100|clinical.trials@bial.com
88735|NCT02151786|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88736|NCT02151773|Takeda|Takeda Study Registration Call Center|+1-877-825-3327|medicalinformation@tpna.com
88737|NCT02151253|Duke University Health System|Andrew D. Krystal, MD, MS|919-971-4355|andrew.krystal@duke.edu
88738|NCT02151058|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com
88739|NCT02150954|Duke University Medical Center|Chad Grotegut , MD||chad.grotegut@dm.duke.edu
88740|NCT02150499|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclousre@sunovion.com
88741|NCT02150460|National Eye Centre, Kaduna. Nigeria|Dr Aminatu Ali AbdulRahman|+2348037878367|aaaminatu@yahoo.com
88742|NCT02150213|Novartis|Study Director|862-778-8300|
88743|NCT02150109|Ascensia Diabetes Care|Jane Wallace, Deputy Director Clinical Trials|574-257-3063|jane.wallace@ascensia.com
88744|NCT02150044|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com
88745|NCT02149875|Shanghai Sixth People's Hospital|Dr. Hao Chen|02164369181 ext 8405|chenhao_316@aliyun.com
88746|NCT02149342|Helsinki university central hospital|Md, PhD Noora Neittaanmäki-Perttu|+358407190362|noora.neittaanmaki@fimnet.fi
88747|NCT02149303|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127 ext +1|clintriage.rdg@boehringer-ingelheim.com
88749|NCT02149108|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88750|NCT02148809|HospitalSS|Dr. Friedrich Boettner|2127742127|boettnerf@HSS.edu
88751|NCT02148718|AbbVie|Global Medical Services|800-633-9110|
88752|NCT02148523|University of Pennsylvania|Dr. Peter P. Reese|215-898-6086|peter.reese@uphs.upenn.edu
88753|NCT02148445|Department of Preventive Medicine & Public Health|Edward F. Ellerbeck, MD, MPH, Chair|913-588-2829|eellerbe@kumc.edu
88754|NCT02148107|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88755|NCT02147691|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com
88756|NCT02147561|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
88757|NCT02147522|USC Suzanne Dworak-Peck School of Social Work|Kathleen Ell, DSW, Principle Investigator|760-399-0263|ell@usc.edu
88758|NCT02147288|Yale University|Dr. Marc Walker||marc.walker@yale.edu
88759|NCT02147093|Johnson & Johnson Vision Care INC.|Tom Karkkainen, OD, MS, FAAO|904-443-3500 ext 3402|TKarkkai@its.jnj.com
88760|NCT02146599|Abbott Medical Optics|Anne Buteyn; Manager, Clinical Research|949-505-2029|anne.buteyn@abbott.com
88762|NCT02146352|Boston Scientific Corp.|Lina Ginnetti|508-683-4512|Lina.Ginnetti@bsci.com
88763|NCT02146326|Indiana University|Michelle Salyers, PhD / Professor, Department of Psychology|317-274-2904|mpsalyer@iupui.edu
88764|NCT02146248|OHSU|Jeffrey T. Jensen|503-629-4058|jensenje@ohsu.edu
88765|NCT02146105|McMaster University|Dr. Monica Maly|905-525-9140 ext 27823|mmaly@mcmaster.ca
88766|NCT02146001|University of Pittsburgh|Dr. Bethany Barone Gibbs|412-383-4002|bbarone@pitt.edu
88767|NCT02145754|University Medical center Ljubljana, Infectious Diseases Department|Daša Stupica|+386 1 522 21 10|dasa.stupica@kclj.si
88768|NCT02145676|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
88769|NCT02145468|GlaxoSmithKline|GSK Response Center|866-435-7343|
88770|NCT02145299|Yale School of Medicine|Dr. Alexandra Lansky|203-737-2142|alexandra.lansky@yale.edu
88771|NCT02145156|University of Colorado Denver|Julie A. Maertens|303-724-7319|julie.maertens@ucdenver.edu
88772|NCT02144337|University of Nottingham (UK)|Helen Quirk|01157484325|ntxhq1@nottingham.ac.uk
88773|NCT02144259|University of Pennsylvania|Dr. Courtney Schreiber|215-615-5234|courtney.schreiber@uphs.upenn.edu
88774|NCT02144220|University of Rochester|Ray Dorsey, MD|585-275-0663|ray.dorsey@chet.rochester.edu
88775|NCT02144012|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
88776|NCT02143947|Quinnipiac University|Juan C Garbalosa, PT, PhD, Director Motion Analysis Laboratory|203 582 8552|juan.garbalosa@quinnipiac.edu
88777|NCT02143583|ANERGIS SA|G. DELLA CORTE Clinical Development Director|+41 21 651 92 30|gilles.dellacorte@anergis.ch
88780|NCT02142712|University of New Mexico - Neurology Department|Dr. Vishnumurthy Shushrutha Hedna|505-272-3342|Drshushrutha@gmail.com
88781|NCT02142504|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88782|NCT02142361|Optometry Research Group (GIO)|Robert Montés-Mico O.D., MPhil, PhD Optometry|34-9635-44764|robert.montes@uv.es
88783|NCT02142153|F2G|Dr Anthony Kennedy|0044 161 785 1273|TKennedy@f2g.com
88784|NCT02141997|AbbVie|Global Medical Information|1-800-633-9110|
88785|NCT02141984|AbbVie|Global Medical Services|800-633-9110|
88786|NCT02141867|South African Surgical Outcomes Study|Prof Bruce Biccard|+27312604328|biccardb@ukzn.ac.za
88787|NCT02141854|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
88788|NCT02141633|University of Miami|Dr Adam Wanner Professor of Medicine Division of Pulmonary and Critical Care Medicine|(305) 243-3045|awanner@med.miami.edu
88789|NCT02141620|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu
88790|NCT02141581|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu
88791|NCT02141516|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
88792|NCT02141360|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com
88793|NCT02141217|GlaxoSmithKline|GSK Response Center|866-435-7343|
88794|NCT02140957|St. Michael's Hospital|Dr. Jonathon Maguire|(416) 919-3462|jonathon.maguire@utoronto.ca
88795|NCT02140788|Duke University Health System|Joseph P. McEvoy|919-819-9295|JMCEVOY@gru.edu
88796|NCT02140645|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88797|NCT02140593|Herlev and Gentofte Hospital University of Copenhagen|Dr. Matias Vested Madsen|+4538683868|matias.vested.madsen@regionh.dk
88798|NCT02140372|NYU School of Medicine|Binita Shah|212-263-4235|binita.shah@nyumc.org
88800|NCT02140060|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com
88801|NCT02139982|The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University|Dr. Ting Li|008613587876896|liting1021@aliyun.com
88802|NCT02139943|Janssen Research & Development, LLC|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com
88803|NCT02139878|University of Prince Edward Island|Kim S. Stote PhD, MPH, RD|518-587-2100 ext 2873|Kim.Stote@esc.edu
88804|NCT02139644|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
88805|NCT02139228|Novartis Vaccines and Diagnostics Srl|Posting Director||RegistryContactVaccinesUS@novartis.com
88806|NCT02139176|UNC Chapel Hill/UNC Project Lilongwe|Nora Rosenberg, PhD|+265 (0)99 109 0676|Nora_Rosenberg@unc.edu
88808|NCT02139046|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88809|NCT02139007|UAB|Jeff Foster|205-996-6086|pjfoster@uabmc.edu
88810|NCT02138838|Amgen Inc.|Study Director|866-572-6436|
88812|NCT02138747|Astellas Pharma US, Inc.|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com
88813|NCT02138461|MDbackline, LLC|John A. Hovanesian, MD|949 951 9248|jhovanesian@mdbackline.com
88814|NCT02138097|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88815|NCT02138006|Karolinska Institutet Södersjukhuset|Thomas Nyström|+46704325214|thomas.nystrom@sodersjukhuset.se
88816|NCT02137785|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|anna.houlihan@sunpharma.com
88817|NCT02137603|All Children's Hospital Johns Hopkins Medicine|Dr. Nicole Chandler|727-767-4170|Nicole.Chandler@jhmi.edu
88818|NCT02137512|Jaeb Center for Health Research|John Lum, Artificial Pancreas Project Director|8139758690|jlum@jaeb.org
88819|NCT02137447|Massachusetts General Hospital|Dr. Daniel Dante Yeh, Assistant Professor of Surgery|6177248604|dyeh2@partners.org
88820|NCT02137382|Abbott|Suntje Sander - Struckmeier|+49 (0) 511 6750 3254|suntje.sander-struckmeier@abbott.com
88822|NCT02136238|University of South Florida|Jason Highsmith|813-974-3806|mhighsmi@health.usf.edu
88825|NCT02135900|Staten Island University Hospital|Michel Chalhoub, MD|7182269000|chalhoubmichel@gmail.com
88826|NCT02135445|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88827|NCT02135432|University of Alabama at Birmingham|Steven M. Rowe|205-975-6385|smrowe@uab.edu
88828|NCT02135016|First Hospital of CMU|Dr. Jun Wang|8602483283100|wjun2000@hotmail.com
88829|NCT02134977|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88830|NCT02134717|University of Pittsburgh|Kevin Gibson MD|412-624-7095|gibsonkf@upmc.edu
88891|NCT02124044|NIH Clinical Center|Masur, Henry|+1 301 496 9320|HMasur@cc.nih.gov
88831|NCT02134587|School of Pharmaceutical Scientes of Universidade Estadual Paulista Júlio de Mesquita Filho, Araraquara, SP (Brazil)|Fabiana Rossi Varallo|5516997629496|varallo.f.r@gmail.com
88832|NCT02134184|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu
88833|NCT02134119|University of Georgia|Jamie Cooper|7065424903|jamie.cooper@uga.edu
88834|NCT02133781|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu
88835|NCT02133664|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu
88836|NCT02133534|Duke University Medical Center|Research Practice Manager|919 681 6819|bixby001@duke.edu
88837|NCT02133352|Boston University|Kimberly Finch|617-638-4475|kimtobin@bu.edu
88838|NCT02133235|NTUH|YJ Cheng|886-2-23123456 ext 62158|chengyj@ntu.edu.tw
88839|NCT02133131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com
88840|NCT02133066|Children's Hospital of Philadelphia|Aaron Chen|2674260383|chena2@email.chop.edu
88842|NCT02132936|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com
88843|NCT02132832|The University of Texas Health Science Center at Houston|Scott D. Lane, PhD|(713) 486-2535|Scott.D.Lane@uth.tmc.edu
88844|NCT02132767|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu
88845|NCT02132611|Cardiovascular Systems, Inc.|Clinical Project Manager|651-259-1600|clinicaltrials_csi@csi360.com
88846|NCT02132572|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
88847|NCT02132169|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com
88848|NCT02132117|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
88849|NCT02131636|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
88850|NCT02131532|University of Edinburgh|Dr Simiao Wu|0044-131-242-6371 ext 26371|simiao.wu@ed.ac.uk
88851|NCT02131402|Optics Department, University of Valencia 46100 Valencia, Spain|Dr. Robert Montés-Mico O.D., MPhil, PhD|34-9635-44764|robert.montes@uv.es
88852|NCT02131311|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com
88853|NCT02131272|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
88856|NCT02130999|Vince and Associates Clinical Research|Melodie Armstrong, MD, MPH|913-696-1601|
88857|NCT02130635|GlaxoSmithKline|GSK Response Center|866-435-7343|
88858|NCT02130284|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com
88859|NCT02130193|GlaxoSmithKline|GSK Response Center|866-435-7343|
88860|NCT02129777|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88861|NCT02129725|Vanderbilt University Medical Center|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu
88862|NCT02129608|Mayo Clinic|Ivana Croghan|507-266-1944|domcro@mayo.edu
88863|NCT02129192|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88864|NCT02129062|UT MD Anderson Cancer Center|Jan Burger, MD/ UT MD Anderson Associate Professor, Leukemia|713-794-4329|CR_Study_Registration@mdanderson.org
88865|NCT02128919|Nathan Kline institute for Psycghatric Research|Robert C Smith MD|845-398-6531|rsmiith@nki.rfmh.org
88866|NCT02128867|vrije universiteit brussel|filip van ginderdeuren|+3224763916|filip.vanginderdeuren@uzbrussel.be
88867|NCT02128542|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
88868|NCT02128490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
88869|NCT02128269|Alexion|Alexion Medical Monitor|617-613-1071|Bert.Yao@alexion.com
88870|NCT02127892|Children's Hospital Los Angeles|Neena Kapoor, M.D.|323-361-2546|nkapoor@chla.usc.edu
88871|NCT02127567|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr
88872|NCT02127372|Duke University Medical Center|Gordana Vlahovic, MD|919-681-4047|Gordana.vlahovic@dm.duke.edu
88873|NCT02127307|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-5431347|jose.zubeldia@ge.com
88874|NCT02126839|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
88875|NCT02126748|Vrije Universiteit Brussel|Filip Van Ginderdeuren|+3224763916|filip.vanginderdeuren@uzbrussel.be
88876|NCT02126670|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com
88877|NCT02126319|Fox Chase Cancer Center|Dr. Suzanne M. Miller|215 728-4069|Suzanne.Miller@fccc.edu
88878|NCT02126306|HMO|Dr Gadi Lalazar|97226777337|lalazar@hadassah.org.il
88879|NCT02125877|Novartis|Study Director|862-778-8300|
88880|NCT02125838|DorkuzEU|Sule Ozbilgin|902324122836|ozbilginsule@gmail.com
88881|NCT02125734|Novartis Pharmaceuticals|Study Director|862-778-8300|
88882|NCT02125604|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
88883|NCT02125292|Shire Development LLC|Study Physician|+1 866 842 5335|
88884|NCT02124863|vrije universiteit brussel|filip van ginderdeuren|+3224763916|filip.vanginderdeuren@telenet.be
88885|NCT02124798|GlaxoSmithKline|GSK Response Center|866-435-7343|
88886|NCT02124603|Casa di Cura Di Stefano|Dr.Marcello Santocono|+393356070002|santocono.m@alice.it
88887|NCT02124460|Massachusetts General Hospital|Dr. Elsie Taveras|617-726-8555|elsie.taveras@mgh.harard.edu
88888|NCT02124304|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777 ext 838|jslaski@ssrehab.com
88889|NCT02124161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-­800­-718­-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88890|NCT02124122|Tulane SPHTM|Richard Oberhelman|5049882511|oberhel@tulane.edu
88892|NCT02123745|ivWatch, LLC|Garret T. Bonnema|1.855.489.2824 ext 7018|garret.bonnema@ivwatch.com
88893|NCT02123472|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
88894|NCT02123459|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
88895|NCT02123446|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
88896|NCT02123017|Cumberland Pharmaceuticals, Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com
88897|NCT02122549|ZOLL|Vice President of Medical Affairs|412-968-3333 ext 14400|stevens@zoll.com
88898|NCT02122445|Sport and Spine Rehab Clincal Research Foundation|Jena Slaski|301-251-2777 ext 838|jslaski@ssrehab.com
88899|NCT02122406|University of Pavia|Vittorio Grosso MD|+393332605945|vittorio.grosso@gmail.com
88900|NCT02121860|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com
88901|NCT02121847|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
88902|NCT02121795|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
88903|NCT02121535|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127 ext +1|clintriage.rdg@boehringer-ingelheim.com
88904|NCT02121522|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88905|NCT02121509|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88906|NCT02121483|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88907|NCT02121210|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
88908|NCT02121067|University of North Carolina|Matthew Zerden, MD, MPH|6179352394|mzerden@gmail.com
88909|NCT02121041|UNC Chapel Hill|Dr. Anthony Viera|984-974-4636|viera@med.unc.edu
88910|NCT02120833|Johnson & Johnson Consumer and Personal Products Worldwide|Chirstopher Nunez, PhD/Study Director|973-385-7984 USA EST|cnunez1@its.jnj.com
88911|NCT02120664|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
88912|NCT02120625|Nimbus Concepts, LLC|J. Scott Bainbridge, MD (PI)|303-522-5219|jscottbainbridge@gmail.com
88913|NCT02120443|ivWatch, LLC|Garret T. Bonnema|1.855.489.2824 ext 7018|garret.bonnema@ivwatch.com
88914|NCT02120417|Incyte Corporation|Study Director|855 463-3463|
88915|NCT02120300|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
88916|NCT02120027|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680 ext 9990|acapriati@menarini-ricerche.it
88917|NCT02120001|Massachusetts General Hospital|Robert Kacmarek, Director Respiratory Care|(617) 726-2000|rkacmarek@mgh.harvard.edu
88918|NCT02119676|Incyte Corporation|Study Director|855 463-3463|
88919|NCT02119663|Incyte Corporation|Study Director|855 463-3463|
88921|NCT02119325|GlaxoSmithKline|GSK Response Center|866-435-7343|
88922|NCT02119299|Scientific Intake|Richard P. Schneider|917-676-6251|rschneider@scientificintake.com
88923|NCT02119286|GlaxoSmithKline|GSK Response Center|866-435-7343|
88924|NCT02119104|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88925|NCT02118961|Mitsubishi Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk / Clinical Development counter||cti-inq-ml@ml.mt-pharma.co.jp/clinicaldevelopment@mail.biken.or.jp
88926|NCT02118896|Astellas Pharma Europe Limited|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com
88927|NCT02118831|California Retina Consultants|Director of Research|8059631648 ext 3034|gabe@californiaretina.com
88928|NCT02118792|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88929|NCT02118766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88930|NCT02118597|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
88931|NCT02118441|Department of Anesthesia, St. Paul's Hospital|S. K. W. Schwarz, MD, PhD|604-806-8337|stephan.schwarz@ubc.ca
88932|NCT02117687|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
88933|NCT02117570|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|
88934|NCT02117544|Alcon Research, Ltd|Clinical Project Lead, Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com
88935|NCT02117479|Incyte Corporation|Study Director|855 463-3463|
88936|NCT02117414|Medtronic, Inc|Evera MRI Clinical Research Specialist|800-328-2518 ext 62813|medtronicCRMtrials@medtronic.com
88937|NCT02117310|The Ohio State University|Dr. Daniel Prevedello, Associate Professor|(614) 685-1965|daniel.prevedello@osumc.edu
88938|NCT02117193|Federal University of Rio Grande do Sul|Dr Marco Aurélio Vaz|555133085860|marcovaz@esef.ufrgs.br
88939|NCT02117050|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
88941|NCT02116530|Indiana University School of Medicine South Bend|Rudolph M. Navari, MD, PhD, FACP|574-252-7225|rmnavari@gmail.com
88942|NCT02116322|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu
88943|NCT02115984|Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences|Dr. Sergey S. Bogachev|+7-963-946-57-69|labmolbiol@mail.ru
88944|NCT02115815|MedImmune, LLC|Judith Falloon, MD|301-398-5000|falloonj@medimmune.com
88945|NCT02115581|Children's Medical Center|Giv Heidari-Bateni MD/MPH|3142991984|givhb@yahoo.com
88946|NCT02115321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
88947|NCT02115269|Abbott|Jean-Pascal Berrou, Global Medical Director CNS/Pain|+41614870457|jean-pascal.berrou@abbott.com
88948|NCT02115256|Icahn School of Medicine at Mount Sinai|Dr. Yaakov Beilin|212-241-7467|yaakov.beilin@mountsinai.org
88949|NCT02114931|Amgen Inc.|Study Director|866-572-6436|
89067|NCT02096731|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88950|NCT02114892|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00 ext 34212|uiec@prodigy.net.mx
88951|NCT02114268|MedImmune, LLC|M. Pamela Griffin, MD, Senior Director|301-398-0000|information.center@astrazeneca.com
88952|NCT02114216|Seoul National University Hospital|Dr. Jinjoo Kim|82-10-6261-6483|jjkim0727@gmail.com
88953|NCT02114177|Janssen Infectious Diseases BVBA|Associate Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com
88954|NCT02114151|Janssen Infectious Diseases - Diagnostics BVBA|Associate Director||ClinicalTrialDisclosure@its.jnj.com
88955|NCT02113579|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com
88956|NCT02113449|GlaxoSmithKline|GSK Response Center|866-435-7343|
88957|NCT02113436|GlaxoSmithKline|GSK Response Center|866-435-7343|
88958|NCT02113124|The Transitional Learning Center at Galveston|Dr. Brent Masel|409-762-6661 ext 411|bmasel@tlcgalveston.org
88959|NCT02113007|Sarah Cannon Development Innovations|Charles H. Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com
88960|NCT02112448|Advocate Children's Hospital|Jamie Penk|7086845580|jamie.penk@advocatehealth.com
88961|NCT02112370|Seoul National University Hospital Department of Surgery|Dr. Kyu Eun Lee|+82)-2-2072-2817|kyueunlee@snu.ac.kr
88962|NCT02111863|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|steven-rosenberg@nih.gov
88963|NCT02111603|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu
88964|NCT02111369|Emory University|Dr. Michael Johns|323-865-9839|
88965|NCT02111252|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com
88966|NCT02111083|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
88967|NCT02110381|University of Michigan|Dr. Elizabeth Jackson|734-998-7411|lisjacks@med.umich.edu
88968|NCT02110238|Seikagaku|Junko Takamura||junko.takamura@seikagaku.co.jp
88969|NCT02110147|Wellstat Therapeutics Corporation|Wellstat Medical Information|800.914.0071|medinfo@wellstat.com
88970|NCT02109731|University of Rochester|Dr. Suzanne Karan|5852751384|suzanne_karan@urmc.rochester.edu
88971|NCT02109640|University of Edinburgh|Hugh M Paterson|44 131 537 1000|hugh.paterson@ed.ac.uk
88972|NCT02109497|Prana Biotechnology|Dr Caroline Herd|+6133494906|info@pranabio.com
88973|NCT02109458|Johns Hopkins University School of Medicine|Dr. Lonny Yarmus|4105025224|lyarmus@jhmi.edu
88974|NCT02109445|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
88975|NCT02109172|Theravance Biopharma US, Inc.|Glenn Crater, Head of Clinical Development & Medical Affairs, Respiratory|650-808-6000|gcrater@theravance.com
88976|NCT02109159|London School of Hygiene and Tropical Medicine|Dr Junko Kiriya|+442076368636|junko.kiriya@lshtm.ac.uk
88977|NCT02109133|Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine,Severance Hospital, Yonsei University Health System|Dr. Sun-Jun, Bae|+82-02-2228-4438|SJBAI1@yuhs.ac
88978|NCT02109107|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com
88980|NCT02108691|Hanyang University|Dr. Yongsoon Park|82-2-2220-1205|yongsoon@hanyang.ac.kr
88981|NCT02108652|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
88982|NCT02108288|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366|
88983|NCT02108223|Sisli etfal training anf research hospital|Fatma yazıcı yılmaz|+905079234033|fatmayazc@gmail.com
88984|NCT02108171|Guangzhou First People’s Hospital, Affiliated Hospital of Guangzhou Medical College|Dr. Xiangcai Ruan|+8620-81048306|xc_ruan@hotmail.com
88985|NCT02107898|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
88986|NCT02107599|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
88987|NCT02107482|Tufts Medical Center|Nicole Dumont|617 636 7462|ndonovan1@tuftsmedicalcenter.org
88988|NCT02107339|NorthShore University HealthSystem|Glenn Murphy|847-570-2760|dgmurphy2@yahoo.com
88989|NCT02107313|Prana Biotechnology|Dr Caroline Herd|+61393494906|info@pranabio.com
88990|NCT02107274|Ministry of Health of Malaysia|Dr. Albert Iruthiaraj L. Anthony|+60174633410|albert5409@yahoo.com
88991|NCT02107196|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680 ext 9990|acapriati@menarini-ricerche.it
88992|NCT02107014|University of Alabama at Birmingham|Dr. Jarred Younger|2059755821|younger@uab.edu
88993|NCT02106962|California Insitute of Renal Research, Inc.|Mark M. Boiskin, M.D.|858-637-4600|mboiskin@bnmg.org
88994|NCT02106923|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
88995|NCT02106832|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com
88996|NCT02106728|Toronto General Hospital|Dr. Gina Dimitropoulos|416-340-3749|gdimit@ucalgary.ca
88997|NCT02106494|Heron Therapeutics|Robert Geller, M.D.|650-366-2626|rgeller@herontx.com
88998|NCT02106403|GlaxoSmithKline|GSK Response Center|866-435-7343|
88999|NCT02106156|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
89000|NCT02105987|GlaxoSmithKline|GSK Response Center|866-435-7343|
89002|NCT02105740|Universidade de Brasília|Gil Montenegro|556181487323|prof.gilmontenegro@gmail.com
89003|NCT02105701|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89005|NCT02105662|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89007|NCT02105467|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
121202|NCT02961244|Dokuz Eylul University Medicine Faculty, General Surgery Department|Ali Kadir Degirmenci|+902324122901|alikadir@hotmail.com
89008|NCT02105454|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89009|NCT02105285|Otsuka Pharmaceutical Co., Ltd.|Deputy General Manager, Headquarters of Clinical Development|+81-3-6361-7366|
89010|NCT02105272|Otsuka Pharmaceutical Co., Ltd.|Deputy General Manager, Headquarters of Clinical Development|+81-3-6361-7366|
89011|NCT02105012|Pearl Therapeutics Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com
89012|NCT02104947|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89013|NCT02104895|Radiation-Oncology Unit, AOU Careggi, Florence University, Florence, Italy|Dr. Icro Meattini|+39055794 ext 7719|icro.meattini@unifi.it
89014|NCT02104830|Biocad|Roman Ivanov, Director of Clinical Trials|+7 (812) 380 49 33 ext 950|ivanov@biocad.ru
89015|NCT02104804|AstraZeneca|Eva Johnsson, MD, PhD, Global Clinical Lead||Eva.Johnsson@astrazeneca.com
89016|NCT02104219|Alexion Pharmaceuticals|Senior Medical Director, Clinical Development|203-272-2596|clinicaltrials@alxn.com
89017|NCT02103855|Indiana University|Jeanne Chen|317-944-3570|jchen@iuhealth.org
89018|NCT02103439|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28 ext 930|linkova@biocad.ru
89019|NCT02103309|Alcon Japan, Ltd.|Director of Clinical Trials|1-888-451-3937|alcon.medinfo@alcon.com
89020|NCT02103114|Duke University|Dr. Edmund Jooste|919-681-4877|edmund.jooste@duke.edu
89021|NCT02103062|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com
89022|NCT02102932|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127 ext +1|clintriage.rdg@boehringer-ingelheim.com
89024|NCT02102399|Federal University of Bahia|Lilian Paternostro|+55 (71) 8191-9730|lilian_fono@hotmail.com
89025|NCT02101359|Laboratoires Thea|Medical director|33-4-73-98-14-36|p.pouliquen@laboratoires-thea.fr
89026|NCT02101294|Finger Relief|Molly Choate Summers|703-517-8951|summers.molly@gmail.com
89027|NCT02101190|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
89028|NCT02101112|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
89029|NCT02101008|Huntsman Cancer Institute|Kenneth Grossmann|801-587-4289|kenneth.grossmann@hci.utah.edu
89030|NCT02100839|Linear Clinical Research Ltd|Dr. Janakan Krihnarajah, MBBS (Hons), FRACP|800 393 8820|JKrishnarajah@linear.org.au
89031|NCT02100826|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
89033|NCT02100579|Northwestern University, Feinberg School of Medicine|Antoun Nader|312-695-3045|a-nader2@northwestern.edu
89035|NCT02100475|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
89036|NCT02100410|Alcon Research, Ltd.|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com
89037|NCT02100189|OHSU|John Hunter, MD|503-494-4937|hunterj@ohsu.edu
89038|NCT02100007|MEI Pharma Inc|Richard Ghalie, MD, Sr Vice President Clinical Development|858 369-7116|rghalie@meipharma.com
89039|NCT02099838|Huazhong University of Science and Technology|Dr. Yu|027-83662883|xfyu188@163.com
89040|NCT02099708|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
89041|NCT02099682|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
89042|NCT02099461|Amgen Inc.|Study Director|866-572-6436|
89043|NCT02099344|Kaiser Permanente NW|Earl Schuman, MD|503-331-6017|kathleen.ann.arnold@kpchr.org
89044|NCT02099318|University Hospitals Cleveland Medical Center|Valerie Cwiklinski Clinical Research Nurse|216-983-5144|valerie.cwiklinski1@uhhospitals.org
89045|NCT02099266|University of Kansas Cancer Center|Dr. Omar Aljitawi|(913) 588-6030|SWILLIAM@kumc.edu
89046|NCT02099084|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu
89047|NCT02099006|University of Rochester|Adrienne Bonham MD|(585) 273-3314|adrienne_bonham@urmc.rochester.edu
89048|NCT02098746|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
89049|NCT02098733|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
89050|NCT02098395|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
89051|NCT02098304|Clark & Watson Dental Practice|Dr Charles Ormond|+44 (0)1324 623445|charlesormond@nhs.net
89052|NCT02098109|Washington University School of Medicine|Camille Abboud, M.D.|314-454-8304|cabboud@wustl.edu
89054|NCT02097849|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
89055|NCT02097823|Prevea Health/St Vincent Hospital|Dr. Catherine Long|9204338670|cathy.long@prevea.com
89056|NCT02097745|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
89057|NCT02097719|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
89058|NCT02097537|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group||clinical@santen.co.jp
89059|NCT02097290|Boston Scientific|Gregory Voss|6515813068|Gregory.Voss@bsci.com
89060|NCT02097238|Children's Oncology Group|Results Reporting Coordinator|626-446-0064|resultsreportingcoordinator@childrensoncologygroup.org
89061|NCT02097108|AGMT|Public contact Daniela Wolkersdorfer|00436626404411|d.wolkersdorfer@agmt.at
89062|NCT02097056|Eisai Korea Inc.|Youngji Pyo|+82-2-3451-5533|y-pyo@eisaikorea.com
89063|NCT02097030|CooperVision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com
89064|NCT02096900|Loma Linda University|Amgad H. Hanna, MD|909-558-4475|ahanna@llu.edu
89065|NCT02096835|Huashan Hospital Fudan University Shanghai, China|Dr.Xiaoyu Yang|086-021-52889999 ext 7693|yangxiaoyu@huashan.org.cn
89066|NCT02096744|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89068|NCT02096718|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89069|NCT02096705|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com
89070|NCT02096692|Biotronik, Inc.|Clinical Studies Engineer|503-451-8049|justin.michalski@biotronik.com
89071|NCT02096679|AstraZeneca|Dr Mireille Cantarini||ClinicalTrialTransparency@astrazeneca.com
89072|NCT02096575|U of New Mexico - Dept of OBGYN/Family Planning|Michel Paves, HS Research Specialist|505-272-9703|MDaliva@salud.unm.edu
89073|NCT02096458|Takeda Development Center Americas, Inc.|Takeda Study Registration Call Center|800-778-2860|medicalinformation@tpna.com
89075|NCT02096042|The University of Texas (UT) MD Anderson Cancer Center|Nitin Jain, MD/Assistant Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org
89076|NCT02095873|University of Warwick|Paul J Thornalley|+442476968594|P.J.Thornalley@warwick.ac.uk
89077|NCT02095691|Biosense Webster, EMEA|Liesbeth Vanderlinden, Manager Clinical Research|+32(0)2 7463527|lvanderl@its.JNJ.com
89078|NCT02095561|INSTITUTO NACIONAL DEL CÁNCER, ARGENTINA|Silvina Arrossi, Phd|541152390562|silviarrossi2020@gmail.com
89079|NCT02095535|UBC Department of Anesthesia - BC Women's Hospital|Tashya De Silva|604-875-2158|tashya.desilva@cw.bc.ca
89080|NCT02095223|University of Miami|Christopher Kuenze|5174325018|kuenzech@msu.edu
89081|NCT02095197|Northwestern University, Feinberg School of Medicine|David Walega, MD|312-695-2500|d-walega@northwestern.edu
89082|NCT02095158|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
89083|NCT02094937|GlaxoSmithKline|GSK Response Center|866-435-7343|
89084|NCT02094898|Mayo Clinic|William V. Bobo, M.D.|507-538-9041|Bobo.William@mayo.edu
89085|NCT02094885|Ethicon, Inc|Jonathan Batiller, Senior Clinical Director|+1 908 218-2492|JBatill2@its.jnj.com
89086|NCT02094677|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com
89087|NCT02094612|Kaiser Permanente Division of Research|Monique Does, Project manager|510-891-3612|monique.does@kp.org
89088|NCT02094573|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
89089|NCT02094534|Orange County Research Center|Joel M. Neutel, M.D., Study Director|714-550-9990|jmneutel@aol.com
89090|NCT02094443|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com
89091|NCT02094352|HSS|Dr. Richman|212.517.4481|RichmanD@HSS.EDU
89092|NCT02094326|Hospital Virgen de la Macarena|Dr. Federico Navarro Sarabia|+34 955 00 80 00|federico.navarro.sarabia@gmail.com
89093|NCT02094300|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|SSnyder@medinst.com
89095|NCT02093962|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com
89097|NCT02093923|Dyax Corp.|Carolyn Soo|+1-617-250-5874|csoo@dyax.com
89098|NCT02093897|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
89099|NCT02093819|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89100|NCT02093702|Barrie and Community Family Health Team|Dr. Andrew Wozniak|(705) 728-2618|andrew.wozniak@barriefht.ca
89102|NCT02093390|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com
89104|NCT02093234|GW Medical Faculty Associates|Richard Katz, MD|202-741-2323|RKatz@mfa.gwu.edu
89105|NCT02093026|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
89106|NCT02092961|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
89107|NCT02092857|University of Alberta|Dr. Tom Clandinin|7804925188|tclandin@ualberta.ca
89108|NCT02092662|University of Haifa|Sharon Israely|972-523-755-091|sharonis@mh.org.il
89109|NCT02092649|University of Guelph|Sebastian Jannas-Vela MSc|(519)-824-4129 ext 53907|sjannas@uoguelph.ca
89110|NCT02092610|Radboud University Hospital Nijmegen Medical Centre|Dr. Myrthe Hol|(024) 36 14934|Myrthe.Hol@radboudumc.nl
89111|NCT02092441|Brooke Army Medical Center|Dr. Michael D. April|210-916-6129|Michael.D.April@post.harvard.edu
89112|NCT02092415|Oregon Health & Science University|Jonathan Lindner MD|503 595-8750|lindnerj@ohsu.edu
89113|NCT02092389|AbbVie|Global Medical Information|1-800-633-9110|
89114|NCT02092350|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com
89115|NCT02092311|OMID FERTILITY CENTER|Dr.Navid Pooyan|00989124474032|navidpooyan@yahoo.com
89116|NCT02092168|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
89117|NCT02092116|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com
89118|NCT02091986|AstraZeneca|Global Clinical Lead Göran Eckerwall||ClinicalTrialTransparency@astrazeneca.com
89120|NCT02091856|West University of Timisoara|Dr. Bogdan Tudor Tulbure|+040745753061|btulbure@gmail.com
89121|NCT02091778|Podiatry and Foot health, Stott Lane Salford ,UK|Paul Chadwick|0161 206 4710|paul.chadwick@salford.nhs.uk
89122|NCT02091752|Novartis|Study Director|862-778-8300|
89123|NCT02091726|University of New England|Peter S. Millard, MD, PhD|2072992131|pmillard@mac.com
89124|NCT02091466|Faculdade de Ciências Médicas da Santa Casa de São Paulo|Dr. Ricardo Caio Gracco De Bernardis|55-11-21767280|rcaiog@yahoo.com.br
89125|NCT02091414|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89126|NCT02090855|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6489|Paul.Sherwin@ge.com
89127|NCT02090777|Duke Eye Center|Jullia Rosdahl MD PhD|919-684-8850|jullia.rosdahl@duke.edu
89128|NCT02090764|Ferrer Internacional, S.A.|Clinical Research Manager|+34 93 509 32 75|nalbareda@ferrer.com
89129|NCT02090413|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
89130|NCT02090088|Amgen Inc.|Study Director|866-572-6436|
89131|NCT02089737|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com
89132|NCT02089347|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
89133|NCT02089191|Alcon Research, Ltd.|Global Medical Affairs Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com
89134|NCT02089113|Ocular Therapeutix, Inc.|Director, Clinical Affairs|781-357-4013|dmulani@ocutx.com
89135|NCT02088957|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
89136|NCT02088177|NYSPI|Dr. Frances R. Levin||frl2@cumc.columbia.edu
89137|NCT02087995|Dexcom, Inc|Andrew Balo/ EVP|8582000203|abalo@dexcom.com
89138|NCT02087943|CelgeneCorp|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|amcclain@celgene.com
89139|NCT02087774|Marshall University|Rebecca Hayes, M.D.|3046173570|hayes79@live.marshall.edu
89140|NCT02087748|Lotus Clinical Research, LLC|Anne Arriaga, VP of Clinical Operations|626-397-3412|anne@lotuscr.com
89141|NCT02087670|Universidad de Antioquia|Jesus Alberto Plata Contreras|5742196478|rehabilitacionsalud@siu.udea.edu.co
89142|NCT02087241|SCRI Development Innovations|Charles H. Davis|+615-524-4341|charles.davis2@scri-innovations.com
89143|NCT02087176|SCRI Development Innovations|Charles H. Davis|+615-524-4341|charles.davis2@scri-innovations.com
89144|NCT02087059|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
89145|NCT02086786|Rovi S.A. Laboratorios Farmacéuticos|Jordi Llaudó Garín ( Clinical Development Manager)|+34913756230|jllaudo@rovi.es
89146|NCT02086708|Massachusetts General Hospital|Dr. Uzma Shah|617-726-1450|USHAH@mgh.harvard.edu
89147|NCT02086591|University of Rochester|Carla Casulo|585-273-3258|carla_casulo@urmc.rochester.edu
89148|NCT02085785|Department of Veterans Affairs|Dr. Alyson Littman, Research Health Scientist|206-277-4182|alyson.littman@va.gov
89149|NCT02085720|Chinese University of Hong Kong|Dr Susanna Ng SS|85226322211|drsssng123@yahoo.com.hk
89150|NCT02085161|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89151|NCT02084797|Oakland University|Tamara Hew-Butler|248-364-8686|hew@oakland.edu
89152|NCT02084706|Brigham and Women's Hospital|Dr. Philip Blazar|617-732-5384|pblazar@partners.org
89153|NCT02084628|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com
89154|NCT02084238|Peking University People's Hospital|Dr. Jing He|86 ext 1861170734|hejing1105@126.com
89155|NCT02084082|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89156|NCT02084069|Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences|Yousef Rezaei|+989126231864|yousefrezaei1986@gmail.com
89157|NCT02084056|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89158|NCT02083965|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com
89159|NCT02083679|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
89160|NCT02083406|Medicines for Malaria Venture (MMV)|Fiona Macintyre, PhD|+41 22 555 0319|macintyref@mmv.org
89161|NCT02083380|Medical University of Vienna, Division of Infectious Diseases and Tropical Medicine|Associate Professor Dr Michael Ramharter|+43140400-44400|michael.ramharter@meduniwien.ac.at
89162|NCT02083263|Karolinska University Hospital|Maria Cecilia Rodriguez Hortal|0046709558699|cecilia.rodriguez-hortal@karolinska.se
89163|NCT02083107|AinShams University|Dr. Mohamed S. Sweed, Dr.Mourad M.El-Said, Dr.Amgad E. Abou-Gamrah, Dr.Mohamed M. Abd-El-Hamid|01001222047 ext +2|drmsweed@gmail.com
89164|NCT02082912|Emory University|Dr. Andrew John Butler|404-413-1415|ajbutle@emory.edu
89165|NCT02082769|Department of Endocrinology, Xijing Hospital, Fourth Military Medical University|Qiuhe Ji|+86-29-84775213|qiuheji@hotmail.com
89166|NCT02082392|New York State Psychiatric Institute|Bret Rutherford|6467748660|brr8@cumc.columbia.edu
89167|NCT02082288|al-azhar university|wael mohamed hamed|002-01001556162|wael79hamed@yahoo.com
89168|NCT02082262|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
89169|NCT02082184|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com
89170|NCT02082158|National Center for Occupational Health and Infection Control|Aaron Eagan|352-376-1611 ext 4973|aaron.eagan@va.gov
89171|NCT02081859|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org
89172|NCT02081677|Johnson & Johnson Vision Care Inc.|Tawnya Wilson, Principal Research Optometrist|904-443-1834|TWilson@ITS.JNJ.com
89173|NCT02081599|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
89174|NCT02081586|University of Pittsburgh School of Nursing|Dr. Judith A. Callan PhD, RN|412-383-5321|callanja@pitt.edu
89175|NCT02081443|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu
89176|NCT02081365|Maurice H. Kornberg School of Dentistry, Temple University|Marisol Tellez M. BDS, MPH, Ph.D|215-707-1773|marisol@temple.edu
89177|NCT02081183|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89178|NCT02081079|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
89179|NCT02081014|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP Drug Development|512-498-2675|mjcummins@xerispharma.com
89180|NCT02081001|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP for Drug Development|512-498-2675|mcummins@xerispharma.com
89181|NCT02080780|Ventrus Biosciences|Ventrus|646-706-5208|VEN307@ventrusbio.com
89182|NCT02080546|Duke University Medical Center|Dr Paula S Lee|919-684-3765|paula.s.lee@duke.edu
89183|NCT02080507|Emory University|Dr. William McDonald|404-712-6945|wmcdona@emory.edu
89184|NCT02080481|Cleveland Clinic|Aplarslan Turan, MD|216-445-9857|turana@ccf.org
89186|NCT02080091|Alimera Sciences, Ltd.|Andrew Joyson - Associate Director, Clinical Operations Europe|+44 1252 354 026|Andrew.Joyson@alimerasciences.com
89187|NCT02079844|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
89188|NCT02079805|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
89189|NCT02079649|Alcon Research, Ltd.|Clinical Project Lead, Pharma, GCRA|1-888-451-3937|alcon.medinfo@alcon.com
89190|NCT02079610|University of Pittsburgh School of Medicine|Kymberly Young, PhD|412-648-6179|youngk@pitt.edu
89191|NCT02079532|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89192|NCT02079519|Hoffmann-La Roche|Medical Communications|800 821-8590|
89193|NCT02079311|Universitätsklinikum Gießen und Marburg GmbH|Prof Alexander Torossian|(+49) 06421 - 286 9864|alexander.torossian@med.uni-marburg.de
89194|NCT02078492|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org
89195|NCT02078193|East Carolina University, Division of Nephrology|Austin Rice|252-744-1904|riceau15@ecu.edu
89196|NCT02078180|University of Michigan|Dr. Duxin Sun|734-763-9783|pharmacy.research@umich.edu
89197|NCT02077374|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com
89198|NCT02076919|Alcon Research, Ltd.|Principal Clinical Scientist, CA CSI ID|1-888-451-3937|alcon.medinfo@alcon.com
89199|NCT02076334|University University Chapel Hill|Abbie Smith-Ryan, PhD|919-962-2574|abbsmith@email.unc.edu
89200|NCT02076009|Janssen R&D US|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com
89201|NCT02075632|GlaxoSmithKline|GSK Response Center|866-435-7343|
89202|NCT02075515|GlaxoSmithKline|GSK Response Center|866-435-7343|
89203|NCT02075463|GlaxoSmithKline|GSK Response Center|866-435-7343|
89204|NCT02075411|Children's Hospital of Philadelphia|Harshad Gurnaney, MBBS, MPH|215-590-1858|gurnaney@email.chop.edu
89205|NCT02075125|Department of Cardiology, College of Medicine, Dong-A University.|Dr. Moo Hyun Kim; Director of Global Clinical Trial Center Dong-A University Hospital.|+82 (51) 240-2976|kimmh@dau.ac.kr
89206|NCT02075073|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534|
89207|NCT02075021|NYU Clinical Cancer Center|Amitabha Mazumder, MD|(212) 731-5757|Amitabha.Mazumder@nyumc.org
89208|NCT02075008|Novartis Pharmaceuticals|Study Director|862-778-8300|
89209|NCT02074995|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
89210|NCT02074982|Novartis Pharmaceuticals|Study Director|862-778-8300|
89211|NCT02074709|University of Texas Southwestern Medical Center|Irina Gasanova|214-590-0064|Irina.Gasanova@UTSouthwestern.edu
89212|NCT02074553|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
89213|NCT02074514|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
89214|NCT02074384|Park Nicollet Institute|Dr. Deborah Mullen|952-993-2070|deborah.mullen@parknicollet.com
89215|NCT02074358|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
89216|NCT02074345|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
89217|NCT02074059|Windtree Therapeutics, Inc.|Executive Director, Biostatistics & Data Management|215-488-9300 ext 9477|psimmons@windtreetx.com
89218|NCT02073747|University Medical Center of Southern Nevada|Emergency Department Research Coordinator|702-224-7124|wesley.forred@umcsn.com
89219|NCT02073656|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
89220|NCT02073461|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com
89221|NCT02073448|Galderma K.K|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com
89222|NCT02072980|Alcon Research, Ltd.|Cecile Maissa, Global Brand Medical Affairs Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com
89223|NCT02072421|Harvard Clinical Research Institute|Priscilla Driscoll-Shemp|617-307-5200|priscilla.driscoll-shempp@hcri.harvard.edu
89224|NCT02072200|Mundipharma Korea Ltd|Kim Bu Yeon|+82 2 568 5689|BuYeon.Kim@mundipharma.co.kr
89225|NCT02072096|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
89226|NCT02071849|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com
89227|NCT02071823|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
89228|NCT02071810|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
89229|NCT02071771|Alcon Research, Ltd.|Sr Global Brand Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com
89230|NCT02071108|Shockwave Medical, Inc.|Gheda Sahyun, Director of Clinical Affairs|510-624-9073|gsahyun@shockwavemedical.com
89232|NCT02070965|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com
89233|NCT02070692|Oregon Health & Science University|Dr. Katharine Simmons|404-718-6619|simmonka@ohsu.edu
89234|NCT02070640|The Ohio State University Wexner Medical Center|Associate Professor|614-293-3230|raaja.narula@osumc.edu
89235|NCT02070588|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com
89236|NCT02070380|Bracco Diagnostics, Inc.|Gianpaolo Pirovano, MD|609-514-2226|gianpaolo.pirovano@diag.bracco.com
89237|NCT02070302|Arizona Arthritis & Rheumatology Research, PLLC|Amanda Santimaw|4806266653|amanda.santimaw@azarthritis.com
89238|NCT02070237|Memorial Care|Dr. Jennifer McNulty|562-933-2730|jjmcnulty@sbcglobal.net
89239|NCT02069093|Novartis Pharmaceuticals|Study Director|862-778-8300|
89240|NCT02068443|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
89241|NCT02068222|AbbVie|Global Medical Information|800-633-9110|
89243|NCT02068027|BDSI|Vice President Clinical Operations|919-582-0294|twarneke@bdsi.com
89244|NCT02067728|University of Illinois College of Medicine at Peoria|Dr. Amy L. Christison|309-655-3613|alc@uicomp.uic.edu
89245|NCT02067585|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca
89246|NCT02067533|Isfahan University of Medical Sciences|Amin Nemati|00989131009918|nemati@med.mui.ac.ir
89247|NCT02067273|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu
89248|NCT02066922|Alcon Research, Ltd.|Clinical Lead, Vision Care Development|1-888-451-3937|alcon.medinfo@alcon.com
89249|NCT02066896|Federal University of Sao Paulo|Tania Sales de Alencar Fidelix|11991346992 ext 11|fidelixtania@gmail.com
89250|NCT02066857|Emory University|Claude Jarrett, M.D.|404-778-8099|CJarrett@wilmingtonhealth.com
89251|NCT02066740|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com
89252|NCT02066727|Tianjin Medical University General Hospital|Dr Yuechun LU|15902233666|luyuechun@sina.com
89253|NCT02066402|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com
89254|NCT02066233|Mayo Clinic|Dr. Prasad G. Iyer|507-284-6469|Iyer.Prasad@mayo.edu
89255|NCT02066051|Mayo Clinic|Dr. Joanne F. Shen|480-301-8377|shen.joanne@mayo.edu
89256|NCT02065453|Saint Louis University|M. Brigid Holloran-Schwartz, MD|314-781-8605 ext 1|holloran@slu.edu
89257|NCT02064985|Pharmaceutical Product Development, LLC.|Rong Fu|86-021-80135112|rong.fu@ppdi.com
89258|NCT02064920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89259|NCT02064907|Takeda Study Registration Call Center|Takeda|+1-877-825-3327|medicalinformation@tpna.com
89260|NCT02064894|CHU Ste-Justine Hospital|Dr. Sylvie Le May|514-343-6384|sylvie.lemay@umontreal.ca
89261|NCT02064231|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1395|dkbir@coloplast.com
89262|NCT02064205|TNO|W.J. Pasman, PhD|+31888665129|wilrike.pasman@tno.nl
89263|NCT02063880|University of Washington|Grace John-Stewart|206 5434278|gjohn@uw.edu
89264|NCT02063854|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
89265|NCT02063737|Carolinas HealthCare System|Dr. Daniel Patterson|704-446-0433|Daniel.Patterson@carolinas.org
89266|NCT02063659|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com
89267|NCT02063516|tianjinMUGH|Dr. Haiyun Wang|008613752211206|wanghy819@hotmail.com
89268|NCT02063230|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com
89269|NCT02063035|Massachusetts General Hospital, Boston, MA, USA|Dr. Kirkham B. Wood|617-726-2000 ext +1|kbwood@stanford.edu
89270|NCT02062905|Ocular Therapeutix, Inc.|Director, Clinical Affairs|781-357-4000|dmulani@ocutx.com
89271|NCT02062879|UC Health University of Cincinnati Medical Center|Sheila Takieddine|513-585-6195|Sheila.Takieddine@UCHealth.com
89272|NCT02062801|Sharp HealthCare|Dr. David R. Gambling|858-395-5668|david.gambling@sharp.com
89273|NCT02062710|Montefiore Medcial Center|Peter Dicpinigaitis, MD|718-904-2676|pdicpini@montefiore.org
89274|NCT02062658|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|6507236158|carolynrodriguez@stanford.edu
89275|NCT02062645|Novartis Pharmaceuticals|Study Director|862-778-8300|
89276|NCT02062580|University of Cape Town and University of Washington|Heather Jaspan|+2721 4066823|hbjaspan@gmail.com
89277|NCT02062502|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89278|NCT02062450|TORNIER SAS|Nathalie TRETOUT|+33 4 76 71 35 00|nathalie.tretout@tornier.com
89279|NCT02062437|Tornier SAS|Nathalie Trétout|+33 4 76 71 35 00|nathalie.tretout@tornier.com
89281|NCT02062359|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov
89282|NCT02062294|Hoffmann-LaRoche|Clinical Operations Department|800-821-8590|switzerland.clinical-research@roche.com
89283|NCT02062177|Università Vita-Salute San Raffaele|Professor Testoni Pier Alberto|+390226432756|testoni.pieralberto@hsr.it
89284|NCT02061748|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89285|NCT02061696|Borgess Heart Institute|Frank Saltiel, MD|269-381-3963|
89286|NCT02061683|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
89287|NCT02061592|Johnson & Johnson Vision Care, Inc|Brian Pall, OD, MS, FAAO - Senior Principal Research Optometrist|904-443-3500 ext 1290|BPALL@its.jnj.com
89288|NCT02061540|Shire|Study Physician|1 866-842-5335|
89289|NCT02061358|Emergent BioSolutions|Timothy Babinchak, MD, Vice President Clinical and Medical Affairs|1-484-318-8851|babinchakt@ebsi.com
89290|NCT02060838|Nationwide Children's Hospital|Aymen Naguib, MD|(614) 722-0596|Aymen.Naguib@nationwidechildrens.org
89292|NCT02060526|Shire|Study Physician|ClinicalTransparency@shire.com|
89293|NCT02059993|State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College|Zhihong Liu|+86-01088398196|zhihongliufuwai@163.com
89294|NCT02059928|Health Partners|Dr. Ralph J Frascone|6512545304|ralph.j.frascone@healthpartners.com
89295|NCT02059902|Health Partners|Dr. William J Mohr|(651)454-5304|William.J.Mohr@healthpartners.com
89296|NCT02059642|Alcobra|Dr. Jonathan Rubin|610-940-1631|jrubin@alcobra-pharma.com
89297|NCT02059291|Novartic Pharmaceuticals|Study Director|862-778-8300|
89298|NCT02059187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89300|NCT02059161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89301|NCT02059135|LFB USA|Laura Massey, Sr. Clinical Project Manager|508-370-5157|laura.massey@lfb-usa.com
89302|NCT02059070|Wayne State University, School of Medicine|Pranav Patel|313-745-7233|gmckelve@dmc.org
89303|NCT02058992|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
89306|NCT02058537|Temple University Hospital|Ron Schey|215-540-0120|Ron.schey@tuhs.temple.edu
89307|NCT02058498|Mayo Clinic Jacksonville|Jennifer Serotta, DNP, ARNP|904-956-3200|serotta.jennifer@mayo.edu
89308|NCT02058290|Pacira Pharmaceuticals, Inc.|Erol Onel, MD|858-625-2424|erol.onel@pacira.com
89309|NCT02058160|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
89310|NCT02058147|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
89311|NCT02058069|MAKO Surgical Corp.|Michael Conditt|7132408675|michael.conditt@stryker.com
89312|NCT02057835|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89313|NCT02057549|The University of Texas Houston Health Science Center|Dr. Carlos J. Roldan MD|713-792 6070|croldan@mdanderson.org
89314|NCT02057406|Duke University Medical Center|Dr. Wei Jiang|919-668-0762|jiang001@mc.duke.edu
89315|NCT02057393|Penn State Hershey Medical Center|Colette Pameijer, Associate Professor of Surgery|717-531-5272|cpameijer@pennstatehealth.psu.edu
89316|NCT02057276|Cincinnati Children's Hospital Medical Center|Steve Wu, MD|513-636-4222|steve.wu@cchmc.org
89317|NCT02057250|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
89318|NCT02057237|Princess Margaret Cancer Centre|Dr. Anthony Joshua|416-946-4501 ext 2520|anthony.joshua@uhn.ca
89319|NCT02056834|Synthes GmbH|Clinical Research Scientist Biomaterials|0041327204465|clinicalaffairs.emea@synthes.com
89320|NCT02056392|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com
89321|NCT02055430|Cairo University|dr Mohammed Said ElSheemy|01006117755|mohammedshemy@yahoo.com
89322|NCT02055404|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|1-888-451-3937|alcon.medinfo@alcon.com
89323|NCT02055352|Novartis Pharmaceuticals|Study Director|862-778-8300|
89324|NCT02054910|University of Alabama at Birmingham|Jaypal Ramesh|205-975-9564|jramesh@uab.edu
89325|NCT02054754|e-Therapeutics Plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk
89326|NCT02054715|University of Rochester Medical Center|Gary R. Morrow, PhD, MS; Deans Professor of Oncology|585-275-9961|Gary_Morrow@urmc.rochester.edu
89327|NCT02054702|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
89328|NCT02054572|Amgen Inc.|Study Director|866-572-6436|
89329|NCT02054481|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89330|NCT02054325|UPECLIN|Dr. Matheus Bertanha|+55 14 38116305|matheus.fameca@ig.com.br
89332|NCT02053493|Duke Clinical Research Insitute|Dr. Adrian Hernandez|919-668-7515|Adrian.Hernandez@duke.edu
89333|NCT02052895|Mochida Pharmaceutical|Hironori Sato|+81-3-3225-6331|hnsato@mochida.co.jp
89334|NCT02052752|GlaxoSmithKline|GSK Response Center|866-435-7343|
89335|NCT02052661|GlaxoSmithKline|GSK Response Center|866-435-7343|
89336|NCT02052635|AstraZeneca AB|Anders Himmelmann, MD PhD|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com
89337|NCT02052544|DSM Nutritional Products Ltd Branch Pentapharm|Anne Brisset|41 61 706 4837|Anne.Brisset@pentapharm.com
89338|NCT02052466|Cleveland Clinic Foundation|Dr. Eric Ricchetti|2164456915|ricchee@ccf.org
89339|NCT02052414|The Center for Clinical Research|James M. North MD|3367656181|jnorth1@ccrpain.com
89340|NCT02052011|Yale School of Medicine|Dr. Basmah Safdar|2037853453|basmah.safdar@yale.edu
89341|NCT02051816|LSU School of Medicine New Orleans|David Janz, MD, MSc|504-568-3167|djanz@lsuhsc.edu
89342|NCT02051790|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
89343|NCT02051595|University of Florida|Dr. Ettore Crimi|617-697-2861|ettorecrimi@gmail.com
89344|NCT02051426|Herzog Hospital|Uriel Heresco-Levy, M.D.|+972-2-5316906|urielh@ekmd.huji.ac.il
89345|NCT02051335|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
89346|NCT02050334|Chemigen|Consultant|317 293-0852|farlowds@yahoo.com
89347|NCT02050321|University of Arizona Cancer Center|Dr. Lee Cranmer|520 626-0501|lcranmer@uacc.arizona.edu
89348|NCT02050048|NorthShore Univeristy HealthSystem|Dr. Russell Brown|847-657-1900|rbrown@northshore.org
89349|NCT02049931|Seoul National University|Professor Jin S. Yeom|82-31-787-7195|highcervical@gmail.com
89350|NCT02049450|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
89351|NCT02049151|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Centre|496151725200|service@merckgroup.com
89352|NCT02048904|University of Missouri|Principal Investigator|573-882-2273 lastrag@healt|lastrag@health.missouri.edu
89353|NCT02048891|Rambam health Care campus|Shahar Kol Director IVF Unit|97247773232|skol@rambam.health.gov.il
89354|NCT02048072|Cantonal Hospital of St. Gallen|Jochen Vehoff|0041714941111|jochen.vehoff@kssg.ch
89355|NCT02047747|University of California, San Diego|David Piccioni M.D., Ph.D.|(858) 822-6346|dpiccioni@ucsd.edu
89356|NCT02047227|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
89357|NCT02046993|Kwong Wah Hospital|Dr Lorna Ng|(852) 23322311|ngl@ha.org.hk
89358|NCT02046980|Daegu Kyungbook Dizziness society|Dr. Hyun Ah Kim|+82-53-250-7475|kha0206@dsmc.or.kr
89359|NCT02046863|Great Lakes NeuroTechnologies Inc|Biomedical Research Manager|2163615410|dheldman@glneurotech.com
89360|NCT02046772|Hospital Universitario Príncipe de Asturias|Antonio Rodríguez Miguel|+34 91 887 81 00 ext 2610|antonio.hupa@gmail.com
89361|NCT02046265|University of Pennsylvania School of Nursing|Dr. Anne Teitelman|215-898-1910|teitelm@nursing.upenn.edu
89362|NCT02046226|Halyard Health, Inc.|David T Curd|470-448-5178|david.curd@hyh.com
89363|NCT02046200|UCLA Department of Psychology|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu
121652|NCT00247624|August Health University|Vaughn McCall|706-721-3141|wmccall@augusta.edu
89365|NCT02045836|GlaxoSmithKline|GSK Response Center|866-435-7343|
121653|NCT00246740|Departments of Pediatrics and Pharmacology, University of Alberta|Dr Richard Schulz|780-492-6581|richard.schulz@ualberta.ca
89485|NCT02026453|Cedars-Sinai Medical Center|Dr. Joshua M. Pevnick|310-423-6976|Joshua.Pevnick@cshs.org
89367|NCT02045732|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
89368|NCT02045511|Johns Hopkins University School of Medicine Dept. Otolaryngology-HNS|Carrie Nieman|3025368362|cnieman1@jhmi.edu
89369|NCT02045264|Shire Development LLC|Study Physician|+1 866 842 5335|
89370|NCT02045238|Hospital Universitario - Sao Paulo University|Dr. Mateus Deckers Leme|X551130919200 ext 9451|mateusdl@gmail.com
89371|NCT02044991|Loyola University|Colleen Fitzgerald, M.D., M.S.|708-216-2180|cfitzgerald@lumc.edu
89372|NCT02044848|Novartis Pharmaceuticals|Study Director|862-778-8300|
89373|NCT02044822|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
89374|NCT02044458|Aurora Health Care, Inc.|Jessica J F Kram, MPH|414-219-5594|jessica.kram@aurora.org
89375|NCT02044393|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89376|NCT02044380|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89377|NCT02044367|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89378|NCT02044302|Yale Center for Clinical Investigations|Katisha Brown CPC|(203) 737-7495|katisha.brown@yale.edu
89379|NCT02043808|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89380|NCT02043782|Coloplast A/S|Medical Director|+45 4911 1395|dkbir@coloplast.com
89381|NCT02043379|UAB Pediatric Cardiac Critical Care Medicine|Jeffrey Alten, MD|(205) 975-3123|jalten@peds.uab.edu
89382|NCT02043366|Tianjin Medical University General Hospital|Dr. Guolin Wang|+8615822855556|wangguolinghad@hotmail.com
89383|NCT02043145|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com
89384|NCT02043132|Beaumont Health|Dr. J. Michael Wiater|248-551-3140|J.Michael.Wiater@beaumont.edu
89386|NCT02042911|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1127|
89387|NCT02042872|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000 ext 5428|william.bauman@va.gov
89388|NCT02042534|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr
89389|NCT02042443|SWOG Statistics & Data Management Center|SWOG Statistician|206-667-4408|
89390|NCT02042404|EarLens Corporation|Dr. Suzanne Levy, Director of Clinical Research|650 366 9000|slevy@earlenscorp.com
89391|NCT02042274|University of Guelph|Dr. David Mutch, Associate Professor|519-824-4120 ext 53322|dmutch@uoguelph.ca
89392|NCT02042131|The University of Utah|Craig Bryan|801-587-7978|craig.bryan@utah.edu
89393|NCT02041533|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
89394|NCT02041520|Instituto Mexicano del Seguro Social, UMAE HE No. 1 Bajio|Dr. Norma Amador|+524777174800 ext 31315|norma.amador@imss.gob.mx
89395|NCT02041377|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com
89396|NCT02041325|BVARI|Dr. Nikhil C. Munshi|857-203-6172|nikhil_munshi@va.gov
89397|NCT02041286|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com
89398|NCT02041221|SPARC|Dr Shravanti Bhowmik|+91 22 66455645|
89399|NCT02040792|Theravance Biopharma US, Inc.|Glenn Crater, Head of Clinical Development & Medical Affairs, Respiratory|650-808-6000|gcrater@theravance.com
89400|NCT02040623|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com
89401|NCT02040532|MGH Center for Women's Mental Health|Dr. Lee Cohen|617-724-0816|lcohen2@partners.org
89402|NCT02040428|Ethicon, Inc.|Richard Kocharian, MD, PhD|1 (908) 218-2013|rkochar1@ITS.JNJ.com
89405|NCT02039817|Conatus Pharmaceuticals|Jean L. Chan, MD|858 376 2632|jchan@conatuspharma.com
89406|NCT02039778|Mount Sinai Beth Israel|Dr. Rahul Parikh|732-253-3939|parikhrr@cinj.rutgers.edu
89407|NCT02039687|Araim Pharmaceuticals, Inc.|Chief Medical Officer|914-762-7586|info@araimpharma.com
89408|NCT02039427|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com
89409|NCT02039414|Western Kentucky University|Dr. Rachel Tinius, Assistant Professor|2707455026|rachel.tinius@wku.edu
89410|NCT02039115|Center for Interventional Endoscopy|Robin (Barron-Nelson) Kangas|407.303.5503|Robin.Barron@flhosp.org
89411|NCT02038959|University of Rochester|Ray Dorsey, MD|585-276-6824|ray.dorsey@chet.rochester.edu
89412|NCT02038933|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
89413|NCT02038907|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
89414|NCT02038790|Indivior, Inc.|Global Director Clinical Development|804-379-1090|
89415|NCT02038543|Mayo Clinic|Dr. John C. Lieske|507-284-2064|Lieske.John@mayo.edu
89416|NCT02038075|University of Utah|Dr. Craig Bryan|8015877978|craig.bryan@utah.edu
89417|NCT02037776|Osaka Medical College|Kazunari Tominaga, M.D., Ph. D.|+81-72-683-1221 ext 8096|in2139@osaka-med.ac.jp
89419|NCT02037477|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
89420|NCT02037425|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cay, M.D.|417-883-7889|rcady@banyangroupinc.com
89421|NCT02037347|Yale University|Brett King MD|203-785-4092|brett.king@yale.edu
89422|NCT02036840|Nationwide Children's Hospital|Ralph Beltran, MD|614-722-4200|Ralph.Beltran@nationwidechildrens.org
89423|NCT02036775|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89424|NCT02036580|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
89425|NCT02036541|Allergan plc|Rupali Nangia|714-246-6020|rupali.nangia@allergan.com
89427|NCT02036424|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com
89428|NCT02036320|Johnson and Johnson Vision Care Inc.|Meredith Jansen,O.D.,M.S., FAAO|904-443-3500 ext 1396|mjanse12@ITS.JNJ.com
89429|NCT02035748|Alcon, a Novartis company|EMEA Medical Affairs Lead, Pharma|1-888-451-3937|alcon.medinfo@alcon.com
89431|NCT02035475|OhioHealth|Dr. Ronney Abaza|614-544-8104|ronney.abaza@ohiohealth.com
89432|NCT02035345|Massachusetts General Hospital|Dr. Aleena Banerji|6177263850|abanerji@mgh.harvard.edu
89433|NCT02035332|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com
89434|NCT02034877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
89435|NCT02034708|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical|+33 (0) 1 45 91 51 84|corinne.dubourdieu@guerbet-group.com
89436|NCT02034591|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
89437|NCT02034578|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
89438|NCT02034565|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
89440|NCT02034513|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
89441|NCT02034162|Janssen R&D US|DIRECTOR CLINICAL LEAD||ClinicalTrialDisclosure@its.jnj.com
89442|NCT02033317|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com
89443|NCT02033213|KBC Zagreb|Maja Karaman Ilić, MD PhD|00385 1 2385 122|majakilic1@gmail.com
89444|NCT02033200|Vivus Inc|VP of Development|650-934-5200|
89445|NCT02033174|IiSGM|Dr Alvarez-Sala|+34 915868287|luisantonio.alvarezsala@salud.madrid.org
89446|NCT02032901|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
89447|NCT02032888|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
89448|NCT02032875|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
89449|NCT02032758|Mayo Clinic in Arizona|Dr. Charles H. Adler|480-301-8100|cadler@mayo.edu
89450|NCT02032706|Advanced Brain Monitoring, Inc.|Daniel Levendowski|760 720 0099 ext x6040|dan@b-alert.com
89451|NCT02032641|Bascom Palmer Eye Institute|Dr. Sara T. Wester|3053266132|SWester2@med.miami.edu
89452|NCT02032420|University of New Mexico|Dr. Nicholas Lam|505-272-2610|nlam@salud.unm.edu
89453|NCT02032407|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
89454|NCT02032238|OD-OS GmbH|Ulrike Weber|+49 332831282 ext 100|ulrike.weber@od-os.com
89455|NCT02032212|Imperial Tobacco Group|Tanvir Walele|0044 177 933 7589|tanvir.walele@uk.imptob.com
89456|NCT02031679|Johns Hopkins University School of Medicine|Dr. Eric Oliver|410-550-2300|eolive15@jhmi.edu
89457|NCT02031471|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
89458|NCT02031458|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com
89459|NCT02030600|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com
89460|NCT02030574|Brown Oncology Research Groupl|Kristen M. Mitchell|4018633000|kristen_mitchell@brown.edu
89461|NCT02030535|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89462|NCT02030405|Stanford University Medical Center|Bruno Carneiro de Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu
89463|NCT02030041|PGIMER|Anil Bhansali|01722756583|ashuendo@gmail.com
89465|NCT02029911|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com
89466|NCT02029846|Johns Hopkins University|Dr. Hsin-Chieh Yeh|410-614-4316|hyeh1@jhmi.edu
89467|NCT02029755|Taipei medical university hospital|Dr. Hsiao-Chien Tsai|+886-2-27372181 ext 8310|hctsai.anes@gmail.com
89468|NCT02029703|Cleveland Clinic|M. Elaine Husni, MD, MPH|216-445-1853|HUSNIE@CCF.ORG
89469|NCT02029521|Intermountain Healthcare|Clark Bishop|385 224 7343|clark.bishop@imail.org
89470|NCT02029495|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com
89471|NCT02029417|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
89472|NCT02029196|Fontem Ventures|Dr Ana Cravo|+441173322528|AnaMaria.Cravo@fontemventures.com
89473|NCT02028780|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89474|NCT02028767|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89475|NCT02028754|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
89476|NCT02028676|Medical Research Council|Professor Ann Sarah Walker|+44 20 7670 4726|rmjlasw@ucl.ac.uk
89477|NCT02028325|Indiana University|Aaron Cohen-Gadol, MD, MSc|317-362-8760|acohen@goodmancampbell.com
89478|NCT02028169|AbbVie|Global Medical Services|800-633-9110|
89479|NCT02028065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89480|NCT02027883|Wellmont CVA Heart Institute|Terrie Walker, Director of Clinical Research|423-230-5643|twalker@mycva.com
89481|NCT02027844|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Deagu, Repulic of Korea|Sun Mee Jung, M.D.|+82-53-620-3368|applejsm@gmail.com
89482|NCT02027402|Seoul St Mary's hospital|Teaho Hong|821052065266|gshth@catholic.ac.kr
89483|NCT02027311|Digestive Disease Center and Department of Internal Medicine, Cheju Halla General Hospital|Dr. Byung Hyo Cha, Director of ETOMI-1 study|+82-64-740-8050|drhyo@hotmail.com
89484|NCT02027272|University of Mississippi Medical Center|James N. Martin, Jr.|601-984-5358|jnmartin@umc.edu
89486|NCT02026258|UConn Health|Flavio Uribe|8606793656|furibe@uchc.edu
89487|NCT02026206|Pusan Natinal University Yangsan Hospital|Professor Yong-Il Shin|82-55-360-2872|rmshin01@gmail.com
89488|NCT02026193|Rambam health Care campus|Dr Shahar Kol , Director IVF Unit|97247773232|skol@rambam.health.gov.il
89489|NCT02026141|University of Saskatchewan-Department of Anesthesia|Dr. Ian Chan|306-717-8028|iac549@mail.usask.ca
89490|NCT02025907|Janssen Research & Development, LLC|Senior Director, Clinical Leader||ClinicalTrialDisclosure@its.jnj.com
89491|NCT02025829|University Hospitals Cleveland Medical Center|Dr. James Chmiel|216-844-3267|James.Chmiel@uhhospitals.org
89492|NCT02025647|NCS Pearson|Dr. Paul E Williams, Sr. Research Director|952-681-4553|paul.e.williams@pearson.com
89493|NCT02025075|Massachusetts General Hospital|Marcos Vidal Melo, MD, PhD|617-726-8980|VidalMelo.Marcos@mgh.harvard.edu
89494|NCT02024971|Takeda Pharmaceuticals Company Limited|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
89495|NCT02024932|Novartis Pharmaceuticals|Study Director|862-778-1873|
89496|NCT02024867|University at Buffalo|Dr. Lucy Holmes|716-878-7277|LHolmes@upa.chob.edu
89497|NCT02024724|Northwestern University, Feinberg School of Medicine|Antoun Nader, M.D.|312-695-4814|a-nader2@northwestern.edu
89498|NCT02024698|CooperVision, Inc.|Manager Global Medical/Scientific Affairs|925-621-3761|javega@coopervision.com
89499|NCT02024386|Duke University School of Medicine|Richard Moon, MD|919-684-6726|richard.moon@duke.edu
89500|NCT02024165|Winnie Palmer Hospital for Women and Babies|John Busowski, MD|407-435-1485|john.busowski@orlandohealth.com
89502|NCT02023918|UCSF|Dr. Ethan Weiss|4155140819|ethan.weiss@ucsf.edu
89503|NCT02023879|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
89504|NCT02023801|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com
89505|NCT02023515|UKentucky|Kelly Webber, PhD, RD, LD|859-257-4351 ext 859|kelly.webber@uky.edu
89506|NCT02023268|Laboratoires Théa|Dr Pascale Pouliquen|04 73 98 14 36|p.pouliquen@laboratoires-thea.fr
89507|NCT02023125|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
89508|NCT02023112|AbbVie|Global Medical Information|800-633-9110|
89509|NCT02023099|AbbVie|Global Medical Services|800-633-9110|
89510|NCT02022748|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD|+1 302-885-8976|Naeem.Khan@astrazeneca.com
89511|NCT02022670|University of Colorado Boulder|Dr. Allison DeVan|303-735-6410|allison.devan@colorado.edu
89512|NCT02022085|Radboud University Medical Centre, Nijmegen, The Netherlands|Professor Emmanuel Mylanus|+31 24 361 1111|Emmanuel.Mylanus@radboudumc.nl
89513|NCT02022020|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89514|NCT02022007|Woman''s Hospital|Dr Karen Elkind-Hirsch|225-231-5275|karen.elkind-hirsch@womans.org
89515|NCT02021812|W.L. Gore & Associates|Jennifer Gorman|928-863-8483|jgorman@wlgore.com
89516|NCT02021461|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com
89517|NCT02021331|University of Michigan|Dr. Robert Eber|734-647-4023|reber@umich.edu
89518|NCT02021071|Philips|Rami Nachabe, PhD|+1-513-926-1486|Rami.Nachabe@philips.com
89519|NCT02020941|IndianaU|Dr. Attaya Suvannasankha|317-944-0920|asuvanna@iu.edu
89520|NCT02020863|University of California, Irvine Health|Maxime Cannesson, PhD|714- 456-5059|mcanness@uci.edu
89521|NCT02020577|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89522|NCT02020512|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
89523|NCT02020369|LFB USA Inc.|Jeffry Lawrence, MD, Vice President, Clinical Development|+1.508.370.5113|jeffry.lawrence@lfb-usa.com
89525|NCT02020135|Progenics Pharmaceuticals, Inc.|Dr. Vincent A. DiPippo|(646) 975-2502|vdipippo@progenics.com
89526|NCT02020031|Mayo Clinic|Dr. Mark J. Spanghel|480-301-5685|Spangehl.Mark@mayo.edu
89527|NCT02019563|The Hospital for Sick Children|Trang Nguyen|6473300825|trang.nguyen@easternhealth.ca
89528|NCT02019550|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
89530|NCT02018809|University of Pennsylvania|Dr. Peter P. Reese|215-898-6086|peter.reese@uphs.upenn.edu
89531|NCT02017574|Baltimore Veterans Affairs|Jeremy Rietschel, PhD|410-605-7000 ext 3233|jeremy.rietschel@va.gov
89532|NCT02017093|University of Haifa|Prof. Eli Carmeli|972-4-8288-397|ecarmeli@univ.haifa.ac.il
89533|NCT02017015|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com
89534|NCT02016963|Human Genome Sciences Inc.|GSK Response Center|866-435-7343|
89535|NCT02016690|AbbVie|Global Medical Services|800-633-9110|
89536|NCT02016625|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89537|NCT02016482|AbbVie|Global Medical Services|800-633-9110|
89538|NCT02016170|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu
89539|NCT02016105|Sandoz|Global Program Medical Director|+49 8024 476 ext 0|biopharma.clinicaltrials@sandoz.com
89540|NCT02015910|Georgetown University Medical Center|Paul J. Kim, DPM, Director of Research|202-444-3059|Paul.J.Kim@gunet.georgetown.edu
89541|NCT02015793|AbbVie|Global Medical Services|800-633-9110|
89542|NCT02015676|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89543|NCT02015663|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
89544|NCT02015546|Duke University Medical Center|Dr. Ashwin Patkar|919-681-0613|ashwin.patkar@duke.edu
89546|NCT02015234|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|212 980 9155 ext 117|greg.sullivan@tonixpharma.com
89547|NCT02015221|Tactile Medical|Director of Clinical Research|6123555121|shoy@tactilemedical.com
89548|NCT02015195|Division of Emergency Medicine, Department of Surgery, Stanford University School of Medicine|Paul Auerbach, MD|650.725.9445|auerbach@stanford.edu
89549|NCT02014584|GlaxoSmithKline|GSK Response Center|866-435-7343|
89550|NCT02014480|GlaxoSmithKline|GSK Response Center|866-435-7343|
89551|NCT02014467|GlaxoSmithKline|GSK Response Center|866-435-7343|
89552|NCT02014441|Amgen Inc.|Study Director|866-572-6436|
89553|NCT02014402|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com
89554|NCT02014363|e-Therapeutics plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk
89555|NCT02014272|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
89556|NCT02014051||Director of Clinical Trials|+81-3-5472-1127|kgoto.34@symbiopharma.com
89557|NCT02013830|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89558|NCT02013817|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89559|NCT02013765|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89560|NCT02013687|Fraunhofer USA Center for Molecular Biotechnology|Dr. Jessica Chichester, Senior Scientist Immunology|302-369-3635|jessica.chichester@fhcmb.org
89561|NCT02013622|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
89562|NCT02013609|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
89563|NCT02013544|Endoceutics|Director of Data Analysis|418-653-0033 ext 215|celine.martel@endoceutics.com
89564|NCT02013531|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
89565|NCT02013388|Nivalis Therapeutics, Inc.|Nivalis Therapeutics, Inc. (Formerly N30 Pharma)|720-945-7700|steven.shoemaker@nivalis.com
89566|NCT02013245|Centre Hospitalier Universitaire Vaudois (CHUV)|Dr. François Spertini, Associate Professor, Division Immunology & Allergy|+41 21 31 40 799|Francois.Spertini@chuv.ch
89567|NCT02013206|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89569|NCT02013050|Soligenix, Inc.|Dr. Richard Straube||rstraube@soligenix.com
89570|NCT02012686|Department of Anesthesiology and Pain Medicine, Gangnam Severance Hospital, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-720, Republic of Korea|Dr Dong Woo Han|82-2-2019-3549|HANESTH@yuhs.ac
89571|NCT02012582|vasopharm GmbH|Dr. Reinhard Schinzel|+49 931 359099 ext 115|schinzel@vasopharm.de
89572|NCT02012452|VA Boston healthcare system|Sandra Japuntich|6082398018|sjjapuntich@gmail.com
89573|NCT02012218|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
89574|NCT02011893|St. Jude Medical|Roni Diaz, Director Clinical Studies|972-309-8601|RDiaz@sjm.com
89575|NCT02011516|University of Pennsylvania|Teresa R. Franklin, Ph.D., Research Associate Professor of Neuroscience in Psychiatry|215-222-3200 ext 119|teresafr@mail.med.upenn.edu
89577|NCT02011464|Maimonides Medical Center|Dr. Piyush M Gupta|7182837189|pgupta@maimonidesmed.org
89578|NCT02011113|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com
89579|NCT02010996|changhai hospital|Bi-Hongda|86-13918233009|bihongda0411@yahoo.com.cn
89580|NCT02010684|University of California Los Angeles|Dr. Jeanne Miranda|310-794-3710|mirandaj@ucla.edu
89581|NCT02010632|Khon Kaen University|Miss Nontaya Nakkam|66862642540|nonna_na@hotmail.com
89582|NCT02010255|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
89583|NCT02010216|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89584|NCT02009982|Emory University|Dr. David De Lurgio|404-251-1481|ddelurg@emory.edu
89585|NCT02009878|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
89586|NCT02009865|AstraZeneca AB|Hong Yang, Study Statistician|+46-(0)317762397|hong.yang1@astrazeneca.com
89587|NCT02009722|Mayo Clinic|Dr. Hans Sviggum|507-581-6083|sviggum.hans@mayo.edu
89588|NCT02009696|Biotronik, Inc.|Clinical Studies Engineer|503-927-7230|justin.michalski@biotronik.com
89589|NCT02009163|Shire Development LLC|Study Physician|+1 866 842 5335|
89590|NCT02008942|PLx Pharma|Ronald Zimmerman, President & CEO|713-842-1249 ext 205|ron.zimmerman@plxpharma.com
89591|NCT02008682|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
89592|NCT02008617|Northwestern University, Feinberg School of Medicine|Rohit Rahangdale, M.D.|312-695-4814|rrahangd@nmff.org
89593|NCT02008526|Friends Research Institute|Dr. Cathy Reback|3234631601|reback@friendsresearch.org
89594|NCT02008227|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
89595|NCT02007954|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu
89596|NCT02007863|University of Miami|Martin Andreansky MD|305-243-0850|mandreansky@med.miami.edu
89597|NCT02007577|Stanford Universtiy|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu
89598|NCT02007434|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com
89599|NCT02007369|School of Public Health, The University of Hong Kong|Dr. Cheung, Yee Tak Derek|+852 39176652|derekcheung@hku.hk
89600|NCT02007278|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
89601|NCT02007252|Novartis Pharmaceuticals|Study Director|862-778-8300|
89602|NCT02007200|University of Michigan Comprehensive Cancer Center|Gregory T. Wolf, M.D.|800-865-1125|gregwolf@umich.edu
89603|NCT02007070|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89604|NCT02006836|Huazhong University of Science and Technology|Dr.Yu|862783662883|xfyu188@163.com
89605|NCT02006732|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89606|NCT02006719|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
89607|NCT02006706|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89608|NCT02006667|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89609|NCT02006407|University of Michigan Comprehensive Cancer Center|Dr. Carl Johannes Koschmann, M.D.|734-647-2893|ckoschma@umich.edu
89610|NCT02006342|The University of Texas Health Science Center at Houston|Dr. Pratik B. Doshi|713-608-6537|Pratik.B.Doshi@uth.tmc.edu
89611|NCT02006108|Stanford University, Department of Radiology|Dr. Heike E. Daldrup-Link|650-497-8601|emisquez@stanford.edu
89612|NCT02005692|Leaf Healthcare, Inc.|Barrett Larson, MD, Chief Medical Officer|650-701-3652|barrett.larson@leafhealthcare.com
89613|NCT02005601|Hospital for Special Surgery|Dr. Jacques Yadeau|212-606-1206|yadeauj@hss.edu
89614|NCT02005562|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89615|NCT02005549|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89616|NCT02005536|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
89617|NCT02005484|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89618|NCT02005393|FujiFilm Medical Systems USA|Robert Uzenoff: Executive Director of Clinical Science|(203) 602-3664|ruzenoff@fujifilm.com
89619|NCT02005211|AstraZeneca|Vice President, Neuroscience iMed||ClinicalTrialTransparency@astrazeneca.com
89620|NCT02005029|Virginia Commonwealth University|Dr. Leslie Cloud|804-662-5304|leslie.cloud@vcuhealth.org
89621|NCT02004990|University of Minnesota|Robert S. Jones DDS PhD|612-626-2900|rsjones@umn.edu
89622|NCT02004886|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89623|NCT02004873|Medtronic Cardiac Rhythm and Heart Failure|Micra Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com
89624|NCT02004847|Philips GmbH Innovative Technologies Aachen|Prof. Dr. Matthias Born|+491735321764|matthias.born@philips.com
89626|NCT02004158|Massachusetts General Hospital|Jeff Huffman|617-724-2910|jhuffman@partners.org
89627|NCT02004132|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
89628|NCT02004093|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89629|NCT02003963|Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632729|amanda.staiano@pbrc.edu
89630|NCT02003638|University of Pennsylvania|Dr. Emil deGoma|2156156521|emil.degoma@uphs.upenn.edu
89631|NCT02003534|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
89632|NCT02003404|Loyola University of Chicago|Dr James Swan, MD|708-485-1271|jswan@lumc.edu
89633|NCT02003391|Alcon Research, Ltd.|Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com
89634|NCT02003352|Brain Synergy Institute|Frederick R Carrick|321-868-6464|drfrcarrick@post.harvard.edu
89635|NCT02003014|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
89636|NCT02002936|SymBio Pharmaceuticals|Katsuhisa Goto|+81-3-5472-1127|
89637|NCT02002871|Philips GmbH Innovative Technologies Aachen|Prof. Dr. Matthias Born|+491735321764|matthias.born@philips.com
89638|NCT02002702|Novartis Pharmaceuticals|Study Director|862 ­778 ­8300|
89639|NCT02002689|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
89640|NCT02002650|Xijing hospital of digestive diseases|Hui Luo|862984771536|fmmulh@163.com
89641|NCT02002221|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
89642|NCT02002208|Atopix Therapeutics Limited|Chief Medical Officer|+44 1235 841 522|atopix@atopixtherapeutics.co.uk
89643|NCT02001181|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
89644|NCT02000973|First Hospital of China Medical University|Jun Wang|8602483283100|wjun2000@hotmail.com
89645|NCT02000921|University of Minnesota|Dorothy Hatsukami|612 626-2121|hatsu001@umn.edu
89646|NCT02000752|Fundación Investigación Biomédica Príncipe de Asturas|Beatriz López Garrido (Midwife)|+34 678210013|bealopega@gmail.com
89647|NCT02000531|HoffmannLa Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com
89648|NCT02000440|GlaxoSmithKline|GSK Response Center|866-435-7343|
89649|NCT02000427|Amgen Inc.|Study Director|866-572-6436|
89650|NCT02000154|SymBio Pharmaceuticals|Katsuhisa Goto|+81-3-5472-1127|
89651|NCT01999894|Forest Research Institute|Ephraim Katz, PhD / Associate Director|201-427-8000 ext 8169|Ephraim.Katz@frx.com
89652|NCT01999400|University of Michigan|Dr. Duxin Sun|734-763-9783|pharmacy.research@umich.edu
89653|NCT01999348|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
89654|NCT01999231|Shanghai Public Health Clinical Center|Shuihua Lu|(+86)18930811818|tubercle@gmail.com
89655|NCT01999192|Biotest AG|Xuefei Zhou Manager Strategy & Development|+496103801 ext 1229|xuefei_zhou@biotest.de
89656|NCT01998919|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89657|NCT01998906|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89658|NCT01998893|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89660|NCT01998737|Bone Index Finland Ltd.|CTO|+358 45 896 2650|janne.karjalainen@boneindex.fi
89661|NCT01998581|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com
89662|NCT01998477|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
89663|NCT01998438|Fuwai Hospital|Dr. Hongwen Ji|+86 13701229553|jihongwen@hotmail.com
89665|NCT01998360|University of New England|Peter S. Millard, MD, PhD|2078663503|pmillard@mac.com
89666|NCT01998269|University of North Carolina at Chapel Hill|Dr. Stacy Bailey|919-843-9834|scbailey@unc.edu
89667|NCT01997905|Methodist Hospital Houston|Basel Ramlawi, MD|713-441-5200|basel.ramlawi@gmail.com
89668|NCT01997892|Amgen Inc.|Study Director|866-572-6436|
89669|NCT01997723|UIllinois|Bharati Prasad|3129968433|bpradsad@uic.edu
89670|NCT01997567|Rush University Medical Center Department of Anesthesiology|Sandeep Amin, M.D|312-942-6449|Sandeep_Amin@rush.edu
89671|NCT01997437|Kuban State Medical University|Dr. Paolo Macchiarini|+7(928)-268-80-00|pmacchiarini@ksma.ru
89672|NCT01997411|Jaeb Center for Health Research|Katrina Ruedy|8139758690|kruedy@jaeb.org
89673|NCT01997398|Barrow Neurlogical Institute / St. Joseph's Hosptial & Medical Center|Francisco A. Ponce, MD|602-406-3242|
89674|NCT01997216|Alcon Research, Ltd.|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com
89675|NCT01996904|CM Chungmu Hospital|Sang-Hoon Lhee|+82(2)2068/4525|cmirb@naver.com
89676|NCT01996813|Loyola University Medical Center|Alexander Tauchen, MD|708-216-9000|atauchen@lumc.edu
89677|NCT01996748|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com
89678|NCT01996709|Alcon Research, Ltd.|Jessie Lemp, DrPH, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com
89679|NCT01996657|Wuhan Asia Heart Hospital|Dr.Litao Zhang|+862765796888 ext 8204|zhengleetau@qq.com
89680|NCT01996410|OhioHealth|John Elliott|614-566-3643|John.Elliott@ohiohealth.com
89681|NCT01996332|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89682|NCT01996319|Novartis Pharmaceuticals|Study Director|862-778-8300|
89683|NCT01995461|Marshfield Clinic Research Foundation|Dr. Rachel Stankowski|715-389-3442|stankowski.rachel@mcrf.mfldclin.edu
89684|NCT01995357|Coloplast A/S|MD, Medical Director|+45 4911 1395|dkbir@coloplast.com
89685|NCT01995136|Alcon Japan, Ltd.|Senior Manager, Phase IV|1-888-451-3937|alcon.medinfo@alcon.com
89686|NCT01995045|Emory University|Dr. Timothy Olsen|404-778-4996|tolsen@emory.edu
89687|NCT01994902|Coloplast A/S|Medical Director|+45 49111395|dkbir@coloplast.com
89688|NCT01994876|Coloplast A/S|Director of Clinical Affairs|+45 4911 25 23|dkdac@coloplast.com
89689|NCT01994863|Coloplast A/S|Director Clinical Affairs||dkdac@coloplast.com
89690|NCT01994785|Cleveland Clinic|John Vargo|216 445-5012|vargoj@ccf.org
89691|NCT01994746|Jaeb Center for Health Research|Katrina Ruedy|8139758690|kruedy@jaeb.org
89692|NCT01994720|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00|
89694|NCT01994486|UNIVERSITY OF FLORIDA|Giuseppe (Joseph) Morelli, MD|352-273-9467|GIUSEPPE.MORELLI@MEDICINE.UFL.EDU
89695|NCT01994291|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com
89696|NCT01993940|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707 ext 1454|shionogiclintrials-admin@shionogi.co.jp
89697|NCT01993888|Ethicon, Inc.|Senior Director of Ethicon Clinical R&D|908-218-2492|jbatill2@its.jnj.com
89698|NCT01993823|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+39933946470|ejimenezv@salvatbiotech.com
89699|NCT01993238|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com
89700|NCT01993030|The Second Xiangya Hospital of Central South University|Dr. Li Qian|+86-13958104032|649418291@qq.com
89701|NCT01992874|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
89702|NCT01992536|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
89703|NCT01992523|Careggi Hospital|Guido Parodi|00390557947732|parodiguido@gmail.com
89704|NCT01992185|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com
89705|NCT01992172|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com
89706|NCT01992107|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
89707|NCT01992094|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
89708|NCT01991990|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
89709|NCT01991548|Medtronic Diabetes|Clinical Research Manager|818-576-5000|
89710|NCT01991314|Barts Health NHS Trust|Prof David Rampton|+442035943500 ext 7885|d.rampton@qmul.ac.uk
89711|NCT01990898|Cleveland Clinic|Dr. Daniel Shoskes||dshoskes@gmail.com
89712|NCT01990859|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
89713|NCT01990794|Cardno|Dr. David Galbraith|415-618-3211|david.galbraith@cardno.com
89714|NCT01990703|University of Utah, Department of OBGYN|Dr. David Turok|801-581-6170|david.turok@hsc.utah.edu
89715|NCT01990677|Wills Eye|Mitchell Fineman,MD|215-928-3092|research@midatlanticretina.com
89716|NCT01990664|Johnson & Johnson Vision Care, Inc.|Jurandir Araujo, Clinical Compliance Manager|9044431379|jaraujo7@its.jnj.com
89717|NCT01990534|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
89718|NCT01990339|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com
89719|NCT01990261|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
89720|NCT01989689|Emory University|Arshed Ali Quyyumi MD/FACC|404-727-3655|aquyyum@emory.edu
89721|NCT01989572|ECOG Statistical Office|Study Statistician|617-632-3012|
89722|NCT01989455|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com
89723|NCT01989195|Stanford University|Phillip C. Yang, MD|650-498-8008|phillip@stanford.edu
89724|NCT01989169|Shire Development LLC|Study Physician|+1 866 842 5335|
89726|NCT01989130|University of California-Davis|Larissa May, MD|916-736-5010|lsmay@ucdavis.edu
89727|NCT01988857|GlaxoSmithKline|GSK Response Center|866-435-7343|
89728|NCT01988662|Novartis Pharmaceuticals|Study Director|862-778-8300|
89729|NCT01988415|Abbott Medical Optics|Janice Tarrant|408-273-4163|janice.tarrant@abbott.com
89730|NCT01988402|San Antonio Military Medical Center|Jay B Higgs,|2109160797|jay.b.higgs.civ@mail.mil
89731|NCT01988129|Brigham and Women's Hospital|Steven W. Lockley PhD|16177324977|slockley@hms.harvard.edu
89732|NCT01988012|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
89733|NCT01987986|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquires@endo.com
89734|NCT01987960|A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com
89736|NCT01987765|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com
89737|NCT01987752|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com
89738|NCT01987583|Ministry of Health|Dr. Nouran Aleyeidi|00966504304577|dr.nouran@live.com
89739|NCT01987557|WilfridLU|Matthew Lasswell|9056992087|lass3260@mylaurier.ca
89740|NCT01987479|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
89741|NCT01987453|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
89742|NCT01987349|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu
89743|NCT01987232|Amgen Inc.|Study Director|866-572-6436|
89744|NCT01987219|NYU School of Medicine|Dr. Horacio Kaufmann|212 263 7225|horacio.kaufmann@nyumc.org
89745|NCT01986985|GE Healthcare|Terri Hanlon, Clinical Affairs Project Manager|609-578-0173|terri.hanlon@GE.com
89746|NCT01986946|Duke University Hospital|Dr. Erin Manning|919-681-3551|erin.manning@duke.edu
89747|NCT01986855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89748|NCT01986790|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu
89749|NCT01986751|University of Alabama Birmingham|Dr. Promil Kukreja|205-996-7025|pkukreja@uabmc.edu
89750|NCT01986361|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com
89751|NCT01986231|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com
89752|NCT01986062|Arbor Pharmaceuticals|Dr. Steve Caras|(470) 235-2327|scaras@arborpharma.com
89753|NCT01985685|Beth Israel Deaconess Medical Center|Dr. Katherine Berg|617-667-5864|
89754|NCT01985581|Center for Pediatric Excellence|Dr. Judy van Stralen|613-726-7355|judyvanstralen@bellnet.ca
89755|NCT01985425|Population Health Research Institute|Dr. Philip Devereaux|905-527-4322 ext 40654|philipj@mcmaster.ca
89756|NCT01985321|Benu BioPharma, Inc.|Dr. Eric M. Morrel|5082085634|emorrel@benubio.com
89757|NCT01985126|Janssen Research & Development, LLC|Senior Director Clinical Leader||ClinicalTrialDisclosure@its.jnj.com
89758|NCT01984697|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89760|NCT01984515|Center for Integrated Healthcare|Dr. Kyle Possemato|315-425-4400 ext 53551|kyle.possemato@va.gov
89761|NCT01984294|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
89762|NCT01984229|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
89763|NCT01983878|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
89764|NCT01983839|Aarhus University Hospital, Department of infectious diseases|Dr Kristina Öbrink-Hansen|+4578452845|krisoebr@rm.dk
89765|NCT01983787|Aarhus University Hospital, Department of infectious diseases|Kristina Öbrink-Hansen|+4578452845|krisoebr@rm.dk
89766|NCT01983566|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89767|NCT01983254|Duke University|Christopher Cox, PI|9196817232|christopher.cox@duke.edu
89768|NCT01983111|Mundipharma Korea Ltd.|PhD. Miyoung Song||miyoung.song@mundipharma.co.kr
89769|NCT01983020|Beth Israel Medical Center|Ronald Kaplan, MD||rkaplan@chpnet.org
89770|NCT01982812|University of Rochester|Gretchen L. Birbeck|585-273-4265|gretchen_birbeck@urmc.rochester.edu
89771|NCT01982695|Nationwide Children's Hopsital|Dr. Jerry R. Mendell|(614) 722-5615|Jerry.Mendell@NationwideChildrens.org
89772|NCT01982539|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com
89773|NCT01982435|Cleveland Clinic Foundation|Dr. Justis Ehlers|216-636-0183|Ehlersj@ccf.org
89774|NCT01982292|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
89775|NCT01982253|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@takeda.com
89776|NCT01981967|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
89777|NCT01981863|Stanford University Medical Center|Peter van der Starre|6507236412|pieterva@stanford.edu
89778|NCT01981616|Millennium Pharmaceuticals Inc.|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com
89779|NCT01981473|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
89780|NCT01981356|Center for Innovation to Implementation, VA Palo Alto HCS|Matthew Boden, Ph.d.|650-493-5000 ext 27529|Matthew.Boden@va.gov
89782|NCT01980992|Icahn School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu
89783|NCT01980940|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89784|NCT01980875|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
89785|NCT01980628|Pharmacyclics, LLC|Isaiah Dimery, MD, Senior Medical Director|408-215-3579|idimery@pcyc.com
89786|NCT01980589|Amgen, Inc.|Study Director|866-572-6436|
89787|NCT01980524|Medical University of Vienna|Dr. Peter Wolf|004314040043110|peter.wolf@meduniwien.ac.at
89788|NCT01980095|RedHill Biopharma|Dr. Ira Kalfus|1-917-817-7517|ira@redhillbio.com
89789|NCT01979185|Shire Development LLC|Study Physician|+1 866 842 5335|
89790|NCT01979133|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146466948|sherwood.brown@utsouthwestern.edu
93144|NCT01602549|GlaxoSmithKline|GSK Response Center|866-435-7343|
89791|NCT01979029|First Hospital of Jilin University|Jian Suo|0431-88785605|suojian42@hotmail.com
89792|NCT01978743|Boston University School of Medicine|Dr. Nina Lin|617-414-5242|nina.lin@bmc.org
89793|NCT01978600|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com
89794|NCT01978145|GlaxoSmithKline|GSK Response Center|866-435-7343|
89795|NCT01978119|GlaxoSmithKline|GSK Response Center|866-435-7343|
89796|NCT01977820|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
89797|NCT01977794|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
89798|NCT01977781|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana, MD, MPH|617-573-4331|reza_dana@meei.harvard.edu
89799|NCT01977729|Yale University|Dr. Wendy Silverman|(203) 737-7053|wendy.silverman@yale.edu
89800|NCT01977690|Johann Wolfgang Goethe University|Stephan Duetzmann|001491781470479|stephan.duetzmann@gmail.com
89801|NCT01977625|University of Pennsylvania|C. Neill Epperson, M.D|215-573-8871|cepp@mail.med.upenn.edu
89802|NCT01977612|Washington University School of Medicine|Lindsay Kuroki, M.D.|314-362-2368|kurokil@wustl.edu
89803|NCT01977573|GlaxoSmithKline|GSK Response Center|866-435-7343|
89804|NCT01977482|GlaxoSmithKline|GSK Response Center|866-435-7343|
89805|NCT01977456|University of Cincinnati|Dr. Opeolu Adeoye|513-558-3117|opeolu.adeoye@uc.edu
89806|NCT01976988|Cedars Sinai Medical Center|Phillip Fleshner MD|310-289-9224|pfleshner@aol.com
89807|NCT01976871|Massachusetts General Hospital|Dr. John W. Winkelman|617-643-9101|jwwinkelman@partners.org
89808|NCT01976845|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Dr. Ronald H Wender|3104231682|ronald.wender@cshs.org
89809|NCT01976819|University Medical Center Groningen and University of Groningen|Prof. Dr. Bernard F.A.M. van der Laan, PhD, MD|0031 (50) 361 27 00|b.f.a.m.van.der.laan@umcg.nl
89811|NCT01976663|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com
89812|NCT01976650|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
89813|NCT01976624|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com
89814|NCT01976572|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
89815|NCT01976507|Vanderbilt University Medical Center|Christopher Ellis||christopher.ellis@Vanderbilt.Edu
89816|NCT01976442|University of Rochester Medical Center|Neil Blumberg MD|(585) 275-3189|neil_blumberg@urmc.rochester.edu
89817|NCT01976338|Novartis|Study Director|862-778-8300|
89818|NCT01976312|Novartis|Study Director|862-778-8300|
89819|NCT01976299|Osprey Medical, Inc|Michele Shepard, Vice President of Clinical Affairs|9529558236|mshepard@ospreymed.com
89820|NCT01976273|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu
89821|NCT01975974|University of Iowa Hospitals and Clinics|Dr. Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu
89822|NCT01975948|Dalhousie University, Department of Psychiatry|Dr. Bianca Lauria-Horner|902-473-5633|bianca.horner@dal.ca
89824|NCT01975909|Beth Israel Deaconess Medical Center|Brad Manor, Ph.D.|617-971-5332|bmanor@bidmc.harvard.edu
89825|NCT01975675|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
89826|NCT01975467|Sonoma Orthopedics|Rick Epstein|8479872516|repstein@sonomaorthopedics.com
89827|NCT01975285|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)
89828|NCT01975246|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89829|NCT01975220|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89830|NCT01974895|GlaxoSmithKline|GSK Response Center|866-435-7343|
89831|NCT01974817|Michigan State University|Dr Subhashis Mitra|517-353-3128|mitrasub@msu.edu
89832|NCT01974752|AstraZeneca|Karin Bowen|+001 301 398 3254|karin.bowen@astrazeneca.com
89833|NCT01974700|Indiana University|Dr. Aaron Cohen-Gadol|317-396-1300|ACohen@goodmancampbell.com
89834|NCT01974323|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
89835|NCT01974245|Federal University of São Paulo|Dr. Lilian Cuppari|+551159048499|lcuppari@uol.com.br
89836|NCT01974141|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
89837|NCT01973777|University of British Columbia|Dr Ellen Wiebe|6047095611|ellenwiebe@gmail.com
89838|NCT01973608|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
89839|NCT01973595|University of Florida|Dr. Bobbi Langkamp- Henken|352-392-1991 ext 205|henken@ufl.edu
89840|NCT01973491|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
89841|NCT01973439|MRC Clinical Trials Unit at UCL|Trial manager|02076704825|silvia.forcat@ucl.ac.uk
89842|NCT01973413|Univeristy of VIrginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu
89843|NCT01973387|Janssen Research & Development, LLC|Vice President (VP)||ClinicalTrialDisclosure@its.jnj.com
89844|NCT01973348|Indiana University|Dr. Daniel Neely, PI|3172741214|deneely@iupui.edu
89845|NCT01973231|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
89846|NCT01973218|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
89847|NCT01973205|Novartis|Clinical Project Leader|9735038000|
89848|NCT01972776|Novartis|Study Director|862-778-8300|
89849|NCT01972659|Kocaeli University Medical Faculty|Assistant Professor Dr Z Ipek ARSLAN AYDIN|00905325011339|zehraipek48@gmail.com
89850|NCT01972516|Dana-Farber Cancer Institute|Susana Campos, MD|617-632-5269|susana_campos@dfci.harvard.edu
89851|NCT01972438|National Institutes of Health|Manuel B. Datiles, III, MD, Principal Investigator, NEI|301-594-7052|DatilesM@nei.nih.gov
89852|NCT01972152|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP, Drug Development|512-498-2675|mcummins@xerispharma.com
89853|NCT01971723|Florida State University|Dr. Michael J. Ormsbee|(850) 644-4793|mormsbee@fsu.edu
89854|NCT01971554|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89855|NCT01971385|Massachusetts General Hospital|Dr. Maria Alora-Palli|6177265066|mpalli@mgh.harvard.edu
89856|NCT01971255|National Institute of Allergy and Infectious Diseases|Matthew James Memoli|+1 301 443 5971|memolim@niaid.nih.gov
89857|NCT01971086|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89858|NCT01970995|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com
89859|NCT01970982|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com
89860|NCT01970878|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com
89861|NCT01970787|Laser Surgery Care|Stephen E Goldstone|212-242-6500|segmd@prodigy.net
89862|NCT01970488|Amgen Inc.|Study Director|866-572-6436|
89863|NCT01970475|Amgen Inc.|Study Director|866-572-6436|
89864|NCT01970397|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
89865|NCT01969799|Cardeas Pharma|Bruce Montgomery, MD|2069713756|bruce.montgomery@cardeaspharma.com
89866|NCT01969747|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89867|NCT01969721|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89869|NCT01969539|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89870|NCT01969435|Washington University School of Medicine|Amanda F. Cashen, M.D.|314-454-8304|acashen@wustl.edu
89871|NCT01969162|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
89872|NCT01969084|Beth Israel deaconess Medical Center|Aristidis Veves|617 632 7075|
89874|NCT01968980|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
89875|NCT01968967|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
89876|NCT01968954|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
89877|NCT01968811|Sahlgrenska university Hospital|Dr Marcus Langenskiöld|+46 709 433160|marcus.langenskiold@vgregion.se
89878|NCT01968694|Brigham & Women's Hospital|Dr. Antje M Barreveld|617-243-6298|abarreveld@partners.org
89879|NCT01968551|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
89880|NCT01968434|Clalit HS|Prof. Herman Avner Cohen|00972 3-939-8203|hermanc@clalit.org.il
89881|NCT01968226|Cleveland Clinic|Dr. Balaji Tamarappoo|216-444-6765|tamarab@ccf.org
89882|NCT01968135|University of Colorado Denver|Chanel Mansfield|303-724-6501|chanel.mansfield@ucdenver.edu
89883|NCT01968057|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
89884|NCT01967940|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
89885|NCT01967836|Ascension Wisconsin|Dr Maureen Greene|414-447-2716|maureen.greene@ascension.org
89886|NCT01967784|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
89887|NCT01967732|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com
89888|NCT01967719|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com
89889|NCT01967706|Philip Morris Products S.A.|Christelle HAZIZA|+41 (58) 242 2625|Christelle.Haziza@pmi.com
89890|NCT01967550|Novartis Consumer Health|Clinical Project Leader pain category|+41223633111|
89891|NCT01967342|University of Alabama|Beverly E. Thorn, Ph.D.|(205) 348-8024|bthorn@ua.edu
89892|NCT01967277|Capillus LLC|Patricia Schnoor|7868881874|pschnoor@capillus.com
89893|NCT01967147|Alcon Research, Ltd.|Global Brand Med Affairs Lead, GCRA, GMA Pharma|1-888-451-3937|alcon.medinfo@alcon.com
89894|NCT01967121|Michigan State University|Tracey Covassin|517-353-2010|covassin@msu.edu
89895|NCT01967069|Promius Pharma|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com
89896|NCT01966926|University of Minnesota|Dr. Jennifer Linde|612-624-0065|linde074@umn.edu
89897|NCT01966770|Clinical Research Center-UC berkely|Meng C. Lin O.D., PhD, FAAO|510-643-9252|mlin@berkeley.edu
89898|NCT01966718|Arthritis Treatment Center|Dr. Nathan Wei|301-694-5800|nwei@arthritistreatmentcenter.com
89899|NCT01966432|Duke University, Dept. of Psychiatry and Behavioral Sciences|Dr. Li-Tzy Wu, Professor in Psychiatry|(919) 889-9369|litzy.wu@duke.edu
89900|NCT01966380|Sahlgrenska university hospital|Prof. Jan Faergemann|031-3421000|jan.faergemann@derm.gu.se
89901|NCT01966354|Complejo Hospitalario de Navarra|Dr. Mikel Batllori|0034 848422174|mikel.batllori.gaston@cfnavarra.es
89902|NCT01966159|Shenyang Northern Hospital (The General Hospital of Shenyang Military Region)|Dr. Hanyaling|024-28897310|hanyl@medmail.com.cn
89903|NCT01966120|Biofrontera Bioscience GmbH|Clinical Trial Department,|+49 2148763226|ameluz@biofrontera.com
89904|NCT01966068|Children's Hospital of Philadelphia|Alexander Fiks, MD, MSCE|267-426-2304|fiks@email.chop.edu
89905|NCT01966042|Federal University of Sao Paulo (UNIFESP)|Dr. Nelson Americo Hossne Junior|+55 11 5571-2719|nelson.hossne@gmail.com
89906|NCT01965938|Vanderbilt University School of Medicine|Dr. Bret Alvis, MD|615-343-6268|bret.d.alvis@vanderbilt.edu
89907|NCT01965899|Medtronic, plc|CRHF Clinical Research|800-328-2518|MedtronicCRMtrials@medtronic.com
89908|NCT01965834|University of Miami|Denise Pereira MD|305-243-4909|dpereira2@med.miami.edu
89909|NCT01965756|Massachusetts General Hospital|Dr. Steven E. Arnold MD|617-643-5607|SEARNOLD@mgh.harvard.edu
89910|NCT01965665|Duke University Medical Center|Michael Kerzner, DMP|919-613-4449|michael.kerzner@duke.edu
89911|NCT01965652|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707 ext 1454|shionogiclintrials-admin@shionogi.co.jp
89912|NCT01965600|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com
89914|NCT01965535|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
89915|NCT01965431|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89916|NCT01965327|Children's Hospital of Philadelphia|David Lynch, MD, PhD|215-590-1719|lynch@email.chop.edu
89917|NCT01965288|CooperVision|Jose A. Vega Sr. Mgr. Global Medical Scientific Affairs|(925) 621-3761|jvega2@coopervision.com
89918|NCT01965262|Coopervision|Paul Chamberlain, BSc Honors, Sr. Manager Clinical Research|(925) 730-6754|pchamberlain@coopervision.com
89919|NCT01965158|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707 ext 1454|shionogiclintrials-admin@shionogi.co.jp
89920|NCT01965067|Department of Anesthesiology and Pain Medicine, Hanyang University Hospital|Kyo Sang Kim, MD, PhD|+82-2-2290-8680|kimks@hanyang.ac.kr
89921|NCT01964976|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
89922|NCT01964950|Takeda Pharmaceutical Company Limited|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
89923|NCT01964898|The Miriam Hospital|Andrew Busch PhD|4017938189|andrew_busch@brown.edu
89924|NCT01964716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
89925|NCT01964547|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
89926|NCT01964352|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89927|NCT01964326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1­-800-­718-­1021|ClinicalTrials.gov_Inquiries@pfizer.com
89928|NCT01964222|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu
89929|NCT01963845|University of California, San Diego|Rohit Loomba, MD professor of Medicine|858-543-2230|roloomba@ucsd.edu
89930|NCT01963767|University of South Florida|Dr. Brent Small|813-974-9746|bsmall@usf.edu
89931|NCT01963676|UNC Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu
89932|NCT01963611|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
89933|NCT01963403|UC Davis|Dr. Mitchell Creinin|916-734-6670|mdcreinin@ucdavis.edu
89934|NCT01963260|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89935|NCT01963143|Bio Products Laboratory|Head of Medical Information|+44 (0)20 8957 2200|medinfo@bpl.co.uk
89936|NCT01963091|MUSC|Dr. Moran-Santa Maria|843-792-8187|moranm@musc.edu
89937|NCT01962974|Janssen Pharmaceuticals|STRATEGIC LEAD||ClinicalTrialDisclosure@its.jnj.com
89938|NCT01962961|Indiana University School of Medicine|Samir K. Gupta|317-274-7926|sgupta1@iu.edu
89939|NCT01962922|Veloxis Pharmaceutical|Leslie Callahan|732-321-3221|lca@veloxis.com
89940|NCT01962675|Shepherd Center|Edelle Field-Fote|404-603-4274|edelle_field-fote@shepherd.org
89941|NCT01962493|GlaxoSmithKline|GSK Response Center|866-435-7343|
89942|NCT01962441|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
89943|NCT01962428|General Hospital of Chinese People’s Armed Police Forces|huiliang Liu|+8601057976707|lhl518@vip.sina.com
89944|NCT01961544|Eisai Inc.|Eisai Medical Services|1-888-422-4743|
89945|NCT01961349|CO RI&A TA, R&D|Hideo Negi|+81 6 4803 3533 ext 4716|H.Negi@astrazeneca.com
89946|NCT01961271|Mundipharma Pte Ltd|Valerie Anne Leck|+65 6511 1165|info.rma@mundipharma.com.sg
89947|NCT01960907|RESTECH srl|Dr. Pasquale Pio Pompilio, R&D manager|+39 02 3659 3690|p.pompilio@restech.it
89948|NCT01960842|AbbVie|Global Medical Information|1-800-633-9110|
89949|NCT01960816|Aerin Medical, Inc.|Scott Wolf, M.D., President and Chief Medical Officer|650-434-3247|scott@aerinmedical.com
89950|NCT01960725|Duke University School of Medicine|Dr. Dennis Clements|919-684-7790|dennis.clements@duke.edu
89951|NCT01960530|Diurnal Limited|Dr John Porter|02920 682069|info@diurnal.com
89952|NCT01960400|Université de Sherbrooke|Dr Yannick Tousignant-Laflamme|819-821-8000 ext 72912|Yannick.Tousignant-Laflamme@USherbrooke.ca
89953|NCT01960387|University of Pittsburgh Cancer Institute|Michael Boyiadzis, MD|412-623-0040|boyiadzism@upmc.edu
89954|NCT01960296|Icahn School of Medicine at Mount Sinai|Dr. Celia M. Divino|212-241-5499|celia.divino@mountsinai.org
89955|NCT01960140|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
89956|NCT01960114|McNeil Consumer Healthcare|Rajesh Mishra, MD, PhD/Vice President, Medical/Clinical Affairs, Global OTC|215-273-8569 USA EST|rmishr16@its.jnj.com
89957|NCT01959945|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064 ext 153|ldunkle@proteinsciences.com
89958|NCT01959932|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com
89959|NCT01959880|Mentor|Michael Schwiers|513-337-1172|mschwier@its.jnj.com
89960|NCT01959685|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com
89961|NCT01959607|Philip Morris Products S.A.|Christelle HAZIZA|+41 (58) 242 2625|Christelle.Haziza@pmi.com
89962|NCT01959581|University of Delaware|Michele A. Lobo|302-831-8526|malobo@udel.edu
89963|NCT01959516|Novartis Pharmaceuticals|Study Director|862-778-8300|
89964|NCT01959503|C.R. Bard|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com
89965|NCT01959412|Novartis Pharmaceuticals|Study Director|862-778-8300|
89966|NCT01959035|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com
89967|NCT01958827|AbbVie|Global Medical Information|800-633-9110|
89968|NCT01958788|Concordia University|Elizabeth Hebert|1-514-848-2424 ext 2199|el_heber@live.concordia.ca
89969|NCT01958671|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
89970|NCT01958645|AstraZeneca|Anders Berggren, MD, PhD||clinicaltrialtransparency@astrazeneca.com
89971|NCT01958619|Medicines for Malaria Venture (MMV)|Dr Thomas Rueckle PhD|+41 22 799 4567|ruecklet@mmv.org
89972|NCT01958606|University of Cincinnati|Pierce Boyne|513-558-7499|Pierce.Boyne@uc.edu
89973|NCT01958346|Teamhealth Anesthesia|Devanand Mangar MD|813-844-4434|devanandmangar@teamhealth.com
89974|NCT01958164|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89975|NCT01958060|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89976|NCT01958021|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
89977|NCT01958008|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127 ext +1|clintriage.rdg@boehringer-ingelheim.com
89978|NCT01957930|Karolinska Institutet Södersjukhuset|Thomas Nyström|+46704325214|thomas.nystrom@sodersjukhuset.se
89979|NCT01957865|Massachusetts General Hospital|Jessica Haberer|617 724 0351|jhaberer@partners.org
89980|NCT01957761|Ann & Robert H. Lurie Children's Hospital of Chicago|Larry Kociolek, MD, MSCI|312-227-4080|lkociolek@luriechildrens.org
89981|NCT01957657|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89982|NCT01957579|MedImmune, LLC|Medical Director||ClinicalTrialTransparency@astrazeneca.com
89983|NCT01957553|Coloplast|Dr. Birte P.Jakobsen|+45 4911 1395|dkbir@coloplast.com
89984|NCT01957488|Coloplast|Medical Director|+45 4911 1395|dkbir@coloplast.com
89985|NCT01957475|Coloplast|Daniel Carter|+45 49112523|dkdac@coloplast.com
89986|NCT01957462|Coloplast|Daniel Carter|+45 49222523|dkdac@coloplast.com
89987|NCT01957410|Janssen Research & Development, LLC|Director||ClinicalTrialDisclosure@its.jnj.com
89988|NCT01957397|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1395|dkbir@coloplast.com
89989|NCT01957384|Coloplast A/S|Marian Dyreborg Sinvani, Clinical Manager|+45 4911 2356|dkmards@coloplast.com
89990|NCT01957215|GlaxoSmithKline|GSK Response Center|866-435-7343|
89991|NCT01957202|GlaxoSmithKline|GSK Response Center|866-435-7343|
89994|NCT01957111|University of Pennsylvania|Philip Gehrman|215-746-3578|gehrman@exchange.upenn.edu
89995|NCT01956240|Methodist University of Piracicaba|Ms Dayana Patricia Rosa|+55 16 3306-6696|dad_rosa@hotmail.com
89996|NCT01956097|Ewha Brain Institute, Ewha W. University|Soonhyun Ban, RN, MS|+82-2-3277-6550 ext 6554|soonhyun.s.ban@gmail.com
89997|NCT01956032|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
89998|NCT01955720|Boehringer Ingelheim pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
89999|NCT01955707|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
90000|NCT01955629|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
90001|NCT01955564|Newron Pharmaceuticals S.p.A.|Dr. Ravi Anand|+39 026103461|ravi@anand.ch
90002|NCT01955473|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
90003|NCT01955369|Klinikum der Stadt Ludwigshafen|Dr. Joachim Wolf|0049-621 ext 4200|joachim.wolf@diakonissen.de
90004|NCT01955161|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com
90005|NCT01955122|UMC Utrecht|Prof. Peter Siersema|+31 88 7559338|P.D.Siersema@umcutrecht.nl
90006|NCT01955083|Chang Gung Memorial Hospital|Dr. Hsueh-Yu Li|886-3-3281200 ext 3967|hyli38@adm.cgmh.org.tw
90007|NCT01955044|NorthShore University HealthSystem|Brandy L Frost|847-570-2033|bfrost@northshore.org
90008|NCT01955005|Iowa City VA Health Care System|Carolyn L Turvey|319 338 0581 ext 7714|Carolyn.Turvey@VA.Gov
90009|NCT01954771|Beijing Anzhen Hospital|Dr.Yingsheng Zhou|0086-010-64456185|zys626@aliyun.com
90010|NCT01954745|Massachusetts General Hospital Cancer Center|Dr. Lipika Goyal|617-724-4000|Lgoyal@partners.org
90011|NCT01954628|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|+1 (604) 629-9223|clinical@aqxpharma.com
90013|NCT01954160|Duke Clinical Research Institute|Kathy Moore|919-668-8065|kathy.moore@dm.duke.edu
90014|NCT01954121|UCB Cares|UCB (Study Director)|+1 887 822 9493|
90015|NCT01953354|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
90016|NCT01953328|Amgen Inc.|Study Director|866-572-6436|
90017|NCT01953237|University of Maryland School of Medicine|Julie Kreyenbuhl|410-637-1864|jkreyenb@psych.umaryland.edu
90018|NCT01953081|Theravance Biopharma US, Inc.|Dr. Brett Haumann, SVP, Clinical Development|650-808-6000|BHaumann@theravance.com
90019|NCT01952834|Medical College of Wisconsin|Dr. Michael Widlansky|414-955-6755|mwidlans@mcw.edu
90020|NCT01952691|Hacettepe University|Gul Oznur Karabicak|+90 505 3569409|guloznur@gmail.com
90021|NCT01952665|CooperVision|Donald Siegel, OD Principal Investigator|(949) 597-4700|dsiegel@coopervision.com
90022|NCT01952600|Arbor Research Collaborative for Health|Dr. Francesca Tentori|7346654108|francesca.tentori@arborresearch.org
90023|NCT01952418|Massachusetts General Hospital|Norman Nishioka, MD|6177264422|NNISHIOKA@PARTNERS.ORG
90024|NCT01952366|Sykehuset Innlandet|Dr. Tom Borza|+47 91834607|tom.borza@sykehuset-innlandet.no
90025|NCT01952301|Perio Health Professionals, PLLC|Dr. Michael K. McGuire|713-783-5442|mkmperio@swbell.net
90026|NCT01952145|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com
90027|NCT01952080|Shire|Global Clinical Development Operations|908-450-5300|mgalen@shire.com
90028|NCT01951950|Northwestern University|John F. Bebawy, MD, Principal Investigator|312-695-0061|j-bebawy@northwestern.edu
90029|NCT01951820|University of Michigan School of Dentistry|Dr. Carlos Gonzalez|734-763-3391|carlosgc@umich.edu
90030|NCT01951703|Clinical Compliance Manager|Jurandir Araujo|904 443-1379|jaraujo7@jnj.com
90031|NCT01951651|Baylor|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu
90032|NCT01951586|Amgen Inc.|Study Director|866-572-6436|
90033|NCT01951573|Alcon Research, Ltd.|Mary Fahmy, Head, Clinical Development, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com
90034|NCT01951417|Galderma Labratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com
90035|NCT01951170|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
90036|NCT01951092|Alpert Medical School of Brown University/The Miriam Hospital|Aadia Rana, MD|401-793-4680|arana@lifespan.org
90037|NCT01951066|Wilmer Eye Institute, Johns Hopkins University School of Medicine|[Peter A. Campochiaro|(410) 955-5106|pcampo@jhmi.edu
90038|NCT01950741|Pusan National University Hospital|Ji Eun Lee, Assoicated professor|+82-51-240-7957|jlee@pusan.ac.kr
90039|NCT01950663|Dean McGee Eye Institute / University of Oklahoma Health Sciences Center|Dr. Stephen R. Fransen|405-271-1092|stephen-fransen@dmei.org
90040|NCT01950364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
90041|NCT01950078|Huazhong University of Science and Technology|Dr. Xianwei Zhang|027 83663173|znpin@sina.cn
90042|NCT01949870|AstraZeneca|Dr Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com
90043|NCT01949545|Amgen, Inc.|Study Director|866-572-6436|
90044|NCT01949532|Amgen, Inc.|Study Director|866-572-6436|
90045|NCT01949389|VA Connecticut Healthcare system|Eric Hermes|203 932 5711 ext 7422|eric.hermes@va.gov
90046|NCT01949155|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com
90047|NCT01949142|Otonomy, Inc|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com
90048|NCT01949051|GlaxoSmithKline|GSK Response Center|866-435-7343|
90049|NCT01948908|Columbia University College of Physicians and Surgeons|Daniel S. Tsze|212-305-9825|dst2141@columbia.edu
90050|NCT01948830|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
90051|NCT01948791|Novartis Pharmaceuticals|Study Director|862-778-8300|
90052|NCT01948518|Cleveland Clinic|Umur Hatipoğlu, MD|216-636-5344|HATIPOU@ccf.org
90053|NCT01948375|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|Zhishun Liu, Director of the study|8610-010-88001124|liuzhishun@aliyun.com.cn
90054|NCT01948193|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
90055|NCT01948141|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
90056|NCT01948076|Brigham and Women's Hospital|Maria Yialamas|617-732-5500|myialamas@partners.org
90057|NCT01948063|BIDMC|Michael W Donnino|617-754-2341|mdonnino@bidmc.harvard.edu
90058|NCT01948050|Beth Israel Medical Center|Helena Knotkova, PhD|212-844-8541|hknotkov@chpnet.org
90059|NCT01947946|AZ-PPD|Steven Fox|441480716682|steven.fox@ppdi.com
90060|NCT01947907|Ascendis Pharma A/S|VP Clinical Development|+49 172 155 2596|mb@ascendispharma.com
90061|NCT01947855|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90062|NCT01947582|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu
90063|NCT01947517|Queen's University|Dr. Stephanie Baxter|613 544 3310|baxters@baxtereyemd.com
90064|NCT01947491|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com
90065|NCT01947335|Heart Institute (Incor)|Dr. Pedro A. Lemos|+55 11 2661 5000|pedro.lemos@incor.usp.br
90066|NCT01947153|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90067|NCT01947127|Faculty of Medicine, Chulalongkorn University|Khrongwong Musikatavorn, M.D.|+6622564553|kmusikatavorn@yahoo.com
90068|NCT01946542|Duke University Medical Center|William Kraus|919-684-2063|william.kraus@duke.edu
90070|NCT01946438|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
90071|NCT01946425|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
90072|NCT01946412|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
90073|NCT01946243|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
90074|NCT01946178|Mirabilis Medica, Inc.|Director of Clinical Affairs|425-486-8230|patrick@mirabilismedica.com
90075|NCT01946126|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
90076|NCT01945970|Unilever R&D Research Vlaardingen|Dr Theo Mulder|+31 10 460 8315|theo.mulder@gmail.com
90077|NCT01945944|Rainbow Babies and Children's Hospital|Steven Shein, MD|216-844-3310|drstevenshein@gmail.com
90078|NCT01945294|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90079|NCT01945242|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
90080|NCT01945138|University of Minnesota|Dr. Melena Bellin|612-624-5409|bell0130@umn.edu
90081|NCT01945112|Stanford Department of Emergency Medicine|Grant Lipman|415-290-9286|gslipman@stanford.edu
90082|NCT01945086|Janssen Research & Development, LLC.|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com
90083|NCT01945034|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90085|NCT01944969|H. Lundbeck A/S|H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@lundbeck.com
90086|NCT01944878|Hallym University College of Medicine, Chuncheon Sacred Heart Hospital|Dr. Chang Seok Bang|+82-33-240-5000|cloudslove@naver.com
90087|NCT01944774|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072 ext 1211|cetsai@taigenbiotech.com
90088|NCT01944670|Skeletal Dynamics, LLC|Ana Escagedo|305-596-7585|AEscagedo@SkeletalDynamics.com
90089|NCT01944631|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90090|NCT01944345|Wenzel Spine, Inc.|Director, Quality & Regulatory Affairs|5123148271|bnowatzke@wenzelspine.com
90091|NCT01944319|Peking University Third Hospital|Dr. Qingtao ZHOU|86-10-82265562|zhouqingtaobysy@sina.com
90092|NCT01944059|University Cincinnati Physicians Company|Vincent Martin, MD|513-558-7581|vincent.martin@uc.edu
90093|NCT01943864|GlaxoSmithKline|GSK Response Center|866-435-7343|
90094|NCT01943565|Brigham and Women's Hospital|Dirk J Varelmann, MD|617-732-8280|dvarelmann@partners.org
90095|NCT01943552|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90096|NCT01943474|C. R. Bard|Gina Gilbert|407-489-0835|gina.gilbert@crbard.com
90098|NCT01943344|Vivasure Medical|Dr Chris Martin|+353 9 395 440|chris.martin@vsuremed.com
90099|NCT01943292|Verastem|Lou Vaickus, MD, FACP/Chief Medical Officer|781-292-4200|lvaickus@verastem.com
90100|NCT01943110|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org
90101|NCT01942785|Email contact via H. Lundbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com
90102|NCT01942733|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com
90103|NCT01942720|Medtronic|Clinical Trials Manager|+972-4-9097952|michal.kedar-datel@medtronic.com
90105|NCT01942161|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Trials|+81-3-6361-7366|
90106|NCT01942148|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Trials|+81-3-6361-7366|
90107|NCT01942135|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90108|NCT01941940|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
90109|NCT01941615|Boehringer Ingelheim|Boehringer Ingelheim Call Center|+1 800 243 0127|clintriage.rdg@boehringer-ingelheim.com
90110|NCT01941498|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com
90111|NCT01941485|Alcon Research, Ltd.|Global Brand Med Affairs Lead, Refractive, VGR|1-888-451-3937|alcon.medinfo@alcon.com
90112|NCT01941472|Peking Union Medical College Hospital|Bin Du|8610-69155036|dubin98@gmail.com
90113|NCT01941186|Child Health Institute of New Jersey|Manuel Jimenez, MD, MS|732-235-6230|jimenema@rwjms.rutgers.edu
90114|NCT01940523|Hospital for Special Surgery|David Mayman MD|212.774.2024|maymand@hss.edu
90115|NCT01940510|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
90116|NCT01940497|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
90117|NCT01940484|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
90118|NCT01940471|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
90119|NCT01940341|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
90120|NCT01940146|SPARC|Shravanti Bhowmik, MD||shravanti.bhowmik@sparcmail.com
90121|NCT01940120|Abbott Vascular Structural Heart (formerly Evalve, Inc.)|Chithra Sangli|650-430-1329|chithra.sangli@av.abbott.com
90122|NCT01939938|Weill Cornell Medical College|Dr. Matthew Ebben|6469629318|mae2001@med.cornell.edu
90123|NCT01939548|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90124|NCT01939496|Janssen Scientific Affairs, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com
90125|NCT01939405|MGH|Dr. Nicolas Oreskovic|6177260593|noreskovic@mgh.harvard.edu
90126|NCT01939314|Indiana University School of Medicine|Jason Schaffer, MD|317-962-8026|jtschaff@iupui.edu
90127|NCT01939145|MGUH Center for Wound Healing and Hyperbaric Medicine|Paul J. Kim, DPM, Director of Research|202-444-3059|Paul.J.Kim@gunet.georgetown.edu
90128|NCT01939002|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
90129|NCT01938989|Alcon Research, Ltd.|Melvin Sarayba, Franchise Head Cataract, GMA|1-888-451-3937|alcon.medinfo@alcon.com
90131|NCT01938430|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
90132|NCT01938391|NYU Langone Medical Center|Anvar Babaev, MD, PHD, FACC, FSCAI|212-263-5656|anvar.babaev@nyumc.org
90133|NCT01938170|UNC Chapel HIll|Ravi Jhaveri MD|919-962-5136|ravi.jhaveri@unc.edu
90134|NCT01938079|Columbia University|Amy L. Dzierba, Pharm.D., BCPS, BCCCP, FCCM|212-305-5852|ald9012@nyp.org
90135|NCT01938066|The Ohio State University|Gayle Gordillo|6142938566|gayle.gordillo@osumc.edu
90136|NCT01938040|Rutgers/State University of New Jersey (NJMS)|Alex Bekker, MD, PhD|973 972-5007|bekkeray@njms.rutgers.edu
90137|NCT01937975|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90138|NCT01937871|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
90139|NCT01937715|Pfizer Inc.|Pfizer ClincialTrials.gov Call Center|+18007181021|ClinicalTrials.gov_Inquiries@pfizer.com
90140|NCT01937598|Div. Diabetology, Med. Dep. I, St. Josef-Hospital (Ruhr-Univeristy Bochum), change of address 01.01.20015|Prof. Dr. M. A. Nauck, Principle Investigator|+49-234-509 ext 6332|michael.nauck@rub.de
90141|NCT01937520|Rutgers, The State University of New Jersey|Dennis Grech, MD|973 972-5007|grechde@njms.rutgers.edu
90142|NCT01937364|Essentia Health|Jeffrey E. Lyon, M.D.|218-786-2802|jeffrey.lyon@essentiahealth.org
90143|NCT01937351|Avinger|Elizabeth De Spain|650.241.7900 ext 7967|edespain@avinger.com
90144|NCT01937312|Alcon Research, Ltd.|Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com
90145|NCT01937299|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com
90146|NCT01937260|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com
90147|NCT01937195|Evangelical Community Hospital|Norman R. Anderson|570-222-2000|nanderson@evanhospital.com
90148|NCT01937130|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com
90149|NCT01937026|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
90150|NCT01936896|Virginia Commonwealth University|Antonio Abbate|8048280513|antonio.abbate@vcuhealth.org
90151|NCT01936870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90152|NCT01936844|Virginia Commonwealth University|Benjamin Van Tassell, PharmD|8048284583|bvantassell@vcu.edu
90153|NCT01936662|IndianaU|Nicole Horn, MD|3179449981|ndhorn@hotmail.com
90154|NCT01936649|GE Healthcare|Dr. Jose Zubeldia|011-44-1494-543137|jose.zubeldia@ge.com
90155|NCT01936623|Friends Research Institute|Robert Schwartz, M.D.|410-837-3977 ext 276|rschwartz@friendsresearch.org
90156|NCT01936467|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu
90157|NCT01936389|NYGRI|Jessica Jasien, MEn|2124777540 ext 371|jjasien.ganyresearch@gmail.com
90159|NCT01936181|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534|
90160|NCT01935622|Virginia Commonwealth University|Antonio Abbate|8048280513|aabbate@vcu.edu
90161|NCT01935180|VA Medical Center|Dr. Heiko Pohl|8022959362 ext 5595|heiko.pohl@dartmouth.edu
90162|NCT01934894|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|Charles.Davis2@scri-innovations.com
90163|NCT01934790|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com
90164|NCT01934582|United Therapeutics Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com
90165|NCT01934517|U of Montreal|Vincent Peloquin|514-343-6056|vincent-claude.peloquin@umontreal.ca
90166|NCT01934504|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
90167|NCT01934231|GlaxoSmithKline|GSK Response Center|866-435-7343|
90168|NCT01934218|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8948|yuko.shibata@seikagaku.co.jp
90169|NCT01933932|AstraZeneca Research and Development|Dr Gabriella Mariani|+44 (0)1763 263801|ClinicalTrialTransparency@astrazeneca.com
90170|NCT01933880|Xi’an Janssen Pharmaceutical Ltd.|Director - CNS & Pain, CDMA, China R&D and SA|+86 10 5821-8307|
90171|NCT01933776|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
90172|NCT01933672|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90173|NCT01933425|Herlev Hospital, University of Copenhagen, Department of Anesthesiology|Dr. Matias Vested Madsen|+4538689058|matias.vested.madsen@regionh.dk
90174|NCT01933399|MUSC|David Morrisette, PhD|843-792-2940|morrisdc@musc.edu
90175|NCT01933334|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
90176|NCT01933230|Cleveland Clinic|Dr. Jose Javier Provencio, Faculty, Neuroinflammation Research Center|216-445-242|provenj@ccf.org
90177|NCT01933048|Uniformed Services University of the Health Sciences|Eugene V. Millar, PhD|301-816-8451|emillar@idcrp.org
90178|NCT01932970|Amgen Inc.|Study Director|866-572-6436|
90179|NCT01932762|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90180|NCT01932606|Mayo Clinic|Dr. Barry A. Borlaug|507-284-6704|Borlaug.Barry@mayo.edu
90181|NCT01932164|Hospital Sirio Libanes|Dra Daniela Franco Bueno|+5511997900159|dbuenousp@gmail.com
90182|NCT01932112|Seoul St Mary's hospital|Y. Oh, director of clinical trial|82-2-2258-1141|oys@catholic.ac.kr
90183|NCT01932060|Stanford University School of Medicine|Dr. Alexander Butwick|(650) 736-8513|ajbut@stanford.edu
90184|NCT01931956|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com
90185|NCT01931878|Yale University School of Medicine|Bahman Jabbari M.D.|203-737-2464|bahman.jabbari@yale.edu
90186|NCT01931865|Yale University School of Medicine|Bahman Jabbari M.D.|203-737-2464|bahman.jabbari@yale.edu
90187|NCT01931839|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
90188|NCT01931709|University of Washington|Jennifer Specht, MD|206-288-6889|jspecht@uw.edu
90189|NCT01931527|Washington University School of Medicine|Elisa Fabbrini, MD, PhD|314-362-8156|efabbrini@dom.wustl.edu
90190|NCT01931475|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
90191|NCT01931397|Oregon Health & Science University|Dr. Amira Al-Uzri , Professor of Pediatrics|503-494-6956|aluzria@ohsu.edu
90192|NCT01931150|Memorial Sloan Kettering Cancer Center|Dr. Mario Lacouture|646-888-6014|LacoutuM@mskcc.org
90193|NCT01930890|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
90194|NCT01930799|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
90195|NCT01930487|Ocular Vascular Research Center, Indiana University School of Medicine|Brent Siesky, PhD, Assistant Director|317-278-0177|bsiesky@indiana.edu
90196|NCT01930435|UCSF|Dr. Sue Yom|415-353-7175|yoms@radonc.ucsf.edu
90197|NCT01930162|Novartis Pharmaceuticals|Study Director|862-778-8300|
90198|NCT01930058|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90199|NCT01930045|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90200|NCT01929993|Fundação Oswaldo Cruz|Dr Fábio Russomano|55 21 25541815|fabiorussomano@gmail.com
90201|NCT01929980|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-9063|Pooja.Khandelwal@cchmc.org
90202|NCT01929889|Northwestern University|Dr. John Csernansky|312-503-9096|jcsernan@nmff.org
90203|NCT01929876|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
90204|NCT01929863|GlaxoSmithKline|GSK Response Center|866-435-7343|
90205|NCT01929759|Boston Medical Center, Boston University School of Medicine|Dr. Nina Lin|617-414-5242|nina.lin@bmc.org
90206|NCT01929681|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu
90207|NCT01929473|IROM CS Co., Ltd.|Tsutomu Takeda|+81-92-738-0500|tsutomu-takeda@irom-cs.co.jp
90208|NCT01929460|Kaiser Permanente, Los Angeles Medical Center|Karl Kwok, MD|800-954-8000|regional-research-committee@kp.org
90210|NCT01929135|Universidad de los Andes|Dra. Catherine Andrade|056-972862308|catherine.perio@gmail.com
93145|NCT01602510|GlaxoSmithKline|GSK Response Center|866-435-7343|
90211|NCT01929083|Indiana University|Dr. James E Tisdale|317-880-5418|jtisdale@purdue.edu
90212|NCT01929044|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90213|NCT01929031|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90214|NCT01928940|GlaxoSmithKline|GSK Response Center|866-435-7343|
90215|NCT01928927|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
90217|NCT01928771|AstraZeneca|Mitchell Goldman , Medical Science Director|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com
90218|NCT01928693|Cornea Consultants of Nashville|Ira Shivitz MD|615-320-7200|jhatley@corneaconsultants.net
90219|NCT01928680|Chinese Academy of Medical Science|Dr. Qiao Li|86-18500027849|liqiaopumc@qq.com
90220|NCT01928615|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
90221|NCT01928472|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
90222|NCT01928433|Universityhospital Gießen and Marburg, Germany|Prof. Dr. med. Florian Wagenlehner|+49-641-98544516|Florian.Wagenlehner@chiru.med.uni-giessen.de
90223|NCT01928381|AstraZeneca Pharmaceuticals LP, Neuroscience Innovative Medicine Unit|Joel Posener, MD - Head Early Clinical Development||CinicalTrialTransparency@astrazeneca.net
90225|NCT01928030|Stanford University|Dr. Mark Pegram, Susy Yuan-Huey Hung Professor|650-723-5801|mpegram@stanford.edu
90226|NCT01927887|Massachusetts General Hospital|Mukesh Harisinghani|6176432009|mharisinghani@partners.org
90227|NCT01927757|Amgen Inc.|Study Director|866-572-6436|
90228|NCT01927575|Fujifilm Medical Systems, U.S.A., Inc.|Robert Uzenoff|(203) 602-3664|ruzenoff@fujifilm.com
90230|NCT01927120|H. Lee Moffitt Cancer Center and Research Institute|Dr. Brian Betts|813-745-5410|brian.betts@moffitt.org
90231|NCT01927055|H. Lundbeck A/S|Study director||LundbeckClinicalTrials@Lundbeck.com
90232|NCT01926977|Sierra Eye Associates|Arshad Khanani M.D., Vitreo-Retinal Diseases and Surgery|775-329-0286|arshad.khanani@gmail.com
90233|NCT01926782|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com
90234|NCT01926626|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu
90235|NCT01926119|Stanford University|Kevin Johnson, PhD RN|(650) 721-1988|johnsk@stanford.edu
90236|NCT01926015|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90237|NCT01925781|Creighton University|Director of Clinical Trials|402-280-4961|sandrabyers@creighton.edu
90238|NCT01925768|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com
90239|NCT01925703|University of Maryland School of Pharmacy, Department of Pharmacy Practice and Science|Dr. Brent N. Reed||breed@rx.umaryland.edu
90240|NCT01925469|University of Pennsylvania|Dr. Emelia Bachman|443-955-9195|emeliacleo@gmail.com
90241|NCT01925417|Rebiotix|Mary Kay Sobcinski, Director of Clinical Operations|6519644488|mksobcinski@rebiotix.com
90242|NCT01925274|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90243|NCT01925209|Novartis Pharmaceuticals|Study Director|862-778-8300|
90244|NCT01925183|Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna|Markus Peck-Radosavljevic (Principal Investigator)|+43 1 40400 ext 47440|markus.peck@meduniwien.ac.at
90245|NCT01925170|Mayo Clinic|Dr. Deborah Rhodes|507-284-7971|rhodes.deborah@mayo.edu
90246|NCT01925144|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
90248|NCT01924949|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
90249|NCT01924871|Chung-Ang University Hospital|Dr. Chong Wha Baek|82-2-6299-2579|nbjhwa@naver.com
90250|NCT01924767|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90251|NCT01924559|Lehigh Valley Hospital|Marna Rayl Greenberg, DO, MPH|484-884-7514|Marna.Greenberg@lvh.com
90252|NCT01924390|UTHSCSA Periodontics|Brian L. Mealey|210-567-3589|mealey@uthscsa.edu
90253|NCT01924299|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
90254|NCT01924182|Medtronic Neuromodulation|Mary Markert Sr Prin Clinical Research Specialist|763-526-8162|mary.a.markert@medtronic.com
90255|NCT01923896|Emory University|William G. Sharp Ph.D.|404-419-5162|wgsharp@emory.edu
90256|NCT01923805|Cleveland Clinic|Alison Klika; Research Program Manager, Adult Reconstruction|216-444-4954|klikaa@ccf.org
90257|NCT01923480|Baxter Healthcare|Aparna Valluru, Clinical Project Manager|224.270.6063|Aparna_Valluru@baxter.com
90258|NCT01923467|University of Michigan|Larry An, MD|734-763-6099|lcan@med.umich.edu
90259|NCT01923389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90260|NCT01922986|University of Minnesota|James R. Carey|612-626-2746|carey007@umn.edu
90261|NCT01922934|Denver Health|Dr. Daniel H. Bessesen|303-602-5021|daniel.bessesen@ucdenver.edu
90262|NCT01922739|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
90263|NCT01922349|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90264|NCT01922271|Novartis Pharmaceuticals|Study Director|862-778-8300|
90265|NCT01922219|NYSPI|Jeffrey Miller, M.D.|646-774-7613|jm2233@cumc.columbia.edu
90266|NCT01922115|UNC Chapel Hill|Dr. Elizabeth Geller|919-966-4717|elizabeth_geller@med.unc.edu
90267|NCT01922089|Novartis Pharmaceuticals|Study Director|862-778-8300|
90327|NCT01912768|Alcon Research, Ltd.|Clinical Project Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com
90268|NCT01922011|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90269|NCT01921894|University of Pittsburgh|Dr. Juan C. Celedon, Niels K. Jerne Professor of Pediatrics|412-692-8429|juan.celedon@chp.edu
90270|NCT01921829|University of Pittsburgh|Dr. Kelly Liang|507-269-7812|liangk@upmc.edu
90271|NCT01921452|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|49-6151-72-5200|service@merckgroup.com
90272|NCT01921348|University of MS Medical Center|Gailen D. Marshall, Jr., MD, PhD, Director, Division of Clinical Immunology and Allergy|6018155527|gmarshall@umc.edu
90273|NCT01921322|Medtronic Diabetes|John Shin, PhD|818-576-4019|john.shin@medtronic.com
90274|NCT01921296|University of Michigan Hospital|Dr. Norah Lynn Henry, Associate Professor of Internal Medicine|734-936-4991|norahh@umich.edu
90275|NCT01921101|University of Illinois at Chicago|Dr. Carol Braunschweig, Professor|3129962575|braunsch@uic.edu
90276|NCT01920958|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com
90277|NCT01920893|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
90278|NCT01920854|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com
90279|NCT01920802|New York State Psychiatric Institute|Jeffrey A. Lieberman, MD|646-774-8436|jlieberman@columbia.edu
90280|NCT01920568|GlaxoSmithKline|GSK Response Center|866-435-7343|
90281|NCT01920282|Virginia Tech|Dr. Kevin Davy|(540) 231-3487|kdavy@vt.edu
90282|NCT01920178|Cambridge Health Alliance|Paul M. Heffernan, D.P.M.|617-665-2556|pheffernan@challiance.org
90283|NCT01919996|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90284|NCT01919801|Shire|Study Physician|1 866-842-5335|
90285|NCT01919723|University of Alabama at Birmingham|Mehak Goel ,PhD|205-975-4021|mehakgoel@uabmc.edu
90286|NCT01919606|St.Barnabas Medical Center|Robert Dorian, MD|973-322-5512|rdorian@sbhcs.com
90287|NCT01919450|Cardiovascular Imaging Technologies, LLC|Timothy M. Bateman, MD|816-531-2842|tbateman@cvit.com
90288|NCT01919229|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
90289|NCT01918800|Portland VA Medical Center|Cinda Hugos|503-220-8262 ext 52338|hugosc@ohsu.edu
90290|NCT01918371|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
90291|NCT01918332|Yonsei University Healthcare System Severance Hospital|Prof. YangSoo Jang|82-2-6924-3109|yejung@lgls.com
90292|NCT01918306|Vanderbilt-Ingram Cancer Center|Dr. Vandana Abramson|800-811-8480|vandana.abramson@vanderbilt.edu
90293|NCT01918085|Coloplast|Henrik Sigaard Knoth|+ 45 4911 3469|dkhsk@coloplast.com
90294|NCT01918033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90295|NCT01917812|Johns Hopkins University School of Medicine|Dr. Seth S Martin|410-955-7376|smart100@jhmi.edu
90296|NCT01917773|Riley Hospital for Children, Indiana University|Joseph Croffie|317-944-3774|jcroffie@iupui.edu
90297|NCT01917656|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
90298|NCT01917526|Mahidol University|Department of Anesthesiology, Siriraj Hospital|66-2-41979889 ext 501|manee95@hotmail.com
90299|NCT01917344|Boston Children's Hospital|Susan Waisbren, P.h.D|617-355-7346|susan.waisbren@childrens.harvard.edu
90300|NCT01917214|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90303|NCT01916928|Medstar Washington Hospital Center|Cecily A. Clark-Ganheart|202-877-3067|ganheartmd@gmail.com
90304|NCT01916681|University of Pennsylvania|Dr. Lisa Levine|2156626913|lisa.levine@uphs.upenn.edu
90305|NCT01916629|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com
90306|NCT01916590|UColorado|Colleen Dingmann R.N. Ph.D.|303-724-7494|colleen.dingmann@ucdenver.edu
90307|NCT01916304|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
90308|NCT01916226|GlaxoSmithKline|GSK Response Center|866-435-7343|
90309|NCT01916109|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org
90310|NCT01914926|Maimonides Medical Center|Christian Fromm, MD; Director of Research|718-283-6391|cfromm@maimonidesmed.org
90311|NCT01915914|GlaxoSmithKline|GSK Response Center|866-435-7343|
90312|NCT01915849|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
90313|NCT01915823|Meda Pharmaceuticals|Dr.Nancy Ruiz,MD|7325642390|nancy.ruiz@meda.us
90314|NCT01915732|GlaxoSmithKline|GSK Response Center|866-435-7343|
90315|NCT01915173|Massachusetts General Hospital|Michelle L. Dossett, MD, PhD, MPH|617-643-6034|mdossett@mgh.harvard.edu
90316|NCT01915108|assistant professor|Dr. Sangjin Park|82-53-620-3366|apsj0718@naver.com
90317|NCT01914757|AstraZeneca|Mitchell Goldman, Medical Science Director|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com
90318|NCT01914679|University of Michigan|Daniel Clauw, MD|734-998-6901|dclauw@med.umich.edu
90319|NCT01914666|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
90320|NCT01914003|QOL Medical, LLC|Heather Elser, Director of Clinical Operations|919-832-4949|helser@qolmed.com
90321|NCT01913795|Boston Children's Hospital|Dr. Wanda Phipatanakul|617-355-6117|Wanda.Phipatanakul@childrens.harvard.edu
90322|NCT01913535|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@mgh.harvard.edu
90323|NCT01913483|Miami Cardiac & Vascular Institute, Baptist Health South Florida|Chief Medical Executive|800-273-2700|MCVI@BaptistHealth.net
90324|NCT01913470|Emory University|Miriam Vos, MD, MSPH|404-727-9930|mvos@emory.edu
90325|NCT01913041|Peking Union Medical College Hospital, Anesthesia Department|Dr. Jie Yi|+86 10 69152025|neyil@pumch.cn
90326|NCT01912781|Alcon Research, Ltd.|Clinical Project Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com
90328|NCT01912599|University of North Carolina|Jean-Claude Mwanza, MD, MPH, PhD|919-843-4917|jean-claude_mwanza@med.unc.edu
90329|NCT01912495|Erasmus MC|B.J.A.Rijnders|0031107034529|b.rijnders@erasmusmc.nl
90330|NCT01912404|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com
90331|NCT01912352|Seoul National University|Dr. Jae-Won Kim|822-2072-3648|adore412@paran.com
90332|NCT01912339|NxThera, Inc.|Vice President, Clinical Affairs|763-515-0404|cogden@nxthera.com
90333|NCT01912222|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com
90334|NCT01911845|AbbVie|Global Medical Information|800-633-9110|
90335|NCT01911793|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com
90336|NCT01911780|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90337|NCT01911689|Sichuan Key Laboratory of Medical Imaging, Department of Radiology, Affiliated Hospital of North Sichuan Medical College|Dr.XiaoMing Zhang|+86 817 2262218|cjr.zhxm@vip.163.com
90338|NCT01911442|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com
90339|NCT01911429|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com
90340|NCT01911403|Hospital de Sao Joao, E.P.E.|Dr. Paulo Morgado|+351 22 551 2100|vilaresmorgado@iol.pt
90341|NCT01911390|Department of Environmental and Radiological Health Sciences|Dr Elizabeth Ryan|970-491-1536|E.P.Ryan@colostate.du
90342|NCT01911351|NYCHHC Jacobi Medical Center|Dr. Sandra Cunningham|718 918 5250|sandra.cunningham@nbhn.net
90343|NCT01911273|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90344|NCT01911260|Federal University of Sao Paulo|Ana Paula Poblacion|+55 11 55391783|anapoblacion@yahoo.com.br
90345|NCT01911221|Novartis Vaccines and Diagnostics|Posting Director||RegistryCpontactVaccinesUS@novartis.com
90346|NCT01911065|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu
90347|NCT01910831|Center for Clinical and Cosmetic Research|Andrew Frisina, Clinical Research Coordinator|305 933 6716|A.Frisina@admcorp.com
90348|NCT01910792|Vitamin D, Skin, and Bone Research Laboratory|Dr. Michael F Holick|6176384546|mfholick@bu.edu
90349|NCT01910688|Columbia University Medical Center|Dr. Julian Abrams|(212) 235-1496|ja660@cumc.columbia.edu
90350|NCT01910636|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
90351|NCT01910441|Novartis|Study Director|862-778-8200|
90353|NCT01910389|New England Research Institutes|Brian Harty|617-972-3224|bhartY@neriscience.com
90354|NCT01910311|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
90356|NCT01910116|Seoul National University Hospital|Prof. Eun Bong Lee|822-2072-3944|leb7616@snu.ac.kr
90357|NCT01910064|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com
90358|NCT01909804|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
90359|NCT01909778|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90360|NCT01909713|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com
90361|NCT01909674|Weill Cornell Medical College|Dr. Matthew Ebben|6469629318|mae2001@med.cornell.edu
90362|NCT01909570|University Hospital Virgen de las Nieves|Dr. Ana Clavero|0034958020482|anaclaverogilabert@gmail.com
90363|NCT01909466|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
90364|NCT01909336|HIMFG|Claudia Montserrat Flores Robles|(52) 5566756686|montseflores@hotmail.com
90365|NCT01909180|GE Healthcare|RIchard Petrisko|262-548-4637|richard.petrisko@ge.com
90366|NCT01909141|Cairo University|Dr. Ghada Abdel Fattah|00201006513305|ghadaabdelfatah2007@yahoo.com
90367|NCT01909011|Mount Sinai Beth Israel|Igor Galynker MD PhD|212-420-4535|igalynke@chpnet.org
90368|NCT01908842|University of Virginia|Dr. Erik Gunderson, MD, FASAM|(434) 202-8612|EWG2N@hscmail.mcc.virginia.edu
90371|NCT01908140|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com
90372|NCT01908127|Tehran University of Medical Sciences|Dr. Mehrsa Paryab|00989121091675|drmparyab@yahoo.com
90373|NCT01907906|Terumo BCT Biotechnologies, LLC|Ray Goodrich, PhD|(303) 231-4832|
90374|NCT01907854|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
90375|NCT01907516|John A Burns School of Medicine / University of Hawaii Dept of Obstetrics and Gynecology|Marguerite Lisa Bartholomew MD|808-983-6761|mbarthol@hawaii.edu
90376|NCT01907490|Hatchtech Pty Ltd|Clinical Manager|+61 3 9092 0490|tahveninen@hatchtech.com.au
90377|NCT01907334|University of Florida|Leslie Hendeles, PharmD|352-273-6027|hendeles@cop.ufl.edu
90378|NCT01907321|University of Florida|Dr. Karen Hegland, PI|352 294-8366|kwheeler@ufl.edu
90379|NCT01907113|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90380|NCT01906658|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com
90381|NCT01906515|Cairo University School Of Medicine|Dr Wael N Awada|00201006481958|waoool@hotmail.com
90382|NCT01906372|University of Pittsburgh, Division of Rheumatology|Rohit Aggarwal, MD|412-647-2840|aggarwalr@upmc.edu
90383|NCT01905956|InQpharm Europe Ltd|Pee-Win Chong|+603 6201 9690 ext 358|pwchong@inqpharm.com
90384|NCT01905657|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90385|NCT01905553|Shire|Study Physician|+1 866 842 5335|
90386|NCT01905540|Shire|Study Physician|+1 866 842 5335|
90387|NCT01905254|Universitiy Clinic Hamburg eppendorf|PD Dr. Ulrike Denzer|040741055380|u.denzer@uke.de
90389|NCT01904773|AstraZeneca Pharmaceuticals LP, Neuroscience Innovative Medicines Unit|Joel Posener, MD - Head, Early Clinical Development||ClinicalTrialTransparency@astrazeneca.net
90390|NCT01904760|Department of Anesthesiology, Peking University School and Hospital of Stomatology, Beijing, China|Xudong Yang|8610-82195287|kqyangxudong@163.com
90391|NCT01904721|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
90392|NCT01904604|DAIT/NIAID|Director, Clinical Research Program|(301) 594-7669|DAITClinicalTrialsGov@niaid.nih.gov
90393|NCT01904279|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
90394|NCT01904149|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Director of Clinical Research|+3905556809933|ACapriati@menarini-ricerche.it
90395|NCT01904071|Maimonides Medical Center|Dr. Eitan Dickman, Director of EM Ultrasound|718-283-6057|edickman@maimonidesmed.org
90396|NCT01904058|Shire|Study Physician|1-866-842-5335|
90397|NCT01903993|Hoffmann-La Roche|Medical Communications|800 821 ext 8590|genentech@druginfo.com
90398|NCT01903876|Georgia State University|Dr. Laura Salazar|404-413-1396|lsalazar1@gsu.edu
90399|NCT01903863|Duke University Hospital|Dr. Caroline Ozment|919-681-2554|
90401|NCT01903460|Shire Development LLC|Study Physician|+1 866 842 5335|
90402|NCT01903265|Tonix Pharmaceuticals|Gregory M. Sullivan, MD, Chief Medical Officer|212 980 9155 ext 117|Gregory.Sullivan@TonixPharma.com
90403|NCT01903187|St. Jude Medical, Inc.|Steven Madej|651-756-2230|smadej@sjm.com
90404|NCT01903148|Hospital de Bellvitge|Dr. Alberto Martínez Castelao|610 459 262|albertomcastelao@gmail.com
90405|NCT01903005|TRY Research|Kent Hoffman, DO|(407) 691-3960|Suboxdoc1@yahoo.com
90406|NCT01902888|W.L. Gore and Associates, Inc.|Arthur Scott / Clinical Study Manager|623.208.3365|artscott@wlgore.com
90407|NCT01902758|University of Montana|Director of the Montana Center for Work Physiology and Exercise Metabolism|406-243-2117|brent.ruby@mso.umt.edu
90408|NCT01902303|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144|
90409|NCT01902134|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Director of Clinical Research|+3905556809933|ACapriati@menarini-ricerche.it
90410|NCT01901588|NYU School of Medicine|Assistant Professor, Department of Anesthesiology, Perioperative Care, and Pain Medicine|212.263.5072|wanda.chin@nyumc.org
90412|NCT01901393|Cumberland Pharmaceutical Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com
90413|NCT01901341|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660|
90414|NCT01901328|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660|
90415|NCT01901302|Cubist Pharamceuticals|Vice President Clinical Research|1.781.860.8660|
90416|NCT01901250|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|sxn15@case.edu
90417|NCT01901211|Holland Bloorview Kids Rehabilitation Hospital|Darcy Fehlings, MD, MSc, FRCP(C)|416-425-6220 ext 3586|dfehlings@hollandbloorview.ca
90418|NCT01901185|Amgen Inc.|Study Director|866-572-6436|
90419|NCT01900431|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
90420|NCT01900314|University of Michigan|Stephan Taylor|734-936-4955|sftaylor@umich.edu
90421|NCT01900249|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com
90422|NCT01900067|Mölnlycke Health Care AB, Surgical Division|Jenny Höglind|0046 31 722 30 00|Jenny.Hoglind@molnlycke.com
90423|NCT01900054|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
90424|NCT01899911|University of California, San Francisco (UCSF)|Philip E. Bickler, MD, PhD, Professor of Anesthesia|415-476-1411|Philip.Bickler@UCSF.edu
90425|NCT01899768|GlaxoSmithKline|GSK Response Center|866-435-7343|
90426|NCT01899742|GlaxoSmithKline|GSK Response Center|866-435-7343|
90427|NCT01899677|Zeynep Kamil Maternity and Children's Education Training Hospital|Ozge Serce (Investigator, MD)|+905323270375|ozge_serce@hotmail.com
90428|NCT01899144|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
90429|NCT01898884|Shire|Study Physician|1 866-842-5335|
90430|NCT01898598|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
90431|NCT01898442|University of Florida - Jacksonville|Dominick J. Angiolillo, MD, PhD|9042443933|dominick.angiolillo@jax.ufl.edu
90432|NCT01898403|Stanford University Medical Center|Dana T Lin, MD; Clinical Assistant Professor|650-498-6000|danalin@stanford.edu
90433|NCT01898286|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com
90434|NCT01898208|Mayo Clinic|Ritu Banerjee, M.D., Ph.D.|507-284-6904|banerjee.ritu@mayo.edu
90435|NCT01898195|Department of Population Health, New York University School of Medicine|Donna Shelley, MD, MPH/ Vice Chair for Research; Associate Professor of Population Health and Medici|646-501-2526|Donna.Shelley@nyumc.org
90436|NCT01898091|Medical University of South Carolina|Susan G. Reed, DDS, MPH, DrPH|843 792-1577|reedsg@musc.edu
90437|NCT01897792|UAB Department of Anesthesiology|Jean-Francois Pittet, MD|205-996-4755|jpittet@uabmc.edu
90438|NCT01897727|University of Alabama at Birmingham|Dr. Eric Judd|205 934-9281|ejudd@uab.edu
90439|NCT01897402|JN-International Medical Corporation|Regulatory Affairs Director|4028843477|dr_orten@jn-vaccines.org
90440|NCT01897285|Arrowe Park Hospital|Mrs Gwenneth Lawrence|0151 678 5111 ext 8362|gwen.lawrence@nhs.net
90441|NCT01897233|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
90442|NCT01897025|National University Hospital|Dr Effie Chew|65-67726198|effie_chew@nuhs.edu.sg
90443|NCT01896986|MCRI|Dr. Nigel Crawford|9345 4772|nigel.crawford@rch.org.au
90444|NCT01896934|Vanderbilt University Medical Center|Dr. Warren D Taylor|615-936-3555|warren.d.taylor@vanderbilt.edu
90445|NCT01896726|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
90446|NCT01896687|Virginia Commonwealth University|Dr. Angela Starkweather|8048283986|astarkweathe@vcu.edu
90448|NCT01896544|Massachusetts General hospital|Tiffany M.N. Otero|4074950753|totero@partners.org
90449|NCT01896297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90450|NCT01896232|Amgen Inc.|Study Director|866-572-6436|
90451|NCT01896206|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|Joseph.Tobias@nationwidechildrens.org
90452|NCT01896193|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
90454|NCT01896050|University of Michigan Comprehensive Cancer Center|Norah Lynn Henry, MD|734-936-4991|norahh@med.umich.edu
90455|NCT01895946|AstraZeneca UK Limited|Dr Justin P. O. Lindemann, MBChB MBA, Medical Science Director, AZD5363|(0)7920 250301 ext +44|Justin.Lindemann@astrazeneca.com
90456|NCT01895634|Johnson & Johnson K.K. Medical Company|Depertment Chief, Clinical Operation|+81-3-4411-6789|yikeda5@its.jnj.com
90457|NCT01895608|James H Quillen VAMC|Dr. Courtney Hall|423-926-1171 ext 7518|courtney.hall@va.gov
90458|NCT01895543|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
90459|NCT01895452|Alkermes, Inc.|ARISTADA Medical Information|866-204-7823|usmedinfo@alkermes.com
90460|NCT01895335|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
90461|NCT01895322|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366|
90462|NCT01895309|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534|
90463|NCT01895270|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu
90464|NCT01895127|Brigham and Women's Hospital|Anil Chandraker|617-732-7412|achandraker@bwh.harvard.edu
90465|NCT01895101|Amphia Hospital|Dr. Thierry V Scohy|0031765955570|tscohy@amphia.nl
90466|NCT01895088|AcuFocus, Inc.|Eugenia Thomas, Director Clinical Trials|9495859511|nthomas@acufocus.com
90467|NCT01895062|5i Sciences|Dr. Richard Rose|858-759-2205|rrose@5isciences.com
90468|NCT01895036|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu
90469|NCT01894984|XIAN-JANSSEN PHARMACEUTICAL|Medical affairs director|86-10-58218307|
90470|NCT01894906|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com
90471|NCT01894672|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman MD|646-888-4162|chapmanp@MSKCC.ORG
90472|NCT01894607|University of Texas (UT) MD Anderson Cancer Center|Ott Le, MD/Associate Professor, Diagnostic Radiation Body Imaging||CR_Study_Registration@mdanderson.org
90473|NCT01894581|University of Colorado Denver|Dr. Alex Polotsky|303-724-2001|alex.polotsky@ucdenver.edu
90474|NCT01894555|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu
90475|NCT01894256|AstraZeneca|Dr Anitra Fielding|+44 1625 582828|anitra.fielding@astrazeneca.com
90476|NCT01894230|Duke University|Dr. Deepak Voora|919-668-1755|Deepak.vorra@duke.edu
90477|NCT01894100|University of North Carolina at Chapel Hill|Yvonne M. Golightly, PT, PhD|919-966-0566|golight@email.unc.edu
90478|NCT01894022|GlaxoSmithKline|GSK Response Center|866-435-7343|
90479|NCT01893905|Complejo Hospitalario de La Coruña (CHUAC)|Dr Francisco Blanco, study coordinator|981 17 80 00|fblagar@sergas.es
90480|NCT01893879|Stanford University|Leslie Roche, RN|650-723-1396|lesroche@stanford.edu
90481|NCT01893567|Galderma Laboratories, L.P.|Senior Clinical Project Manager|817-961-5000|jay.mashburn@galderma.com
90482|NCT01893411|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de
90483|NCT01893359|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com
90484|NCT01893346|AstraZeneca Pharmaceuticals|Paul Newell, MBBS MRCP MFPM|+44 1625 515727|paul.newell@astrazeneca.com
90485|NCT01893281|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
90486|NCT01893203|Helsinki university hospital|Noora Neittaanmäki-Perttu|+358407190362|noora.neittaanmaki@fimnet.fi
90487|NCT01892657|Galderma Laboratories, L.P.|Elizabeth M. Nieman, Medical Information Specialist|817-961-5130|elizabeth.nieman@galderma.com
90488|NCT01892306|Massachusetts General Hospital|Kristen Ellard, PhD|617-726-6422|kellard@partners.org
90489|NCT01892267|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu
90490|NCT01892189|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
90491|NCT01892163|Moorfields Eye Hospital NHS Foundation Trust|Professor Sobha Sivaprasad|02072533411|sobha.sivaprasad@moorfields.nhs.uk
90492|NCT01892020|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
90493|NCT01891890|Emory University|David Loring, PhD|404-778-5943|dloring@emory.edu
90494|NCT01891864|Sandoz|Dr Guido Wuerth - Global Program Medical Director|+4980244762925|guido.wuerth@sandoz.com
90495|NCT01891734|Department of Veterans Affairs San Diego|Kathleen Grubbs|808-383-9757|kathleen.grubbs@va.gov
90496|NCT01891669|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com
90497|NCT01890967|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
90498|NCT01890954|University of Virginia|Daniel Chernavvsky|434-243-1395|drc2v@virginia.edu
90499|NCT01890915|James J. Peters VA Medical Center|Dr. John P. Handrakis|718-584-9000 ext 5439|john.handrakis@va.gov
90500|NCT01890785|Shire Development LLC|Study Physician|+1 866 842 5335|
90501|NCT01890759|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
90502|NCT01890746|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
90504|NCT01890642|Medical College of Wisconsin|Maren Lunoe|414-266-2625|mlunoe@mcw.edu
90505|NCT01890577|Amgen Inc.|Study Director|866-572-6436|
90506|NCT01890512|Guidant Europe SA/NV A Boston Scientific Company|Giovanni Raciti|+39 02 26983213|giovanni.raciti@bsci.com
90507|NCT01890473|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
90508|NCT01890343|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
90509|NCT01890148|AstraZeneca|Larsson, Bengt|+46 (0) 317064277|ClinicalTrialTransparency@astrazeneca.com
90510|NCT01890122|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
90511|NCT01890031|University of Rochester|Robert Block, MD, MPH; Clinical Trial Director|585-275-3356|robert_block@urmc.rochester.edu
90512|NCT01889797|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3627|jmanola@jimmy.harvard.edu
90513|NCT01889667|Oramed|Chief Scientific Officer|+972-2-566-0001|aviva@oramed.com
90514|NCT01889563|Federal university of Sao Carlos|Audrey Borghi e Silva|+55 163351-8952|audrey@ufscar.br
90515|NCT01889420|University of New Mexico|Dulcinea Quintana, MD|505-272-4661|dcandelaria@salud.unm.edu
90516|NCT01889251|Alcon Japan, Ltd.|Group Manager, Clinical Development|+81368995277|
90517|NCT01888965|Georgetown Lombardi Comprehensive Cancer Center|John L Marshall|202 444 7064|marshalj@georgetown.edu
90518|NCT01888952|CTRC@UTHSCSA|Anand Karnad, MD|210-450-1000|karnad@uthscsa.edu
90519|NCT01888900|National Institute of Diabetes and Digestive and Kidney Diseases|Dr. Marc Ghany|301-402-5515|marcg@mail.nih.gov
90520|NCT01888367|Promius Pharma, LLC, Dr. Reddy's Laboratories|VP, Drug Development|609-375-9855|kallenby@drreddys.com
90521|NCT01888003|University of Alabama at Birmingham Department of Anesthesiology and Perioperative Medicine|Dr. Thomas Vetter|205.934.6501|tvetter@uab.edu
90522|NCT01887990|University of Cincinnati|Cheryl McCullumsmith|513-5588022|cheryl.mccullumsmith@uc.edu
90523|NCT01887678|Biologische Heilmittel Heel GmbH|Christine Frank, PhD, Global Clinical Project Manager|+49 7221 501 3188|christine.frank@heel.com
90524|NCT01887470|Cumberland Pharmaceuticals, Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com
90525|NCT01887418|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President Clinical Development|609-329-3020 ext 324|jjaffe@antarespharma.com
90526|NCT01887353|Intermountain Healthcare|T. Jared Bunch|8015074701|jared.bunch@imail.org
90527|NCT01887171|Republican scientific and practical center for organ and tissue transplantation|Aliaksej Shcherba|+375293330689|aleina@tut.by
90528|NCT01887132|National Institute of Mental Health (NIMH)|Ashura W Buckley|(301) 496-5190|shu.buckley@nih.gov
90529|NCT01886963|Carolinas HealthCare System|Dr. Todd Heniford|7043551813|todd.heniford@carolinashealthcare.org
90530|NCT01886937|New York State Psychiatric Institute|Dr. Laurel Mayer|646-774-8067 ext 646|lsm16@cumc.columbia.edu
90531|NCT01886807|UTSouthwestern Medical Center|Dr. Jeffrey Steiner, PI|214-456-0606|jeffrey.steiner@utsouthwestern.edu
90532|NCT01886781|University of Stellenbosch, South Africa|Cheryl Stevenson|0827514411|cheryl@retaildc.co.za
90533|NCT01886716|Miami University|Dr. Elise Clerkin|513-529-2483|clerkiem@miamioh.edu
90534|NCT01886690|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
90535|NCT01886313|Winston Pharmaceuticals|Dr. Scott B. Phillips|8473628200|scott@winstonlabs.com
90536|NCT01886300|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
90537|NCT01886287|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org
90538|NCT01886235|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
90539|NCT01885910|DermResearch, PLLC|Dr. Leon Kircik|502-451-9000|wedoderm@yahoo.com
90540|NCT01885871|Cutera, Inc|Clinical Research Department|1-888-428-8372|gweiss@cutera.com
90541|NCT01885559|Mayo Clinic|Dr. Vicente Torres||torres.vicente@mayo.edu
90542|NCT01885117|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
90543|NCT01885104|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90544|NCT01885000|Galderma|Nabil Kerrouche|+33 4 93 95 70 70|nabil.kerrouche@galderma.com
90545|NCT01884688|University of Arkansas for Medical Sciences|Frits van Rhee|501-526-6990|vanrheefrits@uams.edu
90546|NCT01884675|GlaxoSmithKline|GSK Response Center|866-435-7343|
90549|NCT01884519|GlaxoSmithKline|GSK Response Center|866-435-7343|
90550|NCT01884064|University of Minnesota|Dr. Teresa Jacobson Kimberley|612-626-4096|tjk@umn.edu
90552|NCT01883986|VA Puget Sound Health Care System|Lynn F. Reinke, PhD, ARNP|206-277-4186|lynn.reinke1@va.gov
90553|NCT01883908|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu
90554|NCT01883895|UW Madison|Nalini Sehgal|608-263-8639|sehgal@rehab.wisc.edu
90555|NCT01883635|University of Rochester|Dr. Charles Kamen|585-275-9958|charles_kamen@urmc.rochester.edu
90556|NCT01883453|Umeå University|Dr Krister Tano|0046705569043|krister.tano@umu.se
90557|NCT01883440|Umeå University|MD, PhD Krister Tano|0046705569043|krister.tano@umu.se
90558|NCT01883427|Umeå University|MD, PhD Krister Tano|0046705569043|krister.tano@umu.se
90559|NCT01882907|Pusan National University Hospital|In Joo Kim|+82-51-240-7224|injkim@pusan.ac.kr
90560|NCT01882868|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
90561|NCT01882725|Arizona Institute of Footcare Physicians|Kerry Zang, DPM|480-834-8804|kerryzang@aol.com
90562|NCT01882647|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|585-571-1800|clinicalreseach@therapeuticsinc.com
90563|NCT01882543|Department of Urology, Queens University, Ontario|J. Curtis Nickel|613-548-2497|jcn@queensu.ca
90564|NCT01882465|Johnson & Johnson Vision Care Inc.|Charis Lau, PharmD, OD, FAAO- Principal Research Optometrist|904-433-3500|charislau@gmail.com
90565|NCT01882439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|
90566|NCT01882413|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
90567|NCT01882257|University of Michigan Health System|Robert G. Sitrin, M.D.|(734) 936-5201|rsitrin@umich.edu
90568|NCT01882062|Inserm U1127|Dr Fanny MOCHEL|+33 (0)1 5727 46 78|fanny.mochel@upmc.fr
90569|NCT01881984|University of Pittsburgh|Dr. Gerard Vockley|412-692-7746|gerard.vockley@chp.edu
90570|NCT01881932|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu
90571|NCT01881776|StLukeNY|Dr.Admir Hadzic|212-665-1400|admir@nysora.com
90572|NCT01881737|Stanford University School of Medicine|Antonio Hardan, MD|(650) 736-1235|hardanay@stanford.edu
90573|NCT01881126|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
90574|NCT01881087|Fundación Valle del Lili|Dr. Fredy Ariza, MD., MSc., PhD(a).|+57 3319090 ext 4122|fredyariza@hotmail.com
90575|NCT01880840|Meda Pharmaceutical|Dr.Nancy Ruiz Chief Medical Officer|732 564 2200 ext 2390|nancy.ruiz@meda.us
90576|NCT01880736|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
90577|NCT01880723|University of Arizona|Courtney Wheatley|507-266-2696|wheatley.courtney@mayo.edu
90578|NCT01880697|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
90579|NCT01880515|Instituto Nacional de Cancerología|Oscar Arrieta|+52 55 56 28 04 00 ext 832|ogar@servidor.unam.mx
90580|NCT01880437|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
90581|NCT01880424|AstraZeneca|Peter Zeng|+86 21 6030 1867|peter.zeng@astrazeneca.com
90582|NCT01880320|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com
90583|NCT01880099|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu
90584|NCT01880086|Weill Cornell Medical College|Dr. Peter N. Schlegel|2127465491|pnschleg@med.cornell.edu
90585|NCT01879852|University of Florida|Dr. Terese Chmielewski|(352)273-6104|tchm@ufl.edu
90586|NCT01879800|Baylor College of Medicine|Dr. Lilian Dindo|713-791-1414 ext 10296|lilian.dindo@bcm.edu
90587|NCT01879735|Dept. of Nuclear Medicine & PET-center, Dept. of Hepatology and Gastroenterolgy. Aarhus University Hospital|Susanne Keiding M.D., Associate professor, D.Sc.|+45 7846 3031|susanne@pet.auh.dk
90588|NCT01879722|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com
90589|NCT01879683|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
90590|NCT01879618|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90591|NCT01879579|New York University School of Medicine|Dr. Natalie Levy|2122638924|Natalie.Levy@nyumc.org
90592|NCT01879553|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
90593|NCT01879540|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
90595|NCT01879371|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90596|NCT01879345|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
90597|NCT01879332|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
90598|NCT01879319|Amgen Inc.|Study Director|866-572-6436|
90599|NCT01879176|Medical University of Vienna|Dr. Martin H. Bernardi|004314040041090|martin.bernardi@meduniwien.ac.at
90600|NCT01879059|University of Kansas Medical Center|John P. Thyfault, PhD|913-588-1790|jthyfault@kumc.edu
90601|NCT01878825|GlaxoSmithKline|GSK Response Center|866-435-7343|
90602|NCT01878812|GlaxoSmithKline|GSK Response Center|866-435-7343|
90603|NCT01878799|National Institute of Allergy and Infectious Diseases|Dr. Shyam Kottilil|+1 301 435 0936|skottilil@niaid.nih.gov
90604|NCT01878656|Chung-Ang University Hospital|Dr. Chong Wha Baek|82-2-6299-2579|nbjhwa@naver.com
90605|NCT01878604|Central South University|Shuiping Zhao|86-731-85295806|zhaosp@medmail.com.cn
90606|NCT01878526|Khon Kaen University|Dr.Chingching Foocharoen|6643363746|fching@kku.ac.th
90607|NCT01878214|Washington University School of Medicine in St. Louis|Jaime Strickland, MA|314-454-7337|jstrickl@dom.wustl.edu
90608|NCT01878175|Durham VA Medical Center|Kelli Allen|919-286-0411 ext 7090|kelli.allen@va.gov
90609|NCT01878149|Baxano Surgical®|Sr. Director of Clinical Affairs|919.899.9760|teresa.schroeder@baxsurg.com
90610|NCT01878097|University of Kentucky|Dr. Ann Coker|859-323-6758|ann.coker@uky.edu
90611|NCT01877941|University of California San Francisco|Arthur Wallace, M.D., Ph.D.|415-750-2069 ext 3732|art.wallace@va.gov
90612|NCT01877720|Seoul National University College of Medicine|Dr. Han-Suk Kim|82-2-2072-1696|kimhans@snu.ac.kr
90613|NCT01877668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|
90614|NCT01877538|Department of Nuclear Medicine & PET Center, Aarhus University Hospital|Dr. Per Borghammer|+0045 23818581|perborgh@rm.dk
90616|NCT01877408|University of New England|Dr. Peter Millard|2078663503|pmillard@mac.com
90617|NCT01877343|University of Florida|Dr. Curt DeGroff|352-273-7770|degroffc@peds.ufl.edu
90618|NCT01877278|University of Messina|Gianfilippo Bagnato|00390902212502|gianbagnato@gmail.com
90619|NCT01877161|Seoul National University Bundang Hospital|Nam-Jong Paik|031-787-7731 ext 7731|njpaik@snu.ac.kr
90620|NCT01877148|Universidade Federal de Pernambuco|Kátia Monte-Silva|+ 55 (81) 2126-7579|monte.silvakk@gmail.com
90621|NCT01876992|Johns Hopkins University|Sally Radovick|7322359524 ext 7733073353|sradovick@jhmi.edu
90622|NCT01876979|OMFS & HD|Department Chair|302-320-6458|dmeara@christianacare.org
90623|NCT01876823|Columbia Psychiatry|Dr. Gregory Pelton, MD|(646) 774-8669|ghp4@columbia.edu
90624|NCT01876810|Centre for Addiction and Mental Health|Bernard LeFoll|416-535-8501 ext 34772|bernard.lefoll@camh.ca
90626|NCT01876732|Staten Island University Hospital|Suzanne El-Sayegh|718-226-6158|uviola@siuh.edu
90629|NCT01876329|Keesler Medical Center|Matthew B. Carroll, MD|228-376-3629|matthew.carroll.1@us.af.mil
90630|NCT01875991|Amgen Inc.|Study Director|866-572-6436|
90631|NCT01875978|China Medical University Hospital|Dr. Dalong Chen|+886-227919696 ext 1205|my686chen@gmail.com
90632|NCT01875848|VACT West Haven HealthCare System|William, Becker M.D|203-932-5711 ext 2247|william.becker4@va.gov
90633|NCT01875783|Joslin Diabetes Center|Dr. Jennifer Sun|617-209-2554|jennifer.sun@joslin.harvard.edu
90634|NCT01875731|Hospital General de Niños Pedro de Elizalde|Dr. Fernando Torres|+54 11 43632100 ext 1014|torresfernandoadrian@gmail.com
90635|NCT01875510|Dr. Sami Ulus Children's Hospital|Dr. Serdar Beken|00903123056449|serbeken@gmail.com
90636|NCT01875471|Johnson & Johnson Vision Care|Daria Wicks|1 904 443-1391|RA-VISUS-ClnclStds@its.jnj.com
90637|NCT01875445|University of Chicago|Dr. Jon Grant|773-834-3778|jongrant@uchicago.edu
90638|NCT01875159|Uniformed Services University|Carl E. Hunt, M.D.|240-694-2676|carl.hunt@usuhs.edu
90639|NCT01874951|Depression Clinical and Research Program, Massachusetts General Hospital|David Mischoulon, MD, PhD, Director of Research|617-724-5198|dmischoulon@partners.org
90640|NCT01874665|ARIAD Pharmaceuticals, Inc.|David Kerstein, MD|+1 (617) 494-0400|David.Kerstein@ariad.com
90641|NCT01874340|Novartis|Study Director|862-778-8300|
90642|NCT01874275|Independent Principal Investigator|Charlotte Stelly-Seitz, MD|713-523-3463|drstellyseitzmd@gmail.com
90643|NCT01874262|AstraZeneca|Susanna Jerström|+46 8 553 260 00|
90644|NCT01874145|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
90645|NCT01874132|University of Trás-os-Montes e Alto Douro|Professor Nelson Sousa|259350756 ext +351|nelsons@utad.pt
90647|NCT01873989|Yale University|Dr. Declan Barry|203-285-2708|declan.barry@yale.edu
90649|NCT01873859|Cardiovascular research center, Shahid Beheshti University of Medical Sciences|Dr. Saeed Alipour Parsa, director of clinical trial|+9821 2208 3106|s_alipour@sbmu.ac.ir
90650|NCT01873729|Pediatric Psychopharmacology at Massachusetts General Hospital|Dr. Thomas Spencer|6177243883|tspencer@partners.org
90651|NCT01873417|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com
90652|NCT01872819|University of Washington|Dr. Pamela Becker|206-288-7273|pbecker@u.washington.edu
90653|NCT01872715|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com
90654|NCT01872611|Alcon Research, Ltd.|Therapeutic Unit Head, Cornea and Inflammation|1-888-451-3937|alcon.medinfo@alcon.com
90655|NCT01872078|AstraZeneca Pharmaceuticals LP|Martin L. Scott, MD/PhD|781-472-5130|martin.scott@astrazeneca.com
90656|NCT01871870|Legacy Health System|Dr. Ken Ward|971-570-2632|kenward503@msn.com
90658|NCT01871558|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
90659|NCT01871532|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
90660|NCT01871519|Medtronic Spinal|Clinical Department|1800-876-3133 ext 6068|msbkclinicalresearch@medtronic.com
90661|NCT01871402|Therapeutics, Inc.|Clinical Research, Therapeutics, Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com
90662|NCT01871285|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
90663|NCT01871142|Colorado State University|Christopher Bell, Ph.D.|(970) 491-7522|christopher.bell@colostate.edu
90664|NCT01871090|St Jude Medical, Inc.|Todd Stirman, Clinical Manager|(972) 526-9625|Tstirman@sjm.com
90665|NCT01870999|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Medical Affairs|800-562-3974|
90666|NCT01870973|The Ohio State University|Dr. Melissa Drum|6142923596|drum.13@osu.edu
90667|NCT01870921|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com
90668|NCT01870856|Alcon Research, Ltd.|Anne Brobst, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com
90669|NCT01870843|Xian-Janssen Pharmaceutical Ltd|Associate TA Manager||ClinicalTrialDisclosure@its.jnj.com
90670|NCT01870739|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
90671|NCT01870596|Sidney Kimmel Comprehensive Cancer Center|B. Douglas Smith|(410) 287-2935|bdsmith@JHMI.edu
90672|NCT01870583|Stony Brook Medicine|Dr David Garry|631-444-7650|david.garry@stonybrookmedicine.edu
90673|NCT01870388|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
90674|NCT01869959|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
90675|NCT01869699|University of California, San Francisco|Dr. Hildy Schell-Chaple|415-353-1039|hildegarde.schell-chaple@ucsf.edu
90676|NCT01869686|Amgen Inc.|Study Director|866-572-6436|
90677|NCT01869647|Yale Emergency Medicine|Dr. Chris L. Moore|(203)737-3313|chris.moore@yale.edu
90678|NCT01869478|Mayo Clinic|Kevin M. Barrett, MD|904-953-9740|Barrett.Kevin@mayo.edu
90679|NCT01869348|The University of Texas Medical Branch|Eloisa Martinez|4092669643|esmartin@utmb.edu
90680|NCT01869075|Sunnybrook HSC|Artemis Diamantouros|416-480-6100 ext 3654|artemis.diamantouros@sunnybrook.ca
90681|NCT01868997|Horizon Pharma USA, Inc.|Julie Ball, Executive Director||clinicaltrials@horizonpharma.com
90682|NCT01868893|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
90683|NCT01868776|The Ohio State University|Dr. Melissa Drum|6142923596|drum.13@osu.edu
90684|NCT01868633|University of Iowa|Dr. Unyime Ituk|3193562633|unyime-ituk@uiowa.edu
90685|NCT01868542|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
90686|NCT01868503|Stanford University|Dr. Kathleen Horst|6507360921|kateh@stanford.edu
90688|NCT01868243|Hospital Ana Nery|Andre Rodrigues Duraes|+557191888399|andreduraes@gmail.com
90689|NCT01868074|University of Iowa|Neil Segal, M.D., M.S.|3193560737|segal-research@uiowa.edu
90690|NCT01868035|GlaxoSmithKline|GSK Response Center|866-435-7343|
90691|NCT01868009|GlaxoSmithKline|GSK Response Center|866-435-7343|
90693|NCT01867658|C.R. Bard Inc.|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com
90694|NCT01867632|MUHC|Dr. Mirko Gilardino|514.934.1934|Mirko.Gilardino@muhc.mcgill.ca
90696|NCT01867164|Global Clinical Operations Mexico|Clinical Research Director|+52 55 5484 3184|
90698|NCT01867021|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
90699|NCT01866709|ZS Pharma, Inc|Henrik Rasmussen, MD, PhD|443-699-5230|hrasmussen@zspharma.com
90700|NCT01866423|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist|323-865-0454|Victoria.Soto@med.usc.edu
90702|NCT01866306|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90703|NCT01866293|Memorial Sloan Kettering Cancer Center|Sergio Giralt, MD|212-639-6009|GiraltS@mskcc.org
90704|NCT01866163|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com
90705|NCT01866150|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com
90706|NCT01865812|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com
90707|NCT01865747|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com
90708|NCT01865084|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
90709|NCT01864538|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilso2112@gmail.com
90710|NCT01864434|University of Tennessee|Adrija Sharma, Ph. D.|8659742093|asharma1@utk.edu
90711|NCT01864174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
90712|NCT01864148|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
90713|NCT01864005|Astrazeneca|Judith Hsia|1-301-398-0102|judithhsia@astrazeneca.com
90714|NCT01863953|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
90715|NCT01863771|Janssen Pharmaceutical K.K.|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com
90716|NCT01863680|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
90717|NCT01863667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90718|NCT01863433|bioCSL PTY LTD|bioCSL, Head of Clinical Operations|csl.clinicaltrials@csl.com.au|csl.clinicaltrials@csl.com.au
90719|NCT01863368|Alcon Research, Ltd.|Global Brand Med Affairs Lead, Pharma, GCRA|1-888-451-3937|alcon.medinfo@alcon.com
90720|NCT01863134|First Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland|Miroslaw Wilczynski|+48 32 20 24 025|miroslaw.wilczynski@cardiosurg.pl
90721|NCT01862991|Stanford University|Dr. Kate Shaw|6507211562|familyplanningresearch@stanford.edu
90722|NCT01862484|The University of Texas Health Science Center at San Antonio|Steven R. Pliszka MD|210-567-0136|pliszka@uthscsa.edu
90723|NCT01862419|Yale University School of Medicine|Francis Perry Wilson, MD MSCE|2037371704|francis.p.wilson@yale.edu
90724|NCT01862159|Region Örebro län, Sweden AND Örebro University, Sweden|Dr Erik Stenberg|+46196021000|erik.stenberg@regionorebrolan.se
90725|NCT01862133|Regenstrief Institute|William M. Tierney, MD|(317) 274-9094|wtierney@regenstrief.org
90726|NCT01861925|Haag Streit AG|Dr. Lucio Robledo, Clinical Trials Biometry|+41 31 978 01 11 ext 209|lucio.robledo@haag-streit.com
90727|NCT01861756|Aristotle University Thessaloniki|Dr. Apostolos Tsapas||atsapas@auth.gr
90728|NCT01861704|InSound Medical, Newark, California|Tanya Arbogast, Study Principal Investigator|510-792-4000|Srikant.Mantha@phonak.com
90729|NCT01861522|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
90730|NCT01861457|Medical University of South Carolina|Shaun A. Nguyen, MD, Associate Professor- Director of Clinical Research|8437921356|nguyensh@musc.edu
90731|NCT01861301|University of Chicago|Hedy Kindler, MD|773-702-0360|hkindler@medicine.bsd.uchicago.edu
90732|NCT01860989|Novartis Pharmaceuticals|Study Director|862-778-8300|
90733|NCT01860976|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
90734|NCT01860846|AbbVie|Global Medical Services|800-633-9110|
90735|NCT01860703|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com
90736|NCT01860677|McLean Imaging Center, McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu
90737|NCT01860586|Mid-Atlantic Retina|Dr. Jason Hsu, Principal Investigator|215-928-3092|jshu@midatlanticretina.com
90738|NCT01860573|Women & Infants Hospital|Dr. Joseph Bliss|4012741100|jbliss@wihri.org
90739|NCT01860534|University of Texas medical Branch, Galveston|Dr. Cara Geary|409-772-2815|cageary@utmb.edu
90740|NCT01860521|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|Dr. Umberto Leone Roberti Maggiore|00393289461340|ulrm@libero.it
90741|NCT01860170|Spectrum Health|A. Samer A;-Homsi|616-486-5933|a.samer.al-homsi@spectrumhealth.org
90742|NCT01860079|AcibademU|Prof.Dr.Şevket Görgülü|+902623174444 ext 4123|sevket5@yahoo.com
90743|NCT01859988|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com
90744|NCT01859949|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90745|NCT01859793|Medical College of Wisconsin|Michael E. Widlansky|414-955-6806|mwidlans@mcw.edu
90746|NCT01859715|University of Colorado|Andrew A Monte, MD||andrew.monte@ucdenver.edu
90747|NCT01859702|Alcon Research, Ltd.|Abayomi Ogundele, Global Medical Affairs Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com
90748|NCT01859637|Sandoz Biopharmaceutical, Hexal AG|Roumen Nakov|+49 8024 4764704|roumen.nakov@sandoz.com
90749|NCT01859611|ELECTRONIC ENGINEERING EL.EN. SPA|ALESSANDRO BIZZARRI STUDY DIRECTOR|+390558826807|A.BIZZARRI@ELEN.IT
90750|NCT01859598|The George Institute for Global Health at Peking University Health Science Center|Pro. Linong Ji|82800577|jiln@bjmu.edu.cn
90751|NCT01859507|Cairo University. Department of Obstetrics and Gynecology|Abdelmaguid Ramzy|+201008606060|amramzy@gmail.com
90752|NCT01859494|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com
90753|NCT01859390|University of Colorado School of Medicine|Dr. Scott Sagel, Professor of Pediatrics|720-777-2522|scott.sagel@ucdenver.edu
90754|NCT01859247|The University of New Mexico Health Sciences Center|Dr. Sarah Pirio Richardson, MD|505-272-3342|spiriorichardson@salud.unm.edu
90755|NCT01859143|MedImmune, LLC|Raburn Mallory, MD/Senior Director, Clinical Development|301-398-0000|malloryr@medimmune.com
90756|NCT01859078|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
90757|NCT01859013|University of Minnesota|Claudia Fox|612-626-6616|lusc0001@umn.edu
90758|NCT01858766|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
90759|NCT01858701|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com
90760|NCT01858636|St. Jude Medical|Andrew Campbell|+1.651.756.5538|acampbell2@sjm.com
90761|NCT01858389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|
90762|NCT01858376|The Ohio State University|Chandan K. Sen|6142477786|chandan.sen@osumc.edu
90763|NCT01857986|Hospitech Respiration|Clinical Trials Manager|+972-3-9191648 ext 5|adir@hospitech.co.il
90764|NCT01857882|University Health Network|Dr. Toni Zhong|416-340-3858|toni.zhong@uhn.ca
90765|NCT01857713|Somna Therapeutics, L.L.C.|James Miller|262-345-5553 ext 102|jmiller@somnatherapeutics.com
90766|NCT01857622|Daiichi Sankyo.,LTD|Kenichi Sakakura, Manager|81-90-1885-0271|sakakura.kenichi.ef@daiichisankyo.co.jp
90767|NCT01857583|Daiichi Sankyo.,LTD|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp
90768|NCT01857531|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu
90769|NCT01857362|Swedish Orphan Biovitrum|Dr Erik Brouwer, Medical Director|+4686972000|erik.brouwer@sobi.com
90770|NCT01857323|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com
90772|NCT01857258|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu
90773|NCT01857206|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
90774|NCT01857102|Johnson and Johnson Vision Care Inc.|Kathrine E. Osborn, OD, MS, FAAO- DIRECTOR GLOBAL STRATEGIC CLAIMS|904-443-1032|KOSBORN@its.jnj.com
90775|NCT01857063|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90776|NCT01856933|Brown University Oncology Research Group (BrUOG)|Heinrich Elinzano, MD|4018633000|kayla_rosati@brown.edu
90777|NCT01856764|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
90779|NCT01856673|CISALVA, Universidad del Valle|Maria Isabel Gutierrez|+57-2-5577206 ext 103|maria.gutierrez@correounivalle.edu.co
90780|NCT01856569|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90781|NCT01856530|Boston University|Dr. Stefan G. Hofmann|617-353-9233|shofmann@bu.edu
90782|NCT01856361|Weill Cornell Medical College|Peter N Schlegel, MD|2127465491|pnschleg@med.cornell.edu
90783|NCT01856322|National Cancer Institute|Dr. Marybeth Hughes|301-594-9341|hughesm@mail.nih.gov
90784|NCT01856257|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
90785|NCT01855997|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
90786|NCT01855958|Hospital de Clínicas de Porto Alegre|Wolnei Caumo, MD,PhD.|+555133598430|caumo@cpovo.net
90787|NCT01855945|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
90788|NCT01855919|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
90789|NCT01855074|Janssen. Pharmaceutical Companies of Johnson and Johnson|Medical Manager Neurosciences|+507-3989740|dmuschet@its.jnj.com
90790|NCT01854944|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
90791|NCT01854905|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
90792|NCT01854697|AbbVie|Global Medical Information|800-633-9110|
90793|NCT01854658|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com
90794|NCT01854645|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com
90795|NCT01854632|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org
90796|NCT01854593|Department of Ophthalmology, Surugadai Hospital of Nihon University|Dr. Ayumu Manabe|+81-3-3293-1711 ext 429|ayumu.m76@gmail.com
90797|NCT01854528|AbbVie|Global Medical Information|800-633-9110|
90798|NCT01854281|University Hospital Motol|Jakub Honek, MD|+42022443 ext 4901|jakub.honek@gmail.com
90799|NCT01854268|University of Florida|Alexandra E. Brandimore, M.A. CCC/SLP|352-273-3711|aessman@ufl.edu
90800|NCT01854242|University of Florida|David A. Weinstein, MD, MMSc|3522650855|weinsda@peds.ufl.edu
90801|NCT01854047|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
90802|NCT01853982|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660|
90803|NCT01853839|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90804|NCT01853696|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org
90805|NCT01853605|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com
90806|NCT01853475|Medicines for Malaria Ventire (MMV)|Dr Thomas Rueckle|+41 22 799 4567|ruecklet@mmv.org
90807|NCT01853397|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com
90808|NCT01853384|Smith & Nephew, Inc|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com
90809|NCT01853371|Ministry of Health|Dr. Nouran Aleyeidi|00966504304577|dr.nouran@live.com
90810|NCT01853332|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678630|cmantzor@bidmc.harvard.edu
90811|NCT01853254|Hoffmann-La Roche|Medical Communications|800 821-8590|
90812|NCT01853215|Vidacare Corporation|Larry J. Miller, MD|210-375-8500|larry.miller@vidacare.com
90813|NCT01853176|Emory University|Albert Losken MD|404-686-8143|alosken@emory.edu
90814|NCT01853085|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
90815|NCT01853072|Alcon Research, Ltd.|Therapeutic Unit Head, Cornea and Inflammation|1-888-451-3937|alcon.medinfo@alcon.com
90816|NCT01853046|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com
90817|NCT01852955|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu
90818|NCT01852825|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90819|NCT01852812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90820|NCT01852669|Monash University|Dr Shaun Lee|55145890|shaun.lee@monash.edu
90821|NCT01852591|H. Lee Moffitt Cancer Center and Research Institute|Frederick Locke, M.D.|813-745-3509|frederick.locke@moffitt.org
90822|NCT01852383|New York State Psychiatric Institute|Dr. D.P. Devanand|(646) 774-8658|dpd3@columbia.edu
90823|NCT01852214|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu
90824|NCT01852175|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD-Associate Professor of Medicine Director, Cardiovascular Research|+1-904-244-3005|dominick.angiolillo@jax.ufl.edu
90825|NCT01852162|University of Florida|Dominick Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu
90826|NCT01852019|The Medicines Company|Jayne Prats, PhD - VP, Global Knowledge Management|888-779-MDCO ext 1510|jayne.prats@themedco.com
90827|NCT01851876|Karadeniz Technical University, School of Medicine, Dept Obs and Gyn.|Dr. Suleyman Guven, Director of clinical trial|+904623775869|drsuleymanguven@yahoo.com
90828|NCT01851863|Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai, China|Sheng-Liang Chen, MD|86-21-58752345|slchenmd@hotmail.com
90829|NCT01851772|Xoft, Inc.|John Delucia, VP RA QA CA|6038825200|jdelucia@icadmed.com
90830|NCT01851720|Johns Hopkins School of Medicine|Alex Coon|410-955-2438|acoon2@jhmi.edu
90831|NCT01851655|University of Florida|Dr. Terese Chmielewski|352-273-6104|tchm@ufl.edu
90832|NCT01851590|Department of Cardiac Surgery, Heart and Lung Centre, Helsinki University Hospital, Finland|Janne Jokinen, MD, PhD, Consultant Cardiothoracic Surgeon|50 554 8103 ext +358|janne.jokinen@helsinki.fi
90833|NCT01851330|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
90834|NCT01850589|Staten Island University Hospital|Dr. Jonathan Deitch, PI, Director of Vascular Surgery|718-226-9000 ext 1278|jonathan_deitch@siuh.edu
90835|NCT01850550|Penn State Hershey Medical Center|Jennifer Kraschnewski|717-531-8161|jkraschnewski@hmc.psu.edu
90836|NCT01850485|Medical Center Leeuwarden|Matty Koopmans, MSc|0031582866738|matty.koopmans@znb.nl
90837|NCT01850394|Faculty of Medicine, Ramathibodi Hospital, Mahidol University|Dr. Paphon Sa-ngasoongsong|66-2-2011589|chan3s@hotmail.com
90838|NCT01849848|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1127|
90839|NCT01849770|University of Washington|Michael D. Weiss, MD||mdweiss@uw.edu
90840|NCT01849692|Alcon Research, Ltd.|Clinical Project Group Leader, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com
90841|NCT01849588|Massachusetts General Hospital|Dr. Andrew Zhu|617-724-4000|azhu@partners.org
90842|NCT01849562|Achillion Pharmaceuticals|Kevin Kucharski, VP of Clinical Operations|203-624-7000|Kkucharski@achillion.com
90843|NCT01849497|Amgen Inc.|Study Director|866-572-6436|
90844|NCT01849458|Tornier Inc.|Marcela Bravo|9526837481|marcela.bravo@tornier.com
90845|NCT01849419|University of Chicago|Dr. Harriet de Wit|(773) 702-3560|hdew@uchicago.edu
90846|NCT01849289|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
90847|NCT01849068|Laval University|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca
90848|NCT01848990|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889|
90849|NCT01848977|Seoul National University Hospital|Jin-Tae Kim|82-10-6260-8490|jintae73@gmail.com
90850|NCT01848938|Umeå University, Umeå, Sweden|Dr. Eva Samuelsson|+46706966440|eva.samuelsson@umu.se
90851|NCT01848899|NYU Langone Medical Center|Binita Shah|212-263-4235|binita.shah@nyumc.org
90852|NCT01848847|namik kemal university|cem celik|905324205365|cemcel@yahoo.com
90853|NCT01848834|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90854|NCT01848756|Esanex Inc|Eric Orlemans, Chief Scientific Officer|919-338-2019|eorlemans@esanexpharma.com
90855|NCT01848366|William Beaumont Hospital|Dr. Kenneth Peters|248-551-0387|Kenneth.Peters@Beaumont.org
90856|NCT01848288|Alcon Research, Ltd.|Doug Fanney, Director, Global Medical Affairs, Cataract Instrumentation|1-888-451-3937|alcon.medinfo@alcon.com
90857|NCT01848210|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
90858|NCT01848145|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|Charles.Davis2@scri-innovations.com
90859|NCT01848054|PRA International|Lynn R. Webster, MD|801-892-5140|LRWebsterMD@gmail.com
90860|NCT01847547|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90861|NCT01847443|GlaxoSmithKline|GSK Response Center|866-435-7343|
90862|NCT01847430|GlaxoSmithKline|GSK Response Center|866-435-7343|
90863|NCT01847196|BiO2 Medical|Margaret Tumas, VP of Clinical Affairs|720-635-3232|mtumas@bio2medical.com
90864|NCT01847131|Faculty of Medicine Siriraj Hospital, Mahidol University|Torpong Thongngarm, M.D.|66-2-419-8263|torpong.tho@mahidol.ac.th
90865|NCT01846741|Cyberonics, Inc.|Bita Najimipour, Clinical Study Manager|(281) 228-7370|bita.najimipour@cyberonics.com
90866|NCT01846455|RECKITT BENCKISER PHARMACEUTICALS, INC.|Reckitt Benckiser Pharmaceuticals, Inc.|804-379-1090|
90867|NCT01846442|Endoceutics|Director of Data Analysis|418-653-0033 ext 215|celine.martel@endoceutics.com
90868|NCT01846416|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
90869|NCT01846299|Novartis|Study Director|862-778-8300|
90870|NCT01846104|Department of Clinical Research Division of Medicine USAMRIID|Matthew Chambers, MD|301-619-6731|matthew.s.chambers@mail.mil
90871|NCT01846039|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
90872|NCT01845831|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu
90873|NCT01845220|Johns Hopkins University|Jed W. Fahey, Sc.D.|4106142607|jfahey@jhmi.edu
90874|NCT01845155|Deutsches Zentrum für Musiktherapieforschung (Viktor Dulger Institut) DZM e.V. - German Center for Music Therapy Research|Dr. Heike Argstatter|+49-6221-7963960|heike.argstatter@dzm-heidelberg.de
90875|NCT01845103|CryoLife, Inc.|Scott Capps, MS/ Vice President, Clinical Research|800-438-8285|clinicaltrialregistration@cryolife.com
90876|NCT01845077|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90877|NCT01845025|Novartis Pharmaceuticals|Study Director|862-778-8300|
90878|NCT01844895|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
90879|NCT01844856|Tetraphase Pharmaceuticals, Inc.|Chief Medical Officer|+1.617.715.3600|
90880|NCT01844830|Loma Linda University|Yiming Li, DDS|909-558-4600|kkellingsworth@llu.edu
90881|NCT01844817|Sarah Cannon Development Innovations|Charles Davis, RAC||Charles.Davis2@scri-innovations.com
90882|NCT01844778|Novartis|Study Director|862-778-8300|
90883|NCT01844700|Zucker Hillside Hospital, Division of Psychiatry Research|Anil Malhotra, MD|718-470-8281|amalhotra@nshs.edu
90884|NCT01844687|Columbia University Medical Center|Margaret Haney, PhD., Professor|(646) 774-6153|mh235@columbia.edu
90885|NCT01844531|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90888|NCT01844479|University of Michigan|James Wrobel, DPM, MS|734-647-4940|jswrobel@med.umich.edu
90889|NCT01844388|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
90890|NCT01844206|Columbia University|Dr. Allison Lee|305-582-6077|al3196@cumc.columbia.edu
90891|NCT01843972|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90892|NCT01843933|Yale University|Melissa Langhan|2037377413|melissa.langhan@yale.edu
90893|NCT01843920|Mid Atlantic Retina|Jason Hsu, MD|215-928-3092|research@midatlanticretina.com
90894|NCT01843777|National Center for Rehabilitative Auditory Research|M. Samantha Lewis, PhD|503-220-8262 ext 51996|Michele.Lewis3@va.gov
90895|NCT01843673|Virginia Commonwealth University|Joshua Evans, Ph.D.|804-628-0661|jevans2@mcvh-vcu.edu
90896|NCT01843660|Janssen China, Beijing|Therapeutic Area Physician|+86-10-58218709|
90897|NCT01843465|Clinique Pasteur, Toulouse, France|Dr Serge Boveda|(33) 5 62 21 16 45 ext 8819|sboveda@clinique-pasteur.com
90899|NCT01843348|Novartis Pharmaceuticals|Study Director|862-779-8300|
90900|NCT01843192|Ethicon, part of Johnson & Johnson|Michael Schwiers|513-337-1172|mschwier@its.jnj.com
90901|NCT01842906|Stanford Department of Emergency Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu
90902|NCT01842841|Shire|Study Physician|1 866-842-5335|
90903|NCT01842789|Acessa Health, Inc.|Laura Kemp, Clinical Affairs Consultant|4083751465|lkemp@acessahealth.com
90904|NCT01842646|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jeffrey Lancet|813-745-1387|jeffrey.lancet@moffitt.org
90905|NCT01842633|GlaxoSmithKline|GSK Response Center|866-435-7343|
90906|NCT01842607|GlaxoSmithKline|GSK Response Center|866-435-7343|
90907|NCT01842594|Shin Kong Wu Ho-Su Memorial Hospital|Kwan-Hwa Chi|+886-28332211 ext 2612|M006565@ms.skh.org.tw
90908|NCT01842464|Western Galilee MC|Menahem Neuman|+972546444033|mneuman@netvision.net.il
90909|NCT01842438|Australian Catholic University|Prof Liz Forbat, PI|+61 475978476|elizabeth.forbat@acu.edu.au
90910|NCT01841970|Medtronic Surgical Innovations|Study Director, Clinical Research|508-452-4028|
90911|NCT01841697|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
90912|NCT01841619|UC Irvine Dermatology Research Center|Sergei A. Grando|949 824 7103|sgrando@uci.edu
90913|NCT01841593|SSAT Research, Chelsea & Westminster Hospital|Dr. Marta Boffito|+442033155601|marta.boffito@chelwest.nhs.uk
90914|NCT01841567|Klinik und Poliklinik für Orthopädie und Unfallchirurgie der Uniklinik Köln|Dr Kourosh Zarghooni|+49 2247887294|kourosh.zarghooni@uk-koeln.de
90915|NCT01841216|Sport & Spine Rehab Clinical Research Foundation|Jena Etnoyer, Clinical Research Coordinator|240-766-0300 ext 838|jetnoyer@ssrehab.com
90916|NCT01841021|H. Lee Moffitt Cancer Center and Research Institute|Dr. Lubomir Sokol|813-745-8212|lubomir.sokol@moffitt.org
90917|NCT01840943|Xian Janssen Pharmaceutical LTD|Senior Director Clin Development||ClinicalTrialDisclosure@its.jnj.com
90918|NCT01840605|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
90919|NCT01840410|Novartis|Study Director|862-778-8300|
90920|NCT01840319|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90921|NCT01840072|Tulane University|Dr. Jiang He|5049885165|jhe@tulane.edu
93267|NCT01590563|Synexus Hungary|Dr. Beata Szoczei, MD|+36 1 436 7330|
90922|NCT01839695|Medtronic Vascular|Anna Busman, Sr. Clinical Research Specialist|707-591-7633|rs.medtroniccardiovascularclinicaltrials@medtronic.com
90923|NCT01839604|AstraZeneca Pharmaceuticals LP|Martin Scott, MD/PhD|Martin.Scott@astrazeneca.com|Martin.Scott@astrazeneca.com
90924|NCT01839318|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com
90925|NCT01839279|Acorda Therapeutics, Inc.|Executive Medical Director|914-437-4300 ext 5263|paupperle@acorda.com
90926|NCT01839058|Western University|Keith McIntosh|519-646-6100 ext 61312|keith.mcintosh@sjhc.london.on.ca
90927|NCT01838980|Motus GI Medical Technologies Ltd.|Medical Consultant|+972-4-6214446 ext 104|rose@motusgi.com
90928|NCT01838941|McGill University Health Centre|Dr. Nancy Braverman, Associate Professor, Human Genetics and Pediatrics|(514) 934-1934 ext 23404|nancy.braverman@mcgill.ca
90929|NCT01838785|Chang Gung Memorial Hospital|Dr. kun-Ju Lin|033281200 ext 2632|lin4857@adm.cgmh.org.tw
90930|NCT01838694|Invion, Inc.|Mitchell Glass, M.D., EVP of R&D|+61 7 3295 0500|mitchell.glass@inviongroup.com
90931|NCT01838681|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@lundbeck.com
90932|NCT01838642|National Cancer Institute|Dr. James Gulley|301-496-4916|gulleyj@mail.nih.gov
90933|NCT01838616|Grünenthal GmbH|Study Director|+49 241 569 ext 3223|Clinical-Trials@grunenthal.com
90934|NCT01838590|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
90935|NCT01838499|AstraZeneca|Humphrey Gardner MD FCAP|+1 781 839 4523|Humphrey.Gardner@astrazeneca.com
90936|NCT01838213|Vestre Viken Hospital Trust|Arne Søraas, PhD|+4790652904|arne@meg.no
90937|NCT01838044|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90938|NCT01837966|NYU School of Medicine|Associate Professor ; Res Program Dir/Medical Dir Day Surgery; Vice Chair for Education|212.263.5072|michael.wajda@nyumc.org
90939|NCT01837797|Study Director|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com
90940|NCT01837719|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
90941|NCT01837680|Roosevelt Hospital, Mount Sinai Health System|Dr. Kimberly M. Herrera||kimmerher@gmail.com
90942|NCT01837550|Sodra Alvsborg, Hearing Organisation|Milijana Malmberg, PhD student|0046 703 80 36 63|milijana.lundberg.malmberg@vgregion.se
90943|NCT01837537|Medtronic|Michael Luna-Victoria|303 305 2463|michael.luna-victoria@medtronic.com
90944|NCT01837524|Kaiser Center for Clinical and Outcomes Research|Kristina Lewis|404-364-7150|khlewis@wakehealth.edu
90945|NCT01836809|Virginia Commonwealth University|Keyur Shah, MD|804-828-4571|kshah@mcvh-vcu.edu
90946|NCT01836523|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
90947|NCT01836471|Novaratis Pharmaceuticals|Study Director|862-778-8300|
90948|NCT01836458|Novartis Pharmaceuticals|Study Director|862-778-8300|
90949|NCT01836133|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
90950|NCT01836042|Glaukos|Jeff Wells, PharmD, MBA, RAC|949-367-9600 ext 227|jwells@glaukos.com
90951|NCT01835912|BrockU|Panagiota Klentrou|19056885550 ext 4538|nklentrou@brocku.ca
90952|NCT01835899|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
90953|NCT01835756|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com
90954|NCT01835743|Coughlin Foot and Ankle Clinic|Michael Coughlin, MD|208-367-3330|thefootmd@gmail.com
90955|NCT01835496|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com
90957|NCT01835431|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
90958|NCT01835379|Smith & Nephew, Inc.|Vice President, Medical & Clinical Affairs|817-302-3914|jaime.dickerson@smith-nephew.com
90959|NCT01835262|Maimonides Medical Center|Antonios Likourezos|718-283-6896|alikourezos@maimonidesmed.org
90961|NCT01835015|Alcon Research, Ltd.|Director, Translational Medicine Expert, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com
90962|NCT01834651|Cedars-Sinai Medical Center|Dr. Edwin Posadas|310-423-7600|Edwin.Posadas@cshs.org
90963|NCT01834404|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu
90964|NCT01834274|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
90965|NCT01834261|Stony Brook University|Lilianne Mujica Parodi, PhD / Study Principal Investigator|631-632-1008|lilianne.strey@stonybrook.edu
90966|NCT01834222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90967|NCT01834027|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu
90968|NCT01833988|Massachusetts General Hospital Diabetes Research Center|Dr. Steven J. Russell|617.726.1848|sjrussell@partners.org
90969|NCT01833897|New York State Psychiatric Institute|Joshua Kantrowitz|646-774-6738|jkantrowitz@nki.rfmh.org
90970|NCT01833845|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100 ext 104|arnona@biolinerx.com
90971|NCT01833741|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
90972|NCT01833533|AbbVie|Global Medical Information|800-633-9110|
90973|NCT01833481|University of Tennessee|Dr. Richard D. Komistek|8659742093|rkomiste@utk.edu
90974|NCT01833403|University of Minnesota|Lisa Chow MD|612-625-8934|chow0007@umn.edu
90975|NCT01833247|Stanford University Department of Neurology|Robert S. Fisher, MD, PhD|650-7215289|robert.fisher@stanford.edu
90976|NCT01833130|Allergan, Inc|Medical Director,||clinicaltrials@allergan.com
90977|NCT01833117|Alcon Research, Ltd.|Michela Montecchi-Palmer, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com
90978|NCT01833078|University of Pennsylvania|Dr. Anne Cappola, PI|215-573-5359|acappola@mail.med.upenn.edu
90979|NCT01833065|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
90980|NCT01832766|University of Colorado Denver|Lynn Johnson, Pharm.D.|303 724 6221|lynn.johnson@ucdenver.edu
90981|NCT01832506|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
90982|NCT01832493|Medtronic CRHF|Medtronic SOCR Clinical Trial Leader|1-800-328-2518|medtronicCRMtrials@medtronic.com
90983|NCT01832155|University of Minnesota|Corjena Cheung, Assistant Professor|612-624-5198|corjena@umn.edu
90984|NCT01831934|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu
90985|NCT01831817|GlaxoSmithKline|GSK Response Center|866-435-7343|
90987|NCT01831726|Novartis Pharmaceuticals|Study Director|862-778-8300|
90988|NCT01831466|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90989|NCT01831258|SleepMed of South Carolina|Dr Richard Bogan|8777537633|rbogan@sleepmedinc.com
90990|NCT01831219|Think Surgical|Senior Manager of Clinical Applications|510-249-2339|nnetravali@thinksurgical.com
90991|NCT01831154|James A Haley Veterans Hosptial|Dr. Sierra Gower|(813) 972-2000 ext 5946|sierra.gower@va.gov
90992|NCT01830933|University of California, San Francisco|Celia P. Kaplan, Professor|415-502-5601|celia.kaplan@ucsf.edu
90993|NCT01830920|Thrasos Therapeutics, Inc.|Jerome Rossert, MD, PhD, Chief Scientific Officer||Jerome.Rossert@thrasos.com
90994|NCT01830881|Oregon Health and Science University|Lisa Bayer, MD|503-494-3666|whru@gmail.com
90995|NCT01830855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
90996|NCT01830790|Duke University|Sharon Fekrat: Associate Professor of Ophthalmology|(919) 681-0341|Sharon.Fekrat@dm.duke.edu
90997|NCT01830699|Keesler Medical Center|Matthew B. Carroll, MD|228-376-3629|matthew.carroll.1@us.af.mil
90998|NCT01830543|Janssen Scientific Affairs, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com
90999|NCT01830205|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
91000|NCT01830140|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
91001|NCT01830127|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91002|NCT01829919|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com
91003|NCT01829516|University of California, San Francisco|Jennifer Mitchell, PhD|510-985-3921|jennifer.mitchell@ucsf.edu
91004|NCT01829503|University of Pittsburgh Cancer Institute|Dr. Annie P. Im|412-623-2393|imap@upmc.edu
91005|NCT01829477|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
91006|NCT01829464|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
91007|NCT01829399|Anesthesiology Department, University of NC at Chapel Hill|Randall F. Coombs, M.D.|919-966-5136|rcoombs@aims.unc.edu
91008|NCT01829243|Duke University Medical Center|Ashwin A. Patkar, MD|919-668-3626|ashwin.patkar@duke.edu
91009|NCT01829230|Vistakon USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com
91010|NCT01829191|Vistakon, USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com
91011|NCT01828593|Entera Health|Senior Director, Clinical Research|515-963-7565|audrey.shaw@enterahealth.com
91012|NCT01828476|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|732-235-5773|steinmn@cinj.rutgers.edu
91013|NCT01828281|Chinese University of Hong Kong|Prof David SC Hui|2632 3134|dschui@cuhk.edu.hk
91014|NCT01828216|Chinese University of Hong Kong|David SC Hui|852 2632 2211|dschui@cuhk.edu.hk
91015|NCT01828164|SmileSonica Inc.|John Simon, Regulatory Affairs Manager|780-975-0095|john@johnsimon.ca
91016|NCT01828112|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
91017|NCT01828099|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
91019|NCT01827670|GlaxoSmithKline|GSK Response Center|866-435-7343|
91020|NCT01827592|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
91021|NCT01826370|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91022|NCT01827475|Emergency Medicine, Stony Brook U|Dr. Adam Singer|631 444 7856|adam.singer@stonybrook.edu
91023|NCT01827462|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu
91024|NCT01827371|Group Health Research Institute|Lisa Jackson, M.D., M.P.H.|206-442-5216|Jackson.L@ghc.org
91025|NCT01827358|University of Maryland Medical Center|Karen Kotloff, MD|410-706-5328|kkotloff@medicine.umaryland.edu
91026|NCT01827332|MUSC|Aimee McRae-Clark|843-792-5216|mcraeal@musc.edu
91027|NCT01827319|CryoLife, Inc.|Scott Capps|800-438-8285|brown.carolyn@cryolife.com
91028|NCT01827306|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|7179915595|jslaski@ssrehab.com
91029|NCT01827267|Puma Biotechnology|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com
91030|NCT01827254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91031|NCT01826981|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
91032|NCT01826812|The Wilmer Eye Institute, Johns Hopkins|Dr. Esen K. Akpek|410-955-5214|esakpek@jhmi.edu
91033|NCT01826604|Saint Louis University|Dr. Katherine M. Scolari Childress|314-977-2090|scolarik@slu.edu
91034|NCT01826513|University of Western Australia|Prof. David Hillman & Prof. Peter Eastwood|+61 8 9346 1706|peter.eastwood@health.wa.gov.au
91035|NCT01826214|Novartis Pharmaceuticals|Study Director|82-778-8300|trialandresults.registries@novartis.com
91036|NCT01826201|Moleculin, LLC|Chief Medical Officer|713-953-7676 ext 232|Carena@moleculin.com
91037|NCT01825837|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com
91038|NCT01825577|Saint Louis University|Dr. Ahsan Khan|314-977-4826|khanay@slu.edu
91039|NCT01825408|UNC Department of Otolaryngology|Dr. Adam Zanation||adam_zanation@med.unc.edu
91040|NCT01825200|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064 ext 153|ldunkle@proteinsciences.com
91041|NCT01825122|Invion, Inc.|Mitchell Glass, M.D., EVP of R&D|+61 7 3295 0500|mitchell.glass@inviongroup.com
91042|NCT01824901|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|
91043|NCT01824823|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|
91044|NCT01824602|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com
91045|NCT01824589|Advanced Circulatory|Sr. Clinical Research Associate|651.403.5600|nburkhart@advancedcirculatory.com
91046|NCT01824576|Advanced Circulatory|Sr. Clinical Research Associate|651.403.5606|nburkhart@zoll.com
91047|NCT01824498|USDA, GFHNRC|Susan Raatz, PhD, RD|701-795-8294|susan.raatz@ars.usda.gov
91048|NCT01824446|Shire Development LLC|Study Physician|+1 866 842 5335|
91049|NCT01824355|Ascensia Healthcare|Jane Wallace|574-257-3063|jane.wallace@ascensia.com
91050|NCT01824342|Amgen Inc.|Study Director|866-572-6436|
91051|NCT01824303|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
91052|NCT01824160|Johns Hopkins University|RICHARD RINGEL|410-714-6745|rringel@jhmi.edu
91053|NCT01823679|Stanford University Medical Center|Alexander Dimitrios Colevas, MD|650-724-9707|colevas@stanford.edu
91054|NCT01823653|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com
91055|NCT01823614|Central Research Institute for Epidemiology|Dmitry Kireev|+74959749646 ext 2227|dmitry.kireev@pcr.ru
91056|NCT01823536|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
91058|NCT01823341|Jaeb Center for Health Research|Judy Sibayan, MPH, CCRP|813-975-8690|jsibayan@jaeb.org
91059|NCT01823289|Department of Respiratory Medicine, SHANGHAI First People’s Hospital Affiliated to SHANGHAI JiaoTong University|Director of Respiratory Department|86-21-63071428|xzhou53@163.com
91060|NCT01823224|Womack Army Medical Center|Anthony R Plunkett, MD|910-907-6000|anthonyrplunkett@gmail.com
91061|NCT01823146|University of Florida|Dr. Natalie Ebner|203 691 0371|natalie.ebner@ufl.edu
91062|NCT01822899|GlaxoSmithKline|GSK Response Center|866-435-7343|
91063|NCT01822821|Cleveland Clinic|Nicole Zimmerman|216-636-9449|zimmern2@ccf.org
91064|NCT01822756|Incyte Corporation|Study Director|1-855-463-3463|
91065|NCT01822691|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rami Komrokji|813-745-4692|rami.komrokji@moffitt.org
91066|NCT01822678|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com
91067|NCT01822665|GlaxoSmithKline|GSK Response Center|866-435-7343|
91068|NCT01822574|Mayo Clinic|Robert T. Trousdale, M.D.|507-284-6586|trousdale.robert@mayo.edu
91069|NCT01822548|Azienda ospedaliero-universitaria di Parma|Prof.ssa Ivana Zavaroni|+390521033306|ivana.zavaroni@unipr.it
91070|NCT01822535|James J. Peters VA Medical Center|Dr. John P. Handrakis|718-584-9000 ext 5439|john.handrakis@va.gov
91071|NCT01822301|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu
91072|NCT01822223|University of Alabama at Birmingham|Michael S. Reddy, DMD, DMSc|2059344720|mreddy@uab.edu
91073|NCT01822197|Nationwide Childrens Hospital|Dr Ben Kopp|6147224766|benjamin.kopp@nationwidechildrens.org
91074|NCT01822119|The HEARing CRC & Hearworks, Audiology Hearing and Speech Science, Melbourne, Australia|Professor Robert Cowan|+61 3 9035 5346|r.cowan@unimelb.edu.au
91075|NCT01821963|University of Texas (UT) MD Anderson Cancer Center|Harrys A. Torres, MD/Assistant Professor, Infectious Diseases|713-745-0490|CR_Study_Registration@mdanderson.org
91076|NCT01821937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91077|NCT01821859|Oregon Health and Science University|Tanja Pejovic|503-494-5125|pejovict@ohsu.edu
91078|NCT01821807|Adiyaman University Research Hospital, Department of Anesthesiology and Reanimation|Dr. Ruslan Abdullayev|+905063010833|ruslan_jnr@hotmail.com
91079|NCT01821534|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
91080|NCT01821417|University of Alabama at Birmingham|Nicolaas C. Geurs, DDS MS|2059344506|ngeurs@uab.edu
91081|NCT01821378|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com
91082|NCT01821352|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com
91083|NCT01821326|Shanghai Jiaotong University|Dr.Zhizheng GE|86-68383015|tanwei_1987@163.com
91084|NCT01821118|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com
91085|NCT01821105|The Ohio State University|Edward Martin, MD|614-293-8843|Edward.Martin@osumc.edu
91086|NCT01820585|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com
91087|NCT01820559|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com
91088|NCT01820416|Dept. of Communication Sciences & Disorders, University of Iowa|Shawn S Goodman|319-335-8700|shawn-goodman@uiowa.edu
91089|NCT01820364|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com
91090|NCT01819935|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91091|NCT01819922|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91093|NCT01819415|Maisonneuve-Rosemont Hospital|Dr. Flavio Rezende|514-867-2990|frezendef@hotmail.com
121654|NCT00232583|UT Southwestern Medical Center|Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu
91095|NCT01819272|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com
91096|NCT01819194|Vistakon|Daria Wicks|904-443-1391|RA-VISUS-ClnclStds@its.jnj.com
91097|NCT01818752|Amgen Inc.|Study Director|866-572-6436|
91098|NCT01818700|Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University school of medicine, Seoul Korea|Dr. Whan Eoh|82-2-3410-3491|w.eoh@samsung.com
121655|NCT00126568|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Panayiotis Savvides|216-844-5946|Panayiotis.Savvides@uhhospitals.org
91099|NCT01818596|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
91100|NCT01818414|University of Minnesota|Christy Boraas, MD, MPH|612-273-7111|bora0021@umn.edu
91101|NCT01818336|AllerQuest|Dr. Franklin Adkinson Jr., MD-Vice President, Chief Medical Officer|410-550-2051|fadkinson@allerquest.com
91102|NCT01818297|Medtronic Neuromodulation|Neuro Clinical Trials||medtronicneurotrials@medtronic.com
91103|NCT01818141|Hartford Hospital|Dr. David P. Nicolau, PharmD, FCCP, FIDSA|860-972-3941|david.nicolau@hhchealth.org
91104|NCT01817907|Brigham and women's Hospital|D. Andrew Wellman|617-732-8483|awellman@rics.bwh.harvard.edu
91105|NCT01817855|AstraZeneca|Naimish Patel|+1 781 839 4061|Naimish.Patel@astrazeneca.com
91106|NCT01817790|GlaxoSmithKline|GSK Response Center|866-435-7343|
91107|NCT01817777|GlaxoSmithKline|GSK Response Center|866-435-7343|
91109|NCT01817725|Chang Gung Memorial Hospital, Linkou Branch|Dr. Ming-Wei Lai|886-3-3281200 ext 8969|a22141@adm.cgmh.org.tw
91110|NCT01816776|Respicardia, Inc.|Linda Nelson, VP Clinical Affairs|952-540-4479|lnelson@respicardia.com
91111|NCT01816685|Duke University|Andrew Krystal|(919) 668-1212|andrew.krystal@dm.duke.edu
91112|NCT01816477|Mayo Clinic|Dr. Dawn E. Jaroszewski|480-301-7865|Jaroszewski.Dawn@mayo.edu
91113|NCT01816451|University of Trás-os-Montes and Alto Douro|Ph.D. Laura Castro de Garay|+55 21 22275084|laura@virtualsoftware.com.br
91114|NCT01816295|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
91115|NCT01816243|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200|
91117|NCT01815918|Hospital for Special Surgery|Kethy Jules-Elysee, MD|212-606-1206|JulesElyseeK@HSS.EDU
91118|NCT01815840|Hoffmann-La Roche|Medical Communications|800 821-8590|
91119|NCT01815736|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
91120|NCT01815671|Specialists in Gastroenterology, LLC|Leonard Weinstock, MD|314-997-0554 ext 102|lw@gidoctor.net
91121|NCT01815645|Federal University of Sao Paulo|Andre Q. C. Miguel|005511 965884111|aqcmiguel@gmail.com
91122|NCT01815138|UConn Helth|Lawrence Engmann|8605258283|lengmann@uchc.edu
91123|NCT01815099|Hartford Hospital|Gretchen Diefenbach|860-545-7685|gretchen.diefenbach@hhchealth.org
91124|NCT01815008|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu
91125|NCT01814878|Janssen Korea/25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|Clinical Research Director|82-2-2094-4518|
91126|NCT01814800|ADMA Biologics|Jimmy Mond, M.D., Ph.D|201-478-5552|jmond@admabio.com
91127|NCT01814787|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu
91128|NCT01814774|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
91129|NCT01814761|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
91131|NCT01814722|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91132|NCT01814696|Partners Healthcare Connected Health Innovation|Kamal Jethwani, MD, MPH|617-724-3410|kjethwani@partners.org
91133|NCT01814670|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
91134|NCT01814553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91135|NCT01814397|University of Michigan Comprehensive Cancer Center|Dr. Norah Lynn Henry|734-936-4991|norahh@med.umich.edu
91136|NCT01814332|San Francisco VA Medical Center|Jennifer Hlavin|415-221-4810 ext 26624|jennifer.hlavin@va.gov
91137|NCT01814241|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu
91138|NCT01814137|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
91139|NCT01814046|National Cancer Institute|Dr. Udai Kammula|301-435-8606|uk3t@nih.gov
91140|NCT01813890|Janssen Research & Development, L.L.C.|Mila Etropolski, Clinical Leader|609-730-4537|MEtropol@its.jnj.com
91141|NCT01813721|Amgen Inc.|Study Director|866-572-6436|
91143|NCT01813019|Novartis Pharmaceuticals|Study Director|862-778-8300|
91144|NCT01812837|UC Davis|Dr. Raja Sivamani|9167035145|rksivamani@ucdavis.edu
91145|NCT01812707|Sanofi|Trial Transparency Team||Contact ­-US@sanofi.com
91146|NCT01812681|Dr. Sami Ulus Children's Hospital|Dr. Serdar Beken|00903123056449|serbeken@gmail.com
91147|NCT01812655|Arkansas Children's Hospital|Debra Jeffs, PhD, RN, Principal Investigator|501-364-3239|jeffsda@archildrens.org
91148|NCT01812473|Universitaire Ziekenhuizen Leuven|Kim Vanstraelen, PharmD|0032 16 342339|kim_vanstraelen@hotmail.com
91149|NCT01812057|Duke University Medical Center|Dr Terrence K Allen|9196682024|terrence.allen@duke.edu
91150|NCT01812044|Duke University Medical Center|Laura Enyedi, M.D.|919-684-2038|laura.enyedi@dm.duke.edu
91151|NCT01811953|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91152|NCT01811732|Melinta Therapeutics, Inc.|Sue Cammarata (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com
91153|NCT01811706|University of Florida|Dr. Guangbin Xia, Assistant Professor|352-273-5550|guangbin.xia@neurology.ufl.edu
91154|NCT01811680|Tan Tock Seng Hospital|Dr Karen Chua|65 68894580|karen_chua@ttsh.com.sg
91155|NCT01811563|Duke University Medical Center|Samuel Wellman, MD|919-681-4055|samuel.wellman@duke.edu
91156|NCT01811485|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
91157|NCT01811472|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
91158|NCT01811355|Mayo Clinic, Jacksonville|Dr. Bjorn Oskarsson|9049536896|oskarsson.bjorn@mayo.edu
93509|NCT01565902|Novartis Pharmaceuticals|Study Director|862-778-8300|
91160|NCT01811303|RSSL|Rungano Munyuki (Clinical Project Manager)|0118 9184034|
91161|NCT01811238|Samsung Medical Center|Dr.Sungsoo Chung|82-3410-1226|ssc0385@skku.edu
91162|NCT01811186|Asan Medical Center|Hoseong Lee|82-2-3010-3521|hosng@amc.seoul.kr
91163|NCT01810952|Baylor College of Medicine|Professor of Medicine|713-660-9902|glennc@bcm.edu
91164|NCT01810939|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com
91165|NCT01810783|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com
91166|NCT01810692|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91167|NCT01810666|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
91168|NCT01810380|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com
91169|NCT01810302|University of Florida|Dr. Spiros Blackburn|(352) 273-9000|spiros.blackburn@neurosurgery.ufl.edu
91170|NCT01810289|University of California at San Francisco|Dr. Elvin Geng|415-476-4082 ext 409|elvin.geng@ucsf.edu
91171|NCT01810263|Seoul National University Bundang Hospital|Nam-Jong Paik|82-031-787-7731|njpaik@snu.ac.kr
91172|NCT01810042|Pusan National University Hospital|Ji Eun Lee|+82-51-240-7957|jlee@pusan.ac.kr
91173|NCT01809938|GuysThomasNHSTrust / Rockingham General Hospital|Dr. Sam Hillyard|+61424055820|sghillyard@yahoo.co.uk
91174|NCT01809834|School of Optometry, University of Waterloo|Lyndon Jones, PhD, FCO|519-888-4742|ljones@uwaterloo.ca
91176|NCT01809327|Janssen Research & Development, LLC|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com
91177|NCT01809314|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
91178|NCT01809262|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91179|NCT01809197|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com
91180|NCT01809106|Mario Negri Institution|Dr. Oscar Corli|+390239014564|oscar.corli@marionegri.it
91181|NCT01809054|Sinai Center for Thrombosis Research|Kevin Bliden|4106014795|kbliden@lifebridgehealth.org
91182|NCT01808963|UC Davis Medical Center|Dr. Neal Fleming|916-734-5394|nwfleming@ucdavis.edu
91183|NCT01808950|Galderma Spirig|Dr. Francine Santoro|+41623878720|francine.santoro@galderma.com
91184|NCT01808755|Divisione Urologia IRCCS Policlinico San Matteo Pavia, Italy|D. Porru|39-0382-503868/503872|danieleporru@tin.it
91185|NCT01808651|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
91186|NCT01808612|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
91187|NCT01808547|InSite Vision|Director of Clinical Trials|510-747-1269|jhutcheson@insite.com
91188|NCT01808534|IndianaU|Dr. Lawrence H. Einhorn|(317)274-3515|leinhorn@iu.edu
91189|NCT01808508|Children's Hospital of Philadelphia|Carole L. Marcus, MBBCh|267-426-5842|marcus@email.chop.edu
91190|NCT01808339|GlaxoSmithKline|GSK Response Center|866-435-7343|
91191|NCT01808326|GlaxoSmithKline|GSK Response Center|866-435-7343|
91192|NCT01808313|GlaxoSmithKline|GSK Response Center|866-435-7343|
91194|NCT01808248|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
91195|NCT01808209|Opthalmic Research Group, Aston University, Birmingham, UK|Jonathan Walker||JWalker@coopervision.co.uk
91196|NCT01808092|AstraZeneca|David Wilson, Statistical Team Leader - Infection|+44 1625 517830|David.wilson2@astrazeneca.com
91197|NCT01808066|CogCubed|Chief Medical Officer|612-250-9737|monika@cogcubed.com
91198|NCT01807949|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
91199|NCT01807923|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
91201|NCT01807624|Jean Brown Research Center|Dr. Derek Muse|(801) 261-2000|participate@jeanbrownresearch.com
91202|NCT01807455|Q-Med AB|Chief Medical Officer|+ 46 (0) 18 474 90 00|Reception.SEUPP@galderma.com
91203|NCT01807234|Johns Hopkins University School of Medicine|Dr. B. Lee Peterlin|410-550-9550|hnitchi1@jhmi.edu
91204|NCT01807156|Emory University|Bassel El-Rayes, MD|404-778-1900|bassel.el-rayes@emoryhealthcare.org
91205|NCT01807000|Shire Development LLC|Study Physician|+1 866 842 5335|
91206|NCT01806961|Sipirig AG|Dr. Francine Santoro|+41 62 387 87 87 ext 87 20|francine.santoro@galderma.com
91207|NCT01806857|Center for Neurological Study|Richard Smith, MD|858-455-5463|cnsonline@ymail.com
91208|NCT01806779|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu
91209|NCT01806714|University of Rochester|Dr. Cynthia Rand|585 275-9316|cynthia_rand@urmc.rochester.edu
91210|NCT01806623|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91211|NCT01806584|Shire Development LLC|Study Physician|+1 866 842 5335|
91212|NCT01806545|Shire Development LLC|Study Physician|+1 866 842 5335|
91213|NCT01806389|Johns Hopkins University School of Medicine|Dr. Lauren Jansson|410-550-5438|ljansson@jhmi.edu
91215|NCT01806051|Children's Hospital Los Angeles|Linda Randolph, M.D.|323-361-2178|lrandolph@chla.usc.edu
91216|NCT01805882|National Institute of Allergy and Infectious Diseases|Shyam Kottilil MD|+1 410 706 4872|Skottilil@ihv.umaryland.edu
91217|NCT01805687|Cornerstone Therapeutics, Inc.|W. James Alexander, MD, MPH|919-678-6925|jim.alexander@chiesi.com
91218|NCT01805323|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
91219|NCT01805297|Dean McGee Eye Institute|Robert E. Leonard, II, MD|405-271-6060|sonny-icks@dmei.org
91220|NCT01805180|Terumo BCT|Raymond P. Goodrich, PhD / VP, Scientific and Clinical Affairs; Chief Science Officer-BBT|303.205.2680|Ray.Goodrich@terumobct.com
91222|NCT01804946|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761575 ext 302|PutilovskiyMA@materiamedica.ru
91223|NCT01804881|North York Family Health Team|Principal Investigator|4164943003 ext 130|dsouthgate@nyfht.com
91225|NCT01804673|Clinic for Anaesthesiology, Intensive Care Unit and Pain Therapy at the Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Str. 33, 48149 Munster.|Head|+49 251 / 83 - 4 72 52|
91226|NCT01804257|Zucker Hillside Hospital, Glen Oaks, NY|John M. Kane MD|(718) 470-8141|psychiatry@nshs.edu
91227|NCT01804140|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
91228|NCT01804075|Eastern Maine Medical Center|Dr. Mark Brown|207-973-9503|mbrown@emh.org
91229|NCT01804062|Medtronic|Michael Luna-Victoria|303 305 2463|michael.luna-victoria@medtronic.com
91230|NCT01804036|University of Utah|Yoshio Nakamura, PhD|801-585-7690|yn5@utah.edu
91231|NCT01803737|University of Arizona|David O. Garcia, PhD|520-626-4641|davidogarcia@email.arizona.edu
91232|NCT01803607|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91234|NCT01802554|University of California San Diego|Brent T Mausbach, PhD|858-822-7529|BMausbach@ucsd.edu
91235|NCT01802515|Yale University|Dr. Mehmet Sofuoglu, Principal Investigator|203 937-4809|mehmet.sofuoglu@yale.edu
91236|NCT01802320|The University of Texas MD Anderson Cancer Center, Clinical Research Operations|Dr. Scott Kopetz/Associate Professor, GI Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org
91237|NCT01802151|Department of Food Science and Human Nutrition, University of Florida|Dr. Wendy Dahl|352-392-1991 ext 224|wdahl@ufl.edu
91238|NCT01801982|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91239|NCT01801735|Iroko Pharmaceuticals, LLC|Alexis Gomez, Director of Clinical Operations|267-546-1426|agomez@iroko.com
91240|NCT01801475|Stanford University|Dr. David R Drover|6507250364|ddrover@stanford.edu
91241|NCT01801436|Janssen Pharmaceutical Taiwan|Medical Affairs Director|+886-2-23762155|
91242|NCT01801358|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com
91243|NCT01801280|Charité University Hospital - Department of Nephrology|Olesja Rissling|+49 30 450 514 153|olesja.rissling@charite.de
91244|NCT01801124|Maimonides Medical Center|Mark Kronefeld, MD|(718) 283-8816|
91245|NCT01801111|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com
91246|NCT01800968|Duke Clinical Research Institute|Adrian Hernandez, MD|919-668-7515|adrian.hernandez@duke.edu
91247|NCT01800916|Coloplast A/S|Marian Sinvani|+45 49112356|dkmards@coloplast.com
91248|NCT01800903|Coloplast A/S|Trine Møller Senior Clinical Manager|+45 4911 2174|dktrm@coloplast.com
91249|NCT01800890|Coloplast A/S|Marian Sinvani|+45 4911 2356|dkmards@coloplast.com
91250|NCT01800786|Brigham and Women's Hospital|Ina Djonlagic|617 667 5129|idjonlag@bidmc.harvard.edu
91251|NCT01800318|University of Arkansas for Medical Sciences|Richard W. Hall, professor of pediatrics, co-director of neonatal intensive care unit|501-680-7894|HallRichardw@uams.edu
91253|NCT01799941|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com
91254|NCT01799720|Universidad Miguel Hernández|Dr. Elena García García|965222025 ext 2025|egarcia@umh.es
91255|NCT01799590|Janssen Pharmaceutical KK Japan|Group Manager|+81-3-4411-5072|
91256|NCT01799239|Coloplast A/S|Camilla Felsvang Vibjerg, Senior Clinical manager|+45 4911 1990|dkcfv@coloplast.com
91257|NCT01799226|UMichigan|Janet Kinney|734-615-5452|kinneyj@umich.edu
91258|NCT01798992|University of Colorado, Denver|Dr. Michael Bristow, MD PhD|303-724-5453|Michael.Bristow@ucdenver.edu
91259|NCT01798966|Hamilton Glaucoma center|Anjali Parekh|+1858 822-1553|anjalism@gmail.com
91260|NCT01798927|UT Southwestern Medical Center|Karen McCain, PT, DPT, NCS|214-648-1559|karen.mccain@utsouthwestern.edu
91261|NCT01798706|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
91262|NCT01798485|Synta Pharmaceuticals|President, Chief Executive Officer|781-541-7261|
91263|NCT01798394|University of Minnesota|Nicole Tosun|612-624-5439|tosun004@umn.edu
91264|NCT01798316|Northwell|Director of Clinical Research, Department of Anesthesiology|718-470-7630|odowling@northwell.edu
91265|NCT01798264|Intarcia|Michelle Braon|510-782-7800|
91266|NCT01798186|Johns Hopkins University|Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu
91267|NCT01798134|Boston Scientific Corporation|Senior Clinical Program Manager|763-494-2172|hansenj2@bsci.com
91268|NCT01798004|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
91269|NCT01797783|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-888-451-3937|alcon.medinfo@alcon.com
91270|NCT01797731|Hospital for Special Surgery|David Mayman|2127742024|maymand@hss.edu
91271|NCT01797705|DeVilbiss Healthcare|Jim Froehlich|814-443-7692|Jim.Froehlich@devilbisshc.com
91272|NCT01797536|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91274|NCT01797445|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
91275|NCT01797380|Duke University Health Systems|Harold Goforth, M.D.|216-636-3999|goforth@ccf.org
91276|NCT01797328|UHLinkopeing|Fredrik H Nystrom|+46101037749|fredrik.h.nystrom@liu.se
91279|NCT01797029|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org
96548|NCT00073008|GlaxoSmithKline|GSK Response Center|866-435-7343|
91280|NCT01796977|Halyard Health, Inc.|Director of Clinical Affairs|470-448-5352|david.curd@hyh.com
91281|NCT01796964|Alcon Research, Ltd.|Clinical Project Group Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com
91282|NCT01796860|University of Texas Southwestern Medical Center|Karen J McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu
91283|NCT01796548|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200 ext 5888|
91284|NCT01796236|Head and Neck Surgery, Maastricht University Medical Center, Maastricht|Professor Robert Stokroos|0031 - 43 387 54 00|robert.stokroos@mumc.nl
91285|NCT01795937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91286|NCT01795898|Janssen Philippines|Medical Affairs Manager|+632-8247901|
91287|NCT01795859|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
91288|NCT01795716|Shanghai Jiaotong University School of Medicine Ruijin Hospital|Dr. Zhou Li|13816510379|lizhou999_999@yahoo.com
91289|NCT01795547|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com
91290|NCT01795534|Bangor University|Dr Jamie Macdonald|+441248383272|j.h.macdonald@bangor.ac.uk
91291|NCT01794949|Emory University|Henry Liberman, MD|404-686-2503|hliberm@emory.edu
91292|NCT01794936|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu
91293|NCT01794845|University of Miami|Matthew C. Abramowitz MD|305-243-4319|MAbramowitz@med.miami.edu
91294|NCT01794806|University of Iowa|Gustavo Avila-Ortiz|3193357241|gustavo-avila@uiowa.edu
91295|NCT01794741|Meda Pharmaceuticals|Dr Nancy Ruiz, MD|732 564 2390|nancy.ruiz@meda.us
91296|NCT01794455|Vanderbilt University|Dr. Warren Taylor|615-936-3555|warren.d.taylor@vanderbilt.edu
91297|NCT01794000|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
91298|NCT01793883|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com
91299|NCT01793688|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91300|NCT01793285|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91301|NCT01792986|Intermountain Heart Institute|Benjamin D. Horne|8015074708|benjamin.horne@imail.org
91302|NCT01792830|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu
91303|NCT01792635|Pfizer, Inc.|Pfizer ClnicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91304|NCT01792518|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91305|NCT01791972|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|1-215-591-3000|ustevatrials@tevapharm.com
91306|NCT01791894|Stanford University School of Medicine, Department of Dermatology|Jean Y Tang MD PhD|650-721-7149|baileyhi@stanford.edu
91307|NCT01791803|North Shore Medical Center|Dr. Faysal M. Hasan|978-741-1200 ext 4901|fhasan@partners.org
91308|NCT01791725|Transition Therapeutics Ireland Limited|Aleksandra Pastrak,MD, PhD, VP of Clinical Development and Medical Officer|+1 416 263 1227|apastrak@transitiontherapeutics.com
91309|NCT01791491|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
91310|NCT01791465|Vanderbilt University Medical Center|John Koethe MD|615-343-0533|john.r.koethe@vanderbilt.edu
91311|NCT01791413|Mahidol University|Dr. Weena Krutsawad|66812070264|vna_fe2@hotmail.com
91312|NCT01791244|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
91313|NCT01791205|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
91314|NCT01791153|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
91315|NCT01789775|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com
91316|NCT01790828|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91317|NCT01790750|University of Florida|Curt DeGroff|(352) 273-7831|degroffc@peds.ufl.edu
91318|NCT01790685|Johns Hopkins|Dr. Peter A. Campochiaro|410-955-5106|pcampo@jhmi.edu
91320|NCT01790633|Service des maladies infectieuses et tropicales - Hôpital Saint-Antoine|Dr. Julie Bottero|+33 1 49 28 04 24|julie.bottero@aphp.fr
91321|NCT01790581|UNC Charlotte|Erik Wikstrom|704-778-5784|ewikstrom@uncc.edu
91322|NCT01790516|Inova Health Care System|Dr John Deeken, PI|703 776 8161|john.deeken@inova.org
91323|NCT01790490|NYSPI|Elias Dakwar, MD|(646) 774-8728|dakware@nyspi.columbia.edu
91324|NCT01790178|Duke University|Lisa Hobson-Webb|919-668-2277|lisa.hobsonwebb@dm.duke.edu
91325|NCT01789970|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
91326|NCT01789814|Tufts Medical Center|Carey Kimmelstiel, MD Director of the Adult Cardiac Catheterization Laboratory|617-636-4504|Ckimmelstiel@tuftsmedicalcenter.org
91327|NCT01789606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91328|NCT01789476|Cara Therapeutics, Inc.|Frédérique Menzaghi, PhD, Vice President Research & Development|(203) 567-1502|fmenzaghi@caratherapeutics.com
91329|NCT01789255|University of Michigan Comprehensive Cancer Center|Pavan Reddy, M.D.|734-647-5954|reddypr@umich.edu
91330|NCT01789138|Department of Public Health, University of Tartu, ESTONIA|Prof. Anneli Uusküla|+372 7374195|anneli.uuskula@ut.ee
91331|NCT01788566|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
91333|NCT01788228|GlaxoSmithKline|GSK Response Center|866-435-7343|
91334|NCT01788215|University of Rochester|Kathleen Hoeger MD MPH|585-275-7891|kathleen_hoeger@urmc.rochester.edu
91335|NCT01788163|AstraZeneca|Haiyi Jiang/Asia Medical Director|+86 21 60302408|Haiyi.Jiang@astrazeneca.com
91336|NCT01788046|Amgen Inc.|Study Director|866-572-6436|
96905|NCT00106964|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com
91337|NCT01787838|Carilion Clinic|Rebecca Culver Clark|540-588-8184|rcclark@carilionclinic.org
91338|NCT01787825|CapsoVision, Inc.|Director of Clinical Affairs|408-624-1488 ext 117|andra.thomas@capsovision.com
91339|NCT01787799|Boston Scientific|Peter Maurer, MPH; Director of Clinical Trials|508-683-6678|peter.maurer@bsci.com
91340|NCT01787760|Vistakon, USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com
91341|NCT01787591|The Ohio State University|Richard S. Bruno, PhD, RD|614-292-1698|bruno.27@osu.edu
91342|NCT01787461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91343|NCT01787383|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leopharma.com
91344|NCT01787279|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
91345|NCT01787240|MGH|Dr. Cristina Cusin|617 726 6421|ccusin@partners.org
91346|NCT01787188|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com
91347|NCT01787175|University of Utah Health Care System|Dr. Jonathan Nebeker|801-582-1565 ext 2458|Jonathan.Nebeker@hsc.utah.edu
91348|NCT01787032|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91349|NCT01786993|St. Jude Medical|Director of Clinical Studies|972-309-8000 ext 8087|ccohorn@sjm.com
91350|NCT01786954|Duke Eye Center|Dr Paul Hahn|919-684-5631|paul.s.hahn@duke.edu
91352|NCT01786876|Shire Development LLC|Study Physician|+1 866 842 5335|
91353|NCT01786707|University of Miami School of Medicine|Dr. Rodolfo Alejandro|3052435324|ralejand@med.miami.edu
91354|NCT01786668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91355|NCT01786629|Braintree Laboratories, Inc.|John McGowan, Director Clinical Research|781-843-2202|jmcgowan@braintreelabs.com
91356|NCT01786551|Brigham and Women's Hospital|Gail K Adler|617-732-5661|gadler@partners.org
91357|NCT01786330|University of Kansas School of Medicine - Wichita|Zachary Kuhlmann, DO|316-685-7234|zkuhlmann@kumc.edu
91358|NCT01786252|Michigan State University|Dr. Asgerally Fazleabas|(517) 884-6031|asgi@hc.msu.edu
91359|NCT01786239|Northwell Health|Delbert Robinson MD|7184708195|drobinso@northwell.edu
91360|NCT01786174|Massachusetts General Hospital|James D. Berry, MD, MPH|617-726-5097|jdberry@mgh.harvard.edu
91361|NCT01786161|Massachusetts General Hospital|Hsin Lin|6177241314|hlin13@mgh.harvard.edu
91362|NCT01786109|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu
91363|NCT01785875|Amgen Inc.|Study Director|866-572-6436|
91364|NCT01785849|Amgen Inc.|Study Director|866-572-6436|
91365|NCT01785628|China Medical University Hospital|The chief, Department of Neurology|8864-22052121 ext 5035|d8079@mail.cmuh.org.tw
91366|NCT01785615|University of Florida College of Medicine Jacksonville|Dr. Gladys Velarde|(904)244-2060|Gladys.Velarde@jax.ufl.edu
91367|NCT01785602|Novartis|Study Director|862-778-8300|
91368|NCT01785524|Victoria University|Jason D. Allen, PhD|61 3 9919 4264|jason.allen@vu.edu.au
91369|NCT01785472|Novartis|Study Director|862-778-8300|
91370|NCT01785186|Tropical Institute of the Ludwig-Maximilians University in Munich, Germany|Dr. Norbert Heinrich|0049 89 2180 17605|heinrich@lrz.uni-muenchen.de
91371|NCT01785160|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91372|NCT01785134|Karolinska Institutet|Dr Erik Näslund|+46812355017|Erik.Naslund@ki.se
91373|NCT01785095|IBSA Institut Biochimique SA|IBSA Clinical Research Manager|+41583601000|rd@ibsa.com
91374|NCT01784965|Stanford Universtiy|Gerald Reaven, Professor Emeritus|650-724-3416|greaven@stanford.edu
91375|NCT01784666|Massachusetts General Hospital, Center for Quantitative Health|Dr. Roy Perlis|617-643-6310|rperlis@partners.org
91376|NCT01784614|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
91377|NCT01783938|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
91378|NCT01783912|Center for Tobacco Research and Intervention|Bruce Christiansen|608-262-4087|bc1@ctri.wisc.edu
91379|NCT01783886|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
91380|NCT01783860|Rasoule-Akram Hospital|Dr. Mohsen Bahmani-Kashkouli|00982166558811|bahmanik@eyeplasticsurgeries.com
91381|NCT01783821|Mayo Clinic|Dr. Emir Festic|904-953-9758|Festic.Emir@mayo.edu
91382|NCT01783730|AbbVie|Global Medical Services|800-633-9110|
91383|NCT01783678|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
91384|NCT01783639|Gardia Medical|Dr. Vardit Segal|+972-4-6277166 ext 106|Vardit@Gardiamedical.com
91385|NCT01783561|Neonatal Research Institute, Sharp Mary Birch Hospital for Women and Newborns|Anup Katheria, M.D.|858-939-4170|anup.katheria@sharp.com
91386|NCT01783548|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
91387|NCT01783496|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com
91388|NCT01783483|Zimmer Biomet|Brian M Hatcher, PhD|904-741-4400|brian.hatcher@zimmerbiomet.com
91389|NCT01783470|NIDDK / NIH|Aaron M. Cypess, MD, PhD, MMSc|301-435-9267|aaron.cypess@nih.gov
91390|NCT01783418|Ste-Justine's Hospital|Catherine Malboeuf-Hurtubise, Post-doctoral fellow|514-343-6111 ext 4594|catherine.malboeuf-hurtubise@umontreal.ca
91391|NCT01783236|Weill Cornell Medicine|Hugh Hemmings, MD, PhD|212-746-2953|hchemmi@med.cornell.edu
91392|NCT01783080|NY State Psychiatric Institute|David J Hellerstein MD, Professor of Clinical Psychiatry, Columbia|646-774-8000|hellers@nypsi.columbia.edu
91393|NCT01783054|Medical University of South Carolina|Eric Kimchi, MD|842-792-4271|kimchi@musc.edu
91394|NCT01783015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91395|NCT01782898|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu
91396|NCT01782885|Universidad Autónoma de Nuevo León|M Sc Mario Simental-Mendía|+52 (81) 8329 4174|mario.simental@gmail.com
91397|NCT01782872|Hospital for Special Surgery|Dr. Jacques YaDeau|212774224|yadeauj@hss.edu
91398|NCT01782859|Hospital for Special Surgery|Kethy Jules-Elysee, MD|2126061206|juleselyseek@hss.edu
91399|NCT01782742|Cleveland Clinic Lou Ruvo Center for Brain Health|Jeffrey Cummings, MD, ScD|702.483.6029|cumminj@ccf.org
91400|NCT01782664|GlaxoSmithKline|GSK Response Center|866-435-7343|
91401|NCT01782482|Alcon Research, Ltd.|Sharon Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com
91402|NCT01782469|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
91403|NCT01782326|Novartis Pharmaceuticals|Study Director|862-778-8300|
91404|NCT01782222|UCB|UCB Cares|+1 877 822 9493|
91405|NCT01781962|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
91406|NCT01781806|UCLA CARE Center|Dr. Raphael J. Landovitz|(310) 825-6689|rlandovitz@mednet.ucla.edu
91407|NCT01781637|Boston Children's Hospital|Lynda Schneider|617-355-6180|lynda.schneider@childrens.harvard.edu
91408|NCT01781481|Children's HOspital of Eastern Ontario|Dr. Janice Cohen|613-737-7600 ext 2497|cohen@cheo.on.ca
91409|NCT01781403|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr
91410|NCT01781299|University of Pittsburgh Plastic Surgery|Kenneth Shestak|412-641-1487|shestakkc@upmc.edu
91411|NCT01781208|Cincinnati Children's Hospital Medical Center, Department of Radiology|Jonathan Dillman, MD|513 803-7114|jonathan.dillman@cchmc.org
91412|NCT01781169|Shenzhen Center for Chronic Disease Control|Dr. Ji-Chang Zhou|86-755-25503842|jichangzhou@gmail.com
91413|NCT01781078|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com
91414|NCT01781026|Yale University|Harriet Kluger||Harriet.Kluger@yale.edu
91415|NCT01780987|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com
91416|NCT01780974|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu
91417|NCT01780935|Novartis Pharmaceuticals|Study Director|862-778-8300|
91418|NCT01780922|Washington State Unviversity|Boon P. Chew|5093351427|boonchew@wsu.edu
91419|NCT01780870|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu
91420|NCT01780584|Pediatric Cardiac ICU National Cardiovascular Center Harapan Kita|Dr Eva M Marwali, Principal Investigator|+62215684085 ext 2807|evamarwali@yahoo.com
91422|NCT01780389|Duke University Medical Center|David Marks, MD|619 668-2859|d.marks@duke.edu
91423|NCT01780350|University of Texas Health Science Center San Antonio|David Wampler, PhD|210.567.7598|wamplerd@uthscsa.edu
91424|NCT01780337|Columbia University|William Whang|212-305-8620|ww42@cumc.columbia.edu
91425|NCT01780324|Seattle Children's Hospital|Neil Uspal, MD|206-987-2599|neil.uspal@seattlechildrens.org
91426|NCT01779648|SMG-SNU Boramae Medical Center|Principal Investigator|+82-10-9988-2691|turejsreal@hanmail.net
91427|NCT01779219|Wroclaw University Hospital, Department of Neurosurgery|Dr. Marcin Czyz|+48 734-34-00|mt.czyz@gmail.com
91428|NCT01779167|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu
91429|NCT01778985|University of Texas Southwestern Medical Center|David D. Rahn, M.D.|214-648-6430|david.rahn@utsouthwestern.edu
91430|NCT01778855|UCLA|David S Liebeskind, MD|310-794-6379|dliebeskind@mednet.ucla.edu
91431|NCT01778751|Durham Veterans Affairs Medical Center|Dr Matthew J Crowley|919-286-6936|matthew.crowley@va.gov
91432|NCT01778530|National Cancer Institute|Dr. Joohee Sul|301-402-6298|Joohee_Sul@nih.gov
91433|NCT01778296|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com
91434|NCT01778127|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|901-595-5157|kiri.ness@stjude.org
91435|NCT01778062|Novartis Pharmaceuticals|Study Director|862-778-8300|
91436|NCT01778049|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91437|NCT01778023|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
91438|NCT01777945|Hoffmann-La Roche|Medical Communications|1-800-821-8590|
91439|NCT01777932|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
91440|NCT01777776|Array BioPharma, Inc.|Study Director|303-381-6604|info@arraybiopharma.com
91441|NCT01777763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
91442|NCT01777620|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
91443|NCT01777581|Duke University Medical Center|David Marks, MD|919 668-2859|d.marks@duke.edu
91444|NCT01777438|UZ Leuven|Dr Hellings|+32 16 332338|peter.hellings@uzleuven.be
91445|NCT01777425|UZ Leuven|Prof. Dr. P. Hellings|+3216332340|peter.hellings@uzleuven.be
91446|NCT01777412|Johns Hopkins University|Michael Levy|443-287-4412|mlevy@jhmi.edu
91448|NCT01777321|GlaxoSmithKline|GSK Response Center|866-435-7343|
91449|NCT01777282|GlaxoSmithKline|GSK Response Center|866-435-7343|
91450|NCT01777269|GlaxoSmithKline|GSK Response Center|866-435-7343|
91451|NCT01777217|Century Cancer Centers|Dr. Sanjay Mehta|713-631-8181|
91452|NCT01777191|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
91453|NCT01777126|Pharmacy Department, University Hospitals Leuven & Department of Pharmaceutical and Pharmacological Sciences, KULeuven, Belgium|Peter Declercq|003216342340|peter.declercq@uzleuven.be
91454|NCT01776645|Stanford University|Dr. Sean Mackey|650-724-2795|smackey@pain.stanford.edu
91455|NCT01776554|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com
91456|NCT01776541|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
91457|NCT01776268|Vanderbilt University Medical Center|James Wynn MD||james.wynn@peds.ufl.edu
91458|NCT01775995|University of Wisconsin Madison|Aleksandra Zgierska, MD PhD|(608) 263-7882|aleksandra.zgierska@fammed.wisc.edu
91459|NCT01775852|Baylor College of Medicine|Lilian Dindo, PhD|713-791-1414 ext 10296|lilian.dindo@bcm.edu
91460|NCT01775774|University of California San Francisco|Michael A. Matthay, MD|415-353-1206|michael.matthay@ucsf.edu
91461|NCT01775670|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org
91462|NCT01775553|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|212-241-7873|ajai.chari@mountsinai.org
91463|NCT01775189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91464|NCT01775137|Novartis Pharmaceuticals|Study Director|862-778-8300|
91465|NCT01774981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
91466|NCT01774968|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
91467|NCT01774929|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200 ext 5888|
91468|NCT01774903|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200|
91469|NCT01774851|Merrimack Pharmaceuticals|MM-111 Medical Director|617-441-1000|
91470|NCT01774604|Penn State Hershey Medical Center/Dartmouth-Hitchcock Medical Center|John M. Levenick|603-667-1332|jlevenick@hmc.psu.edu
91471|NCT01774344|Bayer|Therapeutic Area Head||clinical-trials-contact@bayer.com
91472|NCT01774305|Yonsei Univ. Health System, Gangnam Severance Hospital|Dr. Jeongsoo Lee|+82-2-2019-6092|ration99@yuhs.ac
91473|NCT01774253|NMTRC|Giselle Sholler, MD|6162670335|genevieve.bergendahl@helendevoschildrens.org
91474|NCT01774149|Norwegian Center for Integrated Care and Telemedicine|Dr. Stein Olav Skrøvseth|+4795805841|stein.olav.skrovseth@telemed.no
91475|NCT01774110|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu
91476|NCT01774097|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|lemmoye@msn.com
91477|NCT01774084|Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden;|Thomas Nyström MD, PhD|+4686163211|thomas.nystrom@ki.se
91478|NCT01774045|Taipei Veterans General Hospital|Dr. Cheng-Ta Li|886-2-2871-2121 ext 7027|on5083@msn.com
91479|NCT01773889|The Cancer and Therapy Center at The University of Texas Health Science Center San Antonio|Tyler Curiel, MD|210-562-5287|CURIELT@UTHSCSA.EDU
91480|NCT01773473|Eli Lilly and Company|Medical Officer|800-545-5979|
91481|NCT01773291|Kaohsiung Chang Gung Memorial Hospital|Wen-Long Hu, Deputy Director, Department of Chinese Medicine|+886-7-7317123 ext 2334|oolonghu@gmail.com
91482|NCT01773226|Zimmer Biomet|Linda Korthout, Scientific Affairs Specialist|+31.610.072.853|Linda.Korthout.external@zimmerbiomet.com
91483|NCT01773135|Ain Shams University Maternity Hospital|Mohamed Saied Eldein El-Safty, Lecturer of Obstetrics and Gynecology Faculty of Medicine - Ain Shams|01003922211 ext 002|dr.mai_elshahm@yahoo.com
91484|NCT01773122|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
91485|NCT01772654|Mayo Clinic|Cheolsu Shin, M.D.|507-284-4961|shin@mayo.edu
91486|NCT01772576|Boston Scientific|Ursula Appl|003224167213|ursula.appl@bsci.com
91487|NCT01772550|Becton, Dickinson and Company|Randall Jones, MD|801 565-2843|randall_jones@bd.com
91488|NCT01772537|The Johns Hopkins University|Dr. Charles Brown|410-955-0994|cbrown@jhmi.edu
91489|NCT01772368|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|
91490|NCT01772316|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
91491|NCT01772147|GlaxoSmithKline|GSK Response Center|866-435-7343|
91493|NCT01771991|Sanford Health|Dr Chad Spanos MD|605-328-8200|
91494|NCT01771965|MUSC|Tracy Stecker, PhD|843.792.7287|stecker@musc.edu
91495|NCT01771913|Faculdade de Medicina - Universidade de Sao Paulo|Dr. Luiz Alexandre Lorico Tissiani|55-11-981798707|latissiani@gmail.com
91496|NCT01771172|Medtronic, Inc.|Medtronic CRDM Clinical Trial Manager|763-505-6000|medtronicCRMtrials@medtronic.com
91497|NCT01770860|Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.|Associate Director, Clinical Research|973-385-7984|
91498|NCT01770743|Emergent BioSolutions|Dr. Gurdyal Kalsi|301-216-9927|kalsig@ebsi.com
91499|NCT01770691|ConTIPI LTD.|Dr. Elan Ziv|972-4-627-6066|eziv@contipi.com
91500|NCT01770652|ApoPharma Inc.|Fernando Tricta, MD|Phone: 416-401-7332|ftricta@apopharma.com
91501|NCT01770509|The Department of Dermatology, Sheba Medical Center|Dr. Shoshana Greenberger|972-3-5302443|shoshana.greenberger@sheba.health.gov.il
91502|NCT01770483|SIMS|Prof. Faisal Masud|00923004260213|faisalmasud@hotmail.com
91503|NCT01770431|Huazhong University of Science and Technology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong Wuhan, Hubei, China|Xiaoping Chen, Professor|+86 27 83663400|chenxp@medmail.com.cn
91504|NCT01770392|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91505|NCT01770379|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
91506|NCT01770366|Baystate Medical Center|Sofija Zagarins|413-794-2876|sofija.zagarins@baystatehealth.org
91507|NCT01770314|Inflexxion|Emil Chiauzzi|617-614-0429|echiauzzi@inflexxion.com
91509|NCT01769612|Institut Pasteur of Tunis|Afif Gen Salah, MD, PhD|011-216-71-792-429|noemailavailable@no.com
91510|NCT01769586|VA Connecticut Healthcare System|Dr. Loren Laine|203-932-5711|loren.laine@yale.edu
91511|NCT01769508|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
91512|NCT01769443|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
91514|NCT01769378|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
91516|NCT01769352|Johns Hopkins University School of Medicine|Dr. Peter A. Campochiaro|410-955-5106|pcampo@jhmi.edu
91517|NCT01769339|Janssen Philippines|Medical Affairs Manager|+6328248935|
91518|NCT01769326|University of California Irvine|Steven Cramer, M.D.|(949) 824-8748|scramer@uci.edu
91519|NCT01769248|Northwestern University|Srinadh Komanduri|312-695-0484|koman1973@gmail.com
91520|NCT01769222|Stanford University Medical Center|George Albert Fisher, MD|650-725-9057|georgeaf@stanford.edu
91521|NCT01769196|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
91522|NCT01769105|Department of ophthalmology, University of Duesseldorf|Dr. David Finis|+49 211 8117320|David.Finis@med.uni-duesseldorf.de
91523|NCT01768676|Vivus|Wesley D Day, PhD|650-934-5200|
91524|NCT01768572|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
91525|NCT01768559|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
91526|NCT01768325|Indiana University School of Medicine|John DeWitt, MD|317-944-1113|jodewitt@iu.edu
91527|NCT01768286|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
91528|NCT01768117|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91529|NCT01768013|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com
91530|NCT01768000|Centre for Addiction and Mental Health|Sean Kidd|416-535-8501 ext 36295|sean.kidd@camh.ca
91531|NCT01767987|Kettering Health Network|Suzanne Coleman, PhD|937-395-8390|suzanne.coleman@khnetwork.org
91532|NCT01767701|Queen Mary University of London|Professor Gavin Giovannoni||g.giovannoni@qmul.ac.uk
91533|NCT01767688|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91534|NCT01767597|Service des maladies infectieuses et tropicales - Hôpital Saint-Antoine|Dr. Julie Bottero|+33 1 49 28 04 24|julie.bottero@aphp.fr
91535|NCT01767519|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
91537|NCT01767467|GlaxoSmithKline|GSK Response Center|866-435-7343|
91538|NCT01767376|GlaxoSmithKline|GSK Response Center|866-435-7343|
91539|NCT01767285|Duke University|Dr. Beverly Gray|919-684-8111|beverly.gray@dm.duke.edu
91540|NCT01767116|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
91541|NCT01767103|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com
91542|NCT01767064|USCalifornia|Jason Doctor|213.821.8142|jdoctor@usc.edu
91543|NCT01766921|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com
91544|NCT01766778|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
91545|NCT01766713|UCSD|Rohit Loomba|858-534-2624|roloomba@ucsd.edu
91546|NCT01766466|The Medicines Company|Jayne Prats, PhD - VP, Global Knowledge Management|888.779.MDCO ext 1510|jayne.prats@themedco.com
91547|NCT01766440|Galderma|Michael Graeber|(817)961-5000|michael.graeber@galderma.com
91548|NCT01766336|Transition Therapeutics Ireland Limited|Aleksandar Pastrak, MD, PhD, Vice President Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com
91549|NCT01766310|Queen Sirikit National Institute of Child Health|Dr. Orawan Iamopas|66-2-354-8415 ext 3327|orawaneamopas@yahoo.com
91550|NCT01766102|Massachusetts General Hospital|Michelle Specht, MD|617-726-0340|MSPECHT@mgh.harvard.edu
91551|NCT01766076|Makarere University|Damalie Nakanjako|41407000 ext 249|dnakanjako@gmail.com
91552|NCT01766050|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
91553|NCT01766037|Aspire Bariatrics, Inc.|VP Regulatory & Quality|484-200-1031|monica.ferrante@aspirebariatrics.com
91554|NCT01766024|BIOCAD|Director of Clinical Trials|7 (812) 380 49 33 ext 925|biryulin@biocad.ru
91555|NCT01765972|Johnson & Johnson Vision Care Inc.|Katherine Osborn Lorenz, OD, MS|614 459-9477|KOSBORN@its.jnj.com
91556|NCT01765803|University of New Mexico|Stuart Winter, MD|505-272-4461|SWinter@salud.unm.edu
91557|NCT01765764|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
91558|NCT01765582|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
91559|NCT01765569|Organization: Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
91560|NCT01765543|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
91562|NCT01765465|DongGuk University Ilsan Hospital|Dr. In Woong Han||cardioman76@gmail.com
91563|NCT01765426|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
91564|NCT01765270|Duke Clinical Research Institute|L. Kristin Newby, MD, MHS|919-668-8805|kristin.newby@duke.edu
91565|NCT01765192|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
91567|NCT01765153|University of Alberta|Dr. Jaynie Yang|780-492-2894|jaynie.yang@ualberta.ca
91568|NCT01764997|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
91569|NCT01764945|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91570|NCT01764919|Biomed valley discoveries|Dr. Michelle Zhang, Executive Director|7815339412|mzhang@biomed-valley.com
91571|NCT01764841|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com
91572|NCT01764685|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@mail.med.upenn.edu
91573|NCT01764607|University of Florida|Priya K Gopalan|352-273-8699|gopalpk@ufl.edu
91574|NCT01764386|Orexigen Therapeutics, Inc.|Executive Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com
91575|NCT01764022|BIOCAD|Biryulin Andrey|+7812380 49 33 ext 925|biryulin@biocad.ru
91576|NCT01763996|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
91577|NCT01763918|Amgen Inc.|Study Director|866-572-6436|
91578|NCT01763905|Amgen Inc.|Study Director|866-572-6436|
91579|NCT01763866|Amgen Inc.|Study Director|866-572-6436|
91580|NCT01763827|Amgen Inc.|Study Director|866-572-6436|
91581|NCT01763645|BIOCAD|Biryulin Andrey|+7812380 49 33 ext 925|biryulin@biocad.ru
91582|NCT01763567|Medtronic, Inc.|Julie Sekella|818-576-5000|Julie.Sekella@medtronic.com
91583|NCT01763047|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD., M.S., F.A.A.O- Senior Principal Research Optometrist|904-443-3500 ext 3402|TKarkkai@its.jnj.com
91584|NCT01762982|GlaxoSmithKline|GSK Response Center|866-435-7343|
91585|NCT01762904|Universidad de Guanajuato|Alejandro E. Macías|+52 477 7 14 58 59 ext 4644|aaeemmhh@yahoo.com
91586|NCT01762800|GlaxoSmithKline|GSK Response Center|866-435-7343|
91587|NCT01762761|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
91588|NCT01762722|Duke University Medical Center|Dr David MacLeod|919-812-3201|david.macleod@duke.edu
91589|NCT01762501|Sogo Rinsho Medefi Co., Ltd|Naoyuki Takano|+81-3-6901-6079|takano.naoyuki@sogo-medefi.jp
91590|NCT01762345|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com
91591|NCT01762059|Massachusetts General Hospital|Dr. Steven J. Russell|617-726-1848|sjrussell@mgh.harvard.edu
91592|NCT01761747|Dana-Farber Cancer Institute|Dr. Peter Hammerman|617-632-6335|phammerman@partners.org
91593|NCT01761565|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com
91594|NCT01761279|Portsmouth Hospitals NHS Trust|Dr Pete Basford, Endoscopy Research Fellow|+447890990445|petebasford@hotmail.com
91595|NCT01761175|CHU de Québec, Département d'Anesthésie-Réanimation de l'Hôpital de l'Enfant-Jésus|Dre Marie-Josée Nadeau|418 649-5807|marie-josee.nadeau@fmed.ulaval.ca
91596|NCT01761162|Biotronik, Inc.|Clinical Studies Engineer|503-927-7230|justin.michalski@biotronik.com
91597|NCT01761019|Department of Dermatology, University of Pittsburgh School of Medicine|Laura K. Ferris, MD, PhD|412-647-2013|ferrlk@upmc.edu
91598|NCT01760993|Shire|Study Physician|+1 866 842 5335|
91599|NCT01760941|Virginia Commonwealth University/Massey Cancer Center|Drew Moghanaki, MD, MPH|804-765-5850|Drew.moghanaki@vcuhealth.org
91600|NCT01760889|Shire|Study Physician|+1 866 842 5335|
91601|NCT01760876|Queen Mary Hospital,University of Hong kong|Prof. Stephen Wai-luen LEE|(852) 22555409 or 28181314|prof.stephenlee@gmail.com ; kongsl@hku.hk
91602|NCT01760785|Denver Research Institute|Dr. Thomas Beresford|303-399-8020 ext 3732|thomas.beresford@ucdenver.edu
91603|NCT01760473|New York State Psychiatric Institute|Dr. Sandra Comer|646 774-6146|sdc10@columbia.edu
91604|NCT01760304|Brigham and Women's Hospital|Dr. Miguel Divo|8573070311|mdivo@bwh.harvard.edu
91605|NCT01759602|Johns Hopkins University|Michael Levy, MD, PhD|443-287-4412|mlevy@jhmi.edu
91606|NCT01759511|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
91607|NCT01759420|Carl R Darnall Army Medical Center|Peter Moffett MD|254-288-8302|peter.m.moffett.mil@mail.mil
91608|NCT01759381|Duke|Carlos A. Bagley|919-943-1564|carlos.bagley@gmail.com
91609|NCT01759368|VTT Technical Research Centre of Finland|Anna-Leena Orsama|+358408485966|anna-leena.orsama@vtt.fi
91610|NCT01759290|Abbott Vascular|Kunal Sampat|408-845-0746|kunal.sampat@av.abbott.com
91611|NCT01759264|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
91612|NCT01759251|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com
91613|NCT01759160|First Affiliated Hospital of Sun Yat-sen University|Dr. Xia Feng|008613688877856|fengxiar@yahoo.cn
91614|NCT01758900|Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine|Zhizheng Ge, MD. Ph.D. Director of the Clinical Trials|86-21-68383015|zhizhengge@yahoo.com.cn
91615|NCT01758289|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
91616|NCT01757964|University of Washington|David Suskind MD Professor of Pediatrics|206-987-2521|Jani.Klien@seattlechildrens.org
91617|NCT01757847|VA San Diego Healthcare System|Niloofar Afari, PhD|858-642-3387|niloofar.afari@va.gov
91618|NCT01757704|Lunds University|Dr. Bansi Koul|+4646171649|bansi.koul@skane.se
91619|NCT01757691|Novartis|Study Director|862-778-8300|
91620|NCT01757561|FirstSunYetSen|Juan-ying Guo|8602087755766(8273)|gjunying@aliyun.com
91622|NCT01757275|AstraZeneca|Huifang Chen|+86 21 60301335|ariel.chen@astrazeneca.com
91623|NCT01757197|Weill Cornell Medicine|Usama Gergis, MD|(212) 746-2119|usg2001@med.cornell.edu
91624|NCT01757184|Alexion Pharmaceuticals|Mark Friedman, Medical Director|781-357-9953|mark.friedman@alxn.com
91625|NCT01756976|Haemonetics|Clinical Project Manager|781-356-9595|michael.dioguardi@haemonetics.com
91626|NCT01756586|University of Chicago|TARIQ MALIK|773-834 3643|tmalik@dacc.uchicago.edu
91627|NCT01756391|Boston Children's Hospital|Wanda Phipatanakul|617-355-6117|wanda.phipatanakul@childrens.harvard.edu
91628|NCT01756300|Biosense Webster, EMEA|Liesbeth Vanderlinden, Manager Clinical Research|+32(0)2 7463527|lvanderl@its.JNJ.com
91629|NCT01756274|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com
91630|NCT01756235|AbbVie|Global Medical Information|800-633-9110|
91631|NCT01756157|Shire|Study Physician|1866-842-5335|
91632|NCT01756079|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91633|NCT01756053|Center for Interdisciplinary Research on Nicotine Addiction|Benjamin Albelda (Project Manager)|2157467173|albeldab@mail.med.upenn.edu
91634|NCT01755702|GlaxoSmithKline|GSK Response Center|866-435-7343|
91635|NCT01755637|GlaxoSmithKline|GSK Response Center|866-435-7343|
91636|NCT01755455|Dartmouth-Hitchcock Medical Center|Alex H. Gifford, M.D.|603-650-5533|alex.h.gifford@hitchcock.org
91637|NCT01755234|Northwestern University|Gildasio De Oliveira|312-695-4858|g-jr@northwestern.edu
91638|NCT01755169|MUSC|Dr. Amy-Lee Bredlau|843-876-0444|bredlau@musc.edu
91639|NCT01755156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91640|NCT01755143|Medtronic Cardiac Rhythm and Heart Failure|5076MRI Clinical Team|1-800-328-2518|MedtronicCRMtrials@medtronic.com
91641|NCT01755026|west virginia university|michael stitely|304-293-5631|mstitely@hsc.wvu.edu
91642|NCT01754922|VA NJ Health Care System|Dr. Michael Falvo|973-676-1000 ext 2423|Michael.Falvo@va.gov
91643|NCT01754766|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
91644|NCT01754727|AbbVie|Global Medical Information|800-633-9110|
91645|NCT01754714|Abbott|Associate Director Clinical Services|+31 29-44-79-196|taco.baardman@abbott.com
91646|NCT01754623|Florida Hospital Orlando (Formerly at Moffitt Cancer Center)|Ravi Shridhar, M.D., Ph.D.|407-303-5857|ravi.shridhar.md@flhosp.org
91647|NCT01754519|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
91648|NCT01754493|New York State Psychiatric Institute|Roberto Lewis-Fernandez|646-774-8102|rlewis@nyspi.columbia.edu
91649|NCT01754480|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com
91650|NCT01754467|Northwestern University|Christine Pellegrini, PhD|312-503-1395|c-pellegrini@northwestern.edu
91651|NCT01754402|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|cristina.gasparetto@duke.edu
91652|NCT01754389|Dana Farber Cancer Institute|Dr. John Koreth|617-632-2949|John_Koreth@dfci.harvard.edu
91653|NCT01754376|MGH Cancer Center|Ryan Sullivan|617-724-4000|rsullivan7@mgh.harvard.edu
91654|NCT01754259|Brigham and Women's Hospital|Dr. Marcelo Di Carli|617-732-6291|mdicarli@partners.org
91655|NCT01754194|Medtronic MITG|Maria Young - Clinical Research Manager|+353 (0)1 4381611|maria.young@medtronic.com
91656|NCT01753856|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
91658|NCT01753557|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
91659|NCT01753518|Mayo Clinic|Dr. Margaret Dow|507-266-8008|dow.margaret@mayo.edu
91660|NCT01753336|Ipsen Biopharmaceuticals, Inc.|Medical Director||clinical.trials@ipsen.com
91661|NCT01753323|Novartis Pharmaceuticals|Study Director|862-778-8300|
91662|NCT01753310|Ipsen Biopharmaceuticals, Inc.|Medical Director||clinical.trials@ipsen.com
91663|NCT01753115|Emergent BioSolutions|Robert Hopkins, MD, MPH & TM, FACP, FIDSA, Medical Monitor|301-944-0136|HopkinsR@ebsi.com
91664|NCT01753076|GlaxoSmithKline|GSK Response Center|866-435-7343|
91665|NCT01752907|Amgen Inc.|Study Director|866-572-6436|
91666|NCT01752855|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
91667|NCT01752023|SKCCC at Johns Hopkins|Ronan Kelly, MD|443-287-0005|rkelly25@jhmi.edu
91668|NCT01751867|Janssen R&D US|SR DIR COMPD DEV TM LDR|1 908 704-5197|
91669|NCT01751802|Psyadon Pharmaceuticals|President/CEO|301-919-2020|info@psyadonrx.com
91670|NCT01751724|University of Miami|Eduardo Bancalari M.D., Director Division of Neonatology|3055856408|ebancalari@miami.edu
91671|NCT01751386|National Institute on Alcohol Abuse and Alcoholism|Lorenzo Leggio|+1 301 435 9398|lorenzo.leggio@mail.nih.gov
91672|NCT01751308|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
91673|NCT01751178|GlaxoSmithKline|GSK Response Center|866-435-7343|
91674|NCT01751165|GlaxoSmithKline|GSK Response Center|866-435-7343|
91675|NCT01751113|GlaxoSmithKline|GSK Response Center|866-435-7343|
91676|NCT01751087|Planned Parenthood League of Massachusetts, Inc.|Principal Investigator|617.616.1600|
91677|NCT01751022|Medtronic|Shelby Li|+17635262704|shelby.li@medtronic.com
91678|NCT01750931|GlaxoSmithKline|GSK Response Center|866-435-7343|
91679|NCT01750840|Biomet|Manager of Research|973-299-9300 ext 3415|hallie.murray@zimmerbiomet.com
91680|NCT01750684|Acorda Therapeutics, Inc.|Chief Scientific Officer|914-347-4300|acorda@acorda.com
91681|NCT01750502|Department of Cardiology, the Second Affiliated Hospital, Wenzhou Medical University, Zhejiang province, Wenzhou,China|Dr. JiFei Tang|15968766021|jiftang@126.com
91682|NCT01750398|SKCCC at Johns Hopkins|Samuel Denmeade|410-955-8875|denmesa@jhmi.edu
91683|NCT01750346|National Institutes of Health|Dr. Codrin Lungu|301-402-0976|lunguci@ninds.nih.gov
91684|NCT01750294|Indiana University & Richard L Roudebush VA Medical Center|Rajiv Agarwal, MD, FAHA, FASN, FASH|317-988-2241|ragarwal@iu.edu
91685|NCT01750281|AstraZeneca|Dr Gabriella Mariani|+44 (0)207 6048000|ClinicalTrialTransparency@astrazeneca.com
91686|NCT01750255|Universidad de Antioquia|Pedro Amariles Muñoz|57 4 2195456|pedro.amariles@udea.edu.co
91687|NCT01750242|Medtronic Neuromodulation|Stephanie Salisbury|763-526-8096|stephanie.salisbury@medtronic.com
91688|NCT01750086|Massachusetts General Hospital|Dr. Joy Tsai|617-726-6723|jntsai@mgh.harvard.edu
91689|NCT01749982|Columbia University|Megan N Hall|212-305-3161|mh2825@columbia.edu
91690|NCT01749956|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com
91691|NCT01749800|Spaulding Rehabilitation Hospital|Paolo Bonato|+1-617-952-6319|pbonato@partners.org
91692|NCT01749735|Spaulding Rehabilitation Hospital|Dr. Paolo Bonato|617-952-6319|pbonato@partners.org
91693|NCT01749631|AbbVie|Global Medical Information|800-633-9110|
91694|NCT01749605|University of Iowa|Brett Faine, PI|319-310-8067|brett-faine@uiowa.edu
91696|NCT01749410|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
91698|NCT01748942|Oregon Health and Science University|Daniel Clayburgh, MD PhD|503-494-8510|clayburg@ohsu.edu
91699|NCT01748916|University of Hohenheim|Dr. Ralf Schweiggert|0049-711-459-22995|ralf.schweiggert@uni-hohenheim.de
91701|NCT01748799|Centre for Addiction and Mental Health (CAMH)|Bernard Le Foll|416.535.8501 ext 34772|bernard.lefoll@camh.ca
91702|NCT01748760|Brown University|Shirley Yen, Ph.D.|401-444-1915|Shirley_Yen_PhD@Brown.edu
91703|NCT01748695|Brigham and Women's Hospital|Dr. Christine N. Sang, Director of Translational Pain Research|617-525-7246|csang@partners.org
91704|NCT01748643|Ziekenhuis Oost-Limburg|Dr. Pascal Vanelderen|+3289325298|pascal.vanelderen@gmail.com
91705|NCT01748227|Richard L. Roudebush VAMC HSR&D|Dr. Marianne Matthias|317-988-4514|marianne.matthias@va.gov
91706|NCT01748071|Huazhong University of Science&Technology|Xianwei Zhang|027 83662853|ourpain@163.com
91707|NCT01748045|Tufts Medical Center|Dr. Christiane Dammann|617-636-8738|cdammann@tuftsmedicalcenter.org
91708|NCT01747928|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91709|NCT01747850|CAMH|Dr. Jose Trigo|416.535.8501 ext 30021|jose.trigo@camh.ca
91710|NCT01747811|University of Arizona|William Killgore|520-621-0605|killgore@psychiatry.arizona.edu
91711|NCT01747772|Division of Abdominal Imaging and Interventional Radiology, Massachusetts General Hospital|Anthony E. Samir MD||asamir@partners.org
91712|NCT01747655|AbbVie|Global Medical Information|1-800-633-9110|
91713|NCT01747629|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com
91714|NCT01747343|University of Kansas|Brian D. Greer, Ph.D.|386-852-7171|brian.greer@unmc.edu
91715|NCT01747330|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com
91716|NCT01746940|STATKING Clinical Services|Lori Christman, PhD|513-858-2989 ext 317|lori@statkingclinical.com
91717|NCT01746862|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
91718|NCT01746784|N30 Pharmaceuticals|Dr. Steven Shoemaker|720-945-7700|steven.shoemaker@n30pharma.com
91719|NCT01746511|University of Rochester|Carl D'Angio|585-273-4911|carol_dangio@urmc.rochester.edu
91720|NCT01746368|Tuscaloosa VA Medical Center (Retired)|Ann Mahaney-Price, DNP|205-409-8301|amparnp@yahoo.com
91721|NCT01746264|Mayo Clinic|Dr. Seema Kumar|507-538-2724|Kumar.Seema@mayo.edu
91722|NCT01746173|Dana-Farber Cancer Institute|Philippe Armand MD, PhD|617.632.2305|Philippe_Armand@dfci.harvard.edu
91723|NCT01746108|GlaxoSmithKline|GSK Response Center|866-435-7343|
91724|NCT01745952|UZ Leuven|Prof W Van Paesschen & Dr L Seynaeve|+3216349062|laura.seynaeve@uzleuven.be
91725|NCT01745913|Weill Cornell Medical College|Koen van Besien, MD|2127462646|kov9001@med.cornell.edu
91726|NCT01745848|University of Pittsburgh|Dr. Jessica Bon Field|412-648-6494|bonjm@upmc.edu
91727|NCT01745380|University of Pennsylvania School of Dental Medicine|Elliott V. Hersh, Principal Investigator|215-898-9686|evhersh@pobox.upenn.edu
91728|NCT01745133|DermResearch PLLC|leon kircik|5023965310|wedoderm@yahoo.com
91729|NCT01745055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91730|NCT01744977|Durham Veterans Affairs Medical Center|Hayden Bosworth, PhD|919-286-6936|hayden.bosworth@va.gov
91731|NCT01744860|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
91732|NCT01744821|Northwestern University|Assistant Professor|312-472-4684|dcarson@nm.org
91733|NCT01744730|Duke Clinical Research Institute, Duke University School of Medicine|Kevin Watt, MD|919-668-8556|kevin.watt@dm.duke.edu
91734|NCT01744691|Pharmacyclics, Inc.|Dr. Alvina Chu|855-427-8846|medinfo@pcyc.com
91735|NCT01744496|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
91737|NCT01744392|Health Services Research & Development, Durham VAMC|Hayden B. Bosworth, PhD|919-286-0411 ext 7107|hayden.bosworth@va.gov
91738|NCT01744353|Brown Oncology Research Group|Kristen M. Mitchell|4018633000|kristen_mitchell@brown.edu
91739|NCT01744340|BrUOG-Brown University Oncology Research Group|Howard Safran, MD|4018633000|kristen_mitchell@brown.edu
91740|NCT01744197|Evergreen Hematology and Oncology|Melanie Matson, RN, BSN|5094642873|mmatson@evergreen4cure.com
91741|NCT01743963|Eastern Colorado Health Care System, VA|Liron Caplan, Primary Investigator|7208575103|liron.caplan@ucdenver.edu
91742|NCT01743729|Shire|Study Physician|1866-842-5335|
91743|NCT01743521|Kirby Institute|A/Prof Gail Matthews|+61 (0)2 9385 0900|gmatthews@kirby.unsw.edu.au
91744|NCT01743092|Centre for Addiction and Mental Health|Nigel Turner, Ph.D.|416-535-8501 ext 36063|nigel.turner@camh.ca
91745|NCT01743027|Alcon Research, Ltd.|James Wheeler, Unit Head, Pharma|1-888-451-3937|alcon.medinfo@alcon.com
91746|NCT01742936|Nationwide Children's Hospital|Vidya Raman, MD|614-722-4200|Vidya.Raman@nationwidechildrens.org
91747|NCT01742897|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-739-7200 ext 5888|
91748|NCT01742832|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu
91749|NCT01742364|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org
91750|NCT01741792|Amgen, Inc.|Study Director|866-572-6436|
91751|NCT01741701|University of Kansas Medical Center|Dr. Rajesh Pahwa|913-588-6782|rpahwa@kumc.edu
91752|NCT01741688|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
91753|NCT01741350|University of Connecticut|Dr. Michael M. Copenhaver, Ph.D.|860 208-3632|michael.copenhaver@uconn.edu
91754|NCT01741272|Alberta Health Services|Dr. Robert Balyk|7804395858|rbalyk6@aol.com
91755|NCT01740817|University of Texas Health Science Center at San Antonio|Dr. Nicolas Musi|200-562-6152|musi@uthscsa.edu
91756|NCT01740726|Emory University School of Medicine|Research Coordinator|404-727-4799|sean.carey@emory.edu
91757|NCT01740713|Consorzio per Valutazioni Biologiche e Farmacologiche|Clinical Research Coordinator|0039 0382 25075|mariagraziafelisi@cvbf.net
91758|NCT01740440|BioMedical Research Ltd|Gary Rainsford|0035391774361|grainsford@bmr.ie
91760|NCT01740414|New York State Psychiatric Institute|Dr. Sandra Comer|646-774-6146|comersd@nyspi.columbia.edu
91762|NCT01740388|Valeant Pharmaceuticals|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com
91763|NCT01740362|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91765|NCT01740206|Nationwide Children's Hospital|Richard Cartabuke, MD|614-722-4200|Richard.Cartabuke@nationwidechildrens.org
91766|NCT01740089|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28 ext 930|linkova@biocad.ru
91767|NCT01739803|University of Tennessee College of Pharmacy|Marie Chisholm-Burns|901-448-7141|mchisho3@uthsc.edu
91768|NCT01739790|Minneapolis VA Healthcare System|Dennis E. Niewoehner, MD|612-467-4412|niewo001@umn.edu
91769|NCT01739595|Repros Therapeutics Inc|Jennifer Wike|2817193402|jwike@reprosrx.com
91771|NCT01738984|University of Hawaii, School of Nursing and Dental Hygiene|Cheryl Albright|8089569716|cherylal@hawaii.edu
91772|NCT01738971|University of Edinburgh|Dr Lucy Michie|0131 5361542|michieluc@yahoo.co.uk
91773|NCT01738919|Aarhus University Hospital|Janni Kjaergaard Thillemann|+45 28137303|teamjanni@gmail.com
91774|NCT01738750|University of Utah|Dr. Eric Scaife|801-662-2950|eric.scaife@imail2.org
91775|NCT01738737|University of Sao Paulo|Sarah Rubia Ferreira de Meneses|+55(11)470898-71|sarah.meneses@usp.br
91776|NCT01738698|Shire|Study Physician|+1 866 842 5335|
91777|NCT01738646|Duke Univeristy Medical Center|Katherine Peters|919 684-3914|katherine.peters.@dm.duke.edu
91778|NCT01738581|University of Minnesota|Dr. Teresa Kimberley|612-626-4096|tjk@umn.edu
91779|NCT01738438|Dana-Farber Cancer Institute|Sara Tolaney, MD|617.632.2335|Sara_Tolaney@DFCI.HARVARD.EDU
91780|NCT01738321|Nationwide Children's Hospital|Senthil Krishna, MD|614-722-4200|Senthil.Krishna@nationwidechildrens.org
91781|NCT01737996|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91782|NCT01737944|Antares Pharma|Jonathan Jaffe, MD; Vice President Clinical Development|1-609-359-3020 ext 324|jjaffe@antarespharma.com
91783|NCT01737931|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
91784|NCT01737879|Amgen Inc.|Study Director|866-572-6436|
91785|NCT01737840|Akdeniz University|Cenker Eken|00905321593948|cenkereken@akdeniz.edu.tr
91786|NCT01737762|Smith and Nephew|Dr Innes Cargill|817-302-3913|innes.cargill@smith-nephew.com
91787|NCT01737710|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
91788|NCT01737684|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91789|NCT01737593|UCLA|Dr. Wendy Ren|310.267.8678|wren@mednet.ucla.edu
91790|NCT01737021|Imperial College London|Professor Elena Garralda|+44 (0)20 3312 6085|e.garralda@imperial.ac.uk
91791|NCT01736930|Jaeb Center for Health Resesarch|Roy W. Beck, MD, PhD|813-975-8690|jdrfapp2@jaeb.org
91792|NCT01736917|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org
91793|NCT01736696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91794|NCT01736657|Terumo BCT, Inc.|Ray Goodrich, Phd, VP Scientifc and Clinical Affairs|303-205-2680|
91796|NCT01736540|Novartis|Study Director|862-778-8300|
91797|NCT01736527|Bausch & Lomb Incorporated|Raphaële Siou-Mermet, MD, MS|+33160871491|raphaele.siou-mermet@bausch.com
91799|NCT01736215|Janssen Cilag Thailand|Medical Affairs Director|+6627927232|
91800|NCT01736176|AbbVie|Global Medical Services|800-633-9110|
91802|NCT01735877|Christian Medical College & Hospital|Dr Jeyaraj D Pandian|09915784750|jeyarajpandian@hotmail.com
91803|NCT01735630|Transition Therapeutics Ireland Limited|Aleksandra Pastrak, MD, PhD, Vice President Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com
91804|NCT01735617|Diurnal Ltd.|CEO|+44 (0) 871 716 8848|info@diurnal.co.uk
91805|NCT01735396|Tisch Cancer Center, Icahn School of Medicine at Mount Sinai|Dr. Matthew David Galsky|212-689-5412|matthew.galsky@mssm.edu
91806|NCT01735214|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
91807|NCT01735201|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
91808|NCT01735175|Sandoz|Strategic Planning, Biopharmaceutical Clinical Development|+49 (0) 8024 476 – 0|biopharma.clinicaltrials@sandoz.com
91809|NCT01734993|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
91810|NCT01734889|Swedish Orphan Biovitrum|Medical Director|+46 8 697 20 00|erik.brouwer@sobi.com
91811|NCT01734785|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91812|NCT01734772|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91813|NCT01734655|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu
91814|NCT01734551|University of Kentucky|Dr. Henrietta S. Bada, Professor and Vice Chair, Academic Affairs|859-323-1019|hbada2@uky.edu
91815|NCT01734395|Jan-Cil Korea|Clinical Research Director|82 2 2094 ext 4518|
91816|NCT01734317|Mölnlycke Health Care|Joan Wilson|+1 706-650-1012|joan.wilson@molnlycke.com
91817|NCT01734239|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91818|NCT01734161|Weill Cornell Medicine|Klaus Kjaer, MD|(212) 746-2953|klk9001@med.cornell.edu
91819|NCT01733953|University of Minnesota|Cameron Naughton|612-625-3623|naug0009@umn.edu
91820|NCT01733758|GlaxoSmithKline|GSK Response Center|866-435-7343|
91821|NCT01733745|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com
91822|NCT01733732|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com
91823|NCT01733329|Hospital Universitario José Eleuterio González, Universidad Autónoma de Nuevo León|Dr. Flavio Hernández Castro|8112776459|flaviohernandezc@yahoo.com
91824|NCT01733316|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com
91825|NCT01733277|ArthroLab Inc.|Dr Jean-Pierre Pelletier|15148908000 ext 26666|dr@jppelletier.ca
91826|NCT01732263|Shire Development LLC|Study Physician|+1 866 842 5335|
91827|NCT01733121|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com
91828|NCT01733069|Gen-Probe Incorporated|Jennifer Reid, Director of Clinical Affairs|858-731-5985|jennifer.reid@hologic.com
91829|NCT01733056|Emory University|Dr. Robert Swerlick|404-727-3669|rswerli@emory.edu
91830|NCT01732926|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
91831|NCT01732913|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
91832|NCT01732835|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com
91833|NCT01732796|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91834|NCT01732770|Amgen Inc.|Study Director|866-572-6436|
91835|NCT01732757|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
91836|NCT01732692|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com
91837|NCT01732588|MMV|Dr Fiona Macintyre|+41 22 799 4060 ext 4078|macintyref@mmv.org
91838|NCT01732549|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
91839|NCT01732510|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91840|NCT01732484|Medical University of Vienna|Prof. Dr. R. Menapace|+43 699 19660272|rupert.menapace@meduniwien.ac.at
91841|NCT01732471|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
91843|NCT01731990|Novartis Pharmaceuticals|Study Director|862-778-8300|
91844|NCT01731938|Grifols Therapeutics, Inc.|Henry Li, PhD, RAC|1-919-316-6042|Henry.Li@Grifols.com
91845|NCT01731470|Beaumont Hospital, Royal Oak|Kenneth Peters MD|248-551-0387|Kenneth.Peters@Beaumont.edu
91846|NCT01731119|UNC-Chapel Hill|Dr. Linmarie Sikich||linmarie_sikich@med.unc.edu
91847|NCT01731041|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD-Associate Professor of Medicine Director, Cardiovascular Research|+1-904-244-3005|dominick.angiolillo@jax.ufl.edu
91848|NCT01730378|GlaxoSmithKline|GSK Response Center|866-435-7343|
91849|NCT01730339|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1­800­718­1021|ClinicalTrials.gov_Inquiries@pfizer.com
91850|NCT01730053|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com
91851|NCT01730040|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com
91852|NCT01729871|Janssen Scientific Affairs, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com
91853|NCT01729728|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com
91854|NCT01729559|Scripps Mercy Hospital|Steven R. Shackford, MD|619-299-2600|shackford.steven@scrippshealth.org
91855|NCT01729338|Duke University Medical Center|Gwynn Long|919-668-0838|gwynn.long@duke.edu
91856|NCT01729247|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA|919-449-8873|Nancy.Herje@aerocrine.com
91857|NCT01729026|South Texas Veterans Health Care System; University of Texas Health Science Center at San Antonio|Dr. Stephen Stern|210-887-3754|stephen.stern@va.gov; sterns@uthscsa.edu
91858|NCT01728792|Takeda|Takeda Study Registration Call Center, Central Contact|+1-877-825-3327|medicalinformation@tpna.com
91859|NCT01728584|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91860|NCT01728376|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91861|NCT01728337|CBED|Dr Doris Hexsel|30262633|cbed@cbed.com.br
91862|NCT01728324|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91863|NCT01728246|Janssen Pharmaceutica|Medical Affairs Manager|+632-8247901|
91864|NCT01728116|GI Dynamics, Inc|Brian Callahan|781.357.3302|bcallahan@gidynamics.com
91865|NCT01728077|Cares|UCB|+1844599 ext 2273|
91866|NCT01727895|Radboud UMC|Drs. Jenneke Leentjens|0031-243668420|Jenneke.Leentjens@radboudumc.nl
91867|NCT01727791|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
91868|NCT01727713|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974|
91869|NCT01727700|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
91870|NCT01727505|University of Miami School of Medicine, Dept. of Pediatrics - Div. of Neonatology|Nelson Claure, MSc, PhD, Director Neonatal Pulmonary Research Lab|305 585 6408|nclaure@miami.edu
91871|NCT01727414|Cincinnati Children's Hospital|Tanya Froehlich|5136361154|tanya.froehlich@cchmc.org
91872|NCT01727258|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com
91873|NCT01727180|Far Eastern Memorial Hospital|Hon-Yen Wu, MD, PHD|+886-2-8966-7000 ext 1164|honyenwu@gmail.com
91874|NCT01727167|Duke University Medical Center|John J. Freiberger, M.D.|919-684-6726|john.freiberger@duke.edu
91875|NCT01727141|Novartis Pharmaceuticals|Study Director|862-778-8300|
91876|NCT01727024|Novartis Pharmaceuticals|Study Director|862-778-8300|
91877|NCT01726621|Medtronic MiniMed, Inc|Clinical Research Manager|8185765171|julie.sekella@medtronic.com
91878|NCT01726517|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
91879|NCT01726504|Guang An Men Hosptial of China Academy of Chinese Medical Sciences|Liu Zhishun|86 13651016313|liuzhishun@hotmail.com
91880|NCT01726335|Janssen-Cilag Ltd.|Medical Group Manager|+55 11 30302738|
91881|NCT01726049|University Hospital Groningen, NL|E.S. Hoendermis, MD, PHD|0031503616161|e.s.hoendermis@umcg.nl
96906|NCT00107042|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com
91882|NCT01726023|AstraZeneca|David Wilson, Statistical Team Leader - Infection|+44 1625 517830|David.Wilson2@astrazeneca.com
91883|NCT01725984|Ludwig Maximilian Universität|Dr. Ricarda Bauer|+49 89 7095|Ricarda.Bauer@med.uni-muenchen.de
91884|NCT01725529|Janssen R&D US|ASSOCIATE DIRECTOR, MEDICAL DEPARTMENT||ClinicalTrialDisclosure@its.jnj.com
91885|NCT01725451|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
91886|NCT01725386|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
91887|NCT01725308|Astellas Pharma Inc.|Head of Clinical Development Administration||Astellas.resultsdisclosure@astellas.com
91888|NCT01725282|Astellas Pharma Inc.|Vice President, Clinical Development Administration||clinicaltrials@us.astellas.com
91889|NCT01725217|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
91890|NCT01724528|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Clinical Research Director|+39 055 5680 ext 9933|acapriati@menarini-ricerche.it
91891|NCT01724359|Jan-Cil Mexico|GERENTE MEDICO REGIONAL|52 55 5237 3410|
91892|NCT01724216|Spectrum Health|Mark Charles DeLano, M.D., Principal Investigator|616-363-7339|delanom@msu.edu
91893|NCT01724177|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com
91894|NCT01724021|Hoffmann-La Roche|Medical Communications|800-821-8590|
91895|NCT01723904|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
91896|NCT01723722|Eastern Maine Medical Center|Dr Mark S Brown|207-973-8670|mbrown@emh.org
91897|NCT01723397|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu
91898|NCT01723254|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com
91899|NCT01723228|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
91900|NCT01722994|University of Mississippi Medical Center|Dr. Robert Brodell|601-815-8000|rbrodell@umc.edu
91901|NCT01722877|Midwest Cardiovascular Research Foundation|Dr Nicolas W Shammas|5633200263|shammas@mchsi.com
91902|NCT01722734|Harvard School of Public Health|Dr Günther Fink|6174327389|gfink@hsph.harvard.edu
91903|NCT01722552|Boston University School of Public Health|Dr Lora Sabin|617-414-1272 ext 617|lsabin@bu.edu
91905|NCT01722435|Centre for Interdisciplinary Addiction research of Hamburg University ZIS|Prof. Dr. Jens reimer|+4940741057900|reimer@uke.de
91906|NCT01722266|University at Buffalo|Nitesh D Kuhadiya,MD,MPH ;Co-Investigator;Assistant Professor of Medicine, Section of Endocrinology|716-626-7998|niteshku@buffalo.edu
91907|NCT01722162|Washington University School of Medicine|Manik A. Amin, M.D.|314-362-9115|manikamin@wustl.edu
91908|NCT01722097|Herlev Hospital, University of Copenhagen, Department of Anaesthesiology|Dr. Matias Vested Madsen|+45 38683868|matias.vested.madsen@regionh.dk
91909|NCT01722071|University of Michigan|Tiffany Love, PhD|734-219-3674|tiflove@umich.edu
91910|NCT01721967|Duke University Health System|Andrew Wang, MD|919-681-6197|a.wang@duke.edu
91911|NCT01721837|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
91912|NCT01721772|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
91915|NCT01721564|Royal Prince Alfred Hospital, Sydney, Australia|Prof David Celermajer|+61 2 9515 6519|david.celermajer@email.cs.nsw.gov.au
91916|NCT01721486|Beaumont Hsopital|Kaveh Aslani, MD|248-898-1907|kaveh.aslani@beaumont.org
91917|NCT01721330|Massachusetts General Hospital|Leah Feinberg|617-726-4651|lkfeinberg@mgh.harvard.edu
91918|NCT01721317|GlaxoSmithKline|GSK Response Center|866-435-7343|
91919|NCT01721226|George Washington University|Dr. Irene Kuo|202-994-0367|ikuo@gwu.edu
91920|NCT01721161|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
91921|NCT01721109|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
91922|NCT01721096|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com
91923|NCT01721070|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com
91925|NCT01720797|University of Florida|Calogero Dolce, DDS, PhD|352-273-5700|cdolce@dental.ufl.edu
91926|NCT01720602|University of Washington|Hannah Linden, MD|206-288-6989|hmlinden@u.washington.edu
91927|NCT01720316|McLean Hospital|Dr. Deborah L. Levy|617-855-2854|dlevy@mclean.harvard.edu
91928|NCT01720251|ANERGIS SA|Dr Gilles DELLA CORTE Clinical Development Director|+41 21 651 92 30|gilles.dellacorte@anergis.ch
91929|NCT01720043|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu
91930|NCT01719861|Stanford University Medical Center|Joel Neal, MD, PhD; Assistant Professor of Medicine|650-725-3081|jwneal@stanford.edu
91931|NCT01719757|Suyoun Yang|CR head|82-2-527-9219|suyoun.yang@mundipharma.co.kr
91932|NCT01719653|Gastroenterology Services, Ltd|David Gerard, MD|630 969 1167|davidpgerard@comcast.net
91933|NCT01719172|Covidien|Julie Totten|781-839-1729|Julie.Totten@Covidien.com
91934|NCT01719003|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127 ext +1|clintriage.rdg@boehringer-ingelheim.com
91935|NCT01718691|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1125|
91936|NCT01718535|Mount Sinai Services Inc.|Azar Azad|416-856-8545|aazad@mtsinai.on.ca
91937|NCT01718509|Shire Development LLC|Study Physician|+1 866 842 5335|
91938|NCT01718483|Shire Development LLC|Study Physician|+1 866 842 5335|
91939|NCT01718028|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D.|1-888-451-3937|alcon.medinfo@alcon.com
91940|NCT01717989|Amgen Inc.|Study Director|866-572-6436|
91941|NCT01717976|Durham VA HSR&D|Susan N. Hastings|919-286-0411 ext 4033|susan.hastings@va.gov
92003|NCT01712256|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com
91942|NCT01717872|Women and Children's Hospital of buffalo|Dr. Jerrold Lerman|716 878 7701|jerrold.lerman@gmail.com
91943|NCT01717768|TesoRx Pharma LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500 ext 104|karl@tesorx.com
91944|NCT01717638|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
91945|NCT01717456|University of North Carolina at Chapel Hill|William E. Whitehead, PhD, Professor of Medicine|(919) 843-6961|William_Whitehead@med.unc.edu
91946|NCT01717391|The University of Iowa|John M. Buatti, MD|319-356-2699|john-buatti@uiowa.edu
91947|NCT01717326|Merck Sharp & Dohme Corp.|Results Point of Contact* Name or Official Title Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91948|NCT01717313|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91949|NCT01717287|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91951|NCT01717040|Univeristy Hospitals Cleveland Medical Center|Carla Conroy, MPH|216-844-2871|carla.conroy@UHhospitals.org
91952|NCT01717014|Covidien|Julie Doyle|781-839-1729|Julie.Doyle@Covidien.com
91953|NCT01716754|Novartis Pharmaceuticals|Study Director|862-778-8300|
91954|NCT01716663|Biosense Webster|Ellen Harris, Project Manager, Clinical Operations|909-839-7376|eharris8@its.jnj.com
91955|NCT01716585|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
91956|NCT01716559|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
91957|NCT01716520|GlaxoSmithKline|GSK Response Center|866-435-7343|
91958|NCT01716468|VA Pittsburgh Healthcare System|Jocelyn Tan, MD|412-360-6178|Jocelyn.Tan@va.gov
91959|NCT01716455|Shire Development LLC|Study Physician|+1 866 842 5335|
91960|NCT01716234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91961|NCT01716221|University of Colorado|Dr. Olga Klepitskaya|303-724-8984|olga.klepitskaya@ucdenver.edu
91962|NCT01716169|Stanford School of Medicine|Dr. Alfred Lane|650 721 7166|atlane@stanford.edu
91963|NCT01716156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
91964|NCT01716052|UTHSCSA @CTRC|Dr. Kenneth Kist|210-450-5600|KIST@UTHSCSA.EDU
91965|NCT01716013|OptMed|Associate Director of Quality Assurance|(908) 720-2372|nyajnik@optmed.com
91966|NCT01715948|Capital Health|Dr. Manohar Bance|902-473-5975|m.bance@dal.ca
91967|NCT01715896|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com
91968|NCT01715857|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
91969|NCT01715831|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
91970|NCT01715415|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
91971|NCT01715298|Novartis Pharmaceuticals|Study Director|862-778-8300|
91972|NCT01715207|SamsungMC|Prof Duk-Kyung Kim|01099333413|dukkyung.kim@samsung.com
91973|NCT01715129|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
91974|NCT01715064|University of Guelph-Humber|Dr. Daniel Santa Mina|416-798-1331 ext 6065|daniel.santamina@guelphhumber.ca
91975|NCT01714635|Abbott Medical Optics|Kendra Hileman, Ph.D., Director, Clinical Research & Development|714-247-8613|kendra.hileman@amo.abbott.com
91976|NCT01714609|Yale University|Dr. Garcia-Tsao|(203) 737-6063|guadalupe.garcia-tsao@yale.edu
91977|NCT01714544|Promius Pharma|Director Clinical Operations|609-282-1404|jfraser@drreddys.com
91978|NCT01714505|University of Virginia|Boris Kovatchev, PhD|434-924-5592|boris@virginia.edu
91979|NCT01714492|The University of Tennessee|Richard Komistek, Ph. D.|8659744159|rkomiste@utk.edu
91980|NCT01714336|Mayo Clinic|Dr. Mark Pagnano|507-284-2511|pagnano.mark@mayo.edu
91981|NCT01714232|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com
91986|NCT01713660|AMO|Carrie Garufis|7145663728|carrie.garufis@amo.abbott.com
91987|NCT01713621|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 03 00|moehrlej@mmv.org
91988|NCT01713608|Medicines for Malaria Venture|Dr Fiona Macintyre|+41 22 799 4078|macintyref@mmv.org
91989|NCT01713530|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
91990|NCT01713400|H. Lee Moffitt Cancer Center and Research Institute|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org
91991|NCT01713348|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com
91992|NCT01713283|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
91993|NCT01713036|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
91994|NCT01712984|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
91995|NCT01712854|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu
91996|NCT01712776|Cleveland Clinic|Dr. Sharon E. Mace, Director of Research, ESI|(216) 445-4598|maces@ccf.org
91997|NCT01712711|Tehran University of Medical Sciences|Professor Raika Jamali|00982163120000 ext 411|jamalira@tums.ac.ir
91998|NCT01712685|National Cancer Institute|Dr. Adam Metwalli|301-435-6237|metwallia@mail.nih.gov
91999|NCT01712516|Novartis Pharmaceuticals|Study Director|862-778-8300|
92000|NCT01712399|MedImmune, LLC.|Marius Albulescu, MD|301-398-0000|clinicaltrialenquiries@medimmune.com
92001|NCT01712360|Merz North America, Inc.|Ashlee Duncan|984-222-6040|Ashlee.Duncan@merz.com
92002|NCT01712334|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
92004|NCT01712204|TWi Biotechnology, Inc.|Medical Director|+886-2-26573350 ext 368|Carl.Brown@twipharma.com
92005|NCT01712178|AbbVie|Global Medical Services|800-633-9110|
92006|NCT01712074|Pfizer|Pfizer|1-8007181021|ClinicalTrials.gov_Inquiries@pfizer.com
92007|NCT01712061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92008|NCT01712009|Amgen Inc.|Study Director|866-572-6436|
92009|NCT01711918|University of Iowa|Dr. Ron Schey|3193849756|ron-schey@uiowa.edu
92010|NCT01711866|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
92011|NCT01711853|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92012|NCT01711736|GlaxoSmithKline|GSK Response Center|866-435-7343|
92013|NCT01711645|Vanderbilt Medical Center|Kathryn M. Edwards, MD|615-322-3078|Kathryn.edwards@vanderbilt.edu
92014|NCT01711424|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
92015|NCT01711359|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92016|NCT01711216|Abbott|Senior Global Medical Director|+49 160 749 0615|Claire.Pexman-Fieth@abbott.com
92017|NCT01711177|Université de Montreal|Pierre Forcier|514-343-7468|pierre.forcier@umontreal.ca
92018|NCT01710839|Retina Consultants of Houston|Charles C Wykoff, PhD, MD|713-524-3434|ccwmd@houstonretina.com
92019|NCT01710800|Walter Reed National Military Medical Center|Dr. Fouad J. Moawad|(301) 400-1551|Fouad.Moawad@us.army.mil
92020|NCT01710787|Jean Brown Research|Adam D. Marberger, DDS|801-261-2000|
92021|NCT01710657|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
92022|NCT01710527|GlaxoSmithKline|GSK Response Center|866-435-7343|
92023|NCT01710514|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
92024|NCT01710501|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92025|NCT01710358|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92026|NCT01710345|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com
92027|NCT01710332|Mid Atlantic Retina|Allen C. Ho, MD|215-459-0477|mformoso@midatlanticretina.com
92029|NCT01710033|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92030|NCT01710020|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92031|NCT01709903|Novartis Pharmaceuticals|Study Director|862-778-8300|
92032|NCT01709864|Novartis Pharmaceuticals|Study Director|862-778-8300|
92033|NCT01709799|University of Florida|Dr. Dawn Bowers|(352) 392-3450|dawnbowers@phhp.ufl.edu
92034|NCT01709786|University of Cincinnati|Betty Tsuei, MD|513-558-5661|Betty.Tsuei@uc.edu
92036|NCT01709578|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
92037|NCT01709513|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com
92038|NCT01709500|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com
92039|NCT01709474|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
92040|NCT01709422|Prince of Songkhla University|Dr. Nisa Netinatsunton|6674451965 ext 9|nisasan@yahoo.com
92041|NCT01709383|Georgetown University|Elizabeth H. Lacey, PhD, Study Coordinator|202-877-1124 ext 202|ehl4@georgetown.edu
92042|NCT01709331|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92043|NCT01709305|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92044|NCT01709227|Stanford University|David Kwiatkowski|650-721-3290|david.kwiatkowski@stanford.edu
92045|NCT01709162|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
92046|NCT01709136|Children's Hospital of Pittsburgh|Dr. Rakesh Sindhi, MD|412-692-6110|rakesh.sindhi@chp.edu
92047|NCT01709084|Janssen R&D US|Director, R&D, Medical Departement||ClinicalTrialDisclosure@its.jnj.com
92048|NCT01708967|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr
92049|NCT01708954|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|
92050|NCT01708915|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92051|NCT01708902|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92053|NCT01708317|Washington University School of Medicine|Dr. Fahd A Ahmad|314-286-0298|ahmad_f@kids.wustl.edu
92054|NCT01708291|University of Rochester|Sandra Jee|585-273-4657|sandra_jee@urmc.rochester.edu
92055|NCT01708278|University of Michigan|Fernando Martinez|(734) 763-2540|fmartine@umich.edu
92056|NCT01708213|TauTona Group|Ann Thomas|650-331-2461|athomas@tautonagroup.com
92057|NCT01708187|Orthopedic Foot and Ankle Center|Gregory Berlet, MD|614-895-8747|ofacresearch@orthofootankle.com
92058|NCT01708174|Novartis Pharmaceuticals|Study Director|862-778-8300|
92059|NCT01708122|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center - Urology|Richard Reznichek|3102222724|RReznichek@dhs.lacounty.gov
92060|NCT01708057|AstraZeneca|Carin Jorup||aztrial_results_posting@astrazeneca.com
92061|NCT01707667|Shire Development LLC|Study Physician|+1 866 842 5335|
92062|NCT01707654|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com
92063|NCT01707290|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
92064|NCT01707238|Visioncare Research Ltd.|Graeme Young|01252 718719 ext 207|g.young@visioncare.co.uk
92065|NCT01707225|Virginia Commonwealth University|Rajiv Malhotra, DO|804-828-9071|rajiv.malhotra@vcuhealth.org
92066|NCT01707095|University of Colorado|Thomas Robinson|303-724-2728|thomas.robinson@ucdenver.edu
92068|NCT01706965|New York State Psychiatric Insititute|Marlene Carlson|646-774-8436|marlene.carlson@nyspi.columbia.edu
92069|NCT01706952|McGill University Health Centre|Marc A. Tewfik|+15147976673|marc.tewfik@mcgill.ca
92070|NCT01706926|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com
92071|NCT01706822|Covidien|Julie Doyle|781-839-1729|Julie.Doyle@Covidien.com
92072|NCT01706770|Foresight Regulatory Strategies, Inc.|William J. Gleason, O.D.|(978) 658-6888 ext 151|
92073|NCT01706666|Mayo Clinic Cancer Center|Craig B Reeder, MD|4803018335|Reeder.Craig@mayo.edu
92074|NCT01706588|The School of Dentistry, University of Birmingham|Prof. Thomas Dietrich|+44-121-46 65494|t.dietrich@bham.ac.uk
92075|NCT01706575|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
92076|NCT01706549|Tampere University Hospital|MD Satu Pokkinen|+3583311611|Satu.pokkinen@pshp.fi
92078|NCT01706250|GlaxoSmithKline|GSK Response Center|866-435-7343|
92079|NCT01706159|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
92080|NCT01706146|Northwestern University|Adin-Cristian Andrei, Ph.D.|312-694-0509|Adin-Cristian.Andrei@nm.org
92081|NCT01705717|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
92082|NCT01705652|The University of Texas Health Science Center at San Antonio Department of Radiation Oncology|Gregory P. Swanson, MD|210-450-1109|swansong@uthscsa.edu
92083|NCT01705574|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
92084|NCT01705496|Biomed valley discoveries|Dr. Michelle Zhang, Executive Director|7815339412|mzhang@biomed-valley.com
92085|NCT01705145|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
92086|NCT01704976|BUAS|Slavko Rogan (Study Chair)|+41 31 848 35 56|slavko.rogan@bfh.ch
92087|NCT01704846|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92088|NCT01704781|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com
92089|NCT01704755|AbbVie (prior sponsor, Abbott)|Global Medical Information|800 633-9110|
92090|NCT01704651|Mayo Clinic|Dr. Jamie N. Bakkum-Gamez|507-266-8661|Bakkum.Jamie@mayo.edu
92091|NCT01704599|Dept. Dermatology Wayne StateUniversity|Peter J. Aronson, MD|(313)_745-7845|paronson@med.wayne.edu
92092|NCT01704521|University of Cincinnati|Kenneth E. Sherman, MD. PhD|513-558-3918|kenneth.sherman@uc.edu
92093|NCT01704495|AstraZeneca|Medical Science Director Bengt Larsson||ClinicalTrialTransparency@astrazeneca.com
92094|NCT01704404|Theravance Biopharma US, Inc.|Glenn Crater, Head of Clinical Development & Medical Affairs|650-808-6000|GCrater@theravance.com
92096|NCT01704261|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92097|NCT01704196|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov
92098|NCT01704079|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com
92099|NCT01703988|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
92100|NCT01703858|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92101|NCT01703845|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92102|NCT01703832|Biologische Heilmittel Heel GmbH|Christine Frank, PhD|+49 7221 501 3188|christine.frank@heel.com
92103|NCT01703819|Biologische Heilmittel Heel GmbH|Christine Frank, PhD|+49 7221 501 3188|christine.frank@heel.com
92104|NCT01703741|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
92105|NCT01703702|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
92106|NCT01703663|University of Michigan|Devin L. Brown, MD, MS|734-936-9075|devinb@umich.edu
92107|NCT01703286|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92108|NCT01703260|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
92109|NCT01703221|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92110|NCT01703091|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92111|NCT01703000|Boston Scientific|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com
92112|NCT01702987|Beth Israel Deaconess Medical Center|Jim Wu|617-754-2390|jswu@bidmc.harvard.edu
92113|NCT01702961|Baylor College of Medicine|George Carrum, MD||GCarrum@houstonmethodist.org
92115|NCT01702532|GlaxoSmithKline|GSK Response Center|866-435-7343|
92116|NCT01702519|GlaxoSmithKline|GSK Response Center|866-435-7343|
92117|NCT01702454|GlaxoSmithKline|GSK Response Center|866-435-7343|
92118|NCT01702363|GlaxoSmithKline|GSK Response Center|866-435-7343|
92119|NCT01702311|Emory University|Guillermo Umpierrez, MD|404-778-1663|geumpie@emory.edu
92120|NCT01702298|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92121|NCT01702259|Surgeon's Inc.|Dr. Robert F. Jackson|765-662-8303|rjlipodr@comteck.com
92122|NCT01702246|UCSF Benioff Children's Hospital Oakland|Dr. Carolyn Hoppe|(510)428-3193|choppe@mail.cho.org
92123|NCT01702233|Biologische Heilmittel Heel|Dr Istvan Zatik|+497221501(0) ext 3192|istvan.zatik@heel.com
92124|NCT01702025|Department of Health and Exercise Science|Christopher Bell, Ph.D.|(970) 491-7522|christopher.bell@colostate.edu
92125|NCT01701999|California Department of Public Health|Dr. Jessica Khouri|510-231-7600|Jessica.Khouri@cdph.ca.gov
92126|NCT01701674|H. Lee Moffitt Cancer Center and Research Institute|Dr. Amod Sarnaik|813-745-8581|amod.sarnaik@moffitt.org
92127|NCT01701622|University of Mississippi Medical Center|Debbie Minor|601-984-6888|DMinor@umc.edu
92128|NCT01701505|Big Grins Pediatric Dentistry|Dr. Gregory D. Evans, DDS|970-407-1020|greg@biggrinswithdrgreg.com
92129|NCT01701414|Dept of Emergency Medicine, Rhode Island Hospital|Francesca Beaudoin MD, MS|401-444-2577|fbeaudoin@lifespan.org
92130|NCT01701401|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
92131|NCT01701375|Johns Hopkins University|Ivana Gojo, MD|410-502-7726|Igojo1@jhmi.edu
92132|NCT01701362|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92133|NCT01701271|Bio Basic Europe|Prof. Fulvio Marzatico|(39) 0382 - 506390|fulviomk@unipv.it
92134|NCT01701245|electroCore LLC|Annelie Andersson|+46 721 803076|annelie.andersson@electrocorellc.com
92135|NCT01701115|HSS|Dr. Daniel Maalouf|(212) 606-1000|MaaloufD@HSS.EDU
92136|NCT01701102|Hospital for Special Surgery|Jennifer Cheng|212-774-7377|chengj@hss.edu
92137|NCT01701063|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
92138|NCT01701037|Vanderbilt-Ingram Cancer Center|Mark C. Kelley|615-936-7423|mark.kelley@vanderbilt.edu
92139|NCT01701024|Exec Dir Clinical Dir|Johnson Varughese|908-927-1162|johnson.varughese@valeant.com
92140|NCT01701011|UMCU|Henrietta Ockhuijsen 1,*, Agnes van den Hoogen, Marinus Eijkemans , Nick Macklon, Jacky Boivin|+31307553628|h.d.l.ockhuysen@umcutrecht.nl
92141|NCT01700907|Sapporo Medical University School of Medicine|Michiaki Yamakage|+81116112111 ext 3568|yamakage@sapmed.ac.jp
92142|NCT01700816|Massachusetts General Hospital|Carlos Fernandez Robles MD|6176432410|cfernandez-robles@mgh.harvard.edu
92143|NCT01700530|University of Missouri|John P. Thyfault, PhD|573-874-9728|thyfaultj@missouri.edu
92144|NCT01700517|Madre Teresa´s Hospital|Dr Lucio Honorio de Carvalho Júnior|+55 31 33398000|luciohcj@gmail.com
92145|NCT01700387|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cady|417-883-7889|rcady@banyangroupinc.com
92146|NCT01700348|Philips Oral Healthcare, Inc|Marcia Delaurenti, Clinical Project Manager|425-908-1212|marcia.delaurenti@philips.com
92147|NCT01700335||Director of Clinical Trials|+81-3-5472-1127|kgoto.34@symbiopharma.com
92148|NCT01700192|Merck Sharp & Dohme Corp.|Senior Vice President, Global Corporate Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92149|NCT01700179|Achillion Pharmaceuticals|Kevin Kucharski, VP of Clinical Operations|203-624-7000|Kkucharski@achillion.com
92150|NCT01700140|SymBio Pharmaceuticals|Nobuyuki Koseki|+81-3-5472-1127|
92151|NCT01699867|Johns Hopkins Medicine|Lisa K. Jacobs, M.D.|410-502-0880|ljacob14@jhmi.edu
92152|NCT01699815|Duke University School of Nursing|Virginia C. Muckler|919-684-9307|chris.muckler@duke.edu
92153|NCT01699789|RAND Corporation|Kenneth B. Wells|310-794-3728|kwells@mednet.ucla.edu
92154|NCT01699763|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com
92155|NCT01699750|Alcon Research, Ltd.|Jessie Lemp, DrPH|1-888-451-3937|alcon.medinfo@alcon.com
92156|NCT01699698|Kyushu University|Dr. Taketo Matsunaga|092-642-5444|mtaketo@surg1.med.kyushu-u.ac.jp
92157|NCT01699685|Novartis Pharmaceuticals|Study Director|862-778-8300|
92158|NCT01699607|Yale|Dr. Kelly Cosgrove, Ph.D.|203-737-6969|kelly.cosgrove@yale.edu
92159|NCT01699373|Changi General Hospital|Dr Lim Yean Chin|+65 68503831|yean_chin_lim@cgh.com.sg
92160|NCT01699087|Alcon, A Novartis Division|Expert Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com
92161|NCT01699022|SPARC|Dr. Shravanti Bhowmik|02266455645 ext 5626|shravanti.bhowmik@sparcmail.com
92162|NCT01698814|Alcon Research, Ltd.|Terri Pasquine, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com
92163|NCT01698801|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com
92164|NCT01698775|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92165|NCT01698710|Massachusetts General Hospital|Dr. William Brugge|6173083532|Brugge.William@mgh.harvard.edu
92166|NCT01698684|Vivus, Inc.|Wesley W Day, PhD|650-934-5200|
92167|NCT01698554|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
92168|NCT01698528|Joslin Diabetes Center|Dr William Hsu|617-309-5803|william.hsu@joslin.harvard.edu
92169|NCT01698502|University of Copenhagen|Michael Lund|+45 3532 7519|michaeltl@sund.ku.dk
92170|NCT01698320|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com
92171|NCT01698268|Beaumont Health|Kaveh Aslani, MD|248-898-81905|kaslani@beaumont.org
92172|NCT01697969|Alcon Research, Ltd.|Danyel Crout Carr, MS, CCRA|1-888-451-3937|alcon.medinfo@alcon.com
92173|NCT01697956|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
92174|NCT01697696|Novartis Pharmaceuticals|Study Director|862-778-8300|
92175|NCT01697592|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92176|NCT01697501|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com
92177|NCT01697462|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
92178|NCT01697449|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
92179|NCT01697358|Medtronic Restorative Therapies Group - Pain Stim|Restorative Therapies Group Clinical Trials||medtronicneurotrials@medtronic.com
92180|NCT01697345|Creighton University|Dr. Melissa A Dahir|402-657-2847|melissadahir@creighton.edu
92181|NCT01697319|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com
92182|NCT01696994|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov
92183|NCT01696981|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov
92184|NCT01696968|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov
92186|NCT01696929|Georgia Regents University|Dr. Brian Miller|706-721-4445|brmiller@gru.edu
92187|NCT01696773|The Ohio State University|Steven J. Schwartz|614-292-2934|schwartz.177@osu.edu
92188|NCT01696760|The Ohio State University Comprehensive Cancer Center|Joel Mayerson, MD|614-293-4420|joel.mayerson@osumc.edu
92189|NCT01696695|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
92190|NCT01696643|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660|
92191|NCT01696357|University of Rochester Medical Center|Hyekyun Rhee|5852763775|hyekyun_rhee@urmc.rochester.edu
92192|NCT01696214|University of California San Diego|Dr. Joe Ramsdell|619-543-7241|jramsdell@ucsd.edu
92193|NCT01696188|Sidney Kimmel Medical College at Thomas Jefferson University|Dr. Eric Schwenk|215-955-6161|Eric.Schwenk@jefferson.edu
92195|NCT01696071|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92196|NCT01696058|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92197|NCT01696045|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com
92198|NCT01695772|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
92199|NCT01695746|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
92200|NCT01695668|University of Michigan|Dr Shahzad Mian|734-647-8397|smian@med.umich.edu
92201|NCT01695369|University of Houston, College of Optometry, TERTC|Jan Bergmanson, OD,PhD|713-743-1950|jbergmanson@uh.edu
92202|NCT01695330|Oncotherapeutics|Dr. James Berenson|310-420-9649|jberenson@berensonocology.com
92203|NCT01695304|Centers for Disease Control and Prevention|Ciara O'Reilly, PhD|404-639-1953|bwf1@cdc.gov
92205|NCT01695044|Progenics Pharmaceuticals, Inc.|Dr. Vincent A. DiPippo|(646) 975-2502|vdipippo@progenics.com
92206|NCT01694771|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92207|NCT01694706|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92208|NCT01694667|University of California, San Francisco|Stephen Bent|415-221-4810 ext 3457|Stephen.Bent@ucsf.edu
92209|NCT01694641|Kaali Inst. IVF Center|Dr Peter Kovacs|36-1-202-2802|peterkovacs1970@hotmail.com
92210|NCT01694420|Duke University Medical Center|Mehri McKeller, MD|919-668-0242|kara.mcgee@duke.edu
92211|NCT01694199|Regenesis Biomedical, Inc.|Dr. Rick Isenberg|877-970-4970|isenberg@regenesisbio.com
92212|NCT01694108|Rigshospitalet|Lone Graff Stensballe, Research leader, Pediatrician, PhD|+0045 35459727|lone.graff.stensballe@regionh.dk
92213|NCT01693900|Beaumont Health|Randy Fayne, DO|248-898-1905|rfyane@beaumont.org
92215|NCT01693484|LSU Health Science Center Shreveport|Dr Todd Jaeblon|318 675 6180 ext 419|tjaebl@lsuhsc.edu
92216|NCT01693367|AO Foundation|Clinical Operations Manager of Clinical Investigation and Documentation|0041 44 200 24 67|andreas.faeh@aofoundation.org
92217|NCT01693185|Konkuk University Medical Center|Dr. Tae-Yop Kim, Professor of Anesthesiology|82-2-2030-5445|taeyop@gmail.com
92218|NCT01693029|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|004980244760|biopharma.clinicaltrials@sandoz.com
92219|NCT01692951|Cleveland Clinic Foundation|Daniel Sessler, MD|216-444-4900|sessled@ccf.org
92220|NCT01692938|Stanley M. Truhlsen Eye Institute|Quan Nguyen, MD Director of the Stanley M. Truhlsen Eye Institute|402-559-4276|quan.nguyen@unmc.edu
92221|NCT01692782|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com
92223|NCT01692626|West Virginia University|Mohammed Almubarak, MD, Assistant Professor|304-293-4229|malmubarak@hsc.wvu.edu
92224|NCT01692340|The Ohio State University|Steven K. Clinton, MD PhD|614-293-2886|steven.clinton@osumc.edu
92225|NCT01692301|Novartis Pharmaceuticals|Study Directors|862-778-8300|trialandresults.registries@novartis.com
92226|NCT01691885|GlaxoSmithKline|GSK Response Center|866-435-7343|
92227|NCT01691794|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
92228|NCT01691781|Brigham and Women's Hospital|Anand Vaidya|6175258285|avaidya1@partners.org
92229|NCT01691690|Nationwide Children's Hospital|Dr. Arlyne Thung|(614) 722-4200|Arlyne.Thung@NationwideChildrens.org
92230|NCT01691612|Brigham & Women's Hospital|Elliot Israel, M.D.|617-732-8110|eisrael@partners.org
92231|NCT01691560|GlaxoSmithKline|GSK Response Center|866-435-7343|
92232|NCT01691534|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org
92233|NCT01691521|GlaxoSmithKline|GSK Response Center|866-435-7343|
92234|NCT01691508|GlaxoSmithKline|GSK Response Center|866-435-7343|
92235|NCT01691482|GlaxoSmithKline|GSK Response Center|866-435-7343|
92236|NCT01691339|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
92237|NCT01691326|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
92238|NCT01691313|Laguna Pharmaceuticals, Inc.|Howard C. Dittrich|858-405-1429|HDittrich@lagunarx.com
92239|NCT01691248|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92240|NCT01691092|Yale University - Psychiatry Department|Irina Esterlis, Ph.D.|(203)737-6820|irina.esterlis@yale.edu
92241|NCT01691014|Pfizer ClinicalTrials.gov Call Center, Pfizer, Inc.|Pfizer Inc.|001 800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92242|NCT01690923|ResMed Ltd|Xueling Zhu, Clinical Consultant|61288842265|xueling.zhu@resmed.com.au
92243|NCT01690663|the University of Pennsylvania|Jiabin Liu, MD, PhD|215-573-8208|jiabin.liu@uphs.upenn.edu
92244|NCT01690546|Duke University Medical Center|Paolo Mannelli, M.D|919-681-0613|paolo.mannelli@dm.duke.edu
92245|NCT01690299|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|clinicaltrialdisclosure@celgene.com
92246|NCT01690273|Universidade Sao Paulo|Andrea Lopes Gallinaro; Researcher|55112601 ext 8022|algallinaro@gmail.com
92247|NCT01690117|University of Leipzig, Medical Faculty, Clinic and Policlinic for Psychiatry and Psychotherapy|Prof. Dr. Hermann-Josef Gertz|0049 (0)341 97 24420|Hermann-Josef.Gertz@medizin.uni-leipzig.de
92248|NCT01690052|Indiana University School of Dentistry|Juan F. Yepes DDS, MD, MPH, MS, DrPH, Associate Professor|317-944-9601|jfyepes@iupui.edu
92249|NCT01690000|Aarhus University|Anne Kristine Amstrup|4578467681|anne_kristine_am@hotmail.com
92250|NCT01689857|Seoul National University Bundang Hospital|Dr. Chanyeong Heo|82317877222|lionheo@snu.ac.kr
92251|NCT01689779|Massachusetts General Hospital|Sadeq A. Quraishi, MD|617-726-3030|squraishi@mgh.harvard.edu
92252|NCT01689649|Janssen-Cilag Taiwan|Medical Director|886 2 23762155|
92253|NCT01689532|Janssen Pharmaceutical K.K.|Senior Manager||ClinicalTrialDisclosure@its.jnj.com
92254|NCT01689519|Hoffmann-La Roche|Medical Communications|800 821-8590|
92255|NCT01689441|Brigham and Women's Hospital|David Leaf, MD, MMSc|617-732-5500|deleaf@partners.org
92256|NCT01689363|Amphastar Pharmaceuticals, Inc.|Gisela Sharp|(909) 980-9484 ext 2016|GiselaS@amphastar.com
92257|NCT01689350|School of Pharmaceutical Sciences, Sun Yat-sen University|Lingyan CHEN, Master candidate|+8615018706960|chlingy@mail2.sysu.edu.cn
92258|NCT01689337|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
92259|NCT01689324|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
92260|NCT01689207|AstraZeneca|Paul Newell, Medical Science Director|+44 1625 515727|paul.newell@astrazeneca.com
92261|NCT01689155|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com
92263|NCT01688882|Novartis Pharmaceuticals|Study Director|862-778-8300|
92264|NCT01688830|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92265|NCT01688726|Alcon Research, Ltd.|Abayomi Ogundele, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com
92266|NCT01688635|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92267|NCT01688609|St. Luke's International Hospital|Dr. Teruo Yamauchi|+81-3-3541-5151|tryhi@luke.ac.jp
92268|NCT01688336|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
92269|NCT01688310|Catholic University of Mozambique Medical School|Dr. Peter Millard|2078663503|pmillard@mac.com
92271|NCT01688050|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com
92272|NCT01687790|University of Pittsburgh|Dr. Christiane Hakim|412-641-1965|chakim@magee.edu
92273|NCT01687478|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92274|NCT01687283|GlaxoSmithKline|GSK Response Center|866-435-7343|
92275|NCT01687270|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
92276|NCT01687257|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
92277|NCT01687244|FKD Therapies Oy|David Sawutz, PhD|416-607-9515|david.sawutz@fkdtherapies.com
92278|NCT01687218|Division of Infectious Diseases - UPMC|Ross D. Cranston, MD, FRCP|412-383-2054|rdc27@pitt.edu
92279|NCT01687114|Tufts University|Oliver Chen|617-5563128|oliver.chen@tufts.edu
92280|NCT01687101|Thomas Jefferson University, Jefferson Headache Center|Stephen D Silberstein, MD|215-955-2243|bruce.smith@jefferson.edu
92281|NCT01687088|Thomas Jefferson University|Michael J. Marmura, MD|215-955-2243|michael.marmura@jefferson.edu
92282|NCT01687036|Medical University Innsbruck, Department of Internal Medicine III, Cardiology|Markus Stühlinger, MD|+43 512 504 ext 81 320|markus.stuehlinger@uki.at
92283|NCT01686932|Novartis|Study Director|862-778-8300|
92285|NCT01686646|GlaxoSmithKline|GSK Response Center|866-435-7343|
92287|NCT01686568|Mayo Clinic|Dr. Ian R. Lanza|507-255-8147|lanza.ian@mayo.edu
92288|NCT01686503|Eastern Virginia Medical School|Dr. Stephanie Troy|757-446-8999|troysb@evms.edu
92289|NCT01686451|Department of Cardiology, the Second Affiliated Hospital, Wenzhou Medical University, Zhejiang province, Wenzhou, 325000, China|Dr. JiFei Tang|+8615968766021|jiftang@126.com
92290|NCT01685996|Johns Hopkins University School of Medicine|Dr. Annie Umbricht, M.D.|410-550-1917|annieumbricht@jhu.edu
92291|NCT01685983|Janssen R&D BE|Senior Director||ClinicalTrialDisclosure@its.jnj.com
92292|NCT01685801|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
92293|NCT01685684|Collegium Pharmaceutical|VP, Clinical Development|+1.781.713.3669|clinicaltrials@collegiumpharma.com
92294|NCT01685606|Brown University Oncology Research Group (BrUOG)|Dr. Peter Quesenberry|4018633000|kayla_rosati@brown.edu
92295|NCT01685567|Silk Road Medical, Inc.|Linda Ruedy. Sr. Director, Clinical and Regulatory Affairs|(408) 585-2113|lruedy@silkroadmed.com
92296|NCT01685437|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
92297|NCT01685320|Campus Bio-medico University|Prof. Massimiliano Carassiti|+39-06-225411952|m.carassiti@unicampus.it
92299|NCT01685216|Shire Development LLC|Study Physician|+1 866 842 5335|
92300|NCT01685203|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
92301|NCT01685060|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
92302|NCT01684930|Victoria University|Jason D. Allen, PhD|61 3 9919 4264|jason.allen@vu.edu.au
92303|NCT01684878|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
92304|NCT01684839|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com
92305|NCT01684826|Philips|Frank Everaerts|+31630728782|frank.everaerts@philips.com
92307|NCT01684566|Camurus AB|Håkan Olsson DDS, PhD|+46 46 2863852|Hakan.Olsson@camurus.com
92308|NCT01684436|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
92309|NCT01684423|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com
92310|NCT01684410|Grifols Therapeutics Inc.|Henry Li, PhD|919-316-6042|henry.li@grifols.com
92312|NCT01684046|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com
92313|NCT01684033|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com
92314|NCT01684007|Alcon Research, Ltd.|Magda Michna, Expert Clinical Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com
92315|NCT01683838|Acorda Therapeutics, Inc.|Chief Scientific Officer|914-347-4300 ext 5102|ablight@acorda.com
92316|NCT01683812|Boston Children's Hospital|Michele DeGrazia PhD, RN, NNP-BC, FAAN|617-919-1222|Michele.DeGrazia@childrens.harvard.edu
92317|NCT01683630|Unversity of Manotiba|Salah Mahmud|204-272-3139|salah.mahmud@umanitoba.ca
92318|NCT01683604|HoffmannLaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
92319|NCT01683526|Beth Israel Medical center|Michael Silverberg|2124202377|msilverberg2@chpnet.org
92320|NCT01683409|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92321|NCT01683383|Stanford University School of Medicine|Krisa P. Van Meurs, M.D.|+1 650 723 5711|vanmeurs@stanford.edu
92322|NCT01683266|Sanofi|Trial Transparency Team||Contact­-US@sanofi.com
92323|NCT01683058|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
92325|NCT01682954|Ohio State University|Dr. Carla Miller|614-292-1391|miller.4453@osu.edu
92326|NCT01682876|Novartis Vaccines and Diagnostics|Posting Director||registrycontactvaccinesus@novartis.com
92327|NCT01682863|Novartis Pharmaceuticals|Study Director|862-778-8300|
92328|NCT01682837|UT Southwestern Medical Center at Dallas|John Poindexter|2146486857|john.poindexter@utsouthwestern.edu
92329|NCT01682759|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92330|NCT01682720|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
92331|NCT01682681|Janssen Korea, Location: 25F, LS , Yongsan Tower, 191, Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|Clinical Research Associate, Medical affairs|82-2-2094-4837|
92332|NCT01682642|Fertility Center AZ Jan Palfijn|dr. Wim Decleer, PI|0032 9 325 92 20 ext 09/2248851|wim.decleer@janpalfijngent.be
92333|NCT01682603|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825 ext 2113|hck@tzuchi.com.tw
92334|NCT01682538|Swedish Orphan Biovitrum|Medical Director|+4686972000|erik.brouwer@sobi.com
92335|NCT01682460|CCLR|Research Manager|519-888-4742|cclr2@sciborg.uwaterloo.ca
92336|NCT01682135|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92338|NCT01682031|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
92339|NCT01681849|Emory University|Dr. J. Douglas Bremner|404-712-9569|doug.bremner@emory.edu
92340|NCT01681628|Thought field Therapy Foundation UK Ltd.|Dr R H Robson|+44 (0)1952550688|r.robson2@btinternet.com
92341|NCT01681576|Novartis|Study Director|862-778-8300|
92342|NCT01681511|ICET, Inc.|Dr. Shantha Sarangapani|781-769-6064|Shantha@icetinc.com
92343|NCT01681472|Isofol Medical|Anders Rabbe|+46 (0)707 64 65 00|anders.rabbe@isofolmedical.com
92344|NCT01681368|National Cancer Institute|Dr. Christina Annunziata|301-402-7189|annunzic@mail.nih.gov
92345|NCT01681277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92346|NCT01681212|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
92347|NCT01681121|Jazz Pharmaceuticals|Yuan Lu, MS|650 496 2855|yuan.lu@jazzpharma.com
92348|NCT01681095|William Beaumont Hospital|Marc P. Sakwa, M.D.|248/898-0123|marc.sakwa@beaumont.org
92349|NCT01681069|Analyze & Realize GmBH|Dr Christof Jänicke|+49 30 40 00 83 23|cj@a-r.com
92350|NCT01681004|SI-BONE, Inc.|Daniel Cher, Vice President of Clinical Affairs|408-207-0700|dcher@si-bone.com
92351|NCT01680991|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
92352|NCT01680900|University of Pennsylvania|Dr. Ellen Freeman|215-662-3329|freemane@mail.med.upenn.edu
92353|NCT01680861|Miami Transplant Institute|Jeffrey Gaynor, Ph.D. biostatistician||jgaynor@med.miami.edu
92354|NCT01680848|Dental PBRN Japan|Director of the Dental PBRN Japan|+81-93-285-3022|info@dentalpbrn.jp
92357|NCT01680549|Texas Tech University Health Sciences Center|Nancy Swinford|806-743-2569|nancy.swinford@ttuhsc.edu
92358|NCT01680497|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
92359|NCT01680458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92360|NCT01680341|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
92361|NCT01680328|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
92362|NCT01680172|Mayo Clinic|Robert Bright, MD|480-301-4853|bright.robert@mayo.edu
92363|NCT01680159|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
92364|NCT01680016|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
92365|NCT01679613|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92366|NCT01679600|Bern University of Applied Sciences|Dr. Oliver Stoller|+41344264195|oliver.stoller@bfh.ch
92367|NCT01679314|electroCore LLC|Annelie Andersson|+46 721 803076|annelie.andersson@electrocorellc.com
92368|NCT01679236|University of Wisconsin|James M. Davis MD, Assistant Professor, Duke University|608-217-9405|jjamesdavis@hotmail.com
92369|NCT01679197|University of Michigan|Dr. Elif Oral|7346157271|eliforal@med.umich.edu
92370|NCT01679028|Tasly Pharmaceuticals, Inc.|Dr. Henry SUN|240-744-6225|henrysunusa@gmail.com
92371|NCT01679002|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
92372|NCT01678976|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com
92373|NCT01678911|Rehabilitation Institute of Chicago|Director of the Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org
92374|NCT01678885|Pennington Biomedical Research Center|Corby Martin, Ph.D.|225-763-2585|corby.martin@pbrc.edu
92375|NCT01678846|London School of Hygiene and Tropical Medicine|Dr Karen Devries|0207958 8164 ext 8164|Karen.Devries@lshtm.ac.uk
92376|NCT01678820|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92377|NCT01678807|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92378|NCT01678313|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825 ext 2113|hck@tzuchi.com.tw
92379|NCT01678196|Minneapolis VA Healthcare Service Center|Christopher Erbes, PhD|612-725-2000 ext 2125|christopher.erbes@va.gov
92380|NCT01678131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92381|NCT01677988|Medical University of South Carolina|Paul O'Brien, MD|843-792-4271|obrienpe@musc.edu
92382|NCT01677936|Louisville Metabolic and Atherosclerosis Research Center|Kathy Schmitz RN|502.515.5672|kschmitz@lmarc.com
92383|NCT01677910|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com
92384|NCT01677858|Amgen Inc.|Study Director|866-572-6436|
92385|NCT01677767|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
92386|NCT01677624|Eisai Co., Ltd.|Shin Maeda|+81-3-3817-5252|
92387|NCT01677507|University of Michigan|Dr. Sayoko Moroi|734-763-3732|smoroi@med.umich.edu
92388|NCT01677299|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com
92389|NCT01677286|Boston Medical Center|John Berk, MD|617-638-4494|jberk@bu.edu
92390|NCT01677195|University of Texas Health Science Center at San Antonio / University of California, Davis* current|Dr. Bradley H. Pollock, PI|(530) 752-7250|pbollock@ucdavis.edu
92391|NCT01677182|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
92392|NCT01676961|NYU Clinical Cancer Center|Amitabha Mazumder, MD|(212) 731-5757|Amitabha.Mazumder@nyumc.org
92393|NCT01676896|UTexasAustin|Sharon Horner|512-471-7951|shorner@mail.nur.utexas.edu
92394|NCT01676714|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu
92395|NCT01676532|St.Michael's Hospital|Sloane Freeman|416-864-6060 ext 77042|freemansl@smh.ca
92396|NCT01676415|NORTHWESTERN UNIVERSITY|BRUCE TAN|3126958182|CPRICE2@NM.ORG
92397|NCT01676298|Spartan Bioscience Inc.|Dr. Chris Harder|613-228-7756 ext 778|chris.harder@spartanbio.com
92398|NCT01676220|Sanofi|Trial Transparency Team||Contact ­-US@sanofi.com
92399|NCT01676012|Radboudumc|Dr. Erik van der Heijden|0031243614579|Erik.vanderHeijden@radboudumc.nl
92400|NCT01675830|Boston Children's Hospital|Karen Sakakeeny|617-355-6369|Karen.Sakakeeny@childrens.harvard.edu
92401|NCT01675661|Medical University of South Carolina|Kevin Gray, MD|843-792-6330|graykm@musc.edu
92402|NCT01675544|Creighton University School of Medicine|Dr. Venkata M. Alla|(402) 280-4292|venkataalla@creighton.edu
92403|NCT01675531|Seoul ST.Mary's Hospital|Jin-Hyong Kang|82-2-2258-6043|jinkang@catholic.ac.kr
92404|NCT01675492|Abbott Medical Optics|Director, Clinical Operations|714-247-8628|lachelle.arredondo@abbott.com
92405|NCT01675453|Academician EN Meshalkin State Budget Research Institute of Circulation Pathology|Dr. Evgeny Fominskiy|+79139538754|evfominskiy@gmail.com
92406|NCT01675427|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
92407|NCT01675167|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
92408|NCT01675141|National Cancer Institute|Dr. Dickran Kazandijian|301-451-2677|kazandijiandg@nih.gov
92409|NCT01675128|National Cancer Institute|Dr.Tim Greten|301-451-4723|gretentf@mail.nih.gov
92410|NCT01675063|Emory University|James Blum|404-778-3482|jmblum@emory.edu
92411|NCT01675050|University of Michigan|Ismaeel Hashemi, M.D. Principal Investigator|6169165566|ismaeel.hashemi@gmail.com
92412|NCT01675011|Boston Scientific|Anastasia Becker - Director of Clinical Trials|763-494-2170|Ana.Becker@bsci.com
92413|NCT01674725|AbbVie|Global Medical Information|800-633-9110|
92414|NCT01674712|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com
92415|NCT01674647|Bayer HealthCare AG|Bayer HealthCare AG||clinical-trials-contact@bayerhealthcare.com
92416|NCT01674634|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
92417|NCT01674621|Radius Health Inc.|Program Director|(617) 551-4700|info@radiuspharm.com
92418|NCT01674062|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
92419|NCT01674010|Transition Therapeutics Ireland Limited|Aleksandra Pastrak,MD, PhD, VP of Clinical Development and Medical Officer|+1 416 263 1227|apastrak@transitiontherapeutics.com
92420|NCT01673984|Ipsen|Medical Director, Uro-Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
92481|NCT01668654|GlaxoSmithKline|GSK Response Center|866-435-7343|
92421|NCT01673919|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
92422|NCT01673867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
92423|NCT01673854|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
92424|NCT01673828|Department of Neurology, School of Medicine, University of California, Davis|Dr. Michael Rogawski|916-734-6285|rogawski@ucdavis.edu
92425|NCT01673802|University of Alabama at Bimringham|John V. Thomas, MD; Principal Investigator|205-996-4132|jvthomas@uabmc.edu
92426|NCT01673698|ReShape Medical|Director of Clinical Operations|94429-6680|lfong@reshapemedical.com
92427|NCT01673620|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92428|NCT01673594|Massachusetts General Hospital|Research Regulatory Coordinator|617-726-4651|apulli@mgh.harvard.edu
92429|NCT01673568|Hvidovre Hospital University of Copenhagen|Mette W. Christoffersen|38625826|mette.willaume@gmail.com
92430|NCT01673490|GlaxoSmithKline|GSK Response Center|866-435-7343|
92431|NCT01673425|VA National Center for Occupational Health & Infection Control|Lewis Radonovich|352-376-1611 ext 4988|Lewis.radonovich@va.gov
92432|NCT01673347|William Beaumont Hospital|Erin Baker, PhD|248-551-1816|erin.baker@beaumont.org
92433|NCT01673282|UCB Cares|UCB (Study Director)|+1 887 822 9493|
92434|NCT01673256|St. Jude Medical Inc.|Kyle Brunner|651.756.3482|kbrunner02@sjm.com
92435|NCT01673191|Retinal Consultants of Arizona|Dr. Pravin Dugel|602-222-2221|PDugel@gmail.com
92436|NCT01673178|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92437|NCT01673126|Coma Science Group, University of Liège|Aurore Thibaut and Pr Steven Laureys|003243662362|athibaut@ulg.ac.be
92438|NCT01673113|Massachusetts General Hospital|Dr. Lilit Garibyan|617-726-6168|lgaribyan@partners.org
92439|NCT01673009|Indiana University|Kent Robertson MD PhD|317-944-8784|krobert@iu.edu
92440|NCT01672996|GE Healthcare|Rubin Sheng, MD|609-514-6899|Rubin.Sheng@ge.com
92441|NCT01672983|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
92442|NCT01672970|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
92443|NCT01672957|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
92444|NCT01672827|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6820|paulsherwin@ge.com
92445|NCT01672788|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92446|NCT01672723|University of California, Los Angeles|Dr. Naomi Eisenberger|310-267-5196|neisenbe@ucla.edu
92447|NCT01672658|Rehabilitation Instititute of Chicago|Arun Jayaraman, PT, PhD|312-238-2091|a-jayaraman@northwestern.edu
92448|NCT01672294|VA HSRD Durham VA Medical Center|Karen Steinhauser, PhD|9196682148|karen.steinhauser@va.gov
92450|NCT01671748|Cardiff and Vale University Health Board|Dr Judith White|02920744771|judith.white3@wales.nhs.uk
92451|NCT01671605|Vanderbilt University Medical Center|Valentina Kon|6153224883|valentina.kon@vanderbilt.edu
92452|NCT01671488|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu
92453|NCT01671293|Universidad del Desarrollo|J. Carola Pérez Ewert|5623279875|janetperez@udd.cl
92454|NCT01671280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92455|NCT01671111|Shire|Study Physician|1866-842-5335|
92456|NCT01671059|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
92457|NCT01670825|Johns Hopkins Hospital|Steven Cohen|410-955-1818|scohen40@jhmi.edu
92458|NCT01670721|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
92459|NCT01670656|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92460|NCT01670526|Hines CSPCC|Tom Sindowski|708-202-5858|tom.sindowski@va.gov
92461|NCT01670487|Cleveland Clinic|Dr. Sharon Mace|216-445-4598|maces@ccf.org
92462|NCT01670279|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
92463|NCT01670201|Harborview Medical Center / Seattle, Washington|Dr Nicole Gibran|206-744-3140|nicoleg@uw.edu
92464|NCT01670045|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
92465|NCT01670019|Duke University|John Beyer, M.D.|919-668-0209|john.beyer@dm.duke.edu
92466|NCT01669902|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
92467|NCT01669863|Hannover Medical School|Dr Marius Hoeper|00495115323530|hoeper.marius@mh-hannover.de
92468|NCT01669811|Clinical Statistics & Programming Department, Clinical Science Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com
92469|NCT01669785|Salus Research, Inc.|Jeffery L. Milleman, DDS, MPA|260-755-1099|
92470|NCT01669720|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu
92471|NCT01669629|Vistakon|Kathy Osborn, OD, MS, FAAO, FBCLA Senior Principal Research Optometrist|904 443-1032|kosborn@its.jnj.com
92472|NCT01669603|University of Virginia|Ronald Turner||rbt2n@virginia.edu
92473|NCT01669577|University of São Paulo|Luiz Guilherme Villares da Costa, MD|5511985584737|lgvc76@yahoo.com.br
92474|NCT01669174|Novartis Pharmaceuticals|Study Director|862-778-8300|
92475|NCT01669148|Massachusetts General Hospital|Thomas J. Brady, MD|6177268294|tbrady@mgh.harvard.edu
92476|NCT01669122|GlaxoSmithKline|GSK Response Center|866-435-7343|
92477|NCT01668836|Heart Institute (InCor), University of São Paulo Medical School|Antonio de Padua Mansur - Associate Professor|55-11-26615387|apmansur@usp.br; apmansur@yahoo.com
92478|NCT01668797|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
92480|NCT01668667|XenoPort, Inc.|XenoPort Call Center|877-936-6778|
92482|NCT01668628|The Catholic University of Korea|Dr. Hye Eun Yoon|82-32-280-5886|berrynana@catholic.ac.kr
92483|NCT01668589|Amgen Inc.|Study Director|866-572-6436|
92484|NCT01668173|Memorial Sloan Kettering Cancer Center|Dr. Raajit Rampal|212-639-2194|RampalR@mskcc.org
92485|NCT01668030|University of Louisville School of Nursing|Dr. Carlee Lehna, Associate Professor|502-852-3913|carlee.lehna@louisville.edu
92486|NCT01668017|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
92487|NCT01668004|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92488|NCT01667978|Montefiore|Jessica Atrio|718 405 82 60|jatrio@montefiore.org
92489|NCT01667926|Massachusetts General Hospital|Dr. Cristina Cusin|6177263855|ccusin@mgh.harvard.edu
92490|NCT01667900|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92491|NCT01667848|LudwigBoltzmannIOL|Dr. Bettina Klugsberger|+43 732 7806 2133|Bettina.Klugsberger@akh.linz.at
92492|NCT01667796|Johns Hopkins|Ellen Mowry|4106141522|vitamindtrialms@jhmi.edu
92493|NCT01667731|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
92494|NCT01667679|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com
92495|NCT01667536|Progenics Pharmaceuticals, Inc.|Senior Director, Clinical Science Communications|914 784-1825|vdipippo@progenics.com
92496|NCT01667471|Hoffmann-LaRoche or Genentech, Inc|Medical Communications|800-821-8590|genentech@druginfo.com
92497|NCT01667432|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
92498|NCT01667224|Clinical Trial Center for Functional Food in Chonbuk National University Hospital|Dr. Soo-Wan Chae|82-63-250-2348|soowan@jbnu.ac.kr
92499|NCT01667107|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92500|NCT01666951|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com
92501|NCT01666912|UNC_ChapelHill|Amy G. Bryant, Assistant Professor|919-843-5633|amy_bryant@med.unc.edu
92502|NCT01666782|Rochester General Hospital|Saad Jamshed, MD|585-922-4020|Saad.Jamshed@rochesterregional.org
92503|NCT01666210|Ocular Therapeutix, Inc.|Eric Ankerud|781-357-4013|eankerud@ocutx.com
92504|NCT01666197|Novartis Consumer Health SA|Clinical Project Leader|41223635293|
92505|NCT01666119|BDSI|Enoch Bortey|919 582 9050|ebortey@bdsi.com
92506|NCT01666002|Stanford University|Jean Tang MD PhD, assistant professor|650-723-6316|tangy@stanford.edu
92507|NCT01665950|Massachusetts General Hospital, Center for Quantitative Health|Dr. Roy Perlis|617-643-6310|rperlis@partners.org
92508|NCT01665911|Indiana University School of Dentistry|Frank Lippert|317-274-8822|flippert@iu.edu
92509|NCT01665807|Mount Sinai Hospital, IDERU|Brenda L. Coleman, PhD,|416-586-4800 ext 4538|bcoleman@mtsinai.on.ca
92511|NCT01665508|Massachusetts General Hospital|Nandita S. Scott|6177241739|nsscott@partners.org
92512|NCT01665170|PASCOE pharmazeutische Präparate GmbH|Dr. Gabriele Weiß|0641-7960|klinischeforschung@pascoe.de
92513|NCT01665157|National Taiwan University Hospital|Han-Mo Chiu, M.D., Ph.D.||hanmochiu@ntu.edu.tw
92514|NCT01665053|Boston Scientific|Patricia O'Mara, Clinical Trial Manager|518-792-5673|patricia.o'mara@bsci.com
92515|NCT01664975|Zhengzhou University|Mingzhi Zhang|0371-66295564|mingzhi_zhang@126.com
92516|NCT01664949|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
92518|NCT01664806|University of Colorado School of Medicine|Dr. Thomas Robinson|303-724-2728|thomas.robinson@Ucdenver.edu
92519|NCT01664793|University of Pittsburgh|Richard K. Zimmerman|412-383-2355|zimmer@pitt.edu
92520|NCT01664624|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
92521|NCT01664559|BWH|Dr. Lynn Ngo, Lead Study Coordinator/investigator|(617)732-8798|llngo@partners.org
92522|NCT01664533|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
92523|NCT01664494|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com
92524|NCT01664247|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
92525|NCT01664117|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
92526|NCT01664104|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
92527|NCT01664052|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
92528|NCT01664039|Alcon Research, Ltd|Global Brand Lead, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com
92529|NCT01663987|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92530|NCT01663922|St Stephens AIDS Trust|Dr Akil Jackson|0203 315 6503|akil.jackson@chelwest.nhs.uk
92531|NCT01663779|Yale School of Medicine|Kevin M. Schuster|203-785-2572|kevin.schuster@yale.edu
92532|NCT01663727|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com
92533|NCT01663714|GlaxoSmithKline|GSK Response Center|866-435-7343|
92534|NCT01663532|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
92535|NCT01663506|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
92536|NCT01663363|Abbott Medical Optics|Ann Murphy, Manager, Clinical Research|619-518-4158|Ann.Murphy@abbott.org
92537|NCT01663285|University of Michigan Comprehensive Cancer Center|Dr. Ajjai Alva|734-647-8921|ajjai@umich.edu
92538|NCT01663233|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|
92539|NCT01663103|University of Colorado Anschutz Medical Campus|Dr. Kristen Nowak|303-724-4842|Kristen.Nowak@ucdenver.edu
92540|NCT01663012|Stanford University School of Medicine650-|Lawrence Recht, MD, Professor of Neurology|650-725-8630|lrecht@stanford.edu
92541|NCT01662999|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
92542|NCT01662986|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92543|NCT01662908|Daiichi Sankyo, Inc.|Senior Director, CVM TA Development|732-590-5000|
92544|NCT01662882|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
92545|NCT01662856|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com
92546|NCT01662791|Mayo Clinic|Dr. John K. DiBaise|480-301-6990|DiBaise.John@mayo.edu
92547|NCT01662765|Bahcesehir University, School of Medicine|Dr. Mehmet Kaplan|+905056268899|dr.kaplan27@gmail.com
92548|NCT01662648|Janssen China|Regional Medical Franchis Director AP|+86 10 582 187 66|
92549|NCT01662635|Thoracic Oncology Unit. Instituto Nacional de Cancerología|Oscar Gerardo Arrieta-Rodríguez|+52 55 56280400 ext 832|ogar@unam.mx
92550|NCT01662583|Columbia University|Melissa Stockwell, MD MPH|212-342-5372|mss2112@columbia.edu
92551|NCT01662531|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
92552|NCT01662492|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
92554|NCT01662362|Abbott|Barbara Kaesdorf, Associate Director Clinical Affairs|847-937-8702|barbara.kaesdorf@abbott.com
92555|NCT01662310|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director Clinical Leader||ClinicalTrialDisclosure@its.jnj.com
92556|NCT01662115|Cleveland Clinic Florida|Chief Academic Office|9546595278|weisse@ccf.org
92557|NCT01662102|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com
92558|NCT01662063|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
92559|NCT01662024|Brigham and Women's Hospital|Christopher C. Thompson, MD, MSc|617-525-8266|ccthompson@bwh.harvard.edu
92561|NCT01661933|The Prince Charles Hospital|Dr John Croese. The Chief Investigator|+61733716164|jcroese@bigpond.com
92562|NCT01661881|Dana-Farber Cancer Institute|Philippe Armand MD, PhD|617.632.2305|Philippe_Armand@dfci.harvard.edu
92563|NCT01661790|China PLA General Hospital|Dr. Nan Du|86-13911599657|dunan05@aliyun.com
92564|NCT01661621|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825 ext 2113|hck@tzuchi.com.tw
92565|NCT01661270|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
92566|NCT01661205|AtriCure, Inc.|Vice President, Clinical Operations|513-755-4562|SZink@AtriCure.com
92567|NCT01661179|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
92568|NCT01661140|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
92569|NCT01661114|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu
92570|NCT01661062|University of Michigan Comprehensive Cancer Center|Avraham Eisbruch, M.D.|734-936-4302|eisbruch@umich.edu
92571|NCT01660906|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
92572|NCT01660893|University of Maryland|Dr. Sharon M. Gordon|410-706-1656|sgordon@dental.umaryland.edu
92573|NCT01660815|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
92574|NCT01660802|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
92575|NCT01660763|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com
92576|NCT01660737|PASCOE Pharamzeutische Präparate GmbH|Jennifer Lebert|0049+(0)641-7960-955|Jennifer.lebert@pascoe.de
92577|NCT01660698|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, Principal Investigator|+41217858054|maurice.beaumont@rdls.nestle.com
92578|NCT01660672|University of Rochester Medical Center|Gretchen Birbeck|585-273-4265|Gretchen_Birbeck@URMC.Rochester.edu
92579|NCT01660334|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92580|NCT01660321|ParaPro|Director, Quality and Regulatory|317-810-6205|kerrym@parapro.com
92581|NCT01660230|ZZ Biotech, LLC|Kent Pryor, PhD, MBA, Chief Operating Officer||kpryor@zzbiotech.com
92582|NCT01660191|University of Kansas Medical Center|Julie-Ann Dutton|913-588-4064|JDUTTON@kumc.edu
92583|NCT01659021|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
92584|NCT01658943|SWOG Statistical Center|SWOG Statistician|206-667-4408|
92585|NCT01658904|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@dc10a.nci.nih.gov
92586|NCT01660022|Medicines for Malaria Venture|Fiona Macintyre|0041 22 555 0319|macintyref@mmv.org
92587|NCT01659996|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
92588|NCT01659853|Galerma Laboratories|Dr. Warren Winkelman|817-961-5494|warren.winkelman@galderma.com
92589|NCT01659736|The Institute of Living|Gretchen J. Diefenbach, Ph.D|860-545-7685|Gretchen.Diefenbach@hhchealth.org
92590|NCT01659567|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
92591|NCT01659554|Columbia University Medical Center|Reena M. Vattakalam, CCRP|212-342-6895|rmv2110@cumc.columbia.edu
92592|NCT01659320|Weill Cornell Medical College|Dr. George Alexopoulos, M.D.|914-997-5767|galexopoulos@med.cornell.edu
92593|NCT01659268|College of Nursing at Ribeirão Preto, University of Sao Paulo|Cesar Eduardo Pedersoli|55(16)3602-3421|cesinhajardel@ig.com.br
92594|NCT01659125|Institute of Living|Gretchen J. Diefenbach|860-545-7685|gretchen.diefenbach@hhchealth.org
92595|NCT01658839|Alcon Research, Ltd.|Theresa Landry, Project Head, Clinical Trial Management|1-888-451-3937|alcon.medinfo@alcon.com
92597|NCT01658735|University of Utah School of Medicine|Matthew A Hughes, MD, MPH|8015814800|matthew.hughes@hsc.utah.edu
92598|NCT01658657|UNC Chapel Hil|Anthony Viera|919-966-0758|viera@med.unc.edu
92599|NCT01658579|Sanofi|Trial Transparency Team||Contact­-US@sanofi.com
92600|NCT01658514|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com
92601|NCT01658436|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|trialandresults.registries@novartis.com
92602|NCT01658072|Hospital for Special Surgery|Kethy Jules-Elysee, MD|2126061206|juleselyseek@hss.edu
92603|NCT01658020|Asan Midical Center|Principal Investigator|+82-2-3010-3136|ymoh55@amc.seoul.kr
92604|NCT01657903|GlaxoSmithKline|GSK Response Center|866-435-7343|
92605|NCT01657877|GlaxoSmithKline|GSK Response Center|866-435-7343|
92606|NCT01657461|Medtronic|Manish Gupta, Sr. Director of Medical Affairs|949 297 5494|manish.s.gupta@medtronic.com
92607|NCT01657370|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
92608|NCT01657292|Birken AG|Head of pharmaceutical development|+49 7233 97490|t.zahn@birken.eu
92609|NCT01657032|The Medical University of Warsaw|Hanna Szajewska, Malgorzata Pieścik-Lech|+48-22-45-23-309|hania@ipgate.pl
92610|NCT01657019|Shire Development LLC|Study Physician|+1 866 842 5335|
92611|NCT01656967|The University of Texas Health Science Center at Houston|Dr. Carin A. Hagberg|(713) 500-6240|Carin.A.Hagberg@uth.tmc.edu
92612|NCT01656889|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com
92613|NCT01656850|Taipei Medical University|Liu, Jen-Fang|+886-3-2118999 ext 5487|liujenfa@mail.cgust.edu.tw
92614|NCT01656772|Stereotaxis, Inc.|Qun Sha M.D. (Study Director)|314-678-6143|qun.sha@stereotaxis.com
92615|NCT01656759|Rush University|Sean Kearns|708-236-2664|sean_m_kearns@rush.edu
92616|NCT01656486|Carolinas Medical Center|David Iannitti, MD|704-446-2772|david.iannitti@carolinashealthcare.org
92618|NCT01656434|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92619|NCT01656408|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92620|NCT01656304|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org
92621|NCT01656252|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|jmanola@jimmy.harvard.edu
92622|NCT01656161|Debiopharm International|Eija Lundstrom, Medical Director|+41 21 321 06 03|eija.lundstrom@debiopharm.com
92623|NCT01656031|Comprehensive Cancer Center of Wake Forest University|Dr. Bayard Powell|336-716-7970|bpowell@wakehealth.edu
92624|NCT01655498|Pelvalon|Director of Clinical|650-276-0130|
92625|NCT01655381|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
92626|NCT01655329|Georgetown University Medical Center|Matthew T. Freedman|4105429680|MTFreedman@verizon.net
92627|NCT01655043|Northwestern University|Dr. James Carr|(312)926-2270|jcarr@northwestern.edu
92628|NCT01654887|Icahn School of Medicine at Mount Sinai|Dr. James Tsung|212-241-6272|james.tsung@mountsinai.org
92629|NCT01654861|Eastern Regional Medical Center|Eiko Klimant, MD|215-537-7400|eiko.klimant@ctca-hope.com
92630|NCT01654796|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-2513|MFAVA@mgh.harvard.edu
92631|NCT01654666|XuanWu Hospital, Capital Medical University|Xunming Ji, M.D.,Ph.D|8683198127|jixunming@vip.163.com
92632|NCT01654601|The Catholic university of Korea|Won-myung Bahk. M.D. PhD.|82-2-3779-1051|wmbahk@catholic.ac.kr
92633|NCT01654549|Tehran University of Medical Sciences|Dr Raika Jamali|982163120000 ext 411|jamalira@tums.ac.ir
92634|NCT01654536|Sunovion|Respiratory Medical Director|1-866-503-6351|
92635|NCT01654523|University of Michigan|Joseph Himle - Professor|7343303258|himlej@umich.edu
92636|NCT01654302|Northwestern University|Julia Marks, CRC|312-503-1215|julia.marks@northwestern.edu
92637|NCT01654276|University of Texas Southwestern Medical Center|Naim Maalouf. MD|214-648-2954|naim.maalouf@utsouthwestern.edu
92638|NCT01654263|Group Health Research Institute|Lisa A. Jackson, MD, MPH|206-442-5216|Jackson.L@ghc.org
92639|NCT01654250|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92640|NCT01654224|University of Pittsburgh|David Nace, MD, MPH|412 692-2366|naceda@upmc.edu
92641|NCT01654107|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|7322354341|marc.steinberg@rutgers.edu
92642|NCT01653964|Mayo Clinic|Dr. Carrie Hruska|5072663991|hruska.carrie@mayo.edu
92643|NCT01653782|Karolinska Institute|Dr. Irene Jensen|+46852483218|irene.jensen@ki.se
92644|NCT01653743|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
92645|NCT01653509|GlaxoSmithKline|GSK Response Center|866-435-7343|
92646|NCT01653418|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu
92647|NCT01653262|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
92648|NCT01653158|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92649|NCT01653132|Beth Israel Deaconess Medical center|Dr. Pushpa Narayanaswami|617-667-8130|pnarayan@bidmc.harvard.edu
92651|NCT01652885|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92652|NCT01652729|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com
92653|NCT01652716|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com
92654|NCT01652703|Amgen Inc.|Study Director|866-572-6436|
92655|NCT01652690|Amgen Inc.|Study Director|866-572-6436|
92656|NCT01652664|Alcon Research, Ltd.|Subha Venkataraman, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com
92657|NCT01652573|Yale School of Medicine|Dr. Karl Insogna|203-737-2871|karl.insogna@yale.edu
92658|NCT01652495|Istituto Ortopedico Rizzoli|Milva Battaglia, Director of Clinical Trials|0516366026 ext 0039|milva.battaglia@ior.it
92659|NCT01652287|Georgetown University Medical Center, Department of Family Medicine|Director of Research Programs|202-687-1600|FamilyMedResearch@georgetown.edu
92660|NCT01652001|University of Granada|Dr. Gómez-Moreno|+34000000000|ggomez@ugr.es
92661|NCT01651949|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92662|NCT01651936|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinialTrialsDisclosure@merck.com
92663|NCT01651780|The Medicines Company|Global Health Science Center|800-388-1183|
92665|NCT01651260|Hollister Incorporated|Malford Cullum|847-918-3975|malford.cullum@Hollister.com
92666|NCT01651208|University of Miami|Ana M. Palacio|3052439754|apalacio2@med.miami.edu
92667|NCT01651104|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
92668|NCT01651000|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com
92669|NCT01650831|Exalenz.Bioscience Ltd.|Avraham Hershkowitz, Clinical Trials Manager|+972-8-9737513|avrahamh@exalenz.com
92670|NCT01650805|ARIAD Pharmaceuticals, Inc.|Maureen Conlan, Senior Medical Director|1-617-621-2316|Maureen.Conlan@ariad.com
92671|NCT01650779|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
92672|NCT01650519|Cumberland Pharmaceutical Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com
92674|NCT01650324|Taipei Medical University - Wanfang Hospital|Dr. Yi-Jen Chen|886-2-2930-7930 ext 2543|yjchen@tmu.edu.tw
92675|NCT01650285|BrUOG|Dr. Anthony Mega|4018633000|kayla_rosati@brown.edu
92676|NCT01650246|Ardea Biosciences, Inc.|Maple Fung, MD|1-858-652-6721|mfung@ardeabio.com
92678|NCT01649804|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
92679|NCT01649791|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
92680|NCT01649557|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
92681|NCT01649505|Oregon Health and Science University|Dr. Juliana Hansen|503-494-4834|hansenju@ohsu.edu
92682|NCT01649362|Centre Hospitalier de Luxembourg|Dr Manon Bache|+352 4411 3157|manon.bache@hotmail.com
92683|NCT01649297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92684|NCT01649232|Spanish Neurometrics Foundation|Dr. Moises Aguilar-Domingo, Chairman of Spanish Neurometrics Foundation|+34 634548720|moises.aguilar@gmail.com
92685|NCT01649180|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|jmanola@jimmy.harvard.edu
92686|NCT01648920|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA. Director, Clinical Development and Medical Affairs|919-449-8873|nancy.herje@aerocrine.com
92687|NCT01648790|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92688|NCT01648699|Janssen Philippines|Medical Affairs Manager|+632-8248935|
92689|NCT01648582|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92690|NCT01648530|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
92691|NCT01648491|Beaumont Hospital - Royal Oak|Kenneth Peters MD|248-551-0387|Kenneth.Peters@Beaumont.org
92692|NCT01648452|National Eye Institute|Paul A Sieving, MD, PhD|301-496-2234|ps261o@nih.gov
92693|NCT01648140|GlaxoSmithKline|GSK Response Center|866-435-7343|
92694|NCT01648101|GlaxoSmithKline|GSK Response Center|866-435-7343|
92695|NCT01647945|Stanford University|Dr. Edda Spiekerkoetter|650-724-1493|eddas@stanford.edu
92696|NCT01647737|Georgia Regents University|Dr. Scot DeRossi, Chairman of the ORal Medicine & Diagnostic Sciences Department|706-721-2607|Sderossi@gru.edu
92697|NCT01647711|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92698|NCT01647542|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
92699|NCT01647464|OHSU|Jonathan Lindner|5034948750|lindnerj@ohsu.edu
92700|NCT01647438|Northwestern University|Dr. Namratha Kandula, Principal Investigator|312-503-6470|nkandula@nm.org
92701|NCT01647217|Tissuetech Inc|Hosam El Sheha, MD, PhD|305-274-1299|hsheha@tissuetechinc.com
92702|NCT01646827|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974|
92703|NCT01646814|PLxPharma|Regulatory Affairs Director|17138421249|regaffairs@plxpharma.com
92705|NCT01646671|Novartis Pharmaceuticals|Study Director|+1-862-778-8300|
92706|NCT01646398|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92707|NCT01646385|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92708|NCT01646320|AstraZeneca Pharmaceuticals|Eva Johnsson, Clinical Science Lead|+46 31 7762484 ext 762 484|Eva.Johnsson@astrazeneca.com
92709|NCT01646268|UCB Clinical Trial Call Center|Study Director|+1 844-599-2279|
92710|NCT01646255|UCB|Study Director|+1877 822 ext 9493|
92712|NCT01646151|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
92713|NCT01646138|National Institute of Allergy and Infectious Diseases|Matthew J. Memoli|+1 301 443 5971|memolim@niaid.nih.gov
92714|NCT01646125|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
92715|NCT01646073|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
92716|NCT01646021|Janssen Research & Development, LLC|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com
92717|NCT01645735|Cerexa, Inc|Medical Monitor|(510) 285-9200|
92718|NCT01645709|CaloSyn Pharma Inc.|Stephen Snowdy, PhD|404-863-8892|ssnowdy@ansleyvc.com
92719|NCT01645280|Janssen Pharmaceuticals|Senior Director Clin Development||ClinicalTrialDisclosure@its.jnj.com
92720|NCT01645176|Stanford University School of Medicine|Mark C. Genovese|650-498-4528|genovese@stanford.edu
92721|NCT01645111|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org
92722|NCT01645098|Nationwide Children's Hospital|Marco Corridore, MD|614-722-4200|Marco.Corridore@nationwidechildrens.org
92723|NCT01645059|Hospital San Pedro Alcántara|Dr. Santiago González Santiago||santidatvs@hotmail.com
92724|NCT01644734|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92725|NCT01644695|Institute For Advanced Reconstruction|Dr. Andrew Elkwood, MD|732-741-0970|aelkwood@hotmail.com
92726|NCT01644643|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com
92727|NCT01644617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92729|NCT01644474|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
92730|NCT01644396|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
92731|NCT01644331|Duke Clinical Research Institute|G. Michael Felker, MD|919-668-8919|Michael.Felker@duke.edu
92732|NCT01644292|University of Manitoba|Ed Giesbrecht|204-977-5630|Ed.Giesbrecht@med.umanitoba.ca
92733|NCT01644240|Theravance Biopharma US, Inc.|Dr. Brett Haumann, SVP, Clinical Development|650-808-6000|BHaumann@theravance.com
92734|NCT01644188|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
92735|NCT01644175|Sanofi|Trial Transparency Team||Contact -US@sanofi.com
92736|NCT01644058|Université de Montréal|Elham Emami, DDS, MSc, PhD|514-343-6111 ext 6053|elham.emami@umontreal.ca
92737|NCT01643928|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92738|NCT01643902|Johns Hopkins University School of Medicine|Victor C. Urrutia|410-955-2228|vurruti1@jhmi.edu
92739|NCT01643876|Université de Montréal|Dr. Elham Emami|5143436111 ext 6053|elham.emami@umontreal.ca
92740|NCT01643798|Medical University of South Carolina|Joseph Taylor|8437295729|taylorjj@musc.edu
92741|NCT01643668|Massachusetts General Hospital|Yi-Bin Chen, MD|617-726-0187|YCHEN6@PARTNERS.ORG
92742|NCT01643616|HELIOS-Kliniken Schwerin, Germany|Dr. Ronald Seidel|0049 385 5204251|ronald.seidel@helios-kliniken.de
92743|NCT01643525|Johns Hopkins University|Dr. Paul Nyquist||pnyquis1@jhmi.edu
92744|NCT01643213|Boston Scientific|Clinical Research Information|855-213-9890|BSNClinicalTrials@bsci.com
92745|NCT01643044|Wayne State University|Steven Ondersma, PhD|313-444-9797|sondersm@med.wayne.edu
92746|NCT01642914|Forest Research Institute|Steven Shiff, Executive Director, Clinical Development|201-427-8000 ext 8077|Steven.Shiff@actavis.com
92747|NCT01642732|University of Michigan Hospital|Dr. Daniel Hamstra, Associate Professor of Radiation Oncology|734-936-4300|dhamm@umich.edu
92748|NCT01642615|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
92749|NCT01642602|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
92750|NCT01642589|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
92751|NCT01642485|Richmond Pharmacology Ltd|Dr Jorg Taubel|+44(0)2086645200|j.taubel@richmondpharmacology.com
92752|NCT01642407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
92753|NCT01642277|Loyola University Chicago, Microbiology and Immunology|Dr. Alan J. Wolfe|224-392-4002|awolfe@luc.edu
92754|NCT01642238|Icahn School of Medicine at Mount Sinai|Dr. Juan J. Badimon|(212) 241-8484|Juan.Badimon@mssm.edu
92755|NCT01642212|Shire Development LLC|Study Physician|+1 866 842 5335|
92756|NCT01642147|Huashan Hospital Fudan University|Xiao-Yu Yang|086-021-52889999 ext 7693|xiaoyuyangfudan@gmail.com
92757|NCT01642082|NRG Oncology|Linda Gedeon, BA, CCRP Clinical Research Coordinator|716-845-1169|lgedeon@gogstats.org
92758|NCT01642004|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
92759|NCT01641991|Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center|David Bernstein, MD, MA|513-636-7625|david.bernstein@cchmc.org
92760|NCT01641978|Hospital Universitario de Getafe|Susana Arias Rivera|+34916839360 ext 2459|susana.arias@salud.madrid.org
92761|NCT01641952|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
92762|NCT01641939|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
92763|NCT01641926|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92764|NCT01641900|Massachusetts General Hospital|Dara S. Manoach, Principal Investigator|617-724-6148|dara.manoach@mgh.harvard.edu
92765|NCT01641861|Khon Kaen University|Dr. Kemporn Kitsahawong|66-910-566-996|kkempo@kku.ac.th
92766|NCT01641835|Heidelberg Engineering GmbH|Gerhard Zinser, PhD|+4962216463 ext 0|Contact@HeidelbergEngineering.com
92767|NCT01641822|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
92768|NCT01641692|GlaxoSmithKline|GSK Response Center|866-435-7343|
92769|NCT01641653|Rutgers-New Jersey Medical School|Vasanti Tilak, MD|973 972-7477|tilakva@njms.rutgers.edu
92770|NCT01641640|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
92772|NCT01641237|GlaxoSmithKline|GSK Response Center|866-435-7343|
92773|NCT01641159|University of Cincinnati College of Medicine; Department of Psychiatry|Dr. Theresa Winhusen|513-585-8227|winhust@ucmail.uc.edu
92774|NCT01641133|GlaxoSmithKline|GSK Response Center|866-435-7343|
92775|NCT01641120|Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital|Lindsay Tuttle, MPH|860-714-2149|LTuttle@stfranciscare.org
92776|NCT01641081|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com
92777|NCT01640964|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
92778|NCT01640925|Houston Methodist Hospital|Dr. Joshua Swan|713-441-0165|jtswan@houstonmethodist.org
92779|NCT01640548|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
92780|NCT01640353|SI-BONE, Inc.|Daniel Cher, MD, Vice President of Clinical Affairs|650-269-5763|dcher@si-bone.com
93143|NCT01602562|GlaxoSmithKline|GSK Response Center|866-435-7343|
92781|NCT01640340|Ohio State University Medical Center|Rachel Layman, MD|614-293-0066|Rachel.Layman@osumc.edu
92782|NCT01640327|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
92783|NCT01640314|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
92784|NCT01640197|Northumbria University|Emma Wightman|(+44) 0191 2437253|emma.l.wightman@northumbria.ac.uk
92785|NCT01640184|Peking University International Hospital|Dr. Zhang Dongliang|+86-10-69006561|zhangdongliang@pkuih.edu.cn
92786|NCT01640171|Retina Vitreous Associates of Florida|Steven Cohen|7274459110|scohen@health.usf.edu
92787|NCT01640054|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
92788|NCT01639833|Covidien|Michael Rohan|781-839-1757|Michael.Rohan@Covidien.com
92791|NCT01639729|AcelRx|Pamela Palmer|650-216-3500|ppalmer@acelrx.com
92792|NCT01639703|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com
92793|NCT01639560|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu
92794|NCT01639469|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov
92796|NCT01639352|University of Miami|Lynn Feun, M.D.|305-243-4909|lfeun@med.miami.edu
92797|NCT01639222|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
92798|NCT01639157|University of Kentucky|William W. Stoops, Ph.D.|859-257-5388|william.stoops@uky.edu
92799|NCT01639144|Center for Research & Grants, Baptist Health South Florida|Gary M. Kiebzak, Ph.D., Co-investigator and Clinical Research Administrator|786-268-6224|garyk@baptisthealth.net
92801|NCT01638559|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
92802|NCT01638507|Medtronic, Coronary Clinical Affairs|Lisa Bousquette, Clinical Research Director|(707) 591-2967|lisa.r.bousquette@medtronic.com
92803|NCT01638468|Boston Scientific|DeeAnn Tinjum|763-494-1927|deeann.tinjum@bsci.com
92804|NCT01638312|Kaohsiung Medical University Chung-Ho Memorial Hospital|JihJin Tsai, MD|886-7-3121101 ext 6358|jijits@cc.kmu.edu.tw
92805|NCT01638000|Astellas Pharma Europe Ltd|Medical Director||Astellas.resultsdisclosure@astellas.com
92807|NCT01637935|Takeda|Head, Pharmacoepidemiology|+1-877-825-3327|trialdisclosures@takeda.com
92808|NCT01637922|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92809|NCT01637584|UPittsburgh|Dr. Anne Germain|4123832150|germax@upmc.edu
92810|NCT01637272|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
92811|NCT01637246|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
92812|NCT01637090|Boston Medical Center|Adam Lerner, MD|617-638-8265|adam.lerner@bmc.org
92813|NCT01636986|Alcon Research, Ltd.|Jami Kern, PhD|1-888-452-3937|alcon.medinfo@alcon.com
92814|NCT01636960|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92815|NCT01636947|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92816|NCT01636778|GlaxoSmithKline|GSK Response Center|866-435-7343|
92817|NCT01636765|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
92818|NCT01636713|GlaxoSmithKline|GSK Response Center|866-435-7343|
92819|NCT01636661|University of Minnesota|Dr. Bernadette Gillick|612.626.6415|brown029@umn.edu
92820|NCT01636466|Emory University|Dr. Ashtar Chami|404-712-7735|ashtar.chami@emory.edu
92821|NCT01636414|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2265|susan.odum@orthocarolina.com
92822|NCT01636362|Molnlycke Health Care AB|Joan Wilson|706 504 8997|joan.wilson@molnlycke.com
92823|NCT01636258|The Cleveland Clinic|Adam M. Bernstein MD|216-448-8538|bernsta2@ccf.org
92824|NCT01636206|Shire|Study Physician|1866-842-5335|
92825|NCT01636102|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
92826|NCT01636076|Novartis Pharmaceuticals|Study Director|862-778-8300|
92827|NCT01636063|Baystate Medical Center|David R Kattan|413-794-5256|davidrkattan@gmail.com
92828|NCT01635933|Alcon Research, Ltd.|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com
92829|NCT01635920|Alcon Research, Ltd.|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com
92830|NCT01635881|Boston Scientific|Andrey Nersesov, Clinical Trial Manager|1-508-683-4988|Andrey.Nersesov@bsci.com
92831|NCT01635855|Merz Pharmaceuticals North America|Merz Pharmaceuticals North America|800-334-0514|clinicaltrials@merzusa.com
92832|NCT01635764|AbbVie|Global Medical Services|800-633-9110|
92833|NCT01635504|University of British Columbia|Dr. Shannon Humphrey|(604) 714-0222|shannon@carruthers-humphrey.com
92834|NCT01635439|NWAFH|Ahmed Abdelaziz|0096644411088|webmaster@nwafh.med.sa
92835|NCT01635244|University of Michigan|David Bach, MD|734-615-4907|dbach@med.umich.edu
92836|NCT01635218|Hospital Juárez de México|Dr. Emma del Carmen Macías-Cortés|+52 55 5747 7605|ecmc2008@hotmail.es
92837|NCT01635062|Brigham and Women's Hospital|Dr. Anand Vaidya (Asst Professor of Medicine)|6175258285 ext 617|avaidya1@partners.org
92838|NCT01634854|Vanderbilt University Medical Center|Angela Wilson-Liverman CNM||angela.wilson-liverman@vanderbilt.edu
92839|NCT01634659|Alcon Research, Ltd.|Jami Kern, MBA, PhD|1-888-451-3937|alcon.medinfo@alcon.com
92840|NCT01634620|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA|919-449-8873|Nancy.Herje@aerocrine.com
92841|NCT01634555|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92842|NCT01634360|Eisai Call Center|Eisai Inc.|888-422-4743|
92843|NCT01634256|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Sang-Wook Kim, MD|82-63-276-8284|clickm@jbnu.ac.kr
92844|NCT01634243|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
92845|NCT01634165|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92846|NCT01634152|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92847|NCT01634139|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92848|NCT01634113|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92849|NCT01634100|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
92850|NCT01633944|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
92851|NCT01633892|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu
92852|NCT01633853|Peking University Internetional Hospital|Dr. Zhang Dongliang|+86-10-69006561|zhangdongliang@pkuih.edu.cn
92853|NCT01633827|Brigham and Women's Hospital|David Andrew Wellman|617-732-8483|awellman@rics.bwh.harvard.edu
92854|NCT01633814|University of Missouri|Principal Investigator|573-884-5220|fadelp@health.missouri.edu
92855|NCT01633788|Allergan plc|Ronald Bradford|1-714-846-5486|Bradford_Ron@allergan.com
92856|NCT01633320|Edouard Herriot hôspital Anaesthesia and intensive care|Dr Emmanuel Boselli|+334711689|emmanuel.boselli@chu-lyon.fr
92857|NCT01632995|Bridge HIV, San Francisco Department of Public Health|Dr. Albert Liu, Clinical Research Director|415-437-7408|albert.liu@sfdph.org
92859|NCT01632878|Mylan|Patrick Aubonnet / Medical Director||patrick.aubonnet@mylan.com
92860|NCT01632800|Weinberg Medical Physics LLC|Irving Weinberg MD PhD|3013467944|inweinberg@gmail.com
92861|NCT01632735|Azusa Pacific University|Dr. Rachel Gonzales Castaneda|6268156000 ext 2744|rcastaneda@apu.edu
92862|NCT01632709|Rehabilitation Institute of Chicago|Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org
92864|NCT01632423|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
92865|NCT01632267|AssureRx|Joel Winner, MD|513-234-0510|jwinner@assurerxhealth.com
92866|NCT01632215|Federal University of São Paulo|Dr. Rioko K. Sakata|055 11 5084 7463|riokoks.dcir@epm.br
92867|NCT01632150|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
92868|NCT01632020|University of Arkansas for Medical Sciences|Daisy Wade|5016868274|dewade@uams.edu
92869|NCT01631929|HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE|Ferreira Juan Pablo MD|+5491136085959|ferreirajuanpablo@hotmail.com
92870|NCT01631864|Novartis Pharmaceuticals|Study Director|862-778-8300|
92871|NCT01631825|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
92872|NCT01631812|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
92873|NCT01631682|Massachusetts General Hospital|Scott P. Orr, Ph.D.|617-643-7269|scott_orr@hms.harvard.edu
92874|NCT01631630|National Institute on Alcohol Abuse and Alcoholism|Diazgranados, Nancy|+1 301 435 9386|nancy.diazgranados@nih.gov
92875|NCT01631435|Given Imaging- Covidien|Ravit Peled , Clinical trials manager|+972 (4) 909-7894 ext 7894|Ravit.peled@covidien.com
92877|NCT01631227|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com
92878|NCT01631149|Leiden University Medical center|Dr. Albert Dahan|3171 526 2301|a.dahan@lumc.nl
92879|NCT01631110|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com
92880|NCT01631071|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com
92881|NCT01630694|University of Rochester|Jacek Wojtczak|585-273-2972|jacek_wojtczak@urmc.rochester.edu
92882|NCT01630135|GlaxoSmithKline|GSK Response Center|866-435-7343|
92883|NCT01630109|Genesys Regional Medical Center Office of Research|Dr. Steven Brooks|8106067722|Steven.Brooks@genesys.org
92884|NCT01629823|ALA-ACRC|Janet T Holbrook, PhD, MPH|443-287-3170|jholbro1@jhu.edu
92885|NCT01629797|Northwestern University|Hae Bae|312-695-6829|j-bae@northwestern.edu
92886|NCT01629784|Northwestern University|Hae Bae, CRCC|312-695-6829|j-bae@northwestern.edu
92887|NCT01629771|Northwestern University|Clinical Trials Unit Coordinator|312-695-6829|j-bae@northwestern.edu
92888|NCT01629706|Alcon Research, Ltd.|Alan Landers, Project Head, Vision Care R&D|1-888-451-3937|alcon.medinfo@alcon.com
92889|NCT01629693|Alcon Research, Ltd.|Jessie Lemp, GMA Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com
92890|NCT01629667|MedImmune, LLC|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
92891|NCT01629589|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
92892|NCT01629290|University of Michigan School of Dentistry|Danika Downey, DDS|330-877-8783|danika.downey@gmail.com
92893|NCT01629134|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com
92894|NCT01628965|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
92895|NCT01628926|Otsuka Pharmaceutical Co, Lts.|Director of Clinical Research and Development|+81-3-6361-7366|
92896|NCT01628913|Novartis Pharmaceuticals|Study Director|862-778-8300|
92897|NCT01628848|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6131-7366|
92898|NCT01628692|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
92899|NCT01628614|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
92900|NCT01628601|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
92901|NCT01628588|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
92902|NCT01628510|Washington University|Roberta Pineda|314-286-1304|pineda_r@kids.wustl.edu
92903|NCT01628367|University of Michigan|Dr. Hom-Lay Wang|734-647-6175|homlay@umich.edu
92904|NCT01628250|Ruijin Hospital, Shanghai Jiao Tong University School of Medicine|Dr. Bo Feng|021-64458887|fengbo2022@163.com
92905|NCT01628042|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92906|NCT01627860|Janssen-Cilag Taiwan|Medical Director|886 2 23762155|
92907|NCT01627782|Janssen Research & Development, LLC|Senior Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com
92908|NCT01627561|GlaxoSmithKline|GSK Response Center|866-435-7343|
92909|NCT01627340|GlaxoSmithKline|GSK Response Center|866-435-7343|
92911|NCT01627249|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrstat2@jaeb.org
92912|NCT01627002|ProtAffin Biotechnologie AG|ProtAffin Biotechnologie AG|Not Available|office@protaffin.com
92913|NCT01626820|GlaxoSmithKline|GSK Response Center|866-435-7343|
92914|NCT01626690|University of Wisconsin School of Medicine and Public Health|Dr. Kristopher Schroeder, MD|608-263-8100|kmschro1@wisc.edu
92915|NCT01626456|Alkermes, Inc.|ARISTADA Medical Information|866-274-7823|usmedinfo@alkermes.com
92916|NCT01626391|TauRx Therapeutics Ltd|Dr. Jiri Hardlund|+44 (0)1224438550|JHH@taurx.com
92917|NCT01626118|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com
92919|NCT01625910|University of Minnesota, Department of Family Medicine and Community Health|Steven D. Stovitz, MD, MS|612-310-2344|sstovitz@umphysicians.umn.edu
92920|NCT01625845|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, Ph.D.|(317) 274-6761|jstew@iupui.edu
92921|NCT01625689|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org
92922|NCT01625507|University of Alberta|Dr. Catherine Chan|780-492-9939|cbchan@ualberta.ca
92923|NCT01625455|VANDERBILT UNIVERSITY MEDICAL CENTER|Nancy J. Brown, M.D., Principal Investigator|6153438701|nancy.j.brown@vanderbilt.edu
92924|NCT01625377|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
92925|NCT01625338|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
92928|NCT01625169|USC|LaShonda Spencer|323 226-6437|lspencer@usc.edu
92930|NCT01624948|UCSF|Allison Webber MD|415 353 8382|allison.webber2@ucsf.edu
92931|NCT01624740|Boston Scientific|Nitzan Mekel-Bobrov, PhD|661-949-4537|Nitzan.Mekel-Bobrov@bsci.com
92932|NCT01624467|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92933|NCT01624363|Indiana Universtiy Schol of Medicine|John DeWitt, MD, Director, Endoscopic Ultrasound|317-944-1113|jodewitt@iu.edu
92934|NCT01624350|Medtronic|Medtronic (Sponsor)|508.452.4095|michelle.v.disalvo@medtronic.com
92935|NCT01624259|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92937|NCT01624168|Appalachian State University|Dr. Karen Caldwell, Professor|828-262-6045|caldwellkaren@appstate.edu
92938|NCT01623869|Memorial Sloan-Kettering Cancer Center|Sandra Pierina D'Angelo, M.D.||dangelos@mskcc.org
92939|NCT01623830|Emory University|Barbara Rothbaum|404-712-8866|brothba@emory.edu
92940|NCT01623479|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
92941|NCT01623466|Agile Therapeutics|Lisa Flood|609-683-1880|lflood@agiletherapeutics.com
92942|NCT01623323|OptiNose|Jennifer Carothers|908-432-3061|jennifer.carothers@optinose.com
92943|NCT01623271|Massachusetts General Hospital|Jianren Mao, MD, PhD|617-724-6102|jmao@mgh.harvard.edu
92944|NCT01623154|Otsuka America Pharmaceutical, Inc|Tao Wang, PhD|240-683-3213|Tao.Wang@otsuka-us.com
92945|NCT01623115|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
92946|NCT01623050|SinuSys Corporation|Janie Mandrusov, Director of Pre-Clinical and Clinical Development|4084104411|emandrusov@sinusys.com
92947|NCT01622673|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92948|NCT01622660|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org
92949|NCT01622296|UCSF School of Dentistry|Dr. Susan Parveen Tavana|415-476-1891|susan.tavana@ucsf.edu
92950|NCT01622257|Assistant professor of Obstetrics & Gynecology, Ain-shams faculty of medicine|Dr. Moustafa Ibrahim|00201001955996|mi_monem@yahoo.com
92951|NCT01622231|GlaxoSmithKline|GSK Response Center|866-435-7343|
92953|NCT01621776|University of Florida|Janet Silverstein, MD|352-334-1390|silvejh@peds.ufl.edu
92954|NCT01621672|University of Arkansas for Medical Sciences|Bart Barlogie|526-6990 ext 2420|barlogiebart@uams.edu
92955|NCT01621633|Novartis Pharmaceuticals|Study Director|862-778-8300|
92956|NCT01621477|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|901-595-2766|brandon.triplett@stjude.org
92957|NCT01621191|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92958|NCT01621178|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
92959|NCT01621126|Massachusetts General Hospital|Dr. Jon J.P. Warner, Chief of Shoulder Service MGH, Harvard Professor of Orthopaedics.|617-724-3140|jwarner@mgh.harvard.edu
92960|NCT01621009|University of Wisconsin Center for Tobacco Research and Intervention|Timothy Baker, PhD, Director of Research|(608) 262-7568|tbb@ctri.wisc.edu
92961|NCT01620489|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
92962|NCT01620255|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com
92963|NCT01620177|National Advanced Driving Simulator|Dr. Timothy L. Brown, Co-PI|319-335-4785|timothy-l-brown@uiowa.edu
92964|NCT01620138|Universidade Federal do Rio de Janeiro|Monica Gadelha|+552139382323|mgadelha@hucff.ufrj.br
92965|NCT01620086|University of Arkansas for Medical Sciences|Erik Messias, MD|501-526-8142|emessias@uams.edu
92966|NCT01620060|Sunovion|Medical Director, CNS|1-866-503-6351|
92967|NCT01620047|Gulf-to-Bay Anesthesiology Associates LLC|Director of Research|813-844-4413|rkarlnoski@fgtba.com
92968|NCT01619878|Novartis Pharmaceuticals|Study Director|862-778-8300|
92969|NCT01619800|Icahn School of Medicine at Mount Sinai|Vivek Reddy|212-241-7114|vivek.reddy@mountsinai.org
92970|NCT01619787|SUNYBuffalo|Leonard H. Epstein|716-829-3400|ckk@buffalo.edu
92971|NCT01619774|University of Texas (UT) MD Anderson Cancer Center|Michael Davies, Associate Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org
92972|NCT01619579|VA Medical Center & UCSD Center for Pain Medicine|Tobias Moeller-Bertram, MD|858-552-8585 ext 3123|tmoellerbertram@ucsd.edu
92973|NCT01619059|AstraZeneca Pharmaceuticals|Eva Johnsson, Clinical Science Lead|+46 31 7762484 ext 762484|Eva.Johnsson@astrazeneca.com
92974|NCT01618968|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President Clinical Development|609-359-3020 ext 324|jjaffe@antarespharma.com
92975|NCT01618955|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President-Clinical Development|609-359-3020 ext 324|jjaffe@antarespharma.com
92976|NCT01618942|Huazhong University of Science&Technology|Xianwei Zhang|027 83662853|ourpain@163.com
92977|NCT01618864|Iluminage|Director of Clinical Affairs|+972 547 800 260|doranr@iluminagebeauty.com
92978|NCT01618838|Georgetown University Hospital|Dr. Sean Collins|202-444-3062|spc9@gunet.georgetown.edu
92979|NCT01618708|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
92980|NCT01618669|Astellas Pharma Global Development, Inc. (APGD)|Senior Medical Director, Medical Affairs||Astellas.resultsdisclosure@astellas.com
92981|NCT01618422|Chinese University of Hong Kong|Prof David SC Hui|2632 3134|dschui@cuhk.edu.hk
92982|NCT01618266|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
92983|NCT01618240|Massachusetts General Hospital|Hooman Mirzakhani|617-291-9779|hmirzakhani@partners.org
92984|NCT01618227|Massachusetts General Hospital|Neal Chen|617-726-4700|nchen1@partners.org
92985|NCT01618214|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
92987|NCT01618019|Hanyang University|Dr. Yongsoon Park|82-2-2220-1205|yongsoon@hanyang.ac.kr
92988|NCT01617681|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com
92989|NCT01617668|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
92990|NCT01617655|Sanofi|Trial Transparency Team||Contact­-US@sanofi.com
92991|NCT01617603|Medical School, Michael White Diabetes Centre, 220-236, Anlaby Road,|Prof. Stephen Atkin, Principal Investigator|+44(0)1482 675312|Stephen.Atkin@hyms.ac.uk
92992|NCT01617577|University of South Florida|Professor Juan Sanchez-Ramos|813-974-5841|jsramos@health.usf.edu
92993|NCT01617447|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366|
92994|NCT01617434|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
92995|NCT01617369|University of North Carolina Chapel Hill|Dr. Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu
92996|NCT01617187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
92997|NCT01617070|USC/Keck School of Medicine|Shoji Yano|323-226-3816|syano@usc.edu
92998|NCT01617005|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
92999|NCT01616953|University of Michigan|Dr. Darnell Kaigler|734-615-4023|dkaigler@umich.edu
93000|NCT01616771|Seoul National University Hospital|Jin-Tae Kim|82-10-6260-8490|jintae73@gmail.com
93001|NCT01616576|Advanced Bionics, LLC|Cedric Navarro, Vice President of Regulatory/Clinical Affairs and Quality|(661) 362-1963|Clinical.Research@advancedbionics.com
93002|NCT01616459|GlaxoSmithKline|GSK Response Center|866-435-7343|
93003|NCT01616173|Northwestern University, Feinberg School of Medicine|Rohit Rahangdale MD|312-695-3045|ryrahangdale@hotmail.com
93004|NCT01616056|FHCRC|Stephanie J. Lee MD MPH|206-667-6190|sjlee@fhcrc.org
93005|NCT01615939|Northwestern University, Feinberg School of Medicine|Antoun Nader|312-695-3045|a-nader2@northwestern.edu
93006|NCT01615822|Medicines for Malaria Venture|Fiona Macintyre, PhD|+41 22 555 0319|macintyref@mmv.org
93007|NCT01615809|Fundaciò per la Recerca i la Docencia sant Joan de Deu|Rosa Maria morales Palau|936009751|rmorales@fsjd.org
93009|NCT01615328|Seoul National University Bundang Hospital|Jin-Sup Yeom|82-31-787-7190|highcervical@gmail.com
93010|NCT01615263|Institut universitaire de cardiologie et de pneumologie de Québec, Laval University|Dr Jean S. Bussières, anesthesiologist, director of research|418 656-4870|jbuss@criucpq.ulaval.ca
93011|NCT01615198|Novartis|Study Director|862-778-8300|
93013|NCT01614886|Novartis Pharmaceuticals|Study Director|862-778-8300|
93014|NCT01614795|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
93015|NCT01614769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93016|NCT01614613|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com
93017|NCT01614600|Alcon Research, Ltd.|Jami Kern, MBA, PhD|1-888-451-3937|alcon.medinfo@alcon.com
93018|NCT01614574|Shire|Bjorn Mellgard, MD, PhD|+41 22 419 4110|bmellgard@shire.com
93019|NCT01614509|Yeungnam University College of Medicine|Dr. Min Sagong|82-53-620-4191|msagong@ynu.ac.kr
93020|NCT01614470|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
93021|NCT01614457|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
93022|NCT01614249|University of Nairobi|Mrs. Rose Okoyo Opiyo|+254 020 2726300 ext 43481|roseopiyo@uonbi.ac.ke
93024|NCT01613599|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
93025|NCT01613417|Executive Director, MRI|Gianpaolo Pirovano, MD|609-514-2226|gianpaolo.pirovano@diag.bracco.com
93026|NCT01613378|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
93027|NCT01613339|Orebro county council|Dr. Anette Forsberg|+46-19-602 5788|anette.forsberg@orebroll.se
93028|NCT01613326|Novartis Pharmaceuticals|Study Director|4 161 324 1111|
93029|NCT01613313|GerutZ|Dr. Zachary E.Gerut|516 295-2100|Drgerut@drgerut.com
93030|NCT01613248|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
93031|NCT01613131|University of Colorado Denver|Chanel Mansfield|303-724-6501|chanel.mansfield@ucdenver.edu
93032|NCT01613027|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
93033|NCT01613014|NIAAA|Megan Ryan, Clinical Program Director|3014434225|mryan1@mail.nih.gov
93034|NCT01612858|Tufts Medical Center|Rakhi Kohli MD MS|617-636-4709|rkohli@tuftsmedicalcenter.org
93036|NCT01612702|Joint Reconstruction Center, Seoul National University Bundang Hospital|Dr. TK Kim|82-31-787-7196 ext 7200|osktk@snubh.org
93037|NCT01612676|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
93038|NCT01612494|Washington University School of Medicine|Dr. Angela Lumba-Brown|314-362-4325|lumba_a@kids.wustl.edu
93039|NCT01612221|Huntsman Cancer Institute|Kimberlee Taylor|801-213-5673|Kimberlee.Taylor@hci.utah.edu
93040|NCT01612156|University of Southern California|Begum Ozel, MD|323-441-9589|ozel@usc.edu
93041|NCT01612000|Protein Sciences Corproation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064 ext 153|ldunkle@proteinsciences.com
93042|NCT01611974|Shire Development LLC|Study Physician|+1 866 842 5335|
93043|NCT01611948|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu
93044|NCT01611883|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93045|NCT01611857|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com
93047|NCT01611779|Siesta Medical, Inc.|Michael Kolber|408-320-9424|mkolber@siestamedical.com
93048|NCT01611662|Fox Chase Cancer Center|Elizabeth Plimack, MD|215-728-3889|Elizabath.Plimack@fccc.edu
93049|NCT01611571|Columbia University Medical Center|Marcella Walker MD|212-342-5351|mad2037@columbia.edu
93051|NCT01610791|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
93052|NCT01610713|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
93053|NCT01610700|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
93054|NCT01610687|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
93055|NCT01610596|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com
93056|NCT01610570|National Cancer Institute|Dr. Brigitte Widemann|301-496-7387|widemanb@mail.nih.gov
93057|NCT01610557|National Eye Institute (NEI) at National Institutes of Health (NIH)|Henry E Wiley, MD, Principal Investigator|(301) 451-4260|wileyhe@mail.nih.gov
93059|NCT01610453|Stavanger UH|Professor Torbjørn Moe Eggebø|+4792699433|tme@lyse.net
93060|NCT01610297|Novartis|Study Director|862-778-8300|
93061|NCT01610167|Salus Research, Inc.|Jeffery L. Milleman, DDS, MPA|(260) 755-1099|
93062|NCT01610154|Fuwai Hospital|Dr. Hui Wang|86-010-88396587|wh_endo@163.com
93063|NCT01610076|Mayo Clinic|Kianoush Kashani; Principal Investigator|5072667093|kashani.kianoush@mayo.edu
93064|NCT01610063|Mayo Clinic|Dr. Daniel K. Hall-Flavin|507-255-4151|flavin.daniel@mayo.edu
93065|NCT01610037|Novartis Pharmaceuticals|Study Director|862-778-8300|
93066|NCT01610011|McLean Hospital|Marc J. Kaufman, Ph.D., Principal Investigator|617-855-3469|kaufman@mclean.harvard.edu
93067|NCT01609790|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
93068|NCT01609582|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
93069|NCT01609543|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
93070|NCT01609478|Novartis Pharmaceuticals|Clinical Disclosure Office|+1(862)778-8300|
93071|NCT01609257|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com
93072|NCT01609062|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com
93073|NCT01609023|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
93074|NCT01609010|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
93075|NCT01608971|Heart and Diabetes Center NRW|Andreas Koster|0043 5731 3284|akoster@hdz-nrw.de
93076|NCT01608815|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
93077|NCT01608724|Astrazeneca Investment (China) Co., Ltd.|Anya Huang, Brand Physician|+86 21 6030 2032|anya.huang@astrazeneca.com
93078|NCT01608672|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
93079|NCT01608659|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
93080|NCT01608490|PneumRx|Ashley Burns|+1 650 625 8910 ext 6122|Ashley.Burns@btgplc.com
93081|NCT01608321|VA Palo Alto Health Care System|Director, WRIISC|650-493-5000|wes.ashford@va.gov
93082|NCT01608308|The University of Texas Health Science Center at Houston|Davide Cattano|(713) 500-6200|Davide.Cattano@uth.tmc.edu
93083|NCT01608295|UCLA|Helen Lavretsky, M.D.|310-794-4619|hlavretsky@mednet.ucla.edu
93084|NCT01608100|Abbott Diagnostics Division|Karla Grasso, Clinical Research Manager|1 224-667-5602|karla.grasso@abbott.com
93085|NCT01607853|Leo Pharma A/S|Clinical Trial Disclosure Manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com
93086|NCT01607645|FHCRC|Derek L. Stirewalt|2066675386|dstirewa@fhcrc.org
93087|NCT01607593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93088|NCT01607476|Mayo Clinic|Dr. Val Lowe|507-255-3616|vlowe@mayo.edu
93089|NCT01607450|Indiana University|Kieren J Mather MD FRCPC|317-278-7826|kmather@iu.edu
93090|NCT01607411|GlaxoSmithKline|GSK Response Center|866-435-7343|
93091|NCT01607398|GlaxoSmithKline|GSK Response Center|866-435-7343|
93093|NCT01607320|Greenville Health System|Bruce Lessey|864-455-1600|blessey@ghs.org
93094|NCT01607203|AZ JAN PALFIJN|dr.Decleer Wim|+32 9 325 92 20 ext 092248851|wim.decleer@janpalfijngent.be
93095|NCT01607112|GlaxoSmithKline|GSK Response Center|866-435-7343|
93096|NCT01606800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93097|NCT01606748|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
93098|NCT01606735|Icon Bioscience, Inc|Wendy Murahashi, MD|6503694049|wendymurahashi@iconbioscience.com
93099|NCT01606670|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
93100|NCT01606319|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.573.0336|dmauger@psu.edu
93101|NCT01606306|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.573.0336|dmauger@psu.edu
93102|NCT01606254|Janssen Pharm KK Japan|Medical Director|81-3-4411 ext 5509|
93103|NCT01606228|Janssen China|Medical Affairs Director, CNS, Asia Pacific|8610 5821 8766|
93104|NCT01606202|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
93105|NCT01606189|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
93106|NCT01606176|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
93107|NCT01606150|Georgetown University NICU|Judith Palafoutas, Research Director|202 444 8756|jxp11@gunet.georgetown.edu
93108|NCT01606137|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
93110|NCT01606007|AstraZeneca Pharmaceuticals|Boaz Hirshberg||ClinicalTrialTransparency@astrazeneca.com
93111|NCT01605942|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
93112|NCT01605916|Biometrics Department, Science Affairs Division, R&D, Astrazeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com
93113|NCT01605877|Alcon Japan, Ltd.|Hiroshi Kodama, Group Manager|81-3-6899-5000|
93114|NCT01605825|Acorda Therapeutics, Inc.|Study Director|914-347-4300|
93115|NCT01605799|San Francisco VA Medical Center|Dr. Shira Maguen|415-221-4810 ext 22511|shira.maguen@va.gov
93116|NCT01605669|Naval Medical Center San Deigo|LCDR William Bennett MD FACC|619-532-7400|william.bennett5@med.navy.mil
93117|NCT01605617|Mayo Clinic|Dr. Jeffrey L. Cornella|480-342-2867|cornella.jeffrey@mayo.edu
93118|NCT01605552|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, Ph.D.|(317) 274-6761|jstew@iupui.edu
93119|NCT01605539|Icahn School of Medicine at Mount Sinai|Yasmin Hurd, PhD|212-824-9314|yasmin.hurd@mssm.edu
93120|NCT01605461|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93121|NCT01605370|Mayo Clinic|Marek Belohlavek, M.D., Ph.D.|408-301-6694|belohlavek.marek@mayo.edu
93122|NCT01605292|Long Beach VA Medical Center|Arnold Seto, MD, MPA|(562) 826-8000 ext 5486|arnold.seto@va.gov
93123|NCT01604941|Shire Development LLC|Study Physician|+1 866 842 5335|
93124|NCT01604850|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
93125|NCT01604772|Memorial Sloan Kettering Cancer Center|Alan Ho, M.D.||hoa@mskcc.org
93126|NCT01604278|Novartis Pharmaceuticals|Study Director|862-778-8300|
93127|NCT01604265|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
93128|NCT01604122|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93129|NCT01604109|ThammasatU|Thanya Sitthisettapong|6629869213 ext 7150|thanyasang@yahoo.com
93130|NCT01603940|Hospital Universitario Pedro Ernesto (UERJ)|Ronaldo Altenburg Gismondi, MD, PhD|+5521996092383|ronaldogismondi@gmail.com
93131|NCT01603875|Queen Saovabha Memorial Institute|Dr. Terapong Tantawichien|66225201614 ext 125|terapong_tantawichien@hotmail.com
93132|NCT01603459|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de
93133|NCT01603420|The Proton Collaborative Group|Corey Woods|630-836-8668|cwoods@pcgresearch.org
93134|NCT01603394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93135|NCT01603277|KaloBios Pharmaceuticals Inc.|Nestor Molfino, MD|650-243-3100|nmolfino@kalobios.com
93136|NCT01603121|Eastern Virginia Medical School|Dr. David Lieb, Principal Investigator|7574465910|liebdc@evms.edu
93137|NCT01603082|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9393|ClinicalTrialTransparency@astrazeneca.com
93138|NCT01603056|ALK-Abelló A/S|Vivian Wang, Sr. Medical Affairs Manager|86 - 10 5166 8198|Vivian.Wang@alk.net
93139|NCT01603043|Alcon Research, Ltd.|Yamini Patel, PhD, Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com
93140|NCT01602965|Istituto Ortopedico Rizzoli|Mariela Terrafino|0516366694 ext 0039|cristiana.forni@ior.it
93141|NCT01602744|Tel Aviv University|Dvora Frankenthal|0097235326835|shai_f@zahav.net.il
93142|NCT01602731|VA Loma Linda Healthcare System|Dr. Helme Silvet, cardiologist|9095836097|helme.silvet@va.gov
93146|NCT01602484|Brigham and Women's Hospital|Dr. Eric Bluman|6179837363|ebluman@partners.org
93147|NCT01602471|Certus International, Inc.|Edward M. Aten, M.D.|603.627.1212|eaten@certusintl.com
93148|NCT01602380|AstraZeneca|Mehdi Fazal, MD||ClinicalTrialTransparency@astrazeneca.com
93149|NCT01602341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93150|NCT01602198|Cleveland Clinic|Stephen Rao|216-444-1025|raos2@ccf.org
93152|NCT01601977|GSTT|Gill Arbane, Clinical trials coordinator|02071888070|gill.arbane@gstt.nhs.uk
93153|NCT01601821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93154|NCT01601782|University of Michigan|Jon Jacobson, MD|734-936-4365|jjacobsn@umich.edu
93155|NCT01601704|Orexigen Therapeutics, Inc.|Global Head of Development|858-875-8600|MedInfo@Orexigen.com
93156|NCT01601691|Oulu University Hospital|Dr. Markku Vaarala|+3588315 ext 2840|markku.h.vaarala@ppshp.fi
93157|NCT01601470|Novartis Pharmaceuticals|Study Director|862-778-8300|
93158|NCT01601236|Mallinckrodt|Lawrence Hill|(908) 238-6370|lawrence.hill@mallinckrodt.com
93159|NCT01601132|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
93160|NCT01600950|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
93161|NCT01600885|Yale University|John Krystal, MD|203-785-6396|john.krystal@yale.edu
93162|NCT01600729|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
93164|NCT01600703|University Health Network|Dr. Gary Lewis|416-340-4270|gary.lewis@uhn.ca
93165|NCT01600677|UPittsburgh|Steven M. Handler, MD, PhD|412-864-1878|handler@pitt.edu
93166|NCT01600495|University of São Paulo.|Prof. Alessandra Cristina Marcolin|Tel.: (16) 36022587 ext 55 +|dralemar@uol.com.br
93167|NCT01600482|Vasorum Ltd|Dr James Coleman|00 353 1 4035460|jcoleman@vasorum.ie
93168|NCT01600326|University of Michigan|Jon Jacobson|734 936-4365|jjacobsn@umich.edu
93169|NCT01600287|Postgraduate Institute of Medical Education and Research|Dr G D Puri|00919914209509|gdpuri007@hotmail.com
93170|NCT01600222|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com
93171|NCT01600092|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93172|NCT01600053|University of California, San Diego|Thomas Kipps, MD|(858) 534-5400|tkipps@ucsd.edu
93173|NCT01600014|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com
93174|NCT01599832|University of Chicago Comprehensive Cancer Center|Walter Stadler|(773) 702-4150|wstadler@medicine.bsd.uchicago.edu
93175|NCT01599806|AstraZeneca/ PPD|Gayan Makumburage|9105588682|gayan.makumburage@ppdi.com
93176|NCT01599741|Philips|Thijs Grunhagen|+31 6 11645166|thijs.grunhagen@philips.com
93177|NCT01599650|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
93178|NCT01599637|Novartis Pharmaceuticals|Study Director|862-778-8300|
93179|NCT01599585|National Center for Telehealth and Technology|Larry D. Pruitt, PhD|253-968-2946|larry.d.pruitt21.civ@mail.mil
93180|NCT01599325|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com
93181|NCT01599234|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
93182|NCT01599104|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|
93183|NCT01598987|Novartis Pharmaceuticals|Study Director|862-778-8300|
93184|NCT01598779|University of Buenos Aires|Dr. Laura Fleider|541159508000 ext 8582|laurafleider@hotmail.com
93185|NCT01598740|Sorbent Therapeutics, Inc.|Howard Dittrich, MD|858-405-1429|hdittrich@sorbent.com
93186|NCT01598610|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com
93187|NCT01598545|Emory University|Dr. Grant Lynde|404-778-3900|glynde@emory.edu
93188|NCT01598532|Spaulding Rehabilitation Hospital|Ross D. Zafonte, DO|617-952-5227|rzafonte@partners.org
93189|NCT01598506|Emory University|Dr. Grant Lynde|404-778-3900|glynde@emory.edu
93190|NCT01598428|Shandong University|Dr.Yang Gao|0086-543-89268587|pinkapples@126.com
93191|NCT01598350|University of Puget Sound|Julia Looper, PT PhD|253 879 2895|jlooper@pugetsound.edu
93192|NCT01598207|Temple University|Dr. Ron Schey|215-707-9900|Ron.schey@tuhs.temple.edu
93193|NCT01598129|Oncos Therapeutics|Director, Clinical Operations||info@oncos.com
93194|NCT01598064|National Cheng Kung University Hospital|Dr. Po Lin Chen|886-2353535 ext 4733|n939492@mail.hosp.ncku.edu.tw
93195|NCT01597908|GlaxoSmithKline|GSK Response Center|866-435-7343|Novartis.email@novartis.com
93196|NCT01597843|Clement J Zablocki VA Medical Center|Jeff Whittle, MD, MPH|414-384-2000 ext 46444|jeffrey.whittle@va.gov
93198|NCT01597635|GlaxoSmithKline|GSK Response Center|866-435-7343|
93199|NCT01597596|Sanofi|Trial Transparency Team||Contact ­US@sanofi.com
93200|NCT01597492|GlaxoSmithKline|GSK Response Center|866-435-7343|
93201|NCT01597479|Hospital de la Santa Creu i Sant Pau|Dra. Mireia Rodriguez Prieto|677896054|mrodriguezpr@santpau.cat
93202|NCT01597440|Children's National Health System|Dr. Mendel Tuchman||mtuchman@childrensnational.org
93203|NCT01597245|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
93204|NCT01597141|Maine Medical Center Research Institute|William R. McFarlane, M.D.|207-662-4348|mcfarw@mmc.org
93205|NCT01597128|University of Kentucky Medical Center|J. Scott Roth, M.D.|859-323-6346 ext 246|arockich@uky.edu
93206|NCT01597050|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com
93207|NCT01596972|Planned Parenthood League of Massachusetts|Director of Clinical Research and Training|617.616.1600|agoldberg@pplm.org
93208|NCT01596842|Dong-A University|Professor|82-51-240-2811|anws@dau.ac.kr
93209|NCT01596582|Boston Medical Center|Paul C. Schroy III, MD, MPH|671-638-8335|paul.schroy@bmc.org
93210|NCT01596504|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
93211|NCT01596231|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu
93212|NCT01596088|Kissei Pharmaceutical Co., Ltd|Clinical Development Division||rinsyousiken@pharm.kissei.co.jp
93213|NCT01596062|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
93214|NCT01595854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93215|NCT01595438|AstraZeneca/ PPD|Gayan Makumburage|9105588682|gayan.makumburage@ppdi.com
93216|NCT01595386|University of Alabama at Birmingham, Pediatric Cardiac Critical Care|Jeffrey Alten, M.D., Director of Clinical and Translational Research Department|205-975-3123|jalten@peds.uab.edu
93217|NCT01595282|PPLM|Principal Investigator|617-616-1600|
93218|NCT01594970|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
93219|NCT01594762|Dipexium Pharmaceuticals, Inc|Robert J DeLuccia|+19145226503|delucciarj@gmail.com
93220|NCT01594749|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93221|NCT01594515|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93222|NCT01594424|Cedars-Sinai Medical Center, Comprehensive Transplant Center|Jua Choi, PharmD|310-248-8186|jua.choi@cshs.org
93225|NCT01593215|RegionSkane|Anders Rosengren|+4640391169|anders.rosengren@med.lu.se
93226|NCT01594294|Alcon Research, Ltd.|Renee Garofalo, OD, FAAO|1-888-451-3937|alcon.medinfo@alcon.com
93227|NCT01594125|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93228|NCT01593852|Catharina Hospital Eindhoven|Lukas Dekker, MD, PhD|+31 40 239 7000|lukas.dekker@catharina_ziekenhuis.nl
93229|NCT01593787|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|
93230|NCT01593722|Laboratory of Parasitic Diseases, NIAID, NIH|Dr. Amy Klion|301-435-8903|aklion@niaid.nih.gov
93232|NCT01593592|Tropical Medicine Departement, Faculty of Medicine, Zagazig University, Egypt|Dr Mohamed Emara|+2 0100 272 4482|emara_20007@yahoo.com
93233|NCT01592864|GlaxoSmithKline|GSK Response Center|866-435-7343|
93234|NCT01592851|GlaxoSmithKline|GSK Response Center|866-435-7343|
93235|NCT01592786|Forest Research Institute|Joel Trugman, MD|201-427-8000 ext 8681|Joel.Trugman@frx.com
93236|NCT01592773|Forest Research Institute|Joel Trugman, MD|201-427-8681|Joel.Trugman@frx.com
93237|NCT01592760|Universtiy of Wisconsin School of Medicine and Public Health|Richard E. Galgon, MD, MS|608-263-8100|galgon@wisc.edu
93238|NCT01592708|UNC Chapel Hill|Dr. Jay Anderson, PI|919-966-5136|janderson@aims.unc.edu
93239|NCT01592695|University of Iowa|Mark Vander Weg, PhD|319-338-0581 ext 7717|mark-vanderweg@uiowa.edu
93240|NCT01592435|Carestream Health, Inc.|Susan Pate, MS, RN, RAC, Senior Manager, Clinical Affairs|585-627-6557|susan.pate@carestream.com
93241|NCT01592396|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com
93242|NCT01592344|Bioness|Charlene Myers, Contractor|9499101655|cahanderson@msn.com
93243|NCT01592292|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
93244|NCT01592071|University of Miami|Dr. John Lewis|(305) 243-6227|jelewis@miami.edu
93245|NCT01592045|United Therapeutics Corporation|Allison Lim|919-425-8799|alim@unither.com
93246|NCT01592006|University of Chicago Medical Center|Dr. Helen S. Te|773-702-2395|hte@medicine.bsd.uchicago.edu
93247|NCT01591954|Department of Biomedical Engineering, Johns Hopkins University|Jeffrey H. Siewerdsen, PhD / Professor of Biomedical Engineering|443-287-6269|jeff.siewerdsen@jhu.edu
93248|NCT01591863|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93250|NCT01591681|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D.|813-975-8690|jdrfapp2@jaeb.org
93251|NCT01591616|Virginia Commonwealth University, School of Dentistry|Tegwyn H. Brickhouse, DDS, PhD|(804) 827-2699|thbrickhouse@vcu.edu
93252|NCT01591499|CooperVision|Caroline Bonneville and Sandrine Cheneau, Study Managers|+33609202762|caroline.bonneville@coopervision-fr.com
93253|NCT01591460|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
93254|NCT01591408|NavalMCSD|Julie Onton|619-553-6228|julie.a.onton.ctr@mail.mil
93255|NCT01591382|Brigham and Women’s Hospital|Dr. Srdjan S. Nedeljkovic||snedeljkovic@partners.org
93256|NCT01591317|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
93257|NCT01591044|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com
93258|NCT01591018|University Hospital Ostrava|David Skoloudik|00420597375630|skoloudik@hotmail.com
93259|NCT01591005|University Hospital Ostrava|Prof. David Skoloudik, MD, Ph.D.|+420597375613|skoloudik@hotmail.com
93260|NCT01590979|Staten Island University Hospital, Northwell Health|Soad Bekheit, MD|718-226-6629|msills@northwell.edu
93261|NCT01590888|Prana Biotechnology|Dr Caroline Herd|+61393494906|info@pranabio.com
93263|NCT01590810|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93264|NCT01590797|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
93265|NCT01590771|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93266|NCT01590758|Dipexium Pharmaceuticals, Inc|Robert J DeLuccia|+19145226503|delucciarj@gmail.com
93268|NCT01590550|Loma Linda University|Rita Sheth, MD|909-558-8242|rsheth@llu.edu
93269|NCT01590264|Washington University in Saint Louis|Dr. Jay F. Piccirillo|314-362-8641|piccirilloj@ent.wustl.edu
93270|NCT01590238|New York Eye & Ear Infirmary|Anthony P Sclafani, MD|212-979-4200|asclafani@nyee.edu
93271|NCT01590212|University of Glasgow|Prof. Phil Wilson|+44 (0)1463 255892|p.wilson@abdn.ac.uk
93272|NCT01589978|Boston Scientific|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com
93273|NCT01589822|Ethicon|Director of Clinical Development|1 908 218-2492|JBatill2@its.jnj.com
93274|NCT01589653|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
93275|NCT01589601|Duke University Medical Center|Joseph G. Rogers, MD|919-681-1370|joseph.rogers@duke.edu
93276|NCT01589510|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
93277|NCT01589497|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
93278|NCT01589484|University of Sao Paulo Medical School|Dr. Fabio Torricelli|+55 11 94308951|fabio_torri@yahoo.com.br
93279|NCT01589445|Ministry of Science and Technology, Government of the People's Republic of Bangladesh|Dr. Masuma Parvin|88 01819141258|acmasuma@gmail.com
93280|NCT01589237|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
93281|NCT01588951|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Margaret Showel, MD|410-614-0675|mshowel1@jhmi.edu
93282|NCT01588561|McLean Hospital|Scott Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu
93283|NCT01588548|AstraZeneca|Karen Keating|+1 781 839 4182|karen.keating@astrazeneca.com
93284|NCT01588496|Amgen Inc.|Study Director|866-572-6436|
93285|NCT01588444|UT Health Sci Ctr San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu
93287|NCT01588405|United Therapeutics|Nicole Leedom|919-425-5870|nleedom@unither.com
93288|NCT01588353|XIA Project, Pharmaceuticals Sales Division, Asahi Kasei Pharma Corporation|Norihiro Tateishi, Manager|+81-3-3296-3641|xia_project@om.asahi-kasei.co.jp
93289|NCT01588158|Massachusetts General Hospital|Neal Chen, MD||nchen1@partners.org
93290|NCT01588106|GWT-TUD GmbH|Dr. Carsta Köhler|+49 (0) 351 25933 100|contact@gwtonline.de
93291|NCT01587989|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
93292|NCT01587963|Rutgers RWJMS|Vincente Gracias|732-235-7920|graciavh@rwjms.rutgers.edu
93293|NCT01587950|GlaxoSmithKline|GSK Response Center|866-435-7343|
93295|NCT01587885|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93296|NCT01587651|Daiichi Sankyo Medical Affairs|Fred Lipkin|973-944-2216|flipkin@dsi.com
93297|NCT01587118|Tuscaloosa Research and Education Advancement Corp|Sandra Creel|205-554-2000 ext 1-2840|sandra.creel@va.gov
93299|NCT01587079|Pearl Therapeutics, Inc|Colin Resiner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com
93300|NCT01587027|Medical Center of the Rockies|Gary Luckasen, M.D.|(970)624-1686|gary.luckasen@uchealth.org
93301|NCT01587014|Medical Center of the Rockies|Dr. Julie Dunn|970-624-1680|julie.dunn@uchealth.org
93302|NCT01587001|National Jewish Health|Nabeel Hamzeh|303-270-2613|hamzehn@njhealth.org
93303|NCT01586975|Northwestern University|Northwestern University|312.503.4394|r-bernstein@northwestern.edu
93304|NCT01586962|Novartis|Clinical Project Leader|+41223633111|
93305|NCT01586897|Massachusetts General Hospital|Steven J. Atlas, Director of Massachusetts General Primary Care Practice Based Research Network|617-724-4736|satlas@partners.org
93306|NCT01586819|Loyola University Chicago|Rebecca Tung, M.D.|708-216-8000|rtung@lumc.edu
93307|NCT01586806|Hospital for Special Surgery|Dr. Mary Chisholm|2126061206|chisholmm@hss.edu
93308|NCT01586364|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
93309|NCT01586338|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
93310|NCT01586312|Instituto de Biología y Genética Molecular (IBGM)|Professor Javier Garcia-Sancho|34 983 423 084|jgsancho@ibgm.uva.es
93311|NCT01586195|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
93312|NCT01586026|Bard Access Systems, Inc.|Christopher DiMatteo|801-522-5000|chris.dimatteo@crbard.com
93313|NCT01585987|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
93314|NCT01585961|Biosense Webster|Ellen Harris, Project Manager, Clinical Operations|909-839-7376|eharris8@its.jnj.com
93315|NCT01585779|Medtronic Coronary and Structural Heart|Shari Benoit|(763) 514-4000 ext 9749|shari.g.benoit@medtronic.com
93316|NCT01585597|Emory University|Christopher Horn|404 387 7320|cmhorn@emory.edu
93317|NCT01585584|University of Calgary|Dr. Samuel Lee|403-220-8457|samlee@ucalgary.ca
93318|NCT01585558|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
93319|NCT01585441|National Eye Institute|Emily Chew, MD|301-496-6583|emily.chew@nih.gov
93321|NCT01585324|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
93322|NCT01585272|Novartis Pharmaceutical|Study Director|862-778-8300|
93323|NCT01585246|Michigan State University|Dr. Gwen Wyatt|517-884-4630|gwyatt@msu.edu
93324|NCT01585038|Indiana University School of Medicine|Samir K Gupta, Md, MS|317-274-7926|sgupta1@iu.edu
93325|NCT01584843|GlaxoSmithKline|GSK Response Center|866-435-7343|
93326|NCT01584648|GlaxoSmithKline|GSK Response Center|866-435-7343|
93327|NCT01584544|Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College|Dr. Jing Jin|8601087788122|jingjin1025@163.com
93328|NCT01584518|Creighton University|Dr Anjan Talukdar|402-280-3586|talukdar.anjan@gmail.com
93329|NCT01584479|University of Michigan|William Giannobile, Principal Investigator|734-764-1562|wgiannob@umich.edu
93330|NCT01584388|MGH Rheumatology|John H Stone|617-726-7938|jhstone@partners.org
93331|NCT01584232|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
93332|NCT01583894|Boston Scientific Corporation|Nitzan Mekel-Bobrov, Director of Scientific Communications|6619494537|nitzan.mekel-bobrov@bsci.com
93333|NCT01583647|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93334|NCT01583543|Massachusetts General Hospital|Dr. Edwin Choy|617-724-4000|echoy@mgh.harvard.edu
93335|NCT01583530|GlaxoSmithKline|GSK Response Center|866-435-7343|
93336|NCT01583452|ITESM - Pediatrics Division|Gabriela López Jaimez|+527211476044|gabylopez7@gmail.com
93337|NCT01583374|Celgene Corporation|Anne McClain, Senior Study Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com
93338|NCT01583218|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000|
93339|NCT01583101|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu
93341|NCT01582945|Massachusetts General Hospital|Dr. Cristina Cusin|6177266421|ccusin@mgh.harvard.edu
93342|NCT01582880|Massachusetts Eye and Ear Infirmary|Dr. Joseph Ciolino, MD|617-573-4437|joseph_ciolino@meei.harvard.edu
93343|NCT01582854|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
93344|NCT01582789|CooperVision, US|Don Siegel, OD|623-544-3877|dsiegel@coopervision.com
93345|NCT01582490|Pacira Pharmaceuticals, Inc.|Erol Onel, MD|858-625-2424|erol.onel@pacira.com
93346|NCT01582477|St. Elizabeth's Medical Center|Andrew Sternlicht, MD|617-789-2777|andrew.sternlicht@steward.org
93347|NCT01582308|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93348|NCT01582282|Procter and Gamble|John McRorie, PhD|513-622-1423|mcrorie.jw@pg.com
93349|NCT01582243|Novartis Pharmaceuticals|Study Director|862-778-8300|
93350|NCT01582178|Vitkovice Hospital|Premysl Falt, MD|+420595633 ext 205|faltprem@centrum.cz
93351|NCT01582139|University of Virginia|Marc D Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu
93352|NCT01582100|Northwestern University|Christine Ebert Nelson|3126954513|c-ebert@northwestern.edu
93353|NCT01582009|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
93354|NCT01581931|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93355|NCT01581684|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93356|NCT01581658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93358|NCT01581541|Stanford University School of Medicine|Dr. Shivaani Kummar|650-724-9084|skummar@stanford.edu
93359|NCT01581437|Virginia CU|Kenneth Ellenbogen|804-828-7565|kellenbogen@mcvh-vcu.edu
93360|NCT01581307|H. Lee Moffitt Cancer Center and Research Institute|Dr. Sarah Hoffe|813-745-4380|sarah.hoffe@moffitt.org
93361|NCT01581281|Cincinnati Children's Hospital Medical Center|Scott Powers, PhD|513-636-8106|scott.powers@cchmc.org
93362|NCT01581021|University of Mississippi Medical Center|Dr. Lawrence Haber|601-984-6525|lhaber@umc.edu
93363|NCT01581008|VA Eastern Colorado Health Care System|David Bekelman, MD, MPH|720-857-5088|david.bekelman@va.gov
93364|NCT01580995|VAORD|Mary Jane Burton|6013624471|mary.burton2@va.gov
93365|NCT01580904|Universidade Estadual da Paraíba|Impacto da Atenção Farmacêutica em pacientes diabéticos (IPCD)|558387010977|patriciatrindad@yahoo.com.br
93366|NCT01580618|Kaiser Permanente|Hyo-Chun Yoon, MD, PHD|8084327342|Hyo-Chun.Yoon@nsmtp.kp.org
93367|NCT01580592|Charité – University of Berlin; Dpt. of Dermatology and Allergy|Professor Dr. Martin Metz|+49 30 450 518 159|martin.metz@charite.de
93368|NCT01580488|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com
93369|NCT01580423|Dartmouth-Hitchcock Medical Center|Donald A. Mahler|603 650-5533|Donald.a.mahler@hitchcock.org
93370|NCT01580306|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93371|NCT01580098|Landeskrankenanstalten-Betriebsgesellschaft|Dr. Hannes Steinberger|+4346355212 50303|hannes.steinberger@kabeg.at
93372|NCT01580072|Landeskrankenanstalten-Betriebsgesellschaft|Dr. Hannes Steinberger|+4346355212 50303|hannes.steinberger@kabeg.at
93373|NCT01580020|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
93374|NCT01579916|MedImmune, LLC|Raburn Mallory, MD/Senior Director Clinical Development|301-398-0000|malloryr@medimmune.com
93375|NCT01578850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93376|NCT01579747|Univeristy of New Mexico|Nicholas Lam|505 272 2610|nlam@salud.unm.edu
93377|NCT01579669|Portland State University|Christina Nicolaidis, MD, MPH|5037259603|nicol22@pdx.edu
93378|NCT01579578|AstraZeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com
93379|NCT01579565|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com
93380|NCT01579474|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93381|NCT01579305|Allergan, Inc.|Medical Monitor|805 961 5000|devicetrials@allergan.com
93382|NCT01579084|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
93383|NCT01579045|Vistakon/Johnson & Johnson Vision Care|Katherine Osborn Lorenz, OD MS|904-443-3123|kosborn@its.jnj.com
93384|NCT01579006|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
93385|NCT01578993|Semprus BioSciences|Ulla Wallin, Director of Clinical Research|1-617-577-2205|ulla.wallin@semprusbio.com
93386|NCT01578980|University of Virginia|Boris Kovatchev, PhD|434-924-5592|bpk2u@virginia.edu
99007|NCT00321763|GlaxoSmithKline|GSK Response Center|866-435-7343|
93387|NCT01578785|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
93388|NCT01578772|UCLA|Dr. Jordan Lake|310-557-2273|jlake@mednet.ucla.edu
93389|NCT01578707|Pharmacyclics LLC|Dr. George Cole|408-990-7340|gecole@pcyc.com
93390|NCT01578330|Novartis|Study Director|862-778-8300|trialandresults.registries@novartis.com
93392|NCT01578187|Syneron Beauty|Doran Rozen, Director of Clinical Affairs|+972-54-7800260|Doran.Rozen@syneron.com
93393|NCT01578044|VA Eastern Colorado Health Care System|P. Michael Ho|720-857-2115|michael.ho@va.gov
93394|NCT01578031|University of Pennsylvania|Samuel T. Kuna, MD|215-823-4400|skuna@mail.med.upenn.edu
93395|NCT01577966|UAB|Burt Nabors, MD|205-934-2424|bnabors@uabmc.edu
93396|NCT01577758|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com
93397|NCT01577745|MedImmune, LLC|Mohammed Dar|301-398-1008|information.center@astrazeneca.com
93398|NCT01577732|GlaxoSmithKline|GSK Response Center|866-435-7343|
93399|NCT01577706|McLean Hospital|Dr. J. Eric Jensen|617-855-3366|ejensen@mclean.harvard.edu
93400|NCT01577628|Innovaderm Research|Dr Robert Bissonnette|514-521-4285|rbissonnette@innovaderm.ca
93401|NCT01577381|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93402|NCT01577329|University of Michigan|Roxane Raffin Chan|7344780170 ext 734|roxchan@comcast.net
93403|NCT01577186|Janssen Research & Development|Medical Director|886 2 23762155|
93404|NCT01577160|Janssen Research & Development|Medical Director|886 2 23762155|
93405|NCT01577108|China Medical University Hospital|Ming Ho, MD|886422052121 ext 2063|mi.ho@msa.hinet.net
93406|NCT01576952|InSite Vision|Director of Clinical Trials|510-747-1269|jhutcheson@insite.com
93407|NCT01576939|Stanford University|Quynh Le|650-725-0203|qle@stanford.edu
93408|NCT01576809|Novartis Consumer Health|Clinical project Leader|41223633111|
93409|NCT01576718|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
93410|NCT01576471|Coronado Biosciences|Vice President, Clinical Operations|7816524516|nsilver@coronadobio.com
93411|NCT01576367|Novartis Pharmaceuticals|Study Director|862-778-8300|
93412|NCT01576341|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com
93413|NCT01576159|Middle East Technical University|Ozgur Celik PhD.|+903122104016 ext 3663|ozgur@udel.edu
93414|NCT01576146|Amgen, Inc|Study Director|866-572-6436|
93415|NCT01576120|Given Imaging|"Ravit Peled | Clinical Trials Manager"|+972 (4) 909-7894 ext 7894|Ravit.peled@covidien.com
93417|NCT01576042|Duke Clinical Research Institute|Sana M. Al-Khatib, MD, MHS|919-668-8649|sana.alkhatib@dm.duke.edu
93418|NCT01575912|Centre Hospitalier Esquirol|Dr Murielle Girard|0033555431028|murielle.girard@ch-esquirol-limoges.fr
93419|NCT01575899|Buddhist Tzu Chi General Hospital|Dr. Ming-Cheh, Chen|+886-910-521003|MingCheh_chen@tzuchi.com.tw
93420|NCT01575769|Hoffmann-LaRoche or Genentech, Inc|Medical Communications|800 821-8590|genentech@druginfo.com
93421|NCT01575756|Octapharma USA|Director of Clinical Operations|201 604-1149|sylvia.werner@octapharma.com
93422|NCT01575561|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com
93423|NCT01575522|Dana-Farber Cancer Institute|Sara M. Tolaney, MD, MPH|617.632.5743|Sara_Tolaney@dfci.harvard.edu
93424|NCT01575197|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org
93425|NCT01575080|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com
93426|NCT01575054|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
93427|NCT01575028|Nationwide Children's Hospital|Tarun Bhalla|(614) 722-4200|Tarun.Bhalla@NationwideChildrens.org
93428|NCT01574703|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93429|NCT01574651|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
93430|NCT01574612|Meda Pharmaceutical|David Ginsberg, DO|732 564 2200|ginsberg.david@gmail.com
93431|NCT01574326|Genzyme Corporation|Trial Transparency Team||Contact-US@sanofi.com
93432|NCT01574248|Vanderbilt University Medical Center|Nancy J. Brown, M.D.|6153438701|nancy.j.brown@vanderbilt.edu
93433|NCT01574183|MUSC|Aimee McRae-Clark, PharmD|843-792-5216|mcraeal@musc.edu
93434|NCT01574105|Saskatoon Health Region|Mark Rosin|306-655-2128|mark.rosin@sasktoonhealthregion.ca
93435|NCT01574079|University of Mississippi Medical Center|Principle investigator|601-984-6369|lbarnes@umc.edu
93436|NCT01573910|Alcon Research, Ltd.|Firoz Vohra, Project Head, Pharma|1-888-451-3937|alcon.medinfo@alcon.com
93437|NCT01573767|GlaxoSmithKline|GSK Response Center|866-435-7343|
93438|NCT01573624|GlaxoSmithKline|GSK Response Center|866-435-7343|
93439|NCT01573325|Northwestern Memorial Hospital|Rebecca Duke DNP, MSN, NP-BC Transplant Surgery Nurse Practitioner|3126951686|rduke@nmh.org
93440|NCT01573260|McGill University|Dr.Ronald B Postuma|514-934-8026|ron.postuma@mcgill.ca
93441|NCT01573000|GlaxoSmithKline|GSK Response Center|866-435-7343|
93442|NCT01572948|University of Alabama at Birmingham, Division of Pulmonary, Allergy, and Critical Care Medicine|J. Michael Wells, M.D.|205-934-6047|jmwells@uab.edu
93443|NCT01572792|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com
93444|NCT01572740|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
93445|NCT01572727|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
93446|NCT01572675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93448|NCT01572207|Case Western Reserve University|Matthew Plow|216-368-8969|map208@case.edu
93449|NCT01571557|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
93450|NCT01571453|Study Director|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com
93451|NCT01571362|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93452|NCT01571232|Retina Macula Institute|Ron P. Gallemore M.D., Ph.D.|310-944-9393|rongallemoremd@gmail.com
93453|NCT01570751|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
93454|NCT01570686|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
93455|NCT01570634|Salient Pharmaceuticals Incorporated|Richard scruggs|7135899859|rscruggs@salientpharmaceuticals.com
93456|NCT01570309|Jacobi Medical Center|Dr Seth I Sokol|718-918-5735|seth.sokol@nbhn.net
93457|NCT01570244|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93459|NCT01569841|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
93460|NCT01569828|Novartis Pharmaceuticals|Study Director|862-778-8300|
93461|NCT01569815|Novartis Pharmaceuticals|Study Director|862-778-8300|
93462|NCT01569763|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|Eugenes@minervasurgical.com
93463|NCT01569568|Children's National Medical Center|Dr. Andrea Gropman|202-476-2120|agropman@childrensnational.org
93464|NCT01569529|University of Illinois at Chicago, Institute for Health Research and Policy|Dr. Robin Mermelstein|312 996-1469|robinm@uic.edu
93465|NCT01569464|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493|
93466|NCT01569438|Afferent Pharmaceuticals|Clinical Development|650-286-1276|info@afferentpharma.com
93467|NCT01569152|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinialTrialsDisclosure@merck.com
93468|NCT01569126|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
93469|NCT01569087|Biocad|Roman Ivanov, Director of Clinical Trials|+7 (812) 380 49 33 ext 950|ivanov@biocad.ru
93470|NCT01569074|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
93471|NCT01568905|University of Minnesota Tobacco Research Programs|Dorohty Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu
93472|NCT01568892|GlaxoSmithKline|GSK Response Center|866-435-7343|
93473|NCT01568866|Amgen, Inc.|Study Director|866-572-6436|
93474|NCT01568827|The Ohio State University|Dr. Joseph Kitzmiller|6142928438|joseph.kitzmiller@osumc.edu
93475|NCT01568593|Laboratoires Thea|Dr Pascale POULIQUEN|0473981436|p.pouliquen@laboratoires-thea.fr
93476|NCT01568424|St. Jude Medical|Poornima Sood|+1.781.852.8334|psood@sjm.com
93477|NCT01568112|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
93478|NCT01568073|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
93479|NCT01568047|BIAL – Portela & Cª S.A.|Head of Clinical Research|+351-229866100|clinical.trials@bial.com
93480|NCT01568034|BIAL – Portela & Cª S.A.|Head of Clinical Research|+351-229866100|clinical.trials@bial.com
93481|NCT01568021|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
93482|NCT01568008|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
93483|NCT01567943|Washington State University|Michael McDonell|509 368-6967|mmcdonell@wsu.edu
93484|NCT01567852|University of NewMexico|Dr. Tony Yen|505-272-2610|tyen@salud.unm.edu
93485|NCT01567839|The Ohio State University, Division of Endodontics|Dr. John Nusstein|614-292-9412|nusstein.1@osu.edu
93486|NCT01567826|Icahn School of Medicine at Mount Sinai|Dr. Pedro R. Moreno||pedro.moreno@mountsinai.org
93487|NCT01567371|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org
93488|NCT01567163|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
93489|NCT01567150|Hollister Incorporated|Director, Global Clinical Affairs|8479183996|ginger.salvadalena@hollister.com
93490|NCT01567020|VA Portland Health Care System|Dr. Frederick Gallun|5032208262 ext 57472|Frederick.Gallun@va.gov
93491|NCT01566981|Department of family medicine, Medical Faculty in Ljubljana|Dr. Rade Iljaž|'386 31 300- 381|radeiljaz@gmail.com
93492|NCT01566838|Cardiac, Vascular, and Thoracic Surgery Associates|Sandeep Khandhar, MD|703-280-5858|SKhandhar@CVTSA.com
93493|NCT01566721|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com
93494|NCT01566630|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
93495|NCT01566604|Novartis|Study Director|862-778-8300|
93496|NCT01566539|Emory University|Dr. James Rilling|404-727-3062|jrillin@emory.edu
93497|NCT01566526|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
93498|NCT01566500|Columbia University|Marie Chesaniuk|212-854-0127|mc3333@columbia.edu
93499|NCT01566461|Medtronic Endovascular Therapies|Arslan Malik, Sr. Clinical Research Manager||arslan.malik@medtronic.com
93500|NCT01566435|Washington University School of Medicine|Douglas Adkins, M.D.|314-747-7402|dadkins@wustl.edu
93501|NCT01566409|Pediatric Department, Hospital Lillebaelt, Kolding|Dr. Line Modin|0045 61386349|line.modin@rsyd.dk
93502|NCT01566370|Yale/VA Connecticut Healthcare system|Albert Arias|2039325711 ext 8155|albert.arias@va.gov
93503|NCT01566331|University of Padua|Dr. Erich Cosmi|+393398146745|ecosmi@hotmail.com
93504|NCT01566162|Sunovion|Medical Director CNS Clinical Trials|1-866-503-6351|clinicaltrialdisclosure@sunvion.com
93505|NCT01566149|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
93506|NCT01566084|University of Colorado Denver|Dr. Kristen Jablonski|303-724-4842|KRISTEN.NOWAK@UCDENVER.EDU
93507|NCT01565993|Hospital Universitario Severo Ochoa|Dra Elvira Quintanilla|34 914818000 ext 8326|elviramquintanilla@hotmail.com
93508|NCT01565980|Michigan State University College of Nursing|Rebecca H. Lehto, PhD, Assistant Professor|517-353-4757|rebecca.lehto@hc.msu.edu
93510|NCT01565889|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
93511|NCT01565850|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
93512|NCT01565707|Astellas Pharma Europe B.V.|Medical Director, Medical Science - Urology||Astellas.resultsdisclosure@astellas.com
93514|NCT01565564|Tianjin Medical University|Dr. Xilin Yang|+86 22 83336727|yangxilin@tijmu.edu.cn
93515|NCT01565551|University of California, San Francisco|Geoffrey Manley, MD, PhD|415-206-8300|manleyg@neurosurg.ucsf.edu
93516|NCT01565538|Sun Yat-sen University Cancer Center|Dr. Si-Yu Wang|020-87343439|wsysums@163.net
93517|NCT01565382|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
93518|NCT01565369|Avid Radiopharmaceuticals|Chief Medical Officer|215-798-0700|clinicaloperations@avidrp.com
93519|NCT01565356|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
93520|NCT01565343|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
93521|NCT01565330|Avid Radiopharmaceuticals|Chief Medical Officer|215-290-0700|clinicaloperations@avidrp.com
93522|NCT01565291|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
93523|NCT01565148|University of Nebraska|Quan Dong Nguyen|4025592020|quan.nguyen@unmc.edu
93524|NCT01565083|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
93525|NCT01564953|Aarhus University Hospital|Dr. Sarah Hashim Ali Hussein|0045 42660308|sarsuri@hotmail.com
93526|NCT01564862|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
93527|NCT01564758|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93528|NCT01564732|Duke University Medical Center|Dana Portenier, M.D.|919-470-7031|dana.portenier@duke.edu
93529|NCT01564706|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
93530|NCT01564693|SAPIENZA UNIVERSITY OF ROME|PROF. ALESSANDRO LAVIANO|+390649973902|alessandro.laviano@uniroma1.it
93531|NCT01564537|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
93532|NCT01564459|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93533|NCT01564407|University of Pittsburgh|Amy Steele, RN, MSN, CCRC|412-641-3728|steeleam@upmc.edu
93534|NCT01564394|Huntsman Cancer Institute, University of Utah|Anita Y. Kinney, PhD|801-585-1151|anita.kinney@hci.utah.edu
93535|NCT01563978|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44-1625-512415|dave.goldstraw@astrazeneca.com
93536|NCT01563536|AbbVie|Global Medical Services|800-633-9110|
93537|NCT01563406|Rush University Medical Center|Mary Hayden, MD|3129428727|mhayden@rush.edu
93538|NCT01563198|Hypnalgesics, LLC d/b/a Comfort Talk|Elvira V. Lang, MD (PI of SBIR grant)|617 734 9087|drevlang@gmail.com
93539|NCT01563185|Horizon Pharma|Julie Ball, Senior Director of Clinical Development & Operations|224-383-3059|jball@horizonpharma.com
93540|NCT01563172|GlaxoSmithKline|GSK Response Center|866-435-7343|
93541|NCT01563081|GlaxoSmithKline|GSK Response Center|866-435-7343|
93542|NCT01563055|GlaxoSmithKline|GSK Response Center|866-435-7343|
93543|NCT01563029|GlaxoSmithKline|GSK Response Center|866-435-7343|
93544|NCT01563003|University of South Florida|Eric Storch, Ph.D.|727-767-8230|estorch@health.usf.edu
93545|NCT01562886|Imperial College London|Dr Borja Mora Peris|020 3312 6789|b.mora-peris@imperial.ac.uk
93546|NCT01562873|Dana-Farber Cancer Institute|Nancy Lin, MD|617.632.2335|Nancy_Lin@dfci.harvard.edu
93547|NCT01562756|Palmer College of Chiropractic|Ting Xia, PhD (Principal Investigator)|563-884-5161|Ting.Xia@palmer.edu
93548|NCT01562743|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-6361-7366|
93549|NCT01562678|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|617-667- 8630|cmantzor@bidmc.harvard.edu
93550|NCT01562613|Abbott|Taco Baardman||taco.baardman@abbott.com
93551|NCT01562548|GlaxoSmithKline|GSK Response Center|866-435-7343|
93552|NCT01562327|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
93553|NCT01562314|GW Research Ltd.|Clinical Operations Director|+44 (0)1980 557000|rp@gwpharm.com
93554|NCT01562275|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
93555|NCT01562132|Yale University|Dr. Ana-Claire Meyer|203-737-8372|ana-claire.meyer@yale.edu
93556|NCT01561898|Janssen Pharm KK Japan|Medical Director|03-4411-5067|
93557|NCT01561716|University of Rochester|Dr. Isabel D Fernandez|585-275-9554|Diana_Fernandez@URMC.Rochester.edu
93558|NCT01561703|University of Missouri - Department of Otolaryngology - Head and Neck Surgery|Research Coordinator|5738822549|schneiderri@health.missouri.edu
93559|NCT01561560|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com
93560|NCT01561469|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93561|NCT01561313|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
93562|NCT01561300|Unilever R&D Vlaardingen|Dr Theo Mulder|+31 10 460 8315|theo.mulder@unilever.com
93563|NCT01561079|Johns Hopkins University School of Medicine|Dr. Lauren M Jansson|410-550-5438|ljansson@jhmi.edu
93564|NCT01560988|Brigham and Women's Hospital|Dr. Joshua Boyce|617-525-1261|jboyce@partners.org
93565|NCT01560975|NYEE|Dr. Robert Ritch|+1 212 477 7540|ritchmd@earthlink.net
93566|NCT01560819|Helen DeVos Children's Hospital of Spectrum Health Hospitals|Dr. Sachin Kunde|616-267-2100|sachin.kunde@helendevoschildrens.org
93567|NCT01560507|Duke University Medical Center|Dr. Jed Rose|919-668-5055|jed.rose@duke.edu
93568|NCT01560429|Queen's University|Dr. Vidur Shyam|(613) 548-7827|shyamv@kgh.kari.net
93569|NCT01560403|NPS Pharmaceuticals, Inc.|Executive Director, Clinical Development|908-450-5300|info@npsp.com
93570|NCT01560260|Sarcoma Alliance for Research through Collaboration (SARC)|Kristen Nuyen, Research Project Manager|734-930-7600|sarc@sarctrials.org
93571|NCT01560234|AstraZeneca R&D|Ajay Aggarwal||ClinicalTrialTransparency@astrazeneca.com
93572|NCT01560143|University of Michigan|Manjunath Pai|7346473466|amitpai@med.umich.edu
93573|NCT01559935|Weill Cornell Medicine|Jennifer Hess|6469629440|jmh2004@med.cornell.edu
93574|NCT01559922|Suneva Medical, Inc.|Suneva Medical,Inc.||Acne.ScarInfo@sunevamedical.com
93575|NCT01559857|Stanford University|Dr. Natalie Rasgon|6507249694|natalie.rasgon@stanford.edu
93576|NCT01559844|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
93577|NCT01559675|Cedars Sinai Medical Center|Dr. Phillip Fleshner|310-289-9224|pfleshner@aol.com
93578|NCT01559649|Michael E. DeBakey VA Medical Center|Stephanie Daniels|713-743-2570|skdaniels@uh.edu
93579|NCT01559506|Nimbic Systems|Sean Self|281-565-5715|self@nimbicsystems.com
93580|NCT01559454|University at Buffalo|Dr. Ricahrd Blondell|716-816-7237|blondell@buffalo.edu
93581|NCT01559311|St. Jude Medical (Hong Kong) Ltd|Clinical Project Leader Asia|29967605|lyim@sjm.com
93582|NCT01559116|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93583|NCT01559064|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com
93584|NCT01559012|Città della Salute e della Scienza Ospedale Sant'Anna. Servizio di Medicina Interna|Dr. Aldo Maina M.D. Obstetric Medicine|0039011313 ext 5735|amaina@cittadellasalute.to.it
93585|NCT01558791|National Center for PTSD|Dr. Jessica Hamblen, PI|802-296-5132 ext 5389|Jessica.Hamblen@va.gov
93586|NCT01558739|Novartis Pharmaceuticals|Study Director|862-778-8300|
93587|NCT01558700|Northwestern University|Apkar Vania Apkarian|(312) 503-0404|a-apkarian@northwestern.edu
93588|NCT01558674|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93589|NCT01558596|Minneapolis VA Medical Center|Santiago Garcia, MD|6124673670|santiago.garcia@va.gov
93590|NCT01558492|Weill Cornell Medicine|Himisha Beltran, MD|646-962-2072|hip9004@med.cornell.edu
93591|NCT01558297|Yale Medical School|Dr. Rachel Barnes|2037856395|rachel.barnes@yale.edu
93592|NCT01558271|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
93593|NCT01558128|Weill Cornell Medicine, Department of Anesthesiology|Michele Steinkamp, Research Nurse Specialist|212-746-2953|mls9004@med.cornell.edu
93594|NCT01558089|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com
93595|NCT01557959|Wake Forest Baptist Health|Dr. William J. Petty|336-716-3313|wpetty@wakehealth.edu
93596|NCT01557946|McLean Hospital, Biological Psychiatry Laboratory|Dr. Brian Brennan, MD|617-855-2911|bbrennan@partners.org
93597|NCT01557920|Massachusetts General Hospital|Dr. Matthias Eikermann|6176434408|meikermann@partners.org
93598|NCT01557894|Babes-Bolyai University|Bogdan Tudor Tulbure|+40745753061|btulbure@gmail.com
93599|NCT01557868|American Orthopaedic Society for Sports Medicine|Dr. Barton Mann|847-292-4900|bart@aossm.org
93600|NCT01557842|Biosense Webster, Inc.|Karen Cropper, Manager, Clinical Operations|(800) 729-9010 ext 8607|Kcropper@its.jnj.com
93601|NCT01557699|SERUM INSTITUTE OF INDIA LIMITED|Dr Prasad Kulkarni|+912026602384|drpsk@seruminstitute.com
93603|NCT01557582|VentriPoint, Inc.|Jim bodtke, Vice President Clinical Affairs and Development|206-283-0221|jbodtke@ventripoint.com
93604|NCT01557569|UAMS|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu
93605|NCT01557504|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93606|NCT01557348|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
93607|NCT01557322|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93608|NCT01557283|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93610|NCT01556997|Symplmed Pharmaceuticals LLC|Jeff Feldstein, Sr. Vice President and CMO|888-552-9769|feldstein@symplmed.com
93611|NCT01556932|Virginia Commonwealth University/ Hospice & Pallative Medicine|Devon S. Flecher, MD|804-828-9723|dsfletcher@mcvh-vcu.edu
93612|NCT01556906|Aegerion Pharmaceutical|Chief Medical Officer|617-500-7867|
93613|NCT01556763|EnVivo Pharmaceuticals, Inc.|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|617-225-4264|mgawryl@envivopharma.com
93614|NCT01556724|University of Pittsburgh|Susan Sandusky|412-383-1036|sis127@pitt.edu
93615|NCT01556633|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
93616|NCT01556594|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
93617|NCT01556451|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93618|NCT01556204|Cleveland Clinic|Tommaso Falcone, M.D.|216-444-1752|falcont@ccf.org
93619|NCT01556165|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com
93620|NCT01556061|University of Texas at Houston Medical School/ Dept. of Anesthesiology|Dr. Davide Cattano MD PhD|713-500-6235|davide.cattano@uth.tmc.edu
93621|NCT01555983|UC Davis (currently at UC San Diego)|Barth Wilsey MD|916-402-2270|bwilsey@ucsd.edu
93622|NCT01555931|University of North Carolina School of Medicine|Dr. Gretchen Stuart|919-962-4880|gstuart@med.unc.edu
93623|NCT01555567|University of Michigan|Riann Palmieri-Smith|7346153154|riannp@umich.edu
93624|NCT01555463|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
93625|NCT01555164|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
93626|NCT01555151|Novartis Pharmaceuticals|Clinical Disclosure Office|+1(862)778-8300|
93627|NCT01555138|Novartis Pharmaceuticals|Study Director|862-778-8300|
93628|NCT01555073|Northwestern University, Feinberg School of Medicine|Antoun Nader, MD|312-695-3045|a-nader2@northwestern.edu
93629|NCT01554982|Keryx|Lisa Loram|919-434-6195|lisa.loram@keryx.com
99496|NCT00353795|NIH|David Bluemke|301 402 1854|bluemked@nih.gov
93630|NCT01554904|University of Florida|Richard B Berry, M.D. Principal Investigator|3522621575|Richard.Berry@medicine.ufl.edu
93631|NCT01554891|Geisel School of Medicine at Dartmouth|Laura A. Flashman, Ph.D.|6036505824|flashman@dartmouth.edu
93632|NCT01554579|Afferent Pharmaceuticals|Clinical Development|650-286-1276|info@afferentpharma.com
93633|NCT01554241|University of California, San Francisco|Janice B.Schwartz, M.D., Professor of Medicine|(415) 406-1573|janice.schwartz@ucsf.edu
93634|NCT01554176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93635|NCT01554163|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93636|NCT01553851|Washington University School of Medicine|Dr. Douglas Atkins|314-747-8475|datkins@dom.wustl.edu
93637|NCT01552772|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
93639|NCT01552681|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
93640|NCT01553708|Faculty of Pharmaceutical Sciences, Chulalongkorn University|Associate Prof. Pornanong Aramwit, Pharm.D., Ph.D.|+66-02-218-8409|paramwit@gmail.com
93641|NCT01553539|Wake Forest University Health Sciences|Dr. William J. Petty|336-716-3313|wpetty@wakehealth.edu
93642|NCT01553318|Wake Forest Baptist|dennis ang|336-716-4209|dang@wakehealth.edu
93643|NCT01553292|University of Manitoba|Dr Yahya Al Ethawi|0012049634721|yalethawi@hsc.mb.ca
93644|NCT01553240|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu
93645|NCT01552954|Department of Internal Medicine, Seoul National University Bundang Hospital|Ho Jun Chin|+82-10-7360-7025|mednep@snubh.org
93646|NCT01552928|Shire Development LLC|Study Physician|+1 866 842 5335|
93647|NCT01552915|Shire Development LLC|Study Physician|+1 866 842 5335|
93648|NCT01552902|Shire|Study Physician|1 866-842-5335|
93649|NCT01552889|Washington University School of Medicine|Dr. Robert Carney|314-286-1313|carneyr@wustl.edu
93650|NCT01552876|Johnson & Johnson Vision Care|Katherine Osborn OD, MS FAAO|1 904 443-1032|kosborn@its.jnj.com
93651|NCT01552603|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com
93652|NCT01552343|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
93653|NCT01552057|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
93654|NCT01551979|Beth Israel Deaconess Medical Center|Mark Halko|6176670367|mhalko@bidmc.harvard.edu
93655|NCT01551888|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com
93656|NCT01551758|GlaxoSmithKline|GSK Response Center|866-435-7343|
93657|NCT01551693|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu
93658|NCT01551355|Icahn School of Medicine at Mount Sinai|Dr. Valentin Fuster|212-241-3852|valentin.fuster@mssm.edu
93659|NCT01551303|Massachusetts General Hospital|Dr. Elizabeth Hoge|617-724-0859|ehoge@partners.org
93660|NCT01551199|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 791-1414 ext 25513|ellen.teng@va.gov
93661|NCT01551173|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
93662|NCT01551095|Johns Hopkins University|Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu
93663|NCT01551082|Alliance of Cardiac Vascular and Thoracic Surgeons|Jeremy Smith RN|4236245200|jsmith@actvsurgeons.com
121656|NCT00098020|National Institutes of Diabetes, Digestive, and Kidney Disorders|Dr. Jeffery Kopp|301-594-3403|koppj@mail.nih.gov
93665|NCT01550965|AbbVie|Global Medical Information|800-633-9110|
93666|NCT01550952|Hospital for Special Surgery|Dr. Jacques YaDeau|2127742224|yadeauj@hss.edu
93667|NCT01550809|Departamento de Endocrinología y Nutrición, Hospital Clínico Universitario de Valencia, Universitat de València, Valencia, Spain|Francisco Javier Ampudia Blasco|+34 96 3862665|Francisco.J.Ampudia@uv.es
93668|NCT01550744|Janssen Biotech, Inc|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com
93669|NCT01550705|University of Utah|John D. Phillips, Ph.D.|801-581-6650|john.phillips@hsc.utah.edu
93670|NCT01550549|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
93671|NCT01550302|University of Washington|Srdjan Jelacic|(206) 598-3777|sjelacic@uw.edu
93672|NCT01550289|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
93673|NCT01549977|Takeda|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
93674|NCT01549964|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com
93675|NCT01549951|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com
93676|NCT01549925|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu
93677|NCT01549873|Nationwide Children's Hospital|David Martin, MD|614-722-4200|David.Martin@nationwidechildrens.org
93678|NCT01549860|VP Medical Affairs|Pamela Unger|(952) 224-8755|punger@celleration.com
93679|NCT01549613|University of Cincinnati, Dept. of Emergency Medicine|George J. Shaw, MD, PhD|513-558-8098|shawge@ucmail.uc.edu
93680|NCT01549405|Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital|Dr Derya Özkan|00903125962553|derya_z@yahoo.com
93681|NCT01549392|London Health Sciences Hospital|Barbara Fisher|519-685-8650|barbara.fisher@lhsc.on.ca
93682|NCT01549340|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
93683|NCT01549275|Kaohsiung Medical University Hospital|Dr. Zu-Yau LIn|886-7-323-4553|linzuyau@yahoo.com.tw
93684|NCT01549223|Brigham and Women's Hospital|Lawrence Tsen, MD|617-732-8216|ltsen@partners.org
93685|NCT01549041|DukeUMC|Joseph P McEvoy, MD|9198199295|JPMCEVOY@DUKE.EDU
93686|NCT01549002|ColumbiaU|Dr. Daniel Fenster|212-305-9825|dbf2114@columbia.edu
93687|NCT01548885|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com
93688|NCT01548833|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com
99497|NCT00353873|GlaxoSmithKline|GSK Response Center|866-435-7343|
121657|NCT00065065|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu
93689|NCT01548742|Minneapolis VA Medical Center|Kelvin O. Lim, MD (Principal Investigator)|612-467-3323|kolim@umn.edu
93690|NCT01548638|University of Pennsylvania Perelman School of Medicine|Dr. Rebecca Ashare|2157465789|rlashare@mail.med.upenn.edu
93691|NCT01548573|University of Iowa|Guido Tricot, MD, PhD|319-356-3425|guido-tricot@uiowa.edu
93692|NCT01548417|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu
93693|NCT01548287|AstraZeneca Pharmaceuticals LP, Neuroscience iMed|Joel Posener, MD||clinicaltrialtransparency@astrazeneca.net
93694|NCT01547806|National Cancer Institute|Dr. Daniel H. Fowler|240-760-6164|dhfowler@helix.nih.gov
93695|NCT01547728|Mayo Clinic Rochester|Dr. William Oliver|507-255-4240|oliver.william@mayo.edu
93696|NCT01547715|Novartis Vaccines and Diagnostics SRL|Posting Director||RegistryContactVaccinesUS@novartis.com
93697|NCT01547598|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
93700|NCT01547247|Digestive Diseases Center, Vítkovice Hospital, Ostrava, Czech Republic|Přemysl Falt MD|+420602689561|faltprem@centrum.cz
93701|NCT01547130|Wyckoff Heights Medical Center|Dr Vijaypal Arya|718-326-0400|varyamd@yahoo.com
93702|NCT01546922|University Medical Center Groningen|A. P. van Beek, MD PhD|00315036110388|a.p.van.beek@umcg.nl
93703|NCT01546883|University of Utah|Clinical Research Manager|8015873889|christina.pacchia@hsc.utah.edu
93704|NCT01546688|Eisai Call Center|Eisai Inc.|888-422-4743|
93705|NCT01546675|Department of Veterans Affairs|Linda Resnik, PT, PhD|401-273-7100 ext 2368|linda.resnik@va.gov
93706|NCT01546649|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
93707|NCT01546636|NorthShore University HealthSystem|Glenn Murphy, MD, Director of Clinical Research|847-570-2760|gmurphy@northshore.org
93708|NCT01546623|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com
93709|NCT01545388|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93710|NCT01545375|GlaxoSmithKline|GSK Response Center|866-435-7343|
93711|NCT01546519|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
93712|NCT01546454|University of Arizona|Dr. Randy Bogan|520-621-1487|boganr@email.arizona.edu
93713|NCT01546402|Post Graduate Institute of Medical Education and Research|Aniruddha Agarwal|+911722756111|aniruddha9@gmail.com
93714|NCT01546285|GE Healthcare|Jeffrey Conner - Global Research Manager|414.721.2423|Jeffrey.Conner@ge.com
93715|NCT01546207|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y. Reddy|212-241-7114|vivek.reddy@mountsinai.org
93716|NCT01546194|NorthShore University HealthSystem|Glenn Murphy|847-570-2760|dgmurphy2@yahoo.com
93717|NCT01546155|Massachusetts General Hospital|Dr. Jian Kong|617-726-7893|JKONG2@mgh.harvard.edu
93718|NCT01546142|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com
93720|NCT01545765|Galderma|Farzaneh Sidou Clinical Project Manager)|00.33.4.93.95.70.70|farzaneh.sidou@galderma.com
93721|NCT01545700|NorthShore University HealthSystem|Glenn S. Murphy, MD|847-570-2760|dgmurphy2@yahoo.com
93722|NCT01545518|Emory University|Dr. Charles M. Epstein|404-778-3633|cepstei@emory.edu
93723|NCT01545336|University of Pennsylvania|Dr. Steven M. Kawut|215-573-0258|kawut@upenn.edu
93725|NCT01545193|NorthShore University HealthSystem|Glenn S. Murphy,MD|847-570-2760|dgmurphy2@yahoo.com
93727|NCT01544920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93728|NCT01544582|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93729|NCT01544478|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93730|NCT01544361|MedImmune, LLC.|Joseph M. Parker, Director, Clinical Development|301-398-0000|parkerj@medimmune.com
93731|NCT01544348|MedImmune|Claire Birrell, Senior Clinical Scientist|301-398-0000|birrellc@medimmune.com
93732|NCT01544309|Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University|Hisao Ogawa, Ph.D; Study Chair|+ 81 963735175|ogawah@kumamoto-u.ac.jp
93734|NCT01544166|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
93736|NCT01544114|Horizon Pharma, Inc.|Julie Ball, Executive Director of Clinical Development & Operations||clinicaltrials@horizonpharma.com
93737|NCT01544062|University of Washington|Srdjan Jelacic, MD|(206) 598-3777|sjelacic@uw.edu
93738|NCT01544023|University of Rostock, Klinikum Südstadt der Hansestadt Rostock, Frauenklinik|Dr. Max Dieterich|+4938144016145|max.dieterich@uni-rostock.de
93739|NCT01543958|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
93740|NCT01543828|Novartis Pharmaceuticals|Study Director|862-778-8300|
93741|NCT01543685|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com
93742|NCT01543607|Mass. General Hospital|William R. Brugge|617-724-0578|wbrugge@partners.org
93743|NCT01543581|Loma Linda University Health, Department of Dermatology|Dr. Abel Torres, PI|(909) 558-2055|atorres@llu.edu
93744|NCT01543568|Retina Consultants of Houston|David Brown, MD|713-524-3434|dmbmd@houstonretina.com
93745|NCT01543503|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
93746|NCT01543204|Amgen Inc.|Study Director|866-572-6436|
93748|NCT01543074|Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston TX|Rod Dashwood|7136777806|rdashwood@ibt.tamhsc.edu
93749|NCT01542957|Universitat de Barcelona|Prof. Guillem Feixas|0034 933125100|gfeixas@ub.edu
93750|NCT01542788|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
93751|NCT01542684|The University of Texas MD Anderson Cancer Center|Zeev Estrov, MD/Professor|713-794-1675|eharriso@mdanderson.org
93752|NCT01542645|NorthShore University HealthSystem|Glenn Murphy, MD|847-570-2760|dgmurphy2@yahoo.com
93755|NCT01542528|Yale University|Dr. James Leckman|203-785-5880|james.leckman@yale.edu
93756|NCT01542502|Virginia Commonwealth University|Antonio Abbate|804-828-0513|aabbate@vcu.edu
93757|NCT01542372|Massachusetts|Dr. Devon Hinton|617-620-4522|DHINTON1@mgh.harvard.edu
93758|NCT01542307|Massachusetts General Hospital|Aneesh Singhal, MD|6177268459 ext 4|asinghal@partners.org
93759|NCT01542255|Dartmouth-Hitchcock|Marc Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org
93760|NCT01542125|Alberta Health Services|Research Coordinator|780-492-2398|manu.saraswat@albertahealthservices.ca
93761|NCT01542034|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com
93762|NCT01541969|University of Nottingham|Professor Deborah Hall, Professor of Hearing Sciences|+44 (0) 115 823 2600|deborah.hall@nottingham.ac.uk
93763|NCT01541930|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com
93764|NCT01541917|Children's Mercy Hospital|Mark Connelly, PhD (Principal Investigator)|816-234-3000 ext 3193|mconnelly1@cmh.edu
93765|NCT01541865|Boston Scientific|Angela Schutt, Clinical Trial Manager|763-494-2166|angela.schutt@bsci.com
93766|NCT01541826|University of Wisconsin-Madison, Department of Food Science|Dr. Bradley Bolling|608-890-0212|bwbolling@wisc.edu
93767|NCT01541735|Instituto Mexicano del Seguro Social|PhD. Manuel González Ortiz|33 36176000 ext 31494|uiec@prodigy.net.mx
93768|NCT01541644|University of Maryland Baltimore Greenebaum Cancer Center|Emily Parks|410-328-7340|eparks@umm.edu
93769|NCT01541553|LEO Pharma A/S|Clinical trial disclosure|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com
93770|NCT01541397|The University of Texas Health Science Center at Houston|Heather Saavedra|713-500-7098|Heather.Saavedra@uth.tmc.edu
93771|NCT01541384|University of Pennsylvania|Dr. Peter Reese|215-898-6086|peter.reese@uphs.upenn.edu
93772|NCT01541371|CDMA, Beijing|Therapeutic Area Manager|00861058218352|
93773|NCT01541358|David Geffen School of Medicine at UCLA|Andrew Quon, MD|310-983-1419|AQuon@mednet.ucla.edu
93774|NCT01541254|MicroVention, Inc.|Mary Schmitz|714-247-8025|mary.schmitz@microvention.com
93775|NCT01540981|UNMC|Joyce Black|(402) 559-6573|jblack@unmc.edu
93776|NCT01540851|Brigham and Women's Hospital|Elena Losina, PhD|617-732-6928|elosina@partners.org
93777|NCT01540825|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93779|NCT01540487|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93780|NCT01540370|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
93781|NCT01540266|University Hospital Basel|Dr. med. Roland Bingisser|+41 61 265 58 30|roland.bingisser@usb.ch
93782|NCT01540162|National Medical University Odessa|Prof. Mykola L. Aryayev, MD & PhD|+380 48 740 5249|nataly_kononenko@ukr.net
93783|NCT01540045|Instituto Nacional de Cancerología de México|Dr. Oscar Arrieta|5628-0400 ext 832|ogarrieta@gmail.com
93784|NCT01539980|Faculty of Pharmaceutical Sciences, Chulalongkorn University|Professor Pornanong Aramwit, Pharm.D., Ph.D.|+66899217255|aramwit@gmail.com
93785|NCT01539811|Greenville Health System|Dr. David Cull|8644548295|dcull@ghs.org
93787|NCT01539642|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com
93788|NCT01539590|Yale University Medical Center|Dr. Joesph Brennan|(203) 483-8300|Brennan.Joesph@yale.edu
93789|NCT01539538|AcelRx|Pamela Palmer|650-216-3500|ppalmer@acelrx.com
93790|NCT01539525|Yale University School of Medicine|Kimberly A Yonkers|203-764-6621|kimberly.yonkers@yale.edu
93791|NCT01539512|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
93792|NCT01539317|Oregon Health and Science University|Dr. Martha Goetsch|503-494-3666|whru@ohsu.edu
93793|NCT01539135|Tulane University Hospital and Clinics|Dr. Sabrina Bent|5049887137|sabrina.bent@hcahealthcare.com
93794|NCT01539083|Janssen R&D|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com
93795|NCT01539070|Instituto Mexicano del Seguro Social|MPH. Gloria Oliva Martínez Andrade|5556059862 ext 21075|gloria_olivam@hotmail.com
93796|NCT01538862|Vanderbilt University|Haydar Frangoul, MD, MS|615-342-7339|Haydar.Frangoul@hcahealthcare.com
93797|NCT01538472|University of Texas (UT) MD Anderson Cancer Center|Issa Khouri, MD / Professor, Stem Cell Transplant|713-745-2803|CR_Study_Registration@mdanderson.org
93798|NCT01537900|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93799|NCT01537835|Denver Health and Hospital Authority|Marisha Burden, MD|303-602-5011|Marisha.Burden@dhha.org
93800|NCT01537783|Brigham and Women's Hospital|Scott Weiner, MD, MPH|617-732-5640|sweiner@bwh.harvard.edu
93801|NCT01537666|Savara Inc.|Taneli Jouhikainen, MD, MBA; Chief Operating Officer|(888) 302-4876|info@savarapharma.com
93802|NCT01537549|Weill Cornell Medicine|Dr. Claire Henchcliffe|2127462584|clh2007@med.cornell.edu
93803|NCT01537432|Novartis Pharmaceuticals|Study Director|862-778-8300|
93865|NCT01533935|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93804|NCT01537367|Division of HIV/AIDS (Epidemiology Branch), National Center for HIV/Hepatitis/STD/Tuberculosis Prevention, Centers for Disease Control and Prevention|Lytt I. Gardner, Ph.D., CDC Project Officer|(404) 639-6163|lig0@cdc.gov
93805|NCT01537315|University of Arkansas for Medical Sciences|Dumitru Rotaru, MD, PI|501/526-6919|drotaru@uams.edu
93806|NCT01537302|Austin Heart|Matthew Selmon, MD|512-788-2692|matthew.selmon@hcahealthcare.com
93807|NCT01537198|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
93808|NCT01537185|Comprehensive Clinical Development Northwest|Dr. Royce Morrison|206 285 3500|ckeech@path.org
93809|NCT01537133|Penn State University|David Mauger|717-531-7178|dtm5@psu.edu
93810|NCT01537120|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93811|NCT01537081|Reckitt Benckiser LLC|Gail Solomon,MS; Director Clinical Development|973-404-2752|gail.solomon@rb.com
93812|NCT01537068|NYSPI|David Hellerstein MD|646-774-8000|desdesk@nyspi.columbia.edu
93813|NCT01537042|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493|
93814|NCT01536951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
93815|NCT01536938|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com
93816|NCT01536886|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com
93817|NCT01536860|RSSL|Rungano Munyuki|+44 118 918 4166|rungano.munyuki@rssl.com
93818|NCT01536704|GlaxoSmithKline|GSK Response Center|866-435-7343|
93819|NCT01536587|GlaxoSmithKline|GSK Response Center|866-435-7343|
93820|NCT01536574|GlaxoSmithKline|GSK Response Center|866-435-7343|
93821|NCT01536561|GlaxoSmithKline|GSK Response Center|866-435-7343|
93822|NCT01536496|Denver Health Medical Center|Ernest E. Moore|303.602.1817|Ernest.Moore@dhha.org
93823|NCT01536418|GlaxoSmithKline|GSK Response Center|866-435-7343|
93824|NCT01536405|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93825|NCT01536379|GlaxoSmithKline|GSK Response Center|866-435-7343|
93826|NCT01536366|BIAL – Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|jose.rocha@bial.com
93827|NCT01536262|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93829|NCT01536184|Child Development Clinic SSCY Centre|Dr. Ana Hanlon-Dearman|204-258-6628|ahdearman@hsc.mb.ca
93830|NCT01536171|University of Florida|Dr. Heather K. Vincent, PhD|352-273-7410|vincehk@ortho.ufl.edu
93831|NCT01536145|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93832|NCT01536119|University of Toronto|Jennifer Abbass Dick||jennifer.abbass@mail.utoronto.ca
93833|NCT01536093|Seoul National University College of Medicine|Dr. Juyoung Lee|82-31-787-7301|lamb4122@snu.ac.kr
93834|NCT01536067|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
93835|NCT01536015|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
93836|NCT01535976|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu
93837|NCT01535807|Inova Heart and Vascular Institute|Lisa Fornaresio, PhD|703-776-7071|lisa.fornaresio@inova.org
93838|NCT01535729|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
93839|NCT01535664|Acorda Therapeutics, Inc.|Gustavo Suarez, MD|(914) 326-5394|gsuarez@acorda.com
93840|NCT01535638|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93841|NCT01535599|Alcon Research, Ltd.|Sally Scheib, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com
93842|NCT01535560|Alcon Research, Ltd.|Sally Schieb, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com
93843|NCT01535365|Stony Brook U|Adam Singer|631-444-7856|adam.singer@stonybrook.edu
93844|NCT01535326|Dalin Tzu Chi Hospital|Dr. Yu-Hsi Hsieh|88652648000 ext 5241|hsieh.yuhsi@msa.hinet.net
93845|NCT01535261|Novartis|Study Director|862-778-8300|
93846|NCT01535235|Medical College of Wisconsin|Dr. Leslie Cockerham|414-805-0738|lcockerham@mcw.edu
93847|NCT01535222|The Medicines Company|Andreas van de Locht|+4989244180862|andreas.locht@themedco.com
93848|NCT01535118|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93849|NCT01535040|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu
93851|NCT01534962|Menarini Ricerche S.p.A|Angela Capriati MD PhD, Head of Corporate Clinical Research|00390555680 ext 9933|acapriati@menarini-ricerche.it
93852|NCT01534910|Los Angeles Biomedical Research Institute|Dr Matthew Budoff|310-222-4107|mbudoff@labiomed.org
93853|NCT01534897|Massachusetts General Hospital Cancer Center|Dr. Lori J. Wirth|617 724 4000|lwirth@mgh.harvard.edu
93854|NCT01534689|Regulatory Insight, Inc.|Clinical Consultant|6157129743|elvira@reginsight.com
93855|NCT01534676|Columbia University Medical Center|Eldad Hod, MD|212-342-5648|eh2217@cumc.columbia.edu
93856|NCT01534637|Comprehensive Cancer Center of Wake Forest University|James Lovato, MS|336-713-4172|jlovato@wakehealth.edu
93857|NCT01534533|Peking University|Dr. Zhiyong Zou|+8610-13581525193|harveyzou2002@bjmu.edu.cn
93858|NCT01534520|UPittsburgh|Dionne Best|412-641-5496|dbest@upmc.edu
93859|NCT01534351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93860|NCT01534208|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com
93861|NCT01534182|Novartis|Study Director|+1 (862) 778-8300|
93862|NCT01534143|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kahdimi, M.D.|(313) 576-8022|zalkadh@emory.edu
93863|NCT01534078|Massachusetts General Hospital|Jeremy Abramson, MD|617-724-4000|JABRAMSON@mgh.harvard.edu
93864|NCT01533974|Fred Hutchinson Cancer Research Center|Jonathan B. Bricker, Ph.D.|206-667-5074|jbricker@fredhutch.org
93866|NCT01533922|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93867|NCT01533753|University of Wisconsin Carbone Cancer Center|Dr. Justine Bruce|608-263-7107|jybruce@medicine.wisc.edu
93868|NCT01533597|Soonchunhyang Bucheon Hospital|Dr. Kwang-Woo Lee|+82 32 621 5465|urolkw@schmc.ac.kr
93869|NCT01533493|Massachusetts General Hospital|Joseph Biederman|617-724-1743|jbiederman@partners.org
93870|NCT01533428|Astellas Pharma Global Development|Medical Science Director, Global Medical Science|+31(0)715454002|Astellas.resultsdisclosure@astellas.com
93871|NCT01533259|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
93872|NCT01533246|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org
93873|NCT01533181|H. Lee Moffitt Cancer Center and Research Institute|Dr. Alberto Chiappori|813-745-2158|alberto.chiappori@moffitt.org
93874|NCT01533116|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
93875|NCT01533077|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
93877|NCT01532999|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|lori.davis@va.gov
93878|NCT01532973|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93879|NCT01532934|University of Rochester|Marc T. Swogger, Ph.D.|585-275-7418|marc_swogger@urmc.rochester.edu
93880|NCT01532869|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
93881|NCT01532635|Thomas Jefferson University|Neal Flomenberg, MD|215-955-8874|Neal.Flomenberg@jefferson.edu
93882|NCT01532570|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
93883|NCT01532453|Galderma Spirig|Dr. Francine Santoro|+41 62 387 87 87 ext 87 20|Francine.santoro@galderma.com
93884|NCT01532414|Repros Therapeutics Inc.|Jennifer L Wike, Director of Regulatory Affairs|281-719-3402|jwike@reprosrx.com
93886|NCT01532349|Johns Hopkins University|Dr. Meredith Atkinson|410-955-2467|matkins3@jhmi.edu
93887|NCT01532141|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
93888|NCT01532128|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
93889|NCT01531998|University of Texas (UT) MD Anderson Cancer Center|Jatin J. Shah, MD/Associate Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org
93890|NCT01531725|ZNA Middelheim Department Interventional Cardiology, Antwerpen, Belgium|Paul Vermeersch, MD, PhD|+32 3 280 3211|paul.vermeersch@zna.be
93891|NCT01531387|St. Jude Children's Research Hospital|James M. Boyett, PhD|901-595-4986|james.boyett@stjude.org
93893|NCT01531335|Pontificia Universidad Javeriana|Dr Saul Rugeles|5715946161 ext 2240|rujeles@javeriana.edu.co
93894|NCT01531205|H. Lee Moffitt Cancer Center and Research Institute|Julio Pow-Sang, M.D.|813-745-2226|julio.powsang@moffitt.org
93895|NCT01530997|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
93896|NCT01530880|Columbia University|Michael Schmidt|212-305-8745|mjs2134@columbia.edu
93897|NCT01530477|GE Healthcare|Yi Xia|1 (608) 221-1551 ext 500-3045|Yi.Xia@ge.com
93898|NCT01530464|Duke University Medical Center|Dr. Thies Schroeder|919 681 4721|thies.schroeder@duke.edu
93899|NCT01530399|TMC|Peter Villiger|+19732906340|peter.villiger@themedco.com
93900|NCT01530334|SPARC CONSULTING SRL|Claudio Iannacone|+39 0243119667|info@sparcconsulting.com
93901|NCT01530243|Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences|Yousef Rezaei|+989126231864|yousefrezaei1986@gmail.com
93902|NCT01530087|Hollister Incorporated|Director, Global Clinical Affairs|847.918.3467|Stacy.Haddad@hollister.com
93903|NCT01529827|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
93904|NCT01529645|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com
93905|NCT01529632|Novartis Pharmaceuticals|Study Director|862-778-8300|
93906|NCT01529515|Janssen Research & Development, LLC|Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com
93907|NCT01529502|Massachusetts General Hospital|Dr. Lorenzo Berra|617 724 1901|LBERRA@MGH.HARVARD.EDU
93908|NCT01529450|Stanford University|Anne Chang, MD|(650) 721 7151|alschang@stanford.edu
93909|NCT01529385|Center for Lower Extremity Ambulatory Research|Ryan Crews, Clinical Scientist|847-578-8437|ryan.crews@rosalindfranklin.edu
93910|NCT01529268|Johns Hopkins Data Coordinating Center|Laura Wilson|410-955-0719|lwilson9@jhu.edu
93911|NCT01529203|Galderma|Clinical Project Manager|(33) 4 92 38 67 33|may.ma@galderma.com
93912|NCT01529112|Eisai Call Center|Eisai Inc.|888-422-4743|
93913|NCT01528969|Kuwait University, Faculty of Dentistry|Prof. Eino Honkala|+965 65638938|eino.honkala@hsc.edu.kw
93914|NCT01528891|Children's Hospital of Pittsburgh of UPMC|Peter J. Davis, MD|4126925260|davispj@anes.upmc.edu
93915|NCT01528735|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93916|NCT01528696|University of Michigan|Mark Chames|734 764-1406|mchames@med.umich.edu
93917|NCT01528605|Peking University|Xiaoming Lin|010-82805336|linbjmu@bjmu.edu.cn
93919|NCT01528345|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
93920|NCT01528332|Philips Consumer Lifestyle|Dr. Elke Naujokat|+31 (0) 631974213|elke.naujokat@philips.com
93921|NCT01528319|Johnson & Johnson K.K. Medical Company|Department Chief, Clinical Development & PMS|+81-3-4411-6789|yikeda5@its.jnj.com
93922|NCT01528293|Georgetown University Medical Center|Paul J. Kim, DPM, Director of Research, MGUH Center for Wound Healing and HBOT|202-444-3059|Paul.J.Kim@gunet.georgetown.edu
93923|NCT01528215|DENTSPLY Implants|Manager Global Clinical Affairs|+46313763500|ClinicalResearchMolndal@dentsplysirona.com
93924|NCT01528150|St. Jude Medical|Director Clinical Studies|+1 818 493 3648|aoza@sjm.com
93925|NCT01527942|ST. FRANCIS HOSPITAL AND MEDICAL CENTER|Ioannis Raftopoulos, MD||IRaftopo@stfranciscare.org
93926|NCT01527513|BIAL – Portela & Cª SA|Director R&D|+351-229866100|clinical.trials@bial.com
93927|NCT01527487|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
93928|NCT01527370|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93929|NCT01527162|Seattle Children's Research Institute|Kristie Bjornson, PhD, PT|206 884-2066|kristie.bjornson@seattlechildrens.org
93930|NCT01527006|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com
93931|NCT01526902|Indiana University|Pete Kollbaum, OD, PhD, FAAO, FBCLA, Principal Investigator|812-856-0108|kollbaum@indiana.edu
93932|NCT01526785|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
93933|NCT01526733|Halozyme Therapeutics, Inc|Vice President, Endocrinology Clinical Development|858-794-8889|
93934|NCT01526629|Medtronic|Latifa Foudali|0155381700|latifa.foudali@medtronic.com
93935|NCT01526551|University of Kentucky College of Public Health|Dr. Robin Vanderpool|859-218-2102|robin@kcr.uky.edu
93936|NCT01526538|Johns Hopkins University|Matthew Johnson Ph.D.|4105500056|mwj@jhu.edu
93937|NCT01526343|Washington University School of Medicine|Jennifer Bell, Manager of Clinical Trials|314-747-6969|jennifer.bell@wustl.edu
93938|NCT01526213|UNC-Chapel Hill|Mary F. Paine, RPh, PhD|919-966-9984|mpaine@unc.edu
93939|NCT01526148|University Hospitals Cleveland Medical Center|Keming Gao, MD, PhD|216-844-2865|keming.gao@UHhospitals.org
93940|NCT01525927|North Shore LIJ Cancer Institute|Jeffrey Revello Sr. Administrative Manager|516 734 7629|jrevello@nshs.edu
93941|NCT01525849|Entellus Medical|Ellen O'Malley|763-463-1598|eomalley@entellusmedical.com
93942|NCT01525745|Beth Israel Deaconess Medical Center|Anand Mahadevan, MD|617-667-2345|amahadev@bidmc.harvard.edu
93943|NCT01525667|Pluristem Ltd.|Dr.Esther Lukasiewicz Hagai|+972-972-74-710-8600 ext 694|estherl@Pluristem.com
93944|NCT01525641|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93945|NCT01525628|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93946|NCT01525615|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93947|NCT01525563|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com
93948|NCT01525550|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93949|NCT01525420|Fred Hutchinson Cancer Research Center|Jonathan B. Bricker, Ph.D.||jbricker@fhcrc.org
93950|NCT01525407|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|2066672827|mmielcar@fredhutch.org
93951|NCT01525238|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com
93952|NCT01525225|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
93953|NCT01525173|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
93954|NCT01524913|Emory University|Gary Bouloux, MD, DDS|404-778-4500|gfboulo@emory.edu
93955|NCT01524900|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93957|NCT01524796|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com
93959|NCT01524770|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
93960|NCT01524627|UPenn|Teresa R. Franklin, Ph.D.|215-746-1883|teresafr@mail.med.upenn.edu
93961|NCT01524302|Michigan State University|Dr. Gary E. Stein|517-353-5126|steing@msu.edu
93962|NCT01524198|King Saud University|Dr. Abdullah Alangari|966506287276|alangari100@gmail.com
93963|NCT01523964|DART Therapeutics|Chief Operating Officer|415-341-5783|egoldstein@dartrx.com
93964|NCT01523899|University of California-Davis|Larissa May, MD|9167345000|lsmay@ucdavis.edu
93965|NCT01523886|Herlev Hospital|Mona R Gätke, MD, PH.D.|004538662420|mona.gatke@regionh.dk
93966|NCT01523873|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 51 84|corinne.dubourdieu@guerbet-group.com
93967|NCT01523756|Coloplast A7S|Marianne Raff|+45 4911 2562|dkmr@oloplast.com
93968|NCT01523743|Hopital Raymond poincare|Pref. Emmanuel Chartier-kastler|+33 1 42 17 71 29|emmanuel.chartier-kastler@psl.aphp.fr
93969|NCT01523613|University of Michigan|Dr. Mathilde Peters||mcpete@umich.edu
93970|NCT01523587|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
93971|NCT01523457|Yale University|Jill Lacy|+1 (203) 737-1600|jill.lacy@yale.edu
93972|NCT01523392|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com
93973|NCT01523366|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com
93974|NCT01523301|UCB|Study Director|+1877 822 9493|
93975|NCT01522976|SWOG Statistical Center|Leukemia Committee Statistician|206-667-6597|amoseley@fredhutch.org
93976|NCT01522963|University of Minnesota|Michael Kotlyar|6126251160|kotly001@umn.edu
93977|NCT01522937|University of Michigan Comprehensive Cancer Center|Dr. Kyle Cuneo, M.D.|734-936-4300|kcuneo@umich.edu
93978|NCT01522924|University of Louisville|Dr. Jacqueline Singleton|502-852-2611|jasing02@louisville.edu
93979|NCT01522703|Johns Hopkins University School of Medicine|Elizabeth Matsui, MD MHS|410-502-3858|ematsui@jhmi.edu
93980|NCT01522456|Galderma Laboratories, L.P.|Elizabeth M. Nieman, Associate Medical Information Specialist|817-961-5130|elizabeth.nieman@galderma.com
93981|NCT01522339|Cincinnati Children's Hospital Medical Center|Jean Tkach|513-636-7166|jean.tkach@cchmc.org
93982|NCT01522235|Beth Israel Deaconess Medical Center|Dr. Roy Freeman|6176328454|rfreeman@bidmc.harvard.edu
93983|NCT01522131|The University of Texas Health Science Center at Houston|Rosemary Thomas, DMD, MS|713-486-4074|rosemary.thomas@uth.tmc.edu
93984|NCT01521923|UCB Cares|UCB (Study Director)|+1 887 822 9493|
93985|NCT01521897|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93986|NCT01521884|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
93987|NCT01521871|Oslo University Hospital, Rikshospitalet|Dr. Ole Øyen|+4723070000|ooyen@ous-hf.no
93988|NCT01521845|Shaheed Beheshti Medical University|Dr.Jamshid Salamzadeh|00982188662334|j.salamzadeh@yahoo.com
93989|NCT01521780|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
93990|NCT01521559|Regeneron|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com
93991|NCT01521546|The Ohio State University|Subha V. Raman, MD|(614)293-8963|raman.1@osu.edu
93992|NCT01521507|TearScience, Inc.|Study Director|919-467-4007|cstevens@tearscience.com
93993|NCT01521364|University of Groningen, University Medical Center Groningen|Dr. J.W.C. Alffenaar|+31-50-3614070 ext 40378|j.w.c.alffenaar@umcg.nl
93994|NCT01521260|University Medical Center Groningen - Center for dentistry and oral hygiene|Y.C.M. de Waal|+31 50-3639051|y.c.m.de.waal@umcg.nl
93995|NCT01521143|Prima BioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au
93996|NCT01521026|UCSD|Elizabeth Twamley, PhD|6195436684|etwamley@ucsd.edu
93997|NCT01520987|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
93998|NCT01520922|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
93999|NCT01520909|GlaxoSmithKline|GSK Response Center|866-435-7343|
94000|NCT01520727|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
94001|NCT01520714|The Heart Hospital Baylor Plano|Research Manager|469-814-4712|natalie.settele@baylorhealth.edu
94002|NCT01520558|Coronado Biosciences|Vice President, Clinical Operations|7816524516|nsilver@coronadobio.com
94003|NCT01520532|Medtronic AF Solutions|Jay Kelley, Director of Clinical Research|+1.760.827.0076|jay.l.kelley@medtronic.com
94004|NCT01520506|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com
94005|NCT01520454|Beth Israel Deaconess Medical Center|Dr. Christos Manztoros|617-667-8630|cmantzor@bidmc.harvard.edu
94006|NCT01520402|Mount Sinai School of Medicine|Dr. Daniella Kadian-Dodov|(212) 241-9454|daniella.kadian-dodov@mssm.edu
121658|NCT00003830|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org
94008|NCT01519934|Ulthera, Inc.|Lisa Misell, PhD, VP Clinical Affairs|4806194069|
94009|NCT01519921|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
94010|NCT01519882|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
94011|NCT01519817|National Cancer Institute|Dr. James Gulley|301-480-8870|gulleyj@mail.nih.gov
94012|NCT01519791|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
94013|NCT01519778|Cubist Pharmaceuticals|Carisa De Anda, Phd, Vice President Clinical Research|8583522639|carisa.deanda@cubist.com
94014|NCT01519765|Stanford University|Dr. Linh Tran|925-642-2241|lltran20@gmail.com
94015|NCT01519713|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
94016|NCT01519700|Sandoz|Dr. Roumen Nakov, Global Programme Medical Director|+49 8024 4764704|roumen.nakov@sandoz.com
94017|NCT01519674|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
94018|NCT01519661|Novartis Pharmaceuticals|Study Director|862-778-8300|
94019|NCT01519648|National Hematological Society|Professor Galina A Klyasova|+7(495)6125181|klyasova.g@blood.ru
94020|NCT01519518|Liverpool Heart and Chest Hospital|Dr Rod Stables|01512281616 ext 1489|rod.stables@lhch.nhs.uk
94021|NCT01519466|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com
94022|NCT01519427|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu
94023|NCT01519323|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
94024|NCT01519284|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
94025|NCT01519271|University of Pennsylvania|Daniel Weintraub, MD|215-349-8207|Daniel.Weintraub@UPHS.UPENN.EDU
94026|NCT01519245|University of Saskatchewan|Dr. Kelsey Brose, Primary Investigator|306-655-1483|kelsey.brose@saskcancer.ca
94028|NCT01519167|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com
94029|NCT01519089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94030|NCT01518946|Shire|Study Physician|+1 866-842-5335|
94031|NCT01518530|Hillel Yaffe Medical Center|Dr. Yaron River|972-523-756-446|yaronr@hy.health.gov.il
94032|NCT01518322|Aerocrine, Inc.|Nancy Herje|919-449-8873|Nancy.Herje@aerocrine.com
94033|NCT01518270|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
94034|NCT01518257|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
94035|NCT01518244|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com
94036|NCT01518192|Department of Infectious Diseases, University Medical Center Ljubljana|Franc Strle|+386 1 522 2610|franc.strle@kclj.si
94037|NCT01518153|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-8750|CR_Study_Registration@mdanderson.org
94038|NCT01517984|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
94039|NCT01517893|University of Massachusetts Medical School|John E. Harris, MD, PhD|508-856-1982|john.harris@umassmed.edu
94040|NCT01517750|HELIOS-Klinik Ambrock|Dr Georg Nilius|+492331-9742005|klinik-ambrock.pneumo@t-online.de
94041|NCT01517529|University of Cincinnati|Dr. Mohamed Tarek M Shata|(513) 558-6110|mohamed.shata@uc.edu
94042|NCT01517412|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
94043|NCT01517373|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94044|NCT01517295|International Clinical Research Institute|Srinivas Nalamachu|913.317.5300|nalamachu@yahoo.com
94045|NCT01517282|MorphoSys|Roman Korolkiewicz|+49 89 89927 208|roman.korolkiewicz@morphosys.com
94046|NCT01517178|Bispebjerg Hospital|Tonny Karlsmark||tkar0002@bbh.regionh.dk
94047|NCT01517074|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov
94048|NCT01516970|Janssen-Cilag GmbH|Medical Leader, Medical Department||ClinicalTrialDisclosure@its.jnj.com
94049|NCT01516892|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
94050|NCT01516879|Amgen Inc.|Study Director|866-572-6436|
94051|NCT01516749|University of California, San Francisco|Kieron S. Leslie, MD|415-206-4777|lesliek@derm.ucsf.edu
94052|NCT01516736|Sandoz|Strategic Planning, Biopharmaceutical Clinical Development|+49 (0) 8024 476 – 0|biopharma.clinicaltrials@sandoz.com
94053|NCT01516632|Center for Innovative Public Health Reserch|Dr. Michele Ybarra|(877) 302-6858 ext 1-801#|michele@innovativepublichealth.org
94054|NCT01516437|GlaxoSmithKline|GSK Response Center|866-435-7343|
94055|NCT01516268|Tehran University of Medical Sciences|Dr. Laleh Eslamian|0098218490 ext 2415|leslamian@tums.ac.ir
94056|NCT01516034|Dr David Friedman Laser & Skin Center|David J. Friedman, Principal Investigator|+972-2-5635673|drfriedmanlaser@gmail.com
94057|NCT01516008|Janssen Research & Development, L.L.C.|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com
94058|NCT01515956|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|PSlasor@bmrn.com
94059|NCT01515943|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org
94060|NCT01515891|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
94061|NCT01515865|Shire Development LLC|Study Physician|+1 866 842 5335|
94062|NCT01515696|Medical University of Vienna|Nadja Haiden M.D.|+431404003232|nadja.haiden@meduniwien.ac.at
94063|NCT01515657|PLx Pharma|Ronald Zimmerman|1-713-842-1249 ext 205|ron.zimmerman@plxpharma.com
94064|NCT01515566|University of Texas MD Anderson Cancer Center|David Hui, MD, MSc, FRCPC / Asst. Professor, Palliative Care and Rehabilitation Medicine|713-792-6085|CR_Study_Registration@mdanderson.org
94065|NCT01515540|Northwestern University|Javeria Ali Hashmi|3125037991|j-hashmi@northwestern.edu
94066|NCT01515488|Maricopa Integrated Health System|Madhumita Sinha, MD, MHSM|602-344-5404|madhumita_sinha@dmgaz.org
94067|NCT01515423|Janssen Research & Development, LLC|Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com
94068|NCT01515410|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com
94069|NCT01515345|Kaiser Franz Josef Hospital|Univ.Prof. Dr Günter Christ|+43160191 ext 2508|guenter.christ@wienkav.at
94072|NCT01515072|Rutgers-New Jersey Medical School|Baburao Koneru, MD, MPH|(973) 972-9599|koneruba@njms.rutgers.edu
94073|NCT01515046|The University of Iowa|Joseph J. Cullen, MD, FACS|319-353-8297|joseph-cullen@uiowa.edu
94074|NCT01514864|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
94075|NCT01514786|UMichigan|Dr. Masahito Jimbo|734-998-7120|mjimbo@med.umich.edu
94077|NCT01514734|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com
94078|NCT01514630|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu
94079|NCT01514513|Tec Laboratories, Inc.|Wendy Langley|5419264577 ext 338|wendy@teclabsinc.com
94080|NCT01514461|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
94081|NCT01514448|Novartis Pharmaceuticals|Study Director|862-778-8300|
94082|NCT01514422|Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai|Dr. Dan V. Iosifescu|212-241-4480|dan.iosifescu@mssm.edu
94083|NCT01514318|DJO Surgical|Dr. Jane M. Jacob|512-834-6323|jane.jacob@djoglobal.com
94084|NCT01514292|Dexcom, Inc|Andy Balo, SVP, Regulatory, Clinical and Biometrics|8582000200|abalo@dexcom.com
94085|NCT01514240|Biometrics Department, Science Affairs Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com
94086|NCT01514162|St Jude Medical|Jennifer Johnson|6517566803|jjohnson101@sjm.com
94087|NCT01514149|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com
94088|NCT01514136|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1990|dkbir@coloplast.com
94089|NCT01513902|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1­-800-­718-­1021|ClinicalTrials.gov_Inquiries@pfizer.com
94090|NCT01513590|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
94091|NCT01513473|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
94092|NCT01513460|Novartis Pharmaceuticals|Study Director|862-778-8300|
94093|NCT01513447|Northwestern University Feinberg School of Medicine|Cynthia A. Wong, M.D.|312-472-3585|c-wong2@northwestern.edu
94094|NCT01513330|Coloplast A/S|Director of Clinical Trials|+45 4911 3595|dkbir@coloplast.com
94095|NCT01513317|Janssen Research & Development|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com
94096|NCT01513291|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94097|NCT01513239|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94098|NCT01513148|Shenandoah University|Dr. Todd Telemeco|540-545-7398|ttelemec@su.edu
94939|NCT01436643|Novartis Pharmaceuticals|Study Director|862-778-8300|
94099|NCT01513122|The Kirby Institute|Prof Sean Emery|+61293850900|semery@kirby.unsw.edu.au
94100|NCT01512979|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
94101|NCT01512849|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
94102|NCT01512745|Fudan University Shanghai Cancer Center, Shanghai; PLA Cancer Centre, The 81 Hospital of PLA, Nangjing|Co-Director of Clinical Trials|021-64433755|fudanlijin@163.com,qinsk@csco.org.cn
94103|NCT01512368|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Dr. Daniel Cuevas-Ramos|525554870900 ext 2407|shiverqks@hotmail.com
94104|NCT01512225|Sunnybrook Research Institute|Dr. Elizabeth Asztalos|416-480-6100, ext 87791|elizabeth.asztalos@sunnybrook.ca
94105|NCT01512160|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94106|NCT01512108|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
94107|NCT01511978|Jacobus Pharmaceutical Company, Inc.|Dr. Kathy Aleš, Medical Director|6099217447 ext 231|kathy.ales@jacobus-pharmaceutical.com
94108|NCT01511939|Arthritis Treatment Center|Manager, Clinical Research Department|301-624-1168|tgillis@arthritistreatmentcenter.com
94109|NCT01511809|Ospedale San Raffaele|Dr. Antonella Castagna|00390226437934|castagna.antonella1@hsr.it
94110|NCT01511536|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
94111|NCT01511445|Amedica Corporation|Sonny Bal, MD|(573) 808-4512|SBal@amedica.com
94112|NCT01511315|UCSF Psoriasis Center|Mio Nakamura, MD|4154764701|mio.nakamura@ucsf.edu
94113|NCT01511107|Children's Hospital of Pittsburgh of UPMC|Dr. Alejandro Hoberman|412-692-5249|hobermana@upmc.edu
94114|NCT01511016|Baylor College of Medicine|Leanne Scott, PhD, Director of Sponsored Programs|713-798-6978|lbscott@bcm.edu
94115|NCT01510912|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com
94117|NCT01510769|Ardea Biosciences, Inc.|Maple Fung, MD|1-858-652-6671|mfung@ardeabio.com
94118|NCT01510756|University of California, San Diego|Thomas Kipps, MD|(858) 534-5400|tkipps@ucsd.edu
94119|NCT01510717|Alcon Research, Ltd.|Magda Michna, PhD|1-888-451-3937|alcon.medinfo@alcon.com
94120|NCT01510704|Acacia Pharma Ltd|Dr Gabriel Fox||gabrielfox@acaciapharma.com
94122|NCT01510457|Rehabilitation Institute of Chicago Center for Pain Studies|Dr. R. Norman Harden|312.238.5654|centerforpainstudies@ric.org
94123|NCT01510379|The Ohio State University|Kyle A. Perry, MD|614-293-5815|kyle.perry@osumc.edu
94124|NCT01510327|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com
94125|NCT01510158|Ardea Biosciences, MD|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com
94126|NCT01510145|Alcon Research, Ltd|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com
94127|NCT01509807|University of South Florida|Jorge Marcet, MD|813-844-4545|jmarcet@health.usf.edu
94128|NCT01509664|New York Obesity Nutrition Research Center|Dr Allan Geliebter|212-523-4184|ag58@columbia.edu
94129|NCT01509638|Cleveland Clinic Florida|Marylise Boutrous, MD|954-659-5000|canedoj@ccf.org
94130|NCT01509625|Hospital Clínico San Cecilio Granada|Dr Isabel Blancas|+34 958023498|blancaslb@hotmail.com
94131|NCT01509586|Medical University of South Carolina|Dr. Matthew J. Carpenter|843-876-2436|carpente@musc.edu
94132|NCT01509105|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94133|NCT01509079|HealthPartnersInstitute|Dr. Alice Shapiro|952-993-1704|shapia@parknicollet.com
94134|NCT01509053|Otsuka Pharmaceutical Development & Commercialization, Inc.|Medical Affairs|800-562-3974|
94135|NCT01509040|University of Washington Harborview Center for Pre Hospital Emergency Care|Dr. Graham Nichol|206-521-1728|nichol@uw.edu
94136|NCT01508936|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
94138|NCT01508832|University of California San Francisco|Ronald D Miller, MD|415 476-9034|millerr@anesthesia.ucsf.edu
94139|NCT01508702|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com
94140|NCT01508676|Massachusetts General Hospital|Dr. Jianren Mao|6177246102|mghpainresearch@partners.org
94141|NCT01508455|Hospira|Dr. Marcelo Garcia da Rocha|224-212-4424|marcelo.rocha@hospira.com
94142|NCT01508325|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
94143|NCT01508169|Hospital de Clinicas da Universidade Estadual de Campinas (Unicamp)|Cecilia de Morais Barbosa|+55-19-35217113|cecimbarbosa@gmail.com
94144|NCT01508130|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
94145|NCT01508117|University of Cincinnati|Alison Kastl|513-584-0436|kastla@ucmail.uc.edu
94146|NCT01508052|Gachon University|Dr.Kwak|82324603400|hyun615@gilhospital.com
94147|NCT01508013|East Tennessee State University|Dr. Joel Hillhouse|423-439-4332|hillhous@etsu.edu
94149|NCT01507831|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
94150|NCT01507662|University of Iowa|Dr. Fredric Wolinsky|(319) 384-3821|fredric-wolinsky@uiowa.edu
94151|NCT01507493|Huazhong University of Science&Technology|Xianwei Zhang|13037154560|znpain@sina.com
94152|NCT01507246|Atlanta Colon and Rectal Surgery|Stephen Cohen, MD|770-997-1975|klong@atlantacolon.com
94153|NCT01507233|University of Miama/Jackson Memorial Hospital|Keith Candiotti, MD|305-585-5332|info@jhsmiami.org
94154|NCT01507220|The Ohio State University|Sergio Bergese, MD|(614) 293-9027|bergese.1@osu.edu
94155|NCT01507181|Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai|Dr. J. W. Murrough|212-241-7574|james.murrough@mssm.edu
121206|NCT02817763|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br
121207|NCT02814279|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br
121208|NCT02801006|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com
94156|NCT01507155|Genomind|Dr. Rachel Scott|267-989-3435|rscott@genomind.com
94157|NCT01507103|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
94158|NCT01507090|Children's Mercy Hospital|Principal Investigator|816-234-3059|srahman@cmh.edu
94159|NCT01507051|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
94160|NCT01506960|Massachusetts General Hospital|Iris McNulty|617 726 2612|imcnulty@partners.org
94161|NCT01506947|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110|
94162|NCT01506908|GlaxoSmithKline|GSK Response Center|866-435-7343|
94163|NCT01506882|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
94164|NCT01506726|Duke University Medical Center|Harvey J. Cohen, MD|919-660-7502|harvey.cohen@dm.duke.edu
94165|NCT01506596|Vector Oncology LLC|Dr. Mark Walker, VP of Scientific Affairs|901-435-5570|mwalker@vectoroncology.com
94166|NCT01506362|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100 ext 135|arnona@biolinerx.com
94167|NCT01506323|VA San Diego Healthcare System|Dr. Jill E. Bormann|858-552-8585 ext x2378|jill.bormann@va.gov
94168|NCT01506193|GlaxoSmithKline|GSK Response Center|866-435-7343|
94169|NCT01505881|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
94170|NCT01505764|Department of Veterans Affairs|Jose M Garcia MD, PhD, Clinician Investigator|206-7642984|jose.garcia@va.gov
94171|NCT01505647|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94172|NCT01505608|NMTRC|Giselle Sholler, MD|6162670335|genevieve.bergendahl@helendevoschildrens.org
94173|NCT01505465|HSS|Dr. Memtsoudis|(212) 606-1000|MemtsoudisS@hss.edu
94174|NCT01505387|Analyze & Realize|Felix Alt|+49 30 40008100|Falt@a-r.com
94175|NCT01505374|Hospital for Special Surgery|Stavros G. Memtsoudis, MD, PhD|212-606-1206|memtsoudiss@hss.edu
94176|NCT01505114|Fred Hutchinson cancer Research center|Chunyuan Wu|206-667-5567|cwu@scharp.org
94177|NCT01504997|Shizuoka Cancer Center|Doctor Masanori Tokunaga|81-55098908777|m.tokunaga@scchr.jp
94178|NCT01504971|ChinaPLAGH|Dr. Weifeng Wang|0086-13911952018|wangwf301@hotmail.com
94179|NCT01504958|Beth Israel Deaconess Medical Center|Alvaro Pascual-Leone, M.D., Ph.D.|617-667-0203|apleone@bidmc.harvard.edu
94180|NCT01504867|Mayo Clinic|Dr. Daryl J. Kor|507-284-7678|Kor.Daryl@mayo.edu
94181|NCT01504854|Alzheimer's Disease Cooperative Study|Michael Rafii, MD, PhD|858-846-1300|mrafii@ucsd.edu
94182|NCT01503749|Seoul National University Hospital|Pf. Jung-Hwan Yoon|82-2-2072-2228|yoonjh@snu.ac.kr
94183|NCT01503021|Rockwell Medical, Inc|Senior Director, Clinical Research|248-960-9009|rd@rockwellmed.com
94184|NCT01502787|University of Texas Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|wanpen.vongpatanasin@utsouthwestern.edu
94185|NCT01502761|University of Southern California|Dr. William J Mack|323 442 7512|william.mack@med.usc.edu
94186|NCT01502709|University of North Carolina|Dr Asma Khan|919 537 3389|asma_khan@dentistry.unc.edu
94187|NCT01502644|Brigham and Women’s Hospital|Ajay D. Wasan, M.D., M.Sc.||awasan@partners.org
94188|NCT01502423|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
94189|NCT01502410|Children's Oncology Group|Results Reporting Coordinator|626-241-0064|resultsreportingcoordinator@childrensoncologygroup.org
94190|NCT01502371|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94191|NCT01502332|USaoPaulo|Dr Alcino Costa Leme|55 11 989044014|costaleme@uol.com.br
94192|NCT01502228|IndianaU|Dr. Theodore Logan|(317) 948-7449|tlogan@iu.edu
94193|NCT01502033|Mayo Clinic|Dr. Paul Croarkin|(507) 293-2557|croarkin.paul@mayo.edu
94194|NCT01501162|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr
94195|NCT01501110|Hospital de Clínicas de Porto Alegre|Josi Vidart|+55 51 98472520|josividart@gmail.com
94196|NCT01500772|Debiopharm International S.A.|Vice President, Clinical Research and Development|4121 321 01 11|info-international@debiopharm.com
94197|NCT01500746|Northwestern University|Dr. Elliot Hirsch|312-695-6022|elliot-hirsch@md.northwestern.edu
94198|NCT01500720|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
94199|NCT01500694|Shire|Study Physician|1 866-842-5335|
94200|NCT01500629|Johnson & Johnson Consumer and Personal Products Worldwide|Daniel Qi, MD, PhD, Director, Clinical Research|973 385-2260|dqi6@its.jnj.com
94201|NCT01500434|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com
94202|NCT01500382|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94203|NCT01500317|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu
94204|NCT01500278|Cares|UCB|+1877 822 ext 9493|
94205|NCT01500252|UAlberta|Dr. Lauren Beaupre|780-407-3945|lauren.beaupre@albertahealthservices.ca
94206|NCT01500226|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|781-257-2536|mhuber@tesarobio.com
94207|NCT01500213|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|862.228.2483|mhuber@tesarobio.com
94208|NCT01500135|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
94210|NCT01500083|Lundbeck Canada Inc.|Lundbeck Canada Inc.|+45 36301311|LundbeckClinicalTrials@lundbeck.com
94211|NCT01500031|Boston Scientific|Director Clinical Trials|708-771-4737|Pamela.Grady@bsci.com
94212|NCT01499862|Department of Physical Therapy and Rehabilitation, University of California San Francisco|Dr. Nancy N. Byl|415-514-4816|byln@ptrehab.ucsf.edu
94213|NCT01499849|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|781.257.2536|mhuber@tesarobio.com
94214|NCT01499810|Research Institute of Cradiology, Siberian Branch of Russian Academy of Sciences|Dr. Stanislav Pekarskiy|+73822558122|pekarski@cardio-tomsk.ru
94215|NCT01499667|Novartis Pharnaceuticals|Study Director|862-778-8300|
95297|NCT01405508|UCB Cares|UCB (Study Director)|+1 887 822 9493|
94216|NCT01499654|Northwestern University|Edwin Wu, MD|847-535-7270|ed-wu@northwestern.edu
94217|NCT01499576|Konyang University Hospital|Dr. Kyung Ho SONG, Assistnat Professor of Konyang University||postit2@daum.net, postit@kyuh.ac.kr
94218|NCT01499498|Imperial College London|Dr Borja Mora Peris|020 3312 6789|b.mora-peris@imperial.ac.uk
94219|NCT01499355|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
94220|NCT01499303|AstraZeneca|Bernadette Weidman|800-456-3669|ClinicalTrialTransparency@astrazeneca.com
94221|NCT01499290|AstraZeneca|Paul Newell, Medical Science Director|+44 1625 515727|paul.newell@astrazeneca.com
94222|NCT01499277|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com
94223|NCT01499199|GlaxoSmithKline|GSK Response Center|866-435-7343|
94224|NCT01499173|University of Michigan, Neurology|Dr. Lesli Skolarus|734-936-9075|lerusche@umich.edu
94226|NCT01499134|Thomas Jefferson University|Danielle Duffy MD|215 955 5050|Danielle.Duffy@jefferson.edu
94227|NCT01499095|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
94228|NCT01499082|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
94229|NCT01498822|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
94230|NCT01498744|Ann and Robert H. Lurie Children's Hospital of Chicago|Katherine A Barsness|3122274210|kbarsness@luriechildrens.org
94231|NCT01498692|Boston Scientific|Ruth M. Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com
94232|NCT01498679|GlaxoSmithKline|GSK Response Center|866-435-7343|
94233|NCT01498653|GlaxoSmithKline|GSK Response Center|866-435-7343|
94234|NCT01498640|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
94235|NCT01498601|Fraser Health|Trudy Robertson RN, MSN, CNN(c)|604-520-4715|Trudy.Robertson@fraserhealth.ca
94236|NCT01498588|Emory University|Keerthi Gogineni, MD, MSHP|404-778-1801|keerthi.gogineni@emory.edu
94237|NCT01498575|The Children's Hospital of Philadelphia|Dennis Durbin, MD, MSCE|215-590-7331|DURBIND@EMAIL.CHOP.EDU
94238|NCT01498549|Yale University|Dr. Mehmet Sofuoglu, Professor of Psychiatry; Director of VA New England Mental Illness Research, Ed|(203) 937-4809|mehmet.sofuoglu@yale.edu
94239|NCT01498458|University Hospital Heidelberg|Dr. Andreas Schneeweiss|+49 (0)6221 56 36051|andreas.schneeweiss@med.uni-heidelberg.de
94240|NCT01498419|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|Dan.Everitt@tballiance.org
94241|NCT01498185|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com
94242|NCT01498120|UCB BIOSCIENCES GmbH|Clinical Trial Registries and Results Disclosure|40789+49 2173 48 ext 15 15|clinicaltrials@ucb.com
94243|NCT01498068|Janssen Belgium|Compound Development Team Leader|32 14 64 13 70|
94244|NCT01497938|Medtronic|Thomas Troub|(818) 576-3142|thomas.troub@medtronic.com
94245|NCT01497899|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
94246|NCT01497756|uNewMexico|Mark Hauswald MD|505-269-6699|markhauswald@gmail.com
94247|NCT01497665|Angiochem Inc.|Betty Lawrence, Vice President, Development|514-788-7800 ext 205|blawrence@angiochem.com
94248|NCT01497366|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
94249|NCT01497275|Duke University Medical Center|Anne Beaven, MD|919-668-1211|anne.beaven@duke.edu
94250|NCT01497262|Novartis Pharmaceuticals|Study director|862-778-8300|
94251|NCT01497197|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
94252|NCT01497171|Mayo Clinic|Dr. Emanuel C. Trabuco|507-284-7519|trabuco.emanuel@mayo.edu
94254|NCT01496807|H. Lee Moffitt Cancer Center and Research Institute|Dr. Andrew Brohl|813-745-3242|andrew.brohl@moffitt.org
94255|NCT01496469|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
94256|NCT01496456|UMichigan|Dr. Mathilde C Peters||mcpete@umich.edu
94257|NCT01496430|Takeda|Medical Director; Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
94258|NCT01496352|Dr. Reddy's Laboratories, Inc.|Kent Allenby, MD, VP, Drug Development|609-375-9855|kallenby@drreddys.com
94259|NCT01496313|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
94260|NCT01496287|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com
94261|NCT01496274|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
94262|NCT01496248|Krea University College of Medicine|Young-Hoon Ko|+82-31-412-5140|korean@chol.com
94263|NCT01496183|The State University of New York at Buffalo|Dr. Elsa Daurignac, Research Assistant Professor|716-898-4540|ecd3@buffalo.edu
94265|NCT01495975|MGH Diabetes Center|Nancy Wei, MD|617-724-7597|ncwei@mgh.partners.org
94266|NCT01495923|The Johns Hopkins Hospital|Steven Cohen|410-955-1818|scohen40@jhmi.edu
94267|NCT01495858|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
94268|NCT01495793|UCB Pharma|UCB Clinical Trial Call Center|+1877-822 ext 9493|
94269|NCT01495702|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
94270|NCT01495689|Ottawa Hospital Research Institute|Smita Pakhale|613-737-8899 ext 79428|spakhale@ohri.ca
94271|NCT01495585|National Insitute of DIabetes and Digestive and Kidney Diseases|Dr. Theo Heller|301-402-7147|hellert@mail.nih.gov
94272|NCT01495572|National Cancer Institute|Udai Kammula M.D.|301-435-8606|kammulau@mail.nih.gov
94273|NCT01495481|University of Pittsburgh|Dr. Gaurav Arora|412-692-6054|gaurav.arora@chp.edu
94274|NCT01495286|University of Arkansas|Anita Mitchell PhD, coinvestigator|501-686-7021|AMitchell@uams.edu
94275|NCT01495000|GlaxoSmithKline|GSK Response Center|866-435-7343|
94276|NCT01494987|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
94277|NCT01494818|Alcon Research, Ltd.|Renee Garofalo, OD, FAAO|1-888-451-3937|alcon.medinfo@alcon.com
94278|NCT01494753|Laboratoires Théa|Dr Pascale Pouliquen - Medical Director|33 473 981 436|p.pouliquen@laboratoires-thea.fr
94279|NCT01494649|GlaxoSmithKline|GSK Response Center|866-435-7343|
94280|NCT01494610|GlaxoSmithKline|GSK Response Center|866-435-7343|
94281|NCT01494584|GlaxoSmithKline|GSK Response Center|866-435-7343|
94282|NCT01494545|Alcon Research, Ltd|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com
94283|NCT01494532|GlaxoSmithKline|GSK Response Center|866-435-7343|
94284|NCT01494506|Merrimack Pharmaceuticals, Inc.|Dr. Eliel Bayever|6174411000 ext 7676|EBayever@merrimack.com
94285|NCT01494467|Galderma R&D, LLC|Clinical Science Director|609-409-7701|
94286|NCT01493180|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
94287|NCT01494350|Institut Pasteur of Tunis|Afif Ben Salah, MD, PhD|011-216-71-792-429|afif.bensalah@pasteur.rns.tn
94288|NCT01494298|Mercer University College of Pharmacy|Gina Ryan Clinical Professor|678.547.6222|ryan_gj@mercer.edu
94289|NCT01493947|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com
94290|NCT01493687|Galderma R&D, LLC|Clinical Science Director|609-409-7701|
94291|NCT01493557|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
94292|NCT01493531|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com
94293|NCT01493427|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com
94294|NCT01493167|Helsinki University Hospital|Dr Nina Linfors|358 9 4711|nina.c.lindfors@hus.fi
94295|NCT01493089|Norgine Ltd|Dr. Richard Ng Kwet Shing|+441895453584|RNg@Norgine.com
94296|NCT01492439|Centre for Addiction and Mental Health|Dr. Sean A. Kidd|416-535-8501 ext 6295|sean.kidd@camh.ca
94297|NCT01492426|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
94298|NCT01492400|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
94299|NCT01492088|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
94300|NCT01491984|IWK Health Centre|Dr. Ronald George|902-470-6627|rbgeorge@dal.ca
94301|NCT01491919|Duke Clinical Research Institute|Uptal Patel, MD|919-668-4601|uptal.patel@duke.edu
94302|NCT01491802|Queen's University|Kathy Webb|613-549-6666 ext 4950|kw2@queensu.ca
94304|NCT01491672|Novartis|Study Director|862-778-8300|
94305|NCT01491633|Dana-Farber Cancer Institute|Dr. Peter Hammerman|617-632-3000|phammerman@partners.org
94306|NCT01491607|Emergent BioSolutions|Dr. Robert Hopkins|(301) 944-0136|hopkinsr@ebsi.com
94307|NCT01491490|GW Research Ltd.|Mr Colin Stott|+44 (0)1980 557000|cgs@gwpharm.com
94308|NCT01491113|UCB|UCB Clinical Trials Call Center|+1 877 822 9493|
94309|NCT01491035|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com
94310|NCT01491022|University of Miami|Dr Corneliu Luca|3052432235|cluca@med.miami.edu
94311|NCT01490931|Univeristy of Pennsylvania School of Dental Medicine|Elliot V Hersh DMD, MS, PhD Professor of Pharmacology|215-898-9686|evhersh@pobox.upenn.edu
94312|NCT01490866|SCRI Development Innovations|Charles H. Davis, RAC|615 524-4341|charles.davis2@scri-innovations.com
94313|NCT01490840|Novartis|Study Director|862-778-8300|
94314|NCT01490697|Massachusetts General Hospital|Roger K. Pitman, MD|617-726-5333|roger_pitman@hms.harvard.edu
94315|NCT01490632|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
94316|NCT01490294|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
94317|NCT01490190|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
94318|NCT01490151|Stanford University|Dr. Bruce Buckingham, MD|408-356-0911|buckingham@stanford.edu
94319|NCT01490125|Novartis|Study director|41 61 324 1111|
94320|NCT01490086|Reviva Pharmaceuticals, Inc.|Marc Cantillon, M.D|408-960-2209|mcantillon@revivapharma.com
94321|NCT01490060|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|(713) 792-7966|CR_Study_Registration@mdanderson.org
94322|NCT01489956|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
94323|NCT01489891|Hospital Universitario Infanta Cristina|Dr. Felipe de la Morena|0034659716030|felipe_de_la_morena@hotmail.com
94324|NCT01489826|e-Therapeutics plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk
94325|NCT01489670|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
94326|NCT01489527|H. Lee Moffitt Cancer Center and Research Institute|Anna R. Giuliano, Ph.D.|813-745-6820|anna.giuliano@moffitt.org
94327|NCT01489358|Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr Julie E Ledgerwood||ledgerwood@mail.nih.gov
94328|NCT01489254|Synthon BV|VP Clinical Development|+3124727700|clinicaltrials@synthon.com
94329|NCT01489189|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrnet@jaeb.org
119016|NCT02694744|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com
94331|NCT01488877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94332|NCT01488578|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94333|NCT01488487|Div. of Hematology and Oncology, Univ. of North Carolina at Chapel Hill|Dr. Hanna Sanoff|919-966-4431|hanna_sanoff@med.unc.edu
94334|NCT01488448|Children's Hospital at Montefiore/Albert Einstein College of Medicine|Dr. Alyssa Silver|718-741-2304|alysilve@montefiore.org
94335|NCT01488409|Massachusetts General Hospital|Steven K. Grinspoon|617-724-9109|sgrinspoon@partners.org
94336|NCT01488370|Loma Linda University Department of Anesthesiology|Elizabeth Ghazal, MD|909-558-4475|EGhazal@llu.edu
94337|NCT01488188|International Vaccine Institute|Dr. Jae Seung Yang|82-2-881-1198|jsyang@ivi.int
94338|NCT01488097|Alexion Pharmaceuticals|Alexion Pharmaceuticals||clinicaltrials@alexion.com
94339|NCT01488071|H. Lundbeck A/S|H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@lundbeck.com
94340|NCT01488019|Mylan UK|Dik Ng, PhD, Director Clinical Science|+44 1304626895|dik.ng@mylan.co.uk
94341|NCT01487954|Case Comprehensive Cancer Center AND Summa Health System|Dr. Charles A. Kunos, MD, PhD|(330) 375-3557|kunosc@summahealth.org
94342|NCT01487863|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com
94343|NCT01487668|Department of Veterans Affairs, VA Ann Arbor Healthcare System|Amy M. Kilbourne, PhD, MPH|734-845-3452|amy.kilbourne@va.gov
94344|NCT01487577|Children's Hospital of Pittsburgh of UPMC|Randy M. Windreich, MD|412-692-5225|randy.windreich@chp.edu
94345|NCT01487525|University of Iowa|Dr. Neil Segal|3193358204|segal-research@uiowa.edu
94346|NCT01487499|University of Florida|Michael A. Jantz, MD|352-273-8737|michael.jantz@medicine.ufl.edu
94347|NCT01486966|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
94348|NCT01486927|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
94349|NCT01486758|Washington University in St. Louis|Dr. Avraham Beigelman (PI)|314-454-2694|beigelman_a@kids.wustl.edu
94350|NCT01486615|B. P. Koirala Institute of Health Sciences|Dr Krishna Pokharel|0977-9841986321|drkrishnapokharel@gmail.com
94351|NCT01486446|Xenon Pharmaceuticals Inc.|Dr. Y Paul Goldberg|604 484 3300|pgoldberg@xenon-pharma.com
94352|NCT01486238|Valley Retina Institute, PA|Victor Gonzalez, MD|956-631-8875|research@vritx.com
94353|NCT01486199|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu
94354|NCT01486043|Children's Hospital Los Angeles|Dr. Jamie Wood|323-361-7388|jawood@chla.usc.edu
94355|NCT01485991|Janssen IDV - Janssen Dx|Trial Physician||ClinicalTrialDisclosure@its.jnj.com
94356|NCT01485887|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
119017|NCT02684188|University of Montana|Tom Seekins, Ph.D.|2432654 ext 406|TOm.Seekins@UMontana.edu
94358|NCT01485640|Sunovion|Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com
94359|NCT01485536|The University of Texas (UT) MD Anderson Cancer Center|Yasuhiro Oki, Associate Professor, Lymphoma/Myeloma|713-792-7734|CR_Study_Registration@mdanderson.org
94360|NCT01485380|Massachusetts General Hospital|Dr. Oluwaseun Johnson-Akeju|6177247200|oluwaseun.akeju@mgh.harvard.edu
94361|NCT01485354|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org
94362|NCT01485172|GlaxoSmithKline|GSK Response Center|866-435-7343|
94363|NCT01485094|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com
94364|NCT01484977|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493|
94365|NCT01484951|Alcon Global Medical Affairs|Abayomi Ogundele, Pharm.D|1-888-451-3937|
94366|NCT01484938|Alcon Research, Ltd.|Jami Kern, Ph.D., Global Medical Affairs|800-862-5266|
94367|NCT01484912|Sinphar Pharmaceutical Co., Ltd. Taiwan|Justine Tang||justine@sinphar.com.tw
94368|NCT01484873|Vanderbilt University|Ashley Shoemaker|615-343-8116|ashley.h.shoemaker@vanderbilt.edu
94369|NCT01484834|UNESC|Dr. Antonio Jose Grande|04834312500 ext 2571|grandeto@unesc.net
94370|NCT01484652|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com
94371|NCT01484561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
119018|NCT02564055|GlaxoSmithKline|GSK Response Center|866-435-7343|
94373|NCT01484314|Brigham and Womens Hospital/ Dana Farber Cancer Institute|Dr. Nancy Berliner|617-732-5840|nberliner@parnes.org
94374|NCT01484197|Novartis Pharmaceuticals|Study Director|862-778-8300|
94375|NCT01484132|New England Research Institutes|Felicia Trachtenberg, Principal Research Scientist|617-972-3120|ftrachtenberg@neriscience.com
94376|NCT01484054|Johnson & Johnson Vision Care|Michael Mayers, OD, FAAO|904-443-3252|mmayers@its.jnj.com
94377|NCT01484041|Georgetown University|Dr. Claudine Isaacs|2024443677|isaacsc@georgetown.edu
94378|NCT01484028|Vistakon, Johnson and Johnson Vision Care|Dr. Michael Mayers, O.D., FAAO, Senior Research Optometrist|1 904 443 3252|mmayers@its.jnj.com
94379|NCT01483963|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
94380|NCT01483937|BalanceSense LLC|Karen L. Atkins PhD PT|407 625 9680|atkins.balancesense@gmail.com
94381|NCT01483924|ApoPharma Inc.|Fernando Tricta, MD|Phone: 416-401-7332|ftricta@apopharma.com
94382|NCT01483820|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org
94383|NCT01483651|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com
94384|NCT01483625|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
94385|NCT01483599|Janssen Research & Development, LLC|Senior Director, Clinical Leader||ClinicalTrialDisclosure@its.jnj.com
94386|NCT01483378|NYU Langone Medical Center|Dr. Elisabeth J. Cohen|212-263-3262|elisabeth.cohen@nyumc.org
94387|NCT01483352|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
94388|NCT01483209|Duke University Medical Center|Dr. Cynthia Shortell|919-681-2223|cynthia.shortell@duke.edu
94389|NCT01483183|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
94390|NCT01483118|Columbia University, Department of OBGYN|Roger A. Lobo M.D.|212-3056337|ral35@columbia.edu
94391|NCT01482910|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
94392|NCT01482884|AstraZeneca|Mark Berner Hansen|+46 31 776 4794|Mark.Berner.Hansen@astrazeneca.com
94393|NCT01482819|Johnson & Johnson Vision Care|Daria Wicks, Senior Clinical Research Manager|904-443-1391|RA-ClnclStds@its.jnj.com
94394|NCT01482767|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
94395|NCT01482429|Federal University of Uberlândia|Liliane Barbosa da Silva Passos|553432182150|lilibsp@yahoo.com.br
94396|NCT01482325|GE Healthcare|Global Research Manager|414 721 2423|Jeffrey.Conner@ge.com
94397|NCT01482312|Alcon Research|Director of Alcon Clinical|1-800-241-7629|
99498|NCT00347360|GlaxoSmithKline|GSK Response Center|866-435-7343|
94398|NCT01482221|AstraZeneca|Sanjeev Pathak||ClinicalTrialTransparency@astrazeneca.com
94399|NCT01482091|Albert Einstein College of Medicine/Children's Hospital at Montefiore|Dr. Daniel Fein|718-920-5312|dfein@montefiore.org
94400|NCT01482065|Johns Hopkins University|Dr. Seva Polotsky, M.D., PhD|410-550-6386|vpolots1@jhmi.edu
94401|NCT01481935|University of Maryland School of Medicine|Anthony D. Harris, MD MPH|410-706-0064|aharris@epi.umaryland.edu
94402|NCT01481896|Anderson Orthopaedic Research Institute|Robert H. Hopper, Jr., PhD|(703) 619-4411|research@aori.org
94403|NCT01481740|Department of Women's & Obstetric Anesthesia, IWK Health Centre|Dr. Ronald B George|902-470-6627|rbgeorge@dal.ca
94404|NCT01481558|University of Sao Paulo|Claudia Kimie Suemoto|551130618249|cksuemoto@usp.br
94405|NCT01481376|Surgical Department of the Protestant Hospital|Docteur Dieter BIRK|06332 422120|
94406|NCT01481324|Shriners Hospital for Children|Dr. Todd Milbrandt|859-266-2101|tmilbrandt@shrinenet.org
94407|NCT01481129|Centre Léon Bérard (now CHLS)|Dr Hervé Ghesquieres|0426556824|herve.ghesquieres@chu-lyon.fr
94408|NCT01481116|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
94409|NCT01480674|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
94410|NCT01480596|GlaxoSmithKline|GSK Response Center|866-435-7343|
94411|NCT01480297|The University of Michigan|Rodica Pop-Busui, MD, PhD|734-763-3056|rpbusui@umich.edu
94412|NCT01480284|GlaxoSmithKline|GSK Response Center|866-435-7343|
94413|NCT01480232|Massachusetts General Hospital-Center for Addiction Medicine|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu
94414|NCT01480219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94415|NCT01480089|Loyola University|Elizabeth Mueller, M.D.|708-216-2180|emuelle@lumc.edu
94416|NCT01480076|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
94417|NCT01479868|Janssen Research & Development|Director & Study Responsible Scientist||ClinicalTrialDisclosure@its.jnj.com
94418|NCT01479777|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|Dr. Cristina Sadowsky|443-923-9210|sadowsky@kennedykrieger.org
94419|NCT01479764|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com
94420|NCT01479725|Beaumont Hospital, Royal Oak|Dr. Kenneth Peters|248-551-0387|Kenneth.Peters@Beaumont.edu
94421|NCT01479621|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|
94422|NCT01479595|Novartis|Study Director|862-778-8300|
94423|NCT01479543|Hero Institute for Infant Nutrition|Esther Matencio Hilla|+0034 968 89 89 00|esther.matencio@hero.es
94424|NCT01479530|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
94425|NCT01479517|Rock Dental Clinic|Christina Sletten, DDS|719-599-9700|
94426|NCT01479374|Alcon Research, Ltd.|Abhijit Narvekar, MS, MBBS|1-888-451-3937|alcon.medinfo@alcon.com
94427|NCT01479127|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
94429|NCT01478971|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com
94430|NCT01478958|University of Reading|Professor Julie Lovegrove|+44 (0)118 3786418|j.a.lovegrove@reading.ac.uk
94431|NCT01478828|The SKCCC at Johns Hopkins|Dr. Phuoc Tran|410-614-6477|tranp@jhmi.edu
94432|NCT01478620|"Kiev regional City Hospital"|Ivanov, Dmitry|+38 (039) 247 12 36|ivanovdd@i.kiev.ua
94433|NCT01478594|AVEO|Medical Director|1.617.588.1960|clinical@aveooncology.com
94434|NCT01478373|Novartis Pharmaceuticals|Study Director|862-778-8300|
94435|NCT01478360|Novartis Pharmaceuticals|Study Director|862-778-8300|
94436|NCT01478347|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
94437|NCT01478256|George John MD|George John|5028949757|grjohn777@yahoo.com
94438|NCT01478113|Massachusetts General Hospital|Maren Nyer|617-643-4897|mnyer@partners.org
94439|NCT01478087|Mayo Clinic|Jeffrey Lawrence Winters, MD|507-538-1707|winters.jeffrey@mayo.edu
94440|NCT01478048|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
94441|NCT01478009|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Chang-Seop Lee|82-63-276-8284|lcsmd@jbnu.ac.kr
94442|NCT01477892|Seoul National University Hospital|Pf. Han-suk Kim|+82-2-2072-0647|kimhans@snu.ac.kr
94443|NCT01477853|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94444|NCT01477762|Emory University|Dr. Tanja Jovanovic|(404) 778-1485|tjovano@emory.edu
94445|NCT01477749|Dendreon Pharmaceuticals, Inc.|Lynn Ngo|206-274-6763|lngo@dendreon.com
94446|NCT01477710|University of Cincinnati|Richard Branson|513-558-6785|bransonrd@uc.edu
94447|NCT01477567|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
94448|NCT01477463|Stanford University School of Medicine|Jean Y Tang MD PhD, assistant professor|650-721-7149|baileyhi@stanford.edu
94449|NCT01477450|University of Cincinnati|Richard Branson||bransord@uc.edu
94450|NCT01477333|United Therapeutics Corp.|Kevin LaLiberte, PharmD|919-425-8176|KLaliberte@unither.com
94451|NCT01476748|BWH|Dr. JI Einarsson|617-525-8582|jeinarsson@partners.org
94452|NCT01476722|alcon Blobal Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937|
94453|NCT01476696|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
94454|NCT01476475|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
94455|NCT01476345|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
94456|NCT01476202|GlaxoSmithKline|GSK Response Center|866-435-7343|
94457|NCT01475955|DUSA Pharmaceuticals, Inc|Manager of Clinical Studies||houlihana@dusapharma.com
94458|NCT01475851|GlaxoSmithKline|GSK Response Center|866-435-7343|
94459|NCT01475838|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
94460|NCT01475734|GlaxoSmithKline|GSK Response Center|866-435-7343|
94462|NCT01475487|Department of Anesthesia and Pain Management, Mount Sinai Hospital Toronto, Canada|Dr Naveed Siddiqui|4165864800 ext 5270|naveed.siddiqui@uhn.ca
94463|NCT01475474|Renew Medical, Inc.|Victoria Mackinnon, Vice President, Regulatory, Clinical & Quality|1-888-987-2929|victoria@renew-medical.com
94464|NCT01475461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94465|NCT01475305|Medimmune, LLC|Hasan Jafri, Medical Director|301-398-4431|jafrih@medimmune.com
94466|NCT01475253|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
94467|NCT01475214|Jean Mayer Human Nutrition Research Center on Aging at Tufts University|Dr. Bess Dawson-Hughes|617-556-3066|bess.dawson-hughes@tufts.edu
94468|NCT01475175|Medtronic CRDM|AdOpt CRT Clinical Research Specialist|800-328-2518 ext 62736|medtronicCRMtrials@medtronic.com
94469|NCT01475097|GE Healthcare|Debra Mansfield|609-514-6329|dabra.mansfield@ge.com
94470|NCT01475071|Galderma|Cyril Moulin|+33 4 92 38 30 14|cyril.moulin@galderma.com
94471|NCT01474993|UMass Memorial Medical Center|Andrew Zimmerman, M.D.|508-856-3279|Andrew.Zimmerman@umassmemorial.org
94472|NCT01474915|The Ohio State University Department of Anesthesiology|Andrew Otey|6142933559|Andrew.otey@osumc.edu
94473|NCT01474876|AbbVie|Global Medical Information|800-633-9110|
94474|NCT01474863|Vanderbilt University Medical Center|Todd Rice, MD|6153223412|todd.rice@vanderbilt.edu
94475|NCT01474772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94476|NCT01474746|University of California, Davis, MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu
94477|NCT01474681|Novartis Pharmaceuticals|Study Director|862-778-8300|
94478|NCT01474590|University of Western Ontario and Windsor Clinical Research Inc., 2224 Walker Rd. Suite 300, Windsor, ON, Canada|Dr. Jerry Tan||jerrytan@bellnet.ca
94479|NCT01474551|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org
94480|NCT01474538|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
94481|NCT01474512|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
94482|NCT01474434|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
94483|NCT01474317|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com
94484|NCT01474291|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
94485|NCT01474239|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
94486|NCT01474213|Department of Anaesthetics, Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine|Dr. Jiang Hong|86-21-13512122883|hr310@vip.sina.com.cn
94487|NCT01474200|Baxter Healthcare Corporation|Drew Jones, MD, Senior Medical Director|224-270-2659|drew_jones@baxter.com
94488|NCT01474122|Actelion Pharmaceuticals Ltd|Angelina Marr|+41 61 565 63 69|angelina.marr@actelion.com
94489|NCT01474109|Actelion Pharmaceuticals Ltd|Angelina Marr|+41 61 565 63 69|angelina.marr@actelion.com
94490|NCT01473992|University of South Florida|M. Jason Highsmith|8139743806|mhighsmi@health.usf.edu
94491|NCT01473953|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
94492|NCT01473836|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94493|NCT01473758|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
94494|NCT01473745|ChangGungMH|Dr. Yi Hsuan Chen|+886227135211 ext 3533|acantehr@gmail.com
94495|NCT01473602|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
94496|NCT01473589|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
94497|NCT01473563|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
94498|NCT01473524|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com
94499|NCT01473394|Forest Research Institute, Inc.|Carl Gommoll|201 427-8000|
94500|NCT01473381|Forest Research Institute|Suresh Durgam, MD Clinical Asset Lead for Vilazodone - Senior Director – Clinical Development|201 427-8000 ext 8172|suresh.durgam@frx.com
94501|NCT01473368|Beth Israel Deacones Medical Center|Ciaran Kelly, MD|617-667-1272|ckelly2@bidmc.harvard.edu
94502|NCT01473160|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|+49 6022 240 520|joachim.nick@cibavision.com
94503|NCT01472939|Shire Development LLC|Study Physician|+1 866 842 5335|
94504|NCT01472874|Yale|Dr. Schilsky|203-785-2565|michael.schilsky@yale.edu
94505|NCT01472835|Johns Hopkins|Steven Cohen|410-955-1818|scohen40@jhmi.edu
94506|NCT01472822|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Jeong-Hwan Seo, MD|82-63-276-8284|vivaseo@jbnu.ac.kr
94507|NCT01472562|Weill Cornell Medicine|Jia Ruan M.D, Ph.D|646.962.2064|amr2017@med.cornell.edu
94508|NCT01472432|Second University Naples|Dr Raffaele Marfella|++390815665110|raffaele.marfella@unina2.it
94509|NCT01472380|Mutual Pharmaceutical Company, Inc.|VP, Clinical Development and Medical Affairs|215-697-1743|clinicaltrials@urlmutual.com
94510|NCT01472341|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94511|NCT01472289|TotipotentSC|Dr. Venkatesh Ponemone|+91-124-4976860|venkatesh.ponemone@totipotentsc.com
94512|NCT01472185|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
94513|NCT01471782|Amgen, Inc|Study Director|866-572-6436|
94514|NCT01471691|Thomas Hanscom AMC|Thomas O'Hearn MD|310-829-3303|tohearn@gmail.com
94515|NCT01471639|Cleveland Clinic Healthcare System|Sharon Mace MD|216-445-4598|maces@ccf.org
94516|NCT01471626|CHU St Pierre|Dr Marie Bruyneel|003225354219|marie_bruyneel@tpierre-bru.be
94517|NCT01471574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
94518|NCT01471379|UNC Chapel Hill|Dr. Spencer Dorn Associate Professor|919-966-0141|sdorn@med.unc.edu
94519|NCT01471353|University of Florida|Dr. Thomas J. George, Jr.|352-273-8008|thom.george@medicine.ufl.edu
94520|NCT01471197|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
94521|NCT01471171|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com
94522|NCT01471041|Vital Access|Mark Crawford|8014339390|mcrawford@vital-access.com
94523|NCT01471015|University of Utah|Dr. Mariana Baserga|801-581-7052|mariana.baserga@hsc.utah.edu
94524|NCT01470859|Department of Neurology, Huashan Hospital affiliated to Fudan University.|Dr. Jian Wang|+86-13321934789|wangjian336@hotmail.com
94525|NCT01470651|New York State Psychiatric Institute-Research Foundation for Mental Hygene|Judith Rabkin|646-774-8075|jgr1@cumc.columbia.edu
94526|NCT01470469|Shire Development LLC|Study Physician|+1 866 842 5335|
94527|NCT01470417|University of Florida|Thomas J. George, Jr., MD|(352) 273-8008|thom.george@medicine.ufl.edu
94528|NCT01470248|Emory University|Taofeek K. Owonikoko, MD, PhD, MSCR|404-778-1900|towonik@emory.edu
94529|NCT01470196|Dana-Farber Cancer Institute|Steven P. Treon, MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu
94530|NCT01470170|Department of Thoracic Medicine|Dr. Yu-Lun, Lo|+886-3-3281200 ext 5108|loyulun@hotmail.com
94531|NCT01470144|Actelion Pharmaceuticals Ltd|Thomas Pfister, PhD||thomas.pfister@actelion.com
94532|NCT01470118|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
94533|NCT01470001|University at Buffalo|Dr Tova Ablove|716-878-7138|tablove@buffalo.edu
94534|NCT01469819|Texas Tech University Health Sciences Center El Paso|Dr. Irene Sarosiek|(915)215-5254|irene.sarosiek@ttuhsc.edu
94536|NCT01469715|University of Virginia|Stacey Anderson, MD||sg4c@virginia.edu
94537|NCT01469637|Shire Development LLC|Study Physician|+1 866-842-5335|
94538|NCT01469546|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden, M.D.|734-936-0453|fworden@umich.edu
94539|NCT01469364|Duke University|Dr. Scott Palmer|919-684-0245|palme002@mc.duke.edu
94540|NCT01469234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
94541|NCT01469182|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
94542|NCT01469065|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94543|NCT01469052|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94544|NCT01469039|Alkermes, Inc.|ARISTADA Medical Information|866-274-7823|
94545|NCT01469000|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
119020|NCT02515851|University Louisville|Nancy Alsip|502-852-2610|nlalsi01@exchange.louisville.edu
94547|NCT01468818|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov
94548|NCT01468675|Brigham and Women's Hospital|Jennifer Haas, M.D.|617-525-6652|jhaas@partners.org
94549|NCT01468584|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
94550|NCT01468558|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com
94551|NCT01468350|Acorda Therapeutics, Inc.|Vice President - Clinical Development & Medical Affairs|914-347-4300|hhenney@acorda.com
94552|NCT01468337|National Eye Institute|Emily Chew, MD|301-496-6583|emily.chew@nih.gov
94553|NCT01468311|National Cancer Institute|Dr. Thomas Waldmann|301-496-6653|tawaldt@helix.nih.gov
94554|NCT01468233|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
94555|NCT01468207|AbbVie|Global Medical Information|1-800-633-9110|
94556|NCT01468181|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
94557|NCT01468077|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
94559|NCT01467960|Villa Melitta|Sarah Dassati|+39 0471 471 ext 471|sarahdassati@yahoo.it
94560|NCT01467947|CSL Behring|Program Director, Clinical R&D|Use email contact|clinicaltrials@cslbehring.com
94561|NCT01467934|Columbia University|Melissa Stockwell|212-342-5732|mss2112@columbia.edu
94562|NCT01467882|Debiopharm International, S.A.|Eija Lundström|:+41 21 3210111|eija.lundstrom@debiopharm.com
94563|NCT01467713|Takeda|Medical Director, Clinical Science|1-877-825-3327|trialdisclosures@takeda.com
94564|NCT01467700|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
94565|NCT01467661|Shire|Study Physician|1 866-842-5335|
94566|NCT01467583|Harper University Hospital|Krista Wahby, Critical Care Pharmacist in the Medical ICU|313-745-2711|kwahby@dmc.org
94567|NCT01467570|The Medical University of Warsaw|Hanna Szajewska, Malgorzata Piescik-Lech|+48-22-45-23-309|hania@ipgate.pl
94568|NCT01467557|Vistakon|Jurandir Araujo|+1 904 443-1379|jaraujo7@its.jnj.com
94569|NCT01467505|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
94570|NCT01467492|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
94571|NCT01467479|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
94572|NCT01467076|Wayne State University|Beena Sood, M.D.|313-745-5638|bsood@med.wayne.edu
94573|NCT01467037|McGill University Health Centre|Dr Caroline Quach, Pediatric Infectious Diseases Consultant & Medical Microbiologist|514-934-1934 ext 24485|caroline.quach@mcgill.ca
94574|NCT01466881|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|hongli@fredhutch.org
94575|NCT01466790|Janssen Research & Development, LLC|Medical Leader||ClinicalTrialDisclosure@its.jnj.com
94576|NCT01466764|Stanford University|Gary Peltz|650-721-2487|gpeltz@stanford.edu
94577|NCT01466673|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-739-7200 ext 5888|
94579|NCT01466595|Center for Biostatisticis in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
94580|NCT01466491|Oregon Health & Science University|Dr. Paula Bednarek|503-494-3666|whru@ohsu.edu
121209|NCT02657031|University Medical Center Emergency Department|Dr. Tony Zitek|7022247124|zitek10@gmail.com
121210|NCT02643862|Stanford|Dr. Kari Nadeau|650-867-4592|knadeau@stanford.edu
119022|NCT02514889|UCLA Fielding School of Public Health, 650 Charles Young Drive, Los Angeles, CA 90095|William J. McCarthy, Ph.D., Professor|310-794-7587|wmccarth@ucla.edu
94582|NCT01466361|GlaxoSmithKline|GSK Response Center|866-435-7343|
94583|NCT01466348|GlaxoSmithKline|GSK Response Center|866-435-7343|
94584|NCT01466270|Wake Forest School of Medicine|Dr. Doug Case|336-716-1048|dcase@wakehealth.edu
94585|NCT01466192|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
94586|NCT01466179|Amgen Inc.|Study Director|866-572-6436|
94587|NCT01466153|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazenca.com
94588|NCT01466127|Massachusetts General Hospital|Elizabeth Hoge, M.D.|617-724-0859|ehoge@mgh.harvard.edu
94589|NCT01466075|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com
94590|NCT01466062|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
119023|NCT02474901|University of Colorado|Adriana Weinberg, MD|3037244480|adriana.weinberg@ucdenver.edu
94592|NCT01465958|Grifols Therapeutics Inc|Henry Li, PhD|800-20-2807|henry.li@grifols.com
94593|NCT01465802|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94594|NCT01465763|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94595|NCT01465412|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94596|NCT01465386|FHCRC|Elihu Estey, MD|206-288-7176|eestey@seattlecca.org
94597|NCT01465347|Diffusion Pharmaceuticals Inc|Chief Executive Officer|(434) 220-0718|DKalergis@diffusionpharma.com
94598|NCT01465230|Yale University|Dr. Terri Parker|203-737-5312|terri.parker@yale.edu
94599|NCT01465178|University of Wisconsin|Neil Binkley|608-265-6410|nbinkley@wisc.edu
94600|NCT01465048|University of Oxford|Dr Susanne Sheehy||susanne.sheehy@balliol.ox.ac.uk
94601|NCT01465022|University of New Mexico|Eve Espey MD, MPH, Principal Investigator|505 272 6372|eespey@salud.unm.edu
94602|NCT01464996|University of North Carolina at Chapel Hill School of Dentistry|Dr. Andre Ritter, Professor and Chair|919-537-3987|andre_ritter@unc.edu
94603|NCT01464931|Amgen Inc.|Study Director|866-572-6436|
94604|NCT01464879|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
94605|NCT01464840|University of Alabama at Birmingham|Amelia Sutton, M.D., Ph.D.|205-934-5612|alsutton@uab.edu
94606|NCT01464827|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
94607|NCT01464788|McGovern Medical School UTHealth - Houston|Dr. Andrew Barreto|713-500-7002|andrew.d.barreto@uth.tmc.edu
94608|NCT01464619|The Children's Hospital of Philadelphia|James Guevara, MD, MPH|215-590-1130|guevara@email.chop.edu
94609|NCT01464424|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com
94610|NCT01464359|University of Minnesota, Pediatrics Blood and Marrow Transplant|Michael R Verneris|612-626-2961|verneris@umn.edu
94611|NCT01464307|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de
94612|NCT01464255|Clinical Research Center, University of California, Berkeley, School of Optometry|Thao N Yeh, O.D.|(510) 642-9649|thaoyeh@berkeley.edu
94613|NCT01464229|MGH|Esther Howe|617-726-8895|ehowe3@partners.org
94614|NCT01464190|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com
94615|NCT01464021|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
94616|NCT01463982|HanmiPharma|Director of clinical research team|8224109038|jajung@hanmi.co.kr
94617|NCT01463878|Eastern Virginia Medical School|Dr Paul Marik|757-446-8910|marikpe@evms.edu
94618|NCT01463696|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94619|NCT01463683|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94621|NCT01463384|Huntington Medical Research Institutes|Principal Investigator|6263975840|mrs@hmri.org
94622|NCT01463293|Fonterra Research Centre|Dr James Dekker|+64 6 350 6323|james.dekker@fonterra.com
94623|NCT01463111|Emory University|Dr. Boadie Dunlop|404-727-8969|bdunlop@emory.edu
94624|NCT01463033|Children's National Medical Center|Dr. Pavel Klein, P.I.|301-704-4925|kleinp@epilepsydc.com
94625|NCT01463007|BrUOG-Brown University Oncology Research Group|Dr. Jaroslaw Hepel|4018633000|kristen_mitchell@brown.edu
94626|NCT01462942|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com
94627|NCT01462929|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com
94628|NCT01462877|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com
94629|NCT01462812|OptiNose|Sr. Director of Clinical Development|(267) 364-3620|jennifer.carothers@optinose.com
94630|NCT01462773|The Ohio State University Comprehensive Cancer Center|William Carson|614-293-6306|william.carson@osumc.edu
94631|NCT01462695|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
94632|NCT01462435|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com
94633|NCT01462370|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94634|NCT01462357|GlaxoSmithKline|GSK Response Center|866-435-7343|
94636|NCT01462318|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
94637|NCT01462279|Beth Israel Deaconess Medical Center|Dr. Michael W. Donnino|6177542341|mdonnino@bidmc.harvard.edu
94638|NCT01462266|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94639|NCT01462227|Yale University|Robert Stanley Sherwin, MD|203 737 1932|robert.sherwin@yale.edu
94640|NCT01462162|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
94641|NCT01462084|Stanford Sleep Medicine|Michelle Cao, DO, FAASM|(650) 723-6601 ‎|michellecao2007@gmail.com
94642|NCT01462045|University of New Mexico|Sang Hwan Kim, PhD/Lead Investigator|5057954545|sanghk@gmail.com
94643|NCT01461993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94644|NCT01461980|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94645|NCT01461811|Alcon Research, Ltd.|Mary Fahmy, OD, Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com
94646|NCT01461733|The Ottawa Hospital Research Institute|Salmaan Kanji|613-737-8899 ext 78159|skanji@toh.on.ca
94648|NCT01461655|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com
94649|NCT01461551|Ruijin Hospital|Dr. Lijie Jia|13916667704|litery0301@163.com
94650|NCT01461538|Seattle Genetics, Inc.|Chief Medical Office|855-473-2436|medinfo@seagen.com
94651|NCT01461473|Stanford University|Clete A. Kushida, M.D., Ph.D.|650-721-7560|clete@stanford.edu
94652|NCT01461369|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com
94653|NCT01461096|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
94654|NCT01461057|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
94655|NCT01461044|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
94657|NCT01460927|El.En. Electronic Engineering S.p.A.|Alessandro Bizzarri|+39 055 8826807|a.bizzarri@elen.it
94658|NCT01460732|Hypertension Center, Third University Department of Medicine|George S. Stergiou|0030 210 7763117|gstergi@med.uoa.gr
94659|NCT01460628|Brigham & Women's Hospital|Dr. Hadine Joffe|617-732-4906|hjoffe@partners.org
94660|NCT01460446|Hoffmann-La Roche|Medical Communications|800 821-8590|
94661|NCT01460342|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
94662|NCT01460303|UMass Medical School|Dr. Michael K. Flynn||Michael.Flynn@umassmemorial.org
94663|NCT01460290|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|2168442808|martha.sajatovic@uhhospitals.org
94664|NCT01459913|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
94665|NCT01459796|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com
94666|NCT01459783|University of California Los Angeles|Joshua Chodosh or Barbara Vickrey|310-206-7671|jchodosh@mednet.ucla.edu
94667|NCT01459705|DCoE|Gregory A. Gahm, PhD|253-320-5772|gregory.a.gahm.civ@mail.mil
94668|NCT01459653|Sandoz GmBH|Andriy Krendyukov, Global Medical Director|+49 8024 4764855|andriy.krendyukov@sandoz.com
94669|NCT01459588|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
94670|NCT01459068|Johns Hopkins Bloomberg School of Public Health|Courtland Robinson|4104155266|crobinso@jhsph.edu
94671|NCT01459016|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
94672|NCT01458951|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94673|NCT01458639|Cyclomedica Australia Pty Ltd|Gary Somerville, Quality and Regulatory Manager|+61 (0)2 9541 0411|gsomerville@cyclomedica.com.au
94674|NCT01458587|DUSA Pharmaceuticals, Inc.|Anna Houlihan|9147608796|houlihana@dusapharma.com
94675|NCT01458574|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94676|NCT01458561|CryoLife, Inc.|Scott B. Capps, Vice President, Clinical Research|770-419-3355|capps.scott@cryolife.com
94677|NCT01458535|AbbVie|Global Medical Services|800-633-9110|
94678|NCT01458392|Acceleron Pharma Inc.|Dr. Matthew Sherman, Chief Medical Officer|617-649-9200|msherman@acceleronpharma.com
94679|NCT01458288|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072 ext 1211|cetsai@taigenbiotech.com
94680|NCT01458275|Sunovion|Respiratory Medical Director|1-866-503-6351|
94681|NCT01458249|Eisai Co., Ltd.|Sun Asami|+81-3-3817-5252 ext 5252|
94682|NCT01458210|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
94683|NCT01458171|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
94684|NCT01458106|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com
94685|NCT01457950|GlaxoSmithKline|GSK Response Center|866-435-7343|
94686|NCT01457885|University of Michigan Comprehensive Cancer Center|Dr. John Magenau, M.D.|734-936-8785|johnmage@umich.edu
94687|NCT01457846|Astrazeneca|Donal Landers|+44 1625 231890|Donal.Landers@astrazeneca.com
94688|NCT01457703|University of Colorado Denver|Clinical Research Regulatory Manager|303-724-6501|Chanel.mansfield@ucdenver.edu
94689|NCT01457521|Gynuity Health Projects|Elizabeth Raymond|2124481230|eraymond@gynuity.org
94690|NCT01457430|MGH Allergy Associates|Dr. Aleena Banerji|617-726-3850|abanerji@mgh.harvard.edu
94691|NCT01457417|Healthcare Pharmaceuticals, Inc|Cynthia Sirard, MD|617-714-0357|CSirard@hcven.com
94692|NCT01457339|Shire Development LLC|Study Physician|1 866-842-5335|
94693|NCT01457053|University of Cincinnati Medical Center|Dr. Myron C. Gerson/Professor of Medicine|5135583074|myron.gerson@uc.edu
94694|NCT01457014|Sleep and Alertness Research Inc.|Sharon A. Chung|416-603-5275|sachung@uhnres.utoronto.ca
94695|NCT01456962|University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences|Peter Anderson, Pharm D|303-724-6128|peter.anderson@ucdenver.edu
94696|NCT01456936|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94697|NCT01456780|Massachusetts Eye and Ear|Dr. Reza Dana|617-573-4431 ext 4431|Reza_Dana@meei.harvard.edu
94698|NCT01456299|Ajou University|Dr.Kim|82-32-460-3400|kjyeop@ajou.ac.kr
94699|NCT01456195|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com
94700|NCT01456169|Takeda GlobalResearch and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
94701|NCT01456143|Mt Sinai|Brett Miles||Brett.Miles@mountsinai.org
121214|NCT02506101|Johns Hopkins Medicine|Dr. Ginette Okoye|410-502-7546|CTReP@jhmi.edu
121215|NCT02504099|AbbVie|Global Medical Services|800-633-9110|
94702|NCT01456130|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
94703|NCT01456052|Lexicon Pharamceuticals, Inc.|Manager of Regulatory Affairs|281-863-3260|plogan@lexpharma.com
94704|NCT01456039|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com
94705|NCT01456000|CardioFocus, Inc.|Burke Barrett, VP Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com
94706|NCT01455545|SESCAM - HOSPITAL UNIVERSITARIO DE GUADALAJARA|Dr. Carlos Almonacid|+34 655 53 44 75|caralmsan@gmail.com
94708|NCT01455428|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94709|NCT01455415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94710|NCT01455220|University of South Florida|Dr.Tuan Vu/ Dr. Derrick Robertson|813-974-6378|droberts@health.usf.edu
94711|NCT01455194|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
94712|NCT01455181|NPS Pharmaceuticals|Executive Director, Clinical Development|+1 908-450-5300|info@npsp.com
94713|NCT01455064|Abbott Diabetes Care|Shridhara A. Karinka, Ph.D., Director of Clinical Affairs|510-749-6393|SHRIDHARA.ALVA@ABBOTT.COM
94714|NCT01455012|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
94715|NCT01454947|University of Southern California|Jason N. Doctor|213.821.8142|jdoctor@usc.edu
94716|NCT01454934|Eisai Inc.|Eisai Medical Services|1-888-422-4743|
94717|NCT01454830|The Pennsylvania State University|Amy M. Sawyer, PhD|814-863-1020|ams24@psu.edu
94718|NCT01454791|MS Center at Evergreenhealth Care|Theodore R, Brown, MD Principle Investigator|425-899-5350|trbrown@evergreenhealth.com
94719|NCT01454778|Sanford Health|Dr. Patrick Kelly|605-312-7300|Patrick.Kelly@SanfordHealth.org
94720|NCT01454726|Xuan Wu Hospital of Capital Medical University|Dr. Jianping JIA|0086-10-83198899 ext 8650|jiajp@vip.sina.com
94721|NCT01454583|Foundation Stiftung Institut fuer Herzinfarktforschung Ludwigshafen, Germany|Professor Dr. Uwe Zeymer|+49 621 503 2813|Uwe.Zeymer@t-online.de
94722|NCT01454531|ALK-ABELLÓ|ALICIA MARIN|+34 913276127|amaes@alk.net
94723|NCT01454505|Alcon Research, Ltd.|Terri Pasquine, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com
94724|NCT01454414|University of North Carolina at Chapel Hill|Dr. Meagan Vaughn|9196986208|meagan.vaughn@unc.edu
94725|NCT01454401|Reapplix Blokken 45 3460 Birkerød Denmark|MD, PhD Senior Consultant Magnus Löndahl||magnus.londahl@med.lu.se
94726|NCT01454258|University Hospital Frankfurt|Prof Dr Dr Kai Zacharowski, FRCA|004969630186668|kai.zacharowski@kgu.de
94727|NCT01454063|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com
94728|NCT01453998|GlaxoSmithKline|GSK Response Center|866-435-7343|
94729|NCT01453946|Perrigo|Beatriz North|718-960-0163|beatriz.north@perrigo.com
94730|NCT01453894|Northwestern University Feinberg School of Medicine|David W. Baker, MD, MPH|312-503-6400|dbaker1@nmff.org
94731|NCT01453855|Alcon Research, Ltd.|Theresa A Landry, PhD|1-888-451-3937|alcon.medinfo@alcon.com
94732|NCT01453725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94733|NCT01453595|Memorial Sloan Kettering Cancer Center|Dr. Martin Voss|646-422-4631|vossm@mskcc.org
94734|NCT01453569|Shanghai Greenvalley Pharmaceutical Co., Ltd.|Dr. Xianliang Xin|86 21-50504988 ext 1370|xinxianliang@hotmail.com
94735|NCT01453413|Taking Control of Your Diabetes|Dr. Steven Edelman, MD|858-755-5683|svedelman@vapop.ucsd.edu
94736|NCT01453387|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
94737|NCT01453374|Alkermes|Bernard L. Silverman, MD|781-609-6000|Bernard.Silverman@alkermes.com
94739|NCT01453296|GlaxoSmithKline|GSK Response Center|866-435-7343|
94740|NCT01453166|Instituto de Ensino e Pesquisa do Hospital do Coração|Dr. Otavio Berwanger|+ 55 11 30536677 ext 8201|oberwanger@hcor.com.br
94741|NCT01453075|VA ORD|Mary Jane Burton|6013624471 ext 1251|mary.burton2@va.gov
94742|NCT01453049|GlaxoSmithKline|GSK Response Center|866-435-7343|
94743|NCT01453036|The Catholic University of Korea|Dr. Jin Il Kim|+82-2-3779-2382|jikim@catholic.ac.kr
94744|NCT01453023|GlaxoSmithKline|GSK Response Center|866-435-7343|
94745|NCT01452854|UCSF|Dr. Mitchell Rosen|415-353-7394|thomas.remble@ucsfmedctr.org
94747|NCT01452425|UCLouvain|Pr Patrice Forget|3227641821|forgetpatrice@yahoo.fr
94748|NCT01452347|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
94749|NCT01452269|University of Rochester|Dr. Steven Barnett|585-275-0560|steven_barnett@urmc.rochester.edu
94750|NCT01452152|University of Maryland School of Medicine|Dr. Alan R. Shuldiner|410-706-1623|ashuldin@medicine.umaryland.edu
94751|NCT01452126|UNM Department of Anesthesiology|Dr Tim Petersen|5052722610 ext 505|timpetersen@salud.unm.edu
94752|NCT01451983|Cleveland Clinic Center for Autism|Thomas W. Frazier, PhD|216-448-6440|fraziet2@ccf.org
94753|NCT01451931|University of California, San Francisco|Dr. Rebecca Smith-Bindman|415-353-4946|rebecca.smith-bindman@ucsf.edu
94754|NCT01451814|Brown University School of Public Health|Dr. Christopher Kahler|401 863-6651|Christopher_Kahler@brown.edu
94755|NCT01451775|boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
94756|NCT01451762|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu
94757|NCT01451749|Dongzhimen Hospital,Beijing University of Chinese Medicine|Dr.Jinzhou Tian|86-10-84013380|jztian@hotmail.com
94758|NCT01451723|Louisiana Health Sciences Center-New Orleans|Jesus Lovera MD|50-903 9302|jlover@lsuhsc.edu
94759|NCT01451645|Regeneron|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com
99740|NCT00362609|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
94760|NCT01451632|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com
94761|NCT01451554|Mayo Clinic|Jon O. Ebbert, MD|507-255-3965|ebbert.jon@mayo.edu
94762|NCT01451541|Sunovion|Respiratory Medical Director|1-866-503-6351|
94763|NCT01451437|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94764|NCT01451424|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com
94765|NCT01451411|Cumberland Pharmaceuticals Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com
94766|NCT01451398|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com
94767|NCT01451203|Astellas Pharma Inc|Vice President, Japan/Asia Clinical Development||Astellas.resultsdisclosure@astellas.com
94768|NCT01450813|Fletcher Allen Health Care at The University of Vermont|Donald Mathews, M.D.|(802) 847-2415|Donald.Mathews@vtmednet.org
94769|NCT01450800|Duke University Medical Center|Dr. Alexis Dieter|919-401-1006|alexis.dieter@duke.edu
94770|NCT01450787|Coa Research Foundation|Kenneth A Beckman, MD|614-506-4720|kenbeckman22@aol.com
94771|NCT01450761|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
94772|NCT01450696|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
94773|NCT01450683|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu
94774|NCT01450631|KCI USA, Inc.|Jill Twardowski, Director of Clinical Operations|210-515-4166|jill.twardowski@kci1.com
94775|NCT01450397|Hospital for Special Surgery|Scott W. Wolfe|212-606-1529|WolfeS@hss.edu
94776|NCT01450319|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
94777|NCT01450306|Hartford Hospital|Dr David Tolin|860-545-7685|dtolin@harthosp.org
94778|NCT01450189|University of North Carolina at Chapel Hill|William C Miller|9199669407|bill_miller@unc.edu
94779|NCT01450007|Mayo Clinic|Dr. David M. Rosenfeld|480-301-7586|Rosenfeld.David@mayo.edu
94780|NCT01449955|UT Southwestern/VA North Texas|Dr. Alina Suris|214-857-0334|alina.suris@va.gov
94782|NCT01449812|GlaxoSmithKline|GSK Response Center|866-435-7343|
94783|NCT01449747|The Catholic University of Korea|Dr. Ji Hyun Kim|82-2-961-4534|kjhyun@catholic.ac.kr
94784|NCT01449734|CSCC Germany, Jena University Hospital|Christiane Hartog, MD|+49 3641 9323171|christiane.hartog@med.uni-jena.de
94785|NCT01449721|Christiana Care Health System|Ryan Arnold, MD, Director of Research, Emergency Medicine|302-733-5108|ryarnold@christianacare.org
94786|NCT01449708|Coastal Anesthesiology|Patrick Ziemann-Gimmel, MD|904-819-4478|pziemann@yahoo.com
94787|NCT01449682|Retina Macula Institute|Ron P. Gallemore, M.D., Ph. D.|310) 944-9393|rongallemoremd@gmail.com
94788|NCT01449539|University of Arkansas for Medical Science-MIRT|Sarah Waheed, MD|501-686-8230|mirt@uams.edu
94789|NCT01449526|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|585-338-6399|robert.steffen@bausch.com
94790|NCT01449513|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com
94791|NCT01449461|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
94792|NCT01449370|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
94793|NCT01449305|isRed Pharma & Biotech Research Corporation|Mirror Hsieh|886-8-7628188|mingrong@bioisred.com
94794|NCT01449279|Stanford Cancer Institute|Dr. Susan J Knox|650-725-2720|sknox@stanford.edu
94795|NCT01449266|Guerbet|Dr. Pierre Desché, MD - VP Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com
94796|NCT01449240|Shire|Study Physician|+1 866 842 5335|
94797|NCT01449006|St Vincent's Hospital, Sydney, Australia|Prof. Bruce Brew|61 2 8382 1111 ext 4100|bruce.brew@svha.org.au
94798|NCT01448850|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com
94800|NCT01448616|University of Washington|Rachel Bender Ignacio, MD MPH|2065204340|rbi13@uw.edu
94801|NCT01448525|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
94802|NCT01448486|St. Vincent's Hospital, Sydney|Prof. Bruce Brew|61 2 8382 1111 ext 4100|b.brew@unsw.edu.au
94803|NCT01448356|Singapore Eye Research Institute|Dr Andrea Petznick|+65 6322 ext 4512|andrea.petznick@seri.com.sg
94804|NCT01448213|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org
94805|NCT01448057|Novartis consumer Health a GSK Consumer Healtcare company|Director Clinical research Respiratory|(1) 5512065988|anna.x.grinienko@gsk.com
94806|NCT01448044|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
94807|NCT01447927|University Hospitals of Cleveland, Case Medical Center|Dr. Amitabh Chak|216-844-5385|Amitabh.chak@case.edu
94808|NCT01447914|University of Texas (UT) MD Anderson Cancer Center|Robert Orlowski, MD, PhD / Professor, Department of Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org
94809|NCT01447849|TexasTech|Dr. Jerzy Sarosiek, Director, Mol. Medicine Research|915-215-5255|jerzy.sarosiek@ttuhsc.edu
94810|NCT01447719|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
94811|NCT01447706|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com
94812|NCT01447576|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974|
94813|NCT01447511|University of Minnesota|Dr. Richard Brundage|612-624-3115|brund001@umn.edu
94814|NCT01447446|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
94815|NCT01447433|Changhai Hospital|Prof. Donglian Cai|86 21 81873168|nutrition1226@126.com
94816|NCT01447420|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
94817|NCT01447225|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com
94818|NCT01447121|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3062|carmine.greene@ascensia.com
94819|NCT01447017|Centre for Clinical Studies in Malmö|Dr. Pekka Koskinen|+46 (0)40 97 12 60|pekka@clsm.se
94820|NCT01446796|Duke University Medical Center|Michel Khouri, MD|919 684 8111|michel.khouri@duke.edu
94821|NCT01446705|Center for Health Information and Communication, Roudebush VA Medical Center|Dr. David A. Haggstrom|317-988-2067|dahaggst@iu.edu
94822|NCT01446419|Relievant Medsystems, Inc.|V.P. of Clinical & Regulatory Affairs|650-261-2259|lhook@relievant.com
94823|NCT01446289|Novartis vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com
94824|NCT01446250|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com
94825|NCT01446237|GlaxoSmithKline|GSK Response Center|866-435-7343|
94826|NCT01446003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94827|NCT01445951|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com
94828|NCT01445873|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94829|NCT01445847|King Saud University Medical City - College of Medicine|Dr. Khalid Al-Faleh, Chairman, Institutional Review Board|966556031222|kfaleh@ksu.edu.sa
94830|NCT01445769|Incyte Corporation|Study Director|855 463-3463|
94831|NCT01445678|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com
94832|NCT01445652|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com
94833|NCT01445626|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
94834|NCT01445613|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com
94835|NCT01445548|National Eye Institute|Wai T. Wong, MD, PhD|301-496-7566|wongw@nei.nih.gov
94836|NCT01445028|MidAtlantic Retina|Richard Kaiser, MD|800-331-6634|rkaiser@midatlanticretina.com
94837|NCT01444924|University of Wisconsin Hospitals and Clinics|Dr. David Kushner|608-263-0796|dmkushner@facstaff.wisc.edu
94838|NCT01444911|University of Wisconsin Carbone Cancer Center|Dr. David Kushner|608-263-1210|dmkushner@facstaff.wisc.edu
94839|NCT01444898|Children's Hospital Los Angeles|Dr. Mitchell Geffner|323-361-7032|mgeffner@chla.usc.edu
94840|NCT01444781|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
94841|NCT01444651|Massachusetts General Hospital|Dr. Jennifer Ho|617-726-6411|jho1@partners.org
94842|NCT01444456|Amgen Inc.|Study Director|866-572-6436|
94843|NCT01444430|AstraZeneca Research and Development|Carin Jorup, Global Clinical Lead (GCL) SYMBICORT|+46 31 7761000|Carin.Jorup@astrazeneca.com
94844|NCT01444417|Amgen Inc.|Study Director|866-572-6436|
94845|NCT01444391|Acclarent|Director Clinical|650-687-5888|lenglan1@its.jnj.com
94846|NCT01444378|Abbott Vascular|Robert McGreevy|408-845-3932|Robert.mcgreevy@abbott.com
94847|NCT01444300|Oregon Health & Science University|Dr. Michelle Cameron|503-218-1971|cameromi@ohsu.edu
94848|NCT01444287|Vistakon|Noel Brennan|1 904 4433494|nbrenna2@its.jnj.com
94849|NCT01444092|Perrigo|Beatriz North|718-960-0163|beatriz.north@perrigo.com
94850|NCT01443923|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov
94851|NCT01443858|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu
94852|NCT01443845|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
94853|NCT01443494|Intensive Care Unit, Zhongda Hospital, Southeast University|Jingyuan Xu|86-025-83262550|xujingyuanmail@163.com
94854|NCT01443403|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp
94855|NCT01443364|UCB|UCB Clinical Trial Call Center|+1877 822 ext 9493|
94856|NCT01443130|University of Maryland School of Medicine|Miriam K. Laufer, MD, MPH|410-706-5333|mlaufer@medicine.umaryland.edu
94857|NCT01443078|Memorial Sloan Kettering Cancer Center|Chaft, Jamie, MD|646-888-4545|ChaftJ@mskcc.org
94859|NCT01442844|Massachusetts General Hospital|Dr. Alexandra Kimball|617-726-5066|harvardskinstudies@partners.org
94860|NCT01442779|Texas Tech University Health Sciences Center|Lorenz Lutherer, MD, PhD|806-743-2532|Lorenz.Lutherer@ttuhsc.edu
94861|NCT01442688|Shire Pharmaceutical|Study Physician|1 866-842-5335|
94862|NCT01442675|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
94863|NCT01442493|Friends Research Institute|Robert Schwartz, M.D.|410-837-3977 ext 276|rschwartz@friendsresearch.org
94864|NCT01442376|Helsinn Healthcare SA|Spinelli Tulla|+4191985 21 21|tulla.spinelli@helsinn.com
94865|NCT01442181|UF Healthcare|Dr. Thomas Beaver|352-273-5503|thomas.beaver@surgery.ufl.edu
94866|NCT01442155|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
94867|NCT01442129|Mount Sinai|Deborah D. Ascheim, MD, Associate Professor, Clinical Director of Research, InCHOIR|212-659-9567|deborah.ascheim@mountsinai.org
94868|NCT01442103|Molnlycke Health Care|Joan wilson|+1 706-650-1012|joan.wilson@molnlycke.com
94869|NCT01442064|Genentech|Genentech||ctg-post-d@gene.com
94870|NCT01442038|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
94871|NCT01441973|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
94872|NCT01441960|Mass General Hospital|Ala Nozari|978-318-3933|anozari@partners.org
94873|NCT01441843|Erasmus University Medical Centre|Dr. M. Klimek|+31107033713|m.klimek@erasmusmc.nl
94874|NCT01441765|Beth Israel Deaconess Medical Center|Dr. David Avigan, Principal Investigator|617-667-9920|davigan@bidmc.harvard.edu
94875|NCT01441596|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
94876|NCT01441570|Brigham and Women's Hospital|Dr. Steven Gabardi|617-732-7658|sgabardi@partners.org
94877|NCT01441466|Princess Amlia Children's Clinic, Isala|Jolita Bekhof|+31384245050|j.bekhof@isala.nl
94878|NCT01441440|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inuiries@pfizer.com
100837|NCT00439244|Novartis Pharmaceuticals|Study Director|862-778-8300|
94879|NCT01441414|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94880|NCT01441401|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94881|NCT01441245|Department of Internal Medicine, University of Siena, Le Scotte hospital, Siena, Italy|Alberto Palazzuoli MD, Cardiology Unit|+39577585363|palazzuoli2@unisi.it
94882|NCT01441180|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov
94883|NCT01441102|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov
94884|NCT01441076|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Grayson, Peter|+1 301 827 9187|peter.grayson@nih.gov
94885|NCT01440972|University of Iowa|Dr. Neil Segal|3193358204|segal-research@uiowa.edu
94886|NCT01440959|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr
94887|NCT01440946|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
94888|NCT01440881|University of Florida|Dr. Thomas Beaver|352-273-5501|thomas.beaver@surgery.ufl.edu
94889|NCT01440764|Beth Israel Deaconess Medical Center|Robert Banzett, PhD|(617)667-0572|rbanzett@bidmc.harvard.edu
94890|NCT01440647|Women & Infants Hospital of Rhode Island|Abbot R. Laptook, MD, Professor of Pediatrics The Warren Alpert Medical School of Brown University M|401-274-1122 ext 7404|ALaptook@WIHRI.org
94891|NCT01440634|UT Southwestern Medical Center|Dr. Carlos H Timaran|2146450533|timaran1@msn.com
94892|NCT01440595|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94893|NCT01440569|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
94894|NCT01440543|Digestive Diseases Center, Vitkovice Hospital, Ostrava, Czech Republic|Premysl Falt MD|+420602689561|faltprem@centrum.cz
94895|NCT01440517|GE Healthcare|Arnold Jacobson, M.D.|1-609-514-6325|Arnold.Jacobson@ge.com
94896|NCT01440387|GlaxoSmithKline|GSK Response Center|866-435-7343|
94897|NCT01440374|Novartis Pharmaceuticals|Study Director|862-778-8300|
94898|NCT01440322|Alcon Research, Ltd.|Sharon Holden Thomas, Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com
94899|NCT01440283|St. Jude Children's Research Hospital|Chia-ho Hua, PhD|901-595-3610|chia-ho.hua@stjude.org
94900|NCT01440101|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com
94901|NCT01440049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94902|NCT01439971|Catalyst Biosciences|Chief Medical Officer|1-650-266-8671|hlevy@catbio.com
94903|NCT01439945|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu
94904|NCT01439867|Amgen Inc.|Study Director|866-572-6436|
94905|NCT01439724|Instituto Nacional de Cancer|Dr. Heliton Spindola Antunes|55 21 32076597|hspindola@inca.gov.br
94906|NCT01439672|University of Virginia|Sue Brown, MD||sab2f@virginia.edu
94908|NCT01439282|Eisai Inc.|Eisai Medical Services|1-888-422-4743|
94909|NCT01439204|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
94911|NCT01439126|Concordia Pharmaceuticals Inc.|John AR McCleery, CPA, CA, Managing Director and CFO|1-246-256-1861|jmccleery@concordiarx.com
94912|NCT01439074|Changhai Hospital of Shanghai|Prof Xia, Zhaofan|+86 2181873471|
94913|NCT01438996|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com
94914|NCT01438814|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
94915|NCT01438710|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com
94916|NCT01438541|Molnlycke Health Care AB|Tina Kjellén|+46317223098|tina.kjellen@molnlycke.com
94917|NCT01438489|MedImmune, LLC|Gabor Illei, MD, Senior Director|301-398-0000|illeig@Medimmune.com
94918|NCT01438424|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
94919|NCT01438307|UAB|Francisco Robert, MD|205-934-5077|paco@uab.edu
94920|NCT01438294|Universidade Nove de Julho|Evelim Leal de Freitas Dantas Gomes, PhD PT|5511976333349|evelimfreitas@hotmail.com
94921|NCT01438229|St. Jude Medical|Steven Madej|651-756-2230|smadej@sjm.com
94922|NCT01438177|Perlmutter Cancer Center|Amitabha Mazumder, MD|212-731-5757|amitabha.mazumder@nyumc.org
94923|NCT01438151|Mount Sinai|Dr. Shradha Agarwal|212-659-9261|shradha.agarwal@mssm.edu
94924|NCT01438060|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
94925|NCT01437995|Johns Hopkins University|Alexis Rea|4432878496|area5@jhu.edu
94926|NCT01437943|Brigham and Women's Hospital|Anil Chandraker, MD|617-732-7412|achandraker@partners.org
94927|NCT01437878|Actelion Pharmaceutical Ltd|Maziar Assadi Gehr|+41 61 565 5525|maziar.assadi-gehr@actelion.com
94928|NCT01437540|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com
94929|NCT01437501|Johns Hopkins Bloomberg School of Public Health|Thomas W. Kensler, PhD|410-955-1292|tkensler@jhsph.edu
94931|NCT01437423|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
94932|NCT01437397|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com
94933|NCT01437319|Johnson &Johnson Vision Care, Inc|Tawnya Wilson, OD Principal Research Optometrist|904-443-3500 ext 1834|TWilson@ITS.JNJ.com
94934|NCT01437267|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com
94935|NCT01437124|Wirral NHS Trust|Hussain Kazi|0151 678 6111|hussainkazi@nhs.net
94936|NCT01437111|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94938|NCT01436799|Gachon University Gil Medical Center|Dr.HJ Kwak|82-32-460-3400|hyun615@gilhospital.com
119029|NCT02317549|Leading BioSciences|Tom Hallam, PhD, MBA|631-739-3088|tom.hallam@leadingbiosciences.com
94940|NCT01436526|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
94941|NCT01436500|Cumberland Pharmaceuticals Inc|Jerry Fox, DVM|615-255-0068|jfox@cumberlandpharma.com
94942|NCT01436435|Boston Scientific|DeeAnn Tinjum, Clinical Trial Manager|763-494-1927|deeann.tinjum@bsci.com
94943|NCT01436370|Department of Internal Medicine, University of Iowa|Jack Stapleton, MD|319-356-3168|jack-stapleton@uiowa.edu
94944|NCT01436305|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
94945|NCT01436279|Boston Medical Center|Olivera Vragovic|617 414 7304|Olivera.Vragovic@bmc.org
94946|NCT01436266|Boston Medical Center|Sarita Sonalkar, MD|617 414 7304|sarita.sonalka@bmc.org
94947|NCT01436253|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
94948|NCT01436201|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
94949|NCT01436175|Shire|Study Physician|1 866-842-5335|
94950|NCT01436162|Shire Development LLC|Study Physician|+1 866 842 5335|
94951|NCT01436149|Shire|Study Physician|+1 866 842 5335|
94952|NCT01436110|GlaxoSmithKline|GSK Response Center|866-435-7343|
94953|NCT01436084|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Professor, Leukemia|1-877-MDA-6789|CR_Study_Registration@mdanderson.org
94954|NCT01436071|GlaxoSmithKline|GSK Response Center|866-435-7343|
94955|NCT01436045|HealthPartners Institute for Education and Research|Michael H Rosenbloom, MD|6512547900|michael.h.rosenbloom@healthpartners.com
94956|NCT01436006|Università di Palermo|Sergio Salerno|00390916552315 ext 2315|sergio.salerno@unipa.it
94957|NCT01435928|Sunovion|Medical Director, CNS|1-866-503-6351|
94958|NCT01435798|Translational Pain Research, Brigham and Women's Hospital|Christine N. Sang, MD, MPH|617-525-7246|paintrials@partners.org
94959|NCT01435759|Shire|Study Physician|+1 866 842 5335|
94960|NCT01435655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
94961|NCT01435577|Grünenthal GmbH|Director of Clinical Trials|+241 569 3223|
94962|NCT01435460|Bausch & Lomb, Incorporated|Tuyen Ong|(973) 360-6389|tuyen.ong@bausch.com
94965|NCT01435122|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jonathan R. Strosberg|813-745-3636|jonathan.strosberg@moffitt.org
94966|NCT01435031|Abbott Vascular|Jennifer M Jones-McMeans, PhD (Associate Director Clinical Research)|408-845-1459|jennifer.jones@av.abbott.com
94967|NCT01434823|University of Pennsylvania|Dr. Meeta P. Kerlin|215.614.0627|meeta.prasad@uphs.upenn.edu
94968|NCT01434693|Coronado Biosciences|Vice President Clinical Operations|781.652.4516|nsilver@coronadobio.com
94969|NCT01434680|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
94970|NCT01434654|St Vincent's Hospital, Sydney|Prof. Bruce Brew|+61 2 8382 1111 ext 4100|b.brew@unsw.edu.au
94971|NCT01434641|St. Luke's-Roosevelt Hospital|E. Gordon DePuey, M.D.|212-523-3400|edepuey@chpnet.org
94973|NCT01434342|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu
94974|NCT01434186|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484 ext 762 484|Eva.Johnsson@astrazeneca.com
94975|NCT01434121|Virginia Commonweath University|Alpha A. Fowler, III, MD|804-628-5710|afowler@mcvh-vcu.edu
94976|NCT01434030|University of Virginia|Boris P Kovatchev, Ph.D.|434-924-5592|bpk2u@virginia.edu
94977|NCT01433913|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu
94978|NCT01433731|TetraLogic Pharmaceuticals|Vice President, Clinical Research|610-889-9900|jeffrey.skolnik@tetralogicpharma.com
94979|NCT01433549|Alcon Research, Ltd.|R. Alan Landers, O.D., M.S., F.A.A.O.|1-888-451-3937|alcon.medinfo@alcon.com
94980|NCT01433471|NYU Langone Medical Center|Martin Wolff|(646) 329-7259|martin.wolff@nyumc.org
94981|NCT01433354|Novartis Pharmaceuticals|Study Director|862­-778­-8300|
94982|NCT01433263|Novartis Pharmaceuticals|Study Director|862-778-8300|
94983|NCT01433250|Novartis Pharmaceuticals|Study Director|862-778-8300|
94984|NCT01433172|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jhanelle Gray|813-745-3050|jhanelle.gray@moffitt.org
94985|NCT01433159|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com
94986|NCT01433107|Novartis|Clinical Project leader|+41223633111|
94987|NCT01433081|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu
94988|NCT01433055|Maryland Psychiatric Research Center|Deanna L. Kelly, Pharm.D., BCPP|410-402-6861|dkelly@mprc.umaryland.edu
94989|NCT01433042|Given Imaging Ltd.|Director of Clinical affairs|+972-4-9097774|Hila.Debby@givenimaging.com
94990|NCT01433016|Exalenz Bioscience|Clinical Trials Manager|+972-8-9737513|avrahamh@exalenz.com
94991|NCT01432938|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
94992|NCT01432886|Eisai Co., Ltd.|Tadashi Nakanishi|81-3-3817-5252 ext 5252|
94993|NCT01432756|Boston Children's Hospital|Laura Bogart|857-218-4073|laura.bogart@childrens.harvard.edu
94994|NCT01432626|University of Pittsburgh|Dr. Prem Soman|412 647 3435|somanp@upmc.edu
94995|NCT01432600|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rachid Baz|813-745-8212|rachid.baz@moffitt.org
94996|NCT01432574|H. Lee Moffitt Cancer Center and Research Institute|Anna Giuliano, Ph.D.|813-745-6820|anna.giuliano@moffitt.org
94997|NCT01432561|University of California San Diego|Dr. Ranjan Dohil, P.I.|619-471-9554|rdohil@ucsd.edu
94998|NCT01432535|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
94999|NCT01432457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95000|NCT01432444|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
95001|NCT01432405|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu
95002|NCT01432379|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
95003|NCT01432366|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95004|NCT01432327|Katholieke Universiteit Leuven|Karen Van Hoye|0032498617141|Karen.Vanhoye@faber.kuleuven.be
95005|NCT01432275|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com
95006|NCT01432262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95007|NCT01432236|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95008|NCT01432015|Gynecologic Oncology Associates|John P. Micha, M.D.|949-642-5165|Research@gynoncology.com
95009|NCT01431989|GlaxoSmithKline|GSK Response Center|866-435-7343|
95010|NCT01431976|GlaxoSmithKline|GSK Response Center|866-435-7343|
95011|NCT01431963|GlaxoSmithKline|GSK Response Center|866-435-7343|
95012|NCT01431950|GlaxoSmithKline|GSK Response Center|866-435-7343|
95013|NCT01431846|Eastern Colorado Health Care System|Dr. Michael Ho|720-857-5115|michael.ho@va.gov
95014|NCT01431755|Q-Med AB|Head of Medical Affairs|+46 (0) 18 474 90 00|reception.SEUPP@galderma.com
95015|NCT01431716|Actelion Pharmaceuticals Ltd|Thomas Pfister, PhD, Senior Clinical Scientist|+41 61 565 5932|thomas.pfister@actelion.com
95016|NCT01431703|Shanghai Jiaotong university|Dr Ge zhi zheng|86021-34506250|shenyufeng303@gmail.com
95017|NCT01431521|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95018|NCT01431508|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95019|NCT01431391|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com
95020|NCT01431339|Durata Therapeutics|Michael Zelasky|203-871-4616|mzelasky@duratatx.com
95021|NCT01431300|Duke University Medical Center|Charles Kim|919-684-7284|charles.kim@duke.edu
95022|NCT01431287|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95023|NCT01431274|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95024|NCT01431170|NJMS, Rutgers University|Suqin Guo, MD|973-972-2031|guos1@njms.rutgers.edu
95025|NCT01431144|University of Louisville|Henry Greenwell, Principal Investigator|502-852-6928|henry.greenwell@louisville.edu
95026|NCT01431131|University of Louisville|Dr. Henry Greenwell, Principal Investigator|502-852-6928|henry.greenwell@louisville.edu
95027|NCT01431079|University of Cincinnati|Dr. Manoj Sharma, PI|513-556-3878|manoj.sharma@uc.edu
95028|NCT01431014|Chang Gung Memorial Hospital|Lun-Jou Lo, MD,Hye-Young Kim, MD||lunjoulo@cgmh.org.tw
95029|NCT01430819|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
95030|NCT01430754|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com
95031|NCT01430741|Bedford VA|Dr. David Smelson, Professor|781-570-1903|david.smelson@va.gov
95032|NCT01430624|Medical University of South Carolina|Heidi Resnick, Ph.D.|843-792-2945|resnickh@musc.edu
95033|NCT01430611|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
95034|NCT01430585|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95035|NCT01430468|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-445-5151|iannotj@ccf.org
95036|NCT01430403|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
95037|NCT01430325|Intermountain Healthcare|Lindell K. Weaver, MD|801-408-3623|lindell.weaver@imail.org
95038|NCT01430182|Baylor College of Medicine|Neil Bailard|713-798-7356|bailard@bcm.edu
95039|NCT01430169|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
95040|NCT01430130|Neodyne Biosciences|Kristin Prosak|650-543-7129 ext 126|kprosak@neodynebio.com
95041|NCT01430104|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
95042|NCT01430091|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
95043|NCT01429623|Bar Ilan University|Jonathan Rabinowitz, PhD|+972544643889|Jonathan.Rabinowitz@biu.ac.il
95044|NCT01429584|University of Utah Department of Anesthesiology|Dr. Elizabeth Thackeray|(801) 581-6393|elizabeth.thackeray@hsc.utah.edu
95045|NCT01429532|SunYat-senU|Prof. Yizhi Liu|+86-20-87330341|Reviewborad_SYsU@163.com
95046|NCT01429441|ThromboGenics N.V.|Dr. Petra Kozma-Wiebe|+32 16 751 497|petra.kozma@thrombogenics.com
95047|NCT01429259|Hartford Hospital|Joseph L. Kuti, Pharm.D.|860-972-3612|joseph.kuti@hhchealth.org
95048|NCT01429077|Rehabilitation Institute of Chicago|Leora R. Cherney, PhD|312-238-1117|Lcherney@ric.org
95049|NCT01429064|Orion Pharma, Development, R&D|Head of Oncology|+358 10 4261|mika.mustonen@orionpharma.com
95050|NCT01429051|Takeda|Medical Director|+1-800-778-2860|clinicaltrialregistry@tpna.com
95051|NCT01428882|Hospital San Pedro de Alcantara, Caceres|Dr. Javier Molina-Infante|0034927621543|xavi_molina@hotmail.com
95052|NCT01428765|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95053|NCT01428713|Baylor College of Medicine/TCH|Dr. Lakshmi Srivaths|832-822-1514|lvsrivat@txch.org
95054|NCT01428661|Vanda Pharmaceuticals Inc.|Curt Wolfgang, Ph.D.|202-734-3400|curt.wolfgang@vandapharma.com
95055|NCT01428583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95056|NCT01428336|Cleveland Clinic Foundation|Seenia Peechakara|216 4105901|peechas@ccf.org
95060|NCT01428115|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
95061|NCT01428076|BTG International Inc.|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com
95062|NCT01428063|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
95063|NCT01427933|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
95064|NCT01427920|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
95065|NCT01427907|Fresenius Medical Care, North America|Mayuri Thakuria MD (MBBS), MPH|781-699-4645|mayuri.thakuria@fmc-na.com
95066|NCT01427881|Fred Hutchinson Cancer Research Center|Marco Mielcarek, MD|206-667-2827|mmielcar@fredhutch.org
95067|NCT01427803|Bayer HealthCare LLC, Consumer Care|Head Medical Affairs||clinical-trials-contact@bayerhealthcare.com
95068|NCT01427751|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com
95069|NCT01427738|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
95070|NCT01427517|University of Minnesota|Mary Holmay|612-812-5854|holma101@umn.edu
95071|NCT01427504|University of Colorado|Dr. Jennifer Kiser|303-724-6131|jennifer.kiser@ucdenver.edu
95072|NCT01427309|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
95073|NCT01426958|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95074|NCT01426867|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com
95075|NCT01426854|Alcon (China) Ophthalmic Product Co., Ltd.|Terence Li, Clinical Research Manager, Development & Medical Affairs, China|+86 10 5829 1452|Terence.li@alcon.com
95076|NCT01426789|Novartis Pharmaceuticals|Study Director|862-778-8300|
95077|NCT01426763|ViroPharma|Chief Scientific Officer|610-458-7300|
95078|NCT01426555|VA Boston Healthcare System|Dr. Antonio Lazzari|857-364-6381|antonio.lazzari@va.gov
95079|NCT01426516|Genomind|Dr. Rachel Scott|267-989-3435|rscott@genomind.com
95080|NCT01426438|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
95081|NCT01426425|Medtronic|Jo Krueger, Senior Clinical Research Specialist|7635261551|jo.krueger@medtronic.com
95082|NCT01426373|Kythera Biopharmaceuticals, Inc.|Clinical Trial Disclosure||clinical_trials@kythera.com
95083|NCT01426360|Sun Yat-sen University|Dr. Liu Hongchun|86-0-13826189071|hongchun751@sina.com
95084|NCT01426347|Johns Hopkins University|Uzma Jalal Haque|410-550-0578|uhaque@jhmi.edu
95085|NCT01426269|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com
95086|NCT01426230|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com
95087|NCT01426113|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
95088|NCT01425879|The Ohio State University|Tanios Bekaii-Saab, MD|614-293-9863|tanios.bekaii-saab@osumc.edu
95089|NCT01425853|Bioiberica|Clinical R&D Manager|+34934904908|mherrero@bioiberica.com
95090|NCT01425814|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com
95091|NCT01425749|University of Virginia|Craig L Slingluff Jr|434-924-1730|cls8h@virginia.edu
95092|NCT01425632|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
95093|NCT01425528|University of utah|Kathryn Swoboda MD|801-585-9717|Swoboda@genetics.utah.edu
95094|NCT01425463|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
95095|NCT01425359|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
95096|NCT01425307|The University of Texas School of Public Health|Barry Robert Davis|713-500-9515|barry.r.davis@uth.tmc.edu
95097|NCT01425268|AirXpanders|Director of Clinical Affairs|650-390-9000 ext 9003|kkelley@airxpanders.com
95098|NCT01425229|University of Heidelberg|Prof. Gerd Mikus|4962215639197|gerd.mikus@med.uni-heidelberg.de
95099|NCT01425203|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95100|NCT01425190|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95101|NCT01424943|Institute for Families in Society, University of South Carolina|Dr. Cheri Shapiro|803-777-8760|cshapiro@mailbox.sc.edu
95102|NCT01424930|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com
95103|NCT01424813|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
95104|NCT01424644|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
95105|NCT01423617|Analyze & Realize|Dr Christof Jänicke|+49 30 40 00 83 23|cj@a-r.com
95106|NCT01424501|GlaxoSmithKline|GSK Response Center|866-435-7343|
95107|NCT01424306|Fred Hutchinson Cancer Research Center|Mario Kratz|206-667-7362|mkratz@fredhutch.org
95108|NCT01424228|Shire Development LLC|Study physician|+1 866 842 5335|
95109|NCT01424189|Alcon Research, Ltd.|Expert Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com
95110|NCT01424072|University of São Paulo|Leonice Fumiko Sato Kurebayashi|5511 991126023|fumie_ibez@yahoo.com.br
95111|NCT01424033|University of Michigan|Jan Stevens|7349365566|janstev@med.umich.edu
95112|NCT01423916|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
95113|NCT01423773|Alcon Research|Head, Clinical Trial Management|1-800-241-7629|
95114|NCT01423760|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
95115|NCT01423604|Incyte Corporation|Study Director|1-855-463-3463|
95117|NCT01423162|Food and Nutrition Research Institute|Trinidad P. Trinidad|6328372071 ext 2281|trinidadtp@yahoo.com.ph
95118|NCT01423084|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com
95119|NCT01422915|BrighamHospital|Dr. Peter V. Tishler|617-525-2123|repvt@channing.harvard.edu
95120|NCT01422889|Boston Scientific|Peter Maurer, MPH; Director, Clinical Trials|508-683-6678|Peter.Maurer@bsci.com
95121|NCT01422876|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95122|NCT01422850|CytoVac A/S|Christer Lundell-Ek, Project Manager - Clinical Development||cle@cytovac.dk
95123|NCT01422824|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com
95124|NCT01422720|BIAL – Portela & Cª S.A.|Director R&D|+351-229866100|clinical.trials@bial.com
95126|NCT01422434|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com
95128|NCT01422382|Kowa Research Institute, Inc|Roger Morgan, MD FACS|919-433-1600|RMorgan@kowaus.com
95129|NCT01422369|Kowa Research Institute, Inc|Roger Morgan, MD FACS|919-433-1600|RMorgan@kowaus.com
95130|NCT01422356|Melbourne Sexual Health Centre, Alfred Health|Associate Professor Marcus Chen|+61 3 9341 6260|mchen@mshc.org.au
95131|NCT01422304|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95132|NCT01422239|Yale University School of Medicine|Andrea Weinberger, Ph.D.|203-974-7598|andrea.weinberger@yale.edu
95133|NCT01422226|University of Colorado Denver|Christina Gavito|303-724-5559|christina.gavito@ucdenver.edu
95134|NCT01422213|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
95135|NCT01422187|Target Health Inc.|Glen Park|212-681-2100|gpark@targethealth.com
95136|NCT01422070|Università degli Studi di Ferrara|Dr Maurizia Capuzzo|+393355932642|cpm@unife.it
95137|NCT01421719|Stanford University|Rodney U. Anderson, MD|6504984240|rua@stanford.edu
95138|NCT01421667|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com
95139|NCT01421654|ResMed|Amy Blase/Clinical Research Manager|858-836-6715|amy.blase@resmed.com
95140|NCT01421641|Oregon Health & Science University|Paula Bednarek|(503) 418-4500|bednarek@ohsu.edu
95141|NCT01421589|Massachusetts General Hospital|Hideo Makimura, MD, PhD|617-726-8277|hmakimura@partners.org
95142|NCT01421511|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370 ext 241|philippe.prokocimer@cubist.com
95143|NCT01421498|Shire|Study Physician|1 866-842-5335|
95144|NCT01421472|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com
95145|NCT01421459|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
95146|NCT01421355|Brigham and Women's Hospital|Joshua Beckman, MD|617-732-6320|jbeckman@partners.org
95147|NCT01421303|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95148|NCT01421277|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6327|ClinicalTrialsDisclosure@merck.com
95149|NCT01421147|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
95150|NCT01421134|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com
95152|NCT01420848|University of São Paulo|Leonice Fumiko Sato Kurebayashi|(5511 991126023)|fumie_ibez@yahoo.com.br
95153|NCT01420289|Calvary Hospital|Oscar M. Alvarez PhD, Director Center for Curative and Palliative Wound Care|718-518-2577|oalvarez@calvaryhospital.org
95154|NCT01420146|Institut Jules Bordet|Dr Géraldine Gebhart|025413095 ext +32|geraldine.gebhart@bordet.be
95155|NCT01420081|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95156|NCT01419977|Duke University Medical Center|Nirmish Shah, MD|919-684-5350|nirmish.shah@duke.edu
95157|NCT01419795|Fred Hutchinson Cancer Research Center|Dr. Mohamed Sorror|206-667-6298|msorror@fredhutch.org
95158|NCT01419769|Boston Scientific Corp.|Lina Ginnetti|508-683-4512|Lina.Ginnetti@bsci.com
95159|NCT01419639|NYU Langone Medical Center|Matthias A. Karajannis|212 263 9959|matthias.karajannis@nyumc.org
95160|NCT01419314|Texas Woman's University|Roberto Sandoval PT|713-859-9351|rsandoval@mail.twu.edu
95161|NCT01419275|Stanford University|Dr. Greg Zaharchuk|650-736-6172|susanmir@stanford.edu
95162|NCT01419249|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
95163|NCT01419236|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
95164|NCT01419197|Hoffmann-La Roche|Medical Communications|800 821-8590|
95165|NCT01419184|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660|
95166|NCT01419171|Peter Maurer, Director Clinical Trials|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com
95167|NCT01419028|Alexion International Sarl|Alexion Pharmaceuticals||clinicaltrials@alxn.com
95168|NCT01418937|GlaxoSmithKline|GSK Response Center|866-435-7343|
95169|NCT01418703|University of Virginia|Marc D Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu
95170|NCT01418482|Uppsala Akademiska Hospital, Dept. of Plastic Surgery|Fredrik Huss|+46 771 405 405|Fredrik.Huss@surgsci.uu.se
95171|NCT01418365|Shire Pharmaceutical|Study Physician|1 866-842-5335|
95172|NCT01418209|Brigham and Women's Hospital|Hadine Joffe, MD, MSc|617-732-4906|hjoffe@partners.org
95173|NCT01418001|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org
95174|NCT01417936|EMD Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
95175|NCT01417481|Instituto Nacional de Enfermedades Respiratorias|Dr. Mario H. Vargas|(+55)54871771|mhvargasb@yahoo.com.mx
95176|NCT01417455|Instituto de Medicina Molecular|João Eurico Fonseca|+351217999544 ext 47221|jecfonseca@gmail.com
95177|NCT01417377|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
95178|NCT01417195|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
95179|NCT01417156|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95180|NCT01417104|The Ohio State University|Sanjay Rajagopalan, MD|614-247-7760|sanjay.rajagopalan@osumc.edu
95181|NCT01417078|Acorda Therapeutics, Inc.|Executive Medical Director - Clinical Development & Medical Affairs|914-347-4300 ext 5367|dsquillacote@acorda.com
95182|NCT01417026|Children's Hospital of Philadelphia|Robert Schultz, PhD|267-426-7540|schultzrt@email.chop.edu
95183|NCT01416610|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com
95185|NCT01416571|GlaxoSmithKline|GSK Response Center|866-435-7343|
95186|NCT01416272|Bausch & Lomb / Valeant Pharmaceuticals|Robert Steffen, OD, MS|585-338-6399|robert.steffen@bausch.com
95187|NCT01416181|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
95188|NCT01416155|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
95189|NCT01416142|Bausch & Lomb Incorporated|Dr. William Reindel|(585) 338-8129|william.reindel@bausch.com
95190|NCT01416129|University of South Florida|Jason Highsmith|813-974-3806|mhighsmi@health.usf.edu
95191|NCT01416025|JohnHopkinsU|Dr. Darin Ostrander|(443) 287-6217|dostrander@jhu.edu
95192|NCT01415986|Roswell Park Cancer Institute|Gal Shafirstein, D.Sc.|716-845-4025|Gal.Shafirstein@RoswellPark.org
95193|NCT01415960|Grand Strand Urology Carolina Urology Reseearch Centre|Dr. Neal Shore MD|+1 843 839 1679|nshore@grandstrandurology.com
95194|NCT01415921|New York University School of Medicine|Stuart Katz, MD|212-263-3946|stuart.katz@nyumc.org
95195|NCT01415908|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133 ext 6068|msbkclinicalresearch@medtronic.com
95196|NCT01415583|Massachusetts Eye and Ear Infirmary|Dr. Christopher Hartnick, Division Director, Pediatric Otolaryngology Director, Pediatric Airway, V|617-573-4206|christopher_hartnick@meei.harvard.edu
95197|NCT01415531|Forest Research Institute|Tatjana Lukic, MD, MSc|(201) 427-8649|tanya.lukic@frx.com
95198|NCT01415518|AstraZeneca|Goran Eckerwall||ClinicalTrialTransparency@astrazeneca.com
95199|NCT01415453|Columbia University Medical Center|Dr Ronald Silverman|2123055484|rs3072@columbia.edu
95200|NCT01415427|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|pslasor@bmrn.com
95201|NCT01415401|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader|1-888-451-3937|alcon.medinfo@alcon.com
95202|NCT01415349|Shire Pharmaceutical|Study Physician|1 866 842 5335|
119036|NCT02059174|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95205|NCT01414634|Neuroimmunology and MS Research, Department of Neurology, University Hospital Zürich, 8091 Zürich, Switzerland|Roland Martin|044 255 11 25|roland.martin@usz.ch
95206|NCT01414413|Liverpool School of Tropical Medicine|Dr Peter MacPherson|0044151 705 3100|p.macpherson@liv.ac.uk
95207|NCT01412983|Bausch & Lomb|Dr. Robert Steffen|1 585 338 6399|robbert.steffen@bausch.com
95208|NCT01414244|Tulane University|QiQi Zhou|988-7800|qiqi06@gmail.com
95209|NCT01414205|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
95210|NCT01414192|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95211|NCT01414166|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95212|NCT01414153|Lpath, Inc.|Susan E. Hazel|858-926-3205|shazel@lpath.com
95213|NCT01414114|Amgen, Inc|Study Director|866-572-6436|
95214|NCT01414036|Boston Medical Center|Karen E. Lasser|617-414-6688|karen.lasser@bmc.org
95215|NCT01414010|Beth Israel Deaconess Medical Center|Ciaran Kelly, MD|617-667-1272|ckelly2@bidmc.harvard.edu
95216|NCT01413958|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95217|NCT01413750|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
95218|NCT01413542|Department of Medicine Vanderbilt University Medical Center|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu
95220|NCT01413360|Seoul National University Hospital|Jung-Hwan Yoon|+82-2-2072-2228|yoonjh@snu.ac.kr
95221|NCT01413204|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
95222|NCT01413191|University of Texas (UT) MD Anderson Cancer Center|Sapna P. Patel, MD / Professor|713-792-2921|CR_Study_Registration@mdanderson.org
95223|NCT01412957|Amgen Inc.|Study Director|866-572-6436|
95224|NCT01412944|Novartis|Study Director|862-778-8300|
95225|NCT01412918|Medical College of Wisconsion|Dr. David Friedland|414-805-|dfriedland@mcw.edu
95226|NCT01412879|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|
95227|NCT01412801|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
95229|NCT01412424|Cedars-Sinai Medical Center|Shlomo Melmed, MD|310 423-4691|melmed@csmc.edu
95230|NCT01412333|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
95231|NCT01412281|Crucell Switzerland|Medical Affairs Director|+41(0)319806111|info@crucell.com
95232|NCT01412229|UNC Lineberger|Robin Johnson|(919) 966-1125|Robin_V_Johnson@med.unc.edu
95233|NCT01412164|Shanghai Microport Medical (Group) Co.,Ltd.|Kefei Li|+86-21-38954600×6700|kfli@microport.com
95234|NCT01412151|Massachusetts General Hospital|Steven M. Hersch, MD, PhD|617-726-1254|hersch@helix.mgh.harvard.edu
95235|NCT01412086|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
95236|NCT01411891|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|Dr. Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu
95238|NCT01411696|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
95239|NCT01411592|University of Kiel|Dr. Martin Sasse, D.M.D., Assistant Professor|+494315972874|sekretariat@proth.uni-kiel.de
95240|NCT01411501|Guang'an Men Hospital Affiliated to China Academy of Chinese Medical Sciences|Liu Zhishun|8610-010-88001124|liuzhishun@aliyun.com
95241|NCT01411488|Cleveland Clinic|Nancy Albert|216-444-7028|albertn@ccf.org
95242|NCT01411228|Target Health Inc.|Glen Park|212-681-2100|gpark@targethealth.com
95243|NCT01411215|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95244|NCT01411137|Impax Laboratories, Inc.|Michelle Landolfi, Senior Director, Regulatory Affairs|(510) 240-6496|Michelle.Landolfi@impaxlabs.com
95245|NCT01410773|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com
95246|NCT01410604|Hospital Regional de Alta Especialidad del Bajio|M.D. Maria L. Evia-Viscarra|+52 (477) 267-2000 ext 1405|evialola@hotmail.com
95247|NCT01410565|Spectrum Pharmaceutical Inc.|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com
95248|NCT01410474|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
95249|NCT01410448|Novartis Pharmaceuticals|Study Director|862-778-8300|
95251|NCT01410357|Case Western Reserve University School of Medicine and Neurological Institute|Dr. Martha Sajatovic|216-844-2808|martha.sajatovic@uhhospitals.org
95252|NCT01410240|Baxter BioScience|Maurice Bagot D'Arc, MD, Sr Medical Director Medical Affairs , BioSurgery||maurice_bagot_d'arc@baxter.com
95254|NCT01410110|Yale University School of Medicine|Morris Bell, Ph.D.|203-932-5711 ext 2281|morris.bell@yale.edu
95255|NCT01409993|Vanderbilt University Medical Center|Nancy J. Brown, M.D., Principal Investigator|6153438701|nancy.j.brown@vanderbilt.edu
95256|NCT01409837|University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu|Dr. Anthony Mbah, Principal investigator|2348051519065|cmd_unth@yahoo.com
95257|NCT01409707|University of Mississippi Medical Center|Dr. Scott Coffey|601-815-5588|scoffey@umc.edu
95258|NCT01409564|Seoul National University Hospital|Prof. Jung Seok Choi|82-2-870-3461|choijs@neuroimage.snu.ac.kr
95259|NCT01409434|University of Florida|Dr. Rhonda Cooper-DeHoff|352-273-6184|dehoff@cop.ufl.edu
95260|NCT01409382|Hospital Federal dos Servidores do Estado|Dr. Silvia Hoirisch-Clapauch|55-21-999737500|sclapauch@gmail.com
95261|NCT01409291|Creighton University|Kathleen Packard, PharmD, MS, BCPS (AQ Cardiology)|402-481-3915|kathleenpackard@creighton.edu
95262|NCT01409239|The Ohio State University|Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu
95263|NCT01409213|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95265|NCT01408992|Khon Kaen University|Dr. Kwanchanok Yimtae|66-43348396|kwayim@kku.ac.th
95267|NCT01408888|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
95268|NCT01408862|Institute of Medical Research (UBA-CONICET)|Dr. Carlos Jose Pirola|541145148701 ext 167|cpirola@ciudad.com.ar
95269|NCT01408719|Agriculture and Agri-food Canada|Dr. Nancy Ames|204-474-7187|nancy.ames@agr.gc.ca
95270|NCT01408706|Wheaton Franciscan Healthcare - All Saints|Dr. James Taylor|262-687-5000|james.taylor@wfhc.org
95271|NCT01408628|University of Kansas Medical Center|Virginia Lewis|913-588-2097|vlewis@kumc.edu
95272|NCT01408537|Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Thailand|Dr. Pornthep Chanthavanich|6623549161|tmpct@mahidol.ac.th
95273|NCT01408485|St. Jude Medical|Nancy Ouch, Senior Clinical Project Manager|949-769-5000|NOuch@sjm.com
95274|NCT01408329|Stanford University|Anne L Friedlander|650-725-7531|afriedlanderCW@gmail.com
95275|NCT01408303|AstraZeneca Pharmaceuticals|Torbjörn Lundström||ClinicalTrialTransparency@astrazeneca.com
95276|NCT01408277|Smith & Nephew Biotherapeutics|Jaime E Dickerson, Jr, PhD|817-302-3914|jaime.dickerson@smith-nephew.com
95277|NCT01407575|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu
95278|NCT01407523|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
95279|NCT01407354|University Maryland Rehabilitation and Orthopaedic Institute|Paula Richley Geigle PT PhD|410 448 6773|pgeigle@umm.edu
95280|NCT01407276|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95281|NCT01407068|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
95282|NCT01406990|Creighton University|Dr. Katie Packard, PharmD|402-280-4566|kathleenpackard@creighton.edu
95283|NCT01406938|Novartis Pharmaceutical|Study Director|862-778-8300|trialandresults.registries@novartis.com
95284|NCT01406795|Stanford University|Rusty Hofmann|6507366096|lhofmann@stanfordhealthcare.org
95285|NCT01406574|Otsuka Pharmaceutical Co., Ltd|"Leader of Department of Small Global Clinical Development"|+81-3-6361-7366|
119040|NCT01931462|University of Wisconsin|Director of Clinical Research, Department of Surgery|608-262-0540|clinicalresearch@surgery.wisc.edu
95287|NCT01406015|Brigham and Women's Hospital|Dr. Rajesh K. Garg||RGARG@bwh.harvard.edu
95288|NCT01405950|Acorda Therapeutics, Inc.|Herbert Henney, PharmD|914-347-4300 ext 5138|hhenney@acorda.com
95289|NCT01405937|Merck Sharp & Dohme Corp|Vice President, Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95290|NCT01405924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95291|NCT01405898|Queen Mary University London|Professor Amrita Ahluwalia|02078825720|a.ahluwalia@qmul.ac.uk
95292|NCT01405820|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
95293|NCT01405794|University of Utah|Dr. Mark Munger|801-581-6165|mmunger@hsc.utah.edu
95294|NCT01405768|Washington University School of Medicine|L. Stewart Massad, M.D.|314-362-3181|massadl@wudosis.wustl.edu
95295|NCT01405742|University of Pittsburgh|Margaret V. Ragni, MD, MPH|412-209-7288|ragni@pitt.edu
95296|NCT01405560|Merck Sharp & Dohme Corp|Vice President, Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95298|NCT01405469|University Hospital Hamburg-Eppendorf|Prof. Dr. Thomas Rösch, Principal Investigator|+49 40 7410 50098|t.roesch@uke.de
95299|NCT01405313|ResMed|Director Medical Affairs|+6128841000|adamb@resmed.com.au
95300|NCT01405027|Chronic Liver Disease Foundation|Dr. Fred Poordad|732-381-8887|poordad@txliver.com
95301|NCT01404988|VA New York Harbor Healthcare System|Sundar Natarajan, MD, M.Sc.|212-951-3395|sundar.natarajan@va.gov
95302|NCT01404936|UT MD Anderson Cancer Center|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org
95303|NCT01404923|Laboratoires Mayoly Spindler|Clinical trials Manager|33 134805555|contact_essais_cliniques@mayoly-spindler.fr
95304|NCT01404832|Dallas VAMC|Stuart Spechler|214-374-7799|sjspechler@aol.com
95305|NCT01404650|Sarah Cannon Research Institute|Johanna Bendell, MD|877-691-7274|asksarah@sarahcannon.com
95306|NCT01404611|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com
95307|NCT01404572|Bristol-Myers Squibb (BMS)|BMS Study Director||Clinical.Trials@bms.com
95308|NCT01404559|University of South Florida|William S. Quillen|8139749863|wquillen@health.usf.edu
95309|NCT01404429|PGIMER, India|Varun Dhir, Assistant Professor, Internal Medicine|+91-8872229998|varundhir@gmail.com
95310|NCT01404260|Shanghai Chest Hospital|Shun LU|86-2162821990|shun_lu11@163.com
95311|NCT01404234|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
95312|NCT01404208|MGH|Dr. Daniel Geller|617 724 5141|dan.geller@mgh.harvard.edu
95313|NCT01404078|St John's Research Institute|Dr. Alben Sigamani|+918049467080|alben@sjri.res.in
95314|NCT01404039|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526156|felipe.fregni@ppcr.hms.harvard.edu
95315|NCT01403987|Boston Medical Center|Brian Jacobson, MD, Principal Investigator|617-6386563|brian.jacobson@bmc.org
95316|NCT01403805|Department of Dentistry, Yubari Kibounomori, Japan|Dr. Masahiro Hatta|+81-123-52-4339|masahiro.hatta@hotmail.co.jp
95317|NCT01403441|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu
95318|NCT01403376|Sanofi|Trial Transparency Team||Contact_US@sanofi.com
95319|NCT01403194|Mayo Clinic|Dr. Seema Kumar|507-538-2724|kumar.seema@mayo.edu
95320|NCT01403090|BiO2 medical|Luis Angel, MD|2102139778|langel@bio2medical.com
95321|NCT01403051|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
95322|NCT01402986|MedImmune, LLC|Meena Jain, MB BChir, Director, Clinical Development,|301-398-0000|JainM@medimmune.com
95323|NCT01402947|Shire Pharmaceutical|Study Physician|1 866-842-5335|
95324|NCT01402869|Loma Linda University|Dr. Lauren Gutenberg|909-558-4690|lgutenberg@llu.edu
95325|NCT01402817|Indiana University School of Medicine - Pediatrics|Chie-Schin Shih, MD|317-948-8568|shih2@iu.edu
95326|NCT01402700|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com
95327|NCT01402570|University of Michigan|Claire Z. Kalpakjian|734-763-0153|clairez@umich.edu
95328|NCT01402427|State Health Center, Hungary|Istvan Hizoh, MD, PhD / Senior Consultant|+36 1 4651800 ext 71773|ihizoh@web.de
95329|NCT01402284|National Cancer Institute|Dr. Dickran Kazandijian|301-480-8870|kazandijiandg@mail.nih.gov
95330|NCT01402141|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Baek-Hwan Cho, MD|82-63-250-1579|chobh@jbnu.ac.kr
95331|NCT01402128|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Soo-Wan Chae, MD|82-63-276-8284|soowan@jbnu.ac.kr
95332|NCT01402115|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Dal-Sik Kim, MD|82-63-276-8284|dskim@chonbuk.ac.kr
95333|NCT01402102|Clinical trial center for Functional Food in Chonbuk Nat'l University Hospital|Dr. Dal-Sik Kim|82-63-250-1793|dskim@chonbuk.ac.kr
95334|NCT01402063|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu
95336|NCT01401842|University of South Florida|John M. Mayer, DC, PhD / Study Director|813-974-3818|jmayer2@health.usf.edu
95337|NCT01401647|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org
95338|NCT01401595|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, Ph.D.|215-898-2823|kca@mail.med.upenn.edu
95339|NCT01401582|Geman Centr for Neurodegenerative Diseases (DZN)|PD Dr. JR Thyrian|+49383486 ext 7592|rene.thyrian@dzne.de
95340|NCT01401517|TheraVasc Inc.|Tony Giordano|318-349-3851|tgiordano@theravasc.com
95341|NCT01401478|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
95342|NCT01401465|Sunovion|Respiratory Medical Director|1-866-503-6351|
95343|NCT01401452|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110|
95344|NCT01401361|St. Jude Medical|Nancy Ouch|+19497695041|NOuch@sjm.com
95345|NCT01401322|Stanford University|Bruno C. Medeiros|650-498-6000|
95346|NCT01401283|Hamburg Eppendorf University Hospital|Daniel A. Reuter, MD|+49-40-7410-0|dreuter@uke.de
95348|NCT01401166|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
95349|NCT01401153|Research Institute of Child Nutrition|Prof. Dr. Mathilde Kersting|+49-231-792210-18|kersting@fke-do.de
95350|NCT01401101|RAND Corporation|Lisa S. Meredith, PhD|310.393.0411 ext 7365|seidel@rand.org
95351|NCT01401062|NYU Langone Medical Center|Nelly Huppert|212-731-5003|Nelly.Huppert@nyumc.org
95352|NCT01401049|NYU School of Medicine|Mitchell Lee, MD|212.263.5071|mitchell.lee@nyumc.org
95353|NCT01401023|Michigan State University|Dr. Gary Stein, Pharm D|517-353-5126|steing@msu.edu
95354|NCT01401010|Michigan State University|Gary E Stein|517-353-5126|Gary.Stein@hc.msu.edu
95355|NCT01400958|H. Lee Moffitt Cancer Center and Research Institute|Peter A. Forsyth, M.D.|813-745-3063|peter.forsyth@moffitt.org
95356|NCT01400932|GlaxoSmithKline|GSK Response Center|866-435-7343|
95357|NCT01400919|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com
95358|NCT01400906|GlaxoSmithKline|GSK Response Center|866-435-7343|
95359|NCT01400893|CytoPherx, Inc|H. David Humes|734-997-7055 ext 302|dhumes@cytopherx.com
95360|NCT01400880|University of Florida|Dr. Tony Gregg|352-265-0111|greggar@ufl.edu
95361|NCT01400841|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com
95362|NCT01400698|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de
95363|NCT01400516|Brigham and Women's Hospital|Daniel H Solomon, MD, MPH||dsolomon@partners.org
95364|NCT01400451|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
95365|NCT01400425|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
95366|NCT01400412|ACTG Network Coordinating Center, Social and Scientific Systems|ACTG Clinicaltrials.gov Coordinator|301-628-3313|ACTGCT.Gov@s-3.com
95367|NCT01400243|Southern Illinois University Carbondale|David G. Gilbert|618-453-3527|dgilbert@siu.edu
95369|NCT01400113|St. Joseph's Hospital Health Center|Michael Pratts, MD|315-726-8610|michael.pratts@sjhsyr.org
95370|NCT01399866|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu
95371|NCT01399788|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95372|NCT01399723|KEMRI-Wellcome Trust Research Prorgamme|Dr. Ambrose Agweyu|254202715160|aagweyu@kemri-wellcome.org
95373|NCT01399697|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
95374|NCT01399619|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95375|NCT01399593|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com
95376|NCT01399268|HSS|Dr. Jules|212.606.1206|JulesK@hss.edu
95377|NCT01399229|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com
95378|NCT01399190|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
95379|NCT01399125|Novartis Pharmaceuticals|Study Director|8627788300|
95380|NCT01399099|Neodyne Biosciences|Kristin Prosak|650-543-7129 ext 126|kprosak@neodynebio.com
95381|NCT01399047|University of Rochester Medical Center|Erika Augustine, MD, MS|585-275-2808|erika_augustine@urmc.rochester.edu
95382|NCT01399008|Metabolex|Mary Jean Stempien, M.D., Acting Chief Medical Officer|510-293-8800|mjstempien@metabolex.com
95383|NCT01398982|UHN|Kate Butler|416-340-4800 ext 2343|kbutler@uhnresearch.ca
95384|NCT01398956|UCB Cares|UCB (Study Director)|+1887822 ext 9493|
95386|NCT01398852|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM
95387|NCT01398839|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM
95388|NCT01398787|Alcon Research, Ltd.|Sharon Holden Thomas, Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com
95389|NCT01398514|Massachusetts General Hospital|Dr. Naomi Simon|617-726-7913|nsimon@partners.org
95390|NCT01398475|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
95391|NCT01398410|Eisai Co., Ltd.|Nobuyuki Sugisaki|+81-3-3817-3908 ext 3908|
95392|NCT01398176|UFlorida|Dr. Susan S. Percival|352-392-1991 ext 201|percival@ufl.edu
95393|NCT01397890|AstraZeneca|Nongluk Yimsuan|66 2 7397400 ext 429|ClinicalTrialTransparency@astrazeneca.com
95394|NCT01397851|independent|Richard Sedlmayr|6468412169|richard.sedlmayr@gmail.com
95395|NCT01397786|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
95396|NCT01397747|Exact Sciences|Director of Clinical Operations|608-284-5700|tvaughn@exactsciences.com
95397|NCT01397617|Nobel Biocare Services AG|Head Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com
95398|NCT01397591|OHSU Knight Investigational Cancer Services|Jeff Donovan|503-494-7702|mastersj@ohsu.edu
95399|NCT01397461|Ferrer Internacional, S.A.|Clinical Research Manager|+34 93 509 32 75|nalbareda@ferrer.com
95400|NCT01397448|Eisai Co., Ltd.|Nobuyuki Sugisaki|+81-3-3817-3908 ext 3908|
95401|NCT01397409|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
95402|NCT01397253|University of Pittsburgh|Kenneth J Smith, MD, MS|4126474794|smithkj2@upmc.edu
95403|NCT01397084|AstraZeneca|James Armbrust||aztrial_results_posting@astrazeneca.com
95404|NCT01396525|AbbottVascular|David R Rutledge|408-845-3820|david.rutledge@av.abbott.com
95405|NCT01396512|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
95406|NCT01396434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95407|NCT01396421|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974|
95408|NCT01396395|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
95409|NCT01396382|Vanderbilt-Ingram Cancer Center|Dr. Ronald Walker|615-343-8516|ronald.walker@vanderbilt.edu
95410|NCT01396265|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95411|NCT01396239|Sarepta Therapeutics, Inc.|Edward M. Kaye MD, Interim CEO, SVP & Chief Medical Officer|1-617-274-4003|EKaye@Sarepta.com
95412|NCT01396226|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
95413|NCT01396187|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95414|NCT01396161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95415|NCT01396083|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
95416|NCT01396070|Stanford University Medical Center|Youn H Kim, MD|650-521-3545|younkim@stanford.edu
95417|NCT01396057|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
95418|NCT01396044|Northwestern University|Dr. Curtis Weiss|(312) 695-6439|curtisweiss@northwestern.edu
101083|NCT00454909|GlaxoSmithKline|GSK Response Center|866-435-7343|
95419|NCT01396005|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6327|ClinicalTrialsDisclosure@merck.com
95420|NCT01395966|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com
95421|NCT01395914|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com
95422|NCT01395901|Helsinn Healthcare SA|Salvatore Chessari|+41 91 985 21 21|salvatore.chessari@helsinn.com
95423|NCT01395888|GlaxoSmithKline|GSK Response Center|866-435-7343|
95424|NCT01395823|Dialysis Clinic Inc|Karen Majchrzak|615-342-0483|karen.majchrzak@dciinc.org
95425|NCT01395797|New York State Psychiatric Institute|Sandra Comer PhD|646 774-6146|sdc10@columbia.edu
95426|NCT01395784|New York State Psychiatric Institute|Jermaine Jones, PhD|646 774-6113|jonesje@nyspi.columbia.edu
95427|NCT01395524|AstraZeneca|Mark Sostek||aztrial_results_posting@astrazeneca.com
95428|NCT01395394|Emory University|Kathryn Coakley|404-778-1286|kcoakle@emory.edu
95429|NCT01395368|Washington University in St. Louis|Dr. Jay F. Piccirillo, Professor|314 362-8641|piccirilloj@ent.wustl.edu
95430|NCT01395277|University of Texas at Austin|Dr. R. Matthew Brothers|512-232-6016|r.m.brothers@austin.utexas.edu
95431|NCT01395043|Aalborg Hospital|Dr Nils Bjerregaard|004522860649|niheb@rn.dk
95432|NCT01395017|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
95433|NCT01394991|Johnson and Johnson PRD|Clinical Development Team Lead|1 908 218 6097|
95434|NCT01394978|Davol, Inc.|Dawn Heimer, PhD|+1-401-825-8681|Dawn.Heimer@CRBard.com
95435|NCT01394926|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6820|Paulsherwin@ge.com
95436|NCT01394718|Children's Hospital of Philadelphia|Athena Zuppa, MD, MSCE|267-426-7359|zuppa@email.chop.edu
95437|NCT01394692|Johann Wolfgang Goethe University|Dr. Christian Senft|+49 69 63015939|c.senft@med.uni-frankfurt.de
95438|NCT01394614|Center for Advanced Research in Sleep Medicine|Dr. Jacques Montplaisir|514-388-2693|jy.montplaisir@umontreal.ca
95439|NCT01394510|VA Puget Sound Health Care System|Kristina Utzschneider, MD|206-277-3568 ext 6-3568|kutzschn@uw.edu
95440|NCT01394276|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
95441|NCT01394250|The Chidren's Hospital of Philadelphia|Deb Potts|215-590-7098|pottsd@email.chop.edu
95442|NCT01394185|Johns Hopkins University|Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu
95443|NCT01394159|Center for Interventional Endoscopy, Florida Hospital|Dr Shyam Varadarajulu|407-303-2570|svaradarajulu@yahoo.com
95444|NCT01393964|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
95445|NCT01393899|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95446|NCT01393743|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com
95447|NCT01393730|Dana-Farber Cancer Institute|Dr. Mary-Ellen Taplin|617-582-7221|mary_taplin@dfci.harvard.edu
95448|NCT01393704|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org
95449|NCT01393626|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95450|NCT01393613|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
95451|NCT01393600|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com
95452|NCT01393444|University of Pittsburgh|Jennifer Collinger|412-383-1274|collingr@pitt.edu
95453|NCT01393132|Wayne State Univeristy, Detroit, MI|Gabriel Sosne, MD|248-594-6702|gsosne@med.wayne.edu
95454|NCT01393106|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
95455|NCT01392742|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
95456|NCT01392703|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
95457|NCT01392677|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com
95459|NCT01392560|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95460|NCT01392547|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
95461|NCT01392495|Novartis Pharmaceuticals|Study Director|862-778-8300|
95462|NCT01392378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95463|NCT01392326|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
95464|NCT01392300|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de
95465|NCT01391325|Ardea Biosciences, Inc.|Vice President, Clinical Research and Development|858.652.6587|sbaumgartner@ardeabio.com
95466|NCT01391312|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
95467|NCT01391299|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
95468|NCT01391286|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
95469|NCT01391273|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
95470|NCT01392170|University of Texas (UT) MD Anderson Cancer Center|Alfonso Quintas-Cardama, MD/Professor, Leukemia|713-745-4009|CR_Study_Registration@mdanderson.org
95471|NCT01392053|Universidade de São Paulo|Prof Silvana Quintana|55 16 3602-2813|quintana@fmrp.usp.br
95472|NCT01391858|UTexas Southwestern Medical Center|Babatunde Ogunnaike|(214) 590 ext 8536|Babatunde.Ogunnaike@UTSouthwestern.edu
95473|NCT01391819|GlaxoSmithKline|GSK Response Center|866-435-7343|
95474|NCT01391663|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
95475|NCT01391611|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu
95476|NCT01391559|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org
95477|NCT01391507|Janssen Research & Development, LLC|Associate Director Biostatistics||ClinicalTrialDisclosure@its.jnj.com
95478|NCT01391468|China Medical University|II-Kuan Wang|88975681050|ikwang@seed.net.tw
95479|NCT01391013|Jan-Cil Italy|Therapeutic Area Medical Manager|39 02 2510589|
95480|NCT01391000|Istituto Ortopedico Rizzoli|Dr Roberta Monesi|0516366694 ext 0039|cristiana.forni@ior.it
119042|NCT01877421|Oral Health Research Institute, Indiana University School of Dentistry|Domenick T. Zero, DDS, MS|240-457-0668|dzero@iu.edu
95482|NCT01390909|GlaxoSmithKline|GSK Response Center|866-435-7343|
95483|NCT01390870|GlaxoSmithKline|GSK Response Center|866-435-7343|
95484|NCT01390857|GlaxoSmithKline|GSK Response Center|866-435-7343|
95485|NCT01390844|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95486|NCT01390818|Merck Serono, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+496151725200|service@merckgroup.com
95487|NCT01390779|UCSD|Mona Moshtaghi|858 534-6290|momoshta@ucsd.edu
95488|NCT01390649|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
95489|NCT01390441|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
119043|NCT01876706|NeoTract|Emily Hergenreter Director of Clinical Affairs|650-739-5570|ehergenreter@neotract.com
95491|NCT01390415|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95492|NCT01390402|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation||CR_Study_Registration@mdanderson.org
119044|NCT01870076|Shriners Hosptials for Children|Laura Fowler/Clinical Research Coordinator|513-872-6000 ext 6249|lfowler@shrinenet.org
95494|NCT01390259|University of Virginia|Marc Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu
95495|NCT01390233|University of Arizona (Investigator has changed institutions - study completed at University of South Carolina)|Meg Hill, MBBS|520 626 6174|meghanhill@obgyn.arizona.edu
95496|NCT01390181|Grand Traverse Heart Associates|Anna Booher|231 935-5800|annabooher3@gmail.com
95497|NCT01390038|Tornier/Wright Medical|Josh Myers|9529217119|josh.myers@wright.com
95498|NCT01389973|Janssen, R&D, LLC, Spring House, PA|Senior Director, Clinical Development, Immunology||ClinicalTrialDisclosure@its.jnj.com
95499|NCT01389882|Seoul National University Hospital|Dr. Juyoung Lee|lamb4122@snu.ac.kr|lamb4122@snu.ac.kr
95500|NCT01389856|Actelion Pharmaceuticals Ltd|Pegah Nowbakht/Senior Clinical Trial Scientist|+41 61 565 68 41|pegah.nowbakht@actelion.com
95501|NCT01389817|Medical College of Wisconsin|Harry T. Whelan M.D.|414-266-3466|hwhelan@mcw.edu
95503|NCT01389323|BristolMyers Squibb|BristolMyers Squibb Study Director||Clinical.Trials@bms.com
95504|NCT01389284|Bayer HealthCare LLC, Consumer Care|Head Medical Affairs||clinical-trials-contact@bayerhealthcare.com
95505|NCT01389102|KV Pharmaceutical Company|Jim Joffrion|314-645-6600 ext 3410|jjoffrion@kvph.com
95506|NCT01389076|University of Michigan Comprehensive Cancer Center|Dr. Mark Kaminski, M.D.|734-936-5310|mkaminsk@umich.edu
95507|NCT01388946|Aretaieo Hospital University of Athens|Argyro Fassoulaki|+30 6936701333|fassoula@aretaieio.uoa.gr
95508|NCT01388920|Theratechnologies|Senior Medical Advisor|514-336-7800|jmamputu@theratech.com
95509|NCT01388907|Sofradim Production COVIDIEN|Patrice BECKER, Global Director, Clinical Affairs|+33 4 74 08 92 38|patrice.becker@covidien.com
95510|NCT01388816|Proprietary Products, Dr. Reddy's Laboratories, Inc.|Kent Allenby, MD|609-375-9855|kallenby@drreddys.com
95511|NCT01388790|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
95512|NCT01388647|Vector Oncology|Vice President of Scientific Affairs|901-435-5550 ext 1759|mwalker@vectoroncology.com
95513|NCT01388530|David Geffen School of Medicine at UCLA|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu
95514|NCT01388491|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
95515|NCT01388361|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
95516|NCT01388166|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95517|NCT01387789|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
95518|NCT01387737|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
95519|NCT01387672|Womens' College Hospital|Dr. Sophie Jamal|416-351-3732 ext 2873|sophie.jamal@wchospital.ca
95520|NCT01387594|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95521|NCT01387581|MelaSciences|Mrinalini Roy|800-729-8849|mishti@melasciences.com
95522|NCT01387542|Janssen-Cilag Ltd.: 106 Moo 4 Lad Krabang Industrial Estate, Chalongkrung Rd., Lamplatew, Lad Krabang, Bangkok 10520|Medical Affairs Director|+66 2 7397200 ext 5888|
95523|NCT01387464|InSite Vision|Director of Clinical Trials|510-747-1269|jhutcheson@insite.com
95524|NCT01387347|ReGenTree, LLC|Won S. Yang, President & CEO|609-734-4328|wonsyang@regentreellc.com
95528|NCT01387178|GlaxoSmithKline|GSK Response Center|866-435-7343|
95530|NCT01387074|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
95531|NCT01387022|CAPRISA|Head of Statistics and Data Management|+27 31 260 4392|nonhlanhla.yende@caprisa.org
95532|NCT01386983|GlaxoSmithKline|GSK Response Center|866-435-7343|
95533|NCT01386944|UCB|UCB Clinical Trial Call Center|++1 877 822 9493|
95534|NCT01386788|EKoch|Ernst Koch|++49 6257 1788|Ernst.MW.Koch@t-online.de
95535|NCT01386632|Sanford Clinical Research|Dr. Steven Powell|605-328-8000|patientquestionsSHDCA@sanfordhealth.org
95536|NCT01386606|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com
95537|NCT01386528|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com
95538|NCT01386125|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
95539|NCT01386008|Clinical Research Center (CRC) UC Berkeley School of Optometry|Meng Lin, OD, PhD|(510) 642-9731|
95540|NCT01385995|Brigham and Women's Hospital|Dr. Susan Redline|857-307-0352|sredline1@rics.bwh.harvard.edu
95542|NCT01385696|Almirall S.A.|Clinical Project Leader and Trial Manager|+34 93 291 3200|
95543|NCT01385644|The Prince Chalres Hospital|Assoc Professor Daniel Chambers|+61 7 3139 4000|daniel.chambers@health.qld.gov.au
95544|NCT01385579|Northwestern University|Dr. Muriel Jean-Jacques, Assistant professor|312-503-9642|mjean@nmff.org
95545|NCT01385566|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95546|NCT01385371|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
95547|NCT01385293|Duke University|Andrew J. Armstrong, MD ScM FACP|919 668 4667|andrew.armstrong@duke.edu
95548|NCT01385202|Biosense Webster, Inc.|Robert Stagg, Manager, Clinical Operations|(800) 729-9010 ext 8611|RStagg@its.jnj.com
95549|NCT01385189|George Washington University|Dr. David J. Diemert, Associate Professor|202.994.2909|ddiemert@gwu.edu
95550|NCT01385137|SWOG Statistical Center|Study Statistician|206-667-4623|
95551|NCT01385033|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95552|NCT01384760|ChineseUHK|Dr Susanna S Ng|(852) 98075787|drsssng123@yahoo.com.hk
95553|NCT01384539|University of Colorado|Dr. Jessica Kendrick|303-602-5012|Jessica.Kendrick@ucdenver.edu
95554|NCT01384292|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
95555|NCT01384019|Seoul national university Bundang hospital|Dr. Chang-Hwan Yoon|+82-31-787-7052|changhwanyoon@snubh.org
95556|NCT01383993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95557|NCT01383954|Brigham and Women's Hospital|Ajay D. Wasan, M.D., M.Sc.||awasan@partners.org
95559|NCT01383720|Boston Scientific Corporation|Director of Clinical Trials, Valves|408-370-1550|
95560|NCT01383707|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
95561|NCT01383681|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
95562|NCT01383616|Hospital for Special Surgery|Brian Rebolledo, MD|212-606-1172|rebolledob@hss.edu
95563|NCT01383499|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95564|NCT01383486|Bayer HealthCare LLC, Consumer Care|Head Clinical and Medical Affairs||clinical-trials-contact@bayerhealthcare.com
95565|NCT01383447|Johns Hopkins Sidney Kimmel Cancer Center|Dr. Patrick Brown|410-614-4915|pbrown2@jhmi.edu
95566|NCT01383421|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110|
95567|NCT01383356|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95568|NCT01383213|IRCCS Fondazione Cà Granda Policlinico Milano|Dr Roberto Cosentini|+390255033618 ext 3618|r.cosentini@gmail.com
95569|NCT01383200|Bascom Palmer Eye Institute|Dr. Sonia Yoo|305-243-2020|syoo@med.miami.edu
95570|NCT01383174|University of California San Francisco|Dr. Anna Maria Napoles|415-476-6290|anapoles@ucsf.edu
95571|NCT01383096|Nucleus Network|Peter Hodsman|+ 613 9076 8900|businessdevelopment@nucleusnetwork.com.au
95572|NCT01383005|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
95573|NCT01382940|Hoffmann-La Roche|Medical Communications|800 821-8590|
95574|NCT01382901|Luitpold Pharmaceuticals, Inc.|Marc Tokars|601-650-4200 ext 805|mtokars@lpicrd.com
95575|NCT01382719|Palatin Technologies, Inc.|Jeffrey Edelson, MD, FRCPC|(609) 495-2200|jedelson@palatin.com
95576|NCT01382446|SJHMC|Tracy L. Thomas MSN RN CCRN ACNS-BC|602-406-2567|Tracy.Thomas007@dignityhealth.org
95577|NCT01382303|Ajou University|Kwan Woo Lee|82-31-219-4526|LKW65@ajou.ac.kr
95578|NCT01382251|Department of Anesthesiology, The Ottawa Hospital|Dr. Gregory L Bryson|613.761.4169|glbryson@ottawahospital.on.ca
95579|NCT01382225|Alcon Research, Ltd.|Michela Montecchi-Palmer, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com
95580|NCT01382212|AbbVie|Global Medical Information|800-633-9110|
95581|NCT01382186|Center of Innovation on Disability and Rehabilitation Research|Dr. Jolie Haun|813-558-7622|jolie.haun@va.gov
95582|NCT01382108|Centre for Contact Lens Research|Kathy Dumbleton|519-888-4567 ext 32694|kdumble@uwaterloo.ca
95583|NCT01381952|Karolinska University Hospital|Dr. Söderman|+46851774037|michael.soderman@karolinska.se
95584|NCT01381926|UAB|Dr. Amy Warriner|205-996-4004|awarriner@uabmc.edu
95585|NCT01381900|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736|
95586|NCT01381679|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95587|NCT01381575|GlaxoSmithKline|GSK Response Center|866-435-7343|
95588|NCT01381549|GlaxoSmithKline|GSK Response Center|866-435-7343|
95589|NCT01381471|GlaxoSmithKline|GSK Response Center|866-435-7343|
95590|NCT01381406|GlaxoSmithKline|GSK Response Center|866-435-7343|
95591|NCT01381120|Barrie Urology Associates|Dr. Joseph Zadra||joezadra@rogers.com
95592|NCT01381016|University of Colorado Denver|Associate Professor|(303) 724-2037|alex.polotsky@ucdenver.edu
95594|NCT01380782|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|6176322166|pwen@partners.org
95595|NCT01380769|Cerulean Pharma Inc.|Adrian Senderowicz|617 551 9600|asenderowicz@ceruleanrx.com
95596|NCT01380730|Amgen Inc.|Study Director|866-572-6436|
95897|NCT01355705|Stanford University|Michaela Liedtke, MD|650-498-6000|mliedtke@stanford.edu
95597|NCT01380639|Schön Klinik Berchtesgadener Land|Dr. Klaus Kenn|+49 8652 931541|kkenn@schoen-kliniken.de
95598|NCT01380379|Stanford University|Dr. Jennifer Keller|650-724-0070|jkeller@stanford.edu
95599|NCT01380366|Northwestern University|Dr. Jonathan Fryer, MD|312-695-2125|jfryer@nmh.org
95600|NCT01380327|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
95601|NCT01380197|Morehouse School of Medicine|Iris Buchanan|404-398-9578|ibuchanan@msm.edu
95602|NCT01380145|Ludwig Institute for Cancer Research|Andrew Park, PharmD, Clinical Project Manager|(212) 450-1587|apark@licr.org
95603|NCT01380093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95604|NCT01380080|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
95605|NCT01379963|Hoffmann­LaRoche|Medical Communications|800­821­8590|genentech@druginfo.com
95606|NCT01379937|GlaxoSmithKline|GSK Response Center|866-435-7343|
95607|NCT01379781|Columbia University Medical Center|Catherine Monk, Ph.D., Assoc Professor|(646) 774-8941|cem31@columbia.edu
95608|NCT01379768|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629|
95609|NCT01379703|Abbott|Global Medical Services|1-800-633-9110|
95610|NCT01379664|Cleveland Clinic Foundation|Daniel Sessler|216-444-4900|DS@OR.org
95611|NCT01379651|Unit of Pediatrics, Fatebenefratelli Hospital, Benevento, Italy|Dr. Iride Dello Iacono|+39 824 771111|iridedello@hotmail.com
95612|NCT01379625|Oregon Health & Science University|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu
95613|NCT01379534|Novartis|Study Director|862-778-8300|
95614|NCT01379521|Novartis Pharmaceuticals|Study Director|862-778-8300|
95615|NCT01379183|Mayo Clinic|Dr. Jeff L. Fidler|507-284-5010|fidler.jeff@mayo.edu
95616|NCT01378988|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com
95617|NCT01378975|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
95618|NCT01378962|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
95619|NCT01378520|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org
95620|NCT01378429|Sunovion|Respiratory Medical Director|866-503-6351|
95621|NCT01378416|Eisai Inc.|Yufang Lu, MD PhD|1-888-422-4743|
95622|NCT01378325|AUBMC|Sahar Siddik-Sayyid|9611350000 ext 6380|ss01@aub.edu.lb
95623|NCT01378221|Heart and Diabetes Center North Rhine-Westphalia, Germany|Dr. Armin Zittermann|+49 5731 97 ext 1912|azittermann@hdz-nrw.de
95624|NCT01378195|Photozig, Inc.|Bruno Kajiyama|650-694-7496|info@photozig.com
95625|NCT01378117|EUSOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu
95626|NCT01378104|the Catholic University of Korea|Dr. Kwon|+82322805886|doctorkwon@catholic.ac.kr
95627|NCT01378065|Coloplast Corp|Cathy Bartz|612-834-3127|uscmba@coloplast.com
95628|NCT01377636|New York University Langone Medical Center, Anesthesiology|Patrick Linton, MD, Director of Adult Off-Site Anesthesia Services|212-263-5072|Patrick.Linton@nyumc.org
95629|NCT01377623|UMDNJ-New Jersey Medical School|Alex Bekker|973-972-5007|alex.bekker@nyumc.org
95630|NCT01377584|University of Pittsburgh|Faith Luyster, PhD|412-624-7910|fsl3@pitt.edu
95631|NCT01377480|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95632|NCT01377467|University Hospital Zürich|Prof. Rudolf P. Wüthrich|+41 44 255 33 84|rudolf.wuethrich@usz.ch
95634|NCT01377402|Stavanger University Hospital|Dennis WT Nilsen, MD, phd, professor|+4795777735|dnilsen1@getmail.no
95635|NCT01377233|H. Lundbeck A/S|Study director||LundbeckClinicalTrials@Lundbeck.com
95636|NCT01377194|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000 ext 8124|carl.gommoll@frx.com
95637|NCT01377012|Novartis|Study Director|862-778-8300|
95638|NCT01376908|BioMarin Pharmaceutical Inc.|Medical Information Services|+1-800-983-4587|medinfo@bmrn.com
95639|NCT01376804|Hoffman-LaRoche|Medical Communications|800-821-8590|
95641|NCT01376557|Lexicon Pharmaceuticals, Inc.|Dr. Paul Strumph|(281) 863-3302|pstrumph@lexpharma.com
95642|NCT01376388|GlaxoSmithKline|GSK Response Center|866-435-7343|
95643|NCT01376362|National Institutes of Health|Hatice Nida Sen, Principal Investigator, National Eye Institute|(301) 402-3254|senh@nei.nih.gov
95644|NCT01376349|Alliance for Clinical Trials in Oncology|Debra Barton, R.N., Ph.D.||debbartn@med.umich.edu
95645|NCT01376297|Helsinn Healthcare SA|Head of Clinical Development|+41 91 9852121|marco.palmas@helsinn.com
95646|NCT01376245|GlaxoSmithKline|GSK Response Center|866-435-7343|
95647|NCT01376089|GE Healthcare|Lauren Lim, PharmD|1-626-356-1937|lauren.lim@ge.com
95648|NCT01376050|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com
95649|NCT01376037|Center for Clinical and Cosmetic Research|Mark S. Nestor, M.D., Ph.D|305-933-6716|nestormd@ADMCORP.com
95650|NCT01375777|Amgen Inc.|Study Director|866-572-6436|
95651|NCT01375764|Amgen Inc.|Study Director|866-572-6436|
95652|NCT01375751|Amgen Inc.|Study Director|866-572-6436|
95653|NCT01375660|Jesse Brown VA Medical Center|Dr. Barengolts, Attending Endocrinologist, Chief, Section of Endocrinology|312-569-7651|Elena.Barengolts@va.gov
95654|NCT01375608|NIH, NHLBI, MCHB|Dr Matthew Hsieh|301-402-7687|matthewhs@nhlbi.nih.gov
95655|NCT01375569|National Cancer Institute|Dr. Tim Greten|301-451-4723|gretentf@mail.nih.gov
119048|NCT01856491|Boston Scientific|Anneleen Viville|0032479983495|anneleen.viville@bsci.com
95657|NCT01375127|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95658|NCT01375049|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
96130|NCT00006170|University of Pittsburgh|Dr. Michele Levine|412-647-0703|levinem@upmc.edu
95659|NCT01374971|Nathan Wei, MD, PA dba Arthritis Treatment Center|Nathan Wei, MD|301-694-5800|nwei@arthritistreatmentcenter.com
95660|NCT01374919|Auerbach Hematology Oncology Assoc|Dr. Michael Auerbach|410-780-4050|mauerbachmd@abhemonc.com
95661|NCT01374802|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95662|NCT01374568|UAB|Dr. Amy Warriner|2059964004|awarriner@uabmc.edu
95663|NCT01374451|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
95664|NCT01374438|Metabolic Solutions Development Company|Dr. Jerry Colca|269.343.8732|jcolca@msdrx.com
95665|NCT01374425|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
95666|NCT01374269|Grupo Rehabilitacion en Salud|Dr. Fabio Salinas Duran|5742196475|fabios@une.net.co
95667|NCT01374178|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
95668|NCT01374087|Ipsen Pharma S.A|Elena Hernández Yuste, BsC, MBA|+936858100|clinical.trials@ipsen.com
95669|NCT01373918|University of California, Los Angeles|Dr. Kara L. Calkins|310 825-9330|KCalkins@mednet.ucla.edu
95670|NCT01373671|Siemens Medical Solutions USA, Inc.|Director of Clinical Affairs|610-448-6468|lesley.ewing@siemens.com
95671|NCT01373450|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95672|NCT01373346|Gangnam severance hospital|Seung Ho Choi, M.D., Ph.D.|82-2-2019-3374|choish@yuhs.ac
95673|NCT01373294|H. Lee Moffitt Cancer Center and Research Institute|Dr. Mayer Fishman|813-745-8311|mayer.fishman@moffitt.org
95674|NCT01373281|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
95675|NCT01372995|Emory University|Jenny Han, MD|404-616-0821|jehan2@emory.edu
95676|NCT01372878|Given Imaging|"Ravit Peled | Biostatistics and Data Management Manager"|+972 (4) 909-7894 ext 7894|ravit.peled@givenimaging.com
95677|NCT01372813|National Cancer Institute, National Institutes of Health|Marston Linehan, M.D.|301-496-6353|linehanm@mail.nih.gov
95678|NCT01372748|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org
95679|NCT01372605|University of North Carolina-Chapel Hill|Dr. Brian Pence|9199667446|bpence@unc.edu
95680|NCT01372501|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com
95681|NCT01372462|Clinical Research Consulting|Richard J. Morishige, MS, RRT|510-606-0375|rjmorishige@gmail.com
119050|NCT01814748|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95683|NCT01372384|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
95684|NCT01372202|SKCCC|Ronan Kelly, MD|443-287-0005|rkelly25@jhmi.edu
95685|NCT01372150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95686|NCT01371994|Astellas Pharma Global Development, Inc.|Medical Director, Urology||clinicaltrials@us.astellas.com
95687|NCT01371877|University of Nebraska Medical Center|Dr. Jill Poole|402-559-4087|japoole@unmc.edu
95688|NCT01371851|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu
95689|NCT01371838|AstraZeneca Pharmaceuticals|Melnick, David A / Exec Dir Med Science|+1 302 886 5627|David.Melnick@astrazeneca.com
95691|NCT01371786|Sunovion|Respiratory Medical Director|1-866-503-6351|
95692|NCT01371747|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com
95693|NCT01371734|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95694|NCT01371721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95695|NCT01371708|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|
95696|NCT01371643|NYU Langone Medical Center|David Kleinberg|212 263 6772|David.Kleinberg@nyumc.org
95697|NCT01371565|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com
95698|NCT01371552|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|+49 6022 240 520|joachim.nick@cibavision.com
95699|NCT01371539|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-800-241-7629|
119052|NCT01762943|University of North Carolina at Chapel Hill|Dr. Crystal Schiller|9199664810|crystal_schiller@med.unc.edu
95701|NCT01371006|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95702|NCT01370863|Shire Development LLC|Study Physician|+1 866 842 5335|
95703|NCT01370837|Maastricht University Medical Center|Kristy Pickwell|+31433877019|k.pickwell@mumc.nl
95704|NCT01370733|University of California Los Angeles|Dr. Andrew Leuchter, MD|(310) 825-0207|afl@ucla.edu
95705|NCT01370694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95706|NCT01370655|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95707|NCT01370642|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95708|NCT01370616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95709|NCT01370603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95710|NCT01370590|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95711|NCT01370538|AstraZeneca|Gerard Lynch|1625 518062 ext +44|aztrial_results_posting@astrazeneca.com
95712|NCT01370525|AstraZeneca|Gerard Lynch|1625 518062 ext +44|aztrial_results_posting@astrazeneca.com
95713|NCT01370460|Henry Ford Health System|Andrew Georgiadis, MD|313-916-7520|ageorgi1@hfhs.org
95714|NCT01370408|Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com
95715|NCT01370369|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
95716|NCT01370356|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95717|NCT01370265|Mayo Clinic|Dr. Panithaya Chareonthaitawee|507-284-1648|chareonthaitawee.panithaya@mayo.edu
95718|NCT01370083|Toronto Rehabilitation Institute - University Health Network|Prof. Catriona Steele|4165973422 ext 7603|catriona.steele@uhn.ca
95719|NCT01370005|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95720|NCT01369888|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov
95721|NCT01369875|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov
95722|NCT01369849|Mayo Clinic|Wei Ding, MBBS, PhD||ding.wei@mayo.edu
95723|NCT01369784|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea (GELTAMO)|Dr. Carlos Panizo|+ 34 948 25 54 00|cpanizo@unav.es
95724|NCT01369758|Hologic, Inc|Christina Mastandrea|508-263-8772|Christina.Mastandrea@Hologic.com
95725|NCT01369745|Zalicus|Margaret Lee,PhD|617-301-7142|mlee@zalicus.com
95726|NCT01369732|Yonsei University College of Medicine|Dr. Yon Hee Shim|82220193547|tren125@yuhs.ac
95727|NCT01369706|Deutsches Herzzentrum München|Prof. Dr. Christof Kolb|+49891218 ext 2020|kolb@dhm.mhn.de
95728|NCT01369680|Medical University of South Carolina|Dr. Amy-Lee Bredlau|843-792-2957 ext 62872|bredlau@musc.edu
95730|NCT01369615|Purdue Pharma L.P.|Clinical Leader|800-733-1333|
95731|NCT01369485|Ethicon Surgical Care|John Lombard, Manager Clinical Research|908 218 2877|Jlombar8@its.jnj.com
119055|NCT01718353|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
95735|NCT01369225|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95736|NCT01369030|Pamlab, Inc.|Lori W Barrentine, MS, PA-C, Director of Clinical Affairs|985-867-5788|lbarrentine@pamlab.com
95741|NCT01368809|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Paul F White|214-7703775|paul.white@cshs.org
95742|NCT01368653|Rutgers, The State University of New Jersey|Danielle E. McCarthy, Ph.D.|848-932-5870|demccart@rci.rutgers.edu
95743|NCT01368536|Novartis Pharmaceuticals|Study Director|862-778-8300|
95744|NCT01368432|Johns Hopkins University & school of Medicine|Vani Rao|410-550-2288|vrao@jhmi.edu
95745|NCT01368406|Programa de Esquizofrenia PROESQ UNIFESP|Cecilia Attux|551155733599|cattux@gmail.com
95746|NCT01368276|Amgen, Inc.|Study Director|866-572-6436|
95747|NCT01368263|Washington University School of Medicine|Timothy Pluard, M.D.|314-362-5645|tpluard@saint-lukes.org
95748|NCT01368211|Transfusion Service Rigshospitalet - Dept of Immunology, Copenhagen Denmark|Dr. Pär Johansson|+45 35452030|per.johansson@rh.regionh.dk
95749|NCT01368185|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95750|NCT01368081|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95751|NCT01368042|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
95752|NCT01367886|Washington University School of Medicine|H. Henry Lai, MD|314-362-8295|laih@wudosis.wustl.edu
95753|NCT01367860|IOT/HC University of SãoPaulo|Dr. Alexandre Cristante Fogaça|+55 11 2661-6951|aacristante@uol.com.br
95754|NCT01367834|UNC Chapel Hill|Rebecca Knickmeyer Santelli|9199662216|rebecca_knickmeyer@med.unc.edu
95755|NCT01367704|Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center|Dr. Elizabeth Miller|412-692-8504|elizabeth.miller@chp.edu
95756|NCT01367457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|800-718-1021 ext 001|ClinicalTrials.gov_Inquiries@pfizer.com
95757|NCT01367249|Bausch & Lomb Incorporated|James Gow|949-788-6000|james.gow@bausch.com
95758|NCT01367158|Novartis Vaccines|Posting Director||RegistryContactVaccineUS@novartis.com
95759|NCT01367119|Mayo Clinic|Dr. Keith G. Rassmussen|507-284-2933|rasmussen.keith@mayo.edu
95760|NCT01367080|Dong Wha Pharm. Co. Ltd.|Cheol-Hee Lim. Clinical Research Manager (CRM)|+82-2-2021-9300 ext 551|cheolhee.lim@dong-wha.co.kr
95761|NCT01366976|Vanderbilt University School of Medicine|Mias Pretorius|16153220758|mias.pretorius@vanderbilt.edu
95762|NCT01366885|OHSU|Dr. Gene Stubbs|503-939-7351|stubbsgene@comcast.net
95763|NCT01366872|Orthopaedic Associates of Michigan, PC|Dr. John G. Anderson|616-459-7101 ext 797|John.Anderson@oamichigan.com
95764|NCT01366846|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
95765|NCT01366638|Janssen Pharmaceutical K.K., Japan|Director|81 3 44115639|
95767|NCT01366521|GlaxoSmithKline|GSK Response Center|866-435-7343|
95768|NCT01366443|University of Utah Medical Center, Dept. of OB/GYN|Dr. Michael Draper, MD University of Utah Medical Center, Dept. of OB/GYN|801-581-7647|mike.draper@hsc.utah.edu
95769|NCT01366417|CareFusion|Jennifer Raeder-Devens|847-454-4939|jennifer.raeder-devens@carefusion.com
95770|NCT01366209|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
95771|NCT01366196|Hss|Dr. Michael Urban|(212) 606-1000|UrbanM@hss.edu
95773|NCT01365910|Vanderbilt-Ingram Cancer Center|Dr. Jordan Berlin|615-343-4128|jordan.berlin@vanderbilt.edu
95774|NCT01365845|University of Florida Proton Therapy Institute|Dr. Julie Bradley|904-588-1800|jbradley@floridaproton.org
95775|NCT01365819|UCLA, Dept of Family Medicine|Dr. Steve Shoptaw|310-794-0619|sshoptaw@mednet.ucla.edu
95776|NCT01365650|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200 ext 828|dbregman@lpicrd.com
95777|NCT01365624|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D|610-650-4200 ext 828|dbregman@lpicrd.com
95778|NCT01365611|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200 ext 828|dbregman@lpicrd.com
95779|NCT01365585|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95780|NCT01365546|Octapharma|Director of Clinical Operations|4152609577|sylvia.werner@octapharma.com
95781|NCT01365507|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
95782|NCT01365494|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
95783|NCT01365481|Novartis Pharmaceuticals|Study Director|862 ­778 ­8300|
95784|NCT01365468|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
95785|NCT01365455|Novartis Pharmaceuticals|Study Director|862-778-8300|
95786|NCT01365273|Monlycke Health Care|Joan Wilson, MSN, MHA, RN|706 504 8997|joan.wilson@molnlycke.com
95787|NCT01365130|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org
95788|NCT01365091|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
95789|NCT01365052|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
95790|NCT01365039|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|(585) 338-6399|robert.steffen@bausch.com
95791|NCT01364922|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
95792|NCT01364896|University of Pittsburgh|Ross Cranston|412-383-1675|rdc27@pitt.edu
95793|NCT01364740|Stanford University|Clete A. Kushida, MD, PhD|650-721-7560|clete@stanford.edu
95794|NCT01364727|Stanford University Medical Center|Heather A Wakelee, MD|650-736-7221|hwakelee@stanford.edu
95795|NCT01364649|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
95796|NCT01364558|University of Minnesota|Dr. James Cloyd, Director for Center for Orphan drug research|612-624-4609|cloyd001@umn.edu
95797|NCT01364428|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
95798|NCT01364389|Novartis Pharmaceuticals|Study Director|862-778-8300|
95799|NCT01364298|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
95800|NCT01364259|Stanford University Cancer Center|Dr. Scott G. Soltys, Assistant Professor|650.724.1569|sgsoltys@stanford.edu
95801|NCT01364207|Massachusetts Eye and Ear Infirmary|Dr. Louis R. Pasquale|617-573-4240 ext 4240|aliya_jiwani@meei.harvard.edu
95802|NCT01363986|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
95803|NCT01363908|Shire Development LLC|Study Physician|+1 866 842 5335|
95804|NCT01363843|BrUOG|William Sikov, MD and Kimberly Perez, MD|4018633000|kayla_rosati@brown.edu
95805|NCT01363765|InCo-TB project, Gama Filho University|Anete Trajman|5521-82189194|atrajman@gmail.com
95806|NCT01363713|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp
95807|NCT01363700|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp
95808|NCT01363661|ECSOR|Jacques Bruhwyler, Project Manager|3267444093|Jacques.Bruhwyler@ecsor.com
95809|NCT01363492|Shire Development LLC|Study Physician|+1 866 842 5335|
95811|NCT01363440|Regeneron|Clinical Trial Management|914 847 7000|clinicaltrials@regeneron.com
95812|NCT01363401|Hanyang University Seoul Hospital|Seung-Hyun Kim, M.D., Ph.D.|+82-2-2290-8114|kimsh1@hanyang.ac.kr
95813|NCT01363349|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100 ext 135|arnona@biolinerx.com
95814|NCT01363297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95815|NCT01363076|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com
95816|NCT01363050|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200 ext 828|dbregman@lpicrd.com
95817|NCT01363011|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
95818|NCT01362946|Penn State Hershey Medical Center|Dr. Dan Waschbusch|7175318514|dwaschbusch@hmc.psu.edu
95819|NCT01362907|Alcon Research|Joachim Nick, Dipl. Ing. (FH)|+49 6022 240 520|joachim.nick@cibavision.com
95820|NCT01362894|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-800-241-7629|
95821|NCT01362686|Regenstrief Insitute|Dr. Noll Campbell|317-274-9051|cambenl@regenstrief.org
95822|NCT01362608|Novartis|Clinical Disclosure Office|862-778-8300|
95823|NCT01362530|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95824|NCT01362517|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com
95825|NCT01362491|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95826|NCT01362439|Janssen-Cilag SpA, Cologno Monzese, Milan - Italy|Therapeutic Area Medical Manager|+39 0225101|
95827|NCT01362348|GlaxoSmithKline|GSK Response Center|866-435-7343|
95828|NCT01362296|GlaxoSmithKline|GSK Response Center|866-435-7343|
95829|NCT01362244|GlaxoSmithKline|GSK Response Center|866-435-7343|
119059|NCT01692730|University of Rochester|Scott McIntosh|585-275-0511|scott_mcintosh@urmc.rochester.edu
95831|NCT01362192|Main Line Center for Laser Surgery|Eric F. Bernstein, M.D., M.S.E.|610-645-5551|dermguy@dermguy.com
95833|NCT01362062|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
95834|NCT01362049|University of Vermont Medical Center, Burlington, VT|Dr. Sharon M. Henry|(802) 847-7633|Sharon.Henry@uvm.edu
95835|NCT01361867|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org
95836|NCT01361854|CHU St Pierre|Dr Marie Bruyneel|003225354219|Marie_BRUYNEEL@stpierre-bru.be
96131|NCT00006178|National Institutes of Health|Dr. Allan D. Kirk||allank@intra.niddk.nih.gov
95837|NCT01361633|Anxiety Disorders Center, Institute of Living/Hartford Hospital|Gretchen Diefenbach, Ph.D.|860-545-7685 ext 5-7396|gdiefen@harthosp.org
95838|NCT01361620|George Washington University|Dr. Timothy McCaffrey|(202) 994-8919|mcc@email.gwu.edu
95839|NCT01361594|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu
95840|NCT01361568|Cara Therapeutics|Frédérique Menzaghi, PhD; Vice President, Research & Development|203-567-1502|fmenzaghi@caratherapeutics.com
95841|NCT01361464|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org
95842|NCT01361308|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com
95843|NCT01361178|University of Pittsburgh|Andrej Petrov, MD|412-648-6215|petrovaa@upmc.edu
95844|NCT01361126|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
95845|NCT01361113|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
95846|NCT01361048|UAB|Dr. Jane Schwebke|205-975-5665|schwebke@uab.edu
95847|NCT01361009|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95848|NCT01360996|Woman's Hospital|Dr Karen Elkind-Hirsch|225-231-5275|karen.elkind-hirsch@womans.org
95849|NCT01360840|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
95850|NCT01360645|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974|
95851|NCT01360632|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
95852|NCT01360554|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95853|NCT01360450|Johns Hopkins Medical Institution|Estelle B Gauda|4106140151|egauda1@jhmi.edu
95854|NCT01360021|Astrazeneca|Goran Eckerwall, MD||aztrial_results_posting@astrazeneca.com
95855|NCT01359943|Novartis Pharmaceuticals|Study Director|862-778-8300|
95856|NCT01359904|MUHC|Sameena Iqbal|5149341934 ext 44034|sameena.iqbal@mcgill.ca
95857|NCT01359748|Aguiflai Iberica, SL|Angel Pons Ferré|+34 93 7540370|calidad@keito.com
95858|NCT01359735|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com
95859|NCT01359644|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Trials@bms.com
95860|NCT01359449|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
95861|NCT01359410|Washington University School of Medicine|William Hawkins, M.D.|314-362-7046|hawkinsw@wustl.edu
95862|NCT01359371|VA Center for Clinical Management Research Health Services|Sonia A. Duffy, Ph.D., R.N., FAAN|734.395.0613|Sonia.Duffy@va.gov
95863|NCT01359254|The University of Chicago Medicine|Andrew Artz, MD, MS|(773) 834-8980|aartz@medicine.bsd.uchicago.edu
95864|NCT01359150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95865|NCT01359111|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org
95866|NCT01358864|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95867|NCT01358825|GlaxoSmithKline|GSK Response Center|866-435-7343|
95868|NCT01358760|Endoceutics|Director of Data Analysis|418-653-0033 ext 215|celine.martel@endoceutics.com
95869|NCT01358734|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com
95870|NCT01358708|Aptalis Pharma US, Inc.|Robert Winkler MD, VP, Clinical Development and Operations|(908) 429-4479 ext 4175|rwinkler@aptalispharma.com
95871|NCT01357551|Durham VA Medical Center|Dr. Corrine Voils|9192860411 ext 5196|corrine.voils@va.gov
95872|NCT01358578|Novartis|Study Director|862-778-8300|
95873|NCT01358526|Purdue Pharma L.P.|Clinical Leader|800-733-1333|
95874|NCT01358357|Sunovion Pharmaceuticlas Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com
95875|NCT01358175|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
95876|NCT01357980|Ipsen|Medical Director Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
95877|NCT01357915|GlaxoSmithKline|GSK Response Center|866-435-7343|
95878|NCT01357889|GlaxoSmithKline|GSK Response Center|866-435-7343|
95879|NCT01357850|GlaxoSmithKline|GSK Response Center|866-435-7343|
95880|NCT01357720|Crucell Switzerland AG|Medical Affairs Director|+41(0)319086111|info@crucell.com
95881|NCT01357655|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
95882|NCT01357616|Alcon Research, Ltd.|Mandy Ye, Head, Clinical Trial Management, Asia|1-888-451-3739|alcon.medinfo@alcon.com
95884|NCT01357239|Novartis Pharmaceuticals|Study Director|862-778-8300|
95885|NCT01357161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95886|NCT01357148|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95887|NCT01357135|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95888|NCT01356966|Emory University|Dr. Jeanie Park|404-727-1386|jeanie.park@emory.edu
95889|NCT01356940|MS Center at Evergreenhealth|Theodore R. Brown, MD|425-899-5350|trbrown@evergreenhealth.com
95890|NCT01356667|UCLA, Integrated Substance Abuse Programs|Dr. Daniel Dickerson|562-277-0310|daniel.dickerson@ucla.edu
95891|NCT01356602|Novartis Pharmaceuticals|Study Director|862-778-8300|
95892|NCT01356589|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
95893|NCT01356498|Savient Pharmaceuticals, Inc.|Chief Medical Officer|732-418-9300|
95894|NCT01356407|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
95895|NCT01356147|Stanford University School of Medicine/Division of Neonatology|Dr. Melissa Scala|650-724-9653|mscala@stanford.edu
95896|NCT01355978|Clinical Research Consuting|Richard J. Morishige, MS, RRT|510-606-0374|rjmorishige@gmail.com
95898|NCT01355679|NMTRC at Spectrum Health|Giselle Sholler, MD|616-267-0334|giselle.sholler@helendevoschildrens.org
95899|NCT01355627|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
95900|NCT01355588|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200 ext 828|dbregman@lpicrd.com
95901|NCT01355523|Herlev Hospital, Department of Surgery|MD Melissa Voigt Hansen|+45 20661119|melissa.voigt.hansen@regionh.dk
95902|NCT01355484|GTx Inc.|Senior Director, Clinical Operations|1-901-261-3795|mdesordi@gtxinc.com
95903|NCT01355471|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com
95904|NCT01355458|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com
95905|NCT01355419|CHU St Pierre|Dr Marie Bruyneel|00325354219|Marie_BRUYNEEL@stpierre-bru.be
95906|NCT01355302|Eisai Inc.|Eisai Medical Services|888-422-4743|
95907|NCT01355224|Boston University School of Public Health|Dr. Catharine Wang|617-638-5187|clwang@bu.edu
95908|NCT01355081|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
95909|NCT01355068|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95910|NCT01354990|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95911|NCT01354938|Abbott|Esther Oppermann, Clinical Trial Manager|49 511 6750 3954|
95912|NCT01354899|Molnlycke Health Care AB|Tina Kjellen|+46317223098|tina.kjellen@molnlycke.com
95913|NCT01354652|AsanMC|Dr. Han Chu Lee|82230103915|hch@amc.seoul.kr
119060|NCT01660412|UAMS|James A Ntambi|5015265062|jantambi@uams.edu
95915|NCT01354314|The Johns Hopkins University|Dr. Ned Sacktor|410-550-1045|sacktor@jhmi.edu
95916|NCT01354223|Foresight Regulatory Strategies, Inc.|William J. Gleason, O.D.|978-658-6888 ext 151|
95917|NCT01354197|Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand|Kaweesak Chittawatanarat|053-935533|kchittaw@gmail.com
95918|NCT01354145|Bioiberica|Marta Herrero - Clinical R&D Manager|+34934904908|mherrero@bioiberica.com
95919|NCT01354132|Beth Israel Deaconess Medical Center|Larry Seidman, PhD|617 754-1238|lseidman@bidmc.harvard.edu
95920|NCT01354106|cyberDERM|Dr. Gary Grove|610-325-0112|GGrove@cyberderm-inc.com
95921|NCT01354028|University of Arkansas for Medical Sciences|Dr Richard W Hall MD, Professor of Neonatology|501-680-7894|HallRichardW@uams.edu
95922|NCT01354015|Tulane University|Dr Vivian Fonseca|5049884026|vfonseca@tulane.edu
95923|NCT01353976|AmDerma Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amderma.com
95924|NCT01353963|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com
95925|NCT01353911|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95926|NCT01353898|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95927|NCT01353859|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
95928|NCT01353664|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com
95929|NCT01353586|Biosense Webster, Inc|Kendra McInnis, Manager, Clinical Operations|909-839-7284|kmcinnis@its.jnj.com
95930|NCT01353508|Novartis|Study Director|862-778-1873|
95931|NCT01353274|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95932|NCT01353222|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com
95933|NCT01353144|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121 ext 8233|pihsu@vghks.gov.tw
95934|NCT01353079|GREER Laboratories, Inc.|Terrance Coyne, M.D., Executive Vice President of Research & Development; Chief Medical Officer|(828) 759-7495|tcoynemd@greerlabs.com
95935|NCT01352845|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95936|NCT01352793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
95937|NCT01352741|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|
95938|NCT01352715|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
95939|NCT01352585|Shire Development LLC|Study Physician|+1 866 842 5335|
95940|NCT01352546|Plastic Surgery Professional Association|Peter T. Pacik, MD, FACS|603 387 7735|ptpacik@verizon.net
95941|NCT01352507|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
95942|NCT01352468|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|5136368296|jeff.epstein@cchmc.org
95943|NCT01352442|AcuFocus, Inc.|Eugenia Thomas, OD|949-585-9511|ethomas@acufocus.com
95944|NCT01352416|William Beaumont Hospital|Ilana Kutinsky, DO|248-267-5050|ikutinsky@beaumont.edu
95946|NCT01351623|Memorial Sloan Kettering|Nikoletta Lendvai, MD|(212) 639-3368|lendvain@mskcc.org
95947|NCT01351506|Chiang Mai University|Dr.Kaweesak Chittawatanarat|+66815951259|kchittaw@gmail.com
95948|NCT01351480|AARDS Research, Inc.|Norman B Gaylis, MD|305-652-6676|drnbg@rheum-care.com
95949|NCT01351415|Hoffmann-La Roche|Medical Communications|888-6821-8590|genentech@druginfo.com
95950|NCT01351337|Huashan Hospital|Dr Jinsong Wu|862152888771|wjsongc@126.com
95951|NCT01351090|Luitpold Pharmaceuticals, Inc.|David Bregamn, M.D., Ph.D.|610-650-4200 ext 828|dbregman@lpicrd.com
95952|NCT01351077|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu
95953|NCT01351064|IUSM|Aaron Carroll|3172789696|aaecarro@iu.edu
95954|NCT01351025|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|301-628-3313|ACTGCT.Gov@s-3.com
95955|NCT01350999|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
95956|NCT01350973|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
95957|NCT01350947|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu
95959|NCT01350804|Novartis|Study Director|862-778-8300|
95960|NCT01350583|H. Lee Moffitt Cancer Center and Research Institute|Robert J. Gillies, Ph.D. - Principal Investigator|813-745-8355|robert.gillies@moffitt.org
95961|NCT01350544|RAND Corporation|Laura M. Bogart, PhD|(310) 393-0411 ext 7281|lbogart@rand.org
95962|NCT01350479|VA Maryland Healthcare System|Mary-Claire Roghmann|410-706-0062|mroghman@epi.umaryland.edu
95963|NCT01350414|Boston Scientific|Narinder Shargill|408-635-3907|Narinder.Shargill@bsci.com
95964|NCT01350388|University of Utah|Srinivasan Beddhu, M.D.|801-585-3810|srinivansan.beddhu@hsc.utah.edu
95965|NCT01350271|University of Kelaniya|Dr Balachandran Kumarendran|0094112961140|drbkumaran@gmail.com
95966|NCT01350258|Thomas Jefferson University|Dolores Grosso, CRNP, DNP|215-955-8874|Dolores.Grosso@jefferson.edu
95967|NCT01350245|Thomas Jefferson University|Dolores Grosso, CRNP, DNP|215-955-8874|Dolores.Grosso@jefferson.edu
95968|NCT01350232|Thomas Jefferson University|Joanne Filicko-O'Hara, MD|215-955-8874|jef001@jefferson.edu
95969|NCT01350128|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com
95970|NCT01350115|Novartis Pharmaceuticals|Study Director|862-778-8300|
95971|NCT01349972|University of North Carolina, Lineberger Comprehensive Cancer Center|Joshua Zeidner|(919) 962-5164|Joshua_Zeidner@med.unc.edu
95972|NCT01349959|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Clinical Research Office|410-955-8866|jhcccro@jhmi.edu
95974|NCT01349920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95975|NCT01349907|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
95976|NCT01349829|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com
95977|NCT01349816|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com
95978|NCT01349803|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com
95979|NCT01349790|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com
95980|NCT01349595|Mayo Clinic|Dr. Mark Stegall|507-266-2812|Stegall.Mark@mayo.edu
95981|NCT01349491|University of Oklahoma Health Sciences Center|Stavros Stavrakis|405-271-9696 ext 37539|stavros-stavrakis@ouhsc.edu
95982|NCT01349465|Janssen Research & Development, LLC|Study Responsible Scientist||ClinicalTrialDisclosure@its.jnj.com
95983|NCT01349231|Yale University, Connecticut Mental Health Center|Dr. Michael Bloch, MD, MS|203-737-4809|michael.bloch@yale.edu
95984|NCT01349192|University of North Carolina, Chapel Hill|Marianne S. Muhlebach, PI|(1) 919 966 1055|Marianne_Muhlebach@med.unc.edu
95985|NCT01349114|University of Alabama at Birmingham|David A. Calhoun, MD|205-934-4633|dcalhoun@uab.edu
95986|NCT01348854|Abbott Medical Optics|Carrie Garufis|714-247-8200|carrie.garufis@amo.abbott.com
95987|NCT01348789|Northwestern Memorial Hospital|Dr. Jerome M. Garden|312-280-0891|j-garden@northwestern.edu
95988|NCT01348776|Syneron Beauty|Doran Rozen, Director of Clinical Affairs|+972-54-7800260|Doran.Rozen@syneron.com
95989|NCT01348607|SunCoast CCOP Research Base|Cristina Burroughs, Clinical Research Administrator|(813) 396-9237|Cristina.Burroughs@epi.usf.edu
95990|NCT01348425|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com
95991|NCT01348165|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
95992|NCT01348139|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
95993|NCT01348100|Novartis Pharmaceuticals|Study Director|862 778-8300|
95994|NCT01348087|Novartis Pharmaceuticals|Study Director|862-778-8300|
95995|NCT01347931|Clinical Reseach Consulting|Richard J. Morishige, MS, RRT|510-606-0375|rjmorishige@gmail.com
95996|NCT01347879|Virginia Clinical Research, Inc.|Dr David Pariser|757-625-0151|dpariser@pariserderm.com
95997|NCT01347840|Ethicon Endo-Surgery, Inc.|Amy Mahanes|513-337-8366|amahanes@its.jnj.com
95998|NCT00000125|Washington University School of Medicine|Michael Kass MD|314-362-5713|kass@vision.wustl.edu
95999|NCT00000134|Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu
96000|NCT00000135|Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu
96001|NCT00000136|The Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu
96002|NCT00000142|Johns Hopkins Bloomberg School of Public Health|Dr. Curtis Meinert|410-955-8175|cmeinert@jhsph.edu
96003|NCT00000143|Johns Hopkins School of Public Health|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu
96004|NCT00000371|Freedom Clinic Trail, Massachusetts General Hospital|Dr. Donald Goff|617-921-7899|goff@psych.mgh.harvard.edu
96005|NCT00000378|New York State Psychiatric Institute|Steven Roose MD|646-774-8661|spr2@columbia.edu
96006|NCT00000392|NIMH|Benedetto Vitiello, MD - Supervisory Medical Officer|301-443-3357|bvitiell@mail.nih.gov
96007|NCT00000479|Brigham and Women's Hospital|Julie E. Buring|617 732 4965|jburing@rics.bwh.harvard.edu
96008|NCT00000575|Johns Hopkins Bloomberg School of Public Health, Dept of Epidemiology|Alice Sternberg|410-955-3752|asternbe@jhsph.edu
96009|NCT00000620|Wake Forest School of Medicine|Tim Craven / Senior Biostatistician|336-716-6109|tcraven@wakehealth.edu
96010|NCT00001151|NIH|Stephen J. Marx, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|3014965051|marxs@mail.nih.gov
96011|NCT00001566|National Cancer Institute (NCI), National Institutes of Health (NIH)|Crystal Mackall, M.D.|301-402-5940|mackallc@mail.nih.gov
96012|NCT00001575|National Cancer Institute|Thomas Waldmann M.D.|301-496-6653|waldmann@nih.hhs.gov
96013|NCT00001586|National Cancer Institute, National Institutes of Health|Wyndham H. Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov
96015|NCT00001656|National Institute of Mental Health|Judith L. Rapoport, M.D.|301-496-6080|rapoporj@mail.nih.gov
96016|NCT00001703|National Cancer Institute, National Institutes of Health|Samir N. Khleif, M.D.|301-496-0901|khleifs@mail.nih.gov
96017|NCT00001723|National Institute of Child Health and Human Development, NIH|Jack A. Yanovski, MD, PhD, Chief SGO, PDEGEN|301-496-4686|yanovskj@mail.nih.gov
96018|NCT00001941|National Cancer Institute, National Institues of Health|Thomas Waldmann, M.D.|301-496-6653|tawald@mail.nih.gov
96019|NCT00001959|NIDDK, NIH|Jeffrey B Kopp, MD|3015943403|jbkopp@nih.gov
96020|NCT00001962|NIH National Heart, Lung and Blood Institute|Neal Young MD|301-496-5093|youngns@nhlbi.nih.gov
96021|NCT00001984|NIDDK, NIH|Dr. Alan Kirk||allank@intra.niddk.nih.gov
96022|NCT00001262|National Institute of Child Health and Human Development|Kaler, Stephen G|+1 301 451 6034|kalers@mail.nih.gov
96023|NCT00001304|National Institute of Child Health and Human Development|WINER, Karen|+1 301 435 6877|winerk@mail.nih.gov
96024|NCT00001213|National Institutes of Health|Rachel J. Bishop, MD, Principal Investigator, National Eye Institute|301-402-3771|bishopra@nei.nih.gov
96025|NCT00001832|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov
96026|NCT00002525|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012|
96027|NCT00002540|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov
96028|NCT00002558|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org
96029|NCT00002597|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
96030|NCT00002601|City of Hope|Paul Frankel, Ph.D.|(626)256-4673 ext 65265|pfrankel@och.org
96031|NCT00002651|SWOG Statistical Center|Study Statistician|206-667-4623|
96032|NCT00002766|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak|212-639-5518|maslakp@mskcc.org
96033|NCT00002842|City of Hope|Jeffrey Longmate, Ph.D.|626-256-4673|jlongmate@coh.org
96034|NCT00002850|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu
96035|NCT00002874|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
96036|NCT00002931|City of Hope|Paul Frankel, Ph.D.|626-359-8111 ext 65265|pfrankel@coh.org
96037|NCT00002975|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
96038|NCT00003138|ECOG Statistical Office|Study Statistician|617-632-3012|
96039|NCT00003199|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org
96040|NCT00003222|University of Virginia|Craig L. Slingluff, MD|434-924-1730|CLS8H@hscmail.mcc.virginia.edu
96041|NCT00003224|University of Virginia|Craig Slingluff|434-924-1730|cls8h@virginia.edu
96042|NCT00003377|Gynecologic Oncology Group Statistical & Data Center|Melissa Leventhal|(716)845-5702|mleventhal@gogstats.org
96044|NCT00003457|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
96045|NCT00003458|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
96046|NCT00003459|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
96047|NCT00003460|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
96048|NCT00003468|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
96049|NCT00003469|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
96050|NCT00003470|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
96051|NCT00003473|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
96052|NCT00003475|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
96053|NCT00003476|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
96054|NCT00003477|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
96055|NCT00003479|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
96056|NCT00003483|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
96057|NCT00003537|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
96058|NCT00003590|SWOG Statistical Center|Study Statistician|(206)667-4623|
119064|NCT01625221|Torax Medical, Inc.|VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com
96060|NCT00003726|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|james.r.rigas@hitchcock.org
96061|NCT00003782|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600|
96062|NCT00003820|Stanford University|Ranjana Advani, MD, Professor of Lymphoma|650-725-6456|radvani@stanford.edu
96063|NCT00003298|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012|
96064|NCT00003869|Mayo Clinic|Dr. Edith A. Perez||perez.edith@mayo.edu
96065|NCT00003875|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org
96066|NCT00003895|Providence Cancer Center, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center|Walter J. Urba, MD, PhD; Physician Director of Research|503-215-5696|Walter.Urba@providence.org
96067|NCT00003896|SWOG Statistical Center|Gynecologic Committee Statistician|206-667-4623|
96068|NCT00004143|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|Mitchell.Horwitz@duke.edu
96069|NCT00004146|Adult Brain Tumor Consortium|Stuart A Grossman|410-955-3657|jfisher@jhmi.edu
96070|NCT00004228|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96071|NCT00003631|Memorial Sloan Kettering Cancer Center|Dr. Joachim Yahalom|1212-639-5999|yahalomj@mskcc.org
96072|NCT00003641|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012|
119065|NCT01594385|St. Luke's University Health Network|Stanislaw P. Stawicki, M.D.|484-526-4426|stanislaw.stawicki@sluhn.org
96073|NCT00004412|Boston University School of Medicine|Douglas V. Faller, Ph.D., M.D., Susan P. Perrine, M.D.|(617) 638-5639|sperrine@bu.edu
96074|NCT00004859|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012|
96075|NCT00004888|Eastern Cooperative Oncology Group Statistical Office|Study Statistician|617-632-3012|
96076|NCT00004978|Division of Biostatistics, University of Minnesota|James Neaton, PhD|612-626-9040|jim@ccbr.umn.edu
96077|NCT00004980|Yale University School of Medicine|Ralph Hoffman|203-688-9734|ralph.hoffman@yale.edu
96078|NCT00003901|Memorial Sloan Kettering Cancer Center|Valerie Rusch, MD|212-639-5873|ruschv@mskcc.org
96079|NCT00003907|ECOG Statistical Office|Study Statistician|617-632-3012|
96082|NCT00004092|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626) 256-4673 ext 65265|pfrankel@coh.org
96083|NCT00004500|Discovery Laboratories, Inc.|Dr. Robert Segal|215-488-9300|rsegal@discoverylabs.com
96084|NCT00004547|National Cancer Institute, National Institutes of Health|Marybeth S. Hughes, M.D.|301-594-9341|hughesm@mail.nih.gov
96085|NCT00004562|New York University School of Medicine|Judith S. Hochman, M.D.|212-263-6927|judith.hochman@nyumc.org
96086|NCT00004563|University of Texas Health Science Center at Houston|Maureen Mayes, MD|+1 (713) 500-6900|Maureen.D.Mayes@uth.tmc.edu
96087|NCT00004635|National Cancer Institute, National Institutes of Health|William L. Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov
96088|NCT00004732|Mayo Clinic|Thomas G. Brott, MD - Principal Investigator|904-953-0556|Brott.thomas@mayo.edu
96089|NCT00005047|University of Southern California|Dr. Susan Groshen|323-865-0375|Susan.Groshen@med.usc.edu
96090|NCT00005879|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu
96091|NCT00005901|National Institute of Child Health and Human Development|Joan Marini|+1 301 594 3418|marinij@cc1.nichd.nih.gov
96092|NCT00005906|TMB/NHLBI|Joel Moss|301-496-1597|mossj@nhlbi.nih.gov
96093|NCT00005908|National Cancer Institute, National Institutes of Health|JoAnne Zujewski, M.D.|301-435-9207|zujewskij@mail.nih.gov
96094|NCT00005937|NIH National Heart, Lung and Blood Institute|Neal S. Young MD|301-402-1806|youngns@nhlbi.nih.gov
96095|NCT00005947|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com
96096|NCT00005957|Juravinski Cancer Centre at Hamilton Health Sciences|Dr. Timothy J. Whelan|1(905) 387-9495|twhelan@HHSC.CA
96097|NCT00006011|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
96098|NCT00006409|University of North Carolina - Chapel Hill|June Stevens|919-966-7218|june_stevens@unc.edu
96099|NCT00006478|University of Nebraska Medical Center Division of Oncology/Hematology|Bryan Ludwig, Regulatory Coordinator|402-559-8071|bmludwig@unmc.edu
96100|NCT00006489|University of Pennsylvania|Dr. Edna Foa|215-746-3327|foa@mail.med.upenn.edu
96101|NCT00006604|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org
96102|NCT00006721|SWOG Statistical Center|Study Statistician|206-667-4623|
96103|NCT00006903|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org
96104|NCT00006916|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org
96105|NCT00007345|National Cancer Institute|Dr. Kieron Dunleavy|301-435-1007|DunleavK@mail.nih.gov
96106|NCT00007475|National Institute of Diabetes & Digestive & Kidney Diseases|Jeffrey B. Kopp, MD|+1 (301) 594-3403|jbkopp@nih.gov
96107|NCT00007644|Minneapolis VA Medical Center|Timothy Wilt, MD|612-467-2158|timothy.wilt@va.gov
96108|NCT00005669|National Institute of Child Health and Human Development, NIH|Jack A. Yanovski, MD, PhD, Chief, Unit on Growth and Obesity|301-496-0858|yanovskj@mail.nih.gov
96109|NCT00010439|Medical University of South Carolina|Deborah A Bowlby, M.D., Assistant Professor, Pediatric Endocrinology|843-792-6807|bowlbyd@musc.edu
96110|NCT00010803|University of Virginia|Steven T. DeKosky MD|434-924-5118|SD3ZC@hscmail.mcc.virginia.edu
96111|NCT00011986|Gynecologic Oncology Group Statistical and Data Center|Linda Gedeon, BS, CCRP|716-845-1169|lgedeon@gogstats.org
96112|NCT00012012|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org
96113|NCT00012298|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu
96114|NCT00006110|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
96115|NCT00006237|SWOG statistical office|SWOG Melanoma Statistician|206-667-4408|
96116|NCT00006244|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org
96117|NCT00006289|National Institute of Nursing Research|Dr. Leorey Saligan (Principal Investigator, former PI: Dr. Raymond Dioone)|301-451-1685|saliganl@mail.nih.gov
96118|NCT00006305|University of Pittsburgh|Dr. Maria Brooks|4126241618|brooks@edc.pitt.edu
96119|NCT00006389|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
96120|NCT00006392|SWOG Statistical Center|Study Statistician|2066674623|
96121|NCT00014495|Memorial Sloan Kettering Cancer Center|Dr. Martin Tallman|212-639-3842|tallmanm@mskcc.org
96122|NCT00014560|Dartmouth Hitchcock|Dr. Pamela Ely|603-653-9071|
96123|NCT00014911|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
96124|NCT00015457|National Institutes of Health|Barbara I Karp, MD|301-496-0150|karpb@ninds.nih.gov
96125|NCT00015847|OHSU Knight Cancer Institute|Dr. Brian Druker|(503) 494 5596|drukerb@ohsu.edu
96126|NCT00016354|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Antonio Wolff|410-614-4192|awolff@jhmi.edu
96127|NCT00006151|University of Pennsylvania|Peter Gariti||gar1iti@mail.med.upenn.edu
96128|NCT00006156|National Institute of Child Health and Human Development|Nelson, Lawrence Merle|+1 301 402 6608|nelsonl@mail.nih.gov
96129|NCT00006164|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|James E. Everhart, MD, MPH, Project Officer|301-594-8878|EverhartJ@extra.niddk.nih.gov
96133|NCT00008138|SWOG Statistical Center|GYN Committee Statistician|206-667-4623|
96134|NCT00008385|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012|
96135|NCT00009737|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
96136|NCT00010257|ECOG Statistical Office|Study Statistician|617-632-3012|
96137|NCT00016913|Department of Medicine, Memorial Sloan-Kettering Cancer Center|Wm. Kevin Kelly, DO||kellyw@mskcc.org
96138|NCT00019604|National Cancer Institute, National Institutes of Health|Caryn Steakley|301-435-3685|steaklec@mail.nih.gov
96139|NCT00019747|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov
96140|NCT00020722|Barbara Ann Karmanos Cancer Institute|Lawrence G. Lum, M.D., D.Sc|(313) 576-8326|luml@karmanos.org
96141|NCT00021229|Pediatric Brain Tumor Consortium|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|901-595-4986|james.boyett@stjude.org
96142|NCT00021255|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
96143|NCT00021541|National Institutes of Health, National Cancer Institute|Brigitte Widemann, M.D.|301-496-7387|widemanb@mail.nih.gov
96144|NCT00013611|University of Minnesota|Gary Collins, M.S.|612-626-9006|gary-c@ccbr.umn.edu
96145|NCT00022490|OHSU Knight Cancer Institute|Dr. Brian Druker|(503) 494 5596|drukerb@ohsu.edu
96146|NCT00022516|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org
96148|NCT00022672|Hoffman-LaRoche|Medical Communications|800-821-8590|
96149|NCT00022698|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
96150|NCT00022763|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
96151|NCT00023309|National Institute of Diabetes and Digestive and Kidney Diseases, NIH|Marc G. Ghany, M.D|3014961721|marcg@mail.nih.gov
96152|NCT00023322|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Theo Heller, M.D.|(301) 402-7147|Theoh@mail.nih.gov
96153|NCT00023452|CDC|Dr Elsa Villarino|404-639-5340|mev1@cdc.gov
96154|NCT00023595|Duke University Health System|Dr. Eric Velazquez|919-668-8700|velaz002@mc.duke.edu
96155|NCT00023673|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org
96157|NCT00023764|Memorial Sloan-Kettering Cancer Center|Dr. John Gerecitano|212-639-3748|gerecitj@mskcc.org
96158|NCT00024102|University of North Carolina|Hyman Muss, MD||hyman.muss@gmail.com
96159|NCT00024167|University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD/Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org
96160|NCT00024258|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner|212-639-6793|kushnerb@mskcc.org
96163|NCT00025259|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96164|NCT00017563|OHSU Knight Cancer Institute|Tomasz Beer, M.D.|503-494-1080|beert@ohsu.edu
96165|NCT00018031|NIAID/NIH|Dr. Shyam Kottilil|301-435-036|skottilil@niaid.nih.gov
96167|NCT00025662|NHLBI|A. John Barrett|301-402-4170|barrettjj@mail.nih.gov
96168|NCT00027378|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu
96169|NCT00027560|Memorial Sloan-Kettering Cancer Center|Dr. Hugo Castro-Malaspina|212-639-8197|castro-h@mskcc.org
96170|NCT00027846|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96171|NCT00028002|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org
96172|NCT00028093|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Combination of Pegylated Interferon and Ribavirin as Therapy for Patients With Chronic Hepatitis C W|3014961333|hoofnaglej@extra.niddk.nih.gov
96173|NCT00028262|National Institute of Child Health and Human Development|Dr. Anil Mukherjee|+1 301 496 7213|mukherja@exchange.nih.gov
96174|NCT00028769|SWOG Statistical Center|Study Statistician|206-667-4623|
96175|NCT00029107|NIAID/NIH|Michael C Sneller, MD|301-496-0491|msneller@niaid.nih.gov
96176|NCT00029146|University of North Carolina at Chapel HIll|William J. Powers, MD||powersw@neurology.unc.edu
96177|NCT00029172|Roudebush VAMC Center of Excellence|Dr. Linda Williams|317-988-3337|linda.williams6@va.gov
96178|NCT00029536|Beth Israel Deaconess Medical Center|Dr. Andrew G. Herzog|781-431-0277|aherzog@bidmc.harvard.edu
96179|NCT00022633|Cleveland Clinic|Dr. Derek Raghavan|216-445-6888|raghavd@cc.ccf.org
96180|NCT00030147|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov
96181|NCT00032487|Hines CSPCC|Project Manager|708-202-5785|tamara.paine@va.gov
96182|NCT00032591|Palo Alto CSPCC|Bob Edson|(650) 493-5000 ext 22250|Bob.Edson@va.gov
96183|NCT00032630|VA Medical Center, Denver, Colorado|Frederick Grover, MD|303-393-2863|Frederick.Grover@ucdenver.edu
96184|NCT00033293|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96185|NCT00033371|University of Texas (UT) MD Anderson Cancer Center|Patrick Lynch, MD/Professor, Gastroenterology/Hepatology|713-794-5073|CR_Study_Registration@mdanderson.org
96186|NCT00033514|Medical University of South Carolina|Carolyn Britten|843-792-4271|britten@musc.edu
96187|NCT00033540|Southwest Oncology Group (SWOG) Statistical Center|Study Statistician|206-667-4623|
96188|NCT00033631|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
96189|NCT00033657|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012|
96190|NCT00033917|Yale University School of Medicine|Dr. Laura Ment|203-785-5708|laura.ment@yale.edu
96191|NCT00025883|National Institute of DIabetes and Digestive and Kidney Dseases, National Institutes of Health|Dr. Phillip Gorden|301-402-7340|phillipg@mail.nih.gov
96192|NCT00026221|The Ohio State University Comprehensive Cancer Center|William E. Carson III, MD|614-293-6306|William.Carson@osumc.edu
96193|NCT00026312|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96194|NCT00026494|Memorial Sloan Kettering Cancer Center|Dr. Lisa Deangelis|212-639-7997|deangell@mskcc.org
96195|NCT00027027|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
96196|NCT00035555|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
96197|NCT00035815|Mayo Clinic|Eric J. Sorenson, MD|507 538-1037|sorenson.eric@mayo.edu
96198|NCT00035932|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
96199|NCT00036270|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96200|NCT00036569|National Cancer Institute|Kathy Warren, M.D.|301-435-4683|warrenk@mail.nih.gov
96201|NCT00036738|Fred Hutchinson Cancer Research Center|Dr. George Georges|206-667-6886|ggeorges@fredhutch.org
96202|NCT00037830|Thomas Jefferson University|Dr. Jay Schneider|215-503-0370|jay.schneider@jefferson.edu
96203|NCT00030823|Memorial Sloan Kettering Cancer Center|Dr. Teresa Gilewski|646-888-4557|gilewskt@mskcc.org
96204|NCT00030901|SWOG Statistical Center|Study Statistician|206-667-4623|
96205|NCT00030992|National Cancer Institute, National Institutes of Health|Tito Fojo, M.D.|301-496-2631|FojoT@mail.nih.gov
96206|NCT00031447|Collaborative Antiviral Study Group|Penelope M Jester|205-934-2424|pjester@peds.uab.edu
96207|NCT00031460|Collaborative Antiviral Study Group|Penelope M. Jester|(205) 934-2424|pjester@peds.uab.edu
96210|NCT00031694|Montefiore Medical Center-New York cancer Consortium|NYCC Regulatory Coordinator|7183796862|sforde@montefiore.org
96211|NCT00038103|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
96212|NCT00040664|GlaxoSmithKline|GSK Response Center|866-435-7343|
96213|NCT00040742|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu
96214|NCT00040846|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org
96215|NCT00040937|SWOG|Robert Z. Orlowski, MD,PhD|(713) 792-2860|rorlowsk@mdanderson.org
96216|NCT00041067|SWOG|Study statistician|206-667-4623|
96217|NCT00041080|Gynecologic Oncology Group (GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org
96218|NCT00041119|Dana-Farber Cancer Institute|Lawrence N. Shulman, M.D.|(617)-632-2277|Lawrence_Shulman@dfci.harvard.edu
96219|NCT00041132|SWOG Statistical Center|Study Statistician|206-667-4623|
96220|NCT00041392|Duke University|Dr. Mark F. Newman|919-681-6646|newma005@mc.duke.edu
96221|NCT00041470|University of Washington|Julie Gralow, MD|206-288-2053|pink@u.washington.edu
96222|NCT00041717|Acorda Therapeutics, Inc.|Andrew Blight, Ph.D. Chief Scientific Officer|914-347-4300 ext 5102|ablight@acorda.com
96223|NCT00041756|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com
96224|NCT00041938|Columbia University|Dr. J.L.P. (Seamus) Thompson|212-342-1252|jlt12@columbia.edu
96225|NCT00042224|Northshore LIJ Health System|Georgios Petrides, M.D.|718-470-8569|GPetride@NSHS.EDU
96226|NCT00042432|Amgen Inc.|Study Director|866-572-6436|
96227|NCT00042939|ECOG Statistical Office|Study Statistician|617-632-3012|
96228|NCT00042991|Operations and Biostatistics Center for Pediatric Brain Tumor Consortium (PBTC)|Mehmet Kocak|9015952947|mehmet.kocak@stjude.org
96229|NCT00043186|Amgen Inc.|Study Director|866-572-6436|
96230|NCT00046930|ECOG Statistical Office|Study Statistician|617-632-3012|
96231|NCT00047008|NRG Oncology|Wendy Seiferheld||SeiferheldW@nrgoncology.org
96232|NCT00047320|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org
96233|NCT00047385|Early Detection Research Group, NCI, NIH|Christine D. Berg, M.D.|301-496-8544|bergc@mail.nih.gov
96234|NCT00047463|Vanderbilt University|Beth Malow/Principal Investigator|615-322-0283|beth.malow@vanderbilt.edu
96235|NCT00047619|University of Calgary|Dr. Chester Ho|(403) 944 4620|chester.ho@albertahealthservices.ca
96236|NCT00047697|University of Pittsburgh|Benjamin L. Handen, PhD|412-235-5445|handenbl@upmc.edu
96237|NCT00047879|National Cancer Institute, National Institutes of Health|Howard A. Fine, M.D.|301-402-6383|hfine@mail.nih.gov
96238|NCT00048035|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
96239|NCT00048061|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
96240|NCT00048074|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
96241|NCT00048165|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
96242|NCT00048347|NIAID|Peter Mannon, MD|205-934-4726|pmannon@uab.edu
96243|NCT00048542|Abbott|Global Medical Services|800-633-9110|
96244|NCT00048568|Bristol Myers-Squibb|BMS Study Director||clinical.trials@bms.com
96245|NCT00048581|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
96246|NCT00048724|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
96247|NCT00048737|UT MD Anderson Cancer Center|Issa Khouri, MD / Professor||rvalverde@mdanderson.org
96248|NCT00048893|National Cancer Institute (NCI), National Institutes of Health (NIH)|Claude Sportes, M.D.|301-435-5280|csportes@mail.nih.gov
96249|NCT00048932|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
96250|NCT00048997|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||seiferheldw@nrgoncology.org
96251|NCT00049036|AIDS Malignancy Consortium|Jeannette Lee|501-526-6712|jylee@uams.edu
96252|NCT00049127|Mayo Clinic|Kurt A. Jaeckle, M.D.|5072841370|jaecle.kurt@mayo.edu
96253|NCT00049257|Translational Oncology Research International|Dr. Fairooz Kabbinavar, Chief Medical Officer|310 824 1934|FKabbina@mednet.ucla.edu
96254|NCT00049322|University of California Los Angeles|Carolyn Britten, M.D.|310 829 4971|cbritten@mednet.ucla.edu
96255|NCT00049504|Fred Hutchinson Cancer Research Center|Rachel Salit|206-667-1317|rsalit@fredhutch.gov
96256|NCT00049517|ECOG Statistical Office|Statistician|617-632-3012|
96257|NCT00049530|ECOG Statistical Office|Study Statistician|617-632-3012|
96258|NCT00049543|NCIC Clinical Trials Group|Dr. Keyue Ding|1-613-533-6000 ext 77705|king@ctg.queensu.ca
96259|NCT00038467|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96260|NCT00038610|The University of Texas (UT) MD Anderson Cancer Center|Naval Daver, MD/Leukemia||CR_Study_Registration@mdanderson.org
96261|NCT00038857|MDAnderson Cancer Center|Dr. Richard E. Champlin|713-792-8750|celsaenz@mdanderson.org
96262|NCT00038948|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
96263|NCT00039130|Duke University Medical Center|David Rizzieri, M.D.||rizzi003@dm.duke.edu
96264|NCT00039195|Memorial Slaon Kettering|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org
96265|NCT00039377|Roswell Park Cancer Institute|Meir Wetzler, M.D.||meir.wetzler@roswellpark.org
96266|NCT00039741|Center for Biostatistics in AIDS Research, Harvard School of Public Health|ClinicalTrials.gov Coordinator|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
96267|NCT00039871|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
96268|NCT00040365|National Cancer Institute (NCI), National Institutes of Health (NIH)|Kevin A. Camphausen|301-496-5457|camphauk@mail.nih.gov
96269|NCT00049842|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
96270|NCT00050011|Novartis Pharmaceuticals|Study Director|862-778-8300|
96271|NCT00050622|Florida International University|William E. Pelham, Jr.|305-348-3002|wpelham@fiu.edu
96272|NCT00050778|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
96273|NCT00050960|Eisai Call Center|Eisai, Inc.|888-422-4743|
96274|NCT00050986|University of Texas, M. D. Anderson Cancer Center|Mark Gilbert, MD||CR_study_registration@mdanderson.org
96275|NCT00051025|Eisai Call Center|Eisai Inc|888-422-4743|
96276|NCT00051168|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
96278|NCT00051558|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
96279|NCT00051636|Novartis|Study Director|862-778-8300|
96280|NCT00052078|Johns Hopkins University|John Walkup|212-746-1891|jtw9001@med.cornell.edu
96281|NCT00052429|Memorial Sloan Kettering Cancer Center|Dr. Suzanne Wolden|212-639-5148|woldens@mskcc.org
96282|NCT00052715|North American Brain Tumor Consortium|Michael Prados, MD|410-955-8837|jfisher@jhmi.edu
96283|NCT00052962|National Cancer Institute, National Institutes of Health|Marybeth Hughes, M.D.|301-594-9341|hughesm@mail.nih.gov
96284|NCT00053014|SWOG statistical office|SWOG leukemia statistician|206-667-4408|
96286|NCT00044512|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
96287|NCT00044655|NYSPI|Nancy H. Covell, Ph.D.|6469450227|covelln@nyspi.columbia.edu
96288|NCT00045032|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com
96289|NCT00045110|Adult Brain Tumor Consortium|Lauren E Abrey, MD|410-955-8837|jfisher@jhmi.edu
96290|NCT00045162|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|
96291|NCT00045305|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|
96292|NCT00045435|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|206-667-4961|bsandmai@fhcrc.org
96293|NCT00045487|University of Texas Health Science Center San Antonio|Alain Mita, MD|210-450-5094|goodwine@uthscsa.edu
96294|NCT00045630|SWOG Statistical Center|Study Statistician|206-667-4623|
96296|NCT00045734|Adult Brain Tumor Consortium (ABTC)|Patrick Wen, MD|410-955-8837|jfisher@jhmi.edu
96297|NCT00045942|Novartis|Study Director|862-778-8300|
96298|NCT00046228|Centocor Inc.|Executive Director Clinical Research|1-800-972-9063 ext 6171|EBarnath@ITS.JNJ.COM
96299|NCT00046475|Shire|Study Physician|+1 866 842 5335|
96300|NCT00046566|Tulane University|Jiang He, MD, PhD, Chair of Epidemiology|5049885165 ext 504|jhe@tulane.edu
96301|NCT00046839|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org
96302|NCT00046891|Mayo Clinic|Debra L. Barton, R.N., Ph.D.|507-266-6247|barton.debra@mayo.edu
96304|NCT00053417|Acorda Therapeutics|Andrew Blight, PhD|914-347-4300 ext 102|ablight@acorda.com
96305|NCT00053482|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
96306|NCT00053495|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
96307|NCT00053677|University of Chicago|Dr. Jon E. Grant|773-834-1325|jongrant@uchicago.edu
96308|NCT00053703|UNC Chapel Hill|Linmarie Sikich, MD|919-972-9744|lsikich@med.unc.edu
96309|NCT00057941|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012|
96310|NCT00057954|ECOG Statistical Office|Study Statistician|617-632-3012|
96311|NCT00058019|University of Chicago Medical Center|Dr. Sonali M. Smith|773-834-2895|smsmith@medicine.bsd.uchicago.edu
96312|NCT00058214|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
96313|NCT00058240|The Ohio State University Comprehensive Cancer Center|John Byrd, MD|614-293-3196|John.Byrd@osumc.edu
96314|NCT00058539|Hoffmann-LaRoche|Medical Communications|: 800-821-8590|genentech@druginfo.com
96315|NCT00058552|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
96316|NCT00058825|Baylor College of Medicine|George Carrum, MD||GCarrum@houstonmethodist.org
96317|NCT00059215|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
96318|NCT00059332|UCLA, David Geffen School of Medicine|Dr. Jeffrey Saver|310-794-6379|jsaver@mednet.ucla.edu
96319|NCT00059475|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-6375|nciirbadmin@mail.nih.gov
96320|NCT00059787|Montefiore Medical Center - New York Cancer Consortium|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org
96321|NCT00059839|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96322|NCT00060008|Children's Hospital of Philadelphia|Dr. Michael Fisher|215 590 2800|fisherm@email.chop.edu
96323|NCT00060333|Mayo Clinic|Barbara A. Pockaj, MD|507/284-3559|pockaj.barbara@mayo.edu
96324|NCT00060346|ECOG Statistical Office|Study Statistician|617-632-3012|
119070|NCT01533038|NeoTract|Director of Clinical Affairs|925-401-0641|ehergenreter@neotract.com
96326|NCT00060840|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com
96327|NCT00043550|Adelphi University, The Derner Institute of Advanced Psychological Studies|Jacques P.Barber, PhD, Dean and Professor|516.877.4807|jbarber@adelphi.edu
96328|NCT00043979|National Cancer Institute, National Institutes of Health|Dr. Terry Fry|301-402-0215|fryt@mail.nih.gov
96329|NCT00044005|Sunovion|Josephine Cucchiaro, PhD|201-592-2050|josepine.cucchiaro@sunovion.com
96330|NCT00044044|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com
96331|NCT00050089|VAMC Bronx|Dr. Sheldon Brown|(718) 584-9000 ext 6666|sheldon.brown@va.gov
96332|NCT00050167|UT MD Anderson Cancer Center|Aman Buzdar, M.D./Professor||agmadrig@mail.mdanderson.org
96333|NCT00060944|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com
96334|NCT00061048|National Cancer Institute, National Institutes of Health|Thomas A. Waldmann, M.D.|301-496-6653|Thomas.Waldmann2@nih.gov
96335|NCT00061633|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com
96336|NCT00061893|Children's Oncology Group|Results Reporting Coordinator||resultsreportingcoordinator@childrensoncologygroup.org
96337|NCT00061932|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org
96338|NCT00061945|University of Chicago Medical Center|Wendy Stock, M.D.||wstock@medicin.bsd.uchicago.edu
96339|NCT00062010|ECOG Statistical Office|Study Statistician|617-632-3012|
96340|NCT00062374|Memorial Sloan-Kettering Cancer Center|Dr. David P. Kelsen|646-888-4179|kelsend@mskcc.org
96341|NCT00062439|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|
96342|NCT00062647|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com
96343|NCT00062738|UMDNJ - RWJMS|Matthew Menza, MD|732-235-4440|menza@umdnj.edu
96344|NCT00062751|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
96345|NCT00062764|National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health|Jay H. Hoofnagle, MD|3014961333|hoofnaglej@extra.niddk.nih.gov
96346|NCT00063154|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com
96347|NCT00063232|National Institute of Diabetes and Digestive and Kidney Diseases|Jay Hoofnagle, M.D.|3014961333|hoofnaglej@extra.niddk.nih.gov
96348|NCT00063258|University of Texas M.D. Anderson Cancer Center|Mellanie Price, B.S.|713-792-4392|mejprice@mdanderson.org
96349|NCT00063362|University Hospitals Case Medical Center|Dr. Keming Gao|216-844-2865|keming.gao@UHhospitals.org
96350|NCT00063570|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
96351|NCT00063622|Virginia Commonwealth University|Arun J. Sanyal||asanyal@mcvh-vcu.edu
96352|NCT00063635|Columbia University Medical Center|Joel E. Lavine, MD, PhD||jl3553@columbia.edu
96353|NCT00063934|UTMDACC|Francisco Esteva, MD, PHD / Professor|713-792-2817|nsyates@mdanderson.org
96354|NCT00063986|ECOG Statistical Office|Study Statistician|617-632-3012|
96355|NCT00064025|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@norgoncology.org
96356|NCT00064038|SWOG|Robert Z. Orlowski, MD, PhD|(713) 792-2860|rorlowsk@mdanderson.org
96357|NCT00055237|National Cancer Institute, National Institutes of Health|Robert Yarchoan, M.D.|301-496-0328|Robert.Yarchoan@nih.gov
96358|NCT00055471|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
96359|NCT00055497|Abbott|Global Medical Services|800-633-9110|
96360|NCT00055601|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
96361|NCT00055692|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org
119071|NCT01524978|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
96363|NCT00056316|University of Missouri-St. Louis|Ann M. Steffen, PhD, Associate Professor|314-516-5382|ann_steffen@umsl.edu
96364|NCT00056407|GlaxoSmithKline|GSK Response Center|866-435-7343|
96365|NCT00056472|Weill Cornell Medical College|Barnett S. Meyers, MD|914-997-5721|bmeyers@med.cornell.edu
96366|NCT00056498|Maryland Psychiatric Research Center|Robert W. Buchanan, MD|410-402-7876|rwbuchanan@mprc.umaryland.edu
96367|NCT00056550|GTC Biotherapeutics|Denise Tilton, RN, MHA, Director Clinical Development|508-370-5257|denise.tilton@gtc-bio.com
96368|NCT00056563|Center for Management of Complex Chronic Care|Frances M. Weaver, Ph.D, Study Investigator|(708) 202-2414|Frances.Weaver@va.gov
96369|NCT00056862|National Institute of Diabetes and Digestive and Kidney Diseases|Jay H. Hoofnagle, M.D.|3014961333|hoofnaglej@extra.niddk.nih.gov
96370|NCT00057330|GlaxoSmithKline|GSK Response Center|866-435-7343|
96372|NCT00057577|Vanderbilt University|Dr. Steven D. Hollon|615-322-3369|steven.d.hollon@vanderbilt.edu
96373|NCT00057681|Washington University in St. Louis|Barbara Geller, M.D.|314-747-3657|gellerb@wustl.edu
96374|NCT00057746|NRG Onoclogy|Wendy Seiferheld||seiferheldw@nrg.oncology.org
96375|NCT00057785|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org
96376|NCT00057811|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96377|NCT00057837|ECOG Statistical Office|Study Statistician|617-632-3012|
96378|NCT00057863|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org
96379|NCT00057876|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012|
96380|NCT00064259|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org
96381|NCT00064298|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu
96382|NCT00064350|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012|
96383|NCT00064987|Massachusetts General Hospital|Dr. William Crowley|617-724-2470|wcrowley@partners.org
96385|NCT00065156|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
96386|NCT00065260|NIH NHLBI|Dr. Danielle Townsley|301-402-3477|townsleydm@mail.nih.gov
96387|NCT00065429|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com
96388|NCT00065442|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com
96389|NCT00065468|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96390|NCT00065507|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
96391|NCT00065611|NIDDK, NIH|Jeffrey B Kopp, MD|3015943403|jbkopp@nih.gov
96392|NCT00065806|Duke University Medical Center|Laura Schanberg, MD|919-684-6575|laura.schanberg@duke.edu
96393|NCT00066066|The Forsyth Institute|Ricardo P Teles, DDS, DMSc|617 892-8556|rteles@forsyth.org
96394|NCT00066170|Jazz Pharmaceuticals, Inc|Grace Wang, MD Director of Clinical Development & Medical Monitor|650-496-3777|
96395|NCT00066222|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org
96396|NCT00066365|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96397|NCT00066469|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org
96399|NCT00066690|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org
96400|NCT00066703|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org
96401|NCT00066742|SWOG Statistical Center|Lung Committee Statistician|206-652-2267|
96402|NCT00066781|Mayo Clinic|Matthew Goetz, M.D.|(507) 284-2511|goetz.matthew@mayo.edu
96403|NCT00066807|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org
96404|NCT00066937|Johns Hopkins University|Jennifer Haythornthwaite|410-550-7985|jhaytho1@jhmi.edu
96405|NCT00066963|Professor, S/D- PREV/REST|Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu
96406|NCT00067236|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com
96407|NCT00067470|BioMarin Pharmaceutical Inc.|Medical Information Services|800-983-4587|medinfo@bmrn.com
96408|NCT00053846|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu
96409|NCT00054028|The Ohio State University Comprehensive Cancer Center|Maryam Lustberg, MD|614-293-0066|Maryam.Lustberg@osumc.edu
96410|NCT00054132|Memorial Sloan Kettering Cancer Center|Dr. Maura Dickler|646-888-4560|dicklerm@mskcc.org
96411|NCT00054275|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Paula Silverman, MD|216-844-3951|paula.silverman@uhhospitals.org
96412|NCT00054327|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Kenneth Cooke MD|216-844-3345|kenneth.cooke@uhhospitals.org
96413|NCT00054639|UT MD Anderson Cancer Center|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org
96414|NCT00054665|National Cancer Institute, National Institues of Health|Wyndham Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov
96415|NCT00054691|University of Texas (UT) MD Anderson Cancer Center|Bonnie Glisson, MD / Professor, Thoracic/Head & Neck Med Oncology|713-792-6363|CR_Study_Registration@mdanderson.org
96416|NCT00054704|NIMH, DIRP, Experimental Therapeutics and Pathophysiology Branch|Dr. Carlos Zarate|3014510861|zaratec@mail.nih.gov
96417|NCT00054717|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
96418|NCT00054847|Southern Arizona VA Health Care System|Steven Goldman, MD|(520) 792-1450 ext 4624|Steven.Goldman@va.gov
96419|NCT00061373|NIH/NINDS and University of Texas Southwestern, Clinical Research Institute of Austin|Steven Warach, MD, PhD; Principal Investigator|512-324-8383|swarach@seton.org
96420|NCT00067808|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, MD / Professor|713-792-7026|
96421|NCT00069641|Shire|Study Physician|1 866-842-5335|
96422|NCT00069784|sanofi|Trial Transparency Team||Contact_US@sanofi.com
96423|NCT00069823|Johns Hopkins University|Ellen Brown|443-287-3170|ala-acrc@jhsph.edu
96424|NCT00069953|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org
96425|NCT00070018|SWOG Statistical Center|Study Statistician|206-667-4623|
96426|NCT00070109|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org
96427|NCT00070135|The Ohio State University|Steven Devine, MD||steven.devine@osumc.edu
96428|NCT00070291|ECOG Statistical Office|Study Statistician|617-632-3012|
96431|NCT00070564|SWOG Statistical Center|Breast Committee Statistician|206-667-4623|jmiao@fredhutch.org
96432|NCT00070941|NYU Parkinson and Movement Disorders Center|Dr. Alessandro Di Rocco|212-263-4838|Alessandro.Dirocco@nyumc.org
96433|NCT00071006|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96434|NCT00071032|Rutgers Robert Wood Johnsom Medical School|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@rutgers.edu
96435|NCT00071058|National Cancer Institute, National Institutes of Health|Antonio Fojo, M.D.|301-496-2631|FojoT@mail.nih.gov
96436|NCT00071110|University of Pittsburgh|Benoit H. Mulsant, MD|(416) 535-8501 ext 3655|benoit_mulsant@camh.net
96437|NCT00071396|The University of Texas M. D. Anderson Cancer Center|Alessandra Ferrajoli, MD, BS / Assistant Professor|713-745-4613|eharriso@mdanderson.org
96438|NCT00071487|GlaxoSmithKline|GSK Response Center|866-435-7343|
96439|NCT00071513|Univeristy of Washington|Elizabeth McCauley, PHD, Principal Investigator|206-987-2579|eliz@uw.edu
96440|NCT00071721|Alzheimer's Disease Cooperative Study|Paul Aisen|858-622-2028|paisen@ucsd.edu
96441|NCT00071760|ViiV Healthcare|GSK Response Center|866-435-7343|
96442|NCT00071799|Celgene Corporation|CL Beach||CLBeach@celgene.com
96443|NCT00071812|GlaxoSmithKline|GSK Response Center|866-435-7343|
96444|NCT00071890|INSERM U897 Bordeaux FRANCE|Pr G. Chene|557571392 ext +33|genevieve.chene@isped.u-bordeaux2.fr
96445|NCT00071981|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012|
96446|NCT00072176|Princess Margaret Hospital, Toronto, Canada|Dr. Amit M. Oza|416 946 4501 ext 2818|amit.oza@uhn.ca
96447|NCT00072189|California Cancer Consortium|DCC Project Administrator|: 626-256-4673 ext 60094|CCCP@coh.org
96448|NCT00064662|New England Research Institutes|Anne M. Stoddard, ScD|617-972-3331|astoddard@neriscience.com
96449|NCT00064701|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com
96451|NCT00064792|NICHD, NIH|Dr. Forbes Porter, Clinical Director, NICHD|301-435-4432|fdporter@mail.nih.gov
96452|NCT00064844|Yale University School of Medicine|Ned Cooney, PhD|860-594-6339|ned.cooney@yale.edu
96453|NCT00072280|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96454|NCT00072293|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org
96455|NCT00072449|Johns Hopkins University|Dr. Stuart A Grossman|410-955-3657|jfisher@jhmi.edu
96456|NCT00072475|University of Minnesota|Pankaj Gupta, M.D.||gupta013@umn.edu
96457|NCT00072514|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org
96458|NCT00072566|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
96459|NCT00073307|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
96460|NCT00073333|University of Central Florida|Deborah C. Beidel, Ph.D.|407-823-3254|deborah.beidel@ucf.edu
96461|NCT00073528|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
96462|NCT00073918|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu
96463|NCT00073983|SARC|SARC Chief Operating Officer|734-930-7600|sarc@sarctrials.org
96464|NCT00074035|The Ohio State University Medical Center|Sherif S. Farag, M.D., Ph.D.||farag-1@medctr.osu.edu
96465|NCT00074152|International Breast Cancer Study Goup|Barbara Ruepp|+4131 3899222|barbara.ruepp@ibcsg.org
96466|NCT00074165|OHSU Knight Cancer Institute|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu
96467|NCT00074269|UCSD|Dr. Edward Ball, Director BMT Program|858-822-6600|tball@ucsd.edu
96468|NCT00074412|Statistical Center for HIV/AIDS Research and Prevention|Statistical Research Associate|2066677524|cherron@fhcrc.org
96469|NCT00074581|Fred Hutchinson Cancer Research Center|Dr. Deborah Donnell|2066675661|deborah@scharp.org
96470|NCT00074711|Creighton University|Robert P Heaney, MD|402 280 4029|rpheaney@creighton.edu
96471|NCT00074802|Temple University|Richard G. Heimberg, Ph.D.|215.204.7489|heimberg@temple.edu
96472|NCT00074815|Duke University School of Medicine|Jeffrey Sapyta, PhD|919-668-0069|jeffrey.sapyta@duke.edu
96473|NCT00074958|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
96474|NCT00074984|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
96475|NCT00075023|NINR/NIH|Suzanne Wingate|301-827-0982|suzanne.wingate@nih.gov
96476|NCT00075088|University of California, San Francisco|Barbara J Drew, PhD|415-476-4302|barbara.drew@nursing.ucsf.edu
96477|NCT00075218|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
96478|NCT00075270|GlaxoSmithKline|GSK Response Center|866-435-7343|
96480|NCT00075478|Fred Hutchinson Cancer Research Center/|Dr. Brenda Sandmaier|206-667-4961|bsandmai@fhcrc.org
96481|NCT00075504|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org
96482|NCT00075582|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96483|NCT00075608|Boston Medical Center|Principal Investigator|617-638-8261|sfenness@bu.edu
96484|NCT00075725|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96485|NCT00075764|SWOG|Breast Committee Statistician|206-667-4623|
96486|NCT00075803|NHLBI|Nancy DiFronzo, PhD|301-435-0065|difronozon@nhlbi.nih.gov
96488|NCT00075829|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com
96489|NCT00067990|University_of_Minnesota|Hassan N. Ibrahim, MD|(612) 624-9444|ibrah007@umn.edu
96490|NCT00068107|Baylor Research Institute|Dr. Raphael Schiffmann|214-820-4533|raphael.schiffmann@baylorhealth.edu
96491|NCT00068237|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org
96492|NCT00068341|Jonsson Comprehensive Cancer Center|Helena Chang, M.D., Ph.D., Revlon/UCLA Breast Center|310-794-5640|hchang@mednet.ucla.edu
96493|NCT00068380|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
96494|NCT00068393|ECOG Statistical Office|Study Statistician|617-632-3012|
96495|NCT00068419|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96496|NCT00068575|UT MD Anderson Cancer Center|Peter Pisters, MD / Professor||asanmigu@mdanderson.org
96497|NCT00068588|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
96498|NCT00068601|SWOG Statistics and Data Management Center|Cancer Survivorship Committee Statistician|206-667-4623|
96499|NCT00068718|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org
96500|NCT00068770|Johns Hopkins University|Dr. Stuart A Grossman|410-955-3657|jfisher@jhmi.edu
96501|NCT00068822|Mayo Clinic|David F. Kallmes, M.D.|507-266-3350|kallmes.david@mayo.edu
96502|NCT00069095|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
96503|NCT00069108|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
96504|NCT00069121|Hoffman-LaRoche|Medical Communications|800-821-8590|
96505|NCT00069160|National Cancer Institute, National Institutes of Health|Susan E. Bates, M.D.|301-402-1357|BatesS@mail.nih.gov
96507|NCT00069264|Eisai Inc.|Dr. Peter Tarassoff|888-422--4743|
96508|NCT00069277|Eisai Inc|Eisai Call Center|888-422-4743|
96509|NCT00069329|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Goldbach-Mansky, Raphaela|+1 301 435 6243|goldbacr@mail.nih.gov
96510|NCT00075881|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012|
96511|NCT00075946|ECOG Statistical Office|Study Statistician|617-632-3012|
96512|NCT00076011|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96513|NCT00076024|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96514|NCT00076050|University of Miami|Silvina Levis MD|305-575-3388|slevis@med.miami.edu
96515|NCT00076102|National Cancer Institute (NCI), National Institutes of Health (NIH)|Brigitte C. Widemann, M.D.|301-496-7387|widemanb@mail.nih.gov
96516|NCT00076219|VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA|Paul M. Palevsky MD|410-360-3932|paul.palevsky@va.gov
96517|NCT00076245|Department of Psychology, University of Vermont|Kelly J. Rohan, Ph.D.|802-656-0798|kelly.rohan@uvm.edu
96518|NCT00078286|Duke University|Dr. Ranga Krishnan|919-668-3647|krish001@mc.duke.edu
96519|NCT00078312|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879|
96520|NCT00078325|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879|
96521|NCT00078377|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879|
96522|NCT00078403|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
96523|NCT00078559|University of Wisconsin - Department of Medicine, Madison, Wisconsin|Arjang Djamali, MD, MS, FASN|608-262-7330|axd@medicine.wisc.edu
96524|NCT00078715|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|Dr. Carlos A. Zarate, Jr.|301-451-0861|zaratec@mail.nih.gov
96525|NCT00078728|The Johns Hopkins University School of Medicine|Golda Ginsburg, PhD,Professor|410-955-1544|gginnsbu@jhmi.edu
119077|NCT01408914|Harvard Medical School|Carole Mitnick|617-432-6018|Carole_Mitnick@hms.harvard.edu
96527|NCT00078767|Allegheny Singer Research Institute|Judith Cohen, MD||judith.cohen@ahn.org
96528|NCT00078949|NCIC|Seninor Biostatistician for LY12|613-533-6000 ext 77703|bechen@ctg.queensu.ca
96529|NCT00079001|Massachusetts General Hospital|Matthew Smith, MD, PhD||smith.matthew@mgh.harvard.edu
96530|NCT00079040|ECOG Statistical Office|Study Statistician|617-632-3012|
96531|NCT00079183|Fred Hutchinson Cancer Research Center|Dr. Paul A. Carpenter|(206) 667-5191|pcarpent@fredhutch.org
96532|NCT00079274|North Central Cancer Treatment Group|Dr. Steven Alberts|507-284-8432|alberts.steven@mayo.edu
96533|NCT00079326|Dana-Farber Cancer Institute|Craig Bunnell|617-632-3800|cbunnell@partners.org
96534|NCT00079339|Pediatric Brain Tumor Consortium|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|901-595-4986|james.boyett@stjude.org
96535|NCT00079391|NIH National Heart, Lung and Blood Institute|Minocher Battiwalla|301-402-4170|battiwalla@nhlbi.nih.gov
96536|NCT00079417|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org
96537|NCT00079677|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879|
96538|NCT00079781|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com
96539|NCT00079937|Novartis Pharmaceuticals|Study Director|862-778-8300|
96540|NCT00080119|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
96541|NCT00080223|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
96542|NCT00080288|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879|
96543|NCT00080301|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
96544|NCT00080470|Boston Scientific|Director of Clinical Operations|866-360-4747|Valerie.Lucero-Cimmarust@bsci.com
96545|NCT00080483|University of Pennsylvania|Peter J. Snyder M.D.|215-898-0208|pjs@mail.med.upenn.edu
96546|NCT00080535|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitmar@mail.nih.gov
96547|NCT00072761|Vanderbilt University School of Medicine|Michael R. DeBaun, MD, MPH|615-875-3040 ext 5-3040|m.debaun@vanderbilt.edu
96549|NCT00073021|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
96551|NCT00080899|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext : 60094|CCCP@coh.org
96552|NCT00080912|NCIC Clinical Trials Group|Dr. Bingshu Chen|613-533-6000 ext 77703|bechen@ctg.queensu.ca
96553|NCT00080938|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012|
96554|NCT00081497|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
96555|NCT00081653|Hoffmann-La Roche|Clinical Trials Study Director|+1 973 235 5000|
96556|NCT00081731|University of Toledo|Christopher Cooper, MD|419-383-6297|christopher.cooper@utoledo.edu
96557|NCT00081770|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
96558|NCT00081861|U.T. M.D. Anderson Cancer Center|Barbara Pro, MD / Associate Professor||CR_Study_Registration@mdanderson.org
119079|NCT01391546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96560|NCT00082017|National Cancer Institute, National Institues of Health|Wyndham Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov
96561|NCT00082173|Johns Hopkins University|Dr. Richard Chaisson|410-955-1755|rchaiss@jhmi.edu
96562|NCT00082329|NHLBI NIH|Dr. Richard Childs|301-594-8008|childsr@nhlbi.nih.gov
96563|NCT00082342|NINDS, NIH|Mark Hallett, MD, Chief|301-496-9526|hallettm@ninds.nih.gov
96564|NCT00082355|NIHCC|Dr Richard Chang|301-402-0256|rchang@cc.nih.gov
96565|NCT00082368|National Cancer Institute|Dr. Peter Choyke|301-402-8409|peter_choyke@nih.gov
96566|NCT00082381|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
96567|NCT00082407|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
96568|NCT00082433|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
96569|NCT00082758|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96570|NCT00082810|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org
96572|NCT00083122|Mayo Clinic Cancer Center|Keith C. Bible, M.D, Ph.D.||Bible.Keith@mayo.edu
119080|NCT01380834|Children's Hospital of UPMC|Dr. Mihaela Visoiu|412-692-5260|visoium@upmc.edu
96574|NCT00083226|ECOG Statistical Office|Study Statistician|617-632-3012|
96575|NCT00083382|UAMS Myeloma Institute|Bart Barlogie|526-6990 ext 2420|barlogiebart@uams.edu
96576|NCT00083551|UAMS Myeloma Institute|Bart Barlogie|501-526-6990 ext 2420|barlogiebart@uams.edu
96577|NCT00083616|Amgen Inc.|Study Director|866-572-6436|
96578|NCT00083720|ImClone, LLC|Chief Medical Officer||ClinicalTrials@imclone.com
96579|NCT00083759|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
96580|NCT00083889|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
96582|NCT00084084|Shire Human Genetic Therapies|Anna Wijatyk, MD, Medical Director|781-482-9622|awijatyk@shire.com
96583|NCT00084136|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
96584|NCT00076258|UT Southwestern Medical Center|Madhukar H Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu
96585|NCT00076336|Novartis Pharmaceuticals|Study Director|862-778-8300|
96586|NCT00076570|NIDDK, National Institutes of Health|Dr. Monique Cho|3014355058|moniquec@intra.niddk.nih.gov
96587|NCT00076687|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
96588|NCT00076752|National Cancer Institute, National Institutes of Health|Dr. Steven Pavletic|301-402-4899|pavletis@mail.nih.gov
96589|NCT00076804|Johns Hopkins University Center for TB Research|Richard E. Chaisson|4109551755|rchaiss@jhmi.edu
96590|NCT00076999|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
96591|NCT00077207|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|Resultsreportingcoordinator@childrensoncologygroup.org
96592|NCT00077376|ECOG Statistical Office|Study Statistician|617-632-3012|
96593|NCT00077610|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
96594|NCT00077623|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
96595|NCT00077636|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
96596|NCT00077649|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
96597|NCT00077675|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com
96598|NCT00077766|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
96599|NCT00077857|Hoffman-LaRoche|Medical Communications|800-821-8590|
96600|NCT00077922|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitmar@mail.nih.gov
96601|NCT00077974|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
96602|NCT00084266|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96603|NCT00084318|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
96604|NCT00084383|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu
96606|NCT00084487|Case Comprehensive Cancer Center|Afshin Dowlati MD|216-844-1228|afshin.dowlati@uhhospitals.org
96607|NCT00088153|Massachusetts General Hospital|Anne Klibanski|617-726-3870|aklibanski@partners.org
96608|NCT00088166|Celtic Pharma Development Services America Inc|Patrick O'Connor, MD, Managing Director Clinical Development|212-616-4050|patrick.oconnor@dev.celticpharma.com
96609|NCT00088218|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org
96610|NCT00088374|National Cancer Institute, National Institutes of Health|William M. Linehan, M.D.|301-496-6353|linehanm@mail.nih.gov
96611|NCT00088465|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
96612|NCT00088530|CTIBioPharma Corp.|Simran Bedi Singh|(206) 272-4000|ssingh@ctibiopharma.com
96613|NCT00088595|Novartis Pharmaceuticals|Study Director|862-778-8300|
96614|NCT00088621|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com
96615|NCT00088634|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com
96616|NCT00088881|ECOG Statistical Office|Study Statistician|617-632-3012|
96617|NCT00088907|ECOG Statistical Office|Study Statistician|617-632-3012|
96619|NCT00088985|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@UNC.med.edu
96620|NCT00089011|Fred Hutch|David G Maloney, MD PhD|(206) 667-5616|dmaloney@fredhutch.org
96621|NCT00089076|Mayo Clinic|Dr. Stephen Ansell|507-284-0923|ansell.stephen@mayo.edu
96622|NCT00089141|Fred Hutchinson Cancer Research Center (FHCRC)|Paul J. Martin, M.D.|206-667-4798|pmartin@fhcrc.org
96623|NCT00089297|ECOG Statistical Office|Study Statistician|617-632-3012|
96624|NCT00089414|Behavioral Endocrinology Branch/National Institute of Mental Health/NIH|Pedro E. Martinez, M.D., Principal Investigator|301-402-0615|martinep@mail.nih.gov
96625|NCT00089479|Hoffman-LaRoche|Medical Communications|800-821-8590|
96626|NCT00089505|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|(617) 432-2829|CBAR.ClinicalTrials.gov@sdac.harvard.edu
96627|NCT00089544|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org
96628|NCT00089583|ViiV Healthcare|GSK Response Center|866-435-7343|
96630|NCT00089635|Amgen Inc.|Study Director|866-572-6436|
96631|NCT00089648|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
96632|NCT00089661|Amgen Inc.|Study Director|866-572-6436|
96633|NCT00089674|Amgen Inc.|Study Director|866-572-6436|
96634|NCT00089752|University of Pennsylvania School of Nursing|Terri E. Weaver, PhD, RN, FAAN|215-898-2992|tew@nursing.upenn.edu
96635|NCT00089778|National Cancer Institute (NCI), National Institutes of Health (NIH)|James Yang, M.D.|301-496-1574|jamesyang@mail.nih.gov
96636|NCT00089791|Amgen Inc.|Study Director|866-572-6436|
96637|NCT00089843|Massachusetts General Hospital|Anne Klibanski, M.D.|617-726-3870|aklibanski@partners.org
96638|NCT00089895|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
96639|NCT00089986|GlaxoSmithKline|GSK Response Center|866-435-7343|
96640|NCT00089999|GlaxoSmithKline|GSK Response Center|866-435-7343|
96641|NCT00090051|Hoffmann-La Roche|Medical Communications||global.clinical_trial_registry@roche.com
96642|NCT00090103|GlaxoSmithKline|GSK Response Center|866-435-7343|
96643|NCT00090142|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96644|NCT00090220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96645|NCT00090233|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
96646|NCT00090259|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
96647|NCT00090285|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96648|NCT00090363|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
96649|NCT00090402|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu
96650|NCT00090493|University of Arkansas for Medical Sciences - MIRT|Frits van Rhee, MD, PhD|(501) 686-8230|vanrheefrits@uams.edu
96651|NCT00090519|Chromaderm|info@chroma-derm.com||info@chroma-derm.com
96652|NCT00090545|National Cancer Institute, National Institues of Health|William Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov
96653|NCT00090584|New England Research Institutes|Anne Stoddard, ScD|617-972-3331|astoddard@neriscience.com
96654|NCT00090610|Duke University Medical Center|Angeles Alvarez Secord, Director of Gynecologic Oncology Clinical Trials|919-684-3765|secor002@mc.duke.edu
96655|NCT00090753|Hoffmann-La Roche|Medical Communications|800-821-8590|
96656|NCT00081159|University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org
96657|NCT00081263|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org
96658|NCT00081289|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org
96659|NCT00081328|TODAY Coordinating Center at George Washington University Biostatistics Center|Dr. Kathryn Hirst, Coordinating Center PI|301-881-9260 ext 8025|khirst@bsc.gwu.edu
96660|NCT00081458|NPS Pharmaceuticals|Head of Clinical Research|908-450-5300|info@npsp.com
96661|NCT00090766|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
96662|NCT00090779|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
96663|NCT00090844|Division of Hematology & Oncology, University of California, San Francisco|Pamela Munster, MD|415-476-1000|Pmunster@medicine.ucsf.edu
96664|NCT00090857|Dana-Farber Cancer Institute|Judy E. Garber, MD, MPH|617.632.2282|Judy_Garber@dfci.harvard.edu
96665|NCT00090987|AMC|Jeannette Y. Lee, Director of Statistical Center|(501) 526-6712|jylee@uams.edu
96666|NCT00091026|University of Chicago|Hedy Kindler, MD|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu
96667|NCT00091169|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012|
96668|NCT00094497|University Hospital of Wuerzburg, Germany|Martin Fassnacht|+49-931-201-39021|fassnacht_m@ukw.de
96669|NCT00094536|Cooper Surgical|Chief Medical Officer|203-601-5200|Robert.Auerbach@coopersurgical.com
96670|NCT00094575|VAMC Minneapolis, MN|Dr. Frank A. Lederle|612-725-2158|Frank.Lederle@va.gov
96671|NCT00094653|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
96672|NCT00094757|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96673|NCT00094770|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
96674|NCT00094809|Amgen Inc.|Study Director|866-572-6436|
96675|NCT00094835|Amgen Inc.|Study Director|866-572-6436|
96676|NCT00094861|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com
96678|NCT00094900|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Raphaela Goldbach-Mansky, MD|13014356243|goldbacr@mail.nih.gov
96679|NCT00095056|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
96680|NCT00095121|Gilead Sciences|John Flaherty, PharmD, Director, Clinical Research|650-522-5592|John.Flaherty@gilead.com
96681|NCT00095147|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
96682|NCT00095173|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
96683|NCT00095199|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
96684|NCT00095212|Massachusetts General Hospital|Steven Grinspoon, MD|617 724 9109|sgrinspoon@partners.org
96685|NCT00095238|Britol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
96686|NCT00095303|University of Miami Miller School of Medicine|Viviana E. Horigian, MD|305-243-4305|vhorigian@med.miami.edu
96687|NCT00095498|Amgen Inc.|Study Director|866-572-6436|
96688|NCT00095563|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca
96689|NCT00095576|Merck, Sharp & Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
96690|NCT00095628|London Regional Cancer Centre|Dr. Eric Winquist|519-685-8600 ext 53243|eric.winquist@lhsc.on.ca
96692|NCT00095836|Massachusetts General Hospital|John Clark, MD|617-724-4000|jrclark@partners.org
96693|NCT00095875|Dana Farber Cancer Institute|Robert I Haddad, MD|617-632-3090|rihaddad@partners.org
96694|NCT00095940|Pediatric Brain Tumor Consortium|Assistant Director Operations and Biostatistics Center|901-595-2617|dana.wallace@stjude.org
96696|NCT00096018|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
96697|NCT00096031|SWOG Statistical Center|Study Statistician|206-667-4623|
96698|NCT00096044|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
96699|NCT00096109|Barbara Ann Karmanos Cancer Institute|Elaina Gartner, M.D.|(425) 527-4398|egartner@seagen.com
96700|NCT00096122|UT MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org
96701|NCT00096135|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96702|NCT00096161|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org
96703|NCT00096174|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012|
96704|NCT00096200|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Steven Waggoner, MD|216-844-5011|steven.waggoner@uhhospitals.org
96705|NCT00096226|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org
96706|NCT00096265|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org
96707|NCT00096278|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600|
96708|NCT00096356|Wake Forest University Comprehensive Cancer Center|Dr. Glenn Lesser|(336) 713-5440|glesser@wakehealth.edu
96709|NCT00096382|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov
96711|NCT00096460|The EMMES Corporation|Adam Mendizabal, PhD|(301) 251-1161 ext 221|amendizabal@emmes.com
96712|NCT00096486|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org
96713|NCT00096538|Memorial Sloan Kettering Cancer Center|Dr. Ariela Noy|212-639-7423|noya@mskcc.org
96714|NCT00096681|Desmond Tutu HIV Centre|Prof LG Bekker|+2721 633 6599 ext 21|Linda-Gail.Bekker@hiv-research.org.za
96715|NCT00096785|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
96716|NCT00096941|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com
96717|NCT00096954|Hoffman-LaRoche|Medical Communications|800-821-8590|
96718|NCT00096993|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com
96719|NCT00085423|Dartmouth-Hitchcock|Dr. Marc Ernstoff|603 650 5534|marc.s.ernstoff@hitchcock.org
96720|NCT00085436|Dartmouth-Hitchcock Medical Center|Dr. Marc S. Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org
96721|NCT00085540|Adult Brain Tumor Consortium (ABTC)|Howard Fine, MD|410-955-8837|jfisher@jhmi.edu
96722|NCT00085566|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher|646-422-4323|scherh@mskcc.org
96723|NCT00085631|Duke University Medical Center|Dr Mark Dewhirst|919 6683726|joan.cahill@dm.duke.edu
96724|NCT00085644|Abbott|Global Medical Services|800-633-9110|
96725|NCT00085709|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408|
96726|NCT00085735|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org
96727|NCT00085839|Astellas Pharma Global Development|Medical Monitor||clinicaltrials@us.astellas.com
96728|NCT00085917|RCHSPB|John Tierney|301-451-5136|john.tierney@nih.gov
96729|NCT00086047|Cincinnati Children's Hospital Medical Center|Susmita Kashikar-Zuck, PhD|513 636 6337|Susmita.Kashikar-Zuck@cchmc.org
96730|NCT00086138|JHU|Paul Rosenberg|410-550-9883|prosenb9@jhmi.edu
96731|NCT00086190|University of Rochester Medical Center|Irene H. Richard, MD|585-341-7500|irene_richard@urmc.rochester.edu
96732|NCT00086281|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director Clinical Development & Medical Monitor|650-496-3777|
96733|NCT00086307|NIMH|Dr. Carlos A. Zarate|301-451-0861|zaratec@mail.nih.gov
96734|NCT00086346|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
96735|NCT00086385|University of California, San Francisco|Sharon M. Hall, PhD|415-476-7574|sharon.hall@ucsf.edu
96736|NCT00086411|University of Pennsylvania|Peter Gariti, Ph.D.|215-222-3200 ext 0|gar1iti@mail.med.upenn.edu
96737|NCT00086450|Icahn School of Medicine at Mount Sinai|Dr. Valentin Fuster, M.D., Ph.D.|212-860-1056|valentin.fuster@mssm.edu
96738|NCT00086502|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
96739|NCT00086515|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96740|NCT00086580|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
96741|NCT00086619|Massachusetts General Hospital|Robert Neer, MD|617-726-6723|rneer@partners.org
96742|NCT00086684|Janssen R&D US|SENIOR DIRECTOR CLINICAL LEADER|1 609 730-4529|
96743|NCT00086957|City of Hope|Paul Frankel, Ph.D.|626-359-8111 ext 65265|pfrankel@coh.org
96744|NCT00086996|SWOG Statistical Center|Study Statistician|206-667-4623|
96745|NCT00087139|ECOG Statistical Office|Study Statistician|617-632-3012|
96746|NCT00087152|SWOG|Lead Statistician - Breast Cancer Committee|(206) 839-1761|williamb@crab.org
96747|NCT00087438|Radition Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@gmail.com
96748|NCT00087490|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96749|NCT00087516|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
96750|NCT00087529|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
96751|NCT00087555|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director of Clinical Development & Medical Monitor|650-496-3777|
96752|NCT00087568|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
96753|NCT00087594|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
96754|NCT00087607|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
96755|NCT00087633|Hoffmann-La Roche|Medical Communications|800-821-8590|
96756|NCT00087646|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
96757|NCT00087672|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes, M.D./ Professor|713-794-5783|eharriso@mdanderson.org
96758|NCT00087685|The University of Texas (UT) MD Anderson Cancer Center|Karen H. Lu, MD, Chair, Gynecologic Oncology & Reproductive Medicine|713-745-8902|CR_Study_Registration@mdanderson.org
96759|NCT00087698|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
96760|NCT00097253|The Ohio State University, Department of Psychiatry|Janice K. Kiecolt-Glaser, PhD|614-292-0033|Kiecolt-Glaser.1@osu.edu
96761|NCT00097370|GlaxoSmithKline|GSK Response Center|866-435-7343|
96762|NCT00097448|Massachusetts Eye and Ear Infirmary|Dr. Steven Rauch|617-573-1166|steven_rauch@meei.harvard.edu
96763|NCT00097500|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
96764|NCT00097539|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
96765|NCT00097591|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
96766|NCT00097695|Shire Human Genetic Therapies, Inc.|Alan Kimura, MD, PhD|781-482-0738|akimura@shire.com
96767|NCT00097708|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director Clinical Development & Medical Monitor|650 - 496 - 3777|
96768|NCT00097721|Eisai Inc|Eisai Call Center|888-422-4743|
96769|NCT00097773|Seattle Childrens Hospital|Bonnie Ramsey, MD|206-987-5725|bonnie.ramsey@seattlechildrens.org
96770|NCT00097786|Novartis Pharmaceuticals|Study Director|862 778-8300|
96771|NCT00097981|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Medical Director|1 215 325-5329|
96772|NCT00098059|Novartis Pharmaceuticals|Study Director|862-778-8300|
96773|NCT00098254|National Cancer Institute|Giuseppe Giaccone, M.D., PH.D.|301-496-4916|giacconeg@mail.nih.gov
96774|NCT00098293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96775|NCT00098306|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96776|NCT00098345|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
96777|NCT00098371|The Ohio State University Comprehensive Cancer Center|John Byrd, MD|614-293-9869|John.Byrd@osumc.edu
96779|NCT00098670|The Ohio State University|Dr. Thomas Lin||thomas.lin@osumc.edu
96780|NCT00098722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96781|NCT00098748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
96782|NCT00098774|University of California, San Francisco|James Rubenstein, MD, PhD||jamesr@medicine.ucsf.edu
96783|NCT00098787|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012|
96784|NCT00098813|Memorial Sloan-Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org
96786|NCT00098865|DFCI|Mark W. Kieran, MD, PhD|617-632-4907|mark_kieran@dfci.harvard.edu
96787|NCT00098956|The Ottawa Hospital|Dr. Glenwood Goss|613-737-7700 ext 56708|ggoss@ottawahospital.on.ca
96788|NCT00099021|Masonic Cancer Center, University of Minnesota|Frank G. Ondrey, M.D.|612-625-3200|ondre002@umn.edu
96789|NCT00099047|Cleveland Clinic|Matt Kalaycio, MD|216-444-3705|kalaycm@ccf.org
96790|NCT00099268|Novartis Pharmaceuticals|Study Director|862 778-8300|
96791|NCT00099359|Westat|Margaret Camarca, Project Director|301-517-4128|margaretcamarca@westat.com
96792|NCT00099437|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
96793|NCT00099632|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|(617) 432-2829|CBAR.ClinicalTrials.gov@sdac.harvard.edu
96794|NCT00099983|VA Connecticut HCS|John Krystal, MD|203-937-4790|john.krystal@yale.edu
96795|NCT00100048|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96796|NCT00084617|National Cancer Institute|Joanna Brell MD|240-276-7050|brelljm@mail.nih.gov
96797|NCT00084682|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org
96798|NCT00084747|UCLA|Dr. Gary Schiller|310-206-5755|gschiller@mednet.ucla.edu
96799|NCT00084838|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu
96800|NCT00084864|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
96801|NCT00085098|Children's Oncology Group|Results Coordinator|(626) 447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96802|NCT00085202|St. Jude Children's Research Hospital|Amar Gajjar, MD|866-278-5833|info@stjude.org
96803|NCT00085254|Adult Brain Tumor Consortium (ABTC)|Louis Burt Nabors, MD|205-934-1432|bnabors@uab.edu
96804|NCT00085293|University of Texas MD Anderson Cancer Center|Steven I. Sherman, MD / Professor||CR_Study_Registration@mdanderson.org
96805|NCT00085410|Fox Chase Cancer Center|Assistant Professor, Medical Oncology|215-214-1676|crystal.denlinger@fccc.edu
96806|NCT00091260|Boston Medical Center|Vaishali Sanchorawala|6176386521|vaishali.sanchorawala@bmc.org
96807|NCT00091273|University of Virginia|Craig L. Slingluff, MD|434-924-1730|cls8h@virginia.edu
96808|NCT00091390|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org
96809|NCT00091442|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Director Medical Leader|908 218 7361|
96810|NCT00091507|Tufts Medical Center|Co-Principal Investigator|617-636-8788|jbeshansky@tuftsmedicalcenter.org
96811|NCT00091949|Yale School of Medicine|Walter N. Kernan|203-764-7000|walter.kernan@yale.edu
96812|NCT00091962|University of Pittsburgh School of Medicine|Dr. Bruce L Rollman, Principal Investigator|(412) 692-2659|rollmanbl@upmc.edu
96813|NCT00092118|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
96814|NCT00092131|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
96815|NCT00092417|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
96816|NCT00092443|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96817|NCT00092456|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96818|NCT00092495|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
96819|NCT00092521|Merck Sharp & Dohme Corp.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96820|NCT00092534|Merck Sharp & Dohme Corp.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96821|NCT00092547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96822|NCT00092677|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96823|NCT00093015|Amgen Inc.|Study Director|866-572-6436|
96824|NCT00093041|Genmab A/S|VP Clinical Operations Eva Järlid Westerberg|+45 7020 2728|E.Westerberg@genmab.com
96825|NCT00093145|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
96826|NCT00093379|The University of Texas (UT) MD Anderson Cancer Center|Cathy Eng, MD/ Professor||CR_Study_Registration@mdanderson.org
96827|NCT00093470|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012|
96828|NCT00093496|Mayo Clinic Cancer Center|Charles Erlichman, M.D.||erlichman.charles@mayo.edu
96830|NCT00093782|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca
96831|NCT00093808|Mayo Clinic|Winston Tan, MD|904-953-7290|Tan.Winston@mayo.edu
96832|NCT00093847|Massachusetts General Hospital|Dr George Papakostas, M.D.|6177266697|gpapakstas@partners.org
96833|NCT00094055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96834|NCT00094094|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96835|NCT00094107|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96836|NCT00094172|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
96837|NCT00094302|New England Research Institutes|Brian Harty|617-972-3224|bharty@neriscience.com
96839|NCT00094458|Centocor Ortho Biotech Services, L.L.C.|Study Director|215 325-7405|
96840|NCT00100178|Barbara Davis Center for Childhood Diabetes, Health Sciences Center, University of Colorado|Peter Gottleib, MD|303-724-6714|Peter.Gottleib@uchsc.edu
119087|NCT01294150|NeoTract|Emily Hergenreter Director of Clinical Affairs|650-739-5570|ehergenreter@neotract.com
96842|NCT00100659|Johns Hopkins University School of Medicine|Kathleen B. Schwarz, M.D.|410-955-8769|kschwarz@jhmi.edu
96843|NCT00100698|Massachusetts General Hospital|Janet Lo|617-724-9109|jlo@partners.org
96844|NCT00100789|SWOG Statistical Center|Study Statistician|206-667-4623|
96845|NCT00100802|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org
96846|NCT00100815|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
96847|NCT00100841|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org
96848|NCT00100932|Eisai|Dr. Peter Tarassoff|888-422-4743|
96850|NCT00101101|H. Lee Moffitt Cancer Center and Research Institute|Sophie Dessureault, M.D., Ph.D.|813-745-1965|sophie.dessureault@moffitt.org
96851|NCT00101166|H. Lee Moffitt Cancer Center and Research Institute|Dr. Sophie Dessureault|813-745-1965|sophie.dessureault@moffitt.org
96852|NCT00101192|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-341-3408|mleventhal@gogstats.org
96853|NCT00101283|ECOG Statistical Office|Study Statistician|617-632-3012|
96854|NCT00101361|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov
96855|NCT00101400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
96856|NCT00101413|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
96857|NCT00101439|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96858|NCT00101452|Massachusetts General Hospital|Maurizio Fava|617-724-2513|mfava@partners.org
96859|NCT00101582|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com
96860|NCT00101647|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
96861|NCT00101660|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
96862|NCT00101686|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
96863|NCT00101816|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
96864|NCT00101868|University of Illinois|James F. Graumlich, MD, Professor of Medicine|309-655-7734|jfg@uic.edu
96865|NCT00101907|Amgen Inc.|Study Director|866-572-6436|
96866|NCT00101933|Medtronic Neuromodulation|Michele Herzog, Clinical Study Manager|763-526-8092|medtronicneurotrials@medtronic.com
96867|NCT00102063|Otsuka Pharmaceutical Development & Commercialization, Inc.|Margaretta Nyilas|609-452-5673|Margaretta.nyilas@otsuka-us.com
96868|NCT00102440|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
96869|NCT00102518|Otsuka Pharmaceutical Development & Commercialization, Inc.|Margaretta Nyilas|609-452-5673|Margaretta.nyilas@otsuka-us.com
96870|NCT00102531|Insmed|Margaret Galluzzi|(908) 977-9900|Margaret.Galluzzi@Insmed.com
96871|NCT00102596|NINDS/NIH|Mark Hallett, M.D.|301-496-9526|hallettm@ninds.nih.gov
96872|NCT00102687|Celgene Corporation|CL Beach||CLBeach@celgene.com
96873|NCT00102804|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
96874|NCT00103012|National Institutes of Health, Clinical Center, Department of Pharmacy|Scott Penzak|301-496-2997|spenzak@cc.nih.gov
96875|NCT00103116|UKentucky|Edward Hirschowitz|8596081981|eahirs2@uky.edu
96876|NCT00103142|Duke University Medical Center|Dr. Michael Morse|919-684-5705|michael.morse@dm.duke.edu
96877|NCT00103194|"ECOG Statistical Office"|"Study Statistician"|617-632-3012|
96878|NCT00091572|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
96879|NCT00091793|Amgen Inc.|Study Director|866-572-6436|
96880|NCT00091819|Theravance, Inc.|Steven Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com
96881|NCT00091832|Amgen Inc.|Study Director|866-572-6436|
96882|NCT00103207|ECOG Statistical Office|Study Statistician|617-632-3012|
96883|NCT00103259|Eastern Cooperative Oncology Group (ECOG) Statistical Office|ECOG Statistician|617-632-3012|
96884|NCT00103311|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
96885|NCT00103506|Janssen R&D UK|Project Physician||ClinicalTrialDisclosure@its.jnj.com
96886|NCT00105534|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
119088|NCT01231620|GlaxoSmithKline|GSK Response Center|866-435-7343|
96888|NCT00105586|Washington University in St. Louis|Eric Lenze|314-362-1671|lenzee@wustl.edu
96889|NCT00105989|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
96890|NCT00106002|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
96891|NCT00106028|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
96892|NCT00106080|Department of Veterans Affairs, Health Services Research and Development|David H. Au, MD, MS|206-764-2430|david.au@va.gov
96893|NCT00106106|NIH/National Institute on Alcohol Abuse and Alcoholism|Markus A. Heilig, M.D., Ph.D.|301-435-9386|mheilig@mail.nih.gov
96894|NCT00106119|National Institute of Diabetes and Digestive and Kidney Diseases|Dr. Kong Chen|3014511636|chenkong@niddk.nih.gov
96895|NCT00106184|University of Pittsburgh|Chester V. Oddis, MD|412-383-8861|cvo5@pitt.edu
96896|NCT00106249|CUNY|Dr. Antonio Mantovani|212-650-5417|amantovani@med.cuny.edu
96897|NCT00106353|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96898|NCT00106392|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com
96899|NCT00106431|Celgene Corporation|Elizabeth Faust, PhD, Vice President, Clinical Research Services|617/583-1300|EFaust@Celgene.com
96900|NCT00106535|Hoffmann-La Roche|Medical Communications|800-821-8590|
96901|NCT00106626|Merck & Co., Inc.|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
96902|NCT00106639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96903|NCT00106704|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96904|NCT00106938|Abbott Vascular|Jennifer M Jones-McMeans, PhD (Associate Director Clinical Research)|408-845-1459|jennifer.jones@av.abbott.com
96907|NCT00107120|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Daniel Ventura, PhD|201-427-8252|daniel.ventura@frx.com
96908|NCT00107172|Boston Medical Center|Hiran C. Fernando, MD|617-638-5600|hiran.fernando@bmc.org
96909|NCT00107198|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
96910|NCT00107276|SWOG|Study statistician|206-667-4623|
96911|NCT00107315|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
96912|NCT00107380|SWOG Statistical Center|Study Statistician|206-667-4623|
96913|NCT00107536|The Ohio State University Comprehensive Cancer Center|Tanio Bekaii-Saab, MD|614-293-9863|Tanios.Bekaii-Saab@osumc.edu
96914|NCT00107575|Brown University|Christopher Kahler|(401) 863-6651|Christopher_Kahler@brown.edu
96915|NCT00107614|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990 ext 2461|pettynathanm@uams.edu
96916|NCT00107653|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
96917|NCT00107783|NHGRI|William Gahl, MD/Clinical Director|301-402-2739|gahlw@mail.nih.gov
96918|NCT00107900|Daiichi Sankyo, Inc.|Victor Fernandez|732-590-5000|vfernandez@dsi.com
96919|NCT00107952|Theravance Biopharma Antibiotics, Inc.|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com
96920|NCT00107978|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com
96921|NCT00107991|UPenn|Jennifer Goldfarb|215-662-2540|jennifer.goldfarb@uphs.upenn.edu
96922|NCT00108069|National Cancer Institute|Kathy Warren, M.D.|301-435-4683|warrenk@box-w.nih.gov
96923|NCT00108082|GlaxoSmithKline|GSK Response Center|866-435-7343|
96924|NCT00108160|VA Ann Arbor Healthcare System|Suzanne F. Bradley, M.D.|734-845-5820 ext 55826|sbradley@umich.edu
96925|NCT00108277|VA Palo Alto Health Care System / Stanford University School of Medicine|Walton T. Roth, M.D.|650-493-5000 ext 65243|wtroth@stanford.edu
96926|NCT00108303|VA|Dr. Robert Freedman|3037244940|Robert.Freedman@ucdenver.edu
96927|NCT00108342|Department of Veterans Affairs - VAGLA|Nina G. Schneider, Ph.D., Principle Investigator|310-268-3059|ngs@ucla.edu
96928|NCT00108355|VA-CT Healthcare System|Guadalupe Garcia-Tsao|203-932-5711 ext 2210|guadalupe.garcia-tsao@yale.edu
96929|NCT00108433|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
96930|NCT00110890|Amgen Inc.|Study Director|866-572-6436|
96931|NCT00110994|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
96932|NCT00111007|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
96933|NCT00111657|Duke University Medical Center|John S. Sundy, MD, PhD|919-684-2347|john.sundy@duke.edu
96934|NCT00111761|Amgen Inc.|Study Director|866-572-6436|
96935|NCT00111813|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96936|NCT00111917|National Jewish Health|Lisa Maier, MD|303-398-1983|maierl@njhealth.org
96937|NCT00112047|Gilead Sciences|Dara Wambach MA, Associate Director, Regulatory Affairs|650-522-5163|dara.wambach@gilead.com
96938|NCT00112112|MedImmune, LLC|Raburn Mallory|301-398-0000|malloryr@medimmune.com
96939|NCT00112151|Univeristy of Colorado at Denver|Dr. Robert S. Schwartz, Head, Division of Geriatric Medicine|303-724-1919|robert.schwartz@ucdenver.edu
96940|NCT00112294|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
96941|NCT00112359|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com
96942|NCT00112385|Brigham and Women's Hospital|A Pilot Study of Etanercept in Dermatomyositis|617-732-8046|aamato@partners.org
96943|NCT00112437|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
96944|NCT00112463|Wake Forest School of Medicine|Dr. Doug Case|336-716-1048|dcase@wakehealth.edu
96945|NCT00112489|NRG Oncology - Buffalo Office|Melissa Leventhal|716-341-3408|mleventhal@gogstats.org
96946|NCT00112593|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org
96947|NCT00112671|Princess Margaret Phase II Consortium|Dr. Srikala Sridhar|416-946-4501 ext 2662|srikala.sridhar@uhn.ca
96948|NCT00112723|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-293-3507|Jeffrey.Jones@osumc.edu
96949|NCT00112736|Adult Brain Tumor Consortium (ABTC)|Dr. Patrick Y Wen||pwen@partners.org
96950|NCT00112840|University of Miami – Sylvester Comprehensive Cancer Center|Jaime Merchan, M.D.||jmerchan2@med.miami.edu
96951|NCT00112866|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-8837|jfisher@jhmi.edu
96952|NCT00112905|ECOG Statistical Office|Study Statistician|617-632-3012|
96953|NCT00112918|Hoffman-LaRoche|Medical Communications|800-821-8590|
96954|NCT00113022|Experimental Therapeutics and Pathophysiology Branch, NIMH|Dr. Carlos Zarate|301-451-0861|zaratec@mail.nih.gov
96955|NCT00113087|New England Research Institute|Lynn Sleeper|617-972-3235|lsleeper@neriscience.com
96956|NCT00113217|University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD / Associate Professor|713-792-2830|CR_Study_Registration@mdanderson.org
96957|NCT00113230|UT MD Anderson Cancer Center|Christopher H. Crane, MD / Associate Professor|713-792-2933|
96958|NCT00113269|Astellas Pharma Global Development|Senior Medical Director||clinicaltrials@us.astellas.com
96959|NCT00113295|Massachusetts General Hospital|Naomi M. Simon, M.D., M.Sc.|(617) 726-7913|nsimon@partners.org
96960|NCT00113321|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, M.D., Professor|713/792-7026|eharriso@mdanderson.org
96961|NCT00113334|University of Texas (UT) MD Anderson Cancer Center|Edward Kim, MD, BS / Assistant Professor|713-792-6363|CR_Study_Registration@mdanderson.org
96962|NCT00113360|UT M. D. Anderson Cancer Center|James Yao, M.D./Associate Professor|713-792-2828|CR_Study_Registration@mdanderson.org
96963|NCT00113373|NRG Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
96964|NCT00113386|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org
96965|NCT00113399|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org
96966|NCT00103610|Genzyme Corporation|Genzyme MedInfo||medinfo@genzyme.com
96967|NCT00103662|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
96968|NCT00103740|Novartis Pharmaceuticals|Study Director|862-778-8300|
96969|NCT00103844|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
96970|NCT00103857|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
96971|NCT00104052|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
96972|NCT00104104|Novatis Pharmaceuticals|Study Director|862-778-8300|
96973|NCT00104234|BioMarin Pharmaceutical Inc.|Medical Information Services|8009834587|medinfo@bmrn.com
96974|NCT00104247|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com
96975|NCT00104299|DAIT/NIAID|Associate Director, Clinical Research Program|(301) 594-7669|DAITClinicalTrialsGov@niaid.nih.gov
96976|NCT00104416|GlaxoSmithKline|GSK Response Center|866-435-7343|
96977|NCT00104520|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com
96978|NCT00104572|NIA|Josephine M. Egan,MD, clinical director NIA|410-558-8414|eganj@grc.nia.nih.gov
96979|NCT00104637|Columbia University|David J. Lederer, MD|212-305-7771|dl427@columbia.edu
96980|NCT00104650|Amgen Inc.|Study Director|866-572-6436|
96981|NCT00104728|H. Lee Moffitt Cancer Center and Research Institute|Dr. Eric Haura|813-745-6826|eric.haura@moffitt.org
96982|NCT00104871|The University of Texas (UT) MD Anderson Cancer Center|Steven Sherman, MD / Professor||CR_Study_Registration@mdanderson.org
96983|NCT00104884|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|
96984|NCT00105001|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org
96985|NCT00105027|The EMMES Corporation|Paul C. VanVeldhuisen, Ph.D.|301-251-1161|score@emmes.com
96986|NCT00105066|National Institute On Aging|Dr. James Strait|4105588084|straitj@mail.nih.gov
96987|NCT00105079|Hoffman-LaRoche|Medical Communications|800-821-8590|
96988|NCT00105157|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
96989|NCT00105183|Fresenius Biotech|Regulatory Affairs|781 699 4618|anne.kuan@fresenius-biotech.com
96990|NCT00105196|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
96991|NCT00105235|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
96992|NCT00105443|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
96993|NCT00105469|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
96994|NCT00105482|Yale School of Medicine, Department of Psychiatry|Stephanie Samples O'Malley PhD, Director, Division of Substance Abuse Research|(203) 974-7590|stephanie.omalley@yale.edu
96995|NCT00113425|University of Michigan Dept of Dermatology|Dr. Jeffrey Orringer|734-936-4075|jorringe@umich.edu
96996|NCT00113490|MedImmune|M. Pamela Griffin, MD/ Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com
96997|NCT00113516|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
96998|NCT00113529|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
96999|NCT00113568|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
97000|NCT00113607|Janssen R&D US|Director Clinical Research Medical Leader|908 704 5779|
97002|NCT00114127|Massachusetts General Hospital|Dr. Naomi Simon|617-726-7913|nsimon@partners.org
97003|NCT00114166|NRG Oncology, Statistics and Data Management Center - Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org
97004|NCT00114244|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
97005|NCT00114504|Kurume University|Hisashi Kai|+81-942-31-7562|naikai@med.kurume-u.ac.jp
97006|NCT00114517|University of Southern California|Howard N. Hodis, M.D., Director, Atherosclerosis Research Unit|323 442 1478|athero@usc.edu
97007|NCT00114530|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
97008|NCT00114634|NICHD, NIH|Forbes D Porter|301-435-4432|fdporter@mail.nih.gov
97010|NCT00114959|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
97011|NCT00114972|Boston Scientific|Nic Van Dyck / Senior Program Manager|+ 31 43 356 8328|vandyckn@bsci.com
97012|NCT00115063|PenningtonBRC|Tiffany Prather, RN, CDE|225-763-2979|tiffany.prather@pbrc.edu
97013|NCT00115297|UMass|Craig M. Lilly, MD|508-868-5106|craig.lilly@umassmed.edu
97014|NCT00115349|UCL Cancer Institute|John Porter, MD, Principal Investigator|+011 (44) 207 679 6224|j.porter@ucl.ac.uk
97015|NCT00115739|University of Michigan Comprehensive Cancer Center|Frances Worden, M.D.|(734) 615-6633|fworden@umich.edu
97016|NCT00115765|Amgen Inc.|Study Director|866-572-6436|
97017|NCT00115804|University of Cincinnati|Dr. Lesley Arnold|513-475-8110|lesley.arnold@uc.edu
97018|NCT00115869|Fred Hutchinson Cancer Research Center|Arthur V. Peterson, Jr. PhD|206-667-5131|avpeters@fhcrc.org
97019|NCT00115934|New England Research Institutes|Lynn Sleeper, ScD|617-972-3235|lsleeper@neriscience.com
97020|NCT00116168|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com
97021|NCT00116207|University of Michigan|Eva L. Feldman, Professor of Internal Medicine|7347637274|efeldman@med.umich.edu
97022|NCT00116272|Amgen Inc.|Study Director|866-572-6436|
119091|NCT01187446|Stanford University Medical Center|Youn H Kim, MD|650-521-3545|younkim@stanford.edu
97024|NCT00108485|Diabetes Research Institute|Dr. Ronald Goldberg|305-243-6574|RGoldber@med.miami.edu
97025|NCT00108524|Durham VAMC|William S Yancy, Jr. MD, MHSc|919-286-0411 ext 7770|william.yancy2@va.gov
97026|NCT00108550|VA San Diego Healthcare System|J. H. Atkinson MD|858-642-3775|joseph.atkinson@va.gov
97027|NCT00108628|Philadelphia VA Medical Center|Dr. Richard Ross|(215) 823-4046|Richard.Ross2@va.gov
97028|NCT00108732|ECOG Statistical Office|Study Statistician|617-632-3012|
97029|NCT00108862|Center for Biostatistics in AIDS Research, Harvard School of Public Health|ClinicalTrials.gov Coordinator|(617)432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
97030|NCT00108953|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
97031|NCT00109005|National Cancer Institute, National Institutes of Health|Caryn Steakley|301-435-3685|steaklec@mail.nih.gov
97032|NCT00109031|Swedish Orphan Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com
97033|NCT00109343|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
97034|NCT00109473|Cincinnati Children's Hospital Medical Center|Lee A. Denson|513-636-7575|lee.denson@cchmc.org
97035|NCT00109577|University of Calgary|Dr. Bonnie Kaplan|403-955-7363|kaplan@ucalgary.ca
97036|NCT00109590|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|(617) 432-2829|CBAR.ClinialTrials.Gov@sdac.harvard.edu
97037|NCT00109733|EMD Serono|Sanja Dragnic/Medical Responsible|+7816814017|sanja.dragnic@emdserono.com
97038|NCT00109772|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
97039|NCT00109837|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408|
97040|NCT00109850|SWOG Statistical Center|Study Statistician|206-667-4623|
97041|NCT00109876|Rhode Island Hospital/Alpert Medical School|Damian E. Dupuy, MD|401 - 444 - 5184|ddupuy@lifespan.org
97042|NCT00109928|SWOG Statistical Center|Study Statistician|206-667-4623|
97043|NCT00109967|Mayo Clinic|Stephen M. Ansell, M.D., Ph.D.||ansell.stephen@mayo.edu
97044|NCT00110019|ECOG Statistical Office|Study Statistician|617-632-3012|
97045|NCT00110084|Mayo Clinic|Dr. Vivek Roy|507-284-1159|roy.vivek@mayo.edu
97046|NCT00110136|Wake Forest CCOP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu
97047|NCT00110214|Thomas Jefferson University|William Kevin Kelly, DO||wm.kevin.kelly@jefferson.edu
97048|NCT00110305|Janssen-Virco BE|Director|32 14 641418|
97049|NCT00110357|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97050|NCT00110396|Merck Serono SA|Bettina Stubinski/Medical Responsible|+41224143396|
97051|NCT00110461|Otsuka Pharmaceutical Development & Commercialization, Inc.|Andy Forbes||andy.forbes@otsuka-us.com
97052|NCT00110513|GTC Biotherapeutics|Denise Tilton, RN, MHA, Director Clinical Affairs|508-370-5257|denise.tilton@gtc-bio.com
97053|NCT00110617|Novartis Pharmaceuticals|Study Director|862-778-8300|
97054|NCT00110812|University of Minnesota|Deborah Wentworth|612-726-9005|wentw001@umn.edu
97055|NCT00116649|Graceway Pharmaceuticals LLC|Sharon Levy, MD VP Product Development|267-948-0500|sharon.levy@gracewaypharma.com
97056|NCT00116688|Amgen Inc.|Study Director|866-572-6436|
97057|NCT00116753|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
97058|NCT00116779|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
97059|NCT00116805|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
97060|NCT00116831|GlaxoSmithKline|GSK Response Center|866-435-7343|
97061|NCT00117156|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(617) 632-3316|Jennifer_Brown@dfci.harvard.edu
97062|NCT00117286|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
97063|NCT00117312|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
97064|NCT00117338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
97065|NCT00117559|VA Boston Healthcare System|Amy Silberbogen, Ph.D.|857-364-4797|amy.silberbogen@va.gov
97066|NCT00117585|Portland VA Medical Center|Dr. David Hickam|(503) 721-7817|david.hickam@va.gov
97068|NCT00117637|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
97069|NCT00117676|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
97070|NCT00117715|Children's Mercy Hospital|J. Steven Leeder|816-234-3059|sleeder@cmh.edu
97071|NCT00117793|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|Glenn K. Klute, PhD|206-277-6724|Glenn.Klute@va.gov
97072|NCT00117806|James A. Haley Veterans' Hospital|Lisa Ottomanelli, PhD|813-558-3917|lisa.ottomanelli@va.gov
97073|NCT00117845|National Cancer Institute, National Institutes of Health|Thomas Waldmann, M.D.|301-496-6656|tawald@mail.nih.gov
97074|NCT00117949|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
97075|NCT00117962|Washington University School of Medicine|Dr. Ramaswamy Govindan||rgovinda@dom.wustl.edu
97076|NCT00117988|UT MD Anderson Cancer Center|Dr. Anas Younes, MD / Professor||etubbs@mdanderson.org
97077|NCT00118040|University of Wisconsin|Howard H. Bailey, M.D.|608-263-8624|hhbailey@wisc.edu
97078|NCT00118053|Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
97079|NCT00118092|Karmanos Cancer Institute at Wayne State University|Elisabeth Iljas Heath, M.D.||heathe@karmanos.org
97080|NCT00118131|Cancer Institute of New Jersey|Dr. Joseph Aisner|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
97081|NCT00118144|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
97083|NCT00118248|Washington University School of Medicine|Jeffrey F. Moley, M.D.||moleyj@wustl.edu
97084|NCT00118287|Fred Hutchinson Cancer Research Center|Bart Scott|206-667-1990|bscott@fredhutch.org
97085|NCT00118352|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org
97086|NCT00118365|University of California, Irvine|Dr. Frank Meyskens, Jr.|714-456-6310|flmeyske@uci.edu
97087|NCT00118378|New York State Psychiatric Institute|Dr. Judith Rabkin|212.543.5762|jgr1@columbia.edu
97088|NCT00118404|The University of Texas Southwestern Medical Center|Dr. Robin B. Jarrett, Professor of Psychiatry|214-648-5345|Robin.Jarrett@UTSouthwestern.edu
97089|NCT00118417|Massachusetts General Hospital|Naomi M. Simon, MD|617-726-7913|nsimon@partners.org
97090|NCT00118430|Indiana University|Kurt Kroenke|3172749046|kkroenke@regenstrief.org
97091|NCT00118482|University of Calgary|Dr. Robert S. Sheldon|403-2208191|sheldon@ucalgary.ca
97092|NCT00118534|VA Puget Sound (Seattle)|Dr. Miles McFall|(206) 764-2177|Miles.McFall@va.gov
97093|NCT00118703|GlaxoSmithKline|GSK Response Center|866-435-7343|
97094|NCT00118742|Hoffmann-La Roche|Medical Communications|800-821-8590|
97095|NCT00118755|Hoffmann-La Roche|Medical Communications|800-821-8590|
97096|NCT00118898|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
97097|NCT00118911|Massachusetts General Hospital|Susan Sprich, Ph.D.|617-726-5991|ssprich@partners.org
97098|NCT00119015|University of Chicago|Robert Naclerio|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu
97099|NCT00119041|Louis Stokes VA Medical Center|David C. Aron, MD, MS|(216) 791-2300 ext 5702|david.aron@va.gov
97100|NCT00119158|The Children's Hospital of Philadelphia|Jonathan Spergel|215 590 1000|spergel@email.chop.edu
97101|NCT00119262|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012|
97102|NCT00119379|University Hospitals Case Medical Center|Dr. Grace McComsey|216-844-2739|mccomsey.grace@clevelandactu.org
97103|NCT00119392|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org
97104|NCT00119405|Case Western Reserve University|Grace McComsey|216-844-3607|mccomsey.grace@clevelandactu.org
97105|NCT00113763|Amgen Inc.|Study Director|866-572-6436|
97106|NCT00113841|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor|713-792-9660|xzhou@mdanderson.org
97107|NCT00113880|MedImmune, LLC|Chris Ambrose, MD, Sr Director, Medical Affairs|301-398-0000|ambrosec@medimmune.com
97109|NCT00119678|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
97110|NCT00121134|DFCI|Dr Harold J. Burstein|617-632-3800|hal_burstein@dfci.harvard.edu
97111|NCT00121186|SWOG Statistical Center|Study Statistician|206-667-4623|
97112|NCT00121199|SWOG Statistical Center|Study Statistician|206-667-4623|
97113|NCT00121225|Princess Margaret Cancer Centre|Dr. David Hogg|416-946-4501 ext 4521|david.hogg@uhn.ca
97114|NCT00121238|University of Michigan Comprehensive Cancer Center|Maha Hussain, M.D.|(734)936-8906|mahahuss@med.umich.edu
97115|NCT00121472|Thoratec Corporation|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|(781) 852-8334|psood@thoratec.com
97116|NCT00121485|Thoratec Corporation|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|781 852 8334|psood@thoratec.com
119093|NCT01177735|University of Arkansas for Medical Sciences|Saad Usmani, MD|501-526-6876|
119094|NCT01165229|GlaxoSmithKline|GSK Response Center|866-435-7343|
97119|NCT00121719|Eisai Inc.|Eisai Medical Services|888-422-4743|
97120|NCT00121810|Hoffmann-La Roche|Medical Communications|800-821-8590|
97121|NCT00121836|Hoffmann-LaRoche|Medical Communications|800-821-8590|
97122|NCT00122109|VA Pacific Islands Healthcare System|Leslie A. Morland, PsyD, Principal Investigator|(808) 566-1934|leslie.morland@va.gov
97123|NCT00122135|Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), MEDVAMC, Houston, TX|Dr. Ursula Braun|832 687 1645|ubraun@bcm.edu; ursula.braun@va.gov
97124|NCT00122187|VAHSRD|Linda Humphrey|503-220-8262 ext 57176|linda.humphrey@va.gov
97125|NCT00122317|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com
97126|NCT00122369|Beth Israel Deaconess Medical Center (at time of study); now Hypnalgesics, LLC|Elvira V. Lang, MD|978 404 9724|elang@bidmc.harvard.edu
97127|NCT00122382|Bristol-Myers Squibb|Study Director||Clinical.Trials@bms.com
97128|NCT00122447|Emory University School of Medicine|Mary Rhee, M.D.|404-778-1660|mrhee@emory.edu
97129|NCT00122460|Merck Serono|Inmaculada Ollero/Clinical Trial Manager|+34935655433|iollero@merck.es
97130|NCT00122681|GlaxoSmithKline|GSK Response Center|866-435-7343|
97131|NCT00122954|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu
97132|NCT00122980|Baylor College of Medicine|Russell E. Ware, MD, PhD, Director, Texas Children's Hematology Center|(832) 824-1368|reware@bcm.edu
97133|NCT00123123|University at Buffalo|Frank A. Scannapieco|716-829-3373|fas1@buffalo.edu
97134|NCT00123162|MS Hershey Medical Center|Richard S Legro MD|717-531-8478|rsl1@psu.edu
97135|NCT00123409|Philadelphia VAMC|David Oslin|2158235894|dave.oslin@upenn.edu
97136|NCT00123422|Edward Hines Jr. ,VA Hospital|Eileen Collins|708-202-3525|eileen.collins@va.gov
97137|NCT00123474|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
97138|NCT00123487|Bristol-Myers Squibb|: Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
97139|NCT00116857|Washington University School of Medicine|Robert M. Carney, Ph.D.|314-286-1313|carneyr@bmc.wustl.edu
97140|NCT00123604|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu
97141|NCT00123630|University of Utah|Dr. John Fang|801-581-7802|john.fang@hsc.utah.edu
97142|NCT00123643|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu
97143|NCT00123682|VA New York Harbor Healthcare System|Dr. Scott Sherman, PI|212-686-7500 ext 7386|scott.sherman@va.gov
97144|NCT00123734|AGEN Biomedical Ltd|Dr Michael Gerometta|+61 408 885 416|mgerometta@agenix.com
97145|NCT00124449|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
97146|NCT00124462|Boston Univeristy|ClinicalTrials.gov Administrator|617 638 8862 ext 617|damusk@bu.edu
97147|NCT00124579|SWOG|Robert Z. Orlowski, MD, PhD|(713) 792-2860|rorlowsk@mdanderson.org
97148|NCT00124618|Mayo Clinic|Aminah Jatoi, M.D.|507/538-0268|jatoi.aminah@mayo.edu
97149|NCT00124657|St. Jude Children's Research Hospital|Alberto Broniscer, MD|866-966-5934|info@stjude.org
97150|NCT00124709|Novartis Pharmaceuticals|Study Director|862-778-8300|
97151|NCT00124735|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
97152|NCT00124748|Novartis Pharmaceuticals|Study Director|862-778-8300|
97153|NCT00124943|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
97154|NCT00124982|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
97155|NCT00125034|Merck Serono|Inmaculada Ollero/Clinical Trial Manager|+34935655433|iollero@merck.es
97156|NCT00125138|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com
97157|NCT00125164|Ipsen|Medical Director, Pediatric Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
97158|NCT00125190|Ipsen|Cathryn Clary, M.D.|+1 650-624-4919|cathryn.clary@ipsen.com
97159|NCT00125242|VA Salt Lake City Health Care System|Dr. Julie Wambaugh|801-582-1565 ext 1363|julie.wambaugh@health.utah.edu
97160|NCT00125268|Mayo Clinic|Dr. Matthew A. Butters|480-301-7745|butters.matthew@mayo.edu
97161|NCT00125515|New York Psychiatric Institute|Dr Adam Bisaga|212-543-6542|bisagaa@nyspi.columbia.edu
97162|NCT00125528|Northwestern Universiyt|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu
97163|NCT00125593|Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford|Professor Colin Baigent|+44 1865 743743|colin.baigent@ctsu.ox.ac.uk
97164|NCT00125619|VA Brain Rehabilitation Research Center|Dr. Carolynn Patten|352.376.1611 ext 4160|patten@phhp.ufl.edu
97165|NCT00125658|VA Brain Rehabilitation Research Center|Dr. Carolynn Patten|352.376.1611 ext 4160|carolynn.patten@va.gov
97166|NCT00125931|McLean Hospital|Beth Murphy, MD PhD|617-855-2297|BMurphy5@partners.org
97167|NCT00125957|McLean Hospital|Dr. Beth Murphy|617-855-2000 ext 2297|bmurphy5@partners.org
97168|NCT00126113|National Center for Rehabilitative Auditory Research|Gabrielle Saunder Ph.D.|503-220-8262 ext 56210|gabrielle.saunders@va.gov
97169|NCT00126126|Miami VAHS & University of Miami, Department of PT|Robert Gailey, PhD, PT|305-284-4535|rgailey@miami.edu
97170|NCT00126191|DFCI|Ann LaCasce, MD|617-632-5959|ALACASCE@PARTNERS.ORG
97171|NCT00126425|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com
97172|NCT00126438|GE Healthcare|Jose Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com
97173|NCT00126490|H. Lee Moffitt Cancer Center and Research Institute|Mayer Fishman, M.D., Ph.D.|813-745-8311|mayer.fishman@moffitt.org
97174|NCT00126503|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu
97175|NCT00126555|University of Texas MD Anderson Cancer Center|Randal S. Weber, MD / Professor||CR_Study_Registration@mdanderson.org
119095|NCT01118117|Terumo Medical Corporation|Adam Thompson, Clinical Program Manager|201-398-3283|adam.thompson@terumomedical.com
97178|NCT00126594|University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org
97179|NCT00126659|UT MD Anderson Cancer Center|Eric Jonasch, MD / Associate Professor||caperez@mdanderson.org
97180|NCT00126737|Edward Hines, Jr. VA Hospital|Elly Budiman-Mak, MS MPH MD|708-202-2414|elly.mak@va.gov
97181|NCT00126750|VA Bedford CHOIR|Dr. Thomas Houston II|781-687-2884|thomas.houston2@va.gov
97182|NCT00120042|The University of Western Australia|Dr Jan Dickinson|61-8-93401330|Jan.Dickinson@uwa.edu.au
97183|NCT00120250|Massachusetts General Hospital|Dr. Mark Pollack|312-942-5372|mark_pollack@rush.edu
97184|NCT00120289|Axio Research, LLC|Ruth McBride|206-577-0212|ruthm@axioresearch.com
97185|NCT00120406|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com
97186|NCT00120523|MEDA Pharma GmbH & Co. KG|Clinical Research|+49 6172 888 ext 01|clinical.research@medapharma.de
97187|NCT00120627|VA San Diego Healthcare System|Jill E. Bormann, PhD, RN, FAAN|858-552-8585 ext 2378|jill.bormann@va.gov
97188|NCT00120874|NYU Langone Medical Center|Barry Reisberg|121-263-8550|barry.reisberg@nyumc.org
97189|NCT00126776|Minneapolis VAMC|Kathryn Rice MD|612 725 2000 ext 4400|kathryn.rice@va.gov
97190|NCT00127036|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-2069|jonathan.strosberg@moffitt.org
97191|NCT00127101|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com
97192|NCT00127166|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
97193|NCT00127192|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
97195|NCT00127413|VA Boston Healthcare System|John D. Otis|8573645740|john.otis@va.gov
97196|NCT00127530|Acorda Therapeutics, Inc.|Andrew Blight, Chief Scientific Officer|914-347-4300 ext 102|ablight@acorda.com
97197|NCT00127660|University of Minnesota|Lisa Harnack, DrPH|612-626-9398|harna001@umn.edu
97198|NCT00127712|Purdue University|James E. Tisdale|317-613-2315 ext 306|jtisdale@iupui.edu
97199|NCT00127790|Universityy of Rochester|Wilfred Pigeon, PhD|(585) 275-3374|wilfred_pigeon@urmc.rochester.edu
97200|NCT00127803|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
97201|NCT00127842|Amgen Inc.|Study Director|866-572-6436|
97202|NCT00127855|GlaxoSmithKline|GSK Response Center|866-435-7343|
97203|NCT00127933|Hoffman-LaRoche|Medical Communications|800-821-8590|
97204|NCT00128180|UNewMexico|Gregory Mertz, MD|5059808601|gmertz@salud.unm.edu
97205|NCT00128193|Colorado State University, Department of Microbiology, Immunology and Pathology|Patrick J. Brennan, Ph.D.|970-491-6700|patrick.brennan@colostate.edu
97206|NCT00128206|University of California, San Francisco|Mary White|415-476-5213|mary.white@nursing.ucsf.edu
101084|NCT00454987|GlaxoSmithKline|GSK Response Center|866-435-7343|
97207|NCT00128219|University of Pittsburgh School of Medicine|Sharon Hillier, Ph.D.|412-641-6435|hillsl@mwri.magee.edu
97208|NCT00128401|National Institute of Mental Health|Cameron, Jennifer Ann|+1 301 402 9356|cameronj@mail.nih.gov
97209|NCT00128492|Gilead Sciences, Inc.|Mark Bresnik, Director of Clinical Research|650-522-5934|Mark.Bresnik@gilead.com
97210|NCT00128661|GlaxoSmithKline|GSK Response Center|866-435-7343|
97211|NCT00128713|New England Research Institutes|Susan Assmann, PhD|617-923-7747 ext 548|sassmann@neriscience.com
97212|NCT00128830|Tibotec Pharmaceuticals|Trial Physician|+32-14-607-767|
97213|NCT00128921|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990 ext 2461|pettynathanm@uams.edu
97214|NCT00129116|GlaxoSmithKline|GSK Response Center|866-435-7343|
97215|NCT00129129|GlaxoSmithKline|GSK Response Center|866-435-7343|
97216|NCT00129220|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97217|NCT00129246|Associate Professor of Psychiatry and Program Director, Smoking Cessation Service at Smilow Cancer Hospital at Yale-New Haven|Benjamin A. Toll, PhD|(203) 974 5767|benjamin.toll@yale.edu
97218|NCT00129259|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
97219|NCT00129272|The University of Tennessee|Uma Rao, MD|615-794-3351|urao@utk.edu
97220|NCT00129311|Yale Unviersity|Dr. Andrea Weinberger|203-974-7598|andrea.weinberger@yale.edu
97221|NCT00129402|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
97222|NCT00129441|University of Pittsburgh|David A. Lewis, MD|(412) 246-6010|lewisda@upmc.edu
97223|NCT00129467|Portland Veterans Affairs Medical Center|Dr. Linda Ganzini|(503) 220-8262 ext 56492|linda.ganzini@va.gov
97224|NCT00129480|Portland VA Medical Center|Steven K. Dobscha MD|503-220-8262 ext 52207|steven.dobscha@va.gov
97225|NCT00129545|Boston Scientific|Watchman Trial Manager|1-800-227-3422|
97226|NCT00129623|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
97227|NCT00123955|Wake Forest Baptist Health|Dr. Dalane Kitzman|336-716-3274|dkitzman@wakehealth.edu
97228|NCT00124020|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com
97229|NCT00124072|CTSU, University of Oxford|CTSU Reception|01865 743743|secretary@ctsu.ox.ac.uk
97230|NCT00124176|Children's Hospital of Philadelphia|Joseph Zorc, MD|215-590-1944|zorc@email.chop.edu
97231|NCT00129727|Massachusetts General Hospital|Richard T Penson MD MRCP|617-726-5867|rpenson@partners.org
97232|NCT00129766|MedImmune|M. Pamela Griffin, Sr. Director, Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com
97233|NCT00129961|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
97234|NCT00129974|Tufts Medical Center|Research Administration||mcoughlin@tuftsmedicalcenter.org
97235|NCT00130117|BIDMC|Christos Mantzoros|6176678630|cmantzor@bidmc.harvard.edu
97236|NCT00130247|Case Western Reserve University, Tuberculosis Research Unit|John L. Johnson, M.D., Principal Investigator|(216) 368-1949|jlj@case.edu
97237|NCT00130286|Weill Cornell Medical College|Dr. Marshall J. Glesby|212-746-4177|mag2005@med.cornell.edu
97238|NCT00130520|Arizona Cancer Center, University of Arizona|Setsuko K. Chambers, M.D.|520-626-0950|schambers@azcc.arizona.edu
97239|NCT00130637|National Eye Institute, NIH|H. Nida Sen, MD, MHS|301-435-5139|senh@nei.nih.gov
97240|NCT00130689|Dana-Farber Cancer Institute|Jennifer Ang Chan, MD, MPH|617-632-6315|jennifer_chan@dfci.harvard.edu
97242|NCT00130780|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris, Attending|+1646-888-4205|krism@mskcc.org
97243|NCT00130793|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
97244|NCT00130832|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
97245|NCT00130923|Psychopharmacology Research Group|Dr. Mary Brunette|603-271-5747|mary.f.brunette@hitchcock.org
97246|NCT00131248|UT Houston Medical School|Kathleen A. Kennedy, MD, MPH|713 500-6708|kathleen.a.kennedy@uth.tmc.edu
97247|NCT00131352|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
97248|NCT00131378|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@partners.org
97249|NCT00131456|Columbia University|Dr. Frances R. Levin|212-543-5896|frl2@columbia.edu
97250|NCT00131508|St Jude Children's Research Hospital|Winfred Wang|1-866-278-5833|info@stjude.org
97251|NCT00131573|Boston Scientific|Director of Clinical Operations|866-360-4747|valerie.lucero-cimmarusti@bsci.com
97252|NCT00131664|Dr. Anatoly Langer, Chair CHRC, Canadian Heart Research Centre|Dr. Robert Josse|416-977-8010|langera@chrc.net
97253|NCT00131677|Centers for Disease Control and Prevention (CDC)|Taraz Samandari|404-639-1676|tts0@cdc.gov
97254|NCT00131885|University of Utah|Patricia Murphy, DrPH|801-793-5729|patricia.murphy@nurs.utah.edu
97255|NCT00131911|Mayo Clinic Cancer Center|Timothy J. Hobday M.D.||Hobday.timothy@mayo.edu
97256|NCT00131937|ECOG Statistical Office|Study Statistician|617-632-3012|
97257|NCT00132002|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
97258|NCT00132028|SWOG Statistical Center|Study Statistician|206-667-4623|
97259|NCT00132132|SEMC|Dr. Shirley Gonzalez|617-926-0114|shirley.gonzalez@steward.org
97260|NCT00132314|VA New England Mental Illness, Research, Education and Clinical Center|Robert Rosenheck, MD|(203) 932-5711 ext 3723|Robert.Rosenheck@va.gov
97261|NCT00132496|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500|
97262|NCT00132678|Johnson & Johnson Pharmaceutical Research and Development|Director of Clinical Research|609 730-4576|
97263|NCT00132691|Center for Presventive Ophthalmology and Biostatistics, Department of Ophthalmology, University of Pennsylvania|John H. Kempen, MD, PhD, MUST Trial Vice-Chairman|215-615-1500|john.kempen@uphs.upenn.edu
97264|NCT00132730|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
97265|NCT00132769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
97266|NCT00132808|Novartis Pharmaceuticals|Study Director|862-778-8300|
97267|NCT00132873|Jazz Pharmaceuticals, Inc.|Mortimer Mamelak, MD|650 496 3777|roman.skowronski@jazzpharma.com
97268|NCT00136695|Massachusetts General Hospital|Dr. Benjamin Leder|617-726-6723|bzleder@partners.org
97269|NCT00136760|Brown University|Jennifer Tidey, Ph.D.|401-863-6418|Jennifer_Tidey@brown.edu
97270|NCT00136812|Stanord University|Judith Prochaska, PhD, MPH; Associate Professor|650-724-3608|JPro@stanford.edu
97271|NCT00136838|New York State Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|bisagaa@nyspi.columbia.edu
97272|NCT00136916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97273|NCT00136955|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97274|NCT00137046|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97275|NCT00137111|St. Jude Children's Research Hospital|Ching-Hon Pui|1-866-278-5833|info@stjude.org
97276|NCT00137267|Bedford VA Medical Center|Dr. David Smelson|781-687-2845|david.smelson@va.gov
97277|NCT00137280|Greater Los Angeles Veterans Healthcare Center|Dr. Alexander S. Young|310-268-3416|alexander.young@va.gov
97278|NCT00137423|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97279|NCT00137436|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97280|NCT00137449|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97281|NCT00137631|Department of Human Development, State University of New York at Binghamton|Leo Wilton, PhD|607-777-9215|lwilton@binghamton.edu
97282|NCT00137969|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
97283|NCT00138034|Radboud University Medical Center Nijmegen|Professor Doctor F.W.A. Verheugt|+31(0)24-3614533|f.verheugt@cardio.umcn.nl
97284|NCT00138073|Massachusetts General Hospital|Jaime Chang|617-726-9069|jchang4@partners.org
97285|NCT00138125|University of California at Los Angeles|Richard J. Pietras, M.D. Ph.D|310 825 9769|rpietras@ucla.edu
97286|NCT00138151|Rutgers Cancer Institute of New Jersey|Lorna Rodriguez, MD, PhD|732-235-8675|rodriglo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
97287|NCT00138203|University of Wisconsin Carbone Cancer Center|Dr. Anne Traynor|(608) 262-8158|amt@medicine.wisc.edu
97288|NCT00138294|Baylor College of Medicine|Pedro A Piedra, MD|713-798-5240|ppiedra@bcm.edu
97290|NCT00138645|Pennington Biomedical Research Center|Corby K. Martin, Ph.D.; Assistant Professor|225-763-2585|martinck@pbrc.edu
97291|NCT00138658|OncoGenex Pharmaceuticals|Dr. Patricia Stewart, Vice President Medical Affairs|425-686-1500|psstewartmd@oncogenex.com
97292|NCT00138671|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97293|NCT00130039|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr
97294|NCT00143247|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97295|NCT00143312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97296|NCT00143390|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97297|NCT00143403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97298|NCT00143455|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97300|NCT00143598|Centre for Clinical Epidemiology, Jewish General Hospital|Dr. Susan R Kahn|514-340-8222 ext 7587|susan.kahn@mcgill.ca
97301|NCT00143819|UMDNJ-Robert Wood Johnson Medical School|Dr M Magliocco||maglioma@yahoo.com
97302|NCT00143845|University of Michigan Comprehensive Cancer Center|Dr. John Levine, M.D.|734-936-8456|jelevine@umich.edu
97303|NCT00144027|Central Arkansas Veterans Healthcare System|Jeff Pyne|501-257-1083|jeffrey.pyne@va.gov
97304|NCT00144170|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
97305|NCT00144300|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
97306|NCT00144339|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
97307|NCT00144391|Charles R. Drew University of Medicine and Science|Dr. Theodore Friedman|310-668-5197|theodorefriedman@cdrewu.edu
97308|NCT00144781|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
97309|NCT00144963|Talon Therapeutics|VP, Regulatory Affairs|650-228-5066|ttarlow@talontx.com
97310|NCT00145041|Talon Therapeutics|Chief Medical Officer|650-588-6404|info@talontx.com
97311|NCT00145119|Medtronic Bakken Research Center|Director CRDM|+31 43 3566 ext 566|
97312|NCT00145249|University of Alabama at Birmingham|Peter G. Pappas, MD|205-934-9951|pappas@uab.edu
97313|NCT00145327|Novartis Pharmaceuticals|Study Director|862-778-8300|
97314|NCT00145418|Oncology Specialists, S.C.|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net
97315|NCT00134381|UMDNJ-Robert Wood Johnson Medical School|Dr M Magliocco||maglioma@yahoo.com
97316|NCT00134563|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com
97317|NCT00134719|GlaxoSmithKline|GSK Response Center|866-435-7343|
97318|NCT00134784|Institute for Neurodegenerative Disorders|Principal Investigator|203 401 4300|kmarek@indd.org
97319|NCT00134901|New York State Psychiatric Institute|Dr Adam Bisaga|(646) 774-6155|bisagaa@nyspi.columbia.edu
97320|NCT00135200|University of Michigan Comprehensive Cancer Center|Dr. Mark Kaminski, M.D.|(734) 936-5310|mkaminsk@umich.edu
97321|NCT00135330|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
97322|NCT00135356|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
97323|NCT00135694|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
97324|NCT00135798|University Colorado, Denver|Gregory T. Everson, M.D., Director of Hepatology|720-848-2245|greg.everson@UCDenver.edu
97325|NCT00136084|St. Jude Children's Research Hospital|Jeffrey Rubnitz, M.D|1-866-278-5833|info@stjude.org
97326|NCT00136318|Kliniken Essen-Mitte, Department of Psychiatry|Professor Dr. Martin Schaefer|+49201-17430001|m.schaefer@kliniken-essen-mitte.de
97327|NCT00136357|The Center for Mind-Body Medicine|Dr. James Gordon|202-966-7338|jgordon@cmbm.ort
97328|NCT00145496|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
97329|NCT00145509|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
97330|NCT00145574|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com
97331|NCT00145587|St. Jude Children's Research Hospital|Kimberly Kasow, DO|901-595-3300|kimberly_kasow@med.unc.edu
97332|NCT00145600|St. Jude Children's Research Hospital|Monika Metzger, MD|1-866-278-5833|info@stjude.org
97333|NCT00145626|St. Jude Children's Research Hospital|Brandon Triplett, MD|866-278-5833|referralinfo@stjude.org
97334|NCT00145704|Upstate Orthopedics|Timothy A. Damron|315-464-8602|damront@upstate.edu
97335|NCT00145795|The University of Chicago Department of Health Studies, Section of Infectious Diseases and Global Health|Dr. David Pitrak|(773) 702-2710|dpitrak@medicine.bsd.uchicago.edu
97336|NCT00146757|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
97337|NCT00146770|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
97338|NCT00146848|Clinical Affairs|Kira Stolen|1 800 CARDIAC|cshd@bsci.com
97339|NCT00147030|National Perinatal Epidemiology Unit, University of Oxford|Director of NPEU Clinical Trials Unit|01865 289700 ext 89728|ctu@npeu.ox.ac.uk
97340|NCT00147199|United Therapeutics|Inhaled Treprostinil Program Head|919-485-8350|clinicalrecordsmanagement@unither.com
97341|NCT00147212|MGH Cancer Center|M. Dror Michaelson, MD PhD|6177261594|dmichaelson1@partners.org
97342|NCT00147225|University of Texas MD Anderson Cancer Center|Dr. Saroj Vadhan-Raj|713-792-7966|svadhanr@mdanderson.org
97343|NCT00147238|UT MD Anderson Cancer Center|Haesun Choi, MD / Professor|713-745-4693|
97344|NCT00147277|Medtronic Italia S.p.A.|Laura Manotta|003902241371|laura.manotta@medtronic.com
97345|NCT00147290|Medtronic|Elisabetta Santi|003906328141|elisabetta.santi@medtronic.com
97346|NCT00147316|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
97347|NCT00147446|Northwestern University|David C. Mohr|312-503-3128|m.lisetteluistro@northwestern.edu
97348|NCT00147498|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97349|NCT00147537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97350|NCT00147745|Daiichi Sankyo, Inc|John Raia, Senior Director, Professional Affairs|(973) 944-2683|jraia@dsi.com
97351|NCT00147823|SUNY Upstate Medical University|Timothy A. Damron, MD|315-464-8604|damront@upstate.edu
97352|NCT00147966|UCSD|Arthur Kavanaugh|858-657-7040|akavanaugh@ucsd.edu
97353|NCT00148109|University of Michigan Comprehensive Cancer Center|Dr. Rashmi Chugh|(734) 936-5710|rashmim@umich.edu
97354|NCT00148122|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden|734-936-0453|fworden@umich.edu
97355|NCT00148317|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu
97356|NCT00148668|Dana-Farber Cancer Institute|Dr Eric Winer|617-632-2335|eric_winer@dfci.harvard.edu
97357|NCT00148733|University of Bergen|Tor A Strand|90971086|tor.strand@cih.uib.no
97358|NCT00148759|Emory University|Ighovwerha Ofotokun, MD, MSc|404-616-0659|iofotok@emory.edu
97359|NCT00148798|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
97360|NCT00148954|Boston Scientific|Greg Voss, Clinical Director|651-581-3068|gregory.voss@bsci.com
97361|NCT00149214|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97362|NCT00149227|Department of Cardiology, Kyoto Prefectural University of Medicine|Prof. Hiroaki Matsubara|+81-75-251-5511|matsubah@koto.kpu-m.ac.jp
97363|NCT00133575|Brigham and Women’s Hospital|Lindsey R. Baden, M.D.|617-732-6801|LBaden@partners.org
97364|NCT00133705|University of Rochester|Dr. Kevin Fiscella|585-271-1206 ext 205|kevin_fiscella@urmc.rochester.edu
97365|NCT00140556|Duke University Medical Center, Dept Radiation Oncology|David Brizel, MD|919 668-5637|david.brizel@duke.edu
97366|NCT00140621|Sanofi|Trial Transparency Team||Contact-US@Sanofi.com
97367|NCT00140842|Massachusetts General Hospital|Madhu Misra, MD|617-724-5602|mmisra@partners.org
97368|NCT00141037|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
97369|NCT00141102|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97370|NCT00141115|New York State Psychiatric Institute|John J. Mariani|2125435987|jm2330@columbia.edu
97371|NCT00141219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97372|NCT00141271|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97373|NCT00141297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97374|NCT00141453|Daiichi Sankyo, Inc|Howard Kessler|732-590-5032|hmkessler@dsi.com
97375|NCT00141518|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
97376|NCT00141726|University of Michgan Comprehensive Cancer Center|Gregory Yanik, M.D.|734-936-8785|gyanik@umich.edu
97377|NCT00141739|Blood and Marrow Transplant Program, University of Michigan|Dr. John E. Levine|734-936-8456|jelevine@med.umich.edu
97378|NCT00141765|University of Michigan Cancer Center|Dr. John E. Levine, MD|734-936-8456|jelevine@umich.edu
101146|NCT00456625|GlaxoSmithKline|GSK Response Center|866-435-7343|
97379|NCT00141778|Vanderbilt University School of Medicine|Dr. Mias Pretorius|16153430665|mias.pretorius@vanderbilt.edu
97380|NCT00141817|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97381|NCT00141921|Amgen Inc.|Study Director|866-572-6436|
97382|NCT00142116|Dana Farber Cancer Institute|Steven P. Treon MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu
97383|NCT00142168|DFCI|Steven P. Treon MD PhD|617 632 2681|steven_treon@dfci.harvard.edu
97384|NCT00142298|Novartis Pharmaceuticals|Study Director|862-778-8300|
97385|NCT00142415|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org
97386|NCT00142597|University of Michigan|Richard E. Harris|734-998-6996|reharris@med.umich.edu
97387|NCT00142818|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200 ext 109|kampman@mail.med.upenn.edu
97388|NCT00142909|Yale University School of Medicine|Rajita Sinha, Ph.D|203-737-5805|rajita.sinha@yale.edu
97389|NCT00142935|The Miriam Hospital/Brown University|Josiah D. Rich, MD, MPH|401-793-4770|jrich@lifespan.org
97390|NCT00149994|Novartis Pharmaceuticals|Study Director|862-778-8300|
97391|NCT00150176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
97392|NCT00150345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97393|NCT00150462|Amgen, Inc.|Study Director|866-572-6436|
97394|NCT00150592|Shire Pharmaceuticals|Timothy Whitaker, MD||twhitaker@shire.com
97395|NCT00150618|Shire Pharmaceuticals|Timothy Whitaker, MD||twhitaker@shire.com
97396|NCT00150969|University Health Network|Dr. Angela M Cheung|416-340-4841|jscher@uhnresearch.ca
97397|NCT00151281|Weill Cornell Medical College|Dr. Jia Ruan|646-962-2068|jruan@med.cornell.edu
97398|NCT00151320|Weill Cornell Medicine|John Leonard, MD|646.962.2064|amr2017@med.cornell.edu
97399|NCT00151372|Weill Cornell Medical College|George S. Alexopoulos, M.D.|914-997-5767|gsalexop@med.cornell.edu
97401|NCT00151476|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97402|NCT00151775|Daiichi Sankyo|Howard Kessler, Senior Director Regulatory Operations|732-590-5032|hmkessler@dsi.com
97403|NCT00151814|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com
97404|NCT00151892|Shire Pharmaceutical|Timothy Whitaker, M.D.||twhitaker@shire.com
97405|NCT00151996|Shire Pharmaceutical|Timothy Whitaker, MD||twhitaker@shire.com
97406|NCT00152009|Shire Pharmaceuticals|Timothy Whitaker, MD||twhitaker@shire.com
97407|NCT00133809|Emory University|Nicole Turgeon MD|404-727-3257|nturgeo@emory.edu
97408|NCT00133952|Chromaderm|info@chroma-derm.com||info@chroma-derm.com
97409|NCT00133978|Clinical Evaluation Research Unit|Dr. Daren Heyland|613-549-6666 ext 4847|dkh2@queensu.ca
97410|NCT00134004|Johns Hopkins University|Dr. Ephraim Fuchs|410-419-6479|fuchsep@jhmi.edu
97411|NCT00134043|The Ohio State University Comprehensive Cancer Center|Manisha Shah, MD|614-293-8629|manisha.shah@osumc.edu
97412|NCT00134056|University of Southern California Norris Comprehensive Cancer Center|Dr. David I Quinn|3238653956|diquinn@med.usc.edu
97413|NCT00139477|Nemours Children's Clinic|Dr. Nelly Mauras, Chief, Division of Endocrinology|904-697-3674|nmauras@nemours.org
97414|NCT00139659|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97415|NCT00139737|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97416|NCT00139776|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97417|NCT00139997|Yale University|Paul Desan, MD, PhD|203 785 2618|paul.desan@yale.edu
97418|NCT00140140|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
97419|NCT00140231|BIDMC|Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu
97420|NCT00140244|BIDMC|Dr. Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu
97421|NCT00140413|Children's Hospital Los Angeles|Dr. Mark Borchert|323-361-6219|mborchert@chla.usc.edu
97422|NCT00140426|University of Colorado School of Medicine, Childrens Hospital Colorado|Jennifer Hagman MD|720-777-2539|jennifer.hagman@childrenscolorado.org
97423|NCT00146328|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
97424|NCT00152516|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
97426|NCT00153920|Dana-Farber Cancer Institute|Paul G. Richardson|617.632.2104|Paul_Richardson@dfci.harvard.edu
97427|NCT00153985|Dana-Farber Cancer Institute|Catherine Wu, MD|617-632-5943|cwu@partners.org
97428|NCT00154063|Eisai Call Center|Eisai Inc.|888-422-4743|
97429|NCT00154102|Merck Serono|Monika Foerster/Clinical Trial Leader|+496151729517|monika.foerster@merck.de
97430|NCT00154284|Novartis Pharmaceuticals|Study Director|862-778-8300|
97431|NCT00154297|Novartis Pharmaceuticals|Study Director|862-778-8300|
97432|NCT00154310|Novartis Pharmaceuticals|Study Director|862-778-8300|
97433|NCT00154375|Novartis Pharmaceuticals|Study Director|862-778-8300|
97434|NCT00154466|National Taiwan University Hospital|Dr. Bai-Chin Lee|0223123456 ext 63352|lebai@ntu.edu.tw
97435|NCT00149630|Baylor College of Medicine|Thomas R. Kosten, M.D.|(713) 794-7032|kosten@bcm.edu
97436|NCT00149643|University of Pittsburgh|Jack R. Cornelius, M.D.|412-246-6906|corneliusjr@upmc.edu
97437|NCT00149669|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu
97438|NCT00149747|Stanford Prevention Research Center|Abby C. King|6507252826|king@stanford.edu
97440|NCT00149825|Stanford University, School of Medicine|Rachel Manber, PhD|650-724-2377|Rmanber@stanford.edu
97441|NCT00149890|Novartis Pharmaceuticals|Study Director|862-778-8300|
97443|NCT00156065|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
97444|NCT00156910|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com
97445|NCT00156923|Alkermes, Inc.|Bernard L. Silverman / VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com
97446|NCT00156936|Alkermes, Inc.|Bernard L. Silverman / VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com
97449|NCT00157196|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
97450|NCT00157209|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
97451|NCT00157248|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
97452|NCT00157573|MGH DF/HCC|Richard T Penson MD MCCP|617-726-8566|rpenson@partners.org
97453|NCT00157755|Medtronic Neuromodulation|Clinical Program Manager|763-526-8172|medtronicneurotrials@medtronic.com
97454|NCT00157820|Hospital General Universitario de Valencia, Spain|Dr.A.Quesada||aquesadad@secardiologia.es
97455|NCT00157950|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
97456|NCT00158054|Columbia University Medical Center|Karina W Davidson, PhD|212-342-4493|kd2124@cumc.columbia.edu
97457|NCT00158184|Substance Use Research Center|Dr. Sandra D. Comer|212-543-5981|sdc10@columbia.edu
97458|NCT00158197|Friends Research Institute|Joy Chudzynski|323-333-8122|joychud@ucla.edu
97459|NCT00158223|Icahn School of Medicine at Mount Sinai|Dr. Joseph I. Friedman|631-761-3607|joseph.friedman@mssm.edu
97460|NCT00158249|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu
97461|NCT00158262|Massachusetts General Hospital|Roger K. Pitman, M.D.|617-726-5333|roger_pitman@hms.harvard.edu
97462|NCT00158379|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de
97463|NCT00158600|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
97464|NCT00158743|BTG International Inc|Suzanne Ward Pharm D|610-278-1660|suzanne.ward@btgplc.com
97465|NCT00158756|GlaxoSmithKline|GSK Response Center|866-435-7343|
97466|NCT00158925|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com
97467|NCT00159419|Indiana University School of Medicine|Dr. Linda DiMeglio|317-944-3889|
97468|NCT00159432|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist|323-226-6384|victoria.soto@med.usc.edu
97469|NCT00152763|University Health Network, Toronto General Hospital|Dr. Jane Irvine|(416) 736-5115 ext 22444|jirvine@yorku.ca
97470|NCT00152971|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
97471|NCT00153062|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
97472|NCT00153101|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
97473|NCT00153166|Brigham and Women's Hospital|Mark Creager|617-732-5267|mcreager@partners.org
97474|NCT00153179|Brigham and Women's Hospital|Mark A. Creager|617-732-6320|mcreager@partners.org
97475|NCT00159783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
97476|NCT00159822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97477|NCT00160524|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
97478|NCT00160563|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
97479|NCT00160641|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
97480|NCT00160693|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
97481|NCT00160706|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
97482|NCT00161213|UMDNJ|Dr. Susan Goodin (Deputy Director, Associate Director for Clinical Science)|732-235-6783|goodin@umdnj.edu
97483|NCT00161382|The University of Texas Health Science Center at Houston (UTHealth) School of Public Health|Dr. Susan R. Tortolero|713-500-9634|Susan.Tortolero@uth.tmc.edu
97484|NCT00161473|VA Puget Sound Healthcare System|Lucy Y. Wang, M.D.|206-277-5089|wanglucy@u.washington.edu
97485|NCT00161616|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
97486|NCT00162032|Lantheus Medical Imaging|Qi Zhu, MD|978-671-8605|Qi.Zhu@lantheus.com
97487|NCT00162097|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
97489|NCT00162136|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
97490|NCT00162266|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com
97491|NCT00162370|Lantheus Medical Imaging|Sr. Director, Clinical Operations|978-671-8705|stiedek@lantheus.com
97492|NCT00162773|Johns Hopkins University School of Medicine|Clinical Trials Program JHU ICTR|410-550-6484|registerclinicaltrials@jhmi.edu
97493|NCT00156247|UMDNJ-Robert Wood Johnson Medical School|Melissa Magliocco, MD|(732) 235-5735|maglioma@umdnj.edu
97494|NCT00156390|University of Pittsburgh|Dr. Samir Saba|412-802-3372|sabas@upmc.edu
97495|NCT00156533|University of Rochester|Wilfred Pigeon|585 275-3374|wilfred_pigeon@urmc.rochester.edu
97496|NCT00156715|Dartmouth Medical School|Christopher OKeefe, M.A|603-271-5287|chris.okeefe@hitchcock.org
97497|NCT00156819|Johns Hopkins Center for Clinical Trials|Razan Yasin|443-287-5796|ryasin1@jhu.edu
97498|NCT00162942|Otsuka America Pharmaceutical, Inc|Tao Wang|240-683-3213|tao.wang@otsuka-us.com
97499|NCT00162981|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com
97500|NCT00163020|Obstetrix Medical Group, Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@pediatrix.com
101801|NCT00498433|Novartis Pharmaceuticals|Study Director|862-778-8300|
97501|NCT00163657|Baylor University Medical Center|Goran Klintmalm, MD Director|214-820-2050|michelle.acker@baylorhealth.edu
97502|NCT00165503|Brigham and Women's Hospital|Dr. David Sugarbaker|617-732-5004|dsugarbaker@partners.org
97503|NCT00165646|Eisai Co.,Ltd. Eisai Product Creation Systems|Nobuyuki Sugisaki, Study Director|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp
97504|NCT00165672|Eisai Co.,Ltd. Eisai Product Creation Systems|Nobuyuki Sugisaki, Study Director|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp
97505|NCT00165698|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affaires|81-3-3817-3914|
97506|NCT00165776|Eisai Co., Ltd.|Hiroki Shimizu, Study Director|+81-3-3817-5245|
97507|NCT00165789|Eisai Call Center|Eisai Inc.|888-422-4743|
97508|NCT00165841|Eisai Medical Research Inc.|Yufang Lu, Study Director|201-403-2500|
97509|NCT00165958|Emory University|Dr. Suephy Chen|4047783084|schen2@emory.edu
97510|NCT00165984|Emory University|Paul Kirshbom|404-785-6330|pkirshb@emory.edu
97511|NCT00159861|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97512|NCT00159874|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97513|NCT00159913|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97514|NCT00159965|Rhode Island Hospital|W. Curt LaFrance, Jr., MD, MPH|401-444-3534|William_LaFrance_Jr@Brown.edu
97515|NCT00160199|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32(0)2 509 69 77|sven.voet@solvay.com
97516|NCT00160251|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
97517|NCT00166036|Emory University|Arshed A Quyyumi, MD|404 712 2741|aquyyum@emory.edu
97518|NCT00166114|University of Miami School of Medicine|Dominique Musselman, MD, MSCR|404-723-8361|dmusselman@med.miami.edu
97519|NCT00166166|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu
97520|NCT00166205|Worldwide Clinical Operations|Sheryl Helsinger, Director|513-337-3079|shelsing@its.jnj.com
97521|NCT00166296|Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona|Crisanto Diez-Quevedo|+34934978814|cdiezquevedo.germanstrias@gencat.cat
97522|NCT00167778|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|Glenn K. Klute, PhD|206-277-6724|Glenn.Klute@va.gov
97523|NCT00168038|CSL Behring|Clinical Trial Disclosure Manager||clinicaltrials@cslbehring.com
97524|NCT00168064|Yaupon Therapeutics|H. Jeffrey Wilkins, MD|4843247935 ext 935|hjwilkins@yaupontherapeutics.com
97525|NCT00168103|CSL Behring|Clinical Program Director|Use email contact|clinicaltrials@cslbehring.com
97526|NCT00168298|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com
97527|NCT00168311|Monash Alfred Psychiatry Research Centre|Professor Paul Fitzgerald|+61 3 9076 6564|p.fitzgerald@alfred.org.au
97528|NCT00168324|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com
97529|NCT00168337|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
97530|NCT00168389|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
97531|NCT00168428|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com
97532|NCT00168454|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com
97533|NCT00168805|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
97534|NCT00168818|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
97535|NCT00168831|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
97536|NCT00168844|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
97537|NCT00169442|GlaxoSmithKline|GSK Response Center|866-435-7343|
97538|NCT00170157|Mayo Clinic|Eugene D. Kwon||kwon.eugene@mayo.edu
97539|NCT00163189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97540|NCT00163215|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97542|NCT00171704|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300|
97543|NCT00171834|Novartis Pharmaceuticals|Study Director|862-778-8300|
97544|NCT00171873|KKS Marburg|Carmen Schade-Brittinger|0049-6421-2866458|carmen.brittinger@kks.uni-marburg.de
97545|NCT00171925|Novartis Pharmaceuticals|Study Director|862-778-8300|
97546|NCT00172042|Novartis Pharmaceuticals|Study Director|862-778-8300|
97547|NCT00172185|NPS Pharmaceuticals|Vice President, Clinical Development|908-450-5300|info@npsp.com
97548|NCT00166361|Mayo Clinic|Dr. Lance A. Mynderse|507-284-1250|mynderse.lance@mayo.edu
97549|NCT00166504|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
97550|NCT00166517|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
97551|NCT00166712|Comprehensive Transplant Center, Northwestern University|Joseph Leventhal, MD, PhD, Associate Professor|(312) 695-1703|jleventh@nmh.org
97554|NCT00167206|Masonic Cancer Center, University of Minnesota|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu
97555|NCT00167245|University of Pennsylvania|Dr. Kyle Kampman|2152223200 ext 109|kampman@mail.med.upenn.edu
97556|NCT00167310|UPittsburgh|Dr. Jeffrey K. Yao, Research Professor|412-360-6781|jkyao@pitt.edu
97557|NCT00167388|University of Pittsburgh|Dr. Toby Yanowitz|412-641-4111|yanotd@mail.magee.edu
97558|NCT00167544|Nationwide Children's Hospital Clinical Research Institute|Dr. Nehal Parikh|614-355-6657|nehal.parikh@nationwidechildrens.org
97559|NCT00174187|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97560|NCT00174252|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97561|NCT00174265|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
97562|NCT00174291|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97563|NCT00175877|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
97564|NCT00176202|University of Illinois at Chicago|Dr Mani Pavuluri|3124130064|mpavuluri@psych.uic.edu
97565|NCT00176228|Uillinois|Dr. Mani Pavuluri|312 4130064|mpavuluri@psych.uic.edu
97566|NCT00176254|University of Kentucky|Dr. Emily Van Meter/Assistant Professor, Division of Cancer Biostatistics|859-323-3076|emily.vanmeter@uky.edu
97567|NCT00176306|University of Kentucky|Aaron Cook|8593239258|amcook0@email.uky.edu
97568|NCT00176436|Maryland Psychiatric Research Center|M. Patricia Ball, R.N., C.,M.S.|410-402-7663|pball@mprc.umaryland.edu
97569|NCT00176462|Rutgers Cancer Institute of New Jersey|Richard Drachtman, MD|732-235-8675|drachtri@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu
97570|NCT00176488|Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
97571|NCT00176501|Rutgers Cancer Institute of New Jersey|Dr. Roger Strair, MD, PhD|732-235-8675|strairrk@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
97572|NCT00176605|Rutgers Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
97573|NCT00176631|Rutgers Cancer Institute of New Jersey|Dr. Robert DiPaola, MD|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
97574|NCT00176644|Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
97575|NCT00176800|University of Michigan Comprehensive Cancer Center|Dr. Susan Urba, M.D.|734-615-4762|surba@umich.edu
97576|NCT00176826|University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu
97579|NCT00176865|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu
97580|NCT00176878|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu
97581|NCT00176904|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu
97582|NCT00176917|Masonic Cancer Center, University of Minnesota|Paul J. Orchard, M.D.|612-626-2313|orcha001@umn.edu
97583|NCT00177164|UPMC|K.N. Roy Chengappa|412-246-5006|chengappakn@upmc.edu
97584|NCT00177216|University of Pittsburgh|Jean Miewald|412-246-6406|miewaldjm@upmc.edu
97585|NCT00177255|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu
97586|NCT00177294|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu
97587|NCT00177307|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu
97588|NCT00177671|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu
97589|NCT00177866|University of Pittseburgh|George Arnold, MD|412 621-2334|Arnoldgl@upmc.edu
97590|NCT00177970|UPittsburgh|Dr. George Arnold|4126212334|arnoldgl@upmc.edu
97591|NCT00178126|University of PIttsburgh|David Brienza|(412) 624-6383|DBrienza@pitt.edu
97592|NCT00178178|University of Rochester|Dr. Robert Bronstein|585-275-1024|robert_bronstein@urmc.rochester.edu
97593|NCT00178191|University of Rochester|Michael Flynn|585-273-3232|Michaelk_flynn@urmc.rochester.edu
97594|NCT00170625|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de
97595|NCT00170846|Novartis Pharmaceuticals|Study director|862-778-8300|
97596|NCT00170950|Novartis Pharmaceuticals|Study Director|862 778-8300|
97597|NCT00171054|Novartis Pharmaceuticals|Study Director|862-778-8300|
97598|NCT00171210|Novartis Pharmaceuticals|Study Director|862-778-8300|
97599|NCT00171301|Novartis Pharmaceuticals|Study Director|862-778-8300|
97600|NCT00171314|Novartis Pharamaceuticals|Novartis Pharmaceuticals|862-778-8300|
97601|NCT00171340|Novartis Pharmaceuticals|Study Director|862- 778 8300|
97602|NCT00178256|University of Rochester|Yuhchyau Chen MD, PhD|585-275-5575|yuhchyau_chen@urmc.rochester.edu
97604|NCT00178477|University of Rochester Medical Center|Walter O'Dell, Ph.D.|585-275-9996|walter_odell@urmc.rochester.edu
97605|NCT00178503|University of Texas Medical School at Houston|Deborah A. Pearson, Ph.D.|713-486-2588|Deborah.A.Pearson@uth.tmc.edu
97606|NCT00180271|Boston Scientific|Lisa Melchior|800 227 3422|lisa.melchior@bsci.com
97607|NCT00180323|Rigshospitalet, Copenhagen Unviversity Hospital, Denmark|Dr. Jesper Hastrup Svendsen||jesper.hastrup.svendsen@rh.regionh.dk
97608|NCT00180479|Abbott Vascular|Ellen Travis, Clinical Science|408-845-1512|Ellen.Travis@av.abbott.com
97609|NCT00180687|Imperial College London|Dr. Nawar Alkhamesi|442033121110|n.alkhamesi@imperial.ac.uk
97610|NCT00181155|Johns Hopkins University|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu
97611|NCT00181610|Massachusetts General Hospital|Corrine Welt, MD|617-726-8437|cwelt@partners.org
97613|NCT00181714|Massachusetts General Hospital|Paul Hammerness, MD|617-503-1063|phammerness@partners.org
97614|NCT00181766|Massachusetts General Hospital|Joseph Biederman, MD|617-726-1743|jbiederman@partners.org
97615|NCT00181844|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org
97616|NCT00181883|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org
97617|NCT00182000|Massachusetts General Hospital|Sabine Wilhelm, PhD|6177246146|swilhelm@partners.org
97618|NCT00182078|Massachusetts General Hospital|Dr. Frederick J. Stoddard Jr., M.D.|6173714762|fstoddard@partners.org
97619|NCT00182091|Massachusetts General Hospital|Dr. Anne Klibanski|617-726-3870|
97620|NCT00182637|UC Irvine|Dr. Lauren Pinter-Brown|(714) 456-5153|lpinterb@uci.edu
97621|NCT00182689|SWOG Statistical Center|Study Statistician|206-667-4623|
97622|NCT00182728|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
97623|NCT00174382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97624|NCT00174447|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97625|NCT00174460|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97626|NCT00174785|sanofi-aventis|International Clinical Development (ICD), Clinical Study Director||GV-Contact-us@sanofi-aventis.com
97627|NCT00174915|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
97628|NCT00174941|Takeda Global Research & Development Center, Inc.|Sr VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
97629|NCT00174954|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
97630|NCT00174967|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
97631|NCT00175006|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
97632|NCT00175019|Takeda Global Research & Development Center, Inc.|Senior Vice President, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
97633|NCT00182754|Mayo Clinic|Aminah Jatoi, M.D|507-284-4918|jatoi.aminah@mayo.edu
97634|NCT00182767|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org
97635|NCT00182793|City of Hope|Paul Frankel, Ph.D.|626-359-8111 ext 65265|pfrankel@coh.org
97636|NCT00183963|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|Victoria.Soto@med.usc.edu
97637|NCT00184002|USC Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu
97638|NCT00184028|USC/Norris Comrpehensive Cancer Center|Barbara Gitlitz, MD|323-865-3906|Gitlitz@usc.edu
97639|NCT00184054|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|victoria.soto@med.usc.edu
97640|NCT00184093|USC Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu
97641|NCT00184548|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
97642|NCT00184600|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
97643|NCT00184717|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
97644|NCT00185211|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
97645|NCT00185380|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
97646|NCT00185458|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
97647|NCT00185588|Stanford University|George Albert Fisher, Associate Professor of Medicine, Stanford University|650-725-9057|georgeaf@stanford.edu
97648|NCT00185640|Stanford University|Robert Lowsky|650-723-0822|rlowsky@stanford.edu
97649|NCT00185679|Stanford Cancer Institute|Ginna G Laport, MD|650-723-8222 ext 13911|ginna.laport@stanford.edu
97650|NCT00185692|Stanford University|Robert Lowsky|650-723-0822|rlowsky@stanford.edu
97651|NCT00185965|School of Medicine, Stanford University|Ronald Levy, MD / Robert K and Helen K Summy Professor of Medicine|650-725-6452|levy@stanford.edu
97652|NCT00186017|Stanford University School of Medicine|Dr. Terence A. Ketter, MD.|6507232507|tketter@stanford.edu
97653|NCT00186043|Bipolar and Depression Research Program, Stanford University, School of Medicine, VA Palo Alto Health Care System|Trisha Suppes MD, PhD|6504962567|tsuppes@stanford.edu
97654|NCT00186056|Stanford University|Brent Solvason|650-723-8331|solvason@stanford.edu
119109|NCT00902278|University of Massachusetts Medical School|Mary Co|5088562927|mary.co@umassmed.edu
97656|NCT00186186|Stanford University|Dr. Terence Ketter, Chief Bipolar Disorder Clinic|650-723-2515|tketter@stanford.edu
97657|NCT00178633|University of Texas Medical School at Houston|Heinrich Taegtmeyer, MD, DPhil, Principal Investigator|713 500-6569|heinrich.taegtmeyer@uth.tmc.edu
97658|NCT00178685|University of Rochester|Dr. Geoffrey Williams|585-530-2050|geoffrey_williams@urmc.rochester.edu
97659|NCT00178711|University of Texas Health Science Center|Guy L Clifton|2024224824|guy@guyclifton.com
97660|NCT00178841|Vanderbilt University Dermatology|John Zic, MD|615-322-6485|john.zic@vanderbilt.edu
97661|NCT00178919|Vanderbilt University|Italo Biaggioni|615-343-6499|italo.biaggioni@vanderbilt.edu
97662|NCT00179309|National Cancer Institute, National Institutes of Health|Dr. James Gulley, M.D., Ph.D.|301-435-2956|gulleyj@mail.nih.gov
97663|NCT00179413|BIDMC|Dr. Nezam Afdhal|617632118|nafdhal@bidmc.harvard.edu
97664|NCT00179478|University of California San Diego|Revere P Kinkel MD (PI)|619-543-5295|rkinkel@ucsd.edu
97665|NCT00179517|Beth Israel Deaconess Medical Center|Andrew G Herzog MD,MSc|781-431-0277|aherzog@bidmc.harvard.edu
97666|NCT00179621|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
97667|NCT00179647|Celgene Corporation|Robert D. Knight, M.D.|908-673-9749|rknight@celgene.com
97668|NCT00179660|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
97669|NCT00179673|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|888-260-1599|clinicaltrialdisclosure@celgene.com
97670|NCT00179959|Children's Memorial Hospital|Amy Paller, MD|312-695-6829|apaller@nmff.org
97671|NCT00186446|Stanford University|aimee-noelle swanson|650-736-4559|aimnoe@stanford.edu
97672|NCT00186485|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu
97673|NCT00186537|Stanford University|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu
97674|NCT00190671|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97675|NCT00190684|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97676|NCT00190749|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97677|NCT00190775|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97678|NCT00190983|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97679|NCT00191100|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97680|NCT00191113|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97681|NCT00191139|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97682|NCT00191152|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97683|NCT00191165|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97684|NCT00191191|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97685|NCT00191269|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97686|NCT00191282|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97687|NCT00191308|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97688|NCT00191334|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97689|NCT00191386|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97690|NCT00191451|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97691|NCT00191477|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97692|NCT00191646|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97693|NCT00191724|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97694|NCT00191789|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97695|NCT00191815|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97696|NCT00191854|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97697|NCT00191906|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97698|NCT00191945|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97699|NCT00191984|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97700|NCT00192023|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
97701|NCT00192036|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97702|NCT00192075|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
97703|NCT00183092|UCaliforniaSF|Michael Geschwind, MD, PhD|415-476-2901|mgeschwind@memory.ucsf.edu
97704|NCT00183196|Medical University of South Carolina|Raymond F. Anton, MD|843-792-1226|antonr@musc.edu
97705|NCT00183248|University of Miami|George W. Burke III, M.D.|(305) 355-5060|Gburke@med.miami.edu
97706|NCT00183274|UPENN|Karl Rickels, M.D.|215-746-6417|krickels@mail.med.upenn.edu
97707|NCT00183339|University of North Carolina|Linmarie Sikich, MD|919 966 8653|Lsikich@med.unc.edu
97708|NCT00183430|VA Puget Sound HCS|Murray A. Raskind, MD|206-277-3797|Murray.Raskind@va.gov
97709|NCT00183456|Johns Hopkins Bloomberg School of Public Health|Carl Latkin, PhD||clatkin@jhsph.edu
97710|NCT00183469|University of Texas Health Science Center San Antonio|Charles L. Bowden, M.D. Clinical Professor|210 567 5405|bowdenc@uthscsa.edu
97711|NCT00183625|Semel Institute at UCLA|Stephen R. Marder, M.D.|310-268-3647|marder@ucla.edu
97712|NCT00183677|Massachusetts General Hospital|Dan Iosifescu, MD, MSc||diosifescu@partners.org
97713|NCT00183729|Washington University School of Medicine|Eric Lenze|314-362-1671|lenzee@wustl.edu
97714|NCT00183794|USC/Norris Cancer Comprehensive Cancer Center|Agustin Garcia, MD|323-865-3900|aagarcia@usc.edu
97715|NCT00192296|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com
97716|NCT00193037|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com
97717|NCT00193050|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSarah@scresearch.net
97718|NCT00193063|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net
97719|NCT00193128|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
97720|NCT00193180|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net
97721|NCT00193206|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net
97722|NCT00193219|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net
97723|NCT00193258|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
97724|NCT00193375|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net
97725|NCT00193414|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
97726|NCT00193427|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net
97727|NCT00193453|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|askSarah@scresearch.net
97728|NCT00193479|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com
97729|NCT00193492|Sarah Cannon Research Institute|John Hainsworth MD|1-877-691-7274|asksarah@scresearch.net
97730|NCT00193596|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
97731|NCT00193609|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
97732|NCT00194012|Johns Hopkins University School of Medicine|Robert Findling, MD, MBA, Director, Child and Adolescent Psychiatry|410-614-3225|rfindli1@jhmi.edu
97733|NCT00194025|Case Western Reserve University and Unversity Hospitals Case Medical Center|Martha Sajatovic MD|216-844-2808|martha.sajatovic@uhhospitals.org
97734|NCT00194077|Johns Hopkins University School of Medicine|Robert Findling, MD,MBA Director, Child and Adolescent Psychiatry|410-614-3225|rfindli1@jhmi.edu
97736|NCT00194532|University Of Washington|Ann Stapleton, MD|206-616-4121|stapl@uw.edu
97737|NCT00194610|University of Washington|Claire Yang, MD|206-744-6384|cyang@uw.edu
101920|NCT00505934|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
97739|NCT00194792|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu
97740|NCT00194896|University of Washington|Jerry P. Palmer, MD|206-764-2495|jpp@u.washington.edu
97741|NCT00195013|Weill Cornell Medicine|Linda Vahdat, MD|646-962-9888|ltv2001@med.cornell.edu
97742|NCT00195039|Weill Cornell Medicine|Scott Tagawa, MD||guonc@med.cornell.edu
97743|NCT00187200|St. Jude Medical|Ashish Oza|(818) 493-3648|aoza@sjm.com
97744|NCT00187226|St. Jude Children's Research Hospital|Thomas E. Merchant, DO, PhD|901-595-3604|thomas.merchant@stjude.org
97745|NCT00187486|University of California San Francisco|Michael Prados, MD|415 353 2076|PradosM@neurosurg.ucsf.edu
97746|NCT00187655|UCSF|Richard Castro, MD|4155144363|Rich.Castro@ucsf.edu
97747|NCT00187681|UCSF|Kathy Giacomini, Ph.D|4154761936|Kathy.Giacomini@ucsf.edu
97748|NCT00187720|UCSF|Kathy Giacomini, Ph.D|4154761936|Kathy.Giacomini@ucsf.edu
97749|NCT00187876|University of Florida|Peter Indelicato, MD|352-273-7017|wernegs@ortho.ufl.edu
97751|NCT00189098|Wilhelmina Children's Hospital, University Medical Center Utrecht|Prof. A. Schilder|0031 302504580|A.Schilder@umcutrecht.nl
97752|NCT00189137|University of Michigan Comprehensive Cancer Center|Dr. Scott Schuetze, M.D., Ph.D.|1-800-865-1125|scotschu@umich.edu
97753|NCT00189202|University of Michigan|Dr. Akinlolu Ojo, Professor of Medicine|734 9364890|aojo@umich.edu
97754|NCT00189306|Graceway Pharmaceuticals|Medical Director|267-984-0400|jim.lee@gracewaypharma.com
97756|NCT00189436|Allegheny Singer Research Institute, WPAHS|David Skoner, MD|412-359-4099|dskoner@wpahs.org
97757|NCT00189462|West Penn Allegheny Health System|David Skoner, MD|4123594099|dskoner@wpahs.org
97758|NCT00189475|Allegheny Singer Research Institute, WPAHS|David Skoner, MD|4123594099|dskoner@wpahs.org
97759|NCT00189488|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com
97761|NCT00195260|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97762|NCT00195273|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
97763|NCT00195338|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97764|NCT00195351|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
97765|NCT00195403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97766|NCT00195429|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
97767|NCT00195442|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97768|NCT00195494|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
97769|NCT00195507|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
97770|NCT00199381|Kyowa Hakko Kirin Pharma, Inc.|Director of Clinical Trials|609-919-1100|mcantillon@kyowa-kirin-pharma.com
97771|NCT00199914|Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand|Manee Rattanachaiyanont|+66-2419-4657|manee.rat@mahidol.ac.th
97772|NCT00200057|Medtronic Neuromodulation|Chad Giese|763-377-5955|chad.giese@medtronic.com
97773|NCT00200343|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
97774|NCT00200356|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
97775|NCT00200785|Silliker, Inc./Plant Bioactives Research Institute, Inc.|Larry D. Lawson|801-226-3041|larry.lawson@silliker.com
97776|NCT00200967|Penn State College of Medicine|Vernon M. Chinchilli|717-531-4262|vchinchi@psu.edu
97777|NCT00201006|University of Florida|Michael G. Perri, PhD|352 273-6214|mperri@ufl.edu
97778|NCT00201123|NYU School of Medicine|William Rom MD|212 263-6479|William.Rom@nyumc.org
97779|NCT00201201|University of Connecticut|Patricia J. Neafsey, PhD|860-486-0779|pjneafsey@actualmeds.com
97780|NCT00201240|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com
97781|NCT00201409|University of Michigan|Dr. Robert Hyzy|7349365201|rhyzy@umich.edu
97782|NCT00186875|St. Jude Children's Research Hospital|Sima Jeha, MD|866-278-5833|info@stjude.org
97783|NCT00186888|St. Jude Children's Research Hospital|Ibrahim Qaddoumi MD|1-866-278-5833|info@stjude.org
97784|NCT00186901|St. Jude Children's Research Hospital|Sue Kaste, DO|866-278-5833|referralinfo@stjude.org
97785|NCT00187096|St. Jude Children's Research Hospital|Jeffrey Rubnitz, MD|1-866-278-5833|info@stjude.org
97786|NCT00187135|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|866-278-5833|referralinfo@stjude.org
97787|NCT00192647|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
97788|NCT00201448|Virginia Commonwealth University|Stuart Adler|8048281807|sadler@vcu.edu
97789|NCT00201643|Obstetrix Medical Group, Inc.|Kimberly A. Maurel, MSN, CNS|714-593-9171|kimberly_maurel@pediatrix.com
97790|NCT00201734|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, MD|614-293-9863|tanios.bekaii-saab@osumc.edu
97791|NCT00201773|The Ohio State University Comprehensive Cancer Center|Steven Provoski, MD|614-293-8700|Stephen.Povoski@osumc.edu
97792|NCT00203047|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
97793|NCT00203203|Texas Heart Institute|Emerson C. Perin, M.D., Ph.D.|832-355-9405|eperin@texasheart.org
97794|NCT00203216|Thomas Jefferson University/Jefferson Headache Center|Dr. William Young, Principal Investigator|215-955-2243|William.B.Young@Jefferson.Edu
97795|NCT00203229|Thomas Jefferson University|M. Alan Stiles|215-955-6215|Alan.Stiles@Jefferson.edu
97796|NCT00203242|Thomas Jefferson University/Jefferson Headache Center|Stephen D. Silberstein-Principal Investigator|215-955-9477|Stephen.Silberstein@jefferson.edu
97797|NCT00203268|Thomas Jefferson University|Stephen D. Silberstein, MD|215-955-2243|Stephen.Silberstein@Jefferson.edu
102163|NCT00513370|Abbott|Medical Information Specialist|1-800-633-9110|
97798|NCT00203294|Thomas Jefferson University|Kathleen Bradley|215-955-2025|Kathleen.Bradley@Jefferson.edu
97799|NCT00203307|Thomas Jefferson University/ Jefferson Headache Center|Stephen D. Silberstein, M.D.- Principal Investigator|215-955-2243|stephen.silberstein@jefferson.edu
97800|NCT00203411|Translational Research in Oncology|Dr. Arash Naeim|310 267-6810|anaeim@mednet.ucla.edu
97801|NCT00203424|Translational Oncology Research International|Dr. Fairooz F. Kabbinavar, Chief Medical Officer|310-824-1934|FKabbina@mednet.ucla.edu
97802|NCT00203476|TuscaloosaREAC|Raela Williford, PharmD|(205) 554-2000 ext 2433|Raela.Williford@va.gov
97803|NCT00203502|University of Arkansas for Medical Sciences|Dr. Issam Makhoul|5016868274|MakhoulIssam@uams.edu
97804|NCT00203892|University of Chicago|Dr. Hedy Kindler|773-702-0360|hkindler@medicine.bsd.uchicago.edu
97805|NCT00203931|University of Chicago|Kristen Wroblewski|773-702-7173|kwroblewski@health.bsd.uchicago.edu
97806|NCT00203996|The University of Chicago|David A. Ehrmann, MD|(773) 702-6138|dehrmann@medicine.bsd.uchicago.edu
97807|NCT00204373|The University of Alabama at Birmingham|Dr. C. Mel Wilcox|205-934-6060|melw@uab.edu
97808|NCT00204932|U Wisconsin-Madison|Dale Schoeller Principal Investigator|608-262-1082|dschoell@nutrisci.wisc.edu
97809|NCT00205049|University of Wisconsin|Research Program Manager - Kelly Richie|608-262-5404|kr2@medicine.wisc.edu
97811|NCT00196326|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|
97812|NCT00196716|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com
97813|NCT00196937|GlaxoSmithKline|GSK Response Center|866-435-7343|
97814|NCT00196976|GlaxoSmithKline|GSK Response Center|866-435-7343|
97815|NCT00197002|GlaxoSmithKline|GSK Response Center|866-435-7343|
97816|NCT00197015|GlaxoSmithKline|GSK Response Center|866-435-7343|
97817|NCT00197028|GlaxoSmithKline|GSK Response Center|866-435-7343|
97818|NCT00197106|GlaxoSmithKline|GSK Response Center|866-435-7343|
97819|NCT00197119|GlaxoSmithKline|GSK Response Center|866-435-7343|
97820|NCT00197184|GlaxoSmithKline|GSK Response Center|866-435-7343|
97821|NCT00197236|GlaxoSmithKline|GSK Response Center|866-435-7343|
97822|NCT00197392|Codman & Shurtleff, Inc|J. Thomas Megerian, MD|508.880.8274|jmegeri1@its.jnj.com
97823|NCT00197496|University of Waterloo|Dr. Lora Giangregorio|5198884567 ext 36357|lmgiangr@uwaterloo.ca
97824|NCT00198029|Hospital for Special Surgery|Dr. Lisa Mandl|212-774-2555|MandlL@hss.edu
97825|NCT00198042|Hospital for Special Surgery|Scott Rodeo, MD|212-606-1000|rodeos@hss.edu
97826|NCT00198081|Indiana University|Christian M. Schmidt, MD|317-278-8349|maxschmi@iupui.edu
97827|NCT00198133|IndianaU|Patrick J. Loehrer, Sr., M.D.|(317)944-0920|ploehrer@iu.edu
97828|NCT00198822|Center for Human Nutrition, Department of International Health, Johns Hopkins Bloomberg School of Public Health|Prof. Keith P West, Jr., Principal Investigator|410-955-2061|kwest@jhsph.edu
97830|NCT00205712|Washington University School of Medicine|John Newcomer, MD|314-362-3153|newcomerj@wustl.edu
97831|NCT00205777|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97832|NCT00205803|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97833|NCT00205855|Boston Scientific Corporation|Natalie Bloom Lyons|763-228-9040|lyonsn@bsci.com
97834|NCT00205881|Advanced Bionics, LLC|Kenneth Ripley|(661) 362-4572|Kenneth.Ripley@advancedbionics.com
97835|NCT00206076|Drexel University College of Medicine|David Reich, MD|215-762-7143|David.Reich@DrexelMed.edu
97836|NCT00206102|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
97837|NCT00206427|Baylor Breast Cancer|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.tmc.edu
97838|NCT00206440|Baylor College of Medicine|Mothaffar Rimawi|713 798 1999|rimawi@bcm.tmc.edu
97839|NCT00206518|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu
97840|NCT00206726|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
97841|NCT00207090|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
97842|NCT00207142|Bristol-Myers Squibb|Study Director||clinical.trials@bms.com
97843|NCT00207714|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399|
97844|NCT00207727|Centocor Research & Development, Inc.|Sr. Dir. Clinical Research|1-800-457-6399|
97845|NCT00207740|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399|
97846|NCT00207883|Children's Healthcare of Atlanta / Emory University|Jana Stockwell, MD|404-785-1600|jana.stockwell@choa.org
97848|NCT00208091|Clinical Motor Physiology Laboratory|Dr. Seth Pullman|212-305-3808|sp31@columbia.edu
97849|NCT00195650|Abbott|Global Medical Services|800-633-9110|
97850|NCT00195663|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
97851|NCT00195676|Abbott|Global Medical Services|800-633-9110|
97852|NCT00195702|Abbott|Global Medical Services|800-633-9110|
97853|NCT00195715|Abbott|Global Medical Services|1-800-633-9110|
97854|NCT00195819|Abbott|Global Medical Services|800-633-9110|
97855|NCT00196105|Cook|Scott Snyder|765-463-7537|ssnyder@medinst.com
97856|NCT00196196|Codman & Shurtleff, Inc.|Jandira Ramos, MPH|508-828-3127|jramos8@its.jnj.com
97857|NCT00196313|Duramed Research|Duramed Research Protocol Chair|215-293-7279|role_medical_affairs@tevapharm.com
97858|NCT00201825|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, MD|614-293-6529|Tanios.Saab@osumc.edu
97860|NCT00201851|International Breast Cancer Research Foundation|Richard R. Love|608-698-7881|richardibcrf@gmail.com
97861|NCT00201864|The Ohio State University|Ewa Mrozek|614-293-7956|Ewa.Mrozek@osumc.edu
97863|NCT00202449|VA PSHCS|Murray Raskind, MD|206-764-2702|Murray.Raskind@va.gov
97864|NCT00202722|Sorlandet Hospital HF|Tor Tveit|+4738073608|tor.tveit@sshf.no
97865|NCT00202839|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
97866|NCT00202878|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
97867|NCT00208325|DePuy International|Kimberly Dwyer, Ph.D, CCRA||kdwyer2@its.jnj.com
97868|NCT00208494|DePuy Orthopaedics, Inc.|Jennifer Hoag, MS, Project Leader, Clinical Research|574-372-7399|JHoag2@its.jnj.com
97869|NCT00208507|DePuy Orthopaedics, Inc|Dave Whalen|574-372-7028|DWhalen@its.jnj.com
97870|NCT00209417|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|Paul.Gordon@ge.com
97871|NCT00209560|Eisai Inc|Eisai Medical Services|1-888-422-4743|
97872|NCT00210470|IRX Therapeutics, Inc.|Zygmund Roth, Ph.D., V.P., Regulatory Affairs and QA|631-465-2028|zroth@irxtherapeutics.com
97873|NCT00210626|Centocor Ortho Biotech Services, LLC (COBS)|Vice President Medical Affairs|215-325-4464|
97874|NCT00210639|Janssen R&D US|Director, Clinical Research|1 609 730-3158|
97876|NCT00211172|Kaiser Permanente Center for Heatlh Research|David H. Smith|503-335-6302|david.h.smith@kpchr.org
97878|NCT00211510|Medtronic, Inc|John Shin, PhD, MBA|818 576 4019|john.shin@medtronic.com
97879|NCT00211536|Sr. Clinical Research Manager|John Shin|818-576-4019|john.shin@medtronic.com
97880|NCT00211692|VA San Diego Healthcare System|Samuel B. Ho, MD, Chief GI Section|858-552-8585 ext 2631|samuel.ho2@va.gov
97881|NCT00211809|Icahn School of Medicine at Mount Sinai|Dr. Andrea Allen|212-241-3176|andrea.allen@mssm.edu
97882|NCT00211887|Icahn School of Medicine at Mount Sinai|Dr. Fred D. Lublin|212-241-6854|fred.lublin@mssm.edu
97883|NCT00212134|Emory School of Medicine|Scott R Lambert, MD, Study Chairman|404-778-3709|slamber@emory.edu
97884|NCT00213135|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
97886|NCT00214201|UW Madison|Director of Clinical Trials|608-263-2565|
97887|NCT00214383|University of Wisconsin - Madison|Alice Pulvermacher|(608) 262-8448|alice.pulvermacher@chess.wisc.edu
97888|NCT00214461|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
97889|NCT00214487|Dr. Thomas Aller, Optometrist Inc.|Dr. Thomas Aller|650 871-1816|cptreyes@earthlink.net
97890|NCT00214526|Boston Scientific Corporation|Mark G. Grubb|412-749-1423|Mark.Grubb@bsci.com
97891|NCT00214539|Asthmatx, Inc.|Narinder S Shargill, PhD|408-419-0100|
97892|NCT00214786|Baylor University Medical Center|Dr. Marlon Levy|214-820-2050|Marlon.Levy@baylorhealth.edu
97893|NCT00214903|Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD|+49 (0) 30 945 101 20|dinger@zeg-berlin.de
97894|NCT00215137|Duke University Medical Center Dept of Psychiatry|Wei Zhang MD|919 684 5645|wei.zhang@duke.edu
97895|NCT00215150|Duke University Medical Center|Wei Zhang, MD|(919) 684 5645|wei.zhang@duke.edu
97896|NCT00208767|Emory University School of Medicine|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu
97897|NCT00208949|Emory University|Dr. Sagar Lonial|404-778-1900|SLONI01@emory.edu
97898|NCT00208975|Emory University|Dr. Christopher Flowers|404-778-3942|crflowe@emory.edu
97899|NCT00209027|Emory University|Erica Duncan|404-321-6111 ext 7532|erica.duncan@va.gov
97900|NCT00209092|Emory University|Dr. Amelia Zelnak|404-778-1900|amelia.zelnak@emory.edu
97901|NCT00209131|Emory University|Dr. Kenneth Ogan|404-778-4898|kogan@emory.edu
97902|NCT00209170|University of Miami School of Medicine|Dominique Musselman, MD|404-723-8361|dmusselman@med.miami.edu
97903|NCT00209274|Abbott Vascular Structural Heart (formerly Evalve, Inc.)|Chithra Sangli|650-421-6994|chithra.sangli@av.abbott.com
97904|NCT00209339|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com
97905|NCT00215540|Discovery Laboratories, Inc.|Dr. Robert Segal|215-488-9300|rsegal@discoverylabs.com
97906|NCT00215553|Discovery Laboratories, Inc.|Robert Segal, MD|215-488-9300|rsegal@discoverylabs.com
97907|NCT00215657|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
97908|NCT00215683|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
97909|NCT00216060|Hoosier Oncology Group|Christopher Sweeney, M.B., B.S.|(617) 632 4524|christopher_sweeney@dfci.harvard.edu
97910|NCT00216086|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org
97911|NCT00216099|Hoosier Cancer Research Network|Jeff Smith|317-921-2050|jsmith@hoosiercancer.org
97912|NCT00216125|Hoosier Cancer Research Network|Georgia Gould|3176385842 ext 10|ggould@hoosiercancer.org
97913|NCT00216203|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org
97914|NCT00216320|Innovative Neurotronics|Director of Clinical Research|512-721-1922|hrogers@ininc.us
97915|NCT00216476|Janssen Cilag European Medical Affairs|EMEA Medical Affairs Director Psychiatry|+34 91 7228043|
97916|NCT00216671|Janssen Cilag Spain|EMEA Medical Affairs Director Psychiatry|+34 91 7228043|
97917|NCT00216736|Joseph Epstein Centre for Emergency Medicine Research|Prof Anne-Maree Kelly|+61383456666|anne-maree.kelly@wh.org.au
97918|NCT00217022|Mayo Clinic, Rochester MN|Dr. Darrell Pardi|507-538-1231|pardi.darrell@mayo.edu
97919|NCT00217087|Mayo Clinic|Kenneth Wang MD|507-255-7495|wang.kenneth@mayo.edu
97920|NCT00217399|Georgetown University|Dr. Claudine Isaacs|202-444-3677|isaacsc@georgetown.edu
97921|NCT00217425|ECOG Statistical Office|Study Statistician|617-632-3012|
97922|NCT00217438|Fred Hutchinson Cancer Research Center|Dr. William Bensinger|206-667-4933|wbensing@fhcrc.org
97923|NCT00217464|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
97924|NCT00217490|Kaiser Permanente Center for Health Research|Victor J. Stevens, PhD|503 335 6751|victor.j.stevens@kpchr.org
97925|NCT00217581|Barbara Ann Karmanos Institute|Philip A. Philip, M.D., Ph.D., F.R.C.P|(313) 576-8746|philipp@karmanos.org
97926|NCT00217620|SWOG Statistical Center|Study Statistician|206-667-4623|
97927|NCT00217672|University of California, Los Angeles|Sara Hurvitz, M.D.|310-829-5471|shurvitz@mednet.ucla.edu
97928|NCT00217724|OHSU Knight Cancer Institute|Joseph Bublao|503-494-1054|bubaloj@ohsu.edu
97929|NCT00217971|Columbia University|Frances R. Levin, M.D.|(212) 543-5896|frl2@columbia.edu
97930|NCT00218023|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu
97931|NCT00218062|The University of Texas Health Science Center at Houston|Dr Joy M. Schmitz|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu
97933|NCT00218335|Johns Hopkins Bloomberg School of Public Health|Carl Latkin, PhD||clatkin@jhsph.edu
97934|NCT00218439|University of Minnesota College of Pharmacy|Dr. Michael Kotlyar|612-625-1160|kotly001@umn.edu
97935|NCT00218465|Center for Addiction Medicine|Sara Carlini|617-643-1990|scarlini@partners.org
97936|NCT00218543|COLUMBIA UNIVERSITY|Frances R Levin, MD|212-543-5896|FRL2@COLUMBIA.EDU
97937|NCT00212264|University of Alabama at Birmingham|Patricia S Goode, MD|2055587064|pgoode@uabmc.edu
97938|NCT00212355|Nobelpharama|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp
97939|NCT00212758|Oregon Health & Science University|Dr. Amira Al-Uzri|503-494-7327|aluzria@ohsu.edu
97940|NCT00218634|Mass General Hospital|Steven Safren|617 724 0817|ssafren@partners.org
97941|NCT00219141|Novartis Pharmaceuticals|Study Director|862 778-8300|
97942|NCT00219284|Novartis Pharmaceuticals|Study Director|862-778-8300|
119115|NCT00748969|LA Biomed at Harbor-UCLA Medical Center|Dr. Lynda Polgreen|310-222-1972|lpolgreen@labiomed.org
97944|NCT00219544|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97945|NCT00219557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
97946|NCT00220636|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu
97947|NCT00220701|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu
97948|NCT00220727|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com
97949|NCT00220740|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com
97950|NCT00220779|Talecris Biotherapeutics|Ralph Kantor, PhD|1-800-520-2807|ralph.kantor@talecris.com
97951|NCT00220805|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com
97952|NCT00220961|University of Texas Health Science Center at San Antonio|Ralph DeFronzo, MD|210-567-6691|defronzo@uthscsa.edu
97953|NCT00221195|Tulane University|Cindy Leissinger|504-988-5433|cleissi@tulane.edu
97954|NCT00221299|Unversity of California Davis|Nancy E. Lane MD, Director, Center for Musculoskeletal Health|916 734-0753|nancy.lane@ucdmc.ucdavis.edu
97955|NCT00215787|Head and Neck Surgery Associates|Scott Phillips|317-926-1056|sphillips@hnsaonline.com
97956|NCT00215930|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|Gerald Bepler, M.D., via Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org
97957|NCT00215943|H. Lee Moffitt Cancer Center and Research Institute|Melissa Alsina, M.D.|813-745-6886|melissa.alsina@moffitt.org
97958|NCT00222105|University of Kansas Medical Center|Cancer Center Clinical Trials Office|(913) 945-5059|SWILLIAM@kumc.edu
97959|NCT00222729|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu
97960|NCT00223236|The University of Texas Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D., Professor|214-645-6950|sherwood.brown@utsouthwestern.edu
97961|NCT00223496|UTHSCSA|Dr. Charles Bowden|210-567-5479|Bowdenc@uthscsa.edu
97962|NCT00223652|Northwestern University|David C. Mohr|312- 503-1403|d-mohr@northwestern.edu
97963|NCT00223678|Vanderbilt Medical Center|Dr. Anthony Langone|615-936-1179|anthony.langone@vanderbilt.edu
97964|NCT00223704|Vanderbilt University|Mias Pretorius, Associate Professor of Anesthesiology and Clinical Pharmacology|615-8757402|mias.pretorius@vanderbilt.edu
97966|NCT00223808|CTVHCS|Charles Burgar, MD|254/743-0085|charles.burgar1@va.gov
97967|NCT00223821|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu
97968|NCT00223977|Watson Laboratories, Inc|Gary Hoel, RPh, PhD|801-588-6641|gary.hoel@watson.com
97969|NCT00224003|Watson Laboratories, Inc|Gary Hoel, RPh, PhD|801-588-6641|gary.hoel@watson.com
97970|NCT00224016|Watson Laboratories, Inc|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com
97971|NCT00224029|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com
97972|NCT00224042|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com
97973|NCT00224055|Watson Pharmaceuticals, Inc|Naomi Dahl, PharmD Director, Clinical Affairs||Naomi.dahl@watson.com
97974|NCT00224107|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com
97975|NCT00224120|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com
97976|NCT00224133|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com
97977|NCT00224289|Principal Investigator|Bruce Shields, MD|203-785-6288|bruce.shields@yale.edu
97978|NCT00224484|GlaxoSmithKline|GSK Response Center|866-435-7343|
97979|NCT00224770|Johns Hopkins University|Dr. Daniel F. Hanley|(410) 614-6996|dhanley@jhmi.edu
97980|NCT00225212|Stanford University Medical Center|Neal Birkett, MS, RAC|650-723-6456|nbirkett@stanford.edu
97981|NCT00225251|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu
97982|NCT00225277|Takeda Global Research and Development Center Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com
97983|NCT00225420|Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu
97984|NCT00225498|Feinstein Institute for Medical Research, Zucker Hillside Hospital|Anil K. Malhotra, MD|718-470-8012|malhotra@lij.edu
97985|NCT00225732|Cumberland Pharmaceuticals Inc.|Amy Rock, Ph.D.|615-255-0068|arock@cumberlandpharma.com
97986|NCT00225784|Dartmouth-Hitchcock|J. Marc Pipas, MD|603-650-9474|J.Marc.Pipas@hitchcock.org
97987|NCT00226239|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu
97988|NCT00226577|Karmanos Cancer Institute|Gerold Bepler, M.D., Ph.D. via Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org
97989|NCT00226590|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|Gerald Bepler, M.D., Ph.D., c/o Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org
97990|NCT00226655|Celtic Pharma Development Services America Inc|Director Medical Sciences|(212) 616 4016|henk-andre.kroon@dev.celticpharma.com
97991|NCT00226811|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
97992|NCT00227019|Stanford University|Heather Wakelee, MD|650-736-7221|hwakelee@stanford.edu
97993|NCT00227266|University of Utah|Sandra Reyna, M.D.|801-581-3551|sreyna@genetics.utah.edu
97994|NCT00227305|AstraZeneca|Seroquel Medical Science Director, MD||AZTrial_Results_Posting@astrazeneca.com
97995|NCT00227344|Biosense Webster, Inc.|Pat Ticknor, Clinical Operations|909-839-8500|PTicknor@its.jnj.com
97996|NCT00227370|Duke Clinical Research Institute|Scott M. Palmer, MD, MHS|919 684 0254|scott.palmer@duke.edu
97997|NCT00227539|University of Washington|Renato G. Martins|206-288-6680|rgmart@uw.edu
97998|NCT00227591|ECOG Statistical Office|Study Statistician|617-632-3012|
97999|NCT00227721|Barbara Ann Karmanos Cancer Institute|Robert Morris, M.D.|313-576-9436|rmorris@med.wayne.edu
98000|NCT00227760|Princess Margaret Cancer Centre - University Health Network|Dr. Srikala Sridhar|416-946-2249|srikala.sridhar@uhn.ca
98001|NCT00227903|Yale University|Dr. Kimberly Yonkers|1-203-764-6621|Kimberly.Yonkers@yale.edu
98003|NCT00228384|W. L. Gore & Associates, Inc.|Chad Badorek|800/437-8181|cbadorek@wlgore.com
98004|NCT00228553|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879|
98005|NCT00228566|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879|
98006|NCT00228813|Emory University|Kuang-Yueh Chiang, MD|404-785-0858|kchian2@emory.edu
98007|NCT00228917|GlaxoSmithKline|GSK Response Center|866-435-7343|
98008|NCT00228943|Indiana University|Janet S. Carpenter|317-278-6093|carpentj@iupui.edu
98009|NCT00229203|PharmaMar USA Inc|Claudia Silvia Corrado M.D.|1 212 201 6770|cscorrado@pharmamar.com
98010|NCT00229619|NIH National Heart, Lung and Blood Institute|Adrian Wiestner MD, NHLBI|301-594-6855|wiestnera@nhlbi.nih.gov
98011|NCT00229658|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
98012|NCT00229723|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
98013|NCT00229931|Dean McGee Eye Institute|Robert E. Leonard, II, MD|405-271-6307|sonny-icks@dmei.org
98014|NCT00229957|McMaster University|Dr. Julie Richardson|905-525-9140 ext 27811|jrichard@mcmaster.ca
98015|NCT00229970|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98016|NCT00230009|Wayne State University|Steven J. Ondersma, ,PI|313-577-6680|s.ondersma@wayne.edu
98017|NCT00230022|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu
98018|NCT00230048|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu
98019|NCT00230100|McLean Hospital|Shelly F. Greenfield, MD, MPH|617-855-2241|sgreenfield@mclean.harvard.edu
98020|NCT00230126|The Ohio State University|Miguel Villalona|614-366-5068|miguel.villalona@osumc.edu
98021|NCT00230178|Sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com
98022|NCT00230282|Stanford University|Steven E. Coutre, Associate Professor of Medicine|650-723-6661|coutre@stanford.edu
98023|NCT00230737|University of Pennsylvania|Dr. Nalaka Gooneratne|2674083789|ngoonera@upenn.edu
98024|NCT00230802|Brigham & Women's Hospital|Erik Alexander, MD|6177325666|ekalexander@partners.org
98025|NCT00224874|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com
98026|NCT00224952|The Children's Mercy Hospital|J. Steven Leeder Pharm D, PhD|816-234-3059|sleeder@cmh.edu
98027|NCT00225017|Northwestern University|Robert Murphy|312-503-9000|r-murphy@northwestern.edu
98028|NCT00225147|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com
98029|NCT00230971|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
98030|NCT00231062|Acclarent|Laura England, Manager-Clinical Affairs|650-687-4466|lenglan1@its.jnj.com
98031|NCT00231114|Asthmatx, Inc.|Narinder S Shargill, PhD|408-419-0100|
98032|NCT00231153|Cadence Pharmaceuticals, Inc.|Catherine Hardalo, MD Vice President Anti-Infectives, Clinical Development|858-436-1439|chardalo@cadencepharm.com
98033|NCT00231179|Children's Hospital of Philadelphia|Jerilynn Radcliffe, PhD|215-590-7446|Radcliffe@email.chop.edu
98034|NCT00234494|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org
98035|NCT00234832|Abbott|Global Medical Services|800-633-9110|
98036|NCT00234884|Abbott|Global Medical Services|1-800-633-9110|
98037|NCT00235326|McMaster University|John Marshall|9055212100 ext 76782|marshllj@mcmaster.ca
98038|NCT00235391|Novartis Pharmaceuticals|Study Director|862-778-8300|
98039|NCT00235443|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
98040|NCT00235456|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org
98041|NCT00235573|University of Florida|Gail Kauwell|352-392-1991 ext 227|gkauwell@ufl.edu
98103|NCT00234286|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu
98042|NCT00235716|Dept. of Veterans Affairs Cooperative Stduies Program|Peter Guarino, PhD, Director WH-CSPCC|203-932-5711 ext 3780|peter.guarino@va.gov
98043|NCT00235755|GlaxoSmithKline|GSK Response Center|866-435-7343|
98044|NCT00235833|Abbott|Medical Information Specialist|800-633-9110|
98045|NCT00235872|Abbott|Global Medical Services|800-633-9110|
98046|NCT00235989|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
98047|NCT00236080|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879|
98048|NCT00236184|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500|
98049|NCT00236197|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500|
98050|NCT00236899|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
98051|NCT00236938|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com
98052|NCT00236951|Luitpold Pharmaceuticals|Marc Tokars, Senior Director of Clinical Operations|610-650-4200 ext 805|mtokars@lpicrd.com
98053|NCT00236977|Luitpold Pharmaceuticals, Inc.|Marc L. Tokars, Sr. Director of Clinical Operations|610-650-4200|mtokars@lpicrd.com
98054|NCT00237042|University of Washington|Dr. Judith Turner|206-543-3997|jturner@u.washington.edu
98055|NCT00237185|Novartis|Study Director|862-778-8300|
98056|NCT00237458|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
98057|NCT00237666|The Medical Research Network, LLC|Dr. Michael Liebowitz|(212) 595-5012|MLiebowitz@MedicalResearchNetwork.com
98058|NCT00237692|Center for Primary Care, HSRD COIN|Hayden B. Bosworth, PhD|919-286-0411 ext 7107|hayden.bosworth@va.gov
98059|NCT00237718|Vanderbilt University|T. Alp Ikizler, MD||alp.ikizler@vanderbilt.edu
98060|NCT00237744|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|(352) 376-1611 ext 6603|jjd17@case.edu
98061|NCT00237770|James J Peters VA Medical Center|Dr. Jill M. Wecht, principal Investigator|718 584-9000 ext 3122|jm.wecht@va.gov
98062|NCT00237796|VA San Diego Healthcare System, San Diego|Eric Granholm, PhD|858-552-8585 ext 7768|egranholm@ucsd.edu
98063|NCT00237809|Yale University|Dr. Deepak Cyril D'Souza|203-932-5711 ext 2594|deepak.dsouza@yale.edu
119117|NCT00723255|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
98065|NCT00238121|University of Chicago Comprehensive Cancer Center|Dr. Gini Fleming|773-702-6712|gfleming@medicine.bsd.uchicago.edu
98066|NCT00238238|Meyer Cancer Center, Weill Cornell Medical College|John P Leonard, M.D.||jpleonar@med.cornell.edu
98067|NCT00238264|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
98068|NCT00238303|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-3902|galanis.evanthia@mayo.edu
98069|NCT00238355|OHSU Knight Cancer Institute|Dr. Lynne Strasfeld|503-494-1551|strasfel@ohsu.edu
119118|NCT00692185|New York State Psychiatric Institute|Evelyn Attia, MD|212-543-5923|ea12@columbia.edu
98072|NCT00238615|Stanford University|Dr. Heather Wakelee|650-736-7221|hwakelee@stanford.edu
98073|NCT00239005|Novartis Pharmaceuticals|Study Director|862-778-8300|
98074|NCT00239226|Medtronic BRC - Medtronic Italia SpA|Giorgio Corbucci - Sr Principal Scientist|+39 02 241371|giovanna.zucchi@medtronic.com
98075|NCT00239356|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
98076|NCT00239642|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|601-650-4200|dbregman@lpicrd.com
98077|NCT00239681|AstraZeneca|Torbjorn Lundstrom||ClinicalTrialTransparency@astrazeneca.com
98078|NCT00239720|University of Chicago|Marcus Clark, MD|773-702-0202|mclark@medicine.bsd.uchicago.edu
98079|NCT00239733|Weill Cornell|Kristen Marks|212-746-4177|markskr@med.cornell.edu
98080|NCT00239837|University of Oregon|Dr Leslie Leve|541-346-9528|leve@uoregon.edu
98081|NCT00232141|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98082|NCT00232180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98083|NCT00232479|UMiami|Judith Hurley|305-243-6698|jhurley@miami.edu
98084|NCT00232505|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
98085|NCT00232544|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov
98086|NCT00232557|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov
98088|NCT00232596|GlaxoSmithKline|GSK Response Center|866-435-7343|
98089|NCT00232739|Cordis|Sidney Cohen, MD PhD, Vice President|650 614-2726|scohen7@its.jnj.com
98090|NCT00233064|MedImmune, LLC|Hasan S. Jafri, MD|301-398-0000|
98091|NCT00233090|Icahn School of Medicine at Mount Sinai|Wayne A Gordon, PhD|212-659-9372|wayne.gordon@mssm.edu
98092|NCT00233103|Icahn School of Medicine at Mount Sinai|Wayne A Gordon, PhD|212-659-9372|wayne.gordon@mssm.edu
98094|NCT00233402|Photocure|Yngvil Kloster Thomas|+1 2167732505|ykt@photocure.no
98095|NCT00233454|Stanford University Medical Center|Jason R Gotlib, MD, Associate Professor of Medicine (Hematology)|650-867-2823|jason.gotlib@stanford.edu
98096|NCT00233519|University of Rochester Medical Center|Richard T. Moxley, III MD|585-275-5006|RichardT_Moxley@urmc.rochester.edu
98097|NCT00233948|City of Hope|Paul Frankel, Ph.D.|626-256-4673 ext 65265|pfrankel@coh.org
98099|NCT00234039|SWOG Statistical Center|Study Statistician|206-667-4623|
98100|NCT00234065|Department of Clinical Research and Development, Otsuka Pharmaceutical Co., Ltd.|Masahiko Abe, Director Cardiovascular Projects|+81-6-6943-7722 ext 2545|abems@otsuka.jp
98101|NCT00234078|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
98102|NCT00234104|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314|
98104|NCT00239928|Pfizer, Inc.|Pfizer Clinical Trails.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98105|NCT00240071|University of Alabama at Birmingham|Carla I Falkson|205-975-2691|cfalkson@uab.edu
98106|NCT00240097|UAB|Dr. Francisco Robert|205-934-5077|pacorobertuab@cs.com
98107|NCT00240110|Univeristy of Miami|Dr. Ihsan Salloum|305-243-7931|isalloum@med.miami.edu
98108|NCT00240162|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu
98109|NCT00240227|VA Puget Sound Health Care System|Andrew J. Saxon, M.D.|206-764-2782|andrew.saxon@va.gov
98111|NCT00241904|Johns Hopkins University|Dr. Jerilyn Allen|410-614-4882|jallen1@jhu.edu
98112|NCT00242216|The University of Texas Health Science Center at Houston|Dr. Roberto C. Arduino, Professor of Medicine|713-500-6731|roberto.c.arduino@uth.tmc.edu
98114|NCT00242502|University of Texas MD Anderson Cancer Center|Ahmed Kaseb, MD/ Professor||MJLim@mdanderson.org
98115|NCT00242567|Novartis Pharmaceuticals|Study Director|862-778-8300|
98116|NCT00242580|Novartis Pharmaceuticals|Study Director|862 778-8300|
98117|NCT00242619|Stanford University|Dr. Natalie Rasgon|(650) 724-6689|natalie.rasgon@stanford.edu
98118|NCT00242632|Stanford University|Dr. Natalie Rasgon|(650) 724-6689|natalie.rasgon@stanford.edu
98119|NCT00242658|Penn State Milton S. Hershey Medical Center|Chris Sciamanna, MD, MPH|717-531-8161|cns10@psu.edu
98120|NCT00242684|Central Arkansas Veterans Healthcare System|Melinda Bopp, Project Coordinator|501-257-2045|melinda.bopp@va.gov
98121|NCT00242710|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98122|NCT00243022|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Glen Stevens||steveng@ccf.org
98123|NCT00243061|Juravinski Cancer Centre|Dr. Elaine McWhirter|905-387-9495 ext 67559|elaine.mcwhirter@hrcc.on.ca
98124|NCT00243074|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|jmoon@fredhutch.org
98125|NCT00243191|SARC|SARC, Chief Operating Officer|734-930-7600|sarc@sarctrials.org
98126|NCT00243243|US Army Institute of Surgical Research|David G. Baer, PhD, Director Research|210-539-4327|david.g.baer@us.army.mil
98127|NCT00243269|University of Rochester|Joseph Roscoe PhD|585 275-9962|joseph_roscoe@urmc.rochester.edu
98128|NCT00243347|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
98130|NCT00243412|Hoffman-LaRoche|Medical Communications|800-821-8590|
98131|NCT00243503|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98132|NCT00243659|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
98133|NCT00243919|Duke University|Pamela W. Duncan, PT, PhD, FAHA, FAPTA|919-681-2060|pamela.duncan@duke.edu
98134|NCT00243932|Columbia University|Petra Kaufmann, MD, MSc|(212) 342-1252|pk88@columbia.edu
98135|NCT00244010|St. Jude Children's Research Hospital|Kimberly Kasow, DO|901-595-3300|kimberly_kasow@med.unc.edu
98136|NCT00244101|Vermont Oxford Network|Roger F. Soll, MD|802 865 4814 ext 212|roger.soll@vtmednet.org
98137|NCT00244140|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
98138|NCT00231283|Cordis|Sidney Cohen, MD PhD, Vice President|650 614-2726|scohen7@its.jnj.com
98139|NCT00231309|Emory University|Kuang-Yueh Chiang, MD|404-785-1441|kuang-yueh.chiang@choa.org
98140|NCT00231465|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org
98141|NCT00231478|Hoffman-LaRoche|Medical Communications|800-821-8590|
98142|NCT00231777|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98143|NCT00231816|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98144|NCT00244374|University of California, San Francisco|Dr. Paula J. Lum|415-476-4082 ext 411|plum@php.ucsf.edu
98145|NCT00244621|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
98146|NCT00245102|Memorial Sloan-Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org
98147|NCT00245128|OHSU Knight Cancer Institute|Dr. Michael Mauro|503-494-1080|maurom@ohsu.edu
98148|NCT00245219|Carnegie Mellon University|Michael F. Scheier, PhD|412-268-3791|Scheier@cmu.edu
98149|NCT00245466|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
98150|NCT00245557|McLean Hospital|Brent Forester MD|617-855-3622|bforester@mclean.harvard.edu
98151|NCT00245570|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98152|NCT00245635|Montefiore Medical Center, Albert Einstein College of Medicine|Eric Hollander, MD|7189204287|eholland@montefiore.org
98153|NCT00245856|University of Oklahoma Health Sciences Center|Suman Rathbun MD|4052714742 ext 44773|suman-rathbun@ouhsc.edu
98154|NCT00245960|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
98155|NCT00246012|Centocor, Inc.|Senior Director|908-927-2116|
98156|NCT00246025|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
98157|NCT00246090|Eisai Call Center|Eisai Inc.|888-422-4743|
98158|NCT00246259|Janssen Inc., Toronto, ON, Canada|Director Medical Affairs - CNS|+1-416-382-5094|
98159|NCT00246324|LSU Health Sciences Center in Shreveport Department of Neurology|Alireza Minagar, MD|318-813-1481|aminag@lsuhsc.edu
98160|NCT00246337|Merck Sharp & Dohme Corp|Vice President of Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
98161|NCT00246376|Baylor College of Medicine|Ashok Balasubramanyam, MD, Prinicipal Investigator|713-798-8654|ashokb@bcm.edu
98162|NCT00246519|University of Florida|Julie A. Johnson|352-273-6007|johnson@cop.ufl.edu
119121|NCT00661089|The Rehabilitation Institute of Chicago|Dr. Christina Marciniak|312-238-1000|cmarciniak@ric.org
98163|NCT00246571|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98164|NCT00246753|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
98165|NCT00246805|Medtronic BRC - Medtronic Italia|Giorgio Corbucci - Sr Principal Scientist|+39 02 241371|giovanna.zucchi@medtronic.com
98166|NCT00247273|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
98167|NCT00247377|UCI|Ninh Nguyen|714-456-8598|ninhn@uci.edu
98168|NCT00247416|University of Kentucky Markey Cancer Center|Suzane Arnold, MD|859 323 8043|smarno0@uky.edu
98169|NCT00247611|Center for Health, Intervention & Prevention|Dr. Jeffrey Fisher, Principal Investigator|(860) 486-4940|jeffrey.fisher@uconn.edu
98170|NCT00240331|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
98171|NCT00240487|The Children's Hospital of Philadelphia|Richard Lin|2155905505|linr@email.chop.edu
98172|NCT00240500|GlaxoSmithKline|GSK Response Center|866-435-7343|
98173|NCT00240526|GlaxoSmithKline|GSK Response Center|866-435-7343|
98174|NCT00240539|GlaxoSmithKline|GSK Response Center|866-435-7343|
98175|NCT00240981|Brigham & Women's Hospital|Dr. Shalender Bhasin|617-525-9150|sbhasin@partners.org
98176|NCT00240994|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
98177|NCT00241176|NYU School of Medicine, NYU Child Study Center|Barbara J Coffey, M.D, M.S.|(212)263-3926|barbara.coffey@mssm.edu
98178|NCT00241280|Johnson & Johnson Vision Care, Inc.|David C. Turner, Ph.D. GLOBAL PLATFORM SR DIRECTOR, R&D|904-443-3500 ext 3479|DTURNER2@its.jnj.com
98179|NCT00241358|Washington University School of Medicine|John F. DiPersio, M.D., Ph.D.|314-454-8603|jdipersi@wustl.edu
98180|NCT00241644|GlaxoSmithKline|GSK Response Center|866-435-7343|
98181|NCT00247676|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98182|NCT00247962|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
119122|NCT00657553|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-569-6990 ext 2461|pettynathanm@uams.edu
98184|NCT00249496|Johns Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu
98185|NCT00249613|UCLA Integrated Substance Abuse Programs|Michael Prendergast|310-267-5503|mlp@ucla.edu
98186|NCT00249795|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com
98187|NCT00249821|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
98188|NCT00249873|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com
98189|NCT00250276|GlaxoSmithKline|GSK Response Center|866-435-7343|
98190|NCT00250432|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98191|NCT00250458|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
119123|NCT00620945|Cleveland Clinic|Muhammad A. Mumtaz, MD|216 444 9125|mumtazm@ccf.org
98193|NCT00250497|University_of_Minnesota|Dr. Dianne Neumark-Sztainer, Professor|612-624-0880|neuma011@umn.edu
98194|NCT00250588|CCHMC|Michael Seid|5138030083|michael.seid@cchmc.org
98195|NCT00250679|Sepracor Inc.|Respiratory Medical Director|1-866-503-6351|
98196|NCT00250705|The University of Iowa|An Open Label Trial of Aripiprazole in the Treatment of Conduct Disorder in Adolescents.|319-356-1482|Samuel-Kuperman@uiowa.edu
98197|NCT00250718|University of New Mexico|Dulcinea Quintana, MD|505-272-4661|dcandelaria@salud.unm.edu
98198|NCT00250835|University of New Mexico|Fa-Chyi Lee, MD|5059250405|flee@salud.unm.edu
98199|NCT00250926|Dana Farber Cancer Institute|Steven P. Treon MD PhD|617 632 2681|steven_treon@dfci.harvard.edu
98200|NCT00251004|Novartis Pharmaceuticals|Study Director|862-778-8300|
98201|NCT00251225|University of Pittsburgh Cancer Institute|Leonard J. Appleman, MD, PhD|412-648-6507|applemanlj@upmc.edu
98202|NCT00251238|Radboud University Nijmegen, The Netherlands|Dr. SJH Bredie, MD, PhD|0031 24 3618819|bas.bredie@radboudumc.nl
98203|NCT00251303|National Institute of Mental Health, Pediatrics and Developmental Neuroscience Branch|Dr. Susan E. Swedo|301-496-5323|swedos@mail.nih.gov
98204|NCT00251316|NIDDK, NIH|Dr. Monica Skarulis|301-496-6087|monicas@intra.niddk.nih.gov
98205|NCT00251589|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98206|NCT00251641|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
98207|NCT00251693|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com
98208|NCT00251719|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com
98209|NCT00251745|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com
98210|NCT00251758|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com
98211|NCT00251862|Boston Medical Center|Dr. Paul C. Schroy III|617-638-8335|paul.schroy@bmc.org
98212|NCT00251927|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
98213|NCT00244712|GlaxoSmithKline|GSK Response Center|866-435-7343|
98214|NCT00244725|GlaxoSmithKline|GSK Response Center|866-435-7343|
98215|NCT00244764|GlaxoSmithKline|GSK Response Center|866-435-7343|
98216|NCT00244855|Fred Hutchinson Cancer Research Center|Dr. David Maloney|206-667-5616|dmaloney@fredhutch.org
98217|NCT00244881|Dana-Farber Cancer Institute|Dr Harold Burstein|617-632-3800|hburstein@partners.org
98218|NCT00244933|Barbara Ann Karmanos Cancer Institute|Amy Weise, M.D.|313-576-8599|weisea@karmanos.org
98219|NCT00244985|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
98220|NCT00245011|Sidney Kimmel Comprehensive Cancer Center|David M. Loeb, M.D., Ph.D., Director, Musculoskeletal Tumor Program|410.502.7247|loebda@jhmi.edu
119124|NCT00612456|GlaxoSmithKline|GSK Response Center|866-435-7343|
119125|NCT00577512|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990 ext 2461|pettynathanm@uams.edu
98222|NCT00245050|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Vivian von Gruenigen, MD|216-844-5011|vev1@case.edu
98223|NCT00245063|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
98224|NCT00251979|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
98225|NCT00252057|Boston Medical Center|Brian Jack PI|617-414-44675|brian.jack@bmc.org
98227|NCT00252187|Mayo Clinic|Dr. Horng H. Chen|507-778-2354|chen.horng@mayo.edu
98228|NCT00252239|University of Virginia Health System|Dr. E. Clarke Haley, Jr.|434-924-8041|ech@virginia.edu
98229|NCT00252967|Brown University|Samuel Dudley, MD, PhD|4014443024|samuel_dudley@brown.edu
98230|NCT00253019|Emory University|Carrie Cwiak, MD, MPH|404-778-1696|ccwiak@emory.edu
98231|NCT00253370|ECOG Statistical Office|Study Statistician|617-632-3012|
98232|NCT00253435|Chidlren's Hospital Los Angeles|Araz Marachelian, MD, NANT Medical Director|323-3691-5687|amarachelian@chla.usc.edu
98233|NCT00253448|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Research Investigator|937-395-8646|douglas.einstein@khnetwork.org
98234|NCT00253513|OHSU Knight Cancer Institute|Eneida Nemecek, MD|(503) 494-0829|nemeceke@ohsu.edu
98235|NCT00253643|Oregon Health & Science University|Dr. Jackilen Shannon|503-220-8262 ext 54868|shannoja@ohsu.edu
98236|NCT00253708|Beth Israel Deaconess Medical Center|Russell S. Phillips, MD|6174322222|Russell_phillips@hms.harvard.edu
98237|NCT00253747|University of CIncinnati|Dr. Theresa Winhusen|513-487-7800|winhusen@carc.uc.edu
98238|NCT00253890|Butler Hospital|Dr. Michael D. Stein, MD|401-455-6646|mstein@butler.org
98239|NCT00253981|William Beaumont Army Medical Center|COL Richard Petri, Chief Integrative Pain Management|915-742-3245|richard.petri@amedd.army.mil
98240|NCT00254072|UC Irvine Medical Center|Ninh T. Nguyen, M.D.|714-456-8580|ninhn@uci.edu
98241|NCT00254163|Ocala Oncology|Dr. Craig Reynolds|(352) 732-4032|Craig.Reynolds@USOncology.com
98242|NCT00254293|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
98243|NCT00254462|University of Nebraska Medical Center|Christopher J. Kratochvil, M.D.|402-552-6005|ckratoch@unmc.ed
98244|NCT00254501|University of Florida|Dale Kraemer||Dale.Kraemer@jax.ufl.edu
98245|NCT00254540|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98246|NCT00254566|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98247|NCT00254592|University of California Irvine Medical Center|Rita S. MEHTA, MD|(714) 456-5153|rsmehta@uci.edu
98248|NCT00254982|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
98249|NCT00254995|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com
98250|NCT00255008|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
98251|NCT00255034|Merck, Sharp & Dohme Corp.|Senior Vice Predsident, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
98252|NCT00255047|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
98253|NCT00255086|VA Palo Alto Health Care System|Wes Ashford, PhD, MD|650-493-5000|wes.ashford@va.gov
98254|NCT00255125|Kansas City VA Medical Center|Dr. Peter Van Veldhuizen|816-861-4700|peter.vanveldhuizen@va.gov
98255|NCT00255151|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com
98256|NCT00255164|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com
98257|NCT00255177|VGX Pharmaceuticals, LLC|Mary Giffear, Sr. Clinical Scientist|267 440 4220|mgiffear@inovio.com
98258|NCT00255190|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
98259|NCT00248170|Novartis|Study Director|862-778-8300|
98260|NCT00248287|Baylor Sammons Cancer Center|Dr. Joyce O’Shaughnessy|(214) 370 -1796|Joyce.OShaughnessy@usoncology.com
98261|NCT00248495|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
98262|NCT00248547|Oregon Health & Science University, Knight Cancer Institute|Joseph Bubalo, PharmD|503-494-1054|bubaloj@ohsu.edu
98263|NCT00248560|Barbara Ann Karmanos Cancer Institute|Ammar Sukari, M.D.|313-576-8751|sukaria@karmanos.org
98264|NCT00248612|Center for Anxiety and Related Disorders at Boston University|Todd J. Farchione, PhD|617 353 9610|tfarchio@bu.edu
98265|NCT00248625|University of Pittsburgh|Robert H. Squires, Jr.|412-692-8648|squiresr@upmc.edu
98266|NCT00248638|Emory University|Thomas R. Ziegler M.D.|4047277354|Tzieg01@emory.edu
98267|NCT00248651|Mayo Clinic|Dr. Yuri A. Saito Loftus|507-266-9094|saito.yuri@mayo.edu
98268|NCT00248781|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov
98269|NCT00248794|VA Connecticut Healthcare System|Gary Bryson|860-594-6348|gary.bryson@va.gov
98270|NCT00248807|James J Peters VAMC|Dr. Jill M. Wecht; Principal Investigator|718 584-9000 ext 3122|JM.Wecht@va.gov
98271|NCT00249002|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
98272|NCT00249249|Kowa Research Europe, Ltd.|Dr Neil Hounslow|+44 118 922 9004|nhounslow@kowa.co.uk
98273|NCT00249288|Schizophrenia Program, Massachusetts General Hospital|Michelle Hill|617-912-7846|michelehill1@gmail.com
98274|NCT00249379|Virginia Commonwealth University|Michael Weaver, MD|804-828-1283|mweaver@mcvh-vcu.edu
98275|NCT00255684|Wake Forest|Gordon L. Phillips|604.875.4111 ext 67806|gophilli@wakehealth.edu
98276|NCT00255723|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org
98277|NCT00258440|Oregon Health and Science Univeristy|Joseph Bubalo|503-494-8007|bubaloj@ohsu.edu
98278|NCT00258674|Baylor Research Institute|Baylor Research Institute|214-820-9991|Elizabeth.Cothran@baylorhealth.edu
98279|NCT00258817|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
98280|NCT00258830|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
98281|NCT00258856|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
98282|NCT00258882|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com
98283|NCT00258895|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
98284|NCT00258908|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
98285|NCT00259012|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
98286|NCT00259090|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
98287|NCT00259272|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
98288|NCT00259285|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
98289|NCT00259298|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
98290|NCT00259610|University of Alabama at Birmingham|Dr. Jeffrey R. Curtis,|205-934-7733|jcurtis@uab.edu
98291|NCT00259649|University of Pittsburgh|Dawn marcus|412-953-4797|marcusd@upmc.edu
98292|NCT00259740|Amgen Inc.|Study Director|866-572-6436|
98293|NCT00259857|Medical University of South Carolina|Deborah A Bowlby, MD, Asst.Professor, Pedeiatric Endocrinology|843-792-6807|bowlbyd@musc.edu
98294|NCT00260065|Eisai Inc.|Eisai Call Center|888-422-4743|
98295|NCT00260195|RAND Corporation|Lisa Jaycox|703-344-8236 ext 5118|jaycox@rand.org
98296|NCT00260208|Novartis Pharmaceuticals|Study coordinator|862-778-8300|
98297|NCT00260429|Auxilium Pharmaceuticals, Inc.|Greg Kaufman, MD; Senior Director of Clinical Development|484 321 5900 ext 5920|gkaufman@auxilium.com
98298|NCT00260533|University of California San Diego|Murray B. Stein MD, MPH|858-534-6400|mstein@ucsd.edu
98299|NCT00260689|NHLBI, NIH|Danielle Townsley MD|301-402-3477|townsleydm@nhlbi.nih.gov
98300|NCT00260832|Eisai Inc.|Peter Tarassoff, MD, PhD, Study Director|201-949-4611|Peter_Tarasoff@eisai.com
98301|NCT00252382|Sunesis Pharmaceuticals, Inc.|Linda Neuman, MD, Vice President, Clinical Development|(650) 266-3760|l.neuman@sunesis.com
98302|NCT00252499|VA Puget Sound Health Care System|Kristina Utzschneider, MD|206-277-3568|kristina.utzschneider@va.gov
98303|NCT00252512|Minneapolis VA Health Care System|Hildi Hagedorn|612-467-3875|hildi.hagedorn@va.gov
98304|NCT00252538|VA Long Beach Healthcare System|Peter Hauser|562 826 8000 ext 2629|peter.hauser2@va.gov
98305|NCT00252564|US Oncology|Allen L. Cohn|303- 388-4876|Allen.Cohn@USOncology.com
98306|NCT00252590|VA San Diego Healthcare/University of California, San Diego|Dr. Susan Tate|619-426-9402|srtate@ucsd.edu
98307|NCT00252629|Northport, VAMC|Mohammad M. Amin, MD|6312614400 ext 2469|mohammad.amin2@va.gov
98308|NCT00252694|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com
98309|NCT00252720|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com
98310|NCT00252733|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com
98311|NCT00260962|Ottawa Hospital Research Institute|Dr. Hany Bissada|613-798-5555 ext 78042|hbissada@ottawahospital.on.ca
98312|NCT00263887|Talecris Biotherapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com
98313|NCT00264004|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
98314|NCT00264147|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98315|NCT00264238|Stanford University School of Medicine, Dept of Psychiatry|Dr John Barry, Professor|(650) 725-5588|jbarry@stanford.edu
98316|NCT00264290|University of California, San Francisco|Peter W. Hunt, M.D.|415-476-4082 ext 345|phunt@php.ucsf.edu
98317|NCT00264303|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
98318|NCT00264381|University of Oklahoma Health Sciences Center|Suman Rathbun MD,MS|405271-4742 ext 44773|suman-rathbun@ouhsc.edu
98319|NCT00264498|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
98320|NCT00264537|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399|
98321|NCT00264550|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399|
98322|NCT00264576|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
98323|NCT00264641|Hypoglycaemia Research Group|Prof. Birger Thorsteinsson|+4548294829|Birger.Thorsteinsson@regionh.dk
98324|NCT00264797|Univ of Colorado Denver; Univ of Cincinnati|Dr. Paula Riggs; Dr. Theresa Winhusen|303-724-2235; 513-487-7800|paula.riggs@ucdenver.edu; winhusen@carc.uc.edu
98325|NCT00264810|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com
98326|NCT00264849|Novartis Pharmaceuticals|Study Director|862-778-8300|
98327|NCT00264875|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98328|NCT00265083|Centocor Research and Development, Inc.|Director, Clinical Research|1-800-457-6399|
98329|NCT00265096|Centocor Research and Development, Inc.|Director, Clinical Research|1-800-457-6399|
98330|NCT00265109|Rhode Island Hospital Body Dysmorphic Disorder Program|Katharine A. Phillips MD|401-444-1646|katharine_phillips@brown.edu
98331|NCT00265122|Centocor Research & Development, Inc.|Sr. Dir. Clinical Research|1-800-457-6399|
98332|NCT00265200|James Graham Brown Cancer Center, University of Louisville|Goetz H Kloecker, MD|502-562-4358|ghkloe01@louisville.edu
98333|NCT00265239|Kumamoto University|Dr. Kenichi Tsujita|+81-96-373-5175|tsujita@kumamoto-u.ac.jp
98334|NCT00265317|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com
98335|NCT00265330|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98336|NCT00265343|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
98337|NCT00265382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98338|NCT00265395|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
98339|NCT00265473|Schulze Diabetes Institute, University of Minnesota|Melena D. Bellin, MD|612-625-4686|bell0130@umn.edu
98340|NCT00265512|VA Center for Innovation to Implementation|Todd Wagner|6504935000 ext 22048|todd.wagner@va.gov
98341|NCT00265616|CHUV Lausanne|Dr Andrea O. Rossetti|+41 21 314 1190|andrea.rosseti@chuv.ch
98342|NCT00265759|Baylor College of Medicine|Matthew J. Ellis, MB, BChir, BSc., PhD, FRCP|713 798-1999|Matthew.Ellis@bcm.edu
98343|NCT00265785|SWOG Statistical Center|Study Statistician|206-667-4623|
98344|NCT00265798|University of Chicago|Dr. Hedy L. Kindler|773-702-0360|hkindler@medicine.bsd.uchicago.edu
98345|NCT00265850|Alliance for Clinical Trials in Oncology|Alan Venook, M.D.||Venook@cc.ucsf.edu
98346|NCT00265889|Case Comprehensive Cancer Center|Brian Bowell, MD|216-444-6922|bolwelb@ccf.org
98347|NCT00266032|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
98348|NCT00266110|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
98349|NCT00266227|Genentech, Inc.|Medical Communications Specialist|800-821-8590|
98350|NCT00266279|James Graham Brown Cancer Center|Dr. Damien Laber|502-562-3429|bcccto@louisville.edu
98351|NCT00255970|RTI Biologics|Clinical Projects, Director|386-418-8888|rparkhurst@rtix.com
98352|NCT00256204|Teva Branded Pharmaceutical Products R&D|Dennis Ahern, MS, Director|215-293-6339|dennis.ahern@tevausa.com
98353|NCT00256243|Chao Family Comprehensive Cancer Center|Nicole Macaranas, Clinical Research Specialist|(714) 456-6550|nicole.macaranas@uci.edu
98354|NCT00256295|University of California, Irvine|Nicole Macaranas|714-456-6550|nicole.macaranas@uci.edu
98355|NCT00256698|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
98356|NCT00256724|Advanced Circulatory|Nathan Burkhart|651.403.5600|nburkhart@advancedcirculatory.com
119126|NCT00574080|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990 ext 2461|PettyNathanM@uams.edu
98358|NCT00256984|Ethicon Endo-Surgery|Susan Knippenberg, Clinical Scientist|513 337-3452|sknippen@its.jnj.com
98359|NCT00256997|Janssen Inc. Toronto, Ontario, Canada|Director Medical Affairs - CNS|+1-416-382-5094|
98360|NCT00257010|Janssen-Ortho LLC|Vice President, Medical Affairs||ClinicalTrialDisclosure@its.jnj.com
98361|NCT00257166|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98362|NCT00257192|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98363|NCT00257309|Centro Nacional de Investigaciones Cardiovasculares|Héctor Bueno|(+34) 914 531 200 ext 4110|hbueno@cnic.es
98364|NCT00257322|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu
98365|NCT00257556|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
98366|NCT00257608|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
98367|NCT00257660|Ipsen|Senior Director, Medical Development, Neurology||clinical.trials@ipsen.com
98368|NCT00257686|Kowa Research Institute|Bill Arana|9194331600|barana@kowaus.com
98369|NCT00257894|Veterans Affairs Medical Center (VAMC), Providence|Damaris J. Rohsenow, Ph.D.|401-863-6648|damaris.rohsenow@va.gov
98370|NCT00257920|Abbott|Medical Information Specialist|1-800-633-9110|
98371|NCT00257933|The Children's Hospital of Philadelphia|Joseph Zorc, MD|215-590-1944|zorc@email.chop.edu
98372|NCT00258011|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
98373|NCT00258154|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
98375|NCT00258310|Barbara Ann Karmanos Institute|George Yoo, M.D.|(313) 576-9782|yoog@karmanos.org
98376|NCT00258349|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012|
98377|NCT00258362|Masonic Cancer Center, University of Minnesota|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu
98378|NCT00266409|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
98379|NCT00266630|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
98380|NCT00267670|Northwestern University|Mary E. Rinella, MD|312-503-4592|m-rinella@northwestern.edu
98381|NCT00267696|The Ohio State University Comprehensive Cancer Center|Larry Copeland, MD|614-293-8697|Larry.Copeland@osumc.edu
98382|NCT00267748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98384|NCT00267956|Centocor Research & Development, Inc|Senior Director Clinical Research|1-800-457-6399|
98385|NCT00267969|Centocor Research & Development, Inc.|Dir. Clinical Research|1-800-457-6399|
98386|NCT00268203|GlaxoSmithKline|GSK Response Center|866-435-7343|
98387|NCT00268242|The Cleveland Clinic|Anjali S. Advani, MD|216-445-5330|advania@ccf.org
98388|NCT00268346|Cleveland Clinic Taussig Cancer Institute|David Adelstein MD|216-444-9310|adelstd@ccf.org
98389|NCT00268437|Mayo Clinic|Aminah Jatoi, M.D.|507/284-4918|jatoi.aminah@mayo.edu
98390|NCT00268463|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600|
98391|NCT00268762|University of Texas Health Science Center at Houston|Andrew D. Barreto, MD|713-500-7002|andrew.d.barreto@uth.tmc.edu
98392|NCT00268892|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
98393|NCT00268905|Eisai|Prash Krishna, Study Director|888-422-4743|
98394|NCT00268983|GlaxoSmithKline|GSK Response Center|866-435-7343|
98395|NCT00269113|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
98396|NCT00269152|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
98397|NCT00269477|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
98398|NCT00269633|Thomas Jefferson University|Roseann Talarico|215 503 4743|roseann.talarico@jefferson.edu
98399|NCT00269919|Janssen Korea Ltd., Korea|Medical CRA|+82-2-2094-4804|
98459|NCT00266695|Chromaderm|info@chroma-derm.com|info@chroma-derm.com|
98400|NCT00270205|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|(617)432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
98401|NCT00270231|University of Pennsylvania|Caryn Lerman, Ph.D.|215-746-7141|clerman@mail.med.upenn.edu
98402|NCT00255840|CIPRA-SA|Dr Ian Sanne|+27 11 276 8800|isanne@witshealth.co.za
98403|NCT00261443|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
98404|NCT00261495|Janssen Pharmaceutica NV|EMEA Medical Affairs Director Analgesia|+49 4107 312356|kpappert@its.jnj.com
98405|NCT00261716|VAGLAHS at West Los Angeles|Shirley M. Glynn. Ph.D.|310-268-3939|sglynn@ucla.edu
98406|NCT00261833|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
98407|NCT00261846|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98408|NCT00261950|Amgen Inc.|Study Director|866-572-6436|
98409|NCT00262002|Novartis Vaccine and Diagnostics S.r.l|Posting Director||RegistryContactVaccineUS@novartis.com
98410|NCT00262028|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
98411|NCT00262041|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
98412|NCT00262067|Genentech, Inc.|Medical Communications|800 821-8590|
98413|NCT00262080|Dyax Corp.|Pat T Horn|617 250 5948|phorn@dyax.com
98414|NCT00262119|Medtronic|Senior Clinical Research Manager|0039-0632814225|andrea.grammatico@medtronic.com
98416|NCT00262301|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com
98417|NCT00262314|EMD Serono, Inc.|Fernando Dangond, M.D., Medical Responsible|+1 781 681 2348|
98418|NCT00262509|Atlanta VA Rehabilitation R&D Center of Excellence|David A. Ross|404-321-6111 ext 6817|ross0128@bellsouth.net
98419|NCT00262522|Abbott|Global Medical Services|800-633-9110|
98420|NCT00262600|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
98421|NCT00262639|Medical University of South Carolina|Raymond F. Anton, M.D.|843-792-1226|antonr@musc.edu
98422|NCT00262730|Adult Brain Tumor Consortium Central Office- Johns Hopkins|Director of Adult Brain Tumor Consortium|410-955-3657|jfisher@jhmi.edu
98423|NCT00262743|Mayo Clinic|Dr. Tait Shanafelt||shanafelt.tait@mayo.edu
98424|NCT00262821|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
98425|NCT00262834|SKCCC|Vered Stearns|4432876489|vstearn1@jhmi.edu
98427|NCT00262860|University of Rochester|Jonathan W. Friedberg|585-273-4150|jonathan_friedberg@urmc.rochester.edu
98428|NCT00262873|University of Rochester|Jane Liesveld, M.D.|585-275-4099|Jane_Liesveld@urmc.rochester.edu
98429|NCT00262925|ECOG Statistical Office|Study Statistician|617-632-3012|
98430|NCT00262951|University of Minnesota, Masonic Cancer Center|Edward Greeno, M.D.|612-626-6418|green049@umn.edu
98431|NCT00262964|Washington University School of Medicine|Elisa Fabbrini, MD|314-362-8156|efabbrini@dom.wustl.edu
98432|NCT00263211|Department of Medicine Div. of Oncology, Washington University School of Medicine St. Louis MO|Katherine Weilbacher, M.D,|Fax: 314-454-8973|kweiblac@dom.wustl.edu
98433|NCT00263328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98434|NCT00263666|GlaxoSmithKline|GSK Response Center|866-435-7343|
98435|NCT00263757|Mayo Clinic|Dr. Sean M. Caples|507-293-1031|Caples.Sean@mayo.edu
98436|NCT00270257|Fred Hutchinson Cancer Research Center|Senior Statistical Analyst|206-667-6167|geetha@scharp.org
98437|NCT00270296|Harvard TH Chan School of Public Health|Dr. Roger Shapiro|617-432-2334|rshapiro@hsph.harvard.edu
98438|NCT00271219|Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, Johns Hopkins University School of Medicine|Dr. Hendree Jones|919-485-2664|hjones18@jhmi.edu
98439|NCT00271375|Atlanta VAMC|Patricia Griffiths|404-321-6111 ext 7138|Patricia.Griffiths@va.gov
98440|NCT00271544|Medtronic CRDM Clinical Research|Hang Nguyen|800-328-2518 ext 62832|hang.t.nguyen@medtronic.com
98441|NCT00271570|University of California, San Diego|Jane Burns, MD, Professor|858-246-0155|jcburns@ucsd.edu
98442|NCT00271596|University of Iowa; Elks Rehab Hospital|Leigh Beglinger, PhD|319-353-4489|leigh-beglinger@elksrehab.org
98443|NCT00271609|National Cancer Institute, National Institutes of Health|Teri Kreisl, M.D.|301-402-3423|kreislt@mail.nih.gov
98444|NCT00271739|Columbia University|Walter Palmas, M.D.|212-305-3163|wp56@columbia.edu
98445|NCT00271817|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98446|NCT00271856|UCSF Osher Center for Integrative Medicine|Patricia Moran, PhD|415.353.9745|moranp@ocim.ucsf.edu
98447|NCT00271947|Northwestern University|Dr Richard Burt|312-908-0059|rburt@northwestern.edu
98449|NCT00272168|VA Central Office|Wendy Tenhula, Ph.D.|202-461-4167|Wendy.Tenhula@va.gov
98450|NCT00272311|Florida Atlantic University|Charles H. Hennekens, M.D.||chenneke@fau.edu
98451|NCT00272337|Florida Atlantic University|Charles H. Hennekens, M.D.||chenneke@fau.edu
98452|NCT00272779|Bristol-Myers Squibb|BMS Study Director||ClinicalTrials@bms.com
98453|NCT00272792|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com
98454|NCT00272961|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98455|NCT00272987|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
98456|NCT00273052|GlaxoSmithKline|GSK Response Center|866-435-7343|
98457|NCT00273182|Medtronic, Inc.|InSync Registry Clinical Trial Leader||medtroniccrmtrials@medtronic.com
98458|NCT00266656|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
98460|NCT00266799|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
98461|NCT00266812|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
98462|NCT00266825|University of Kansas Medical Center|Dr. Susan Carlson|913-588-5359|SCARLSON@kumc.edu
98464|NCT00267007|Centocor Ortho Biotech Services, LLC (COBS)|Vice President|215 325 4464|
98465|NCT00267046|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor|713-792-7966|xzhou@mdanderson.org
98466|NCT00267059|The University of Texas M. D. Anderson Cancer Center|Alessandra Ferrajoli, MD, BS / Associate Professor|713-792-2063|eharriso@mdanderson.org
98467|NCT00267085|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org
98468|NCT00267098|Medtronic CRDM Clinical|BLOCK HF Clinical Trial Leader|763-526-2729|medtroniccrmtrials@medtronic.com
98469|NCT00267111|Mount Sinai Hospital|Dr. Vibhuti Shah|416-586-4816|vshah@mtsinai.on.ca
98470|NCT00267150|Novartis Pharmaceuticals|Study Director|862-778-8300|
98471|NCT00267189|Novartis Pharmaceuticals|Study Director|862-778-8300|
98472|NCT00267202|Novartis Pharmaceuticals|Clinical Director|862-778-1768|maria.figliomeni@novartis.com
98473|NCT00267293|Penn State Children's Hospital|Ian M Paul, MD, MSc|717-531-5656|ipaul@hmc.psu.edu
98474|NCT00267488|GlaxoSmithKline|GSK Response Center|866-435-7343|
98475|NCT00267631|Maimonides Medical Center|Dr. Estevan Garcia, MD; Principal Investigator|718-283-6352|EsGarcia@maimonidesmed.org
98476|NCT00267644|Maimonides Medical Center|Dr. Eitan Dickman, MD; Principal Investigator|718-283-6057|edickman@maimonidesmed.org
98477|NCT00273754|University of Texas Medical School/ Houston|Samia Khalil, M.D./ Professor|713-500-6242|Samia.N.Khalil@uth.tmc.edu
98478|NCT00273793|UTexas_SanAntonio|Dr. RJ Lamb|210-567-5480|lamb@uthscsa.edu
98479|NCT00273858|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98480|NCT00273910|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov
98481|NCT00275821|Novartis Pharmaceuticals|Study Director|862-778-8300|
98482|NCT00275834|Duke University Medical Center|Kishore Gadde|919-668-0208|kishore.gadde@duke.edu
98483|NCT00276016|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
98484|NCT00276094|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
98485|NCT00276159|Masonic Cancer Center, University of Minnesota|Sarah Cooley, MD|612-625-8474|cool0023@umn.edu
98486|NCT00276250|Emory University|Nicole Turgeon, MD|404-727-3257|nturgeo@emory.edu
98487|NCT00276406|Mayo Clinic|Adil E. Bharucha, MD|507-284-6439|bharucha.adil@mayo.edu
98488|NCT00276419|Mayo Clinic|Dr. Robin L. Smith|507-284-1210|smith.robin@mayo.edu
98489|NCT00276458|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98490|NCT00276484|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
98491|NCT00276549|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Robert Dreicer|216-445-4623|dreicer@ccf.org
98492|NCT00276614|David Geffen School of Medicine at UCLA|Matthew Rettig, M.D.|310-794-3565|mrettig@mednet.ucla.edu
98493|NCT00276861|Dept. of Oncology Johns Hopkins Singapore Intl Medical Center|Gilberto Lopes MD|656-880-2240|glopes@imc.jhmi.edu
98494|NCT00277095|Uromedica|Sabitha R Shriram|763-694-9880 ext 216|sshriram@uromedica-inc.com
98495|NCT00277212|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
98496|NCT00277355|Massachusetts General Hospital|Merit Cudkowicz, MD, MSc|617-726-1873|mcudkowicz@partners.org
98497|NCT00277394|Leo Pharma|Torsten Skov, Senior Medical Advisor|+45 72263990|tosdk@leo-pharma.com
98498|NCT00277446|Northwestern University|Lewis J. Smith|312-503-0501|ljsmith@northwestern.edu
98499|NCT00277524|Medtronic Cardiac Rhythm Disease Management|Melinda Hoey, Clinical Research Specialist|763-526-2831|Melinda.hoey@medtronic.com
98500|NCT00278343|Juarvinski Cancer Centre|Dr. Hal Hirte|905-387-9495|hirteh@hhsc.ca
119129|NCT00541931|Stanford University|Dr. Anne Chang, MD|(650)721-7151|alschang@stanford.edu
98502|NCT00270634|Isotechnika Pharma Inc.|Robert Huizinga|780 487 1600 ext 223|robert.huizinga@isotechnika.com
98503|NCT00270790|University of Maryland School of Medicine|Mohan Suntharalingam|410-328-2328|msuntha@umm.edu
98504|NCT00270842|James A. Haley VA|Dr. Patricia A. Quigley|8135583912|patricia.quigley@va.gov
98505|NCT00270894|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com
98506|NCT00270998|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org
98507|NCT00271011|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski|734-615-3969|zalupski@umich.edu
98508|NCT00271024|University of Chicago|Dr. Andrea King|7737026181|aking@bsdad.uchicago.edu
98509|NCT00271154|Medtronic CRDM|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com
98510|NCT00278473|Icahn School of Medicine at Mount Sinai|Dr. Mary V. Solanto|212-241-5420|Mary.Solanto@mssm.edu
98511|NCT00278525|Northwestern University|Dr. Richard Burt|312-908-0059|rburt@northwestern.edu
98512|NCT00278655|Northwestern University|Dr Richard Burt|312-908-0059|rburt@northwestern.edu
98513|NCT00281879|OHSU Knight Cancer Institute|Dr. Richard Maziarz|503-494-1551|maziarzr@ohsu.edu
98514|NCT00281918|Hoffmann-LaRoche|Medical Communications|800-821-8590|
98515|NCT00281957|SWOG Statistical Office|SWOG melanoma statistician|206-667-4408|
98516|NCT00282048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98517|NCT00282087|SARC|Research Project Manager|(734) 930-7600|sarc@sarctrials.org
98518|NCT00282113|University of California Davis|Mark A. Underwood MD|916-734-5061|mark.underwood@ucdmc.ucdavis.edu
98700|NCT00284934|Novartis Pharmaceuticals|Study Director|862-778-8300|
98519|NCT00282152|Vanderbilt University Medical Center|David Charles, MD||david.charles@Vanderbilt.Edu
98520|NCT00282243|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com
98521|NCT00282256|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com
98522|NCT00282282|Dana-Farber Cancer Institute|Vincent T. Ho, MD Associate Professor of Medicine, Harvard Medical School|(617) 632-5938|vincent_ho@dfci.harvard.edu
98523|NCT00282295|GlaxoSmithKline|GSK Response Center|866-435-7343|
98524|NCT00282308|Genentech, Inc.|Medical Communications|800 821-8590|
98525|NCT00282334|Dept. of Medical Research, Holstebro Hospital|Line Bille Madsen|+45 99125421|linemads@rm.dk
98526|NCT00282347|Genentech, Inc.|Medical Communications|800-821-8590|
98527|NCT00282438|Northwestern University|Dr Richard Burt, Chief, Division of Immunotherapy, Department of Medicine|312-695-4960|rburt@northwestern.edu
98528|NCT00282464|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98529|NCT00282568|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com
119130|NCT00535626|Stryker Orthopedics|Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com
98531|NCT00282815|University of Michigan|Devin Brown, MD|734-936-9075|devinb@umich.edu
98532|NCT00282828|Rush University Medical Center|Mark Pollack, M.D.|312-942-5372|mark_pollack@rush.edu
98533|NCT00282867|University of Virginia|Karen C. Johnston, MD, MSc|434 924-5323|kj4v@virginia.edu
98534|NCT00282919|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98535|NCT00282971|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98536|NCT00282984|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98537|NCT00283049|sanofi-aventis|Medical Affairs study director||publicregistryUSMA@sanofi-aventis.com
98538|NCT00283062|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com
98539|NCT00283075|The Rogosin Institute|Dr. Barry H. Smith, CEO|212-746-1551|bas2005@nyp.org
98540|NCT00283244|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
98541|NCT00283296|Human Engineering Research Laboratories|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu
98542|NCT00283387|Mayo Clinic|Dr. Dawn S. Milliner|507-284-7431|milliner.dawn@mayo.edu
98543|NCT00283400|Baylor College of Medicine|Jose I Suarez, MD, Professor of Neurology|713-798-8472|jisuarez@bcm.edu
98544|NCT00283439|Amgen Inc.|Study Director|866-572-6436|
98545|NCT00283595|Massachusetts General Hospital|Anne Klibanski, MD|617-726-3870|aklibanski@partners.org
98546|NCT00283686|Emory University|Dr. Arlene Chapman|(404) 712‐1993|abchapm@emory.edu
98548|NCT00283816|University of Rochester Medical Center|Kathleen M. Hoeger, MD, MPH|585-275-7891|Kathy_Hoeger@urmc.rochester.edu
98549|NCT00283842|Wyeth|U.S. Contact Center||clintrialresults@wyeth.com
98550|NCT00283868|University of California, San Diego|Brett C. Meyer, MD|619-543-7760|bcmeyer@ucsd.edu
98551|NCT00284050|Novartis Pharmaceuticals|Study Director|862 778-8300|
98552|NCT00284089|Novartis Pharmaceuticals|Study Director|862 778-8300|
98553|NCT00284141|Sanofi|Trial Transparency Team||Contact-Us@Sanofi.com
98554|NCT00284154|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
98555|NCT00284180|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net
98556|NCT00274261|NICHD|Jason Woo, MD, MPH|301-496-1662|woojj@mail.nih.gov
98558|NCT00274456|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
98559|NCT00274469|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
98560|NCT00274625|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com
98561|NCT00274651|Topotarget A/S|PRS Admnistrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com
98562|NCT00274716|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98563|NCT00274742|Amgen Inc.|Study Director|866-572-6436|
98564|NCT00274768|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Antonio Wolff|410-614-6192|awolff@jhmi.edu
98565|NCT00274781|The Cleveland Clinic|Mikkael Sekeres, MD, MS|216-445-9353|sekerem@ccf.org
98566|NCT00274846|Masonic Cancer Center, University of Minnesota|Jeffrey Miller, M.D.|612-625-7409|mille011@umn.edu
98568|NCT00274937|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
98569|NCT00275002|Pediatric Brain Tumor Consortium|Dana Wallace|901-595-2617|dana.wallace@stjude.org
98570|NCT00275028|Dana-Farber Cancer Institute|Kimberley MacNeill|617-632-2621|kmacneill@partners.org
98571|NCT00275262|Abbott|Global Medical Services|800-633-9110|
98572|NCT00275275|University of Kansas Medical Center|Kelly E. Lyons, PhD|913-588-7159|klyons@kumc.edu
98573|NCT00275301|University of Minnesota|S. Charles Schulz, MD|612-273-9820|scs@umn.edu
98574|NCT00275340|University of Toronto|Monica Parry, RN, PhD, CCN(C)||parrym@kgh.kari.net
98575|NCT00275392|James H. Quillen VAMC|Courtney D. Hall, PhD|423-926-1171 ext 7518|courtney.hall@va.gov
98576|NCT00275561|Mayo Clinic|Jeffrey A. Alexander, MD, Assistant Professor of Medicine|507-538-2403|alexander.jeffrey14@mayo.edu
98577|NCT00284518|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
98578|NCT00284557|Emory University|Anne L. Dunlop, MD, MPH|404-712-8520|amlang@emory.edu
98579|NCT00285207|TigrisPharmaceuticals|Chief Medical Officer||info@tigrispharma.com
119131|NCT00524589|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
98580|NCT00285246|Edith Nourse Rogers Memorial VA Hospital|Karen S. Quigley, Ph.D., Research Physiologist|781-687-2273|karen.quigley@va.gov
98581|NCT00285467|Indiana University School of Medicine|Sharon Moe, MD|317-278-2868|smoe@iupui.edu
98583|NCT00285649|Palmer College of Chiropractic|Ting Xia, PhD (Principal Investigator)|563-884-5161|Ting.Xia@palmer.edu
98584|NCT00285779|Stanford University Department of Dermatology|David Fiorentino|650-723-6316|fiorentino@stanford.edu
98585|NCT00285818|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu
98586|NCT00285857|Stanford University|James M. Ford|(650) 498-6689|jmf@stanford.edu
98587|NCT00286078|Boston Scientific|Clinical Research Information|855-213-9890|BSNClinicalTrials@bsci.com
98588|NCT00286091|Amgen Inc.|Study Director|866-572-6436|
98589|NCT00286156|Cleveland Clinic|Dr William Braun Consultant Staff Nephrology, Cleveland Clinic|216/444/6995|braunw@ccf.org
98590|NCT00286182|Columbia University|Mathew Maurer, MD, Professor of Medicine at the Columbia University Medical Center|212-305-9808|msm10@cumc.columbia.edu
98591|NCT00286221|Johns Hopkins School of Medicine|Dr. Bradford Winters|4109559080|bwinter1@jh.edu
98592|NCT00286325|Duke University Medical Center|Dr. Russell P Hall|919-684-3110|hall0009@mc.duke.edu
98593|NCT00286429|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
98594|NCT00286442|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
98595|NCT00286455|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
98596|NCT00286468|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
98597|NCT00286494|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
98598|NCT00286728|VAHSRD|Christine Timko|650-617-2746|Christine.Timko@va.gov
98599|NCT00286741|Durham VA Medical Center|David Edelman|919-286-6936|dedelman@duke.edu
98600|NCT00286754|Department of Veterans Affairs|Sundar Natarajan, MD, Staff Physician|212-686-7500 ext 3287|Sundar.Natarajan@va.gov
98602|NCT00287053|Pennington Biomedical Reseach Center|Corby Martin, Ph.D.; Assistant Professor|225-763-2585|martinck@pbrc.edu
98603|NCT00287079|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
98604|NCT00287222|University of Arkansas for Medical Sciences|Sandy Annis|5016868274|amannis@uams.edu
98605|NCT00287339|UNC_ChapelHill|Dr Nicholas Shaheen|919 9667047|nshaheen@med.unc.edu
98607|NCT00287586|Brigham and Women's Hospital|Shalendar Bhasin, MD||Sbhasin@partners.org
98608|NCT00279591|University of Arkansas for Medical Sciences|Dr. Michael Stroud|501-364-1861|StroudMichaelH@uams.edu
98609|NCT00279708|The National Institutes of Health/ The National Heart, Lung, and Blood Institute|Joseph Fontana, MD|301-451-7740|fontanaj@nhlbi.nih.gov
98610|NCT00279916|Mayo Clinic|Dr. Laura Orvidas|507-284-3410|orvidas.laura@mayo.edu
98611|NCT00279955|Medtronic CRDM Clinical Research|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com
98612|NCT00280059|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98613|NCT00280150|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
98614|NCT00280241|University of Pittsburgh|Michael Boyiadzis, MD|412-623-0040|boyiadzism@upmc.edu
98615|NCT00280293|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu
98616|NCT00280384|Eisai Co., Ltd.|Hiroki Shimizu, Study Director|81-3-3817-5235|h3-shimizu@hhc.eisai.co.jp
98617|NCT00280397|Eisai Co., Ltd.|Akihiko Tsuruoka|+81-3-3817-5252 ext 5252|
98618|NCT00280566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98619|NCT00280683|UCaliforniaDavis|Dr. Nicholas Kenyon|916-734-3564|njkenyon@ucdavis.edu
98620|NCT00280735|UNC Lineberger Comprehensive Cancer|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
98621|NCT00280748|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
98622|NCT00280826|National Eye Institute|Robert Nussenblatt, MD, MPH|301-496-3123|drbob@intra.nei.nih.gov
98623|NCT00280904|Codman & Shurtleff|J. Thomas Megerian|1-508-828-8274|jmegeri1@its.jnj.com
98624|NCT00280917|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il
98625|NCT00281021|James Graham Brown Cancer Center, University of Louisville|Dr. Goetz Kloecker|502-562-4358|ghkloe01@exchange.louisville.edu
98626|NCT00281099|Medtronic, Inc.|MVP Clinical Trial Leader||medtroniccrmtrials@medtronic.com
98627|NCT00281320|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
98628|NCT00281463|Human Engineering Research Laboratories|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu
98629|NCT00281528|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
98630|NCT00281580|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
98631|NCT00281632|GlaxoSmithKline|GSK Response Center|866-435-7343|
98632|NCT00281658|GlaxoSmithKline|GSK Response Center|866-435-7343|
98633|NCT00281697|Genentech, Inc.|Medical Communications|800 821-8590|
98634|NCT00281827|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu
98635|NCT00281840|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Panayiotis Savvides, MD|216-844-5946|Panayiotis.Savvides@uhhospitals.org
98636|NCT00287716|InterMune, Inc.|Bill Bradford, MD, PhD|(415) 466-2200|bbradford@intermune.com
98637|NCT00287729|InterMune, Inc.|Bill Bradford, MD, PhD|(415) 466-2200|bbradford@intermune.com
98638|NCT00287872|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivan Borrello|(410) 955-4967|iborrell@jhmi.edu
98639|NCT00288509|Ipsen|Senior Director, Medical Development, Neurology||clinical.trials@ipsen.com
98641|NCT00288587|Cleveland Clinic Foundation|Leighann Cesar, RN|216-445-6551|cesar1@ccf.org
98642|NCT00288600|Fundação Oswaldo Cruz|Maria Elisabeth Moreira|552125541911|bebeth@iff.fiocruz.br
98643|NCT00288626|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
98644|NCT00288639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98645|NCT00288704|Regeneron Pharmaceuticals|Doug Nadler, MS Statistics|914 345 7905|clinicaltrials@regeneron.com
98646|NCT00288860|Nationa Center for PTSD Dissemination & Training Division|Craig S. Rosen|650-493-5000 ext 22812|craig.rosen@va.gov
98647|NCT00288886|Salem Veterans Affairs Medical Center|Steven Lash, Ph.D.|(540)982-2463 ext 2593|Steven.Lash@va.gov
98648|NCT00288912|Durham VA HSR&D|Dr. Kelli Allen|919-286-0411 ext 7090|kelli.allen@va.gov
98649|NCT00289016|Amgen, Inc.|Study Director|866-572-6436|
98650|NCT00289094|DePuy Orthopaedics, Inc.|Tammy O'Dell, EMT, CCRA|574-372-7104|TOdell2@its.jnj.com
98651|NCT00289107|DePuy Orthopaedics|Tammy O'Dell, EMT, CCRA|574-372-7104|TOdell2@its.jnj.com
98652|NCT00289120|Emory University|Kenneth Ogan|404-778-4898|kogan@emory.edu
98653|NCT00289133|DePuy Orthopaedics, Inc.|Clinical Portfolio Leader|574-372-7231|shimden@its.jnj.com
98654|NCT00289185|GlaxoSmithKline|GSK Response Center|866-435-7343|
98655|NCT00289211|ViroPharma|Chief Scientific Officer|610-458-7300|
98656|NCT00289276|Medtronic CRDM Clinical Research|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com
98657|NCT00289289|Medtronic CRDM Clinical|Jen Lahr||jen.lahr@medtronic.com
98658|NCT00289341|Rockefeller University|Mayu Frank|212-327-7443|frankm@rockefeller.edu
98659|NCT00289458|University of Saskatchewan|Dr. Cathy M. Arnold|306 966 6588|cathy.arnold@usask.ca
98660|NCT00289471|Durham VAMC|John W. Williams|919-286-6963|jw.williams@duke.edu
98662|NCT00289718|GlaxoSmithKline|GSK Response Center|866-435-7343|
98663|NCT00289744|GlaxoSmithKline|GSK Response Center|866-435-7343|
98664|NCT00289757|GlaxoSmithKline|GSK Response Center|866-435-7343|
98665|NCT00289770|GlaxoSmithKline|GSK Response Center|866-435-7343|
98666|NCT00289783|GlaxoSmithKline|GSK Response Center|866-435-7343|
98667|NCT00289848|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
98668|NCT00289874|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98669|NCT00289887|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98670|NCT00289900|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98671|NCT00289913|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com
98672|NCT00289978|Novartis Pharmaceuticals|Study Director|862 778-8300|
98673|NCT00289991|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98674|NCT00290147|Naval Medical Research Center, Viral Diseases Department|Charmagne Beckett, LCDR, MC, USNR|301-295-6400|charmagne.beckett@med.navy.mil
98675|NCT00290186|Dayton Children's Hospital|Daniel J. Lacey, MD, PhD|937-641-3080|LaceyD@childrensdayton.org
98676|NCT00290199|UAB|Dr. Alan Tita|205-934-9616|atita@uab.edu
98677|NCT00290238|RS Medical|Clinical Research Manager|360-891-7299|
98678|NCT00290251|NICHD, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov
98679|NCT00290290|Baylor College of Medicine|Rabih Darouiche, M.D.|713-794-8858|rabihd@bcm.edu
98680|NCT00290329|GlaxoSmithKline|GSK Response Center|866-435-7343|
98681|NCT00290407|James Graham Brown Cancer Center|Roger H Herzig, MD|502/396-3119|rhherz01@louisville.edu
98682|NCT00290472|University of Chicago Comprehensive Cancer Center|Dr. Sonali M. Smith|7738342895|smsmith@medicine.bsd.uchicago.edu
98683|NCT00290537|U.T. M.D. Anderson Cancer Center|Vali Papadimitrakopoulou, MD / Associate Professor|713-792-6363|
98684|NCT00290615|Duke University Medical Center|Brant Hamel|919-68-1861|brant.hamel@duke.edu
98685|NCT00290654|Masonic Cancer Center, University of Minnesota|Todd Tuttle, M.D.|612-625-2991|tuttl005@umn.edu
98687|NCT00290732|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu
98688|NCT00290758|NorthwesternU|Seema Khan, MD|312-695-0288|skhan@nmh.org
98689|NCT00278863|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr
98690|NCT00278876|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr
98691|NCT00278889|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
98693|NCT00278954|Bio Products Laboratory|Margaret Stratford Bobbitt|+44 20 8258 2288|Margaret.Stratford-Bobbitt@bpl.co.uk
98694|NCT00278993|Eisai Call Center|Eisai Inc.|888-422-4743|
98695|NCT00279201|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
98696|NCT00279214|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
98697|NCT00279305|Type 1 Diabetes TrialNet|Carla Greenbaum, MD||cjgreen@benaroyaresearch.org
98698|NCT00284739|Kaiser Permanente|Hyo-Chun Yoon, MD,PHD|8084327342|Hyo-Chun.Yoon@nsmtp.kp.org
98699|NCT00284856|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98701|NCT00285012|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98702|NCT00290771|Novartis Pharmaceuticals|Study Director|862 778-8300|
98703|NCT00290810|Mayo Clinic|Tait Shanafelt, M.D.||shanafelt.tait@mayo.edu
98704|NCT00290888|Pan Am Clinic|Dr. Peter MacDonald|204-925-7480|pmacdonald@panamclinic.com
98706|NCT00294554|Johns Hopkins University School of Medicine|Laura Marsh, MD|713-794-8907|laura.marsh2@va.gov
98707|NCT00294645|Medtronic CRDM|CRDM Clinical|800-328-2518|medtroniccrmtrials@medtronic.com
98708|NCT00294658|University of Alabama at Birmingham|Dr. Gary Cutter, Professor|205-975-5048|cutter@uab.edu
98709|NCT00294671|Amyloidosis Center, Boston Medical Center|Dr. John L. Berk|617-638-4494|jberk@bu.edu
98710|NCT00294684|NIDDK|Ed Doo||dooe@niddk.gov
98711|NCT00294723|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
98712|NCT00294762|Astellas Pharma Global Development|Medical Monitor||clinicaltrials@us.astellas.com
98713|NCT00295009|DePuy Synthes|Erin Prifogle|508-977-6451|eprifog1@its.jnj.com
98714|NCT00295061|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com
98715|NCT00295490|University of Southampton|Dr Sarah Brien|07870642667|sbb@southampton.ac.uk
98716|NCT00295503|UT Southwestern|Jonathan Dowell|214-648-4180|jonathan.dowell@utsouthwestern.edu
98717|NCT00295633|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
98718|NCT00295750|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
98719|NCT00295854|Medicinova Inc|Richard E. Gammans PhD Chief Developing Officer|848-373-1500|gammans@medicinova.com
98720|NCT00295880|Masonic Cancer Center, University of Minnesota Blood and Marrow Transplant Program|John E. Wagner, M.D.|612-626-2961|wagne002@umn.edu
98721|NCT00296036|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu
98722|NCT00296192|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
98723|NCT00296231|University of Iowa|Tarah Colaizy||tarah-colaizy@uiowa.edu
98724|NCT00296244|Thomas Jefferson University|Carlo Gerardo B Ramirez, MD|215-955-5909|carlo.ramirez@jefferson.edu
98725|NCT00296296|Stanford University|Stephan Busque, MD|650-498-6189|sbsuque@stanford.edu
98726|NCT00296322|Asan Medical Center, University of Ulsan College of Medicine|Dr. Yoon-Koo Kang|+82-2-3010-3230|ykkang@amc.seoul.kr
98727|NCT00296335|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr
98728|NCT00296374|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
98729|NCT00296400|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
98730|NCT00296491|GlaxoSmithKline|GSK Response Center|866-435-7343|
98731|NCT00296504|ViiV Healthcare|GSK Response Center|866-435-7343|
98732|NCT00296517|GlaxoSmithKline|GSK Response Center|866-435-7343|
98733|NCT00296647|UW-Center for Tobacco Research and Intervention|Stevens Smith, PhD|608-262-7563|sss@ctri.medicine.wisc.edu
98734|NCT00296816|Sanofi|Trial Trans[parency Team||Contact_us@sanofi.com
98735|NCT00297037|University of Utah|Dr. Christopher Hull|801-581-6465|christopher.hull@hsc.utah.edu
98736|NCT00288054|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|
98737|NCT00288067|University of Washington|Dr. Ajay Gopal|206-288-2035|agopal@uw.edu
98738|NCT00288080|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
98739|NCT00297102|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
98740|NCT00297115|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
98741|NCT00297167|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1- 800- 472- 2634|
98742|NCT00297232|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
98743|NCT00297258|GlaxoSmithKline|GSK Response Center|866-435-7343|
98744|NCT00298233|Oxford University Clinical Research Unit|Dr. Jeremy Farrar|+84 839237954|info@oucru.org
98745|NCT00298272|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com
98746|NCT00298363|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
98747|NCT00298558|New England Research Institutes|Sharon L. Tennstedt, PhD|617-972-3362|stennstedt@neriscience.com
98748|NCT00298610|Walter Reed Army Institute of Research|Shon A. Remich, MD|254-733-628-670|sremich@hotmail.com
98749|NCT00298740|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|410-550-6484|registerclinicaltrials@jhmi.edu
98750|NCT00298766|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM
98751|NCT00299000|BioMarin Pharmaceutical Inc.|Medical Information Services|800-983-4587|medinfo@bmrn.com
98752|NCT00299104|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com
98753|NCT00299130|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
98754|NCT00299156|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD /Professor|713-792-7026|eharrison@mdanderson.org
98755|NCT00299221|Newark Beth Israel Medical Center|David Baran MD|973-926-7205|dbaran@barnabashealth.org
98756|NCT00299416|UT-Houston Health Science Center, Department of Neurology|James C. Grotta, MD|713-500-7088|james.c.grotta@uth.tmc.edu
98757|NCT00299546|Centocor Research & Development, Inc.|Associate Director Clinical Research|1-800-457-6399|
98758|NCT00299689|James Graham Brown Cancer Center, University of Louisville|Dr. Jason Chesney|502/852-3679|jaches03@exchange.louisville.edu
98759|NCT00299702|Ortho-McNeil, Inc. N America Pharm CNS/IM|Therapeutic Area Lead|609-730-3693|
98760|NCT00299741|Massachusetts General Hospital|Dr. Dror Michaelson|617-726-1594|dmichaelson1@partners.org
98761|NCT00299975|Hong Kong Baptist University|Prof. Zhao-xiang Bian|(852) 3411 2905|bzxiang@hkbu.edu.hk
98762|NCT00300235|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000 ext 244|karen_kesler@rhoworld.com
98763|NCT00300274|Novartis Pharmaceuticals|Study Director|862-778-8300|
98764|NCT00300365|University of Pennsylvania|Dr. Richard L. Dunbar|(215) 315-3378|richard.dunbar@uphs.upenn.edu
98765|NCT00300430|Abbott|Medical Information Specialist|800-633-9110|
98766|NCT00300456|Abbott|Medical Information Specialist|800-633-9110|
98767|NCT00300469|Abbott|Medical Information Specialist|800-633-9110|
98768|NCT00300482|Abbott|Medical Information Specialist|800-633-9110|
98769|NCT00300495|Houston Methodist Hospital|Min Kim|7134415177|mpkim@houstonmethodist.org
98770|NCT00300677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98771|NCT00291135|University of Kansas Medical Center Research Institute|Carol J. Fabian, M.D.|913-588-7791|cfabian@kumc.edu
98772|NCT00291161|Houston HSRD Center of Excellence|Mark Kunik, MD, MPH|713-794-8639|kunik.marke@va.gov
98773|NCT00291187|Vanda Pharmaceuticals Inc.|Marlene Dressman, PhD.|202-734-3462|marlene.dressman@vandapharma.com
98774|NCT00291226|Yale University School of Medicine|Scott W. Woods, MD|203-974-7038|scott.woods@yale.edu
98775|NCT00291317|Children's Specialized Hospital|Frank Castello|732 258 7065|fcastello@childrens-specialized.org
98776|NCT00291330|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
98777|NCT00291343|GlaxoSmithKline|GSK Response Center|866-435-7343|
98778|NCT00292162|NHS|Michael MacDonald|01412112000|michael.macdonald@nhs.net
98779|NCT00292188|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98780|NCT00292227|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
98781|NCT00292318|Greater Los Angeles VA Medical Center|Felix W. Leung, MD|818-891-7711 ext 9403|felix.leung@va.gov
98782|NCT00292370|Ralph H. Johnson VA Medical Center|Mark Hamner, MD|843-789-7799|Mark.Hamner@va.gov
98783|NCT00292461|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affaires|81-3-3817-3914|
98784|NCT00292591|Medical University of South Carolina|Dr. Carol Wagner|18437922112|wagnercl@musc.edu
98785|NCT00292981|CSL Behring|Clinical Program Director|Use email contact|clinicaltrials@cslbehring.com
98786|NCT00293020|BioDelivery Sciences International|Andrew Finn, Pharm.D.|919-582-9050|AFinn@bdsi.com
98787|NCT00293059|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
98788|NCT00293241|Medtronic Bakken|Lidwien Vainer|+31 433566752|lidwien.vainer@medtronic.com
98789|NCT00293254|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98790|NCT00293267|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98791|NCT00293293|Moffitt Cancer Center|Patricia L. Judson, M.D.|813-745-1600|Patricia.Judson@moffitt.org
98792|NCT00293384|Barbara Ann Karmanos Cancer Institute|Muneer Abidi, M.D.|(313) 576-8713|abidim@karmanos.org
98793|NCT00293462|University of California, San Francisco|Marylin J. Dodd, RN, PhD, FAAN|415-476-2191|Marylin.dodd@nursing.ucsf.edu
98794|NCT00293540|International Breast Cancer Research Foundation|Richard R. Love, MD|608-698-7881|richardibcrf@gmail.com
98795|NCT00293579|Ohio State University Comprehensive Cancer Center|Anterpreet Neki|614-257-2900|Anterpreet.Neki@osumc.edu
98796|NCT00293709|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98797|NCT00293722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98798|NCT00293813|Amgen Inc.|Study Director|866-572-6436|
98799|NCT00294047|GlaxoSmithKline|GSK Response Center|866-435-7343|
98800|NCT00294060|Medtronic CRDM|P3 Study Team|800-328-2518|medtroniccrmtrials@medtronic.com
98801|NCT00294398|CHOP|Esther Sampayo MD MPH|215-590-1944|sampayo@email.chop.edu
98802|NCT00294515|Hoffmann-La Roche|Medical Communications|800-821-8590|
98803|NCT00300742|UVA Center for Addiction Research and Education|Dr. Nassima Ait-Daoud|434-243-0541|uvacare@virginia.edu
98804|NCT00300755|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
98805|NCT00300781|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com
98806|NCT00300885|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
98807|NCT00301028|UT MD Anderson Cancer Center|Merrill S. Kies, MD / Professor||CR_Study_Registration@mdanderson.org
98808|NCT00304161|University of Pennsylvania|Dr. Daniel Weintraub|215-349-8207|daniel.weintraub@uphs.upenn.edu
98810|NCT00304265|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
98811|NCT00304278|Southern Illinois University|Dr. Krishna Rao|217-545-7969|krao@siumed.edu
98812|NCT00304707|University of Massachusetts Medical School|David Kalman, PhD|9785782371|kalmand@comcast.net
98813|NCT00304746|McLean Hospital|Harrison G Pope Jr., M.D.|617-855-2911|hpope@mcLean.harvard.edu
98814|NCT00304915|Central Arkansas Veterans Healthcare System|Dr. Jeff Pyne|501-257-1083|jmpyne@uams.edu
98815|NCT00304954|NEI|Dr. Robert Nussenblatt, MD, MPH|301-496-3123|robert.nussenblatt@nih.gov
98816|NCT00305162|The Medicines Company|Meredith Todd|+19732906088|meredith.todd@themedco.com
98817|NCT00305227|University of Washington|Ann Stapleton, MD|206-616-4121|stapl@uw.edu
98818|NCT00305253|University of California San Francisco (UCSF)|Suellen Miller|415 597 9394|smiller@globalhealth.ucsf.edu , suellenmiller@gmail.com
98819|NCT00305344|University of Florida|Dr Michael Haller|352.273.9264|hallemj@peds.ufl.edu
98820|NCT00305448|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
98821|NCT00305565|Cyberonics Inc.|Mark Bunker Sr. Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com
98822|NCT00305578|Indiana University|Dr. Amit Anand||aanand@iupui.edu
98823|NCT00305604|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98824|NCT00305643|UT MD Anderson Cancer Center|Scott Kopetz, MD, PHD / Assistant Professor||CR_Study_Registration@mdanderson.org
98947|NCT00318656|GlaxoSmithKline|GSK Response Center|866-435-7343|
98825|NCT00305760|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu
98826|NCT00305773|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Steven Gore, MD||gorest@jhmi.edu
98828|NCT00305877|ECOG Statistical Office|Study Statistician|617-632-3012|
98829|NCT00305942|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
98831|NCT00306189|Amgen Inc.|Study Director|866-572-6436|
98832|NCT00306202|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
98833|NCT00306384|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
98834|NCT00306488|National Eye Institute|Wai Wong, MD, PhD|301-496-7566|wongw@mail.nih.gov
98835|NCT00306527|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
98836|NCT00306592|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com
98837|NCT00306670|Georgetown University|Craig M Kessler, MD|202-444-8676|kesslerc@georgetown.edu
98838|NCT00291551|Paracor Medical, Inc.|Michael Kolber, General Manager, VP, Regulatory Affairs|408-734-6000|info@paracor.com
98839|NCT00291577|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98840|NCT00291655|UCB Pharma|UCB Clinical trial call center|+1 877 822 9493|
98841|NCT00291694|University of Kansas Medical Center|Dr. Carol Fabian|913-588-3666|cfabian@kumc.edu
98843|NCT00297427|University of Pittsburgh|Dr. Sandra Engberg|412-624-6616|sje1@pitt.edu
98844|NCT00297492|University of Vermont|Dr. John Hughes|802-656-9610|John.Hughes@uvm.edu
98845|NCT00297596|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSarah@scresearch.net
98846|NCT00297648|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
98847|NCT00297778|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
98848|NCT00297830|Columbia University|Dr. Elizabeth Shane|2123056289|es54@columbia.edu
98849|NCT00298090|UTHSCSA|Jane Youngers|210-567-2340|youngers@uthscsa.edu
98850|NCT00298155|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu
98851|NCT00306787|Novartis Pharmaceuticals|Study Director|862-778-8300|
98852|NCT00306852|University of Miami|Dr. Steven Gedde|305-326-6435|sgedde@med.miami.edu
98853|NCT00306891|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
98854|NCT00306917|DePuy Orthopaedics, Inc|Barry Sisson|574-372-7156|BSisson@its.jnj.com
98855|NCT00311155|Daiichi Sankyo Pharma Development|Sr. Director, Regulatory Operations|732-590-5032|hmkessler@dsi.com
98856|NCT00311181|St Jude Medical|Ashish Oza|818-493-3648|aoza@sjm.com
98857|NCT00311311|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98858|NCT00311363|XenoPort, Inc.|XenoPort Call Center|877-936-6778|
98859|NCT00311376|Allergan, Inc.|Therapeutic area Head|714-246-4500|clinicaltrials@allergan.com
98860|NCT00311402|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
98861|NCT00311584|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
98862|NCT00311766|RegeneRx Biopharmaceuticals, Inc.|Study Director, David R. Crockford|617-285-5588|dcrockford@regenerx.com
98863|NCT00312195|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333|
98864|NCT00312208|sanofi-aventis|Medical Affairs study director||publicregistryGMA@sanofi-aventis.com
98865|NCT00312221|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333|
98866|NCT00312338|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
98867|NCT00312377|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
98868|NCT00312494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98869|NCT00312572|Purdue Pharma L.P.|Clinical Leader|800-733-1333|
98870|NCT00312728|Hoffman-LaRoche|Medical Communications|800-821-8590|
98871|NCT00312845|Johnson & Johnson Pharmaceutical Research & Development|Yusri A. Elsayed, M.D., M.H.Sc., Ph.D.||YElsaye1@ITS.JNJ.COM
98872|NCT00312858|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
98873|NCT00312884|Imperial College london|Professor Cowie|0207 349 7716|m.cowie@imperial.ac.uk
98874|NCT00312923|Rush University Medical Center|Barbara Swanson|312-942-8977|barbara_a_swanson@rush.edu
98875|NCT00313014|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333|
98877|NCT00313170|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
98878|NCT00313209|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
98879|NCT00313300|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
98880|NCT00313313|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
98881|NCT00301756|Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca
98883|NCT00301821|Mayo Clinic|Ivana N. M. Micallef, M.D.|507-284-4642|micallef.ivana@mayo.edu
98884|NCT00301834|University of California San Francisco|Dr. Morton Cowan|4154762188|mcowan@peds.ucsf.edu
98885|NCT00301873|Duke Comprehensive Cancer Center|Mary Lou Affronti, RN, MSN, ANP, MHSc Senior Investigator|919-684-6239|mary.affronti@duke.edu
98887|NCT00302003|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
98888|NCT00302042|Northwestern University|Dr. Ronald T. Ackermann|3126036400|r.ackermann@northwestern.edu
98889|NCT00302055|Northwestern University|Dr. Ronald T Ackermann|(312) 503-6400|r.ackermann@northwestern.edu
98890|NCT00302068|DukeUMC|Dr. James Blumenthal|919-684-3969|blume003@mc.duke.edu
98891|NCT00302081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
98892|NCT00302107|Tuscaloosa VA Medical Center|Lori Davis, MD|205-554-2000|lori.davis@va.gov
98893|NCT00302133|University of Miami Miller School of Medicine|Ihsan Salloum, MD, MPH|305 243-7931|isalloum@med.miami.edu
98894|NCT00302159|National Cancer Institute, national Institutes of Health|Kevin Camphausen, M.D.|301-496-5457|camphauk@mail.nih.gov
98895|NCT00302211|Actelion Pharmaceuticals US, Inc.|Desilu Villanueva MD, Associate Director, Medical Affairs|650-624-6900|desilu.villanueva@actelion.com
98896|NCT00302328|Glostrup Hospital|Ulrik Christensen|+4538634825|bisan@regionh.dk
98897|NCT00302458|Massachusetts General Hospital|Dr. Thomas Spencer|617-726-1731|spencer@helix.mgh.harvard.edu
98898|NCT00302718|VA HSR&D Center for Innovations in Quality, Effectiveness & Safety (IQuESt)|Dr. Laura A. Petersen|713-794-8623|Laura.Petersen@va.gov
98899|NCT00302848|Berlin Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD, Principal Investigator|+49 30 94510145|dinger@zeg-berlin.de
98900|NCT00302952|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
98901|NCT00303069|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
98902|NCT00303108|New York Oncology Hematology, Albany Medical Center|Dr. Rufus Collea|518-262-6696|rufus.collea@usoncology.com
98903|NCT00303186|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98904|NCT00303316|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
98905|NCT00303329|Novartis Pharmaceuticals|Study Director|862-778-8300|
98906|NCT00303446|National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)|Kenneth Fischbeck, M.D.|301-435-9318|kf@ninds.nih.gov
98907|NCT00303459|Actelion Pharmaceuticals Ltd|Jonathan Tolson|+41 61 565 56 04|jonathon.tolson@actelion.com
98908|NCT00303472|Amgen Inc.|Study Director|866-572-6436|
98909|NCT00303485|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
98910|NCT00303511|Emory University|Dr. Wendy Book|404-778-5545|wbook@emory.edu
98911|NCT00303602|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
98912|NCT00303628|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012|
98913|NCT00303667|Masonic Cancer Center|Sarah Cooley, M.D.|612-626-4024|cool0023@umn.edu
98914|NCT00303823|The University of Arizona|H-H. Sherry Chow, Ph.D.|520-626-3358|schow@azcc.arizona.edu
98915|NCT00303862|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu
98916|NCT00303901|Barbara Ann Karmanos Cancer Institute|Peter Littrup, M.D.|313-576-8758|littrupp@karmanos.org
98917|NCT00303953|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|mleblanc@fhcrc.org
98918|NCT00303966|University of Chicago|Dr. Wendy Stock|773-834-8982|wstock@medicine.bsd.uchicago.edu
98919|NCT00303979|Medtronic Cardiac Rhythm Disease Management|IMPROVE HF, Clinical Research Specialist||medtronicCRMtrials@medtronic.com
98920|NCT00304031|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org
98921|NCT00304070|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
98922|NCT00304096|University of Virginia|Kimberly Bullock, PhD and David Brenin, MD|434-924-0180|kb9d@virginia.edu
98923|NCT00313443|Unité de Recherches Thérapeutiques. Service de Médecine Interne A. Hôpital Lariboisière. Paris, France|Dr Carmelo Lafuente-Lafuente|+33 1 49 95 63 37|c.lafuente@nodo3.net
98924|NCT00313586|ECOG Statistical Office|Study Statistician|617-632-3012|
98925|NCT00313612|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org
98926|NCT00313703|Montefiore Medical Center|Benjamin Friedman|718-920-6626|befriedm@montefiore.org
98927|NCT00313716|Baylor College of Medicine|Claudia Robertson, MD|713-873-2792|claudiar@bcm.edu
98928|NCT00316862|Memorial Sloan-Kettering Cancer Center|David H. Ilson, M.D., Ph.D.||ilsond@mskcc.org
98929|NCT00316888|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012|
98930|NCT00316914|Mayo Clinic|Dr. Axel Grothey|507-184-2779|grothey.axel@mayo.edu
98931|NCT00317044|AstraZeneca|ClinicalTrialTransparency||ClinicalTrialTransparency@astrazeneca.com
98932|NCT00317109|GlaxoSmithKline|GSK Response Center|866-435-7343|
98933|NCT00317226|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com
98934|NCT00317239|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com
98935|NCT00317473|USAMRU-K|Mark A. Withers, MD PhD|+254-722-449-357|aodika@wrp-ksm.org
98936|NCT00317642|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
98937|NCT00317720|UT MD Anderson Cancer Center|Dr. Francisco Esteva|713-563-0742|CR_Study_Registration@mdanderson.org
98938|NCT00317941|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
98939|NCT00318136|Genentech, Inc.|Medical Communications|800-821-8590|
98940|NCT00318292|Mayo Clinic|Michaele Menghini|480-301-6651|menghini.michaele@mayo.edu
98941|NCT00318370|Morphotek, Inc.|Susan Weil, MD|610-423-6182|sweil@morphotek.com
98942|NCT00318409|San Francisco Department of Public Health|Moupali Das, MD, MPH|415-437-6204|moupali.das@sfdph.org
98943|NCT00318461|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
98944|NCT00318474|Saint Joseph's Hospital and Medical Center|Ron Hogg, M.D.|602-406-3246|ronhogg@gmail.com
98945|NCT00318565|Biosense Webster|Christine Liu|9098398608 ext 8608|cliu10@its.jnj.com
98946|NCT00318591|Coloplast|Anna Karina Busch, Intl. Senior Scientific Manager|+45 49112350|dkakb@coloplast.com
98948|NCT00318708|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu
98949|NCT00318812|Ottawa Hospital Research Institute|Dr Deborah Zimmerman, principal investigator|613-738-8400 ext 82534|dzimmerman@toh.on.ca
98950|NCT00318929|Virginia Commonwealth University|Alan R. Towne, MD|804-282-9869|atowne@mcvh-vcu.edu
98951|NCT00319020|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com
98952|NCT00319046|Actelion Pharmaceuticals Ltd|Cécile Luzy, MSc/Clinical Research Scientist|+ 41 61 565 6386|
98953|NCT00319098|GlaxoSmithKline|GSK Response Center|866-435-7343|
98954|NCT00319111|Actelion Pharmaceuticals Ltd|Loïc Perchenet PhD/Clinical Trial Leader|+41 61 565 6457|
98955|NCT00319254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98956|NCT00301080|Northwestern University|Clinical Research Office|312-695-1301|cancertrials@northwestern.edu
98957|NCT00301262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
98958|NCT00301366|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com
98959|NCT00301418|Feinstein Institute for Medical Research|John Boockvar, MD|212-434-3900|jboockvar@northwell.edu
98960|NCT00307034|GlaxoSmithKline|GSK Response Center|866-435-7343|
98961|NCT00307047|Abbott Vascular|Ellen Travis|408-845-1512|ellen.travis@av.abbott.com
98962|NCT00307086|H. Lee Moffitt Cancer Center|Mellisa Alsina, MD|813-745-6886|Melissa.Alsina@moffitt.org
98963|NCT00307125|DAIT/NIAID|Director, Clinical Research Operations Program (CROP)|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
98964|NCT00307151|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org
98965|NCT00307164|Center for Biostatistics in AIDS Research, Harvard School of Public Health|ClinicalTrials.gov Coordinator|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
98966|NCT00308516|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
98967|NCT00308555|UCSF/San Francisco General Hospital|Dr. Donald I. Abrams|415-476-4082 ext 444|dabrams@hemeonc.ucsf.edu
98968|NCT00308581|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
98969|NCT00308620|University of Minnesota|David Boulware|6126269546|boulw001@umn.edu
98970|NCT00308711|Cytokine PharmaSciences, Inc.|Barbara L. Powers|610-687-1776 ext 214|bpowers@cytokinepharmasciences.com
98971|NCT00308737|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com
98972|NCT00308997|Yale University School of Medicine|Ralph Hoffman, MD|203-688-9734|Ralph.Hoffman@yale.edu
98973|NCT00309244|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com
98974|NCT00309387|University of Parma|Giovanni Maraini, MD|+39 0521 238527|maraini@unipr.it
98975|NCT00309452|Yale University|Vinod H. Srihari|2039747816|vinod.srihari@yale.edu
98976|NCT00309465|Beaumont Health System|Tamra Dukatz, CRNA, MSN|248 992-4741 (pager)|tdukatz@beaumont.edu
98977|NCT00309608|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
98978|NCT00309738|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com
98979|NCT00309751|Kowa Research Institute Inc|Bill Arana|919 433 1600|barana@kowaus.com
98980|NCT00309777|Kowa Research Europe, Ltd.|Neil Hounslow|01189229004|nhounslow@kowa.co.uk
98981|NCT00309907|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org
98982|NCT00309946|The University of Chicago|Dr. Hedy Kindler|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu
98983|NCT00309985|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|
98984|NCT00310076|Comprehensive Cancer Center of Wake Forest University|Greg Russell, MS|336-716-5449|grussell@wakehealth.edu
98985|NCT00310310|VA San Diego Healthcare System|Carl J. Stepnowsky,PhD|858-642-1240|Carl.Stepnowsky@va.gov
98986|NCT00310362|MInneapolis VA Health Care System|Dr. Joan Griffin|507-538-1490|griffin.joan@mayo.edu
98987|NCT00310375|GlaxoSmithKline|GSK Response Center|866-435-7343|
98989|NCT00310427|NIH/National Institute on Alcohol Abuse and Alcoholism|Markus A. Heilig, M.D., Ph.D.|301-435-9386|mheilig@mail.nih.gov
98990|NCT00310440|Nor Consult, LLC|Lead Clinical Research Associate|2066076861|p15@nor-consult.com
98991|NCT00310466|ALK-Abelló A/S|Kim Simonsen, Senior Director|+4545747576|
98992|NCT00310791|Children's Hospital Boston|Dr. Catherine Gordon|401-444-4712|cgordon1@lifespan.org
98993|NCT00310804|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
98994|NCT00310817|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
98995|NCT00310856|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
98996|NCT00319436|Yale University School of Medicine, Department of Psychiatry and Yale Child Study Center|Nancy Suchman, Ph.D., Associate Professor|203-937-3486 ext 7430|nancy.suchman@yale.edu
98997|NCT00319449|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
98998|NCT00319501|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
98999|NCT00319553|Sanofi Pasteur Inc.|Medical Director||RegistryContactUS@sanofipasteur.com
99000|NCT00319592|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
99001|NCT00319644|University of California, San Francisco|Julin Tang, MD|415-206-5274|tangj@anesthesia.ucsf.edu
99002|NCT00321672|NeurogesX|Trudy Vanhove, VP Clinical Development|650-393-7444|tvanhove@neurogesx.com
99004|NCT00321698|Portland VAMC|Dr. Mark Garzotto|541-728-0665|garzotto@ohsu.edu
99005|NCT00321711|Amgen Inc.|Study Director|866-572-6436|
99006|NCT00321737|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com
99008|NCT00321789|Veterans Affairs Medical Center|Corrine I. Voils|919-286-0411 ext 5196|corrine.voils@va.gov
99009|NCT00321828|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600|
99010|NCT00321854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
99011|NCT00321893|University of Texas MD Anderson|Powel H. Brown, MD, PhD/Professor of Medicine and Cancer Prevention||CR_Study_Registration@mdanderson.org
99012|NCT00321906|The University of Chicago|Edward Garrity, MD|(773) 834-1119|egarrity@uchicago.edu
99013|NCT00321919|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
99014|NCT00321932|Masonic Cancer Center, University of Minnesota|Linda Burns, M.D.|612-624-8144|burns023@umn.edu
99015|NCT00321984|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com
99016|NCT00322049|U.S. Army Medical Component Armed Forces Research Institute of Medical Services|Wipa Chawachalasai|662-696-2700 ext 4351|wipac@afrims.org
99017|NCT00322101|Fred Hutchinson Cancer Research Center|Bart Lee Scott|206-667-1990|bscott@fhcrc.org
99018|NCT00322153|Forest Research Institute|Stephen M Graham, PhD|201-427-8156|Stephen.Graham@frx.com
99019|NCT00322231|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
99020|NCT00322309|BUPA CSU, Boston University School of Medicine|Maryam Afshar, MD|617-414-1990|maryam.afshar@bmc.org
99021|NCT00322335|GlaxoSmithKline|GSK Response Center|866-435-7343|
99022|NCT00322348|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
99023|NCT00322374|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
99024|NCT00322387|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
99025|NCT00322439|Amgen Inc.|Study Director|866-572-6436|
99026|NCT00322452|AstraZeneca|Gerard Lynch||AZTrial_results_posting@AstraZeneca.com
99028|NCT00322491|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com
99029|NCT00322556|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
99030|NCT00322621|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
99031|NCT00322712|University of New Mexico|Dr. Fa Chyi Lee|505-925-0405|flee@salud.unm.edu
99032|NCT00322777|Canadian Institute of Natural and Integrative Medicine|Dr. Badri Rickhi|403-220-0022 ext 0|b.ricki@cinim.org
99033|NCT00322842|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com
99034|NCT00322855|University of New Mexico|Christine M. Gan, Ph.D|5059250387|cgan@salud.unm.edu
99035|NCT00322881|Dana-Farber Cancer Institute|Ursula A. Matulonis, MD|617-632-2334|umatulonis@partners.org
99036|NCT00323037|CTI Clinical Trial and Consulting Services|Sandy Stagge, RN, BSN|513-619-1837|sstagge@ctifacts.com
99037|NCT00323115|Dartmouth-Hitchcock Medical Center|Dr. Camilo Fadul|603-653-6312|camilo.e.fadul@hitchcock.org
99038|NCT00323193|VA VISN 5 Mental Illness Research, Education and Clinical Center|Richard W. Goldberg, Ph.D.|410-637-1851|richard.goldberg@va.gov
99039|NCT00323258|Duke University Medical Center|Sara Calvert, PharmD|919-668-7540|sara.calvert@duke.edu
99040|NCT00323271|VA Connecticut Healthcare System|Robert Kerns, PhD|203-932-5711 ext 3841|robert.kerns@va.gov
99041|NCT00323284|Glaukos|Jeff Wells, Sr. VP, Clinical, Regulatory, and Quality Affairs|949-367-9600 ext 227|jwells@glaukos.com
99042|NCT00323297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99043|NCT00323310|Bracco Diagnostics Inc|Usha Halemane/Executive Director|609-514-2578|usha.halemane@diag.bracco.com
99044|NCT00323362|Rutgers Cancer Institute of New Jersey|Dr. Joseph Aisner, MD|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
99045|NCT00323427|Portland VA Medical Center|Mitchel Turbin, Ph.D.|503-220-8262 ext 54525|bonnie.becker@va.gov
99046|NCT00323479|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
99047|NCT00323492|Gilead Sciences|Camille Aubron-Olivier|+33(0)1 42 737130|camille.aubron-olivier@gilead.com
99048|NCT00323557|UT MD Anderson Cancer Center|Amar Safdar, MD/Professor||CR_Study_Registration@mdanderson.org
99049|NCT00323609|Medtronic|John Tillman|408-548-6518|tillmj1@mspexcng.medtronic.com
99050|NCT00323622|GlaxoSmithKline|GSK Response Center|866-435-7343|
99051|NCT00323635|Brigham and Women's Hospital|Quentin Regestein|617-732-4497|qregestein@partners.org
99052|NCT00323739|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
99053|NCT00323869|Stanford University Medical Center|Heather A Wakelee, MD, Associate Professor of Medicine (Oncology)|650-498-6000|hwakelee@stanford.edu
99054|NCT00323882|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
99055|NCT00324038|Napp Pharmaceutical Ltd|Dr Paul Schofield, Medical Director|01223424444|info@contact-clinical-trials.com
99056|NCT00324116|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
99058|NCT00324168|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu
99060|NCT00307333|University of Virginia|Joseph R. Moorman, MD|434-982-3367|rm3h@virginia.edu
99061|NCT00307437|Centocor Research & Development, Inc.|Senior Director, Compound Development Team Leader|1 215 793-7612|
99062|NCT00307489|Gilead Sciences, Inc.|Stephen J. Rossi, PharmD|650-522-4212|stephen.rossi@gilead.com
99063|NCT00307684|Janssen-Cilag G.m.b.H.|European Medical Affairs Director Neurology|+49 2137 955258|bschaeu2@its.jnj.com
99064|NCT00307736|Massachusetts General Hospital|Lawrence Blaszkowsky|6177244637|lblaszkowsky@partners.org
99065|NCT00307801|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
99066|NCT00307931|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
99067|NCT00314574|Hoffman-LaRoche|Medical Communications|800-821-8590|
99068|NCT00314808|Duke University|Deborah H. Allen, MSN, RN, CNS, FNP-BC, AOCNP|(919) 681-4719|allen079@mc.duke.edu
99069|NCT00314951|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
99070|NCT00315055|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
99071|NCT00315120|University of North Texas Health Science Center-The Osteopathic Research Center|John C. Licciardone, DO, MS, MBA|817-735-2028|john.licciardone@unthsc.edu
99072|NCT00315146|Wake Forest Universtiy Baptist Medical Center|Stephen Kritchevsky|336-713-8548|skritche@wakehealth.edu
99073|NCT00315302|Jaeb Center for Health Research|Raymond Kraker|813-975-8690|pedig@jaeb.org
99074|NCT00315328|Jaeb Center for Health Research|Raymond Kraker|813-975-8690|pedig@jaeb.org
99075|NCT00315341|University of California, Los Angeles|Walter Ling, M.D.|(310) 933-8111|lwalter@ucla.edu
99076|NCT00315445|Purdue Pharma L.P.|Medical Director|800-733-1333|
99077|NCT00315458|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333|
99078|NCT00315588|University of Miami Miller School of Medicine Miami Fl|Dr. Rodolfo Alejandro|305 243 5324|ralejand@med.miami.edu
99079|NCT00315614|University of Miami|Dr. Rodolfo Alejandro|3052435324|ralejand@med.miami.edu
99080|NCT00315627|University of Miami Miller School of Medicine|Dr. Rodolfo Alejandro|305 243-5324|ralejand@med.miami.edu
99081|NCT00315705|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447|
99082|NCT00315731|GlaxoSmithKline|GSK Response Center|866-435-7343|
99083|NCT00315822|Cleveland Clinic|Daniel Sessler, MD|216-444-4900|sessled@ccf.org
99084|NCT00315939|University of Virginia|Boris Kovatchev, PhD|434-924-5592|bpk2u@virginia.edu
99085|NCT00316004|Clinical Trial Center, University of Washington, Seattle, WA|Susanne May, PhD|206-685-1302|sjmay@uw.edu
99086|NCT00316017|Clinical Trial Center, University of Washington, Seattle, WA|Susanne May, PhD|206-685-1302|sjmay@uw.edu
99087|NCT00316082|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
99088|NCT00316121|Advanced Technologies and Regenerative Medicine, LLC|Manny Lazaro, Director, Clinical Affairs|508-828-2741|mlazaro@its.jnj.com
99089|NCT00316173|GlaxoSmithKline|GSK Response Center|866-435-7343|
99090|NCT00316186|GlaxoSmithKline|GSK Response Center|866-435-7343|
99091|NCT00316199|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99092|NCT00316225|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99093|NCT00316264|MedImmune|Pamela Griffin|301 398 0000|clinicaltrialenquiries@medimmune.com
99094|NCT00316277|McLean Hospital/Harvard Medical School|Roger D. Weiss, M.D.|617-855-2242|rweiss@mclean.harvard.edu
99095|NCT00316303|Dartmouth-Hitchcock|Stanley Rosenberg, Ph.D.|603-653-0740|Stanley.d.rosenberg@dartmouth.edu
99096|NCT00316355|Hartford Hospital|David Tolin|860-545-7685|david.tolin@hhchealth.org
99097|NCT00316693|GlaxoSmithKline|GSK Response Center|866-435-7343|
99098|NCT00316706|GlaxoSmithKline|GSK Response Center|866-435-7343|
99099|NCT00316719|GlaxoSmithKline|GSK Response Center|866-435-7343|
99100|NCT00324233|Coloplast A/S|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com
99101|NCT00324259|Washington University School of Medicine|Dr. Matthew Ellis|314-362-8866|mjellis@bcm.edu
99102|NCT00324272|John Radcliffe Hospital|Mr. Henk Giele, Consultant Plastic & Reconstructive Surgeon|01865 231 056|henk.giele@orh.nhs.uk
99103|NCT00324350|University of California, San Francisco|Dr. Ann Schwartz|415-514-8000|aschwartz@psg.ucsf.edu
99104|NCT00324415|AMC|Director, AMC Statistical Center|501-526-6712|jylee@uams.edu
99105|NCT00325468|Amgen Inc.|Study Director|866-572-6436|
99106|NCT00325598|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8525|izoberi@radonc.wustl.edu
99107|NCT00325754|Harbo-UCLA Research and Education Institute|Richard Casaburi|310-22-8249|casaburi@ucla.edu
99108|NCT00325780|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com
99110|NCT00325897|Denver Health Medical Center|Dr. Richard Albert|303-436-6900|ralbert@dhha.org
99111|NCT00326001|Biotronik GmbH&Co. KG, Berlin, Germany|Dejan Danilovic|+49 9131 8924 7832|dejan.danilovic@biotronik.com
99112|NCT00326118|GlaxoSmithKline|GSK Response Center|866-435-7343|
99113|NCT00326170|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org
99114|NCT00326183|Merck Sharp & Dohme Corp|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
99115|NCT00326196|Roudebush VAMC|Masoor Kamalesh, MD|317-988-2401|masoor.kamalesh@va.gov
99117|NCT00326495|National Cancer Institute|Dr. Alice Chen|240-276-6565|chenali@mail.nih.gov
99118|NCT00326599|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|716-845-4101|alex.adjei@roswellpark.org
99119|NCT00326612|DIvision of Pediatric Emergency Medicine|Maija Holsti, MD, MPH|801-587-7450|maija.holsti@hsc.utah.edu
99120|NCT00326716|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com
99121|NCT00326781|University of Pennsylvania|Caryn Lerman, Ph.D.|215-746-7141|clerman@mail.med.upenn.edu
99122|NCT00326872|Mayo Clinic|Dr. Dusica Babovic-Vuksanovic||dbabovic@mayo.edu
99123|NCT00326885|Fresenius Biotech|Manager, Regulatory Affairs|781-699-4652|bao.le@fresenius-biotech.com
99124|NCT00326898|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|
99125|NCT00326911|ImClone LLC|Chief Medical Officer||ClinicalTrials@ImClone.com
99126|NCT00326950|Eisai Call Center|Eisai Inc.|888-422-4743|
99127|NCT00326963|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
99128|NCT00327015|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
99129|NCT00327171|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com
99130|NCT00327340|OncoGenex Pharmaceuticals|Monica S. Krieger, PhD|425-686-1558|mkrieger@oncogenex.com
99131|NCT00327392|Eisai Inc|Eisai Medical Services|1-888-422-4743|
99132|NCT00327444|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com
99133|NCT00327470|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99134|NCT00327717|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affairs|81-3-3817-3914|
99135|NCT00313846|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333|
99136|NCT00313911|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
99137|NCT00314106|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov
99138|NCT00314132|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
99139|NCT00314145|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
99140|NCT00314236|Piramal Healthcare (Canada) Limited|Alberto Restrepo, MD, Director of Medical and Clinical Affairs|450-686-2437 ext 315|alberto.restrepo@piramal.com
99141|NCT00314249|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|1-201-427-8218|robert.palmer@frx.com
99142|NCT00314262|Emory University School of Medicine|Dong Shin, MD|404-778-2980|dmshin@emory.edu
99144|NCT00314340|UC Davis Medical Center|Barth Wilsey MD|916-843-7165|blwilsey@ucdavis.edu
99145|NCT00314353|NSABP Foundation, Inc.|Diana Gosik|412-330-4692|diana.gosik@nsabp.org
99146|NCT00314366|Texas Heart Institute|Emerson C. Perin, M.D., Ph.D.|832-355-9405|eperin@texasheart.org
99147|NCT00319696|Actelion Pharmaceuticals Ltd|Andjela Kusic-Pajic, MD/Clinical Project Team Leader|+41 61 565 64 17|
99148|NCT00319735|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org
99149|NCT00319748|Masonic Cancer Center, University of Minnesota|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu
99150|NCT00319982|Brigham and Women's Hospital|Carolyn Ho, MD|617-732-5685|cho@partners.org
99151|NCT00320112|VA HSRD|Fatima Makki|734 845 3623|Fatima.Makki@va.gov
99152|NCT00320190|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
99153|NCT00320216|Centocor Research & Development, Inc.|Senior Director Clinical Research|1-800-457-6399|
99154|NCT00320242|Beth Israel Deaconess Medical Center and Harvard Medical School|Dr. David K. Simon, Associate Professor of Neurology|617-735-3251|dsimon1@bidmc.harvard.edu
99155|NCT00320255|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
99156|NCT00320281|Craig Hospital|Dr. Gary Maerz|303-789-8220|adannels@craighospital.org
99157|NCT00320372|Cyberonics, Inc|Mark Bunker, PharmD, Sr. Director, Global Medical Affairs|281-228-7223|mark.bunker@cyberonics.com
99158|NCT00320385|GlaxoSmithKline|GSK Response Center|866-435-7343|
99159|NCT00320411|GlaxoSmithKline|GSK Response Center|866-435-7343|
99160|NCT00320489|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99161|NCT00320515|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99162|NCT00320528|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99163|NCT00320541|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99164|NCT00320593|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org
99165|NCT00320606|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov
99166|NCT00320671|Northwell|Delbert Robinson MD|718.470.8195|drobinson@nshs.edu
99167|NCT00320710|Novartis|Study Director|862-778-8300|
99168|NCT00320749|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, M.D.|614-293-9863|Tanios.Bekaii-Saab@osumc.edu
99169|NCT00320788|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator||clinicaltrials@regeneron.com
99170|NCT00320801|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333|
99171|NCT00321269|Iowa City VA Health Care System|Carolyn Turvey|319 338 0581 ext 7714|Carolyn-Turvey@uiowa.edu
99172|NCT00321321|Gentofte Hospital, University of Copenhagen|Dr. Kasper Aaboe|+4539978474|Kasper@dadlnet.dk
99173|NCT00321373|GlaxoSmithKline|GSK Response Center|866-435-7343|
99174|NCT00321464|Amgen Inc.|Study Director|866-572-6436|
99176|NCT00321620|Amgen Inc.|Study Director|866-572-6436|
99177|NCT00321646|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-8313|mary_taplin@dfci.harvard.edu
99178|NCT00328016|National Institute on Aging|Jessica McNeeley, Research Fellow|410-558-8110|mcneeleyj@mail.nih.gov
99179|NCT00328042|VA San Diego|Dr. Erik Groessl|858-552-8585|erik.groessl@va.gov
99180|NCT00328094|Beth Israel Deaconess Medical Center, Boston, MA|Dr. Balachundhar Subramaniam, MD MPH|6177542675|bsubrama@bidmc.harvard.edu
99181|NCT00328172|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
99182|NCT00328198|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447|
99183|NCT00328263|Bio-K+ International Inc.|Dr. Serge Carrière|450-978-2465|scarriere@biokplus.com
99184|NCT00328770|Liver Transplant Program, University of Alberta Hospitals|Dr. Norman Kneteman|780-407-6168|norm.kneteman@albertahealthservices.ca
99186|NCT00328861|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov
99187|NCT00328926|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
99188|NCT00329030|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com
99189|NCT00329108|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
99190|NCT00329160|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
99314|NCT00336895|UPittsburgh|Dr. Roberto Lopez-Solis|412-647-5173|lopezrc@upmc.edu
99191|NCT00329238|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
99192|NCT00329407|Boston University|Ofra sarid-Segal, MD|617-414-1990|ofra.segal@bmc.org
99193|NCT00329420|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
99194|NCT00329433|Washington University School of Medicine|Michael S. Avidan, MBBCh|314-747-4155|avidanm@wustl.edu
99195|NCT00329524|UAMS Department of Otolaryngology|John Dornhoffer, MD|501-686-7000|dornhofferjohnl@uams.edu
99196|NCT00329550|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
99197|NCT00329602|GlaxoSmithKline|GSK Response Center|866-435-7343|
99198|NCT00329641|SWOG Statistical Office|SWOG Melanoma Statistician|206-667-4408|
99199|NCT00329719|Mayo Clinic|Kurt A. Jaeckle, M.D.|5072842511|jaeckle.kurt@mayo.edu
99200|NCT00329732|Thomas Jefferson University|Kathleen Bradley|215-955-2025|Kathleen.Bradley@jefferson.edu
99201|NCT00329745|GlaxoSmithKline|GSK Response Center|866-435-7343|
99202|NCT00329771|Doylestown Hospital, Pennsylvania|Abraham A. Ashkenazi, M.D./Principal Investigator|215-625-2894|aashkenzai2001@yahoo.com
99203|NCT00329784|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
99204|NCT00329836|Doylestown Hospital|Abraham Ashkenazi, M.D./ Prinicpal Investigator|215-625-2894|aashkenazi@yahoo.com
99205|NCT00329849|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
99206|NCT00329901|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
99207|NCT00330161|University of Michigan Comprehensive Cancer Center|Erin Sargent|(734) 936-3348|esargent@umich.edu
99208|NCT00330174|Medical University of South Carolina|Susan Sonne, PharmD, BCPP|843.792.5221|sonnesc@musc.edu
99209|NCT00330343|JHU|Myron Yaster|9552393|myaster1@jhmi.edu
99210|NCT00330382|University of California, Irvine|Dr. Frank Meyskens, Jr.|714-456-6310|flmeyske@uci.edu
99211|NCT00330421|Dana-Farber Cancer Institute|Jeffrey A. Morgan, M.D.|617-632-5204|jamorgan@partners.org
99212|NCT00330460|Amgen Inc.|Study Director|866-572-6436|
99213|NCT00330564|UT MD Anderson Cancer Center|Quality Assurance Specialist|713-563-1602|caperez@mdanderson.org
99214|NCT00330616|GlaxoSmithKline|GSK Response Center|866-435-7343|
99215|NCT00330668|Ipsen, US|Sr Vice President, Clinical Development and Medical Affairs|clinical.trials@ipsen.com|clinical.trials@ipsen.com
99216|NCT00330681|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
99217|NCT00330733|Phoenix VA Health Care System|Peter Reaven|602 277 5551 ext 5817|Peter.Reaven@va.gov
99218|NCT00330759|Amgen Inc.|Study Director|866-572-6436|
99219|NCT00330876|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com
99220|NCT00330915|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99221|NCT00330928|InfraReDx, Inc|Manager of Clinical Research|781-221-0053|pshah@infraredx.com
99222|NCT00330967|Phoenix VA Health Care System|Charles Oh|602-277-5551 ext 1-5127|charles.oh@va.gov
99223|NCT00331006|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-972-3048|sassmann@neriscience.com
99224|NCT00308061|University of Bamako Faculty of Medicine, Mali|Mahamadou A. Thera, MD MPH|223-222-1809|mthera@mrtcbko.org
99225|NCT00308074|University of Massachusetts Medical School|Dr. Jean A. Frazier|508-856-5896|ChildResearch@umassmed.edu
99226|NCT00308087|Genzyme Corporation|Genzyme MedInfo||medinfo@genzyme.com
99227|NCT00308113|University of Pittsburgh|Dr. Paula R. Clemens|412-648-9762|pclemens@pitt.edu
99228|NCT00308139|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com
99229|NCT00308230|Emory University|Wendy Book|404-778-5545|wbook@emory.edu
99230|NCT00308308|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com
99231|NCT00313781|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99232|NCT00313820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
99233|NCT00324649|Gilead Sciences|Pedro Ferrer|+34 91 771 2478|pedro.ferrer@gilead.com
99234|NCT00324675|"University Hospital Carl Gustav Carus, Dresden"|Dr. Frank Pistrosch|0049 351 4400580|frank.pistrosch@uniklinikum-dresden.de
99235|NCT00324701|Ralph H. Johnson VAMC|Leonard E. Egede, MD, MS|843-789-6670|Leonard.Egede@va.gov
99236|NCT00324740|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org
99237|NCT00324857|VA|Said A. Ibrahim, MD, MPH|215 823 5800 ext 7163|Said.Ibrahim2@va.gov
99238|NCT00324870|Johns Hopkins University|Michael Carducci, MD|410-614-6337|carducci@jhmi.edu
99240|NCT00324961|GlaxoSmithKline|GSK Response Center|866-435-7343|
99241|NCT00324987|SWOG Statistical Center|SWOG Statistician|206-667-4408|
99242|NCT00325039|New England Research Institutes, Inc.|Heather Litman, PhD|617 972 3297|hlitman@neriscience.com
99243|NCT00325078|National Institute of Allergy and Infectious Diseases|De Ravin, SukSee|+1 301 496 6772|sderavin@mail.nih.gov
99244|NCT00325130|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
99245|NCT00325143|GlaxoSmithKline|GSK Response Center|866-435-7343|
99246|NCT00325156|GlaxoSmithKline|GSK Response Center|866-435-7343|
99247|NCT00325195|Savient Pharmaceuticals, Inc.|Medical Director|732-418-9300|
99248|NCT00325234|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99249|NCT00325403|United Therapeutics Corporation|Kevin Laliberte; Senior Director, Product Development|919-425-8176|klaliberte@unither.com
99250|NCT00325416|H. Lee Moffitt Cancer Center and Research Institute|Daniel M. Sullivan, M.D.|813-745-3878|dan.sullivan@moffitt.org
99251|NCT00325442|United Therapeutics Corporation|Kevin Laliberte, PharmD; Senior Director, Product Development|919-425-8176|klaliberte@unither.com
119145|NCT00356863|The Gertner Institute for Epidemiology and Health Service Research|Rachel S Dankner, MD, MPH|972-3-5305390|RachelD@gertner.health.gov.il
99253|NCT00331422|Masonic Cancer Center, University of Minnesota|Melissa Geller, MD|612-626-3111|gelle005@umn.edu
99254|NCT00331552|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu
99255|NCT00332839|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|
99256|NCT00333138|Novartis pharmaceuticals|Study director|862-778-8300|
99257|NCT00333229|Novartis Pharmaceuticals|Study Director|862-778-8300|
99258|NCT00333359|XenoPort, Inc.|XenoPort Call Center|877-936-6778|
99259|NCT00333437|University of California San Francisco|Jeffrey A. Golden, MD|415-353-2935|Jeff.Golden@ucsf.edu
99260|NCT00333619|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 895-9311|cathy.alessi@va.gov
99261|NCT00333710|VA Boston Healthcare System|Amy Silberbogen, Ph.D.|857-364-4707|amy.silberbogen@va.gov
99262|NCT00333762|VA Pittsburgh Healthcare System|Dana Sinciline|412-822-3683|dana.sinciline@va.gov
99263|NCT00333775|Hoffmann-La Roche|Medical Communications|800 821-8590|
99264|NCT00333788|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493|
99265|NCT00333801|Tuscaloosa VA Medical Center|Lori Davis, MD|205-554-3819|lori.davis@va.gov
99266|NCT00333814|Allergan, Inc|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com
99267|NCT00333840|Novartis Pharmaceuticals|Study Director|862-778-8300|
99268|NCT00333866|Organization: Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
99269|NCT00333879|Atlanta VA Rehab R&D Center|David Ross|404-321-6111 ext 6817|rosss0128@bellsouth.net
99270|NCT00333970|VA Connecticut Healthcare System|Dr. Joanna Fiszdon|203-932-5711 ext 2231|joanna.fiszdon@va.gov
99271|NCT00333983|VA Maryland Health Care System, Baltimore|Dr. Susan S. Conroy|(410) 605-7000 ext 3213|susan.conroy@va.gov
99272|NCT00334061|Penumbra Inc|Siu Po Sit, PhD Study Coordinator|510 748 3200 ext 221|siupo.sit@penumbrainc.com
99273|NCT00334074|Baylor University Medical Center|Dr. Edward Agura|214-818-8472|Sandyli@baylorhealth.edu
99274|NCT00334113|VA Boston Healthcare System|Dr. DeAnna Mori|857-364-4121|deanna.mori@va.gov
99275|NCT00334204|University of Mississippi|Tibor Fulop, M.D./Associate Professor of Medicine|601 984-5670|tfulop@umc.edu
99276|NCT00334282|GlaxoSmithKline|GSK Response Center|866-435-7343|
99277|NCT00334295|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
99278|NCT00334542|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu
99280|NCT00334802|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99281|NCT00334815|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|jmoon@fhcrc.org
99283|NCT00334958|Eisai Call Center|Eisai Inc.|888-422-4743|
99284|NCT00335140|Johns Hopkins Cancer Center|Lode Swinnen, MD|(410) 955-8603|lswinne1@jhmi.edu
99285|NCT00335153|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
99286|NCT00328510|Thomas Jefferson University|Maria Werner-Wasik, MD|215-955-7679|Maria.Werner-Wasik@jeffersonhospital.org
99287|NCT00328562|Thomas Jefferson University|Maria Werner-Wasik, MD|215-955-6702|Maria.Werner-Wasik@jeffersonhospital.org
99288|NCT00328614|Thomas Jefferson University|Edouard Trabulsi, MD|215-955-1000|Edouard.Trabulsi@jefferson.edu
99289|NCT00328627|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
99290|NCT00335257|Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD|0049(0)30 945 10120|dinger@zeg-berlin.de
99291|NCT00335283|Vanderbilt University Medical Center|Manager, Clinical Trials|615-322-4643|tina.higginbotham@vanderbilt.edu
99292|NCT00335322|Kirby Institute|Sean Emery|9385 0900|semery@kirby.unsw.edu.au
99293|NCT00335452|sanofi-aventis|Trial Information Transparency Team||GV-Contact-us@sanofi-aventis.com
99294|NCT00335478|OHSU Knight Cancer Institute|Joseph Bubalo, PharmD, BCPS, BCOP|503-494-1080|bubaloj@ohsu.edu
99295|NCT00335504|Mayo Clinic|Dr. Paul Limburg|507-266-9093|limburg.paul@mayo.edu
99296|NCT00335517|University of Rochester|Glenn Rectine, MD|585-275-8780|glenn_rectine@urmc.rochester.edu
99297|NCT00335556|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
99298|NCT00335725|IBSA instutut Biochimique SA|IBSA Clinical Research Manager|+41 58 360 1000|sd@ibsa.ch
99299|NCT00335777|Jefferson Headache Center|Stephen D. Silberstein, MD|215-955-2243|stephen.silberstein@jefferson.edu
99300|NCT00335829|Johns Hopkins, Interventional Radiology|Jeff Geschwind, MD|410-614-6597|jfg@jhmi.edu
99301|NCT00335959|SWOG Statistical Center|Study Statistician|206-667-4623|
99302|NCT00335972|Cleveland Clinic|Rafi Avitsian, M.D|(216)-444-9735|avitsir@ccf.org
99304|NCT00336284|Biotronik, Inc.|Justin Michalski, M.S. / Clinical Studies Engineer|503-675-2155|justin.michalski@biotronik.com
99305|NCT00336323|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|Name/Official Title: Adam Glassman, M.S., Director|(813) 975-8690|drcrnet@jaeb.org
99306|NCT00336479|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com
99307|NCT00336492|Johnson & Johnson Pharmaceutical Research and Development|Senior Director, Clinical Research|610-240-8092|
99308|NCT00336505|Advanced Life Sciences|David Eiznhamer, PhD, Executive Vice President, Clinical Development|630-739-6744|deiznhamer@advancedlifesciences.com
99309|NCT00336544|Advanced Life Sciences|David Eiznhamer, PhD, Executive Vice President, Clinical Development|630-739-6744|deiznhamer@advancedlifesciences.com
99310|NCT00336583|Asan Medical Center|Cheolwon Suh|82 2 3010 3209|csuh@amc.seoul.kr
99311|NCT00336700|UPMC CancerCenter|Herbert Zeh, MD|412-692-2852|zehxhx@upmc.edu
99312|NCT00336817|Upittsburgh|Dr. Roberto Lopez-Solis|412-647-5173|lopezrc@upmc.edu
99313|NCT00336856|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu
99315|NCT00336973|Genentech, Inc.|Medical Communications Specialist|800-821-8590|
99316|NCT00337077|ECOG Statistical Office|Study Statistician|617-632-3012|
99317|NCT00337103|Eisai Inc.|Dr. Martin Olivo, M.D.|888-422-4743|
99318|NCT00337129|SWOG Statistical Center|Head and Neck Committtee Statistician|(206)-667-4623|
99319|NCT00337168|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4623|
99320|NCT00337194|The Ohio State University|Dr. Kristie Blum||kristie.blum@osumc.edu
99321|NCT00337207|Northwestern University|Clinical Research Office Administrator|312-695-1301|cancertrials@northwestern.edu
99322|NCT00337272|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com
99323|NCT00337285|Shire Pharmaceutical Development, Inc.|Timothy Whitaker||twhitaker@shire.com
99324|NCT00337350|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org
99325|NCT00337428|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
99326|NCT00337467|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
99327|NCT00337571|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
99328|NCT00337610|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
99329|NCT00337662|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
99330|NCT00337675|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
99331|NCT00337727|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
99332|NCT00337779|Teva Pharmaceutical Industries, Ltd.|Chen Duksin, MD|972-9-863-4642|chen.duksin@teva.co.il
99333|NCT00337818|GlaxoSmithKline|GSK Response Center|866-435-7343|
99334|NCT00337935|Centocor Ortho-Biotech LLC.|Vice President, Medical Affairs|800.457.6399|
99335|NCT00337987|Yale University School of Medicine|Francine Foss, MD|203-737-5312|francine.foss@yale.edu
99336|NCT00338039|UT MD Anderson Cancer Center|Christopher H. Crane, MD / Professor||CR_Study_Registration@mdanderson.org
99337|NCT00338104|Northwestern University|Mark E. Molitch, M.D.|312 503-4130|molitch@northwestern.edu
99338|NCT00331682|Memorial Sloan-Kettering Cancer Center|Dr. Eileen O'Reilly|646-888-4182|oreillye@mskcc.org
99339|NCT00331760|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org
99340|NCT00331773|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
99341|NCT00331799|Duke University Medical Center Dept of Psychiatry|Wei Zhang MD|919 684 5645|wei.zhang@duke.edu
99342|NCT00331864|Novartis Pharmaceuticals|Study Director|862-778-8300|
99343|NCT00332163|Amgen Inc.|Study Director|866-572-6436|
99344|NCT00332189|BioMarin Pharmaceutical, Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com
99345|NCT00332241|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@BMS.com
99346|NCT00332332|Amgen Inc.|Study Director|866-572-6436|
99347|NCT00332462|Novartis Pharmaceuticals|Study Director|862-778-8300|
99348|NCT00332488|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com
99349|NCT00332579|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu
99351|NCT00332644|University of Wisconsin|Piper, Megan E|608-265-5472|mep@ctri.medicine.wisc.edu
99352|NCT00332696|Novartis Pharmaceuticals|Study Director|862-778-8300|
99353|NCT00332709|Novartis Pharmaceuticals|Study Director|862-778-8300|
99354|NCT00332722|Pain Management Center of Paducah|Dr. Laxmaiah Manchikanti, MD|2705548373 ext 101|drlm@thepainmd.com
99355|NCT00338286|Janssen Research and Development|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com
99356|NCT00338455|Scios R&D, Inc.|Sr. Director Clinical Leader|650 564-5084|
99357|NCT00338598|Yale University|Elizabeth Ralevski Assistant Professor of Psychiatry|+1 203-932-5711 ext 4282|elizabeth.ralevski@yale.edu
99358|NCT00342355|National Institute of Allergy and Infectious Diseases, Dvision of Clinical Research|Michael A Polis, MD, MPH|301-496-8027|mpolis@niaid.nih.gov
99359|NCT00342563|Yale University School of Medicine|Dr. Elizabeth Ralevski|+1 203-932-5711 ext x4282|elizabeth.ralevski@yale.edu
99360|NCT00342628|PDMI, NICHD, NIH|Feng-Ying (Kimi) Lin, MD, MPH|301-496-0295|link@mail.nih.gov
99361|NCT00343044|Benaroya Research Institute at Virginia Mason|Thomas Malpass, M.D., Principal Investigator|206-223-6193|thomas.malpass@vmmc.org
99362|NCT00343083|University of Maryland Baltimore|Ritesh Kataria|410-328-8018|rkataria@umm.edu
99363|NCT00343252|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99364|NCT00343291|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99365|NCT00343382|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-1623|cloprinzi@mayo.edu
99366|NCT00343460|Heron Therapeutics|Robert Geller, M.D.|650-366-2626|rgeller@herontx.com
99367|NCT00343512|Vanderbilt-Ingram Cancer Center|Bapsi Chak, M.D.|615-322-2555|
99368|NCT00343564|Cytokinetics,Inc.|Project Manager|650-624-2918|
99369|NCT00343785|Fred Hutchinson Cancer Research Center|Dr. Rainer Storb, Director Transplantation Biology|2066676839|rstrob@fredhutch.org
99370|NCT00343863|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu
99371|NCT00343889|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
99372|NCT00343915|GlaxoSmithKline|GSK Response Center|866-435-7343|
99373|NCT00344487|University of Maryland Institute of Human Virology|Charles E. Davis, Jr. MD|410-706-1684|cdavis@ihv.umaryland.edu
99374|NCT00344500|Psychiatry Department at VA Greater Los Angeles Healthcare System|Dr. Donna Ames, Principal Investigator|310-478-3037|donna.ames@va.gov
99375|NCT00344682|UMass Medical School|Dr. Kristina Deligiannidis|508-856-5928|kristina.deligiannidis@umassmemorial.org
99376|NCT00344773|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
99377|NCT00344968|Alimera Sciences, Inc.|Kathleen Billman, Senior Director of Scientific Affairs|678-572-1302|kathleen.billman@alimerasciences.com
99378|NCT00345033|Massachusetts General Hospital|David C. Henderson|(617) 912-7800|dchenderson@partners.org
99379|NCT00345046|Indiana University|Louis B. Cantor|317-278-2651|lcantor@iupui.edu
99380|NCT00345176|The EMMES Corporation|Traci Clemons, PhD|301-251-1161 ext 212|tclemons@emmes.com
99381|NCT00345254|Edith Wolf son Medical Cemter|Samuel Lurie|+972-35028329|drslurie@hotmail.com
99382|NCT00345293|Rockefeller University|Mayu Frank, MS, ANP, Clinical Research Nurse Practitioner|212-327-7443|frankm@rockefeller.edu
99383|NCT00345332|University of Rochester|Division of Urogynecology|585-273-3232|amy_keller@urmc.rochester.edu
99384|NCT00345371|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov
99385|NCT00345384|Baylor Research Institute|President Baylor Research Institute|214-820-3296|researchclinicaltrials@baylorhealth.edu
99387|NCT00345540|Novelos Therapeutics, Inc.|Vice President, Clinical Development|617-244-1616|hpalmin@novelos.com
99388|NCT00345579|GlaxoSmithKline|GSK Response Center|866-435-7343|
99389|NCT00345592|S. Anna Hospital|Giovanni Luca Botto|0315851 ext +39|gluca.botto@gmail.com
99390|NCT00345605|Baylor College of Medicine|Dr. Sandesh Nagamani||nagamani@bcm.edu
99391|NCT00345631|Cordis Corporation, a Johnson&Johnson company|Hans-Peter Stoll, M.D.|908-541-4770|hpstoll@its.jnj.com
99392|NCT00345683|GlaxoSmithKline|GSK Response Center|866-435-7343|
99393|NCT00345839|Amgen Inc.|Study Director|866-572-6436|
99394|NCT00345878|GlaxoSmithKline|GSK Response Center|866-435-7343|
99395|NCT00346034|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
99396|NCT00346151|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
99397|NCT00346164|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordintator@childrensoncologygroup.org
99398|NCT00346216|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99399|NCT00346268|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99400|NCT00346333|Harvard Medical School|Eliot L. Berson, M.D.|617-573-3600|marilyn_sullivan@meei.harvard.edu
99401|NCT00346398|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
99402|NCT00346476|Desmond Tutu HIV Centre|Prof LG Bekker|+27216506966|Linda-Gail.Bekker@hiv-research.org.za
99403|NCT00346632|Kyowa Kirin Pharmaceutical Development, Inc.|Project Leader|6099191100|clinical.info@kyowakirin.com
99404|NCT00346697|Johns Hopkins University|Dr Todd Brown, Associate Professor of Medicine and Epidemiology|410-502-2327|tbrown27@jhmi.edu
99405|NCT00346905|Boston Scientific|Director, Endoscopy Clinical Affairs|1-508-333-1015|
99406|NCT00338741|EMD Serono|Liz Gedney/Clinical Trial Leader|+781 681-2179|
99407|NCT00338806|NYSPInstitute|Dr. Helen Verdeli|212 543 5262|verdelih@nyspi.columbia.edu
99408|NCT00338884|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99409|NCT00338962|Yale University|Elizabeth Ralevski|203-932-5711 ext 4282|elizabeth.ralevski@yale.edu
99410|NCT00338988|University Texas MD Anderson Cancer Center|Melanie Thomas, MD/Assistant Professor|713-794-4869|mjlim@mdanderson.org
99411|NCT00339040|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
99412|NCT00339079|Brigham and Women's Hospital|Arthur J. Barsky, MD|617-732-5236|abarsky@partners.org
99413|NCT00339144|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
99414|NCT00339183|Amgen Inc.|Study Director|866-572-6436|
99415|NCT00339833|National Institutes of Health|Jonathan Krakoff, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|6022005217|jkrakoff@mail.nih.gov
99416|NCT00340379|Duke University|Frederick Cassidy|919-575-7801|cassi002@mc.duke.edu
99417|NCT00340678|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Renoprotection in Early Diabetic Nephropathy in Pima Indians|(602) 200-5205|rnelson@phx.niddk.nih.gov
99418|NCT00340704|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
99419|NCT00340834|Novartis Pharmaceuticals|Study Director|862-778-8300|
99420|NCT00347009|GlaxoSmithKline|GSK Response Center|866-435-7343|
99421|NCT00347022|GUERBET|Corinne DUBOURDIEU|+33.1.45.91.50.00|corinne.dubourdieu@guerbet-group.com
99422|NCT00347269|University of Washington|Peter Roy-Byrne MD Professor of Psychiatry|206-313-8504|roybyrne@u.washington.edu
99423|NCT00347308|The New York Eye & Ear Infirmary|Anthony P. Sclafani, MD|212-979-4200|asclafani@nyee.edu
119146|NCT00356603|GlaxoSmithKline|GSK Response Center|866-435-7343|
99425|NCT00348673|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99426|NCT00348686|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
99427|NCT00348790|Northwestern University|Jeffrey Raizer, MD|312-503-4724|jraizer@nmff.org
119147|NCT00350545|Stanford University|David B. Miklos|650 725-4959 ext 650|dmiklos@stanford.edu
99429|NCT00348881|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
99430|NCT00348933|University of California and Rady Children's Hospital, San Diego|Lynne M. Bird, MD|858-966-5840|Lbird@rchsd.org
99431|NCT00349336|Hoffmann-La Roche|Medical Communications|800-821-8590|
99432|NCT00349349|GlaxoSmithKline|GSK Response Center|866-435-7343|
99433|NCT00349388|Atlantic Health System|Dr. Joel Rosh|973-971-5676|joel.rosh@atlantichealth.org
99434|NCT00349466|Can-Fite Biopharma|Pnina Fishman, PhD|011972 3 924 1114|pnina@canfite.co.il
99435|NCT00349622|MGH|Merit Cudkowicz|617-724-1873|mcudkowicz@partners.org
99436|NCT00349713|University of Bamako|Mahamadou A. Thera, MD, MPH, Professor|223-20-22-81-09|mthera@icermaili.org
119148|NCT00320424|GlaxoSmithKline|GSK Response Center|866-435-7343|
99437|NCT00349752|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493|
99438|NCT00349908|Codman & Shurtleff|J. Thomas Megerian, MD|508.828.8274|jmegerian1@its.jnj.com
119149|NCT00291018|DePuy Synthes Spine|Erin Prifogle|508-977-6451|eprifog1@its.jnj.com
99440|NCT00350025|Fox Chase Cancer Center|Dr. Yu-Ning Wong|215-728-3889|yu-ning.wong@fccc.edu
99441|NCT00350142|Stanford Cancer Center|Dr. Albert Koong|650-498-7703|akoong@stanford.edu
99442|NCT00350207|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
99443|NCT00350220|University of Rochester Medical Center|Jill M. Cholette MD|585-275-0189|Jill_Cholette@urmc.rochester.edu
99444|NCT00350272|Achillion Pharmaceuticals, Inc.|Kevin Kucharski, VP of Clinical Operations|203-624-7000|Kkucharski@achillion.com
99445|NCT00350363|Stanford|Professor|650-723-6995|cta@stanford.edu
99446|NCT00350402|University of Florida|Dr. Dawn Bowers|(352) 392-3450|dawnbowers@phhp.ufl.edu
99447|NCT00350519|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Vice President Medical Affairs COBS|215-325-4464|
99449|NCT00350623|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
99450|NCT00350636|Watson Laboratories, Inc|Gary Hoel, PhD, Executive Director|801-808-8866|gary.hoel@watson.com
99451|NCT00350727|GlaxoSmithKline|GSK Response Center|866-435-7343|
99452|NCT00350779|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclsoure@merck.com
99453|NCT00350792|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99454|NCT00350844|Ann and Robert H. Lurie Children's Hospital of Chicago|Dr. Robert I. Liem|312-227-4842|Rliem@luriechildrens.org
99455|NCT00350870|Yale University School Of Medicine Department of Psychiatry|Dr. Kathleen M. Carroll|203-937-3486 ext 7403|kathleen.carroll@yale.edu
99456|NCT00351000|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org
99457|NCT00344019|BIDMC|Director of Clinical Trials|6176678800|dcutlip@bidmc.harvard.edu
99458|NCT00344032|GlaxoSmithKline|GSK Response Center|866-435-7343|
99459|NCT00344175|Kowa Research Institute|Bill Arana|919 433-1600|barana@kowaus.com
99460|NCT00344305|MedImmune, LLC|Raburn Mallory MD/ Sr Dir Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com
99461|NCT00344370|Kowa Research Institute|Bill Arana|919 433-1600|barana@kowaus.com
99462|NCT00344448|National Institute of Dental and Craniofacial Research|Gabor G Illei, Md, principal Investigator|301 496-4072|illeig@mail.nih.gov
99463|NCT00351039|Fox Chase Cancer Center (formerly at H. Lee Moffitt Cancer Center & Research Institute)|George Simon, M.D.|215-728-2509|george.simon@fccc.edu
99464|NCT00351273|University of South Florida|John D. Carter, M.D.|(813) 974-2681|jocarter@health.usf.edu
99465|NCT00351299|BrighamHospital|Dr. Gerald Weinhouse|617-732-5499|gweinhouse@partners.org
99466|NCT00351468|Novartis|Study Director|862-778-8300|
99467|NCT00351533|University of Vermont|Renee Stapleton, MD PhD|802-656-7975|renee.stapleton@uvm.edu
99468|NCT00351741|USAISR|Principal Investigator|210-916-3054|kevin.chung@us.army.mil
99469|NCT00351819|Brigham and Women's Hospital|Dr. Shehzad Basaria|617-525-9150|sbasaria@partners.org
99470|NCT00351936|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org
99472|NCT00352053|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
99473|NCT00352105|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. David Adelstein|216-444-9310|adelstd@ccf.org
99474|NCT00352118|Masonic Cancer Center, University of Minnesota|Frank Ondrey, M.D.|612-625-3200|ondre002@umn.edu
99475|NCT00352365|SWOG|Study Statistician|206-667-4623|
99476|NCT00352417|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com
99477|NCT00352534|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
99478|NCT00352612|Johns Hopkins University|Aaron Chen|4109556143|achen33@jhmi.edu
99479|NCT00352664|UT MD Anderson Cancer Center|Eduardo Bruera, MD / Professor|713-792-6084|
99480|NCT00352690|Washington University School of Medicine|Ramaswamy Govindan, M.D.|314-362-5737|rgovinda@dom.wustl.edu
99481|NCT00352755|Washington University School of Medicine|Dr. James Fleshman|314-747-4610|James.Fleshman@BSWHealth.org
99482|NCT00352781|Centre for Addiction and Mental Health|Co-Investigator|416-535-8501 ext 7422|laurie_zawertailo@camh.net
99483|NCT00352846|The University of Texas (UT) MD Anderson Cancer Center|Fredrick Hagemeister, MD/Professor||psanjorjo@mdanderson.org
99484|NCT00352885|Emory University|Bobbi Woolwine|404-712-9620|bwoolwi@emory.edu
99485|NCT00352911|VGX Pharmaceuticals, LLC|Mary Giffear, Sr. Clinical Scientist|267 440 4220|mgiffear@inovio.com
99486|NCT00353119|Innovaderm Research Inc|Annie Levesque|514-521-4285 ext 222|alevesque@innovaderm.ca
99487|NCT00353262|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
99488|NCT00353275|UT Health Science Center at Houston|Dr. Lillian S. Kao|713-566-5095|Lillian.S.Kao@uth.tmc.edu
99489|NCT00353301|University of Colorado, Denver|Dr. Thomas Flaig|(720) 848-0655|Thomas.Flaig@ucdenver.edu
99490|NCT00353366|GlaxoSmithKline|GSK Response Center|866-435-7343|
99491|NCT00353418|Hoffmann-La Roche|Medical Communications|800-821-8590|
99492|NCT00353431|Intern Medicine Solothurn, Switzerland|Robert Thomann, MD|+41326274501|endodiab.bss@bluewin.ch
99493|NCT00353496|Ipsen|Medical Director Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
99494|NCT00353652|University of Texas Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|wanpen.vongpatanasin@utsouthwestern.edu
99495|NCT00353704|Baerum Hospital|Ulrich J Spreng|004798499184|ulispreng@hotmail.com
99499|NCT00347438|University of Chicago Medical Center|Dr. Funmi Olopade|773-702-1632|folopade@medicine.bsd.uchicago.edu
99500|NCT00347776|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu
99501|NCT00347919|GlaxoSmithKline|GSK Response Center|866-435-7343|
99502|NCT00347932|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com
99503|NCT00347958|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
99504|NCT00348140|GlaxoSmithKline|GSK Response Center|866-435-7343|
99505|NCT00348283|Abbott|Medical Information Specialist|800-633-9110|
99506|NCT00348348|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com
99507|NCT00348374|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
99508|NCT00353977|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov
99509|NCT00354029|Baerum Hospital|Ulrich J Spreng|004798499184|ulispreng@hotmail.com
99510|NCT00354107|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
99511|NCT00354159|Medtronic CRDM|REDUCEhf Clinical Research Specialist|1-800-328-2518 ext 62736|medtronicCRMtrials@medtronic.com
99513|NCT00354341|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
99514|NCT00354432|Wake Forest University School of Medicine|Dr. Doug Case|(336) 716-5425|dcase@wakehealth.edu
99515|NCT00354484|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com
99516|NCT00354601|Wake Forest University Health Sciences|Doug Case Biostatistician|336-716-1048|dcase@wfubmc.edu
99517|NCT00354614|ResMed|VP Medical Affairs|858 836 6782|ResmedScienceCenter@resmed.com.au
99518|NCT00354640|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu
99519|NCT00354679|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org
99520|NCT00354744|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
99521|NCT00354770|University of Chicago|Jon E. Grant|773-834-1325|jongrant@uchicago.edu
99522|NCT00354835|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
99523|NCT00354887|UT MD Anderson Cancer Center|Robert Wolff, MD / Professor|713-792-2828|mjlim@mdanderson.org
99524|NCT00354913|Duke University Medical Center|Dr. Annick Desjardins|919-681-1691|annick.desjardins@dm.duke.edu
99525|NCT00354978|UT MD Anderson Cancer Center|Scott Kopetz, MD Associate Professor|713-792-2828|mjlim@mdanderson.org
99526|NCT00355030|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99527|NCT00355082|GlaxoSmithKline|GSK Response Center|866-435-7343|
99529|NCT00355134|Novartis Pharmaceuticals|Study Director|862-778-8300|
99530|NCT00355147|VA Stroke QUERI Center, Roudebush VAMC|Teresa Damush, Ph.D.|317-988-4277|Teresa.Damush@va.gov
99531|NCT00355199|Ospedale Papa Giovanni XXIII, Bergamo|Alessandro Rambaldi|0352673684 ext +39|arambaldi@asst-pg23.it
99532|NCT00355368|Medical Intensive care unit, University Hospital Basel|Stephan Marsch|+ 41 61 265 2525|smarsch@uhbs.ch
99533|NCT00355394|CHOP|Dr. Nicholas Abend|215-590-1719|abend@email.chop.edu
99534|NCT00355472|Kyowa Hakko Kirin|Project Management Department, Development Division||clinical.info@kyowa-kirin.co.jp
99535|NCT00355615|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
99536|NCT00355706|Pain Management Center of Paducah|Laxmaiah Manchikanti, MD|2705548373 ext 100|drm@asipp.org
99537|NCT00355784|University of Michigan, Ann Arbor, Michigan|Jeffrey F. Horowitz|734-647-1076|jeffhoro@umich.edu
99538|NCT00355797|BIOTRONIK, Inc.|CLEAR Study CSE|503-451-8051|
99539|NCT00355914|Pain Management Center of Paducah, Paducah, KY|Laxmaiah Manchikanti, MD|2705548373 ext 100|drlm@thepainmd.com
99540|NCT00356031|Massachusetts General Hospital|Dr. Sam S. Yoon, Principal Investigator|617 643-9475|syoon@partners.org
99541|NCT00356057|BIOTRONIK, Inc.|Katerina de Metz, Director Clinical Studies|5036752169|katerina.demetz@biotronik.com
99542|NCT00356122|Sanofi-Aventis|Trial Transparency Team||Contact-Us@sanofi.com
99543|NCT00356135|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99544|NCT00356148|Marmara University School of Medicine|Prof. Bahadir M Gulluoglu|902164256565 ext 4012|bmgulluoglu@marmara.edu.tr
99545|NCT00356200|Tufts Medical Center|Alice B Gottlieb, MD, PhD|617 636 4802|agottlieb@tuftsmedicalcenter.org
99546|NCT00356278|Emory University|Barbara O. Rothbaum, PhD, ABPP|404-712-8866|brothba@emory.edu
99547|NCT00356304|VA New Jersey Healthcare System|Alejandro Interian, Principal Investigator|908-647-0180 ext 4617|alejandro.interian@va.gov
99548|NCT00356408|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
99549|NCT00356421|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
99550|NCT00356434|Johns Hopkins Univ|Abimbola Aina|410-955-8496|aaina1@jhmi.edu
99551|NCT00356525|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99552|NCT00356590|Amgen Inc.|Study Director|866-572-6436|
99553|NCT00356811|GlaxoSmithKline|GSK Response Center|866-435-7343|
99555|NCT00356889|University of Wisconsin Cancer Center|William Schelman, M.D.||wrs@medicine.wisc.edu
99556|NCT00351351|IU Health Methodist Hospital|James Lingeman, MD|317-962-0870|lrawlings@iuhealth.org
99557|NCT00351377|Novartis Pharmaceuticals|Study Director|862-778-8300|
99558|NCT00351416|Massachusetts General Hospital|Janet Hall|617-877-1112|jehall@partners.org
99559|NCT00356915|GlaxoSmithKline|GSK Response Center|866-435-7343|
99560|NCT00357006|Monash Alfred Psychiatry Research Centre|Prof Jayashri Kulkarni|+61 390766924 ext 66924|j.kulkarni@alfred.org.au
99561|NCT00357032|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
99562|NCT00357097|GlaxoSmithKline|GSK Response Center|866-435-7343|
99563|NCT00357110|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
99564|NCT00357162|Washington University|Amanda Cashen, M.D.||acashen@im.wustl.edu
99565|NCT00358644|Eisai Inc.|Eisai Call Center|888-422-4743|
99566|NCT00358670|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
99567|NCT00358735|Medical Compression Systems|Clifford W Colwell, M.D Scripps Clinic|972-4-6266630 ext 412|Jbarak@mcsmed.com
99568|NCT00358826|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com
99569|NCT00358917|Abbott|Medical Information Specialist|800-633-9110|
99570|NCT00358956|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
99571|NCT00359021|Tibotec|SENIOR DIRECTOR R&D|1 609 730-7548|
99572|NCT00359138|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
99573|NCT00359203|Medtronic Italia SpA|Silvia Giuli|003932814224|silvia.giuli@medtronic.com
99574|NCT00359216|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
99575|NCT00359281|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867|msumeray@aegerion.com
99576|NCT00359424|University of Cincinnati Academic Health Center|Joseph P. Broderick|513-558-5429|broderjp@ucmail.uc.edu
99577|NCT00359619|GlaxoSmithKline|GSK Response Center|866-435-7343|
99578|NCT00359632|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99580|NCT00359762|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
99581|NCT00359788|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
99582|NCT00359801|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
99583|NCT00359944|Sunovion|Medical Director, CNS|1-866-503-6351|
99584|NCT00359983|GlaxoSmithKline|GSK Response Center|866-435-7343|
99585|NCT00360009|University of Florida Department of Neurology|Michael Okun, M.D.|352-273-5550|okun@neurology.ufl.edu
99586|NCT00360126|GlaxoSmithKline|GSK Response Center|866-435-7343|
99587|NCT00360243|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com
99588|NCT00360269|Medical University of South Carolina|Aimee McRae-Clark, Pharm.D., BCPP|843-792-5215|mcraeal@musc.edu
99589|NCT00360282|University of Pittsburgh|Joseph M. Furman, MD, PhD|(412) 647-2115|furmanjm@upmc.edu
99590|NCT00360308|Eisai Call Center|Eisai Inc.|888-422-4743|
99591|NCT00360334|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
99592|NCT00360360|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-MY-1-SCRI|asksarah@scresearch.net
99593|NCT00360399|Emory University|Helen Mayberg|404-727-6740|hmayber@emory.edu
99594|NCT00360412|Eisai Call Center|Eisai Inc.|888-422-4743|
99595|NCT00360490|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
99596|NCT00360529|Sprout Pharmaceuticals|Sprout Pharmaceuticals|1-919-882-0850|clinicaltrials@sproutpharma.com
99597|NCT00360555|Sprout Pharmaceuticals|Scientific Program Director|9198820850|clinicaltrials@sproutpharma.com
99598|NCT00360568|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
99599|NCT00360672|UT MD Anderson Cancer Center|Gautam Borthakur, M.D./Associate Professor|713-563-1586|eharriso@mdanderson.org
99600|NCT00360685|Moffitt Cancer Center|Janelle Perkins, PharmD|813-745-7226|Janelle.Perkins@moffit.org
99601|NCT00360698|sanofi-aventis|Medical Affairs study director||publicregistryGMA@sanofi-aventis.com
99602|NCT00360724|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu
99603|NCT00360828|H. Lee Moffitt Cancer Center and Research Institute|Edward Pan, M.D.|813-745-3871|edward.pan@moffitt.org
99604|NCT00360971|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org
99605|NCT00361140|Moffitt Cancer Center|Dr. Teresa Field|(813) 745-7202|Teresa.Field@moffitt.org
99607|NCT00361231|Massachusetts General Hospital|Dr. Andrew X. Zhu|617-724-4000|azhu@mgh.harvard.edu
99608|NCT00361257|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
99610|NCT00361283|University of Florida|Reginald F. Frye, PhD, Associate Professor|3522735453|fryerf@ufl.edu
99611|NCT00361335|Centocor, Inc.|Senior Director Clinical Research|1-800-457-6399|
99612|NCT00361374|Massachusetts General Hospital|Dr David Mischoulon, Director of Research, Depression Clinical and Research Program|617-724-5198|dmischoulon@partners.org
99613|NCT00361439|University of Chicago|Jayant Pinto, MD|773-702-6727|jpinto@surgery.bsd.uchicago.edu
99614|NCT00361504|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537|
99615|NCT00363415|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99616|NCT00363467|H. Lee Moffitt Cancer Center|Jeffrey Lancet MD|813-745-6841|Jeffrey.Lancet@moffitt.org
99617|NCT00363545|GlaxoSmithKline|GSK Response Center|866-435-7343|
99618|NCT00363675|Shrines Hospitals for Children - Boston|Mary Jo Baryza, Diredtor of Therapeutic Services|617-371-4749|mbaryza@shrinenet.org
99619|NCT00363779|National Cancer Institute (NCI), National Institutes of Health (NIH)|Thomas Waldmann, M.D.|301-496-6653|Thomas_Waldmann@nih.gov
99620|NCT00363805|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu
99621|NCT00363883|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
102164|NCT00513409|GlaxoSmithKline|GSK Response Center|866-435-7343|
99622|NCT00363896|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com
99623|NCT00364013|Amgen Inc.|Study Director|866-572-6436|
99624|NCT00364130|Children's Hospital of Philadelphia|Mary Leonard, MD, MSCE|215-590-0874|leonard@email.chop.edu
99625|NCT00364156|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu
99626|NCT00364182|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99627|NCT00364286|The University of Texas MD Anderson Cancer Center|Susan O'Brien, MD/ Professor|713-792-7543|eharriso@mdanderson.org
99628|NCT00364351|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
99629|NCT00364377|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu
99630|NCT00364533|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-6780|
99631|NCT00364611|Sanofi-aventis|Trial Transparency Team||Contact-us@sanofi.com
99632|NCT00364793|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
99633|NCT00364819|University of California Davis|Christopher L. Bowlus, MD|916-734-8986|clbowlus@ucdavis.edu
99634|NCT00364832|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
99635|NCT00364845|Amgen Inc.|Study Director|866-572-6436|
99636|NCT00364858|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
99637|NCT00364923|Allos Therapeutics, Inc|Michael Saunders, M.D.|303-426-6262|msaunders@allos.com
99638|NCT00364949|Northwestern University|Dr. Andrea Dunaif|312-503-2902|a-dunaif@northwestern.edu
99639|NCT00365053|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
99640|NCT00365105|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org
99642|NCT00365209|University of California, Irvine|Dr. Frank L. Meyskens, Jr.|714-456-6310|flmeyske@uci.edu
99643|NCT00365261|University of California, San Diego|Joel Dimsdale, M.D., Principal Investigator|619 543-5592|jdimsdale@ucsd.edu
99644|NCT00365274|The University of Texas (UT) MD Anderson Cancer Center|Michelle Fanale, MD / Associate Professor||CR_Study_Registration@mdanderson.org
99645|NCT00365300|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
99646|NCT00365352|XenoPort, Inc.|XenoPort Call Center|877-936-6778|
99647|NCT00365365|Sanofi|Trial Transparency Team||Contact_Us@sanofi.com
99648|NCT00365378|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
99649|NCT00365391|Wayne State University|Philip A. Philip, M.D., Ph.D., F.R.C.P.||philipp@karmanos.org
99650|NCT00365417|NSABP Foundation, Inc.|Diana Gosik|412-330-4692|diana.gosik@nsabp.org
99651|NCT00365456|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com
99652|NCT00365508|University of Pennsylvania|Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu
99653|NCT00365547|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu
99654|NCT00365599|H. Lee Moffitt Cancer Center and Research Institute|Susan Minton, D.O.|813-745-3806|susan.minton@moffitt.org
99655|NCT00365716|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
99656|NCT00365768|Columbia University Medical Center|Julia Glade-Bender, MD|212-305-3379|jg589@cumc.columbia.edu
99657|NCT00365846|Emory University|Stuart Knechtle, MD|404-727-8465|stuart.knechtle@emoryhealthcare.org
99658|NCT00365859|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
99659|NCT00365872|H. Lee Moffitt Cancer Center and Research Institute|Scott J. Antonia, M.D., Ph.D.|813-745-3883|scott.antonia@moffitt.org
99660|NCT00357331|Weill Medical College|Assistant Professor of Medicine|212-746-1670|sinhana@med.cornell.edu
99661|NCT00357370|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com
99662|NCT00357396|Memorial Sloan Kettering Cancer Center|Dr. Susan Prockop|212-639-6715|prockops@mskcc.org
99663|NCT00357500|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu
99664|NCT00357552|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
99666|NCT00357734|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
99667|NCT00357760|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|
99668|NCT00357877|Kaiser Permanente Data Coordinating Center|Dr. William Vollmer|503-335-6755|william.vollmer@kpchr.org
99669|NCT00357903|Amgen Inc.|Study Director|866-572-6436|
99670|NCT00357955|Providence VA Medical Center|Wen-Chih Wu, MD; Principal Investigator|4012737100 ext 6237|wen-chih.wu@va.gov
99671|NCT00357968|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99672|NCT00357994|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
99673|NCT00358007|Thomas Jefferson University|Pramila Rani Anne, MD|215-955-6702|Pramila.Anne@jefferson.edu
99674|NCT00358150|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
99675|NCT00358215|Amgen Inc.|Study Director|866-572-6436|
99676|NCT00358332|University of Maryland School of Medicine|Christopher V. Plowe|410-706-3082|cplowe@medicine.umaryland.edu
99677|NCT00358436|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com
99678|NCT00358449|GlaxoSmithKline|GSK Response Center|866-435-7343|
99679|NCT00358462|University of Washington|Lisa E. Manhart, PhD - PI|206-744-3646|lmanhart@uw.edu
99680|NCT00358501|Jazz Pharmaceuticals|Head of Clinical Development|650.496.3777|
99681|NCT00358527|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
99682|NCT00358579|Singapore General Hospital|A/Prof Marcus Ong Eng Hock|+6563213590|marcus.ong.e.h@sgh.com.sg
99683|NCT00365976|Duke University|Jenny Bridgers, CRC|919-684-0752|jenny.bridgers@duke.edu
99684|NCT00366028|Department of Veterans Affairs|Dr. Carol VanDeusen Lukas|857-364-5685|carol.vandeusenlukas@va.gov
99685|NCT00366106|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com
99686|NCT00366249|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
99687|NCT00366275|Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia|Luca Arcaini MD|+390382501308|luca.arcaini@unipv.it
99688|NCT00371839|Portland VAMC|Dr. Marjorie R. Leek|(909)825-7084 ext 7293|Marjorie.Leek@va.gov
99689|NCT00371865|VA San Diego Healthcare System|Dr. Julie Wetherell, PI|858-552-8585 ext 2752|Julie.Wetherell@va.gov
99690|NCT00372060|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
99691|NCT00372190|Radboud University Medical Center|Dr. M.I.J.Withagen|+31 6 51262468|M.I.J.Withagen@umcutrecht.nl
99692|NCT00372385|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com
99693|NCT00372411|Dept. of Veterans Affairs, Cooperative Studies Program, West Haven, CT|Peter Guarino, MPH, PhD, Director, WH-CSPCC|203-932-5711 ext 3780|peter.guarino@va.gov
99694|NCT00372424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99695|NCT00372489|Affymax|VP, Clinical Development|650-812-8700|info@affymax.com
99696|NCT00372528|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99697|NCT00372567|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99698|NCT00372593|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
99699|NCT00372619|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|ResultsReportingCoordinator@childrensoncologygroup.org
99700|NCT00372697|Novartis Pharmaceuticals|Study Director|862 778-8300|
99701|NCT00372775|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99702|NCT00372970|Temple University|Frank Friedenberg|215-707-9900|frank.friedenberg@temple.edu
99703|NCT00372996|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99704|NCT00373113|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99705|NCT00373256|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99706|NCT00373269|Temple University|Dr. Nina T. Gentile|215-707-8402|ngentile@temple.edu
99707|NCT00373295|New York State Psychiatric Institute|Dr. Margaret Haney|646-774-6129|reslabsurc@gmail.com
99708|NCT00373334|Braintree Laboratories, Inc.|Clinical Operations Manager|781-843-2202|jmcgowan@braintreelabs.com
99709|NCT00373360|United Therapeutics Corporation|Rex Mauthe; Senior Director, Regulatory Affairs|919-485-8350|rmauthe@unither.com
99710|NCT00373425|Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Oncology||clinicaltrial.disclosure@us.astellas.com
99711|NCT00373490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
99712|NCT00373529|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
99713|NCT00373685|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99714|NCT00373698|VA Medical Center, White River Junction, VT|Dr. Paula Schnurr and Dr. Mathew Friedman|802-296-5132|Paula.Schnurr@va.gov; Matthew.Friedman@va.gov
99715|NCT00373880|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|646-774-6153|meg.haney@nyspi.columbia.edu
99716|NCT00373958|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99717|NCT00374088|University of Michigan - Pediatric Cardiology|Ranjit Aiyagari, MD|734-647-8761|ranjita@umich.edu
99718|NCT00374127|New York State Psychiatric Institute at Columbia University Medical Center|Dr. Meg Haney, Professor of Neurobiology|6467746153|meg.haney@nyspi.columbia.edu
119155|NCT00243386|Baxter Healthcare Corporation|Wing-Yen Wong, MD, Global Sr Medical Dir Hemophilia||wing_yen_wong@baxter.com
99720|NCT00374231|University of Cincinnati|E. Steve Woodle, MD|(513) 558-6001|woodlees@uc.edu
99721|NCT00374244|Yale University School of Medicine, Dept of Psychiatry|Handan Gunduz-Bruce MD|(203) 932-5711 ext 4130|handan.gunduz-bruce@yale.edu
99722|NCT00374322|GlaxoSmithKline|GSK Response Center|866-435-7343|
99723|NCT00374335|Children's Mercy Hospitals and Clinics|Dr. Kimberly Horii|816-234-3924|kahorii@cmh.edu
99724|NCT00361569|Duramed Research|Duramed Research Protocol Chair|215-293-7279|medicalaffairs@barrlabs.com
99725|NCT00361595|Cleveland Clinic|Chad Deal|216-444-6575|dealc@ccf.org
99726|NCT00361634|Amgen Inc.|Study Director|866-572-6436|
99727|NCT00361972|university of utah|kathryn peterson|8015817804|kathryn.peterson@hsc.utah.edu
99728|NCT00362115|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
99729|NCT00362128|Albert Einstein College of Medicine|Judith Wylie-Rosett|718-430-3345|Judith.Wylie-Rosett@einstein.yu.edu
99730|NCT00362180|Kastle Therapeutics, LLC|Christopher Bryant, Ph.D.|8152633913|cbryant@kastletx.com
99731|NCT00362232|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
99732|NCT00362297|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu
99733|NCT00362336|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
99734|NCT00362375|SisterLove, Inc.|Dazon Dixon-Diallo, Executive Director|404-505-7777|ddiallo@sisterlove.org
99735|NCT00362401|Aarhus University Hospital, Skejby|Dr. Thais A. Pedersen, primary investigator|+45 8949 5484|thais.a.pedersen@ki.au.dk
99736|NCT00362414|University of California Irvine|Dr. Steven Cramer|(714) 456-6876|scramer@uci.edu
99737|NCT00362440|BIDMC|Dr. Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu
99738|NCT00362453|Tufts Medical Center|Chenchen Wang, MD, MSc, Associate Professor|617-636-3251|cwang2@tuftsmedicalcenter.org
99739|NCT00362466|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
99741|NCT00362648|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
99742|NCT00362817|The Ohio State University Medical Center and James Cancer Hospital & Solove Research Inst.|Herbert Newton,|614-293-4448|newton.12@osu.edu
99744|NCT00363038|Northwestern University Department of Dermatology|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu
99745|NCT00363051|Novartis Pharmaceuticals|Novartis Study Director|(862 778-8300|
99746|NCT00363077|GlaxoSmithKline|GSK Response Center|866-435-7343|
99747|NCT00363129|Mayo Clinic|Lisa Kottschade, RN, MSN, CNP|507-284-2511|kottschade.lisa@mayo.edu
99748|NCT00363142|GlaxoSmithKline|GSK Response Center|866-435-7343|
99749|NCT00363168|Johns Hopkins University|Neil M. Bressler|410-955-8342|nbressler@jhmi.edu
99750|NCT00363246|James A. Haley Veterans' Hospital|Andrea M. Spehar, DVM, MPH, JD|813-558-3947|Andrea.Spehar@va.gov
99751|NCT00363298|Stanford University Medical Center, Department of Psychiatry|Lorrin M. Koran, M.D.|650 498-5035|lkoran@stanford.edu
99752|NCT00363311|GlaxoSmithKline|GSK Response Center|866-435-7343|
99753|NCT00374543|Massachusetts General Hospital|Naomi M. Simon, M.D., M.Sc.|(617) 726-7913|nsimon@partners.org
119156|NCT00221117|Toronto RI Institute|Dr. Milos Popovic|416-597-3422 ext 6305|milos.popovic@utoronto.ca
99755|NCT00375427|Novartis Pharmaceuticals|Study Director|862-778-8300|
99756|NCT00375492|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
99757|NCT00375505|Novartis|Study Director|862-778-8300|
99758|NCT00375518|Memorial Sloan Kettering Cancer Center|Dr. David Amar|212-639-6798|amard@mskcc.org
99759|NCT00375674|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1800718 ext 1021|ClinicalTrials.gov_Inquiries@pfizer.com
99760|NCT00375713|UCB Pharma|UCB Clinical Trial Call Center|+ 1 877 822 9493|
99762|NCT00375934|Xanodyne Pharmaceuticals, Inc.|Steve Boesing|1-877-926-6396|clinical-trials@xanodyne.com
99763|NCT00375973|University of Cincinnati College of Medicine|Lesley M. Arnold, M.D.|513-558-7700|lesley.arnold@uc.edu
99764|NCT00375999|Gangnam Severance Hospital, Yonsei University College of Medicine|Dr. Jae Yong Cho|82-2-2019-4363|chojy@yuhs.ac
99765|NCT00376168|Protalix Ltd.|Einat Almon|972-4-9889488 ext 137|einata@protalix.com
99766|NCT00376220|Johns Hopkins University School of Medicine|Jennifer L. Payne M.D.|410-502-0050|jpayne5@jhmi.edu
99767|NCT00376259|Novartis Pharmaceuticals|Study Director|862-778-8300|
99768|NCT00376363|University of North Carolina|Donald Budenz|919-843-0297|donald_budenz@med.unc.edu
99769|NCT00376506|James Madison University|Christy L. Ludlow, PhD|540-568-3876|ludlowcx@jmu.edu
99770|NCT00376532|Thomas Jefferson University|David J. Whellan MD|215 955 2636|david.whellan@jefferson.edu
99771|NCT00376558|nyspi|Diana Martinez|212-543-6628|dm437@columbia.edu
99772|NCT00376597|The Ohio State University Comprehensive Cancer Center|Electra D. Paskett, PhD|614-293-3917|electra.paskett@osumc.edu
99773|NCT00376675|Mayo Clinic|Dr. Amit Sood|507-284-1623|sood.amit@mayo.edu
99775|NCT00376805|Masonic Cancer Center, University of Minnesota|Sarah Cooley, MD|612-625-8474|cool0023@umn.edu
99776|NCT00376935|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|(617) 432-2829|CBAR.ClinicalTrials.gov@sdac.harvard.edu
99779|NCT00377156|Mayo Clinic|Paul Brown, M.D.|507-538-0948|Brown.Paul@mayo.edu
99780|NCT00377234|Hoffmann-LaRoche|Medical Communications|800-821-8590|
99781|NCT00377260|Children's Hospital of Pittsburgh of UPMC|Efficacy of Antimicrobials in Young children with Acute Otitis Media|412-692-5249|Hoberman@chp.edu
99782|NCT00377299|UT Southwestern Medical Center at Dallas|Dr. E. Sherwood Brown, M.D., Ph.D.|214-645-6950|sherwood.brown@utsouthwestern.edu
99783|NCT00377312|University of Pittsburgh|Mara J Horwitz|412-692-2848|horwitz@pitt.edu
99784|NCT00377364|UT Southwetern Medical Center at Dallas|E.Sherwood Brown, M.D., Ph.D.|214-645-6950|Sherwood.Brown@utsouthwestern.edu
99785|NCT00377403|Washington University in St Louis|Jane Garbut,MD|314-454-8613|jgarbutt@dom.wustl.edu
99786|NCT00377429|Fresenius Biotech|Anne Kuan|781 699 4618|anne.kuan@fresenius-biotech.com
99787|NCT00377455|Georgetown University|Dr. Virginia Steen|202-444-6200|steenv@georgetown.edu
99788|NCT00377520|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
99789|NCT00377572|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
99790|NCT00369317|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordintator@childrensoncologygroup.org
99791|NCT00369343|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
99792|NCT00369382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99793|NCT00369486|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|Adam R. Glassman, M.S., Director|(813) 975-8690|drcrnet@jaeb.org
99794|NCT00369512|University of Alabama at Birmingham|Eben Rosenthal, MD Department of Surgery Department|(205) 934-9714|erosenthal@uabmc.edu
99795|NCT00369564|Nemours Children's Clinic|Scott Bradfield, MD|904-697-3793|sbradfie@nemours.org
99796|NCT00369590|Adult Brain Tumor Consortium|Stuart A Grossman, MD Director of ABTC|410-955-8837|grossman@jhmi.edu
99797|NCT00369655|Mayo Clinic|Dr. Timothy Hobday|507-284-1159|hobday.timothy@mayo.edu
99798|NCT00369668|University of Florida, Motor Behavior Laboratory|James Cauraugh, Ph.D., PI|352-294-1623|jcaura@hhp.ufl.edu
99799|NCT00369681|Johns Hopkins University|Dr. Yvette Kasamon|410-955-8839|ykasamon@jhmi.edu
102586|NCT00545103|Shire Development LLC|Study Physician|+1 866 842 5335|
99800|NCT00369746|New York State Psychiatric Institute|Patrick J. McGrath, M.D.|646-774-8076|mcgrath@nyspi.columbia.edu
99801|NCT00369785|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu
99802|NCT00369824|GlaxoSmithKline|GSK Response Center|866-435-7343|
99803|NCT00369915|NIMH/NIH|Maura Furey, PhD|301-594-7773|mfurey@mail.nih.gov
99804|NCT00369928|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com
99805|NCT00369941|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
99806|NCT00369967|VCUHS|Nicole Karjane|804-828-8614|nkarjane@mcvh-vcu.edu
99807|NCT00370032|GlaxoSmithKline|GSK Response Center|866-435-7343|
99808|NCT00370071|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
99809|NCT00370149|Riley Hospital for Children|Elaine G Cox, MD|317-944-7260|elmcox@iu.edu
99810|NCT00370292|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99811|NCT00370331|GlaxoSmithKline|GSK Response Center|866-435-7343|
99812|NCT00370552|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
99813|NCT00370682|Phramongkutklao Hospital, Bangkok, Thailand|Verrachai Watanaveeradej, MD|662-644-8971|veerachaiw@yahoo.com
99814|NCT00370838|Johns Hopkins University|Dr. Harvey Singer|410-955-7212|hsinger@jhmi.edu
99815|NCT00370994|Pain Management Center of Paducah|Dr. Laxmaiah Manchikanti|270-554-8373 ext 101|drlm@thepainmd.com
99816|NCT00371137|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Medical Monitor & Director of Clinical Development|650-496-3777|
99817|NCT00371150|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
99818|NCT00371176|Boston VA Healthcare System|Dr. Brett Litz|857 364 4131|brett.litz@va.gov
99819|NCT00371254|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
99820|NCT00371267|San Francisco VA Medical Center|Timothy P. Carmody, Ph.D.|415-221-4810 ext 6344|Timothy.Carmody@va.gov
99821|NCT00371293|UPenn|Julio Chirinos|2158235800|julio.chirinos@uphs.upenn.edu
99822|NCT00371345|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
99823|NCT00371397|Ohio State University Institute for Behavioral Medicine Research|Janice Kiecolt-Glaser, PhD|614-292-0033|Kiecolt-Glaser.1@osu.edu
99824|NCT00371436|VA RR&D, NCRAR|James A. Henry, Ph.D.|5032208262 ext 57466|james.henry@va.gov
99825|NCT00371449|Mountain Home VA Medical Center|Sherri L. Smith|423.926.1171 ext 7569|sherri.smith@va.gov
99826|NCT00371462|Edward Hines Jr., VA Hospital|Associate Chief of Staff for Research|708-202-5689|eileen.collins@va.gov
99827|NCT00371540|Indiana University School of Medicine|Kara Wools-Kaloustian|317-274-7936|kwools@iu.edu
99828|NCT00371566|GlaxoSmithKline|GSK Response Center|866-435-7343|
99829|NCT00371631|Michael E. DeBakey Veterans Affairs|Dr. Barbara Trautner, MD, PhD|713-440-4438|barbara.trautner@va.gov
99830|NCT00371644|VA North Texas Health Care System|Dr. Alina Suris|2148572312|alina.suris@va.gov
99831|NCT00371683|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
99832|NCT00371761|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
99833|NCT00371787|Centre for Contact Lens Research|Dr. Craig Woods|1-519-888-4567 ext 36547|cawoods@uwaterloo.ca
99834|NCT00371826|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
99835|NCT00377637|Hoffman-LaRoche|Medical Communications|800-821-8590|
99836|NCT00377676|VeroScience|Richard Scranton|401 816-0525|richard_scranton@veroscience.com
99837|NCT00377741|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
99838|NCT00377819|Amgen Inc.|Study Director|866-572-6436|
99839|NCT00377832|Weill Cornell Medical College|Daniel W. Skupski, MD|718-670-1495|dwskupsk@med.cornell.edu
99840|NCT00377858|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99841|NCT00378014|Novartis Pharmaceuticals|Study Director|862-778-8300|
99842|NCT00378079|Friends Research Institute|Dr. Timothy Kinlock|(410) 837-3977 ext 224|tkinlock@friendsresearch.org
99843|NCT00378105|Dana-Farber Cancer Institute|Dr. Richardson|617-632-2104|Paul_Richardson@dfci.harvard.edu
99844|NCT00378209|Dana-Farber Cancer Institute|Dr. Paul Richardson|617-632-2104|Paul_Richardson@dfci.harvard.edu
99845|NCT00378326|Rockefeller University|Robert B. Darnell, MD, PhD|212-327-7474|darnelr@rockefeller.edu
99846|NCT00378352|National Institute on Aging, NIH|Edward Lakatta, M.D.|410-558-8218|lakattae@grc.nia.nih.gov
99847|NCT00378378|Merck, Sharp & Dohme Corp.|Senior Vice Presiden, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
99848|NCT00378508|Yale University|Kevan Herold, MD|203-785-6507|Kevan.Herold@yale.edu
99849|NCT00378534|NIH NHLBI|Minocher Battiwalla, MD|301-827-0939|minoo.battiwalla@mail.nih.gov
99850|NCT00378560|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
99851|NCT00378573|sanofi-aventis|Medical Affairs study director||publicregistryUSMA@sanofi-aventis.com
99852|NCT00378599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
99853|NCT00378703|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|
99854|NCT00378898|Vanderbilt University Medical Center|Dr. Michael Vaezi|615-322-3739|michael.vaezi@vanderbilt.edu
99855|NCT00379080|Adult Brain Tumor Consortium|Stuart A Grossman, MD Director of ABTC|410-955-8837|grossman@jhmi.edu
99856|NCT00379197|University of Minnesota, Dept. Medicine|Dr. Douglas Yee, MD|612-273-5700|yeexx006@umn.edu
99857|NCT00379210|University of Pennsylvania|Amishi Jha|215-898-8011|apjha@psych.upenn.edu
99858|NCT00379236|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
99859|NCT00379288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
99860|NCT00379340|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
99861|NCT00379353|University of Texas M.D. Anderson Cancer Center|Dr. Eduardo Bruera, Professor|713-563-4157|ammarin@mdanderson.org
99862|NCT00379574|Asan Medical Center, Ulsan University College of Medicine|Dr. Cheolwon Suh|+82-2-3010-3209|csuh@amc.seoul.kr
99863|NCT00379587|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH|617-632-5946|corey_cutler@dfci.harvard.edu
99864|NCT00379639|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
99865|NCT00379769|GlaxoSmithKline|GSK Response Center|866-435-7343|
99866|NCT00379795|Genentech|Genentech||ctg-post-d@gene.com
99867|NCT00379808|University of Florida|Dr Julie Johnson, PI|352-273-6007|johnson@cop.ufl.edu
99869|NCT00379834|West Virginia University|Dr. Tony Realini|3045986926|realinia@wvuhealthcare.com
99870|NCT00379899|Amgen Inc.|Study Director|866-572-6436|
99871|NCT00379912|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org
99872|NCT00380029|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
99873|NCT00380068|Gilead Sciences Inc|Martine Allard, PhD; Senior Clinical Research Scientist|650-524-3898|martine.allard@gilead.com
99874|NCT00380081|Purdue Pharma LP|Clinical Leader|800-733-1333|
99875|NCT00380250|Sucampo Pharmaceuticals, Inc.|Taryn Joswick|301-961-3400|info@sucampo.com
99876|NCT00380367|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
99877|NCT00366301|Brigham and Women's Hospital|Aruna Pradhan|617-732-8777|apradhan@partners.org
99878|NCT00366340|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99879|NCT00366444|Xanodyne Pharmaceuticals, Inc.|Steve Boesing|1-877-926-6396|clinical-trials@xanodyne.com
99880|NCT00366457|Massachusetts General Hospital|Lawrence S. Blaszkowsky, MD|6172191230|LBLASZKOWSKY@mgh.harvard.edu
99881|NCT00366548|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
99882|NCT00366626|Medical University of South Carolina|Dr. Raymond F. Anton, Distinguished University Professor|843-792-1226|antonr@musc.edu
99883|NCT00366678|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
99884|NCT00367237|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
99885|NCT00367341|Emory University School of Medicine|Helen Mayberg, MD|404-727-6740|hmayber@emory.edu
99886|NCT00367380|Malaria Vaccine and Drug Development|Sócrates Herrera MD, principal investigator|(572) 5216232 - 5574929|sherrera@inmuno.org
99887|NCT00367432|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
99888|NCT00367484|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Bettina Stubinski/Senior Medical Director|+49 6151 72 5200|service@merckgroup.com
99889|NCT00367601|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org
99890|NCT00367640|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com
99891|NCT00367679|GlaxoSmithKline|GSK Response Center|866-435-7343|
99892|NCT00367744|Case Western Reserve University|Dr. Grace McComsey|216 844 3607|mccomsey.grace@clevelandactu.org
99893|NCT00367770|Actelion Pharmaceuticals Ltd.|Loïc Perchenet, Head of Global Post-Approval Studies|+41 61 565 64 57|loic.perchenet@actelion.com
99894|NCT00367835|Shire Pharmaceuticals|Timothy Whitaker, MD||twhitaker@shire.com
99895|NCT00367991|New York University School of Medicine|Stuart Katz, MD|212-263-3946|stuart.katz@nyumc.org
99896|NCT00368069|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
99897|NCT00368108|Eisai Call Center|Eisai Inc.|888-422-4743|
99898|NCT00368251|UCB|UCB Cares|+1877 822 ext 9493|
99899|NCT00368277|Novaris Phamaceuticals|Study Director|862-778-8300|
99900|NCT00368290|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200 ext 109|kampman@mail.med.upenn.edu
99901|NCT00368316|PDMI, NICHD, NIH|Dr. Rachel Schneerson, Co-Director|301-469-0850|schneerr@mail.nih.gov
99902|NCT00368459|Stanford University|Victor Henderson|650-723-5456|vhenderson@stanford.edu
99903|NCT00368472|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com
99904|NCT00368537|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
99905|NCT00368550|University of Pennsylvania|Henry R. Kranzler, M.D.|215-222-3200 ext 137|kranzler_h@mail.trc.upenn.edu
99906|NCT00368641|Baxter Healthcare|Bruce Culleton, MD|800-422-9837|onebaxter@baxter.com
99907|NCT00368745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
99908|NCT00368849|The University of Iowa|Leigh J. Beglinger, Ph.D.|319-335-8765|leigh-beglinger@uiowa.edu
99909|NCT00368875|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org
99910|NCT00368927|National Jewish Health|James R. Jett, M.D.|303-270-2601|JettJ@NJHealth.org
99911|NCT00368940|Weill Cornell Medicine|Dimitris N. Kiosses, Ph.D.|914-997-4381|dkiosses@med.cornell.edu
99912|NCT00368966|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
99913|NCT00368979|GlaxoSmithKline|GSK Response center|866-435-7343|
99914|NCT00368992|SWOG|Lung Committee Statistician|206-667-4623|
99915|NCT00369122|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org
99916|NCT00369161|Novartis Pharmaceuticals|Study Director|862-778-8300|
99917|NCT00369226|Dana-Farber Cancer Institute|John Koreth, MBBS, D.Phil|(617) 632-2949|jkoreth@partners.org
99918|NCT00369265|Philadelphia ENT Associates|Robert T. Sataloff, M.D., D.M.A., FACS|215-545-3322|rtsataloff@phillyent.com
99919|NCT00369278|Novartis Pharmaceuticals|Study Director|862-778-8300|
99920|NCT00374803|University of Cincinnati|Rita Alloway, PharmD|5135581568|rita.alloway@uc.edu
99921|NCT00374842|GlaxoSmithKline|GSK Response Center|866-435-7343|
99922|NCT00374868|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99924|NCT00380588|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99925|NCT00380692|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99926|NCT00380718|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99927|NCT00384241|Medical College of Georgia, Georgia Regents University|Haidong Zhu MD, PhD, Assistant Professor|706 721 5470|hzhu@gru.edu
99928|NCT00384293|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
99929|NCT00384332|University of Alabama at Birmingham|Candace Cromer|2059753442|clreed@uab.edu
99930|NCT00384397|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
99931|NCT00384670|Department of Pediatrics, Pharamongkutklao Hospital|Sriluck Simasathien ; Infectious Disease Consultant|66-2-644-8971|
99932|NCT00384748|University of Georgia|Neale Chumbler, PhD|706-369-5975|chumbler@uga.edu
99933|NCT00384813|Emory University School of Medicine|Marianne Celano, PhD, ABPP|404-778-1536|mcelano@emory.edu
99934|NCT00384865|Penn|Steven Kawut|215-573-0258|kawut@upenn.edu
99935|NCT00384930|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
99936|NCT00384956|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu
99937|NCT00385138|The Medicines Company|Meredith Todd|973.290.6088|meredith.todd@themedco.com
99938|NCT00385203|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
99939|NCT00385216|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu
99940|NCT00385268|University of Pennsylvania|Dr. Helen Pettinati|215-222-3200 ext 139|helenp@mail.med.upenn.edu
99941|NCT00385515|Mucosal Therapeutics, LLC|Eward G. Fey, PhD|857-228-1100|
99942|NCT00385541|Columbia University|Pamela Flood MD|201-768-8262|pdf3@columbia.edu
99943|NCT00385580|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
99944|NCT00385593|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
99945|NCT00385671|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99946|NCT00385684|Tuscaloosa VA Medical Center|Andrea L. Snow|205-554-2000 ext 2260|lynn.snow@va.gov
99947|NCT00385723|Institute for Behavioral Medicine Research, Ohio State University College of Medicine, OH, USA|Dr. Janice K. Kiecolt-Glaser|+1 614 293 3499|Janice.Kiecolt-Glaser@osumc.edu
99948|NCT00385736|Abbott|Global Medical Services|800-633-9110|
99949|NCT00385762|Weill Cornell Medical College|Peter N Schlegel, MD|2127465491|pnschleg@med.cornell.edu
99950|NCT00385801|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu
99951|NCT00385827|Janssen Research & Development|Director||ClinicalTrialDisclosure@its.jnj.com
99952|NCT00385840|GlaxoSmithKline|GSK Response Center|866-435-7343|
99953|NCT00385918|University of Maryland Rehabiitation and Orthopaedic Institute|Peter H. Gorman, MD Chief Division of Rehabilitation Medicine|410-448-6261|pgorman@umm.edu
99954|NCT00385944|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99955|NCT00385996|Weill Cornell Medical College|Nasser Altorki, MD|212-746-5156|nkaltork@med.cornell.edu
99956|NCT00386009|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99957|NCT00386022|Massachusetts General Hospital|Dr. Janet E. Hall|617-877-1112|hall.janet@mgh.harvard.edu
99958|NCT00386100|GlaxoSmithKline|GSK Response Center|866-435-7343|
99959|NCT00386152|Centocor Ortho Biotech Services, LLC|Nephrology Therapeutic Area, Medical Lead|215-325-4176|
99960|NCT00386243|Center on Implementing Evidence Based Practice|Matthew J. Bair, MD MS|317-988-2058|mbair@iupui.edu
99961|NCT00386256|VA Greater Los Angeles Healthcare System|Nancy Harada, PhD|310-268-3632|Nancy.Harada@va.gov
99962|NCT00386308|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
99963|NCT00386334|Sepracor Inc.|Lunesta Medical Director|1-866-503-6351|
99964|NCT00386360|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
99965|NCT00386425|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
99966|NCT00386477|Indiana University School of Medicine|David M. Haas, MD, MS|317-630-7837|dahaas@iupui.edu
99967|NCT00386607|Novartis Pharmaceuticals|Study Director|862-778-8300|
99968|NCT00366899|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
99969|NCT00367055|GlaxoSmithKline|GSK Response Center|866-435-7343|
99970|NCT00367133|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrnet@jaeb.org
99971|NCT00377962|Novartis Pharmaceuticals|Study Director|862 778-8300|
99972|NCT00386776|Beth Israel Deaconess Medical Center|Dr. Warner V. slack|617 278 8155|wslack@bidmc.harvard.edu
99973|NCT00386880|Doylestown Hospital|Abraham A. Ashkenazi, MD-Principal Investigator|215-625-2894|aashkenazi2001@yahoo.com
99974|NCT00387010|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
99975|NCT00387023|UT MD Anderson Cancer Center|Bita Esmaeli, MD / Professor||CR_Study_Registration@mdanderson.org
99976|NCT00387036|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com
99977|NCT00387088|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
99978|NCT00388947|Whitinsville Medical Center|Dr Samuel Zylstra|508-243-6260|samuelzylstra@milreg.org
99979|NCT00388973|AstraZeneca|Medical Science Director, Seroquel||AZTrial_Results_Posting@astrazeneca.com
99980|NCT00389064|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
99981|NCT00389168|Karolinska Institutet, Stockholm, Sweden|Thomas Kahan, MD|+46 8 123 568 61|thomas.kahan@ds.se
99982|NCT00389207|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
99983|NCT00389324|Grifols Therapeutics, Inc.|Henry Li, PhD|800-520-2807|henry.li@grifols.com
99984|NCT00389441|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
99985|NCT00389467|Georgetown University|Chelsea S. Kidwell, MD|202-687-7302|ck256@georgetown.edu
99986|NCT00389493|New York State Psychiatric Institute|Dr. Helen Blair Simpson|646-774-7000|kimeldo@nyspi.columbia.edu
99987|NCT00389519|King Pharmaceuticals, Inc.|Professional Information Services|1-800-776-3637|
99988|NCT00389532|Sanofi pasteur Inc|Medical Director||RegistryContactUS@sanofipasteur.com
99990|NCT00389805|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu
99991|NCT00389818|AMC|Ronald Mitsuyasu, MD|310-557-1803|rmitsuya@mednet.ucla.edu
99992|NCT00389831|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
99993|NCT00389857|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com
99994|NCT00389974|Princess Margaret Hospital, Toronto, Canada|Dr. Helen Mackay|(416) 946-2253|helen.mackay@uhn.ca
99995|NCT00390013|University of Iowa|Colleen Kennedy Stockdale, MD, MS|319-384-6849|colleen-stockdale@uiowa.edu
99996|NCT00390182|University of Maryland Baltimore|Nancy Kennedy|410-328-2513|nkennedy@umm.edu
99997|NCT00390221|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
99998|NCT00390234|Princess Margaret Hospital|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca
99999|NCT00390364|Sidney Kimmel Comprehensive Cancer Center at JHMI|Manuel Hidalgo, MD (no longer works at Hopkins)|410-502-5328|tbrown55@jhmi.edu
100000|NCT00390416|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org
100001|NCT00390455|Dana-Farber Cancer Institue|Harold Burstein, M.D.||hburstein@partners.org
100002|NCT00390468|UT MD Anderson Cancer Center|Quality Assurance Specialist|713-792-2830|caperez@mdanderson.org
100004|NCT00390559|Virginia Commonwealth University|Thomas Eissenberg|804.827.4617|teissenb@vcu.edu
100005|NCT00390572|VA HSRD|Christi S. Ulmer, PhD|9192860411 ext 4044|christi.ulmer@va.gov
100006|NCT00390611|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
100007|NCT00390689|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
100008|NCT00390780|Bioalliance Pharma|Dr Pierre Attali|+33 (0)1 45 58 76 00|pierre.attali@bioalliancepharma.com
100009|NCT00390806|GlaxoSmithKline|GSK Response Center|866-435-7343|
100010|NCT00390858|Novartis Pharmaceuticals|Study Director|862-778-8300|
100011|NCT00390884|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
100012|NCT00391027|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100013|NCT00391053|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
100014|NCT00391079|GW Pharmaceuticals|Richard Potts Clinical Operations Director|+44 1223 266800|rp@gwpharm.com
100015|NCT00391092|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
100016|NCT00391222|Janssen Cilag Spain|EMEA Medical Affairs Director|+34 91 7228043|
100017|NCT00391274|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100018|NCT00380861|DePuy Orthopaedics|Tammy O'Dell|574-372-7104|TOdell2@its.jnj.com
100019|NCT00380874|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100020|NCT00380978|Department of Anesthesiology; Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu
100021|NCT00381004|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor, Leukemia||CR_Study_Registration@mdanderson.org
100022|NCT00381043|University of North Carolina at Chapel Hill|Dr. J.C. Garbutt|919-966-4652|jc_garbutt@med.unc.edu
100023|NCT00381095|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100024|NCT00381238|GlaxoSmithKline|GSK Response Center|866-435-7343|
100025|NCT00381303|Tibotec Therapeutics Clinical Affairs (TTCA), Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488|
100027|NCT00381810|Genentech, Inc.|Medical Communications Specialist|800 821-8590|genentech@druginfo.com
100028|NCT00381849|Mayo Clinic|Beverly Tietje, Study Coordinator|507-255-0401|tietje.beverly@mayo.edu
100029|NCT00381862|OHSU Knight Cancer Institute|Joseph Bubalo, PharmD, BCPS, BCOP|503-494-1080|bubaloj@ohsu.edu
100030|NCT00381888|Masonic Cancer Center, University of Minnesota|Levi S. Downs, Jr., M.D.|612-626-6628|downs008@umn.edu
100031|NCT00381940|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org
100033|NCT00382031|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com
100034|NCT00382109|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
100035|NCT00382148|Genentech, Inc.|Medical Communications Specialist|800-821-8590|
100036|NCT00382174|RegeneRx Biopharmaceuticals, Inc.|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|301-280-1992 ext 108|nturjman@regenerx.com
100037|NCT00382291|University of Florida|Dr. Regina Bussing|(352) 273-7550|rbussing@ufl.edu
100038|NCT00382408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|info.era-clinical@teva.de
100039|NCT00382590|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-745-3428|eharriso@mdanderson.org
100040|NCT00382720|sanofi-aventis|International Clinical Development Clinical Study Director||contact-us@sanofi-aventis.com
100041|NCT00382733|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com
100042|NCT00382785|University of Delaware|Paula Klemm, PhD, RN, OCN|(302) 831-8501|klemmpa@udel.edu
100043|NCT00382863|Paracor Medical, Inc.|Michael Kolber, General Manager, VP of Regulatory Affairs|408-734-6000|info@paracor.com
100101|NCT00393484|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
100044|NCT00382928|Atlanta Research and Education Foundation|Dr. A. Maziar Zafari|404-321-6111 ext 4019|azafari@emory.edu
100045|NCT00382967|GE Healthcare|Igor Grachev, MD|1-609-514-6857|igor.grachev@ge.com
100046|NCT00382993|Glaxo Smith Kline|GSK Response Center|1-866-435-7343|
100047|NCT00383019|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100048|NCT00383071|SAIC/National Institute of Allergy and Infectious Diseases|John Beigel, M.D.|+1 301 451 9881|jbeigel@niaid.nih.gov
100049|NCT00383084|Johns Hopkins University|Kevin Fontaine, PhD|443-449-4314|kfontai1@jhmi.edu
100050|NCT00383110|Ralph H. Johnson VAMC|Leonard Egede, MD, MS|843-789-6670|leonard.egede@va.gov
100051|NCT00383123|GlaxoSmithKline|GSK Response Center|866-435-7343|
100052|NCT00383149|Organization: Bristol-Myers Squibb|Name/Official Title: BMS Study Director||Clinical.Trials@bms.com
100053|NCT00383162|GlaxoSmithKline|GSK Response Center|866-435-7343|
100054|NCT00383240|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100055|NCT00383266|Washington University School of Medicine|Maria Baggstrom, M.D.|314-362-5740|mbaggstr@dom.wustl.edu
100056|NCT00383331|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
100057|NCT00383435|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100058|NCT00383500|Stanford University|Stanley G. Rockson|650-725-7571|rockson@stanford.edu
100059|NCT00383552|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100060|NCT00383565|MD Anderson Cancer Center|Dr. Luis E. Fayad / Associate Professor|713-792-2860|jmdennison@mdanderson.org
100061|NCT00383643|Stanford University School of Medicine, Dept of Psychiatry|Dr. Jed Black|650 736 4559|jedblack@stanford.edu
100062|NCT00383721|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100063|NCT00383747|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu
121218|NCT02481141|SBI Pharmaceuticals Co, Ltd.|Dr. Riyadh Rehani, President of MENA Region|+973 66394100|rrehani@sbigroup.co.jp
100065|NCT00383786|Baylor College of Medicine|Sanjay Mathew, MD/PI|7137985439|sjmathew@bcm.edu
100066|NCT00383942|Loyola University|Scott Graziano, M.D.|708-216-6288|sgrazia@lumc.edu
100067|NCT00384033|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100068|NCT00384059|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100069|NCT00384085|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi-aventis.com
100070|NCT00384176|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
100071|NCT00384189|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
100072|NCT00391365|Center For Limb Loss Prevention and Prosthetic Engineering, VA Puget Sound Health Care System|Alan Wesley, Program Manager|206 277 1079|alan.wesley@va.gov
100073|NCT00391391|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
100074|NCT00391443|Actelion Pharmaceuticals Ltd|Isabelle Leconte,PhD -Data Science Group Leader, Director|+41 61 565 64 18|isabelle.leconte@actelion.com
100075|NCT00391469|University of Washington|Francis Kim, MD Associate Professor of Medicine|206-744-8712|fkim@u.washington.edu
100076|NCT00391586|Dana Farber Cancer Institute|Dennie Jones, MD|617-632-6478|DennieV_Jones@DFCI.HARVARD.EDU
100077|NCT00391599|Edith Wolfson Medical Center|Investigator|+972-35028329|lurie@wolfson.health.gov.il
100078|NCT00391625|Shire Human Genetics Therapy (Shire HGT)|Eric Crombez, M.D., Senior Medical Director|1-617-349-0200|ecrombez@shire.com
100079|NCT00392288|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
100080|NCT00392379|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu
100081|NCT00392392|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net
100082|NCT00392444|The Ottawa Hospital Cancer Centre|Dr. Scott Laurie|613-737-7700 ext 70175|slaurie@toh.on.ca
100083|NCT00392496|Sunnybrook Health Sciences Centre|Dr. Rena Buckstein|416-480-5847|rena.buckstein@sunnybrook.ca
100084|NCT00392665|Massachusetts General Hospital|Lori J. Wirth, MD|617-724-4000|LWIRTH@mgh.harvard.edu
100086|NCT00392704|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
100087|NCT00392769|UT MD Anderson Cancer Center|Judith Wolff, MD / Professor||CR_Study_Registration@mdanderson.org
100088|NCT00392782|Masonic Cancer Center, University of Minnesota|Daniel Weisdorf, M.D.|612-624-0123|weisd001@umn.edu
100089|NCT00392808|Centro Superior de Investigacion en Salud Publica|Javier Diez-Domingo|+34961925937|diez_jav@gva.es
100090|NCT00392821|Sarah Cannon Research Institute|John D Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net
100091|NCT00392834|University of Arkansas for Medical Sciences|Jeannette Lee, Ph.D.|501-526-6712|jylee@uams.edu
100092|NCT00392860|Human Engineering Research Laboratories|Michael L Boninger|412-822-3700|boninger@upmc.edu
100093|NCT00392925|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
100094|NCT00393029|National Cancer Institute (NCI), National Institutes of Health (NIH)|Steven Rosenberg, M.D., Ph.D.|301-496-4164|Steven.Rosenberg@nih.gov
100095|NCT00393042|Dept. of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu
100096|NCT00393068|Sarah Cannon Research Institute|Johanna C. Bendell, MD|615-329-7274|jbendell@tnonc.com
100097|NCT00393094|National Cancer Institute, National Institutes of Health|Howard A. Fine, M.D.|301-402-6383|hfine@mail.nih.gov
100098|NCT00393367|The Children's Hospital of Philadelphia|Cynthia J. Mollen|215-590-4410|mollenc@email.chop.edu
100099|NCT00393380|The EMMES Corporation|Adam Mendizabal, Statistician|301-251-1161 ext 221|amendizabal@emmes.com
100100|NCT00393458|Novartis Pharmaceuticals|Study Director|862 778-8300|
121219|NCT02460991|Boston Scientific|DeeAnn Tinjum|763-494-1927|deeann.tinjum@bsci.com
100102|NCT00393510|Institute of Chinese Medicine, Chinese University of Hong Kong|Prof. Leung Ping Chung|(852)2252 8863|pingcleung@cuhk.edu.hk
100103|NCT00393523|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
100104|NCT00393705|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100105|NCT00393718|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
100106|NCT00393796|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain, M.D.|1-800-865-1125|mahahuss@umich.edu
100107|NCT00393848|UAMS|Arny Ferrando|501-526-5711|aferrando@uams.edu
100108|NCT00393861|IndianaU|Lawrence H. Einhorn, M.D.|(317) 944-0920|leinhorn@iu.edu
100109|NCT00393874|University of Pittsburgh|Dr. Anne Germain|412-383-2150|GERMAX@upmc.edu
100110|NCT00393887|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com
100111|NCT00393913|NYU School o Medicine|Indu Ayappa, PhD|2125628437|indu.ayappa@nyumc.org
100112|NCT00393939|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100113|NCT00393978|University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience|Melissa P. DelBello, MD|513-558-2989|Melissa.DelBello@uc.edu
100114|NCT00394082|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
100115|NCT00394095|University of Cincinnati|Melissa DelBello, MD|513-558-4489|melissa.delbello@uc.edu
100116|NCT00394212|Davol Inc., Subsidiary of C.R. Bard|Dawn Heimer, Clinical Research|401-825-8681|Dawn.Heimer@crbard.com
100117|NCT00394251|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
100118|NCT00394277|Hoffmann-La Roche|Medical Communications|800-821-8590|
100119|NCT00394329|Penn State College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu
100120|NCT00394355|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100121|NCT00394433|Dana-Farber Cancer Institute|Peter C. Enzinger, MD|617-632-6855|Peter_Enzinger@dfci.harvard.edu
100122|NCT00394472|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
100123|NCT00394524|Emory University|Guillermo Umpierrez, MD|404-778-1665|geumpie@emory.edu
100124|NCT00394589|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100125|NCT00394654|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com
100126|NCT00394706|University of Washington|Siobhan Brown, PhD-Biostatistician|206-685-1302|spes@uw.edu
100127|NCT00394771|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
100128|NCT00394836|GlaxoSmithKline|GSK Response Center|866-435-7343|
100129|NCT00381381|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical team manager|+82-2-3451-5531|jihee_mun@eisaikorea.com
100130|NCT00381485|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@spcorp.com
100131|NCT00381550|Sidney Kimmel Comprehensive Cancer Center|Michael McDevitt, MD PhD|410-955-9175|mmcdev1@jhmi.edu
100132|NCT00381563|New England Baptist Hospital|Director of Clinical Trials|(617)754-6602|pmccree@caregroup.harvard.edu
100133|NCT00381615|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
100134|NCT00381628|University Hospitals Cleveland Medical Center|Dr. James Chmiel|216-844-3267|James.Chmiel@uhhospitals.org
100135|NCT00381641|University of Chicago|Dr. Tanguy Seiwert|(773) 702-2452|tseiwert@medicine.bsd.uchicago.edu
100136|NCT00381680|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
100137|NCT00381693|Mayo Clinic|Dr. Ruben A. Mesa|507-284-3533 ext 4-3533|mesa.ruben@mayo.edu
100138|NCT00381706|Dana Farber Cancer Institute|Peter Enzinger, M.D.||peter_enzinger@dfci.harvard.edu
100139|NCT00387127|GlaxoSmithKline|GSK Response Center|866-435-7343|
100140|NCT00387153|Myriad Therapeutics, Inc.|Richard Wenstrup, MD, VP Chief Medical Officer|801-584-3009|rwenstru@myriad.com
100141|NCT00387335|University of Chicago|Ezra Cohen|773-702-4137|ecohen@medicine.bsd.uchicago.edu
100142|NCT00387348|Massachusetts General Hospital|William F Pirl, MD|617-724-9151|wpirl@partners.org
100143|NCT00387426|UT MD Anderson Cancer Center|Srdan Verstovsek, MD / Associate Professor||eharriso@mdanderson.org
100144|NCT00387621|Mayo Clinic|Dr Horng Chen|507-284-4343|chen.horng@mayo.edu
100145|NCT00387647|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org
100146|NCT00387660|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu
100147|NCT00387673|Miami VA Healthcare System|Kristina Beekhuizen|305-575-7000|Kristina.Beekhuizen@va.gov
100148|NCT00387712|Baltimore VAMC|Charlene Hafer-Macko|410-605-7000 ext 5451|charlene.hafer-macko@va.gov
100149|NCT00387725|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100151|NCT00387764|GlaxoSmithKline|GSK Response Center|866-435-7343|
100152|NCT00387790|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org
100153|NCT00387829|Intergra LifeSciences|Director of Medical Affairs|609-275-0500|clinicalaffairs-neuro@integralife.com
100154|NCT00387881|GlaxoSmithKline|GSK Response Center|866-435-7343|
100155|NCT00387894|University of California San Francisco|Michael Prados, MD|415-353-7500|PradosM@neurosurg.ucsf.edu
100156|NCT00387959|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker|212-639-3468|barkerj@mskcc.org
100157|NCT00388037|Cancer Centre of Southeastern Ontario at Kingston|Dr. James Biagi|(613) 544-2630|jim.biagi@krcc.on.ca
100158|NCT00388154|University of Texas (UT) MD Anderson Cancer Center|Jubilee Brown, MD/Associate Professor, Gynecology Oncology & Reproductive Medicine|713-745-8837|CR_Study_Registration@mdanderson.org
100159|NCT00388349|Stanford University|Dr. Sally Arai|650-723-0822|sarai1@stanford.edu
100160|NCT00388362|Stanford University|Laura Johnston, MD|650-723-0822|janices1@stanford.edu
100161|NCT00388453|Vanderbilt University|Michael Vaezi, MD, PhD|615.322.3739|michael.vaezi@vanderbilt.edu
100162|NCT00388505|Novartis Pharmaceuticals|Study Director|862-778-8300|
100163|NCT00388583|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
100164|NCT00388726|Eisai|Dr. Peter Tarassoff|888-422-4743|
100165|NCT00388804|UT MD Anderson Cancer|Andrew Lee, MD / Professor||lhamblin@mdanderson.org
100166|NCT00394888|Medical College of Wisconsin|Dr. Beth Drolet|414-266-1569|bdrolet@mcw.edu
100167|NCT00394901|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100168|NCT00394914|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100169|NCT00394953|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
100170|NCT00395018|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
100171|NCT00395044|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu
100172|NCT00395057|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
100173|NCT00395083|VA Boston Healthcare System - MAVERIC|Dr. Sarah Leatherman|857-364-4220|sarah.leatherman@va.gov
119163|NCT00083915|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990 ext 2461|pettynathanm@uams.edu
100175|NCT00395161|University of Utah|Jeri Burr, MS, RN-BC, CCRC|801-587-7753|jeri.burr@hsc.utah.edu
100176|NCT00396084|Case Western Reserve University, Tuberculosis Research Unit|John L. Johnson, M.D.|(216) 368-1949|jlj@case.edu
100177|NCT00396097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100178|NCT00396136|Biotronik, Inc.|Clinical Studies|503-451-8050|katerina.demetz@biotronik.com
100179|NCT00396162|University of Michigan|Jeffrey E. Terrell|734 936 7633|terrelj@umich.edu
100180|NCT00396201|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
100181|NCT00396253|Genentech, Inc.|Medical Communications|800-821-8590|
100182|NCT00396266|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
100183|NCT00396279|Amgen Inc.|Study Director|866-572-6436|
100184|NCT00396292|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com
100185|NCT00396318|Genentech, Inc.|Medical Communications|800-821-8590|
100186|NCT00396331|Genzyme|Medical Monitor||medinfo@genzyme.com
100187|NCT00396383|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
100188|NCT00396409|Novartis Pharmaceuticals|Study Director|862-778-8300|
100189|NCT00396565|Janssen Pharmaceutical K.K.|Director of Clinical R&D Dept. 3|81-3-4411-5652 ext 10118|
100190|NCT00396591|sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com
100191|NCT00396630|GlaxoSmithKline|GSK Response Center|866-435-7343|
100192|NCT00396656|Novartis Pharmaceuticals|Study Director|862 778-8300|
100193|NCT00396812|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
100194|NCT00396877|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi-aventis.com
100195|NCT00396981|University of California, UCSF Medical Center|S. Claiboren Johnston, MD, PhD|415-502-7487|Clay.Johnston@ucsfmedctr.org
100196|NCT00397033|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136|
100197|NCT00397150|Centre for International Health, University of Bergen, Norway|Prof Thorkild Tylleskar|+47 55588562|Thorkild.Tylleskar@cih.uib.no
100198|NCT00397189|Neurim Pharmaceuticals|VP clinical and regulatory affairs|+972-3-6499340|Talin@neurim.com
100199|NCT00397215|GlaxoSmithKline|GSK Response Center|866-435-7343|
100200|NCT00397254|Clinvest|M.E. Beach|417-841-3618|mbeach@clinvest.com
100201|NCT00397462|Binghamton University, SUNY|Professor Kenneth McLeod|(607)777-5779|kmcleod@binghamton.edu
100202|NCT00397488|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org
100203|NCT00397514|University of British Columbia|Dr. Shubhayan Sanatani|6048752345 ext 7955|ssanatani@cw.bc.ca
100204|NCT00397540|Seoul National University Hospital Boramae Medical Center|Won Kim|82 2 870 2233|wonshiri@yahoo.com
100205|NCT00397631|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
100206|NCT00397839|Hoffmann-La Roche|Medical Communications|800-821-8590|
100207|NCT00397878|University of Texas MD Anderson Cancer Center|Cathy Eng, MD / Professor|713-792-7734|CR_Study_Registration@mdanderson.org
100208|NCT00397891|Wyeth|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100209|NCT00397904|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org
100210|NCT00397930|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu
100211|NCT00397982|University of Virginia|Craig Slingluff|434 924 1730|cls8h@virginia.edu
100212|NCT00398047|Wake Forest University Health Sciences|Ralph D'Agostino Jr., Ph.D.|113-716-3483|rdagosti@wfubmc.edu
100213|NCT00398073|Memorial Sloan Kettering Cancer Center|Jedd Wolchok, MD, Chief Attending|+1646-888-2315|wolchokj@MSKCC.ORG
100214|NCT00398086|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
100215|NCT00398112|Mayo Clinic|Tait Shanafelt||shanafelt.tait@mayo.edu
100216|NCT00398138|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak, Attending|+1212-639-5518|maslakp@mskcc.org
100217|NCT00398216|Daiichi Sankyo, Inc.|William Maxwell, Assoc. Director|732-590-5000|wmaxwell@dsi.com
100218|NCT00398320|Stanford University School of Medicine|Pamela L Kunz, MD|650-725-8738|pkunz@stanford.edu
100219|NCT00398398|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr
100220|NCT00398411|University of Cologne|Prof. Dr. Oliver A. Cornely|+49 221 478 88794|oliver.cornely@zks-koeln.de
100221|NCT00391716|The Scripps Research Institute|Dr. Barbara J. Mason|858-784-7324|mason@scripps.edu
100222|NCT00391768|Collaborative Antiviral Study Group|Penelope Jester|877-975-7280|PJester@peds.uab.edu
100223|NCT00391807|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
100224|NCT00391846|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
100225|NCT00391872|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
100226|NCT00391898|Novartis Pharmaceuticals|Study Director|862 778-8300|
100227|NCT00391976|Novartis Pharmaceuticals|Study Director|862 778-8300|
100228|NCT00391989|GIMEMA|Dr. Paola Fazy; Dr. Marco Vignetti|+39 06.70390521|gimema@gimema.it
100229|NCT00392171|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100230|NCT00392197|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
100231|NCT00392210|University of Rochester|Michael K. Flynn, MD|585-273-3232|
100232|NCT00392223|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
119165|NCT00068406|NRG Oncology|Linda Gedeon for Wei Deng, PhD.|716-845-1169|lgedeon@gogstats.org
100235|NCT00398866|Hospital for Special Surgery|Dr. Lisa Mandl|2127742754|MandlL@hss.edu
100236|NCT00398918|Boston University|Ofra Sarid-Segal, MD|617-414-1990|ofra.segal@bmc.org
100237|NCT00400569|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org
100238|NCT00400634|Ceregene, Inc.|Raymond T. Bartus, Executive Vice President and Cheif Scientific Officer|858-458-8823|rtbartus@ceregene.com
100239|NCT00400686|Cleveland Clinic|Beth Faiman, MSN,CNP, AOCN|216-445-3738|faimanb@ccf.org
100240|NCT00400712|Queen's University|Brenda Brouwer|613-533-6079|brouwerb@queensu.ca
100241|NCT00400764|Hoffman-LaRoche|Medical Communications|800-821-8590|
100242|NCT00400803|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu
100243|NCT00400829|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
100244|NCT00400881|Texas Tech University|Juan Figueroa-Casas|915 5456626 ext 235|juan.figueroa@ttuhsc.edu
100245|NCT00400946|Dana-Farber Cancer Institute|Lewis B. Silverman, MD|617.632.6191|Lewis_Silverman@dfci.harvard.edu
100246|NCT00401102|Iona College|Dr. Colleen Jacobsonn|646-207-3563|cjacobson@iona.edu
100247|NCT00401193|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
100248|NCT00401245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100249|NCT00401258|McLean Hospital|Brian Brennan, M.D.|617-855-2911|bbrennan@partners.org
100250|NCT00401401|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com
100251|NCT00401414|Brigham and Women's Hospital|Mark A. Creager|617-732-5267|mcreager@partners.org
100252|NCT00401531|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
100253|NCT00401544|Amgen Inc.|Study Director|866-572-6436|
100254|NCT00401622|LifeScan Scotland|Mike Grady|(44) 01463 721889|mgrady@its.jnj.com
100255|NCT00401726|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
100256|NCT00401752|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
100257|NCT00401778|Emory University|Suresh S. Ramalingam, MD|404-778-5378|ssramal@emory.edu
100258|NCT00401830|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493|
100259|NCT00401843|Janssen R&D UK|Project Physician||ClinicalTrialDisclosure@its.jnj.com
100260|NCT00401882|Beaumont|David Haines, MD|248-898-4198|david.haines@beaumont.edu
100261|NCT00401960|Weill Medical College|K Rhee|6469626224|kyr9001@med.cornell.edu
100262|NCT00401973|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100263|NCT00402025|Amgen, Inc.|Study Director|866-572-6436|
100264|NCT00402051|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
100265|NCT00402103|Novartis Pharmaceuticals|Study Director|862-778-8300|
119166|NCT00003389|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012|
100267|NCT00402194|Indiana University|Dr. Kieren Mather|317-278-7826|kmather@iu.edu
100268|NCT00402233|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
100269|NCT00402246|Medtronic, Inc|CONNECT Clinical Trial Specialist||medtronicCRMtrials@medtronic.com
100270|NCT00402285|University of California, San Francisco|Peter Carroll, MD|415-353-7098|pcarroll@urology.ucsf.edu
100271|NCT00402324|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
100272|NCT00402337|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com
100273|NCT00402363|GlaxoSmithKline|GSK Response Center|866-435-7343|
100274|NCT00402597|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|VP FRANCHISE MED LDR|1 908 927 7767|
100275|NCT00402649|University of Maryland Center for Vaccine Development|Ina Stephens, MD|410-706-1123|istephen@medicine.umaryland.edu
100276|NCT00402688|Ortho-McNeil Janssen Scientific Affairs, LLC|Therapeutic Area Lead, Anti-Infective Franchise|908-927-5220|
100277|NCT00402714|Yale University School of Medicine|Francine Foss MD|2037375312|francine.foss@yale.edu
100278|NCT00402727|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
100279|NCT00402740|Abbott Vascular|Ellen Travis, MS, NFP|408 845-1512|Ellen.Travis@av.abbott.com
100280|NCT00402883|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
100281|NCT00402896|The University of Texas (UT) MD Anderson Cancer Center|Carlos A. Jimenez, MD/Professor, Pulmonary Medicine||CR_Study_Registration@mdanderson.org
100282|NCT00395226|Essentia Institute of Rural Health|Brian Johnson|218-786-8856|bjohnson3@eirh.org
100283|NCT00395291|University of Virginia|W. Kline Bolton, MD|434-924-9692|wkb5s@Virginia.edu
100284|NCT00395304|Penn State Hershey College of Medicine|Vernon M. Chinchilli|717-531-4262|vchinchi@psu.edu
119167|NCT00019682|Indiana University Health|Dr Douglas Schwartzentruber|317-948-6873|dschwart@iuhealth.org
100285|NCT00395343|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
100286|NCT00395447|BIOTRONIK, Inc|Crystal Miller, Clinical Studies Engineer|503-451-8051|crystal.miller@biotronik.com
100287|NCT00395460|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
100288|NCT00395486|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
100289|NCT00395512|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
100290|NCT00395629|Novartis Pharmaceuticals|Study Director|862-778-8300|
100291|NCT00395642|BIOTRONIK, Inc.|Katerina de Metz (Director, Clinical Studies)|800-547-0394|katerina.demetz@biotronik.com
100292|NCT00395694|GlaxoSmithKline|GSK Response Center|866-435-7343|
100293|NCT00395733|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
100294|NCT00395746|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
100295|NCT00395850|University of Arkansas for Medical Sciences|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu
100296|NCT00395863|Executive Director, Head Corporate Medical Development|Gianpaolo Pirovano|609-514-2226|gianpaolo.pirovano@diag.bracco.com
100297|NCT00395876|Genentech, Inc.|Medical Communications|800-821-8590|
100298|NCT00395967|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
100299|NCT00395993|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com
100301|NCT00396032|Genentech, Inc.|Medical Communications|800-821-8590|
100302|NCT00402987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100303|NCT00403130|Stanford University Medical Center|George Albert Fisher, MD, PhD|650-725-9057|georgeaf@stanford.edu
100304|NCT00403234|Purdue Pharma L.P.|Clinical Leader, Director of Clinical Research|800-733-1333|
100305|NCT00403273|minneapolis VAMC|jasvinder singh|205-504-9559|
100306|NCT00403585|GlaxoSmithKline|GSK Response Center|866-435-7343|
100307|NCT00403754|Novartis Pharmaceuticals|Study Director|862 778-8300|
100308|NCT00403767|Johnson & Johnson Pharmaceutical Research & Development L.L.C.|Head of Development, CV & UROL|1 908-927-7767|
100309|NCT00403845|Novartis Pharmaceuticals|Study Director|862 778-8300|
100310|NCT00404079|Oslo University Hospital Ullevaal|Project Manager: Philip Wilkens|004723016140|philip.wilkens@medisin.uio.no
100311|NCT00404092|University of Cologne|Oliver A. Cornely|+49 221 478 6494|Oliver.Cornely@zks-koeln.de
100312|NCT00404248|Adult Brain Tumor Consortium Central Office - Johns Hopkins|Director of Adult Brain Tumor Consortum|410-955-3657|jfisher@jhmi.edu
100313|NCT00404352|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
100314|NCT00404495|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100316|NCT00404651|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
100317|NCT00404820|Novartis Pharmaceuticals|Study Director|862 778-8300|
100318|NCT00404924|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
100319|NCT00405067|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867|
100320|NCT00405275|VA Nebraska-Western Iowa Health Care System|James R. O'Dell, MD|402-559-7288|jrodell@unmc.edu
100321|NCT00405288|The Hospital for Sick Children|Dr. Gideon Koren||gkoren@sickkids.ca
100322|NCT00405509|Allegheny General Hospital|Deborah Gentile, MD|412-359-6654|dgentile@wpahs.org
100323|NCT00405548|Mayo Clinic|Dr. Horng H. Chen|507-538-2354|chen.horng@mayo.edu
100324|NCT00405587|Plexxikon Inc.|Dr. Henry Hsu|510-647-4000|hhsu@plexxikon.com
100325|NCT00405639|Mayo Clinic|Dr. Horng H. Chen|507-538-2354|chen.horng@mayo.edu
100326|NCT00405652|Novartis Pharmaceuticals|Study Director|862-778-8300|
100327|NCT00405704|UNC Chapel Hill|Dr. Myra Carpenter, Senior Investigator|919-962-3245|myra_carpenter@unc.edu
100328|NCT00405756|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
100329|NCT00405821|NIAID|Steven Reynolds|256-772-220-087|sjreynolds@niaid.nih.gov
100330|NCT00405912|Mayo Clinic|Dr. Amit Sood|507-266-1944|nicotineresearch@mayo.edu
100331|NCT00405938|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
100332|NCT00405964|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100333|NCT00406029|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
100334|NCT00398983|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD / Associate Professor|713-745-0394|eharrison@mdanderson.org
100335|NCT00399035|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
100336|NCT00399308|Shire Regenerative Medicine|Mollie Carter, MD, Medical Director|(858) 754-5678|mcarter@shire.com
100337|NCT00399360|Massachusetts General Hospital|Dr. Steven Grinspoon, Principal Investigator|617-726-3890|sgrinspoon@partners.org
100338|NCT00399516|Boston Scientific|Brad Hershey, MS|(661) 949-4828|Brad.Hershey@bsci.com
100339|NCT00399542|Sucampo Pharmaceuticals, Inc.|Raymond Panas, PhD|301-961-3400|info@sucampo.com
100340|NCT00399568|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com
100341|NCT00399763|Denver Health|Christian Thurstone, M.D.|303-436-6006|christian.thurstone@dhha.org
100342|NCT00399880|Vanderbilt University Medical Center|Kathryn Goggins, Research Coordinator|6159364819|Kathryn.m.goggins@vanderbilt.edu
100343|NCT00399893|Duke University Medical Center|Michael Freemark, MD|919-684-5091|andrea.haqq@albertahealthservices.ca
100344|NCT00400153|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257 Option 4|clintriage.rdg@boehringer-ingelheim.com
100469|NCT00406718|UT_SanAntonio UTHSCSA|Dr. Dawn Velligan|210-567-5508|velligand@uthscsa.edu
100345|NCT00400179|Taiho Pharma USA, Inc.|Fabio Benedetti, MD, Chief Medical Officer|609-750-5300|benedetti@taihopui.com
100347|NCT00400400|Novartis Pharmaceuticals|Study Director|862-778-8300|
100348|NCT00406107|Palmetto Retina Center|John A. Wells, III, M.D.|803-931-0077|jackwells@palmettoretina.com
100349|NCT00406133|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D., Director|813-975-8690|rbeck@jaeb.org
100350|NCT00406276|Emory University|Dr.Suresh Ramalingam, MD|404-778-5378|ssramal@emory.edu
100351|NCT00406315|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100352|NCT00406354|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
100353|NCT00406367|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503 ext 538|angelika.hanschmann@merz.de
100354|NCT00406393|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com
100355|NCT00407797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100356|NCT00407888|Medical Oncology University of Washington|Hannah Linden MD FACP|206-288-6989|hmlinden@uw.edu
100357|NCT00407966|SKCCC|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu
100358|NCT00408070|UCHC|Paige Dunion|860-679-6571|pdunion@uchc.edu
100359|NCT00408200|University of Pennsylvania|Anthony Killian|215-615-5299|tony.killian@uphs.upenn.edu
100360|NCT00408317|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634|
100361|NCT00408408|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org
100362|NCT00408421|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
100363|NCT00408460|University of Washington|Renato G Martins, MD|206-288-2048|rgmart@uw.edu
100364|NCT00408499|University of California, Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu
100365|NCT00408590|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-2511|galanis.evanthia@mayo.edu
100366|NCT00408603|Sunesis Pharmaceuticals, Inc.|Dr. Linda Neuman, Vice President, Clinical Development|(650) 266-3760|lneuman@sunesis.com
100367|NCT00408629|Abbott|Global Medical Services|800-633-9110|
100368|NCT00408681|Fred Hutchinson Cancer Research Center|Paul J. Martin, M.D.|206-667-4798|pmartin@fredhutch.org
100370|NCT00408876|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
100372|NCT00408928|Thomas Jefferson University|John Wagner, MD|215-955-8874|John.Wagner@jefferson.edu
100373|NCT00408993|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
100374|NCT00409006|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100375|NCT00409175|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100376|NCT00409188|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
100377|NCT00409240|Providence VAMC|Wen-Chih Wu, MD|401-273-7100 ext 6237|wen-chih.wu@va.gov
100378|NCT00409292|Dana-Farber Cancer Institute|Brian Wolpin, MD|617-632-3000|brian_wolpin@dfci.harvard.edu
100379|NCT00409331|UT MD Anderson Cancer Center|Mark Chambers, DMD / Associate Professor|713-745-2672|
100380|NCT00409344|Massachusetts General Hospital|Ulrich Schmidt, MD PhD|617-724-6490|uschmidt@partners.org
100381|NCT00409409|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com
119171|NCT02829983|Universidade Estadual Paulista Júlio de Mesquita Filho|Mauro Pedrine Santamaria|3947-9033|mauro.santamaria@ict.unesp.br
100384|NCT00409578|Novartis Pharmaceuticals|Study Director|862 778-8300|
100385|NCT00409617|Abbott|Global Medical Services|800-633-9110|
100386|NCT00409682|Abbott|Global Medical Services|800-633-9110|
100387|NCT00409708|Novartis Pharmaceuticals|Study Director|862 778-8300|
100388|NCT00409747|NIH/NIMH/PDN Branch|Dr. Susan Swedo|301-496-5323|swedos@mail.nih.gov
100389|NCT00409773|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
100390|NCT00409786|University of Pittsburgh|Kathleen McTigue|412-692-2940|mctiguekm@upmc.edu
100391|NCT00409825|University of Pittsburgh|Steve N. Caritis, MD|412-641-4874|scaritis@mail.magee.edu
100392|NCT00409838|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
100393|NCT00410046|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
100394|NCT00410059|UT MD Anderson Cancer Center|Vice President Clinical Research/Clinical Research Operations|713-792-7734|CR_Study_Registration@mdanderson.org
100395|NCT00410072|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
100396|NCT00410124|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300|
100397|NCT00410150|Cincinnati Children's Hospital Medical Center|Dr. Derek Wheeler|513-636-4239|derek.wheeler@cchmc.org
100398|NCT00410163|GlaxoSmithKline|GSK Response Center|866-435-7343|
100399|NCT00410189|University of Texas (UT) MD Anderson Cancer Center|Anne S. Tsao, MD / Associate Professor, Thoracic/Head & Neck Med Oncology|713-792-6363|CR_Study_Registration@mdanderson.org
100400|NCT00410202|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
100401|NCT00410280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100402|NCT00403403|Genentech, Inc.|Medical Communications|800-821-8590|
100403|NCT00403455|Department of Veterans Affairs|Dr. Zhewu Wang|(843) 789-7949|Zhewu.Wang@va.gov
100404|NCT00403481|Daiichi Sankyo|John J. Raia, R.Ph, Pharm. D.|1-877-437-7763|druginfo@dsus.com
100405|NCT00403546|Massachusetts General Hospital|Donald C. Goff, MD||Donald.Goff@nyumc.org
100406|NCT00410384|GlaxoSmithKline|GSK Response Center|866-435-7343|
100407|NCT00410410|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
100408|NCT00410488|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||CR_Study_Registration@mdanderson.org
100409|NCT00410514|Astellas Pharma Global Development, Inc. (APGD)|Associate Medical Director, Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com
100410|NCT00410605|Univerisity of Wisconsin Carbone Cancer Center|Dr. Natalie Callander|608-265-8690|nsc@medicine.wisc.edu
100411|NCT00410826|University of Washington|Renato G. Martins, MD, MPH|2062882048|rgmart@uw.edu
100414|NCT00411151|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|M. Kabisch|++49 (0)6131-179922|kabisch@izks-mainz.de
100415|NCT00411216|Emory|Susan J Herdman, PT, PhD|4047120612|sherdma@emory.edu
100416|NCT00411398|SUNY Upstate|Thomas Schwartz|3154643166|schwartt@upstate.edu
100417|NCT00411411|Gentofte University Hospital|Dr. Kasper Aaboe|+4522170200|kasper@dadlnet.dk
100418|NCT00411450|Amgen Inc.|Study Director|866-572-6436|
100419|NCT00411463|University of Pittsburgh|Holly Swartz, MD|412-246-5588|swartzha@upmc.edu
100420|NCT00411554|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
100421|NCT00411619|Cincinnati Children's Hospital Medical Center|Dr. David Franz|513-636-4222|david.franz@cchmc.org
100422|NCT00411645|Shire Development LLC|Study Physician|+1 866 842 5335|
100423|NCT00411671|University of Texas (UT) MD Anderson Cancer Center|George Blumenschein, MD / Professor, Thoracic/Head & Neck Med Oncology||CR_Study_Registration@mdanderson.org
100424|NCT00411749|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
100425|NCT00411762|Yale University|Howard Hochster||Howard.Hochster@yale.edu
100426|NCT00411788|Yale University|Abu-Khalaf, Maysa|(203) 785-4095|maysa.abu-khalaf@yale.edu
100427|NCT00412061|Novartis Pharmaceuticals|Study Director|862-778-8300|
100428|NCT00412074|Medical University of South Carolina|Carol Wagner|18437922112|wagnercl@musc.edu
100429|NCT00412087|Medical University of South Carolina|Dr. Carol Wagner|18437922112|wagnercl@musc.edu
100430|NCT00412113|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100431|NCT00412217|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
100432|NCT00412243|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org
100434|NCT00412373|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136|jhulihan@its.jnj.com
100435|NCT00412425|UT MD Anderson Cancer Center|Agop Bedikian, MD Professor||asreckew@mdanderson.org
100436|NCT00412451|ThromboGenics NV|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com
100437|NCT00412464|Children's Hospital Los Angeles|Guy Young|323-361-5507|gyoung@chla.usc.edu
100438|NCT00412516|PATH|Anthony A Marfin, Director Japanese Encephalitis Vaccine Introduction and Sustainability Project|2062853500|aamarfin@path.org
100439|NCT00412529|Novartis Pharmaceuticals|Study Director|862-778-8300|
100440|NCT00412542|UT MD Anderson Cancer Center|Vinay Puduvalli, MD / Associate Professor|713-745-5769|kuhunter@mdanderson.org
100441|NCT00412607|Biosense Webster, Inc.|Karen Cropper, Manager, Clinical Operations|(800) 729-9010 ext 8607|Kcropper@its.jnj.com
100442|NCT00412737|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
100443|NCT00412750|Novartis Pharmaceuticals|Study Director|862-778-8300|
100445|NCT00412854|GlaxoSmithKline|GSK Response Center|866-435-7343|
100447|NCT00412893|Astellas Pharma Global Development, Inc.|Medical Head Immunology, Transplant and Infectious Disease Therapeutic Area||resultsdisclosure@astellas.com
100448|NCT00412932|Daiichi Sankyo|John Raia|973-630-2683|jraia@dsus.com
100449|NCT00412958|ThromboGenics|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com
100450|NCT00412971|Fredriksberg hospital|Gregers G. Hermann|(+45) 38163536|gregershermann@hotmail.com
100451|NCT00412984|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
100452|NCT00413010|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100453|NCT00413036|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
100454|NCT00413049|Novartis Pharmaceuticals|Study Director|862 778-8300|
100455|NCT00413062|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100456|NCT00413153|Massachusetts General Hospital|Steven K. Grinspoon, MD|617-724-9109|sgrinspoon@partners.org
100457|NCT00413192|Eisai Ltd. Mosquito Way, Hatfield, Hertfordshire, AL 10 9SN|Gitta Irmer Associate Director, Data Quality & Standards Global Regulatory Operations|+44 (0) 845 676 1618|
100458|NCT00413218|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704 ext 5473|astellas.resultsdisclosure@astellas.com
100459|NCT00413231|Medtronic Vascular, Inc.|PJ Belmont, Clinical Research Specialist|707-480-3025|PJ.Belmont@Medtronic.com
100460|NCT00413244|Icahn School of Medicine at Mount Sinai|Dr. Mary Ann McLaughlin|(212) 241-3340|maryann.mclaughlin@mountsinai.org
100461|NCT00413283|Amgen Inc.|Study Director|866-572-6436|
100462|NCT00413335|Yale University School of Medicine|Dr. Sonia Caprio, Principal Investigator|203-785-5692|Sonia.Caprio@yale.edu
100463|NCT00413374|Brigham and Women's Hospital|Research Coordinator|617-732-6984|arao2@partners.org
100464|NCT00413400|Massachusetts General Hospital|Steven K. Grinspoon|617-724-9109|sgrinspoon@partners.org
100465|NCT00413413|Novartis Pharmaceuticals|Study Director|862 778-8300|
100466|NCT00406640|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
100467|NCT00406653|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
100468|NCT00406692|Boston University|Clifford Knapp, PhD|617-414-1990|cknapp@bu.edu
100836|NCT00439231|NHLBI/NIH|Georg Aue|301.451.7141|AueG@nhlbi.nih.gov
100470|NCT00406783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100471|NCT00406848|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100472|NCT00407030|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503 ext 538|angelika.hanschmann@merz.de
100473|NCT00407355|Wilmer Eye Institute|Peter Campocahiro|: 410-955-5106|pcampo@jhmi.edu
100474|NCT00407381|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu
100475|NCT00407485|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
100476|NCT00407511|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100477|NCT00407537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100478|NCT00407550|Mayo Clinic|Julian R. Molina, M.D., Ph.D.|507-284-8318|molina.julian@mayo.edu
100479|NCT00407563|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com
100480|NCT00407654|Princess Margaret Cancer Centre|Dr. Malcolm Moore|416-945-2263|malcolm.moore@uhn.ca
100481|NCT00407745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100482|NCT00413478|University of Texas (UT) MD Anderson Cancer Center|Zeev Estrov, MD/Professor, Leukemia|713-794-1675|CR_Study_Registration@mdanderson.org
100483|NCT00413582|Children's Mercy Hospital|Shawn D. St. Peter, MD|816-983-6479|sspeter@cmh.edu
100484|NCT00413634|Shire|Timothy Whitaker, M.D.||twhitaker@shire.com
100485|NCT00413660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100486|NCT00414518|University of Colorado Denver|Michelle A. Barron|303-724-4939|michelle.barron@ucdenver.edu
100487|NCT00414544|Cosmeta, A Gel-Del Technolgies Company|Dr. David B. Masters|651 209-0707|dmasters@gel-del.com
100488|NCT00414596|NEMA Research, Inc|Jospeph V Pergolizzi, MD|239-597-3564|nemaresearch@aol.com
100489|NCT00414609|Novartis Pharmaceuticals|Study Director|862-778-8300|
100490|NCT00414635|Community Research Initiative of New England (CRINE)|Calvin Cohen, MD|617 502 1700|ccohen@crine.org
100491|NCT00414661|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100492|NCT00414700|TiGenix n.v.|Nel Van Lommel, MSc, Manager Clinical Operations Europe, TiGenix n.v.|+3216396060|nel.vanlommel@tigenix.com
100494|NCT00414817|Kaiser Permanente, Center for Health Research|Dr. William Vollmer, Senior Investigator|503-335-6755|
100495|NCT00414908|Abbott Products|Sven Voet - Global Communication|+41 61 487 08 56|sven.voet@abbott.com
100496|NCT00414973|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100497|NCT00415051|US Army Medical Research Institute of infectious Diseases (USAMRIID)|COL Phillip R. Pittman, MD, MPH|301-619-4994|phillip.pitman@amedd.army.mil
100498|NCT00415168|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100499|NCT00415194|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100500|NCT00415493|ASTHMA Inc.|Principal Investigator|(510) 620-5714|dennis.shusterman@cdph.ca.gov
100501|NCT00415506|Oregon Health & Science University|Dr. Eric B. Suhler|503-494-5023|suhlere@ohsu.edu
100502|NCT00415532|Amgen Inc.|Study Director|866-572-6436|
100503|NCT00415597|King Pharmaceuticals Research and Development, Inc.|Vice President, Clinical Development|919-653-7001|
100505|NCT00415623|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100506|NCT00415857|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/792-7305|eharrison@mdanderson.org
100508|NCT00415909|University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor, Leukemia|713-794-5783|CR_Study_Registration@mdanderson.org
100509|NCT00416078|VAGLAHS at West Los Angeles|Dr. Theodore Hahn|3102684108|thahn@ucla.edu
100510|NCT00416182|Vermont Children's Hospital at Fletcher Allen Health Care|Dr. Thomas Lahiri, Principal Investigator|802-847-8600|thomas.lahiri@vtmednet.org
100511|NCT00416195|Eisai Call Center|Eisai Inc.|888-422-4743|
100512|NCT00416455|NRG Oncology Statistics and Data Management Center|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
100513|NCT00416494|Duke University Medical Center|Brant Hamel|919-68-1861|brant.hamel@duke.edu
100514|NCT00416520|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
100515|NCT00416572|Carnegie Mellon University|Michael F. Scheier, PhD|412-268-3791|scheier@cmu.edu
100517|NCT00416624|Mayo Clinic|Charles L. Loprinzi, M.D.|507-266-6247|loprinzi.charles@mayo.edu
100518|NCT00416715|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu
100519|NCT00416793|UT MD Adnderson Cancer Center|Gauri Varadhachary, MD Associate Professor|713-792-2828|mjlim@mdanderson.org
100520|NCT00416884|Center for Hematologic Malignancies|Center for Hematologic Malignancies|503-494-1551|
100521|NCT00417027|Northwestern University Feinberg School of Medicine|Robert J. McCarthy, PharmD|312-926-9015|r-mccarthy@northwestern.edu
100523|NCT00410813|SWOG Statistical Center|SWOG Breast Committee Statistician|206-667-4623|
100524|NCT00417079|sanofi-aventis|International Clinical Development Study Director||GV-Contact-us@sanofi-aventis.com
100525|NCT00417170|Novartis Pharmaceuticals|Study Director|862-778-8300|
100526|NCT00417248|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org
100527|NCT00417274|Clevland BioLabs|Michael Kurman, MD|716-849-6810|mkurman@cbiolabs.com
100528|NCT00419926|Novartis Pharmaceuticals|Study Director|862-778-8300|
100529|NCT00419952|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
100530|NCT00420017|Purdue University|James E Tisdale PharmD|317-613-2315 ext 306|hwroblew@iupui.edu
100531|NCT00420056|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100532|NCT00420095|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
100533|NCT00420147|University of Delaware|Todd Royer|302-831-4351|royer@udel.edu
100534|NCT00420199|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
100535|NCT00420212|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com
100536|NCT00420238|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
100537|NCT00420290|Vanderbilt University|Adriana Hung, MD||adriana.hung@vanderbilt.edu
100538|NCT00420303|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
100539|NCT00420316|GlaxoSmithKline|GSK Response Center|866-435-7343|
100540|NCT00420342|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
100542|NCT00420420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
100543|NCT00420459|Cincinnati Childrens Hospital|Craig Erickson|5136366265|craig.erickson@cchmc.org
100544|NCT00420511|Leadership Sinai Centre for Diabetes, Mount Sinai Hospital|Dr. Ravi Retnakaran|416-586-4800 ext 3941|rretnakaran@mtsinai.on.ca
100545|NCT00420628|Bausch & Lomb|Timothy Comstock OD|(585) 338-6631|tcomstock@bausch.com
100546|NCT00420745|GlaxoSmithKline|GSK Response Center|866-435-7343|
100547|NCT00420784|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com
100548|NCT00420849|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
100549|NCT00420927|Abbott|Global Medical Services|1-800-633-9110|
100550|NCT00420992|King Pharmaceuticals Research and Development, Inc.|Vice President, Clinical Development|919-653-7001|
100551|NCT00421174|The EMMES Corporation|Adam Mendizabal, PhD|(301) 251-1161 ext 221|amendizabal@emmes.com
100552|NCT00421343|Hebrew SeiorLife|Sarah Berry|617-971-5355|sarahberry@hrca.harvard.edu
100553|NCT00421408|Yale University|Dr. Karl Insogna|203-737-2871|Karl.insogna@yale.edu
100555|NCT00421733|Abbott|Global Medical Services|800-633-9110|
100556|NCT00421889|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com
100557|NCT00421928|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537|
100558|NCT00421954|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu
100559|NCT00421993|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com
100560|NCT00422032|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, MD / Professor|713-792-7026|eharriso@mdanderson.org
100562|NCT00422097|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
100563|NCT00422162|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100564|NCT00422201|HRA Pharma|Head of Clinical Research|0033140331130|s.durand@hra-pharma.com
100565|NCT00422227|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
100566|NCT00422279|Nobel Biocare|Isabelle Arrighi, Head Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com
100567|NCT00422292|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
100568|NCT00422383|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
100569|NCT00413777|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
100570|NCT00413894|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
100571|NCT00413920|Novartis Pharmaceuticals|Study Director|862-778-8300|
100572|NCT00413959|Oncology Specialists SC|Sigrun Hallmeyer, MD Director of Research|847-268-8200|shallmeyer@oncmed.net
100573|NCT00413972|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100574|NCT00414011|U.S. Army Warfighter Refractive Surgery Research Center|Principal Investigator|571-231-1600|rose.sia@us.army.mil
100575|NCT00414050|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1 800 672 6372|ClinicalTrialsDisclosure@merck.com
100576|NCT00414167|Yale University School of Medicine|Dr. Marney A. White|203-785-4349|marney.white@yale.edu
100577|NCT00414206|CoMentis, Inc.|Carl Grove|650-869-7600|cgrove@comentis.com
100578|NCT00414310|The University of Texas (UT) MD Anderson Cancer Center|Hagop Kantarjian, MD/Chair, Leukemia Department|713-792-7026|CR_Study_Registration@mdanderson.org
100579|NCT00414388|Oncology Specialists, S.C.|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD (PI)|847-268-8200|shallmeyer@oncmed.net
100580|NCT00414440|Novartis|Study Director|+1 (862) 778-8300|
100581|NCT00414453|University of Rochester|Robert H Dworkin|275-8214|robert_dworkin@urmc.rochester.edu
100582|NCT00414466|Medtronic Neuromodulation|Robert Spencer, Clinical Research Manager|(763) 514-0253|robert.j.spencer@medtronic.com
100583|NCT00422422|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493|
100584|NCT00422448|Medical University of Graz - Austria|Prof. Dr. Iris Zalaudek|+436763328269|iris.zalaudek@gmail.com
100585|NCT00422513|Hoffman-LaRoche|Medical Communications|800-821-8590|
100586|NCT00422656|Dana-Farber Cancer Institute|Irene M. Ghobrial, MD|617-632-4198|irene_ghobrial@dfci.harvard.edu
100587|NCT00422669|Medtronic, Inc.|Optimize RV Trial Leader|1-800-328-2518|medtroniccrmtrials@medtronic.com
100588|NCT00422695|Rutgers School of Dental Medicine|Eli Eliav|973 972 7210|eliavel@sdm.rutgers.edu
100589|NCT00422734|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
100590|NCT00423852|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman, Assistant Attending|+1646-422-4491|Feldmand@mskcc.org
100591|NCT00423878|Columbia University|Dr. Scott Stroup|212-543-5676|stroups@nyspi.columbia.edu
100592|NCT00423891|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
100593|NCT00423917|Mayo Clinic|Winston Tan MD|507/284-1159|tan.winston@mayo.edu
100594|NCT00423930|Memorial Sloan Kettering Cancer Center|David Pfister, MD|646-888-4232|pfisterd@mskcc.org
100595|NCT00423943|University of California, Los Angeles|Michael Minzenberg|310-825-7642|MMinzenberg@mednet.ucla.edu
100596|NCT00424008|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100597|NCT00424021|Gilead Sciences, Inc.|Karen L Miller, PhD|650-524-3892|KarenL.Miller@gilead.com
100599|NCT00424177|GlaxoSmithKline|GSK Response Center|866-435-7343|
100600|NCT00424190|Cerexa|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com
100601|NCT00424255|GlaxoSmithKline|GSK Response Center|866-435-7343|
100602|NCT00424268|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
100603|NCT00424294|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100604|NCT00424346|Novartis Pharmaceuticals|Study Director|862-778-8300|
100605|NCT00424372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100606|NCT00424385|Oncology Specialists, SC|Sigrun Hallmeyer, MD Director of Research; Chadi Nabhan, MD FACP (PI)|847-268-8200|shallmeyer@oncmed.net
100607|NCT00424398|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com
100608|NCT00424476|GlaxoSmithKline|GSK Response Center|866-435-7343|
100609|NCT00424502|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
100610|NCT00424515|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu
100611|NCT00424528|Sepracor Inc|Respiratory Medical Affairs Director|866-503-6351|
100613|NCT00424593|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100614|NCT00424619|McMaster University|Dr. Alexandra Papaioannou|905-521-2100 ext 77715|papaioannou@hhsc.ca
100615|NCT00424632|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100616|NCT00424645|UT MD Anderson Cancer Center|Saroj Vadhan, MD||CR_Study_Registration@mdanderson.org
100617|NCT00424749|Mayo Clinic|Dr. Fernando C. Fervenza||fervenza.fernando@mayo.edu
100618|NCT00424762|University of Texas Southwestern Medical Center at Dallas|Dr. Darren K. McGuire|214 645 7520|darren.mcguire@utsouthwestern.edu
100619|NCT00424775|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
100620|NCT00424827|Universiy of MA Medical School|Bilal Piperdi, MD|508-426-0442|UMMScommunications@umassmed.edu
100621|NCT00425061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100622|NCT00425100|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100623|NCT00425113|National Institute of Allergy and Infectious Diseases|Ray Chen|301-443-5816|ray.chen@nih.gov
100624|NCT00425269|University of Oslo|Victoria Telle Hjellset|0047 22 85 06 12|t.v.t.hjellset@medisin.uio.no
100625|NCT00425308|Novartis Pharmaceuticals|Study Director|862-778-8300|
100626|NCT00425373|Novartis Pharmaceuticals|Study Director|862 778-8300|
100627|NCT00425386|OHSU Knight Cancer Institute|Dr. Christopher Ryan|5034946197|ryanc@ohsu.edu
100628|NCT00425438|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
100629|NCT00425503|Baylor College of Medicine|Dr. Teresa Hayes - Associate Professor|713-794-7368|thayes@bcm.edu
100630|NCT00425607|Dana-Farber Cancer Institute|Dr. Mark Kieran|617-632-4907|mark_kieran@dfci.harvard.edu
100631|NCT00425672|University of Washington|Principal Investigator||TrialTVG@medicine.washington.edu
100632|NCT00425698|Saarland University Medical Centre|Prof. Dr. Danilo Fliser|(49) 6841 ext 1623526|indfli@uks.eu
100633|NCT00425750|Vanderbilt-Ingram Cancer Center|Barbara Murphy, M.D.|615-343-4677|
100634|NCT00425854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
100635|NCT00425945|Stanford University School of Medicine|Dr. Randall Stafford|650-724-2400|rstafford@stanford.edu
100636|NCT00426127|University of Iowa|Daniel Berg, MD|319-353-7800|daniel-j-berg@uiowa.edu
100637|NCT00426153|Mayo Clinic|Marie Hogan, MD, PhD, Assistant Prof of Medicine, College of Medicine|507-266-9364|hogan.marie@mayo.edu
100638|NCT00426231|Johns Hopkins University|Dhananjay Vaidya|410-6142307|dvaidya1@jhmi.edu
100639|NCT00426270|Octapharma USA|Michael Eppolito|201 604-1155|michael.eppolito@octapharma.com
100640|NCT00426283|Cincinnati Children's Hospital Medical Center|Marc E Rothenberg|513-636-7177|rothenberg@cchmc.org
100641|NCT00426361|GlaxoSmithKline|GSK Response Center|866-435-7343|
100642|NCT00417482|New York State Psychiatric Institute|Davangere P. Devanand, MD|212-543-5612|dpd3@columbia.edu
100643|NCT00417612|Yale University School of Medicine|Dr. Thomas O. Carpenter|203-785-6526|thomas.carpenter@yale.edu
100644|NCT00417885|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100645|NCT00417963|C.R. Bard Inc.|Director of Clinical Affairs|480-303-2644 ext 2644|john.reviere@crbard.com
100646|NCT00417976|The Ohio State University|Tanios Bekaii-Saab|614-293-9863|Tanios.saab@osumc.edu
100648|NCT00418015|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|3129269015|r-mccarthy@northwestern.edu
100649|NCT00418093|Dana-Farber Cancer Institute|Neil Horowitz, MD|617-732-8843|nhorowitz@partners.org
100650|NCT00418145|Icahn School of Medicine at Mount Sinai|Dr. Fred Lublin|212-241-6854|fred.lublin@mssm.edu
100651|NCT00418184|Enzymotec Ltd|Yael Richter Ph.D|+972 74 7177 177 ext 144|Yaelr@enzymotec.com
100652|NCT00418262|University of Oklahoma Health Sciences Center|Mark Wolraich, M.D.|(405) 271-5700 ext 45123|mark-wolraich@ouhsc.edu
100653|NCT00418314|St. Jude Medical|Sr. Director Clinical Studies|(408) 522-6410|tshipman@sjm.com
100654|NCT00418379|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com
100655|NCT00418522|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100656|NCT00418561|Shire|Study Physician|1866-842-5335|
100657|NCT00418574|Menarini Ricerche SpA|Clinical Research Director||abagovomab@menarini-ricerche.it
100658|NCT00418665|Amgen Inc.|Study Director|866-572-6436|
100659|NCT00418691|UT MD Anderson Cancer Center|Dr. Jeffrey Wefel, Assistant Professor|713-563-0514|CR_Study_Registration@mdanderson.org
100660|NCT00418717|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
100661|NCT00418834|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
100662|NCT00418886|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
100663|NCT00418938|Amgen Inc.|Study Director|866-572-6436|
100664|NCT00418951|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org
100665|NCT00418964|The Chinese University of Hong Kong|Pauline Lui|852 2632 3072|pauline@ort.cuhk.edu.hk
100666|NCT00418977|Icahn School of Medicine at Mount Sinai|Katharine Loeb, PhD|212-659-8724|katharine.loeb@mssm.edu
100667|NCT00419003|Baylor College of Medicine|Dr. Sanjay Mathew|7137985439|sjmathew@bcm.edu
100668|NCT00419094|UCB, Inc.|Study Director|+1 877 822 9493|
100669|NCT00419120|Tengion, Inc.|Sunita Sheth, MD - Chief Medical Officer|267-960-4805|sunita.sheth@tengion.com
100670|NCT00419159|Novartis Pharmaceuticals|Study Director|862-778-8300|
100671|NCT00419263|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|(919) 859-1302|
100672|NCT00419315|Philadelphia VA Medical Center|David Oslin|215 823 5894|dave.oslin@va.gov
100673|NCT00419341|CSL Behring|Clinical Trial Disclosure Manager|Use email contact.|clinicaltrials@cslbehring.com
100674|NCT00419380|University of Colorado School of Medicine - Department of Pediatric Otolaryngology|Kenny H. Chan, MD|7207774776|kenny.chan@childrenscolorado.org
100675|NCT00419393|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
100676|NCT00419445|CoMentis (formerly Athenagen)|Carl Grove|650-869-7600|cgrove@comentis.com
100677|NCT00419744|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
100678|NCT00419757|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
100679|NCT00419770|Los Angeles Biomedical Research Institute|Brad Spellberg|310-781-3680|bspellberg@labiomed.org
100680|NCT00426556|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
100681|NCT00426660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100682|NCT00426751|GlaxoSmithKline|GSK Response Center|866-435-7343|
100683|NCT00427336|UT MD Anderson Cancer Center|Paolo Anderlini, MD / Professor||mvpacheco@mdanderson.org
100684|NCT00427349|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|
100685|NCT00427557|MD Anderson Cancer Center|Dr. Partow Kebriaei|713-563-5174|celsaenz@mdanderson.org
100686|NCT00427635|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
100687|NCT00427661|University of Pittsburgh-Department of Pediatrics|Nancy Harter-Administrative Director of Research|412-692-7487|harterne@upmc.edu
100688|NCT00427700|Hospital de Clínicas de Porto Alege|Dr. Ricardo Francalacci Savaris|51 33598405|rsavaris@hcpa.ufrgs.br
100689|NCT00427765|UT MD Anderson Cancer Center|Partow Kebriaei, MD/Associate Professor||celsaenz@mdanderson.org
100690|NCT00427778|Queen's University|Dr Marie-Andree Harvey|613-548-6115|harveym@queensu.ca
100691|NCT00427791|UT MD Anderson Cancer Center|Dr. Partow Kebriaei, Associate Professor|713-792-2648|ytdinh@mdanderson.org
100692|NCT00427804|Emory University|Vin Tangpricha, M.D., Ph.D.|404-727-7254|vin.tangpricha@emory.edu
100693|NCT00427895|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100694|NCT00427921|Abbott Laboratories|Medical Information Specialist|Phone: (800) 633-9110|
100695|NCT00427934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100696|NCT00427960|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
100697|NCT00427973|Massachusetts General Hospital Cancer Center|Andrew X. Zhu, MD|617-643-3415|azhu@partners.org
100698|NCT00427999|Novartis Pharmaceuticals|Study Director|862-778-8300|
100699|NCT00428077|University of Utah Huntsman Cancer Institute|Michael Deininger, MD, PhD|801-585-3229|michael.deininger@hci.utah.edu
100700|NCT00428090|GlaxoSmithKline|GSK Response Center|866-435-7343|
100701|NCT00428116|University of Washington|Grace John-Stewart|206 543 4278|gjohn@uw.edu
100702|NCT00428207|Joslin Diabetes Center|Howard Wolpert, MD|6173092665|howard.wolpert@joslin.harvard.edu
100703|NCT00428220|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100704|NCT00428246|Indiana University|Rajiv Agarwal|317-988-2241|ragarwal@iupui.edu
100705|NCT00428298|Johns Hopkins UNiversity School of Medicine|Jennifer L. Payne MD|410-502-0050|jpayne5@jhmi.edu
100706|NCT00428389|Novartis Pharmaceuticals|Study Director|862-778-8300|
100707|NCT00428441|University of Insubria|Dr. Walter Ageno|+39 0332 278831|agewal@yahoo.com
100708|NCT00428584|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|fernando.dangond@emdserono.com
100709|NCT00428597|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100710|NCT00428792|Novartis Pharmaceuticals|Study Director|862 778-8300|
100711|NCT00428844|Cubist Pharmaceuticals, Inc.|Ed Campanaro, VP Clinical Operations|781-860-8318|ed.campanaro@cubist.com
100712|NCT00428922|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy, MD|614-293-0066|Bhuvaneswari.Ramaswamy@osumc.edu
100713|NCT00428948|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974|
100714|NCT00428974|Can-Fite BioPharma Ltd|Pnina Fishman, PhD|011972 3 924 1114|pnina@canfite.co.il
100715|NCT00429026|U.T. M.D. Anderson Cancer Center|Naoto Ueno, MD, PhD / Associate Professor|713-792-8754|CR_Study_Registration@mdanderson.org
100716|NCT00429104|University of Texas MD Anderson Cancer Center|Naoto Ueno, MD.PhD./Professor|713-792-8754|CR_Study_Registration@mdanderson.org
100717|NCT00429143|Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|neal.flomenberg@jefferson.edu
100719|NCT00429182|University of Texas MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org
100720|NCT00429273|University of California, Los Angeles|James T. McCracken, M.D.|310-825-0470|jmccracken@mednet.ucla.edu
100721|NCT00429299|GlaxoSmithKline|GSK Response Center|866-435-7343|
100722|NCT00429364|New England Research Institutes, Inc.|Paul Stark, PhD|617-972-3362|pstark@neriscience.com
100723|NCT00429403|UT MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org
100724|NCT00429416|Thomas Jefferson University|John Wagner, MD|215-955-8874|John.Wagner@jefferson.edu
100725|NCT00429494|The University of Texas (UT) MD Anderson Cancer Center|Dr. Naoto T. Ueno, MD, PhD / Professor||CR_Study_Registration@mdanderson.org
100726|NCT00429507|University of Texas (UT) MD Anderson Cancer Center|Nato Ueno, MD, PhD/Professor, Breast Medical Oncology||CR_Study_Registration@mdanderson.org
100727|NCT00429572|UT MD Anderson Cancer Center|Naoto Ueno, MD, PhD/Professor|713-792-8754|CR_Study_Registration@mdanderson.org
100728|NCT00417417|NHLBI/NIH|Richard O. Cannon III, MD|301-496-9895|cannonr@nih.gov
100729|NCT00422903|GlaxoSmithKline|GSK Response Center|866-435-7343|
100730|NCT00422942|Hoffmann-LaRoche|Medical Communications Organization|800-821-8590|genentech@druginfo.com
100731|NCT00423046|GlaxoSmithKline|GSK Response Center|866-435-7343|
100732|NCT00423085|Novartis Pharmaceuticals|Study Director|862-778-8300|
100733|NCT00423098|Novartis Pharmaceuticals|Study Director|862-778-8300|
100734|NCT00423150|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100735|NCT00423176|Merck, Sharp & Dohme Corp.|Senior Vice Presdient, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100736|NCT00423189|Retina Consultants of Houston|David M. Brown|713-524-3434|dmbmd@houstonretina.com
100737|NCT00423267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100738|NCT00423293|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org
100739|NCT00423319|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
100740|NCT00423332|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
100741|NCT00423358|University of Wisconsin|Karen E Hansen, MD, MS|608-263-3457|keh@medicine.wisc.edu
100742|NCT00423436|UT MD Anderson Cancer Center|Charles S Cleeland, PhD, Professor||asaleeba@mdanderson.org
100743|NCT00423449|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
100744|NCT00423488|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100745|NCT00423579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100746|NCT00423592|Gilead Sciences, Inc.|Annemarie Vance|650-524-3829|Annemarie.Vance@gilead.com
100747|NCT00423605|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Director Clinical Development & Medical Monitor|650-496-3777|
100748|NCT00423657|Cerexa, Inc.|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com
100749|NCT00423670|Merck, Sharp and Dohme|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100750|NCT00423683|North Shore LIJ Health System|Valerie Blake|516-562-0100|vblake@nshs.edu
100751|NCT00423722|UT MD Anderson Cancer Center|Principal investigator: Eduardo Bruera, MD / Professor|713-563-4157|CR_Study_Registration@mdanderson.org
100752|NCT00423735|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org
100753|NCT00423800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100754|NCT00423813|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Medical Monitor & Director of Clinical Development|650-496-3777|
100755|NCT00429663|Boston Medical Center|Paul Tornetta III, MD|617-414-6295|paul.tornetta@bmc.org
100756|NCT00429702|SunCoast CCOP Research Base|SunCoast CCOP Research Base Lead Biostatistician|18009091242|ccop@epi.usf.edu
100758|NCT00429923|Sirion Therapeutics, Inc.|Jeremy Brace|813-496-7325 ext 343|jbrace@siriontherapeutics.com
100759|NCT00429949|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu
100760|NCT00433914|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
100761|NCT00433992|Case Western Reserve University|Dr. Grace McComsey|216-844-2739|mccomsey.grace@clevelandactu.org
100762|NCT00434018|VACO|Dr. Shirley Groer|202-553-9899|Shirley.Groer@va.gov
100763|NCT00434057|Electro-Optical Sciences, Inc.|Joanna Adrian / Director, Clinical Operations and Medical Affairs|(914)591-3783 ext 732|adrian@eosciences.com
100764|NCT00434109|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org
100765|NCT00434122|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
100766|NCT00434148|Novartis Pharmaceuticals|Study Director|862-778-8300|
100767|NCT00434161|Swedish Orphan Biovitrum AB|Medical Director|+4686972000|clinical@sobi.com
100768|NCT00434213|Noven Pharmaceuticals, Inc.|Amaury Sanchez, Sr. Manager, Regulatory Affairs||asanchez@noven.com
100769|NCT00434226|Genentech, Inc.|Medical Communications Specialist|800-821-8590|
100770|NCT00434252|Genentech, Inc.|Medical Communications|800-821-8590|
100771|NCT00434278|Genentech, Inc.|Medical Communications|800-821-8590|
100773|NCT00434330|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com
100774|NCT00434356|Genentech, Inc.|Medical Communications Specialist|800-821-8590|
100775|NCT00434421|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
100776|NCT00434434|Genentech, Inc.|Medical Communications|800-821-8590|
100777|NCT00434590|Novartis Pharmaceuticals|Study Director|862-778-8300|
100778|NCT00434642|Hoffman-LaRoche|Medical Communications|800-821-8590|
100779|NCT00434759|Central Institute of Mental Health, Mannheim, Germany|Prof. Martin Bohus|+49 621 1703 4002|martin.bohus@zi-mannheim.de
100780|NCT00434876|Philadelphia VAMC|Subhajit Chakravorty|215-823-5800 ext 3405|Subhajit.Chakravorty@va.gov
100781|NCT00434954|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
100782|NCT00434967|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
100783|NCT00434993|Acute Respiratory Distress Syndrome (ARDS) Network|David Schoenfeld, ARDSNet CCC PI|617-726-6111|dschoenfeld@partners.org
100784|NCT00435019|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
100785|NCT00435045|GlaxoSmithKline|GSK Response Center|866-435-7343|
100786|NCT00435162|Novartis Pharmaceuticals|Study Director|862-778-8300|
100787|NCT00435188|Durham VA Research and Development|Miriam C. Morey, Ph.D.|919-286-0411 ext 6776|miriam.morey@va.gov
100788|NCT00435370|Baylor College of Medicine|Dr. Thomas R. Kosten|(713) 794-7032|kosten@bcm.edu
100789|NCT00435409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100790|NCT00435487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100791|NCT00435539|ThromboGenics|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com
100792|NCT00435591|Astellas Pharma Global Development|Senior Medial Director, Medical Affairs||clinicaltrials@us.astellas.com
100793|NCT00435825|Hoffman-LaRoche|Medical Communications|800-821-8590|
100794|NCT00435929|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com
100795|NCT00435942|Bolton Medical, Inc.|Annie Weiller|954-838-9699|AWeiller@boltonmedical.com
100796|NCT00435994|Indiana University|Robert Tepper, MD, Ph.D.|317-274-9647|rtepper@iu.edu
100797|NCT00436007|GlaxoSmithKline|GSK Response Center|866-435-7343|
100798|NCT00436046|Baylor College of Medicine|Robert Couch, MD|713-798-4474|rcouch@bcm.tmc.edu
100799|NCT00436163|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
100800|NCT00436215|National Cancer Institute|Dr. Christina Annunziata|301-402-7189|annunzic@mail.nih.gov
100801|NCT00436332|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fhcrc.org
100802|NCT00436345|GlaxoSmithKline|GSK Response Center|866-435-7343|
100803|NCT00426764|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
100804|NCT00426842|James J Peters VAMC|Dr. Jill M. Wecht|718-584-9000 ext 3122|jm.wecht@va.gov
100805|NCT00426855|Kantonsspital Aarau|Dr. Peter Moosmann|+41 62 838 60 51|peter.moosmann@ksa.ch
100806|NCT00427011|Eisai Call Center|Eisai Inc.|888-422-4743|
100807|NCT00427037|Emory University School of Medicine|Vin Tangpricha|404-727-7254|vin.tangpricha@emory.edu
100808|NCT00436436|National Cancer Institute|Dr. Mark Gilbert|301-402-6383|gilbertmr@mail.nih.gov
100809|NCT00436501|UT MD Anderson Cancer Center, Office of Multicenter Clinical Research|Robert Coleman, MD / Professor||CR_Study_Registration@mdanderson.org
100810|NCT00436553|Novartis Pharmaceuticals|Study Director|862 778-8300|
100811|NCT00436566|Mayo Clinic|Dr. Edith A. Perez|507-266-0800|perez.edith@mayo.edu
100812|NCT00436605|Yale University School of Medicine|Harriet Kluger|203-737-2572|Harriet.Kluger@yale.edu
100813|NCT00436618|Mayo Clinic|Thomas E. Witzig M.D.|(507) 284-0527|witzig.thomas@mayo.edu
100814|NCT00436644|Mayo Clinic|Dr. Paul Haluska|507-266-2123|haluska.paul@mayo.edu
100815|NCT00437983|Sourazky Tel-Aviv Medical Center|Prof. A. Korczyn|972-3-6974229|amosk@tasmc.health.gov.il
100816|NCT00438100|The University of Tokyo|Tempei Miyaji|+81-3-5800-9086|tmiyaji@m.u‑tokyo.ac.jp
100817|NCT00438191|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org
100818|NCT00438204|Barbara Ann Karmanos Cancer Institute|Antionette J. Wozniak, M.D., F.A.C.P.|(313)576-8752|wozniakt@karmanos.org
100819|NCT00438360|Novartis Pharmaceuticals|Study Director|862-778-8300|
100820|NCT00438399|Galderma|Farzaneh SIDOU Clinical Project Manager|00 33 4 93 95 70 70 ext 70 51|farzaneh.sidou@galderma.com
100821|NCT00438451|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|C. Ruckes|+49 (0) 6131 17 ext 9919|ruckes@izks-mainz.de
100822|NCT00438464|University of Texas (UT) MD Anderson Cancer Center|Jeri Kim, MD / Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org
100824|NCT00438659|Mayo Clinic|Robert C. Miller, M.D.||miller.robert@mayo.edu
100825|NCT00438672|Massachusetts General Hospital|Dr. David Ring|617-724-3953|dring@partners.org
100826|NCT00438750|Orthopaedic Hand and Upper Extremity Service, Massachusetts General Hospital|David Ring, MD, PhD|617-724-3953|dring@partners.org
100827|NCT00438802|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu
100828|NCT00438815|ViroPharma|Chief Scientific Officer|610-458-7300|
100830|NCT00438880|Mayo Clinic Cancer Center|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu
100831|NCT00438932|University of Miami Miller School of Medicine|Tamara Isakova, MD, MMSc|305-243-4374|tisakova@med.miami.edu
100832|NCT00438971|Rush University|Dr. Mark Pollack|312-942-5372|mark_pollack@rush.edu
100833|NCT00439140|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
100834|NCT00439179|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org
100835|NCT00439218|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com
100838|NCT00439270|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
100839|NCT00439309|Integra LifeSciences|Director, Medical Affairs|609-275-0500|
100840|NCT00439335|Baylor College of Medicine|Shital Patel, MD|713-798-3793|shitalp@bcm.tmc.edu
100841|NCT00439413|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov
100842|NCT00439517|Merck KGaA|Merck KGaA Communication Center|+49-6151-75-5200|service@merckgroup.com
100843|NCT00439569|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com
100844|NCT00439608|BrUOG|Howard Safran, MD|401-863-3000|Hsafran@lifespan.org
100845|NCT00439647|Novartis Pharmaceuticals|Novartis Study Director|862-778-8300|
100846|NCT00439725|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
100847|NCT00439738|Novartis Pharmaceuticals|Study Director|1-862-778-8300|
100848|NCT00439777|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
100849|NCT00439946|United Therapeutics|Remodulin Program Leader|(919) 485-8350|ClinicalRecordsManagement@unither.com
100850|NCT00440011|Allergan, Inc.|Vice President Medical Affairs|(714)246-4500|clinicaltrials@allergan.com
100851|NCT00440050|Oregon Health and Sciences University/Portland VA Medical Center, Portland, Oregon.|Joseph Quinn, MD|503-494-6976|quinnj@ohsu.edu
100852|NCT00440115|Department of Preventive Medicine & Public Health|Edward F. Ellerbeck, MD, MPH, Chair|913-588-2829|eellerbe@kumc.edu
100853|NCT00440180|University of Utah|Marie Gibson|801-213-2845|marie.gibson@hsc.utah.edu
100854|NCT00440193|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
100855|NCT00431444|Novartis Pharmaceuticals|Study Director|862-778-8300|
100856|NCT00431496|Amgen Inc.|Study Director|866-572-6436|
100857|NCT00431626|Northwestern U|Borko D. Jovanovic, MS, PhD|312 503 2008|borko@northwestern.edu
100858|NCT00431834|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com
100859|NCT00431847|Philadelphia Veterans Affairs Medical Center|Rollin M Gallagher, MD, MPH|(215) 823-5800 ext 4907|Rollin.Gallagher@va.gov
100860|NCT00431951|SIGA Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com
100861|NCT00431964|Seattle Children's Hospital|Nicole Hamblett|206-987-5725|tdncc@seattlechildrens.org
100863|NCT00432237|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com
100864|NCT00432276|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
100865|NCT00432341|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com
100866|NCT00432380|GlaxoSmithKline|GSK Response Center|866-435-7343|
100867|NCT00432445|University of Texas (UT) MD Anderson Cancer Center|Dan Gombos, MD/Professor, Ophthalmology|713-792-6920|CR_Study_Registration@mdanderson.org
100868|NCT00432458|Mayo Clinic|Dr. Thomas Witzig||witzig@mayo.edu
100869|NCT00432562|Adventrx Pharmaceuticals|Chief Executive Officer|858-768-6325|culley@adventrx.com
100870|NCT00432601|VA HSRD|Dr. Angela Fagerlin|801-587-1694|angie.fagerlin@hsc.utah.edu
100871|NCT00432666|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503 ext 538|angelika.hanschmann@merz.de
100872|NCT00432744|University of Florida|Dr. Peter W Stacpoole|352-273-9023|pws@ufl.edu
100873|NCT00432809|Cleveland Clinic|Dr. Philip Schauer|216-444-4794|schauep@ccf.org
100874|NCT00432835|University of Mississippi Medical Center|Thomas L. Abell, MD, Professor of Medicine|6019844540|tabell@umc.edu
100875|NCT00432991|Weill Cornell Medicine, Department of Anesthesiology|Michele Steinkamp, Research Nurse Specialist|212-746-2953|mls9004@med.cornell.edu
100876|NCT00433004|University of Pennsylvania|Arden McAllister|215-662-3532 ext 267|arden.mcallister@uphs.upenn.edu
100877|NCT00433017|Novartis Pharmaceuticals|Study Director|862 778-8300|
100878|NCT00433160|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100879|NCT00433199|Abbott|Global Medical Services|800-633-91110|
100880|NCT00433290|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100881|NCT00433329|Actelion Pharmaceuticals, US, Inc.|Rajiv Patni/Medical Officer|(650) 624-6900|
100882|NCT00433381|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org
100883|NCT00433446|SWOG Statistical Center|Study Statistician|206-667-4623|
100884|NCT00433537|ECOG Statistical Office|Study Statistician|617-632-3012|
100885|NCT00433550|Mayo Clinic|Robert R. McWilliams, M.D.||mcwilliams.robert@mayo.edu
100886|NCT00433654|Medtronic, Inc|EnRhythm MRI Clinical Research Specialist|800-328-2518 ext 62813|medtronicCRMtrials@medtronic.com
100887|NCT00433745|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov
100888|NCT00433771|Boston Scientific Corporation|Jeremy Bolt|508-683-4006|boltj@bsci.com
100889|NCT00433836|Novartis Pharmaceuticals|Study Director|862-778-8300|
100890|NCT00440232|Jefferson Headache Center/Thomas Jefferson University|Stephen D. Silberstein, M.D.|215-955-2243|stephen.silberstein@jefferson.edu
100891|NCT00440271|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
100892|NCT00440297|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
100893|NCT00440310|Light Sciences Oncology, Inc.|Vice President of Regulatory Affairs and Clinical Operations|425-957-8986|lisak@lsoncology.com
100894|NCT00440401|Medical Scientific Strategy|Medical Responsible|+45 4677 1111|clinicaltrials@nycomed.com
100895|NCT00440466|J&J PRD|Peter Bowers|908-927-2116|
100896|NCT00440505|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu
100897|NCT00440518|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493|
100898|NCT00440531|Merck Sharp & Dohme Corp|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
100899|NCT00441441|GlaxoSmithKline|GSK Response Center|866-435-7343|
100900|NCT00441467|Eleison Pharmaceuticals|VP Clinical Development|6097211227|matthew.parris@eleison-pharma.com
100901|NCT00441480|The Institute for Lipid and Atherosclerosis Research and Internal Medicine C, Sheba Medical Center, Tel Hashomer|Prof. Dror Harats|972-3-5302940|dror@vbl.co.il
100902|NCT00441545|Shire|Timothy Whitaker, MD||twhitaker@shire.com
100903|NCT00441558|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com
100904|NCT00441584|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100905|NCT00441701|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
100906|NCT00441727|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
100907|NCT00441766|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
100908|NCT00441792|Advocate Christ Medical Center|Erik Kulstad, MD, MS|7086843889|kulstad@uic.edu
100909|NCT00441974|GlaxoSmithKline|GSK Response Center|866-435-7343|
100910|NCT00442013|Johns Hopkins University|Janet Holbrook|443-287-3170|ala-acrc@jhsph.edu
100911|NCT00442117|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclcosure@merck.com
100912|NCT00442169|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
100913|NCT00442286|CVRx|Vice President of Clinical Research|763-416-2876|lgalle@cvrx.com
100914|NCT00442338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
100915|NCT00442351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
100916|NCT00442364|BTG International Inc|David DI Wright MB BS|610-278-1660|david.wright@btgplc.com
100917|NCT00442416|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
100918|NCT00442468|GlaxoSmithKline|GSK Response Center|866-435-7343|
100919|NCT00442507|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5740|dmorgens@dom.wustl.edu
100920|NCT00442546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100921|NCT00442559|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
100922|NCT00442572|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
100923|NCT00442598|Eleison Pharmaceuticals|VP Clinical Development|6097211227|matthew.parris@eleison-pharma.com
119180|NCT02446990|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com
100925|NCT00442689|Northwestern University|Dr. Laura Torchen|312-227-6492|ltorchen@luriechildrens.org
100926|NCT00442702|Hoffman-LaRoche|Medical Communications|800-821-8590|
100927|NCT00442897|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
100928|NCT00442936|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
100929|NCT00442962|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
100930|NCT00443040|Tioga Pharmaceuticals|Dr. Allen Mangel, Chief Medical Officer|919-485-5668|mangel@tiogapharma.com
100931|NCT00443053|GlaxoSmithKline|GSK Response Center|866-435-7343|
100932|NCT00443118|FUNDASAMIN-Fundacion para la Salud Materno Infantil|Edgardo Szyld MD, MSc|5491144093095|eszyld@gmail.com
100933|NCT00443209|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
100934|NCT00443261|University of Kansas Cancer Center|Dr. Stephen Williamson|9139455059|swilliam@kumc.edu
100935|NCT00443352|Thomas Jefferson University|William B Young, MD|215-955-2243|william.b.young@jefferson.edu
100936|NCT00443430|University of Washington and Seattle Children's Hospital|Carol Wallace, MD Principal Investigator|206-987-2057|cwallace@u.washington.edu
100937|NCT00443456|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100938|NCT00443534|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100939|NCT00443560|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy, PharmD|312-926-9015|r-mccarthy@northwestern.edu
100940|NCT00443599|Boston Children's Hospital|Dr. Michael Agus|617-355-5849|michael.agus@childrens.harvard.edu
100941|NCT00443651|Genentech, Inc.|Medical Communications|800-821-8590|
100942|NCT00443703|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
100943|NCT00443729|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
100944|NCT00443755|Mayo Clinic|K. Sreekumaran Nair, MD, Ph.D.|507-255-3605|nair@mayo.edu
121223|NCT02420262|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com
100946|NCT00443820|Novartis Pharmaceuticals|Study Director|862-778-8300|
100947|NCT00430027|University of Colorado, Denver|Dr. Tracey Schefter|720-848-0100|Tracey.Schefter@ucdenver.edu
100948|NCT00430092|Sirion Therapeutics, Inc.|Jeremy Brace|813-496-7325 ext 343|jbrace@siriontherapeutics.com
100949|NCT00430248|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com
100950|NCT00430300|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100951|NCT00430352|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
100952|NCT00430495|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
100953|NCT00430508|Daiichi Sankyo|James McCarthy / Director Regulatory Operations|732-590-3430|jmccarthy@dsus.com
100954|NCT00430625|Shire Human Genetic Therapies (Shire HGT)|Tiffany Crump|484-595-8850|tcrump@shire.com
100955|NCT00430638|Daiichi Sankyo|John J. Raia, R.Ph., Pharm.D.|1-877-437-7763|druginfo@dsus.com
100956|NCT00430677|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
100957|NCT00430716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100958|NCT00430755|Robert-Bosch-Hospital|Prof. Dr. Mark Dominik Alscher|+4971181013496|dominik.alscher@rbk.de
100959|NCT00430768|UMASS Medical School|Dr. Terry Flotte|(508) 856-2107|Terry.Flotte@umassmed.edu
100960|NCT00430781|GlaxoSmithKline|GSK Response Center|866-435-7343|
100961|NCT00430937|Novartis Pharmaceuticals|Study Director|862-778-8300|
119181|NCT02441218|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com
100963|NCT00431041|Astellas Pharma Global Development|Astellas Medical Monitor||ClinicalTrials@us.astellas.com
100964|NCT00431067|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
100965|NCT00431132|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
100966|NCT00431184|McLean Hospital|Beth Murphy MD|617-855-2297|BMurphy5@partners.org
100967|NCT00436748|Amgen Inc.|Study Director|866-572-6436|
100968|NCT00436826|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
100969|NCT00436852|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
100970|NCT00436904|Mayo Clinic|Dr. Clive Zent|507-284-5362|zent.clive@mayo.edu
100971|NCT00436917|Mayo Clinic Jacksonville|Stephanie L. Hines, M.D.|507-266-0800|hines.stephanie@mayo.edu
100972|NCT00436956|National Cancer Institute|William L. Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov
100974|NCT00436982|Department of Orthopedics Hässleholm Hospital Organization|Sören Toksvig-Larsen, M.D., Ph.D., Ass. Professor|+46 (0) 451 29 64 70|ortopeden.hlm@skane.se
100975|NCT00437034|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org
100976|NCT00437073|GlaxoSmithKline|GSK Response Center|866-435-7343|
100977|NCT00437125|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100978|NCT00437203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100979|NCT00437281|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100980|NCT00437398|Mayo Clinic|Dr. Yogish Kudva|507-284-3964|kudva.yogish@mayo.edu
100981|NCT00437489|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
100982|NCT00437645|Novartis Pharmaceuticals|Study Director|862 778-8300|
100983|NCT00443872|University of Kansas Medical Center|Dr. Kelly Lyons|9135887159|klyons@kumc.edu
100984|NCT00443898|Novartis Pharmaceuticals|Study Director|862-778-8300|
100985|NCT00444067|Integra LifeSciences|Director, Medical Affairs|609-275-0500|
100986|NCT00444106|Novartis Pharmaceuticals|Study Director|862-778-8300|
100987|NCT00444145|Vanderbilt University|Dr. Michael Vaezi|615-322-3739|tina.higginbotham@vanderbilt.edu
100988|NCT00446849|Shire Pharmaceutical|Timothy Whitaker, M.D.||twhitaker@shire.com
100989|NCT00446992|University of Nevada School of Medicine|Dr. Brian Kirkpatrick|775-682-8459|bkirkpatrick@medicine.nevada.edu
100990|NCT00447005|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
100991|NCT00447057|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100992|NCT00447122|BrUOG|Howard Safran, MD|4018633000|kayla_rosati@brown.edu
100993|NCT00447226|GlaxoSmithKline|GSK Response Center|866-435-7343|
100994|NCT00447265|DAIT/NIAID|Associate Director for Clinical Research|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
100995|NCT00447278|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100996|NCT00447330|Duke University Medical Center|Brant Hamel|919-668-1861|brant.hamel@duke.edu
100997|NCT00447382|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
100998|NCT00447421|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
100999|NCT00447499|Ipsen|Bert Bakker, MD, PhD.|+1 650 238 1669|bert.bakker@ipsen.com
101000|NCT00447590|Apollo Endosurgery|Laura Eaton, R.N., BSN, CCRN-R|949-468-9301|laura.eaton@apolloendo.com
101001|NCT00447603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101002|NCT00447876|Ipsen|Medical Director||clinical.trials@ipsen.com
101003|NCT00447902|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
101004|NCT00448019|The University of Texas (UT) MD Anderson Cancer Center|MD Anderson Cancer Center Leukemia Department|713-792-7734|CR_Study_Registration@mdanderson.org
101005|NCT00448123|William Beaumont Hospital|Robert Swor, DO|248-89-81970|raswor@beaumont.edu
101006|NCT00448136|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
101007|NCT00448175|Uroplasty, Inc|Clinical Study Manager|952-426-6153|megan.otoole@uroplasty.com
101008|NCT00448201|UNC Lineberger Comprehensive Cancer Center|Dr. Thomas Shea|919-966-7746|tom_shea@med.unc.edu
101009|NCT00448227|Novartis Pharmaceuticals|Study Director|862-778-8300|
101010|NCT00448279|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
101011|NCT00448344|VA Connecticut|Dr. Lori Bastian|860-667-6853|lori.bastian@va.gov
101012|NCT00448357|UNC Lineberger Comprehensive Cancer Center|Dr. Thomas Shea|919-966-7746|tom_shea@med.unc.edu
101013|NCT00448435|GlaxoSmithKline|GSK Response Center|866-435-7343|
101014|NCT00448448|University of Iowa Dept of Orthopaedics and Rehabilitation|Dr. Lori A. Dolan|319-356-1075|lori-dolan@uiowa.edu
101015|NCT00448539|Eisai Call Center|Eisai Inc.|888-422-4743|
101016|NCT00448591|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
101017|NCT00448630|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
101018|NCT00448682|University of Miami Sylvester Comprehensive Cancer Center|Bach Ardalan MD|305-243-6608|bardalan@med.miami.edu
101019|NCT00448708|Angiotech Pharmaceuticals|Dr. Trudy Estridge|604-221-7676|testridge@angio.com
101020|NCT00448760|UM/Sylvester Comprehensive Cancer Center|Bach Ardalan MD, Professor|305-243-4909|bardalan@med.miami.edu
101021|NCT00448864|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660|
101022|NCT00448916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101023|NCT00449033|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
101024|NCT00449046|GlaxoSmithKline|GSK Response Center|866-435-7343|
101025|NCT00449072|sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com
101026|NCT00449150|AEterna Zentaris|Daniel Croteau, Medical Manager|418-652-7669 ext 272|DCroteau@aezsinc.com
101027|NCT00449163|UM/Sylvester Comprehensive Cancer Center|Bach Ardalan MD|305-243-4909|bardalan@med.miami.edu
101028|NCT00449176|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537|
101029|NCT00440557|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Sr Director of Clinical Research|908-927-2116|
101030|NCT00440700|University of Minnesota|Dr. Linda Chlan|612-624-6658|chlan001@umn.edu
101031|NCT00440830|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu
101032|NCT00440947|ViiV Healthcare|GSK Response Center|866-435-7343|
101033|NCT00441012|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101034|NCT00441064|Novartis Pharmaceuticals|Study Director|862-778-8300|
101035|NCT00441103|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
101036|NCT00441116|GlaxoSmithKline|GSK Response Center|866-435-7343|
101038|NCT00441168|Jan-Cilag Germany|EMEA Medical Affairs Director Oncology|+49 2137 955-492|rangermu@its.jnj.com
101039|NCT00441259|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
101040|NCT00441272|National Institute of Allergy and Infectious Diseases|Colleen Hadigan, MD, MPH|301-594-5754|hadiganc@niaid.nih.gov
101041|NCT00441285|Universidad Peruana Cayetano Heredia|Hector H. Garcia, MD, PhD|+511 3287360|hgarcia@jhsph.edu
101042|NCT00441337|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
101043|NCT00441363|VeroScience|Donna Cowan|401 816-0525|donna_cowan@veroscience.com
101044|NCT00449540|Neuralieve|Cynthia Merrell|408-245-6400|cmerrell@neuralieve.com
101045|NCT00449644|Janssen Infectious Diseases – Diagnostics BVBA|Medical Leader|1 609 730-7768|
101046|NCT00449696|Seikagaku Corporation|Clinical Development Dept.|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp
101047|NCT00452673|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
101048|NCT00452699|GlaxoSmithKline|GSK Response Center|866-435-7343|
101049|NCT00452790|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101050|NCT00452868|Wake Forest Baptist Health|Dr. Janet Tooze|336-716-0286|jtooze@wakehealth.edu
101051|NCT00453063|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
101052|NCT00453102|University of Miami|Izidore S. Lossos|305-243-4785|ilossos@med.miami.edu
101053|NCT00453154|Duke University Medical Center|Dr. Neal Ready||ready001@mc.duke.edu
101055|NCT00453193|The University of Texas M D Anderson Cancer Center|Farhad Ravandi-Kashani MD/Associate Professor|713-745-0394|eharriso@mdanderson.org
101056|NCT00453206|Wake Forest University Health Sciences|David Hurd, MD|336-716-2843|dhurd@wakehealth.edu
101057|NCT00453310|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org
101058|NCT00453336|University of Miami Sylvester Comprehensive Cancer Center|Francisco Civantos MD|305-243-5276|fcivanto@med.miami.edu
101059|NCT00453349|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
101060|NCT00453362|Hoffman-LaRoche|Medical Communications|800-821-8590|
101061|NCT00453388|Fred Hutchinson Cancer Research Center|Dr. Hans-Peter Kiem|206-667-4425|hkiem@fredhutch.org
101062|NCT00453973|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com
101063|NCT00453986|GlaxoSmithKline|GSK Response Center|866-435-7343|
101064|NCT00453999|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302|
101065|NCT00454051|Novartis Pharmaceuticals|Study Director|862-778-8300|
101066|NCT00454116|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
101067|NCT00454142|National Cancer Centre Singapore|Dr. Wan Teck LIM|65-64368174|dmolwt@nccs.com.sg
101068|NCT00454181|Amarillo Biosciences, Inc.|Martin J. Cummins|806-376-1741 ext 14|mcummins@amarbio.com
101069|NCT00454194|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|507-284-9265|alex.adjei@roswellpark.org
101070|NCT00454207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
101071|NCT00454246|Hoffman-LaRoche|Medical Communications|800-821-8590|
101072|NCT00454324|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
101073|NCT00454363|University of Texas (UT) MD Anderson Cancer Center, Coordinating Center|James Yao, MD/Professor, GI Medical Oncology, Study Principal Investigator|713-792-2828|CR_Study_Registration@mdanderson.org
101074|NCT00454532|Bionovo|Mary Tagliaferri, MD|5106012000|clinicaltrials@bionovo.com
101075|NCT00454571|The University of Chicago|Walter M. Stadler, MD|(773) 702-6149|wstadler@medicine.bsd.uchicago.edu
101076|NCT00454584|Centocor Research & Development, Inc.|Senior Director, Compound Development Team Leader|1 215-793-7612|
101077|NCT00454636|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
101078|NCT00454649|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101079|NCT00454779|Amgen Inc.|Study Director|866-572-6436|
101080|NCT00454805|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
101081|NCT00454818|Celladon Corporation|Jeffrey J. Rudy, Vice President|1 858-366-4288|jrudy@celladon.net
101082|NCT00454857|Amgen Inc.|Study Director|866-572-6436|
101086|NCT00444457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101087|NCT00444535|Novartis Pharmaceuticals|Clinical Disclosure Office|8620778-8300|
101088|NCT00444587|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
101089|NCT00444600|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrnet@jaeb.org
101090|NCT00444626|Genzyme|Genzyme Medical Information (MedInfo)||medinfo@genzyme.com
101091|NCT00444795|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@Pfizer.com
101092|NCT00444912|Genzyme|Medical Information||medinfo@genzyme.com
101093|NCT00444925|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
101094|NCT00444951|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
101096|NCT00445146|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@Gilead.com
101097|NCT00445211|William Beaumont Hospital|Dr. Justin Trivax|(248)587-2300|Justin.Trivax@beaumont.edu
101098|NCT00445224|University of Kentucky|Dr. Tim L. Uhl Principal Investigator|859-323-1100 ext 80858|tluhl2@uky.edu
101099|NCT00445263|SAMU 93|Pr Frédéric Lapostolle|0033148964454|frederic.lapostolle@avc.aphp.fr
101100|NCT00445302|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447|
101101|NCT00445315|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101102|NCT00445328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
101103|NCT00445341|National Cancer Institute, National Institutes of Health|Kieron Dunleavy, M.D.|301-435-1007|DunleavK@mail.nih.gov
101104|NCT00445432|Abbott|Global Medical Services|800-633-9110|
101105|NCT00445484|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivan Borrello|(410) 955-4967|iborrell@jhmi.edu
101106|NCT00445549|National Cancer Institute, National Institutes of Health|Elise C. Kohn, M.D.|301-496-4916|kohne@mail.nih.gov
101107|NCT00445588|Adult Brain Tumor Consortium|David Peereboom, MD|216-445-6068|peerebd@ccf.org
101108|NCT00445679|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
101109|NCT00445705|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
101110|NCT00445770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101112|NCT00445939|Abbott|Global Medical Services|800-633-9110|
101113|NCT00446030|sanofi-aventis|Trial Transparency Team||Contact-us@sanofi-aventis.com
101114|NCT00446095|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com
101115|NCT00446134|Valeant Pharmaceuticals International, Inc.|Senior Director Clinical Development|908-927-1782|ralph.doyle@valeant.com
101116|NCT00446147|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr
101117|NCT00446199|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
101118|NCT00446251|University of Washington|Dr. Connie L. Davis|206-598-6079|cdavis@u.washington.edu
101119|NCT00446264|University of Lille|Violeta Raverdy|00 33 3 20 62 34 30|vraverdi@univ-lille2.fr
101120|NCT00446290|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr
101121|NCT00446446|Amgen Inc.|Study Director|866-572-6436|
101122|NCT00446459|University of Washington|Dr. Connie L. Davis|206-598-7162|cdavis@u.washington.edu
101123|NCT00446511|Novartis Pharmaceuticals|Study Director|862-778-8300|
101124|NCT00446563|Novartis Pharmaceuticals|Study Director|862-778-8300|
101125|NCT00446641|Asan Medical Center, University of Ulsan College of Medicine|Professor Sun U. Kwon|82-2-3010-3960|sukwon@amc.seoul.kr
101126|NCT00446654|Progen Pharmacauticals Ltd|Director of Clinical Trials|+61 7 32739133|
101127|NCT00446797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
101128|NCT00455195|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
101130|NCT00455429|Janssen Research and Development, 3210 Merryfield Row San Diego, CA 92121|William Barchuk, M.D.|858-784-3111|
101131|NCT00455455|CCLR|Dr Craig A Woods|519 888 4567 ext 36547|cawoods@uwaterloo.ca
101132|NCT00455650|Massachusetts General Hospital|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu
101133|NCT00455663|UTHSCSA|Dawn I. Velligan|210-567-5508|velligand@uthscsa.edu
101134|NCT00455702|Massachusetts General Hopsital|Donald C Goff|617-912-7899|goff@psych.mgh.harvard.edu
101135|NCT00455858|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
101136|NCT00455962|Massachusetts General Hospital|Janet E. Hall, MD|617-877-1112|jehall@partners.org
101137|NCT00455975|Sarah Cannon Research Institute|John Hainsworth MD|1-877-691-7274|asksarah@scresearch.net
101138|NCT00456014|Stony Brook University School of Medicine|Ramin V. Parsey, MD, PhD|631-444-3084|Ramin.Parsey@stonybrookmedicine.edu
101139|NCT00456261|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
101140|NCT00456495|The New York Eye Cancer Center|Clinic Coordinator|212-832-8170|kchin@eyecancer.com
101141|NCT00456508|Shire Development LLC|Study Physician|+1 866 842 5335|
101142|NCT00456521|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|Medinfo@Orexigen.com
101143|NCT00456547|Northwestern University Feinberg School of Medicine|Dr. Robert J McCarthy, Pharm D|312-926-9015|r-mccarthy@northwestern.edu
101144|NCT00456599|University of Michigan|Mark Zalupski, MD|734-615-3969|zalupski@med.umich.edu
101145|NCT00456612|Beth Israel Deaconess Medical Center|Anand Mahadevan, MD|617-667-2345|amahadev@bidmc.harvard.edu
101147|NCT00456755|Department of Otorhinolaryngology, Head & Neck Surgery, West China Hospital, Sichuan University, China|Zhao Yu||yutzhao@gmail.com
101148|NCT00456807|GlaxoSmithKline|GSK Response Center|866-435-7343|
101149|NCT00456846|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com
101150|NCT00456885|BIDMC|Jody Dushay|6177353343 ext 617|jdushay@bidmc.harvard.edu
101151|NCT00456989|University of Louisville|Dr. Damian Laber|502-562-4369|damian.laber@louisville.edu
101152|NCT00457002|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
101153|NCT00457015|Shire Development LLC|Study Physician|+1 866 842 5335|
101155|NCT00457249|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
101156|NCT00457301|Lung transplant program, University of Alberta Hospital|Maria Jose Santana|780-441-1661|msantana@ualberta.ca
101157|NCT00457392|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101158|NCT00457418|Merck Sharp & Dohme Corp.|Senior Vice President,Global CLinical Development||ClinicalTrialsDisclosure@merck.com
101159|NCT00457691|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101160|NCT00457730|MS Center at Evergreenhealth Care|Theodore R. Brown, MD Principle Investigator|425-899-5350|trbrown@evergreenhealth.com
101161|NCT00457743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
101162|NCT00457795|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com
101163|NCT00457821|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com
101164|NCT00457951|Cantex|Claude Bertrand|954-315-3660|cbertrand@cantex.com
101165|NCT00457977|University of Minnesota|Sarah Harnden|612-626-9011|sharnden@ccbr.umn.edu
101166|NCT00444275|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
101167|NCT00449748|The University of Texas M. D. Anderson Cancer Cent|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org
101168|NCT00449787|Montefiore Medical Center|Benjamin Friedman|718-920-6626|bwfriedmanmd@gmail.com
101169|NCT00449865|University of Rochester|Karl Kieburtz, Director of CTSI|585-275-0553|Karl.kieburtz@chet.rochester.edu
101170|NCT00449930|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
101171|NCT00449956|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
101172|NCT00450112|Seikagaku Corporation|Clinical Development Dept.|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp
101173|NCT00450216|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com
101174|NCT00450242|University of North Carolina, Dept. of Obstetrics and Gynecology|Denniz Zolnoun, MD, MPH|919-966-7764|denniz_zolnoun@med.unc.edu
101175|NCT00450255|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
101176|NCT00450294|Department of Anesthesia|Dr. Amit Chopra|204-880-5370|amitchopra1@live.com
101177|NCT00450333|Shire Pharmaceuticals|Timothy Whitaker, MD||twhitaker@shire.com
101178|NCT00450372|UM/Sylvester Comprehensive Cancer Center|Lynn Feun MD|305-243-4909|lfeun@med.miami.edu
101179|NCT00450385|University of Miami|Izidore Lossos MD|305-243-4785|ilossos@med.miami.edu
101180|NCT00450424|Fox Chase Cancer Center|Kristen Sorice|215-214-1433|Kristen.Sorice@fccc.edu
101181|NCT00450437|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com
101182|NCT00450450|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
101183|NCT00450580|GlaxoSmithKline|GSK Response Center|866-435-7343|
101184|NCT00450619|National Cancer Institute, National Institutes of Health|Dr. James Gulley, M.D.|301-435-2956|gulleyj@mail.nih.gov
101185|NCT00450658|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com
101186|NCT00450723|UM/Sylvester Comprehensive Cancer Center|Eli Avisar MD|305-243-4902|eavisar@med.miami.edu
101187|NCT00450749|University of Texas MD Anderson Phase I/II Prevention Consortium|Powel H Brown, MD, PhD/Professor of Medicine and Cancer Prevention||CR_Study_Registration@mdanderson.org
101188|NCT00450801|University of Miami|Izidore Lossos MD|305-243-4785|ilossos@med.miami.edu
101189|NCT00450866|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org
101190|NCT00450983|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org
101191|NCT00451048|Princess Margaret Hospital|Dr. Karen Yee|416-946-4495|karen.yee2@uhn.on.ca
101192|NCT00451191|George Washington University Biostatistics Center|Kathryn Hirst, PhD, Research Professor, PI of coordinating center|301-881-9260 ext 8025|khirst@bsc.gwu.edu
101193|NCT00451204|University of California Los Angeles|Dr. Rhonda Voskuhl|310-206-4636|rvoskuhl@mednet.ucla.edu
101194|NCT00451282|Children's Hospital of Philadelphia|Nancy Kassam-Adams|215-590-3118|nlkaphd@mail.med.upenn.edu
101195|NCT00451451|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com
101196|NCT00451698|Medical College of Wisconsin|Dr. Steven Zangwill|414-266-2380|szangwill@chw.org
101197|NCT00451906|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
101198|NCT00451958|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
101199|NCT00452114|University of Massachusetts Medical School|Stephen Krinzman, Principal Investigator|508-856-1975|stephen.krinzman@umassmed.edu
101201|NCT00452348|GlaxoSmithKline|GSK Response Center|866-435-7343|
101202|NCT00452361|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
101203|NCT00452374|The University of Texas M. D. Anderson Cancer Center|William Wierda, M.D./Associate Professor|713-745-0428|eharriso@mdanderson.org
119188|NCT02277743|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com
101204|NCT00452387|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com
101205|NCT00452400|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
101206|NCT00452426|Ethicon Endo-Surgery|James Martin, PhD|513 337-7000|
101207|NCT00452452|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
101208|NCT00452530|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
101209|NCT00452543|Massachusetts General Hospital|Dr. Janet Witte|617-726-5104|jwitte@partners.org
101210|NCT00458211|Bronx Psychiatric Center|Nigel Bark MD|718 862 5429|Nigel.Bark@omh.ny.gov
101211|NCT00458237|Beth Israel Deaconess Medical Center|Gerburg Wulf|(617) 667-1910|gwulf@bidmc.harvard.edu
101212|NCT00458302|Jan-Cilag Germany|EMEA Medical Affairs Director Virology|+49 7624 907580|
101213|NCT00458406|CTRC, Children's Hospital of Philadelphia|Paul R. Gallagher, MA|215-590-2739|gallagherp@email.chop.edu
101214|NCT00463437|GlaxoSmithKline|GSK Response Center|866-435-7343|
101215|NCT00463567|Novartis Pharmaceuticals|Study Director|862-778-8300|
119189|NCT02274688|University of Washington|Douglas Zatzick|2067446701|dzatzick@uw.edu
101217|NCT00463606|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
101218|NCT00463788|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
101219|NCT00463801|Novartis Pharmaceuticals|Study Director|862-778-8300|
101221|NCT00463866|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
101222|NCT00464087|Medstar Health Research Institute|Ron Waksman, MD|202-877-2812|ron.waksman@medstar.net
101223|NCT00464204|Fresenius Kabi Aktiengesellschaft|Professor Dr. Martin Westphal|+49 6172 686 ext 7280|martin.westphal@fresenius-kabi.com
101224|NCT00464269|UCB|Clinical Trial Call Center|+1 877 822 9493|
101225|NCT00464308|Janssen-Cilag Pty Ltd|Executive Director, Medical & Scientific Affairs|+61 2 9815 3219|mhandel@its.jnj.com
101226|NCT00464334|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101227|NCT00464438|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com
101228|NCT00464464|Rutgers- Robert Wood Johnson Medical School|Dr. Roseanne Dobkin|732-235-4051|dobkinro@rutgers.edu
101229|NCT00464490|University of California San Francisco|Julin F. Tang, MD, MS|415-206-5274|tangj@anesthesia.ucsf.edu
101230|NCT00464542|University of Pittsburgh|Thomas Cherpes|412 692 5930|cherpestl@upmc.edu
101232|NCT00464646|NSABP Foundation, Inc.|Diana Gosik|412-339-5333|diana.gosik@nsabp.org
101233|NCT00464672|Novartis Vaccines and Diagnostics|Novartis Vaccines and Diagnostics||RegContactVacUS.nvdit@Novartis.com
101234|NCT00464685|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
101235|NCT00464698|Massachusetts General Hospital|Darin D. Dougherty, MD|617-724-6300|ddougherty@partners.org
101236|NCT00464711|Massachusetts General Hospital|Dr. Dan Iosifescu||diosifescu@partners.org
101237|NCT00464737|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
101238|NCT00464945|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
101239|NCT00465088|Abbott|Global Medical Services|800-633-9110|
101240|NCT00465101|American Medical Systems|Mara M. LaRock, Senior Manager, Clinical Franchise Lead|952-930-6000|mara.larock@bsci.com
101241|NCT00465179|The University of Texas (UT) MD Anderson Cancer Center|Nizar M Tannir, MD, Professor, Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org
101242|NCT00465361|Children's Mercy Hospitals and Clinics|Sarah S. Nyp|816-234-3000|ssnyp@cmh.edu
101243|NCT00465530|University of Kansas Medical Center|Dr. Julie Wei|(913) 588-6664|jwei@kumc.edu
101244|NCT00465569|Johns Hopkins University|Robert A. Wood, MD|410-955-5883|rwood@jhmi.edu
119191|NCT02159365|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
101246|NCT00465738|Merz Pharmaceuticals GmbH|Claus Goebel, MD|+49-69-1503-6461|claus.goebel@merz.de
101247|NCT00465816|GlaxoSmithKline|GSK Response Center|866-435-7343|
101249|NCT00450073|Emory University|Vin Tangpricha|4047277254|vin.tangpricha@emory.edu
101250|NCT00455520|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Leader|609-730-4537|
101251|NCT00455533|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
101252|NCT00465972|Duke University School of Medicine|Andrew Krystal, MD, MS, Professor of Psychiatry and Behavioral Sciences|919-681-8742|andrew.krystal@duke.edu
101253|NCT00465985|Novartis Pharmaceuticals|Study Director|862-778-8300|
101254|NCT00465998|Stavanger University Hospital|Professor Torbjørn Moe Eggebø|+4792699433|tme@lyse.net
101255|NCT00466167|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
101256|NCT00466193|Purdue Pharma LP|Clinical Leader|800-733-1333|
101257|NCT00466206|UCSF-Benioff Children's Hospital|Michael Harrison, MD|415 476-2538|pedsurg@ucsfmedctr.org
101258|NCT00466947|GlaxoSmithKline|GSK Response Center|866-435-7343|
101259|NCT00466960|Seattle Cancer Care Alliance|Barbara Goff|206-543-3668|bgoff@u.washington.edu
101260|NCT00467038|James J Peters VAMC|Marianne Goodman, MD|718-584-9000 ext 5188|marianne.goodman@va.gov
101262|NCT00467077|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
101263|NCT00467259|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
101264|NCT00467285|Samuel Stratton VAMC|Dr. Subhashini Yaturu|518-626-5642|Subhashini.Yaturu@va.gov
101265|NCT00467363|NICHD|Dr Enrique Schisterman|(301) 435-6893|schistee@mail.nih.gov
101325|NCT00459732|Children's Hospital & Research Center, Oakland|Ellen Fung, PhD RD CCD|510-428-3885 ext 4939|efung@mail.cho.org
101266|NCT00467389|Substance Abuse Research Laboratory, Kansas City VA Medical Center|Kenneth Grasing|(816) 922-2756|kenneth.grasing@va.gov
101267|NCT00467519|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
101268|NCT00467558|University of Minnesota|Jon E. Grant, MD|612-273-9736|grant045@umn.edu
101269|NCT00467584|Mayo Clinic|Dr. Dean M. Wingerchuk|480-301-6328|wingerchuk.dean@mayo.edu
101270|NCT00467597|Portland VA Health Care System (PORVAHCS)|Kathryn Chung, MD|503.220.8262 ext 51091|CHUNGKA@OHSU.EDU
101271|NCT00467610|Rush university medical center|Jamile shammo|312-942-5157|jamile_shammo@rush.edu
101272|NCT00467649|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
101273|NCT00467740|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
101274|NCT00467753|UMDNJ|Sherie Novotny, MD|(732) @35-4119|novotnsl@rutgers.edu
101275|NCT00467779|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
101276|NCT00467831|NHGRI/NIH|Dr. Thomas Markello|301-451-1305|markellot@mail.nih.gov
101277|NCT00467844|GTx Inc.|Senior Director, Clinical Operations|901-523-9700|mdesordi@gtxinc.com
101278|NCT00467857|Kimberly-Clark Health Care|Dr. Shu-Ping Yang|770-587-7267|Shu-Ping.Yang@kcc.com
101279|NCT00467870|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
101280|NCT00467896|Actelion Pharmaceuticals, US, Inc.|Wade Benton, Pharm D / Director, Medical Affairs Veletri and Ventavis|(650) 624-6900|wade.benton@actelion.com
101281|NCT00467961|NIH NHLBI|Minocher Battiwalla, MD|301-827-0939|minoo.battiwalla@mail.nih.gov
101282|NCT00468052|UMDNJ|Anuradha Patel, MD|973 972-5254|patelan@umdnj.edu
101283|NCT00468104|Midwest Pulmonary and critical care|George Thommi|402 206 7372|tommi4@cox.et
101284|NCT00468143|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org
101285|NCT00468208|Vasculitis Clinical Research Consortium|Carol A Langford, MD MHS|216-445-6056|langfoc@ccf.org
101286|NCT00468286|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
101287|NCT00468299|University of Rochester|Dr. Sarah Betstadt|585-276-5368|sarah_betstadt@urmc.rochester.edu
101288|NCT00468312|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
101289|NCT00468481|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
101290|NCT00468546|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
101291|NCT00468559|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
101292|NCT00468585|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-4558|trainat@mskcc.org
101293|NCT00468650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
101294|NCT00468676|Dept Psychiatry, University of Washington Medical School|Dr Wayne Katon, Professor and Vice Chair|206-543-7177|wkaton@uw.edu
101295|NCT00468728|Optimer Pharmaceuticals, Inc.|Chief Scientific Officer|1-855-343-4243|medinfo@optimerpharma.com
101296|NCT00468819|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
101297|NCT00468845|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101298|NCT00468858|GSK|Faina Rose, PhD|610-664-8986|faina.v.rose@gsk.com
101299|NCT00468910|Northwestern University|Dr. Seema Khan|312-503- 4236|skhan@nm.org
101300|NCT00469079|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu
101301|NCT00469092|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
101302|NCT00469209|University of Texas M.D. Anderson Cancer Center|Muzaffar H. Qazilbash, MD|713-745-3458|CR_Study_Registration@mdanderson.org
101303|NCT00469274|Vanderbilt University Medical Center|Dr. Thomas R. Talbot|615-322-2789|tom.talbot@vanderbilt.edu
101304|NCT00469391|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com
101305|NCT00458536|Beth Israel Deaconess Medical Center|David Avigan, MD|617-667-9920|davigan@bidmc.harvard.edu
101306|NCT00458705|Memorial Sloan Kettering Cancer Center|Dr. Heather Landau|212-639-8808|landauh@mskcc.org
101307|NCT00458822|Memorial Sloan Kettering Cancer Center|Dr. Heather Landau|212-639-8808|LandauH@mskcc.org
101308|NCT00458952|Progenics Pharmaceuticals, Inc.|Senior Director, Clinical Science Communications|914 784-1825|vdipippo@progenics.com
101309|NCT00459043|DFCI|Robert Haddad|6176326725|robert_haddad@dfci.harvard.edu
101310|NCT00459056|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu
101311|NCT00459108|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
101313|NCT00459134|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu
101314|NCT00459186|Dana-Farber Cancer Institute|Dr. Mary-Ellen Taplin|617-632-3237|Mary_Taplin@dfci.harvard.edu
101315|NCT00459290|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org
101316|NCT00459303|National Taiwan University Hospital|Fung-Rong Hu|+886223123456 ext 2131|fungronghu@ntuh.gov.tw
101317|NCT00459316|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org
101318|NCT00459342|The University of Texas (UT) MD Anderson Cancer Center|Faye Johnson, MD / Associate Professor|713-792-7734|CR_Study_Registration@mdanderson.org
101319|NCT00459355|Bedford VA Medical Center|Dr. Kathy Horvath|781-687-2006|Kathy.Horvath@va.gov
101320|NCT00459368|Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454|
101321|NCT00459381|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-8837|jfisher@jhmi.edu
101322|NCT00459537|Novartis Pharmaceuticals|Study Director|862 778-8300|
101323|NCT00459667|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
101324|NCT00459706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101620|NCT00490022|University of Washington|Dr. Stephanie Page, PhD, MD|206.616.0483|page@u.washington.edu
101326|NCT00459810|Oregon Health & Science University Knight Cancer Institute|Study Coordinator|(503) 494-2897|eilersk@ohsu.edu
101327|NCT00459862|Mayo Clinic|Julian Molina, M.D, Ph.D.||Molina.julian@mayo.edu
101328|NCT00459875|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org
101329|NCT00459953|Stanford University|Joel D Killen|(650) 723-5895|jkillen@stanford.edu
101330|NCT00459979|CCCC|Dr. Brian Rini|216-444-9567|rinib2@ccf.org
101331|NCT00460031|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org
101332|NCT00460993|Atlanta VA Medical Center|Dr. Patricia C. Griffiths|404-321-6111 ext 7138|Patricia.Griffiths@va.gov
101333|NCT00461032|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101334|NCT00461045|Triphase Accelerator|Associate Director of Clinical and Regulatory Operations|858-295-4337|jennifer.ki@triphaseco.com
101336|NCT00461123|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
101337|NCT00461175|Center for Epidemiology and Health Research, Germany|Dr. Klaas Heinemann|0049 (0) 30 945 101 20|k.heinemann@zeg-berlin.de
101338|NCT00461253|Center for Epidemiology and Health Research, Germany|Dr. Jürgen Dinger|0049 (0) 30 945 101 20|dinger@zeg-berlin.de
101339|NCT00461292|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
101340|NCT00461305|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
101341|NCT00461331|Tulane University Health Sciences Center|Tina K. Thethi, MD, MPH|504-988-5044|tthethi@tulane.edu
101342|NCT00461500|GlaxoSmithKline|GSK Response Center|866-435-7343|
101343|NCT00461513|Veterans Health Administration|Dr. Meg Plomondon|303-370-75770|Meg.Plomondon@va.gov
101345|NCT00461630|Clinical Trial Service Unit, University of Oxford|Professor Jane Armitage|+44 (0)1865 743743|thrive@ctsu.ox.ac.uk
101346|NCT00461682|GlaxoSmithKline|GSK Response Center|866-435-7343|
101347|NCT00461708|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
101348|NCT00461734|Princess Alexandra Hospital|Dr. Gerald Kaye|07 3176 2111|gerald.kaye@health.qld.gov.au
101349|NCT00461786|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
101350|NCT00461812|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu
101352|NCT00461981|MedImmune, LLC|Christopher Ambrose, MD|301-398-0000|ambrosec@medimmune.com
101353|NCT00462020|Children's Mercy Hospital|Shawn D. St. Peter, MD|816-983-6479|sspeter@cmh.edu
101354|NCT00462072|University of Rochester|Rick Barrett|585-275-1647|rick_barrett@urmc.rochester.edu
101355|NCT00462228|Department of Physical Medicine and Rehabilitation, University of Missouri|Dr. S. Jon Rupright|573-882-3101|RuprightJ@health.missouri.edu
101356|NCT00462280|University of California, Irvine|Dr. Kenneth G. Linden|714-456-3719|kglinden@uci.edu
101357|NCT00462306|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu
101358|NCT00462332|GIMEMA Foundation Data Center|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it
101359|NCT00462345|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
101360|NCT00462384|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
101361|NCT00462423|Northern California Medical Center|Lynn E. Spitler, MD|415-435-9861|lynn@drspitler.com
101362|NCT00462449|Department of Physical Medicine and Rehabilitation University of Pittsburgh|Dr. Michael C. Munin|412-648-6848|muninm@upmc.edu
101363|NCT00462462|Orfagen|Clinical Project Manager|+33 5 34 50 64 62|info@orfagen.com
101364|NCT00462501|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org
101365|NCT00462605|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|B. Douglas Smith|410-614-5068|smithdo@jhmi.edu
101366|NCT00462644|Wake Forest University, Department of Surgery|Amy N. Hildreth, MD||ahildret@gmail.com
101367|NCT00462670|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314|
101368|NCT00462709|ViroPharma|Chief Scientific Officer|610-458-7300|
101369|NCT00462722|University of Colorado Anschutz Medical Campus|Catherine Jankowski|303-724-7383|catherine.jankowski@ucdenver.edu
101370|NCT00462748|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
101372|NCT00462839|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|(312)926-9015|r-mccarthy@northwestern.edu
101373|NCT00462865|BrUOG|Bachir Sakr, MD|4018633000|kayla_rosati@brown.edu
101374|NCT00462917|Brigham and Women's Hospital and Harvard Medical School|Robert C. Green, MD, MPH|617-264-5838|rcgreen@genetics.med.harvard.edu
101376|NCT00462982|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org
101377|NCT00463047|Cephalon, Inc.|Medical Monitor|1-800-896-5855|
101378|NCT00463229|McMaster University|Maureen Markle-Reid|905-525-9140 ext 22306|mreid@mcmaster.ca
101379|NCT00463346|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|2039325711 ext 4282|elizabeth.ralevski@yale.edu
101380|NCT00463385|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
101381|NCT00469456|Forest Research Institute, a subsidiary of Forest Laboratories Inc.|Stephen Graham, PhD|201-427-8156|stephen.graham@frx.com
101382|NCT00469508|UCLA Center for Behavioral and Addiction Medicine|Steven Shoptaw PhD|310 794 0619 ext 225|sshoptaw@mednet.ucla.edu
101383|NCT00470054|Wake Forest University|Antonius Miller||aamiller@wfubmc.edu
119195|NCT02033369|NYSPI|Franklin Schneier, MD|646-774-8041|fschneier@nyspi.columbia.edu
101384|NCT00470067|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
101385|NCT00470106|VA Greater Los Angeles|Michael F. Green, PhD|(310)2693376|michael.green6@va.gov
101386|NCT00470158|AHRQ|Stephanie Chang|301 427-1490|stephanie.chang@ahrq.hhs.gov
101387|NCT00470184|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
101388|NCT00470262|Denver VA Medical Center|Dr. Neda Rasouli|303-399-8020 ext 4314|neda.rasouli@ucdenver.edu
101389|NCT00470275|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
101390|NCT00470301|Montefiore Medical Center|NYCC Coordinating Center|718-405-8404|sforde@montefiore.com
101391|NCT00470392|Louis Stokes VA Medical Center and University Hospitals Case Medical Center|Kevin D. Cooper MD|216 844 3111|kevin.cooper@uhhospitals.org
101392|NCT00470418|James J Peters VA Medical Center|Dr. Hillel Grossman|718-584-9000 ext 5752|hillel.grossman2@va.gov
101393|NCT00470470|Memorial Sloan-Kettering Cancer Center|Dr. Richard Carvajal|646-888-4161|carvajar@mskcc.org
101394|NCT00470535|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
101395|NCT00470548|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu
101396|NCT00470600|Cumberland Pharmaceuticals|Amy Rock, Ph.D.|615-255-0068|arock@cumberlandpharma.com
101397|NCT00470626|Cook|Scott Snyder|765-463-7537|ssnyder@medinst.com
101398|NCT00470834|GlaxoSmithKline|GSK Response Center|866-435-7343|
101399|NCT00470847|Dana-Farber Cancer Institute|Nancy Lin, MD|617-632-2335|nlin@partners.org
101400|NCT00471068|Alcon Labs|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
101401|NCT00471107|NIH/NINDS|Eric Wassermann|301-496-0151|wassermanne@ninds.nih.gov
101402|NCT00471146|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101404|NCT00471276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101405|NCT00471315|Medical University of South Carolina|Peter Cotton, MD|(843) 792-6999|CottonP@MUSC.edu
101406|NCT00471328|Novartis Pharmaceuticals|Study Director|862-778-8300|
101407|NCT00471354|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
101408|NCT00471380|Alcon Research, LTD|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
101409|NCT00471445|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu
101411|NCT00471536|Karmanos Cancer Institute at Wayne State University|Ulka Vaishampayan, M.D.||vaishamu@karmanos.org
101412|NCT00471705|Universidad de Antioquia - Colombia|Iván Darío Vélez Bernal|574 + 219 6501 - 02|idvelez@pecet-colombia.org
101413|NCT00471718|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu
101414|NCT00471822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101415|NCT00472030|University of Iowa|Janet Fairley, M.D.|319-384-8560|janet-fairley@uiowa.edu
101416|NCT00472056|UT MD Anderson Cancer Center|Chitra M. Hosing, MD / Associate Professor||mvpacheco@mdanderson.org
101417|NCT00472082|Emory University|Kenneth A. Newell, MD, PhD|404-727-2489|kanewel@emory.edu
101418|NCT00472199|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
101419|NCT00472290|Amgen Inc.|Study Director|866-572-6436|
101420|NCT00472303|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com
101421|NCT00472420|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
101422|NCT00472446|Cantonal Hospital St. Gallen|Thomas Steffen, MD|0041 71 494 1111|thomas.steffen@kssg.ch
101423|NCT00460109|Mayo Clinic|Stephen M. Ansell, M.D., Ph.D.|507/284-4642|ansell.stephen@mayo.edu
101424|NCT00460239|Johns Hopkins University School of Medicine|Eric C. Strain, M.D.|410-550-1191|ecsgss@aol.com
101425|NCT00460265|Amgen Inc.|Study Director|866-572-6436|
101426|NCT00460408|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101427|NCT00460421|Swedish Orphan Biovitrum|Medical Program Director|+46 8 697 20 00|clinical@sobi.com
101428|NCT00460434|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org
101429|NCT00460525|Department of Epidemiology of Parasitic Diseases, University of Bamako|Mahamadou A. Thera, MD, MPH|223-222-8109|mthera@mrtcbko.org
101430|NCT00460551|Genmab A/S|Eva Järlid Westerberg PhD|+45 7020 2728|E.Westerberg@genmab.com
101431|NCT00460564|GlaxoSmithKline|GSK Response Center|866-435-7343|
101432|NCT00460577|Novartis Pharmaceuticals|Study Director|862-778-8300|
101433|NCT00460603|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101434|NCT00460655|GlaxoSmithKline|GSK Response Center|866-435-7343|
101435|NCT00460746|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488|rfalcon@its.jnj.com
101436|NCT00460798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101437|NCT00460811|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com
101438|NCT00466310|DUMC|Rima Kaddurah-Douk, Associate Professor|919-684-2611|rima.kaddurah-daouk@duke.edu
101439|NCT00466323|VA VISN 5 Mental Illness Research, Education and Clinical Center|Amy Drapalski, Ph.D.|410-637-1855|amy.drapalski@va.gov
101440|NCT00466505|Vanderbilt-Ingram Cancer center|Jordan Berlin, MD|615-343-4128|jordan.berlin@vanderbilt.edu
101441|NCT00466687|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, M.D.||jeff.sosman@vanderbilt.edu
101443|NCT00466882|Summa Health System|Scharsu, Rachelle|3303756673|scharsur@summahealth.org
101444|NCT00472576|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|Dr. Carlos Zarate|301-451-0861|zaratec@mail.nih.gov
101445|NCT00472641|Stanford University School of Medicine|Dr. Po W. Wang|650-723-2483|wangp0@stanford.edu
101446|NCT00472732|Children's Research Institute|Andrea Gropman, M.D.|202-476-2120|agropman@childrensnational.org
101447|NCT00472797|EMD Serono, INc.|Fernando Dangond, MD|781 681 2348|fernando.dangond@emdserono.com
101448|NCT00472849|The University of Texas MD Anderson Cancer Center|William G. Wierda, MD, PhD, BS / Associate Professor|713-745-0428|eharriso@mdanderson.org
101449|NCT00474487|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com
101451|NCT00474539|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
101452|NCT00474630|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com
101453|NCT00474708|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
101454|NCT00474760|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101455|NCT00474786|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101456|NCT00474812|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Charles Nock MD|216-844-3862|charles.nock@uhhospitals.org
101457|NCT00474851|Boston Children's Hospital|Dr. Amy D. DiVasta|617-355-3792|Amy.DiVasta@childrens.harvard.edu
101458|NCT00474903|Mayo Clinic Rochester|Paul J. Limburg, M.D., M.P.H.||limburg.paul@mayo.edu
101459|NCT00474929|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu
101460|NCT00474955|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
101461|NCT00474968|CytoCore, Inc.|Richard Domanik, Ph.D.|312-222-9550|rdomanik@cytocoreinc.com
101462|NCT00474994|Memorial Sloan Kettering Cancer Center|Dr. Mary Keohan|646-888-4160|KeohanM@mskcc.org
101463|NCT00475033|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
101464|NCT00475085|University of Rochester|Dr. Charles Heckler|585 273-1141|checkler@urmc.rochester.edu
101465|NCT00475150|University of Wisconsin Comprehensive Cancer Center|Mark B. Juckett, MD||mbj@medicine.wisc.edu
101466|NCT00475176|National Institute of Diabetes and Digestive and Kidney Diseases, National In|Jay H. Hoofnagle, M.D.|301-496-1333|hoofnaglej@mail.nih.gov
101467|NCT00475228|University o Pittsburgh|Heather Hohmann, MD|412-641-1441|hhohmann@mail.magee.edu
101468|NCT00475241|VA Ann Arbor Healthcare System|Dr. Sheila A.M. Rauch|734-845-3545|sherauch@med.umich.edu
101469|NCT00475306|Montefiore Medical Center|Dr. BW Friedman|718-920-6626|befriedm@montefiore.org
101470|NCT00475319|Dermatologicals & Ophthalmologicals, Otsuka Pharmaceutical Co., Ltd.|Eiji Murakami|+81-6-6231-6067|
101471|NCT00475332|University of Florida|Bridget Fitzgerald, Clinical trials coordinator|(352) 265-0680 ext 87829|fitzgb@shands.ufl.edu
101472|NCT00475423|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
101473|NCT00475501|Geriatric Research Education and Clinical Center|Stephen Borst, Ph.D|352-374-6114 ext 5033|stephen.borst@va.gov
101474|NCT00475657|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
101475|NCT00475670|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
101476|NCT00475709|St Jude Medical|Kelly Erickson|16517566580|kaerickson@sjm.com
101477|NCT00475722|University of Michigan|Dr. Zora Djuric|734-615-6210|zoralong@umich.edu
101478|NCT00475735|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101479|NCT00475787|Canandaigua VA Medical Center|Paul Dougherty, DC|585-463-2673|paul.dougherty@va.gov
101480|NCT00475852|Johnson & Johnson Pharmaceutical Research & Development, LLC|Vice President, Franchise Development|610-651-6628|
101481|NCT00475865|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com
101482|NCT00475878|Butler Hospital|Dr. Michael Stein|401-455-6646|michael_stein@brown.edu
101483|NCT00475904|EpiCept Corporation|Chief Medical Officer|914-606-3500|sallard@epicept.com
101484|NCT00476008|Charles E. Schmidt College of Medicine, Florida Atlantic University|Peter Holland, MD|561-297-0164|holland@fau.edu
101485|NCT00476021|University of Pittsburgh|Principal Investigator|412-641-5496|chenba@upmc.edu
101486|NCT00476086|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susanna_campos@dfci.harvard.edu
101487|NCT00476151|EpiCept Corporation|Chief Medical Officer|914-606-3500|deverton@epicept.com
101488|NCT00476229|UT MD Anderson Cancer Center|Chitra M. Hosing, MD/Associate Professor||gmccormi@mdanderson.org
101489|NCT00476242|NYS Psychiatric Institute|Adam Bisaga|646-774-6155|amb107@columbia.edu
101490|NCT00476476|Dana-Farber Cancer Institute|Neil Horowitz MD|617.732.8843|NHOROWITZ@mgh.harvard.edu
101491|NCT00476593|Department of Ophthalmology, St. Olavs Hospital, Trondheim Norway|Dr Alexandra Wexler|99716763 ext 0074|a.wexler@online.no
101492|NCT00476645|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu
101493|NCT00476788|Greenville Hospital System|Elaine Moreland MD|8644545661|emoreland@ghs.org
101494|NCT00476827|Duke University|Kimberly Blackwell, MD|919-668-1748|kimberly.blackwell@duke.edu
101495|NCT00476957|Medtronic Bakken Research Center|Dr. Frank van Leeuwen, Director Clinical Research Coronary and Renal Denervation|+31 43 3566622|frank.van.leeuwen@medtronic.com
101496|NCT00469833|Cincinnati VAMC|David D'Alessio, MD, Section head, Endocrinology, Cincinnati VAMC|513-475-6478|david.d'alessio@va.gov
101497|NCT00469859|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
101498|NCT00469898|Vanderbilt-Ingram Cancer Center|Leora Horn, M.D.|615-322-4967|leora.horn@vanderbilt.edu
101499|NCT00477152|Baxter Halthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com
101500|NCT00477165|Stanford University|Uri Ladabaum, MD, MS||ladabau@stanford.edu
101501|NCT00477191|Department of Dermatology, Mass General Hospital|Alexa Boer Kimball, MD MPH|617-726-0149|akimball@partners.org
101502|NCT00477204|University of Colorado Denver|David Maahs, MD, PhD|303-724-2323|david.maahs@ucdenver.edu
101503|NCT00477230|CardioFocus, Inc.|Burke T. Barrett, Study Director|508 658-7200|bbarrett@cardiofocus.com
101504|NCT00477269|Novartis Pharmaceuticals|Study Director|862-778-8300|
101505|NCT00477295|Eisai Call Center|Eisai Inc.|888-422-4743|
101506|NCT00477594|Genzyme Corporation|Genzyme Medical Information|617-252-7832|
101507|NCT00477607|VA RR&D National Center for Rehbilitative Auditory Research|Dawn Konrad-Martin|503-220-8262 ext 52962|dawn.martin@va.gov
101508|NCT00477633|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
101509|NCT00477672|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com
101510|NCT00477685|Grewal Eye Institute|S.P.S Grewal, MD|+91-172-5056969|drgrewal@gmail.com
101511|NCT00477750|Mayo Clinic|Dr. Vivek Roy||roy.vivek@mayo.edu
101512|NCT00477971|Mayo Clinic|Dr. Morie Gertz||gertz.morie@mayo.edu
101513|NCT00478023|Grunenthal GmbH|Claudia Leinweber|49 241 569 2509|claudia.leinweber@grunenthal.com
101514|NCT00478036|University of Colorado, Dept. of Ophthalmology|Malik Kahook, MD|720-848-2501|Malik.kahook@ucdenver.edu
101515|NCT00478140|The University of Texas (UT) MD Anderson Cancer Center|Dr. Ahmed Kaseb / Associate Professor||CR_Study_Registration@mdanderson.org
101516|NCT00478192|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com
101517|NCT00478205|Eisai Call Center|Eisai Inc.|888-422-4743|
101518|NCT00478218|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu
101519|NCT00478231|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101520|NCT00478244|Masonic Cancer Center, University of Minnesota|John E. Wagner, M.D.|612-626-2961|wagne002@umn.edu
101521|NCT00478257|UCSD|Dr. Sonia Ancoli-Israel|858 642-7710|sancoliisrael@ucsd.edu
101522|NCT00478556|UAB Hospital Radiology|Lisa Nelson|205-934-4015|lnelson@uabmc.edu
101523|NCT00478569|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com
101524|NCT00478608|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
101525|NCT00478647|Shire HGT|Tiffany Crump|484-595-8850|tcrump@shire.com
101526|NCT00478673|Boston Scientific Corporation|Jim Taufen, Regulatory Affairs Manager|763-255-0683|taufenj@bsci.com
101527|NCT00478777|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
101528|NCT00478881|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
101529|NCT00479037|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com
101530|NCT00479089|The University of Texas (UT) MD Anderson Cancer Center|Arlene Siefker-Radtke, MD/Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org
101531|NCT00479154|NINDS/NIH|Fatta Nahab|301-496-9526|nahabf@ninds.nih.gov
101532|NCT00479232|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101533|NCT00479258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
101534|NCT00479336|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
101535|NCT00479388|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
101536|NCT00479401|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
101537|NCT00479466|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101538|NCT00479557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101539|NCT00479674|Duke University Medical Center|Dr. Kimberly Blackwell|919-668-1748|black034@duke.edu
101540|NCT00479713|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101541|NCT00479765|BTG International Inc|Claire Daugherty|610-278-1660|claire.daugherty@btgplc.com
101542|NCT00479856|GlaxoSmithKline|GSK Response Center|866-435-7343|
101543|NCT00479882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101544|NCT00473083|BC Cancer Agency|Dr. Barbara Melosky, Principal Investigator|604-877-6000|BMelosky@bccancer.bc.ca
101545|NCT00473265|Columbia University Medical Center|John P. Bilezikian MD|212-305-2663|jpb2@columbia.edu
101546|NCT00473330|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com
101547|NCT00473382|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com
101548|NCT00473434|Jan-Cil Australia|Regional Medical Affairs Therapeutic Lead Immunol|61 2 88753219|
101549|NCT00473512|Janssen R & D|Senior Director, Clinical Research|(310) 943-8040 ext 2917|
101550|NCT00473564|University of Alabama at Birmingham|William Carroll, MD|205-934-9767|wcarroll@uabmc.edu
101551|NCT00473590|Hoffman-LaRoche|Medical Communications|800-821-8590|
101552|NCT00473642|Retina Specialists of Michigan|Scott Westhouse, DO|616-954-2020|s.westhouse@gmail.com
101553|NCT00473655|AstraZeneca|Gerard Lynch|09645895 ext 44 15|aztrial_results_posting@astrazeneca.com
101554|NCT00473668|GlaxoSmithKline|GSK Response Center|866-435-7343|
101555|NCT00473746|Janssen R&D US|Sr. Director, Clinical Research|(310)914-2917|
101556|NCT00473824|Biotest Pharmaceuticals|Shailesh Chavan, MD|561-989-5748|schavan@biotestpharma.com
101557|NCT00473837|Medical Research Council Unit, The Gambia|Mrs Vivat Thomas-Njie|+220-4495442/6 ext 2204|vthomas@mrc.gm
101558|NCT00473876|University of Dundee|Professor Chim C Lang|0044(0)1382 496375|c.c.lang@dundee.ac.uk
101559|NCT00473889|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
101560|NCT00474045|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
101561|NCT00474058|UCB|UCB Clinical Trial Call Center|+1877 822 9493|
101621|NCT00490035|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
104028|NCT00623103|Novartis Pharmaceuticals|Study Director|862-778-8300|
101562|NCT00474123|Heart Institute (InCor) Hospital of the Faculty of Medicine, University of São Paulo (HCFMUSP)|Comparison of Antiplatelet and Anti-inflammatory Effects of High Dose Statin Monotherapy Versus Mode|55-11-30695058|eduardopesaro@hotmail.com
101563|NCT00474175|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101564|NCT00474188|Celgene Corporation|Robert Kinght, M.D.|908-673-9749|rknight@celgene.com
101565|NCT00474201|National Institutes of Health|Scott Penzak|301-496-2997|sp286u@nih.gov
101566|NCT00474240|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867|
101567|NCT00474383|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024.|Senior Director|310-943-8040 ext 2917|
101568|NCT00480324|GlaxoSmithKline|GSK Response Center|866-435-7343|
101569|NCT00480493|University of Massachusetts, Worcester|Susan Sullivan-Bolyai|508-856-4185|susan.sullivan-bolyai@umassmed.edu
101570|NCT00480857|University of Michigan Comprehensive Cancer Center|Dr. Daniel Hamstra|(734) 936-4300|dhamm@umich.edu
101571|NCT00480987|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org
101572|NCT00481065|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
101573|NCT00481078|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
101574|NCT00481195|Cephalon, Inc.|Medical Monitor|1-800-896-5855|
101575|NCT00481247|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
101576|NCT00481351|Universidade de São Paulo|Otavio Celeste Mangili, MD|+554499928818|otaviomangili@yahoo.com.br
101577|NCT00481507|GEORGETOWN UNIVERSITY|Daniel Merenstein, MD|202-687-2745|djm23@georgetown.edu
101578|NCT00481676|Novartis Pharmaceuticals|Study Director|862 778-8300|
101579|NCT00481767|GlaxoSmithKline|GSK Response Center|866-435-7343|
101580|NCT00481845|Stanford Cancer Institute, Stanford University|Mark Daniel Pegram; Susy Yuan-Huey Hung Professor|650-723-5801|mpegram@stanford.edu
101581|NCT00481871|Allos Therapeutics, Inc.|Michael Saunders, MD|303-426-6262|msaunders@allos.com
101582|NCT00481988|Division of Experimental Therapeutics, NY State Psychiatric Organization|Peter Bulow MD, Assistant Professor of Clinical Psychiatry|(212) 543 5664|pb2182@columbia.edu
101583|NCT00482014|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
101584|NCT00482170|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101585|NCT00482274|Oregon Health & Science University Knight Cancer Institute|Study Coordinator|503 494-2897|eilersk@ohsu.edu
101586|NCT00482391|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang|914-367-7181|dangc@mskcc.org
101587|NCT00482547|C. R. Bard|Vanessa Dell Clinical Research Scientist|908-277-8094|vanessa.dell@crbard.com
101588|NCT00482612|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
101589|NCT00482625|Weill Cornell College of Medicine|Dr. Steven Lipkin|212-774-7160|stl2012@med.cornell.edu
101590|NCT00482703|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
101591|NCT00482729|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
101592|NCT00482911|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-435-7507|sbpso@mail.nih.gov
101593|NCT00483002|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101594|NCT00483041|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com
101595|NCT00483119|NYU School of Medicine|Elise Kelman, Associate Director of Research Administration|2122639073|elise.kelman@nyumc.org
101596|NCT00483184|Nobel Ilac San ve Tic. A.S.|Hasan Zeytin MD., Ph.D.|+90 216 6336012 ext 6012|hasan.zeytin@nobel.com.tr
101597|NCT00483223|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-726-4920|SISAKOFF@mgh.harvard.edu
101598|NCT00483262|Dana-Farber Cancer Institute|Irene Ghobrial, MD|617-632-4198|irene_ghobrial@dfci.harvard.edu
101599|NCT00483327|Perlmutter Cancer Center at NYU Langone|Stephanie Blank, MD|212-731-5705|stephanie.blank@nyumc.org
101600|NCT00477334|Novartis Pharmaceuticals|Study Director|862-778-8300|
101601|NCT00477386|IndianaU|Daniela Matai, MD|317-944-0920|dmatai@iupui.edu
101602|NCT00477451|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com
101603|NCT00477464|GlaxoSmithKline|GSK Response Center|866-435-7343|
101604|NCT00477490|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
101605|NCT00483379|Genzyme Corporation|Genzyme Medical Information|800-745-4447|
101606|NCT00483405|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu
101608|NCT00483548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
101609|NCT00483574|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
101610|NCT00483652|Acorda Therapeutics, Inc.|Andrew Blight, Chief Scientific Officer|(914) 347-4300 ext 102|ablight@acorda.com
101611|NCT00489476|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com
101612|NCT00489489|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com
101613|NCT00489541|Boston Scientific|Andrey Nersesov, Clinical Project Manager|508-683-4988|andrey.nersesov@bsci.com
101614|NCT00489554|GlaxoSmithKline|GSK Response Center|866-435-7343|
101615|NCT00489736|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com
101616|NCT00489853|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
101617|NCT00489866|Durham VAMC|Christine E. Marx, MD|9192860411 ext 7426|marx0001@mc.duke.edu
101618|NCT00489970|GlaxoSmithKline|GSK Response Center|866-435-7343|
101619|NCT00490009|Stanford University Medical Center|Susan J Knox, MD, Associate Professor of Radiation Oncology|650-725-2720|sknox@stanford.edu
101741|NCT00488059|Hoffmann-La Roche|Medical Communications|800-821-8590|
101622|NCT00490061|Stanford University|Quynh Le|650-498-5032 ext 6506370734|qle@stanford.edu
101623|NCT00490100|National Institute of Allergy and Infectious Diseases|De Ravin, SukSee|+1 301 496 6772|sderavin@mail.nih.gov
101625|NCT00490256|Emory University|Paul Kirshbom, MD|404-785-6330|pkirshb@emory.edu
101626|NCT00490269|Uniformed Services University for the Health Sciences|Dr. Lou Cantelina|301-295-3240|louis.cantelina@usuhs.edu
101627|NCT00490477|University of Turin, Italy|V. M. Ranieri, MD|00390116334001|marco.ranieri@unito.it
101628|NCT00490490|Stanford University Medical Center|Susan J. Knox, MD, Associate Professor of Radiation Oncology|(650) 725-2720|sknox@stanford.edu
101629|NCT00490542|Tufts Medical Center|S. Nassir Ghaemi, MD, MPH|617-636-5735|nghaemi@tuftsmedicalcenter.org
101630|NCT00490555|University of Washington|Dr. Stephanie Page|2066160483|page@u.washington.edu
101631|NCT00490646|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
101632|NCT00490698|The University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD / Professor||CR_Study_Registration@mdanderson.org
101633|NCT00490724|Clinical Science Initiative Dept. Janssen Pharmaceutical K.K./ Tokyo Japan|Manager|+81.3.4411.5653|
101634|NCT00490802|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca
101635|NCT00490815|Alimera Sciences, Inc|Kathleen Billman, Senior Director of Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com
101636|NCT00490841|Abbott Vascular|Ellen Travis|408-845-1512|Ellen.Travis@av.abbott.com
101637|NCT00490919|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333|
101638|NCT00490945|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marelene.dressman@vandapharma.com
101639|NCT00490971|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clinical Leader|609-730-2436|
101640|NCT00491075|U.T. MD Anderson Cancer Center|Quality Assurance Specialist|713-792-2830|guclinicaltrials@mdanderson.org
101641|NCT00491179|National Taiwan University Hospital|Chen-Hua Liu|886223123456 ext 63572|jacque_liu@mail2000.com.tw
101642|NCT00491244|National Taiwan University Hospital|Dr. Chen-Hua Liu|+886-2-23123456 ext 63572|jacque_liu@mail2000.com.tw
101643|NCT00491374|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com
101644|NCT00491387|University of Cincinnati|Myron Gerson MD|5135583974|myron.gerson@uc.edu
101645|NCT00491400|Boston University|Joseph A. Vita, MD|617-638-8700|jvita@bu.edu
101646|NCT00491504|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
101647|NCT00491530|Abbott|Medical Information Specialist|800-633-9110|
101648|NCT00491556|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com
101649|NCT00491608|ZymoGenetics, a Bristol-Myers Squibb company|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com
101650|NCT00491738|Genentech, Inc.|Medical Communications Specialist|800-821-8590|
101651|NCT00491764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101652|NCT00491829|Sprout Pharmaceuticals|Scientific Program Director|9198820850|clinicaltrials@sproutpharma.com
101653|NCT00491894|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
101654|NCT00480532|University of Hawaii (UH)|Bliss Kaneshiro|808-203-6500|bkaneshiro@ucera.org
101655|NCT00480636|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101656|NCT00480740|Children's National Medical Center|Dr. Julia Finkel|202-476-4867|jfinkel@childrensnational.org
101657|NCT00480779|University of Pittsburgh|M. Kaye Kramer|4123831286|mkk3@pitt.edu
101658|NCT00492024|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
101659|NCT00492063|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
101660|NCT00492089|The University of Texas MD Anderson Cancer Center|Monica Loghin, MD / Assistant Professor|K Hunter, RN 713-745-5769|CR_Study_Registration@mdanderson.org
101661|NCT00492206|University of Pittsburgh Cancer Institute|Ahmad Tarhini, MD|412-648-6507|tarhiniaa@upmc.edu
101662|NCT00492232|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
101663|NCT00492973|Lexington Clinic|Cale Jacobs, PhD|859-258-8238|cjaco@lexclin.com
101664|NCT00493012|Heart and Diabetes Center North Rhine-Westfalia|Dr. Armin Zittermann|+49 5731 97 ext 1912|azittermann@hdz-nrw.de
101665|NCT00493038|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
101666|NCT00493181|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org
101667|NCT00493220|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com
101668|NCT00493246|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com
101669|NCT00493285|MedImmune, LLC|Elissa Malkin, DO, MPH|301-398-0000|malkine@medimmune.com
101670|NCT00493311|Mallinckrodt Pharmaceuticals|Lawrence Hill|(908) 238-6370|lawrence.hill@mallinckrodt.com
101671|NCT00493454|The University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD / Associate Professor||CR_Study_Registration@mdanderson.org
101672|NCT00493636|ACORN Research, LLC|Study Chair|901-435-5570|lschwartzberg@acornresearch.net
101673|NCT00493649|US Oncology Research, McKesson Specialty Health|Dr. Stephen E Jones|832-381-7580|steve.jones@usoncology.com
101674|NCT00493779|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
101675|NCT00493805|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
101676|NCT00493974|University of Minnesota|Sarah Lindberg|612-626-9011|slindberg@umn.edu
101677|NCT00494013|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
101678|NCT00494026|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
101679|NCT00494091|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101680|NCT00494143|VA Puget Sound Health Care System|Dr. Joseph Czerniecki|206 277 5188|joseph.czerniecki@va.gov
101681|NCT00494221|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
101682|NCT00494234|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com
101683|NCT00494299|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
101685|NCT00494481|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
101686|NCT00494494|University of North Carolina at Chapel Hill|Kennth L. Cohen, MD|919 843-0292|klc@med.unc.edu
101687|NCT00494507|University of Rochester|Robert Griggs, MD|585-275-3707|robert_griggs@urmc.rochester.edu
101688|NCT00494585|The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org
101689|NCT00494676|Schepens Eye Research Institute|Alex Bowers|617-912-2512|alex_bowers@meei.harvard.edu
101690|NCT00494780|GlaxoSmithKline|GSK Response Center|866-435-7343|
101691|NCT00494806|MD Anderson Cancer Center|Robert L. Massey, PhD, RN|713-792-3704|rlmassey@mdanderson.org
101692|NCT00494871|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
101693|NCT00494975|Dermatology|Ko Mei-Ju|886-223123456 ext 2141|kmjmay@gmail.com
101694|NCT00495079|Talon Therapeutics|Chief Medical Officer|650-588-6404|info@talontx.com
101695|NCT00495131|National Taiwan University Hospital|Chen-Hua Liu, MD|886223123456 ext 63572|jacque_liu@mail2000.com.tw
101696|NCT00495157|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu
101697|NCT00495222|Ethicon Endo-Surgery|Susan Knippenberg|513 337-3452|sknippen@its.jnj.com
101698|NCT00495391|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com
101699|NCT00483704|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101700|NCT00483717|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D|601-650-4200 ext 828|dbregman@lpicrd.com
101701|NCT00483756|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101702|NCT00483938|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
101703|NCT00484094|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com
101704|NCT00484159|Johns Hopkins|Steven P. Cohen|410-955-1822|scohen40@jhmi.edu
101705|NCT00484185|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101706|NCT00484289|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
101707|NCT00484315|Boston Scientific|Andrey Nersesov, Clinical Project Manager|508-683-4988|andrey.nersesov@bsci.com
101708|NCT00484393|Fraser Health|Brandi Newby|604-585-5666 ext 774374|brandi.newby@fraserhealth.ca
101709|NCT00484419|Daiichi Sankyo Inc.|John Raia, Director, Professional Affairs|973-630-2683|jraia@dsus.com
101710|NCT00484679|University of Minnesota|Maria Hordinsky, MD|612-624-5721|hordi001@umn.edu
101711|NCT00484939|Hoffmann-La Roche|Medical Communications|800 821-8590|
101712|NCT00485069|GlaxoSmithKline|GSK Response Center|866-435-7343|
101713|NCT00485134|US Army Medical Materiel Development Activity (USAMMDA)|Division of Regulated Activies and Compliance|301-619-0317|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil
101714|NCT00485173|Medtronic Spinal|Clinical Department|1800-876-3133 ext 6068|msbkclinicalresearch@medtronic.com
101715|NCT00485264|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org
101716|NCT00485303|Janssen Research & Development, 10990 Wilshire Blvd, Suite 1200, Los Angeles, California 90024|Senior Director, Clinical Research|(310) 943-8040 ext 2917|
101717|NCT00485433|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com
101718|NCT00485472|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
101719|NCT00485485|UT MD Anderson Cancer Center|Anne Tsao, M.D. / Associate Professor|713-792-6363|mejprice@mdanderson.org
101720|NCT00486954|GlaxoSmithKline|GSK Response Center|866-435-7343|
101721|NCT00487084|Northwestern University|Cynthia A. Wong,M.D.|630-472-3555|c-wong2@northwestern.edu
101722|NCT00487162|UMDNJ-NJMS|J. Jeffrey Freda, MD, MBA|973 972-5007|jjfreda@umdnj.edu
101723|NCT00487188|Hoffman-LaRoche|Medical Communications|800-821-8590|
101724|NCT00487240|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
101725|NCT00487279|St. Jude Medical CRMD|Heidi Hinrichs/Sr. Director, Clinical Operations|(818) 493-3297|hhinrichs@sjm.com
101726|NCT00487396|Given Imaging|Director, Clinical Affairs|+972-4-9097777|Hila.Debby@givenimaging.com
101727|NCT00487435|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537|
101728|NCT00487461|University of Illinois at Chicago|Ali Alaraj, MD|312-996-4842|alaraj@uic.edu
101730|NCT00487552|MED Institute, Inc.|Scott Snyder, Ph.D., Manager, Biostatistics and Data Management, Senior Statistician|765-463-7537|ssnyder@medinst.com
101731|NCT00487565|DePuy Orthopaedics, Inc.|Tammy O'Dell|574-372-7104|TOdell2@its.jnj.com
101732|NCT00487578|Clinvest|M.E. Beach|(417) 841-3618|mbeach@clinvest.com
101733|NCT00487669|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|james.r.rigas@hitchcock.org
101734|NCT00487695|Johns Hopkins University School of Medicine Division of Gastroenterology and Hepatology|Dr. Marcia Canto.|410-614-5388|mcanto@jhmi.edu
101735|NCT00487721|University of Colorado, Denver|Dr. Thomas Flaig|(720) 848 0655|Thomas.Flaig@ucdenver.edu
101736|NCT00487747|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
101737|NCT00487825|Novartis Pharmaceuticals|Study Director|862-778-8300|
101738|NCT00487942|Cephalon, Inc.|Medical Monitor|1-800-896-5855|
101739|NCT00487981|Boston Scientific|Lyn M. Pimentel, M.B.A.|(661) 949-4174|Lyn.Pimentel@bsci.com
101740|NCT00488033|Intermountain Heart Institute|J.Brent Muhlestein|8015074702|jbrent.muhlestein@imail.org
101742|NCT00488293|Department of Veterans Affairs|John D. Whited, MD, MHS|919-286-6926|john.whited@va.gov
101743|NCT00488319|Johnson & Johnson Research & Development, LLC|Director Clinical Research|1-609-730-6771|
101744|NCT00488345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101745|NCT00488475|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101746|NCT00488488|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101747|NCT00488514|GlaxoSmithKline|GSK Response Center|866-435-7343|
101748|NCT00488592|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov
101749|NCT00488618|Allergan, Inc.|Therapeutic Area Head|714-246-4500|
101750|NCT00488631|Janssen Research & Development|Senior Director|215-793-7540|
101751|NCT00488644|UT MD Anderson Cancer Center|Victor Levin, MD, BS / Professor||kuhunter@mdanderson.org
119201|NCT01916824|Emory University|Boadie Dunlop, MD|404-727-8969|bdunlop@emory.edu
101754|NCT00488826|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
101755|NCT00488865|Rex Medical|James Bressler|610-940-0665|ebressler@rexmedical.com
101756|NCT00489086|ChildrensHRCOakland|Raj Prasad|510-450-7602 ext 7602|rprasad@chori.org
101757|NCT00489216|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
101758|NCT00489255|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
101759|NCT00489268|Mayo Clinic, Arizona|David E. Fleischer, M.D.|(480) 301-4461|fleischer.david@mayo.edu
101760|NCT00489359|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
101761|NCT00489411|University of Michigan School of Nursing|Ellen Lavoie Smith, PhD, APRN, AOCN, FAAN|734-936-1267|Ellenls@med.umich.edu
101762|NCT00489424|Novartis Pharmaceuticals|Study Director|862-778-8300|
101763|NCT00495495|Indiana University School of Dentistry|Domenick T. Zero, DDS MS Principal Investigator|317-274-8822|dzero@iupui.edu
101764|NCT00495521|Jacobus Pharmaceutical Company, Inc.|Dr. Kathy Aleš, Medical Director|609-921-7448 ext 238|kathy.ales@jacobus-pharmaceutical.com
101765|NCT00495586|CAMFIC|Carl Llor|+34 3011777|carles.llor@urv.cat
101766|NCT00495612|Genentech, Inc.|Medical Communications|800 821-8590|
101767|NCT00495625|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org
101768|NCT00495677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101769|NCT00495755|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH, FRCP(C)|617-632-5946|cscutler@partners.org
101770|NCT00495794|VA Center for Clinical Management Research; University of Michigan|Dr. Michele Heisler|734-845-3504|mheisler@umich.edu
101771|NCT00496054|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
101772|NCT00496080|Ethicon|Piet Hinoul MD|908-218-2585|phinoul@its.jnj.com
101773|NCT00496197|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101774|NCT00496262|CSL Behring|Program Director, Clinical R&D|Use email contact.|clinicaltrials@cslbehring.com
101775|NCT00496340|H. Lee Moffitt Cancer Center and Research Institute|Marcie Riches, MD|813-745-6284|marcie.riches@moffitt.org
101776|NCT00496366|Rutgers Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-6789|toopmede@cinj.rutgers.edu
101777|NCT00496379|Dana-Farber Cancer Institute|Dr. Nancy Lin|617-632-2335|nlin@partners.org
101778|NCT00496470|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
101779|NCT00496483|Veloxis A/S|Christina Sylvest, Sr VP, Global Clinical Development and Operations|+45 20553877|csy@veloxis.com
101780|NCT00496587|The University of Texas MD Anderson Cancer Center|Dr. Nazir Tannir/|713-792-7734|CR_Study_Registration@mdanderson.org
101781|NCT00496626|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101782|NCT00496730|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
101784|NCT00496782|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
101785|NCT00496808|UT MD Anderson Cancer Center|David Welch, Manager, Clinical Protocol Administration||dwelch@mdanderson.org
101786|NCT00496834|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101787|NCT00496860|Altor Bioscience|Hing C. Wong, Chief Clinical Officer|9544438600|hingwong@altorbioscience.com
101788|NCT00496873|University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD/Associate Professor, Lymphoma/Myeloma||CR_Study_Registration@mdanderson.org
101790|NCT00497055|San Francisco Department of Public Health|Phillip O. Coffin, Director of Substance Use Research|415-437-6282|phillip.coffin@sfdph.org
101791|NCT00497081|San Francisco Department of Public Health|Glenn-Milo Santos, MPH|415.437.6231|glenn-milo.santos@sfdph.org
101792|NCT00497146|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
101793|NCT00497198|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
101794|NCT00497770|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
101795|NCT00497796|Shire Development LLC|Study Physician|+1 866 842 5335|
101796|NCT00497874|Pro-Change Behavior Systems, Inc.|Deborah A. Levesque, Ph.D.|(401) 360-2975|dlevesque@prochange.com
101797|NCT00498173|Lurie Center for Autism, Massachusetts General Hospital|Christopher John McDougle, M.D.|7818601721|cmcdougle@mgh.harvard.edu
101798|NCT00498186|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
101800|NCT00498368|Mayo Clinic|Dr. Fernando Fervenza|507-255-3712|Fervenza.Fernando@mayo.edu
101802|NCT00498485|Rutgers|Dr Benjamin Natelson|973-2236370|bnatelson@chpnet.org
101803|NCT00485693|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com
101804|NCT00485732|GlaxoSmithKline|GSK Response Center|866-435-7343|
101805|NCT00485758|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
101806|NCT00485836|Genentech, Inc.|Medical Communications|800-821-8590|
101808|NCT00486018|Genentech, Inc.|Medical Communications|800-821-8590|
101809|NCT00486044|University of Wisconsin School of Medicine and Public Health|Cynthia M. Carlsson, MD, MS|608-280-7000|cmc@medicine.wisc.edu
101810|NCT00486226|Codman&Shurtleff|Arnaud Nicolas|+33 0 155 004 543|anicolas@its.jnj.com
101811|NCT00486252|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
101812|NCT00486265|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
101813|NCT00486278|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
101814|NCT00486291|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com
101815|NCT00486330|Yale University AIDS Program|R. Douglas Bruce|2037374040|robert.bruce@yale.edu
101816|NCT00486434|Nordic Bioscience A/S|Bente Juel Riis, Medical Director|+4522901317|bjr@nordicbioscience.com
101817|NCT00486447|GE Healthcare|Angela N. Johnson, Senior Manager Clinical Affairs Operations|262-226-9495|angela.johnson@ge.com
101818|NCT00486525|Ohio State University Comprehensive Cancer Center|Janice Kiecolt-Glaser, Principal Investigator|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu
101819|NCT00486642|Bristish Columbia Cancer Agency|Dr. Kim N. Chi|604-877-6000 ext 2746|kchi@bccancer.bc.ca
101820|NCT00486720|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
101821|NCT00486759|Hoffmann-La Roche|Medical Communications|800 821-8590|
101822|NCT00486811|Grünenthal GmbH|Claudia Leinweber|+49 241 569 2509|claudia.leinweber@grunenthal.com
101823|NCT00486837|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com
101824|NCT00486863|Warren Alpert Medical School of Brown University, Lifespan Center for International Health Research|Jennifer Friedman, M.D., Ph.D|(401) 444-7449|jennifer_friedman@brown.edu
101825|NCT00486902|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu
101826|NCT00492284|QLT Inc.|Medical Information Department|1-800-663-5486|medaff@qltinc.com
101827|NCT00492297|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
101828|NCT00492336|Maryland Psychiatric Research Center|Dr. Robert Buchanan, M.D.|410-402-7876|rwbuchanan@mprc.umaryland.edu
101829|NCT00492401|The Ohio State University Comprehensive Cancer Center|William Blum, MD|614-293-9273|William.Blum@osumc.edu
101830|NCT00492531|Professor of Medicine: Chief, Pulmonary, Allergy and Critical Care Medicine: Director, Hemostasis and Vascular Biology Research Institute; University of Pittsburgh School of Medicine|Mark Gladwin|412-692-2117|gladwinmt@upmc.edu
101831|NCT00492544|GlaxoSmithKline|GSK Response Center|866-435-7343|
101832|NCT00492557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101833|NCT00492583|Georgetown University|Daniel J Merenstein, MD|202-687-2745|djm23@georgetown.edu
101834|NCT00492622|University Louisville|Nancy Alsip|502-852-2905|nancy.alsip@louisville.edu
101835|NCT00492726|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
101836|NCT00492752|BAYER|Therapeutic Area Head|<not disclosed>|clinical-trials-contact@bayerhealthcare.com
101837|NCT00492856|SWOG Statistical Center|SWOG Leukemia Committee Statistician|206-667-4408|
101838|NCT00498550|Dartmouth Medical School|Christopher OKeefe|603-271-5287|chris.okeefe@hitchcock.org
101839|NCT00498602|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101840|NCT00498615|Johns Hopkins University|Gwen Leatherman, R.N.|410-550-8582|gleathe@jhmi.edu
101842|NCT00498706|Northwestern University|Dr. David C. Mohr|312-503-1403|d-mohr@northwestern.edu
101843|NCT00498797|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
101844|NCT00499252|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
101845|NCT00499343|U.T. M.D. Anderson Cancer Center|Chitra M. Hosing, MD / Associate Professor|713-792-8750|
101846|NCT00499369|SWOG|Study Statistician|206-667-4623|
101848|NCT00499447|Comprehensive Cancer Center of Wake Forest University|Dr. James Urbanic|336-713-3600|jurbanic@wakehealth.edu
101849|NCT00499460|Clinical Research Division, Fred Hutchinson Cancer Research Center|Danny D. Shen, Member (Retired)|206-685-2920|ds@uw.edu
101850|NCT00499473|The Ohio State University Comprehensive Cancer Center|Robert Cavaliere, MD|614-293-4968|Robert.Cavaliere@osumc.edu
101851|NCT00499486|The Sidney Kimmel Comprehensive Cancer Centre at Johns Hopkins|Dr. Hidalgo||mhidalgo@cnio.es
101852|NCT00499590|OPKO Health, Inc.|Jane Hsiao, PhD, MBA|305-575-6004|jhsiao@opko.com
101853|NCT00499603|The University of Texas MD Anderson Cancer Center|Clinical Research Operations, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org
101854|NCT00499616|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
101855|NCT00499655|City of Hope|Karen L. Reckamp, M.D.|(626) 256-4673|kreckamp@coh.org
101856|NCT00499681|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD, Principal Investigator|615-936-2033|ingrid.mayer@vanderbilt.edu
101857|NCT00499694|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org
101858|NCT00499863|Noven Pharmaceuticals, Inc.|Amaury Sanchez, Sr. Manager, Regulatory Affairs||asanchez@noven.com
101859|NCT00499889|UT MD Anderson Cancer Center|Richard E. Champlin, MD/Professor|713-792-8848|pmcadams@mdanderson.org
101860|NCT00499915|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu
101861|NCT00500071|Shire Pharmaceutical Development Inc|Timothy Whitaker, MD||twhitaker@shire.com
101862|NCT00500110|MD Anderson Cancer Center|Quality Assurance Specialist|713-563-1602|caperez@mdanderson.org
101863|NCT00500149|Shire|Timothy Whitaker, MD||twhitaker@shire.com
101864|NCT00500240|UT MD Anderson Cancer Center|Khanh D Vu, MD/ Associated Professor|713-745-4516|eharriso@mdanderson.org
101865|NCT00500266|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101866|NCT00500292|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
101867|NCT00500318|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com
101868|NCT00500357|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
101869|NCT00500370|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
101870|NCT00500448|University of Michigan|Riann Palmieri-Smith|7346153154|riannp@umich.edu
101871|NCT00500539|Novartis Pharmaceuticals|Study Director|862-778-8300|
101872|NCT00500578|UT MD Anderson Cancer Center|Roy F Chemaly, MD/MPH, MBA /Associate Professor|713-745-1116|rfchemaly@mdanderson.org
101873|NCT00500656|Shire Human Genetic Therapies, Inc.|Alan Kimura, MD, PhD|781-482-0738|akimura@shire.com
101875|NCT00500760|Amgen Inc.|Study Director|866-572-6436|
101876|NCT00501007|Rutgers, The State University of New Jersey|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu
101878|NCT00501085|Apollo Endosurgery, Inc.|Laura Eaton, R.N., BSN, CCRN-R|949-468-9301|laura.eaton@apolloendo.com
101879|NCT00501228|U.T. M.D. Anderson Cancer Center|Martin Korbling, MD / Professor|713-745-3219|
101880|NCT00501293|Shire Pharmaceutical|Timothy Whitaker, MD||twhitaker@shire.com
101881|NCT00501345|UT MD Anderson Cancer Center|Jean-Bernard Durand, MD / Professor||CR_Study_Registration@mdanderson.org
101882|NCT00501540|University of Wisconsin Carbone Cancer Center|Dr. Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu
101883|NCT00501592|Intercept Pharmaceuticals, Inc.|Cathi Sciacca, Sr. Director, Clinical Operations|858-652-6800|csciacca@interceptpharma.com
101884|NCT00501631|Alkermes, Inc.|Bernard L. Silverman, MD|1-781-609-6000|bernard.silverman@alkermes.com
101885|NCT00501644|UT MD Anderson Cancer Center|Michael E. Garcia, RN, BSN||mgarcia@mdanderson.org
101886|NCT00495820|Central Arkansas Veterans Healthcare System|Prasad Padala, MD, MS, Associate Director for Clinical Programs, GRECC|5012572537|prasad.padala@va.gov
101887|NCT00501852|Novartis Pharmaceuticals|Study Director|862-778-8300|
101888|NCT00501891|The Preston Robert Tisch Brain Tumor Center at Duke|Annick Desjardins, MD|919-684-6173|annick.desjardins@duke.edu
101889|NCT00501943|UCSF|Dr Emmanuelle Waubant, MD|415- 514 2468|Emmanuelle.Waubant@ucsf.edu
101890|NCT00501969|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
101891|NCT00501995|Johns Hopkins University|Gwen Leatherman,R.N.,M.S.|410-550-8582|gleathe@jhmi.edu
101892|NCT00504231|University of Washington|Ru-Chien Chi B.S., M.D., M.S.|206 768-5217|rchi@u.washington.edu
101893|NCT00504257|H. Lee Moffitt Cancer Center and Research Institute|Robert Wenham, Principal Investigator|813-745-8478|robert.wenham@moffitt.org
101894|NCT00504426|Headwuarters of New Product Evaluation and Development, Otsuka Pharmaceutical Co., Ltd.|IMAOKA, Kyoji, Operatin Officer, Gemeral Manager|+81-3-6361-7366|
101895|NCT00504504|University of Texas (UT) MD Anderson Cancer|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org
101896|NCT00504556|Daiichi Sankyo Inc.|William Maxwell, Assoc. Director|732-590-5000|wmaxwell@dsi.com
101897|NCT00504595|Novartis Pharmaceuticals|Study Director|862-778-8300|
101898|NCT00504660|UT MD Anderson Cancer Center|Charles A. Conrad, MD / Professor|713-745-1896|skang@mdanderson.org
101899|NCT00504725|Duke University Medical Center|Andrew Shaw MD|9192866938|andrew.shaw@duke.edu
101900|NCT00504751|Weill Cornell Medicine|Richard Furman, MD|646.962.2064|amr2017@med.cornell.edu
101901|NCT00504777|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
101902|NCT00504881|UCB Clinical Trial Call Center|UCB (Study Director)|+1 877 822 9493|
101903|NCT00504894|Weill Cornell Medicine|Kane Pryor|(212) 746-2953|kap9009@med.cornell.edu
101904|NCT00504985|UT MD Anderson Cancer Center|Xin Shelley Wang, MD, MPH / Associate Professor|713-745-3504|
101905|NCT00505076|Semel Institute at UCLA|Stephen R. Marder|310-268-3647|marder@ucla.edu
101906|NCT00505284|Eisai Call Center|Eisai Inc.|888-422-4743|
101907|NCT00505362|Stanford University|Anna Girsen, Manager of Research Operations|6507250499|agirsen@stanford.edu
101908|NCT00505375|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org
101909|NCT00505414|Grünenthal GmbH|Director of Clinical Trials|+49 (0)241 569 3223|Clinical-Trials@grunenthal.com
101910|NCT00505518|Massachusetts General Hospital|Albert Yeung|617-724-5138|ayeung@partners.org
101911|NCT00505622|Eisai Call Center|Eisai Inc.|888-422-4743|
101912|NCT00505635|UT MD Anderson Cancer Center|Nicholas E. Papadopoulos, MD / Professor|713-792-2921|CR_Study_Registration@mdanderson.org
101913|NCT00505661|UT MD Anderson Cancer Center|John Kavanagh, MD / Professor|713-792-2933|
101914|NCT00505687|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
101915|NCT00505752|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
101916|NCT00505765|Semel Institute at UCLA|Stephen R. Marder|310-268-3647|marder@ucla.edu
101917|NCT00505778|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
101918|NCT00505895|University of Texas MD Anderson Cancer Center|Muzaffar Qazilbash, MD / Professor, Stem Cell Transplantation|713-745-4371|CR_Study_Registration@mdanderson.org
101919|NCT00505921|UT MD Anderson Cancer Center|Issa F. Khouri, MD / Associate Professor|713-792-8848|pmcadams@mdanderson.org
101921|NCT00506025|University of California Irvine Medical Center|Deborah A. Wing, MD|714-456-5967|dwing@uci.edu
101922|NCT00506064|UT MD Anderson Cancer Center|Una Srejic, MD / Professor|713-792-6914|CR_Study_Registration@mdanderson.org
101923|NCT00506077|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101924|NCT00506155|University of Texas (UT) MD Anderson Cancer Center|Arlene Siefker-Radtke, MD/Associate Professor, Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org
101925|NCT00506285|Psychiatry Research Clinic|Barrie K. Marchant|801 585-6663|barriemarchant@aol.com
101926|NCT00506350|GlaxoSmithKline|GSK Response Center|866-435-7343|
101927|NCT00506389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101928|NCT00506415|Novartis|Study Director|862 778 8300|
101929|NCT00506441|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
101930|NCT00506454|Sepsicure L.L.C.|Vice President|212-606-4352|bianuale@metromediacompany.com
101931|NCT00506493|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com
101932|NCT00506597|The University of Texas (UT) MD Anderson Cancer Center|Robert J. Wells, MD / Professor||CR_Study_Registration@mdanderson.org
101933|NCT00506662|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
101934|NCT00506675|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-975-8690|pedig@jaeb.org
101935|NCT00506714|Arthritis Foundation|Meika A. Fang, MD|310-478-3711 ext 84503|meika.fang@va.gov
101936|NCT00498927|Memorial Sloan Kettering Cancer Center|Dr. Antonio Omuro|212 639 7523|omuroa@mskcc.org
101937|NCT00498940|Columbia University Medical Center|Santos Cabreriza/ Associate Scientist|212-305-9515|sc45@cumc.columbia.edu
101938|NCT00499031|NRG Oncology Statisics and Data Management Center, Buffalo Office|Melissa Leventhal|716-845-4030|mleventhal@gmail.com
101939|NCT00499096|Department of Veterans Affairs|Dr. Amy M. Kilbourne, PhD, MPH|734-845-3502|Amy.Kilbourne@va.gov
101940|NCT00499109|H. Lee Moffitt Cancer Center and Research Institute|Charles C. Williams, M.D., Study Chair|813-745-7282|charles.williams@moffitt.org
101942|NCT00506831|Stanford University|Lorinda Chung|650-493-5000 ext 62042|shauwei@stanford.edu
101943|NCT00506857|UT MD Anderson Cancer Center|Richard E. Champlin/Professor||ytdinh@mdanderson.org
101944|NCT00506883|AR Scientific, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
101945|NCT00506922|UT MD Anderson Cancer Center|Marcos de Lima, MD / Professor|713-745-3219|bmcmullin@mdanderson.org
101946|NCT00506948|University of Texas (UT) MD Anderson Cancer Center|Amin Alousi, MD / Professor||CR_Study_Registration@mdanderson.org
101947|NCT00507416|Millennium Pharmaceuticals Inc|Medical Director|1-800-778-2860|clinicaltrialregistry@tpna.com
101948|NCT00507429|OXiGENE, Inc.|Peter Langecker, MD, PhD|650 635 7008|plangecker@oxigene.com
101949|NCT00507442|Millennium Pharmaceuticals, Inc|Dixie-Lee Esseltine, MD|(617) 679-7000|
101950|NCT00507455|Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com
101951|NCT00507507|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
101952|NCT00507546|VAPAHCS|Dr. Jamie Zeitzer|6504935000 ext 62410|jzeitzer@stanford.edu
101953|NCT00507559|Medtronic Endovascular|Kristin Schwartz|(763) 514-4000|kristin.schwartz@medtronic.com
101954|NCT00507689|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
101955|NCT00507767|MD Anderson Cancer Center|Dr. Vassiliki Papadimitrakopoulou, Professor|713-792-6363|vpapadim@mdanderson.org
101956|NCT00507819|The Children's Hospital of Philadelphia|David J. Goldberg, MD|267-426-8143|goldbergda@email.chop.edu
101957|NCT00508001|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
101958|NCT00508027|Children's Hospital & Research Center Oakland|Dr. Carolyn Hoppe, Principal Investigator|(510)428-3193|choppe@mail.cho.org
101959|NCT00508118|Duke University Medical Center|Andrew Shaw MD|919 286 6938|andrew.shaw@duke.edu
101960|NCT00508144|The University of Texas (UT) MD Anderson Cancer Center|Ralph Zinner, MD/Thoracic & Head and Neck Medicine|713-792-7734|CR_Study_Registration@mdanderson.org
101961|NCT00508157|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
101962|NCT00508274|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
101963|NCT00508391|BIOTRONIK, Inc.|Clay Cohorn|503-387-2614|clay.cohorn@biotronik.com
101964|NCT00508404|Amgen Inc.|Study Director|866-572-6436|
101965|NCT00508469|Alcon France|Severine Durier, PharmD|+33 1 47 10 48 43|
101966|NCT00508482|Guang'anmen Hospital Affiliated to China Academy of Chinese Medical Sciences|Dr. Zhishun Liu|0086-010-88001124|liuzhishun@aliyun.com
101967|NCT00508521|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|(352) 376-1611 ext 6603|janis.daly@neurology.ufl.edu
101968|NCT00508651|MedImmune, LLC|Judith Falloon, MD|301 398 0000|falloonj@medimmune.com
101969|NCT00508716|Griffin Hospital|Dr. Dorothea Wild|203 7327327|dwild@griffinhealth.org
101970|NCT00508742|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101971|NCT00508755|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|(352) 376-1611 ext 5223|janis.daly@neurology.ufl.edu
101972|NCT00508820|Amgen Inc.|Study Director|866-572-6436|
101973|NCT00508872|UT MD Anderson Cancer Center|Eddie Abdalla, MD/Assistant Professor|713-792-6940|
101974|NCT00508924|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
101975|NCT00509028|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
101976|NCT00509041|University of Minnesota Masonic Cancer Center|Arkadiusz Dudek, MD, PhD||dudek002@umn.edu
101977|NCT00509067|Department of Psychiatry Georgetown University Medical School|Dr. Stephen I. Deutsch|757.446.5888|DeutscSI@EVMS.EDU
108117|NCT00857259|Novartis Pharmaceuticals|Study Director|862-778-8300|
101978|NCT00509106|Cerexa, Inc.|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com
101979|NCT00509197|Hôpital du Sacré-Coeur de Montréal|Dr Catherine Lemiere|514 338 2796|catherine.lemiere@umontreal.ca
101980|NCT00509223|Baker IDI Heart and Diabetes Institute|Jonathan Shaw, MD, FRACP, FRCP|+61 (0) 3 8532 1821|jonathan.shaw@bakeridi.edu.au
101981|NCT00509236|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101982|NCT00509249|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
101983|NCT00509262|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
101984|NCT00509288|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov
101985|NCT00509366|Duke University|Neal Ready, MD, PhD|919-681-6932|neal.ready@duke.edu
101986|NCT00509392|VNUS Medical Technologies / Covidien (sponsor)|Eppie Chang, MS; Director Clinical Research|408-360-7200|eppie.chang@covidien.com
101987|NCT00509496|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov
101988|NCT00509587|Princess Margaret Cancer Centre|Dr. Natasha Leighl|416-946-2399|natasha.leighl@uhn.ca
101989|NCT00509600|UT MD Anderson Cancer Center|Robert J. Wells, MD / Professor|713-792-6620|
101990|NCT00509769|Genentech, Inc.|Medical Communications|800 821-8590|
101991|NCT00509795|Regeneron Pharmaceuticals|Clinical Trials Administrator||clinicaltrials@regeneron.com
101992|NCT00502203|UT MD Anderson Cancer Center|Lois M. Ramondetta, MD / Professor||CR_Study_Registration@mdanderson.org
101994|NCT00502242|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
101995|NCT00502320|Lehigh Valley Hospital|Edward R. Norris, MD|610-402-5766|Edward.Norris@lvh.com
101996|NCT00502593|GlaxoSmithKline|GSK Response Center|866-435-7343|
101997|NCT00502671|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
101998|NCT00502697|Vanderbilt University|Melanie Lutenbacher, PhD, MSN, FAAN|615-343-3314|melanie.lutenbacher@vanderbilt.edu
101999|NCT00502775|GlaxoSmithKline|GSK Response Center|866-435-7343|
102000|NCT00502801|Janssen Scientific Affairs, LLC|Vice President, Data Generation|908 927-2943|
102001|NCT00502840|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
102002|NCT00502853|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
102003|NCT00502905|UT MD Anderson Cancer Center|Gabriela Rondon, MD / Assistant Professor|713 745-2294|celsaenz@mdanderson.org
102004|NCT00502944|Massachusetts General Hospital|Rochelle P. Walensky, MD, MPH|(617) 724-8445|rwalensky@partners.org
102005|NCT00502996|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
102006|NCT00503009|GlaxoSmithKline|GSK Response Center|866-435-7343|
102007|NCT00503113|Hoffman-LaRoche|Medical Communications|800-821-8590|
102008|NCT00503139|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102009|NCT00503308|UCSF, San Francisco General Hospital|Deborah Cohan, MD|415 206 3658|cohand@obgyn.ucsf.edu
102010|NCT00503399|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102011|NCT00503425|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
102012|NCT00503698|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
102013|NCT00503750|Emory University|Dr. Ruth O'Regan|404-778-8808|roregan@emory.edu
102014|NCT00503776|Vanderbilt-Ingram Cancer Center|Barbara Murphy, MD|615-343-9444|barbara.murphy@vanderbilt.edu
102015|NCT00503841|Barbara Ann Karmanos Cancer Institute|Dr. Elaina Gartner|313-576-8724|gartnere@karmanos.org
102016|NCT00503906|UM/Sylvester Comprehensive Cancer CEnter|Stefan Gluck MD|305-243-4909|sgluck@med.miami.edu
102017|NCT00503984|University of Miami|Rakesh Singal MD|305-243-9544|rsingal@med.miami.edu
102018|NCT00503997|Vanderbilt-Ingram Cancer Center|Jill Gilbert, M.D.|615-343-4677|jill.gilbert@vanderbilt.edu
102019|NCT00504075|Bio Products Laboratory Limited|Tim Aldwinckle, MD|+44 2089572565|Tim.Aldwinckle@bpl.co.uk
102020|NCT00504153|The University of Chicago|Dr. Hedy Kindler|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu
102021|NCT00504166|University of California San Francisco|Dr. Thomas M. Link|415-353-2450|Thomas.Link@ucsf.edu
102022|NCT00509873|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com
102023|NCT00509899|Incyte Corporation|Study Director|1-855-463-3463|
102024|NCT00509925|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
102025|NCT00510068|Novartis Pharmaceuticals|Study Director|862-778-8300|
102026|NCT00510146|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102027|NCT00510484|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32 (0)2 509 69 77|sven.voet@solvay.com
102028|NCT00510497|University of Pittsburgh|Sharon A. Riddler, MD, MPH|412-383-1675|riddler@pitt.edu
102029|NCT00510510|Novartis Pharmaceuticals|Study Director|862-778-8300|
102030|NCT00510653|The University of Texas (UT) MD Anderson Cancer Center|David Gershenson, MD / Professor||CR_Study_Registration@mdanderson.org
102031|NCT00510692|S.L.A. Pharma (UK) Ltd|Dr Chris Jordan|+44 (0)1923 681001|cjordan@slapharma.com
102032|NCT00510744|University of Pittsburgh|Stephen O'Keefe|412 648 7217|sjokeefe@pitt.edu
102033|NCT00510783|Emory|Brittney Copeland|404-616-0301|bcopel3@emory.edu
102034|NCT00510809|University of Kansas Medical Center|James Backes, PharmD|(913) 588-5324|JBACKES@kumc.edu
102035|NCT00510835|UPittsburgh|Derek C. Angus, MD, MPH, FRCP|(412) 647-6965|angusdc@ccm.upmc.edu
102036|NCT00510874|GlaxoSmithKline|GSK Response Center|866-435-7343|
102037|NCT00510887|Duke University Medical Center|Dr. David Rizzieri|919-668-1000|rizzi003@mc.duke.edu
102038|NCT00510952|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102039|NCT00511004|NIAID|Thomas B. Nutman|301-496-5398|tnutman@niaid.nih.gov
102040|NCT00511095|Dynavax Technologies, Inc.|Robert Janssen, MD|510-655-0414|rjanssen@dynavax.com
102041|NCT00511108|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
102042|NCT00511134|Yale University|Andrea H. Weinberger, Ph.D.|203-974-7598|andrea.weinberger@yale.edu
102043|NCT00511147|Grifols Therapeutics Inc|Henry Li, PhD|1 + 919 316 6042|henry.li@grifols.com
102044|NCT00511173|Creighton University|Christopher Destache|402-280-4744|destache@creighton.edu
102045|NCT00511199|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102046|NCT00511238|Onyx Pharmaceuticals|Onyx Medical Information|1-877-ONYX-121|medinfo@onyx.com
102047|NCT00511342|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102048|NCT00511355|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102049|NCT00511433|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102050|NCT00511472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102051|NCT00511667|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102052|NCT00511706|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
102053|NCT00511797|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
102054|NCT00511810|University of Cincinnati|Robert McNamara, PhD|513-558-5601|robert.mcnamara@uc.edu
102055|NCT00511836|Alkermes, Inc.|Bernard L. Silverman|781-609-6000|bernard.silverman@alkermes.com
102056|NCT00511862|BTG International Canada Inc.|Director of Clinical Operations|613-801-1880|TheraSphereClinical@btgplc.com
102057|NCT00511901|University of Medicine and Dentistry of New Jersey|Jeffrey L Carson, MD|732-235-7122|carson@umdnj.edu
102058|NCT00511914|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
102059|NCT00511992|University of Oklahoma|Ingrid Block, CTO Director|405 271-8001|ingrid-block@ouhsc.edu
102060|NCT00512096|UT MD Anderson Cancer Center|Cherie A. Perez||caperez@mdanderson.org
119206|NCT01817374|UAB Radiology Research|Marianne Vetrano|205-934-4080|mvetrano@uabmc.edu
102062|NCT00512252|Washington University School of Medicine|Geoffrey L. Uy, M.D.|314-454-8304|guy@dom.wustl.edu
102063|NCT00512278|Cleveland Clinic|Nizar Zein|216-444-6126|zeinn@ccf.org
102064|NCT00512707|Brigham and Women's Hospital|Dr. Shalender Bhasin|617-525-9150|sbhasin@partners.org
102065|NCT00507130|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com
102066|NCT00507208|University of Alabama at Birmingham|William Carroll, MD|205-934-9713|wcarroll@uabmc.edu
102067|NCT00512798|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, M.D.||jeff.sosman@vanderbilt.edu
102068|NCT00512876|U.S. Army Warfighter Refractive Surgery Research Center|Principal Investigator|571-231-1600|rose.sia@us.army.mil
102069|NCT00512902|University of California at Los Angeles|Dr. Daniel Furst, Carl M Pearson Professor of Rheumatology|310-794-9504|defurst@mednet.ucla.edu
102070|NCT00513019|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu
102071|NCT00513071|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
102072|NCT00514501|Progenics Pharmaceuticals, Inc.|Senior Director of Clinical Communications|914 784-1825|vdipippo@progenics.com
102073|NCT00514514|Novartis|Study Director|862-778-8300|
102074|NCT00514592|Umeå University|Dr Elias Johansson|+46907850000|elias.johansson@neuro.umu.se
102075|NCT00514683|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102076|NCT00514709|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
102077|NCT00514735|Medtronic|Linda Nelson, Director of Clinical Research|763-526-2891|linda.k.nelson@medtronic.com
102078|NCT00514813|Shire Pharmaceutical|Timothy Whitaker, MD||twhitaker@shire.com
102079|NCT00514852|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com
102080|NCT00514904|GlaxoSmithKline|GSK Response Center|866-435-7343|
102081|NCT00514917|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com
102082|NCT00514943|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102083|NCT00515008|tufts medical center|chenchen wang|617-636-3251|cwang2@tuftsmedicalcenter.org
102084|NCT00515034|Johnson and Johnson Pharmaceutical Research and Development L.L.C.|Senior Director of Clinical Development|510 248-2310|
102085|NCT00515073|University of Texas MD Anderson Cancer Center|Anuja Jhingran, MD / Professor, Radiation Oncology Department|713-563-6900|CR_Study_Registration@mdanderson.org
102086|NCT00515086|Novartis Pharmaceuticals|Study Director|862-778-8300|
102087|NCT00515099|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
102088|NCT00515112|The University of Chicago|Dr. Walter Stadler|773-702-4400|wstadler@medicine.bsd.uchicago.edu
102089|NCT00515177|University of Minnesota|Cynthia Gross PhD|612-624-8676|gross002@umn.edu
102090|NCT00515203|Amgen Inc.|Study Director|866-572-6436|
102091|NCT00515216|Washington University School of Medicine|A. Craig Lockhart, M.D.|314-362-5740|alockhar@dom.wustl.edu
102092|NCT00515294|Boston University|Jonathan Howland, Professor|617 638 5158|jhowl@bu.edu
102093|NCT00515437|Solstice Neurosciences, Inc|Sharon Reinhard, MS, Director Clinical Development|267-620-8083|sharon.reinhard@solsticeneuro.com
102094|NCT00515463|Amgen Inc.|Study Director|866-572-6436|
102095|NCT00515502|GlaxoSmithKline|GSK Response Center|866-435-7343|
102096|NCT00515541|Invitrox, Inc|Dr. Don A. Gabriel|(919) 485-4600|dgabriel@invitrox.com
102097|NCT00515619|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
102098|NCT00515671|IUPUI|Michelle Salyers|317-274-2904|mpsalyer@iupui.edu
102099|NCT00515697|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102100|NCT00515827|Center for Biostatistics for AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
102101|NCT00515879|Boston University|Dr. Stefan G. Hofmann, Ph.D., Professor of Psychology|617 353 9233|shofmann@bu.edu
102102|NCT00516048|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
102103|NCT00516074|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
102104|NCT00516139|GlaxoSmithKline|GSK Response Center|866-435-7343|
102105|NCT00516165|Massachusetts General Hospital|Dr.Andrew X. Zhu|617-724-4000|azhu@mgh.harvard.edu
102106|NCT00516217|University of Chicago|Sonali Smith, M.D.||smsmith@medicine.bsd.uchicago.edu
102107|NCT00516269|UT MD Anderson Cancer Center|Carmen Escalante, MD / Professor||RABaker@mdanderson.org
102108|NCT00516295|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
102109|NCT00516321|GlaxoSmithKline|GSK Response Center|866-435-7343|
102110|NCT00516386|Massachusetts General Hospital|Madhu Misra, MD|617-724-5602|mmisra@partners.org
102111|NCT00516503|Mayo Clinic|Debra Barton, R.N., Ph.D.||Barton.debra@mayo.edu
102112|NCT00516737|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102113|NCT00516893|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com
102114|NCT00510224|UCSF|Charles J. Ryan, MD|415-353-9279|ryanc@medicine.ucsf.edu
102115|NCT00510276|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102116|NCT00510289|Duke University Medical Center|David Rizzieri, MD|919-668-1014|David.Rizzieri@duke.edu
102117|NCT00516906|3M|J M Heilman|651-733-9897|jmheilman@mmm.com
102118|NCT00516919|Yale University School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu
102119|NCT00517010|University of California Davis|Susanna Park MD PhD|916-734-6074|sscpark@ucdavis.edu
102120|NCT00517075|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu
102121|NCT00517192|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102122|NCT00518284|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
102123|NCT00518323|Johnson & Johnson Pharmaceutical Research & Development|Compound Development Team Leader (CDTL)|609-730-4530|
102124|NCT00518336|GlaxoSmithKline|GSK Response Center|866-435-7343|
102125|NCT00518531|Amgen Inc.|Study Director|866-572-6436|
102126|NCT00518622|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
102127|NCT00518687|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102128|NCT00518713|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com
102129|NCT00518882|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
102130|NCT00518986|Cephalon, Inc.|Medical monitor|1-800-896-5855|
102131|NCT00519077|The University of Chicago|Tanguy Lim-Seiwert|773-702-2452|seiwert@uchicago.edu
102132|NCT00519090|Novartis Pharmaceuticals|Study Director|862-778-8300|
102133|NCT00519194|St. Jude Medical|Sue Walgren, Manager Sr., Clinical Project|6517563210|swalgren@sjm.com
102134|NCT00519285|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com
102135|NCT00519376|GlaxoSmithKline|GSK Response Center|866-435-7343|
102136|NCT00519428|NYSPInstitute|Jonathan W. Stewart, M.D.|212-543-5745|jws6@columbia.edu
102137|NCT00519532|UCB|UCB Clinical Trial Call Center|+18778229493|
102138|NCT00519584|Cleveland Clinic|K. C. Cummings III, MD|216-444-1016|cummink2@ccf.org
102139|NCT00519623|Altea Therapeutics|Pei-Ling Roerig, Sr. Manager Clinical Research, Altea Therapeutics|404-835-6415|proerig@alteatherapeutics.com
102140|NCT00519636|GlaxoSmithKline|GSK Response Center|866-435-7343|
102141|NCT00519649|GlaxoSmithKline|GSK Response Center|866-435-7343|
102142|NCT00519779|The Ohio State University|Dr. Janice Kiecolt-Glaser|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu
102143|NCT00519818|Diurnal Ltd|Richard JM Ross|0044 114 2712386|r.j.ross@sheffield.ac.uk
102144|NCT00519831|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
102145|NCT00519896|University of Washington|Renato G Martins|206-288-2048|rgmart@uw.edu
102146|NCT00520013|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susana_campos@dfci.harvard.edu
102147|NCT00520130|National Cancer Institute|Dr. Steven Z. Pavletic|301- 402-4899|sp326h@nih.gov
102148|NCT00520234|Mycoses Study Group|Luis Ostrosky-Zeichner, MD|(713) 500-6733|Luis.Ostrosky-Zeichner@uth.tmc.edu
102149|NCT00520286|National Institutes of Health|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov
102151|NCT00520351|Centre for Contact Lens Research|Craig A Woods, Research Manager|519-888-4567 ext 36547|cawoods@sciborg.uwaterloo.ca
102152|NCT00520403|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
102153|NCT00520468|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org
102154|NCT00520494|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
102155|NCT00520546|German Federal Armed Forces Hospital, Ulm|Major Medical Corps Dr. Markus Hartenbach|0049 731 1710 1851|markushartenbach@bundeswehr.org
102156|NCT00520572|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
102157|NCT00520676|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102158|NCT00513240|Baylor College of Medicine|Dr. Dean B. Andropoulos|832-826-5831|dra@bcm.edu
102159|NCT00513292|University of Texas MD Anderson Cancer Center, Houston, TX, USA|Aman U. Buzdar, MD|713-792-2817|abuzdar@mdanderson.org
102160|NCT00513305|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855|
102161|NCT00513344|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, Principal Investigator|+41217858054|maurice.beaumont@rdls.nestle.com
102162|NCT00513357|University of Texas MD Anderson Cancer Center|Dr. Egidio Del Fabbro|713-563-4157|ammarin@mdanderson.org
102165|NCT00513435|Memorial Sloan-Kettering Cancer Center|Matthew Fury, MD|646-888-4233|furym@mskcc.org
102166|NCT00513474|Massachusetts General Hospital|Bimalangshu R. Dey, MD, PhD||bdey@mgh.harvard.edu
102167|NCT00513500|Boston University|Kojo Yeboah-Antwi|617-414-1275|kyantwi@bu.edu
102168|NCT00513526|AMC|Group Statistician|501-526-6712|jylee@uams.edu
102169|NCT00513604|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov
102170|NCT00513617|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000 ext 244|karen_kesler@rhoworld.com
102171|NCT00513682|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634|
102172|NCT00513695|Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium|Jennifer Specht, MD|(206) 288-6889|jspecht@uw.edu
102173|NCT00513708|SUNY Buffalo|Schieder, Jeffrey|716-645-2977|jss10@buffalo.edu
102174|NCT00513799|Washington University|Stephanie Fritz|314-454-6050|fritz_s@kids.wustl.edu
102175|NCT00514020|Vanderbilt-Ingram Cancer Center|Laura Goff, MD|615-936-0059|laura.goff@vanderbilt.edu
102176|NCT00514137|Mayo Clinic Cancer Center|Shaji Kumar, M.D.||kumar.shaji@mayo.edu
102177|NCT00514215|Barbara Ann Karmanos Cancer Institute|Peter Littrup, M.D.|313-576-8758|littrupp@karmanos.org
102178|NCT00520741|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
102179|NCT00520767|Barbara Ann Karmanos Cancer Institute|Jeffrey Zonder, M.D.|313-576-8732|zonderj@karmanos.org
102180|NCT00520845|Vanderbilt-Ingram Cancer Center|Dr. Leora Horn|615-322-4967|leora.horn@vanderbilt.edu
102181|NCT00520936|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102182|NCT00520975|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012|
102183|NCT00521001|Mayo Clinic|Svetomir Markovic, MD, PhD|507/284-1370|markovic.svetomir@mayo.edu
102184|NCT00521014|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org
102186|NCT00521352|Columbia University Department of Psychiatry, City University of New York|Dr. Antonio Mantovani|212-650-5417|AMantovani@med.cuny.edu
102187|NCT00521365|AstraZeneca|Gerard Lynch|09645895 ext 4415|ClinicalTrialTransparency@astrazeneca.com
102188|NCT00521456|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com
102189|NCT00521586|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102190|NCT00521599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102191|NCT00521924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102192|NCT00521976|Stavanger University Hospital|Dennis W.T. Nilsen MD PhD FESC FAHA|+4705151 ext 9455|nide@sus.no
102193|NCT00521989|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com
102194|NCT00522041|Allergan plc|Susan Fox, PhD|201-427-8225|susan.fox@allergan.com
102195|NCT00522171|Ethicon Endo-Surgery|Sheryl Helsinger|513-337-3079|SHelsing@its.jnj.com
102196|NCT00522275|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
102197|NCT00522301|Memorial Sloan Kettering Cancer Center|Dr. William Tew|646-888-4220|teww@mskcc.org
102198|NCT00522379|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
102199|NCT00522392|ECOG Statistical Office|Study Statistician|617-632-3012|
102200|NCT00522418|Cyberonics, Inc|Mark Bunker, Senior Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com
102201|NCT00522431|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
102202|NCT00522457|Fresenius Biotech North America|Manager of Regulatory Affairs|781-699-4652|bao.le@fresenius-biotech.com
102203|NCT00522626|Johns Hopkins University School of Medicine|Dr. Lauren Jansson|410-550-5438|ljansson@jhmi.edu
102204|NCT00522795|BrUOG|Kayla Rosati|401-863-3000|Kayla_Rosati@brown.edu
102205|NCT00522873|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
102206|NCT00522925|Ligand Pharmaceuticals, Inc.|Ram Kapil, PhD/ Sr. Director, Clinical Pharmacology|858-550-7603|rkapil@ligand.com
102207|NCT00522951|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
102208|NCT00523237|Stanford University|Philip Grant, MD|650-723-2804|pmgrant@stanford.edu
102209|NCT00523341|Amgen Inc.|Study Director|866-572-6436|
102210|NCT00523367|University of Florida|Juan Munoz, MD|904-633-0089|juan.munoz@jax.ufl.edu
102211|NCT00523419|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102212|NCT00523549|Novartis Pharmaceuticals|Study Director|862-778-8300|
102213|NCT00523614|Berlin Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD, Principal Investigator|+49 30 94510145|dinger@zeg-berlin.de
102214|NCT00523640|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu
102215|NCT00523705|University of Pennsylvania|Ellen Freeman, Principal Investigator|215 662-3329|freemane@mail.med.upenn.edu
102216|NCT00523718|Yale University|Christopher Pittenger|(203) 974-7675|christopher.pittenger@yale.edu
102217|NCT00523744|Novartis Pharmaceuticals|Study Director|862-778-8300|
102218|NCT00517296|Vanderbilt University Medical Center|David A. Schwartz, MD|615-322-4643|david.a.schwartz@vanderbilt.edu
102219|NCT00517361|The University of Chicago|Dr. Rita Nanda|773-834-2756|rnanda@medicine.bsd.uchicago.edu
102220|NCT00517413|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
102221|NCT00517530|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
102222|NCT00517556|The Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu
102223|NCT00517595|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com
102224|NCT00517634|GlaxoSmithKline|GSK Response Center|866-435-7343|
102225|NCT00517699|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
102226|NCT00517751|Medtronic Spinal and biologics|Clinical Department|1800-876-3133 ext 6068|msbkclinicalresearch@medtronic.com
102227|NCT00517829|Texas Oncology, Tyler Cancer Center|Dr. Donald Richards|903-579-9800|donald.richards@usoncology.com
102228|NCT00517881|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
102229|NCT00517933|Duke Clinical Research Institute|Kevin J Anstrom, PhD|919-668-8902|kevin.anstrom@duke.edu
102230|NCT00518011|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
102231|NCT00518089|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com
102232|NCT00518115|GlaxoSmithKline|GSK Response Center|866-435-7343|
102233|NCT00518180|Novartis Vaccine and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com
102234|NCT00518206|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org
102235|NCT00523809|UT MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org
102236|NCT00523848|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
102237|NCT00523939|Duke University Medical Center|Dr. David Rizzieri|919-668-1040|rizzi003@mc.duke.edu
102238|NCT00523978|Medtronic AF Solutions|Linda Nelson, RN, BSN, MBA - AF Solutions Clinical Operations Director|(763)526-2891|linda.k.nelson@medtronic.com
102239|NCT00523991|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102240|NCT00524030|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102241|NCT00524043|Johnson & Johnson Pharmaceutical Research & Development|Clinical Team Leader, Paliperidone|609 730-2436|
102242|NCT00524121|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
102243|NCT00525525|University of California San Francisco|Michael D. Prados, MD, FACP|415-353-2383|pradosm@neurosurg.ucsf.edu
102244|NCT00525603|The University of MD Anderson Cancer Center|William G. Wierda, MD/Associate Professor|713-745-0428|eharriso@mdanderson.org
102246|NCT00525733|Aaron Diamond AIDS Research Center|Martin Markowitz MD|212-448-5020|mmarkowitz@adarc.org
102247|NCT00525798|Nordic Bioscience|Dr. Bente Juul Riis|+45 22901317|bjr@nordicbioscience.com
102248|NCT00525824|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
102249|NCT00525837|Butler Hospital|Noah S. Philip MD|401-455-6258|noah_philip@brown.edu
102250|NCT00525876|UT MD Anderson Cancer Center|Issa F. Khouri, MD/ Professor||celsaenz@mdanderson.org
102251|NCT00525902|Oregon Health & Science University|Eric B. Suhler|503-494-5023|suhlere@ohsu.edu
102252|NCT00525915|University of Texas (UT) MD Anderson Cancer Center|Jaffer Ajani, MD / Professor, GI Medical Oncology|713-792-2828|CR_Study_Registration@mdanderson.org
102253|NCT00526058|B. Braun Medical Inc.|Kevin Minnich, Manager Clinical Affairs/Safety Officer|610-596-2358|kevin.minnich@bbraun.com
102254|NCT00526097|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102255|NCT00526110|The University of Texas (UT) MD Anderson Cancer Center|Jaffer Ajani, MD/Professor, GI Medical Oncology|1-877-632-6789|CR_Study_Registration@mdanderson.org
102256|NCT00526123|Tufts Medical Center|Dr. Klemens B. Meyer|617-636-9421|kmeyer@tuftsmedicalcenter.org
102257|NCT00526162|Medtronic CRDM|CRDM Core Clinical Organization|800-328-2518|jamie.l.reynolds@medtronic.com
102258|NCT00526188|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
102259|NCT00526227|Medtronic CRDM|CRDM Core Clinical Organization|800-328-2518|jamie.l.reynolds@medtronic.com
102260|NCT00526292|Memorial Sloan Kettering Cancer Center|Dr. Katherine Hsu|646-888-2667|hsuk@mskcc.org
102261|NCT00526331|UT MD Anderson Cancer Center|Gabriel Mena, MD / Professor||CR_Study_Registration@mdanderson.org
102262|NCT00526474|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102263|NCT00526630|University of Cincinnati|Alberto Espay, MD|513-403-4600|alberto.espay@uc.edu
102264|NCT00526669|GlaxoSmithKline|GSK Response Center|866-435-7343|
102265|NCT00526799|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org
102267|NCT00526994|CDC|Joanne Klevens|770-488-1386|dzk8@cdc.gov
102268|NCT00527072|Janssen Biotech, Inc.|Sr. Director, Clinical Research - Medical Affairs|215-325-5711|
102269|NCT00527098|University of Miami|Kenneth Proctor, PhD|305-243-4694|kproctor@med.miami.edu
102270|NCT00527111|US Oncology Network, McKesson Specialty Health|Dr. David McCollum|214-370-1080|david.mccollum@usoncology.com
102271|NCT00527124|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath|313-576-8715|heathe@karmanos.org
102272|NCT00527319|Oxford Pharmaceutical Resources, Inc.|Dr. Richard Guarino|973-256-0600|Guarino@oxfordpharm.com
102273|NCT00527332|Deptartment of Obstetrics and Gynecology, University Hospital, Linköping, Sweden|Dr Preben Kjolhede|+46101030000 ext 3187|Preben.Kjolhede@lio.se
102274|NCT00527397|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
102275|NCT00527423|Regeneron Pharmaceuticals|Clinical Trials Administrator||clinicaltrials@regeneron.com
102276|NCT00527475|Texas Retina Associates|David Callanan, MD|817-261-9625|dcallanan@texasretina.com
119209|NCT01748955|New York State Psychiatric Institute|Michael F. Grunebaum, MD|6467747573 ext 646|mgruneb@nyspi.columbia.edu
102278|NCT00527514|Daiichi Sankyo|John Raia|(973) 630-2683|jraia@dsus.com
102279|NCT00527566|National Jewish Health|Michael Wechsler|617-285-4987|wechslerm@NJHealth.org
102280|NCT00527592|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com
102281|NCT00527605|GlaxoSmithKline|GSK Response Center|866-435-7343|
102282|NCT00527618|University of Washington, Virology Research Clinic|Tara Perti, MD|(206) 520-4340|tarap@u.washington.edu
102283|NCT00527722|UT MD Anderson Cancer Center|Sanjay Gupta, MD|713-563-7341|srao@mdanderson.org
102285|NCT00527748|University of Missouri|Dr. Saul G Trevino|573/884-8840|trevinos@health.missouri.edu
102286|NCT00527787|POZEN Inc|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com
102287|NCT00527826|GlaxoSmithKline|GSK Response Center|866-435-7343|
102288|NCT00527878|NIAID, NIH|Alexandra Freeman MD, Staff Clinician, Lead Associate Investigator for Protocol|301-594-9045|freemaal@mail.nih.gov
102289|NCT00527904|POZEN|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com
102290|NCT00527943|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102291|NCT00527982|UT MD Anderson Cancer Center|Waun K. Hong, MD/Professor||CR_Study_Registration@mdanderson.org
102292|NCT00528021|BTG International|Thomas Logan Ph.D.|610-943-3518|thomas.logan@btgplc.com
102293|NCT00521053|Provectus Biopharmaceuticals, Inc.|Eric Wachter, Chief Technology Officer|1-865-769-4011 ext 23|wachter@pvct.com
102294|NCT00521079|EnteroMedics Inc|Senior Vice President of Clinical|651-634-3209|ktweden@enteromedics.com
102295|NCT00521144|Memorial Sloan-Kettering Cancer Center|Dr. Lee Krug|646 888 4201|krugl@mskcc.org
102296|NCT00528112|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com
102297|NCT00528190|Ottawa Hospital Research Institute|Shawn Aaron|613-737-8259|saaron@ohri.ca
102298|NCT00528268|University of Utah|Dr. Kathryn Swoboda|801-585-9717|swoboda@genetics.utah.edu
102299|NCT00528931|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
102300|NCT00528957|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
102302|NCT00529087|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
102303|NCT00529100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102304|NCT00529126|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com
102305|NCT00529152|ApoPharma|Dian Shaw, Manager Clinical Research|416-401-7283|dshaw@apotex.com
102306|NCT00529191|Children's Hospital of Philadelphia|Steven Willi, MD|215-590-3174|willi@chop.email.edu
102307|NCT00529204|University of California Davis Medical Center|Christopher L. Bowlus, MD|916-734-8986|chris.bowlus@ucdmc.ucdavis.edu
102308|NCT00529217|Columbia University Department of Psychiatry, City University of New York|Dr. Antonio Mantovani|212-650-5417|AMantovani@med.cuny.edu
102309|NCT00529243|Kaiser Permanente|William Towner, MD|323-783-7855|William.J.Towner@KP.org
102310|NCT00529282|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clincal Team Lead|908 927-3785|
102311|NCT00529308|Yale University|Dr. Angeli Landeros-Weisenberger||angeli.landeros-weisenberger@yale.edu
102312|NCT00529399|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org
102313|NCT00529451|Novartis Pharmaceuticals|Study Director|862-778-8300|
102314|NCT00529464|UT MD Anderson Cancer Center|Helen E. Rhodes, MD / Assistant Professor|713-792-2933|CR_Study_Registration@mdanderson.org
102315|NCT00529516|GlaxoSmithKline|GSK Response Center|866-435-7343|
102316|NCT00529529|Novartis Pharmaceuticals|Study Director|862 778-8300|
102317|NCT00529542|Milton S. Hershey Medical Center|Richard S. Legro|717-531-8478|rsl1@psu.edu
102318|NCT00529555|Sunstar Americas, Inc|Marie Wilson, Clinical Program Manager|773-481-3327|marie.wilson@us.sunstar.com
102319|NCT00529568|GlaxoSmithKline|GSK Response Center|866-435-7343|
102320|NCT00529633|University of California, Davis|George Kaysen MD PhD, Principal Investigator|916-734-3774|gakaysen@ucdavis.edu
102321|NCT00529659|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102322|NCT00529763|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
102323|NCT00529789|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102324|NCT00530023|Director, Program Management, Clinical Research|Harold Torunsky|8185765445|harold.torunsky@medtronic.com
102325|NCT00530075|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200|
102326|NCT00530088|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
102327|NCT00530257|The Children's Hospital of Philadelphia|Dr. Nathan Blum|215-590-6336|blum@email.chop.edu
102328|NCT00530270|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000 ext 244|karen_kesler@rhoworld.com
102329|NCT00530335|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102330|NCT00530348|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
102331|NCT00530439|Odense University Hospital|Dr. Christina Vinter|+45 21782118|c.vinter@dadlnet.dk
102332|NCT00530504|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com
102333|NCT00530634|City of Hope|Jeff Longmate, Ph.D.|626-256-4673 ext 62478|jlongmat@coh.org
102334|NCT00530712|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com
102335|NCT00530764|GW Pharma Ltd.|Matthew Hersch, Senior Clinical Project Manager|+44 1353 616600|mhersch@gwpham.com
102336|NCT00530777|University of Washington|Dr. Carey Farquhar|206-543-4278|cfarq@uw.edu
102337|NCT00530790|GlaxoSmithKline|GSK Response Center|866-435-7343|
102338|NCT00530816|Onyx Pharmaceuticals, Inc.|Onyx Medical Information|1-877-ONYX-121|medinfo@onyx.com
102339|NCT00530842|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102340|NCT00530855|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
102341|NCT00530894|Edwards Lifesciences|Tenley Koepnick|949-250-6504|tenley_koepnick@edwards.com
102342|NCT00530920|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102343|NCT00530946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
102344|NCT00531011|Abbott Vascular, Italy|Maria Jose' M. Lopera|+39-02-516251|mariajose.lopera@av.abbott.com
102345|NCT00531050|Novartis Pharmaceuticals|Study Director|862-778-8300|
102587|NCT00545155|University of Rochester|Manish N. Shah|585-463-2920|manish.shah@rochester.edu
102346|NCT00531206|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102347|NCT00531284|Amgen, Inc.|Study Director|866-572-6436|
102348|NCT00531427|Purdue Pharma|Clinical Leader, Executive Medical Director|800-733-1333|
102349|NCT00524134|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu
102350|NCT00524225|University of Pittsburgh|Dr. Margaret Ragni, Professor of Medicine|412-209-7288|ragni@dom.pitt.edu
102351|NCT00524264|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com
102352|NCT00524303|GlaxoSmithKline|GSK Response Center|866-435-7343|
102353|NCT00524316|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
102354|NCT00524342|University of Pittsburgh|Dr. Margaret Ragni|412-209-7288|ragni@dom.pitt.edu
102355|NCT00524368|Tibotec Pharmaceuticals, Ireland|Medical Leader|+32 015 461 497|
102356|NCT00524394|University of Texas Health Science Center|James Murphy, PhD|713-500-5714|james.r.murphy@uth.tmc.edu
102357|NCT00524420|University of Washington|David H. Avery, MD, Professor|206-744-4527|averydh@u.washington.edu
102358|NCT00524459|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
102359|NCT00524485|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
102360|NCT00524511|UMass Memorial Medical Center|Dawn Tasillo, MD|5083346255|tasillod@ummhc.org
102361|NCT00524537|AbbVie|Global Medical Information|800-633-9110|
102362|NCT00524576|GlaxoSmithKline|GSK Response Center|866-435-7343|
102364|NCT00524680|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
102365|NCT00524745|PATH|Kathleen Neuzil, Principal Investigator|206-285-3500 ext 4864|kneuzil@path.org
102366|NCT00524771|Center for Epidemiology and Health Research, Germany|Dr. Juergen Dinger|0049 (0)30 945 101 20|dinger@zeg-berlin.de
102367|NCT00524940|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com
102368|NCT00525031|UT MD Anderson Cancer Center|Wen-Jen Hwu, MD/Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org
102369|NCT00525135|University of California San Francisco|UCSF PRS Administrator|415-502-3212|Elaine.Cooperstein@ucsf.edu
102370|NCT00525148|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102371|NCT00525161|University of Kentucky|Dr. Suleiman Massarweh|8593238043|massarweh@uky.edu
102372|NCT00525174|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org
102373|NCT00525265|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314|
102374|NCT00525421|University of California San Francisco|Nita Chainani-Wu|415-476-2045|nita.wu@ucsf.edu
102375|NCT00525499|AndroScience Corp|Charles CY Shih, PhD|(858) 638-7230|cyshih@androscience.com
102376|NCT00525512|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102377|NCT00531453|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM
102378|NCT00531479|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102379|NCT00531518|Maine Medical Center Research Institute|William R McFarlane, M.D.|207-662-4348|mcfarw@mmc.org
102380|NCT00531661|CardioMEMS, Inc.|Jordan Bauman|4043458235|jbauman@cardiomems.com
102381|NCT00531752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102382|NCT00532129|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
102383|NCT00532155|Sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com
102384|NCT00532259|CureTech Ltd.|Director Clinical Resaerch|+972-8-9324000|talh@curetechbio.com
102385|NCT00532298|GlaxoSmithKline|GSK Response Center|866-435-7343|
102386|NCT00532441|Hoosier Cancer Research Network, Inc.|Dr. EG Chiorean, MS|317-921-2050|jsmith@hoosiercancer.org
102387|NCT00532480|Indiana University|Dr. Amit Anand|317-944-7422|aanand@iupui.edu
102388|NCT00532493|VA Puget Sound Health Care System|Dr. Murray Rasknd|(206) 764-2702|Murray.Raskind@va.gov
102389|NCT00532779|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com
102390|NCT00532883|NHLBI|Harvey Luksenburg|301-435-0050|luksenburgh@mail.nih.gov
102391|NCT00532935|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102392|NCT00532948|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
102393|NCT00533117|NYSPI|Barbara Stanley|6467747582|bhs2@columbia.edu
102395|NCT00533351|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
102396|NCT00533442|University of Miami|Dr. George W. Burke, III|305-355-5111|gburke@med.miami.edu
102397|NCT00533507|GlaxoSmithKline|GSK Response Center|866-435-7343|
102398|NCT00533546|University of Rochester|Curtis Benesch, M.D., M.P.H.|585 275-2530|curtis_benesch@urmc.rochester.edu
102399|NCT00533702|Eli Lilly and company|Chief Medical Officer|800-545-5979|
102400|NCT00533897|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
102401|NCT00533949|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
102402|NCT00534001|Roswell Park Cancer Institute|Martin Mahoney|716-845-2300|martin.mahoney@roswellpark.org
102403|NCT00534092|Medtronic Spine LLC|Zhimin Liu|901-399-3123|zhimin.liu@medtronic.com
102404|NCT00534105|Baystate Medical Center|Glenn Markenson MD|413-794-8073|glenn.markenson@bhs.org
119211|NCT01738672|University of Pittsburgh|Ya’aqov Abrams, MD||abramsym@upmc.edu
102406|NCT00534248|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com
102407|NCT00534313|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
102408|NCT00534352|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488|
102409|NCT00534365|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org
102410|NCT00534404|University of Michigan|Larry An, MD|734-763-6099|lcan@med.umich.edu
102411|NCT00534417|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com
102412|NCT00534495|Children's Hospital at Montefiore|Dr.Norman T.Ilowite|718-696-2602|NILOWITE@montefiore.org
102413|NCT00528372|AstraZeneca Pharmaceuticals|Boaz Hirshberg||ClinicalTrialTransparency@astrazeneca.com
102414|NCT00528398|City of Hope National Medical Center|Anthony Stein, M.D.|626-256-4673 ext 82405|AStein@coh.org
102415|NCT00528411|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
102417|NCT00528450|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak|212-639-5518|maslakp@mskcc.org
102418|NCT00528528|Janssen Research & Development, LLC Titusville, NJ|Clinical Leader|609-730-3174|
102419|NCT00528541|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com
102420|NCT00528567|Hoffman-LaRoche|Medical Communications|800-821-8590|
102423|NCT00528775|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
102424|NCT00528788|Duke University Medical Center|Jula Inrig, MD|919-660-6882|Jula.Inrig@duke.edu
102425|NCT00528801|Children's Hospital of Oakland and Research Institute|Elliott Vichinsky, MD|510-428-3651|evichinsky@mail.cho.org
102427|NCT00528866|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
102428|NCT00528879|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
102429|NCT00534599|AstraZeneca|Gerard Lynch||AZtrial_results_posting@astrazeneca.com
102430|NCT00534638|GlaxoSmithKline|GSK Response Center|866-435-7343|
102431|NCT00534794|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com
102432|NCT00534833|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
102433|NCT00536263|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102434|NCT00536341|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
102435|NCT00536380|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102436|NCT00536471|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102437|NCT00536484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
102438|NCT00536510|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102439|NCT00536575|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
102440|NCT00536731|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
102441|NCT00536744|SANUWAVE, Inc.|Dr. Daniel Jorgensen, MD|678-578-0116|daniel.jorgensen@sanuwave.com
102442|NCT00536809|GlaxoSmithKline|GSK Response Center|866-435-7343|
102443|NCT00536874|Memorial Sloan-Kettering Cancer Center|Dr. Eileen O'Reilly|646-888-4182|oreillye@mskcc.org
102444|NCT00536913|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
102445|NCT00536978|UT MD Anderson Cancer Center|Issa F. Khouri, MD / Professor||pmcadams@mdanderson.org
102446|NCT00536991|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
102447|NCT00537017|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102448|NCT00537030|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
102449|NCT00537056|David Geffen School of Medicine at UCLA|Andrew Quon, M.D. Professor Division of Nuclear Medicine|310-983-1419|aquon@mednet.ucla.edu
102450|NCT00537082|Novartis Pharmaceuticals|Study Director|862-778-8300|
102452|NCT00537199|UT MD Anderson Cancer Center|Mark Chambers, MS, DMD / Professor|713-792-6510|
102453|NCT00537238|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102454|NCT00537277|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
102455|NCT00537303|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
102457|NCT00537329|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
102458|NCT00537381|Janssen Research & Development, L.L.C.|Senior Director|908-927-2116|
102459|NCT00537394|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301)628-3313|ACTGCT.Gov@s-3.com
102460|NCT00537407|Debiopharm International S.A.|Jean-Maurice Dumont, Vice President Medical Affairs|4121 321 01 11|jean-maurice.dumont@debiopharm.com
102461|NCT00537485|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6131-7366|
102462|NCT00537511|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
102463|NCT00537680|Santhera Pharmaceuticals|Dr Thomas Meier|+41619068964|thomas.meier@santhera.com
102464|NCT00537745|PIRE|Patricia Hokanson|505-765-2325|info@bhrcs.org
102465|NCT00537771|AstraZeneca|James J. Armbrust|+44 1625 518062|ClinicalTrialTransparency@astrazeneca.com
102466|NCT00537810|Yale University School of Medicine|Dr. Carlos Grilo|2037852792|carlos.grilo@yale.edu
102467|NCT00537823|Washington University School of Medicine|David Linehan, M.D.||David_Linehan@URMC.Rochester.edu
102468|NCT00537940|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102469|NCT00537979|Abbott|Global Medical Services|800-633-9110|
102470|NCT00538213|GlaxoSmithKline|GSK Response Center|866-435-7343|
102471|NCT00538291|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111 ext 65265|pfrankel@coh.org
102472|NCT00538304|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
102473|NCT00538434|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|
102474|NCT00538473|GlaxoSmithKline|GSK Response Center|866-435-7343|
102476|NCT00538590|Hospital of Universität Köln|Thomas Dietlein, Ph. D., MD|+49 221 4785862 ext 4300|thomas.dietlein@uk-koeln.de
102477|NCT00538616|Duke University|Dr. Carmelo Graffagnino|919/681-3751|Carmelo.Graffagnino@duke.edu
102478|NCT00538629|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
102479|NCT00538642|University of Texas Health Science Center at San Antonio|Dr. Alexander Miller|210-567-5508|millera@uthscsa.edu
102480|NCT00531817|Hoffmann-La Roche|Medical Communications|800-821-8590|
102481|NCT00531843|UCSF/SF General Hospital|M. Margaret Knudson, MD|415.205.4623|pknudson@sfghsurg.ucsf.edu
102482|NCT00531882|University Hospitals Case Medical Center|Michael W Konstan, MD|2168445267|michael.konstan@uhhospitals.org
102483|NCT00531934|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
102484|NCT00531947|Mylan Specialty L.P.|Kim Portland, Ph.D.|908.542.2636|kimberly.portland@mylan.com
102485|NCT00531960|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
102486|NCT00538733|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu
102487|NCT00538785|MedImmune, LLC|Pamela Griffin, Senior Director, Clinical Development|301 398 0000|griffinp@medimmune.com
102488|NCT00538824|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu
102489|NCT00538850|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602 910-2617|ldillaha@insysrx.com
102490|NCT00538863|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602-910-2617|ldillaha@insysrx.com
102491|NCT00538902|Abbott|Global Medical Services|800-633-9110|
102492|NCT00538915|DallasAllergyImmunology|Richard L. Wasserman, M.D., Ph.D.|(972) 566-7788|drrichwasserman@gmail.com
102493|NCT00538980|Weill Cornell Medicine|Richard T. Silver, MD|646-962-2273|rtsilve@med.cornell.edu
102494|NCT00539006|GlaxoSmithKline|GSK Response Center|866-435-7343|
102495|NCT00539032|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
102496|NCT00539864|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064 ext 153|ldunkle@proteinsciences.com
102497|NCT00539942|University of Alabama at Birmingham|Warner K. Huh, MD|205-996-4662|warner.huh@ccc.uab.edu
102498|NCT00539994|GlaxoSmithKline|GSK Response Center|866-435-7343|
102499|NCT00540046|Basic Health International|Miriam Cremer MD MPH|(646) 593-8694|miriam.cremer@gmail.com
102500|NCT00540124|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102501|NCT00540228|GlaxoSmithKline|GSK Response Center|866-435-7343|
102502|NCT00540293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
102503|NCT00540423|GlaxoSmithKline|GSK Response Center|866-435-7343|
102504|NCT00540436|GlaxoSmithKline|GSK Response Center|866-435-7343|
102505|NCT00540449|Janssen Infectious Diseases BVBA|Medical Leader||ClinicalTrialDisclosure@its.jnj.com
102506|NCT00540514|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
102507|NCT00540579|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
102508|NCT00540592|GlaxoSmithKline|GSK Response Center|866-435-7343|
102509|NCT00540644|IndianaU|Dr. Attaya Suvannasankha|317-944-0920|asuvanna@iu.edu
102510|NCT00540722|Adult Brain Tumor Consortium (ABTC)|John Fiveash, MD|410-955-8837|jfisher@jhmi.edu
102511|NCT00540969|Mayo Clinic|Matthew Callstrom, M.D., Ph.D.|5072664532|callstrom.matthew@mayo.edu
102512|NCT00541034|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens|1212-639-7053|brentjer@mskcc.org
102514|NCT00541190|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu
102515|NCT00541229|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
102516|NCT00541242|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
102517|NCT00541307|W. L. Gore & Associates, Inc.|Chad Badorek|928/437-8181|cbadorek@wlgore.com
102518|NCT00541346|University of Oklahoma Health Sciences Center|Thomas M. Lock, M.D.|405-271-5700 ext 45167|Thomas-Lock@ouhsc.edu
102519|NCT00541450|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||clinicaltrialsdisclosure@spcorp.com
102520|NCT00541593|Baystate Medical Center|Dr. John R. Romanelli|(413) 794-3175|john.romanelli@bhs.org
102521|NCT00541658|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
102522|NCT00541671|Christiana Care Health System|Deb Marco|302-733-4130|DMarco@christianacare.org
102523|NCT00541775|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102524|NCT00541970|GlaxoSmithKline|GSK Response Center|866-435-7343|
102525|NCT00542178|Wake Forest University School of Medicine|Dr. Walter Ambrosius, PhD|336-716-6281|wambrosi@wakehealth.edu
102526|NCT00534937|Allegheny General Hospital|Dr. Satish Muluk|(412) 359-3714|muluk@usa.net
102527|NCT00534976|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102528|NCT00535002|Medical University of South Carolina|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu
102529|NCT00535132|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136|
102530|NCT00535145|Ortho-McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136|
102531|NCT00535223|Atlanta VA Medical Center|David J. Ready,Ph.D.|(404) 321-6111 ext 7082|David.Ready@va.gov
102532|NCT00535262|Depression Evaluation Service, New York State Psychiatric Institute|Deborah A. Deliyannides, M.D. Research Psychiatrist|(212) 543-5734|deliiyan@nyspi.columbia.edu
102533|NCT00535288|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102534|NCT00535301|SCPMG/Kaiser Permanente|John N. Nguyen, MD|562-657-2642|john.n.nguyen@kp.org
102535|NCT00535392|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
102536|NCT00535405|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102537|NCT00535496|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102538|NCT00535587|Oregon Health & Science University|Kim Dupree Jones|503 494 3837|joneskim@ohsu.edu
102539|NCT00535652|University of Ulm|Prof. Dr. Henne-Bruns, PI|++4973150053500|doris.henne-bruns@uniklinik-ulm.de
102540|NCT00535730|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102541|NCT00535769|MGH Curtis|Dr. Alexa B. Kimball|617-726-5066|harvardskinstudies@partners.org
102542|NCT00535782|Hoffman-LaRoche|Medical Communications|800-821-8590|
102543|NCT00535821|Loma Linda University|H. Bryant Nguyen|909-558-4000 ext 44023|hbnguyen@llu.edu
102544|NCT00535847|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com
102545|NCT00535873|The University of Texas M D Anderson Cancer Center|Alessandra Ferrajoli, MD/Associate Professor|713-792-2063|eharriso@mdanderson.org
102546|NCT00535938|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
102547|NCT00536107|AstraZeneca|Sharon Chang||aztrial_results_posting@astrazeneca.com
102548|NCT00536120|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com
102549|NCT00536172|University of Nebraska|William Burke MD|4025526005|wjburke@Unmc.edu
102550|NCT00536198|Yale University School of Medicine|Kimberly A. Yonkers, M.D.|203-764-5914|Kimberly.Yonkers@yale.edu
102551|NCT00542269|Novartis Pharmaceuticals|Study Director|862 778-8300|
102552|NCT00542308|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com
102553|NCT00542321|University of Texas Health Science Center at Houston|Sandra K. Hanneman, PhD, RN, FAAN|713-500-2030|Sandra.K.Hanneman@uth.tmc.edu
102554|NCT00542386|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
102556|NCT00542490|University of Oklahoma|Lisa Landrum, MD|405 271-8001|lisa-landrum@ouhsc.edu
102557|NCT00542542|University of Texas MD Anderson Cancer Center|Dr. Farzin Goravanchi, Professor, Anesthesiology & Perioperative Medicine|713-563-5613|CR_Study_Registration@mdanderson.org
102558|NCT00542880|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
102559|NCT00542971|The University of MD Anderson Cancer Center|Farhad Ravandi-Kashani, M.D./Associate Professor|713-745-0394|fravandi@mdanderson.org
102560|NCT00542997|CSL Behring|Program Director, Clinical R&D|Use email contact|clinicaltrials@cslbehring.com
102561|NCT00543101|Community Research Initiative of New England (CRINE)|Clavin Cohen MD|617 502 1700|ccohen@crine.org
102562|NCT00543140|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com
102563|NCT00543296|Duke University Medical Center|Glenn J. Jaffe, MD|919-684-4458|jaffe001@mc.duke.edu
102565|NCT00543569|Astellas Pharma Global Development, Inc. (APGD)|Global Head Global Medical Sciences--Transplant and Immunology/Inflammation||Astellas.resultsdisclosure@astellas.com
102566|NCT00543725|Janssen Infectious Diseases BVBA|Medical Leader|32 14 641418|
102567|NCT00543764|BIDMC|Bernard Lee|617-632-7835|blee3@bidmc.harvard.edu
102568|NCT00543803|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102569|NCT00543855|Eisai Co., Ltd.|Masaki Nakagawa, Study Director|+81-3-3817-5245|
102570|NCT00543985|University of Missouri|Kevin C. Dellsperger, MD, PhD, Professor, Internal Medicine|573-884-2013|dellspergerk@health.missouri.edu
102571|NCT00544167|Sarah Cannon Research Institute|John Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net
102572|NCT00544440|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024|Senior Director|310-943-8040 ext 2917|
102573|NCT00544544|McLean Hospital|Brian P. Brennan, M.D.|617-855-2911|bbrennan@partners.org
102574|NCT00544557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1­-800­-718-­1021|ClinicalTrials.gov_Inquiries@pfizer.com
102575|NCT00544648|Vanderbilt-Ingram Cancer Center|Vicki Keedy, MD|615-936-3524|vicki.keedy@vanderbilt.edu
102576|NCT00544674|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com
102577|NCT00544713|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com
102578|NCT00544778|City of Hope National Medical Center|Paul Frankel, Ph. D.|(626)359-8111 ext 65265|pfrankel@coh.org
102579|NCT00544817|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net
102580|NCT00544869|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314|
102581|NCT00544882|Teva Branded Pharmaceutical Products R&D|Director of Clinical Research|610-786-7047|clinicaltrialsdisclosure@tevapharm.com
102582|NCT00544908|City of Hope|Paul Frankel, Ph.D.|626-256-4673 ext 65265|pfrankel@coh.org
102583|NCT00545025|GlaxoSmithKline|GSK Response Center|866-435-7343|
102584|NCT00545051|Hoffmannb-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
102585|NCT00545064|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
102588|NCT00545168|ParaPRO LLC|Director, Quality and Regulatory|317-810-6205|kerrym@parapro.com
102589|NCT00545181|Indiana University School of Medicine|David Haas, MD MS|3176307837|dahaas@iupui.edu
102590|NCT00545233|Hoffman-LaRoche|Medical Communications|800-821-8590|
102591|NCT00545272|Novartis Pharmaceuticals|Study Director|862-778-8300|
102592|NCT00545298|Nitric BioTherapeutics Inc|Frank J. McCaney, CEO Sponsor|215-788-6200|fmccaney@nbtherapeutics.com
102593|NCT00545363|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
102594|NCT00539110|Shriners Hospitals for Children|Michele Gottschlich PhD|513-872-6298|mgottschlich@shrinenet.org
102595|NCT00539188|Yale University School of Medicine|Christopher Pittenger, MD Ph.D|203-974-7675|christopher.pittenger@yale.edu
102596|NCT00539240|Southern Arizona VA Health Care System|Christopher Wendel, MS|520 792 1450 ext 1824|christopher.wendel@va.gov
102597|NCT00539253|Johns Hopkins Hospital|Ihab R. Kamel, M.D. PhD|410-955-4567|ikamel@jhmi.edu
102598|NCT00539279|VA San Diego Healthcare System|Steven R. Thorp, Ph.D., ABPP|(858) 552-8585 ext 2468|Steven.Thorp@va.gov
102599|NCT00539305|University of Washington|Monique Cherrier PhD.|206-277-3594|cherrier@u.washington.edu
102600|NCT00539513|Yale University School of Medicine|Christopher Pittenger, MD Ph.D|203-974-7675|christopher.pittenger@yale.edu
102601|NCT00539526|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com
102602|NCT00539539|Resusciatation Outcomes Consortium, University of Washington|Susanne May, Ph.D.|206-685-1302|sjmay@uw.edu
102603|NCT00539591|St. Jude Children's Research Hospital|Alberto Pappo, MD|901-595-2322|info@stjude.org
102604|NCT00539617|UCSF|W. Michael Korn, MD|415-502-2844|michael.korn@ucsf.edu
102605|NCT00539695|Texas Children's Hospital|Dr. Kathryn Leung|832-824-4219|kleung@bcm.edu
102606|NCT00539734|Prince of Songkla University|Patama Bhurayanontachai|66-74-451380|tpatama@hotmail.com
102607|NCT00545402|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
102608|NCT00545441|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com
102609|NCT00545506|Dep. Anesthesia And Intensive Care|Helmut Hager|+43 1 40400 4102|helmut.hager@meduniwien.ac.at
102610|NCT00545571|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
119215|NCT01697579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102612|NCT00545623|Boston University|Bei-Hung Chang|508-856-8959|bhchang@bu.edu
102613|NCT00545662|Columbia University|Dr. William Friedewald|212-305-3017|wtf1@columbia.edu
102614|NCT00545688|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
102615|NCT00546715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
102616|NCT00546728|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu
102617|NCT00546754|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
102618|NCT00546819|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102620|NCT00546884|University of Minnesota|John Song MD MPH MAT|612-624-8936|songx006@umn.edu
102621|NCT00546897|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu
102622|NCT00546910|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102623|NCT00547118|Maryland Psychiatric Research Center|Dr. Robert W. Buchanan|410-402-7876|rwbuchanan@mprc.umaryland.edu
102624|NCT00547157|Amgen Inc.|Study Director|866-572-6436|
102625|NCT00547365|University of Tennessee Graduate School of Medicine|Alan Solomon, MD|865-305-9167|asolomon@utmck.edu
102626|NCT00547456|North Shore LIJ Health System|Rubin Cohen, MD|516-465-5400|rocohen@nshs.edu
102627|NCT00547521|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
102628|NCT00547534|University of Rochester Medical Center|Dr. Jonathan Friedberg|585-275-4911|Jonathan_Friedberg@urmc.rochester.edu
102629|NCT00547638|Ethicon, Inc.|John Lombard, Clinical Research Manager|908 218 2877|jlombar8@its.jnj.com
102630|NCT00547703|Cleveland Clinic Florida|Fernando Castro|954-659-5646|castrof@ccf.org
102631|NCT00547911|National Institutes of Health|Dr. David Goldstein|301-496-1115|goldsteind@ninds.nih.gov
102632|NCT00548041|Temple University Hospital|Dr. Ellen Tedaldi|215-707-2000|ellen.tedaldi@tuhs.temple.edu
102633|NCT00548132|Washington University School of Medicine|Bernard C. Camins, MD|3144548351|bcamins@dom.wustl.edu
102634|NCT00548145|Osaka University Hospital|Hiroaki Kazui,Ph.D.|81-6-6879-3051|kazui@psy.med.osaka-u.ac.jp
102635|NCT00548184|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu
102636|NCT00548249|Rockwell Medical|Richard C. Yocum, MD|858-229-8585|ryocum@rockwellmed.com
102637|NCT00548262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102638|NCT00548327|Clinical Brain Disoders Branch-National Institute of Mental Health (NIMH)-National Institute of Health (NIH)|Jose A. Apud MD, PhD|301 5946561|apudj@mail.nih.gov
102639|NCT00548340|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com
102640|NCT00548405|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
102641|NCT00548418|Washington University School of Medicine|David G. Mutch, M.D.|314-362-2181|mutchd@wudosis.wustl.edu
102642|NCT00548431|Rigshospitalet, Juliane Marie Centret|Thomas Frandsen|+45 35458364|thomas.leth.frandsen@rh.regionh.dk
119216|NCT01696084|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency||tom.chmielewski@jazzpharma.com
102644|NCT00548548|Hoffman-LaRoche|Medical Communications|800-821-8590|
102645|NCT00548691|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com
102646|NCT00548717|Dana Farber Cancer Institute|Dr. Corey Cutler|617-632-3470|Corey_Cutler@dfci.harvard.edu
102647|NCT00548808|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102648|NCT00548847|Emory University|Martha Arellano, MD|404-778-1900|marella@emory.edu
102649|NCT00548860|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com
102651|NCT00549055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102652|NCT00549172|University of Helsinki|Dr. Teppo Järvinen, Head of study chair||teppo.jarvinen@helsinki.fi
102653|NCT00549198|GlaxoSmithKline|GSK Response Center|866-435-7343|
102654|NCT00542620|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
102655|NCT00542789|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
102656|NCT00542815|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
102657|NCT00542828|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com
102658|NCT00549302|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102659|NCT00549328|GlaxoSmithKline|GSK Response Center|866-435-7343|
102660|NCT00549393|Johns Hopkins University|Dr. Aaron Milstone|4106143917|amilsto1@jhmi.edu
102661|NCT00549445|University of Alabama at Birmingham|J. Edwin Blalock, PhD|205-934-6439|blalock@uab.edu
102662|NCT00549549|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102663|NCT00549562|Indiana University School of Medicine|David D. Dunn MD|317-944-8164|ddunn@iupui.edu
102664|NCT00550953|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102665|NCT00551031|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
102666|NCT00551070|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
102667|NCT00551135|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102668|NCT00551161|North Shore-LIJ Health System|Marc L. Gordon,MD|516-562-3492|MLGordon@nshs.edu
102669|NCT00551174|Hoffmann-La Roche|Medical Communications|800-821-8590|
102670|NCT00551200|Hyperion Therapeutics|Sr. Vice President and Chief Medical Officer, Bruce F. Scharschmidt|(650) 745-7851|bruce.scharschmidt@hyperiontx.com
102671|NCT00551213|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102672|NCT00551291|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
102673|NCT00551369|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
102674|NCT00551421|Dana-Farber Cancer Institute|Dr. Kimmie Ng|617-632-4150|kimmie_ng@dfci.harvard.edu
102675|NCT00551525|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
102676|NCT00551642|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com
102677|NCT00551707|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com
102678|NCT00551746|Intermountain Healthcare|Benjamin D Horne, PhD, MPH|801-507-4708|Benjamin.Horne@imail.org
102681|NCT00552058|UCB|Study Director|+1 877 822 9493|
102682|NCT00552084|Vanderbilt University Medical Center|Dr. C Michael Stein|615-936-3420|mike.stein@vanderbilt.edu
102683|NCT00552110|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102684|NCT00552175|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102685|NCT00552188|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com
102686|NCT00552240|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102687|NCT00552279|GlaxoSmithKline|GSK Response Center|866-435-7343|
102688|NCT00552305|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
102689|NCT00552344|UCB Cares|UCB (Study Director)|+1 887 822 9493|
102690|NCT00552396|Innate Pharma|Dr Renaud Buffet Senior Director, Clinical Development and Translational Research|+33430303032|renaud.buffet@innate-pharma.fr
102691|NCT00552409|University of Washington|Dr. Ian de Boer|206-616-5403|deboer@u.washington.edu
102692|NCT00552422|Columbia University|David Lederer|212-342-4167|tjb2134@cumc.columbia.edu
102693|NCT00552448|TexasTech|Dr. Adaobi Kanu|806 743 7336|adaobi.kanu@ttuhsc.edu
102694|NCT00552513|Population Health Research Institute|TIMACS Project Office|19055244322|timacs@phri.ca
102695|NCT00552578|SUNY Buffalo|R Blondell|716-898-4971|blondell@buffalo.edu
102696|NCT00552669|Centro de Estudios en Cardiologia Intervencionista|Alfredo Rodriguez, MD, PHD|541149648721|rodrigueza@sanatorio-otamendi.com.ar
102697|NCT00552695|Stony Brook U|Adam Singer|631-444-7857|adam.singer@stonybrook.edu
102698|NCT00552760|Lehigh Valley Hospital|Edward R. Norris, MD|(610) 402-5766|Edward.Norris@lvh.com
102699|NCT00552786|National Taiwan University|Dr. Yue-Liang Guo|+886-2-33228216|leonguo@ntu.edu.tw
102700|NCT00552812|Johns Hopkins School of Medicine|Dr. Richard E. Ringel|410-614-6745|rringel@jhmi.edu
102701|NCT00553098|Fred Hutch Cancer Research|Dr. Lauri Burroughs|206-667-2396|lburroug@fredhutch.org
102702|NCT00553150|Mayo Clinic|Jann N. Sarkaria, M.D.|507/284-3559|sarkaria.jann@mayo.edu
102703|NCT00553202|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
102704|NCT00553267|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102705|NCT00553280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102706|NCT00553319|Columbia University|Frances R. Levin, M.D.|646-774-6137|frl2@columbia.edu
102707|NCT00553332|The Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute|Tanios Bekaii-Saab, MD|614-293-9863|Tanios.Bekaii-Saab@osumc.edu
102708|NCT00553358|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
102709|NCT00545740|Shire Development LLC|Study Physician|+1 866 842 5335|
102710|NCT00545753|ParaPRO LLC|Director of Quality and Regulatory|317-810-6205|kerrym@parapro.com
102711|NCT00545766|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
102712|NCT00545779|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
102713|NCT00545792|Dana-Farber Cancer Institute|Akila N. Viswanathan, MD, MPH|617-732-6331|aviswanathan@lroc.harvard.edu
102715|NCT00545948|Duke University Medical Center|Neal Ready, PhD, MD|919-681-6932|neal.ready@duke.edu
102716|NCT00545974|UCSF Memory and Aging Center|Dr. Adam L. Boxer|4154760668|aboxer@memory.ucsf.edu
102717|NCT00546000|Fougera Pharmaceuticals Inc.|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com
102718|NCT00546052|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102719|NCT00546078|GlaxoSmithKline|GSK Response Center|866-435-7343|
102720|NCT00546104|Duke University Health System|Kimberly Blackwell, MD|919-668-1478|kimberly.blackwell@duke.edu
102721|NCT00546117|Washington University|Judith Lieu, MD|314-454-6162|lieuj@wustl.edu
102722|NCT00546156|Dana-Farber Cancer Institute|Dr Ian Krop|617-632-2335|ian.krop@dfci.harvard.edu
102723|NCT00546260|Portola Pharmaceuticals Inc.|Kevin Romanko, Senior Director Clinical Operations|650-246-7305|kromanko@portola.com
102724|NCT00546273|UTE. Fund. Inst. Germans Trias i Pujol|Cristina Vilaplana, MD|+34 93 497 86 81|cvilaplana@gmail.com
102725|NCT00546351|UCB Clinical Trial Call Center|UCB (Study Director)|1-887-822-9493|
102726|NCT00546364|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
102727|NCT00546377|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens, Associate Attending|+1212-639-7053|brentjer@mskcc.org
102728|NCT00546429|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|SHimden@its.jnj.com
102729|NCT00546481|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
102730|NCT00546572|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102731|NCT00546637|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
102732|NCT00553436|Ethicon Endo-Surgery, Inc|Amy Mahanes, Clinical Research Associate II|513-337-8366|amahanes@its.jnj.com
102733|NCT00553462|Yale Cancer Center|Rogerio Lilenbaum, M.D.||Rogerio.lilenbaum@yale.edu
102734|NCT00553475|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
102735|NCT00553501|University of Vermont, Vermont Cancer Center|Barbara Grant, MD||barbara.grant@vtmednet.org
102736|NCT00553514|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
102737|NCT00553605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102738|NCT00553631|Shire HGT|Tiffany Crump, Medical Communications Manager|484-595-8850|tcrump@shire.com
102739|NCT00553644|Veterans Affairs Medical Center/University of Minnesota|Vicki Morrison, M.D.||morri002@umn.edu
102740|NCT00553696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102742|NCT00554099|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
102743|NCT00554190|Carbylan BioSurgery Inc.|Marcee Maroney, VP Clinical Affairs|650 855 6774|mmaroney@carbylan.com
102744|NCT00554216|Vivus, Inc.|Wesley W. Day PhD|650-934-5200|day@vivus.com
102745|NCT00554229|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
102746|NCT00554294|Research Institute of Child Nutrition, Dortmund|Dr. Mathilde Kersting|0049 231 79221013|kersting@fke-do.de
102747|NCT00554372|SillaJen Biotherapeutics, Inc.|Manager, IP, Contracts, Translational Research|415 281 8886|tchiaverotti@sillajen.com
102750|NCT00554619|GlaxoSmithKline|GSK Response Center|866-435-7343|
102751|NCT00554671|Providence VA Medical Center|Wen-Chih Wu, MD|4012737100 ext 6237|wen-chih.wu@va.gov
102752|NCT00554749|Centre for Child and Adolescent Mental Health, Eastern and Southern Norway|Dr. Hanne Kristensen|+4722586000|hanne.kristensen@r-bup.no
102753|NCT00554801|Portland VA Medical Center|Marjorie R. Leek|503-220-8262 ext 54525|Marjorie.Leek@va.gov
102754|NCT00554840|Maryland Psychiatric Research Center|Elaine Weiner, M.D.|410-402-7694|eweiner@mprc.umaryland.edu
102755|NCT00554853|UMichigan|PPAR-gamma agonist, rheumatoid arthritis and cardiovascular disease|734-936-7905|makaplan@umich.edu
102756|NCT00554970|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com
102757|NCT00554996|Barbara Trautner, MD, PhD|Barbara Trautner, MD, PhD|713-440-4438|barbara.trautner@va.gov
102758|NCT00555009|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
102759|NCT00555048|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org
102760|NCT00555061|GlaxoSmithKline|GSK Response Center|866-435-7343|
102761|NCT00555152|University of Texas (UT) MD Anderson Cancer Center|Powel H. Brown, MD/Chair, Clinical Cancer Prevention||CR_Study_Registration@mdanderson.org
102762|NCT00555217|VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA|Linda Fried, MD, MPH|412-360-3930|Linda.Fried@va.gov
102764|NCT00555360|Ann Arbor VA Healthcare System|Dr. John Piette, PhD|734-845-3626|jpiette@umich.edu
102765|NCT00555425|Yale University|Dr. David Fiellin|203-688-2471|david.fiellin@yale.edu
102766|NCT00555438|CHU SAINT-ETIENNE|Pr patrick MISMETTI|33(1)477127788|patrick.mismetti@chu-st-etienne.fr
102767|NCT00555464|Medical College of Wisconsin|Beth Drolet, MD|414-955-2817|sjoachim@mcw.edu
108178|NCT00852540|GlaxoSmithKline|GSK Response Center|866-435-7343|
102768|NCT00555477|University of Michigan Comprehensive Cancer Center|Dr. Norah Lynn Henry|734-936-4991|norahh@umich.edu
102769|NCT00555568|CHOIR (Center for Healthcare Organization & Implementation Research|Susan V. Eisen|781-687-2858|susan.eisen@va.gov
102770|NCT00555620|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102771|NCT00555672|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102772|NCT00555750|Brigham and Women's Hospital|Dr. John Winkelman, MD, PhD|617-278-0061|jwwinkelman@partners.org
102773|NCT00555880|Shire|Study Physician|+1 866 842 5335|
102775|NCT00555906|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102776|NCT00555997|Massachusetts General Hospital|Dr. George Papakostas|617-726-6697|gpapakostas@partners.org
102777|NCT00556049|MGH Cancer Center|Dr. M. Dror Michaelson|617-726-1594|dmichaelson1@partners.org
102778|NCT00556075|Repros Therapeutics Inc.|Jennifer L. Wike|2817193402|jwike@reprosrx.com
102779|NCT00556140|Massachusetts General Hospital|Dr. John Matthews|617-724-0847|jmatthews@partners.org
102780|NCT00556166|Columbia University|Dennis Fowler|212-305-9914|dlf91@columbia.edu
102781|NCT00556322|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
102783|NCT00556400|NICHD|Dr. Pamela Stratton|301 496-9079|strattop@mail.nih.gov
102784|NCT00556426|C.R. Bard|John Reviere, Director of Clinical Affairs|480-303-2644|john.reviere@crbard.com
102785|NCT00549601|Novartis Pharmaceuticals|Study Director|862-778-8300|
102786|NCT00549640|Mayo Clinic|Dr. Richard D. Hurt|507-266-1944|nicotineresearch@mayo.edu
102787|NCT00549718|Sunovion Pharmaceuticals Inc.|Josephine Cucchiaro|201-592-2050|josephine.cucchiaro@sunovion.com
102788|NCT00549757|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
102789|NCT00549770|Novartis Pharmaceuticals|Study Director|862-778-8300|
102790|NCT00549783|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com
102791|NCT00549822|Massachusetts General Hospital|Dr. Paul Goss|617-724-3118|pgoss@mgh.harvard.edu
102792|NCT00549900|GlaxoSmithKline|GSK Response Center|866-435-7343|
102793|NCT00549939|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
102794|NCT00550043|Incyte Corporation|Study Director|1-855-463-3463|
102795|NCT00550147|Indiana University School of Medicine|David W. Dunn, MD|317-944-8162|ddunn@iupui.edu
102796|NCT00550173|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102797|NCT00550277|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com
102798|NCT00550368|Stanford University|Dr. Julie Parsonnet|(650) 725-4561|parsonnt@stanford.edu
102799|NCT00550394|University of Cincinnati|Melissa DelBello, MD, MS|513-558-2989|delbelmp@uc.edu
102800|NCT00550407|GlaxoSmithKline|GSK Response Center|866-435-7343|
102801|NCT00550446|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
119224|NCT01565616|Emory University|Lakshmanan Krishnamurti, MD||lakshmanan.krishnamurti@emory.edu
102803|NCT00550537|Vanderbilt-Ingram Cancer Center|Dr. Leora Horn, Principal Investigator||leora.horn@vanderbilt.edu
102804|NCT00550550|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102806|NCT00550654|National Cancer Institute, National Institutes of Health|Deborah Citrin, M.D.|301-496-5457|citrind@mail.nih.gov
102807|NCT00550680|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
102808|NCT00550732|Merck Sharp & Dohme Corp.|Senior Vice President, Globalo Clinical Development||ClinicalTrialsDisclosure@merck.com
102809|NCT00550745|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102810|NCT00550771|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102811|NCT00550836|Mayo Clinic|Steven R. Alberts, M.D.||alberts.steven@mayo.edu
102812|NCT00550862|Intercept Pharmaceuticals|Dr. David Shapiro|858-652-6800|dshapiro@interceptpharma.com
102814|NCT00556478|Plethora Solutions|Chief Scientific Officer|+44 (0) 20 3077 5400|mail@plethorasolutions.co.uk
102815|NCT00556491|St Louis University|Tarek El-Achkar|317 278 6822|telachka@iu.edu
102816|NCT00556504|TCM Biotech International|Dr. Ya-Chun Wang, EVP/CSO|886-2-26581677 ext 733|yachunwang@tcmbio.com
102817|NCT00556543|Oregon Health & Science University|John Mayberry, MD|503-494-5300|mayberrj@ohsu.edu
102818|NCT00556673|Novartis Pharmaceuticals|Study Director|862-778-8300|
102819|NCT00556712|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
102820|NCT00558285|Novartis Pharmaceuticals|Study Director|862-778-8300|
102821|NCT00558363|GlaxoSmithKline|GSK Response Center|866-435-7343|
102822|NCT00558428|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102823|NCT00558467|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102824|NCT00558558|UT MD Anderson Cancer Center|Ying Guo, MD - Associate Professor|713-745-2327|jaallo@mdanderson.org
102825|NCT00558571|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102826|NCT00558636|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
102827|NCT00558701|USAISR|Leopoldo C. Cancio, COL, MC|210-916-3301|leopoldo.c.cancio.mil@mail.mil
102828|NCT00558753|Rush University Medical Center|Asokumar Buvanendran, M.D.|(312) 942-3685|asokumar@aol.com
121226|NCT02363439|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com
121228|NCT02345226|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
102829|NCT00558792|Bracco Diagnostics Inc|Usha Halemane, Executive Director of Medical Biometrics and Medical Writing|609-514-2578|usha.halemane@diag.bracco.com
102830|NCT00558831|Northwestern University|Amy Paller, MD|312-695-6829|apaller@nmff.org
102831|NCT00558870|University of Texas (UT) MD Anderson Cancer Center|Sriram Yennurajalingam, Palliative Care & Rehabilitation Medicine||CR_Study_Registration@mdanderson.org
102832|NCT00558896|Mayo Clinic|Dr. Martha Lacy||lacy.martha@mayo.edu
102833|NCT00559013|Synovis|Lesa Hobright-Turner, Director of Clinical Affairs|651-796-7506|lesa.hobrightturner@synovissurgical.com
102834|NCT00559104|City of Hope National Medical Center|Dr. Auayporn Nademanee|626-256-4673 ext 62691|anademanee@coh.org
102835|NCT00559273|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
102836|NCT00559364|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634|
102837|NCT00559377|UWMC Dept of Radiology|Joseph G Rajendran|206-221-4421|rajan@u.washington.edu
102838|NCT00559507|Memorial Sloan-Kettering Cancer Center|Clifford Hudis, MD|646-888-4551|hudisc@mskcc.org
102839|NCT00559585|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
102840|NCT00559637|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
102841|NCT00559754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
102842|NCT00559897|Barbara Ann Karmanos Cancer Institute|Dr. Shirish Gadgeel|313-576-8753|gadgeels@karmanos.org
102843|NCT00559936|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-3313|cornea_research@meei.harvard.edu
102844|NCT00559949|UNC Lineberger Comprehensive Cancer Center|Dr. David Neil Hayes|919-966-3786|hayes@med.unc.edu
102845|NCT00559962|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867|
102847|NCT00560066|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
102848|NCT00560105|VA WNY Health Care System|Dr. S. Sethy|716-862-7875|ssethi@buffalo.edu
102849|NCT00560235|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102850|NCT00560313|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
102851|NCT00560352|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
102852|NCT00560391|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
102853|NCT00560404|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
102854|NCT00560417|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102855|NCT00560508|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102856|NCT00560560|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102857|NCT00560573|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102858|NCT00560612|Durham VA Medical Center|Christine Marx, MD|919 286-0411 ext 7426|marx0001@mc.duke.edu
102859|NCT00560703|Organization: Galderma R&D, Inc|Michael Graeber|609-409-7701|clinicaltrials@galderma.com
102860|NCT00560794|Amgen Inc.|Study Director|866-572-6436|
102861|NCT00560833|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102862|NCT00553735|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@MEEI.Harvard.edu
102863|NCT00553787|Vivus, Inc|Wesley W Day PhD|650-934-5200|day@vivus.com
102864|NCT00553839|Stanford University|Chandra Ramamoorthy, MBBS, FRCA|650-723-5728|chandrar@stanford.edu
102865|NCT00560859|University of Pennsylvania|Dr. Susan S. Ellenberg|215-573-3904|sellenbe@upenn.edu
102866|NCT00560885|AtriCure, Inc.|Jim Lucky|1-513-755-4101|jlucky@atricure.com
102867|NCT00560937|Durham Veterans Affairs Medical Center|Christine E. Marx, MD, MA|919 286-0411 ext 7426|marx0001@mc.duke.edu
102868|NCT00560950|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
102869|NCT00561002|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
102870|NCT00561015|Janssen Research & Development, LLC|Clinical Leader|609-730-3174|
102871|NCT00561145|Wageningen University|Dr Lisette de Groot|+31-317482220|lisette.degroot@wur.nl
102872|NCT00561834|Rocky Mountain Lions Eye Institute, Dept. of Ophthalmology|Dr. Naresh Mandava, M.D.|720-848-2500|Naresh.mandava@ucdenver.edu
102873|NCT00561912|UT MD Anderson Cancer Center|Ana M. Aparicio, MD / Assistant Professor||CR_Study_Registration@mdanderson.org
102874|NCT00561925|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102875|NCT00561951|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
102876|NCT00561977|UMass Medical School|Barbara Olendzki, RD MPH LDN|508-856-5195|barbara.olendzki@umassmed.edu
102877|NCT00562094|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com
102878|NCT00562120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102879|NCT00562159|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
102880|NCT00562302|Angiotech|Thomas Doyle|352.338.0440|tdoyle@angio.com
102881|NCT00562315|Emory University|David M. Schuster, MD|404-712-4859|dschust@emory.edu
102882|NCT00562328|Mayo Clinic|Dr. Clive Zent||zent.clive@mayo.edu
102883|NCT00562354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102885|NCT00562588|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102886|NCT00562627|Baerum Hospital|Ulrich Johannes Spreng|004798499184|ulispreng@hotmail.com
102887|NCT00562861|Tufts Medical Center|Nassir Ghaemi|6176365735|nghaemi@tuftsmedicalcenter.org
103126|NCT00564876|Duke University Medical Center|Neal Ready, MD|919-668-6688|neal.ready@duke.edu
102888|NCT00563290|The Ohio State University Comprehensive Cancer Center|Thomas Olencki, DO|614-293-2886|Thomas.Olencki@osumc.edu
102889|NCT00563316|Amgen Inc.|Study Director|866-572-6436|
102890|NCT00563368|Vivus, Inc.|Wesley W. Day PhD|650-934-5200|day@vivus.com
102891|NCT00563381|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102892|NCT00563576|Columiba University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu
102893|NCT00563706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102894|NCT00563797|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|203-932-5711 ext 4282|elizabeth.ralevski@yale.edu
102895|NCT00564265|Hospital de La Serena|Dr. Marcelo A. Beltran|56 - 51 - 485923|beltran_01@yahoo.com
102896|NCT00564278|Columbia Univ Med Center and New York State Psychiatric Institute|Roberto Lewis-Fernandez, MD, Professor of Psychiatry CUMC - NYSPI|646-774-8102|rlewis@nyspi.columbia.edu
102897|NCT00556894|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il
102898|NCT00556933|Wright State University, Dayton, Ohio|R. Brian Stevens, MD, PhD|937-545-4817|rbstevens1@icloud.com
102899|NCT00556946|University of California, Irvine|Kristen M. Kelly, M.D.|949-824-7103|kmkelly@uci.edu
102900|NCT00556972|Coloplast A/S|Thais Benjamin N. Christensen, Senior Clinical Project Manager|+4549112668|dkthc@coloplast.com
102901|NCT00556998|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102902|NCT00557076|Edward Hines, Jr VA Hospital|Dr. Theresa Pape|708-202-4953|Theresa.Pape@va.gov
102903|NCT00557245|University of Washington|Dr. Connie Celum|206-520-3824|ccelum@uw.edu
102904|NCT00557284|IMMUNOe International Research Centers|Dr. Isaac Melamed, principle investigator|303-773-9000|melamedi@immunoe.com
102905|NCT00557310|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
102906|NCT00557323|Shire Pharmaceutical|Timothy Whitaker, M.D.||twhitaker@shire.com
102907|NCT00557349|University of Missouri|Archana Ramaswamy, MD|573-884-4003|ramaswamya@health.missouri.edu
102908|NCT00557362|University of California San Francisco Proctor Foundation|Tom M/ Lietman|4155022662|tom.lietman@ucsf.edu
102909|NCT00557440|Novartis Pharmaceuticals|Study Director|862-778-8300|
102910|NCT00557466|Novartis Pharmaceuticals|Study Director|862-778-8300|
102911|NCT00557492|UPMC CancerCenter|Herbert Zeh, MD|4126922852|zehxhx@upmc.edu
102912|NCT00557505|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102913|NCT00557622|GlaxoSmithKline|GSK Response Center|866-435-7343|
102914|NCT00557830|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com
102915|NCT00557856|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102916|NCT00557947|Ethicon Inc|John Lombard|908-218-2877|Jlombar8@its.jnj.com
102917|NCT00558012|University of Pittsburgh|Dr. Susan Greenspan|412-692-2477|greenspn@pitt.edu
102918|NCT00558025|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102919|NCT00558064|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102920|NCT00558103|GlaxoSmithKline|GSK Response Center|866-435-7343|
102921|NCT00558246|Ethicon|Phyllis Britnell|1 908 218-3060|pbritnel@its.jnj.com
102922|NCT00558259|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
102923|NCT00558272|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
102924|NCT00564447|Inspire Pharmaceuticals, Inc.|Director of Clinical Research|010-941-9777|kkuhn@inspirepharm.com
102925|NCT00564486|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com
102926|NCT00564629|Mallinckrodt Pharmaceuticals|Lawrence Hill|(908) 238-6370|lawrence.hill@mallinckrodt.com
102927|NCT00567840|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org
102928|NCT00567879|Novartis|Study Director|862-778-8300|
102929|NCT00567892|Washington University|Dr. Jay F. Piccirillo|314.362.8641|piccirilloj@ent.wustl.edu
102930|NCT00567996|Novartis Pharmaceuticals|Study Director|862-778-8300|
102931|NCT00568022|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
102932|NCT00568061|INO Therapeutics LLC|James Baldassarre, MD|908-238-6603|james.baldassarre@ikaria.com
102933|NCT00568087|Minneapolis VA Health Care System|Gihyun Yoon, MD|612-467-3996|Gihyun.Yoon@va.gov
119226|NCT01542632|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com
102935|NCT00568334|GlaxoSmithKline|GSK Response Center|866-435-7343|
102936|NCT00568386|Alcon Research|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
102937|NCT00568399|Washington University School of Medicine|James Delmez, MD|314 362 7207|jdelmez@dom.wustl.edu
102938|NCT00568451|Mayo Clinic Cancer Center|Svetomir N. Markovic M.D., Ph.D.|507-284-2511 ext 4-2511|markovic.svetomir@mayo.edu
102939|NCT00568555|Stanford University School of Medicine|Jarred Younger, PhD|650-724-2795|jyounger@stanford.edu
102940|NCT00568685|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
102941|NCT00568776|Transition Therapeutics Ireland Limited|Aleksandra pastrak, MD, PhD, Vice President, Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com
102942|NCT00568854|Los Angeles County Department of Public Health|Dr. Alicia Chang|213-745-0846|alchang@ph.lacounty.gov
102943|NCT00568958|Yale University School of Medicine|Dr. Stephanie S. O'Malley|203-974-7590|stephanie.omalley@yale.edu
102944|NCT00569010|The University of MD Anderson Cancer Center|Jean-Pierre Issa, M.D./Professor|713-745-2260|eharriso@mdanderson.org
102945|NCT00569127|SWOG|SWOG Statistician|206-667-4408|
102946|NCT00569166|Mayo Clinic|Dr. Amit Sood|507-538-7623 ext 8-7623|sood.amit@mayo.edu
103127|NCT00564889|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu
102947|NCT00569192|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com
102948|NCT00569231|University of Arkansas for Medical Sciences|Mayumi Nakagawa, MD, PhD|(501) 686-8635|mnakagawa@uams.edu
102949|NCT00569270|Arthur F Gelb MD|Arthur F Gelb MD Principal Investigator|562-633-2204|afgelb@msn.com
102950|NCT00569374|University of Arkansas for Medical Sciences Center for Addiction Research|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu
102951|NCT00569530|UCSF|Roberta R. Keller MD||roberta.keller@ucsf.edu
102952|NCT00569582|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com
102953|NCT00569660|The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org
102954|NCT00569673|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org
102955|NCT00569777|Vistakon|Brian Pall OD MS FAAO|904-443-1290|
102956|NCT00569803|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
102957|NCT00569855|University of Arkansas, Arkansas Children's Hospital, Dept. of Pediatrics|Research Program Manager, Cardiovascular Surgery, Dept. of Pediatrics|501-364-1100 ext 5859|althagekarena@uams.edu
102958|NCT00569868|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|5015266990 ext 2461|pettynathanm@uams.edu
102959|NCT00569946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
102960|NCT00570037|Duke University Medical Center|Emmanuel Walter MD, Principal Investigator|919-620-5374|walte002@mc.duke.edu
102962|NCT00570141|Healthpoint, Ltd.|Herbert B. Slade, M.D., FAAAI|917-900-4000|bert.slade@healthpoint.com
102963|NCT00561340|University of Nebraska Medical Center|Christopher Kratochvil|4025526005|ckratoch@unmc.edu
102964|NCT00561353|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com
102965|NCT00561392|Novartis Pharmaceuticals|Study Director|862 778-8300|
102966|NCT00561418|The Ohio State University Comprehensive Cancer Center|Craig Hofmeister, MD|614-293-9869|craig.hofmeister@osumc.edu
102967|NCT00561431|University of Alabama at Birmingham|Ashita Tolwani, M.D.|2059752021|atolwani@uab.edu
102968|NCT00561457|Bard Peripheral Vascular|Director of Clinical Affairs|480-303-2644|John.Reviere@crbard.com
102969|NCT00561470|sanofi-aventis|International Clinical Development Study Director||contact-us@sanofi.com
102970|NCT00561574|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102971|NCT00561600|DePuy Orthopaedics|Dave Whalen Clinical Portfolio Leader|574-372-7028|dwhalen@its.jnj.com
102972|NCT00561652|Minneapolis VA Medical Center|Dr. Howard Fink|612-467-3304|howard.fink@va.gov
102973|NCT00561678|Icahn School of Medicine at Mount Sinai|Dr. Stacie Deiner|212-241-7749|stacie.deiner@mountsinai.org
102974|NCT00561730|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com
102975|NCT00561795|GlaxoSmithKline|GSK Response Center|866-435-7343|
102976|NCT00561821|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102977|NCT00570232|University of Alabama at Birmingham|Eben Rosenthal,MD|2059349713|erosenthal@uabmc.edu
102978|NCT00570310|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
102979|NCT00570349|INO Therapeutics|Brahm Goldstein|908-238-6495|brahm.goldstein@ikaria.com
102980|NCT00570362|St.Mary's Hospital, College of Medicine, The Catholic University of Korea|Jung-Il Moon|82-2-3779-2114 ext 1243|jimoon@catholic.ac.kr
102981|NCT00570401|Memorial Sloan Kettering Cancer Center|Dr. Gregory Riely|646-888-4199|rielyg@mskcc.org
102982|NCT00570492|GlaxoSmithKline|GSK Response Center|866-435-7343|
102983|NCT00570505|Apollo Endosurgery|Laura Eaton|949-468-9301|laura.eaton@apolloendo.com
102984|NCT00571103|University of Iowa Carver College of Medicine|Dr. Donald W Black|319-3534431|donald-black@uiowa.edu
102985|NCT00571194|Arkansas Children's Hospital|Dr. Eileen Ellis|501-364-1847|elliseileenn@uams.edu
102987|NCT00571428|Sunovion|Brovana Medical Director|1-866-503-6351|
102988|NCT00571649|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
102989|NCT00571662|University of Nebraska Medical Center Division of Oncology/Hematology|Bryan Ludwig, Regulatory Coordinator|402-559-8071|bmludwig@unmc.edu
102990|NCT00571688|University of Alabama at Birmingham|Tracy Manley|205-975-3442|tlmanley@uabmc.edu
102991|NCT00571701|Northwell Health (previously known as NorthShore-LIJ Health System)|Dr. Bettie Steinberg|516-562-1159|bsteinbe@northwell.edu
102992|NCT00571922|NYU Langone Medical Center|The Office of Clinical Trials|212.263.4210|clinicaltrials@nyumc.org
102993|NCT00571948|Research Institute of Child Nutrition|Dortmund Intervention Trial for Optimization of Infant Nutrition|0049 231 7922100|kersting@fke-do.de
102994|NCT00571961|Yale University AIDS Program|R. Douglas Bruce, MD, MA, MSc|(203) 737-6133|robert.bruce@yale.edu
102995|NCT00571974|Roswell Park Cancer Institute|Gal Shafirstein, D.Sc.|716-845-4025|Gal.Shafirstein@RoswellPark.org
102996|NCT00571987|UAMS|Dr. Suzanne Klimberg|501-686-6504|klimbergsuzanne@uams.edu
102997|NCT00572039|Thomas Jefferson University|Barry W. Rovner, MD|2155031254|Barry.Rovner@jefferson.edu
102998|NCT00572117|Stanford University School of Medicine|Michael J. Ostacher, MD, MPH, MMSc|650-493-5000|ostacher@stanford.edu
102999|NCT00572156|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
103000|NCT00572260|Duke University Health System|Yong Choi, Clinical Research Coordinator|919-684-7584|yong.choi@duke.edu
103001|NCT00572468|Portland VA Health Care System|Wesley Stoller|503-220-8262 ext 54931|wesley.stoller@va.gov
103003|NCT00572572|Hoosier Cancer Research Network|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org
103004|NCT00572624|Washington University School of Medicine|Dr. Linda Peterson, M.D.|314-362-4577|lpeterso@dom.wustl.edu
103005|NCT00572728|ACRIN|Ben Herman|401.863.9188|bherman@stat.brown.edu
103006|NCT00572832|University of Pittsburgh|Richard Zimmerman|412-383-2354|zimmer@pitt.edu
103007|NCT00572897|Univeristy of Illinois Hospital & Health Sciences System|Dr. Damiano Rondelli|312-996-6179|drond@uic.edu
103008|NCT00572910|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
103009|NCT00573066|Children's Hospital of Philadelphia|Athena Zuppa|267-426-7359|zuppa@email.chop.edu
103010|NCT00573131|BTG International|Senior Manager Biostatistics|801-556-8882|claire.daugherty@btgplc.com
103011|NCT00573144|Mayo Clinic|Dr. Horng H. Chen|507-284-1644|chen.horng@mayo.edu
103012|NCT00573157|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
103013|NCT00573170|GlaxoSmithKline|GSK Response Center|866-435-7343|
103014|NCT00573183|Univerity of Washington Alcohol & Drug Abuse Institute|Dr. Dennis Donovan|206-543-0937|ddonovan@u.washington.edu
103015|NCT00573248|University of California, Irvine|Jean Gehricke, Ph.D.|949-824-1834|jgehrick@uci.edu
103016|NCT00573261|Duke University Medical Center|Dr. Wei Jiang|919-668-0762|weijiang@duke.edu
103017|NCT00573287|Geisel School of Medicine at Dartmouth|Alan I. Green, M.D.|6036507549|alan.i.green@dartmouth.edu
103018|NCT00573313|University of California Davis|Dr. Charles H. Halsted|530-752-4054|chhalsted@ucdavis.edu
103019|NCT00573391|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990 ext 2461|pettynathanm@uams.edu
103020|NCT00573430|AstraZeneca|Gerard Lynch|+44 7780 956181 ext 5895|aztrial_results_posting@astrazeneca.com
103021|NCT00573443|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com
103022|NCT00573469|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
103023|NCT00573508|Astellas Pharma Global Development|Astellas Medical Monitor||clinicaltrials@us.astellas.com
103024|NCT00573534|Columbia University/New York State Psychiatric Instittue|Stephen J. Donovan MD|646 774 8078|sd45@columbia.edu
103025|NCT00565058|Aptose Biosciences Inc.|Peter Murray, Director Clinical Development|647-479-9812|pmurray@aptose.com
103026|NCT00565084|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
103027|NCT00565110|USC Suzanne Dworak-Peck School of Social Work|Kathleen Ell, DSW, Principle Investigator|760-399-0263|ell@usc.edu
103028|NCT00565136|Boston Urogynecology Associates|Peter Rosenblatt, MD; Director of Urogynecology|(617) 354-5452|prosenbl@mah.harvard.edu
103029|NCT00565266|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu
103030|NCT00565370|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr
103031|NCT00565409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103032|NCT00565448|sanofi|Trial Transparency Team||Contact-us@sanofi.com
103033|NCT00565461|Valneva Austria GmbH|Head Clinical Development|0043120620 ext 0|info@valneva.com
103034|NCT00565604|Lake Washington Vascular Surgery|Daniel Pepper, MD|(425) 453-1772|
103035|NCT00565617|Medical University of South Carolina|Gregory Sahlem|843-792-5716|sahlem@musc.edu
103036|NCT00565643|Lehigh Valley Health Network|Daniel Kiefer|484-664-7521|daniel_g.kiefer@lvhn.org
103037|NCT00565721|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|paul.gordon@ge.com
103038|NCT00565747|Origio A/S|Chief Scientific Officer|+45 46790200|sbendz@origio.com
103039|NCT00565812|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103040|NCT00566020|GlaxoSmithKline|GSK Response Center|866-435-7343|
103041|NCT00566111|Yale University Department of Psychiatry|Dr. Gerard Sanacora|(203) 974-7535|gerard.sanacora@yale.edu
103042|NCT00566150|Yale University|Dr. Zubin Bhagwagar|203-974-7560|zubin.bhagwagar@yale.edu
103043|NCT00566254|Eisai Call Center|Eisai Inc.|888-422-4743|
103044|NCT00566462|Eisai Call Center|Eisai Inc.|888-422-4743|
103045|NCT00566501|Eisai, Inc.|Andrew Satlin, Senior Vice President, Neuroscience Product Creation Unit|201-949-4597|Andrew_Satlin@eisai.com
103046|NCT00566579|Department of OBGYN, Faculty of Medicine, Khon Kaen University, 40002, THAILAND|Bandit Chumworathayi|66818733327|bunchu@kku.ac.th
103047|NCT00566631|Janssen-Cilag Germany|EMEA Therapeutic Area Leader CNS|+492137955153|
103048|NCT00566696|St. Jude Children's Research Hospital|Brandon Triplett, MD|866-278-5833|referralinfo@stjude.org
103049|NCT00566709|"University Hospital Virgen del Rocío"|Santiago R Leal-Noval, MD, PhD|0034954012528|srlealnoval@gmail.com
103050|NCT00566722|Abbott|Global Medical Services|800-633-9110|
103051|NCT00566735|Massachusetts General Hospital|Dr. John Matthews|617-724-0847|jmatthews@partners.org
103052|NCT00566852|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
103053|NCT00566930|UQTR|Martin Descarreaux|819 376-5011 ext 3077|martin.descarreaux@uqtr.ca
103054|NCT00566943|Synovis Surgical Innovations|Lesa Hobright-Turner, Director Clinical Affairs|651-796-7506|lesa.hobrightturner@synovissurgical.com
103055|NCT00566969|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711 ext 4809|mehmet.sofuoglu@yale.edu
103056|NCT00566982|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
103057|NCT00566995|National Cancer Institute|Dr. W. Marston Linehan|301-496-6353|linehanm@mail.nih.gov
103058|NCT00567008|UPenn|Jennifer Plebani|2152223200 ext 152|jplebani@mail.med.upenn.edu
103059|NCT00567112|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
103060|NCT00567164|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
103061|NCT00567190|Genentech, Inc.|Medical Communications|800 821-8590|
103062|NCT00567229|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun|212-639-3228|hassounh@mskcc.org
103063|NCT00567242|University of Florida|Bruce Crosson, PhD / Professor|352-273-6617|nossorc1@phhp.ufl.edu
103064|NCT00567255|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com
103065|NCT00567268|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103066|NCT00567307|Wake Forest School of Medicine, Winston Salem, NC|Dr. Elsayed Z Soliman, Director of the Epidemiological Cardiology Research Center|336-716-8632|esoliman@wakehealth.edu
103067|NCT00567320|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu
103068|NCT00567476|Novartis Pharmaceuticals|Study Director|862 778-8300|
103069|NCT00567502|Shire|Study Physician|1 866-842-5335|
103070|NCT00567541|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com
103071|NCT00567567|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|Resultsreportingcoordinator@childrensoncologygroup.org
103072|NCT00567593|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu
103073|NCT00573755|Mayo Clinic|Dr. Vivek Roy|507-284-1159|roy.vivek@mayo.edu
103074|NCT00573768|Novartis Consumer Health|Sandy Hamelsky|+19735037258|sandy.hamelsky@novartis.com
103075|NCT00573859|University of California, Irvine|Jean Gehricke, Ph.D.|949-824-1834|jgehrick@uci.edu
103076|NCT00573937|Mayo Clinic|Donald Northfelt, MD|480-301-8335|northfelt.donald@mayo.edu
103077|NCT00575367|Inspire Pharmaceuticals, Inc.|Karen Kuhn/ Director|919 941-9777|kkuhn@inspirepharm.com
103078|NCT00575380|Inspire|Mike Schiewe|919-941-9777|mschiewe@inspirepharm.com
103079|NCT00575510|Mayo Clinic|Dr. Carmen Radecki Breitkopf|507-266-0969|radeckibreitkopf.carmen@mayo.edu
103080|NCT00575588|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
103081|NCT00575666|UMass Medical School|Xiaoduo Fan, MD, MPH, MS|508-856-3881|Xiaoduo.Fan@umassmed.edu
103082|NCT00575887|Marmara University|Ufuk Abacioglu|902123853100|ufuk@abacioglu.com
103083|NCT00575965|Dana Farber Cancer Institute|Steven P. Treon MD, PhD|617 632 5880|steven_treon@dfci.harvard.edu
103084|NCT00576056|University of Pittsburgh Medical Center|Dr. David Geller|412-692-2001|gellerda@upmc.edu
103085|NCT00576147|Baylor College of Medicine|Claudia Robertson|(713) 798-8932|claudiar@bcm.edu
103086|NCT00576199|Hoffmann-La Roche|Medical Communications|800 821-8590|
103087|NCT00576251|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
103088|NCT00576303|F. Hoffmann-La Roche AG|Name/Official Title:Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
103089|NCT00576316|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
103090|NCT00576381|The Children's Hospital of Philadelphia|Dr Athena Zuppa|267-426-5753|zuppa@email.chop.edu
103091|NCT00576420|BAXTER INNOVATIONS GmbH|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com
103092|NCT00576472|St. Jude Children's Research Hospital|Heather Conklin PhD|1-866-278-5833|info@stjude.org
103093|NCT00576524|Children's Hospital of Philadelphia|Marsha Wallace|(215) 590-0119|wallacem@email.chop.edu
103094|NCT00576576|Emory|Dr. Habib Samady|4047781237|hsamady@emory.edu
103095|NCT00576628|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
103096|NCT00576693|Medical University of South Carolina|Marc I. Chimowitz, MBChB|843-792-3020|mchimow@musc.edu
103097|NCT00576732|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clinical Leader|609 730 2317|
103098|NCT00576758|Hoffman-LaRoche|Medical Communications|800-821-8590|
103099|NCT00576823|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com
103100|NCT00576901|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
103101|NCT00576927|Emory University Division of General Medicine and Geriatrics|Dr. Patricia Griffiths|404-321-6111 ext 7138|pcgriff@emory.edu
103102|NCT00577005|University of Massachusetts Medical School|Gerardo Gonzalez, MD|508 856 6480|gerardo.gonzalez@umassmed.edu
103103|NCT00577031|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
103104|NCT00577083|Indiana University|Douglas K Rex, MD|317-948-8741|drex@iu.edu
103105|NCT00577096|University of Arkansas for Medical Sciences|Elizabeth Ann Coleman|501-661-7902|colemanelizabetha@uams.edu
103106|NCT00577122|IndianaU|Kathy Miller, MD||kathmill@iupui.edu
103107|NCT00577135|Duke University|Jeff Sharp|919.668.7086|jeff.sharp@dm.duke.edu
103108|NCT00577356|Virginia Mason Medical Center|Jacqueline Vuky, MD|(206) 223-6193 ext 32246|Jacqueline.Vuky@vmmc.org
103109|NCT00577382|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu
103110|NCT00577395|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
103111|NCT00577408|New York State Psychiatric Institute|Edward V. Nunes, MD|646-774-6122|edward.nunes@nyspi.columbia.edu
103112|NCT00577460|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
103113|NCT00577473|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
103115|NCT00577629|Duke University Medical Center|Anne Beaven, MD|919-684-8964|anne.beaven@duke.edu
103116|NCT00577642|Massachusetts General Hospital|Dr Noopur Raje|6177260711|nraje@partners.org
103117|NCT00577655|Teval Global Respiratory Research LLC|Teva Study Physician|215-293-6482|
103118|NCT00577707|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org
103119|NCT00577720|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
103120|NCT00577772|Mayo Clinic|Dr. John K. DiBaise|480-301-6990|dibaise.john@mayo.edu
103121|NCT00577824|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
103122|NCT00577863|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
103123|NCT00564681|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
103124|NCT00564733|University of Washington|Keith D. Eaton, MD, PhD|2062886249|kdeaton@uw.edu
103125|NCT00564850|Ipsen|Medical Director, Endocrinology||clinical.trials@ipsen.com
103128|NCT00564902|James A. Lovell Federal Health Care Center|Dr. Stuart P. Richer|224-610-5440|Stuart.Richer1@va.gov
103129|NCT00564954|Novartis Pharmaceuticals|Study Director|862-778-8300|
103130|NCT00565045|MetroHealth Medical Center|Dr. Jayme Knutson|216-778-8364|jsk12@case.edu
103131|NCT00570531|University of Michigan Comprehensive Cancer Center|Susan Urba, M.D.|734-615-4762|surba@umich.edu
119229|NCT01520207|Brigham and Women's Hosptial|Dr. Finnian Mc Causland|6177326432|fmccausland@partners.org
103133|NCT00570687|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com
103134|NCT00570713|Morphotek, Inc.|Susan Weil, MD|610-423-6182|sweil@morphotek.com
103135|NCT00570739|Daiichi Sankyo, Inc.|John Raia, Senior Director Professional Affairs|(973) 944-2683|jraia@dsi.com
103136|NCT00570765|Intercept Pharmaceuticals, Inc.|Cathi Sciacca, Sr. Director, Clinical Operations|858-652-6803|csciacca@interceptpharma.com
103137|NCT00570778|Novartis Pharmaceuticals|Study Director|862-778-8300|
103138|NCT00570908|Baylor Coolege of Medicine|Dr. Mothaffar Rimawi|7137981811|rimawi@bcm.edu
103139|NCT00570921|University of Kentucky|Dr. Mara D. Chambers|866-340-4488|mdcham2@email.uky.edu
103140|NCT00570960|University of Virginia|Patrick G. Northup, M.D.|434-924-0000|northup@virginia.edu
103141|NCT00571038|Clement J. Zablocki VA Medical Center|Jeff Whittle, MD, MPH|414-384-2000 ext 46444|jeffrey.whittle@va.gov
103142|NCT00577889|Mayo Clinic Cancer Center|Robert McWilliams, M.D.||McWilliams.robert@mayo.edu
103143|NCT00578071|Duke University Medical Center Radiation Oncology|Dr Brian Czito|668-7336|brian.czito@duke.edu
103144|NCT00578136|The Children's Hospital of Philadelphia|Harshad Gurnaney, MBBS, MPH|267-426-5850|gurnaney@email.chop.edu
103145|NCT00578175|GlaxoSmithKline|GSK Response Center|866-435-7343|
103146|NCT00578214|Mayo Clinic|Dr. Clark C. Otley|507-284-3579|otley.clark@mayo.edu
103147|NCT00578227|GlaxoSmithKline|GSK Response Center|866-435-7343|
103148|NCT00578864|BAYLOR|Peter Zage, MD|832-824-4615|pezage@txch.org
103149|NCT00578877|CONRAD|Jill Schwartz, M.D.|703-276-3913|jschwartz@conrad.org
103150|NCT00578903|Baylor College of Medicine|Kathryn Leung|832-824-4269|kleung@bcm.edu
103151|NCT00578929|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
103152|NCT00578942|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu
103153|NCT00578968|Mayo Clinic|Bruce D. Johnson, PhD|507-284-4441|johnson.bruce@mayo.edu
103154|NCT00579059|Biomet, LLC|Megan Lawson, Clinical Research Specialist|1-800-348-9500 ext 1183|megan.lawson@biomet.com
103155|NCT00579098|Mayo Clinic|Paul A. Friedman, MD|507-255-2398|friedman.paul@mayo.edu
103156|NCT00579111|Baylor|Rammurti Kamble, MD|713-394-6252|rtkamble@tmhs.org
103157|NCT00579137|Baylor|Robert Krance, MD|832-824-4661|rkrance@bcm.edu
103158|NCT00579254|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
103159|NCT00579345|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
103160|NCT00579501|PharmaMar SA, Av de los Reyes 1 Mine Industrial Estate, 28770 Colmenar Viejo, Madrid, Spain|Medical Specialist, Clinical Oncology|+34 91 646-6087|
103161|NCT00579670|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103162|NCT00579813|University of Arkansas for Medical Sciences|Robert E. McGehee Jr., Ph.D.|501-603-1998|rem@uams.edu
103163|NCT00579826|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu
103164|NCT00579982|GlaxoSmithKline|GSK Response Center|866-435-7343|
103165|NCT00580034|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu
103166|NCT00580073|University of Wisconsin-Madison|CRA|608-265-4347|smccarthy@medicine.wisc.edu
103167|NCT00580138|University of Arkansas for Medical Sciences Medical Center|Gary McCullough|501-852-7886|mcculloughgaryh@uams.edu
103168|NCT00580151|University of Texas-Galveston|Walter Meyer, M.D.|409-770-6718|wmeyer@utmb.edu
103169|NCT00580229|University of South Florida|John D. Carter, M.D.|813-974-2681|jocarter@health.usf.edu
103170|NCT00580294|Icahn School of Medicine at Mount Sinai|Marco Pappagallo, MD|212-241-7749|dionne.bobb@mountsinai.org
103171|NCT00580333|Massachusetts General Hospital|Dr. Steven Isakoff|617 726 6500|sisakoff@partners.org
103172|NCT00580372|University of Arkansas for Medical Science|Dr. Bart Barlogie|501-526-2873|
103173|NCT00580398|Massachusetts General Hospital|Elyse Park, Ph.D., MPH|617-724-6836|epark@partners.org
103174|NCT00580502|NYULMC|Heekoung Youn|2122632174|younh01@nyumc.org
103176|NCT00580671|Geisel School of Medicine at Dartmouth|Alan J. Budney, PhD|855-290-2822|alan.j.budney@dartmouth.edu
103177|NCT00580723|University of California, Irvine|Brian Swasdibutra, Clinical Research Coordinator|9498247103|bswasdib@uci.edu
103178|NCT00580788|University of Pittsburgh|Mara J Horwitz, MD|4126922848|horwitz@pitt.edu
103179|NCT00580801|Janssen Research & Development, LLC, Titusville, NJ|Clinical Leader|609-730-3174|
103180|NCT00580840|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
103181|NCT00580853|Yale University|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu
103182|NCT00580866|Vanderbilt|William Obremskey|6159363630|william.obremskey@Vanderbilt.Edu
103183|NCT00580957|Vanderbilt University|Italo Biaggioni, M.D. Professor of Medicine|(615) 936-3420|italo.biaggioni@vanderbilt.edu
103184|NCT00580970|Virginia Commonwealth University/Massey Cancer Center|Mitchell S. Anscher, M.D. Professor and chairman|804-828-7238|mitchell.anscher@vcuhealth.org
103185|NCT00580983|University of Michigan Comprehensive Cancer Center|Dr. Avraham Eisbruch, M.D.|734-936-4302|eisbruch@umich.edu
103186|NCT00581061|University of California, Irvine|Doug Skarecky|714-456-6744|dwskarec@uci.edu
103187|NCT00581100|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
103188|NCT00581113|Virginia Commonwealth University|Martha D. Wellons|804-628-1939|mwellons@vcu.edu
103189|NCT00581230|UT Medical School at Houston|Carin A. Hagberg|713-500-6222|carin.a.hagberg@uth.tmc.edu
119232|NCT01437488|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Jean Hoffman-Censits|215 955-8874|jean.hoffman-censits@jefferson.edu
103192|NCT00574067|Friends Research Institute|Dr. Michael Gordon|410-837-3977 ext 251|mgordon@friendsresearch.org
103194|NCT00574145|Vanderbilt-Ingram Cancer Center|Nancy Wells, DNSc., R.N|615-322-6184|nancy.wells@vanderbilt.edu
103195|NCT00574171|UW Carbone Cancer Center|Dr. William Schelman|608-265-4347|wrs@medicine.wisc.edu
103196|NCT00574249|Abbott|Medical Information Specialist|1-800-633-9110|
103197|NCT00574275|Sanofi|International Clinical Development Study Director||Contact-Us@sanofi.com
103198|NCT00574288|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com
103199|NCT00574340|University of Maryland, Baltimore|Dr. Stephen N. Davis|410-328-2488|sdavis@medicine.umaryland.edu
103200|NCT00574405|Arkansas Children's Hospital Research Institute|Kathryn Thrailkill, MD|501-364-1430|thrailkillkathrynm@uams.edu
103201|NCT00574548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103202|NCT00574704|Cytos Biotechnology AG|Head of Clinical Develpment|+41 44 733 4 ext 7 47|info@cytos.com
103203|NCT00574795|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
103204|NCT00574834|University of Maryland Baltimore|Stephen N. Davis, MBBS- Principal Investigator|410-328-2488|sdavis@medicine.umaryland.edu
103205|NCT00574847|Duke University Medical Center|Wei Jiang, MD|919-668-0762|jiang001@mc.duke.edu
103206|NCT00574873|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103207|NCT00574912|University of Maryland, Baltimore|Dr. Stephen N. Davis|4103282488|sdavis@medicine.umaryland.edu
103208|NCT00574990|Salt Lake City VA HSRD IDEAS 2.0 Center of Innovation|Dr. Charlene Weir|801-582-1565 ext 5114|charlene.weir@utah.edu
103209|NCT00575016|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
103210|NCT00575029|University of Arkansas|Dr. Donald Bodenner|501-526-5710|bodennerdonald@uams.edu
119234|NCT01410227|Baxalta US Inc|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com
103212|NCT00575094|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
103213|NCT00575146|Dr. Senckenberg Institute of Neurooncology|Dr. Johannes Rieger|+49 69 6301 ext 87711|johannes.rieger@med.uni-frankfurt.de
103215|NCT00575185|University of Minnesota|Hank Balfour MD|(612) 626-5670|balfo001@umn.edu
103216|NCT00581347|University of Rochester Medical Center|Peter Szilagyi|585-275-5798|peter_szilagyi@urmc.rochester.edu
103217|NCT00581360|Clinical Research Services, UPCI|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu
103218|NCT00581386|UTHSC- Houston Medical School|Dr. Carin A. Hagberg|713.500.6222|maddukuri.vineela@uth.tmc.edu
103219|NCT00581399|University of California, Irvine Medical Center|Dr. Jeffrey C. Milliken|714-456-3634|jcmillik@uci.edu
103221|NCT00581542|University of Rochester, Strong Mem orial Hospital|Franci Gigilotti|585 275-0588|francis_gigilotti@urmc.rochester.edu
103222|NCT00581555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103223|NCT00581581|University of Rochester|Ronnie Guillet, MD, PhD|585-275-6209|ronnie_guille@urmc.rochester.edu
103224|NCT00582660|University of Alabama at Birmingham|Martin J. Heslin M.D.|205-975-0450|marty.heslin@ccc.uab.edu
103225|NCT00582712|University of Wisconsin Carbone Cancer Center|Director of Clinical Research|608-265-0540|clinicalresearch@surgery.wisc.edu
103226|NCT00582738|Pharmaceuticals|Novartis|41613241111|
119237|NCT01347632|CONRAD|Andrea Thurman|757-446-7444|thurmaar@evms.edu
103228|NCT00582816|University of Wisconsin Carbone Cancer Center|Dr. Ken DeSantes|608-263-8563|kbdesantes@pediatrics.wisc.edu
103229|NCT00582894|University of Oklahoma Health Sciences Center|George Selby, MD|405/271-4022|george-selby@ouhsc.edu
103230|NCT00582907|Shaare Zedek Medical Center/Cleveland Clinic|Philip Hashkes, MD, MSc|972-2-6555307|hashkesp@szmc.org.il
103231|NCT00582933|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-2429|bouladf@mskcc.org
103232|NCT00582946|EarLens Corporation|Sunil Puria|650-366-9000|spuria@earlenscorp.com
103233|NCT00582972|University of Wisconsin|Dr. Karen Hansen|608-263-3457|keh@medicine.wisc.edu
103234|NCT00583115|Indiana University|Ronald Mark Payne MD|317-278-6329|rpayne@iu.edu
103235|NCT00583219|Mayo Clinic|Dr. Steven P. Petrou|904-953-7330|petrou.steven@mayo.edu
103236|NCT00583362|GlaxoSmithKline|GSK Response Center|866-435-7343|
103237|NCT00583453|University of Iowa|Douglas Van Daele|319-353-8162|douglas-van-daele@uiowa.edu
103238|NCT00583466|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|410-550-6484|registerclinicaltrials@jhmi.edu
103239|NCT00583492|Henry Ford Health System|Benjamin Movsas|313-516-2319|bmovsas1@hfhs.org
103240|NCT00583557|GlaxoSmithKline|GSK Response Center|866-435-7343|
103241|NCT00583596|St. Jude Medical Formally AGA Medical Corporation|Jeffrey Mifek|6517565586|jmifek@sjm.com
103242|NCT00583622|The University of Texas MD Anderson Cancer|Yago Nieto, MD, PhD / Professor||celsaenz@mdanderson.org
103243|NCT00583661|Berlin Heart Inc.|Robert Kroslowitz, CEO|1-281-863-9700|kroslowitz@berlinheart.com
103244|NCT00583700|West Virginia University|Geraldine Jacobson, MD, MBA, MPH, FACR|(304) 293-7227|GMJACOBSON@hsc.wvu.edu
103245|NCT00583713|Braintree Laboratories, Inc.|Russell Pelham, PhD|781-843-2202|rpelham@braintreelabs.com
103246|NCT00583908|Vistakon|Kurt Moody, OD FAAO|904-443-3088|kmoody1@its.jnj.com
103247|NCT00583947|Sepracor Inc|Respiratory Medical Director|866-503-6351|
103248|NCT00584077|University of Texas-Galveston|Alexander Duarte, MD|409-772-2436|aduarte@utmb.edu
103249|NCT00584194|USAMRIID Medical Division|Janice Rusnak, MD|301-619-4156|janice.rusnak@amedd.army.mil
103250|NCT00584220|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|kmoody1@its.jnj.com
103251|NCT00584402|University of Califonia, Davis|John McGahan, M.D.|(916)734-0519|john.mcgahan@ucdmc.ucdavis.edu
103252|NCT00584415|University of Oklahoma Health Sciences Center|Sunny Po, MD., Study Principal Investigator|405-271-9696|sunny-po@ouhsc.edu
103253|NCT00584454|UAMRIID Division of Medicine|LTC Robert Rivard, MD|301-619-8244|robert.g.rivard.mil@mail.mil
103254|NCT00584480|UCSF|Robert L. Hendren, D.O.|415-476-7198|Robert.Hendren@ucsf.edu
103255|NCT00584558|University of Oklahoma Health Sciences Center|Karen Beckman, MD|405-271-9696 ext 37536|karen-beckman@ouhsc.edu
103256|NCT00584701|UCSF|Robert Hendren, DO|415-476-7198|robert.hendren@ucsf.edu
103257|NCT00584727|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|
103258|NCT00584740|Novartis|Study Director|862-778-8300|
103259|NCT00584831|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|kmoody1@its.jnj.com
103260|NCT00584844|USAMRIID|Mark Goldberg, MD|301-619-4562|mark.goldberg@amedd.mil
103261|NCT00584857|UAB|J. Michael Straughn, MD|205-934-4986|Michael.straughn@ccc.uab.edu
103262|NCT00584909|UAB|J. MIchael Straughn, MD|205-934-4986|Michael.Straughn@ccc.uab.edu
119238|NCT01335698|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
103264|NCT00584948|University of California, Davis Medical Center|Randi J Hagerman, MD|916-703-0247|randi.hagerman@ucdmc.ucdavis.edu
103265|NCT00584987|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu
103266|NCT00585013|Baylor College of Medicine|Paul Checchia MD|832-826-5011|checchia@bcm.edu
103267|NCT00585039|Phoenix Children's Hospital|Dr Blake Bulloch|602-546-1950|bbulloch@phoenixchildrens.com
103268|NCT00585078|Beth Israel Deaconess Medical Center Beth Israel Deaconess|Rebecca Miksad MD MPH|617.667.2100|rmiksad@bidmc.harvard.edu
103269|NCT00585104|University of Utah Health Sciences Center|Andrew D. Michaels, MD|(801) 585-5971|Andrew.Michaels@hsc.utah.edu
103270|NCT00578279|Indiana University Medical Center|Julia K. LeBlanc, MD|(317) 948-8125|juleblan@iupui.edu
103271|NCT00578305|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
103272|NCT00578318|Georgetown University Medical Center|Alfiee M. Breland-Noblem Ph.D., MHSc|2026872392|ab2892@georgetown.edu
119239|NCT01334710|Emory University|Dr. Bassel El-Rayes|404-778-1900|belraye@emory.edu
103274|NCT00578383|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu
119240|NCT01330420|Massachusetts General Hospital|Kathleen Miller, RN|781-485-6176|kmiller16@partners.org
103276|NCT00578461|Baylor College of Medicine|Robert Krance, MD|832-824-4661|rakrance@txch.org
103277|NCT00578539|Baylor College of Medicine|Robert Krance, MD|832-824-4661|rakrance@txch.org
103278|NCT00578552|Mayo Clinic|Amit Sood|507-266-1944|nicotineresearch@mayo.edu
103279|NCT00578565|Mayo Clinic|Eric. L. Matteson, M.D.|507-284-8450|
103280|NCT00578617|Mayo Clinic|Kristi Monahan|507-255-6676|CABANA@mayo.edu
103281|NCT00578734|Penn State Children's Hospital|Dr. Neal J. Thomas|717-531-5337|nthomas@hmc.psu.edu
103282|NCT00578786|Gilead Sciences, Inc.|Hunter Gillies, MD, DSEM|650-522-1214|hunter.gillies@gilead.com
103283|NCT00578812|NuVasive, Inc|Julie Pairamore, Sr. Manager, Clinical Affairs|858-320-5258|jpairamore@nuvasive.com
103284|NCT00585169|Yale Unviersity|Marc N. Potenza, M.D., Ph.D.|203-737-3553|marc.potenza@yale.edu
103285|NCT00585182|University of Utah|Dr Robert Pendleton|801 581 7818|robert.pendleton@hsc.utah.edu
103286|NCT00585221|Huntsman Cancer Institute|Director of Clinical Trials|801-213-4241|candace.larson@hci.utah.edu
103287|NCT00585286|University of California, Irvine|Christopher Zachary, FRCP, MBBS/Prinicipal Investigator|(949) 824-7103|czachary@uci.edu
103288|NCT00585312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103289|NCT00585351|University of Iowa|Enrique Leira, MD, MS|319-356-8755|enrique-leira@uiowa.edu
103290|NCT00585377|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu
103291|NCT00585468|University of Utah|Fuad Shihab, MD|801-585-3823|fuad.shihab@hsc.utah.edu
103292|NCT00585910|Massachusetts General Hospital|Kerry Brodziak|617-503-1043|kbrodziak@partners.org
103293|NCT00585923|Biomet|Jacquelyn Hughes|973-299-9300 ext 3075|jacquelyn.hughes@biomet.com
103294|NCT00585975|ISTA Pharmaceuticals, Inc.|Tim McNamara, PharmD|949-788-6000|tmcnamara@istavision.com
103295|NCT00586066|Massachusetts General Hospital|Andrew Nierenberg, Principal Investigator|6177240837|anierenberg@partners.org
103296|NCT00586105|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
103297|NCT00586157|Massachusetts General Hospital|Timothy Wilens, MD|617-726-1731|twilens@partners.org
103298|NCT00586170|Biomet|Manager of Research|973-299-9300 ext 3415|hallie.murray@zimmerbiomet.com
103299|NCT00586196|BIDMC|Edward R Marcantonio|617-754-1405|emarcant@bidmc.harvard.edu
103300|NCT00586261|Mayo Clinic|Dr. Patricia Best|507-284-4441|best.patricia@mayo.edu
103301|NCT00586313|Indiana University Hospital|John DeWitt, MD|317-944-1113|jodewitt@iu.edu
103302|NCT00586326|Hologic, Inc.|Nancy Chenette, Director, Clinical Affairs|508-263-8770|nancy.chenette@hologic.com
103304|NCT00586469|GlaxoSmithKline|GSK Response Center|866-435-7343|
103305|NCT00586482|Mayo Clinic|David O. Warner, MD|507-255-4288|warner.david@mayo.edu
103306|NCT00586495|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
103307|NCT00586521|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
103308|NCT00586573|Massachusetts General Hospital|Craig Surman, MD|617-503-1424|csurman@partners.org
103309|NCT00586612|GlaxoSmithKline|GSK Response Center|866-435-7343|
103310|NCT00586625|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com
103311|NCT00586664|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com
103312|NCT00586690|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu
103313|NCT00586703|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu
103314|NCT00586716|Loma Linda University Medical Center|Dr. Pedro Baron|909-558-6792|PBaron@llu.edu
103315|NCT00586729|Maricopa Integrated Health System|Karen Richey, RN|602-344-5125|karen.richey@mihs.org
103316|NCT00586820|Mayo Clinic|Dr. Amir Lerman|507-255-6670|lerman.amir@mayo.edu
103317|NCT00586846|Memorial Sloan Kettering Cancer Center|Dr. Paul Meyers|212-639-5952|meyersp@mskcc.org
103318|NCT00586898|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher|646-422-4323|Scherh@mskcc.org
103319|NCT00587041|Mayo Clinic|Use of Symbiotics to Reduce Urinary Oxalate Excretion|507-266-7960|lieske.john@mayo.edu
103320|NCT00587054|Memorial Sloan-Kettering Cancer Center|Dr. Ann Jakubowski|212-639-5013|jakubowa@mskcc.org
103321|NCT00587067|Memorial Sloan Kettering Cancer Center|Dr. William Jarnagin, MD|212-639-3624|jarnagiw@mskcc.org
103322|NCT00587132|Mayo Clinic|Dr. Naoki Takahashi|507-284-7249|takahashi.naoki@mayo.edu
103323|NCT00587158|Mayo Clinic|Hatem Amer, MD, FASN; Assistant Professor of Medicine; Division of Nephrology and Hypertension|507-256-1963|amer.hatem@mayo.edu
103324|NCT00587171|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H.|813-975-8690|pedig@jaeb.org
103325|NCT00587223|Organogenesis Inc.|Director of Clinical Operations||kgiovino@organo.com
103326|NCT00587288|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
103327|NCT00587431|Memorial Sloan-Kettering Cancer Center|Dr. Dana Rathkopf|646-422-4379|rathkopd@mskcc.org
103328|NCT00587457|MedImmune, LLC.|Mark C Lanasa|301-398-0000|clinicaltrialenquiries@medimmune.com
103329|NCT00587483|Mayo Clinic|Dr. William Mauermann|507-255-4240|mauermann.william@mayo.edu
103330|NCT00587587|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinical@organo.com
103331|NCT00587639|Mayo Clinic|Dr. Christopher Wall|5072843352|wall.chris@mayo.edu
103332|NCT00587678|University of Virginia|Dr Christopher Kramer|434-243-0736|
103333|NCT00587769|Mayo Clinic|Jon O. Ebbert|507-284-2511|ebbert.jon@mayo.edu
103334|NCT00587795|Mayo Clinic|Dr. David Dennison|507-284-7405|Dennison.David@mayo.edu
103335|NCT00587834|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinical@organo.com
103336|NCT00587847|North Shore-Long Island Jewish Health System|Kanti Rai, MD|(718) 470-4050|krai@nshs.edu
103337|NCT00587860|Mayo Clinic|Yuri A. Saito Loftus, M.D., M.P.H.|507-284-5010|saito.yuri@mayo.edu
103338|NCT00587964|Memorial Sloan Kettering Cancer Center|Dr. Kathryn Beal|212-639-5159|bealk@mskcc.org
103340|NCT00588094|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org
103341|NCT00588146|Mayo Clinic|Karen L. Swanson, D.O.|507-255-3214|swanson.karen@mayo.edu
103342|NCT00588159|Mayo Clinic|Dr. Michelle A. O. Kinney|507-266-9877|kinney.michelle@mayo.edu
103343|NCT00588237|Memorial Sloan Kettering Cancer Center|Dr. Jason Konner|646-888-4219|konnerj@mskcc.org
103344|NCT00588341|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|(646) 888-4162|chapmanp@mskcc.org
103345|NCT00588354|Mayo Clinic|Dr. Marc A. Huntoon|(507) 284-2511|huntoon.marc@mayo.edu
103346|NCT00581776|University of Wisconsin- Madison|Brad S Kahl|608-263-1836|bsk@medicine.wisc.edu
103347|NCT00581828|University of Wisconsin|Dr Karen Hansen|608-263-3457|keh@medicine.wisc.edu
103348|NCT00581854|University of Wisconsin|Brad S Kahl, MD|608-263-1836|bsk@medicine.wisc.edu
103349|NCT00581867|University of Kansas Medical Center|Dr. Jeffrey Burns|(913) 588-0555|jburns2@kumc.edu
103350|NCT00581919|University of Wisconsin Hospital and Clinics|Dr. Natalie Callander|608-265-8690|nsc@medicine.wisc.edu
103351|NCT00581945|Study Director|Novartis Pharmaceuticals|862-778-8300|
103352|NCT00581971|UAB Hospital|Dr. Sharon Spencer Professor of Radiation Oncology|205-934-2762|sspencer@uabmc.edu
103354|NCT00582036|University of Oklahoma Health Sciences Center|George Selby, MD|405-271-4022|george-selby@ouhsc.edu
103355|NCT00582075|University of Alabama at Birmingham|John Fiveash, MD|205-975-0224|jfiveash@uabmc.edu
103356|NCT00582114|Professor of Medicine|Dr. Rajiv Agarwal|317-988-2241|ragarwal@iu.edu
103357|NCT00582205|University of Oklahoma|Dr. Joan Walker|405-271-8707|joan-walker@ouhsc.edu
103358|NCT00582309|UNM|Gary Iwamoto|505-272-4751|giwamoto@salud.unm.edu
103359|NCT00582361|UAB|Research Nurse Coordinator|205-996-6781|Talyor.vlack@ortho.uab.edu
103360|NCT00582400|University of Texas Medical Branch at Galveston|Dr. Avi B. Markowitz|4097721164|abmarkow@utmb.edu
103361|NCT00582426|Novartis|Study Director|1-800-778-8300|
103362|NCT00582491|Yale University School of Medicine|Peter Morgan, MD, PhD|203-974-7515|Peter.Morgan@yale.edu
103363|NCT00582517|University of Alabama at Birmingham|Taylor Vlack, RN|205-996-6781|tmwebb@uabmc.edu
103364|NCT00582556|University of Wisconsin Carbone Cancer Center|Dr. Douglas McNeel|608-263-4198|dm3@medicine.wisc.edu
103365|NCT00582608|Memorial Sloan Kettering Cancer Center|Dr. Shakeel Modak|212-639-7623|modaks@mskcc.org
103366|NCT00588380|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu
103367|NCT00588406|North Shore Long Island Jewish Health System|Dr. Robert Silverman|718-470-7501|rsilverman@nshs.edu
103368|NCT00588445|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org
103369|NCT00588471|Mayo Clinic|Dr. Amir Lerman|507-255-7760|lerman.amir@mayo.edu
103370|NCT00588536|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett|212-639-8267|trippet1@mskcc.org
103371|NCT00588640|Memorial Sloan Kettering Cancer Center|Dr. Natalia Moryl|646-888-2681|moryln@mskcc.org
103372|NCT00588666|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org
103373|NCT00588692|Mayo Clinic|Dr. Barry A. Borlaug|507-284-4442|borlaug.barry@mayo.edu
103374|NCT00592007|UC San Diego, Moores Cancer Center|Lyudmila Bazhenova, MD|858 822 6189|lbazhenova@ucsd.edu
103375|NCT00592072|Yale School of Medicine|Dr Robert Sherwin|203-785-6222|robert.sherwin@yale.edu
103376|NCT00592124|Johns Hopkins University|Craig W. Hendrix, MD|1 410 955-9707|chendrix@jhmi.edu
103377|NCT00592176|University of Alabama at Birmingham|Dr. Tyler Hall, M.D.|205-325-8310|tandrewhall@yahoo.com
103378|NCT00592319|Trustee of Boston Univ. Medical Campus|Dr. Zhi Wang|617-414-1590|zwang@bu.edu
103379|NCT00592358|Massachusetts General Hospital|Janet Wozniak, MD|(617)503-1038|jwozniak@partners.org
103380|NCT00592384|University of Washington|Dr. Jesse R. Fann|206 6854280|fann@uw.edu
103381|NCT00592475|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com
103383|NCT00592631|Indiana University|Robert Tepper, MD, Ph.D.|317-274-9647|rtepper@iu.edu
103384|NCT00592683|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org
103385|NCT00592761|UAMS Medical Center|Gary McCullough|501-852-7886|mcculloughgaryh@uams.edu
103386|NCT00592774|Eisai Call Center|Eisai Inc.|888-422-4743|
103387|NCT00592839|Duramed Research|Duramed Research Protocol Chair|215-293-7279|medicalaffairs@barrlabs.com
103388|NCT00592852|Massachusetts General Hospital|Gagan Joshi, MD|617-503-1084|joshi.gagan@mgh.harvard.edu
103389|NCT00592904|Eisai Call Center|Eisai Inc.|888-422-4743|
103390|NCT00592943|Massachusetts General Hospital; Harvard Medical School|Thomas J. Spencer, MD|(617) 726-1731|tspencer@partners.org
103391|NCT00593112|Massachusetts General Hospital|Paul Hammerness, M.D.|617-503-1040|phammerness@partners.org
103392|NCT00593320|Washington University School of Medicine|Jeffrey Bradley, M.D.|314-362-8502|jbradley@radonc.wustl.edu
103393|NCT00593333|Department of Surgery/Division of Orthopaedics|Taylor Vlack, Research Nurse Coordinator|205-996-6781|tmwebb@uabmc.edu
103394|NCT00593346|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8525|izoberi@radonc.wustl.edu
103395|NCT00593372|UAMS Medical Center|Gary McCullough|501-852-7886|garyhmccullough@uams.edu
103396|NCT00593450|CATT Research Group|Dr. Maureen Maguire|215-615-1501|maguirem@mail.med.upenn.edu
103397|NCT00593606|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
103398|NCT00593645|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu
103399|NCT00593684|Baylor Health Care System|Furgan Moin, MD|214-820-7604|Furgan.Moin@baylorhealth.edu
103400|NCT00593736|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
103401|NCT00593814|W.L. Gore and Associates|Tab Bonny|928 864 4275|tbonny@wlgore.com
103402|NCT00593827|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
103403|NCT00593840|Washington University School of Medicine|Wade Thorstad, M.D.|314-362-8516|thorstad@radonc.wustl.edu
103404|NCT00593866|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski|734-615-3969|zalupski@umich.edu
103405|NCT00593918|University of Wisconsin-Madison|Theresa Guilbert, MD|608-263-9608|tguilbert@wisc.edu
103406|NCT00593957|Kennedy Krieger Institute|Dr Sakkubai Naidu Professor of Neurology and Pediatrics|443-923-2778|naidu@kennedykrieger.org
103407|NCT00594022|R.P. Chiacchierini & Associates|R.P. Chiacchierini & Associates|(240) 683-3738|rpc@rpcaconsulting.com
103408|NCT00594035|Integra LifeSciences|Director, Medical Affairs|609-275-0500|
103409|NCT00594100|W. L. Gore & Associates|Andrew Garcia|(800) 437-8181|AGarcia@WLGore.com
103410|NCT00594165|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
103411|NCT00594178|Dept of PM&R; University of Arkansas for Medical Sciences|Thomas S. Kiser|501-221-1311|kiserthomass@uams.edu
103412|NCT00594204|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
103413|NCT00594230|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net
103414|NCT00594256|Nathan Kline Institute|Joshua Kantrowitz MD|845-398-5503|jkantrowitz@nki.rfmh.org
103415|NCT00594308|Indiana University School of Medicine|Robert Nelson, MD|317-278-6871|ronelson@iupui.edu
103416|NCT00594386|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
103417|NCT00594399|Durham VA Medical Center (GRECC/HSRD)|Miriam C. Morey, Ph.D.|919-286-0411 ext 6776|miriam.morey@va.gov
103418|NCT00594425|Virginia Clinical Research, Inc|David Pariser MD|757-625-0151|dpariser@pariserderm.com
103419|NCT00594464|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
103420|NCT00585494|University of Wisconsin Madison|Ann Marie Sheehy, M.D., M.S.|608-335-6734|asr@medicine.wisc.edu
103421|NCT00585533|Huntsman Cancer Institute/University of Utah|Wallace Akerley, MD|801-585-5986|wallace.akerley@hci.utah.edu
103422|NCT00585585|University of Cincinnati|Erik Nelson, MD|513-558-5115|erik.nelson@uc.edu
103423|NCT00585637|Dana-Farber Cancer Institute|Kimmie Ng, MD, MPH|617-632-4150|Kimmie_Ng@dfci.harvard.edu
103424|NCT00585650|Wake Forest Baptist Health, Department of Dermatology|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wakehealth.edu
103425|NCT00585689|University of Michigan Comprehensive Cancer Center|Dr. David Smith, M.D.|734-936-6884|dcsmith@umich.edu
103426|NCT00585715|University of California, Irvine|Kristen M. Kelly, M.D.|949-824-7103|kmkelly@uci.edu
103427|NCT00594516|Johnson & Johnson Pharmaceutical Research & Development|Mila Etropolski, MD Clinical Leader|609-730-4537|metropol@its.jnj.com
103428|NCT00594568|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
103429|NCT00594646|Fenway Health|Dr. Kenneth Mayer|617-927-6400|kmayer@fenwayhealth.org
103430|NCT00594659|Geisel School of Medicine at Dartmouth College|Alan J. Budney, PhD Principal Investigator|855-290-2822|Alan.J.Budney@dartmouth.edu
103431|NCT00594685|New England Research Institutes|Susan Assmann|617-923-7747 ext 548|sassmann@neriscience.com
103432|NCT00594815|Memorial Sloan Kettering Cancer Center|Dr. Antonio Omuro|212-639-7523|omuroa@mskcc.org
103433|NCT00597519|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker|212-639-3468|barkerj@mskcc.org
103434|NCT00597545|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu
103435|NCT00597558|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director|919-843-9087|edwinkim@email.unc.edu
103436|NCT00597584|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com
103437|NCT00597675|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu
103438|NCT00597701|Essentia Health|Charles E Gessert, MD, MPH|218-786-8176|cgessert@eirh.org
103439|NCT00597714|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu
103440|NCT00597727|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu
103441|NCT00597753|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com
103442|NCT00597896|Mount Sinai School of Medicine|Katherine E. Burdick, PhD||katherine.burdick@mssm.edu
103443|NCT00597909|Horizon Pharma plc|Bruce Scharschmidt, MD||bscharschmidt@horizonpharma.com
103444|NCT00598078|Jazz Pharmaceuticals|Grace Wang, MD Director Clinical Development and Medical Monitor|650-496-3777|
103445|NCT00598273|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com
103446|NCT00598442|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com
103447|NCT00598507|H. Lee Moffitt Cancer Center and Research Institute|Ronald DeConti, M.D., Principal Investigator|813-745-8466|ronald.deconti@moffitt.org
103448|NCT00598559|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com
103449|NCT00598585|Charles R. Drew University|Theodore C. Friedman MD PhD|3106685197|theodorefriedman@cdrewu.edu
103450|NCT00598650|Eisai Co., Ltd.|Masaki Nakagawa|+81-3-3817-5245 ext 5245|
103451|NCT00598689|Georgia Regents University|David D. Bogorad, MD, FACS|706-721-1160|dbogorad@gru.edu
103452|NCT00598702|Mallinckrodt Pharmaceuticals|Lawrence Hill, VP Clinical Development|908-238-6370|lawrence.hill@mallinckrodt.com
103454|NCT00598819|University of California, Irvine Medical Center|Dr. Jeffrey C. Milliken|714-456-3634|jcmillik@uci.edu
103455|NCT00598832|Galderma|Michael Graeber MD/ Head of Global Clinical Project Management|609-860-8201|michael.graeber@galderma.com
103456|NCT00598871|ReGenTree, LLC|Won S. Yang, President & CEO|609-734-4328|wonsyang@regentreellc.com
103457|NCT00599014|Emory University|Dr. Javed Butler|404-778-5136|jbutle4@emory.edu
103458|NCT00599027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
103459|NCT00599053|University of Alabama at Birmingham|Dr. David Randolph|205-934-4680|drandolph@peds.uab.edu
103460|NCT00599131|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden|734-936-0453|fworden@umich.edu
103461|NCT00599196|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
103462|NCT00599248|TissueGene, Inc|R. Ogden Copeland|(301) 921-6000 ext 122|ocopeland@tissuegene.com
103463|NCT00599313|Texas Oncology Cancer Center|Dr. Guru Sonpavde|2813327505|Guru.Sonpavde@USOncology.com
103464|NCT00599326|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu
103465|NCT00599339|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
103466|NCT00599521|Galderma|Michael Graeber MD/ Head of Global Clinical Project Management|609-860-8201|michael.graeber@galderma.com
103467|NCT00599755|Merck Sharp and Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
103468|NCT00599872|Greer Laboratories|Bob Esch, VP Research & Development|828.759.7845|esch@greerlabs.com
103469|NCT00599924|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
103470|NCT00600015|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net
103471|NCT00600028|Johns Hopkins University School of Medicine|Maureen R. Horton|410-955-4176|mhorton2@jhmi.edu
103472|NCT00588731|Yale University|Mohini Ranganathan, M.D.|203-932-5711 ext 2546|mohini.ranganathan@yale.edu
103473|NCT00588809|The University of Chicago Medicine|Olatoyosi Odenike, MD|(773) 702-6149|todenike@medicine.bsd.uchicago.edu
103474|NCT00588822|Mayo Clinic|Dr. Benn E. Smith|480-301-6711|bsmith@mayo.edu
103475|NCT00588848|MetroHealth Medical Center|Dr. Dennis Auckley|216-778-7212|dauckley@metrohealth.org
103476|NCT00588861|Biomet Manufacturing|Nick Higdon, Clinical Research Specialist|1-800-348-9500 ext 3047|nicholas.higdon@biomet.com
103477|NCT00588900|UNC Lineberger Comprehensive Cancer Center|Bert O'Neil, M.D.||bert_oneil@med.unc.edu
103478|NCT00588952|Yale University|Ismene Petrakis|203-932-5711 ext 2244|Ismene.petrakis@yale.edu
103479|NCT00588965|MetroHealth Medical Center|Dr. Elizabeth Kaufman|216-778-2349|ekaufman@metrohealth.org
103480|NCT00589108|Mayo Clinic|Dr. Robert T. Trousdale|507-284-3663|trousdale.robert@mayo.edu
103481|NCT00589472|Memorial Sloan Kettering Cancer Center|Dr. Susan Slovin|646-422-4470|slovins@mskcc.org
103482|NCT00589550|The Ohio State University Comprehensive Cancer Center|Thomas Olencki, DO|614-293-2886|Thomas.Olencki@osumc.edu
103483|NCT00589563|City of Hope Medical Center|Dr. Ryotaro Nakamura|626-256-4673 ext 65285|rnakamura@coh.org
103484|NCT00589602|Cleveland Clinic|Jarek Maciejewski, MD|216-445-5962|maciejj@ccf.org
103485|NCT00589628|Duke Health Systems|Dr. C. Egla Rabinovich|919-668-0238|egla.rabinovich@duke.edu
103486|NCT00589667|Memorial Sloan-Kettering Cancer Center|David Pfister, MD|646-888-4232|pfisterd@mskcc.org
103487|NCT00589693|Janssen R&D US|Sr Director Clinical Development|1 510 248-2310|
103488|NCT00589784|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley|212-639-5122|KaleyT@mskcc.org
103489|NCT00589849|Creighton University|Dr. Aryan Mooss|402-280-4566|aryanmooss@creighton.edu
103490|NCT00589888|Emory Univ SOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu
103491|NCT00589914|Johnson & Johnson Pharmaceutical Research & Development LLC|Clinical Leader Psychiatry|1 609 730-2324|
103492|NCT00589979|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator|Use e-mail contact|clinicalsite.inquiries@endo.com
103493|NCT00590005|Emory University Department of Pediatrics|Dr. Anne Fitzpatrick, Director, Emory Asthma Clinical Research Program|404-727-9112|anne.fitzpatrick@emory.edu
103494|NCT00590018|Baylor College of Medicine|Dr. Heather Dickerson|832-826-5637|had@bcm.edu
108419|NCT00876018|GlaxoSmithKline|GSK Response Center|866-435-7343|
103495|NCT00590031|Memorial Sloan Kettering Cancer Center|Dr. David Ilson, Attending|+1646-888-4183|ilsond@mskcc.org
103496|NCT00590044|Emory University SOM|Guillermo Umpierrez|4047781663|geumpie@emory.edu
103497|NCT00590135|Cleveland Clinic|Brian Griffin MD|216-444-6812|Griffib@ccf.org
103498|NCT00590161|Cleveland Clinic Lerner College of Medicine of Case Western Reserve University|Claudia O. Zein, MD, MSc|216-444-0421|zeinc@ccf.org
103499|NCT00590226|EUSOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu
103500|NCT00590317|Emory University|Dr. Daniel Wu|(404) 251-8875|dtwu@emory.edu
103501|NCT00590369|Cleveland Clinic|Nancy M. Albert PhD, RN|216-444-7028|albertn@ccf.org
103503|NCT00590538|The Children's Hospital of Philadelphia|Ronald Rubenstein, MD, PhD|1-215-590-1281|rubensteinr@email.chop.edu
103504|NCT00590564|Memorial Sloan Kettering Cancer Center|Dr. Gary Deng|646-888-0841|dengg@mskcc.org
103505|NCT00590577|Johnson & Johnson Pharmaceutical Research & Development|Compound Development Team Leader, Paliperidone|609-730-4530|
103506|NCT00590590|KV Pharmaceutical|Jim Joffrion, Sr. Director, Clinical Affairs|314-645-6600|jjoffrion@kvph.com
103507|NCT00590720|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com
103508|NCT00590759|W. L. Gore and Associates, Inc.|Robert Makowsky|6232345784|rmakowsk@wlgore.com
103509|NCT00590772|Penn State University|Timothy Craig|717-531-6525|tcraig@psu.edu
103510|NCT00590863|Univeristy of Texas Southwestern Medical Center, Dallas|Madhukar H. Trivedi, M.D.|214-648-0188|Madhukar.Trivedi@UTSouthwestern.edu
103511|NCT00590889|St.Jude Medical|Heidi Hinrichs, VP of Clinical Study Management, St. Jude Medical||hhinrichs@sjm.com
103512|NCT00590902|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org
103513|NCT00590967|Washington University School of Medicine|Perry Grigsby, M.D.|314-362-8502|grigsby@radonc.wustl.edu
103514|NCT00591006|The University of Texas Southwestern Medical Center|E. Sherwood Brown|214 645 6950|sherwood.brown@utsouthwestern.edu
103515|NCT00591019|University of Arkansas for Medical Sciences (UAMS)|Dr John Dornhoffer|501 686-5140|dornhofferjohnl@uams.edu
103516|NCT00591149|University of Kansas Medical Center|Chao Huang, MD|913-588-6029|chuang2@kumc.edu
103517|NCT00591214|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
103518|NCT00591227|Rush University Medical Center|David Baldwin MD|312-942-6163|david_baldwin@rush.edu
103519|NCT00591240|VA Palo Alto Health Care System|Dr. Joseph Liao|650-493-5000 ext 65581|joseph.liao@va.gov
103520|NCT00591253|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
103521|NCT00591266|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
103522|NCT00591305|Boston Medical Center|Zhi Wang, MD|617-414-1590|zwang@bu.edu
103523|NCT00591344|Northwestern University|Daniel Corcos, PhD|708-214-5454|daniel.corcos@northwestern.edu
103524|NCT00591370|Memorial Sloan-Kettering Cancer Center|Dr. Paul Chapman|212-639-7357|chapmanp@mskcc.org
103525|NCT00591565|SUNY Upstate|Thomas Schwartz|3154643166|schwartt@upstate.edu
103526|NCT00591578|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
103527|NCT00591591|ISS, Inc., Champaign Illinois|Antonios Michalos|217-359-8681|antonios.michalos@iss.com
103528|NCT00591721|University of Illinois at Chicago|Marcia Finlayson, PhD|312-996-4603|marciaf@uic.edu
103529|NCT00591734|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
103530|NCT00591760|Federico II University|Prof. Antonio Cittadini|0039(0)817464375|antonio.cittadini@unina.it
103531|NCT00591773|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
103532|NCT00591825|Laureate Institute for Brain Research (LIBR)|Robin Aupperle, PhD|(913) 588-9078|raupperle@laureateinstitute.org
103533|NCT00591851|Memorial Sloan-Kettering Cancer Center|Dr. Chau Dang|914-367-7181|dangc@mskcc.org
103534|NCT00591864|Mayo Clinic|Amy Lynn Conners MD|(507) 284-2511|MBI@mayo.edu
103535|NCT00600067|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com
103536|NCT00600080|Johnson & Johnson Vision Care|Kurt Moody, OD|+1 904 443-3088|kmoody1@its.jnj.com
103537|NCT00600119|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com
103538|NCT00600171|GlaxoSmithKline|GSK Response Center|866-435-7343|
103539|NCT00600353|University of Kansas Medical Center|Dr. Omar Aljitawi|913-588-6029|oaljitawi@kumc.edu
103540|NCT00600821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103541|NCT00600886|Novartis Pharmaceuticals|Study Director|862-778-8300|
103542|NCT00600938|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
103543|NCT00601107|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
103544|NCT00601146|DFCI|Andrea Ng|617-732-6310|ang@lroc.harvard.edu
103545|NCT00601250|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
103546|NCT00601354|Stanford University|Dr. Debra L Safer|650-723-7928|dlsafer@stanford.edu
103547|NCT00601367|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com
103548|NCT00601419|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103549|NCT00601458|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
103550|NCT00601523|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
103551|NCT00601627|Alliance for Clinical Trials in Oncology|George P. Kim, M.D.|507-284-4918|
103552|NCT00601640|University of Arizona/Arizona Cancer Center|Joanne Jeter, MD|520.626.9295|jjeter@azcc.arizona.edu
103553|NCT00601718|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org
103554|NCT00601731|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
103555|NCT00601796|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org
103556|NCT00601835|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
119243|NCT01294319|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Dr. Lynnette Nieman|301-496-4000|niemanl@mail.nih.gov
103558|NCT00601926|The Ohio State University Comprehensive Cancer Center|Paul Monk, MD|614-293-2886|Paul.Monk@osumc.edu
103559|NCT00601952|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|6192293740|namir@mail.sdsu.edu
103560|NCT00601965|Veterans Medical Research Foundation|Dr. Julie Wetherell|858-552-8585 ext 2752|jwetherell@ucsd.edu
103561|NCT00602043|University of Pennsylvania|Dr. David Mankoff|(2015) 615-3687|david.mankoff@uphs.upenn.edu
103563|NCT00602290|University of California, Los Angeles|Dr. Helen Lavretsky|310-794-4619|hlavretsky@mednet.ucla.edu
103564|NCT00602355|Women and Infants Hospital|Caron Zlotnick|401-455-6529|czlotnick@butler.org
103565|NCT00602420|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu
103566|NCT00602446|Masonic Cancer Center, University of Minnesota|Linda J. Burns, MD|612-624-8144|burns019@umn.edu
103568|NCT00602472|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
103569|NCT00602537|University of Pennsylvania|Dr. Jay Amsterdam|(215) 662-3462|jamsterd@mail.med.upenn.edu
103570|NCT00602641|ECOG Statistical Office|Study Statistician|617-632-3012|
103571|NCT00602771|SKCCC|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu
119245|NCT01210170|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu
103573|NCT00602927|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu
103574|NCT00602979|Weill Cornell Medicine|Michele Steinkamp|212-746-2953|mls9004@med.cornell.edu
103575|NCT00603018|UCSD|Walter Kaye, MD/Director, Eating Disorders Program Professor, UCSD Department of Psychiatry|858- 534-8019|wkaye@ucsd.edu
103576|NCT00603044|The University of Chicago Medicine|Fuad Baroody, MD|(773) 702-4790|fbaroody@surgery.bsd.uchicago.edu
103577|NCT00603187|University of Washington|Dr. John K. Amory|206.616.1727|jamory@u.washington.edu
103578|NCT00603239|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
103579|NCT00603265|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660|
103580|NCT00603278|GlaxoSmithKline|GSK Response Center|866-435-7343|
103582|NCT00603304|University of Alabama at Birmingham|Dr. Alan Cantor|(205) 934-6887|acantor@uab.edu
103583|NCT00603382|GlaxoSmithKline|GSK Response Center|866-435-7343|
103584|NCT00594958|Intercell AG|Senior Manager Clinical Research|+43 1 206 20 ext 0|kdubischar-kastner@intercell.com
103585|NCT00595075|Sentara Neurology Specialists|Daniel Cohen|757-388-6323|dacohen@sentara.com
103586|NCT00595088|Bnai Zion Medical Center|Dr. Sarel Halachmi|+97248359542|sarel.halachmi@b-zion.org.il
103587|NCT00595114|Brigham and Women's Hospital|Dr. Bruce D. Levy|617-525-5407|blevy@partners.org
103588|NCT00595127|Memorial Sloan Kettering Cancer Center|Farid Boulad, MD, Attending|+1212-639-2429|bouladf@mskcc.org
103589|NCT00595153|University of California, San Francisco|John V. Fahy, MD, MSc|4154769940|john.fahy@ucsf.edu
103590|NCT00595270|Intercell AG|Senior Manager Clinical Research|+43 1 206 20 ext 0|kdubischar.kastner@intercell.com
103591|NCT00595309|Intercell AG|Senior Manager Clinical Research|+43 1 206 20 ext 1175|kdubischar-kastner@intercell.com
103592|NCT00595335|Mayo Clinic|Dr. Rebecca S. Bahn|507-284-2462|bahn.rebecca@mayo.edu
103593|NCT00595361|Brigham and Women's Hopsital|Elliot Israel, MD|617-732-8110|eisrael@partners.org
103594|NCT00595413|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
103595|NCT00595465|Intercell AG|Senior Manager Clinical Research|+43 1 206 20 ext 1175|kdubischar-kastner@intercell.com
103596|NCT00595504|Massachusetts General Hospital|David C. Henderson, M.D.|617-912-7800|dchenderson@partners.org
103597|NCT00595517|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
103598|NCT00595530|Connecticut Children's Medical Center|Dr. William T. Zempsky|860-837-5207|wzempsk@ConnecticutChildrens.org
103599|NCT00595556|UCHC|Albert J. Arias, M.D.|8606794423 ext 4423|alarias@uchc.edu
103600|NCT00595582|LSU Health Sciences Center, Shreveport LA|Dr. James Patterson/Professor|318-813-2070|jpatte@lsuhsc.edu
103601|NCT00595764|Yale University|Dr. David Fiellin|203-737-3347|david.fiellin@yale.edu
103602|NCT00595790|Intercell AG|Senior Manager Clinical Research|+43 1 206 20 ext 0|kdubischar-kastner@intercell.com
103603|NCT00595868|University of Vermont|John R. Hughes, MD|802-656-3195|john.hughes@uvm.edu
103604|NCT00595881|Children's Hospital of Pittsburgh|Jennifer Marin|412-692-7692|jennifer.marin@chp.edu
103605|NCT00595920|Opexa Therapeutics, Inc.|Kenny Frazier, VP of Clinical Development and Regulatory Affairs|281-775-0660|kfrazier@opexatherapeutics.com
103606|NCT00595946|Sucampo Pharma Americas, LLC|VP, Clinical Development|301-961-3400|info@sucampo.com
103607|NCT00595959|Spectranetics Inc|Thomas M. Rasmussen V.P. Clinical Affairs|719-447-2471|thomas.rasmussen@spnc.com
103609|NCT00596102|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43 1 20620 ext 0|info@valneva.com
103610|NCT00596167|Indiana University School of Medicine|Brian Decker MD, PharmD|317-278-2868|bsdecker@iupui.edu
103611|NCT00596271|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43 1 206 20 ext 0|info@valneva.com
103612|NCT00596362|Memorial Sloan Kettering Cancer Center|Dr. David Abramson|212-639-7232|abramsod@mskcc.org
103613|NCT00596427|Kinemed, Inc|Carine Beysen, PhD|5106556525 ext 123|cbeysen@kinemed.com
103614|NCT00596440|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu
103615|NCT00596453|Johns Hopkins Medical Institutions|Misop Han, M.D.|410-502-7454|mhan1@jhmi.edu
103616|NCT00596466|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103617|NCT00596622|Indiana University School of Medicine|Amit Anand|3172747422|aanand@iupui.edu
103618|NCT00596635|Yale University School of Medicine|Manisha Juthani-Mehta, MD|(203)785-4140|manisha.juthanimehta@yale.edu
103619|NCT00596687|Emory Univ SOM|Guillermo Umpierrez|4047781665|geumpie@emory.edu
103620|NCT00596752|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
103621|NCT00596817|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com
103622|NCT00596830|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103624|NCT00596947|Hospital of the University of Pennsylvania|Jennifer Trofe-Clark, Clinical Transplant Research Pharmacist|215-614-4274|jennifer.trofe-clark@uphs.upenn.edu
103625|NCT00596960|VAMC|Eric Dieperink, MD|612-467-3964|eric.dieperink@va.gov
103626|NCT00597012|The Brigham and Women's Hospital|Jeffrey N. Katz, MD, MSc|617-732-5338|jnkatz@partners.org
103627|NCT00597038|UCSF Helen Diller Family Comprehensive Cancer Center|Adil Daud, Director, Melanoma Clinical Research|415-353-7392|adaud@medicine.ucsf.edu
103628|NCT00597116|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
103629|NCT00597207|ZOLL Medical Corporation|Sr. Director of Clinical Research|978-421-9655|uherken@zoll.com
103630|NCT00597272|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org
103631|NCT00597376|Rush University Medical Center|Raj C. Shah, MD|312-563-2902|Raj_C_Shah@rush.edu
103632|NCT00597402|Duke University Medical Center|Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu
103633|NCT00597428|Sucampo Pharma Americas, LLC|VP, Clinical Development|301-961-3400|info@sucampo.com
103634|NCT00597493|Duke University Health System|David Reardon, MD|617-632-2166|David_Reardon@DFCI.harvard.edu
103635|NCT00597506|Duke University Medical Center|Herbert Hurwitz, MD|919-668-1861|herbert.hurwitz@duke.edu
103636|NCT00603408|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wudosis.wustl.edu
103637|NCT00603447|Amgen, Inc.|Study Director|866-572-6436|
103638|NCT00603473|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103639|NCT00603512|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103640|NCT00603525|GlaxoSmithKline|GSK Response Center|866-435-7343|
103641|NCT00603538|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103642|NCT00603564|IRCCS Fondazione Po.Ma.Re, Milan, Italy|Roberto Cosentini, MD|00390255033602|roberto.cosentini@policlinico.mi.it
103643|NCT00603590|Tehran University of Medical Sciences|Mansoor Rastegarpanah|+989121255960|rastegar@sina.tums.ac.ir
103644|NCT00603642|Amgen Inc.|Study Director|866-572-6436|
103645|NCT00603993|Abbott|Global Medical Services|1-800-633-9110|
103646|NCT00604019|RUSH University Medical Center|Gourang Patel, PharmD|312-942-4258|gourang_p_patel@rush.edu
103647|NCT00604045|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|6192293740|namir@mail.sdsu.edu
103648|NCT00604162|Given Imaging|Hila Debby|+972 4 9097774|Hila.Debby@givenimaging.com
103650|NCT00604188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
103651|NCT00604214|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
103652|NCT00604279|Xian-Janssen Pharmaceutical Ltd|Local Trial Manager|86-10-5821 8213|
103653|NCT00604383|Chromaderm|info@chroma-derm.com||info@chroma-derm.com
103654|NCT00604461|H. Lee Moffitt Cancer Center and Research Institute|Tawee Tanvetyanon, M.D.|813-745-3050|tawee.tanvetyanon@moffitt.org
103655|NCT00604500|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsresultsdisclosure@merck.com
103657|NCT00604565|Rockwell Medical|Ajay Gupta, MD|248-960-9009|rd@rockwellmed.com
103658|NCT00604669|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu
103659|NCT00604695|Brigham & Women's Hospital|C. Michael Gibson, MS, MD|617-632-7753|mgibson@perfuse.org
103660|NCT00604708|Intercell AG|Senior Manager Clinical Research|+43 1 206 20 ext 1175|kdubischar-kastner@intercell.com
103661|NCT00604721|UNC Lineberger Comprehensive Cancer Center|Bert. H. O'Neil, Associate Professor, Clinical Research|919-966-4431|bert_oneil@med.unc.edu
103662|NCT00604786|Johns Hopkins University|Sarbjit S. Saini|410-550-2129|ssaini@jhmi.edu
103663|NCT00604812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
103664|NCT00604825|GlaxoSmithKline|GSK Response Center|866-435-7343|
103665|NCT00604851|University of Virginia|W Gerald Teague|434-243-0613|wgt2p@hscmail.mcc.virginia.edu
103666|NCT00604968|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
103667|NCT00605033|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com
103668|NCT00605072|University of Southern California|Dr. Ihab Hajjar|323-226-6720|ihajjar@usc.edu
103669|NCT00605085|Intercell AG|Senior Manager Clinical Research|+43 1 206 20 ext 1175|kdubischar-kastner@intercell.com
103670|NCT00605150|Carolinas Healthcare System|David Iannitti, MD|704-446-4838|jessica.drummond@carolinashealthcare.org
103671|NCT00605176|Graceway Pharmaceuticals LLC|Sharon F. Levy, MD|267-948-0400|sharon.levy@gracewaypharma.com
103672|NCT00605202|Oulu University Hospital, Department of Internal Medicine|Janne Hukkanen|+358-8-315 6212|janne.hukkanen@oulu.fi
103673|NCT00605267|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
103674|NCT00605280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103675|NCT00605293|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
103676|NCT00605306|Novartis Pharmaceuticals|Study Director|862-778-8300|
103677|NCT00605345|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
103678|NCT00605358|Weill Cornell Medicine|Dr. Jo Anne Sirey|9149974333|jsirey@med.cornell.edu
103679|NCT00605384|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
103680|NCT00605423|Johns Hopkins University|Peter Campochiaro, M.D.||pcampo@jhmi.edu
103681|NCT00605475|Novartis Pharmaceuticals|Study Director|862 778 8300|
103682|NCT00605540|HC/FMB-Unesp|Renata Ferrari|55 14 38116213|renataferrarifisio@gmail.com
103683|NCT00605657|NIAID|V. Koneti Rao, MD|301-496-6502|korao@niaid.nih.gov
103684|NCT00605696|Albert Einstein College of Medicine of Yeshiva University|Michelle Ng Gong, MD, MS|718 920 5464|mgong@montefiore.org
103685|NCT00605722|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
103686|NCT00605813|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
119248|NCT01113580|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com
103688|NCT00605865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103689|NCT00605904|NIAAA, NIH|Markus Heilig|301.435.9386|mheilig@mail.nih.gov
103690|NCT00605917|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103691|NCT00606008|H. Lee Moffitt Cancer Center and Research Institute|Dr. Edward Pan|813-745-3871|edward.pan@moffitt.org
103692|NCT00606021|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
103693|NCT00606034|Mountain Diabetes and Endocrine Center|Dr. Wendy Lane, Director of Clinical Research|828-258-2404 ext 314|mountaindiabetes@msn.com
103694|NCT00606086|GlobeImmune, Inc.|Clinical Operations Manager|3036252700|Alicia.Mattson@globeimmune.com
103695|NCT00606138|Rush University Medical Center|Mathew MacCumber, MD, PhD|312-563-4032|denise_voskuil-marre@rush.edu
103696|NCT00606177|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
103697|NCT00606229|Otsuka Pharmaceutical CO., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
103698|NCT00606281|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
103699|NCT00606320|Otsuka Pharmaceutical Co, Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
103700|NCT00606489|Cumberland Pharmaceuticals|Amy Rock, Doctor of Philosophy (Ph.D.)|6152550068|arock@cumberlandpharma.com
103701|NCT00589121|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
103702|NCT00589277|Yale University School of Medicine|Benjamin Toll, Ph.D. Associate Professor of Psychiatry|(203) 974 5767|benjamin.toll@yale.edu
103703|NCT00589290|National Institutes of Health (NIH), National Cancer Institute (NCI)|Arun Rajan, M.D.|301-594-5322|rajana@mail.nih.gov
103704|NCT00589303|Mayo Clinic|Dr. Win K. Shen|480-342-0348|wshen@mayo.edu
103705|NCT00594854|Pozen Inc.|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com
103706|NCT00594880|the Wistar Institute|Luis Montaner|215 898 3934|montaner@mail.wistar.org
103707|NCT00594906|University of Rochester|Dr. J. Edward Puzas|(585) 275-3664|edward_puzas@urmc.rochester.edu
103708|NCT00594945|Jazz Pharmaceuticals, Inc.|Executive Director, Clinical Development|650 496 3777|
103709|NCT00600613|Memorial Sloan Kettering Cancer Center|Dr. Yoshiya Yamada|212-639-2950|yamadaj@mskcc.org
103710|NCT00600704|Larissa University Hospital Dept. of Anesthesiology|Dr Athina Kleitsaki|00306948481865|theoath1@gmail.com
103711|NCT00600743|St. Luke's/Roosevelt Hospital|Harry R. Kissileff|212-523-4200|hrk2@columbia.edu
103712|NCT00600756|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com
103713|NCT00606502|Allos Therapeutics, Inc|Medical Monitor|303-426-6262|gweems@allos.com
103715|NCT00606580|US Army Medical Materiel Development Activity (USAMMDA)|Division of Regulated Activies and Compliance|301-619-0317|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil
103716|NCT00606593|Actelion Pharmaceuticals Ltd|Pascal Charef/Clinical Trial Leader|+41 61 565 65 65|
103717|NCT00606632|Wilex AG|Roman Bartz|+49 89413138 ext 52|roman.bartz@wilex.com
103718|NCT00606684|GlaxoSmithKline|GSK Response Center|866-435-7343|
103719|NCT00606801|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu
103720|NCT00607321|Medtronic Cardiovascular|K Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com
103721|NCT00607373|Genzyme Corporation|Genzyme Medical Information|617-252-7832|
103722|NCT00607386|Shire HGT|Arian Pano, MD, MPH|781-482-0875|apano@shire.com
103723|NCT00607477|University of Chicago|Michael Maitland, MD, PhD|773-702-4400|mmaitlan@medicine.bsd.uchicago.edu
103724|NCT00607594|Cross Cancer Institute|Dr. Heather-Jane Au|780-432-8500|heathera@cancerboard.ab.ca
103725|NCT00607672|Vanderbilt University School of Medicine|Dr. Mias Pretorius|16153430665|mias.pretorius@vanderbilt.edu
103726|NCT00607724|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
103727|NCT00607789|Lindner Center of HOPE|Susan McElroy, MD|513-536-0718|susan.mcelroy@lindnercenter.org
103728|NCT00607815|Cincinnati VA Medical Center|Dr. Kathleen M. Chard|859-572-6741|Kathleen.Chard@va.gov
103729|NCT00607867|Minneapolis VA Health Care System, Metabolic Research Labortory|Mary C. Gannon, Ph.D.|6124672895|ganno004@umn.edu
103730|NCT00607880|Mayo Clinic|Albert G. Hakaim, M.D.||Hakaim.Albert@mayo.edu
103731|NCT00607893|Case Western Reserve University|Reena Mehra|216-445-1698|mehrar@ccf.org
103732|NCT00607919|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
103733|NCT00607997|Sunesis Pharmaceuticals, Inc.|Linda Neuman, Vice President, Clinical Development|(650) 266-3760|lneuman@sunesis.com
103734|NCT00608023|Theratechnologies|Jean-Claude Mamputu, PhD, Senior Medical Advisor|514-336-7800|jmamputu@theratech.com
103735|NCT00608140|Duke University|Kathy Moore|919-668-8065|kathy.moore@duke.edu
103736|NCT00608205|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. David Adelstein|216-444-9310|adelstd@ccf.org
103737|NCT00608244|Veloxis Pharmaceuticals A/S|Christina Sylvest|+45 20553877|csy@veloxis.com
103738|NCT00608322|Cooper University Hospital|Stephen Trzeciak, MD, MPH|856-342-3342|trzeciak-stephen@cooperhealth.edu
103739|NCT00608426|Center for Chronic Disease Outcomes Research|Steven Fu, Director|612-467-1979|steven.fu@va.gov
103740|NCT00608465|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu
103741|NCT00608491|Duke University|Jenny Ibarra|9192363291|jenny.ibarra@duke.edu
103742|NCT00608517|Vanderbilt-Ingram Cancer Center|Brian Engelhardt, M.D.|615-936-1803|
103744|NCT00608543|UT Southwestern Medical Center|Dr.Prabha Sunderajan|214-648-0156|prabha.sunderajan@utsouthwestern.edu
103745|NCT00608569|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
103746|NCT00608582|VA Boston Healthcare System and Boston University School of Medicine|Margaret Naeser, PhD|857-364-4030|mnaeser@bu.edu
103747|NCT00608634|Arizona Cancer Center|Steven P. Stratton, PhD|520-626-9295|sstratton@azcc.arizona.edu
103748|NCT00608777|DermResearch, PLLC|Leon Kircik, M.D.|502-5451-9000|wedoderm@yahoo.com
103749|NCT00608829|W.L. Gore and Associates|Abe Letter|928 864 3113|aletter@wlgore.com
103750|NCT00608842|Kythera Biopharmaceuticals, Inc.|Clinical Trial Disclosure||clinical_trials@kythera.com
103751|NCT00608868|Medical, Astrazeneca Korea|Hui Jung Sin||huijung.sin@astrazeneca.com
103752|NCT00608881|Massachusetts General Hospital|Dr. Merit Cudkowicz|617-726-0813|mcudkowicz@partners.org
103753|NCT00608907|Johnson & Johnson Pharmaceutical Research & Development|Helgi van de Velde, MD, PhD||HVDVELDE@ITS.JNJ.COM
103754|NCT00608959|Cadence Pharmaceuticals, Inc|Catherine J Hardalo, MD Vice President, Anti-Infectives Clinical Development|858 4361439|chardalo@cadencepharm.com
103755|NCT00608985|Actelion Pharmaceuticals Ltd|Ouali Berkani/Clinical Trial Leader|+41 61 565 5342|
103756|NCT00609167|Mayo Clinic|Dr. A. Keith Stewart||stewart.keith@mayo.edu
103757|NCT00609245|Vanderbilt University Medical Center|Bassel Abou-Khalil, MD|615-936-0060|bassel.abou-khalil@vanderbilt.edu
103758|NCT00609336|University of Washington|Andrew Coveler, MD|206-288-7509|acoveler@uw.edu
103759|NCT00609362|University of Aarhus|Torben Harsløf, MD|+4589497681|torbhars@rm.dk
103760|NCT00609466|Grunenthal|René Allard|49 241 569 3223|Clinical-Trials@grunenthal.com
103761|NCT00609492|GlaxoSmithKline|GSK Response Center|866-435-7343|
103762|NCT00609518|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
103763|NCT00609622|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103764|NCT00609674|GlaxoSmithKline|GSK Response Center|866-435-7343|
103765|NCT00609739|Masonic Cancer Center, University of Minnesota|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu
103766|NCT00609765|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-2069|jonathan.strosberg@moffitt.org
103767|NCT00609804|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
103768|NCT00609869|H. Lee Moffitt Cancer Center and Research Institute|Javier Pinilla-Ibarz|813-745-1387|javier.pinilla@moffitt.org
103769|NCT00609947|Medtronic CardioVascular|Lynda Chaplin - Study Manager|(707) 543-5459|lynda.chaplin@medtronic.com
103770|NCT00603733|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
103771|NCT00603746|GlaxoSmithKline|GSK Response Center|866-435-7343|
103772|NCT00603798|Graceway Pharmaceuticals|Sharon F Levy, MD|267-948-0400|sharon.levy@gracewaypharma.com
103773|NCT00603837|University of Oklahoma Health Sciences Center|Doug Dannaway, MD|405-271-5215 ext 42048|douglas-dannaway@ouhsc.edu
103774|NCT00603889|Albert B. Sabin Vaccine Institute|Dr. David Diemert, Director of Clinical Trials|202-842-5025|david.diemert@sabin.org
119249|NCT01080391|Amgen, Inc.|Study Director|866-572-6436|
103776|NCT00603915|Univerisity Health Network|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.on.ca
103777|NCT00609973|University of North Carolina|Hans Herfarth|9199666806|hherf@med.unc.edu
103778|NCT00609986|Medical University of South Carolina|Dr. Kathie Hermayer|843-792-2529|hermayer@musc.edu
103779|NCT00610129|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy|646-888-4185|ReidyD@mskcc.org
103780|NCT00610155|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103781|NCT00610168|GlaxoSmithKline|GSK Response Center|866-435-7343|
103782|NCT00610207|Cook Biotech, Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@CookBiotech.com
103783|NCT00611247|Stanford University Medical Center|Bruno C Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu
103784|NCT00611325|Duke University Medical Center|Dr. Katherine B. Peters|(919) 684-6173|katherine.peters@duke.edu
103785|NCT00611403|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
103786|NCT00611442|Carl R Darnall Army Medical Center|Dr. Joel Stengel|2545531804|joel.stengel@us.army.mil
103788|NCT00611468|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com
103789|NCT00611533|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu
103790|NCT00611559|GlaxoSmithKline|GSK Response Center|866-435-7343|
103791|NCT00611624|Yale Comprehensive Cancer Center|Kira F. Pavlik, CCRP Clinical Research Coordinator Therapeutic Radiology|(203) 737-2587|kira.pavlik@yale.edu
103792|NCT00611715|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu
103793|NCT00611767|Yale University School of Medicine|Dr. Ismene L. Petrakis, Professor of Psychiatry|203-932-5711 ext 2244|Ismene.petrakis@yale.edu
103794|NCT00611806|Massachusetts General Hospital|Joshua L. Roffman, MD|617-724-1920|jroffman@partners.org
103795|NCT00611884|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
103796|NCT00611897|Yale School of Medicine, Department of Psychiatry|Handan Gunduz-Bruce, MD|(203) 785-2117|handan.gunduz-bruce@yale.edu
103797|NCT00612040|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
103798|NCT00612066|University of California, Los Angeles|Anthony Heaney, M.D. Ph.D|310 267 4980|aheaney@mednet.ucla.edu
103799|NCT00612105|Valeant Pharmaceuticals International, Inc.|Associate Director Clinical Operations|919-294-3080|david.lineberry@valeant.com
103800|NCT00612222|National Cancer Institute (NCI), National Institutes of Health (NIH)|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov
103801|NCT00612313|UT Southwestern Medical Center|Dr. Graham Emslie and Dr. Betsy Kennard|214-456-5900|beth.kennard@utsouthwestern.edu
103802|NCT00612339|Duke University Medical Center|Katherine Peters, MD, PhD|9196846173|katherine.peters@duke.edu
103803|NCT00612352|Yale University|Ismene Petrakis||ismene.petrakis@yale.edu
103804|NCT00612430|Duke University Medical Center|David Reardon, MD|919-668-2329|David_Reardon@DFCI.harvard.edu
103806|NCT00612508|Women's Health Research Unit|Oregon Health & Science University|503-494-3666|whru@ohsu.edu
103807|NCT00612534|AcelRx|Pamela Palmer, MD PhD|650-216-3500|ppalmer@acelrx.com
103809|NCT00612573|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
103810|NCT00612677|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D., via Moffitt Cancer Center|813-745-3050|alberto.chiappori@moffitt.org
103811|NCT00612690|University of Illinois at Chicago|Marc S. Atkins, Ph.D.|312-413-1048|atkins@uic.edu
103812|NCT00612807|Duke University Medical Center|Jill Compton, Ph.D.|919-416-2089|compton@duke.edu
119252|NCT00994643|Thomas Jefferson University|Dr. Matthew Carabasi|215-955-8874|matthew.carabasi@jefferson.edu
103814|NCT00613015|MUSC|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu
103815|NCT00613028|Preston Robert Tisch Brain Tumor Center at Duke|David A. Reardon, MD|919-668-1409|reard003@mc.duke.edu
103816|NCT00613080|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.com
103817|NCT00613106|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com
103818|NCT00613301|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
103819|NCT00613314|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
103820|NCT00613327|Medical Affairs, Janssen Korea|Clinical Research Associate|+82-2-2094-4935|
103821|NCT00613366|Oregon Health & Science University|Dr. Alison Edelman|503.494.5949|edelmana@ohsu.edu
103822|NCT00613379|Cytodyn, Inc.|Dr. Nader Pourhassan|360-980-8524|npourhassan@cytodyn.com
103823|NCT00613405|Medical University of South Carolina|Aimee McRae-Clark, PharmD|843-792-5126|mcraeal@musc.edu
103824|NCT00613509|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
103825|NCT00613574|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
103826|NCT00613626|Hoosier Cancer Research Network|Georgia Gould|317-921-2050|ggould@hoosiercancer.org
103827|NCT00606892|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu
103828|NCT00606905|University of Chicago|Mary D. Stephenson, M.D. MSc|773 834-1167|mstephen@babies.bsd.uchicago.edu
103829|NCT00606931|Naviscan Inc|Judith E Kalinyak, MD, PhD, Medical Director|858-587-3641 ext 108|jkalinyak@naviscan.com
103830|NCT00606944|Seoul National University Bundang Hospital|Sung-Bum Kang|+82-31-787-7093|kangsb@snubh.org
103831|NCT00607048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103832|NCT00607087|sanofi-aventis|Medical Affairs Study Director||publicregistryGMA@sanofi-aventis.com
103833|NCT00607113|UT MD Anderson Cancer Center|Dr. James Yao|713-792-2828|mjlim@mdanderson.org
119253|NCT00993616|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org
103835|NCT00607243|Seoul National University Hospital|Myoung-don Oh, M.D.|+82-2-2072-2945|mdohmd@snu.ac.kr
103836|NCT00607269|Friends Research Institute, Inc.|Jesse B. Fletcher, Ph.D., Statistician|323-463-1601|jfletcher@friendsresearch.org
103837|NCT00613730|Amgen Inc.|Study Director|866-572-6436|
103838|NCT00613821|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|whru@ohsu.edu
103839|NCT00613925|Oregon health & Science University|Alison Edelman, Associate Professor|503-418-2585|edelmana@ohsu.edu
103840|NCT00613938|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Leader|609-730-4537|
103841|NCT00613951|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
103842|NCT00615719|VCU|John D. Grizzard|804-828-8569|jdgrizzard@vcu.edu
103843|NCT00615836|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
103844|NCT00615901|Memorial Sloan Kettering Cancer Center|Dr. Pamela Drullinksy|516-256-3955|drullinp@mskcc.org
103845|NCT00615914|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
103846|NCT00615927|Duke University Medical Center|Annick Desjardins, MD, FRCPC|919-668-|annick.desjardins@dm.duke.edu
103847|NCT00615992|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
103848|NCT00616018|Denver Health|Jody Green|303-389-1246|jody.green@rmpdc.org
103849|NCT00616109|University of Michigan|Gregory Kalemkerian, M.D.|(734) 936-4991|kalemker@umich.edu
103908|NCT00618371|University of Pittsburgh|Deborah McMahon|412-383-1675|mcmahond@pitt.edu
103850|NCT00616122|UCSF Helen Diller Family Comprehensive Cancer Center|Hope S. Rugo|415-353-7618|hrugo@medicine.ucsf.edu
103852|NCT00616239|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu
103853|NCT00616343|Loma Linda University|Dr. David Swope|909-558-4908|Thamilton@llu.edu
103854|NCT00616421|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com
103855|NCT00616434|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com
103856|NCT00616577|Loma Linda University|Charles Lee, MD|909-558-9408|thamilton@llu.edu
103857|NCT00616603|Loma Linda University Department of Anesthesiology|Patricia Moore, CCRP|909-558-8493|pamoore@llu.edu
103858|NCT00616629|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
103859|NCT00616642|University of California Los Angeles|Anthony Heaney, M.D. Ph.D|310 267 4980|aheaney@mednet.ucla.edu
103860|NCT00616655|Sunovion|Eszopiclone Medical Director|866-503-7813|clinicaltrialdisclosure@sunovion.com
119255|NCT00958243|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com
103862|NCT00616772|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
103863|NCT00616902|Abbott|Global Medical Services|800-633-9110|
103864|NCT00616928|GlaxoSmithKline|GSK Response Center|866-435-7343|
103865|NCT00616967|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|443-287-6489|vstearn1@jhmi.edu
103866|NCT00617058|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu
103867|NCT00617084|Medtronic Bakken Research Center B.V.|Miraida Weldam|+ 31 43 356 ext 6652|miraida.weldam@medtronic.com
103868|NCT00617097|University of California, Davis|Dr. Catherine Cansino|9167346930|Catherine.Cansino@ucdmc.ucdavis.edu
103869|NCT00617123|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
103870|NCT00617175|MEDTRONIC Clinical Research Institute|Laura Manotta|+39022413.1|laura.manotta@medtronic.com
103871|NCT00617188|Masonic Cancer Center, University of Minnesota|Peter Argenta, M.D.|612-626-6037|argenta@umn.edu
103872|NCT00617201|University of Kentucky|Dr. Sharon Walsh|859-257-2684|sharon.walsh@uky.edu
103873|NCT00617240|The University of North Carolina at Chapel Hill|Linmarie Sikich, MD|(919) 972-7500|lsikich@med.unc.edu
103874|NCT00617279|W. L. Gore & Associates, Inc.|Chad Badorek, Clinical Study Manager|928.864.3486|cbadorek@wlgore.com
103875|NCT00617305|Gilead Sciences|Ellen Shen, PhD, Senior Manager, Regulatory Affairs|+1 (650) 522-5278|Ellen.Shen@gilead.com
103876|NCT00617357|LifeCell|Dr Michael Franz|908 947 1100|mfranz@lifecell.com
103877|NCT00617396|UNC Chapel Hill|Dr. Douglas Drossman|919-966-0141|douglas_drossman@med.unc.edu
119256|NCT00958126|Seqirus|Clinical Trials Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com
103879|NCT00617461|XenoPort, Inc.|XenoPort Call Center|877-936-6778|
103880|NCT00617591|H. Lee Moffitt Cancer Center and Research Institute|Rachid Baz, M.D.|813-745-8212|rachid.baz@moffitt.org
103881|NCT00617604|Astellas Pharma Europe B.V|Senior Director Medical Science||Astellas.resultsdisclosure@astellas.com
103882|NCT00617669|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
103883|NCT00617708|SWOG|Study Statistician|206-667-4623|
103884|NCT00617773|Recepta Biopharma|Dr. Oren Smaletz, M.D., Medical Director|55 11 3709-2140|oren.smaletz@receptabiopharma.com.br
103885|NCT00617851|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com
103886|NCT00617890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
103887|NCT00617903|Bayer HealthCare Pharmaceuticals, Inc. (formerly Intendis GmbH)|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
103888|NCT00617929|Masonic Cancer Center, University of Minnesota|Jakub Tolar, MD|612-624-7180|tolar003@umn.edu
103889|NCT00617942|Brown University Oncology Research Group (BrUOG)|William Sikov, MD|4018633000|kayla_rosati@brown.edu
103890|NCT00617981|Celsion Corporation|Nicholas Borys, M.D. Senior Vice President and Chief Medical Officer|609-896-9100|nborys@celsion.com
103891|NCT00618072|New York Medical College|Harriette R. Mogul MD MPH|914-594-2278|Harriette_Mogul@NYMC.edu
103892|NCT00610311|National Cancer Institute, National Institues of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov
103893|NCT00610363|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com
103894|NCT00610441|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
103895|NCT00610532|The Ohio State University|Dr. Jim McAuley|614-292-9713|mcauley.5@osu.edu
103896|NCT00610649|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
103897|NCT00610675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
103898|NCT00610688|Cincinnati Children's Hospital Medical Center|Dr. Adekunle Dawodu|513-636-1966|Adekunle.Dawodu@cchmc.org
103899|NCT00610701|University of Missouri|Brett D. Crist, MD|5738826562|cristb@health.missouri.edu
103900|NCT00610714|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
103901|NCT00610740|Masonic Cancer Center, University of Minnesota|Levi Downs, Jr., M.D.|612-626-6628|downs008@umn.edu
103902|NCT00610857|University of Pittsburgh Cancer Institute|Ahmad Tarhini, MD|4126486507|tarhiniaa@upmc.edu
103903|NCT00610883|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett|212-639-8267|trippet1@mskcc.org
103904|NCT00610987|University of Missouri, Department of Orthopaedics|Dr. Brett Crist|573-882-6562|cristb@health.missouri.edu
103905|NCT00611026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103907|NCT00618332|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu
103909|NCT00618410|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu
103910|NCT00618436|University of Pittsburgh|Dr. Lori Shutter|1-412-647-8410|shutterla@upmc.edu
103911|NCT00618449|University of California, San Francisco|Julius Schachter, PhD / Emeritus Professor of Laboratory Medicine|+1 (415) 824-5115|Julius.Schachter@ucsf.edu
103912|NCT00618514|Image Guided Surgery Associates|Robert Worthington-Kirsch|(610) 327-7236|kirsch@igsapc.com
103913|NCT00618540|University of Minnesota, Pediatric BMT|Dr. Angela Smith, MD|612-626-2778|smith719@umn.edu
103914|NCT00618618|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com
103915|NCT00618722|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com
103916|NCT00618748|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
103917|NCT00618774|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
103918|NCT00618787|Tyco Healthcare Group|Tonya Eggleston, RN, MPH, Study Director|(508) 261-8420|Tonya.Eggleston@Covidien.com
103919|NCT00618813|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org
103920|NCT00618826|University of Cincinnati|Alison Kastl|513-584-0436|kastla@ucmail.uc.edu
103921|NCT00618839|Stratatech Corporation|Mary Lokuta|608-441-8358|mlokuta@stratatechcorp.com
103922|NCT00618956|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|201-427-8218|robert.palmer@frx.com
103923|NCT00618982|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
103924|NCT00618995|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
103925|NCT00619060|University of Arizona|Steve Stratton,PhD Chairman of Scientific Review Comittee|(520) 626-9295|SStratton@uacc.arizona.edu
103926|NCT00619073|Children's Hospital Boston|Alan D. Michelson, M.D.|617-919-2116|alan.michelson@childrens.harvard.edu
103927|NCT00619099|Eisai Inc.|Erhan Berrack, M.D.|888-422-4743|
103929|NCT00619151|Sorin Group USA, Inc.|Barbara Mathews Director Clinical and Medical Affairs|512-435-3602|Barbara.mathews@sorin.com
103930|NCT00619177|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
103931|NCT00619190|UNC Chapel Hill|Linmarie Sikich, MD|919-972-7499|lsikich@med.unc.edu
103932|NCT00619229|UCB|UCB Clinical Trial Call Center|+ 1 877 822 9493 (UCB)|
103933|NCT00619242|The University of Chicago|Ezra Cohen, MD|773/702-4137|ecohen@medicine.bsd.uchicago.edu
103934|NCT00619307|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
103935|NCT00619359|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
103936|NCT00619385|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com
103937|NCT00619476|XenoPort, Inc.|XenoPort Call Center|877-936-6778|
103938|NCT00619489|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com
103939|NCT00619502|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
103940|NCT00619619|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103941|NCT00619645|University of California Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu
103942|NCT00619684|Fred Hutchinson Cancer Research Ctr|Dr. William Bensinger|2066674730|wbensing@fredhutch.org
103943|NCT00619762|LifeCell|Director of Clinical Operations|908.809.7856|djacobs@lifecell.com
103944|NCT00619801|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
103945|NCT00619827|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com
103946|NCT00619892|UCSF Fresno|Andrew Goddard, M.D.|559-499-6580|agoddard@fresno.ucsf.edu
103947|NCT00619918|Children's Hospital Los Angeles|Susan Wu|323-361-6177|suwu@chla.usc.edu
103948|NCT00619957|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
103949|NCT00619970|CHLA|Brynie Slome Collins MD|323 361 2181|bcollins@chla.usc.edu
103951|NCT00620022|Novartis Pharmaceuticals|Study Director|862 778-8300|
103952|NCT00620035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
103953|NCT00620074|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
103954|NCT00620113|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
103955|NCT00620126|University of Maryland. Baltimore|PI|410-706-3387|rcross@medicine.umaryland.edu
103956|NCT00620282|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
103957|NCT00620373|Mayo Clinic|Dr. Deborah J. Rhodes|507-538-1703|rhodes.deborah@mayo.edu
103958|NCT00620425|Zogenix, Inc|Edward Smith III, PhD, VP Regulatory Affairs & Product Quality/Safety|510 550 8325|esmith@zogenix.com
103959|NCT00620464|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
103960|NCT00620542|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
103961|NCT00620555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103962|NCT00620659|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
103963|NCT00620698|Beth Israel Deaconess Medical Center|Seward Rutkove|617-667-8130|srutkove@bidmc.harvard.edu
103964|NCT00620711|Vanderbilt university|William F Walsh|615-322-0545|bill.walsh@vanderbilt.edu
103965|NCT00620750|New York University School of Medicine|Marc Gourevitch, MD, MPH|212-263-8553|marc.gourevitch@nyumc.org
103966|NCT00620763|United States Department of Agriculture Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov
103967|NCT00620776|University of Pennsylvania|Dr. Paul Crits-Christoph|(215) 662-7993|crits@mail.med.upenn.edu
103968|NCT00620815|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
103969|NCT00620828|Duke UMC|Michael Bolognesi, MD|919-668-4732 ext 2|bolog002@mc.duke.edu
103970|NCT00620854|Tarsa Therapeutics, Inc.|Thomas Wicks, Ph.D., Vice-President Global RA/QA|267 273 7946|twicks@tarsatherapeutics.com
103971|NCT00614055|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
103972|NCT00614120|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
103973|NCT00614198|Center for Autisme|Lennart Pedersen|44982355|lpe@centerforautisme.dk
103974|NCT00614315|Bard Peripheral Vascular, Inc.|John Reviere, Director, Clinical Affairs|480-303-2644|John.Reviere@crbard.com
103975|NCT00614380|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
103976|NCT00614393|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
103977|NCT00614406|Oregon Health and Sciences University|Allison Edelman, MD, MPH|503-494-5949|edelmana@ohsu.edu
103978|NCT00614445|Duchesnay, Inc.|Michael Gallo|450-433-7734|mgallo@duchesnay.com
103979|NCT00614458|UNC Chapel Hill|Professor of Medicine, Director Translational Research IGHID|919 966 6388|dmargo@med.unc.edu
103980|NCT00614484|Professor of Radiation Medicine, Loma Linda University Medical Center|David Bush MD|909-558-4280|dbush@llu.edu
103981|NCT00614523|Amgen Inc.|Study Director|866-572-6436|
103982|NCT00614575|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
103983|NCT00614614|GlaxoSmithKline|GSK Response Center|866-435-7343|
103984|NCT00614744|Brown University, Women & Infants Hospital of Rhode Island|Abbot Laptook|401-274-1122 ext 47421|alaptook@wihri.org
103985|NCT00614874|Creighton University School of Medicine|Dr. Tammy Wichman|402-449-4486|wichman@creighton.edu
103986|NCT00614913|Radiation Medicine - Loma Linda University Medical Center|David Bush MD|909-558-4280|dbush@dominion.llumc.edu
103987|NCT00614926|Columbia University|Judith Rabkin, PhD|212 543 5762|jgr1@columbia.edu
103988|NCT00614939|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
103989|NCT00614991|Garden State Infectious Disease Associates|David Condoluci|856-566-3190|dcondoluci@gsida.org
103990|NCT00615017|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com
103991|NCT00615030|Novartis Pharmaceuticals|Study Director|862-778-8300|
103992|NCT00615056|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103993|NCT00615069|W.L. Gore and Associates|Jennifer Gorman|928 864 3381|jgorman@wlgore.com
103994|NCT00615108|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
103995|NCT00615199|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
103996|NCT00615264|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com
103997|NCT00615290|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
103998|NCT00615433|Sunovion Pharmacetuicals Inc.|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com
103999|NCT00615459|Novartis Pharmaceuticals|Study Director|862-778-8300|
104000|NCT00615472|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu
104001|NCT00615550|Columbia Laboratories|George W Creasy MD|973-486-8797|Gcreasy@columbialabs.com
104002|NCT00615589|University of Michigan Comprehensive Cancer Center|Dr. Attaphol Pawarode, M.D.|734-936-8785|pawarode@umich.edu
104003|NCT00621023|Duke University Medical Center|Dr. Carlos de Castro|919-684-8964|decas003@mc.duke.edu
104004|NCT00621049|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
104005|NCT00621140|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104006|NCT00621153|AstraZeneca|Gerard Lynch|+44 1509 64589 ext 4589|aztrial_results_posting@astrazeneca.com
104007|NCT00621192|Eunice Kennedy Shriver National Institute of Child Health and Human Development|David Siegel, MD|301-595-8670|siegelda@mail.nih.gov
104008|NCT00621244|Novartis Pharmaceuticals|Study Director|862-778-8300|
104009|NCT00621257|children's Hospital Boston|Helen Pappa, MD, MPH, Principal Investigator|617-355-6058|helen.pappa@childrens.harvard.edu
104010|NCT00621296|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
104011|NCT00621322|GlaxoSmithKline|GSK Response Center|866-435-7343|
104012|NCT00621348|AIIMS|Rakesh Lodha|91 11 26593621|rakesh_lodha@hotmail.com
104013|NCT00622284|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104014|NCT00622336|Celgene Corporation|Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@celgene.com
104015|NCT00622388|GlaxoSmithKline|GSK Response Center|866-435-7343|
104017|NCT00622427|University of Alabama at Birmingham|Rachel Fargason|205-934-5151|mfargason@uab.edu
104018|NCT00622440|UCSF|Naomi Jay, PhD|415-353-7443|Naomi.Jay@ucsf.edu
104019|NCT00622518|University of Washington|James A. Taylor, MD|206-616-1206|uncjat@u.washington.edu
104020|NCT00622635|Novartis Pharmaceuticals|Study Director|862 778-8300|
104021|NCT00622700|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
104022|NCT00622713|Novartis Pharmaceuticals|Study Director|862-778-8300|
104023|NCT00622726|University of Texas Health Science Center-Houston|Helen Mintz-Hittner, M.D.|713-559-5277|Helen.A.Mintz-Hittner@uth.tmc.edu
104024|NCT00622739|Baylor College of Medicine|Kirti Saxena|832-822-4065|kxsaxen1@texaschildrens.org
104025|NCT00622869|Novartis Pharmaceuticals|Study Director|862 778-8300|
104026|NCT00622908|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com
104027|NCT00623012|Yale University|Dr. Stuart Seropian|203-737-2477|Stuart.Seropian@yale.edu
104029|NCT00623181|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
104030|NCT00623194|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
104031|NCT00623233|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
104032|NCT00623428|Hoffman-LaRoche|Medical Communications|800-821-8590|
104033|NCT00623441|Medtronic Bakken Research Center|Sofia Pateraki, MSc - Sr. Clinical Research Specialist|+31 43 3566785|sofia.pateraki@medtronic.com
104034|NCT00623467|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
104035|NCT00623480|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
104036|NCT00623506|Durham VA Medical Center|Christine E. Marx, MD|919 286-0411 ext 7426|marx0001@mc.duke.edu
104037|NCT00623545|University of Wisconsin-Madison|Dale A Schoeller|608-262-1082|dschoell@nutrisci.wisc.edu
104038|NCT00623597|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
104039|NCT00623636|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com
104040|NCT00623714|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
104041|NCT00623727|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
104043|NCT00623779|AstraZeneca|Gerard Lynch|+44 1509 645895|aztrial_results_posting@astrazeneca.com
104044|NCT00623805|Hoffmann-La Roche|Medical Communications|800 821-8590|
104045|NCT00623831|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org
104046|NCT00623935|University of Michigan Comprehensive Cancer Center|Dr. Gregory Yanik, M.D.|734-936-8785|gyanik@umich.edu
104047|NCT00623974|UT MD Anderson Cancer Center|Mimi Hu, MD / Professor||CR_Study_Registration@mdanderson.org
104048|NCT00624052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104049|NCT00624065|GlaxoSmithKline|GSK Response Center|866-435-7343|
104050|NCT00624195|UCSD|Dr. Ron Ellis|619-543-5079|roellis@ucsd.edu
104051|NCT00624221|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org
104052|NCT00624234|Vanderbilt University|Dr. Laurie Cutting|615-875-1054|Laurie.Cutting@Vanderbilt.Edu
104053|NCT00624286|Novartis Pharmaceuticals|Study Director|862 778-8300|
104054|NCT00624338|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
104055|NCT00624377|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104056|NCT00624416|Pennington Biomedical Research Center|Leanne Redman|225-763-0947|Leanne.Redman@pbrc.edu
104057|NCT00624442|Cytokinetics, Inc.|Medical Director|(650) 624-3011|
104058|NCT00624468|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
104059|NCT00624520|Department of Veterans Affairs|Dr Douglas C Russell|608-256-1901|Dcrussel@facstaff.wisc.edu
104060|NCT00624559|University of Delaware|Dr. William Farquhar|302-831-6178|wbf@udel.edu
104061|NCT00624585|H. Lee Moffitt Cancer Center and Research Institute|Alan F. List, Executive Vice President & President, Moffitt Medical Group|813-745-6086|alan.list@moffitt.org
104062|NCT00624780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104063|NCT00624806|Center of Innovation for Complex Chronic Health Care|Marylou Guihan, PhD|708-202-2414|marylou.guihan@va.gov
104064|NCT00624832|Novartis Pharmaceuticals|Study Director|862-778-8300|
104065|NCT00627393|New England Research Institutes, Inc.|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com
104066|NCT00627406|Fertility Clinic Regional Hospital Skive|Dr. Peter Humaidan|+45 78 44 57 60|peter.humaidan@viborg.rm.dk
104067|NCT00627445|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
104068|NCT00627458|GlaxoSmithKline|GSK Response Center|866-435-7343|
104069|NCT00627497|Medtrionic spinal and biologics|Zhimin Liu|901-3993123|zhimin.liu@medtronic.com
104070|NCT00627523|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104071|NCT00627679|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|(650) 386-3100|dkellerman@mappharma.com
104072|NCT00627705|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu
104073|NCT00627861|The Rogosin Institute|Warren Bobb, N.P.|212-746-9114|wab9006@nyp.org
104074|NCT00627926|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com
104075|NCT00627978|Weill Cornell Medicine|Linda Vahdat, MD|646-962-9888|ltv2001@med.cornell.edu
104076|NCT00628030|Virginia Commonwealth University|Suzanne E Mazzeo, Professor of Psychology|804-827-9211|semazzeo@vcu.edu
104077|NCT00628108|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
104078|NCT00628134|University of Pittsburgh|Tim Corcoran, Ph.D.|412-624-8918|corcorante@upmc.edu
104079|NCT00628147|SF VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810 ext 24103|tonya.kaltenbach@va.gov
104080|NCT00628212|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
104081|NCT00628251|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
104082|NCT00628355|Ribeirao Preto Medical School - University of Sao Paulo|Omero Benedicto Poli Neto|551636023183|polineto@fmrp.usp.br
104083|NCT00628407|Children's Hospital of Philadelphia|Vinay Nadkarni, MD|215-590-7430|nadkarni@email.chop.edu
104084|NCT00628446|Carolinas Healthcare System|Dr. Jesse Lieberman|704-355-0649|Jesse.Lieberman@Carolinashealthcare.org
104085|NCT00628589|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com
104086|NCT00628628|The University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||CR_Study_Registration@mdanderson.org
109602|NCT00953147|Sunovion|Respiratory Medical Director|1-866-503-6351|
104087|NCT00628758|AstraZeneca|Gerard Lynch|+44 1509 645895|aztrial_results_posting@astrazeneca.com
104088|NCT00628862|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104089|NCT00628901|Boston Scientific|Ana Becker / Sr. Clinical Program Manager|651-581-4605|Ana.Becker@bsci.com
104090|NCT00628927|University of Cincinnati|Dr. Theresa Winhusen|513-487-7800|winhusen@carc.uc.edu
104091|NCT00629018|UMC Ljubljana|Prof. Dr. Bojan Vrtovec|+3861 522 2844|bvrtovec@stanford.edu
104092|NCT00629239|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104093|NCT00629265|Boston Medical Center|Dr. Susan Langmore, PhD, Director of Speech Language Pathology|617-414-1753|langmore@bu.edu
104094|NCT00629499|Sarah Cannon Research Institute|Director, Breast Cancer Research|615-329-7274|asksarah@scresearch.net
104095|NCT00629525|Duke University|Dr. Daniel George|919-668-4615|daniel.george@duke.edu
104096|NCT00629707|University of California, Davis|Dr. Nicole Glaser|916-734-7098|nsglaser@ucdavis.edu
104097|NCT00629772|Innovaderm Research|Annie Levesque|514 521 4285 ext 222|alevesque@innovaderm.ca
104098|NCT00621504|Cerexa, Inc|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com
104099|NCT00621517|East Tennessee State University|Max Bayard MD|802-524-8805|mmbayard3@gmail.com
104101|NCT00621543|University of Rochester|Sarah Betstadt, MD, MPH|585-276-5368|sarah_betstadt@urmc.rochester.edu
104102|NCT00621582|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104103|NCT00621621|Medtronic- AF Solutions|Adam Cline, MD, MSc.- Sr. Clinical Research Specialist|763-526-9601|adam.cline@medtronic.com
104104|NCT00621686|Mayo Clinic|Evanthia Galanis, M.D.|507/284-3559|Galanis.evanthia@mayo.edu
104105|NCT00621764|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
104107|NCT00621842|Case Western Reserve University|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org
104108|NCT00621855|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104109|NCT00621933|Allergan, Inc|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com
104110|NCT00621946|The University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|Sherwood.Brown@UTSouthwestern.edu
104111|NCT00621959|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
104112|NCT00621985|Children's Hospital Boston|Joseph Majzoub|617-355-7476|joseph.majzoub@childrens.harvard.edu
104113|NCT00622167|Massachusetts General Hospital|Iris McNulty, RN|617 726 2612|imcnulty@partners.org
104114|NCT00629850|Texas State Respiratory Care Department|Chris Russian, Associate Professor|512-245-3794|cr23@txstate.edu
104115|NCT00630058|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
104116|NCT00632411|University of Tennessee Health Science Center|Dr. Robert Klesges|901-448-3174|lcolvin1@uthsc.edu
104117|NCT00632424|Organization: Bristol-Myers Squibb|Name/Official Title: BMS Study Director||Clinical.Trials@bms.com
104118|NCT00632463|ADMA Biologics|Chief Medical Officer|201-478-5552|agrossman@admabio.com
104119|NCT00632489|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
104120|NCT00632502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
104121|NCT00632541|Hoosier Cancer Research Network|Jeff Smith|317-634-5842 ext 41|jsmith@hoosiercancer.org
104122|NCT00632619|Florida International University|James G Waxmonsky|305 348 3258|jwaxmons@fiu.edu
104123|NCT00632632|Weill Cornell Medical College|JoAn Difede, PhD|212 746 3079|jdifede@med.cornell.edu
104124|NCT00632736|GlaxoSmithKline|GSK Response Center|866-435-7343|
104125|NCT00632749|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104126|NCT00632814|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
104127|NCT00632931|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com
104128|NCT00632970|Medical Faculty Associates|Gary Simon|202 741-2234|Gsimon@mfa.gwu.edu
104129|NCT00633009|Nielsen BioSciences, Inc.|Stewart Nielsen|858.571.2726|stewart@nielsenbio.com
104130|NCT00633074|GlaxoSmithKline|GSK Response Center|866-435-7343|
104131|NCT00633087|Rutgers Cancer Institute of New Jersey|Dr. Robert DiPaola, MD|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
104132|NCT00633126|Cerexa, Inc.|David Friedland, MD|510-285-9200|clinicaltrials@cerexa.com
104133|NCT00633139|Shire Human Genetic Therapies, Inc|Norman Barton|781-482-9297|nbarton@shire.com
104134|NCT00633152|Cerexa, Inc.|Vice President, Clinical Sciences|510-285-9200|clinicaltrials@cerexa.com
104135|NCT00633217|GlaxoSmithKline|GSK Response Center|866-435-7343|
104136|NCT00633243|Yale University|R. Douglas Bruce|(203) 737-6133|robert.bruce@yale.edu
104137|NCT00633256|Yale University|James Poling, Ph.D.|203-937-4830|james.poling@yale.edu
104138|NCT00633360|Brigham & Women's Hospital|Dr Hadine Joffe|617-732-4906|hjoffe@partners.org
104139|NCT00633399|Massachusetts General Hospital CNTI|George I Papakostas, M.D. - Scientific Director|6177266697|gpapakostas@partners.org
104140|NCT00633464|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
104141|NCT00633477|Takeda|Takeda Study Registration Call Center|800-778-2860|medicalinformation@tpna.com
104142|NCT00633594|Sarah Cannon Research Institute|Ian Flinn, MD|1-877-691-7274|asksarah@scresearch.net
104143|NCT00633750|Vanderbilt-Ingram Cancer Center|Carlos Arteaga, M.D.|(615) 936-1919|
104144|NCT00633867|NHS Grampian|W Brampton||william.brampton@nhs.net
104145|NCT00633880|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com
104146|NCT00633893|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
110846|NCT01033825|Sunovion|Respiratory Medical Director|1-866-503-6351|
104147|NCT00633919|ALK-Abelló S.A.|Santiago Martín - Trial Manager|+34 913276127|santiago.martin@alk-abello.com
104148|NCT00633932|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104149|NCT00633984|Boston University|Dr. Stefan G. Hofmann|617 353 9233|shofmann@bu.edu
104150|NCT00634010|The University of Texas (UT) MD Anderson Cancer Center|Eduardo Bruera, MD, Chair, Palliative Care Medicine||CR_Study_Registration@mdanderson.org
104151|NCT00634036|University of Pittsburgh|Dr. Fernando Holguin|412-692-2817|holguinf@upmc.edu
104152|NCT00634049|Astellas Pharma Global Development, Inc.|Vice President, Medical Head ID/IM/TX|(224) 205-8800|Astellas.resultsdisclosure@astellas.com
104153|NCT00634088|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
104154|NCT00634114|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104155|NCT00634166|Mylan Pharmaceuticals Inc.|Eric Davis, M.D.|304.554.6503|eric.davis@mylan.com
104156|NCT00634179|Emory University|Christopher R. Flowers, MD, MS|404-778-3935|crflowe@emory.edu
104157|NCT00634244|ECOG Statistical Office|Study Statistician|617-632-3012|
119263|NCT00859573|University of Arkansas for Medical Sciences|Michael J. Mancino, M.D.|501-526-8442|mjmancino@uams.edu
104159|NCT00634322|BTG International (Protherics)|VP Clinical Development, BTG International|610-943-3632|janet.rush@btgplc.com
104160|NCT00634504|BTG International Inc.|SVP, Clinical Development|610-278-1660|angela.ogden@btgplc.com
104161|NCT00634543|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|Clinical Research Director|82-2-2094-4518|
104162|NCT00634569|Grifols|Paul J. Pinciaro, PhD|410-814-7617|paul.pinciaro@grifols.com
104163|NCT00634582|Comprehensive Cancer Center of Wake Forest Univeresity|Gary Schwartz, PhD|336-716-7446|gschwart@wakehealth.edu
104164|NCT00634621|GE Healthcare|Emilio Moreno Carretero, M.D.|011-34-9166-30970|Emilio.Morenocarretero@ge.com
104165|NCT00634647|National Cancer Institute, National Institutes of Health|Dr. William Dahut|301-435-8183|dahutw@mail.nih.gov
104166|NCT00634751|University of Wisconsin Carbone Cancer Center|Dr. Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu
104167|NCT00625131|VA Medical Center, Durham, NC|Angela Kirby, MS; Regulatory Coordinator|9192860411 ext 5526|angela.kirby@va.gov
104169|NCT00625365|Lantheus Medical Imaging|Dana Washburn, M.D.|978-671-8686|dana.washburn@lantheus.com
104170|NCT00625391|Texas Tech University Health Sciences Center|Dr. Chwan-Li Shen|(806) 743-2815|Leslie.Shen@ttuhsc.edu
104172|NCT00625586|MacroGenics, Inc.|Sr. Director of Clinical Operations|650 624 2676|baughmanj@macrogenics.com
104173|NCT00625729|Masonic Cancer Center, University of Minnesota|Veronika Bachanova, M.D.|612-625-5469|bach0173@umn.edu
104174|NCT00625742|University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO/Associate Professor, Palliative Care Med||CR_Study_Registration@mdanderson.org
104175|NCT00625820|University of Michigan|Rajiv Saran, MD|734-763-6611|rsaran@umich.edu
104176|NCT00625872|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104177|NCT00625989|McMaster University|Dr. Gail Gauvreau|905-525-9140 ext 22791|gauvreau@mcmaster.ca
104178|NCT00626028|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com
104179|NCT00626093|St. Jude Medical|Ashish Oza|818-493-3648|aoza@sjm.com
104180|NCT00626210|VAPAHCS|Dr. Jamie Zeitzer|6504935000 ext 62410|jzeitzer@stanford.edu
104181|NCT00626275|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660|
104182|NCT00626327|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
104183|NCT00626340|University of Pennsylvania|Dr. Cynthia Neill Epperson|215-573-8871|cepp@mail.med.upenn.edu
104184|NCT00626392|Abbott|Medical Information Specialist|800-633-9110|
104185|NCT00626431|Abbott|Global Medical Services|800-633-9110|
104186|NCT00626444|Thomas Jefferson University|Daniel Monti, MD|215-955-4410|Daniel.Monti@jefferson.edu
104187|NCT00626522|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com
104188|NCT00626548|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104189|NCT00626561|University of Texas MD Anderson Cancer Center|Michael M. Frumovitz, MD / Professor, Gynecologic Oncology|713-792-9599|CR_Study_Registration@mdanderson.org
104190|NCT00626574|University of South Florida|Enrico M Camporesi MD|813-844-7170|ecampore@health.usf.edu
104191|NCT00626639|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com
104192|NCT00626743|INJE University Pusan Paik Hospital|Jae Gook Shin, MD,PhD|+82-51-890-8954|phshinjg@paik.ac.kr
104194|NCT00626808|MedImmune, LLC|Chris Ambrose|301-398-0000|ambrosec@medimmune.com
104195|NCT00626821|Coloplast|Helle Aaes Senior Scientific Manager|+45 49112949|dkheaa@coloplast.com
104196|NCT00626925|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@mail.med.upenn.edu
104197|NCT00627016|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
104198|NCT00627042|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
104199|NCT00627094|Coloplast|Scientific Manager|+4549113557|dkkg@coloplast.com
104200|NCT00634842|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
104201|NCT00634907|University of Utah|Dr. Gwen McMillin/Principal Investigator|801-583-2787 ext 2671|gwen.mcmillin@aruplab.com
104202|NCT00634920|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
104203|NCT00634933|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104204|NCT00635024|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu
104205|NCT00635050|UAB|John Carpenter, M.D.|205-910-8886 or 205-934-2084|jtc4321@bellsouth.net
104206|NCT00635089|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
104207|NCT00635102|Yale University School of Medicine|Dr John Krystal|203-785-6396|john.krystal@yale.edu
104208|NCT00635128|GlaxoSmithKline|GSK Response Center|866-435-7343|
104209|NCT00635154|Mayo Clinic|Dr. John Lust||lust.john@mayo.edu
104210|NCT00635661|New York University,. Rusk Institute|Dr. Irene Ward|212-263-6073|Irene.ward@nyumc.org
104211|NCT00635700|Yale University|Scott W. Woods, M.D.|203-974-7038|scott.woods@yale.edu
104212|NCT00635804|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
104213|NCT00635817|Abbott|Global Medical Services|800-633-9110|
104214|NCT00635830|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
104215|NCT00635882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
104216|NCT00636077|Kidney Disease Program, University of Louisville|Richard A Ward, Ph.D.|502-852-5757|richard.ward@louisville.edu
104217|NCT00636155|Duke University Medical Center|Mark Lanasa, MD, PhD|919-286-6897|mark.lanasa@duke.edu
104219|NCT00636194|Bausch & Lomb|Robert Steffen OD|(585) 338-6399|robert.steffen@bausch.com
104220|NCT00636207|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
104221|NCT00636220|Chembio Diagnostic Systems, Inc.|Javan Esfandiari|(631) 924-1135 ext 112|jesfandiari@chembio.com
104222|NCT00636363|Bausch & Lomb|Robert Steffen|(585) 338-6399|robert.steffen@bausch.com
104223|NCT00636389|Gambro Renal Products|Jeff Shideman, Ph.D.|952-835-4018|Jeff.Shideman@us.gambro.com
104224|NCT00636441|Duke University Medical Center|P. Kelly Marcom, M.D.|919-684-3877|marco001@mc.duke.edu
104225|NCT00636610|Genentech, Inc.|Medical Communications|800-821-8590|
104226|NCT00636636|Depomed|Head of R&D|650-462-5900 ext 108|msweeney@depomed.com
104227|NCT00636649|Duke University Medical Center|Kishore Gadde|919-668-0208|kishore.gadde@duke.edu
104228|NCT00636701|Atlanta VA Medical Center|Dr. Andrew Butler|404-413-1415|andrewbutler@gsu.edu
104229|NCT00636792|Millennium Pharmaceutical Inc|Carol Satler|(617) 551-3729|
104230|NCT00636805|Duke University Medical Center|Mary Lou Affronti|919-6846239|mary.affronti@dm.duke.edu
104231|NCT00636818|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
104232|NCT00636961|Novartis Pharmaceuticals|Study Director|862-778-8300|
104233|NCT00636987|St Jude Medical|Sr. Clinical Manager|6517566803|jjohnson101@sjm.com
104234|NCT00637000|Reckitt Benckiser Pharmaceuticals, Inc.|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|804-379-1090 ext 7089|ed.johnson@reckittbenckiser.com
104236|NCT00637195|GlaxoSmithKline|GSK Response Center|866-435-7343|
104237|NCT00637247|AmpliMed Corporation|Robert Dorr|520-626-7892|bdorr@azcc.arizona.edu
104238|NCT00637273|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
104239|NCT00637299|Fondazione Salvatore Maugeri|Ercole Zanotti|39 385 247 ext 324|ercole.zanotti@fsm.it
104240|NCT00637312|Orthofix|Ruba Sarris|214-937-2256|rubasarris@orthofix.com
104241|NCT00637377|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
104242|NCT00637416|University of Kansas Medical Center|Director, ENT Clinical Research|(913) 588-7154|ksykes@kumc.edu
104243|NCT00637494|Corcept Therapeutics|Thaddeus S. Block, MD|(650) 688-8816|tblock@corcept.com
104244|NCT00637572|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
104245|NCT00637728|Endo Pharmaceuticals Inc.|M. Todd Kirby, PhD|(484) 216-6491|kirby.todd@endo.com
104246|NCT00637780|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com
104247|NCT00637806|Endo Pharmaceuticals Inc.|M. Todd Kirby, PhD|(484) 216-6491|kirby.todd@endo.com
104248|NCT00637923|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com
104249|NCT00638014|Duke University|Elliott Bennett-Guerrero|9196819660|benne011@mc.duke.edu
104250|NCT00638027|University of Rochester|Cynthia Irish, RN, MSCN|585-275-6120|cindy_irish@urmc.rochester.edu
104251|NCT00638157|Cubist Pharmaceuticals|Ed Campanaro / Vice President, Clinical Operations|781-860-8318|ed.campanaro@cubist.com
104252|NCT00630292|University of North Carolina|William Irvin, Jr. MD / Co-Principal Investigator|919-966-6735|william_irvin@med.unc.edu
104253|NCT00630305|Johnson & Johnson Vision Care, Inc.|Kurt Moody, OD|1-904-443-3088|kmoody1@its.jnj.com
104254|NCT00630331|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
104256|NCT00630396|Georgia Health Sciences University|David Hess, MD|706-721-1691|dhess@georgiahealth.edu
104257|NCT00630409|University of Pittsburgh|Leonard Appleman, MD, PhD|412-648-6538|applemanlj@upmc.edu
104258|NCT00630487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
104259|NCT00630539|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
104260|NCT00630734|University of Colorado Denver|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu
104261|NCT00630747|Shire Human Genetic Therapies|Dr. Arian Pano, Medical Director|781-482-0875|apano@shire.com
104262|NCT00630786|Amgen Inc.|Study Director|866-572-6436|
104263|NCT00630825|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
104264|NCT00630838|University of Michigan|Daniel Teitelabum|734-936-8464|dttlbm@umich.edu
104265|NCT00630864|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104266|NCT00630877|Abbott|Medical Information Specialist|800-633-9110|
104267|NCT00630916|Sorin Group USA|Director of Clinical and Medical Affairs|512-435-3602|barbara.mathews@sorin.com
104567|NCT00667251|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
104269|NCT00630994|Mayo Clinic|Dr. Ruben A. Mesa|507-284-2511|mesa.ruben@mayo.edu
104270|NCT00631007|InteKrin Therapeutics|Chief Executive Officer|650-941-5501|Info@intekrin.com
104271|NCT00631020|UCLA Center for Health Promotion and Disease Prevention|Dr. Steven Shoptaw|310-794-0619 ext 225|sshoptaw@mednet.ucla.edu
104272|NCT00631189|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104273|NCT00631358|Alcon Labs|Alcon Clinical|1-888-451-3937; 1-817-568-6725|medinfo@alconlabs.com
104274|NCT00631371|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104275|NCT00631410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104276|NCT00631449|University of California, San Francisco|Hiroyu Hatano|415-476-4082 ext 122|hhatano@php.ucsf.edu
104277|NCT00631475|Actelion Pharmaceuticals Ltd|Isabelle Leconte, PhD/Data Science Group Leader, Director|+ 41 61 565 64 18|isabelle.leconte@actelion.com
104278|NCT00631488|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
104279|NCT00631540|Cook Incorporated|Scott Snyder, PhD|765-463-7537|ssnyder@medinst.com
104280|NCT00631657|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
104281|NCT00631670|University of Florida, Dept. of Radiation Oncology|Bridget Fitzgerald, Clinical trials coordinator|352-265-0680 ext 87829|fitzgb@shands.ufl.edu
104282|NCT00631696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104283|NCT00631748|VA Puget Sound Health Care System|Andre Tapp, MD|253-589-4176|andre.tapp@va.gov
104284|NCT00631917|Novartis Pharmaceuticals|Study Director|862-778-8300|
104285|NCT00631969|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
104286|NCT00632021|Vanderbilt University Medical Center|Research Coordinator|6159364819|Kathryn.m.goggins@vanderbilt.edu
104287|NCT00632099|New York State Psychiatric Institute|Dr. Suzette Evans|646-774-6136|se18@columbia.edu
104288|NCT00632125|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com
104289|NCT00632203|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
104290|NCT00632229|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu
104291|NCT00632281|University of Florida|Bridget Fitzgerald, Clinical Research Coordinator|352-265-0680 ext 87829|fitzgb@shands.ufl.edu
104292|NCT00638183|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104293|NCT00638222|The University of Toledo, HSC|Christopher Cooper, MD|419.383.6030|christopher.cooper@utoledo.edu
104294|NCT00638235|Eastern Virginia Medical School|Dr. James C Lukban, Professor & Director Division of urogynecology|7574467900|lukbanjc@evms.edu
104295|NCT00638365|KaloBios Pharmaceuticals, Inc.|Nestor A. Molfino, MD., MSc|650-243-3103|nmolfino@kalobios.com
104296|NCT00638378|Incyte Corporation|Study Director|1-855-463-3463|
104297|NCT00638443|University of Rochester|John Markman, MD|585-340-8926|maria_frazer@urmc.rochester.edu
104298|NCT00638924|Unicamp|Juliana Gomes Zabatiero||juzabatiero@yahoo.com.br
104299|NCT00638937|The Ottawa Hospital Cancer Centre|Dr. Scott Laurie|613-737-7700 ext 70175|slaurie@ottawahospital.on.ca
104300|NCT00638963|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
104301|NCT00638989|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com
104302|NCT00639002|Incyte Corporation|Study Director|855 463-3463|
104303|NCT00639093|GRAP, Clinique de Psychologie au Travail|Benoît Girard|418-542-2030|g.r.a.p@videotron.ca
104304|NCT00639158|Abbott|Global Medical Services|800-633-9110|
104305|NCT00639223|U. of Pennsylvania Health System|Steven Halbert MD, MSCE|215 510 2221|shalbert@mail.med.upenn.edu
104306|NCT00639379|Vistakon|Kurt Moody, OD|904-443-3088|
104307|NCT00639418|MedImmune LLC|Chris Ambrose|301-398-0000|ambrosec@medimmune.com
104308|NCT00639457|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu
104309|NCT00639509|Memorial Sloan-Kettering Cancer Center|Ghassan K. Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org
104310|NCT00639678|GlaxoSmithKline|GSK Response Center|866-435-7343|
104311|NCT00639717|University of Michigan Comprehensive Cancer Center|Dr. Gregory Yanik|734-764-3243|jelevine@umich.edu
104312|NCT00639769|Vanderbilt-Ingram Cancer Center|Barbara Murphy, M.D.||barbara.murphy@vanderbilt.edu
104313|NCT00639860|University of Michigan School of Dentistry|Dr. William Giannobile, Chair Department of Periodontics and Oral Medicine|734-763-2105|wgiannob@umich.edu
104314|NCT00640016|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com
104315|NCT00640042|King Pharmaceuticals, Inc.|Professional Information Services|1-800-776-3637|
104316|NCT00640315|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
104317|NCT00640328|GlaxoSmithKline|GSK Response Center|866-435-7343|
104318|NCT00640341|Bausch & Lomb Incorporated|Gerard Cairns|(585) 338-5170|gerard.cairns@bausch.com
104319|NCT00640393|Innovaderm Research Inc|Annie Levesque|514-521-4285 ext 222|alevesque@innovaderm.ca
104320|NCT00640510|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
104321|NCT00640562|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
104322|NCT00640601|AstraZeneca|Gerard Lynch|441625 518062|aztrial_results_posting@astrazeneca.com
104323|NCT00640614|Allerderm|Kim Sullivan|602-225-0595|
104324|NCT00640822|LeoPharma|Torsten Skov|+4520736294|torsten.skov@leo-pharma.com
104325|NCT00640835|Reckitt Benckiser Pharmaceuticals, Inc.|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|804-379-1090 ext 7089|ed.johnson@reckittbenckiser.com
104326|NCT00640926|Melinta Therapeutics, Inc.|Sue Cammarata, MD|(203) 624-5606|scammarata@melinta.com
104807|NCT00672984|Shire Pharmaceutical|Gerald Tremblay, MD||gtremblay@shire.com
104327|NCT00640978|UT MD Anderson Cancer Center|Milind Javle, MD/Associate Professor|713-792-2828|mjlim@mdanderson.org
104328|NCT00641043|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104329|NCT00641056|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
104330|NCT00641147|Johns Hopkins University|Study Coordinator|410-955-3817|lhylind1@jhmi.edu
104331|NCT00635219|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
104332|NCT00635232|Ligand Pharmaceuticals|Director of Project Management|858-550-7892|hzientek@ligand.com
104333|NCT00635349|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|Clinical Research Director|82-2-2094-4518|
104334|NCT00635362|University of Chicago|Amy Whitaker, MD|773-834-4129|awhitaker@babies.bsd.uchicago.edu
104335|NCT00635427|Shire|MedInfo|+1-866-888-0660|US_ShireHGT_Medicalinformation@shire.com
104337|NCT00635492|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
104338|NCT00635570|Department of Obstetrics and Gynecology, The University of Chicago|Melissa Gilliam|773-834-0840|mgilliam@babies.bsd.uchicago.edu
104339|NCT00635609|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
104340|NCT00635648|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
104341|NCT00641537|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
104342|NCT00641563|University Hospital Bern, Switzerland|Dr. M. Hänggi|0316323029|matthias.haenggi@insel.ch
104343|NCT00641641|University of New South Wales|Sean Emery|9385 0900|semery@kirby.unsw.edu.au
104344|NCT00641667|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387|
104345|NCT00641706|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-3902|Galanis.evanthia@mayo.edu
104346|NCT00641719|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
104347|NCT00641745|Sunovion|Josephine Cucchiaro, PhD; Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com
104348|NCT00642473|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
104349|NCT00642603|Genentech, Inc.|Medical Communications|800-821-8590|
104350|NCT00642616|Sanofi|Trial Transparency Team||ContactUS@sanofi.com
104351|NCT00642642|Biologics Consulting Group|Dr/ Joseph Fratantoni|(301) 340-8432|jfratantoni@bcg-usa.com
104352|NCT00642668|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
104353|NCT00642694|UT Southwestern Medical Center|Dr.Prabha Sunderajan- Assistant Professor|214-645-6964|psunderajan@utsouthwestern.edu
104354|NCT00642707|CytoDyn, Inc.|Kush Dhody|301-956-2536|kushd@amarexcro.com
104355|NCT00642746|OHSU Knight Cancer Institute|Charles Lopez, MD|503-494-8534|lopezc@ohsu.edu
104356|NCT00642759|Massachusetts General Hospital|Dr. Rebecca Heist|6177244000|rheist@partners.org
104357|NCT00642772|Center for Health Services Research in Primary Care, Durham VA Medical Center|Dr. Kelli Allen|919-286-0411 ext 7090|kelli.allen@va.gov
104358|NCT00642811|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104359|NCT00642850|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
104360|NCT00642902|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
104361|NCT00642993|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
104362|NCT00643006|Gothenburg University|Dr. K Mannerkorpi|046-31-24220|kaisa.mannerkorpi@rheuma.gu.se
104363|NCT00643097|Duke University Medical Center|Dr. John H. Sampson|919-684-9041|john.sampson@duke.edu
104364|NCT00643201|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
104365|NCT00643448|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104366|NCT00643487|Upstate Medical University|Thomas V. Smallman|315-464-8618|smallmat@me.com
104368|NCT00643578|University of Florida Asthma Research Lab|Dr. Leslie Hendeles|352-273-6027|hendeles@cop.ufl.edu
104369|NCT00643604|United Therapeutics Corporation|Remodulin Program Leader|919-485-8350|clinicalrecordsmanagement@unither.com
104370|NCT00643682|Boston Medical Center|Brian Jacobson, MD, Principal Investigator|6176386563|brian.jacobson@bmc.org
104371|NCT00643760|XenoPort, Inc.|XenoPort Call Center|877-936-6778|
104372|NCT00643851|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com
104373|NCT00643916|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
104374|NCT00644059|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
104375|NCT00644189|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu
104376|NCT00644228|SWOG Statistical Center|Study Statistician|206-667-4623|
104377|NCT00644280|University of California San Francisco|Shan C. Lin, MD|415-353-2608|lins@vision.ucsf.edu
104378|NCT00644332|Gilead Sciences|Emmanuelle Bellemin, Senior Manager, Regulatory Affairs||emmanuelle.bellemin@gilead.com
104379|NCT00644358|Allergan, Inc.|Therapeutic Area Head|1-877-277-8566|IR-CTRegistration@allergan.com
104380|NCT00644592|University of Florida|Reginald F. Frye, PhD, Associate Professor|3522735453|fryerf@ufl.edu
104381|NCT00644657|University of Oklahoma Health Sciences Center|Eliot Schechter, MD|405-456-5378|eliot-schechter@ouhsc.edu
104382|NCT00644787|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387|
104383|NCT00644917|Smith & Nephew Biotherapeutics|Jaime E Dickerson, Jr, PhD|817-302-3914|jaime.dickerson@smith-nephew.com
104384|NCT00638651|University of Miami|Dr. Keyvan Nouri|305-243-3380|knouri@med.miami.edu
104385|NCT00638690|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Research|310-914-2915|
104868|NCT00669916|Novartis|Study Director|862-778-8300|
104386|NCT00638716|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com
104387|NCT00638820|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu
104388|NCT00638846|Vistakon|Kurt Moody OD|904-443-3088|
104389|NCT00638885|Atlanta VAMC|J Douglas Bremner MD|404-712-9569|jdbremn@emory.edu
104390|NCT00644969|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104392|NCT00645047|University of California San Diego|Zia Agha|858-552-8585|zagha@ucsd.edu
104393|NCT00645099|Janssen-Cilag Germany|EMEA Therapeutic Area Leader CNS|+492137955153|
104394|NCT00645164|DFB Pharmaceuticals|Herbert B. Slade MD, FAAAAI|817.302.3919|bert.slade@dfbpharmaceuticals.com
104395|NCT00645671|Bausch & Lomb|Dr. Tuyen Ong|(973) 360-6389|Tuyen.Ong@bausch.com
104396|NCT00645762|Entellus Medical|Entellus Medical|763-463-1599|
104397|NCT00645788|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
104398|NCT00645827|Emory University|G. Randy Smith Jr.|404.686.6730|grsmith@emory.edu
104399|NCT00645853|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
119268|NCT00791648|Vanderbilt University|Frederic Billings|615-343-6268|frederic.t.billings@vanderbilt.edu
104401|NCT00645970|James A. Haley Veterans' Hospital|Kristin Phillips|813-972-2000 ext 6721|kristin.phillips3@va.gov
104402|NCT00646048|Boston Scientific|Colleen Holthe, Clinical Project Manager|651-581-4632|Colleen.Holthe@bsci.com
104403|NCT00646282|Emory University|Dr. Antonio Guasch|404-727-2522|aguasch@emory.edu
104404|NCT00646399|Biosynexus|Irwin Scher, MD|301-330-5800|irwinscher@biosynexus.com
104405|NCT00646581|UMass Medical School|Matthew Goodnow|508-856-2494|matthew.goodnow@umassmed.edu
104407|NCT00646763|Emory University Winship Cancer Institute|Edmund Waller, MD, PhD|1-888-946-7447|ewaller@emory.edu
104408|NCT00646776|Bristol-Myers Squibb|BMS Study Director||ClinicalTrials@bms.com
104409|NCT00646958|Melinta Therapeutics|Eugene Sun, M.D.|203.624.5606|esun@melinta.com
104410|NCT00647270|Abbott|Global Medical Services|800-633-9110|
104411|NCT00647400|Abbott|Global Medical Services|800-633-9110|
104412|NCT00647556|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com
104414|NCT00647998|Hospital of the University of Pennsylvania|Steven Messe, MD|2156623363|messe@mail.med.upenn.edu
104415|NCT00648037|Memorial Sloan Kettering Cancer Center|Papadopoulos, Esperanza, MD (Attending)|+1212-639-8276|papadope@mskcc.org
104416|NCT00648115|VA North Texas Health Care System|James LePage|210-857-0240|james.lepage@va.gov
104417|NCT00648167|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com
104418|NCT00641862|Harvard T.H. Chan School of Public Health|Dr. Christopher Duggan|617-355-7612|christopher.duggan@childrens.harvard.edu
104419|NCT00642174|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
104420|NCT00642278|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736|
104421|NCT00642304|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
104422|NCT00642356|Novartis Pharmaceuticals|Study Director|862 778-8300|
104423|NCT00642369|Guang Dong Provinical Mental Health Institute|Zhang Bin|86-20-81888553|zhang73bin@hotmail.com
104424|NCT00642382|Cartiva, Inc|Director Clinical Operations|770-754-3805|rtownsend@cartiva.net
104425|NCT00642460|Hoffman-LaRoche|Medical Communications|800-821-8590|
104426|NCT00649389|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com
104427|NCT00649428|CBR International Corp.|Kevin Hennegan|720-746-1190|khennegan@cbrintl.com
104428|NCT00649792|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300 ext 4102|ablight@acorda.com
104429|NCT00649961|Imperial College London|Dr Nazakat Merchant|00447825881907|nazakat.merchant@kcl.ac.uk
104430|NCT00650078|Horizon Pharma|Senior Vice President, Clinical Development & Operations|224-383-3012|agrahn@horizonpharma.com
104431|NCT00650091|Duke Clinical Research Institute|Kevin J Anstrom|919-668-8902|kevin.anstrom@duke.edu
104432|NCT00650104|GlaxoSmithKline|GSK Response Center|866-435-7343|
104433|NCT00650260|University of South Florida Dept of Surgery/Anesthesiology|Enrico Camporesi MD|813-844-7170|ecampore@health.usf.edu
104434|NCT00650546|Department of Gastroenterology, San Antonio Uniformed Services Health Consortium|Patrick R Kenney, DO||pat.kenney@us.army.mil
104435|NCT00650585|PIRE|Heddy Clark|919-265-2643|hclark@pire.org
104436|NCT00650767|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com
104437|NCT00650806|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736|
104438|NCT00650845|Guerbet|Pierre Desché, MD - VP Development, Medical and Regulatory Affairs.|+33 1 45 91 50 00|pierre.desche@guerbet-group.com
104440|NCT00651040|Rheumatology Institute Prague|Rheumatology Institute Prague|+420234075111|vencovsky@revma.cz
104441|NCT00651118|Meda Pharmaceutical|David Ginsberg,..|732 564 2364|david.ginsberg@meda.us
104442|NCT00651157|Mayo Clinic Cancer Center|Evanthia Galanis, M.D.||galanis.evanthia@mayo.edu
104443|NCT00651183|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104444|NCT00651261|Dana Farber Cancer Institute|Richard Stone, MD||rstone@partners.org
104445|NCT00651313|Columbia Laboratories, Inc.|George W. Creasy, MD Vice President, Clinical Research|973-486-8797|gcreasy@columbialabs.com
104446|NCT00651482|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu
104447|NCT00651625|University of New Mexico|Wilmer L. Sibbitt, MD, Principal Investigator|505 272-4761|wsibbitt@salud.unm.edu
104448|NCT00651755|University of Texas MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||xzhou@mdanderson.org
104449|NCT00645333|University of Michigan|Anne F. Schott, MD|1-800-865-1125|canceranswerline@umich.edu
104450|NCT00645359|University of Michigan Comprehensive Cancer Center|Dr. Daniel Lebovic, M.D.|734-936-5310|dlebovic@umich.edu
104451|NCT00645411|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
104452|NCT00645528|Hunter Holmes McGuire VA Medical Center|Sonja K Fredrickson, MD|804-675-5151|sonja.fredrickson@va.gov
104453|NCT00645567|James A Haley VA, Tampa|John Lloyd|813-624-8986|john.lloyd2@va.gov
104454|NCT00645593|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain, M.D.|(734) 647-8903|mahahuss@umich.edu
104455|NCT00651820|Healthpoint, Ltd.|Herbert B. Slade, M.D., FAAAI|817-900-4000|bert.slade@healthpoint.com
104456|NCT00651924|VA Connecticut Healthcare System|Robert Kerns, Ph.D.|203-932-5711 ext 3841|robert.kerns@va.gov
104457|NCT00652028|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com
104458|NCT00652093|Translational Pain Research, University of Rochester Medical Center|Dr. John D. Markman, MD|585-276-3616|john_markman@urmc.rochester.edu
104459|NCT00652314|Vascular Solutions, Inc.|Lisa Gallatin, RAC|763-656-4399|lgallatin@vasc.com
104460|NCT00652327|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
104461|NCT00652340|Tragara Pharmaceuticals|Tracy Parrott|858-350-6919|tparrott@tragarapharma.com
104462|NCT00652366|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
104463|NCT00652626|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
104464|NCT00652834|UCLA Kidney Transplant Research Program|Dr. Bunnapradist|310-794-8516|bunnapradist@mednet.ucla.edu
104465|NCT00652899|University of Minnesota, Dept. Ob/Gyn|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu
104466|NCT00652938|GlaxoSmithKline|GSK Response Center|866-435-7343|
104467|NCT00653068|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
104468|NCT00653133|I-Flow Corporation|Alan Dine Director of Clinical Research|513-253-8033|alan.dine@kcc.com
104469|NCT00653159|The University of Chicago Department of Health Studies, Biostatistics Laboratory|Dr. Sydeaka Watson, PhD|773-834-2378|swatson@health.bsd.uchicago.edu
104470|NCT00653224|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
104471|NCT00653263|UArkansas|Michael J Mancino|501-526-8442|mjmancino@uams.edu
104472|NCT00653328|Vanderbilt-Ingram Cancer Center|Marta Crispens, M.D.|800-811-8480|marta.crispens@vanderbilt.edu
104473|NCT00653523|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
104474|NCT00653861|Allergan Medical|Therapeutic Area Head|(805) 961-5500|devicetrials@allergan.com
104475|NCT00653939|OXiGENE, Inc.|Chief Executive Officer|650-635-7000|info@oxigene.com
104476|NCT00654004|Oregon Health & Science Univeristy|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu
104477|NCT00654030|University of Kentucky|Dr. Edward Hirschowitz|859-323-5045|eahirs2@uky.edu
104478|NCT00654095|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
104479|NCT00654147|University of Miami School of Medicine|Director AIDS Clinical Research Unit|305-243-3838|mfischl@med.miami.edu
104480|NCT00654186|Oncology Specialists, SC|Sigrun Hallmeyer, MD|847-268-8200|shallmeyer@oncmed.net
104481|NCT00654329|Children's National Medical Center|Julia C. Finkel, MD|202-476-4867 ext 4867|jfinkel@cnmc.org
104483|NCT00654368|Amgen Inc.|Study Director|866-572-6436|
104484|NCT00654381|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104485|NCT00654420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
104486|NCT00654498|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104487|NCT00654511|Children's National Medical Center|Dexmedetomidine for Immediate Perioperative Analgesia in Pediatric Patients Undergoing Tonsillectomy|202-476-4867 ext 4867|jfinkel@cnmc.org
104488|NCT00654628|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
104489|NCT00654641|West Viginia University|Michael L. Stitely, MD|304-293-1566|mstitely@hsc.wvu.edu
104490|NCT00654654|CBR International Corp.|Kevin Hennegan|(720)746-1190|khennegan@cbrintl.com
104491|NCT00654745|Daiichi Sankyo|James McCarthy|732-590-3430|jmccarthy@dsi.com
104492|NCT00654784|Santhera|Thomas Meier|+4161 906 8964|thomas.meier@santhera.com
104493|NCT00648895|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com
104494|NCT00648908|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300 ext 4102|ablight@acorda.com
104495|NCT00649220|Merz Pharmaceuticals GmbH|Manager Public Disclosure|+49 69 1503 865|matthias.zerm@merz.de
104496|NCT00654836|Loyola University|Shelly S. Lo, M.D.|708-327-3154|shlo@lumc.edu
104497|NCT00654875|Novartis Pharmaceuticals|Study Director|862-778-8300|
104498|NCT00654901|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
104499|NCT00654927|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300 ext 4102|ablight@acorda.com
104500|NCT00654940|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
104501|NCT00654953|UAMS|Alison Oliveto, Ph.D.|501-526-8441|olivetoalison@uams.edu
104502|NCT00654992|Seoul National University Bundang Hospital|Effect of erythropoietin in kidney after cardiac surgery|82-31-787-7014|kyna@snubh.org
104503|NCT00655083|Menarini Group- Clinical Research|Angela Capriati, Clinical research Director|+ 39-055 56809990|acapriati@menarini-ricerche.it
104504|NCT00657267|Dana-Farber Cancer Institute / Brigham & Women's Hospital|Patrick Y. Wen, MD|617-632-2166|pwen@partners.org
104505|NCT00657280|Stanford Hospital and clinics|Dr. Michael Fowler Director of the Heart Failure|650-721-5540|mfowler@stanford.edu
104506|NCT00657358|UAB|Dr. Michael Froelich|205-975-0145|froelich@uab.edu
104507|NCT00657371|UT MD Anderson Cancer Center|Robert S. Bresalier, MD / Professor||CR_Study_Registration@mdanderson.org
104508|NCT00657540|Rocky Mountain Poison and Drug Center|Victoria Anderson - Research Projects Manager|303-389-1236|victoria.anderson@rmpdc.org
119269|NCT00783614|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu
104510|NCT00657657|GlaxoSmithKline|GSK Response Center|866-435-7343|
104513|NCT00658138|University of Bologna, Italy|Professor Giovanni Dondi dall'Orologio|+39 051-2088132|gdondi@alma.unibo.it
104514|NCT00658320|Novartis Pharmaceuticals|Study Director|862-778-8300|
104515|NCT00658333|Novartis Pharmaceuticals|Study Director|862-778-8300|
104516|NCT00658385|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-6684|bouladf@mskcc.org
104517|NCT00658411|Dana-Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|parmand@partners.org
104518|NCT00658528|Eisai Call Center|Eisai Inc.|888-422-4743|
104519|NCT00658541|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
104520|NCT00658567|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com
104521|NCT00658606|Astellas Pharma Canada, Inc.|Director, Scientific Affairs||ClinicalTrials@us.astellas.com
104522|NCT00658619|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
104523|NCT00658632|Eisai Inc.|Eisai Medical Services|888-422-4743|
104524|NCT00658658|Amgen Inc.|Study Director|866-572-6436|
104525|NCT00658684|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104526|NCT00658697|DFCI|Rana R. McKay, MD|6176323237|rana_yehia@dfci.harvard.edu
104527|NCT00658723|ETHICON, Inc.|Jonathan Batiller, Director Clinical Development|908-218-2819|JBatill2@its.jnj.com
104528|NCT00658736|Cleveland Clinic|Dr. Tyler Stevens|216 445-1996|stevent@ccf.org
104529|NCT00658775|Eisai Call Center|Eisai Inc.|888-422-4743|
104530|NCT00658788|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com
119271|NCT00730639|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
104532|NCT00658996|Bausch & Lomb Incorporated|Gerard Cairns, PhD, MCOptom|(585) 338-5170|gerard.cairns@bausch.com
104533|NCT00659061|Aga Khan University|Professor Zulfiqar Ahmed Bhutta|4930051 ext 4782|zulfiqar.bhutta@aku.edu
104534|NCT00659165|Univ NM|Mark Burge|505-272-4658|mburge@salud.unm.edu
104536|NCT00659269|University of New Mexico|Zoneddy Dayao, MD|5059250404|zdayao@salud.unm.edu
104537|NCT00659295|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
104538|NCT00659334|OHSU Knight Cancer Institute|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu
104539|NCT00659360|Cross Cancer Institute|Dr. Margaret Von Mehren|215-214-1663|margaret.vonmehren@fccc.edu
104540|NCT00659373|IBCSG|Rudolph Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org
104541|NCT00659425|MedImmune, LLC|Mark Lanasa, MD Associate Director, Clinical Development, Oncology|301-398-0000|information.center@AstraZeneca.com
104542|NCT00659438|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
104543|NCT00659490|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104544|NCT00659529|National Jewish Health|Jennifer L. Taylor-Cousar, MD|(303) 270-2764|Taylor-CousarJ@NJHealth.org
104545|NCT00659581|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104546|NCT00659607|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104547|NCT00659633|University of Alabama at Birmigham|Dr. Michael Froelich|205-975-3328|mfroelich@uabmc.edu
104548|NCT00652145|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu
104549|NCT00659724|Gambro Renal Products, Inc.|Jeffrey R. Shideman PhD|952-835-4018|Jeff.Shideman@us.gambro.com
104550|NCT00659737|Drexel university|Michael Green|215-762-1524|micheal.green@drexelmed.edu
104551|NCT00659789|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com
104552|NCT00659815|Bausch & Lomb Incorporated|Gerard Cairns|(585) 338-5170|gerard.cairns@bausch.com
104553|NCT00659880|RTI Surgical|Robin Waite, RN|386-418-8888|rwaite@rtix.com
104554|NCT00659945|University of Pittsburgh|Manuel C. Vallejo, MD|412-641-4260|vallejomc@anes.upmc.edu
104555|NCT00659984|NANT Consortium|NANT Operations Center|323-361-5687|nantops@chla.usc.edu
104556|NCT00660010|Abbott Laboratories|Global Medical Services|800-633-9110|
104557|NCT00660023|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
104559|NCT00666835|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com
104560|NCT00666848|Vanderbilt University School of Medicine|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu
104561|NCT00666926|Verastem, Inc.|Mitchell Keegan|617-252-9300|mkeegan@verastem.com
104562|NCT00666965|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
104564|NCT00667095|Mayo Clinic|Dr. Steven P. Petrou|904-953-7330|peterou.steven@mayo.edu
104565|NCT00667186|University of Cincinnati College of Medicine|Michael S. Lyons|513-558-0890|lyonsme@ucmail.uc.edu
104566|NCT00667225|University of North Carolina, Chapel Hill|Dean Morrell|919-843-5539|morrell@med.unc.edu
104869|NCT00669942|Novartis|Study Director|862-778-8300|
104568|NCT00667277|Icahn School of Medicine at Mount Sinai|Dr. Ronald Hoffman|(212) 241-2297|ronald.hoffman@mssm.edu
104569|NCT00667342|St. Jude Children's Research Hospital|Michael Bishop, MD|866-278-5833|referralinfo@stjude.org
104570|NCT00667355|Abbott|Global Medical Services|1-800-633-9110|
104571|NCT00667368|University of Alabama at Birmingham|Dr. Jane Schwebke|205-975-5665|schwebke@uab.edu
104572|NCT00667381|University of California, Irvine|Arnold Seto|714-456-6699|aseto@uci.edu
104573|NCT00667394|National Cancer Institute, National Institutes of Health|Dr. Katherine Warren|301-435-4683|warrenk@box-w.nih.gov
104574|NCT00667420|MassGH|David P. Ryan|617-724-0245|dpryan@partners.org
104575|NCT00667446|AbbVie, (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
104576|NCT00667459|Medtronic Spinal|Clinical Department|1800-876-3133 ext 6068|msbkclinicalresearch@medtronic.com
104577|NCT00667511|NxStage Medical, Inc.|Kristen Sheppard|978-687-4700|
104578|NCT00667563|AMC|Jeannette Y. Lee|5015266712|jylee@uams.edu
104579|NCT00667576|Abbott Japan Co., Ltd.|Global Medical Services|800-633-9110|
104580|NCT00667589|Northwestern University|Hae Bae|312-695-6829|j-bae@northwestern.edu
104581|NCT00667602|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
104583|NCT00667732|Oregon Health and Science University|Dr. Matthew Riddle|503-494-0557|riddlem@ohsu.edu
104584|NCT00667745|Bipolar Clinic and Research Program at|Dr. Andrew Nierenberg, Director of the Bipolar Trials Network|617-724-0837|ANIERENBERG@PARTNERS.ORG
104585|NCT00667810|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104586|NCT00667849|Bioventus LLC|Peter Heeckt, MD (CMO)|1-800-396-4325|peter.heeckt@bioventusglobal.com
104587|NCT00667875|Medical University of South Carolina|Raymond F. Anton, MD|843-792-1226|antonr@musc.edu
104588|NCT00667992|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104589|NCT00668200|Novartis Pharmaceuticals|Study Director|8627788300|
104590|NCT00668265|Beth Israel Medical Center|Igor Galynker, MD|212 420 4535|igalynke@chpnet.org
104591|NCT00668317|Hull and East Yorkshire Hospitals Trust|Clinical trials Manager|01482 624067|c.e.wright@hull.ac.uk
104592|NCT00668382|UMass Medical Scool|Dr. Sheila Noone|508 856 5015|Sheil.Noone@umasmed.edu
104593|NCT00668395|Indiana University School of Medicine|Zeruesenay Desta, PhD|317-274-2823|zdesta@iu.edu
104594|NCT00668434|Kaiser Permanente, Northern California|Dr. Andrew Avins|510-891-3557|andy.l.avins@kp.org
104595|NCT00668525|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Carl Gommoll, MS|201-427-8000|carl.gommoll@frx.com
104596|NCT00668564|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu
104597|NCT00668733|Graceway Pharmaceuticals|Sharon F. Levy, MD / Sr. VP, Clinical Product Development|267-948-0400|sharon.levy@gracewaypharma.com
104598|NCT00668746|OraPharma|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|215-420-4064|bpatel@orapharma.com
104599|NCT00668785|West Coast Retina Medical Group, Inc.|J. Michael Jumper, MD|415-972-4600|jmjumper@westcoastretina.com
104600|NCT00668863|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104601|NCT00668902|Indiana University School of Medicine|Zeruesenay Desta|+1 (317) 274-2823|zdesta@iu.edu
104602|NCT00669019|University of Chicago|Dr. Thomas F. Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu
104603|NCT00669032|Tedec-Meiji Farma, S.A.|R&D Director|918870980|m.gimeno@tedecmeiji.com
104604|NCT00669071|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com
104605|NCT00669110|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104606|NCT00669214|Genentech, Inc.|Medical Communications|800-821-8590|
104607|NCT00669240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104608|NCT00655356|CBR International Corp.|Kevin Hennegan|720-746-1190|khennegan@cbrintl.com
104609|NCT00655486|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493|
104610|NCT00655551|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493|
104612|NCT00655629|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
104613|NCT00655642|Vanderbilt University|Dr. Tyler Barrett|6159360253|tyler.barrett@vanderbilt.edu
104614|NCT00655668|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
104615|NCT00655733|Hutchison MediPharma|Hua Mu,Senior Vice President of Clinical Research and Development|861 3564487805|huam@hmplglobal.com
104616|NCT00655746|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
104619|NCT00655850|University of Alabama at Birmingham|Francisco Robert, MD|205-934-5077|pacorobertuab@cs.com
104620|NCT00655863|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
104621|NCT00655889|Biologics Consulting Group|Dr. Joseph Fratantoni|(301) 340-8432|jfratantoni@bcg-usa.com
104622|NCT00656058|National Cancer Institute|Dr. Ronald E. Gress|301-496-1791|gressr@dc10a.nci.nih.gov
104623|NCT00656084|New York Oncology Hematology|Dr. Lawrence E. Garbo|(518) 489-0044|Lawrence.Garbo@usoncology.com
104624|NCT00656136|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104625|NCT00656175|UCLA CARE Center|Dr. Jordan Lake|310-557-9679|jlake@mednet.ucla.edu
104626|NCT00656201|Brigham and Women's Hospital|Elena Yanushpolsky, MD|617-732-4648|lgreenberg@partners.org
104627|NCT00656292|Mayo Clinic|Michael J. Brown, M.D.|507-284-6317|Brown.Michael3@mayo.edu
104628|NCT00656370|Halozyme Therapeutics Incorporated|Jonathan Leff, M.D., Chief Medical Officer|858-704-8177|jleff@halozyme.com
104629|NCT00656448|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org
104630|NCT00656474|Glycotex|Dr. Reinhard Koenig, CEO|301-670-2825|Reinhard.Koenig@glycotexinc.com
104631|NCT00656487|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu
104632|NCT00656513|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
104633|NCT00656617|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia Department|713-745-3428|CR_Study_Registration@mdanderson.org
104634|NCT00656630|The Scripps Research Institute|Barbara J. Mason, Ph.D.-Principal Investigator|858784-7328|mason@scripps.edu
104635|NCT00656656|University of Lübeck|Prof. Dr. Detlef Zillikens|+49-451-500-41500|detlef.zillikens@uksh.de
104636|NCT00656669|IndianaU|Dr. Kathy Miller|317-944-0920|
104637|NCT00656799|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
104638|NCT00656851|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu
104639|NCT00656916|UT MD Anderson Cancer Center|Lara Bashoura, MD / Assistant Professor||CR_Study_Registration@mdanderson.org
104640|NCT00656968|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|886-7-3422121 ext 8233|pihsu@isca.vghks.gov.tw
104641|NCT00657020|GlaxoSmithKline|GSK Response Center|866-435-7343|
104642|NCT00657046|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com
104643|NCT00657150|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104644|NCT00669279|University of Florida|Dr. Benjamin J Epstein|3523590945|epstein@cop.ufl.edu
104645|NCT00669318|Mayo Clinic Cancer Center|Timothy G. Call MD||call.timothy@mayo.edu
104646|NCT00669331|Pharmaxis Ltd|Dr Brett Charlton, Medical Director|+61 2 94547210|brett.charlton@pharmaxis.com.au
104647|NCT00669396|University of Utah|David Turok, MD|801-581-7647|david.turok@hsc.utah.edu
104648|NCT00669461|University of Arkansas for Medical Sciences|Muhannad Heif, MD|5016500215|mmheif@gmail.com
104649|NCT00669539|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org
104650|NCT00669552|Columbia University|Jose' Dizon, MD|212-305-8559|jmd11@columbia.edu
104651|NCT00669578|Mayo Clinic|Ayalew Tefferi, M.D.||tefferi.ayalew@mayo.edu
104652|NCT00670449|Novartis Pharmaceuticals|Study Director|862 778-8300|
104653|NCT00670462|University of Minnesota|Robert W. Jeffery PhD|612-626-8580|jeffe001@umn.edu
104654|NCT00670540|University Hospital Grenoble|Jean-Luc Bosson|33 4 76 76 50 40|jean-luc.bosson@imag.fr
104655|NCT00670631|University of Iowa|Guido Tricot, MD, PhD||guido-tricot@uiowa.edu
104656|NCT00670709|UCLA|Jennifer Villalobos|310-825-3351|info@brain.ucla.edu
104657|NCT00670748|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov
104658|NCT00670800|University of Michigan|Yolanda Smith|(734) 936-7401|ysmith@umich.edu
104659|NCT00670930|Novartis Pharmaceuticals|Study Director|862-778-8300|
104660|NCT00670956|University of California San Francisco|Hanmin Lee, MD|415-476-4086|hanmin.lee@ucsf.edu
104661|NCT00670982|Dana-Farber Cancer Institute|Harold J. Burstein, MD|617-632-2335|hal_burstein@dfci.harvard.edu
104662|NCT00671060|Gynuity Health Projects|Hillary Bracken|2124481230|hbracken@gynuity.org
104663|NCT00671177|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810 ext 24103|tonya.kaltenbach@va.gov
104664|NCT00671437|Washington University School of Medicine|Dr. Douglas R. Adkins|314-362-5654|dadkins@dom.wustl.edu
104665|NCT00671502|Meda Pharma US|David Ginsberg, MD Sr Medical Director|732 564 2364|david.ginsberg@meda.us
104666|NCT00671515|University Hospitals Cleveland Medical Center|Dr. Joseph Calabrese|216-844-2865|Joseph.Calabrese@UHhospitals.org
104667|NCT00671528|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
104668|NCT00671554|Greenville Hospital System|Joe Stephenson, MD|864-455-3600|joe.stephenson@usoncology.com
104669|NCT00671606|UT MD Anderson Cancer Center|Dr. Michael Frumovitz, ND/Assistant Professor||tjohnsto@mdanderson.org
104670|NCT00671671|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104671|NCT00671723|University of Oklahoma Health Sciences Center|Dr. Houssein Youness|405-271-6173|houssein-youness@ouhsc.edu
104672|NCT00671749|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com
104673|NCT00671788|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@nrgoncology.org
104674|NCT00671853|University Hospitals Cleveland Medical Center|Dr. Kemp Gao|216-844-2865|keming.gao@UHhopsitals.org
104675|NCT00671879|Meda Pharma US|David Ginsberg, DO Sr Dir Medical Scientific Affairs|732 564 2347|david.ginsberg@meda.us
104676|NCT00671918|Navidea Biopharmaceuticals|Dr. Frederick Cope|614-793-7500 ext 140|fcope@navidea.com
104677|NCT00671931|Cincinnati Children's Hospital|Mohamed Mahmoud, MD Principal Investigator|513 636-7426|mohamed.mahmoud@cchmc.org
104678|NCT00671970|Dana Farber Cancer Institute|Dr. David Reardon|(617) 632-2166|David_Reardon@DFCI.HARVARD.EDU
104679|NCT00672100|William Beaumont Hospital|Craig T. Hartrick, MD|248-964-3440|chartrick@beaumont.edu
104680|NCT00672178|Duke University Medical Center|John Kirkpatrick, MD, PhD|919 668-7342|kirkp001@mc.duke.edu
104682|NCT00672243|The Preston Robert Tisch Brain Tumor Center at Duke|David A. Reardon, MD|(919) 668-1409|reard003@mc.duke.edu
104683|NCT00672256|Duke University Medical Center|Joseph McClernon|919-668-3987|mccle011@mc.duke.edu
104684|NCT00672438|Stanford University|Dr. Martin Angst, Professor of Anesthesia|650-498-5109|ang@stanford.edu
104685|NCT00672490|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104686|NCT00672555|Department of surgery, Cantonal hospital of St. Gallen|Lukas Marti; principal investigator|0041794120153|lukas.marti@kssg.ch
104687|NCT00672594|Duke University|Dr. Daniel George|919-668-4615|daniel.george@duke.edu
104688|NCT00672620|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
104689|NCT00672633|Boston Children's Hospital|Dr. Stavroula Osganian, Principal Investigator|8572184728|stavroula.osganian@childrens.harvard.edu
104690|NCT00672646|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104691|NCT00672737|Stanford University|Anthony Doufas, MD, PhD|(650) 498-7699|agdoufas@stanford.edu
104692|NCT00672841|University of Utah|Kimberly E. Hanson, MD, MHS|801.585.2867|kim.hanson@hsc.utah.edu
104693|NCT00672854|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu
104694|NCT00672932|UCSF|Richard W. Price, M.D.|415-206-4487|rwprice@sfgh.ucsf.edu
104695|NCT00672958|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
104696|NCT00660075|Laval University|Patrick Couture|418-654-2106|patrick.couture@crchul.ulaval.ca
104697|NCT00660179|Actelion Pharmaceuticals Ltd|Parisa Danaietash||parisa.danaietash@actelion.com
104698|NCT00660192|Yale School of Medicine|Baman,Jabbari M.D. Porfessor of Neurology|203-737-2464|bahman.jabbari@yale.edu
104699|NCT00660309|Novartis Pharmaceuticals|Study Director|862-778-8300|
104700|NCT00660348|Sidney Kimmel Comprehensive Cancer Center|Michael Erdek, MD|410-502-7388|merdek1@jhmi.edu
104701|NCT00660387|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
104702|NCT00660400|H. Lee Moffitt Cancer Center and Research Institute|Teresa Field, M.D., Ph.D.|813-745-7202|teresa.field@moffitt.org
104703|NCT00660504|Cancer Hospital of Chinese Academy of Medical Sciences|Dr.Sunyan|86-10-87788519|suny@csco.org.cn
104704|NCT00660517|Meda Pharmaceuticals|David Ginsberg, D.O.|7325642364|david.ginsberg@meda.us
104705|NCT00660543|Oregon Health and Science University|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu
104706|NCT00660595|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104707|NCT00660660|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com
104708|NCT00660699|Washington University School of Medicine|Benjamin Tan, M.D.|314-362-5740|btan@dom.wustl.edu
104709|NCT00661193|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org
104710|NCT00661258|Boston University Center for Global Health and Development|Dr. Lora Sabin|617-414-1272|lsabin@bu.edu
104711|NCT00661362|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104712|NCT00661388|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
104714|NCT00661453|University of Utah|Dr. Kathryn Swoboda|801-585-9717|swoboda@genetics.utah.edu
104715|NCT00661479|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
104716|NCT00661492|US Oncology|Dr. Mark T. Fleming|757-827-9400|Mark.Fleming@USONCOLOGY.COM
104718|NCT00661531|Georgetown University|Dr. Claudine Isaacs|2024443677|isaacsc@georgetown.edu
104719|NCT00661544|U.T. M.D. Anderson Cancer Center|Muzaffar H. Qazilbash, MD / Associate Professor|713-745-3458|
104720|NCT00661570|Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5122550|f.hilgers@nki.nl
104721|NCT00661583|University of Colorado Denver|Dr.Malik Kahook|720-848-2020|malik.kahook@ucdenver.edu
104722|NCT00661609|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104723|NCT00661622|Thomas Jefferson University|Takami Sato, MD|215-955-8874|Takami.Sato@jefferson.edu
104724|NCT00661661|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104725|NCT00661674|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu
104726|NCT00661687|Bausch & Lomb Incorporated|Gerard Cairns|(585)338 - 5170|gerard.cairns@bausch.com
104727|NCT00661713|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com
104728|NCT00661726|NERI|Nancy Gee, TCRN Network Manager|617-972-3295|ngee@neriscience.com
104729|NCT00661778|Hoffmann-La Roche|Medical Communications|800 821-8590|
104730|NCT00661830|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|A. Kaiser|++49(0)6131-179921|kaiser@izks-mainz.de
104731|NCT00661895|Creighton Cardiac Center|Tammy Burns, PharmD, Research Manager|402-280-4292|TammyBurns@creighton.edu
104732|NCT00661960|UCaliforniaDavis|David Asmuth/Principal Investigator|9167348695|david.asmuth@ucdmc.ucdavis.edu
104733|NCT00661999|Mayo Clinic Rochester|Dr. Charles L. Loprinzi|507-284-8666|cloprinzi@mayo.edu
104734|NCT00662012|Uniformed Services University of Health Sciences (USUHS)|Naomi Aronson, MD|(301) 295-3621|naomi.e.aronson.civ@mail.mil
104735|NCT00662025|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104736|NCT00662038|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
104737|NCT00662129|Mayo Clinic|Donald W. Northfelt, MD, FACP|507/284-1159|northfelt.donald@mayo.edu
104738|NCT00662155|University of Pennsylvania|Michael Perlis|(215) 746-3577|mperlis@upenn.edu
104739|NCT00662207|Hines VA Hospital, Research Service|James S. Walter, Ph.D.|708-202-5805|James.Walter@va.gov
104740|NCT00662311|Departments of Radiation Oncology and Global Health University of Washington Medical Center|Shilpen Patel|206-598-4100|shilpenp@uw.edu
104741|NCT00662363|Rehabilitation Institute of Chicago|Christina Marciniak|312-238-1000|cmarciniak@ric.org
104742|NCT00662389|Apsara Medical Corporation|Eve Conner, Ph.D. Consultant|510 566-2495|eaconner@sbcglobal.net
104743|NCT00662532|OraPharma|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|215-420-4064|bpatel@orapharma.com
104744|NCT00662545|UCSF SFGH|Anne Luetkemeyer|415 476 4082 ext 130|aluetkemeyer@php.ucsf.edu
104745|NCT00662558|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
104746|NCT00662649|Novartis Pharmaceuticals|Study Director|862 778-8300|
104747|NCT00662675|Johnson & Johnson Pharmaceutical Research & Development, LLC|Director, Clinical Team Leader|609-730-3158|
104748|NCT00662818|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
104749|NCT00662831|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104750|NCT00662857|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com
104752|NCT00663026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104753|NCT00663052|Wyeth, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104754|NCT00663117|Pennsylvania State University, College of Medicine Hershey, PA 17033|Jill P Smith, MD Professor of Medicine, Gastroenterology Division|717-531-3694|jsmith2@psu.edu
104755|NCT00663169|Novartis Pharmaceuticals|Study Director|862-778-8300|
104756|NCT00663208|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
104757|NCT00663234|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org
104758|NCT00663260|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com
104759|NCT00663403|University of Michigan College of Pharmacy|Bruce A. Mueller|7347636629|muellerb@umich.edu
104760|NCT00663702|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com
104761|NCT00663793|University of Washington|John K Amory, MD, MPH|206-616-1727|jamory@u.washington.edu
104762|NCT00663819|CMU College of Medicine|Dr. Anthony Senagore|989-790-1001|anthony.senagore@cmich.edu
104763|NCT00663858|Aeterna Zentaris|Herbert Sindermann|+49 69 42602 3429|HSindermann@aezsinc.com
104764|NCT00663923|Tabriz University of Medical Sciences|Mohammad R sedghipour,MD|+98 411 3306619|sedghipm@yahoo.com
104765|NCT00663962|Queen's University|Pregabalin and Post-thoracotomy pain|(613) 548-7827|zamoraj@kgh.kari.net
104766|NCT00664326|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
104767|NCT00664430|Abbott|Global Medical Services|800-633-9110|
104768|NCT00664521|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
104769|NCT00664534|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
104770|NCT00664560|POZEN Inc|Sr VP Clinical Research|919-913-1030|eorlemans@pozen.com
104771|NCT00664742|Novartis Pharmaceuticals|Study Director|862-778-8300|
104772|NCT00665002|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey E. Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org
104773|NCT00665132|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com
104774|NCT00665353|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
104775|NCT00665366|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
104776|NCT00665431|Pozen|Sr VP Clinical Research|919 913 1030|eorlemans@pozen.com
104778|NCT00665470|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov
104779|NCT00665626|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com
104780|NCT00665704|VA Center for Clinical Management Research Health Services Research & Development, VA Ann Arbor Healthcare System, Ann Arbor, MI.|Sonia A. Duffy, Ph.D., R.N., FAAN|734.395.0613|Sonia.Duffy@va.gov
104781|NCT00665847|Tibotec Pharmaceuticals, Ireland|Senior Director|32 14 641 265|gdsmedt1@its.jnj.com
104782|NCT00665925|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com
104783|NCT00666029|University Hospital Southampton|Professor Christopher Byrne|+44 238120 5006|cdtb@soton.ac.uk
104784|NCT00666198|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104785|NCT00666211|Vanderbilt-Ingram Cancer Center|Nancy Wells, Director of Nursing Research Patient Care Svcs|615-322-6184|nancy.wells@vanderbilt.edu
104786|NCT00666224|Teva Pharmaceutical Industries, Ltd.|Yossi Gilgun, PhD, Global Clinical Leader|972-9-863-1491|yossi.gilgun@teva.co.il
104788|NCT00666276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104789|NCT00666328|The Medicines Company|Jason Campagna. MD, PhD|973-290-6199|jason.campagna@themedco.com
104791|NCT00666458|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104792|NCT00666536|Novartis Pharmaceuticals|Study Director|862-778-8300|
104794|NCT00666588|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
104795|NCT00666666|Rutgers Cancer Institute of New Jersey|Robert DiPaola, MD|732-235-8675|zelinsta@cinj.rutgers.edu, dipaolrs@cinj.rutgers.edu, rizzoji@cinj.rutgers.edu
104796|NCT00666679|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
104797|NCT00666705|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
104798|NCT00666718|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
104799|NCT00666757|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
104800|NCT00660816|CCCC|Dr. Afshin Dowlati|216-844-1228|afshin.dowlati@uhhospitals.org
104801|NCT00660829|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us
104802|NCT00660907|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com
104803|NCT00660985|Galderma|Michael Graeber, MD, Head of Global Clinical Project Management and US Development|609-860-8201|michael.graeber@galderma.com
104804|NCT00661037|Ospedali del Tigullio, Lavagna, Italy|Dr Michele Brignole|0185 329567329 ext 0039|aritmo@asl4.liguria.it
104806|NCT00661141|Horizon Pharma USA, Inc.|Beth Robinson, Executive Director||clinicaltrials@horizonpharma.com
104808|NCT00673049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104809|NCT00673075|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com
104810|NCT00673114|Duke University Medical Center|Dr. Joanne Kurtzberg|919-668-1100|kurtz001@mc.duke.edu
104811|NCT00673127|Beth Israel Deaconess|Steven Balk|617-735-2065|sbalk@bidmc.harvard.edu
104812|NCT00673153|Fred Hutch Cancer Research Center|Roland B. Walter, MD, PhD, MS|(206) 667-3599|
104813|NCT00673179|UT MD Anderson Cancer Center|Peter M. Anderson, MD, PHD / Professor||CR_Study_Registration@mdanderson.org
104814|NCT00673231|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com
104815|NCT00673257|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
104816|NCT00673712|Halyard Health|Sr. Director Clinical Research|5132538033|alan.dine@hyh.com
104817|NCT00673738|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-3050|alberto.chiappori@moffitt.org
104818|NCT00673764|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
104819|NCT00673816|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov
104820|NCT00673855|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
104821|NCT00673881|Radiant Research|Michael H. Davidson, MD FACC|312-494-2220 ext 2220|michaeldavidson@radiantresearch.com
104822|NCT00673933|Dermatology Institute|Dr Ashish Bhatia|630-942-5040|acbhatia@gmail.com
104823|NCT00673959|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
104824|NCT00674115|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
104825|NCT00674128|Mayo Clinic|Gregory Altemose MD|480-301-8000|altemose.gregory@mayo.edu
104826|NCT00674154|Aarhus University Hospital|Lars Rolighed|004520677876|larsrolighed@gmail.com
104827|NCT00674206|Emory University|Dr. Amelia Zelnak|404-778-1900|amelia.zelnak@emoryhealthcare.org
104828|NCT00674323|Novartis Pharmaceuticals|Study Director|862-778-8300|
104830|NCT00674466|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com
104831|NCT00674492|Center for Healthcare Organization and Implementation Research|Jack A. Clark, PhD|781.687.2937|Jack.Clark@va.gov
104832|NCT00674609|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
104833|NCT00674622|University of Pittsburgh School of Medicine Department of Psychiatry|Ronald Glick, MD|412-623-3023|glickrm@upmc.edu
104835|NCT00674700|Stallergenes|Michel Roux, Medical Director|+33 1 55 59 2970|mroux@stallergenes.com
104836|NCT00674739|Graceway Pharmaceuticals|Robert Babilon, Vice President, Product Development|267-948-0400 ext 20428|robert.babilon@gracewaypharma.com
104837|NCT00674765|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200 ext 109|kampman@mail.med.upenn.edu
104838|NCT00674817|GlaxoSmithKline|GSK Response Center|866-435-7343|
104839|NCT00674973|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
104840|NCT00674986|Hoffman-LaRoche|Medical Communications|800-821-8590|
104841|NCT00675103|Savient Pharmaceuticals, Inc.|Chief Medical Officer|732-418-9300|
104842|NCT00675259|The Ohio State University|Ewa Mrozek, MD|614-293-0066|Ewa.mrozek@osumc.edu
104844|NCT00675428|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com
104845|NCT00675441|UT MD Anderson Cancer Center|Amin Alousi, MD / Assisstant Professor||CR_Study_Registration@mdanderson.org
104847|NCT00675558|Columbia University Medical Center|Paul D. Berk, MD|2120-305-4491|pb2158@columbia.edu
104848|NCT00675584|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu
104849|NCT00675597|Memorial Sloan Kettering Cancer Center|Dr. Mark G. Kris|646-888-4205|Krism@mskcc.org
104850|NCT00675766|West Los Angeles Veterans Association|Dr. Charles Hinkin|310-478-3711 ext 44214|chinkin@ucla.edu
104851|NCT00675792|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
104853|NCT00675922|University of Texas Medical Branch|David Herndon, MD|409-770-6731|dherndon@utmb.edu
104854|NCT00675948|GW Pharma LTD.|Mr Richard Potts, Clinical Operations Director|00 44 1223 266 800|rp@gwpharm.com
104855|NCT00675987|Brigham and Women's Hospital|Mark A. Creager, MD|617-732-5267|mcreager@partners.org
104856|NCT00676026|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu
119276|NCT00562484|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com
104858|NCT00676065|Center for Epidemiology and Health Research Germany|Juergen Dinger, MD, PhD|+49 30 945 101 20|dinger@zeg-berlin.de
104859|NCT00676091|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104860|NCT00676130|Brigham and Women's Hospital|Daniel J. Pallin, MD, MPH|617-525-6614|dpallin@partners.org
104861|NCT00676143|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104862|NCT00664066|Shire Pharmaceutical|Timothy Whitaker, MD||twhitaker@shire.com
104863|NCT00664105|Vanderbilt-Ingram Cancer Center|Vicki Keedy, M.D.|(615) 322-4967|
104864|NCT00669617|Novartis Pharmaceuticals|Study Director|862-778-8300|
104865|NCT00669682|Columbia University|Jose' Dizon, MD|212-305-8559|jmd11@columbia.edu
104866|NCT00669864|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
104867|NCT00669903|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104870|NCT00669955|Axcan Pharma Inc.|Monique Giguere, PhD, Programs Director,|1-800-565-3255 ext 2078|
104871|NCT00670007|CSL Behring|Clinical Trial Disclosure Manager|Use Email contact|clinicaltrials@cslbehring.com
104872|NCT00670111|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com
104873|NCT00670202|Brigham and Women's Hospital|Anju Nohria|617-525-7052 ext 617|anohria@partners.org
104874|NCT00670228|sanofi-aventis|Trial Transparency Team||GV-contact-us@sanofi-aventis.com
104875|NCT00670241|LEO Pharma|Anders Rhod Larsen, Scientific Advisor|+4572262990|anders.larsen@leo-pharma.com
104876|NCT00670267|Baylor College of Medicine|N.A. Hanania, M.D.||hanania@bcm.edu
104877|NCT00670306|AEterna Zentaris|Daniel Croteau, Medical Manager|418-652-7669 ext 272|DCroteau@aezsinc.com
104878|NCT00676182|James A. Haley Veterans' Hospital|Dr. Kris Siddharthan|813-558-3950|Krishnaswami.Siddharthan@va.gov
104879|NCT00676195|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu
104880|NCT00676208|Louis Stokes VA Medical Center|Improving Medical Training for the Care of Chronic Conditions|(216) 791-2300 ext 2338|michelle.davidson@va.gov
104881|NCT00676338|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
104882|NCT00676364|Lehigh Valley Health Network|Jenny Boucher|610-402-8844|jenny.boucher@LVH.com
104883|NCT00676403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
104884|NCT00676455|Lahey Clinic|Christopher Wald, MD|781-744-8710|Christopher.Wald@lahey.org
104885|NCT00676494|Pathway Medical Technologies, Inc.|Kevin Peters/Director of Clinical Affairs|425-636-4053|petersk@pathwaymedical.com
104886|NCT00676793|LSU Health, Shreveport|Dr. Jerry w. McLarty, Ph.D.|(318)813-1446|jmclar@lsuhsc.edu
104887|NCT00676806|Tufts Medical Center|Andreas Klein, MD|617-636-8884|aklein2@tuftsmedicalcenter.org
104888|NCT00676897|Beth Israel Deaconess Medical Center|Dr. Michael W. Donnino|6177542341|mdonnino@bidmc.harvard.edu
104889|NCT00677014|Boston Scientific|Greg Voss, Clinical Director|651-581-3068|gregory.voss@bsci.com
104890|NCT00677092|University of Massachusetts Medical School|Jonathan Kay, MD|508-793-6936|jonathan.kay@umassmemorial.org
104891|NCT00677235|Bard Peripheral Vascular|John Van Vleet|1-800-321-4254|John.VanVleet@CRBard.com
104892|NCT00677352|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104893|NCT00677365|Rempex Pharmaceuticals Inc.|Jeff Loutit, MD; Chief Medical Officer|858.875.6665|jloutit@rempexpharma.com
104894|NCT00677534|University of Kansas Medical Center|Dr. Jason Stubbs|913-588-3867|jstubbs@kumc.edu
104895|NCT00677690|Fondazione Salvatore Maugeri, IRCCS, Pavia, Italy|Ercole Zanotti|39 385 247 ext 324|ercole.zanotti@fsm.it
104896|NCT00677807|Novartis Pharmaceuticals|Study Director|862-778-8300|
104897|NCT00677820|MedImmune LLC, an affiliate of AstraZeneca|Raburn Mallory, MD/ Sr Dir Clinical Development|301-398-0000|malloryr@medimmune.com
104898|NCT00677833|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104899|NCT00677898|VA VISN 5 Mental Illness Research, Education and Clinical Center|Julie Kreyenbuhl, Pharm.D., Ph.D.|410-637-1864|Julie.Kreyenbuhl@va.gov
104900|NCT00677924|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com
104901|NCT00678015|University of California, San Francisco|Dr. Terence Friedlander|415-353-7171|terence.friedlander@ucsf.edu
104902|NCT00678041|University of Pittsburgh, UPP13 WH Uro Gynecology - Cor|Gary Sutkin, MD|412--641-1440|gsutkin@mail.magee.edu
104903|NCT00678210|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104904|NCT00678249|Bard Peripheral Vascular, Inc.|John Reviere, Director, Clinical Affairs|480-303-2644|john.reviere@crbard.com
104905|NCT00678288|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
104906|NCT00678379|Charlotte Eye Ear Nose and Throat|Jonathan Moss MD|704-295-3000|jmoss@ceenta.com
104907|NCT00678392|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104908|NCT00678418|Alkermes, Inc.|Bernard L. Silverman, MD|1-781-609-6000|bernard.silverman@alkermes.com
104909|NCT00678470|University of California at San Francisco|John Koo MD|4154764701|john.koo@ucsfmedctr.org
104910|NCT00678535|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de
104911|NCT00678574|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu
104912|NCT00678587|GlaxoSmithKline|GSK Response Center|866-435-7343|
104913|NCT00678639|Wake Forest University Baptist Medical Center|Chadwick Miller, MD|336-716-1740|cmiller@wfubmc.edu
104914|NCT00678691|SUNY Upstate Medical University|Thomas Schwartz|3154643166|schwartt@upstate.edu
104915|NCT00678795|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
104916|NCT00678834|The Ohio State University Wexner Medical Center|Dr. Chandan K. Sen, PhD. Professor and Associate Dean|614-247-7658|chandan.sen@osumc.edu
104917|NCT00678886|GlaxoSmithKline|GSK Response Center|866-435-7343|
104918|NCT00678899|Cochlear Americas|Ginger Grant/Clinical Project Manager|410-375-0883|ggrant@cochlear.com
104919|NCT00679055|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
104920|NCT00679081|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinicaltrials@organo.com
104921|NCT00679172|Emergent Product Development Gaithersburg|Dr. Tim Babinchak|(240) 631-3585|
104922|NCT00679211|Genentech, Inc.|Medical Communications|800-821-8590|
104923|NCT00679263|Medicinova Inc|Kazuko Matsuda, MD, Vice President Clinical Development|858-373-1500 ext 132|matsuda@medicinova.com
104924|NCT00673361|Duke University Medical Center|Michael A Morse, M.D.|919-681-3480|morse004@mc.duke.edu
104925|NCT00673387|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
104926|NCT00673400|Cantonal Hospital St. Gallen, Department of Surgery|Ulrich Beutner PhD|+41 71 494 1111|ulrich.beutner@kssg.ch
105220|NCT00697190|Vistakon|John Buch OD|904-443-1707|
104927|NCT00673439|James Graham Brown Cancer Center|Goetz H Kloecker, MD, MSPH|502/562-4358|ghkloe01@exchange.edu
104928|NCT00673452|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
104929|NCT00673465|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
104930|NCT00673595|Mayo Clinic|Dr. John H. Eisenach|507-266-8715|eisenach.john@mayo.edu
104931|NCT00673660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104932|NCT00673673|Yale University|Dr. Jill Lacy|203-737-1600|jill.lacy@yale.edu
104933|NCT00679302|Southern Illinois University, School of Medicine|Dr. Myto Duong, Pediatric Emergency Medicine Director|217-545-7409|myto_duong@yahoo.com
104934|NCT00679341|Genentech, Inc.|Medical Communications|800 821-8590|
104935|NCT00679354|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
104936|NCT00679367|Boston Medical Center|Vaishali Sanchorawala|617-638-8265|vaishali.sanchorawala@bmc.org
104937|NCT00679380|Santarus, Inc.|Michael Huang, M.D., Senior Medical Director|858-314-5700|contact@santarus.com
104938|NCT00679432|Santarus, Inc.|Michael Huang, MD, Senior Medical Director, Clinical Research|8583145700|mhuang@santarus.com
104939|NCT00679627|Johnson & Johnson Pharmaceutical Research & Development|Director, Clinical Research|1 609-730-7674|
104940|NCT00681265|Eyeon Therapeutics, Inc.|David M. Kleinman||dave@eyeontherapeutics.com
104941|NCT00681291|LifeCell|Donna Jacobs|908-809-7856|djacobs@lifecell.com
104942|NCT00681473|Massachusetts General Hospital|Helen A. Shih, MD|617-724-9627|HSHIH@Partners.org
104943|NCT00681538|GW Pharma Ltd|Richard Potts, Clinical Operations Director|+44 1353 616600|rp@gwpham.com
104944|NCT00681564|Universidad del Valle|Jorge Hernán Ramírez and Adolfo Contreras (adolfo@yahoo.com).|5723753778|jorge.h.ramirez00@gmail.com
104945|NCT00681590|University of Miami|Dr. Silvina Levis|305-575-3388|slevis@miami.edu
104946|NCT00681629|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104947|NCT00681668|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104948|NCT00681811|Shire Human Genetic Therapies, Inc.|Norman Barton|781-482-9297|nbarton@shire.com
104949|NCT00681824|Baxter Healthcare Corporation|Guenter Zuelow, Associate Medical Director||guenter_zuelow@baxter.com
104950|NCT00681863|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
104951|NCT00681889|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-3313|Cornea_Research@meei.harvard.edu
104952|NCT00682357|University of Kansas Medical Center|Dr. Herbert Lindsley|(913) 588-3402|HLINDSLE@kumc.edu
104953|NCT00682461|GlaxoSmithKline|GSK Response Center|866-435-7343|
104954|NCT00682539|Department of Ophthalmology, Medical University Vienna|Dr. Katharina Kriechbaum|00431 40400 79480|katharina.kriechbaum@meduniwien.ac.at
104955|NCT00682565|Cytokinetics, Inc.|Medical Director|650-624-3053|
104956|NCT00682643|GlaxoSmithKline|GSK Response Center|866-435-7343|
104957|NCT00682734|Montefiore Medical Center|Benjamin Friedman|718 920 6626|befriedm@montefiore.org
104958|NCT00682786|Washington University School of Medicine|Benjamin R. Tan, M.D.|314-362-3560|btan@dom.wustl.edu
104959|NCT00682838|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov
104960|NCT00682851|Magee-Womens Research Institute|Lorna Rabe|412-641-6042|lrabe@mwri.magee.edu
104961|NCT00682890|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu
104962|NCT00683020|University of California, San Francisco|Dean Schillinger, MD/Study Principal Investigator|415-206-8940|dschillinger@medsfgh.ucsf.edu
104963|NCT00683046|University of Chicago Medicine|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu
104964|NCT00683085|Research Hospital, The Institute of Medical Science, The University of Tokyo|Hitomi Nagayama, M.D., Ph.D. / Project Lecturer|+81-3-3443-8111|zephyrus@ims.u-tokyo.ac.jp
104965|NCT00683163|UNIVERSITY OF CALIFORNIA, SAN FRANCISCO|Dr. Dennis Black|415-514-8159|dblack@psg.ucsf.edu
104966|NCT00683293|Kantonsspital Aarau|Dimtri SARLOS|00418384141|la.kots@ksa.ch
104967|NCT00683332|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104968|NCT00683384|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104969|NCT00683410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104970|NCT00683449|MediciNova, Inc.|Kazuko Matsuda, MD PhD MPH, Vice President, Clinical Development|858-373-1500 ext 132|matsuda@medicinova.com
104971|NCT00683475|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
104972|NCT00683592|PGxHealth, LLC|Director of Medical Affairs|203-786-3400|
104973|NCT00683618|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
104974|NCT00683657|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
104976|NCT00683774|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu
104977|NCT00683787|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
104978|NCT00676520|Abbott Vascular|Ellen Travis|408-845-3000|Ellen.Travis@av.abbott.com
104979|NCT00676585|Beth Israel Deaconess Medical Center|Dr. Michael Donnino||mdonnino@bidmc.harvard.edu
104980|NCT00676650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104981|NCT00676676|Massachusetts General Hospita|Dr. Karen K. Miller|617-726-3870|kkmiller@partners.org
104982|NCT00676689|Edwards Lifesciences|Sara Scrivano|949-250-5965|Sara_Scrivano@edwards.com
119277|NCT00551759|ECOG Statistical Office|Study Statistician|617-632-3012|
104984|NCT00676780|LSUShreveport|Dr. Jerry W. McLarty, Ph.D.|(318)813-1446|jmclar@lsuhsc.edu
104985|NCT00683800|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
104986|NCT00683826|Columbia University Medical Center|Henry N. Ginsberg MD, Gissette Reyes Soffer MD|2123059298|gr2104@columbia.edu
104987|NCT00683852|Massachusetts General Hospital, CTNI|Martina Flynn, Director, Clinical Trial Operations|617-643-6028|mflynn2@partners.org
104988|NCT00683878|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com
104989|NCT00683904|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
104990|NCT00683917|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com
104991|NCT00683930|Hoffmann-La Roche|Medical Communications|800-821-8590|
104992|NCT00684021|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com
104993|NCT00684047|Grifols Biologicals Inc.|Paul Pinciaro|443-375-8825|Paul.Pinciaro@grifols.com
104994|NCT00684060|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com
104995|NCT00684073|Schering-Plough|Head, Clinical Trials Registry and Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com
104996|NCT00684983|Mayo Clinic|Paul Haluska Jr MD PhD|507-284-1159|haluska.paul@mayo.edu
104997|NCT00684996|SWOG Statistical Center|Study Statistician|206-667-4623|
104998|NCT00685035|University of Minnesota School of Medicine|Dr. Robert Kempainen|612-873-6413|kempa001@umn.edu
104999|NCT00685139|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
105000|NCT00685165|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
105001|NCT00685178|Johns Hopkins University|Dr. Annie Umbricht|410-550-1917|annieumbricht@jhu.edu
105002|NCT00685295|Harvard/MGH|Stephen Thomas|6177267622|sthomasmd@gmail.com
105003|NCT00685334|New York State Psychiatric Institute|Evelyn Attia, MD|212-253-5923|ea12@columbia.edu
105004|NCT00685373|Novartis Pharmaceuticals|Study Director|862-778-8300|
105005|NCT00685399|Novartis Pharmaceuticals|Study Director|862-778-8300|
105006|NCT00685477|Temple University|Alan Maurer, MD|215-707-8269|amaurer@temple.edu
105008|NCT00685659|University of Pennsylvania|James R. McKay, Ph.D.|215-746-7704|jimrache@mail.med.upenn.edu
105009|NCT00685685|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
105010|NCT00685698|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072 ext 1211|cetsai@taigenbiotech.com
105011|NCT00685763|University of Florida Proton Therapy Institute|Charles Nichols, M.D.|904-588-1800|rnichols@floridaproton.org
105012|NCT00685802|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
105013|NCT00685880|Mayo Clinic|Dr. Jeffrey S. Brault|507-284-1643|brault.jeffrey@mayo.edu
105014|NCT00685945|Vanderbilt University|Dr. Mias Pretorius|615-343-0665|mias.pretorius@vanderbilt.edu
105015|NCT00686036|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
105016|NCT00686075|MedImmune, LLC.|Filip Dubovsky, Vice President, Clinical Development|301-398-0000|dubovskyf@medimmune.com
105017|NCT00686127|University of California, San Francisco|Dr. Christine Miaskowski, PI|415-476-9407|chris.miaskowski@nursing.ucsf.edu
119279|NCT00520299|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org
105019|NCT00686205|Abbott Diagnostics Division|Peggy Moreno|847-937-2044|Peggy.Moreno@abbott.com
105020|NCT00686231|UCSF|Andrew Boyle|415-514-0827|aboyle@medicine.ucsf.edu
105021|NCT00686257|Tufts Medical Center|Nicholas Hill MD|617-636-4288|nhill@tuftsmedicalcenter.org
105022|NCT00686335|Horizon Pharma|Senior Vice President, Clinical Development & Operations|224-383-3012|agrahn@horizonpharma.com
105023|NCT00686517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105024|NCT00686543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105025|NCT00686595|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105026|NCT00686634|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu
105027|NCT00686647|AngioScore|Gary Gershony, MD/ Chief Medical Officer|510-933-7900|gary@angioscore.com
105028|NCT00686686|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105029|NCT00686699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105030|NCT00686712|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu
105032|NCT00686777|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105033|NCT00686790|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com
105034|NCT00686803|Palatin Technologies, Inc.|Robert Jordan, Executive Director of Clinical Operations|609.495.2200|rjordan@palatin.com
105035|NCT00686842|AMC|Susan Krown, MD, Protocol Chair|301-251-1161|amcpm@emmes.com
105036|NCT00686855|Dana-Farber Cancer Institute|Nathaniel S. Treister, DMD, DMSc|617-632-2806|ntreister@partners.org
105037|NCT00686881|Merck Sharp & Dohme Corp..|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105038|NCT00686894|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105039|NCT00686959|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
105040|NCT00686972|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu
105041|NCT00686998|Astrazeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
105042|NCT00687076|Baylor College of Medicine|Gerd Brunner, PhD|713-790-5800|gbrunner@bcm.edu
105043|NCT00687167|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
105044|NCT00687193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105045|NCT00687219|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105046|NCT00687297|PrECOG|Study Statistician|617-632-3633|jmanola@jimmy.harvard.edu
105047|NCT00687323|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105048|NCT00687362|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105049|NCT00687401|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105050|NCT00687440|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105051|NCT00679783|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
105052|NCT00679913|Seoul National University Hospital|Sun-Whe Kim, M.D., Ph.D., FACS|82-2-2072-2310|sunkim@plaza.snu.ac.kr
105053|NCT00679939|GlaxoSmithKline|GSK Response Center|866-435-7343|
105054|NCT00679952|Seoul National University College of Medicine|Clinical instructor|82-2-2072-2817|meejookang@gmail.com
105055|NCT00680017|AstraZeneca|Gerard Lynch|+44 1509 645 895|aztrial_results_posting@astrazeneca.com
105056|NCT00680043|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com
105057|NCT00680056|UNIFESP|Danilo Berton|55-11-55718384|dcberton@gmail.com
105058|NCT00680121|University of Kansas Medical Center|Ann Manzardo, PhD|(913) 588-6473|amanzardo@kumc.edu
105059|NCT00680186|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105060|NCT00680225|New England Retina Associates|Dr. Peter Liggett|203-288-2020|neretina@msn.com
105061|NCT00680316|Genentech, Inc.|Medical Communications|800-821-8590|
105062|NCT00680368|Loma Linda VA Healthcare System|T. Michael Kashner, PhD, PI|909 825-7084 ext 2853|michael.kashner@va.gov
105063|NCT00680407|Meda Pharmaceuticals, Inc.|Associate Director, Clinical Research and Operations||michael.purzycki@meda.us
105064|NCT00680459|Baystate Medical Center|Dr. Christine McKiernan|413-794-5370|Christine.McKiernan@bhs.org
105065|NCT00680524|VA Puget Sound Health Care System|Bradford Felker, MD|(206)277-1191|Bradford.Felker@VA.GOV
105066|NCT00680628|Indiana University School of Medicine|Jeffrey Kline|3172873004|jefkline@iupui.edu
105067|NCT00680706|Baystate Medical Center|Howard Smithline|413-794-3433|howard.smithline@baystatehealth.org
105068|NCT00680745|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com
105069|NCT00680771|University of rochester|Wilfred Pigeon|(585) 275-3374|Wilfred_pigeon@urmc.rochester.edu
105070|NCT00680797|VA Greater Los Angeles|Dr. Cathy Lee|310-478-3711 ext 42627|cathy.lee2@va.gov
105071|NCT00680836|George E. Wahlen V.A. Medical Center, Salt Lake City, UT|Ashok Tuteja, M.D.|801-582-1565 ext 4019|ashok.tuteja@va.gov
105072|NCT00680862|VHA|Henry Anaya|310-478-3711 ext 48488|henry.anaya@va.gov
105073|NCT00680901|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
105074|NCT00680914|GlaxoSmithKline|GSK Response Center|866-435-7343|
105075|NCT00680953|Daiichi Sankyo Co., Ltd.|H. Takami|+81 3 5740 3445|takami.hideo.hs@daiichisankyo.co.jp
105076|NCT00681031|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105077|NCT00681044|Boston Medical Center|Dr. Vaishali Sanchorawala, Director of Stem Cell Transplant Program|617-637-7017|vaishali.sanchorawala@bmc.org
105079|NCT00681187|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
105080|NCT00687453|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu
105081|NCT00687531|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105082|NCT00687544|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105083|NCT00687609|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
105084|NCT00687674|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu
105085|NCT00687713|National Institute on Drug Abuse|Ann Anderson, MD|301-827-5916|aanderso@nida.nih.gov
105086|NCT00687804|Novartis Pharmaceuticals|Study Director|862 778-8300|
105087|NCT00688467|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105088|NCT00688519|GlaxoSmithKline|GSK Response Center|866-435-7343|
105089|NCT00688545|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105090|NCT00688636|Univerisity of Pittsburgh|Research Coordinator|412-648-9173|goldbyreffnerka@upmc.edu
105091|NCT00688662|Medical University of South Carolina|Dr Peter Cotton|8438767217|cottonp@musc.edu
105093|NCT00688701|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
105094|NCT00688740|sanofi-aventis|International Clinical Development Study Director||Contact-us@sanofi-aventis.com
105095|NCT00688753|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
105096|NCT00688844|Emory University|Rani H. Singh|404-448-8519|rsingh@emory.edu
105097|NCT00688870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105098|NCT00689026|Georgia Regent University|Dr. Sherman M. Chamberlain, Professor of Medicine|706-721-2238|schamberlain@gru.edu
105099|NCT00689052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105102|NCT00689117|GlaxoSmithKline|GSK Response Center|866-435-7343|
105103|NCT00689221|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
105104|NCT00689260|EMD Serono, Inc.|Sanja Dragnic, MD|781-681-2337|sanja.dragnic@emdserono.com
105105|NCT00689299|Greer Laboratories, Inc. for Antigen Laboratories, Inc.|Mark Hites|828-759-7548|mhites@greerlabs.com
105106|NCT00689338|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105107|NCT00689351|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com
105108|NCT00689390|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105109|NCT00689481|GlaxoSmithKline|GSK Response Center|866-435-7343|
105110|NCT00689611|Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital/McGill University|Dr. Mark J. Eisenberg|514.340.8222 ext 3564|mark.eisenberg@mcgill.ca
105111|NCT00689793|Departement of ambulatory care and community medicine, University of Lausanne, Switzerland|Dr Bernard Favrat MD|+41795566183314|Bernard.favrat@chuv.ch
105112|NCT00689819|Wayne State University|Phillip Levy, MD|3139938558|plevy@med.wayne.edu
105113|NCT00689871|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com
105114|NCT00689884|Dartmouth-Hitchcock Medical Center|John M. Hill, MD - Principal Investigator|603-650-4628|john.m.hill@hitchcock.org
105116|NCT00690040|Hemek Medical center|Dr. Raed Salim|97246494031|salim_ra@clalit.org.il
105117|NCT00690339|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com
105118|NCT00690430|Novartis Pharmaceuticals|Study Director|862-778-8300|
105119|NCT00690443|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867|
105120|NCT00690482|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com
105121|NCT00690495|B.Braun Melsungen AG|Study manager|+49 5661 71 ext 0|studies@bbraun.com
105122|NCT00690573|Abbott|Global Medical Services|800-633-9110|
105123|NCT00690612|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
105124|NCT00684138|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
105125|NCT00684177|GlaxoSmithKline|GSK Response Center|866-435-7343|
105126|NCT00684203|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105127|NCT00684242|UT MD Anderson Cancer Center|Sriram Yennurajalingam, MD / Assistant Professor||CR_Study_Registration@mdanderson.org
105128|NCT00684255|New York Medical College|Dr. Mitchell S. Cairo|914-594-3650|mitchell_cairo@nymc.edu
105129|NCT00684307|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
105130|NCT00684320|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|(619) 229-3740|namir@mail.sdsu.edu
105131|NCT00684411|Dana-Farber Cancer Institute|Eric Jacobsen, MD|617.632.6633|EDJACOBSEN@PARTNERS.ORG
105132|NCT00684424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
105133|NCT00684515|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105134|NCT00684541|SDSU|Professor Nader Amir|6192293744|namir@mail.sdsu.edu
105135|NCT00684554|New York State Psychiatric Institute|Dr. Frances Levin|646-774-6137|frl2@columbia.edu
105136|NCT00684567|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105137|NCT00684593|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105138|NCT00684645|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105139|NCT00684671|GlaxoSmithKline|GSK Response Center|866-435-7343|
105140|NCT00684723|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
105141|NCT00684749|University of Minnesota|Umar Choudry/Bruce Cunningham|6126250697|choud008@umn.edu
105142|NCT00684762|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
105143|NCT00684814|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
105144|NCT00690755|James A. Haley VA Research Department|Robert Farese, MD|813-972-2000|Robert.Farese@va.gov
105145|NCT00690794|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com
105146|NCT00690820|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32(0)2 509 69 77|sven.voet@solvay.com
105148|NCT00690898|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
105149|NCT00691015|Barbara Ann Karmanos Institute|Zaid Al-Kadhimi, M. D.|(404) 778-1900|zalkadh@emory.edu
105150|NCT00691028|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
105151|NCT00691652|OHSU Knight Cancer Institute|Dr. Craig Okada|503-494-1080|Okadac@ohsu.edu
105152|NCT00691665|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
105153|NCT00691704|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|cristina.gasparetto@duke.edu
105154|NCT00691808|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH - Medical Director, Drug safety|281-863-3000|
105155|NCT00691938|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu
105156|NCT00692003|Eisai Inc|Antonio Laurenza, MD, Executive Director|1 201 949-4157|antonio_laurenza@eisai.com
105158|NCT00692198|Johns Hopkins Bloomberg School of Public Health|James Tonascia, PhD|410-955-8175|jtonasc1@jhu.edu
105159|NCT00692211|New Mexico VA Health Care System|Richard Hoffman, MD|505-265-1711 ext 5318|richard.hoffman2@va.gov
105160|NCT00692237|Sapienza University of Rome|Dr Andrea Isidori|+39 0649970540|andrea.isidori@uniroma1.it
105161|NCT00692341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|ClinicalTrials.gov_Inquiries@pfizer.com
105162|NCT00692406|DukeUMC|Dr. F. Joseph McClernon|919-668-3987|mccle011@mc.duke.edu
105163|NCT00692419|VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion|Steven D. Weisbord MD|412-360-3911|steven.weisbord@va.gov
105164|NCT00692692|Vanderbilt University Medical Center|Jason Wendel, MD|615-936-0160|jason.wendel@vanderbilt.edu
105166|NCT00692913|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105167|NCT00693017|Eisai Inc|Antonio Laurenza, MD, Executive Director|1 201 949-4157|antonio_laurenza@eisai.com
105169|NCT00693225|Mayo Clinic|Dr. Yvonne Romero|507-266-9156|romero.yvonne@mayo.edu
105170|NCT00693238|University of Florida|Randal Henderson, MD, MBA|904-588-1800|rhenderson@floridaproton.org
105172|NCT00693420|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com
105173|NCT00693472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105174|NCT00693485|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
105175|NCT00693498|University of Rochester|Jill M. Cholette MD, Principle Investigator|585-275-8138|Jill_Cholette@urmc.rochester.edu
105176|NCT00693628|Department of Orthopedic Surgery & Rehabilitation, Orthotics and Prosthetics Division|Jonathan Day||jonathan-day@ouhsc.edu
105177|NCT00693654|Wake Forest University Health Sciences|Alan Fleischer, Jr., MD|336-716-7753|afleisch@wfubmc.edu
105179|NCT00693706|GlaxoSmithKline|GSK Response Center|866-435-7343|
105180|NCT00693719|University of Arizona Cancer Center|Dr. Robert Livingston|520/626-4175|rlivingston@azcc.arizona.edu
105181|NCT00693784|Spinal Restoration, Inc.|Jeff F. Doerzbacher|512 225-0405|jeffdoerzbacher@spinalrestoration.com
105182|NCT00693992|University of Pittsburgh|Mark A. Socinski, M.D.||socinskima@upmc.edu
105183|NCT00694018|VA Ann Arbor Center for Clinical Management Research|Sarah L. Krein, PhD, RN|734-845-3621|sarah.krein@va.gov
105184|NCT00687830|Cleveland Clinic Florida|Dr. Shibu Varughese and Dr. Anand Kumar|305-310-1238|akuma003@fiu.edu
105185|NCT00687856|University of Pittsburgh|John Gorcsan MD|4126476570|gorcsanj@upmc.edu
105186|NCT00687908|Galderma|Clinical Project Manager|+33 492 95 29 21|jean-charles.dhuin@galderma.com
105187|NCT00687973|Novartis Pharmaceuticals|Study Director|862 778-8300|
105188|NCT00688064|Galderma|Jean-Charles Dhuin, Clinical Project Manager|+33 4 92 95 29 21|jean-charles.dhuin@galderma.com
105189|NCT00688103|School of Medicine, Toho University|Dr. Hideto Kameda|+81-3-3468-1251 ext 2326|hideto.kameda@med.toho-u.ac.jp
105190|NCT00694070|Ascensia Diabetes Care|Clinical Research Scientist|574-257-3063|
105191|NCT00694096|Huntsman Cancer Institute|Mark Wade, Ph.D. - Compliance Officer|801-213-5746|mark.wade@hci.utah.edu
105192|NCT00694109|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
105193|NCT00694122|Massachusetts General Hospital|David M. Nathan, MD|617-726-1848|dnathan@partners.org
105194|NCT00694161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105195|NCT00694304|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
105196|NCT00694356|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105197|NCT00694369|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
105198|NCT00695864|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@pain.stanford.edu
105199|NCT00695903|Cubist Pharmaceuticals|Medical Director||ellie.hershberger@cubist.com
105200|NCT00695955|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
105201|NCT00696020|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105202|NCT00696072|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
105203|NCT00696241|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
105204|NCT00696293|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu
105205|NCT00696384|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
105207|NCT00696423|GlaxoSmithKline|GSK Response Center|866-435-7343|
105208|NCT00696436|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
105211|NCT00696618|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410)641-8762|ejfuchs@jhmi.edu
105212|NCT00696696|NYU Cancer Institute|Deirdre Cohen, MD|212-731-5656|deirdre.cohen@nyumc.org
105213|NCT00696761|the Department of Urology, Asan Medical Center, University of Ulsan College|Kanghyon Song, Myung-Soo Choo, Kyu-Sung Lee, Ji-Yeon Han, Young-Suk Lee,|82-2-3010-3735|mschoo@amc.seoul.kr
105214|NCT00696774|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
105215|NCT00696787|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
105216|NCT00696800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105217|NCT00696878|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105218|NCT00697073|Santhera|Dr Thomas Meier|+41 61 906 8964|thomas.meier@santhera.com
105219|NCT00697112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105221|NCT00697255|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105222|NCT00697515|Shire Pharmaceuticals|Timothy Whitaker, MD||twhitaker@shire.com
105223|NCT00697541|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com
105224|NCT00697593|Merck Serono S.A., a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
105225|NCT00697619|Sun Yat-sen University Cancer Centre|Dr. Li Zhang|86-20-87343458(O)|zhangli6@mail.sysu.edu.cn
105226|NCT00697697|MAP Pharmaceuticals, Inc. a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com
105227|NCT00697788|Mass General Hospital for Children|Erik Shank, MD|6177242250|eshank@partners.org
105228|NCT00697801|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com
105229|NCT00697827|Synthes|Ann Marie Simon|610-719-5418|simon.annmarie@synthes.com
105230|NCT00698009|UT MD Anderson Cancer Center|Dr. Laurence Cooper, Professor||rnjackso@mdanderson.org
105231|NCT00698022|Corcept_Therapeutics|Robert Roe, MD|650-688-8812|rroe@corcept.com
105232|NCT00698035|University of California, San Francisco|Michelle Melisko, MD|415-353-7070|mmelisko@medicine.ucsf.edu
105233|NCT00698139|Columbia University|Dr. Paolo C. Colombo|212-305-2638|pcc2001@columbia.edu
105234|NCT00698204|University of Connecticut Health Center|Dr. Rajesh V. Lalla|860-679-8007|lalla@uchc.edu
105235|NCT00691054|University of Miami Sylvester Comprehensive Cancer Center|Caio Max Rocha Lima MD|305-243-7770|crocha@med.miami.edu
105236|NCT00691093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
105237|NCT00691132|University of Minnesota|Dr. Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu
105238|NCT00691197|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com
105239|NCT00691210|Columbia University Medical Center|Owen A. O'Connor, MD, Ph.D.|212-326-5720|oo2130@cumc.columbia.edu
105240|NCT00691327|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com
105241|NCT00691483|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105242|NCT00698451|Janssen Services, LLC|Senior Director|1 215 325-5329|tmcgowan@its.jnj.com
105243|NCT00698516|GlaxoSmithKline|GSK Response Center|866-435-7343|
105244|NCT00698581|UCB|UCB Cares|+1 877 822 9493|
119284|NCT00462826|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org
105246|NCT00699842|Thomas Jefferson University|Emmanuel Besa, MD|215-955-8874|Emmanuel.Besa@jefferson.edu
105247|NCT00699972|Eisai Call Center|Eisai Inc.|888-422-4743|
105248|NCT00699998|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
105249|NCT00700011|Texas Oncology - Amarillo|Dr. Seah Lim|806-358-8654|seah.lim@usoncology.com
105250|NCT00700063|Leo Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com
105251|NCT00700102|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
105252|NCT00700115|Emory University School of Medicine|Dr. Igho Ofotokun|404-616-0659|iofotok@emory.edu
105253|NCT00700141|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com
105254|NCT00700180|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
105255|NCT00700271|Novartis Pharmaceuticals|Study Director|862-778-8300|
105256|NCT00700310|Eisai Call Center|Eisai Inc.|888-422-4743|
105257|NCT00700375|Osaka General Medical Center|Prevention on Conrast-Induced Nephropathy With Bolus Injection of Sodium Bicarbonate|81-6-6692-1201|u_hiromichi@yahoo.co.jp
105258|NCT00700401|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
105259|NCT00700427|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
105260|NCT00700440|Cancer Center, Sun Yat-sen University|Dr. Lu Tai-xiang|86-20-87343372|lutx@mail.sysu.edu.cn
105261|NCT00700570|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
105262|NCT00700622|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com
119285|NCT00429169|Columbia University/NYSPI|Michael F. Grunebaum, MD|212-543-5842|mfg14@columbia.edu
105264|NCT00700713|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
105265|NCT00700739|DePuy Synthes Spine|Mark Lotito|(508) 880-8045|Mlotito@its.jnj.com
105266|NCT00700752|Vistakon|Kurt Moody OD|904-443-3088|
105267|NCT00700804|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Reserch Center|Janet Hunt, PhD|701-795-8353|janetrhunt@gmail.com
105268|NCT00700817|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
105269|NCT00700973|VA Palo Alto Health Care System|Christine Timko|650-617-2746|Christine.Timko@va.gov
105270|NCT00700999|Jesse Brown VA Medical Center|Dr. K Luan Phan|312-569-7161|Kinh.Phan@va.gov
105271|NCT00701038|The Ohio State Universtiy|Rami Khayat|614-247-7707|rami.khayat@osumc.edu
105272|NCT00701051|Baltimore VA Medical Center|Steven J. Prior, PhD|410-605-7000 ext 4129|steven.prior@va.gov
105273|NCT00701064|VA|Shawn Youngstedt|803-767-3208|shawn.youngstedt@asu.edu
105274|NCT00701090|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105275|NCT00701103|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105276|NCT00701129|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
105277|NCT00701311|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu
105278|NCT00701363|Ipsen|Medical Director, Clinical Endocrinology and Metabolism|clinical.trials@ipsen.com|clinical.trials@ipsen.com
105279|NCT00701389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105280|NCT00701415|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
105281|NCT00701441|Ohio State University|Rami Khayat|614-247-7707|rami.khayat@osumc.edu
105282|NCT00701558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
105283|NCT00701636|LA BioMed at Harbor-UCLA Medical Center|Loren Miller MD|310-222-3813|Lgmiller@ucla.edu
105284|NCT00701662|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
105285|NCT00701675|Ralp H. Johnson VA Medical Center|Olga Brawman-Mintzer, MD|8437242302 ext 2834|mintzero@musc.edu
105286|NCT00701727|Radiant Research|Michael H Davidson, MD FACC|312-494-2220|michaeldavidson@radiantresearch.com
105287|NCT00701779|Deaconess Clinic, Inc.|Paul F. Siami, MD CPI|812-426-9576|research.paul.siami@deaconess.com
105288|NCT00701805|Abbott|Global Medical Services|800-633-9110|
105289|NCT00701935|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
105290|NCT00702143|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
105291|NCT00702208|CUNY School of Public Health, Hunter College|Heidi Jones|212-396-7750|hjon@hunter.cuny.edu
105292|NCT00702221|BTG International Inc.|SVP, Clinical Development|610-278-1660|thomas.king@btgplc.com
105293|NCT00702234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105294|NCT00702273|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105295|NCT00694473|Massachusetts General Hospital|Steven J Russell, M.D. PhD|617-726-8722|sjrussell@mgh.harvard.edu
105297|NCT00694564|UC San Diego|Dr. Jeannie Huang|858-576-1700 ext 7322|jshuang@ucsd.edu
105298|NCT00694603|Massachusetts General Hospital|Dr. Lecia Sequist|617-724-4000|lvsequist@partners.org
105299|NCT00695019|Amarillo Biosciences, Inc.|Martin J. Cummins, Director of Clinical & Regulatory Affairs|806-376-1741 ext 14|mcummins@amarbio.com
105300|NCT00695097|University of California, San Francisco|Flavio Vincenti|415-353-1322|flavio.vincenti@ucsfmedctr.org
105301|NCT00695136|Pediatrics & Developmental Neuroscience Branch, NIMH|Susan E. Swedo, MD|301-496-5323|swedos@mail.nih.gov
105302|NCT00695188|Department of Clinical Pharmacology, Medical University of Vienna|Eva-Luise Hobl|+43 1 40400 2981|eva-luise.hobl@meduniwien.ac.at
105303|NCT00695292|Sarah Cannon Research Institute|Dr. David Spigel|615-329-7274|askSARAH@scresearch.net
105304|NCT00695318|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com
105305|NCT00695396|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Head of Hematology and Nephrology||pbowers@its.jnj.com
105306|NCT00695435|Alcon Research, LTD|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
105307|NCT00695500|National Institute on Alcohol Abuse and Alcoholism|Ramchandani, Vijay|+1 301 402 8527|vijayr@mail.nih.gov
105308|NCT00695565|Arcion Therapeutics, Inc.|Dr. James Campbell|(410) 522-8701|jcampbell@arciontherapeutics.com
105309|NCT00695669|GlaxoSmithKline|GSK Response Center|866-435-7343|
105310|NCT00702299|University of Arizona|Dr. Setsuko Chambers|520/626.0950|schambers@azcc.arizona.edu
105311|NCT00702325|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
105312|NCT00702338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105313|NCT00702364|Craig Hospital|Cynthia Harrison-Felix, PhD|303-789-8565|charrison-felix@craighospital.org
105314|NCT00702377|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
105315|NCT00702403|Fred Hutchinson Cancer Research Center|Dr. Paul A. Carpenter|(206) 667-5191|pcarpent@fredhutch.org
105316|NCT00702468|GW Pharma Ltd|Richard Potts Clinical Operations Director|+44 1353 616600|rp@gwpharm.com
105317|NCT00702507|GlaxoSmithKline|GSK Response Center|866-435-7343|
105318|NCT00702520|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105319|NCT00702546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105320|NCT00702624|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105321|NCT00702923|University of Wisconsin Carbone Cancer Center|Douglas McNeel, M.D., Ph.D.|(608) 263-4198|dm3@medicine.wisc.edu
105322|NCT00702949|Mayo Clinic|Charles Loprinzi, M.D.|507/284-1623|cloprinzi@mayo.edu
105323|NCT00703014|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105324|NCT00703053|Saint Louis University|Robert Belshe, MD|314-977-9030|belsherb@slu.edu
105326|NCT00703118|Tibotec|Medical Leader|1 609 730-3174|
105327|NCT00703157|Medtronic Bakken Research Center, Coronary and Structural Heart Disease Management|Ber Kleijnen|+31 (0) 43 356 6566|ber.kleijnen@medtronic.com
105328|NCT00703261|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
119288|NCT00415610|University of Minnesota|Adnan I Qureshi, MD|612-624-2431|qureshai@gmail.com
105330|NCT00703339|Lung Rx|Rosa Negro-Vilar|240-821-1881|rnegrovilar@lungrx.com
105331|NCT00703391|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
105332|NCT00703508|Virginia Commonwealth University|Dr. Kai Cheang|(804) 828-2257|kicheang@vcu.edu
105333|NCT00703534|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
105334|NCT00703677|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com
105335|NCT00703729|CU Sports Medicine|Dr. Eric McCarty|303-441-2118|cyndi.long@ucdenver.edu
105336|NCT00703781|ISTA Pharmaceuticals, Inc.|Tim McNamara, PharmD|949-788-6000|tmcnamara@istavision.com
105337|NCT00703846|GlaxoSmithKline|GSK Response Center|866-435-7343|
105338|NCT00703885|UCSD|Murray B. Stein MD, MPH|858-534-6451|mstein@ucsd.edu
105339|NCT00703911|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
105340|NCT00703924|Institute Pasteur Tunisia|Afif Ben Salah, MD, PhD|216-71-792-429|afif.bensalah@pasteur.rns.tn
105341|NCT00703937|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com
105342|NCT00703963|Mayo Clinic|Dr. Hartzell V. Schaff|507-255-7068|schaff@mayo.edu
105343|NCT00703976|University of Pittsburgh|Julie Bauman, MD|412-623-7833|baumanje@upmc.edu
105344|NCT00704028|Luitpold Pharmaceuticals, Inc.|Sumita Chowdhury, MD, MPH, FACC, MBA|610-650-4200|SChowdhury@lpicrd.com
105345|NCT00704132|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105346|NCT00704171|Covidien|Jennifer L. Doyle, Global Director of Clinical Affairs|781-839-1770|jennifer.doyle@covidien.com
105347|NCT00704184|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105348|NCT00704340|Integra LifeSciences|Director, Medical Affairs|609-275-0500|
105349|NCT00704353|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com
105350|NCT00704379|Baylor College of Medicine|Dr. Ricardo Jorge|713-794-7010|Ricardo.Jorge@bcm.edu
105351|NCT00704405|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105352|NCT00704418|ISTA Pharmaceuticals, Inc.|Tim McNamara, Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com
105353|NCT00704522|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105354|NCT00704535|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105355|NCT00704717|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105356|NCT00704730|Exelixis, Inc|Yifah Yaron, MD Senior Director, Clinical Research, Clinical Development|650-837-7678|yyaron@exelixis.com
105357|NCT00704769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105358|NCT00704808|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105359|NCT00704847|Nordic Bioscience A/S|Bente Juel Riis, Medical Director|+45 22901317|bjr@nordicbioscience.com
105360|NCT00704912|Penn State College of Medicine, Penn State Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-8478|rsl1@psu.edu
105361|NCT00704938|National Cancer Institute, National Institues of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov
105362|NCT00704964|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105363|NCT00705003|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@partners.org
105364|NCT00705016|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
105365|NCT00705081|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105366|NCT00705107|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105367|NCT00705146|VIHA|Helia Sillem MScOT|2507557611|helia.sillem@viha.ca
105368|NCT00705159|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com
105369|NCT00705224|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105370|NCT00705250|Memorial Sloan Kettering Cancer Center|Craig Moskowitz, MD|(212) 639-7992|moskowic@mskcc.org
105371|NCT00705263|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com
105372|NCT00705289|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105373|NCT00705341|Johns Hopkins University|Anne Capser|410-955-8183|ashankli@jhsph.edu
105374|NCT00705367|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
105375|NCT00705406|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302|
105376|NCT00698646|Novartis Pharmaceuticals|Study Director|862-778-8300|
105377|NCT00698685|University of Arizona, Arizona Cancer Center|Andrew M. Yeager, MD|520-626-0662|ayeager@azcc.arizona.edu
105378|NCT00698815|Massachusetts General Hospital|Rebecca S. Heist, MD||rheist@partners.org
105379|NCT00698841|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
105380|NCT00698867|Zimmer Biomet|Kelly Francher, Clinical Affairs Manager|574-371-9783|kelly.francher@zimmerbiomet.com
105381|NCT00698932|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
105382|NCT00699140|Instituto Grifols, S.A|Marta Carretero, PhD, Clinical Project Leader|+ 34 93 571 22 00|marta.carretero@grifols.com
105383|NCT00699153|Bausch & Lomb, Inc.|Laura Trusso, MS.|(585) 338-5561|laura.trusso@bausch.com
105384|NCT00699192|Novartis Pharmaceuticals|Study Director|862 778-8300|
105385|NCT00699283|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
105386|NCT00699335|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com
105387|NCT00699348|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
105388|NCT00699374|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105389|NCT00699400|EMD Serono, Inc.|Mary C. Mahony, PhD, HCLD (AAB)|781.681.2438|mary.mahony@emdserono.com
105390|NCT00699413|USC|Michael Goran|323.442.3027|goran@usc.edu
105391|NCT00699491|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.||cma@im.wustl.edu
105392|NCT00699582|Eisai Call Center|Eisai Inc.|888-422-4743|
105393|NCT00699608|GlaxoSmithKline|GSK Response Center|866-435-7343|
105394|NCT00699660|Veterans Affairs at TVHS|Theodore Speroff PhD|615-636-9476|ted.speroff@va.gov
105395|NCT00699699|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105396|NCT00699751|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
105397|NCT00705432|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105398|NCT00705523|UPenn|Dr. Jennifer Plebani|215-222-3200 ext 152|jplebani@mail.med.upenn.edu
105399|NCT00705536|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889|
105400|NCT00705575|Novartis Pharmaceuticals|Study Director|862 778-8300|
105401|NCT00705614|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105402|NCT00705653|Progen Industries|Michael Fitzgerald|919-803-9988|michaelf@progen-pharma.com
105403|NCT00705666|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105404|NCT00705679|University of Washington|Jeanne Marrazzo, MD, MPH, FACP, FIDSA|206-744-3679|jmm2@uw.edu
105405|NCT00705718|Medtronic|Karla Betz, Principal Clinical Research Specialist|763-526-2737|karla.h.betz@medtronic.com
105406|NCT00705757|Summa Health System ( at the time of the trial)|Deepak P. Edward, MD|330-780-0399|deepak.edward@gmail.com
105407|NCT00708019|University of California, San Francisco|Christine Miaskowski|415-476-9407|chris.miaskowski@nursing.ucsf.edu
105408|NCT00708032|Johnson & Johnson Vision Care, Inc.|Kathy Osborn, OD|+1 904 443-1032|clinicalstudies@its.jnj.com
105409|NCT00708071|Baxter Innovations, GmbH|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com
119290|NCT00407758|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org
105411|NCT00708110|ViiV Healthcare|GSK Response Center|866-435-7343|
105413|NCT00708162|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
105414|NCT00708175|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
105415|NCT00708201|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660|
105416|NCT00708214|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105418|NCT00708422|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com
105419|NCT00708435|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
105420|NCT00708461|University of Minnesota|Jennifer A. Linde, Ph.D.|612-624-0065|linde074@umn.edu
105421|NCT00708500|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105422|NCT00708526|University of Utah|Dwayne Westenskow, PhD|801-581-2478|Dwayne.Westenskow@hsc.utah.edu
105423|NCT00708643|Vistakon|Kurt Moody, O.D. FAOO|904-443-3088|
105424|NCT00708682|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com
105425|NCT00708708|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105426|NCT00708721|Huntsman Cancer Institute|Dr. Paul Shami|801-585-0100|paul.shami@hci.utah.edu
105427|NCT00708734|Tampa VA Hospital|Tatjana Bulat|8135583932|tatjana.bulat@va.gov
105428|NCT00708851|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel, MD|609-443-4501|dreamacres1@aol.com
105429|NCT00708877|University of Utah|Dr. Jason Schwarz|8015852708|jason.schwartz@hsc.utah.edu
105430|NCT00708942|Photocure|Bjørn Klem, Project Director|+47 22 06 22 10|bk@photocure.no
105431|NCT00709059|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105432|NCT00709098|Actelion Pharmaceuticals Ltd|Laila Rouault, MD/International Clinical Leader|+ 41 61 565 8128|
105433|NCT00709111|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
105434|NCT00709124|Johns Hopkins University School of Medicine|Dr Dale Needham|(410) 955-3467|dale.needham@jhmi.edu
105435|NCT00709228|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105436|NCT00709319|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrstat3@jaeb.org
105437|NCT00709592|Virginia Commonwealth University|Amir A Toor, MD|804-828-4360|atoor@mcvh-vcu.edu
105438|NCT00709618|GlaxoSmithKline|GSK Response Center|866-435-7343|
105439|NCT00709722|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200|
105440|NCT00709735|Massachusetts General Hospital|Roger K. Pitman, M.D.|617-726-5333|roger_pitman@hms.harvard.edu
105441|NCT00709761|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
105442|NCT00709826|Tragara Pharmaceuticals|Tracy Parrott|760-208-6919|tparrott@tragarapharma.com
105443|NCT00709852|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
105444|NCT00709878|Northwestern University|Mario Lacouture, MD|212-610-0079|LacoutuM@mskcc.org
105445|NCT00709891|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
105446|NCT00709956|Actelion|Laila Rouault, M.D.|+ 41 61 565 8128|laila.rouault@actelion.com
105447|NCT00710021|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
105448|NCT00710203|UC Davis, Department of Dermatology|Daniel Eisen, M.D.|916-734-6479|dbeisen@ucdavis.edu
105449|NCT00710385|Substance Abuse|Sandra D. Comer|646-774-6146|sdc10@columbia.edu
105450|NCT00710424|GW Pharm Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
105451|NCT00702650|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
105452|NCT00702689|National Cancer Institute, National Institutes of Health|Edward Cowen, M.D.|301-496-4299|cowene@mail.nih.gov
105453|NCT00702702|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com
105454|NCT00702715|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105455|NCT00702754|Solstice Neurosciences, Inc|Sharon Reinhard, M.S, Associate Director, Clinical Development|267-620-8083|Sharon.Reinhard@solsticeneuro.com
105456|NCT00702780|Seoul National University Hospital|Young Min Choe|82-2-2072-1730|howlow44@daum.net
105457|NCT00702845|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105458|NCT00702884|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab|614-293-6529|Tanios.Bekaii-Saab@osumc.edu
105459|NCT00710554|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
105460|NCT00710593|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com
105461|NCT00710606|Columbia University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu
105462|NCT00710749|Astra Tech AB|Head of Clinical Research Area Health Care|+46317763000|
105463|NCT00710762|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105464|NCT00710814|Columbia University|Judith Korner, M.D., PhD|2123053725|jk181@cumc.columbia.edu
105465|NCT00710840|University of Colorado Denver, Anschutz Medical Center|Dr. Jennifer Stevens-Lapsley|303-724-9170|Jennifer.Stevens-Lapsley@ucdenver.edu
105466|NCT00712725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105467|NCT00712920|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us
105468|NCT00712959|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
105469|NCT00712985|Milton S. Hershey Medical Center|Allan Lipton, MD|717-531-5960|alipton@hmc.psu.edu
105470|NCT00713206|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com
105471|NCT00713219|Memorial Sloan Kettering Cancer Center|Dr. Matthew Fury|646-888-4233|furym@mskcc.org
105472|NCT00713258|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com
105473|NCT00713310|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
105474|NCT00713323|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
105475|NCT00713349|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com
105476|NCT00713479|University of California, Los Angeles|Dr Edythe London|(310) 825-0606|elondon@mednet.ucla.edu
105477|NCT00713544|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
105478|NCT00713596|Mayo Clinic|Dr. Oren Friedman|507-538-1392|
105479|NCT00713609|GlaxoSmithKline|GSK Response Center|866-435-7343|
105480|NCT00713648|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
105481|NCT00713661|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com
105482|NCT00713700|Abbott|Ashish Oza|1-818-493-3648|aoza@sjm.com
105483|NCT00713817|GW Pharma Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
105484|NCT00713830|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
105485|NCT00714051|Edward Hines Jr., VA Hospital|Eileen Collins PhD, RN|708-202-3525|eileen.collins@va.gov
105486|NCT00714168|University of Pittsburgh|John M. Jakicic, PhD|412-383-4001|jjakicic@pitt.edu
105487|NCT00714233|University of Rochester|Kathleen M Hoeger MD MPH|5852757891|Kathy_hoeger@urmc.rochester.edu
105488|NCT00714259|UAB|William Vaughan, MD|20-934-0066|liwilliams@uabmc.edu
105489|NCT00714285|GlaxoSmithKline|GSK Response Center|866-435-7343|
105490|NCT00714311|Medical University of Vienna|Stephan Doering|+43140400 ext 25190|stephan.doering@meduniwien.ac.at
105491|NCT00714389|University of Rochester|Gunhilde Buchsbaum, MD|585-273-3232|gunhilde_buchsbaum@urmc.rochester.edu
105492|NCT00714493|Centocor Ortho Biotech, Inc.|Sr. Director, Clinical Research - Medical Affairs|215-325-6811|Ddeckto2@its.jnj.com
105493|NCT00714571|VA Ann Arbor Healthcare System|Dr. Benjamin M. Hampstead|734-763-9259|Benjamin.Hampstead@va.gov
105494|NCT00714688|Janssen-Cilag Germany|EMEA Medical Affairs Director|+49 2137 955258|
105495|NCT00714714|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director Clinical Operations|949-973-1153|David.Linberry@valeant.com
105496|NCT00714792|University of Rochester|Michael K. Flynn, MD|585-273-3232|michael_flynn@urmc.rochester.edu
105497|NCT00714870|St. Elizabeth's Medical Center|Dr. Shirley Gonzalez|617-926-0114|shirleyg2008@gmail.com
105498|NCT00714948|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org
105499|NCT00715026|Zimmer|Director, Clinical Affairs|574-371-8019|erin.osborn@zimmer.com
105500|NCT00715078|Dendreon|Shabnam Vaziri|206-455-2323|Svaziri@Dendreon.com
105501|NCT00715104|Dendreon Corporation|Lynn Ngo|206-274-6763|lngo@dendreon.com
105502|NCT00715117|Pennsylvania State University|Jill P Smith, MD Professor Emeritus of medicine|717-531-3694|jsmith2@psu.edu
105504|NCT00705874|Progen Pharmaceuticals Pty Ltd|Director of Clinical Trials|+61 7 32739133|darrynb@progen-pharma.com
105505|NCT00705939|Protalix Ltd.|Vice President Product Development|+(972) 4-9889488 ext 137|einata@protalix.com
105506|NCT00706004|University of Arkansas for Medical Sciences|Catherine O'Brien|501-364-1828|obriencatherinee@uams.edu
105507|NCT00706095|Eisai Call Center|Eisai Inc.|888-422-4743|
105508|NCT00706121|SWOG Statistical Center|SELECT/S0000D Statistician|206-667-4623|
105509|NCT00706134|Novartis Pharmaceuticals|Study Director|862-778-8300|
119293|NCT00361218|Massachusetts General Hospital|John W. Denninger, MD, PhD|617-726-2985|jdenninger@partners.org
105511|NCT00706342|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com
105512|NCT00706355|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105513|NCT00706433|Dusa Pharmaceuticals, Inc.|Anna Houlihan||houlihana@dusapharma.com
119294|NCT00361270|Michael E DeBakey VAMC|Wright Williams, Ph.D., ABPP|713-794-7629|wright.williams@va.gov
105515|NCT00706485|Massachusetts General Hospital|Thomas F. DeLaney, M.D.|617-726-6876|tdelaney@mgh.harvard.edu
105516|NCT00706550|Michael E. DeBakey Veterans Affairs Medical Center|Dr. Maria C. Rodriguez-Barradas|713-794-7384|Maria.Rodriguez-Barradas2@va.gov
105517|NCT00706563|GlaxoSmithKline|GSK Response Center|866-435-7343|
105518|NCT00706589|Kiho Moon|Medical Director|+82-2-3287-9009|khmoon@otsuka.co.kr
105519|NCT00706628|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105520|NCT00706641|Hoosier Cancer Research Network, Inc.|Noah Hahn, MD|317-921-2050|jsmith@hoosiercancer.org
105521|NCT00706654|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974|
105522|NCT00706706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105523|NCT00706719|Repros Therapeutics, Inc|Ronald Wiehle, PhD|281.719.3406|rwiehle@reprosrx.com
105524|NCT00706784|MGH|Alexandra B. Kimball, MD|617-726-5066|akimball@partners.org
105525|NCT00706797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
105526|NCT00706810|Huntsman Cancer Institute|Dr. Randy Jensen|801-581-6908|randy.jensen@hci.utah.edu
105527|NCT00706823|University of Texas Medical School at Houston|Carin A. Hagberg, MD|713-500-6222|carin.a.hagberg@uth.tmc.edu
105528|NCT00706836|University of California San Diego|Murray B. Stein MD, MPH|858-534-6400|mstein@ucsd.edu
105529|NCT00706849|Genzyme Corporation|Genzyme Medical Information|617-252-7832|
105530|NCT00706901|Charleston VAMC|Elizabeth Santa Ana, Ph.D.|(843) 789-7168|elizabeth.santaana2@va.gov
105531|NCT00706914|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com
105532|NCT00706966|University of California San Francisco|Mack Roach, MD|415-353-9855|tdiep@radonc.ucsf.edu
105533|NCT00706979|Medical University of South Carolina`|Matthew J. Carpenter|843-792-3974|carpente@musc.edu
105534|NCT00706992|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov
105535|NCT00707031|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
105536|NCT00707057|SCOLR Pharma Inc|Stephen Turner, VP and Chief Technical Officer|425-368-1050 ext 1001|sturner@scolr.com
105537|NCT00707161|Huntsman Cancer Institute|Dennis Shrieve, MD|801-581-8793|dennis.shrieve@hci.utah.edu
105538|NCT00707174|University of Utah|Glen Bowen, MD|801-581-0255|glen.bown@hci.utah.edu
105539|NCT00707239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105540|NCT00707343|Huntsman Cancer Institute|Mark Wade, Ph.D. - Compliance Officer|801-213-5746|mark.wade@hci.utah.edu
105541|NCT00707447|FIDAM|Norbert Hermanns|0049 7931 594 ext 553|hermanns@diabetes-zentrum.de
105542|NCT00707486|HemCon Medical Technologies|Staci McAdams|(503)245-0459 ext 103|staci@hemcon.com
105543|NCT00707577|Massachusetts General Hospital|Dr. Anne Thorndike|617-724-4608|athorndike@mgh.harvard.edu
105544|NCT00707655|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com
105545|NCT00707746|Genzyme Corporation|Genzyme Medical Information|617-252-7832|
105546|NCT00707759|FONDECYT|Maria Angela Delucchi|56-2-25755972|madelucchi@gmail.com
105547|NCT00707863|Indiana Uiniveristy|Amit Anand MD|3172747422|aanand@iupui.edu
105548|NCT00707915|Minami-hanno Hospital|Director of clinical trials|81.42.972.7111|haloperidol1mg@hotmail.com
105549|NCT00707954|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
105550|NCT00707967|GlaxoSmithKline|GSK Response Center|866-435-7343|
105551|NCT00707980|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
105552|NCT00707993|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
105553|NCT00715208|Millennium Pharmaceuticals|Carol Ann Satler, MD, PhD|617- 551-3729|carol.satler@mpi.com
105554|NCT00715299|VAHSRD and Medical University of South Carolina|Steve Kautz, PhD, Principal Investigator|843-792-3867|kautz@musc.edu
105555|NCT00715390|The Children's Hospital of Philadelphia|Ronald Litman, DO|215-590-5091|litmanr@email.chop.edu
105556|NCT00715403|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105557|NCT00715741|University of Utah|Harriet Hopf, MD|801-205-1013|Harriet.Hopf@hsc.utah.edu
105558|NCT00715754|University of Utah|Laurie Moyer-Mileur|801/587-7488|Laurie.Moyer-Mileur@hsc.utah.edu
105559|NCT00715793|University of Pittsburgh|Hussein Tawbi, MD, PhD|713-792-6111|HTawbi@mdanderson.org
105560|NCT00715884|Cordis|Amy Orlick, Associate Director Clinical Research|908-541-4347|AOrlick@its.jnj.com
105561|NCT00715910|GlaxoSmithKline|GSK Response Center|866-435-7343|
105562|NCT00715949|The Children's Hospital of Philadelphia|Michael L. Nance|215-590-5932|nance@email.chop.edu
105563|NCT00715962|Birmingham VAMC|Cynthia J. Brown, MD, MSPH|205-933-8101 ext 7300|cynthia.brownd44b2@va.gov
105564|NCT00716079|The George Institute for Global Health|Professor Craig Anderson|+612 9993 4521|canderson@georgeinstitute.org.au
105565|NCT00716092|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105566|NCT00716417|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105567|NCT00716443|Galderma Laboratories, L.P.|Ron W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com
105568|NCT00716456|Memorial Sloan Kettering Cancer Center|Dr. Gregory J. Riely|646-888-4199|rielyg@mskcc.org
105569|NCT00716482|SuperSonic Imagine|Research Coordinator|+33 442 99 24 24|sharon.bruce@supersonicimagine.fr
105570|NCT00716625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105571|NCT00716742|Allergan, Inc.|Vice President, Global Health Outcomes Strategy and Research|714-246-4500|clinicaltrials@allergan.com
105572|NCT00716807|UCSF|Jon Levine MD, PhD|415-476-5108|jon.levine@ucsf.edu
105574|NCT00716859|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105575|NCT00716963|McMaster University|Dr. Gail Gauvreau|905-525-9140 ext 22791|gauvreau@mcmaster.ca
105577|NCT00717041|University of Rochester|Manish N. Shah, MD MPH|585-275-1198|manish.shah@rochester.edu
105757|NCT00724061|Northwestern University|Dr. Timothy Kuzel|312-695-6180|cancertrials@northwestern.edu
105578|NCT00717054|Drexel University College of Medicine|Michael Green, DO|215-762-7798|michael.green@drexelmed.edu
105579|NCT00717067|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
105580|NCT00717093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105581|NCT00717197|University of Florida|Erin M. Dunbar, MD|(352) 273-9000|edunbar@neurosurgery.ufl.edu
105582|NCT00717236|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
105583|NCT00717249|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S. Principal Research Optometrist|904-443-3500 ext 1290|BPALL@its.jnj.com
105584|NCT00717275|University of Florida|Dr. Erin M. Dunbar|352-273-9000|edunbar@neurosurgery.ufl.edu
105585|NCT00717288|The Ohio State University|Kathleen Dungan, MD|614-292-3800|kathleen.dungan@osumc.edu
105586|NCT00717314|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
105587|NCT00717366|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
105588|NCT00717405|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
105589|NCT00717418|Allergan, Inc.|Vice President, GHOSR|714-246-4500|clinicaltrials@allergan.com
105590|NCT00717522|Celgene Corporation|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
105591|NCT00717574|Department of Anesthesia. OUHSC|Dr. Mehmet Ozcan, MD|405-271-4351|mehmet-ozcan@ouhsc.edu
105592|NCT00717756|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org
105593|NCT00717860|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105594|NCT00717873|Barnes Jewish Hospital|Darnetta Clinkscale|(314) 362-1276|MDB3455@bjc.org
105595|NCT00717886|Memorial Sloan Kettering Cancer Center|Dr. Leslie Montgomery|(212) 639-5386|Montgoml@mskcc.org
105596|NCT00717912|Biofortis|Doctor|0240205799|info@mxns.com
105597|NCT00717977|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D.|813-975-8690|rbeck@jaeb.org
105598|NCT00718042|Abbott Laboratories|Associate Director Clincal Affairs|847-937-8702|barbara.kaesdorf@abbott.com
105599|NCT00718081|AcelRx|Dr. Pamela Palmer|650-216-3500|ppalmer@acelrx.com
105600|NCT00718120|GlaxoSmithKline|GSK Response Center|866-435-7343|
105601|NCT00710866|British Columbia Centre for Disease Control|Danuta M Skowronski, MD|604-660-6067|danuta.skowronski@bccdc.ca
105602|NCT00710879|Bausch & Lomb Incorporated|Joseph Barr, OD, MS|(585) 338-6439|joseph.t.barr@bausch.com
105603|NCT00710905|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
105604|NCT00710931|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
105605|NCT00710944|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com
105606|NCT00710970|Baylor College of Medicine|Seth P. Lerner, M.D., F. A. C. S.|713-798-6841|slerner@bcm.edu
105607|NCT00710996|Alcon Research, Ltd.|Rick Potvin|817-551-4815|Rick.Potvin@alconlabs.com
105608|NCT00711009|Abbott|Global Medical Services|800-633-9110|
105609|NCT00711022|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com
105610|NCT00711087|Baylor College of Medicine|Christopher P. Smith, MD, MBA, MSS|713-798-7498|cps@bcm.edu
105611|NCT00711100|University_of_Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu
105612|NCT00711113|DENTSPLY Implants|Manager Global Clinical Operations|+46313763500|
105613|NCT00711191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105614|NCT00711347|Alcon Research, Ltd.|Erin Rogut|813-426-4036|Erin.Rogut@alconlabs.com
105615|NCT00711425|DENTSPLY Implants|Manager Global Clinical Operations|+46313763500|
105616|NCT00711464|University of California, Los Angeles|Michael Minzenberg, MD|(310) 825-7642|MMinzenberg@mednet.ucla.edu
105617|NCT00711477|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com
105618|NCT00711490|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyelec@nei.nih.gov
105619|NCT00711516|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855|
105620|NCT00711529|Stanford Hospital|Shannon MacLaughlan, MD|650-724-0456|smaclaug@stanford.edu
105621|NCT00711555|University of Illinois|Sandra Cuellar|312-996-6985|scuell1@uic.edu
105622|NCT00711594|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105623|NCT00711646|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
105624|NCT00711802|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660|
105625|NCT00711828|Mayo Clinic|Craig B. Reeder, M.D.||Reeder.Craig@mayo.edu
105626|NCT00711867|Mayo Clinic|Terrence L Trentman MD|480-301-8000|trentman.terrence@mayo.edu
105627|NCT00711880|GW Pharma Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com
105628|NCT00711958|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com
105629|NCT00711971|University of Michigan|Ellen Mozurkewich, Adjunct Assistant Professor|(734) 546-2772|emozurkewich@salud.unm.edu
105630|NCT00711997|BioCancell Ltd.|Monique Ben-Am, M.Sc.|+972-2-5486533|monique.ben-am@biocancell.com
105631|NCT00712010|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont|+41217858054|maurice.beaumont@rdls.nestle.com
105632|NCT00712075|VA San Diego Healthcare System, San Diego|Eric Granholm, PhD|858-552-8585 ext 7768|egranholm@ucsd.edu
105633|NCT00712166|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com
105634|NCT00712179|Ralph H Johnson VA Medical Center|Dr. Steven A Kautz|843-792-3867|kautz@musc.edu
105635|NCT00712244|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
105636|NCT00712335|Inje University|Dr. Chang-Keun Kim|82-2-950-8832|kimck@paik.ac.kr
105637|NCT00712348|Protalix Ltd.|VP Medical Affairs|+972-4-9028100|raul@protalix.com
105638|NCT00712530|Szent Laszlo Hospital, Budapest, Hungary|Dr. Denes Banhegyi|+3614558152|immunol@mail.datanet.hu
105639|NCT00712543|Cumberland Pharmaceuticals Inc.|Bryan Voss, Ph.D.|615-255-0068|bvoss@cumberlandpharma.com
105640|NCT00712673|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
105641|NCT00718237|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105642|NCT00718302|Boston Medical Center|Paul Tornetta, III, MD|617-414-6295|tornetta@bu.edu
105643|NCT00718315|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
105645|NCT00718770|University of Colorado School of Medicine|Joshua Klopper, MD|303-724-3921|joshua.klopper@ucdenver.edu
105646|NCT00718809|IndianaU|Dr. Patrick Loehrer|317-944-0920|ploehrer@iu.edu
105647|NCT00718861|Novartis Pharmaceuticals|Study Director|8627788300|
105648|NCT00718887|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
105649|NCT00719043|GlaxoSmithKline|GSK Response Center|866-435-7343|
105650|NCT00719134|Beth Israel Deacxoness Medical Center|Rami Burstein|617 735 2832|rburstei@bidmc.harvard.edu
105651|NCT00719160|Yale University|Karl L. Insogna, M.D.|203-737-2871|Karl.insogna@yale.edu
119298|NCT00274924|ECOG Statistical Office|Study Statistician|617-632-3012|
105653|NCT00719212|Translational Research In Oncology (formerly CIRG)|Matthieu Rupin|+33 (1) 58 10 08 89|matthieu.rupin@trioncology.org
105654|NCT00719264|Novartis Pharmaceuticals|Study Director|862-778-8300|
105655|NCT00719329|Johns Hopkins Bloomberg School of Public Health|Dr. Luke Mullany|410-502-2626|lmullany@jhsph.edu
105656|NCT00719355|University of Illinois at Chicago|Eileen G. Collins PhD, RN|312-413-5621|ecollins@uic.edu
105657|NCT00719472|Genentech, Inc.|Medical Communications|800-821-8590|
105658|NCT00719537|William Beaumont Hospital|John Uckele|2485510610|john.uckele@beaumont.edu
105659|NCT00719563|University of Michigan School of Nursing|Debra L. Barton, RN, PhD, AOCN, FAAN|734-763-3868|debbartn@umich.edu
105660|NCT00719615|University of Nebraska Medical Center|Whitney S Goldner, MD|402-559-6205|wgoldner@unmc.edu
105661|NCT00719680|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
105662|NCT00719706|McLean Hospital|Dr. Brian Brennan|617-855-2911|bbrennan@partners.org
105663|NCT00719732|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
105664|NCT00719810|Melinta Therapeutics|Eugene Sun, M.D.|203.624.5606|esun@melinta.com
105665|NCT00719849|Fred Hutchinson Cancer Research Center|Dr. Colleen Delaney|2066671385|cdelaney@fredhutch.org
105666|NCT00719862|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2351|WWheeler@medapharma.us
105667|NCT00719901|Mayo Clinic|A. Keith Stewart|480-301-4411|stewart.keith@mayo.edu
105668|NCT00719914|Brigham and Women's Hospital|C. Michael Gibson, MS, MD|617-632-7753|mgibson@perfuse.org
105669|NCT00719953|Sourazky Tel-Aviv Medical Center|Professor N. Vaisman|972-3-6974807|vaisman@tasmc.health.gov.il
105670|NCT00720057|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
105671|NCT00720083|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.com
105673|NCT00720109|Children's Oncology Group|Results Reporting Coordinator|626-241-1546|resultsreportingcoordinator@childrensoncologygroup.org
105674|NCT00720122|Massachusetts General Hospital|Madhusmita Misra, M.D., Associate Professor in Pediatrics, Assistant Pediatrician|617-724-5602|mmisra@partners.org
105675|NCT00720226|Johns Hopkins University School of Medicine|Robert A. Wise|410 550 0545|rwise@jhmi.edu
105676|NCT00720278|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us
105677|NCT00720330|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org
105678|NCT00720343|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu
105679|NCT00720369|McLean Hospital|Cara McCabe, BA|617-855-2410|cfmccabe@partners.org
105680|NCT00720382|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us
105681|NCT00720434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105682|NCT00720473|McLean Hospital|Dr. Brent Forester|(617) 855-3622|bforester@partners.org
105683|NCT00720499|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105684|NCT00720629|H. Lee Moffitt Cancer Center and Research Institute|Lia Perez, M.D.|813-745-7202|lia.perez@moffitt.org
105685|NCT00720759|VAHSRD|Stephen E. Nadeau|352-374-6082|stephen.nadeau@va.gov
105686|NCT00720798|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
105687|NCT00720941|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
105688|NCT00721110|Cleveland Clinic|Daniel Sessler, MD|216-444-4200|sesslerd@ccf.org
105689|NCT00721123|Hoffmann-La Roche|Medical Communications|800 821-8590|
105690|NCT00721136|Johns Hopkins Medical Institutions|Charles Henrikson, MD|503 494 7400|chenriks@jhmi.edu
105691|NCT00721149|Biosense Webster, Inc.|Diana Bordley, Director, Regulatory Affairs|800-729-9010 ext 8604|dbordley@its.jnj.com
105692|NCT00721162|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
105693|NCT00721175|Khon Kaen University|Assist. Prof. Apichat Sangchan|66850004651|apichaz@yahoo.com
105694|NCT00721188|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com
105695|NCT00715559|Mount Sinai School of Medicine|Dr. James Murrough|212-241-7574|james.murrough@mssm.edu
105696|NCT00715624|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
105697|NCT00715650|Yale University|Dr. Marc Rosen|203-932-5711 ext 2575|marc.rosen@yale.edu
105698|NCT00715676|Deltanoid Pharmaceuticals|Hector F. DeLuca, President and Chief Executive Officer|608-238-7710|info@deltanoid.com
105699|NCT00721214|Massey Cancer Center|John M. McCarty, MD|804-828-4360|jmccarty@vcu.edu
105700|NCT00721227|Ethicon Endo Surgery, Inc.|Amy Mahanes, Senior Clinical Research Associate|513-337-8366|amahanes@its.jnj.com
105701|NCT00721253|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
105702|NCT00721279|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105703|NCT00721357|Ralph H Johnson VAMC|Chris Gregory|(843)792-1078|Christopher.Gregory@va.gov
105704|NCT00721396|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
105706|NCT00721500|Vistakon|Kurt Moody OD FAOO / Director|904-443-3088|
105707|NCT00721539|Stanford|Edward Damrose, MD, associate professor|650-725-6500|edamrose@stanford.edu
105708|NCT00721630|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-5209|trainat@mskcc.org
105709|NCT00721734|Amgen, Inc.|Study Director|866-572-6436|
105710|NCT00721799|The University of Iowa Department of Radiology|Yusuf Menda, MD|319-356-3214|yusuf-menda@uiowa.edu
105711|NCT00721955|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|:jcassella@alexza.com
105712|NCT00721968|Glaukos|Jeff Wells. Sr VP, Clinical, Regulatory, and Quality Affairs|949-367-9600 ext 227|jwells@glaukos.com
105713|NCT00722020|Winthrop University|Jon Roberts, MD|516-663-4600|jroberts@winthrop.org
105714|NCT00722072|OHSU Knight Cancer Institute|Dr. Stephen Chui|503-494-8534|chuis@ohsu.edu
105715|NCT00722124|Mayo Clinic|Amit Sood, MD|507-266-1944|nicotineresearch@mayo.edu
105716|NCT00722137|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||clinicaltrialregistry@takeda.com
105717|NCT00722371|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105718|NCT00722423|VA San Diego Healthcare System|Dr. Samuel B. Ho|8586423280|Samuel.Ho2@va.gov
105719|NCT00722436|The Childrens Hospital of Pittsburgh of UPMC|Franklyn Cladis|412-692-5260|cladfp@upmc.edu
105720|NCT00722553|Allos Therapeutics, Inc.|Medical Monitor|303-426-6262|gweems@allos.com
105721|NCT00722566|Johnson & Johnson Pharmaceutical Research & Development|Helgi Van de Velde, M.D., Ph.D.||HVDVELDE@ITS.JNJ.COM
105722|NCT00722722|Mayo Clinic|Mark Stegall, MD|507-266-2812|Stegall.Mark@mayo.edu
105723|NCT00722761|MGH Curtis|Alexa B. Kimball|617-726-5066|harvardskinstudies@partners.org
105724|NCT00722800|MGH|Alexandra B. Kimball, MD|617-726-5066|harvardskinstudies@partners.org
105726|NCT00723008|U.S. Army Institute of Surgical Research|LTC. Elizabeth Mann-Salinas, PhD, RN,CCRN,CCNS|210-916-3527|Elizabeth.Mann@us.army.mil
105727|NCT00723021|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105728|NCT00723073|Brigham and Women's Hospital|David Kubiak, Principle Investigator|617-525-8417|dwkubiak@partners.org
105729|NCT00723125|BrUOG|William Sikov, MD|4018633000|kayla_rosati@brown.edu
105730|NCT00723177|NYSPI/Columbia University|Sandra Comer PhD|646 774-6146|SDC10@columbia.edu
105731|NCT00723190|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
105732|NCT00723203|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111 ext 65265|pfrankel@coh.org
105733|NCT00723229|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu
105735|NCT00723294|Weill Cornell Medicine|Rache M. Simmons, MD|(212) 821-0870|rms2002@med.cornell.edu
105736|NCT00723450|GlaxoSmithKline|GSK Response Center|866-435-7343|
105737|NCT00723489|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
105738|NCT00723528|Janssen Research & Development, LLC|Senior Director, Clinical Development|793-7633 ext 215|
105739|NCT00723554|Actelion Pharmaceuticals, US, Inc.|Wade Benton, PharmD/ Director, Medical Affairs Veletri and Ventavis|(650) 624-6900|wade.benton@actelion.com
105740|NCT00723580|Child Psychopharmacology Institute|Bill J. Duke, Ph.D.|701-241-9281 ext 2|bduke@ChildPsychopharmacologyInstitute.org
105741|NCT00723606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105742|NCT00723632|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105743|NCT00723645|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105744|NCT00723697|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com
105745|NCT00723710|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105746|NCT00723736|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105747|NCT00723749|RB Pharmaceuticals|Global Medical Director|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com
105748|NCT00723788|Children's National Health System|Pranav Vyas, MD|2024760186|PVyas@childrensnational.org
105749|NCT00723801|Brigham and Women's Hospital|Mark Creager|617-732-5267|mcreager@partners.org
105750|NCT00723827|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105751|NCT00723840|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105752|NCT00723892|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800--672-6372|ClinicalTrialsDisclosure@merck.com
105753|NCT00723931|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105754|NCT00723944|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com
105755|NCT00723957|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
105756|NCT00724009|The University of Chicago|Wendy Stock, MD|773-834-8982|wstock@medicine.bsd.uchicago.edu
105758|NCT00724126|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com
105759|NCT00724152|VA Connecticut Healthcare System|Dr. Caroline Schmidt, Co-investigator|203-932-5711 ext 3391|Caroline.Schmidt@va.gov
105760|NCT00718510|Department of Psychiatry, University of Alberta|Dr. Serdar Dursun|(780) 492-7319|dursun@ualberta.ca
105761|NCT00718523|Translational Research In Oncology (formerly CIRG)|Matthieu Rupin|+331 58 10 08 89|matthieu.rupin@trioncology.org
105762|NCT00718640|Janssen Inc., Canada|Director, Medical Affairs Oncology|416-382-5078|
105763|NCT00724243|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105764|NCT00724282|University of Chicago|Andrea Eiring|773-702-3657|aeiring@bsd.uchicago.edu
105765|NCT00724308|VA NY Harbor Healthcare System|Dr. Scott Sherman|212-686-7500 ext 7386|scott.sherman@va.gov
105766|NCT00724347|VANCHCS|David L. Woods, Ph.D.|925-372-2571|David.Woods@va.gov
105767|NCT00724373|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105768|NCT00724451|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105769|NCT00724464|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@Merck.com
105770|NCT00724477|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105771|NCT00727272|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
105772|NCT00727298|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@Merck.com
105773|NCT00727311|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclsoure@merck.com
105774|NCT00727337|Department of Veterans Affairs|Rachel McArdle|727-398-6661 ext 17479|Rachel.mcardle@va.gov
105775|NCT00727402|Case Western Reserve University Dept Ophthalmology & Visual Sciences|Loretta Szczotka-Flynn OD, PhD|216-844-3609|loretta.szczotka@uhhospitals.org
105776|NCT00727506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105777|NCT00727558|Vistakon|Kurt Moody OD, FAAO/ Director|904-443-3088|kmoody1@its.jnj.com
105778|NCT00727571|Amgen Inc.|Study Director|866-572-6436|
105779|NCT00727597|Georegtown University|Dr. Princy Kumar|2024440086|kumarp@georgetown.edu
105780|NCT00727636|Children's Hospital Boston|Dr. Athos Bousvaros|617-355-2962|athos.bousvaros@childrens.harvard.edu
105781|NCT00727649|Birmingham VA Medical Center|Dr. Alayne Markland, PI of this clinical trial|205-933-8101 ext 6365|alayne.markland@va.gov
105782|NCT00727714|Telemark Hospital|Dr. Anne Kristin M. Fell, MD, PhD|+4735003106|annfel@sthf.no
105783|NCT00727740|Yale University School of Medicine|Priya Jamidar, MD|203-785-6228|priya.jamidar@yale.edu
105784|NCT00727844|Tuberculosis Research Section, LCID, NIAID, NIH|Dr. Clifton Barry|301-451-9554|cbarry@niaid.nih.gov
105785|NCT00727857|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
105786|NCT00727909|VA TVHS|Gene W. Bratt, Ph.D.|615-873-6068|gene.bratt@va.gov
105787|NCT00727961|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105788|NCT00728130|Simmons Cancer Institute at Southern Illinois University School of Medicine|Director of Clinical Trials|217-545-1946|krobinson@siumed.edu
105789|NCT00728182|NoNO Inc.|Roberta Anderson, Vice President of Clinical Development|613 833-1020|randerson@nonoinc.ca
105790|NCT00728260|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com
105791|NCT00728416|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105792|NCT00728468|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105793|NCT00728481|Mayo Clinic|Dr. Amy Foxx-Orenstein, D.O., Associate Prof. of Medicine, College of Medicine|480-301-8806|foxx-orenstein.amy@mayo.edu
105794|NCT00728494|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105795|NCT00728507|Johns Hopkins University|Susan Dorman|410-955-1755|dsusan1@jhmi.edu
105796|NCT00728689|Siga Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com
105797|NCT00728728|VHA Durham|Christine E. Marx, MD|9192860411 ext 3626|christine.marx@va.gov
105798|NCT00728754|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com
105799|NCT00728845|Cancer Institute of New Jersey|Dr. Joseph Aisner|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
105800|NCT00728884|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com
105801|NCT00728910|University of Pennsylvania|Richard Dunbar MD|215-662-9024|richard.dunbar@uphs.upenn.edu
105802|NCT00728923|New York State Psychiatric Institute|Dr. Carolyn Rodriguez|212-543-5637|cr2163@columbia.edu
105803|NCT00728962|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com
105804|NCT00728988|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105805|NCT00729157|Memorial Sloan Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org
105806|NCT00729183|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105807|NCT00729248|Northwestern University|Lorenzo Gallon, MD - Study Principal Investigator|312-695-4457|l-gallon@northwestern.edu
105808|NCT00729326|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
105809|NCT00729365|Northwestern University Feinberg School of Medicine|Mark E. Molitch|312 503-4130|molitch@northwestern.edu
105810|NCT00729430|Brigham and Women's Hospital|Dr. Raymond Y. Kwong, Director of Cardiac Magnetic Resonance Imaging|857-307-1960|rykwong@partners.org
105811|NCT00729469|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
105812|NCT00729482|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr
105813|NCT00729521|Medical College of Wisconsin|Peter Layde, MD, MSc|414-955-8113|playde@mcw.edu
105814|NCT00729560|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu
105815|NCT00729612|The Ohio State University|Gregory Otterson, MD|614-293-2887|Greg.Otterson@osumc.edu
105816|NCT00729651|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105817|NCT00729677|Beth Israel Cancer Center|Victoria Rosenwald, RN MPH|212 844-8285|vrosenwa@chpnet.org
105818|NCT00729690|Rush University|Asokumar Buvanendran|(312) 942-3685|asokumar@aol.com
105819|NCT00721578|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105820|NCT00721617|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu
105821|NCT00729781|Medtronic Xomed, Inc.|David Hodge, Project Manager|(+1-904) 281-2774|david.l.hodge@medtronic.com
105822|NCT00729807|University of Maryland Greenebaum Cancer Center|Edward A. Sausville, M.D., Ph.D.|410-328-7394|esausville@umm.edu
105823|NCT00729833|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105824|NCT00729846|California Retina Consultants|Director of Research|8059631648 ext 3034|gabe@californiaretina.com
105825|NCT00729859|University of Washington|Stephanie T. Page, MD, PhD|206-616-0483|page@u.washington.edu
105826|NCT00729924|Vanderbilt University|David W. Haas, MD|615-936-8594|david.w.haas@vanderbilt.edu
105827|NCT00729937|Olive View-UCLA Medical Center|David A. Talan, MD|818-364-3107|dtalan@ucla.edu
105828|NCT00730015|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com
105829|NCT00730028|San Francisco General Hospital, UCSF|Henry F. Chambers, MD|(415) 206 - 5437|hchambers@medsfgh.ucsf.edu
105830|NCT00730041|Medtronic Xomed, Inc.|David Hodge|904-281-2774|david.l.hodge@medtronic.com
105831|NCT00730730|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com
105832|NCT00730756|GlaxoSmithKline|GSK Response Center|866-435-7343|
105833|NCT00730847|GlaxoSmithKline|GSK Response Center|866-435-7343|
105834|NCT00730912|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105835|NCT00730925|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105836|NCT00730964|GE Healthcare|Rubin Sheng, MD|1-609-514-6899|Rubin.Sheng@ge.com
105837|NCT00731042|3M Company|Chou Eyberg|651-737-0934|cieyberg1@mmm.com
105838|NCT00731055|New York State Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|amb107@columbia.edu
105839|NCT00731094|VA Pittsburgh Healthcare System|Kelly Hyman Burkitt, PhD|412-360-2202|Kelly.Burkitt@va.gov
105840|NCT00731120|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
105841|NCT00731133|UAMS|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu
105842|NCT00731198|Changhai Hospital, Second Military Medical University, Shanghai, China|Zhaoshen Li M.D.|86-21-81873271|zhaoshenlismmu@gmail.com
105843|NCT00731211|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
105844|NCT00731341|Galil Medical|Joy Benson, CRA|651-287-5112|joy.benson@galilmedical.com
105845|NCT00731484|TearLab, Inc.|Dr. Benjamin Sullivan|855-832-7522|bdsulliv@TearLab.com
105846|NCT00731549|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974|
105847|NCT00731614|San Francisco VA Medical Center|John R. McQuaid, Ph.D.|415-221-4810 ext 4106|john.mcquaid@va.gov
105848|NCT00731640|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
105849|NCT00731653|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@partners.org
105850|NCT00731666|Coloplast Corp|Clinical Trials Manager|612-302-4990|usdibe@coloplast.com
105851|NCT00731679|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com
105852|NCT00731692|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
119303|NCT00214019|UW Madison|Gina Crisafi|6082654554|gmc@medicine.wisc.edu
105854|NCT00731783|Washington University|Stephanie A. Fritz, M.D., M.S.C.I.|314-454-6050|fritz_s@kids.wustl.edu
105855|NCT00731822|GlaxoSmithKline|GSK Response Center|866-435-7343|
105856|NCT00731874|Weill Cornell Medical College/Division of Transplant Surgery|Dr. Meredith J Aull|(212) 746-0727|mea9008@med.cornell.edu
105857|NCT00731939|Coloplast Corp|Clinical Trial Manager|612-302-4990|usdibe@coloplast.com
105858|NCT00732030|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
105859|NCT00732069|Vanderbilt University|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu
105860|NCT00732160|Vanderbilt University Medical Center|James M. Luther|(615) 936-3420|James.Luther@Vanderbilt.edu
105861|NCT00732199|John D. Dingell VA Medical Center|Susmita Chowdhuri|313 576 1000 ext 3685|susmita.chowdhuri@va.gov
105862|NCT00732212|CURE Digestive Diseases Research Center|Dennis M. Jensen, M.D.|310-268-3569|djensen@mednet.ucla.edu
105863|NCT00732225|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
105864|NCT00732238|Michael E DeBakey VA Medical Center-Baylor College of Medicine|Rabih Darouiche|713-841-3882|rdarouiche@aol.com
105865|NCT00732303|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org
105866|NCT00732381|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105867|NCT00732472|GlaxoSmithKline|GSK Response Center|866-435-7343|
105868|NCT00732615|NPS Pharmaceuticals|Executive Director, Clinical Development|+1 908-450-5300|info@npsp.com
105869|NCT00732641|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105870|NCT00732654|Johns Hopkins University|Corinne Keet|4109555883|pediatricallergy@jhmi.edu
105871|NCT00732680|Mayo Clinic|Rizwan Siwani, MBBS|507-284-9155|siwani.rizwan@mayo.edu
105872|NCT00732758|Children's Hospital of Pittsburgh|Kumaravel Rajakumar|412-692-5822|rajakumark@upmc.edu
105873|NCT00732875|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105874|NCT00732901|Virginia Commonwealth University|F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu
105875|NCT00732940|GlaxoSmithKline|GSK Response Center|866-435-7343|
105876|NCT00732992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105877|NCT00733005|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105878|NCT00733096|Johns Hopkins School of Medicine|Steven P. Cohen|410-955-1822|scohen40@jhmi.edu
105879|NCT00733135|Covidien|Director of Medical Communications|763-591-3047|jean.ahlstrom@covidien.com
105880|NCT00724815|NuPathe Inc.|Mark Pierce, MD, PhD|484-567-0130|mpierce@nupathe.com
105881|NCT00724854|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105882|NCT00724867|GlaxoSmithKline|GSK Response Center|866-435-7343|
105883|NCT00724893|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105884|NCT00724932|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105885|NCT00724945|Vistakon|Thomas Karkkainen OD|904-443-3402|tkarkkai@its.jnj.com
105886|NCT00724958|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialDisclosure@merck.com
105887|NCT00724984|Pharmacyclics|Dr. Thorsten Graef|855-427-8846|pharmacyclics@medcomsol.com
105888|NCT00725010|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105889|NCT00725049|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com
105890|NCT00725075|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105891|NCT00725101|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
105892|NCT00725153|Alcon Research, Ltd.|Jessie Lemp, MS|817-615-2739|Jessie.Lemp@alconlabs.com
105893|NCT00725205|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105894|NCT00725270|Stanford University|Alan Schatzberg|650-723-8331|afschatz@stanford.edu
105895|NCT00725296|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105896|NCT00725361|StanfordU|Lorinda Chung|650-736-0727|shauwei@stanford.edu
105897|NCT00725452|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105898|NCT00725491|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105899|NCT00725504|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@pain.stanford.edu
105900|NCT00725530|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
105901|NCT00725543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105902|NCT00725608|RB Pharmaceuticals|Global Medical Director|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com
105903|NCT00725621|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105904|NCT00725712|GlaxoSmithKline|GSK Response Center|866-435-7343|
105905|NCT00725725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Develpment|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105906|NCT00725751|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105907|NCT00725842|Merck Sharp & Dohme|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105908|NCT00725920|Federal University of Sao Paulo|Marcelo F Mello|55 11 50822860|mf-mello@uol.com.br
105909|NCT00725985|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
105910|NCT00726037|Northwestern Medicine Regional Medical Group|Margret Shoup|630-352-5450|MSHOUP@lumc.edu
105911|NCT00726063|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com
105912|NCT00726180|Universtiy of Michigan|Anne F. Schott, MD|734-936-6000|aschott@umich.edu
105913|NCT00726232|Incyte Corporation|Albert Assad, MD|1-855-463-3463|aassad@incyte.com
105914|NCT00726375|University of Michigan Comprehensive Cancer Center|Dr. Sung Choi|734-615-5707|sungchoi@umich.edu
105915|NCT00726414|Mutual Phrmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
105916|NCT00726453|Medtronic Vascular|K. Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com
105917|NCT00726557|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105918|NCT00726609|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
105919|NCT00726622|Mayo Clinic|Tonia M. Young-Fadok, M.D.||youngfadok.tonia@mayo.edu
105920|NCT00726661|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
105921|NCT00726713|Pamlab Inc.|Page Young, Clinical Project Manager|985-867-5788|pyoung@pamlab.com
105922|NCT00726739|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu
105923|NCT00726752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105924|NCT00726830|University of Texas MD Anderson Cancer Center|Michael J. Fisch, MD, MPH, FACP||CR_Study_Registration@mdanderson.org
105925|NCT00726882|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
105926|NCT00726895|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
105927|NCT00726986|Case Comprehensive Cancer Center|Afshin Dowlati MD|216-844-1228|afshin.dowlati@uhhospitals.org
105928|NCT00726999|Medical College of Wisconsin|Lynn Rusy, MD|414-266-2555|lrusy@chw.org
105929|NCT00727025|Dartmouth-Hitchcock|Dr. Carolyn Kerrigan|603 650-5148|carolyn.l.kerrigan@hitchcock.org
105930|NCT00727064|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
105931|NCT00727090|Northwestern University|Andrew M Naidech|312-503-3592|a-naidech@northwestern.edu
105932|NCT00727194|Alexion Pharmaceuticals|Dr. Jing-Jing Wang|203-272-2596|wangJ@alxn.com
105933|NCT00727220|IndianaU|Linda A DiMeglio|317-944-3889|dimeglio@iu.edu
105934|NCT00727246|University of Pittsburgh|Patricia M Arenth PhD|412-648-6666|arenpm@upmc.edu
105935|NCT00727259|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105936|NCT00733226|Kecioren Education and Training Hospital|Cem Hasan RAZİ|090 312 3659000 ext 1139|cemrazi2@gmail.com
105937|NCT00733278|LA BioMed|Dr. Anita Nelson||anitanelsonwhc@earthlink.net
105938|NCT00733291|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
105939|NCT00733330|DePuy International|Kimberly Dwyer||kdwyer2@its.jnj.com
105940|NCT00733369|DePuy Ortho Joint US|Kimberly Dwyer, PhD, CCRA||kdwyer2@its.jnj.com
105941|NCT00733421|Foot & Ankle Surgical Centre|Jan Jakobsson PI, MD, PhD, Professor|46702500960|jan.jakobsson@ki.se
105942|NCT00733499|DePuy Ortho Joint US|Kimberly Dwyer, PhD, CCRA||kdwyer2@its.jnj.com
105943|NCT00733512|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
105944|NCT00733746|Alliance for Clinical Trials in Oncology|Peter Pisters, MD||ppisters@mdanderson.org
105945|NCT00733824|Washington University School of Medicine|Amanda F. Cashen, M.D.|314-454-8304|acashen@wustl.edu
105946|NCT00733954|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com
105947|NCT00733993|Virginia Commonwealth University|F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu
105948|NCT00734071|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
105949|NCT00734097|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
105950|NCT00734149|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|gaspa001@mc.duke.edu
105951|NCT00734162|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
105952|NCT00734214|McMaster University|Dr. Karen Choong|905-5212100 ext 75617|choongk@mcmaster.ca
105953|NCT00734305|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com
105954|NCT00734344|University of Alabama at Bimingham|Principal Investigator|996-2371|heaths@uab.edu
105955|NCT00734409|Duke University Health System|DaiWai M Olson, PhD RN|(919) 668-3751|Olson006@mc.duke.edu
105956|NCT00734474|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
105957|NCT00734500|Duke University|Michael Cohen-Wolkowiez|9196688812|michael.cohenwolkowiez@duke.edu
105959|NCT00734578|Shire Pharmaceutical|Timothy Whitaker, MD||twhitaker@shire.com
105960|NCT00734591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105961|NCT00734604|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
105962|NCT00734617|Duke Center for Nicotine & Smoking Cessation Research|Jed E. Rose, Ph.D.|919 668-5093|rose0003@mc.duke.edu
105963|NCT00734630|Forest Laboratories, Inc.|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|2014278000 ext 2133|noah.rosenberg@frx.com
105964|NCT00734656|University of Connecticut Health Center|Jonathan Covault|860-679-7560|jocovault@uchc.edu
105965|NCT00734734|Novartis Vaccines and Diagnostics S.r.l|Posting Director||RegistryContactVaccinesUS@novartis.com
105966|NCT00734747|Medigus Ltd|Aviel Roy-Shapira, MD|+972 8646 6880|avrish@gmail.com
105967|NCT00734799|Durham VAMC|Christi S. Ulmer, PhD|9192860411 ext 4044|christi.ulmer@va.gov
105968|NCT00734851|DukeUMC|Andrew J. Armstrong, MD ScM FACP|(919) 668-8797|andrew.armstrong@duke.edu
105969|NCT00734929|Duke University Medical Center|Dr. Ashraf Habib|9196686265|habib001@mc.duke.edu
105970|NCT00734968|University of Missouri|Daniel Jackson MD|573 499 6041|jacksondl@health.missouri.edu
105971|NCT00734994|Duke University, Division of Urology|Brant A. Inman, MD, MS|919 684-1322|brant.inman@duke.edu
105972|NCT00735007|Merck Serono International, S.A., an affiliate of Merck KGaA, Darmstadt, Germany|Elisabetta Verdun di Cantogno|+41 22 414 4887|elisabetta.verdun@merckserono.net
105973|NCT00735072|UCaliforniaSF|Peter W. Hunt, MD|(415) 476-4082 ext 345|phunt@php.ucsf.edu
105974|NCT00735306|Duke University|Dr. Brian Czito|919-668-7336|brian.czito@duke.edu
105975|NCT00735371|Shire Pharmaceuticals|Timothy Whitaker, MD||twhitaker@shire.com
105976|NCT00735397|Eisai Inc.|Eisai Call Center|888-422-4743|
105977|NCT00735436|Duke University Medical Center|Annick Desjardins, MD, FRCPC||annick.desjardins@dm.duke.edu
105978|NCT00735449|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com
105979|NCT00735462|Graceway Pharmaceuticals|Robert Babilon, Vice President, Product Development|267-948-0400 ext 20428|robert.babilon@gracewaypharma.com
105981|NCT00735553|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com
105982|NCT00735618|UT MD Anderson Cancer Center|Ying Guo, MD, MS/Associate Professor||jaallo@mdanderson.org
105983|NCT00735644|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
105984|NCT00735670|University of Michigan Spinal Cord Injury System|Dr. Denise G Tate|734 763-0971|dgtate@umich.edu
105985|NCT00735696|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
105986|NCT00735709|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
105987|NCT00735787|Abbott Laboratories|Global Medical Services|1-800-633-9110|
105988|NCT00735839|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
105989|NCT00735904|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105990|NCT00735917|University of Colorado Cancer Center|Wells A. Messersmith, M.D.||wells.messersmith@ucdenver.edu
105991|NCT00735943|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106048|NCT00739934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
105992|NCT00735969|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|High Dose Ribavirin in Combination With Peginterferon for Patients With Chronic Hepatitis C Genotype|(301) 402-5115|mg228m@nih.gov
105993|NCT00736034|Sourazky Tel-Aviv Medical Center|Dr. V. Vakhapova|972-3-6973698|vedanicek@gmail.com
105994|NCT00736073|DUMC|Dr. Martin Poleski|9196841817|martin.poleski@dm.duke.edu
105995|NCT00736099|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
105996|NCT00736125|Duke University Medical Center|Dr. Terri Monk|919-286-6938|terri.monk@duke.edu
105997|NCT00724568|University of Michigan Comprehensive Cancer Center|Dr. Moshe Talpaz|734-764-8195|mtalpaz@umich.edu
105998|NCT00724594|Medical University of South Carolina|Dr. Dorothea Jenkins|843-792-4341|jenkd@musc.edu
105999|NCT00724698|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com
106000|NCT00724711|Gilead Sciences|Dara Wambach, MA, Associate Director, Regulatory Affairs|650 522 5163|Dara.Wambach@gilead.com
106001|NCT00724750|University of Chicago|Lawrence Gottlieb|(773) 702-6302|lgottlie@surgery.bsd.uchicago.edu
106002|NCT00730132|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106003|NCT00730236|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867|msumeray@aegerion.com
106004|NCT00730275|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106005|NCT00730327|Apollo Endosurgery|Laura Eaton, Study Director, RN, BSN, CCRN-R,|949-468-9301|laura.eaton@apolloendo.com
106006|NCT00730353|Hoosier Oncology Group|Nasser Hanna, M.D.|317-274-3515|nhanna@iupui.edu
106007|NCT00730483|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu
106009|NCT00730691|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
106010|NCT00736190|Gilead Sciences, Inc.|Eduardo Bruno Martins, MD, DPhil, Sr. Director, Medical Affairs - Hepatitis|650-522-5792|eduardo.martins@gilead.com
106011|NCT00736229|Saint Luke's Health System|Steven P. Marso, MD|816-932-5773|smarso@saint-lukes.org
106012|NCT00736242|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106013|NCT00736255|DukeUMC|Scott Kollins, PhD|9196810014|kolli001@mc.duke.edu
106014|NCT00736333|Merck Sharp & Dohme Corp.|Senior Vice President, Global Cllinical Development||ClinicalTrialsDisclosure@merck.com
106015|NCT00736385|Duke University Medical Center|Christopher Kigongo|919-668-6579|christopher.kigongo@duke.edu
106016|NCT00736476|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
106017|NCT00736489|AstraZeneca|Carin Jorup, MSD||ClinicalTrialTransparency@astrazeneca.com
106018|NCT00736502|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
106019|NCT00738023|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu
106020|NCT00738049|University of Texas Medical School at Houston|K. Lance Gould, MD|713-500-6611|K.Lance.Gould@uth.tmc.edu
106021|NCT00738062|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com
106022|NCT00738283|Baylor College of Medicine|Steven A. Abrams, MD|713-798-7164|sabrams@bcm.edu
106023|NCT00738361|Ohio State University Comprehensive Cancer Center|Thomas Olencki, D.O.|614-293-2886|Thomas.Olencki@osumc.edu
106024|NCT00738374|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
106025|NCT00738400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
106026|NCT00738426|Cosmetic Surgery|Dr. Robert F. Jackson|765-662-8303|rjlipodr@comteck.com
106027|NCT00738530|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
106028|NCT00738543|University of Guanajuato|Alejandro Macias|52 477 7145859 ext 400|aaeemmhh@yahoo.com
106029|NCT00738673|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
106030|NCT00738699|Eisai Inc.|Eisai Medical Services|1-888-422-4743|
106031|NCT00738881|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D|507/538-1760|alex.adjei@roswellpark.org
106033|NCT00739024|Swedish Headache Center|Pat Barrodale, RN|206-215-3502|pat.barrodale@swedish.org
106034|NCT00739050|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106035|NCT00739063|UT MD Anderson Cancer Center|Ana Gonzalez-Angulo, MD, MS / Associate Professor||CR_Study_Registration@mdanderson.org
106036|NCT00739102|Cordis Corporation, a Johnson & Johnson company|Patricia Schleckser, Director Medical Affairs|908-541-4564|pschleck@its.jnj.com
106037|NCT00739297|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106038|NCT00739310|Maimonides, Department of Pulmonary Medicine|Kathryn Fitzgerald, NP|718-283-7339|kfitzgerald@maimonidesmed.org
106039|NCT00739336|SUNY Upstate Medical University|Clinical Trials Officer|315-464-5476|Rudesj@upstate.edu
106040|NCT00739583|Johns Hopkins University|Simon C Mears|410-550-0101|smears1@jhmi.edu
106041|NCT00739596|Novartis Pharmaceuticals|Study Director|862-778-8300|
106042|NCT00739648|Rempex Pharmaceuticals|Jeff Loutit, MD; Chief Medical Officer|858.875.6665|jloutit@rempexpharma.com
106043|NCT00739661|Genentech, Inc|Medical Communications|800-821-8590|
106044|NCT00739674|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
106045|NCT00739765|New York State Psychiatric Institute|John C. Markowitz, M.D.|646 774-8098|jcm42@cumc.columbia.edu
106046|NCT00739882|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49 6151 72 5200|service@merckgroup.com
106047|NCT00739908|CeNeRx BioPharma Inc.|Mahnaz Asgharnejad, Pharm.D.; Daniel Burch, M.D.|(919) 655 1435; (919) 674 6041|masgharnejad@cenerx.com; danburch@cenerx.com
106049|NCT00739973|Novartis Pharmaceuticals|Study Director|862 778-8300|
106050|NCT00739999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
106051|NCT00740051|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
106052|NCT00740181|Brown Univeristy Oncology Research Group|James Butera|401-863-3000|Kayla_Rosati@brown.edu
106053|NCT00740207|Bracco Diagnostics Inc.|Usha Halemane|609-514-2578|usha.halemane@diag.bracco.com
106055|NCT00740480|ENTrigue Surgical, Inc.|Gabriele Niederauer, PhD|210-298-6398 ext 6336|gabi.niederauer@entriguesurgical.com
106056|NCT00740584|Starpharma Pty Ltd|Clinical Development Manger|+61 3 9532 2700|clare.price@starpharma.com
106057|NCT00740597|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111 ext 65265|pfrankel@coh.org
106058|NCT00740636|Memorial Sloan Kettering Cancer Center|Dr. Maria C. Pietanza|646-888-4203|PietanzM@mskcc.org
106059|NCT00740714|Weill Medical College of Cornell University|M. Flint Beal, MD|212-746-6575|fbeal@med.cornell.edu
106060|NCT00740727|Massachusetts General Hospital|Stephen H. Thomas MD MPH|6177267622|stephen-thomas@ouhsc.edu
106061|NCT00740779|Watson Pharmaceuticals|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com
106062|NCT00740792|Meda Pharmaceuticals|David Ginsberg,D.O.|7325642364|david.ginsberg@meda.us
106063|NCT00740831|PregLem SA|Dr Elke Bestel|+41 22 884 03 40|medical@preglem.com
106064|NCT00740857|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
119307|NCT00143507|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com
106066|NCT00741013|Washington University School of Medicine|Delphine L. Chen|314-362-7029|chend@mir.wustl.edu
106067|NCT00741026|American Medical Association|Vance L. Albaugh, Principle Investigator|(800) 243-1455|vance.l.albaugh@vanderbilt.edu
106068|NCT00741039|Memorial Sloan Kettering Cancer Center|Dr. Susan Seo|212-639-3151|seos@mskcc.org
106069|NCT00741091|Boston Scientific Corporation|Todd Kornmann, Specialist, Prin Reg Affairs|763-494-1348|Todd.Kornmann@bsci.com
106070|NCT00741104|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106071|NCT00741156|The Hospital for Sick Children|Dr. Kyong-Jin Lee|416-813-7326|kyong-jin.lee@sickkids.ca
106072|NCT00741273|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com
106073|NCT00741286|Department of Neurology, Sanggye Paik Hospital, Inje University College of Medicine|Sang Won Han|82-2-950-8864|swhan@paik.ac.kr
106074|NCT00741338|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
106075|NCT00741390|Becton Dickinson|Kenneth Kassler-Taub, VP Medical Affairs|201-847-7009|kenneth_kassler_taub@bd.com
106076|NCT00741468|Repros Therapeutics Inc.|Jennifer Wike|281-719-3402|jwike@reprosrx.com
106077|NCT00741598|Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai|Dr. Dan V. Iosifescu|212-241-4480|dan.iosifescu@mssm.edu
106078|NCT00741611|CR Bard|Anne Marie Harcarik|908-277-8051|annemarie.harcarik@crbard.com
106079|NCT00741819|United Therpaeutics Corporation|Inhaled Treprostinil Program Head|919-485-8350|clinicalrecordsmanagment@unither.com
106080|NCT00741858|university of illinois at chicago|k.v. slavin|312-996-4842|kslavin@uic.edu
106081|NCT00741936|Hong Kong Baptist University|Prof. Zhao-xiang Bian|(852) 3411 2905|bzxiang@hkbu.edu.hk
106082|NCT00741988|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
106083|NCT00742053|C.R. Bard|Christopher DiMatteo/Clinical Scineces Manager|801-522-5487|chris.dimatteo@crbard.com
106084|NCT00742079|Massachusetts General Hospital|Jennifer Gottlieb, PhD|617-912-7800|jgottlieb2@partners.org
106085|NCT00742170|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu
106087|NCT00742209|XenoPort, Inc.|XenoPort Call Center|877-936-6778|
106088|NCT00742235|Massachusetts General Hospital|Principal Investigator|617-726-3934|ibhan@partners.org
106089|NCT00742274|W.L. Gore and Associates|Jennifer Gorman|928-864-3381|jgorman@wlgore.com
106090|NCT00742313|Duke University Medical Center|Terry Ainsworth, Director, Clinical Research Operations, Education & Training|919-681-7084|terry.ainsworth@duke.edu
106091|NCT00742326|NIAID|Colleen Hadigan MD MPH|301-594-5754|hadiganc@niaid.nih.gov
106092|NCT00742391|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com
106093|NCT00742417|Instituto Grifols S.A.|Mireia Torres|+34935710500 ext 12273|mireia.torres@grifols.com
106094|NCT00742508|GlaxoSmithKline|GSK Response Center|866-435-7343|
106095|NCT00742625|Massachusetts General Hospital Cancer Center|Eyal Attar, MD|617-724-1124|eattar@partners.org
106096|NCT00742781|Pennsylvania State University|Dr. Margherita Cantorna|814-863-2819|mxc69@psu.edu
106098|NCT00742872|American University of Beirut Medical Center|Dr. Ala Sharara|+961-3-350000|as08@aub.edu.lb
106099|NCT00742885|GlaxoSmithKline|GSK Response Center|866-435-7343|
106100|NCT00742924|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org
119309|NCT00110149|BIDMC|Robin Joyce, MD|617-667-9920|rjoyce@bidmc.harvard.edu
106102|NCT00743093|Denver Heatlh Rocky Mountain Poison and Drug Center|Jody Green, PhD|303-389-1246|jody.green@rmpdc.org
106104|NCT00743197|Northwestern University|Dr. Martha Gulati, Principal Investigator|312-695-4965|mgulati@nmh.org
106105|NCT00736580|West Virginia University|Michael Stitely, MD|304-293-1566|mstitely@hsc.wvu.edu
106106|NCT00736723|University|Prof. Dr. Manfred Weiss|#49 731 500 60226|manfred.weiss@uni-ulm.de
106107|NCT00736840|Exalenz Bioscience|Clinical Trial Manager|972-8-9737500 ext 513|avrahamh@exalenz.com
106108|NCT00736853|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K.|Medical Director|+81-3-4411-5509|
106109|NCT00736879|Clinical Trial Transparency|AstraZeneca||Clinical.Trial.Transparency@astrazeneca.com
106110|NCT00736944|Washington University School of Medicine|Dr. Douglas R. Adkins|314-362-5654|dadkins@dom.wustl.edu
106111|NCT00736957|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K. 5-2, Nishi-kanda 3-chome, Cyiyoda-ku, Tokyo 101-0065 JAPAN|Medical Director|+81-3-4411-5509|
106112|NCT00736996|University of Colorado|Robert S. Schwartz, M.D.|303-724-1919|robert.schwartz@ucdenver.edu
106113|NCT00737048|JANSSEN PHARMACEUTICAL. K.K. , Neuroscience Department, Clinical Science Division|Medical Director|+81-3-4411-5509|
106114|NCT00737061|Hologic, Inc.|Edward Evantash, MD, Medical Director, Vice President Medical Affairs|508-263-8475|edward.evantash@hologic.com
106115|NCT00737100|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
106116|NCT00737178|Columbia University|Anne Davis, MD|2123054951|ard4@columbia.edu
106117|NCT00737204|New York State Psychiatric Institute|Judith G. Rabkin, Ph.D., M.P.H.|(646) 774-8075|jgr1@columbia.edu
106118|NCT00737243|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
106119|NCT00737282|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com
106120|NCT00737360|The University of Texas M.D, Anderson Cancer Center|Dr. Anne Tsao, Principal Investigator|713-792-6363|
106121|NCT00737438|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org
106123|NCT00737477|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
106125|NCT00737568|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
106126|NCT00737594|Sucampo Pharmaceuticals, LLC|VP, Clinical Development|301-961-3400|info@sucampo.com
106127|NCT00737633|Vivus, Inc|Wesley W Day, PhD|650-934-5200|day@vivus.com
119310|NCT00095979|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
106129|NCT00737711|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
106130|NCT00737737|National Institutes of Health Clinical Center|Andrew Mannes, M.D.|301-594-3427|Andrew.Mannes@nih.gov
106131|NCT00743249|Alcon Research, Ltd.|Theresa A. Landry, Ph.D.|1-888-451-3937|alcon.medinfo@alcon.com
106132|NCT00743262|Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5252550|f.hilgers@nki.nl
106133|NCT00743275|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
106134|NCT00743288|Oncotherapeutics|Director, Clinical Operations|323-623-1200|lthulin@oncotherapeutics.com
106135|NCT00743366|New York State Psychiatric Institute|Dr. Ziva Cooper|646-774-6129|reslabsurc@gmail.com
106136|NCT00743431|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106137|NCT00743444|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
106138|NCT00743483|Swedish Orphan Biovitrum|Maria Öhman, TA Clinical Head Neonatology|+46 70 694 81 61|maria.ohman@sobi.com
106139|NCT00743509|University of Michigan|Scott Schuetze|734-647-8925|scotschu@umich.edu
106140|NCT00744653|Copenhagen University Hospital Herlev|MD Louise Wichmann Matthiessen|+ 45 38 68 98 58|louise.wichmann.matthiessen@gmail.com
106141|NCT00744692|Duke University Medical Center|Dr. Suhag Parikh|919-668-1100|suhag.parikh@dm.duke.edu
106142|NCT00744757|Medical Affairs, Janssen Taiwan|Medical Director|+886-2-23761255|
106143|NCT00744848|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com
106144|NCT00744874|Medtronic AF Solutions|Linda Nelson, RN, BSN, MBA- AF Solutions Clinical Operations Director|(763)526-2891|linda.k.nelson@medtronic.com
106145|NCT00744939|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
106146|NCT00744978|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106147|NCT00745030|Northwestern University|Angelica Marconi|312-503-1999|a-marconi@northwestern.edu
106148|NCT00745095|JJPVAMC National Center of Excellence for the Medical Consequeunces of Spinal Cord Injury|Dr. Mark A. Korsten, Chief of Gastroenterology|718-584-9000 ext 6753|mark.korsten@va.gov
106149|NCT00745251|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com
106150|NCT00745290|Pacira Pharmaceuticals Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com
106151|NCT00745368|University of Rochester|Robert DiCenzo|518 694 7228|rob.dicenzo@acphs.edu
106152|NCT00745498|Seoul National University Bundang Hospital Department of Ophthalmology|Dr. Se Joon Woo|+82-31-787-7377|sejoon1@hanmail.net
106154|NCT00745875|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
106155|NCT00745901|North America Pharmaceutical (Ortho-McNeil Janssen Scientific Affairs, LLC)|Chief Scientific Officer|1-888-526-5060 ext 2915|
106156|NCT00745940|Lakehead University|Dr. Michel Bédard|807-343-8630|mbedard@lakeheadu.ca
106157|NCT00746096|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp
106158|NCT00746187|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com
106159|NCT00746239|Penn State Hershey Medical Center|Ravi Singareddy|717-531-0040|rsingare@gmail.com
106160|NCT00746330|Novartis Pharmaceuticals|Study Director|862-778-8300|
106161|NCT00746356|St. Jude Medical|Ashish Oza, Clinical Studies Director|818 362 6822 ext 3648|aoza@sjm.com
106162|NCT00746395|University of South Alabama|Jack A. DiPalma, M.D.|251-660-5555|jdipalma@usouthal.edu
106163|NCT00746421|Emory University|Jeffrey Rakofsky, MD|404-712-5083|jrakofs@emory.edu
106164|NCT00746512|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106224|NCT00744042|Alexion Pharma GmbH|Alexion Pharma GmbH||ClinicalTrials@alxn.com
106165|NCT00746551|Mahidol University, Department of Obstetrics and Gynaecology, Division of Maternal Fetal Medicine, Faculty of Medicine, Siriraj Hospital|Pharuhas Chanprapaph|+66819920053|pharuhasc@gmail.com
106166|NCT00746564|St. Jude Medical|Director, Clinical Studies|1-800-733-3455|tshipman@sjm.com
106167|NCT00746590|BTG International Ltd.|Claire Daugherty|+1 801 556 8882|claire.daugherty@btgplc.com
106168|NCT00746668|Jesse Brown VAMC|Dr. Janet P. Szlyk, PhD|312-997-3644|Janet.Szlyk@va.gov
106169|NCT00746694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106170|NCT00746733|Shire Pharmaceuticals|Gerald Tremblay, M.D.||gtremblay@shire.com
106171|NCT00746785|The Mind Reseach Network|Kent Hutchison, Ph.D.|505-272-5028|khutchison@mrn.org
106172|NCT00746798|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
106173|NCT00746863|UNC Hospitals|Gena Dunivan, MD|919-966-4717|gdunivan@med.unc.edu
106174|NCT00746889|UCSD|Jeannie Chao|858-657-7040|j5chao@ucsd.edu
106175|NCT00746941|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com
106176|NCT00746954|Louis Stokes DVA Medical Center|Kingman P. Strohl MD|216-7913800|kingman.strohl@va.gov
106177|NCT00747006|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com
106178|NCT00747149|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
106179|NCT00747214|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com
106180|NCT00747227|Abbott medical Optics, Inc.|Nicholas Taranatino, O.D., Head, Global Clinical Research & Devlopment|866-427-8477 ext 8613|nicholas.tarantino@amo.abbott.com
106181|NCT00747344|Janssen Research & Development, LLC|Director, Clinical Research|215-793-7646|
106182|NCT00747435|MED-EL Corporation|Sr. Clinical Research Associate||clinicaltrials@medelus.com
106183|NCT00747461|CSA Medical|Ann Murphy Legg, Director of Clinical Research|781-538-4732|alegg@csamedical.com
106184|NCT00747474|Taiwan Liposome Company, Ltd.|Shu Chi Hsu|650-872-8816 ext 102|shuchi@tlcbio.com
106185|NCT00747552|University of Utah|Donald Null M.D.|801.588-3865|donald.null@imail.org
106186|NCT00747565|Abbott Medical Optics, Inc.|Nicholas Tarantino, O.D., Head, Global Clinical Research & Development|866-427-8477 ext 8613|nicholas.tarantino@amo.abbott.com
106187|NCT00747617|UCSD School of Medicine|R. Jeffrey Chang, M.D.|858-534-8930|rjchang@ucsd.edu
106188|NCT00747643|H. Lee Moffitt Cancer Center and Research Institute|Thomas H. Brandon, Ph.D.|813-745-1750|thomas.brandon@moffitt.org
106189|NCT00747747|Galsor s.r.l.|Dr. Sandro Soriano/Director of Clinical Trials|0039 0827 601723|sandro.soriano@galsor.it
106190|NCT00747812|Boston Scientific|Lyn Pimentel, Clinical Project Manager|(661) 949-4174|Lyn.Pimentel@bsci.com
106191|NCT00747916|Titus Regional Medical Center|Dr. Gordon Downie|903-572-9050|downieg@trhta.net
106192|NCT00748072|University of Bari|Dr. Carlo Manno|390805478878|c.manno@nephro.uniba.it
106193|NCT00748085|CSA Medical|Ann Murphy Legg, Director of Clinical Research|781-538-4732|alegg@csamedical.com
106194|NCT00748098|XenoPort, Inc.|XenoPort Call Center|877-936-6778|
106195|NCT00748189|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
106196|NCT00748241|Astra Tech AB|Head of Clinical Research Area Dental|+46317763000|
106197|NCT00748553|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu
106198|NCT00748566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106199|NCT00748579|Cytokinetics, Inc.|Medical Director|(650) 624-3011|
106200|NCT00748657|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
106201|NCT00748709|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
106202|NCT00748826|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106203|NCT00748865|Alcon Research Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
106204|NCT00748956|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-659-9145|adriana.feder@mssm.edu
106206|NCT00748982|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
106207|NCT00749073|Vertos Medical|VP Clinical, Regulatory, Quality|9493490008 ext 216|cmyers@vertosmed.com
106208|NCT00749190|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
106209|NCT00749268|Covidien|Jessica Carlson, Clinical Project Manager|(203) 821-4734|jessica.carlson@covidien.com
106210|NCT00749398|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106211|NCT00749463|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com
106212|NCT00749476|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
106213|NCT00749580|USF Health|Charurut Somboonwit, MD|813 3078067|csomboon@health.usf.edu
106214|NCT00749671|Baystate|James R. Cook MD|413-794-4492|james.cook@bhs.org
106215|NCT00749684|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com
106216|NCT00749775|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106217|NCT00749931|Dune Medical Devices|Clinical Research Manager|+97246178000|shiri@dunemedical.com
106218|NCT00749944|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106220|NCT00743574|Yale University|Dr. Lubna Pal|203-737-5619|lubna.pal@yale.edu
106221|NCT00743652|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106222|NCT00743717|Los Alamitos Orthopaedic Group|Dr. Perry Secor|805-384-2748|vsarin@kinamed.com
106225|NCT00744055|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|2039325711 ext 4282|elizabeth.ralevski@yale.edu
106226|NCT00744237|Forest Laboratories, Inc|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|2014278000 ext 2133|noah.rosenberg@frx.com
106227|NCT00744263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106228|NCT00744328|Northwestern University|Research Study Coordinator|312-695-8441|emily.pinheiro@northwestern.edu
106229|NCT00744380|University of Colorado|Robert MacLaren|303 724-2622|rob.maclaren@ucdenver.edu
106230|NCT00744497|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
106231|NCT00744523|Medtronic Aortic and Peripheral Vascular|Arslan Malik, Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com
106232|NCT00744627|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
106233|NCT00749996|Medtronic Spinal & Biologics|Irène Ayer, Clinical research specialist|+41 21 803 84 27|irene.ayer@medtronic.com
106234|NCT00750061|China Spinal Cord Injury Network|Dr. Wendy Cheng|+852 28660829|wendycheng@chinasci.net
106235|NCT00750139|Merz Pharmaceuticals, LLC|Associate Medical Director- Dermatology|800-334-0514|
106236|NCT00750152|Merz Pharmaceuticals, LLC|Merz Pharmaceuticals, LLC|800-334-0514|
106237|NCT00750191|The Center for Clinical Research|Dr. Leonard Kapural|1-336-765-6181|LKapural@ccrpain.com
106238|NCT00750204|Johns Hopkins University School of Medicine|Roy Brower, M.D.|1 (410) 614-6292|rbrower@jhmi.edu
106239|NCT00750269|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
106240|NCT00750282|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com
106241|NCT00750308|Vanderbilt University|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu
106242|NCT00751114|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com
106243|NCT00751140|H. Lee Moffitt Cancer Center and Research Institute|Philippe E. Spiess, M.D.|813-745-8343|philippe.spies@moffitt.org
106244|NCT00751179|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106245|NCT00751296|University Health Network - Princess Margaret Cancer Centre|Dr. Christine Chen|416-946-2827|Christine.Chen@uhn.ca
106246|NCT00751348|GlaxoSmithKline|GSK Response Center|866-435-7343|
106247|NCT00751400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
106248|NCT00751530|Community Research Initiative|Project Manager|617 502 1700|pmacht@crine.org
106249|NCT00751621|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
106250|NCT00751634|Northwestern University|Dr. Andrew Naidech|312-503-3335|a-naidech@northwestern.edu
106251|NCT00751777|Valneva Austria GmbH|Head Clinical Development|0043120620 ext 0|info@valneva.com
106252|NCT00751790|Debiopharm S.A.|Eija Lundström|+41 21 3210111|elundstrom@debiopharm.com
106253|NCT00751881|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
106254|NCT00751933|Haukeland University Hospital|Gunnar Nysæter or Solomon Tefera or Jan Hatlebakk|+47 55972900|jhat@helse-bergen.no
106255|NCT00751972|HeartWare Inc|Director Clinical Project Management|508 739-0867|sbell@heartwareinc.com
106256|NCT00751998|Boston Scientific Corporation|Joyce Peetermans, PhD, Director Endoscopy Clinical|508-683-4211|peetermj@bsci.com
106258|NCT00752128|Medtronic Bakken Research Center B.V.|Marianne Wanten|+3143356 ext 6815|marianne.wanten@medtronic.com
106259|NCT00752232|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106260|NCT00752609|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
106261|NCT00752622|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106262|NCT00752726|GlaxoSmithKline|GSK Response Center|866-435-7343|
106263|NCT00752791|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
106264|NCT00752895|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu
106265|NCT00752973|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914 345 9001|natalie.yantovskiy@taro.com
106266|NCT00752986|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
106267|NCT00753012|Massachusetts General Hospital|Dr. Paul Hammerness|(503)617-1040|phammerness@partners.org
106268|NCT00753142|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu
106269|NCT00753220|Prostate Institute of America|Dr. Duke K. Bahn|888-234-0004|DKBahn@CMHhospital.org
106270|NCT00753272|GlaxoSmithKline|GSK Response Center|866-435-7343|
106271|NCT00753298|Astra Tech AB|Head of Therapeutic Area Health Care|+46317763000|
106272|NCT00753337|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com
106274|NCT00753415|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106275|NCT00753454|UCB Clinical Trial Call Center|UCB (Study Director)|1-887-822-9493|
106276|NCT00753506|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org
106277|NCT00753519|Department of Neurology, Centre Hospitalier Universitaire Vaudois|David H. Benninger, MD||David.Benninger@chuv.ch
121230|NCT02252146|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com
106279|NCT00753623|MGH Center for Translational Pain Research|Dr. Jianren Mao|617-724-6102|mghpainresearch@partners.org
106280|NCT00753636|Northwestern University|Dr. Tanya Simuni, MD|312-503-2970|tsimuni@nmff.org
106281|NCT00753649|GlaxoSmithKline|GSK Response Center|866-435-7343|
106282|NCT00753675|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
106283|NCT00753688|GlaxoSmithKline|GSK Response Center|866-435-7343|
106284|NCT00753714|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
121231|NCT02239094|Depression Evaluation Service (New York State Psychiatric Institute)|David J. Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu
106285|NCT00753766|VA Boston Healthcare System|Paul R. Conlin, M.D.|8572035111|paul.conlin@va.gov
106286|NCT00753896|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
106287|NCT00753922|Ethicon Endo-Surgery|Michael L. Schwiers|513-337-1172|mschwier@its.jnj.com
106288|NCT00754234|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov
106289|NCT00754325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
106290|NCT00754338|Centre for Contact Lens Research|Craig A Woods, Research Manager|1 519 888 4567 ext 36547|cawoods@sciborg.uwaterloo.ca
106291|NCT00754377|Louis Stokes VA Medical Center|Dr. David Aron|(216) 791-2300 ext 5836|david.aron@va.gov
106292|NCT00754390|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov
106293|NCT00754442|University of Maryland School of Medicine|Elizabeth A Streeten, MD|410-328-6219|estreete@medicine.umaryland.edu
106294|NCT00754468|University of Miami|Dr. Alfonso Ribeiro|305-243-4000|Aribeiro@med.miami.edu
106295|NCT00754494|University of California, Irvine|Dr. Timothy R. Morgan|562-826-5756|timothy.morgan@va.gov
106296|NCT00754546|Dartmouth-Hitchcock Medical Center|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org
106297|NCT00754559|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
106298|NCT00754572|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
106299|NCT00754624|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com
106300|NCT00754650|Hoffmann-La Roche|Medical Communications|800 821-8590|
106301|NCT00754741|Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454|chphsr@hfhs.org
106302|NCT00754767|HealthPartnersInstitute|Dr. Alice Shapiro|952-993-1704|shapia@parknicollet.com
106303|NCT00754793|University of Washington|Dr. Greg E. Davis, MD MPH|206-543-5230|gedavis@uw.edu
106304|NCT00754832|Oregon Health & Science University|Dr. Michelle Cameron|503-418-1971|cameromi@ohsu.edu
106306|NCT00755040|Vanderbilt Ingram Cancer Center|Madan Jagasia, M.D.|(615) 936-8422|madan.jagasia@vanderbilt.edu
106307|NCT00755079|VAHSRD|Joshua Hobson, MS|(718) 584-9000 ext 3129|joshua.hobson@va.gov
106308|NCT00755105|USDA Grand Forks Human Nutrition Research Center|Janet Hunt, PhD|701-795-8353|janetrhunt@gmail.com
106309|NCT00755131|University of Naples Federico II|Prof. Carlo Vigorito, Director Cardiac Rehabilitation Unit, Federico II University|+39081746 ext 2639|vigorito@unina.it
106310|NCT00755196|Pfizer,Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106311|NCT00755222|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
119313|NCT03037905|Cleveland Clinic|Christian N. Burchill, PhD, RN, CEN|216-445-9317|burchic@ccf.org
106313|NCT00755261|SKCCC, Johns Hopkins University|Christian Meyer, M.D., Ph.D.|4105025940|cmeyer13@jhmi.edu
106314|NCT00755274|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
106315|NCT00755417|Depomed|Head of Research & Development|650-462-5900 ext 108|msweeney@depomed.com
106317|NCT00755755|PregLem S.A.|Dr Elke Bestel|+41 22 884 03 40|medical@preglem.com
106318|NCT00755807|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
106319|NCT00755846|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
106320|NCT00755911|University of Michigan|Darnell Kaigler|734-998-1468|dkaigler@umich.edu
106321|NCT00755937|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106322|NCT00756002|Takeda Global Research & Development Center, Inc.|Sr VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
106323|NCT00756093|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
106324|NCT00756236|Department of Anesthesia. OUHSC|Dr. Mehmet Ozcan, MD|405-271-4351|mehmet-ozcan@ouhsc.edu
106325|NCT00756314|IMIP - Instituto Materno Infantil Prof. Fernando Figueira|Ana Laura Carneiro Gomes Ferreira - MD|+558121224779|analaura@imip.org.br
106326|NCT00756444|Amgen Inc.|Study Director|866-572-6436|
106327|NCT00756457|Ithaca College|Jeff Houck, PhD|585-340-9619|jhouck@ithaca.edu
106328|NCT00756470|University of Texas (UT) MD Anderson Cancer Center|Ricardo Alvarez, MD/Breast Medical Oncology|713-792-2817|CR_Study_Registration@mdanderson.org
106329|NCT00756548|Braintree Laboratories, Inc.|John McGowan, Director, Clinical Research|781-843-2202|jmcgowan@braintreelabs.com
106330|NCT00756561|University of Washington, Dept. of Medicine|Mara Roth, MD|(206) 221-0519|mylang@u.washington.edu
106331|NCT00756574|McMaster University|Dr. Mark Loeb|905-525-9140 ext 26066|loebm@mcmaster.ca
106332|NCT00756678|Allergan, Inc|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com
106333|NCT00750360|GlaxoSmithKline|GSK Response Center|866-435-7343|
106334|NCT00750373|Asan Medical Center|Dr. Duk-Hyun Kang|82-2-3010-3149|dhkang@amc.seoul.kr
106335|NCT00750737|University of Texas (UT) MD Anderson Cancer Center|Issam Raad, MD / Chair, Infectious Diseases|713-792-7943|CR_Study_Registration@mdanderson.org
106336|NCT00750815|H. Lee Moffitt Cancer Center and Research Institute|Melissa Alsina, M.D.|813-745-6886|melissa.alsina@moffitt.org
106337|NCT00750867|University of Massachusetts Medical School|Dr.Peter Novak|508-334-4973|novakp@ummhc.org
106338|NCT00750880|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
106339|NCT00750893|GlaxoSmithKline|GSK Response Center|866-435-7343|
106340|NCT00750919|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106341|NCT00751036|Novartis Pharmaceuticals|Study Director|862-778-8300|
106342|NCT00756730|Community Research initiavte|Dr. Daniel Skiest|413 794 5376|Daniel.Skiest@baystatehealth.org
106343|NCT00756886|Surgery - Cardiovascular/Thoracic|Ayesha S. Bryant, MD|(205) 996-7561|abryant@uab.edu
106345|NCT00756964|University of Florida|A. Ahsan Ejaz, M.D.|3522735328|ejazaa@medicine.ufl.edu
106346|NCT00756977|Braintree Laboratories|John McGowan|781-843-2202|jmcgowan@braintreelabs.com
106347|NCT00757003|Stanford University|Dr. Daniel Sze, Principal Investigator|650-723-0728|dansze@stanford.edu
106348|NCT00757484|University of Rochester Medical Center|Dr. Erin Duecy|585-275-4004|erin_duecy@urmc.rochester.edu
106349|NCT00757588|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
106350|NCT00757601|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106351|NCT00757627|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
106352|NCT00757666|Boston Scientific|Director of Clinical Affairs|651-582-2277|cshd@bsci.com
106353|NCT00757705|Janssen Research & Development|Medical Director|886 2 23762155|
106354|NCT00757783|Johnson & Johnson Pharmaceutical Research & Development|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488|
106355|NCT00757822|Central Arkansas Veterans Healthcare System|Dr. Muhammad Jaffar|501-688-9310|Muhammad.Jaffar@va.gov
106356|NCT00757848|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
106357|NCT00758043|Vertex Pharmaceuticals Incorporated|Robert Kauffman, MD, PhD|617-444-6158|Robert_Kauffman@vrtx.com
106358|NCT00758069|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
106359|NCT00758160|Janssen Pharmaceutical, Taiwan|Medical Affairs Director|+886-2-23762155|
106360|NCT00758290|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com
106361|NCT00758342|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
106362|NCT00758394|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com
106363|NCT00758420|BTG International Inc.|David Wright MBBS|610-943-3538|david.wright@btgplc.com
106364|NCT00758459|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
106365|NCT00758485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106366|NCT00758498|Cephalon, Inc.|Medical Monitor|1-800-896-5855|
106367|NCT00758550|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
106368|NCT00758563|Colgate Palmolive|William DeVizio - DMD|732-878-7901|William_DeVizio@colpal.com
106369|NCT00758576|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
106370|NCT00758589|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com
106371|NCT00758602|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
106372|NCT00758667|Vanderbilt University|R. Bruce Shack, MD|615-936-0160|bruce.shack@vanderbilt.edu
106373|NCT00758680|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106374|NCT00758706|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
106375|NCT00758745|Alcon Research, Ltd.|Director of Clinical Research|888.451.3937; 817.568.6725|medinfo@alconlabs.com
106376|NCT00758758|Zimmer, Inc|Laura Herdrich, Sr. CRA|952-830-6224|laura.herdrich@zimmer.com
106377|NCT00758771|UCSF|John V. Fahy, MD, MSc|4154769940|john.fahy@ucsf.edu
106378|NCT00758836|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106379|NCT00759031|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com
106380|NCT00759096|Alcon Research, Ltd.|Benny Li, PhD|+86 21 6375 8762|Benny.Li@Alconlabs.com
119316|NCT02758171|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com
106382|NCT00759148|Alcon Research, Ltd.|Alcon Clinical|888.451.3937;817.568.6725|medinfo@alconlabs.com
106383|NCT00759161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106384|NCT00759174|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106385|NCT00759187|Colgate Palmolive|William DeVizio- DMD|732-878-7901|William_Devizio@colpal.com
106386|NCT00759330|Teikoku Pharma USA, Inc.|Director of Clinical Trials|408-501-1821|
106387|NCT00759356|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com
106388|NCT00759395|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
106389|NCT00759473|MUSC|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu
106390|NCT00759525|Brigham and Women's Hospital|Mark A. Creager, MD|617-732-5267|mcreager@partners.org
106391|NCT00759564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106392|NCT00759577|New York University|Dr. Victor Nitti|646 825 6300|Victor.Nitti@NYUMC.org
106393|NCT00759603|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor, Leukemia||CR_Study_Registration@mdanderson.org
106394|NCT00759642|University of Kansas Cancer Center|Priyanka Sharma, MD|913-945-5059|PSHARMA2@kumc.edu
106395|NCT00759655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106396|NCT00759668|Alcon Italia SpA|Marcello Fornoni|39.02.81.303.226|marcello.fornoni@alconlabs.com
106397|NCT00759681|Greenville Memorial Hospital|David Cull, MD|864-455-9825|
106398|NCT00759707|Brigham and Women's Hospital|Dr. Joshua Beckman|6175257053|jbeckman@partners.org
106399|NCT00759759|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com
106400|NCT00753948|James J. Peters VAMC|Joshua Hobson|(718) 584-9000 ext 3129|joshua.hobson@va.gov
106401|NCT00754013|Eisai inc.|Eisai Medical Services|1-888-422-4743|
106402|NCT00754065|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
106403|NCT00754130|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106404|NCT00754156|University of Kentucky Medical Center|Phillip Chang, M.D. PI or Anna Rockich, Pharm.D. GSRP Director|859-323-6346 ext 247|arockich@uky.edu
106405|NCT00759772|Massachusetts General Hospital|Pouneh K. Fazeli, MD|617-726-3870|pkfazeli@partners.org
106406|NCT00759785|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106407|NCT00759811|Instituto de Cardiologia do Rio Grande do Sul|Daniel Medeiros Moreira, MD. MSc.|55 (51) 3219-2802|danielmedeirosmoreira@gmail.com
106408|NCT00759863|Photozig, Inc.|Bruno Kajiyama|650-694-7496 ext 3|lifezig@photozig.com
106409|NCT00759902|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com
106410|NCT00759915|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com
106411|NCT00759941|Alcon Research, Ltd.|Head, Global Medical Affairs|800-862-5266|medinfo@alconlabs.com
106412|NCT00759954|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com
106413|NCT00759967|Ottawa Hospital Research Institute|Dr. Deborah Zimmerman|613-738-8400 ext 82534|dzimmerman@ohri.ca
106414|NCT00760019|Brigham and Women's Hospital|Dr. Joshua Beckman|617-732-6186|jbeckman@partners.org
106415|NCT00760084|Eisai Inc.|Yufang Lu, MD, PhD|888-422-4743|
106416|NCT00761007|Menarini Group- Clinical Research|Angela Capriati MD PhD, Clinical Research Director|+39 055 5680 ext 9933|acapriati@menarini-ricerche.it
106417|NCT00761137|NeuroHealing Pharmaceuticals|Daniel Katzman|617-965-0872|info@neurohealing.com
106418|NCT00761150|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
106419|NCT00761176|Regenesis Biomedical, Inc.|VP of Clinical Research and Regulatory|602-309-2118|mark.davis@regenesisbio.com
106420|NCT00761189|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2094-4804|
106421|NCT00761202|Allergan, Inc.|Vice President Medical Affairs - Europe|(714)246-4500|clinicaltrials@allergan.com
106422|NCT00761215|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370 ext 241|philippe.prokocimer@cubist.com
119318|NCT02549755|Indiana University School of Medicine|Justin Sims, M.D.|317 948-6340|simsjb@iupui.edu
106424|NCT00761306|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
106425|NCT00761319|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com
106426|NCT00761345|Fox Chase Cancer Center|Dr. Steven J. Cohen|215-728-4300|steven.cohen@fccc.edu
106427|NCT00761462|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
106428|NCT00761514|Abbott|Medical Information Specialist|1-800-633-9110|
106429|NCT00761527|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106430|NCT00761579|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2094-4804|
106431|NCT00761592|Allergan, Inc.|Vice President Medical Affairs|(714)246-4500|clinicaltrials@allergan.com
106432|NCT00761605|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2-2094-4804|
106433|NCT00761631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106434|NCT00761735|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106435|NCT00761748|Coloplast A/S|Director of Medical Outcome||dkbir@coloplast.com
106436|NCT00761761|Univeristy Of Pittsburgh Medical Center|K.N. Roy Chengappa, MD|412-246-5006|chengappakn@upmc.edu
106437|NCT00761865|University of Rochester|Benedict DiGiovanni|5852731611|benedict_digiovanni@urmc.rochester.edu
106438|NCT00761930|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com
106439|NCT00761956|Zimmer, Inc|Kacy Arnold, Associate Director, Clinical Affairs|574-371-8336|kacy.arnold@zimmer.com
106440|NCT00761969|Department of Vascular Diseases, University of Ljubljana Med Ctr|Ales Blinc, MD, DSc|+386 1 522 80 32|ales.blinc@kclj.si
106441|NCT00762021|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
106442|NCT00762034|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
106443|NCT00762073|Shire Development LLC|Study Physician|+1 866 842 5335|
106444|NCT00762086|A. Stein Regulatory Affairs Consulting|Shmulik Adler|972-9-767-0002|shmulik@asteinrac.com
106445|NCT00762164|Bronx VA Medical Center|Dr. Lawrence Baruch|718-584-9000 ext 6776|lawrence.baruch@va.gov
106446|NCT00762177|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com
106447|NCT00762216|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
106448|NCT00762229|Bronx VA Medical Center|Dr. Lawrence Baruch|718-584-9000 ext 6776|lawrence.baruch@va.gov
106449|NCT00762268|McLean Hospital|Beth Murphy MD|617-855-2297|BMurphy5@partners.org
106450|NCT00762320|Phoenix Children's Hospital|Laura Clarke-Steffen, PhD, RN|602-933-0234|lclarke@choenixchildrens.com
106451|NCT00762359|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
106452|NCT00762385|Vistakon|Kurt Moody, OD FAAO|904-443-3088|
106453|NCT00762411|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
106454|NCT00762424|WellSpan Health|Barbara Stahlman MS, Clinical Research Associate|717-851-2450|bstahlman@wellspan.org
106455|NCT00762450|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com
106456|NCT00762463|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106457|NCT00762476|University of Virginia|Dr. Ronald Turner|(434) 243-9864|RBT2N@hscmail.mcc.virginia.edu
106458|NCT00762502|Johnson & Johnson Vision Care, Inc.|John Buch, OD|1-904-443-1707|RA-Visus-ClnclStds@its.jnj.com
106459|NCT00762515|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com
106460|NCT00762528|Colgate Palmolive Company|William DeVizio, DMD|732-878-7901|william_Devizio@colpal.com
106461|NCT00762606|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
106462|NCT00762619|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com
106463|NCT00762645|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
106464|NCT00762723|Zimmer|Laura Herdrich|952-830-6224|laura.herdrich@zimmer.com
106465|NCT00762762|Colgate Palmolive Co.|William DeVizio, DMD|732-878-7901|william_devizio@colpal.com
106466|NCT00762788|Vistakon|Kathy Osborn, OD, MS, FAAO, FBCLA Senior Principal Research Optometrist|1 904 443-1032|kosborn@its.jnj.com
106467|NCT00762853|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com
106468|NCT00762892|UT Health Science Center Houston|Tanvir Bell, MD|713-500-6759|Tanvir.K.Bell@uth.tmc.edu
106469|NCT00762970|Vistakon USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com
106470|NCT00762996|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|
106471|NCT00763009|UCHC|Michael Azrin|8606793343|azrin@uchc.edu
106472|NCT00763048|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com
106473|NCT00763061|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
106474|NCT00763139|Vanderbilt|Dr. Charles Michael Stein|615-936-3420|mike.stein@vanderbilt.edu
106475|NCT00763243|Indiana University School of Medicine|William Kronenberger, Ph.D.|317-944-8162|wkronenb@iupui.edu
106476|NCT00763256|Colgate Palmolive Co.|William DeVizio, DMD|732-878-7901|william_devizio@colpal.com
106477|NCT00763269|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com
106478|NCT00763282|Center of Innovation for Complex Chronic Health Care|Marylou Guihan, PhD|708-202-2414|marylou.guihan@va.gov
106479|NCT00763321|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
106480|NCT00763360|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
106481|NCT00763386|Zimmer|Kacy Arnold, Associate Director, Clinical Affairs|574-371-8336|kacy.arnold@zimmer.com
106482|NCT00763412|Washington University in St Louis|Ana Maria Arbelaez|314-286-1138|arbelaez_a@kids.wustl.edu
106483|NCT00757172|Washington University School of Medicine|Dr. A. Craig Lockhart|314-454-8306|alockhar@dom.wustl.edu
106484|NCT00757237|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com
106485|NCT00763451|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
106486|NCT00763490|University of Michigan Comprehensive Cancer Center|Dr. Daniel Couriel, M.D.|734-936-8785|dcouriel@umich.edu
106487|NCT00763698|St. Jude Medical|Director, Clinical Affairs|(408) 522-6410|tshipman@sjm.com
106488|NCT00763750|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org
106489|NCT00766415|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com
106490|NCT00766467|Dana-Farber Cancer Insitute|Eudocia Quant Lee, MD|617-632-2166|eqlee@partners.org
106491|NCT00766493|W. L. Gore & Associates|Bryan Randall|(800) 437-8181|BRandall@WLGore.com
106492|NCT00766506|Janssen-Cilag Ltd. 50-100 Holmers Farm Way, High Wycombe , BUCKS, UK, HP12 4EG|Study Responsible Physician|+44 (0) 1494 567 444|
106493|NCT00766532|University of Wisconsin|Dr. Karen Hansen|608-263-0517|keh@medicine.wisc.edu
106494|NCT00766597|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org
106495|NCT00766636|University of Texas MD Anderson Cancer Center|Jason B. Fleming, MD / Surgical Oncology|713-563-2300|CR_Study_Registration@mdanderson.org
106496|NCT00766649|National Eye Institute|Wai T. Wong|(301) 905-7301|wongw@nei.nih.gov
106497|NCT00766675|Janssen Pharmaceutics Taiwan|Medical Affairs Director|+886-2-23762155|
106499|NCT00766831|Medical Affairs|Clinical Research Associate|82-2-2094-4835|
106500|NCT00767000|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106501|NCT00767039|Boston Medical Center|Alan Fujii MD (PI)|617-4414-3735|Alan.Fujii@bmc.org
106502|NCT00767104|Wake Forest University Health Sciences|Alan Fleischer, Jr. MD|336-716-3775|Afleisch@wfubmc.edu
106503|NCT00767325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
106504|NCT00767338|University of Michigan|Gregory Christman, MD|734-764-8142|growthh@umich.edu
106505|NCT00767364|Wayne State University School of Medicine, Children's Hospital of Michigan|Eric McGrath, MD|313-745-5863|emcgrath@med.wayne.edu
106506|NCT00767455|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com
106507|NCT00767507|The Medicines Company|Meredith Todd - Sr. Director Program Management|+1.973.290.6088|meredith.todd@themedco.com
106508|NCT00767520|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
106509|NCT00767572|UCSF|Dr. Doreen DeFaria Yeh|617-643-7024|ddefariayeh@partners.org
106510|NCT00767624|STANFORD UNIVERSITY|Rachel Manber, PhD|6504981266|rmanber@stanford.edu
106511|NCT00767676|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com
106512|NCT00767767|Weill Cornell Medicine|Kane Pryor|(212) 746-2969|kap9009@med.cornell.edu
106513|NCT00767806|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
106514|NCT00768040|Novartis Pharmaceuticals|Study Director|862-778-8300|
106515|NCT00768053|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106516|NCT00768066|The EMMES Corporation|Adam Mendizabal, Biostatistician|301-251-1161 ext 221|amendizabal@emmes.com
106517|NCT00768118|Barbara Ann Karmanos Cancer Institute|Fazlul Sarkar, Ph.D.|(313) 576-8327|sarkarf@karmanos.org
106518|NCT00768144|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susana_campos@dfci.harvard.edu
106519|NCT00768222|J&J Medical, China Ltd.|Xiaowei SUN, MD PhD|86 10 5952 3103|xsun5@its.jnj.com
106520|NCT00768300|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
106521|NCT00768430|Baylor College of Medicine|Dr. Sanjay Mathew|7137911414 ext 5439|sjmathew@bcm.edu
106522|NCT00768521|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
106523|NCT00768560|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
106524|NCT00768599|AmDerma Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amderma.com
106525|NCT00768651|Faculty of Medicine and Dentistry, University of Alberta|Peter Senior, MD, PhD - Professor of Medicine, Medical Director-Clinical Islet Transplant Program,|780-407-1480|peters@islet.ca
106526|NCT00768755|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106527|NCT00768898|Alcon Research, Ltd.|Alison Ramsey, O.D., Manager|817-551-6986|Alison.ramsey@alconlabs.com
106528|NCT00760214|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
106529|NCT00760266|Novartis Pharmaceuticals|Study Director|862-778-8300|
106530|NCT00760383|Human Physiology, University of Oregon|Hans C. Dreyer, PT, PhD|541-346-5775|hcdreyer@uoregon.edu
106531|NCT00760435|University of California, San Diego|Dr. Adriana H. Tremoulet|858-246-0012|atremoulet@ucsd.edu
106532|NCT00760461|Yale University|Anish A Sheth M.D|203-785-4576|anish.sheth@yale.edu
106533|NCT00760474|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
106534|NCT00760487|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
106535|NCT00760526|Jaeb Center for Health Research|Katrina Ruedy|813-975-8690|direcnet@jaeb.org
106536|NCT00760552|Iowa City VA Health Care System|Dr. Gary Rosenthal|319-338-0581|gary-rosenthal@uiowa.edu
106537|NCT00760578|Metabolic Solutions Development Company|Jerry Colca, PhD|269-343-6732|jcolca@msdrx.com
106538|NCT00760617|GlaxoSmithKline|GSK Response Center|866-435-7343|
106539|NCT00760669|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879|
106540|NCT00760747|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
106541|NCT00760838|Ghent University Hospital|dr. Brusselle Guy|003293322604|guy.brusselle@uzgent.be
106542|NCT00760877|Novartis|Study Director|862-778-8300|
106543|NCT00768989|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
106544|NCT00769015|Thomas Jefferson University|Robin Casten|215-503-1250|Robin.Casten@jefferson.edu
106545|NCT00769067|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106546|NCT00769119|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
106547|NCT00769132|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106548|NCT00769184|NeoStrata Co., Inc.|Barbara Green, RPH, MS|(609) 520-0715|bgreen@neostrata.com
106549|NCT00769561|Department of Clinical Psychology and Psychotherapy, Philipps University of Marburg, Germany|Dr. Meike Shedden Mora|+49-6421-282 ext 3657|m.shedden@staff.uni-marburg.de
106550|NCT00769652|Rutgers Cancer Institute of New Jersey|Dr. Elizabeth Poplin, MD (sub-investigator)|732-235-8675|poplinea@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
106551|NCT00769704|Amgen, Inc.|Study Director|866-572-6436|
106552|NCT00769860|University of Kansas Medical Center|Dr. Richard Barohn|(913) 588-6094|RBAROHN@kumc.edu
106553|NCT00770029|Merz Pharmaceuticals GmbH|Dr. Matthias Zerm|0049-69-1503 ext 865|matthias.zerm@merz.de
106554|NCT00770120|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org
106555|NCT00770146|Genzyme Corporation|Genzyme Medical Information|617-252-7832|
106556|NCT00770211|Merz Pharmaceuticals GmbH|Dr. Matthias Zerm|0049-69-1503 ext 865|matthias.zerm@merz.de
106557|NCT00770289|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106558|NCT00770315|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106560|NCT00770367|Medical University of South Carolina|Dana King MD|843-792-8112|kingde@musc.edu
106561|NCT00770432|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106562|NCT00770484|Vanderbilt University|Italo Biaggioni, MD., Professor of Medicine and Pharmacology|(615) 936-3420|italo.biaggioni@vanderbilt.edu
106563|NCT00770510|Eisai Co., Ltd.|Atsushi Kamijo, Study Director|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp
106564|NCT00770562|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
106565|NCT00770588|AstraZeneca|Gerard Lynch|52564555 ext 86 21|aztrial_results_posting@astrazeneca.com
106566|NCT00770653|Takeda Pharma GmbH, Aachen (Germany)|Medical Director|+49 800 8253325|clinicaltrialregistry@tpna.com
106567|NCT00770679|Johns Hopkins University School of Medicine|Harry Silber, M.D., Ph.D. Assistant Professor of Medicine, Division of Cardiology|4105505717|hsilber@jhmi.edu
106568|NCT00770692|Eisai Co., Ltd.|Atsushi Kamijo, Study Director|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp
106569|NCT00770757|Washington University School of Medicine|John F. DiPersio, M.D., Ph.D.|314-454-8603|jdipersi@dom.wustl.edu
106570|NCT00770770|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com
106571|NCT00770809|University of North Carolina – Lineberger Comprehensive Cancer Center|Lisa Carey, M.D.||lisa_carey@med.unc.edu
106572|NCT00770861|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com
106573|NCT00770913|Eisai Co.,Ltd. Eisai Product Creation Systems|Tomoki Kubota, Study Director|+81-3-3817-3908|t2-kubota@hhc.eisai.co.jp
106574|NCT00770965|Novartis|Study Director|862-778-8300|
106575|NCT00770991|Cleveland Clinic|Dr. Carol Burke|216 444-6864|burkec1@ccf.org
106576|NCT00771056|Northwell Health (formerly North Shore LIJ Health System)|Kanti R Rai, MD|(718)470-4050|krai@nshs.edu
106577|NCT00771173|Loyola University Chicago|Dr. Linda Brubaker|708-216-3960|lbrubaker@lumc.edu
106578|NCT00771238|Nebraska Medical Center|Joyce Black, PhD, RN|402-559-6573|JBlack@unmc.edu
106579|NCT00771264|Uroplasty, Inc.|Susan Holman, Cheif Operating Officer|952-426-6143|susan.holman@uroplasty.com
106580|NCT00771277|VA Medical Center Memphis|Dr. Linda O. Nichols|901 523-8990 ext 5082|linda.nichols@va.gov
106581|NCT00771316|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106582|NCT00771407|LifeCell Corporation|Chief Medical Officer|908-947-1104|mfranz@lifecell.com
106583|NCT00771472|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106584|NCT00771537|Indiana University|Gregory D Zimet|317-274-8812|gzimet@iupui.edu
106585|NCT00771602|UT MD Anderson Cancer Center|Stefan Faderl, MD / Professor|713-745-4613|
106586|NCT00771615|GlaxoSmithKline|GSK Response Center|866-435-7343|
119320|NCT02515058|UT Health Science Center at San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu
106588|NCT00771745|University of Cincinnati|Dr. Rita Alloway|513-558-1568|Rita.Alloway@uc.edu
106589|NCT00771758|Ortho-McNeil Janssen Scientific Affair, LLC.|Senior Director of Clinical Development, Pain|(908)927-5465|
106591|NCT00771849|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
106592|NCT00771875|University of Cincinnati|E. Steve Woodle, MD|513-558-6001|woodlees@ucmail.uc.edu
106593|NCT00771914|University of Rochester Division of Epidemiology, Department of Community and Preventive Medicine|Robert Block, MD, MPH, FACP|585-275-3356|robert_block@urmc.rochester.edu
106594|NCT00771927|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
106595|NCT00771953|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu
106596|NCT00763815|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
106597|NCT00763867|Duke University|Jenny Ibarra|919.236.3291|jenny.ibarra@duke.edu
106598|NCT00763919|University Hospitals Case Medical Center|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org
106599|NCT00763958|University of Alabama at Birmingham|Dr. Karen Cropsey|205-917-3786 ext 205|kcropsey@uab.edu
106600|NCT00763971|Shire Pharmaceutical|Study Physician|1 866-842-5335|
106601|NCT00764309|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
106602|NCT00764322|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
106603|NCT00764361|Nanotherapeutics, Inc.|John Abernethy, MD - Medical Director|386-462-9663 ext 326|jabernethy@nanotherapeutics.com
106604|NCT00764465|GSIDA|David Condoluci|856-566-3190|dcondoluci@gsida.org
106605|NCT00764478|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106606|NCT00764504|DJO Surgical|Manager of Clinical Affairs|512-832-9500 ext 6323|jane.jacob@djosurgical.com
106607|NCT00764660|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106608|NCT00764673|DJO Surgical|Manager of Clinical Affairs|512-832-9500 ext 6323|jane.jacob@djosurgical.com
106609|NCT00764790|GlaxoSmithKline|GSK Response Center|866-435-7343|
106610|NCT00764868|Shire Pharmaceutical|Timothy Whitaker, MD||twhitaker@shire.com
106611|NCT00764881|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
106612|NCT00764946|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106613|NCT00765037|DJO Surgical|Jane M. Jacob - Manager of Clinical Affairs|512-834-6323|jane.jacob@djosurgical.com
106614|NCT00765063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106615|NCT00765076|GlaxoSmithKline|GSK Response Center|866-435-7343|
106616|NCT00765102|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
106617|NCT00765128|Mayo Clinic|Mitchell R. Humphreys MD|480-301-8000|humphreys.mitchell@mayo.edu
106618|NCT00765193|Department of Dermatology, Medical University of Graz-Austria|Iris Zalaudek, MD|+436763328269|iris.zalaudek@medunigraz.at
106619|NCT00765206|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106620|NCT00765232|Mayo Clinic|Mitchell R. Humphreys MD|480-301-8000|humphreys.mitchell@mayo.edu
106621|NCT00765245|Vanderbilt-Ingram Cancer Center|Dr. Nishitha Reddy|800-811-8480|nishitha.reddy@vanderbilt.edu
106622|NCT00765336|Medicis Global Services Corporation|Director of Clinical Trials||ClinicalTrials@Medicis.com
106623|NCT00765362|DJO Surgical|Manager of Clinical Affairs|512-832-9500 ext 1323|jane.jacob@djosurgical.com
106624|NCT00765375|DeNova Research|Jack Arkins, Data Manager|312-335-2070|jack@drdayan.com
106625|NCT00765388|Coloplast A/S|Seema Suchdev Wrisberg|+4549113519|dkssw@coloplast.com
106626|NCT00765570|Summa Health System|Tracy Mondello, MS|330-375-6131|mondellot@summahealth.org
106627|NCT00765648|Cleveland Clinic|Frank Peacock MD|(216) 445-4557|peacocw@ccf.org
106628|NCT00765661|Veloxis|Christina Sylvest, Sr VP Global Clinical Development & Operations|45 20553877|csy@veloxis.com
106629|NCT00765674|Novartis Pharmaceuticals|Study Director|862 778-8300|
106630|NCT00765726|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106631|NCT00765765|Cancer Institute of New Jersey|Dr. Vassiliki Karantza|732-235-8675|karantva@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
106632|NCT00765817|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
106633|NCT00765843|Rosalind Franklin University of Medicine and Science|Ryan Crews|847-578-8437|ryan.crews@rosalindfranklin.edu
106634|NCT00765882|Forest Research Institute|Paul F.C. Eng, PhD. Director, Clinical Development|201-427-8071|Paul.Eng@frx.com
106635|NCT00765895|Johns Hopkins Data Coordinating Centers|Mark Van Natta|410-614-1362|mvannat1@jhu.edu
106636|NCT00765947|Novartis Pharmaceuticals|Study Director|862-778-8300|
106637|NCT00766051|University of Utah at the time of the study|Lynne La Corte, PhD, OTR/L, OTD|970 4330981|lflacorte@independence.net
106638|NCT00766090|GlaxoSmithKline|GSK Response Center|866-435-7343|
106639|NCT00766363|EnVivo Pharmaceuticals, Inc.|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|617-225-4264|mgawryl@envivopharma.com
106640|NCT00766376|Palomar Medical Technologies, Inc.|Director of Regulatory Affairs|781-993-2414|stimberlake@palomarmedical.com
106641|NCT00772005|Cephalon, Inc.|Vice President, Clinical Research, CNS/Pain|1-800-896-5855|
106642|NCT00772031|The EMMES Corporation|Anne S Lindblad, PhD|301 251 1161 ext 105|alindblad@emmes.com
106643|NCT00772070|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com
106644|NCT00772109|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
106645|NCT00772148|Veloxis Pharmaceuticals|Christina Sylvest|+45 20553877|csy@veloxis.com
106646|NCT00772538|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
106647|NCT00772577|Novartis Pharmaceuticals|Study Director|862-778-8300|
106648|NCT00772590|Kirby Institute, University of New South Wales|Sean Emery|+612 938509900|semery@kirby.unsw.edu.au
106649|NCT00772603|Supernus Pharmaceuticals, Inc|Stefan Schwabe, M.D., Ph.D., Chief Medical Officer|301-838-2500 ext 2527|sschwabe@supernus.com
106650|NCT00772629|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
106652|NCT00772707|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937|
106653|NCT00772772|The Rockefeller University|Dr. Mansih Ponda|212-327-7631|mponda@rockefeller.edu
106654|NCT00772889|GlaxoSmithKline|GSK Response Center|866-435-7343|
106655|NCT00772915|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu
106656|NCT00772928|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
106657|NCT00772941|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106658|NCT00772954|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
106659|NCT00772967|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106660|NCT00773097|University Pittsburgh|Robert E. Schoen ME|412-648-9115|rschoen@pitt.edu
106661|NCT00773136|University of Miami|Dr. Sara Wester|305-326-6132|swester2@med.miami.edu
106662|NCT00773253|University of California San Francisco|Graham A. Glass, MD|415-353-2311|Graham.Glass@ucsf.edu
106663|NCT00773279|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
106664|NCT00773370|VA Medical Center, Baltimore Maryland|Mary Stuart, ScD, VA Research Investigator|410-455-2084|stuart@umbc.edu
106665|NCT00773383|Hoffman-LaRoche|Medical Communications|800-821-8590|
106666|NCT00773461|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
106667|NCT00773474|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org
106668|NCT00773734|Celgene Corporation|Anne McClain|888-243-1360|clinicaltrialdisclosure@celgene.com
106669|NCT00773786|Saint Francis Hospital and Medical Center|Richard ZuWallack, MD||rzuwalla@stfranciscare.org
106670|NCT00773955|Washington University|Maria Q. Baggstrom, M.D.||Mbaggstr@im.wustl.edu
106671|NCT00773968|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
106672|NCT00774046|University of Chicago|Dr. Lucy A. Godley|773-702-4140|lgodley@medicine.bsd.uchicago.edu
106673|NCT00774163|Tulane University School of Public Health and Tropical Medicine|Dr. Richard Oberhelman|504-988-2511|oberhel@tulane.edu
106674|NCT00774267|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106675|NCT00774306|Thomas Jefferson University|Dr. Scott Mintzer|215-955-1222|scott.mintzer@jefferson.edu
106676|NCT00774397|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
106677|NCT00774748|UNC Chapel Hill School of Medicine Dept. Hematology|Clinical Research Coordinator|919-966-2359|catherine_soriano@med.unc.edu
106678|NCT00774787|Rigel Dermatology|Darrell Rigel|212-684-5964|dsrigel@prodigy.net
106679|NCT00774800|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889|
106680|NCT00774852|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
106681|NCT00774930|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
106682|NCT00769314|BioAlliance Pharma|Dr Pierre ATTALI|+33145587600|pierre.attali@bioalliancepharma.com
106683|NCT00774995|GlaxoSmithKline|GSK Response Center|866-435-7343|
106684|NCT00775021|Vistakon|Kurt Moody, Director Design R&D|904-443-3088|
106685|NCT00775190|Beaumont Health System|Evie Russell, RN|248-898-5388|Evie.Russell@beaumont.org
106686|NCT00775203|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
106687|NCT00775229|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu
106688|NCT00775944|University of Nottingham|Graeme Docherty|01158321380|graeme.docherty@nottingham.ac.uk
106689|NCT00775983|UCSF|Abby Sokoloff|4155140440|sokoloffa@obgyn.ucsf.edu
106690|NCT00776009|Novartis Pharmaceuticals|Study Director|862 778-8300|
106691|NCT00776100|Mayo Clinic|Steven E. Schild, M.D.|507-538-1760|sschild@mayo.edu
106692|NCT00776230|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43120620 ext 0|info@valneva.com
106693|NCT00776295|H. Lee Moffitt Cancer Center|Mohamed Kharfan Dabaja, MD|961-1350000 ext 5350|MK143@aub.edu.lb
106694|NCT00776555|Shire Pharmaceutical|Gerald Tremblay, M.D.||gtremblay@shire.com
106695|NCT00776594|Dana Farber Cancer Institute|Mary-Ellen Taplin, MD|617-632-6328|Mary_taplin@dfci.harvard.edu
106696|NCT00776659|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106697|NCT00776789|AIIMS|Dr Anu Thukral|01126594605|dranuthukral@yahoo.com
106698|NCT00776919|GlaxoSmithKline|GSK Response Center|866-435-7343|
106699|NCT00776984|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
106700|NCT00776997|Torax Medical|Amy Derosier, VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com
106701|NCT00777023|Depomed|Head of R&D|650-462-5900 ext 108|msweeney@depomed.com
106876|NCT00792116|Baylor|Craig Johnston|713-798-2068|caj@bcm.edu
106702|NCT00777049|Translational Research in Oncology (TRIO)|Valérie Bee-Muntenau, Director of Project Management|+33 1 58 10 09 09|Valerie.Bee@trioncology.org
106703|NCT00777062|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200 ext 109|kampman@mail.med.upenn.edu
106704|NCT00777153|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
106705|NCT00777179|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
106706|NCT00777205|Veterans Affairs Healthcare System|Marcia Valenstein, MD|734-845-3649|marcia.valenstein@va.gov
106707|NCT00777257|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
106708|NCT00777335|University of California Los Angeles (UCLA) / Cancer International Research Group (CIRG) (Translational Research in Oncology TRIO) Inc.|Dr. Richard Finn|+ 1 310 586 2091|RFinn@mednet.ucla.edu
106709|NCT00777556|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
106710|NCT00777608|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106711|NCT00777634|McLean Hospital|Study Coordinator|617-855-2984|eryan@mclean.harvard.edu
106712|NCT00777764|Genentech, Inc.|Medical Communications|800-821-8590|
106713|NCT00777790|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
106714|NCT00777803|Merz Pharmaceuticals GmbH|Matthias Zerm|+49 69 1503 ext 865|matthias.zerm@merz.de
106715|NCT00777855|UCSF|Leslie Benet|(415) 476-3853|leslie.benet@ucsf.edu
106716|NCT00777946|Novartis Pharmaceuticals|Study Director|862-778-8300|
106717|NCT00778102|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
106718|NCT00778167|University of Colorado Denver|Dr. David R. Camidge|720-848-0449|ross.camidge@ucdenver.edu
106719|NCT00778258|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
106720|NCT00778310|University of Texas Health Science Center at San Antonio|Steven R. Pliszka MD|210-567-5475|pliszka@uthscsa.edu
106721|NCT00778336|Boston Scientific Corporation|DeeAnn Tinjum|763-450-8707|deeann.tinjum@bsci.com
106722|NCT00778375|University of Texas (UT) MD Anderson Cancer Center|Farhad Ravandi-Kashani, Professor, Leukemia Department||CR_Study_Registration@mdanderson.org
106723|NCT00772304|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
106724|NCT00772369|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
106725|NCT00772382|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
106726|NCT00772447|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
106727|NCT00778622|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
106728|NCT00778648|Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie , Charité - Universitätsmedizin Berlin, Germany|Dr. Stephanie Roll|+49 30 450 529023|stephanie.roll@charite.de
106729|NCT00780572|VA SLC HCS|Director HSR&D|801-582-1565|IDEAS@va.gov
106730|NCT00780676|University of Texas (UT) MD Anderson Cancer Center|Stacy Moulder, MD/Associate Professor, Breast Medical Oncology|713-792-2360|CR_Study_Registration@mdanderson.org
106731|NCT00780741|Jaeb Center for Health Research|Ray Kraker, Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org
106732|NCT00780910|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
106733|NCT00781079|Pittsburgh VA|Matthew Chinman|412 360-2438|matthew.chinman@va.gov
106734|NCT00781274|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
106735|NCT00781326|University of Pittsburgh|Ellen Whyte, MD|412 246 5066|whyteem@upmc.edu
106736|NCT00781365|HealthPartners Institute for Education and Research|Dr. Karen Margolis, MD MPH|952-967-7301|karen.l.margolis@healthpartners.com
106737|NCT00781391|Daiichi Sankyo, Inc.|James Hanyok, Sr. Director|732-590-5000|jhanyok@dsi.com
106738|NCT00781456|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
106739|NCT00781508|MetroHealth Medical Center|Robert C. Bahler, MD|216 778-2431|rbahler@metrohealth.org
106740|NCT00781599|University of Kansas Medical Center|Dr. Nikki Nollen|(913) 588-3784|NNOLLEN@kumc.edu
106741|NCT00781859|ThromboGenics|Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com
106743|NCT00781950|St. Boniface Hospital Research Centre|Dr. Grant Pierce|(204) 235-3414|GPierce@sbrc.ca
106744|NCT00781963|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 895-9311|Cathy.Alessi@va.gov
106745|NCT00782067|Novartis Pharmaceuticals|Study Director|862-778-8300|
106746|NCT00782171|Institut Straumann AG - Clinical Research|Institut Straumann AG|+41 61 965 11 11|research@straumann.com
106747|NCT00782184|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106748|NCT00782210|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
106749|NCT00782288|Johns Hopkins University|Pamela L. Zeitlin, M.D., Ph.D., Professor and Director of SOM Pediatric Pulmonary|443-287-8981|pzeitlin@jhmi.edu
106750|NCT00782340|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com
106751|NCT00782379|Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com
106752|NCT00782418|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106753|NCT00782483|University of Arkansas for Medical Sciences/Arkansas Children's Hospital|Dr. Gal Shafirstein|501-364-7546|jboswell@uams.edu
106754|NCT00782496|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com
106755|NCT00782509|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
106756|NCT00782626|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu
106757|NCT00782639|Bracco Diagnostics, Inc|Usha Halemane|609-514-2578|usha.halemane@diag.bracco.com
107237|NCT00805675|Novartis Pharmaceuticals|Study Director|862-778-8300|
106758|NCT00782717|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937 and 817.568.6725|medinfo@alconlabs.com
106759|NCT00782821|University of Cincinnati|E. Steve Woodle, MD|513-558-6001|woodlees@ucmail.uc.edu
106760|NCT00782834|Fox Chase Cancer Center|Margaret von Mehren, M.D., Director of Sarcoma Oncology|215-728-2814|margaret.vonMehren@fccc.edu
106761|NCT00775346|Covidien|Manager, Clinical Affairs|303 305 2591|Norma.Prince@Covidien.com
106762|NCT00775411|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
106763|NCT00775437|AbbVie|Global Medical Information|800-633-9110|
106764|NCT00775450|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
106765|NCT00775463|United Therapeutics Corporation|Oral Treprostinil Program Head|919-485-8350|klaliberte@unither.com
106766|NCT00775528|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32 (0)2 509 69 77|sven.voet@solvay.com
106768|NCT00775606|Rush University Medical Center|Allan R. Tenorio|312-942-3665|allan_s_tenorio@rush.edu
106769|NCT00775645|SWOG Statistical Center|Study Statistician|206-667-4623|
106770|NCT00775658|Vanderbilt Medical Center|John Fahrenholz, M.D.|615-936-2727|john.m.fahrenholz@vanderbilt.edu
106771|NCT00775671|Vanderbilt University|Nancy J Brown|615-343-8701|nancy.j.brown@vanderbilt.edu
106772|NCT00783094|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
106773|NCT00783198|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106774|NCT00783224|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
119323|NCT02432300|EmotEd, LLC|Dawn Neumann|716-713-5048|dneumann73@gmail.com
106776|NCT00783302|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|paul.gordon@ge.com
106777|NCT00785291|UCSF Comprehensive Cancer Center|Hope Rugo, M.D.||hrugo@medicine.ucsf.edu
106778|NCT00785356|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com
106779|NCT00785486|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com
106780|NCT00785512|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com
106781|NCT00785577|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
106782|NCT00785629|Denver Nephrologists, P.C.|Geoffrey A. Block, MD|303-364-4775|gablock@denverneph.net
106783|NCT00785707|MED-EL Corporation|Sr. Clinical Research Associate||clinicaltrials@medelus.com
106784|NCT00785772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106785|NCT00785785|Novartis Pharmaceuticals|Study Director|862-778-8300|
106786|NCT00785798|Yale University School of Medicine|Francine Foss, MD||Francine.Foss@yale.edu
106787|NCT00785980|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
106788|NCT00786032|Hines Coordinating Center|Project Manager|708-202-5785|tamara.paine@va.gov
106789|NCT00786188|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com
106790|NCT00786422|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
106791|NCT00786474|Duke University Medical Center|Thomas Ortel, MD, PhD, Principal Investigator|919-684-5350 ext 3|thomas.ortel@duke.edu
106792|NCT00786487|University of Minnesota|Dr. Lisa Chow|612-625-8934|chow0007@umn.edu
106793|NCT00786565|Bausch & Lomb|Jon Hayashida|(585) 338-6370|jon.hayashida@bausch.com
106794|NCT00786643|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com
106795|NCT00786682|Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
106796|NCT00786799|University of California, San Francisco|Robert L. Hendren, D.O.|415-476-7198|robert.hendren@ucsf.edu
106797|NCT00786838|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Senior Medical Director|1 908 704-5779|
106798|NCT00786864|University of the Witwatersrand|Gina L Fanucchi|+27 11 616 4400|gfanucs@mweb.co.za
106799|NCT00786916|Akron Children's Hospital|Michael D. Reed, Pharm.D.|330-543-3193|MReed@chmca.org
106800|NCT00786994|Center for Dermatooncology, Department of Dermatology, University Hospital Tübingen, Tübingen, Germany|Dr Annette Pflugfelder||annette.pflugfelder@med.uni-tuebingen.de
106801|NCT00787020|Duke University Medical Center|DaiWai M Olson|9196683751|Olson006@mc.duke.edu
106802|NCT00787124|Duke University Medical Center|Brian Smith|9196688951|brian.smith@duke.edu
106803|NCT00787137|PanGenetics UK Limited|John Powell|+441763257869|info@pangenetics.com
106804|NCT00787150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106805|NCT00787189|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com
106806|NCT00787202|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106807|NCT00787241|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu
106808|NCT00787254|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
106809|NCT00787267|Duke University Medical Center|Michael Kelley , MD|919-286-0411 ext 7326|kelleym@duke.edu
106810|NCT00787319|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106811|NCT00787332|Canyon Pharmaceuticals|Director of Clinical Trials|888-434-7003|info@canyonpharma.com
106812|NCT00787527|University of Texas MD Anderson Cancer Center|Yasuhiro Oki, MD/ Associate Professor|713-792-2860|yoki@mdanderson.org
106813|NCT00787566|Aviana Consulting, LLC|Vanaja V. Ragavan, M.D.|610-795-7403|vvragavan@comcast.net
106814|NCT00787605|Novartis Pharmaceuticals|Study Director|862-778-8300|
106815|NCT00787618|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com
106816|NCT00787644|University of Vermont|Dr. Anne Dixon|802 656 3525|anne.dixon@uvm.edu
106817|NCT00778817|The University of Chicago|Walter M. Stadler, MD|(773) 702-6149|wstadler@medicine.bsd.uchicago.edu
106818|NCT00778830|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
106819|NCT00778869|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106820|NCT00778895|GlaxoSmithKline|GSK Response Center|866-435-7343|
106821|NCT00778921|Novartis Pharmaceuticals|Study Director|862-778-8300|
106822|NCT00778999|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106823|NCT00779025|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com
106824|NCT00779038|Janssen-Cilag Belgium|Study Responsible Physician|003214649584|
106825|NCT00779116|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106827|NCT00779155|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303-795-3222|abraswell@pico-tesla.com
106828|NCT00779246|Christiana Care Health System|Marci Drees, MD, MS|302-733-5602|mdrees@christianacare.org
106829|NCT00779259|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
106830|NCT00779285|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106831|NCT00779311|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com
119325|NCT02363270|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org
106833|NCT00779506|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
106834|NCT00779558|Stanford University|Alan Schroeder|408 885-5260|alan.schroeder@hhs.sccgov.org
106835|NCT00779584|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106836|NCT00779675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106837|NCT00779701|Temple University Hospital|Dr. Nina Gentile|215-707-2000 ext 8402|ngentile@temple.edu
106838|NCT00779766|GlaxoSmithKline|GSK Response Center|866-435-7343|
106839|NCT00779779|GlaxoSmithKline|GSK Response Center|866-435-7343|
106840|NCT00779857|AtriCure, Inc.|Jim Lucky|1-513-755-4101|jlucky@atricure.com
106841|NCT00779909|Boston University School of Dental Medicine|Raul I Garcia, DMD|617-638-6385|rig@bu.edu
106842|NCT00780273|University if Rochester Medical Center|Dr. George Romanos|585-276-4149|GeorgiosRomanos@urmc.rochester.edu
106843|NCT00780338|RAND|Matthew Chinman|412 683-2300 ext 4287|chinman@rand.org
106844|NCT00780403|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
106845|NCT00780416|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
106846|NCT00780455|Bayer Healthcare AG|Medical Affiars Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
106847|NCT00780481|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu
106848|NCT00787761|Blood and Marrow Transplant Group of Georgia|Asad Bashey, MD, PhD, Principal Investigator|404-255-1930|abashey@bmtga.com
106849|NCT00787787|Cancer Consortium|Medical Director, Clinical Research Support|206-667-5767|lmendels@fredhutch.org
106850|NCT00787800|Mayo Clinic|Paul A. Friedman, MD, Professor of Medicine|507-284-7661|friedman.paul@mayo.edu
106851|NCT00787839|Atlanta VA Medical Center|Lawrence S Phillips, MD|404-728-7608|lawrence.phillips@va.gov
106852|NCT00787852|BrUOG|Howard Safran, MD|4018633000|kayla_rosati@brown.edu
106853|NCT00787891|Janssen R&D US|PORTFOLIO/CDT LEADER|1 609 730-2548|
106854|NCT00787904|Emory University|Vin Tangpricha|404-727-7254|vin.tangpricha@emory.edu
106855|NCT00787917|Novartis Pharmaceuticals|Study Director|862 778-8300|
106856|NCT00787930|Duke University Medical Center|John Beyer, MD|919-668-0209|john.beyer@dm.duke.edu
106857|NCT00787943|Northwestern University|Amy Paller, MD|312-695-3721|apaller@northwestern.edu
106858|NCT00788008|Duke University Medical Center|Deborah Attix, PhD|919-668-2846|deborah.koltai@dm.duke.edu
106859|NCT00788073|Seaside Therapeutics|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|617-374-9009 ext 1015|pwang@seasidetherapeutics.com
106860|NCT00791479|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
106861|NCT00791492|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106862|NCT00791518|GlaxoSmithKline|GSK Response Center|866-435-7343|
106863|NCT00791557|University Hospitals of Cleveland|Dr. Amanda Suggs, MD|216-844-7546|Amanda.suggs@uhhospitals.org
106865|NCT00791661|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106867|NCT00791765|Amgen Inc.|Study Director|866-572-6436|
106868|NCT00791778|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
106869|NCT00791817|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com
106870|NCT00791908|Northwestern University|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu
106871|NCT00791921|Professor, Department of Allergy and Rheumatology, Division of Internal Medicine, Graduate School of Medicine, University of Tokyo|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|+81 3 5800 8825|yamamoto-tky@umin.ac.jp
106872|NCT00791934|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com
106873|NCT00791973|University of Chicago|Dr. Robert Naclerio|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu
106874|NCT00791999|Medical Advisor of the Clinical Trial|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|+81 3 5800 8825|yamamoto-tky@umin.ac.jp
106875|NCT00792103|NuPathe Inc.|Mark Pierce, MD PhD|484-567-0130|mpierce@nupathe.com
106877|NCT00792259|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM
106878|NCT00792298|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106879|NCT00792428|Beth Israel Deaconess Medical Center|Gottfried Schlaug, MD, PhD|617-632-8917|gschlaug@bidmc.harvard.edu
106880|NCT00792610|National Taiwan University Hospital|Jan, Chyi-Feng|886-2-23562147|jcf036@ntu.edu.tw
106881|NCT00792623|GlaxoSmithKline|GSK Response Center|866-435-7343|
106882|NCT00792636|GlaxoSmithKline|GSK Response Center|866-435-7343|
106883|NCT00792688|Glycotex, Inc.|Dr. Reinhard Koenig, CEO|301-670-2825|Reinhard.Koenig@glycotexinc.com
106884|NCT00792701|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org
106885|NCT00792805|Novartis Pharmaceuticals|Study Director|862 778-8300|
106886|NCT00792922|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu
106887|NCT00792935|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
106889|NCT00793104|RI Biologics|Robin Waite , Clinical Projects Director|386-418-8888|rwaite@rtix.com
106890|NCT00793169|Northwestern University|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu
106891|NCT00793182|Mallinckrodt Pharmaceuticals|Anthony Lassiter, MD|314-654-6880|anthony.lassiter@mallinckrodt.com
106892|NCT00793325|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106893|NCT00793403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106894|NCT00793455|Northwestern University|Kenzie A. Cameron, PhD, MPH|312-503-3910|k-cameron@northwestern.edu
106895|NCT00793520|Forest Research Institute|Allan Spera|201-427-8399|allan.spera@frx.com
106896|NCT00793546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106897|NCT00793572|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|(206) 667-2827|mmielcar@fhcrc.org
106898|NCT00793585|1st Affiliated Hospital, Sun Yat-Sen University|Xueqing Yu , M.D. & Ph.D.|8620-87766335|yuxq@mail.sysu.edu.cn
119328|NCT02289833|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
106900|NCT00793624|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
106901|NCT00793650|Emory University|Dr. Sagar Lonial|404-727-5572|sloni01@emory.edu
119329|NCT02266875|OhioHealth|Dr. Kruti Patel, DO|614-857-7735|kruti.patel@ohiohealth.com
106903|NCT00793793|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
106904|NCT00793819|Watson Pharmaceuticals|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com
106905|NCT00793871|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106906|NCT00793910|Carl R. Darnall Army Medical Center|Matthew Kuhnle, DO|216-965-3518|matthew.kuhnle@us.army.mil
106907|NCT00783432|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2351|wwheeler@medapharma.us
106909|NCT00783692|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com
106911|NCT00783718|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com
106912|NCT00783796|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com
106913|NCT00783835|Janssen-Cilag Farmaceutica Ltda|Medical Manager|+55 11 30302738|
106914|NCT00783952|Massachusetts General Hospital|Robert M Kacmarek PhD, RRT|617-314-2222|rkacmarek@partners.org
106915|NCT00783965|ChildrensHRCOakland|Raj Prasad|510-450-7602 ext 7602|rprasad@chori.org
106916|NCT00784030|New York University School of Medicine|Dr. Irina Barash|212.263.5851|irina.barash@nyumc.org
106917|NCT00784095|VA Health Services Research and Development|Dr. Karen Steinhauser|9196682148|karen.steinhauser@va.gov
106918|NCT00784134|Johns Hopkins University Division of Brain Injury Outcomes|Dr. Daniel F. Hanley|4106146996|dhanley@jhmi.edu
106919|NCT00784147|TaiMed Biologics, Inc.|Stanley T. Lewis, Jr., MD|949-769-6543 ext 108|stlewis@taimedbiologics.com
106920|NCT00784238|Clinical Research Team, Medical Affairs Korea|Senior Clinical research Associate|82-2-2094-4804|
106921|NCT00784277|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537|
106922|NCT00784368|Global Medical Organization; Janssen R&D|Director, Established Products|(609) 730-7674|
106923|NCT00784459|Washington University|Dr Jonathan Green|314-747-3591|jgreen@wustl.edu
106924|NCT00784550|GlaxoSmithKline|GSK Response Center|866-435-7343|
106925|NCT00784563|Veterans Affairs Medical Center of Iowa City|Ergun Y. Uc, MD|319-356-8753|ergun-uc@uiowa.edu
106926|NCT00784654|Shire Development LLC|Study Physician|1 866-842-5335|
106927|NCT00784719|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106928|NCT00784784|Mount Sinai Hospital|Dr. Brenda Coleman|416-586-4800 ext 4161|bcoleman@mtsinai.on.ca
106929|NCT00784810|Napp Pharmaceuticals Ltd|Director of Medical Affairs|01223 424444|
106930|NCT00784836|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com
106931|NCT00784849|LSU Dept of Surgery|Dr. Eugene Woltering|504 464-8500|ewolte@lsuhsc.edu
106932|NCT00784875|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
106933|NCT00784927|Mayo Clinic Arizona|Craig B. Reeder, MD||Reeder.Craig@mayo.edu
106934|NCT00784979|Tampa General Hospital|Dr. John Leone|813-844-5666|jpleone@tgh.org
106935|NCT00785044|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com
106936|NCT00785213|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
106937|NCT00794118|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
106938|NCT00794144|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
106939|NCT00794157|Novartis Pharmaceuticals|Study Director|862 778-8300|
106940|NCT00794170|University of Pennsylvania|Karen Glanz|215-898-0613|kglanz@upenn.edu
106941|NCT00794196|Parc Sanitari Sant Joan de Déu|Dr. Antoni Serrano Blanco|+34936406350 ext 12215|aserrano@pssjd.org
106942|NCT00794313|Oregon Health & Science Universtiy|Kathyrn Chung MD|503 721 - 1091|chungka@ohsu.edu
106943|NCT00801632|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
106944|NCT00801684|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|bernard.silverman@alkermes.com
106945|NCT00801801|UAB|Dr. Francisco Robert|205-934-5077|pacorobertuab@cs.com
106946|NCT00801827|Vanderbilt_University|Julia Dunn, MD|615-343-8389|julia.dunn@va.gov
119332|NCT02092220|Massachusetts General Hospital|Dr Steven J Russell|617-726-1848|sjrussell@partners.org
106948|NCT00801983|University of Pittsburgh|Dr. Nancy Baker|412 383-6607|nab36@pitt.edu
106949|NCT00802074|Garden State Infectious Disease Associates|David Condoluci|856-566-3190|dcondoluci@gsida.org
106950|NCT00802100|Columbia University|Scott Stroup|(212) 543-5676|stroups@nyspi.columbia.edu
106951|NCT00802178|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
106952|NCT00802204|Vanderbilt University|Julia Dunn, MD|615-343-8389|julia.dunn@va.gov
106953|NCT00802360|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
106954|NCT00802412|VA San Diego|Neal Doran, PhD|8585528585 ext 2421|neal.doran@va.gov
106955|NCT00802503|Geneva University Hospitals, Division of Intensive Care,Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14/Switzerland|Dr CP Heidegger|+41223827440|claudia-paula.heidegger@hcuge.ch
106956|NCT00802529|Imperial College London|Professor Adolfo Bronstein (Clinical professor and Head of neuro-otology group)|(0)20 3313 5525 ext +44|a.bronstein@imperial.ac.uk
106957|NCT00802633|Vanderbilt University|Sam Chang|615-322-2101|sam.chang@Vanderbilt.Edu
106958|NCT00802659|Washington University School of Medicine|Jeffrey Bradley, M.D.|314-362-8525|jbradley@radonc.wustl.edu
106959|NCT00802672|Perrigo Company|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com
106960|NCT00802685|University of Miami|Ilene R. S. Sosenko, M.D.|305-585-6408|isosenko@miami.edu
106961|NCT00802737|GlaxoSmithKline|GSK Response Center|866-435-7343|
106962|NCT00802841|Novartis|Study Director|862-778-1873|
106963|NCT00802867|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
106964|NCT00802880|Washington University School of Medicine|Brian Van Tine, M.D., Ph.D.|314-362-5817|bvantine@dom.wustl.edu
106965|NCT00802893|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu
106966|NCT00802997|Baylis Medical|Meghal Khakhar, Director of Regulatory and Scientific Affairs|9056024875|mkhakhar@baylismedical.com
106967|NCT00803010|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-4673 ext 2556|Joseph.Pidala@moffitt.org
106968|NCT00803023|Jazz Pharmaceuticals|Director of Clinical Development|650-496-3777|
106969|NCT00803049|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
106971|NCT00803101|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
106972|NCT00803114|University of Toronto|Dr. Alison Macarthur|416 586 4800 ext 6632|alison.macarthur@uhn.on.ca
106973|NCT00803179|UMass Medical School|Michael Stalvey, MD, Principal Investigator|508-856-4280|mstalvey@peds.uab.edu
106974|NCT00803244|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com
106975|NCT00803270|New England Resesarch Institutes|Anne M. Stoddard|617-972-3331|astoddard@neriscience.com
106976|NCT00803283|Janssen Taiwan|Medical Advisor|886-2-23762158|
106977|NCT00803361|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
106978|NCT00803400|Psychiatry Academic Unit at J.A.Fernandez Hospital, University of Buenos Aires Medicine School Department of Mental Health|Dr. Marcelo Rudelir|54 11 48254740|mrudelir@hotmail.com
106979|NCT00803413|Hospital das Clínicas - São Paulo University School of Medicine|Mario Fereira Junior|55 11 3069-7691|mariofj@uol.com.br
106980|NCT00803517|Samsung Medical Center|Jiwon Lim|82-10-9933-5596|samnyasa@naver.com
106981|NCT00803543|University of Alabama at Birmingham|Nicholas Van Wagoner|205-934-2840|nvw@uab.edu
106982|NCT00803595|Daiichi Sankyo Pharma Development|Howard Kessler|732-590-5032|hmkessler@dsi.com
106983|NCT00803634|The Medicines Company|Jason Campagna|973-290-6199|jason.campagna@themedco.com
106984|NCT00803647|NSABP Foundation|Diana Gosik, Director Department of Site and Study Management|412-339-5333|diana.gosik@nsabp.org
106985|NCT00803686|Tarsa Therapeutics, Inc|Nicholas LaBella, Jr. Vice-President Global RA/QA|267-273-7944|nlabella@tarsatherapeutics.com
106986|NCT00803712|Amgen Inc.|Study Director|866-572-6436|
106987|NCT00803738|Perrigo Pharmaceuticals|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com
106988|NCT00803751|UT Medical School, Houston|Maria Matuszczak|713-498-2768|maria.matuszczak@uth.tmc.edu
106989|NCT00803777|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com
106990|NCT00803790|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com
106991|NCT00803959|New England Research Institutes|Heather Litman, PhD|617 972 3297|hlitman@neriscience.com
106992|NCT00789035|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
106993|NCT00789074|Queen Mary University of London|Professor Peter Hajek|+44 207 882 8231|p.hajek@qmul.ac.uk
106994|NCT00789113|University of Minnesota College of Pharmacy|Dr. Rory P. Remmel|6126240472|remme001@umn.edu
106995|NCT00789191|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
106996|NCT00789256|Dartmouth-Hitchcock Medical Center|Marc Gautier, MD - Principal Investigator|603-650-5529|marc.gautier@hitchcock.org
106997|NCT00789321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com
106998|NCT00789373|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
106999|NCT00789438|Institut für Anästhesiologie und Operative Intensivmedizin, Universitätsklinukum Schleswig-Holstein, Campus Kiel|Christoph Ilies M.D.|+49-431-597 ext 2991|christoph.ilies@anaesthesie.uni-kiel.de
107000|NCT00789477|Regeneron|Clinical Trial Management|9148475385|clinicaltrials@regeneron.com
107001|NCT00789529|Manhattan Vision Associates / Institute for Vision Research|Dr. George Zikos|2126884277|gzikos@mvaivr.com
107002|NCT00789555|Alcon Research|Terri Pasquine, Sr. Clinical Lead|817-551-4760|terri.pasquine@alconlabs.com
107003|NCT00789581|Sarah Cannon Development Innovations|Charles H. Davis, RAC|615 524-4341|charles.davis2@scri-innovations.com
107004|NCT00789672|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org
107005|NCT00789685|Faron Pharmaceuticals Limited|Dr Ilse Piippo, MD|+358 2469 5151|ilse.piippo@faronpharmaceuticals.com
107006|NCT00789698|Sunovion Pharmaceuticals|Medical Director, CNS|1-866-503-6351|
107008|NCT00789737|Daiichi Sankyo Pharma Development|Director Metabolic Clinical Development|732-590-5000|
107009|NCT00789750|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400|
107010|NCT00789802|Washington University|Dr. Tessa Madden|3147471331|maddent@wustl.edu
107011|NCT00789815|Chung Gung Memorial Hospital|Ting-Yu Lin|886 3 3281200 ext 5108|yuebaoyuebao@yahoo.com.tw
107012|NCT00789828|Novartis Pharmaceuticals|Study Director|862-778-8300|
107013|NCT00789854|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
107014|NCT00789880|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
107015|NCT00789958|SWOG|SWOG Statistician|206-667-4408|
107016|NCT00789997|The Ottawa Hospital Research Institute|Dr Shawn Aaron||saaron@ohri.ca
107017|NCT00790023|Sunovion|Respiratory Medical Director|1-866-503-6351|
107018|NCT00790036|Novartis Pharmaceuticals|Study Director|862-778-8300|
107019|NCT00790062|University of Alabama at Birmingham|Alan T. N. Tita, MD|(205) 934-9616|atit@uab.edu
107020|NCT00790192|Sunovion|Josephine Cucchiaro, PhD, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com
107021|NCT00790205|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107022|NCT00790218|Can-Fite BioPharma|Sari Fishman, Director of Clincal Trials|972528998666|sari@canfite.co.il
107023|NCT00790270|Stony Brook U|Adam Singer|631 444 7856|adam.singer@stonybrook.edu
107024|NCT00790296|University of Connecticut Health Center|Andrew Winokur MD PhD|860-679-6775|awinokur@uchc.edu
107025|NCT00790400|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300|
107026|NCT00790452|UT MD Anderson Cancer Center|Victor A Levin, MD, BS / Professor||CR_Study_Registration@mdanderson.org
107027|NCT00790556|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107029|NCT00790647|Boston Medical Center|Vaishali Sanchorawala|617-638-8265|vaishali.sanchorawala@bmc.org
107030|NCT00790673|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il
107031|NCT00790738|The Zucker Hillside Hospital|Raphael J. Braga, MD|718-4708060|rbraga@nshs.edu
107032|NCT00790751|Vivus, Inc|Wesley W Day PhD|650-934-5200|
107033|NCT00790790|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
107034|NCT00790803|Wake Forest Baptist Health Eye Center|Dr. Shree Kurup|336-716-4091|skurup@wakehealth.edu
107035|NCT00790855|The University of MD Anderson Cancer Center|Hagop M. Kantarjian, M.D.|713-792-7026|eharriso@mdanderson.org
107036|NCT00790907|GlaxoSmithKline|GSK Response Center|866-435-7343|
107037|NCT00791037|University of Washington|Dr. Mary L. Disis|206-543-8557|ndisis@u.washington.edu
107038|NCT00791076|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu
107039|NCT00791089|University of Michigan|Hakan Oral|734 936-6868|oralh@med.umich.edu
107040|NCT00791102|University of Chicago|Robert Naclerio, MD|773-702-0080|rnacleri@surgery.bsd.uchicago.edu
107041|NCT00791128|GI Dynamics, Inc.|Project Manager, Clinical and Regulatory|781.357.3263|kwoessner@gidynamics.com
107042|NCT00791258|Daiichi Sankyo, Inc|John Raia|(973) 944-2683|jraia@dsi.com
107043|NCT00791323|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com
107044|NCT00791336|The University of Iowa|John M. Buatti, M.D., Chair, Department of Radiation Oncology|319-356-2699|john-buatti@uiowa.edu
107045|NCT00791388|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com
107046|NCT00804193|Perrigo|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com
107047|NCT00808132|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107048|NCT00808236|BeneChill, Inc.|Becky Inderbitzen, Vice President of Clincial Affairs|858-695-8118|binderbitzen@benechill.com
107049|NCT00808249|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
107050|NCT00808340|Vistakon|Tom Karkkainen, OD|904-443-3402|
107052|NCT00808444|GlaxoSmithKline|GSK Response Center|866-435-7343|
107053|NCT00808470|University of Texas at Dallas|Dr. Colleen Le Prell|214-905-3018|colleen.leprell@utdallas.edu
107054|NCT00808483|University of Oslo|Professor Anne Marit Mengshoel|004790036933|a.m.mengshoel@medisin.uio.no
107055|NCT00808509|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
107056|NCT00808639|Dana-Farber Cancer Institute|Toni Choueiri, MD|617-632-5456|toni_choueiri@dfci.harvard.edu
107057|NCT00808769|The Procter & Gamble Company|John Mcrorie, PhD, FACG, AGAF|513-622-1423|mcrorie.jw@pg.com
107058|NCT00808808|MedImmune, LLC|Seth Toback, MD|301-398-0000|tobacks@medimmune.com
107059|NCT00808834|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
107060|NCT00808899|St. Jude Children's Research Hospital|Wayne L. Furman|1-866-278-5833|info@stjude.org
107061|NCT00809055|Brigham and Women's Hospital|Dr. Terrie Inder|617-525-6650|tinder@partners.org
107062|NCT00809094|Stanford University|Dr. Carol Conrad|650-723-8325|cconrad@stanford.edu
107063|NCT00809133|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107064|NCT00809146|University of Michigan|Robert Silbergleit MD, Principal Investigator|734-232-2142|robie@umich.edu
107065|NCT00809159|Novartis|Study Director|862-778-8300|
107066|NCT00809185|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Anjali Advani|216-445-9354|advania@ccf.org
107067|NCT00809276|SKCCC|Leo Luznik, MD|410-502-7732|lluznik2@jhmi.edu
107068|NCT00809328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107069|NCT00809445|Columbia University, Mailman School of Public Health|Dr. Lisa Metsch|212-305-3577|lm2892@columbia.edu
107070|NCT00809458|UNM Cancer Center|Richard Lauer, MD|505-925-0390|rlauer@salud.unm.edu
107071|NCT00809471|Vivus, Inc|Wesley W Day PhD|650-934-5200|
107072|NCT00809523|Yale University|Paul Desan, MD, PhD|203 785 2618|paul.desan@yale.edu
107073|NCT00809614|Novartis|Study Director|862-778-8300|
107074|NCT00809757|Sunovion|Respiratory Medical Director|1-866-503-6351|
107075|NCT00809809|Integrative Medicine Institute|David Riley, MD|505 690-0688|dsriley@integrativemed.org
107076|NCT00809835|Yale University School of Medicine|Kathleen M. Carroll, Ph.D., Albert E Kent Professor of Psychiatry|203.937.3486 ext 7403|kathleen.carroll@yale.edu
107077|NCT00809848|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
107078|NCT00809926|Novartis Pharmaceuticals|Study Director|862-778-8300|
107079|NCT00809965|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Development Head Cardiovascular/Urology|1 215 628-5257|
107081|NCT00810069|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
107082|NCT00810082|Dartmouth College|Dr. Jon D. Lurie, MD, MS|603-653-3575|Jonathan D. Lurie <Jonathan.D.Lurie@hitchcock.org>
107083|NCT00810095|MindFrame, Inc .|Dr. Thomas J. McCarthy|949-204-0806|tmccarthy@mindframeinc.com
107084|NCT00810108|University of California San Diego|Dr. Brookie M. Best, Associate Professor|858-822-5550|brookie@ucsd.edu
107085|NCT00810199|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
107086|NCT00810277|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
107087|NCT00810303|Department of Clinical Pharmacology|Danilo Wegner|+4903834865640|dwegner@uni-greifswald.de
107088|NCT00810342|University of Hawaii, School of Nursing|Cheryl Albright|8089569716|cherylal@hawaii.edu
107089|NCT00810355|Richard L. Roudebush VA Medical Center|Dr. Paul Lysaker|317-988-2546|paul.lysaker@va.gov
107090|NCT00810368|Georgetown University Medical Center|Dr. James N Baraniuk|202-687-8231|baraniuklab@gmail.com
107091|NCT00810394|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu
107092|NCT00810511|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
107093|NCT00810576|UT MD Anderson Cancer Center|Barbara Pro, MD|713-792-2933|
107094|NCT00810602|University of Michigan Comprehensive Cancer Center|Dr. Sung Choi|734-764-8630|sungchoi@med.umich.edu
107095|NCT00788255|Stanford University School of Medicine|Dr. Alexander Butwick|(650) 736-8513|ajbut@stanford.edu
107096|NCT00788372|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387|
107097|NCT00788593|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634|
107099|NCT00788710|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
107100|NCT00788775|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu
107101|NCT00788957|Amgen Inc.|Study Director|866-572-6436|
107102|NCT00794365|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107103|NCT00794469|Hadassah Medical Organization|Gal Dubnov-Raz|+972+54-4570250|gal-d@bezeqint.net
107104|NCT00794508|University of California Los Angeles|Dr. Donald B. Kohn|310-794-1964|dkohn1@mednet.ucla.edu
107106|NCT00794560|Pharmaceutical Care Research Group, University of Basle, Switzerland|Dr. Seraina Mengiardi|061 267 15 29 ext 0041|seraina.mengiardi@unibas.ch
107107|NCT00794664|Genzyme Corporation|Genzyme Medical Information|617-252-7832|
107108|NCT00794677|Children's Hospital Oakland Research Institute|Ronald M Krauss|510.450.7912|rkrauss@chori.org
107109|NCT00794820|University of Texas (UT) MD Anderson Cancer Center|Susan O'Brien, MD/ Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org
107110|NCT00794924|Kaplan-Harzfeld Geriatric Medical Center|Hilla Zaharoni|97288595350|hilla_z@clalit.org.il
107111|NCT00794963|North Shore Long Island Jewish Health System, Zucker Hillside Hospita, Glen Oaks, NY|Peter Manu, MD|718 470-8290 pmanu@nshs.edu|
107112|NCT00795002|The Sidney Kimmel Comprehensive Cancer Center|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu
107113|NCT00795132|University of Utah|Dr. Michael Pulsipher|801-588-2680|michael.pulsipher@hsc.utah.edu
107114|NCT00795145|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
107115|NCT00795184|Mauna Kea Technologies|Christophe Bailleul|+ 33 1 70 08 09 74|christopheb@maunakeatech.com
107116|NCT00795210|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@partners.org
107117|NCT00795288|Washington University|Michael Diringer|314-362-2999|diringerm@wustl.edu
107118|NCT00795340|Division of Medical Oncology, the Ottawa Hospital, Ottawa, Ontario, Canada|Dr. Scott Laurie|1-613-737-7700|slaurie@toh.on.ca
107119|NCT00795366|University of Miami|Kenneth Proctor, PhD, Professor of Surgery|305-585-1178|kproctor@med.miami.edu
107120|NCT00795509|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107121|NCT00795535|University of Miami|Kenneth Proctor, PhD, Professor of Surgery|305-355-4960|kproctor@med.miami.edu
107122|NCT00795600|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
107123|NCT00795639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107124|NCT00795704|University of Mississippi Medical Center|Daniel Riche|601-984-2640|driche@umc.edu
107125|NCT00795717|Tufts University School of Medicine|Christine A. Wanke, MD|617-636-3811|christine.wanke@tufts.edu
107126|NCT00795769|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org
107127|NCT00795886|Primary Children's Medical Center|Michael Pulsipher, MD|801-662-4732|Michael.Pulsipher@hsc.utah.edu
107128|NCT00795951|Rady Children’s Hospital, San Diego, CA|SE Jacob, MD and L Eichenfield, MD|858-576-1700 ext 4825|leichenfield@rchsd.org
107129|NCT00796003|Janssen Pharm KK Japan|Director|+81-3-4411-5801|
107130|NCT00796120|PharmaMar SA Av de los Reyes 1, Poligono Industrial La Mina 28770 Colmenar Viejo, Madrid, Spain|Medical Specialist, Clinical Oncology|+34 91 646-6087|
107131|NCT00796224|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
107132|NCT00796302|Ohio State University|Michael Aman|614-688-4196|Aman.1@osu.edu
107133|NCT00796315|Procter & Gamble|Guhan Balan|513.622.2657|balan.g@pg.com
107134|NCT00796328|IWK Health Centre|Dr. Ron George|470-6627|rbgeorge@dal.ca
107135|NCT00796367|Vivus, Inc|Wesley W Day, PhD|650.934.5200|day@vivus.com
107136|NCT00796419|Emory University|Greg Martin, MD, MSc|404-616-0148|greg.martin@emory.edu
107137|NCT00796510|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107138|NCT00796523|University of Toledo|Jonna M. McRury, M.D.|419-389-1118|jmcrury@aol.com
107139|NCT00796549|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107140|NCT00796614|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107141|NCT00796627|Johns Hopkins University|Dr. John Harmon|410-550-0405|jharmon@jhmi.edu
107142|NCT00796653|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107143|NCT00796666|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107144|NCT00796705|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
107145|NCT00796718|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
107146|NCT00796744|US Biotest|Dr. Shelagh Verco|805-595-1300|shelagh.verco@usbiotest.com
107147|NCT00796757|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
107149|NCT00796926|Singapore National Eye Center|Dr Louis Tong|65 62277255|Louis.tong.h.t@snec.com.sg
107150|NCT00796991|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
107151|NCT00797108|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107152|NCT00797212|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com
107153|NCT00797277|National Taiwan University Hospital|Dr. Tzung-Jeng Hwang|+886-2-23123456 ext 66792|tjhwang@ntu.edu.tw
107154|NCT00797316|Novartis Pharmaceuticals|Study Director|862-778-8300|
107155|NCT00797459|Medicis|Ron Staugaard|480-291-5652|rstaugaard@medicis.com
107156|NCT00797511|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
107157|NCT00797563|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com
107158|NCT00799227|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
107159|NCT00799292|Mt Sinai School of Medicine, Department of Obstetrics and Gynecology|Charles Ascher-Walsh MD, MPH|212-241-2827|charles.ascher-walsh@mssm.edu
107160|NCT00799396|University of Maryland School of Medicine|Alan R Shuldiner, MD|410-706-1623|ashuldin@medicine.umaryland.edu
107161|NCT00799409|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136|
107162|NCT00799422|Alcon Research, Ltd.|Head, Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com
107163|NCT00799435|Baylor|David Aguilar, MD|713-798-0280|daguilar@bcm.edu
107164|NCT00799474|The University of North Carolina at Chapel Hill, Gillings School of Global Public Health|Dr. Noel Brewer, PhD|919-966-3282|ntb1@unc.edu
107165|NCT00799487|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136|
107166|NCT00799578|Columbia University|Dr. Joel Lavine|212 304 5533|jl3553@columbia.edu
107167|NCT00799591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107168|NCT00799604|The Medicines Company|Jason Campagna. MD, PhD|973-290-6199|jason.campagna@themedco.com
107171|NCT00799708|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
107172|NCT00799773|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-923-7747 ext 548|sassmann@neriscience.com
107173|NCT00799825|GlaxoSmithKline|GSK Response Center|866-435-7343|
107174|NCT00799903|GlaxoSmithKline|GSK Response Center|866-435-7343|
107175|NCT00800202|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
107176|NCT00800254|University of Colorado Denver|Jennifer Stevens-Lapsley, PhD|303-724-9170|jennifer.stevens-lapsley@ucdenver.edu
107177|NCT00800345|Vector Oncology|Vice President of Scientific Affairs|901.435.5570 ext 1759|mwalker@vectoroncology.com
107178|NCT00800384|Population Health Research Institute, McMaster University|Dr. Jeff Healey|001 905 330 6760|jeff.healey@phri.ca
107179|NCT00800436|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
107180|NCT00800540|Alcon Research, Ltd.|Director, Global Medical Affairs|1-888-451-3937|
107181|NCT00800683|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107182|NCT00800735|Hoffmann-La Roche|Medical Communications|800 821-8590|
107183|NCT00800839|The University of Texas (UT) MD Anderson Cancer Center|Amin M. Alousi, MD/Stem Cell Transplantation||CR_Study_Registration@mdanderson.org
107184|NCT00800865|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107185|NCT00800982|University of California San Francisco|Dr Ethan Levin|4154764019|levine@derm.ucsf.edu
107186|NCT00801099|Swiss Tropical Institute|Franziska Saxer, MD||franziskabrenneke@yahoo.com
107187|NCT00801138|Cleveland Clinic Foundation|Daniel I Sessler, MD|2164458396|sesslerd@ccf.org
107188|NCT00801229|Massachusetts General Hospital|Joseph Biderman, MD|617-726-1746|
107189|NCT00801242|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
107190|NCT00810641|KONOS|Treatment of apogeotropic HC BPPV|82 10 5538 6565|ohsun@jbnu.ac.kr
107191|NCT00810693|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
107192|NCT00810719|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu
107193|NCT00810771|VA Ann Arbor Healthcare System, Center for Clinical Management Research|Sarah Hawley, Ph.D.|734-936-8816|sarahawl@umich.edu
107194|NCT00810901|University of Hawaii, School of Nursing|Cheryl Albright|8089569716|cherylal@hawaii.edu
107195|NCT00811382|BIOTRONIK|Mathias Freudigmann|+49(0)30 68905 - 1248|mathias.freudigmann@biotronik.com
107196|NCT00811395|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com
107197|NCT00811434|Riley Hospital|Girish Subbarao|317-944-3774|gsrao@iupui.edu
107198|NCT00811473|AstraZeneca|Gerard Lynch||aztrail_results_posting@astrazeneca.com
107199|NCT00811564|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com
107200|NCT00811577|Capstone Therapeutics Corp.|Denise Lamon|602-286-5206|dlamon@capstonethx.com
107201|NCT00811590|Huntsman Cancer Institute|Dr. Randall Burt|801-585-3281|randall.burt@hci.utah.edu
107202|NCT00811642|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
107203|NCT00811655|Duke University Medical Center|Denise Lally-Goss, NP|919-684-3862|denise.lallygoss@dm.duke.edu
107204|NCT00811720|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
107205|NCT00811733|GlaxoSmithKline|GSK Response Center|866-435-7343|
107206|NCT00811798|GlaxoSmithKline|GSK Response Center|866-435-7343|
107207|NCT00811850|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com
119336|NCT01961297|Icahn School of Medicine at Mount Sinai|Dr. Kristina Simonyan|212-241-0656|kristina.simonyan@mssm.edu
107209|NCT00811941|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
107210|NCT00811954|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
107211|NCT00812006|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
107212|NCT00812097|Mentor|Michael Schwiers|513-337-1172|mschwier@its.jnj.com
107213|NCT00812110|Akron Children's Hospital|P. Cooper White, M.D.|330-543-8530|CWhite@chmca.org
107214|NCT00812253|The Ohio State University|Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu
107215|NCT00812331|Janssen Research & Development United States|Global Clinical DVLP Manager||ClinicalTrialDisclosure@its.jnj.com
107216|NCT00812461|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
107217|NCT00812487|Ohio State University|Kathleen Dungan, MD, MPH|614-685-3333|kathleen.dungan@osumc.edu
107218|NCT00812565|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201-604-1155|michael.eppolito@octapharma.com
107219|NCT00812604|University of Hong Kong|Dr. Ricky Wing Kit Wong, Associate professor in orthodontics|852-2859 0554|fyoung@hkucc.hku.hk
107220|NCT00812812|GlaxoSmithKline|GSK Response Center|866-435-7343|
107221|NCT00812877|Oregon Health & Science University|Dr. Thomas J. Hilton|503.494.8672|hiltont@ohsu.edu
107222|NCT00812916|Biosense Webster, EMEA|Nathalie Macours|+32 2 7463076|MNathalie@its.jnj.com
107223|NCT00812929|GlaxoSmithKline|GSK Response Center|866-435-7343|
107224|NCT00812955|AstraZeneca|Gerard Lynch|+44 1509 645 895|aztrial_results_posting@astrazeneca.com
107225|NCT00812968|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
107226|NCT00812981|GlaxoSmithKline|GSK Response Center|866-435-7343|
107227|NCT00813098|Lexicon Pharmaceuticals, Inc.|Clinical Project Manager|281-863-3000|
107228|NCT00813111|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com
107229|NCT00813150|Jan-Cil Germany|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com
107230|NCT00813319|Emory University Rollins School of Public Health|Dr. Ralph DiClemente, Principal Investigator|404-727-0237|rdiclem@emory.edu
107231|NCT00813488|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855|
107232|NCT00813592|Huntsman Cancer institute|Randy Jensen, MD, PhD|801-585-0255|randy.jensen@hci.utah.edu
107233|NCT00813709|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
107234|NCT00813748|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
107235|NCT00813761|Vistakon|Kristy Canavan, OD|1-904-443-1474|kcanava2@its.jnj.com
107236|NCT00805545|University of Florida|Patrick Duff, M.D.|352 273 7673|duffp@ufl.edu
107238|NCT00805740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107240|NCT00805792|Mayo Clinic|James F. Meschia, MD|904-953-2903|meschia.james@mayo.edu
107241|NCT00805870|Western Michigan University|Dr. Christopher C. Cheatham|269-387-2542|chris.cheatham@wmich.edu
107242|NCT00805935|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
107243|NCT00805961|Sarah Cannon Research Institute|John D. Hainsworth, MD.|877-691-7274|ASKSARAH@scresearch.net
107244|NCT00806026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107245|NCT00806078|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com
107246|NCT00806195|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
107247|NCT00806221|Oregon Health & Science University|Eric Simpson, MD, MCR|503-494-2121|simpsone@ohsu.edu
107248|NCT00806234|Johns Hopkins University|Dr. Mark Riddle|410-302-6120|mriddle1@jhmi.edu
107249|NCT00806260|Vivus, Inc.|Wesley W Day, PhD|650-934-5200|day@vivus.com
119338|NCT01866319|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107251|NCT00806390|UMaryland|Stephen Gottlieb|410-328-8788|sgottlie@medicine.umaryland.edu
107252|NCT00806403|Sahlgren's University Hospital/S, Gothenburg|Lars Grip||lars.grip@vgregion.se
107253|NCT00806416|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
107254|NCT00806442|Brigham and Women's Hospital|Elliot Israel, MD|617-732-2801|eisrael@partners.org
107255|NCT00806494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107256|NCT00806546|NuPathe Inc.|Mark Pierce, MD, PhD|484-567-0130|mpierce@nupathe.com
107257|NCT00806585|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDevelopment@merck.com
107258|NCT00806598|The University of Texas MD Anderson Cancer Center|Tapan Kadia, MD/Assistant Professor|713-563-3534|eharriso@mdanderson.org
107259|NCT00806624|Daiichi Sankyo.,LTD|Atsushi Nonogaki, Manager|81-80-3029-7553|nonogaki.atsushi.zz@daiichisankyo.co.jp
107260|NCT00806676|Johns Hopkins University School of Medicine|Dr. Jeffrey Fadrowski|410-955-2467|jfadrow1@jhmi.edu
107261|NCT00806819|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107262|NCT00806988|Icahn School of Medicine at Mount Sinai|Alan Moskowitz, MD|212-659-9568|alan.moskowitz@mountsinai.org
107263|NCT00807001|Idenix Pharmaceuticals, Inc.|John Z. Sullivan-Bolyai, MD, MPH|877-433-6491|
107264|NCT00807014|GlaxoSmithKline|GSK Response Center|866-435-7343|
107265|NCT00807040|Icahn School of Medicine at Mount Sinai|Alan Moskowitz, MD|212-659-9568|alan.moskowitz@mountsinai.org
107266|NCT00807092|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
107267|NCT00807209|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com
107268|NCT00807235|Discovery Laboratories, Inc.|Robert Segal, MD|215-488-9300|rsegal@discoverylabs.com
107269|NCT00807248|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
107270|NCT00807365|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|4105506484|registerclinicaltrials@jhmi.edu
107271|NCT00807456|DENTSPLY Implants|Manager Global Clinical Affairs|+46313763500|ClinicalResearchMolndal@dentsplysirona.com
107272|NCT00807560|Icahn School of Medicine at Mount Sinai|Katharine Loeb, PhD|212-659-8724|Katharine.Loeb@mssm.edu
107273|NCT00807573|Memorial Sloan Kettering Cancer Center|Dr. Maria Pietanza, Assistant Attending|+1646-888-4203|PietanzM@mskcc.org
107274|NCT00807846|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107275|NCT00807885|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com
107276|NCT00807937|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
107277|NCT00807989|Yonsei University Severance Hospital|Dr. Yoon||BILEE@yuhs.ac
107278|NCT00808015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107279|NCT00808028|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107280|NCT00808067|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107281|NCT00808080|UC San Diego Moores Cancer Center|Dr. Thomas Lane, Stem Cell Lab Director|858-822-5364|jreiner@Ucsd.edu
107282|NCT00813800|Mayo Clinic|Mark Frye, MD|507-255-9391|mfrye@mayo.edu
107283|NCT00813813|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com
107284|NCT00813904|ZymoGenetics, a Bristol-Myers Squibb company|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com
107285|NCT00813917|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu
107286|NCT00813943|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
107287|NCT00813982|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
107288|NCT00813995|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107289|NCT00814710|GlaxoSmithKline|GSK Response Center|866-435-7343|
107290|NCT00814775|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org
107291|NCT00814788|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu
107292|NCT00814801|Janssen Pharm KK Japan|Director|81-3-4411-5717|
107293|NCT00814879|Yale University School of Medicine: Internal Medicine: Infectious Diseases: AIDS Care Program / Viral Hepatitis Program|Dr. Michael J. Kozal|(203)737-4040|michael.kozal@yale.edu
107294|NCT00814892|Mayo Clinic|Dr. Manish Kohli|507-284-2511|kohli.manish@mayo.edu
107471|NCT00824265|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
107295|NCT00814970|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com
107296|NCT00814983|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|Mitchell.Horwitz@duke.edu
107297|NCT00815035|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu
107298|NCT00815087|Wang tyng|Dr.Wang TG|+886-2-23123456 ext 67587|patty.jt@gmail.com
107299|NCT00815191|Cleveland Clinic Foundation|Daniel Sessler|216-444-4900|DS@OR.org
107300|NCT00815295|Duke University Medical Center|Neal Ready, MD|919-668-6688|neal.ready@duke.edu
107301|NCT00815308|Shandong Cancer Hospital and Institute|Jinming Yu|86-531-87984729|jn7984729@public.jn.sd.cn
107302|NCT00815347|University of Connecticut Health Center|MArk Metersky, MD|860-679-3582|metersky@nso.uchc.edu
107303|NCT00815360|Retina Associates of Florida, P.A.|Dr. Ivan J. Suner|813-875-6373|ivansuner@gmail.com
107304|NCT00815490|Duke University Medical Center|Dr David MacLeod|919-812-3201|david.macleod@duke.edu
107305|NCT00815516|Astellas Pharma Global Development, Inc. (APGD)|Senior Medical Director, Global Medical Science||Astellas.resultsdisclosure@astellas.com
107306|NCT00815659|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
107307|NCT00815685|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D., via Moffitt Cancer Center|813-745-6885|nagi.kumar@moffitt.org
107308|NCT00815698|Herlev Hospital, dept. of Surgery|Jacob Rosenberg|+45 26237323|jacob.rosenberg@regionh.dk
107309|NCT00815776|Ascentia Health, Inc.|Lawrence G. Clayton, M.A., Study Director|(815) 484-9258|LGClayton@aol.com
107310|NCT00815919|Dana-Farber Cancer Institute|John Koreth, MBBS, DPhil|617-632-2949|John_Koreth@dfci.harvard.edu
107311|NCT00816023|Cubist Pharmaceuticals, Inc.|Alistair Wheeler, MD, MFPM, Senior Director Clinical Research|781-860-8660|awheeler@cubist.com
107312|NCT00816036|Department of Veterans Affairs|David Katz, MD, MSc|319-338-0581 ext 7598|david-katz@uiowa.edu
107313|NCT00816101|Sheftel Associates Dermatology, LLC|Scott Sheftel, MD|520-293-5757 ext 7106|ssheftel@sheftelderm.com
107314|NCT00816166|Codman Neuro|Jonathan Megerian, MD PhD|508-880-8274|jmegeri1@its.jnj.com
107315|NCT00816348|NSLIJ Health System|Cindy Haller MD|516-472-3650|challer@lij.edu
107316|NCT00816400|MedImmune|A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575|1-877-240-9479|information.center@astrazeneca.com
119339|NCT01864200|BTG|Shirley Steiner, Director of Clinical Operations|610 943 3631|shirley.steiner@btgplc.com
107318|NCT00816595|Mayo Clinic|Tait Shanafelt, M.D.||shanafelt.tait@mayo.edu
107319|NCT00816777|Generic Devices Consulting, Inc|John Greenbaum|772-353-5301|genericd@bellsouth.net
107320|NCT00816829|Solvay Pharmaceuticals|Sven Voet, Global Communication|+32 (0) 2 509 69 77|sven.voet@solvay.com
107321|NCT00816907|Columbia University|Dr. Scott Stroup|212-543-5676|stroups@nyspi.columbia.edu
107322|NCT00798096|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com
107323|NCT00798135|IndianaU|Kathy Miller, MD||kathmill@iupui.edu
107324|NCT00798161|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107325|NCT00798304|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107326|NCT00798317|ThromboGenics|Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com
107327|NCT00798369|Novartis Pharmaceuticals|Study Director|862-778-8300|
107328|NCT00798434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107329|NCT00798486|Ascensia Diabetes Care|Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com
107330|NCT00798577|Alcon Labs|Alcon Clinical|1.888.451.3937; 817.568.6725|medinfo@alconlabs.com
107331|NCT00798590|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu
107332|NCT00798603|Roswell Park Cancer Institute|Grace K. Dy, M.D.|507-284-9265|grace.dy@roswellpark.org
107333|NCT00798655|University of Pittsburgh|Robert Ferris, MD|412-647-4654|ferrrl@UPMC.EDU
107334|NCT00798707|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107335|NCT00798720|University of Wisconsin|Abigail Mapes, Thoracic Oncology Research Program Manager|(608) 262-8158|acmapes@medicine.wisc.edu
107336|NCT00798759|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com
107337|NCT00798889|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107338|NCT00798967|NPS Pharmaceuticals|Head, Clinical Development|908-450-5300|
107339|NCT00804570|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
107340|NCT00804596|Ascensia Diabetes Care|Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com
119340|NCT01859312|National Institute of Child Health and Human Development (NICHD)|Deborah P. Merke, MD, MS|301-496-0718|DMerke@cc.nih.gov
107342|NCT00804648|Vistakon|Arthur Shedden MD|904-443-1557|
107343|NCT00804687|Janssen Research and Development|Senior Medical Director|858-784-3111|
107344|NCT00804713|USUHS|James Mancuso|301-295-3734|james.mancuso@usuhs.edu
107346|NCT00804908|AbbVie|Global Medical Information|800-633-9110|
107347|NCT00804986|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
107348|NCT00805025|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
107349|NCT00805038|Case Western Reserve University|Ash Sehgal|216-778-7728|axs81@cwru.edu
107350|NCT00805142|Janssen R&D, 1125 Trenton-Harbourton Road, Titusville, PA 18902, USA|Senior Director, Clinical Leader|609-730-6777|
119342|NCT01793935|University of Pittsburgh|Dr. K.N. Roy Chengappa - PI|412-246-5006|chengappakn@upmc.edu
107352|NCT00805285|University of Maryland, Baltimore|Raymond Cross, MD, MS|410-706-3387|rcross@medicine.umaryland.edu
107353|NCT00805389|GlaxoSmithKline|GSK Response Center|866-435-7343|
107354|NCT00805467|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
107355|NCT00805480|Novartis Pharmaceuticals|Study Director|862-778-8300|
107356|NCT00805493|Emotion and Development Branch, NIMH-IRP|Kenneth Towbin, M.D., Chief Clinical Child and Adolescent Psychiatry|301-402-4403|Kenneth.Towbin@nih.gov
107357|NCT00811018|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107358|NCT00811057|University of Mississippi Medical Center|Dr. Rick Martin|601-815-7035|rmartin@umc.edu
107359|NCT00811070|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107360|NCT00811135|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
107361|NCT00811174|Octapharma|Michael Eppolito|201-604-1155|michael.eppolito@octapharma.com
107362|NCT00811252|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
107363|NCT00817206|Veloxis Pharmaceuticals A/S|Christina Sylvest|+45 20553877|csy@veloxis.com
107364|NCT00817219|LEO Pharma A/S|Malin Järnkrants|+45 7226 2990|malin.jaernkrants@leo-pharma.com
107365|NCT00817336|Nathan Kline Institute|Joshua Kantrowitz|646-774-6738|jk3380@cumc.columbia.edu
107366|NCT00817479|The University of Chicago, Department of Medicine|Dr. Gini Fleming, MD|(773) 702-6149|gfleming@medicine.bsd.uchicago.edu
107367|NCT00818441|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107368|NCT00818454|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107369|NCT00818519|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
107370|NCT00818623|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
107371|NCT00818649|Masonic Cancer Center, University of Minnesota|Erica Warlick, M.D.|612-625-5467|ewarlick@umn.edu
107373|NCT00818753|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107374|NCT00818766|Brigham & Women's Hospital|David Oxman, MD|215-503-1198|doxman2001@yahoo.com
107376|NCT00818805|Alcon Labs|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
107377|NCT00818883|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
107378|NCT00818961|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com
107379|NCT00819013|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
107380|NCT00819039|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107381|NCT00819052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107382|NCT00819091|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107383|NCT00819156|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
107384|NCT00819182|Indiana University|Janet S Carpenter, PhD, RN, FAAN|317-278-6093|carpentj@iupui.edu
107385|NCT00819234|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
107386|NCT00819247|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
107387|NCT00819260|Dartmouth-Hitchcock|Carolyn L. Kerrigan MD|603-650-5148|carolyn.kerrigan@hitchcock.org
107388|NCT00819286|Biomet Microfixation|Brian Hatcher|904-741-4400|brian.hatcher@biomet.com
107390|NCT00819403|Univ Maryland|Dr Michael Miller|410 328-6299|mmiller@medicine.umaryland.edu
107391|NCT00819507|Oregon Health & Science University|Eric Simpson|503-494-2121|simpsone@ohsu.edu
107392|NCT00819585|Novartis Pharmaceuticals|Study Director|862-778-8300|
107393|NCT00819637|Henry Ford Health System, Detroit, Michigan|Richard M Nowak MD|313 881 0023|rnowak1@hfhs.staff
107394|NCT00819741|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
107395|NCT00819767|Novartis Pharmaceuticals|Study Director|862 778-8300|
107397|NCT00819832|UT MD Anderson Cancer Center|Dawid Schellingerhout, MD/Asst. Professor||CR_Study_Registration@mdanderson.org
107398|NCT00819910|Brooke Army Medical Center|Ahmad Slim, MD|2109164717|ahmad.slim@us.army.mil
107399|NCT00820222|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
107400|NCT00820248|Canadian Cancer Trials Group|Wendy Parulekar|613-533-6430|wparulekar@ctg.queensu.ca
107401|NCT00820443|MicroPort Orthepedics|Matt C. Paul, Project Manager|(901) 867-4350|mpaul@ortho.microport.com
107402|NCT00820534|Novartis Consumer Health|Head of Clinical Research|+4122363311|
107403|NCT00820573|University of Texas HSC at San Antonio|Eugenio Cersosimo, MD PhD|210 358 7200|Eugenio.cersosimo@uhs-sa.com
107404|NCT00820612|University of Michigan|B. Joseph Elmunzer, MD.|735 615 6652|badihe@umich.edu
107405|NCT00820664|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
107406|NCT00820755|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
107407|NCT00820872|Mayo Clinic|Alvaro Moreno-Aspitia, M.D.|(904) 953-7291|morenoaspitia.alvaro@mayo.edu
107408|NCT00797667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107409|NCT00797797|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|1-201-427-8218|robert.palmer@frx.com
107410|NCT00797823|Legacy Health System|W Kenneth Ward MD|503-413-5171|wardk@ohsu.edu
107411|NCT00797862|Novartis Pharmaceuticals|Study Director|862- 778- 8300|
107412|NCT00797966|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974|
107413|NCT00798018|Department of Anesthesiology, West China Second Hospital|Han Huang|80-028-8550-3753|huanghan1981@hotmail.com
107414|NCT00814138|University of Kansas Medical Center|Richard J. Barohn, MD/ Chairman of Neurology|913-588-6094|rbarohn@kumc.edu
107415|NCT00814164|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
107416|NCT00814177|McMaster University|Sam Schulman, MD|1-905-5270271 ext 44479|schulms@mcmaster.ca
107417|NCT00814255|NYUmed|Howard Trachtman|646-501-2663|howard.trachtman@nyumc.org
107418|NCT00814307|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107420|NCT00814333|University of Kansas Medical Center|Kevin Sykes, PhD|913-588-7154|ksykes@kumc.edu
107421|NCT00814346|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
107422|NCT00814463|Duke University Medical Center|Denise Lally-Goss, NP|919-684-3862|denise.lallygoss@dm.duke.edu
107423|NCT00814489|GlaxoSmithKline|GSK Response Center|866-435-7343|
107424|NCT00814502|Massachusetts General Hospital|Kaloyan Tanev, M.D.|617-726-7511|ktanev@partners.org
107425|NCT00814580|Ortho-McNeil Janssen Scientific Affair, LLC|Senior Director of Clinical Development, Pain|(908)927-5469|GVorsang@its.jnj.com
107426|NCT00814632|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu
107427|NCT00814658|Jan-Cil Brazil|Medical Group Manager|55 11 3030-2770|
107428|NCT00814671|Johns Hopkins University|Susan Dorman|410-955-1755|dsusan1@jhmi.edu
107429|NCT00814697|The NY Memory and Healthy Aging Services|Dr. Gayatri Devi|212-517-6881|gd@nymemory.org
107430|NCT00821041|University of Manitoba|Study Coordinator|204-787-5098|NVincent@exchange.hsc.mb.ca
107431|NCT00821093|Novartis Pharmaceuticals|Study Director|862 778-8300|
107432|NCT00821119|Instituto Materno Infantil prof. Fernando Figueira|Jucille Meneses|55 (81) 2122-4100 ext 4135|jmeneses@elogica.com.br
107433|NCT00821184|Lahey Clinic|John T. Stoffel, MD|781-744-5481|John.T.Stoffel@lahey.org
107434|NCT00821236|Durrie Vision|Brigette Ellis|913-491-3330 ext 7255|bellis@durrievision.com
107436|NCT00822172|CPC Clinical Research|William Hiatt, MD, President|3038609900|william.hiatt@cpcmed.org
107437|NCT00822185|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
107438|NCT00822237|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107439|NCT00822328|Cheng Hsin Rehabilitation Medical Center|Dr.Yi-Hsien Lin|+886-2-28264400 ext 5750|d49311001@ym.edu.tw
107440|NCT00822354|Northwestern University|Clinical Trials Coordinator|312-695-6829|j-bae@northwestern.edu
107441|NCT00822510|University of Arizona College of Nursing|Terry Badger, PhD, PMHCNS-BC, FAAN|520-626-6058|tbadger@email.arizona.edu
107442|NCT00822523|Loma Linda University|Gordon Perterson, MD|909-558-4000|gpeterson@llu.edu
107443|NCT00822588|Astra Tech AB|Head of Clinical Research Area Health Care|+46317763000|
107444|NCT00822679|University of Arizona|Sairam Parthasarathy|5206266109|sparthasarathy@deptofmed.arizona.edu
107445|NCT00822692|Wilford Hall Medical Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com
107446|NCT00822757|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107447|NCT00822770|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PhD / Associate Professor|713-794-1628|mkonople@mdanderson.org
107448|NCT00822900|Emergency Neurosciences, Emergency Medicine, Emory University|David W. Wright, Associate Professor, Department of Emergency Medicine, Emory University|404-778-1709|david.wright@emory.edu
107449|NCT00822926|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu
107450|NCT00823043|Vistakon|Arthur Shedden MD|904-443-1557|
107451|NCT00823069|Medicis|Mary Sanstead|480-291-5926|msanstead@medicis.com
107452|NCT00823082|GrifolsTherapeutics Inc.|Michael Ken Woodward, BSc, M.Sc|+1 919-316-6675|michael.woodward@grifols.com
107453|NCT00823095|Loma Linda University Medical Center|Deborah Dodge|(909) 558-4000 ext 48500|ddodge@llu.edu
107454|NCT00823199|Bronx Psychiatric Center|Nigel Bark MD|7188625429|Nigel.Bark@omh.ny.gov
107455|NCT00823212|Boston Scientific Corporation|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com
107456|NCT00823264|Emory University|Dr. Brent Morgan|404-616-4403|bmorg02@emory.edu
107457|NCT00823303|Washington University School of Medicine|Dr. Daniel W. Coyne|3143627211|dcoyne@dom.wustl.edu
107458|NCT00823472|UMC Utrecht|Prof. dr. B.C.J.M. Fauser|+31-88-7557524|b.c.fauser@umcutrecht.nl
107459|NCT00823615|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
107460|NCT00823719|GlaxoSmithKline|GSK Response Center|866-435-7343|
107461|NCT00823797|University of Washington|Maciej Mrugala, MD, PhD, MPH|206-543-4069|mmrugala@uw.edu
107462|NCT00823823|Children's Hospital Boston|Dr. Donald Bae|617-355-6808|donald.bae@childrens.harvard.edu
107463|NCT00823836|GlaxoSmithKline|GSK Response Center|866-435-7343|
107464|NCT00823901|MGH CURTIS|Alexandra B. Kimball, MD|617-726-5066|harvardskinstudies@partners.org
107465|NCT00823966|Pfizer, Inc.|Pfizer ClinicalTraials.gov Call Center|1-800-718-1021|ClinicalTraials.govCallCenter@pfizer.com
107466|NCT00823979|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107467|NCT00824005|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com
107468|NCT00824044|Massachusetts General Hospital|Dr. Amy Farabaugh|617-726-1629|afarabaugh@partners.org
107469|NCT00824070|Bausch & Lomb Inc|Tuyen Ong, MD|(973) 360-6389|tuyen.ong@bausch.com
107470|NCT00824161|The University of Texas M.D. Anderson Cancer Center|Scott Kopetz, MD|713-792-2828|
107472|NCT00824291|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107473|NCT00824369|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107474|NCT00824382|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107475|NCT00824408|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107476|NCT00824421|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107477|NCT00824434|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com
107478|NCT00824460|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com
107479|NCT00824473|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us
107480|NCT00817531|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu
107481|NCT00817596|Medasys, Inc.|Clinical Trials Manager|973-426-9229|jarrambide@medasyspumps.com
107482|NCT00817778|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
107483|NCT00817804|Respironics California|Adam Seiver|760-703-6993|adam.seiver@philips.com
107484|NCT00817843|UMC Utrecht|Professor F.L.J. Visseren, MD PhD|0031-88-7555555|f.l.j.visseren@umcutrecht.nl
107485|NCT00817999|Creighton University|Tammy Burns, PharmD|402-280-4292|TammyBurns@creighton.edu
107486|NCT00818116|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
107487|NCT00818168|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
107488|NCT00818207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107489|NCT00818246|RoseLab Skin Optics Laboratory|Dr Daniel Barolet|(514) 343-4444|daniel.barolet@mcgill.ca
107490|NCT00818259|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107491|NCT00818272|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
107492|NCT00818324|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
107493|NCT00818337|Creighton University|Kathleen Packard, PharmD|402-280-2668|kpackard@creighton.edu
107494|NCT00818389|Massachusetts General Hospital|Elizabeth Simpson|617-726-3430|esimpson1@partners.org
107495|NCT00824512|Ipsen|Medical Director, Primary Care|clinical.trials@ipsen.com|clinical.trials@ipsen.com
107496|NCT00824538|University of California San Francisco|Hope S Rugo|415-353-7618|hrugo@medicine.ucsf.edu
107497|NCT00824564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107498|NCT00824616|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107499|NCT00824655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107500|NCT00824720|Vistakon|Brian Schwam MD/Director Clinical Affairs & Ocular Sciences|904-443-1482|
107501|NCT00824733|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy, MD|614-293-8858|Bhuvaneswari.Ramaswamy@osumc.edu
107502|NCT00824746|Chonnam National University Hwasun Hospital|Young-Chul Kim, MD, PhD|82-61-379-7614|kyc0923@jnu.ac.kr
107503|NCT00824772|Inje University|Kye-Min Kim, Associate Professor, Dept of Anesthesiology & Pain Medicine|82-2-950-1168|kyemin@paik.ac.kr
107504|NCT00824824|Massachusetts Eye and Ear Infirmary|Louis R. Pasquale, MD|617-573-4270|Louis_Pasquale@meei.harvard.edu
107505|NCT00826176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
107506|NCT00826202|Nathan Kline Institute|Daniel Javitt MD, PhD|845-398-6534|javitt@nki.rfmh.org
107507|NCT00826228|Northwestern University Feinberg School of Medicine|Thomas J Schnitzer|3125032315|tjs@northwestern.edu
107508|NCT00826267|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107509|NCT00826280|Astellas Pharma Global Development|Senior Medical Director||clinicaltrials@us.astellas.com
107510|NCT00826449|University of Texas (UT) MD Anderson Cancer Center|Faye Johnson, Associate Professor, Thoracic/Head & Neck Med Oncology||CR_Study_Registration@mdanderson.org
107511|NCT00826540|Mayo Clinic|Dr. Axel Grothey, M.D.|(507) 284-4430|grothey.axel@mayo.edu
107512|NCT00826618|University of Miami|Thomas A. Albini, MD|3054825006|talbini@med.miami.edu
107513|NCT00826800|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org
107514|NCT00826943|Vanderbilt University|Douglas Tzanetos|615-942-7971|dtzanetos@hotmail.com
107515|NCT00827073|Robert Cizik Eye Clinic|Joseph Selem, MD|713-559-5263|laurabaker@cizikeye.org
107516|NCT00827099|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com
107517|NCT00827112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107518|NCT00827242|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
107519|NCT00827255|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com
107520|NCT00827372|IndianaU|Kathy Miller, MD|317-944-0920|kathmill@iupui.edu
107521|NCT00827502|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
107522|NCT00827541|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107523|NCT00827567|Penn State|Allan Lipton, MD|717-531-5960|alipton@psu.edu
107524|NCT00827606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107525|NCT00827632|Columbia University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu
107526|NCT00827827|Baltimore VAMC|Frederick M. Ivey|410-375-8419|fivey@grecc.umaryland.edu
107527|NCT00827918|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107528|NCT00827931|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107529|NCT00827944|Derriford Hospital, Department of Surgery|Pr. Andrew KINGSNORTH|+44 175 276 3017|Andrew.Kingsnorth@phnt.swest.nhs.uk
107530|NCT00827983|IBSA Institut biochimique|Clinical trial manager|+41583601000|barbara.cometti@ibsa.ch
107531|NCT00828061|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
107532|NCT00828074|City of Hope|Paul Frankel, Ph.D.|626-359-8111 ext 65265|pfrankel@coh.org
107533|NCT00828113|University of Wisconsin School of Medicine and Public Health|Douglas E. Jorenby, Ph.D.|6082627527|dej@ctri.medicine.wisc.edu
107534|NCT00828139|SWOG Statistical Center|Lung Committee Statistician|2066674623|jmoon@fredhutch.org
107535|NCT00828178|Johns Hopkins University School of Medicine|Dr. Michelle Petri|410-955-9114|mpetri@jhmi.edu
107536|NCT00828191|IBSA Institut Biochimique SA|IBSA U.S. Agent|805 376 00 78|cejtwsxx@verizon.net
107537|NCT00828204|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com
107538|NCT00828295|Helsinn Healthcare SA|Salvatore Chessari|+41 91 985 21 21|salvatore.chessari@helsinn.com
107539|NCT00828308|BrUOG|Anthony Mega, MD|4018633000|kayla_rosati@brown.edu
107540|NCT00828321|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107541|NCT00828347|Department of Nephrology, Kumamoto University Graduate School of Medical Sciences|A study of maintenance therapy after intravenous maxacalcitol for secondary hyperparathyroidism|+81-96-373-5164|m-adachi@gpo.kumamoto-u.ac.jp
107542|NCT00828412|Promius Pharma|Joanne Fraser|908 429-4504|joannefraser@promiuspharma.com
107543|NCT00828464|GlaxoSmithKline|GSK Response Center|866-435-7343|
107544|NCT00828516|Lynda Jackson Macmillan Centre|Dr Beverley de Valois|+44(0)1923-844456|beverley.devalois@nhs.net
107545|NCT00828542|Sao Paulo University|Dr. Milena Bastos Brito|551636022814|milenabastos@usp.br
107546|NCT00828568|Taro Pharmaceuticals USA|Medical Director|(914) 345-9001 ext 6427|medical.affairs@taro.com
107547|NCT00821327|US Oncology Research, McKesson Specialty Health|Dr. Matthew D. Galsky|212-659-5412|matthew.galsky@mssm.edu
107548|NCT00821431|ConvaTec|Kim Peters, Director of Clinical Affairs|07889841338|kim.peters@convatec.com
107549|NCT00821509|National Institute for Health and Welfare|Tapani Hovi, Project Leader|+358 400 517299|tapani.hovi@thl.fi
107550|NCT00821587|University of Florida|Roberto J. Firpi-Morell, MD|352-273-9500 ext 9466|firpirj@medicine.ufl.edu
107551|NCT00821678|VA HSR&D|John Fortney|206.764.2821|john.fortney@va.gov
107552|NCT00821821|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
107553|NCT00821873|RTI Biologics|Robin Waite, Director, Clinical Projects|386-418-8888 ext 4172|rwaite@rtix.com
107554|NCT00821886|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
107555|NCT00821951|Yale University|Dr. Roy H Decker, MD PhD|203 737-2758|roy.decker@yale.edu
107557|NCT00828711|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
107558|NCT00828750|GlaxoSmithKline|GSK Response Center|866-435-7343|
107559|NCT00828841|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com
107560|NCT00833755|Massachusetts General Hospital|Dr. Jianren Mao|6177246102|mghpainresearch@partners.org
107561|NCT00833781|Mass General Hospital|Dr. Rajesh Gandhi|617-724-9690|rgandhi@partners.org
107562|NCT00833794|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
107563|NCT00833833|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
119347|NCT01704287|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107565|NCT00833898|University of Colorado Denver|Mark L. Laudenslager, PhD|303-724-9279|biel@ucdenver.edu
107566|NCT00833911|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
107567|NCT00833924|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com
107568|NCT00833937|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107569|NCT00833976|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org
107570|NCT00834041|Novartis Pharmaceuticals|Study Director|862 778-8300|
107571|NCT00834067|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107572|NCT00834080|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|Bernard.Silverman@alkermes.com
107573|NCT00834132|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107574|NCT00834171|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com
107575|NCT00834197|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107576|NCT00834210|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com
107577|NCT00834236|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121 ext 8233|pihsu@vghks.gov.tw
107578|NCT00834249|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107579|NCT00834275|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107580|NCT00834288|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
107581|NCT00834340|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107582|NCT00834366|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
107583|NCT00834405|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107584|NCT00834418|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107585|NCT00834431|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107586|NCT00834444|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107587|NCT00834483|Rush University Medical Center|Dr. Brett R. Levine|312-432-2466|brettlevine@gmail.com
107588|NCT00834522|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107589|NCT00834535|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107590|NCT00834561|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107591|NCT00834574|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107592|NCT00834587|Teva Pharmaceuticals USA|Manger, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107593|NCT00834613|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107594|NCT00834626|Kirloskar Hospital|Dr. Neeraj Gupta|+91-40-23296241|drugale@kirloskarhospital.com
107595|NCT00834639|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107596|NCT00834678|The Ohio State University Comprehensive Cancer Center|Rachel Layman, MD|614-366-8541|Rachel.Layman@osumc.edu
107597|NCT00834717|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107598|NCT00834743|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107599|NCT00834756|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107600|NCT00834795|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107601|NCT00834808|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
107602|NCT00834834|NYSPI|Barbara Stanley, Ph.D.|6467747582|stanley@nyspi.columbia.edu
107603|NCT00834873|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107604|NCT00834886|University of Bergen|Dr. Bjørn Bjorvatn|55586130|bjorn.bjorvatn@igs.uib.no
107605|NCT00834899|University of North Carolina at Chapel Hill|Kenneth I. Ataga, MD|919-966-0178|kataga@med.unc.edu
107606|NCT00834912|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
107607|NCT00834964|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107608|NCT00834977|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107609|NCT00834990|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107610|NCT00835003|Aarhus University Hospital, Dep. Obstetrics and Gynecology, Aarhus, Denmark|MD, PhD Julie Glavind|+4578450000|julie.glavind@dadlnet.dk
107611|NCT00835042|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107612|NCT00835068|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107613|NCT00835081|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107614|NCT00835120|University Hospitals Case Medical Center|Carla Conroy|216-844-2871|carla.conroy@Uhhospitals.org
107615|NCT00835146|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107616|NCT00835159|NYU Langone Medical Center|ALEXANDER ZASLAVSKY|212-263-5569|michael.haile@nyumc.org
107617|NCT00835172|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107618|NCT00835185|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
107619|NCT00835198|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com
107620|NCT00835211|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107621|NCT00835224|James J Peters VAMC|Dr. Jill M. Wecht|718 584-9000 ext 3122|jm.wecht@va.gov
107622|NCT00835237|GlaxoSmithKline|GSK Response Center|866-435-7343|
107623|NCT00835263|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107624|NCT00835276|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107625|NCT00835341|Peking University School of Oncology|Department of Etiology|+8610-88196752|dengdajun@bjmu.edu.cn
107626|NCT00835354|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107627|NCT00835367|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107628|NCT00835380|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107629|NCT00835406|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107630|NCT00835484|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107631|NCT00835497|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107632|NCT00835510|Taro Pharmaceuticals|Medical Director|(914) 345-9001 ext 6427|medical.affairs@taro.com
107633|NCT00835536|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107634|NCT00835549|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107635|NCT00835575|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107636|NCT00835588|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107637|NCT00835614|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107638|NCT00835640|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107639|NCT00835666|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107640|NCT00835679|Vanderbilt-Ingram Cancer Center|Emily Chan, MD|615-343-4677|emily.chan@vanderbilt.edu
107641|NCT00835692|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107642|NCT00835705|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107644|NCT00835796|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107645|NCT00835861|Maternal-Fetal Medicine and Obstetrics at UT Southwestern|M. Ashley Hickman Zink|469-303-3591|m.ashley.hickman@gmail.com
107646|NCT00835900|Roswell Park Cancer Institute|Dr. Martin Mahoney|7168452300|martin.mahoney@roswellpark.org
107647|NCT00835926|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
107648|NCT00835978|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107649|NCT00835991|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107650|NCT00836004|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107651|NCT00836017|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
107652|NCT00836056|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107653|NCT00836095|Penn State Milton S. Hershey Medical Center|Sonia Vaida MD, Professor of Anesthesiology|7175318433|svaida@hmc.psu.edu
107654|NCT00824850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107658|NCT00825266|Stanford University|Roham Zamanian|650-725-5495|roham.zamanian@stanford.edu
107659|NCT00825305|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com
107660|NCT00825318|St. Luke's-Roosevelt Hospital Center|James Jones, MD|2125233530|JaJones@chpnet.org
107661|NCT00825344|Johns Hopkins|Dr. Steven P. Cohen|410-955-1818|scohen40@jhmi.edu
107662|NCT00825500|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com
107663|NCT00825565|Ann and Robert H. Lurie Children's Hospital of Chicago|Lori Asztalos, MD|312-227-6486|masztalos@luriechildrens.org
107664|NCT00825630|Sharon Hospital|Dr. Haim Shirin|0097239372231|haims3@clalit.org.il
107665|NCT00825682|Sheba Medical Center|Dr Dorit Gamus|+972-3-5303956|dorit.gamus@sheba.health.gov.il
107666|NCT00825734|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
107667|NCT00825786|University of North Carolina, Department of Anesthesiology, University of North Carolina|Priya Kumar, MD|(919) 966-5136|pkumar@aims.unc.edu,
107668|NCT00825812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
107669|NCT00825825|Steward St. Elizabeth's Medical Center|Tara Lauriat, Ph.D.|617-789-2404|tara.lauriat@steward.org
107670|NCT00825916|Capstone Therapeutics|Denise Lamon, Director of Regulatory Affairs|800-937-5520 ext 5206|dlamon@capstonethx.com
107671|NCT00825994|Massachusetts General Hospital|Marlene Freeman, MD|617-643-6403|mfreeman@partners.org
107672|NCT00826007|William Beaumont Hospital|Tamra Dukatz, CRNA, MSN|2489924741|tdukatz@beaumont.edu
107673|NCT00826111|Steward St. Elizabeth's Medical Center of Boston, Inc.|Tara Lauriat, Ph.D.|617-789-2404|tara.lauriat@steward.org
107674|NCT00836277|University of Pittsburgh Cancer Institute|Weijing Sun, MD|412-864-7764|sunw@upmc.edu
107675|NCT00836342|Clinical Unit for Research Trials in Skin, Massachusetts General Hospital|Kristen Corey|617-726-1302|kcorey1@partners.org
107676|NCT00836355|New York University Langone Medical Center|Saran Jonas|212 263 7591|Saran.Jonas@nyumc.org
107677|NCT00836407|The Sidney Kimmel Comprehensive Cancer Center at Johns|Dr. Dung Le||dle@jhmi.edu
107678|NCT00836433|Durham VA GRECC|Dr. Cathleen Colon-Emeric|9192860411 ext 6777|cathleen.colonemeric@va.gov
107679|NCT00836472|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107680|NCT00836498|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com
107681|NCT00836641|Goethe University Childrens Hospital|Prof Markus Rose|0049-696301 ext 5754|Markus.Rose@kgu.de
107682|NCT00836693|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
107683|NCT00836706|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107684|NCT00836719|LSU Health Sciences Center-New Orleans|Jesus Lovera MD|5045686700|jlover@lsuhsc.edu
107685|NCT00836745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107686|NCT00836875|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107687|NCT00836901|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107688|NCT00836953|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
107689|NCT00837031|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
107690|NCT00837148|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org
107691|NCT00837161|Philips Healthcare|Sarah Baxter|425-487-7665|sarah.baxter@philips.com
107692|NCT00837200|Milton S Hershey Medical Center|Joseph J Drabick, MD|717-531-5911|jdrabick@hmc.psu.edu
107693|NCT00837213|GlaxoSmithKline|GSK Response Center|866-435-7343|
107694|NCT00837252|National Eye Institute|Catherine M. Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov
107695|NCT00837330|Southeast Retina Center, P.C.|Dr. Dennis M Marcus Principal Investigator|706-650-0061|dmarcus@southeastretina.com
119349|NCT01650545|University of Maryland|Aldo Tullio Iacono|410 328 4351|aiacono@umm.edu
107697|NCT00837447|Ewha Womans University School of Medicine|Young-Hoo Kim, MD|822-26505900|younghookim@ewha.ac.kr
107698|NCT00837486|Medtronic Neuromodulation|Eric Williamson, Clinical Evidence Specialist|763-526-7982|medtronicneurotrials@medtronic.com
107699|NCT00837512|Emory University School of Medicine|Dr. Eric Felner|404-727-7651|efelner@emory.edu
107700|NCT00837577|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107701|NCT00837616|Nemours Children's Clinic|Dr. Nelly Mauras|(904) 697-3674|nmauras@nemours.org
107702|NCT00837759|NIDDK, National Institutes of Health|Dr. Rana Malek|3015945288|malekr@mail.nih.gov
107703|NCT00837824|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com
107704|NCT00837876|Vanderbilt-Ingram Cancer Center|Jordan Berlin, MD|615-343-4128|jordan.berlin@vanderbilt.edu
107705|NCT00837967|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
107706|NCT00838097|Amgen Inc.|Study Director|866-572-6436|
107707|NCT00838110|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107708|NCT00838136|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107709|NCT00838162|Jan-Cil UK|VP Head of Discovery & Early Development|44 1494 553458|ksimmen1@its.jnj.com
107710|NCT00838201|Amgen Inc.|Study Director|866-572-6436|
107711|NCT00838279|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107712|NCT00838331|Emory University|John Roback, MD PhD|404-712-1774|jroback@emory.edu
107713|NCT00838513|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc||clinicaltrials@alxn.com
107714|NCT00838526|Eisai Call Center|Eisai Inc.|888-422-4743|
107715|NCT00838578|KYOWA KIRIN PHARMA|Project Leader|6099191100|clinical.info@kyowa-kirin-pharma.com
107716|NCT00838630|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107717|NCT00838682|The Catholic University of Korea, Uijeongbu St. Mary's Hospital|Hiun-Suk Chae|82-31-820-3019|chs@catholic.ac.kr
107718|NCT00838903|GlaxoSmithKline|GSK Response Center|866-435-7343|
107719|NCT00838916|GlaxoSmithKline|GSK Response Center|866-435-7343|
107720|NCT00838929|Thomas Jefferson University|Wenyin Shi, MD, PhD|215-955-4111|Wenyin.Shi.@jefferson.edu
107721|NCT00838981|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu
107722|NCT00839072|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
107723|NCT00839098|Human Engineering Reserach Laboratories|Clinical Coordinator|412-822-3700|annmarie.kelleher@va.gov
107724|NCT00828945|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107725|NCT00828984|Northwestern University|Dr. Seema Khan|312-503-4236|s-khan2@northwestern.edu
107727|NCT00829036|Atlanta VA Rehab R&D Center of Excellence|David A. Ross|404-321-6111 ext 6817|ross0128@bellsouth.net
107728|NCT00829049|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com
107729|NCT00829166|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
107730|NCT00829179|Duke University Medical Center|John S. Sundy M.D. PhD|(919) 668-2169|john.sundy@duke.edu
107731|NCT00829244|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
107732|NCT00829283|Yale School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu
107733|NCT00829296|University of Chicago|Dr. George Bakris|773-702-7936|gbakris@medicine.bsd.uchicago.edu
107734|NCT00829309|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107735|NCT00829387|VA Connecticut Healthcare System|Rebecca Czlapinski|203-932-5711 ext 3357|rebecca.czlapinski@va.gov
107736|NCT00829426|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107737|NCT00829439|Boston Children's Hospital|Wen-Hann Tan|617-355 6394|wen-hann.tan@childrens.harvard.edu
107738|NCT00829452|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107739|NCT00829504|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107740|NCT00829530|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107741|NCT00829621|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu
107742|NCT00829673|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107743|NCT00829686|Wilford Hall Medical Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com
107744|NCT00829712|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107745|NCT00829738|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com
107746|NCT00829764|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107747|NCT00829790|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107748|NCT00829829|Regeneron Pharmaceuticals, Inc. Phone:|Clinical Trial Management||clinicaltrials@regeneron.com
107749|NCT00829868|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107750|NCT00829933|Daiichi Sankyo.,LTD|So Yoshino, Manager|81-90-8024-0742|yoshino.so.ej@daiichisankyo.co.jp
107751|NCT00829985|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
107752|NCT00829998|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107753|NCT00830024|Teva Pharmaceuticals USA|Manger, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107754|NCT00830037|Indiana University School of Medicine & Richard L Roudebush VA Medical Center|Rajiv Agarwal, MD, FAHA, FASN, FASH|317-988-2241|ragarwal@iu.edu
107755|NCT00830076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107756|NCT00830115|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com
107757|NCT00830128|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107758|NCT00830167|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107759|NCT00830206|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107760|NCT00830219|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107761|NCT00830232|Dallas VA Medical Center|Dr. Carlos H Timaran|2148570336|carlos.timaran@va.gov
107762|NCT00830258|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107763|NCT00830284|Boston Children's Hospital|Brian Kendall Walsh|6179193692|brian.walsh@childrens.harvard.edu
107764|NCT00830310|University Hospitals Case Medical Center|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org
107765|NCT00830336|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107766|NCT00830362|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu
107767|NCT00830375|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu
107768|NCT00830388|University of Alabama at Birmingham|Wendy Cantrell|205-502-9960|wcantrell@uabmc.edu
107769|NCT00830440|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3263|kwoessner@gidynamics.com
107770|NCT00830596|Palmer College of Chiropractic|Christine Goertz, DC, PhD, Principal Investigator|(563) 884-5150|christine.goertz@palmer.edu
107771|NCT00830765|UMississippi|Dr John Morrison|601-984-5300|jmorrison@umc.edu
107772|NCT00831233|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
107773|NCT00831272|University of Pennsylvania|David Oslin|215 823 5894|oslin@upenn.edu
107774|NCT00831311|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
107776|NCT00831415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
107777|NCT00831428|University of Dundee|Dr Karine Clearie|01382 496440|k.clearie@dundee.ac.uk
107778|NCT00831441|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
107779|NCT00831480|Baylor College of Medicine|Dr. Gilad E. Amiel|713-798-4079|lhiggins@bcm.edu
107780|NCT00831493|UT MD Anderson Cancer Center|Sunil Krishnan, MD / Associate Professor||mclemons@mdanderson.org
107781|NCT00831675|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
107782|NCT00831701|Department of Urology, University Hospital Zürich, Switzerland|Räto T. Strebel|0041-44-2551111|raeto.strebel@ksgr.ch
107783|NCT00831753|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
107784|NCT00831766|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jeffrey Lancet|813-745-1387|jeffrey.lancet@moffitt.org
107785|NCT00831779|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com
107786|NCT00831844|Children's Oncology Group|Results Reporting Coordinator|626-241-0064|Resultsreportingcoordinator@childrensoncologygroup.org
107787|NCT00831987|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
107788|NCT00832000|University of Kansas Medical Center|Richard J. Barohn, MD|913-588-6095|rbarohn@kumc.edu
107789|NCT00832078|Coloplast|Scientific Manager|+4549113557|dkkg@coloplast.com
107790|NCT00832091|RegeneRx Biopharmaceuticals, Inc.|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|301-208-9191 ext 108|nturjman@regenerx.com
107791|NCT00832117|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
107792|NCT00832130|TearScience, Inc. (formerly Kolis Scientific)|Christy Stevens, OD|919-459-4815|cstevens@tearscience.com
107793|NCT00832260|Hospital Universitari i politecnic La Fe|Dr. José Olagüe|+34 961 24 40 00|jolague@terra.com
107794|NCT00832299|Beth Israel Medical Center|Peter Kozuch, MD||pkozuch@chpnet.org
107795|NCT00832338|Emory University|Jane Meisel, MD|404-778-1900|jane.l.meisel@emory.edu
107796|NCT00832377|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107797|NCT00832390|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
107798|NCT00832416|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
107799|NCT00832455|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
119350|NCT01639001|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107801|NCT00832572|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
107802|NCT00832585|Rush University Medical Center - Department of Dermatology|Dr. Michael D. Tharp|312-563-4001|derm@rush.edu
107803|NCT00832624|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107805|NCT00832650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107806|NCT00832819|Eisai Co., Ltd.|Wataru Yusa|+81 3-3817-5252 ext 5252|
107807|NCT00832871|University of New Mexico Comprehensive Cancer Center|Dr. Fa-chyi Lee|505-925-0405|FLee@salud.unm.edu
107808|NCT00832975|Hospital Clínico Universitario Puerta de Hierro|Dr Ignacio Fernández Lozano|913445000|iflozano@secardiologia.es
107809|NCT00833027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107810|NCT00833040|AcelRx Pharmaceuticals, Inc.|Dr. Pamela Palmer|650-216-3504|ppalmer@acelrx.com
107811|NCT00833053|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com
107812|NCT00833092|USDA Grand Forks Human Nutrition ResearchCenter|Forrest H Nielsen, PhD|701-790-8455|forrest.nielsen@ars.usda.gov
107813|NCT00833248|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
107814|NCT00833365|University of Utah|Dr. Gary Chan|801-587-7508|gary.chan@hsc.utah.edu
107815|NCT00833417|Genentech, Inc.|Medical Communications|800-821-8590|
107816|NCT00833443|UCLA|Keith Heinzerling MD|323-461-3106|kheinzerling@mednet.ucla.edu
107817|NCT00833469|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org
107818|NCT00833482|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
107819|NCT00833521|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107820|NCT00833547|Massachusetts General Hospital|Dr. Dara Manoach|617-726-6148|dara@nmr.mgh.harvard.edu
107821|NCT00833560|Jan-Cil Germany|Therapeutic Areas Director|+49 2137 955-492|
107822|NCT00833586|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107823|NCT00833638|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
107824|NCT00833664|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107825|NCT00833690|The Parkinson Study Group|Michael A. Schwarzschild, MD, PhD|617-724-9611|mschwarzschild@partners.org
107826|NCT00833703|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com
107827|NCT00839241|Astra Tech AB|Head of Clinical Research Area Health Care|+46317761000|
107828|NCT00839306|Eisai Inc.|Eisai Medical Services|888-422-4743|
107829|NCT00839319|University of Washington|Mara Roth, MD|206-221-0519|mylang@u.washington.edu
107830|NCT00839423|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
107831|NCT00839436|NIAID|Dr. Virginia Sheikh|3014357939|sheikhv@niaid.nih.gov
107833|NCT00841321|Portland VA Medical Center Multiple Sclerosis Center of Excellence|Dennis Bourdette, MD|503-220-8262 ext 54594|dennis.bourdette@va.gov
107834|NCT00841412|Tennessee Valley Healthcare System, GRECC and Vanderbilt University, School of Medicine, Division of Geriatrics, Center for Quality Aging|Sandra F. Simmons, PhD, Associate Professor of Medicine|615-343-6729|Sandra.Simmons@Vanderbilt.edu
107835|NCT00841542|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107836|NCT00841555|The Ohio State University Comprehensive Cancer Center|Mario Ammirati, MD|614-293-1970|Mario.Ammirati@osumc.edu
107837|NCT00841659|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107838|NCT00841672|Novartis Pharmaceuticals|Study Director|862-778-8300|
107839|NCT00841698|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107840|NCT00841763|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
107841|NCT00841776|GlaxoSmithKline|GSK Response Center|866-435-7343|
107842|NCT00841815|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107843|NCT00841906|Sleep Center of Greater Pittsburgh|Sukhdev Grover MD|412-681-7771|Info@SleepCenterOfGreaterPittsburgh.com
107844|NCT00841971|University of Pittsburgh|Dr Nina Singh|412 360-1688|nis5@pitt.edu
107845|NCT00842023|Western University of Health Sciences|Dr. Sheryl L. Chow|9094695379|schow@westernu.edu
107846|NCT00842075|UColorado|Dr. H. Peter Chase|303-724-2323|peter.chase@ucdenver.edu
107848|NCT00842231|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
107849|NCT00842244|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107850|NCT00842257|Massachusetts General Hospital|Dr. David Patrick Ryan, Chief, Hem/Onc|617-974-4545|DPRYAN@mgh.harvard.edu
107851|NCT00842335|Jubilant Clinsys Inc.|Jane Fisher, Senior Manager, Regulatory Affairs|+1 (919) 518-8786|jfisher@clinsys.com
107852|NCT00842348|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
107853|NCT00842361|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
107854|NCT00842543|Nemours Children's Clinic|J. Atilio Canas MD|9046973600 ext 3674|jcanas@nemours.org
107855|NCT00842608|Regenstrief Institute, Inc.|Dr. Malaz Boustani|(317) 274-9235|mboustan@iu.edu
107856|NCT00842712|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
107857|NCT00842751|University of Washington, Dept. of Medicine|John Amory, MD|(206) 616-1727|jamory@u.washington.edu
107858|NCT00842829|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
107859|NCT00842946|Department of Veterans Affairs (formerly Drexel University)|Dr. Erica England|207-239-6323|elengland02@yahoo.com
107860|NCT00842985|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu
107861|NCT00843024|GlaxoSmithKline|GSK Response Center|866-435-7343|
107862|NCT00843050|Piramal Healthcare Limited|Dr. Alan Hatfield|02230275000 ext 5002|alan.hatfield@piramal.com
107863|NCT00843115|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
107864|NCT00843167|Oregon Health & Science University|Dr. Jackilen Shannon|541-706-6861|shannoja@ohsu.edu
107865|NCT00843180|UCSF|Dr. Wolf Mehling, MD|415-353 9506|mehlingw@ocim.ucsf.edu
107866|NCT00843284|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
107867|NCT00843310|NYU Cancer Institute|Hearn J. Cho, MD|212-263-9274|hearn.jay.cho@med.nyu.edu
107868|NCT00843349|University of Miami|Dr. Myles Wolf, Associate Professor of Medicine, Chief-Division of Nephrology and Hypertension|305-243-7745|mwolf@med.miami.edu
107870|NCT00843479|Laboratory of Investigation on Metabolism and Diabetes - LIMED / State University of Campinas - Brazil|Dr. Bruno Geloneze|+55 19 35218589|bgeloneze@terra.com.br
107871|NCT00843492|GlaxoSmithKline|GSK Response Center|866-435-7343|
107872|NCT00843622|Fagerström Consulting AB|Dr Karl Fagerström||karl.fagerstrom@swipnet.se
107873|NCT00843635|University of Miami|Donald T. Weed MD FACS|305-243-9095|dweed@miami.edu
107874|NCT00843713|University of California, San Francisco|Priscilla Hsue, MD|415-206-8257|Priscilla.Hsue@ucsf.edu
107875|NCT00843778|UCB|UCB Clinical Trial Call Center|+1 877 822 ext 9493|
107876|NCT00830791|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|(800) 672-6372|ClinicalTrialsDisclosure@merck.com
107877|NCT00830804|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
107878|NCT00830947|OrthoAccel Technologies, Inc.|Zaffer Syed, Director of Clinical & Regulatory Affairs|(832) 803-0339|zsyed@orthoaccel.com
107879|NCT00830960|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
107880|NCT00831129|University of Chicago|Dr. George Bakris|773-702-7936|bbrisky@medicine.bsd.uchicago.edu
107881|NCT00843830|University of Michigan Comprehensive Cancer Center|Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu
107882|NCT00843843|Rush University Medical Center|Dr. Helen Burgess|3125634785|Helen_J_Burgess@rush.edu
107883|NCT00843986|Astellas Pharma Global Development|Medical Director||clinicaltrials@us.astellas.com
107884|NCT00844051|Children's Hospital Los Angeles|Pia Pannaraj, MD, MPH|323-361-2509|ppannaraj@chla.usc.edu
107885|NCT00844090|Omaha VA Medical Center|Cyrus Desouza MD|402-995-5506|cyrus.desouza@va.gov
107886|NCT00845897|Washington University School of Medicine|Mary Hastings PT, DPT, ATC|314 286 1433|hastingsmk@wustl.edu
107887|NCT00845975|McDonald hearing Aid Centers|Louis A Looper, MA, CCC-A|916-218-4100|llooper@hearingmed.com
107888|NCT00846027|Hoffmann-La Roche|Medical Communications|800 821-8590|
107889|NCT00846066|Childrens Mercy Hospital|Nasreen Talib MD, MPH.|816-234-3242|ntalib@cmh.edu
107890|NCT00846287|UMass Medical School|Dr. Mitchell Albert|(807) 684-7270|albertmi@tbh.net
107891|NCT00846365|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
107892|NCT00846391|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107893|NCT00846495|Clinvest|Rebecca Browning|417-841-3664|rbrowning@clinvest.com
107894|NCT00846521|Yale University School of Medicine|Tania Burgurt, MD|203-785-7152|tania.burgurt@yale.edu
107895|NCT00846547|Seaside Therapeutics|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|617-374-9009 ext 1015|pwang@seasidetherapeutics.com
107896|NCT00846573|UMass Medical School|Dr. Mitchell Albert|(617) 875-2141|albertmi@tbh.net
107897|NCT00846586|Novartis Pharmaceuticals|Study Director|862 778-8300|
119351|NCT01626352|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com
107899|NCT00846768|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107900|NCT00846807|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107901|NCT00846846|Medtronic Cardiovascular|Lisa Bousquette, Director Clinical Research Coronary and Renal Denervation||lisa.r.bousquette@medtronic.com
107902|NCT00846885|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107903|NCT00847002|Tactile Systems Technology, Inc|Sunday Hoy, Director of Clinical Research|612.355.5100|
107904|NCT00847015|Memorial Sloan Kettering Cancer Center|Dr. M. Catherine Pietanza|646-888-4203|pietanzm@mskcc.org
107905|NCT00847132|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|jhuffman@partners.org
107906|NCT00847145|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
107907|NCT00847197|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107908|NCT00847210|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
107909|NCT00847288|Medtronic Cardiac Rhythm Disease Management|OptiVol Care Pathway Clinical Team|1-800-328-2518|medtronicCRMtrials@medtronic.com
107910|NCT00847301|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
107911|NCT00847405|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107912|NCT00847509|Certus International, Inc.|Edward M. Aten, M.D.|603.627.1212|eaten@certusintl.com
107913|NCT00847535|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com
107914|NCT00847561|The Johns Hopkins University School of Medicine|Dr. Golda Ginsburg|410-955-1544|gginsbu@jhmi.edu
107915|NCT00847587|UUtah|Kirtly Parker Jones|801-581-3834|kirtly.jones@hsc.utah.edu
107916|NCT00847613|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107917|NCT00847626|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
107918|NCT00847665|University Hospital Virgen de las Nieves|Dr. Francisco Manzano|34958020125|fmanzano@mailpersonal.com
107919|NCT00847704|Oregon Health & Science University|Paul J. Cordo|503-418-2520|cordop@ohsu.edu
107920|NCT00847808|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
107921|NCT00847886|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH - Medical Director, Drug Safety|281-863-3000|
107923|NCT00848016|Mayo Clinic Cancer Center|Michael E. Menefee, M.D.||menefee.michael@mayo.edu
107924|NCT00848042|Nanospectra Biosciences, Inc.|Robin Dickson|7138422720 ext 216|rdickson@nanospectra.com
107925|NCT00848081|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
107926|NCT00848107|United Therapeutics Corporation|Rex Mauthe, Assoc VP, Regulatory Affairs|(919) 485-8350|RMauthe@unither.com
107927|NCT00848120|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
107928|NCT00848172|NINDS|Mark Hallett|301-496-9526|hallettm@ninds.nih.gov
107929|NCT00848185|IVI Madrid|Dra Cerrillo|911802900|maria.cerrillo@ivi.es
107930|NCT00848198|TearLab, Inc.|Michael Berg, VP of Regulatory|858-795-6887|mberg@TearLab.com
107931|NCT00848211|Thymon LLC|Gideon Goldstein, MD, PhD|(973) 467-9558|gidgold@gmail.com
107932|NCT00848237|University of north Carolina|Nicholas Shaheen|(919) 966-7047|nshaheen@med.unc.edu
107933|NCT00848250|Vanderbilt University Medical Center|Mias Pretorius|615-8757402|mias.pretorius@vanderbilt.edu
107934|NCT00848354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107935|NCT00848367|Ottawa Hospital Research Institute|Dr. Giorgio Tasca|1-613-737-8085|gtasca@toh.on.ca
107936|NCT00839527|GlaxoSmithKline|GSK Response Center|866-435-7343|
107937|NCT00839540|Michigan State University|Dr. Gary E.Stein, Pharm.D.|517-353-5126|steing@msu.edu
107938|NCT00839800|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
107939|NCT00839917|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107940|NCT00839930|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107941|NCT00839956|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org
107942|NCT00839982|FCHRC|Elihu Estey, MD, Director of AML Program|206-288-7176|eestey@seattlecca.org
107943|NCT00840060|Lamar University|Monica Harn|409-880-8174|monica.harn@lamar.edu
107944|NCT00840073|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107945|NCT00840086|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
107946|NCT00840099|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107947|NCT00840203|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107948|NCT00840216|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107949|NCT00840281|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107950|NCT00840294|University of Chicago|Scott Eggener|(773) 702-5195|seggener@surgery.bsd.uchicago.edu
107951|NCT00840411|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107952|NCT00840450|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org
107953|NCT00840476|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107954|NCT00840632|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107955|NCT00840658|University of California, San Diego|Steffanie Strathdee, PhD|(858) 822-1952|sstrathdee@ucsd.edu
107956|NCT00840840|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107957|NCT00840866|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107958|NCT00840879|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107959|NCT00840996|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org
107960|NCT00841035|University of Alabama at Birmingham|Research Nurse Supervisor of Clinical trials|(205)975-0450|jhrichardson@uabmc.edu
107961|NCT00841087|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
107962|NCT00841204|The University of Arizona|H-H. Sherry Chow, Ph.D.|520-626-3358|schow@azcc.arizona.edu
107963|NCT00848484|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
107964|NCT00848497|Baylor College of Medicine|Mohit Khera, MD|713-798-6593|mkhera@bcm.edu
107965|NCT00848510|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
107966|NCT00848536|Alcon Research, Ltd.|Director Alcon Clinical|888.451.3937 or 817.568.6725|
107967|NCT00848549|Eisai Call Center|Eisai Inc.|888-422-4743|
107968|NCT00848926|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com
107969|NCT00848965|GlaxoSmithKline|GSK Response Center|866-435-7343|
107970|NCT00849017|GlaxoSmithKline|GSK Response Center|866-435-7343|
107971|NCT00849056|GlaxoSmithKline|GSK Response Center|866-435-7343|
107972|NCT00849108|Lantheus Medical Imaging|Cesare Orlandi, MD, Chief Medical Officer|978-671-8686|cesare.orlandi@lantheus.com
107973|NCT00849121|University of Wisconsin Carbone Cancer Center|Dr. Douglas McNeel|608-265-8131|dm3@medicine.wisc.edu
107974|NCT00849147|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com
107975|NCT00849186|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
107976|NCT00849212|Eisai Call Center|Eisai Inc.|888-422-4743|
107977|NCT00849251|University of Washington|Dr. Pamela Becker|206-616-1589|pbecker@uw.edu
107978|NCT00849290|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com
107979|NCT00849381|GlaxoSmithKline|GSK Response Center|866-435-7343|
107980|NCT00849472|GlaxoSmithKline|GSK Response Center|866-435-7343|
107981|NCT00849485|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-3848-5525|clinicaltrialqueries@tevausa.com
107982|NCT00849524|University of California, San Diego|Januario Castro, MD|(858) 822-6600|jecastro@ucsd.edu
107983|NCT00849680|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com
107984|NCT00849693|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
107985|NCT00849797|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107986|NCT00849810|University of Mississippi Medical Center|Professor of Medicine|601-984-5600|DMinor@umc.edu
107987|NCT00849862|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107988|NCT00849875|GlaxoSmithKline|GSK Response Center|866-435-7343|
107989|NCT00849901|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
107990|NCT00849940|Duke University Medical Center|David MacLeod, M.B.|919-681-3551|david.macleod@dm.duke.edu
107991|NCT00850031|AcuFocus, Inc|Eugenia Thomas, Director Clinical Trials|949/585-9511 ext 129|nthomas@acufocus.com
107992|NCT00850070|The Children's Health Council|Glen R. Elliott, Ph.D., M.D.|650.688.3649|gelliott@chconline.org
107993|NCT00850096|CPEX Pharmaceuticals, Inc.|Chief Medical Officer|603-658-6100 ext 503|
107994|NCT00850135|Stanford University School of Medicine|Yasser El-Sayed, MD|(650) 723-3198|Yasser.el-sayed@stanford.edu
107995|NCT00850174|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
107996|NCT00850200|University of Florida Proton Therapy Institute|Bradford Hoppe, MD, MPH|904-588-1800|bhoppe@floridaproton.org
108115|NCT00857233|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
107997|NCT00850343|Astellas Pharma Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@astellas.com
107998|NCT00850395|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
107999|NCT00850421|Park Nicollet Institute|Park Nicollet Institute|952-993-3123|
108000|NCT00850460|The Rockefeller University Center for Clinical and Translational|Principal Investigator|212 327-8408|trinnamaningatmd@yahoo.com
108001|NCT00850499|Johnson & Johnson Pharmaceutical Research & Development|Andrew Cakana, MD, FRC Path||[ACAKANA@ITS.JNJ.COM
108002|NCT00850538|New England Baptist Hospital|Carl Talmo|617-724-5474|ctalmo@nebh.org
108003|NCT00850564|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@partners.org
108004|NCT00850603|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com
108005|NCT00850720|Children's Healthcare of Atlanta|Kiran Hebbar, MBBS|404-785-1600|kiran.hebbar@choa.org
108006|NCT00850759|UAB|David Schwebel|205-934-8745|schwebel@uab.edu
108007|NCT00850889|Allergan, Inc.|Steven P. James, MD, VP, Global Medical Affairs|714-246-4500|james_steven@allergan.com
108008|NCT00850993|InfaCare Pharmaceutical|Dan Isaacman|(267) 515-5852|disaacman@infacare.com
108009|NCT00851006|University of Utah|Douglas Kondo, M.D.|801-587-1549|doug.kondo@hsc.utah.edu
108010|NCT00851084|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com
108011|NCT00851279|Stereotaxis Inc.|Dr Qun Sha, MD, Director of Clinical Trials|314 678 6143|qun.sha@stereotaxis.com
108012|NCT00851318|Astellas Pharma Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@astellas.com
108013|NCT00851409|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com
108014|NCT00844194|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108015|NCT00844298|Asan Medical Center, University of Ulsan College of Medicine|Dr. Dae-Young Kim|82230105930|dani@amc.seoul.kr
108016|NCT00844376|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
108017|NCT00844415|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108018|NCT00844428|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alxn.com
108019|NCT00844480|Northwestern University|Thomas Schnitzer|312-503-2315|tjs@northwestern.edu
108020|NCT00844519|University of California San Francisco|Dr. Priscilla Hsue|415-206-8257|phsue@medsfgh.ucsf.edu
108021|NCT00844532|Abbott Vascular|David R Rutledge|408-845-3820|david.rutledge@av.abbott.com
108022|NCT00844545|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc||clinicaltrials@alxn.com
108023|NCT00844558|University of Iowa|Neil Segal|3193560737|segal-research@uiowa.edu
108024|NCT00844597|Sarepta Therapeutics|Edward M. Kaye, MD, Interim CEO, SVP & Chief Medical Officer|617-274-4003|EKaye@Sarepta.com
108025|NCT00844649|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com
108026|NCT00844714|University of California, San Francisco|Priscilla Hsue, MD|415-206-8257|phsue@medsfgh.ucsf.edu
108027|NCT00844753|University of Pittsburgh|Ben Handen|412-235-5452|HandenBL@upmc.edu
108028|NCT00844805|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com
108029|NCT00844831|University of Louisville|John M. Wo, MD|502-852-6991|johnwogi@gmail.com
108030|NCT00844844|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc.||clinicaltrials@alxn.com
108031|NCT00844857|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
108032|NCT00844883|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu
108033|NCT00844896|Massachusetts General Hospital|Frederick J. Stoddard Jr., M.D.,|(617) 371-4762|fstoddard@partners.org
108034|NCT00845000|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108035|NCT00845065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
108036|NCT00845130|Univeristy of Kansas Medical Center|In-Young Choi, Ph.D.|913-588-0174|ichoi@kumc.edu
108038|NCT00845195|Alcon Research Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
108039|NCT00845429|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
108040|NCT00845481|LEO Pharma|Torsten Skov, Senior Medical Advisor|+45 20 73 62 94|torsten.skov@leo-pharma.com
108041|NCT00845663|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493|
108042|NCT00845676|San Francisco General Hospital/UCSF|Brad Hare, MD|415-476-4082 ext 556|chare@php.ucsf.edu
108043|NCT00845702|Guerbet|Pierre Desche, MD, Head of Clinical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com
108044|NCT00845728|Novartis Pharmaceuticals|Study Director|862-778-8300|
108045|NCT00845832|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
108046|NCT00845845|The University of Illinois Chicago|Scott Cotler, M.D. Professor of Medicine|708-216-3789|scotler@lumc.edu
108047|NCT00845858|Evoke Pharma|Marilyn R. Carlson|858-345-1494|mcarlson@evokepharma.com
108048|NCT00851552|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
108050|NCT00851630|Duke University Medical Center|Dr. Nathan Thielman|919-6687174|n.thielman@duke.edu
108051|NCT00851643|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com
108052|NCT00851682|Washington University|Robert Grubb, III|314 454-7185|grubbr@wudosis.wustl.edu
108054|NCT00851786|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
108116|NCT00857246|Perlmutter Cancer Center|Theresa Ryan, MD|212-731-5430|theresa.ryan@nyumc.org
108055|NCT00851799|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
108056|NCT00854308|Hoffman-LaRoche|Medical Communications|800-821-8590|
108057|NCT00854360|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
108058|NCT00854373|University of California, San Francisco|Mitchell P. Rosen, MD|415-353-7475|rosenm@obgyn.ucsf.edu
108059|NCT00854581|University of Miami|Juan Carlos Ramos MD|305-243-4909|jramos2@med.miami.edu
108060|NCT00854594|Louis Stokes VA Medical Center|Jeneen Shell-Boyd|(216) 791-2300 ext 5831|Jeneen.shell-boyd@va.gov
108061|NCT00854607|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108062|NCT00854620|Stanford University, Stanford Cancer Center|Sandy Srinivas, MD|650-725-2078|sandysri@stanford.edu
108063|NCT00854724|BPRL, McLean Hospital|David M. Penetar|617-855-2913|dpenetar@mclean.harvard.edu
108064|NCT00854906|University of Arkansas for Medical Sciences|Richard Harper|501 526-6000 ext 2616|harperricharda@uams.edu
108065|NCT00855062|Harvard School of Public Health|Sachiko Miyahara|617-432-2837|miyahara@sdac.harvard.edu
108066|NCT00855166|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com
108067|NCT00855218|BAYER|Therapeutic Area Head||clinical-trial-contact@bayerhealthcare.com
108068|NCT00855309|Comprehensive Cancer Center of Wake Forest University|LeAnne Kenndy, PharmD|336-713-3416|lakenned@wakehealth.edu
108070|NCT00855439|University of Michigan|Rodica Pop-Busui, MD, PhD|734 647-9809|rpbusui@med.umich.edu
108071|NCT00855465|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
108072|NCT00855582|Eli Lilly and Company|Chief Medical Office|800-545-5979|
108073|NCT00855595|Intendis GmbH|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
108074|NCT00855738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108075|NCT00855816|VA Palo Alto Health Care System / Stanford University School of Medicine|Walton T. Roth, M.D.|650-493-5000 ext 65243|wtroth@stanford.edu
108076|NCT00855842|Boston University|Lynn Borgatta, MD|617-414-3440|lynn.borgatta@bmc.org
108077|NCT00855868|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
108078|NCT00855894|Genentech, Inc.|Medical Communications|800 821-8590|
108079|NCT00855920|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com
108080|NCT00855933|The Procter & Gamble Co.|Jon Witt|513-622-2963|witt.jj.2@pg.com
108081|NCT00855959|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
108082|NCT00856024|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClincialTrialsDisclosure@merck.com
108083|NCT00856050|Dana-Farber Cancer Institute|Dr. Suzanne George|617-632-5204|sgeorge2@partners.org
108084|NCT00856180|Dana-Farber Cancer Institute|Ursula A. Matulonis, MD|617-632-2334|umatulonis@partners.org
108085|NCT00856193|Novartis Pharmaceuticals|Study Director|862-778-8300|
108086|NCT00856206|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com
108087|NCT00856232|UMDNJ|Dr. Boris Veysman|732-235-8717|veysmabo@umdnj.edu
108088|NCT00856245|University of Kansas Cancer Center|Siddhartha Ganguly, MD|(913) 588-6030|sganguly@kumc.edu
108090|NCT00856297|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
108091|NCT00856323|Friends Research Institute, Inc.|Dr. Cathy Reback|323-463-1601|reback@friendsresearch.org
108092|NCT00856349|Medtronic Cardiac Rhythm Disease Management|Daniel Lexcen, Clinical Research Specialist|763-526-9702|daniel.lexcen@medtronic.com
108093|NCT00856388|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
108094|NCT00856414|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com
108095|NCT00856492|SWOG Statistical Center|Breast Committee Statistician|206-667-4623|
108096|NCT00856518|North Florida/South Georgia Veterans Health System|Dr. Janis Daly|352-376-1611 ext 5223|janis.daly@neurology.ufl.edu
108097|NCT00856544|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108098|NCT00856557|Jesse Brown VA Medical Center|Dr. Saul J. Weiner|3125192697|Saul.Weiner@va.gov
108099|NCT00856583|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com
108100|NCT00856635|Teva Pharmaceuticals, Medical Affairs|Scott Kolodny, M.D.|440-327-1811|scott.kolodny@tevapharm.com
108101|NCT00856661|H. Lundbeck A/S|study director||LundbeckClinicalTrials@Lundbeck.com
108102|NCT00856726|University of Alabama at Birmingham|Orlando Gutierrez|205-996-2736|ogutierrez@uabmc.edu
108103|NCT00856739|Stanford University, Palo Alto Veterans Hospital|Dr. Thomas P. Andriacchi, Ph.D.|650-723-8024|tandriac@stanford.edu
119355|NCT01547286|Massachusetts General Hospital|Dr. Robert Scott Harris, MD|617-726-9429|rsharris@mgh.harvard.edu
108105|NCT00848783|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org
108106|NCT00856778|Coloplast Corp|Clinical Trial Manager|612-302-4990|usdibe@coloplast.com
108107|NCT00856791|Onconova Therapeutics, Inc.|Francois E. Wilhelm, MD, PhD|609 281-7086|fwilhelm@onconova.us
108108|NCT00856830|Univeristy of Alabama at Birmingham|Francisco Robert, MD, Department of Medicine, Division of Hematology and Oncology|205-934-5077|pacorobertuab@cs.com
108109|NCT00856843|Braintree Laboratories, Inc.|John McGowan|781-843-2202|jmcgowan@braintreelabs.com
108110|NCT00856908|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
108111|NCT00856934|CHUV - CPR|Dr. Wassim Raffoul|+41 21 314 25 05|Wassim.Raffoul@chuv.ch
108112|NCT00856973|Sunovion|CNS Medical Director|866-503-6357|
108113|NCT00856986|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
121233|NCT02227329|Mayo Clinic|Dr. Ryan Hurt|507-284-4461|Hurt.Ryan@mayo.edu
121234|NCT02221674|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 ext 3223|Clinical-Trials@grunenthal.com
108118|NCT00857272|Braintree Laboratories, Inc.|John McGowan, Associate Director, Clinical Research|781-843-2202|jmcgowan@braintreelabs.com
108119|NCT00857285|Daiichi Sankyo, Inc.|Senior Director, Regulatory Operations|732-590-5000|hmkessler@dsus.com
108120|NCT00857311|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
108121|NCT00857415|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
108122|NCT00857454|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
108123|NCT00857506|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
108124|NCT00857532|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com
108125|NCT00857545|NRG Oncology|Linda Gedeon for Wei Deng PhD|716-845-1169|lgedeon@gogstats.org
108126|NCT00857584|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
108127|NCT00857623|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
108128|NCT00857649|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
108129|NCT00857714|IndianaU|Sunil Badve, MD|317-491-6417|sbadve@iupui.edu
108130|NCT00857766|GlaxoSmithKline|GSK Response Center|866-435-7343|
108131|NCT00857792|The University of Chicago Medical Center|Victor Mor-Avi|773-702-7780|vmoravi@bsd.uchicago.edu
108132|NCT00857818|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
108133|NCT00857896|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108134|NCT00857948|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com
108135|NCT00857961|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
108136|NCT00858013|Ajou University|Kwan Woo Lee|82-31-219-4526|lkw65@ajou.ac.kr
108137|NCT00858143|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
108138|NCT00858208|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108139|NCT00858247|Mayo Clinic|Seema Kumar, MD|507-284-3300|kumar.seema@mayo.edu
108140|NCT00858390|The University of Texas Health Science Center at Houston|G Hergenroeder, Principal Investigator|7135006130|Georgene.W.Hergenroeder@uth.tmc.edu
108141|NCT00858403|H. Lee Moffitt Cancer Center and Research Institute|Eric Haura, M.D., via Moffitt Cancer Center|813-745-6827|eric.haura@moffitt.org
108142|NCT00858442|coaniquem|M Beatriz Quezada.MD|56-2-28734077|investigacion@coaniquem.cl
108143|NCT00858468|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
119356|NCT01540773|Pennington Biomedical Research Center|Dr. Frank Greenway, Chief of Outpatient Clinic|225-763-2578|Frank.Greenway@pbrc.edu
108145|NCT00858507|Providence VA Medical Center|Thomas O'Toole, MD|4012737100|thomas.otoole@va.gov
108146|NCT00858637|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
108147|NCT00858689|FRAXA Research Foundation|Michael R. Tranfaglia MD|978-462-1990|info@fraxa.org
108149|NCT00858780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108150|NCT00858832|USF Health Department of Obstetrics and Gynecology|Patrick Teefey MD|813-259-8680|ObGynClinicalResearch@health.usf.edu
108151|NCT00858845|University of California, Los Angeles (UCLA)|Dr. Holly R. Middlekauff|310-206-6672|hmiddlekauff@mednet.ucla.edu
108152|NCT00858858|VA|Stuart Spechler|214-857-1603|Stuart.Spechler@va.gov
108153|NCT00858962|Yale University AIDS Program|R. Douglas Bruce, MD, MA|(203) 737-6133|robert.bruce@yale.edu
108154|NCT00859014|University of Texas Health Science Center|Dr. Sean I. Savitz, Professor and Director of Stroke|713.500.7083|sean.i.savitz@uth.tmc.edu
108155|NCT00859027|University of Connecticut Health Center|Pamela Taxel MD|860-679-4743|taxel@nso.uchc.edu
119358|NCT01468012|New York State Psychiatric Institute|Adam Bisaga|646-774-6155|bisagaa@nyspi.columbia.edu
108157|NCT00859053|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
108158|NCT00859131|Medical University of South Carolina|Kenneth Chavin, MD, PhD|843-792-3368|chavinkd@musc.edu
108159|NCT00859222|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|617-632-2166|Patrick_Wen@dfci.harvard.edu
108160|NCT00859313|AcelRx Pharmaceuticals, Inc.|Dr. Pamela Palmer|650-216-3504|ppalmer@acelrx.com
108161|NCT00859339|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org
108162|NCT00859430|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
108163|NCT00859469|Columbia University|Joshua Leinwand|212-305-4076|jcl2125@columbia.edu
108164|NCT00859508|Synthes USA HQ, Inc.|Heidi Hausner, Clinical Research Manager|610-719-5707|hausner.heidi@synthes.com
108165|NCT00859521|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
108166|NCT00859547|ZymoGenetics|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com
108168|NCT00859586|NIH NHLBI|Dr. Minoo Battiwalla|301-827-0939|battiwam@nhlbi.nih.gov
108169|NCT00859638|McMaster University|Dr. Julie Richardson|(905) 525-9140 ext 27811|jrichard@mcmaster.ca
108170|NCT00859651|Columbia University|Katherine Crew, MD|212-305-1732|kd59@cumc.columbia.edu
108171|NCT00851890|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
108172|NCT00851903|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com
108173|NCT00852124|UMARYLAND|Alessio Fasano|617-726-1450|afasano@partners.org
108174|NCT00852137|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com
108175|NCT00852397|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108176|NCT00852475|Baltimore VAMC and University of Maryland Medical Center|Michael Miller, MD|4103286299|mmiller@medicine.umaryland.edu
108177|NCT00852527|Southern AZ VA Health Care System|Dr. Judith Babcock-Parziale, PI|520-7921450 ext 5698|judith.babcock@va.gov
108179|NCT00852592|UPittsburgh|Assistant Professor of Psychiatry|412-246-5248|sitdk@upmc.edu
108180|NCT00852631|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com
108181|NCT00852761|GlaxoSmithKline|GSK Response Center|866-435-7343|
108182|NCT00852917|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
108183|NCT00852930|Vanderbilt University School of Nursing|Sheila H, Ridner, PHD|615-322-0831|Sheila.Ridner@Vanderbilt.edu
108184|NCT00852969|Tufts Medical Center|Mark Sarnak, MD|617 636-1182|msarnak@tuftsmedicalcenter.org
108185|NCT00852995|Smith & Nephew|Jamie E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com
108186|NCT00853021|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org
108187|NCT00853073|Wills Eye Hospital|Principal Investigator|215-928-3211|marlenemoster@gmail.com
108188|NCT00853099|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
108189|NCT00853151|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
108190|NCT00853229|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org
108191|NCT00853242|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
108192|NCT00853333|University of Alabama at Birmigham|Michael Froelich|(205)975-0145|froelich@uab.edu
108193|NCT00853385|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108194|NCT00853567|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com
108195|NCT00853593|Medtronic, Inc|4396 Clinical Research Specialist|800-328-2518 ext 62808|medtronicCRMtrials@medtronic.com
108196|NCT00853606|Vivus, Inc|Wesley W Day PhD|650-934-5200|
108197|NCT00853658|Novartis Pharmaceuticals|Study Director|862-778-8300|
108198|NCT00853723|UPittsburgh|Mara J Horwitz|4126922848|horwitz@pitt.edu
108199|NCT00853749|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108200|NCT00853762|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
108201|NCT00853827|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
108202|NCT00853840|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
108203|NCT00853905|Wills Eye Hospital Glaucoma Research|Marlene Moster MD|215-825-4713|jmolineaux@willseye.org
108204|NCT00853957|Novartis Pharmaceuticals|Study Director|862-778-8300|
108205|NCT00853970|ISTA Pharmaceuticals, Inc.|Tim McNamara, Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com
108206|NCT00853996|University of Kansas Mecical Center|Bruce F. Kimler Ph.D|913-588-4523|bkimler@kumc.edu
108207|NCT00854087|SCTI Research Foundation|Dr. Tarek Hassanein|6195220330|thassanein@livercenters.com
108208|NCT00854113|Theracos|Yuan-Di Halvorsen|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu
108209|NCT00859833|Univesity of Utah|Sheldon Litwin|801-581-7715|sheldon.litwin@hsc.utah.edu
108210|NCT00859898|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
108211|NCT00859937|University of Chicago Comprehensive Cancer Center|Dr. Stuart Wong|773-702-9311|swong@mcw.edu
108212|NCT00859950|Weill Cornell Medical College|Dr. Ana Krieger|646-962-7378|ack2003@med.cornell.edu
108213|NCT00860028|Yale School of Medicine|Dr. Stephanie O'Malley|203-974-7590|stephanie.omalley@yale.edu
108214|NCT00860067|MedImmune LLC, an affiliate of AstraZeneca AB|Judith Falloon, MD/ Sr. Dir. Clinical Development|301-398-0000|falloonj@medimmune.com
108215|NCT00860457|Lombardi Comprehensive Cancer Center, Georgetown University Hospital|Dr. Chaitra Ujjani|202-444-1212|csu@georgetown.edu
108216|NCT00860470|JHSPH|Keith P. West, Jr.|4109552061|kwest@jhsph.edu
108217|NCT00860535|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108219|NCT00860795|University of Washington|James A Taylor, MD|206-616-1206|uncjat@u.washington.edu
108220|NCT00860847|Los Angeles Biomedical Research Inst.|Dr Matthew Budoff|310-222-4107|mbudoff@labiomed.org
108221|NCT00860951|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu
108222|NCT00861146|Yale University School of Medicine|Ned L. Cooney, PhD|860-594-6339|ned.cooney@yale.edu
108223|NCT00861198|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu
108224|NCT00861263|University of FLorida|Dr. Peter Draganov MD|352-273-9472|peter.draganov@medicine.ufl.edu
108225|NCT00861341|University of Rochester, Wilmot Cancer Center|Charles Francis, MD|585-275-3761|Charles_Francis@urmc.rochester.edu
108226|NCT00861471|New York University Cancer Institute|Anna Ferrari, MD|212-731-5389|anna.ferrari@nyumc.org
108227|NCT00861601|GlaxoSmithKline|GSK Response Center|866-435-7343|
108228|NCT00861614|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
108229|NCT00861692|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
108230|NCT00861705|Warren Alpert Medical School of Brown University, Department of Medicine|William M. Sikov, M.D.|401-793-7151|wsikov@lifespan.org
108231|NCT00861744|GlaxoSmithKline|GSK Response Center|866-435-7343|
108232|NCT00861757|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
108234|NCT00862082|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com
108235|NCT00862121|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
108236|NCT00862134|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com
108237|NCT00862186|Seattle Children's Hospital|Catherine Fiona Macpherson, PhD|206-987-2032|catherine.macpherson@seattlechildrens.org
108238|NCT00862251|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108239|NCT00862277|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
108240|NCT00862459|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
108241|NCT00862537|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303 795-3222|abraswell@pico-tesla.com
108242|NCT00862563|Department of Psychiatry, Boston Univ School of Medicine|Dr. Domenic A Ciraulo, Professor|617-414-1990|dciraulo@bu.edu
108243|NCT00862641|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com
108244|NCT00862654|Galderma|Farzi Sidou, Clinical Project Manager|+33 4 93 95 70 51|farzaneh.sidou@galderma.com
108245|NCT00862719|IndianaU|Dr. Sherif Farag|317-944-0920|ssfarag@iu.edu
108246|NCT00862745|University of California, San Francisco|Dr. Jeanette Brown|415-353-9751|brownj@obgyn.ucsf.edu
108247|NCT00862784|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
108248|NCT00862810|Duke University Health System|Emmanuel Walter MD, MPH|919-620-5346|walte002@mc.duke.edu
108249|NCT00862823|University of Alabama at Birmingham|Jennifer King|205-934-2696|jenking@uab.edu
108250|NCT00862836|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
108251|NCT00862849|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889|
108252|NCT00862940|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
108254|NCT00863109|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108255|NCT00864682|Virginia Mason Medical Center|Joseph M. Neal, MD|206-223-6980|anejmn@vmmc.org
108256|NCT00864708|NF/SG VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|(352) 376-1611 ext 5223|janis.daly@neurology.ufl.edu
108257|NCT00864851|Shire Human Genetic Therapies, Inc. (Shire HGT)|Anna Wijatyk, MD, Medical Director|781-482-9622|awijatyk@shire.com
108258|NCT00864916|Indiana University School of Medicine|Samir K. Gupta, MD|317-274-7926|sgupta1@iu.edu
108259|NCT00865020|Novartis Pharmaceuticals|Study Director|862-778-8300|
108260|NCT00865046|VA Pittsburgh Healthcare System|Dr. Debra K. Weiner|412-360-2920|debra.weiner@va.gov
108261|NCT00865098|Merck Serono Co., Ltd, Tokyo, Japan|Masataka Ota|+81 0 3 6853 8611|
108262|NCT00865124|Brigham and Women’s Hospital|Gail K. Adler|617-732-5661|gadler@partners.org
108263|NCT00865189|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
108264|NCT00865202|University of Colorado|Thomas Robinson MD|303-724-2728|thomas.robinson@ucdenver.edu
108265|NCT00865306|Massachusetts General Hospital|Dina R. Hirshfeld-Becker, PhD|617-503-1408|dhirshfeld@partners.org
108266|NCT00865345|Medtronic|Scott Lee M.D.|818-576-4204|scott.w.lee@medtronic.com
108267|NCT00865514|University of Florida|Dr. Peter W. Stacpoole|(352) 273-9023|pws@ufl.edu
108268|NCT00865709|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
108269|NCT00865904|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
108270|NCT00866034|UMC Utrecht|Ouijdane Hamdine, MD|+31-88-7557524|O.Hamdine@umcutrecht.nl
108271|NCT00866047|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com
108272|NCT00866177|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org
108273|NCT00866281|Novartis Pharmaceuticals|Study Director|862-778-8300|
108274|NCT00866294|GlaxoSmithKline|GSK Response Center|866-435-7343|
108275|NCT00866307|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
108276|NCT00866320|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org
108278|NCT00866606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108279|NCT00866658|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
108280|NCT00866697|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
108281|NCT00866723|Dana-Farber Cancer Institute|Panagiotis Konstantinopoulos|(617) 632-5269|panagiotisa_konstantinopoulos@dfci.harvard.edu
108282|NCT00866775|Sunovion Phamaceuticals Inc.|Eslicarbazepine acetate Medical Director|866-503-7813|clinicaltrialsdisclosure@sunovion.com
108283|NCT00866788|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
108284|NCT00866814|C.R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com
108285|NCT00866905|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
108286|NCT00866918|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
108287|NCT00867009|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
108288|NCT00867035|Department of Orofacial Sciences, University of California, San Francisco|Milton Robert Wirthlin, DDS, MS|415-476-1731|m.robert.wirthlin@ucsf.edu; ddsmmr@att.net
108290|NCT00860158|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org
108291|NCT00860249|Northwestern University, Department of General Internal Medicine|Kenzie A. Cameron, PhD, MPH|312-503-3910|K-Cameron@northwestern.edu
108292|NCT00860262|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108293|NCT00860314|University Hospital Hamburg-Eppendorf, Heart Center|Tim Risius, MD|+49-40-42803 ext 4142|risius@uke.uni-hamburg.de
108294|NCT00860405|Fresenius Kabi Aktiengesellschaft, Else-Kröner-Str. 1, 61352 Bad Homburg, Germany|Professor Dr. Martin Westphal, Chief Medical Officer|+49 6172 686 7280|martin.westphal@fresenius-kabi.com
108295|NCT00867139|FHCRC|Michael Boeckh MD|206 667 6706|mboeckh@fhcrc.org
108296|NCT00867165|Merck Sharp & Dohme.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
121235|NCT02210000|GlaxoSmithKline|GSK Response Center|866-435-7343|
121236|NCT02207569|Medtronic|Sara Saul|763-526-1965|sara.m.saul@medtronic.com
108297|NCT00867321|Mayo Clinic|Steven R. Alberts, MD MPH|507/284-4918|Alberts.steven@mayo.edu
108298|NCT00867360|Stanford University|Dr. Alan Schatzberg|650-723-6811|afschatz@stanford.edu
108299|NCT00867529|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org
108300|NCT00867568|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org
108301|NCT00867659|Virginia Center for Reproductive Medicine|Dr Fady Sharara|7034377722|fsharara@vcrmed.com
108302|NCT00868101|Universidade de Sao Paulo|Marcos Alves Pavione|55 79 9199 9576|mapavione@hotmail.com
119361|NCT01401257|Hôpital La Timone, Marseille|Pr Shahram ATTARIAN|04 91 38 65 ext 79|shahram.attarian@ap-hm.fr
108304|NCT00868192|Washington University School of Medicine|David G. Mutch, M.D.|314-362-2181|mutchd@wudosis.wustl.edu
108305|NCT00868218|University of Bergen|Professor Rebecca Jane Cox|+4755974668|rebecca.cox@uib.no
108306|NCT00868231|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com
108307|NCT00868296|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
108308|NCT00868309|Instituto Bioclon S.A. de C.V.|Walter Garcia|+52 (55)54883700 ext 3785|wgarcia@silanes.com.mx
108309|NCT00868348|Aarhus University Hospital|Karen V Andersen|51263173 ext 0045|karenand@rm.dk
108310|NCT00868374|University Hospitals Cleveland Medical Center|Dr. Keming Gao|216-844-2865|keming.gao@UHhospitals.org
108311|NCT00868439|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com
108312|NCT00868452|Sunovion|Medical Director, CNS|1-866-503-6351|
108313|NCT00868517|Department of Veterans Affairs|Michelle Kennedy Prisco|202-745-8000 ext 56235|michelle.prisco@va.gov
108314|NCT00868530|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108315|NCT00868699|Sunovion|Medical Director, CNS|1-866-503-6351|
108316|NCT00868712|Walter Reed Army Medical Center, Cardiology Service|Todd C. Villines, MD|301-295-7839|todd.villines@us.army.mil
108317|NCT00868751|Tufts Medical Center|Research Administration||mcoughlin@tuftsmedicalcenter.org
108318|NCT00868790|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108319|NCT00868959|Sunovion|Medical Director, CNS|1-866-503-6351|
108320|NCT00868998|Columbia University|Robert Fine|212-305-1168|rlf20@columbia.edu
108321|NCT00869050|Columbia University|Dr. Paul Oberstein|212-305-0592|po2178@cumc.columbia.edu
108322|NCT00869089|University Hospitals Case Medical Center|Neil J. Korman, MD Principal Investigator|216-844-7164|neil.korman@UHHospitals.org
108323|NCT00869128|Shoham Geriatric Medical Center, Pardes Hana, Israel|D. Garfinkel , MD|Tel: 972-4-6375667|dorong@shoham.health.gov.il
108324|NCT00869141|Stein Eye Institute|Dr. Simon K. Law|(310)794-1477|law@jsei.ucla.edu
108325|NCT00869167|California Pacific Medical Center|Brandon Lu, M.D., M.S.|415-923-3421|lubs@sutterhealth.org
108326|NCT00869258|Columbia University|Robert Fine, MD|212-305-1168|rlf20@columbia.edu
108328|NCT00869349|Brigham and Women's Hospital|Nancy A. Shadick|617-732-5266|nshadick@partners.org
108329|NCT00869362|Massachusetts General Hospital Diabetes Center|Deborah J. Wexler MD|617-726-8722|dwexler@partners.org
108330|NCT00869375|OUHSC|J. Emilio Exaire MD|405 271 4742 ext 44744|jose-exaire@ouhsc.edu
108331|NCT00869401|Mayo Clinic|Nadia Laack M.D.|5072844561|laack.nadia@mayo.edu
108332|NCT00869414|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu
108333|NCT00869518|University of California, San Francisco|Brian S. Schwartz, MD|415-476-5767|brian.schwartz@ucsf.edu
108334|NCT00869557|Gilead Sciences, Inc|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
108335|NCT00869609|University of Pittsburgh|Trevor J Orchard|412-383-1032|tjo@pitt.edu
108336|NCT00869622|VA Boston Healthcare System|Antonio A. Lazzari, M.D., Ph.D|(857) 364-6381|Antonio.Lazzari@va.gov
108337|NCT00869778|Institute of Immunology，PLA|Dr.Wu|02368752230 ext 86|wuyuzhang@yahoo.com
108338|NCT00869791|Impax Laboratories, Inc.|Michelle Landolfi, PhD. Sr. Director, Regulatory Affairs|(510) 240-6496|Michelle.Landolfi@impaxlabs.com
108339|NCT00869947|Eastern Colorado Healthcare System|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov
108340|NCT00869960|UAB|Jennifer King|205-934-2696|jenking@uab.edu
108341|NCT00863317|Richmond Emergency Physicians Inc|Frank Petruzella|773 447-2489|fpetruzella@gmail.com
108342|NCT00863330|Aurora Health Care|IIR regulatory specialist|414-219-7886|jackie.blundon@aurora.org
108343|NCT00863343|Meso Scale Diagnostics, LLC.|Dennis Mertz, Director Regulatory and Clinical Affairs|240 631-2522 ext 2809|dmertz@mesoscale.com
108344|NCT00863356|HemCon Medical Technologies|V.P., Clinical Affairs|971.223.4904|jody.oyama@hemcon.com
108345|NCT00863434|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu
108346|NCT00863512|Duke University Medical Center|David Harpole, M.D.||david.harpole@duke.edu
108347|NCT00863551|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com
108348|NCT00863655|Novartis Pharmaceuticals|Study Director|862-778-8300|
108349|NCT00863707|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com
108350|NCT00863746|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
108351|NCT00863798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108352|NCT00864032|University of California Davis Comprehensive Cancer Center|Dr. Robert J. Canter|916-734-5907|robert.canter@ucdmc.ucdavis.edu
108353|NCT00864084|The University of Manitoba|Ms Elizabeth Harvey|204-977-5656|harveye@cc.umanitoba.ca
108354|NCT00864123|University of South Florida|Eric Storch, Ph.D.|727-767-8230|estorch@health.usf.edu
119362|NCT01376700|Baxter Innovations GmbH|Armin Reininger, MD, Senior Medical Director & Head, Medical Affairs, Hemophilia||armin_reininger@baxter.com
108356|NCT00864253|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com
108417|NCT00875836|MUSC|Dr. Aimee McRae-Clark|843.792.5216|mcraeal@musc.edu
108357|NCT00864383|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|Dan.Everitt@tballiance.org
108358|NCT00864513|Georgetown University|Dr. Jimmy Hwang|202-444-2198|jh96@gunet.georgetown.edu
108359|NCT00864539|National Nutrition and Food Technology Research Institute|Dr. Tirang R. Neyestani|(+9821)22376471|neytr@yahoo.com
108360|NCT00869999|Massachusetts General Hospital Cancer Center|Jeffrey Barnes, MD|617-724-4000|jabarnes@partners.org
108361|NCT00870103|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
108362|NCT00870194|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
108363|NCT00870467|Abbott|Global Medical Services|800-633-9110|
108364|NCT00870545|Memphis VAMC|Dr. Linda Nichols|901 523-8990 ext 5082|linda.nichols@va.gov
108365|NCT00870584|Novartis Pharmaceuticals|Study Director|862-778-8300|
108366|NCT00870688|Desitin|Lohmueller|0049(0)40-59101 ext 373|lohmueller@desitin.de
108367|NCT00870740|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
108368|NCT00870896|University of South Florida|Thomas Truncale|813 974 8952|ttruncal@health.usf.edu
108369|NCT00871000|GlaxoSmithKline|GSK Response Center|866-435-7343|
108370|NCT00871117|GlaxoSmithKline|GSK Response Center|866-435-7343|
108371|NCT00871143|Institute of Psychiatry|Dr. David Veale|0203 228 3461|david.veale@kcl.ac.uk
108372|NCT00871169|University of New Mexico Comprehensive Cancer Center|Fa-chyi Lee, MD|505-925-0405|flee@salud.unm.edu
108373|NCT00871234|Indiana University School of Medicine|Samir K. Gupta, MD, MS|317-274-7926|sgupta1@iupui.edu
108374|NCT00871286|Northwestern|Rakesh Chandra|312-695-8182|rchandra@nmff.org
108375|NCT00871338|GlaxoSmithKline|GSK Response Center|866-435-7343|
108376|NCT00871351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
108377|NCT00871377|UCLA School of Medicine|Christopher M. DeGiorgio, MD|310-206-3753|cmd@mednet.ucla.edu
108378|NCT00871403|GlaxoSmithKline|GSK Response Center|866-435-7343|
108379|NCT00871429|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu
108380|NCT00871494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108381|NCT00871624|Tufts Medical Center|Russel Roberts, PharmD|617-636-4576|rroberts@tuftsmedicalcenter.org
108382|NCT00871689|Masonic Cancer Center, University of Minnesota|Michael Verneris, M.D.|612-626-2961|verneris@umn.edu
108383|NCT00871715|University of Southern California|Carolee Winstein, Principal Investigator|3234422903|winstein@usc.edu
108384|NCT00871728|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879|
108385|NCT00871741|GlaxoSmithKline|GSK Response Center|866-435-7343|
108386|NCT00871780|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com
108387|NCT00871819|Boston Scientific|Nitzan Mekel-Bobrov, Ph.D.|(661) 949-4537|Nitzan.Mekel-Bobrov@bsci.com
108388|NCT00871871|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
108389|NCT00871975|LABORIE|Clinical Research Administrator|905 612 1170 ext 2274|acampbell@laborie.com
108390|NCT00872001|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
108391|NCT00872027|University of Minnesota|Craig Weinert MD|612-624-0999|weine006@umn.edu
108392|NCT00872079|University of Louisville|Michael Brier|502-852-0246|mbrier@louisville.edu
108393|NCT00872170|New England Research Institutes|Nancy Gee|617-972-3295|ngee@neriscience.com
108394|NCT00872339|New England Research Institutes|Felicia Trachtenberg|6179723120|ftrachtenberg@neriscience.com
108395|NCT00872430|Hospital de Clínicas de Porto Alegre|Dr. Paulo Dornelles Picon|55 xx 51 21018752|paulopicon@gmail.com
108396|NCT00872521|Jan-Cil Australia|Regional Medical Affairs Director Asia Pacific|61 427564369|
108397|NCT00872534|PLx Pharma|Ronald Zimmerman, CEO & President|1-713-842-1249 ext 205|ron.zimmerman@plxpharma.com
108398|NCT00872599|Vanderbilt University|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu
108399|NCT00872729|Horizon Orphan LLC|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com
108400|NCT00872833|New England Research Institutes, Inc.|Eric Gerstenberger|6179237747|egerstenberger@neriscience.com
108401|NCT00872898|Forest Research Institute|Ephraim Katz, PhD / Associate Director|201-427-8000 ext 8169|Ephraim.Katz@frx.com
108402|NCT00867451|Cincinnati Children's Hospital Medical Center|Richard Gilman, Ph.D.|513-636-8172|richard.gilman@cchmc.org
108403|NCT00867490|Novartis Pharmaceuticals|Study Director|862 778-8300|
108404|NCT00867503|University Of Arizona|Dr. Setsuko K Chambers|520/626-0950|schambers@azcc.arizona.edu
108405|NCT00872989|SWOG Statisticial Center|Lung Committee Statistician|206-667-4623|
108406|NCT00873015|University of Virginia Medical Center|Dr. Edward Oldfield|(434) 982-0059|EHO4U@hscmail.mcc.virginia.edu
108407|NCT00873041|Novartis Pharmaceuticals|Study Director|862-778-8300|
108408|NCT00873093|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
108409|NCT00873119|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com
108410|NCT00875550|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com
108411|NCT00875563|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com
108412|NCT00875589|Daroff-Dell'Osso Ocular Motility Laboratory|Jonathan Jacobs, PhD|216-791-3800 ext 2947|jxj24@case.edu
108413|NCT00875615|University of Miami Sylvester Comprehensive Cancer Center|Lynn Feun MD|305-243-4981|lfeun@med.miami.edu
108414|NCT00875706|Department of Veterans Affairs|Dr. Carol VanDeusen Lukas|857-364-5685|carol.vandeusenlukas@va.gov
108415|NCT00875797|UMCLjubljana|Lidija Kompan, principal Investigator|0038651301781|lidija.kompan@gmail.com
108416|NCT00875810|MedtronicSpineECA|Cristina Faria|+41 21 802 70 00|cristina.faria@medtronic.com
108418|NCT00875979|Hoffmann-La Roche|Medical Communications|800 821-8590|
108420|NCT00876265|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com
108421|NCT00876343|Otsuka Pharmaceutical Co., Ld.|Director of Clinical Research and Development|+81-3-6361-7366|
108422|NCT00876447|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
108423|NCT00876460|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108424|NCT00876694|Novartis Pharmaceuticals|Study Director|862-778-8300|
108425|NCT00876733|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108426|NCT00876915|University of Rochester|Charles Francis, MD|(585) 275-5823|charles_francis@urmc.rochester.edu
108427|NCT00876928|Charles R. Drew University|Mayer B. Davidson, MD|323 357-3439|mayerdavidson@cdrewu.edu
108428|NCT00877006|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com
108429|NCT00877032|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108430|NCT00877058|Göteborg University|Professor Synneve Dahlin-Ivanoff (Research leader)|+46317865733|synneve.dahlin-ivanoff@gu.se
108431|NCT00877071|University of Pittsburgh Medical Center|Dr. David Geller|412-692-2001|gellerda@upmc.edu
108432|NCT00877370|University of Michigan|Bruce A. Mueller|(734) 615-4578|muellerb@umich.edu
108433|NCT00877383|Novartis Pharmaceuticals|Study Director|862 778-8300|
108434|NCT00877448|BiondVax Pharmaceuticals Ltd.|Tamar Ben-Yedidia, PhD|972-8-9302529|benyedidia@BiondVax.com
108435|NCT00877487|Shire Pharmaceutical|Timothy Whitaker, MD||twhitaker@shire.com
108436|NCT00877604|Fondazione Istituto Neurologico Carlo Besta|Alberto Albanese|+39 02 2392 4552|alberto.albanese@unicatt.it
108437|NCT00877773|University of Texas (UT) MD Anderson Cancer Center|Daniel Karp, MD / Professor, Investigational Cancer Therapeutics||CR_Study_Registration@mdanderson.org
108438|NCT00877799|Cara Therapeutics Inc.|Frédérique Menzaghi, PhD, Vice President Research & Development|203-567-1502|fmenzaghi@caratherapeutics.com
108439|NCT00877877|GlaxoSmithKline|GSK Response Center|866-435-7343|
108440|NCT00877890|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
108441|NCT00877929|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108442|NCT00870363|University of California Davis Medical Center|David M Asmuth|(916) 734-8695|dasmuth@ucdavis.edu
108443|NCT00878228|Hospital for Special Surgery|Dr. David Kim|212-606-1206|KimD@hss.edu
108444|NCT00881959|Zimmer Dental|Hai Bo Wen|760 929 4312|haibo.wen@zimmer.com
108445|NCT00882102|The University of Texas MD Anderson Cancer Center|Gautam Borthakur, MD/Associate Professor|713-563-1586|eharriso@mdanderson.org
108446|NCT00882206|University of Minnesota, Pediatric Hematology Dept.|Dr. Michael Burke, MD|612.672.7422|
108447|NCT00882310|Columbia University|Paul Oberstein, MD|212-305-0592|po2178@cumc.columbia.edu
108448|NCT00882362|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
108449|NCT00882440|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
108450|NCT00882518|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
108452|NCT00882583|FDA|Shanthi Marur|2404026373|shanthi.marur@fda.hhs.gov
108453|NCT00882661|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com
108454|NCT00882687|Shire|Study Physician|1 866-428-5335|
108455|NCT00882713|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
108456|NCT00882778|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
108457|NCT00882908|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com
108458|NCT00882921|Shire|Arian Pano|+1 866 842 5335|
108459|NCT00883090|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
108460|NCT00883103|Baystate Medical Center|Oz Harmanli, MD|4137945608|oz.harmanli@baystatehealth.org
108461|NCT00883116|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
108462|NCT00883129|David Geffen School of Medicine at UCLA|Donald P. Tashkin, M.D.|310-825-5316|dtashkin@mednet.ucla.edu
108463|NCT00883168|Meda Pharmaceuticals, Inc.|David Ginsberg,D.O.|732 564-2364|david.ginsberg@meda.us
108464|NCT00883181|Amgen Inc.|Study Director|866-572-6436|
108465|NCT00883233|Galderma|Jean-Charles Dhuin|+33492952921|jean-charles.dhuin@galderma.com
108466|NCT00883246|Covidien|Director of Scientific Communications|763-398-7000|jean.ahlstrom@covidien.com
108467|NCT00883337|sanofi|Trial Transparency Team||Contact-US@sanofi.com
108468|NCT00883389|University of Maryland, School of Medicine|Dr. Jeffrey C. Fink, Associate Professor, Nephrology|410-328-5720|jfink@medicine.umaryland.edu
108469|NCT00883493|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
108470|NCT00883558|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889|
108471|NCT00883675|Maestro|Michael Mann, MD|650-380-9579|michael.mann@ucsfmedctr.org
108472|NCT00883740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108473|NCT00883753|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
108474|NCT00883779|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
108475|NCT00884039|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org
108476|NCT00884065|Catalan Institut of Health - Servei de Rhb Sant Ildefons|Martín Eusebio Barra López||martinbarra@gmail.com
108477|NCT00884117|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
108478|NCT00884221|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
108479|NCT00884273|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
108480|NCT00884325|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com
108481|NCT00884377|Walter Reed Army Medical Center|Dr. Naomi Aronson, Principal Investigator|202-782-8691|naronson@usuhs.mil
108482|NCT00884390|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108483|NCT00873327|Duke University Medical Center|Brian Smith, MD. MPH|919-668-8951|brian.smith@duke.edu
108484|NCT00873457|Duke University Medical Center|Daphne Friedman, MD|919-684-9220|daphne.friedman@dm.duke.edu
108485|NCT00873730|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
108486|NCT00873782|University of North Carolina at Chapel HIll|William J. Powers, MD|919 966 8178|powersw@neurology.unc.edu
108487|NCT00873821|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108488|NCT00873860|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com
108489|NCT00873873|National Jewish Health|Head, Pediatric Clinical Pharmacology|303-398-1193|szeflers@njhealth.org
108490|NCT00873912|MedImmune, LLC|Elissa Malkin, DO|301-398-0000|malkine@medimmune.com
108491|NCT00874029|Halt Medical, Inc|Laura Kemp, Sr. VP Clinical Affairs|408-375-1465|lkemp@haltmedical.com
108492|NCT00874094|NY Eye & Ear Infirmary|Anthony P Sclafani, MD|212-979-4200|asclafani@nyee.edu
108494|NCT00874250|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com
108495|NCT00874276|University of Florida|Dr. Peter Stacpoole/Principal Investigator|1-352-273-9023|pws@ufl.edu
108496|NCT00874497|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
108497|NCT00874510|Center for Health Incentives and Behavioral Economics|Kevin Volpp, MD, PhD|215.573-0270|volpp70@exchange.upenn.edu
108498|NCT00874549|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
108499|NCT00874770|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com
108500|NCT00874822|University of Nebraska Medical Center|Jason Shiffermiller, MD, MPH|402-559-7299|jshiffermiller@unmc.edu
108501|NCT00874848|Biothera|Jamie Lowe, Vice President, Clinical Development|651-256-4653|jlowe@biothera.com
108502|NCT00874887|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com
108503|NCT00874939|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108504|NCT00875017|Shire Pharmaceutical|Gerald Tremblay, M.D.||gtremblay@shire.com
108505|NCT00875212|Federal University of Paraiba|Fabio Correia Sampaio (research leader)|+55 83 3216 7795|fabios@ccs.ufpb.br
108506|NCT00875329|Tampa VAMC|Rodney Vanderploeg, Ph.D|(813) 972-2000 ext 6728|Rodney.Vanderploeg@va.gov
108507|NCT00875394|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
108508|NCT00875420|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com
108509|NCT00875433|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108510|NCT00875485|GlaxoSmithKline|GSK Response Center|866-435-7343|
108511|NCT00884585|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
108513|NCT00884832|Mayo Clinic|Dr. Adil E. Bharucha|507-266-9156|bharucha.adil@mayo.edu
108514|NCT00884897|Maryland Psychiatric Research Center|Deanna L. Kelly Pharm.D., BCPP|410-402-96860|dkelly@mprc.umaryland.edu
108515|NCT00884910|Netherlands Cancer Institute|Prof Dr FJM Hilgers|+31 20 512 2550|f.hilgers@nki.nl
108516|NCT00884949|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com
108517|NCT00885079|Otsuka Pharmaceutical Co., Ltd.|Mr. Kyoji Imaoka|-81-6-6943-7722|
108518|NCT00885092|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com
108519|NCT00885105|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
108520|NCT00885118|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108521|NCT00885170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108522|NCT00885352|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108523|NCT00885365|Chiesi Farmaceutici S.p.A.|Chiesi Clinical Trials||clinicaltrials_info@chiesi.com
108524|NCT00885378|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
108525|NCT00885482|Catholic University of S. Heart|Andrea De Luca|+390630155366|deluca.andrea@fastwebnet.it
108526|NCT00885534|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org
108527|NCT00885638|Lund University|Professor Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se
108528|NCT00885677|Medtronic EMEA RCC|Valentina Amori|3425417863|valentina.amori@medtronic.com
108529|NCT00885742|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
108530|NCT00885755|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
108531|NCT00885768|Kidney Reasearch Center, Tehran University of Medical Sciences|Mohammad Reza Khatami MD|00982161192659|khatami@hbi.ir
108532|NCT00885846|Bastyr University|Guan-Cheng Sun, PhD|425-602-3389|gsun@bastyr.edu
108533|NCT00886015|JohnHopkins U|Sheila West|410-955-2606|shwest@jhmi.edu
108534|NCT00886119|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
108535|NCT00886145|James J. Peters VA Medical Center|William A. Bauman|718-584-9000 ext 5428|william.bauman@va.gov
108536|NCT00886288|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108537|NCT00886340|Yale School of Nursing|Robin Whittemore, PhD|203-737-2351|robin.whittemore@yale.edu
108538|NCT00886483|The Ohio State University|L. Eugene Arnold, M.D. M.Ed.|614-685-6708|L.Arnold@osumc.edu
108539|NCT00886587|Johnson & Johnson Consumer Inc|Amisha Parikh-Das, PhD/Study Director|973 385-2863 USA EST|AParikh1@its.jnj.com
108540|NCT00886600|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
108541|NCT00886613|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108542|NCT00886626|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu
108543|NCT00886639|Schön Klinik BGL|Dr. Klaus Kenn|0865293 ext 1540|iheinzelmann@schoen-kliniken.de
108544|NCT00886704|Ludwig Maximilians-University Munich|Clemens von Schacky, Head, Preventive Cardiology, University of Munich|+498951600 ext 2165|clemens.vonschacky@med.uni-muenchen.de
108545|NCT00886743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108546|NCT00886769|Novartis Pharmaceuticals|Study Director|862-778-8300|
108547|NCT00886795|Johns Hopkins University|Clifton O. Bingham III, M.D.|410-550-0578|cbingha2@jhmi.edu
108548|NCT00886821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108549|NCT00886834|University of Utah, Department of Obstetrics and Gynecology|Dr. David Turok|801-581-7647|david.turok@hsc.utah.edu
108550|NCT00886899|BridgePoint Medical|VP, Clinical Affairs|763-225-8500|jschultz@bridgepointmedical.com
108551|NCT00886938|Washington University|Dr. Jay F Piccirillo|(314) 362-8641|piccirilloj@ent.wustl.edu
108552|NCT00887159|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012|
108553|NCT00887198|Janssen R&D US|SENIOR DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com
108554|NCT00887224|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
108555|NCT00887250|Merck & Co., Inc.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
108556|NCT00887289|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108557|NCT00887315|Department of Health Studies, University of Chicago|Dr. Sang Mee Lee|773-834-6765|slee@health.bsd.uchicago.edu
108558|NCT00878501|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
108559|NCT00878553|Somnus Therapeutics, Inc|Dr. Christine Blumhardt, Chief Regulatory Officer|617-710-0928|cblumhardt@somnusthera.com
108560|NCT00878605|VA Greater Los Angeles Healthcare System|Dr. Zhaoping Li, Section Chief|310-268-3528|zhaoping.li@va.gov
108561|NCT00878644|University of Utah|Marianne Gildea, BSN, MS; Director of THAPCA Trials|801-608-4907|marianne.gildea@hsc.utah.edu
108563|NCT00878722|Topotarget A/S|PRS Admnistrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com
108564|NCT00878800|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com
108565|NCT00878826|Stanford University|Dr. Deirdre Lyell|650-736-1191|dlyell@stanford.edu
108566|NCT00878878|GE Healthcare|Ruben Sheng, M.D.|1-609-514-6899|Rubin.Sheng@ge.com
108567|NCT00879398|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108568|NCT00879411|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108569|NCT00879619|University of California, Irvine|Nicole Macaranas, Clinical Research Specialist|714-456-6550|nicole.macaranas@uci.edu
108570|NCT00879645|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com
108571|NCT00879684|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108572|NCT00879697|University of São Paulo|Raphael Dias|55 81 9728 6878|raphaelritti@gmail.com
108573|NCT00879710|Medical College of Wisconsin|Srividya Kidambi, MD, MS|414-955-4843|skidambi@mcw.edu
108574|NCT00879775|Department of Family Medicine, Dongguk University Ilsan Hospital, Republic of Korea|Sang-Yeon Suh, M.D.,Ph.D|0082-031-961-7490|fmmodel@gmail.com
108575|NCT00879814|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108576|NCT00879879|SunCoast CCOP Research Base|Dr. Jeffrey Krischer, Principal Investigator|813-396-9245|ccop@epi.usf.edu
108577|NCT00879970|GlaxoSmithKline|GSK Response Center|866-435-7343|
108578|NCT00879996|SUNY Buffalo|Dr. Richard Blondell|716-898-4971|blondell@buffalo.edu
108579|NCT00880009|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108581|NCT00880100|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1- 800- 472- 263|
108582|NCT00880165|Philadelphia VA Medical Center|Samuel T. Kuna, MD|215-823-4400|Samuel.Kuna@va.gov
108583|NCT00880191|Mayo Clinic|Debra L. Barton RN, PhD, AOCN|507/284-1623|barton.debra@mayo.edu
108584|NCT00880230|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com
108585|NCT00880256|VA Puget Sound Health Care System|Dr. David Kearney|206-764-2285|david.kearney@va.gov
108586|NCT00880269|Novartis Pharmaceuticals|Study Director|862-778-8300|
108587|NCT00880334|Dana-Farber Cancer Institute|Toni Choueiri, MD|617-632-5456|toni_choueiri@dfci.harvard/edu
108589|NCT00880399|GlaxoSmithKline|GSK Response Center|866-435-7343|
108590|NCT00880425|Thomas Jefferson University|Jessica Ailani, MD/ Headache Fellow|631-807-8194|Jessica.Ailani@gmail.com
108591|NCT00880542|University of Calicornia Los Angeles (UCLA)|William Tap, MD|888-798-0719|wtap@mednet.ucla.edu
108592|NCT00880555|Department of Veterans Affairs|Dr. David Glenn Clark|843-792-7446|clarkda@musc.edu
108593|NCT00880568|Merck Sharp & Dohme|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108594|NCT00880581|Stanford University|Ronald Levy|6507256452|levy@stanford.edu
108595|NCT00880620|Impax Laboratories, Inc.|Michelle Landolfi, PhD, Senior Director Regulatory Affairs|510-240-6496|Michelle.Landolfi@impaxlabs.com
121240|NCT02158936|Novartis Pharma AG|Study Director|862-778-8300|
108596|NCT00880685|University of Chicago|Dr. Jon Grant|773-834-1326|jongrant@uchicago.edu
119365|NCT01220609|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
108598|NCT00880750|Shire Pharmaceutical|Gerald Tremblay, M.D.||gtremblay@shire.com
108599|NCT00880763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
119366|NCT01180049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108601|NCT00880919|University of Minnesota|Dr. S. Charles Schulz, MD|612-273-9820|scs@umn.edu
108602|NCT00881205|Novartis Pharmaceuticals|Study Director|862-778-8300|
108603|NCT00881335|Shanghai Tenth People's Hospital, Tongji University|Zhang Xiangyu|86-21-66307174|xiangyu62@126.com
108604|NCT00881465|University of South Florida|Eric Storch, Ph.D.|7277678230|estorch@health.usf.edu
108605|NCT00881504|Georgetown University Medical Center|Dr. John L Marshall|202-444-7064|marshalj@georgetown.edu
108606|NCT00881530|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108607|NCT00881608|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com
108608|NCT00881621|Georgetown University|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu
108609|NCT00881647|University of California, San Francisco|Thomas C. Neylan, MD|415-750-6961|thomas.neylan@ucsf.edu
108610|NCT00881712|University of Florida Proton Therapy Institute|Bradford Hoppe, M.D.|904-588-1800|bhoppe@floridaproton.org
108611|NCT00881751|Medical University of South Carolina|Kate Anderton, MPH, CCRP|anderton@musc.edu|anderton@musc.edu
108612|NCT00881868|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com
108613|NCT00881894|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
108614|NCT00887341|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
108615|NCT00887354|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
108617|NCT00887471|SUNY Downsate Medical Center|Nira A Goldstein, MD|718-270-1638|ngoldstein@downstate.edu
108618|NCT00887484|GlaxoSmithKline|GSK Response Center|888-435-7343|
108620|NCT00887549|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
108621|NCT00887562|Columbia University|Michio Hirano, MD|12123051048|mh29@cumc.columbia.edu
108622|NCT00887575|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
108623|NCT00887588|Novartis Pharmaceuticals|Study Director|862-778-8300|
108624|NCT00887640|Duke University Medical Center|Dr. Andrew Armstrong|919-668-8108|andrew.armstrong@dm.duke.edu
108625|NCT00887653|THE MIRIAM HOSPITAL|Aadia Rana|4017934680|arana@lifespan.org
119369|NCT01023958|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108627|NCT00888654|Barbara Ann Karmanos Cancer Institute|Elisabeth Heath, M.D.|313-576-8715|heathe@karmanos.org
108628|NCT00888849|Ethicon Endo Surgery, Inc|Sheryl Helsinger/Clinical Affairs Director|513-337-3079|shelsing@its.jnj.com
108629|NCT00888940|Cubist Pharmaceuticals, Inc.|Alistair Wheeler, MD MFPM, Senior Director Clinical Research|781-860-8660|awheeler@cubist.com
108630|NCT00888979|UConn Health|Cheryl Oncken|860-679-3425|oncken@uchc.edu
108631|NCT00889187|Brigham and Women's Hospital / Dana Farber Cancer Institute|Harvey Mamon, MD, PhD|617-732-8564|HMAMON@LROC.HARVARD.EDU
108632|NCT00889200|Butler Hospital|Linda Carpenter, MD|401 455 6349|Linda_Carpenter_MD@Brown.edu
108633|NCT00889252|Vistakon|Brian Pall OD MS FAAO|904-443-1290|
108634|NCT00889265|Zimmer Dental|Dr Hai Bo Wen, Director of Research|760-929-4312|haibo.wen@zimmer.com
108635|NCT00889330|Johnson & Johnson Vision Care, Inc.|Arthur Shedden, MD|904-443-1557|ashedden@its.jnj.com
108636|NCT00889421|Oregon Health & Science University|Dr. Eric Suhler|503-494-5023|suhlere@ohsu.edu
108638|NCT00889603|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108639|NCT00889681|Medtronic- AF Solutions|Dana Wigert- Sr. Clinical Research Specialist|763-526-2802|dana.wigert@medtronic.com
108640|NCT00889707|Sophiris Bio Corp (formerly Protox Therapeutics)|Chief Medical Officer|858-255-4711|richard@sophiris.com
108641|NCT00889720|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108642|NCT00889824|WashingtonU|Joel Goebel, MD|(314) 362-7344|goebelj@ent.wustl.edu
108643|NCT00889863|Novartis Pharmaceuticals|Study Director|862-778-8300|
108644|NCT00889915|Duke Clinical Research Institute - Duke University School of Medicine|John S. March, MD, MPH|919-668-7818|john.march@duke.edu
108645|NCT00889928|Ethicon Endo Surgery, Inc|Sheryl Helsinger|513-337-3079|SHelsing@its.jnj.com
108646|NCT00890084|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108647|NCT00890097|Alcon Research, Ltd.|Dana Sager, Clinical Manager Group Leader|1-888-451-3937|alcon.medinfo@alcon.com
108648|NCT00890201|Hospital de La Serena|Marcelo A. Beltran, M.D. - Department of Surgery - Hospital de La Sererna|56 51 485923|beltran_01@yahoo.com
108649|NCT00890409|Children's Hospital, Fudan University|Prof. Xiaomei Shao|86-21-64931913|zhou_wenhao@yahoo.com.cn
108650|NCT00890552|Stanford University School of Medicine|Brenda Hann, RN, MBA, CCRC|650-723-0966|bhann@stanford.edu
108651|NCT00890591|Daiichi Sankyo Pharma Development|Howard Kessler|732-590-5032|hmkessler@dsus.com
108652|NCT00890656|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org
108653|NCT00890682|Pacira Pharmaceuticals, Inc|Executive Medical Director|203-837-6500|ErolOnel@pacira.com
108654|NCT00890695|KEMRI/Wellcome Trust Research Programme|Dr James Berkley|+254 41 522535|jberkley@kilifi.kemri-wellcome.org
108655|NCT00890721|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com
108656|NCT00890916|Louis Stokes Cleveland VAMC|Dr. Kevin Kilgore|216-9573657|klk4@case.edu
108657|NCT00890929|Stanford University Medical Center|Bruno C Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu
108658|NCT00890981|Amgen Inc.|Study Director|866-572-6436|
108659|NCT00891020|Hoffman-LaRoche|Medical Communications|800-821-8590|
108660|NCT00878969|Vanderbilt University|T. Alp Ikizler, MD|615-343-6104|alp.ikizler@vanderbilt.edu
108661|NCT00879034|Dana-Farber Cancer Institute|Dr. Mark Kieran|617-632-4907|mark_kieran@dfci.harvard.edu
108662|NCT00879190|Stanford University, Department of Obstetrics & Gynecology|Anna Girsen, Manager of Maternal-Fetal Medicine Research Operations|(650) 725-0499|agirsen@stanford.edu
108663|NCT00879229|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
108664|NCT00879255|Department of Veterans Affairs|Leslie A. Morland, Clinical Psychologist|(619) 497-8406|leslie.morland@va.gov
108665|NCT00879333|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
108666|NCT00879359|Cleveland Clinic|Lynn Borzi|2164453158|borzil@ccf.org
108667|NCT00884754|London Health Sciences Centre|Philip Jones|519-685-8500 ext 36306|philip.jones@lhsc.on.ca
108668|NCT00884793|UCSF|Steven Yukl|415-221-4810 ext 3930|steven.yukl@ucsf.edu
108669|NCT00884806|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com
108670|NCT00891046|Novartis Pharmaceuticals|Study Director|862­-778­-8300|
108671|NCT00891176|GlaxoSmithKline|GSK Response Center|866-435-7343|
108672|NCT00891202|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
108673|NCT00891293|GlaxoSmithKline|GSK Response Center|866-435-7343|
108674|NCT00891371|Ipsen|Medical Director, Gastroenterology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
108675|NCT00891618|University of Texas MD Anderson Cancer|Michael Wang, MD / Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org
108676|NCT00891657|Integra LifeSciences|Director, Medical Affairs|609-275-0500|
108677|NCT00891735|Genentech, Inc.|Medical Communications|800-821-8590|
108678|NCT00891774|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com
108679|NCT00891813|Abbott|Global Medical Services|1-800-633-9110|
119370|NCT00982189|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu
108681|NCT00891904|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
108682|NCT00891930|Amgen Inc.|Study Director|866-572-6436|
108683|NCT00891982|GlaxoSmithKline|GSK Response Center|866-435-7343|
108684|NCT00891995|Jaeb Center for Health Research|Katrina Ruedy|8139758690|kruedy@jaeb.org
108685|NCT00892008|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
108686|NCT00892047|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu
119371|NCT00952822|Baxter Healthcare Corporation|Wing-Yen Wong, MD, Global Sr Medical Dir Hemophilia||wing_yen_wong@baxter.com
108688|NCT00892151|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com
108689|NCT00892177|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-7733|galanis.evanthia@mayo.edu
108690|NCT00892281|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com
108691|NCT00892437|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
108692|NCT00892606|University Louisville|Nancy Alsip|502-852-2905|nlalsi01@exchange.louisville.edu
108693|NCT00892697|University at Buffalo|Andrew Talal, MD|716-888-4737|ahtalal@buffalo.edu
108694|NCT00892710|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
108695|NCT00892723|Capstone Therapeutics|Denise Lamon|800-937-5520 ext 5206|dlamon@capstonethx.com
119372|NCT00939627|Vanderbilt Ingram Cancer Center|Jill Gilbert, M.D.|615-343-4677|jill.gilbert@vanderbilt.edu
108697|NCT00892957|BAXTER INNOVATIONS GmbH|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com
108698|NCT00893074|Johns Hopkins University|Ryan Vandrey, PhD|410-550-4036|rvandrey@jhmi.edu
108699|NCT00893113|Chesapeake Urology Research Associates|Ronald Tutrone, MD|443.471.5742|hthomas@cua.md
108700|NCT00893152|VA HSR&D Center for Mental Healthcare & Outcomes Research|Ellen P. Fischer, PhD|501-257-1711|Ellen.Fischer@va.gov
108701|NCT00893464|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
108702|NCT00893737|Clinvest|Rebecca Browning|(417) 841-3664|rbrowning@clinvest.com
108703|NCT00893763|University of South Florida|Cindy L. Munro, APRN, PhD|813-974-7597|cmunro2@health.usf.edu
108704|NCT00893789|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
108705|NCT00893971|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|605-305-2600|creisner@pearltherapeutics.com
108706|NCT00893997|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org
108707|NCT00894127|bioAffinity|Maria Zannes|505-400-9747|mz@bioaffinitytech.com
108708|NCT00887679|Duke University Medical Center|Dr. Ashwin A Patkar Associate Professor|919-668-3626|ashwin.patkar@duke.edu
108709|NCT00887744|Medtronic Spinal & Biologics Europe and Central Asia|E. Wülfert, Medical Affairs & Clinical Operations Director||inca.studyregistration@medtronic.com
108710|NCT00887809|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org
108711|NCT00887822|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
108712|NCT00887913|Syneron Medical Ltd|Hanit Brenner-Lavie|972-73-244-2200 ext 581|hanitb@syneron.com
108713|NCT00887965|Amgen Inc.|Study Director|866-572-6436|
108714|NCT00887978|United Therapeutics Corporation|Kevin Laliberte, PharmD|919-425-8350|klaliberte@unither.com
108715|NCT00888134|Massachusetts General Hospital|Donald P. Lawrence|617-643-3614|dplawrence@mgh.harvard.edu
108716|NCT00888238|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
108717|NCT00888329|Mayo Clinic|Javier Magrina MD|480-301-8000|magrina.javier@mayo.edu
108718|NCT00888355|Merck & Co., Inc.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
108720|NCT00888433|Baker IDI Heart and Diabetes Institute|Murray Esler, Principal Investigator||murray.esler@bakeridi.edu.au
108721|NCT00888459|Mayo Clinic|Jon O. Ebbert|507-266-1944|ebbert.jon@mayo.edu
108722|NCT00894166|Duke University Medical Center|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@duke.edu
108723|NCT00894244|Northwestern University|Dr. Murad Alam|(312) 695-6785|m-alam@northwestern.edu
108724|NCT00894322|Clinical Trial Transparency|AstraZeneca||Clinical.Trial.Transparency@astrazeneca.com
108725|NCT00894361|Minneapolis Veterans Affairs Medical Center (VAMC)|Terence J. Gioe, M.D.|612-467-1780|tjgioe@gmail.com
108726|NCT00894387|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
108727|NCT00894465|Washington University School of Medicine|Dr. Paul Austin|(314) 454-6034|austinp@wustl.edu
108728|NCT00896233|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
108729|NCT00896337|Boston Scientific|Angela Schutt|763-494-2166|schutta@bsci.com
108730|NCT00896454|Amgen Inc.|Study Director|866-572-6436|
108731|NCT00896649|Boston Medical Center|Gustavo Mercier, House Radiologist|617-638-6610|gustavo.mercier@bmc.org
108732|NCT00896779|Stanford University|Steven Sanislo, MD|650-723-6995|ssanislo@stanford.edu
108733|NCT00897104|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
108734|NCT00897390|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
108735|NCT00897715|VA Tennessee Valley Healthcare System.|Adriana Hung|615-873-7480|adriana.hung@va.gov
108736|NCT00897897|Philips Healthcare|Director, Clinical and Regulatory Affairs|425-487-7665|sarah.baxter@philips.com
108737|NCT00897910|Barbara Ann Karmanos Cancer Institute|Zaid S. Al-Kadhimi, M.D.|313-576-8022|alkadhiz@karmanos.org
108738|NCT00897949|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108739|NCT00898222|Brigham and Women's Hospital|Dr. Shamsah Kazani|617-732-8201|skazani@partners.org
108740|NCT00898443|UAB|Marsha Wakefield, M.D.|205-934-4696|mwakefield@uab.edu
108741|NCT00898560|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
108742|NCT00898677|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108743|NCT00898807|Johns Hopkins|Anne Casper|410-955-8183|ashankl1@jhu.edu
108744|NCT00891436|Rush University Medical College|James N. Moy, M.D.|312-942-6176|jmoy@rush.edu
108745|NCT00891462|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com
119373|NCT00916032|Baxter|Brigitt Abbuehl, MD, Medical Director, Hematology/Hemophilia||brigitt_abbuehl@baxter.com
108747|NCT00899353|Marshall University Joan C. Edwards School of Medicine|Dr. W. Elaine Hardman|304-696-3721|hardmanw@marshall.edu
108748|NCT00899379|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108749|NCT00899392|Children's Hospital of Philadelphia/OHSU/Doernbecher Children's Hospital|Joel A Friedlander|503-494-1078|friedlan@ohsu.edu
108750|NCT00899470|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
108751|NCT00899574|NYU Cancer Institute|Sylvia Adams, MD|212-263-6485|sylvia.adams@nyumc.org
108752|NCT00899600|Dartmouth-Hitchcock Medical Center|Dr. Randy Loftus|6036504642|randy.w.loftus@hitchcock.org
108753|NCT00899678|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
108754|NCT00899717|University of Santiago de Compostela|Urbano Santana Penín|0034647344093|urbano.santana@usc.es
108755|NCT00900029|Smith & Nephew, Inc.|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com
108756|NCT00900146|Novartis Pharmaceuticals|Study Director|862-778-8300|
108757|NCT00900159|Brigham and Women's Hospital; Harvard Medical School|Dr. Orfeu M. Buxton|617-507-9177|Orfeu_Buxton@HMS.Harvard.edu
108758|NCT00900237|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
108759|NCT00900627|Astrazeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com
108760|NCT00900666|Mary Free Bed Rehabilitation Hospital|Krisanne B. Chapin, PhD|616-493-9831|krisanne.chapin@maryfreebed.com
108761|NCT00900731|Novartis Pharmaceuticals|Study Director|862 778-8300|
108762|NCT00900757|Duke University Medical Center|Mary Lou Affronti|919-684-6239|mary.affronti@dm.duke.edu
108763|NCT00900796|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108764|NCT00900822|Institut Straumann AG|Clinial Trial Manager|+41 61 965 11 11|info@straumann.com
108765|NCT00901017|Institut Straumann AG|Marc Quirynen, Professor|+4161965 ext 1235|michael.hotze@straumann.com
108766|NCT00901186|Novartis Pharmaceuticals|Study Director|1-862-778-8300|
108767|NCT00901225|Duke University Medical Center|Mitchell E Horwitz, MD, Principal Investigator|919-668-1045|mitchell.horwitz@duke.edu
108768|NCT00901316|Texas Children's Hospital|Sheldon L. Kaplan, MD|832-824-4330|skaplan@bcm.edu
108769|NCT00901342|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com
108770|NCT00901459|Duke Center for Nicotine and Smoking Cessation Research|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@mc.duke.edu
108771|NCT00901576|Shire Pharmaceutical|Gerald Tremblay, MD||gtremblay@shire.com
108772|NCT00901628|Joint Reconstruction Center, Seoul National University Bundang Hospital|Tae Kyun Kim|82-31-787-7196|osktk@snubh.org
108774|NCT00894504|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
108775|NCT00894517|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
108776|NCT00894543|University of Pennsylvania School of Medicine|Dr. Ellen W. Freeman|215-349-5521|freemane@mail.med.upenn.edu
108777|NCT00894556|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108778|NCT00894647|Graceway Pharmaceuticals|Vice President Medical Affairs|267-948-0400|Sharon.levy@gracewaypharma.com
108779|NCT00894699|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com
108780|NCT00894790|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108781|NCT00894803|University of Cincinnati|Dr Arthur Pancioli|513-558-8087|arthur.pancioli@uc.edu
108782|NCT00894933|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com
108783|NCT00895011|Vivus, Inc.|Wesley W Day, PhD|650-934-5200|medaffairs@vivus.com
108784|NCT00895180|Sidney Kimmel Comprehensive Cancer Center|Dr. Jaishri Blakely|(410) 955-8893|
108785|NCT00895193|University of Kansas Medical Center|Julie-Ann Dutton, MS, RD|(913) 588-4064|jdutton@kumc.edu
108786|NCT00895232|Luitpold Pharmaceuticals, Inc.|Marc Tokars, Director of Clinical Operations|610-650-4200|mtokars@lpicrd.com
108787|NCT00895245|University of Washington|Dr. Keith Eaton|206-288-2048|kdeaton@uw.edu
108788|NCT00895284|Mayo Clinic|Dr. Rosanne Kho|408-301-5811|kho.rosanne@mayo.edu
108789|NCT00895310|University of California Davis|Analyst|9167340294|pkaujla@ucdavis.edu
108790|NCT00895453|Vienna Medical School|Armin Witt MD|+43140400 ext 2821|armin.witt@meduniwien.ac.at
108791|NCT00895531|University Louisville|Nancy Alsip|502-852-2905|nlalsi01@exchange.louisville.edu
108792|NCT00895583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108793|NCT00895661|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu
108794|NCT00895752|Cincinnati Childrens Hospital|Craig Erickson MD|5136366265|craig.erickson@cchmc.org
108795|NCT00895817|Walter Reed Army Medical Center|Dr. Fouad J Moawad|(301) 295-4600|fouad.moawad@us.army.mil
108796|NCT00895830|Acacia Pharma Ltd|Dr Gabriel Fox||gabrielfox@acaciapharma.com
108797|NCT00895843|University of Manchester|Mr Sin L Yong|01612756806|sin.l.yong@manchester.ac.uk
108798|NCT00895895|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108799|NCT00895934|Fred Hutchinson Cancer Research Center|Roland B. Walter, MD, PhD|206-667-3599|rwalter@fhcrc.org
108800|NCT00895947|Amarillo Biosciences, Inc.|Martin J. Cummins|806-376-1741 ext 14|mcummins@amarbio.com
108801|NCT00896025|University of Texas Southwestern Medical Center|William M. Lee, MD|214-645-6111|william.lee@utsouthwestern.edu
108802|NCT00896038|National Institute on Alcohol Abuse and Alcoholism|Melanie Schwandt|3014516960|melanies@mail.nih.gov
108803|NCT00896051|Tibotec|Senior Director|+32 (0) 14 641 265|
108804|NCT00896064|GlaxoSmithKline|GSK Response Center|866-435-7343|
108805|NCT00896168|Xian-Janssen Pharmaceutical Ltd|Director of Medical Affairs|(8610) 5821 8359|
108806|NCT00902161|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108807|NCT00902174|Novartis Pharmaceuticals|Study Director|862-778-8300|
108808|NCT00902226|H. Lundbeck A/S|Study Director|email contact via ext Lundbeck|LundbeckClinicalTrials@lundbeck.com
108809|NCT00902265|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
108810|NCT00902668|Virginia Commonwealth University|Laurie W. Cuttino, MD|804-828-7232|LCuttino@mcvh-vcu.edu
108811|NCT00902746|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp
108812|NCT00902850|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|585-338-6399|Robert.Steffen@bausch.com
108813|NCT00903006|University of Texas MD Anderson Cancer Center|Ana Gonzalez-Angulo, MD / Associate Professor, Breast Medical Oncology|713-792-2817|CR_Study_Registration@mdanderson.org
108814|NCT00903032|VA ECHCS|P. Michael Ho|720-857-5115|Michael.Ho@va.gov
108815|NCT00903162|Dana-Farber Cancer Institute|Ann Partridge, MD, MPH|617.632.3800|ann_partridge@dfci.harvard.edu
108816|NCT00903175|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
108817|NCT00903331|Actelion Pharmaceuticals Ltd|Parisa Danaietash||parisa.danaietash@actelion.com
108818|NCT00903344|University of Kansas Medical Center|Dr. Leigh Eck|913-588-6022|leck2@kumc.edu
108819|NCT00903357|Department of Pediatrics, Soonchunhyang University Hospital|Bok Yang Pyun, M.D.|+82-2-709-9339|bypyun@hanmail.net
108820|NCT00903370|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu
108821|NCT00903383|Lexicon Pharmaceuticals, Inc.|Joel Freiman, MD, MPH|281-863-3070|
119374|NCT00912509|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org
108824|NCT00903448|The Procter & Gamble Company|John Mcrorie, PhD, FACG, AGAF|513-622-1423|mcrorie.jw@pg.com
108825|NCT00903617|GlaxoSmithKline|GSK Response Center|866-435-7343|
108826|NCT00903630|University of Minnesota, Dept. of OBGYN|Dr. Levi Downs, Jr|612-626-3111|downs008@umn.edu
108827|NCT00903682|Janssen-Cilag EMEA|EMEA Medical Affairs Director Virology|+31 6 542 454 37|
108828|NCT00903695|UOklahoma Health Sciences Center|Marilee Monnot, PhD|405-456-5773 ext 5773|marilee-monnot@ouhsc.edu
108829|NCT00903877|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu
108830|NCT00903929|University of Rochester|Jane L. Liesveld|585-275-5823|jane_liesveld@urmc.rochester.edu
108832|NCT00904007|Veterans Affairs Boston Healthcare System|Dr. B. Price Kerfoot|7742869230|price.kerfoot@gmail.com
108833|NCT00904150|Centre for Neuroscience and Trauma, Queen Mary, University of London|Professor Anne MacGregor|+44 7774 868628|e.macgregor@qmul.ac.uk
108834|NCT00904189|University of Rochester Medical Center|Steven Swarts|5852755623|christine_huggins@urmc.rochester.edu
119376|NCT00851721|Baxter Healthcare Corporation|Wing-Yen Wong, MD, Global Sr Medical Dir Hemophilia||wing_yen_wong@baxter.com
108835|NCT00904215|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108836|NCT00904371|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108837|NCT00904423|Stanford Cancer Institute, Stanford University|Mark D Pegram, MD|650-723-5801|mpegram@stanford.edu
108838|NCT00904618|Centre Hospitalier Universitaire de Sherbrooke|Louis-Olivier Gagnon|1-819-437-4965|louis.olivier.gagnon@gmail.com
108839|NCT00904670|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108840|NCT00904722|The University of Texas (UT) MD Anderson Cancer Center|Sattva S. Neelapu, MD/Associate Professor, Lymphoma/Myeloma||CR_Study_Registration@mdanderson.org
108841|NCT00904748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108842|NCT00904826|Mayo Clinic|Dr. Sean J. Pittock|507-284-4741|pittock.sean@mayo.edu
108843|NCT00904839|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108844|NCT00904917|Children's Hospital of Philadelphia|Rhonda C. Boyd, Ph.D.|215-590-3945|boydr@email.chop.edu
108845|NCT00904943|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
108846|NCT00904982|University of Pennsylvania Perelman School of Medicine|Stephen E. Kimmel, MD, MSCE/Director, Clinical Epidemiology|(215) 898-1740|stevek@mail.med.upenn.edu
108847|NCT00904995|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org
108848|NCT00905021|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu
108849|NCT00905034|University of Texas (UT) MD Anderson Cancer Center|Gautam Borthakur, MD/Associate Professor, Leukemia|713-563-1586|CR_Study_Registration@mdanderson.org
108850|NCT00905125|Medicine and Molecular Virology & Microbiology, Baylor College of Medicine|Shital M. Patel, M.D.|713-798-3793|shitalp@bcm.edu
108851|NCT00905151|Tufts Medical Center|Associate Professor|617-636-2569|linker@tuftsmedicalcenter.org
108852|NCT00905164|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
108853|NCT00905255|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
108854|NCT00905268|The National Hospital, University College London|Prof. Nicholas William Wood|020 7837 3611|n.wood@ucl.ac.uk
108855|NCT00905307|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800-562-3924|
108856|NCT00905346|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
108857|NCT00905359|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133 ext 6068|msbkclinicalresearch@medtronic.com
108858|NCT00905424|Shire Pharmaceuticals, Ltd.|Timothy Whittaker, M.D.||twhitaker@shire.com
108859|NCT00905437|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108860|NCT00905489|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108861|NCT00907335|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com
108862|NCT00907374|Charles R. Drew University|Mayer B. Davidson, MD|323 357-3439|mayerdavidson@cdrewu.edu
108863|NCT00907426|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
108864|NCT00907478|Amgen Inc.|Study Director|866-572-6436|
108865|NCT00907517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108866|NCT00907621|Department of General practice, University of Oslo|Dr. Holgeir Skjeie|+4722850550|Holgeir.Skjeie@medisin.uio.no
108867|NCT00907738|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108868|NCT00907777|GlaxoSmithKline|GSK Response Center|866-435-7343|
108869|NCT00907803|SIGA Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com
108870|NCT00907881|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108871|NCT00907907|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
108872|NCT00908011|St. Paul's Hospital/University of B.C.|Dr. Greg Bondy|604-806-8192|gbondy@providencehealth.bc.ca
108873|NCT00908037|GlaxoSmithKline|GSK Response Center|866-435-7343|
108874|NCT00908076|Baylor College of Medicine|Christine Hunter|713-798-6556|chunter@bcm.edu
108875|NCT00908115|GlaxoSmithKline|GSK Response Center|866-435-7343|
108876|NCT00908128|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
108877|NCT00908141|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Robert Dreicer MD|216-445-4623|dreicer@ccf.org
108878|NCT00908232|Janssen-Cilag Germany|EMEA Medical Affairs Director Oncology|+49 2137 955-492|
108879|NCT00908310|GE Healthcare|Debra Mansfield|609-514-6329|debra.mansfield@ge.com
108880|NCT00908349|Supernus Pharmaceuticals, Inc|Janet K. Johnson, PhD|301-838-2623|jjohnson@supernus.com
108881|NCT00908375|Northwestern University|K Malik|3129262280|kmalikmd@yahoo.com
108883|NCT00908583|University of Cincinnati|E. Steve Woodle|513-558-6001|woodlees@ucmail.uc.edu
108884|NCT00908596|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
108885|NCT00908648|Gastroenterology Unit, Valduce Hospital - Como - Italy|Dr Vittorio Terruzzi, Director of Gastroenterology Unit|+39031324009|vterruzzi@valduce.it
108886|NCT00908687|Valneva Austria GmbH|Head Clinical Development|0043120620 ext 0|info@valneva.com
108887|NCT00908882|Eastern Colorado Health Care System|Catherine Battaglia PhD RN|720-857-5099|catherine.battaglia@va.gov
108888|NCT00908895|Département d'orthopédie, CHA-Pavillon Enfant-Jésus Québec|Dr Stéphane Pelet, MD, PhD|418-649-0252 ext 3165|stephane.pelet.ortho@gmail.com
108889|NCT00908908|Eisai Call Center|Eisai Inc.|888-422-4743|
108890|NCT00908960|Beth Israel Deaconess Medical Center|Jeffrey Zwicker, MD|617-667-9299|jzwicker@bidmc.harvard.edu
108891|NCT00909038|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108892|NCT00909064|UC Davis|Gavin Pereira|916-534-0919|gcpereira@ucdavis.edu
108893|NCT00909155|University of Wisconsin|Dr. Michael Peterson|608 265 8130|mpeterson2@wisc.edu
108894|NCT00909181|Antares Pharma|Kaushik Dave|609 359 3020|kdave@antarespharma.com
108895|NCT00909324|Novartis Pharmaceuticals|Study Director|862 778-8300|
108896|NCT00909389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
108897|NCT00909428|Loyola University Chicago|Mary P FitzGerald|708-216-2170|mfitzg8@lumc.edu
108898|NCT00909480|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
108899|NCT00909532|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com
108900|NCT00909545|Feinberg School of Medicine, Northwestern University|Tanya Simuni, MD|312-503-2970|TSimuni@nmff.org
108901|NCT00909610|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
108902|NCT00909649|Mansoura university hospital|Elnakeeb Ayman|0106752021|elnakeebayman@yahoo.com
108903|NCT00909727|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com
108904|NCT00909753|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
108905|NCT00909779|Sunovion|Respiratory Medical Director|1-866-503-6351|
108906|NCT00909792|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
108907|NCT00909844|Ipsen Pharma|Medical Director, Endocrinology||clinical.trials@ipsen.com
108908|NCT00902304|Novartis Pharmaceuticals|Study Director|862-778-8300|
108909|NCT00902330|Virginia Commonwealth University|Debra Lyon, RN, PhD, FNP|804-828-7743|delyon@vcu.edu
108910|NCT00902538|Daiichi Sankyo Europe GmbH|Bettina Ammentorp|0049 89 7808 0 ext 585|bettina.ammentorp@daiichi-sankyo.eu
108911|NCT00902564|H. Lundbeck A/S|Study Director|Email contact via ext Lundbeck|LundbeckClinicalTrials@lundbeck.com
108912|NCT00909857|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
108914|NCT00910000|Dana-Farber Cancer Institute|Ursula Matulonis, MD|617-632-2334|umatulonis@partners.org
108915|NCT00910039|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org
108916|NCT00910091|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
108917|NCT00910273|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108918|NCT00910299|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
108919|NCT00910520|Allergan, Inc|Therapeutic Area Head,|714-246-4500 ext:|clinicaltrials@allergan.com
108920|NCT00910624|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
108921|NCT00910663|TEVA Pharmaceuticals USA|Associate DIrector, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
108922|NCT00910689|Ohio University|Kenneth Holroyd|(740) 593-1085|holroyd@ohio.edu
108923|NCT00910715|UMC Ljubljana, Department of Infectious Diseases|Dr.Dasa Stupica|+386 1 522 2110|cerar.dasa@gmail.com
108924|NCT00910728|AstraZeneca|Dr Gregory Curt, MD|+1 301 398 0109|Gregory.Curt@astrazeneca.com
108925|NCT00910845|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
108926|NCT00910858|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
108927|NCT00910871|Janssen Infectious Diseases – Diagnostics BVBA|Medical Leader|1 609 730-7768|
108928|NCT00910910|Celgene Corporation|Anne McClain, Senior Manager of Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com
108929|NCT00910988|Washington University|Julie Schweiger/Michael Yingling|3143623153/5735791412|schweigj@psychiatry.wustl.edu/yinglinm@psychiatry.wustl.edu
108930|NCT00911144|GlaxoSmithKline|GSK Response Center|866-435-7343|
108931|NCT00911157|GlaxoSmithKline|GSK Response Center|866-435-7343|
108932|NCT00911170|Amgen Inc.|Study Director|866-572-6436|
108933|NCT00911274|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
108934|NCT00911300|GlaxoSmithKline|GSK Response Center|866-435-7343|
108935|NCT00911326|Navidea Biopharmaceuticals|Dr. Frederick O. Cope, Chief Scientific Officer|614-793-7500 ext 140|fcope@navidea.com
108936|NCT00911443|R&D Department - Sigma-Tau SpA|Roberto Camerini|+390691393562|roberto.camerini@sigma-tau.it
108937|NCT00911495|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com
108938|NCT00911534|Eisai Call Center|Eisai Inc.|888-422-4743|
108939|NCT00911547|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108940|NCT00911612|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu
108941|NCT00911625|Rush University Medical Center|David Baldwin, MD|312-942-2813|david_baldwin@rush.edu
108942|NCT00911742|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
108943|NCT00911768|Kyung Hee East-West Neo Medical Center|Jae-Woo Park, KMD, PhD|+082-02-440-6219|pjw2907@khu.ac.kr
108944|NCT00911807|EBEWE Pharma|Dr. Philipp Novak|01143-7665-8123 ext 733|philipp.novak@ebewe.com
108945|NCT00911859|Janssen R&D BE|Senior Director||ClinicalTrialDisclosure@its.jnj.com
108946|NCT00911898|South Texas Accelerated Research Therapeutics|Dr. Muralibhar Beeram|210-593-5921|murali.beeram@stoh.com
108947|NCT00911937|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108948|NCT00911989|Ethicon-Endo Surgery|Director of Clinical Operations|1.513.337.3079|SHelsing@its.jnj.com
108949|NCT00912002|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
108950|NCT00912015|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
108951|NCT00912028|University of Campinas, Brazil|Carlos E Leite Arieta MD, PhD||ra-visus-clnclstds@its.jnj.com
108952|NCT00912093|Shire|Alan Kimura, MD, PhD|1-617-482-0738|akimura@shire.com
108953|NCT00912158|Chest Department, Faculty of Medicine, Assiut University- EGYPT|Dr. Maha K Ghanem, MD, FCCP|+ 2 0127694434|mahaghanem@hotmail.com
108955|NCT00912288|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108956|NCT00912301|Mayo Clinic|Michael L. Camilleri, MD|507-266-2306|camilleri.michael@mayo.edu
108957|NCT00912405|Intersect ENT|James Stambaugh|650-641-2103|jstambaugh@intersectent.com
108959|NCT00905515|East Carolina University|Director of Clinical Trials|252-744-3773|parkerk@ecu.edu
108960|NCT00905554|Valduce Hospital - Como - Italy|Vittorio Terruzzi, MD|+39031324009|vterruzzi@valduce.it
108961|NCT00905567|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
108962|NCT00905580|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|Dr. So Yeon Kim|82-2-2227-3642|kimsy326@hanmail.net
108963|NCT00905606|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
108964|NCT00905632|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108965|NCT00905827|Department of Veteran Affairs|Kathryn Magruder|843-789-7280|Kathryn.Magruder@va.gov
108966|NCT00905840|Johannes-Gutenberg-University Mainz|Prof. Dr. Dr Bilal Al-Nawas, Principal Investigator|0049 6131 17 ext 3083|al-nawas@mkg.klinik.uni-mainz.de
108967|NCT00906035|Upenn|Emile Mohler, MD|215-573-6606|Emile.Mohler@uphs.upenn.edu
108968|NCT00906074|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108969|NCT00906087|University of Michigan|Sayoko E. Moroi|734-763-3732|smoroi@med.umich.edu
108970|NCT00906178|Center for Innovative Public Health Reserch|Dr. Michele Ybarra|877-302-6858 ext 1-801#|michele@innovativepublichealth.org
108971|NCT00906204|Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA|Dr. R. Brian Stevens, MD, PhD, FACS|937-545-4817|rbstevens1@icloud.com
108972|NCT00906243|University of Florida|Dr. Johannes Vieweg|352 273-6815|j.vieweg@urology.ufl.edu
108973|NCT00906282|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com
108974|NCT00906347|University of Texas Southwestern Medical Center|Dr. April Bleich|214-648-2316|april.bleich@gmail.com
108975|NCT00906399|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com
108976|NCT00906425|Institut Straumann|Michael Hotze, PhD|+4161965 ext 1235|michael.hotze@straumann.com
108977|NCT00906503|Barbara Ann Karmanos Cancer Institute|Barbara Ann Karmanos Cancer Institute|313-576-9370|davisv@karmanos.org
108978|NCT00906698|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
108979|NCT00906776|Rotschild hospital|Prof Philippe Bouchard|+33614656947|phbouch@noos.fr
108980|NCT00906789|Georgetown University Medical Center|Matthew T. Freedman|4105429680|MTFreedman@verizon.net
108981|NCT00906945|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu
108982|NCT00906971|Universidade Federal de Pernambuco|Carlos André Gomes Silva|+55 83 9913-4949|carlosandrejpa@hotmail.com
108983|NCT00907088|The Hospital for Sick Children|Dr. Patricia Parkin|416-813-7654 ext 301544|patricia.parkin@sickkids.ca
108984|NCT00907101|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com
108986|NCT00907257|Valeant Pharmaceuticals International, Inc|David Lineberry|949-973-1153|David.Lineberry@valeant.com
108987|NCT00912743|Astra Zeneca LLP|Angela Sawyer, Clinical Delivery Director|+44 1625 512397|angele.sawyer@astrazeneca.com
108988|NCT00912782|Emory University|Monnie Wasse MD/MPH / Associate Professor of Medicine|404-727-1598|hwasse@emory.edu
108989|NCT00912795|Center for Innovative Public Health Research|Dr. Michele Ybarra|877-302-6858 ext 1 – 801#|michele@innovativepublichealth.org
108990|NCT00912808|Oregon Health & Science University|Kathryn Chung, MD|503 220 8262 ext 51091|chungka@ohsu.edu
108991|NCT00912912|The University of Texas (UT) MD Anderson Cancer Center|Lance Pagliaro, MD/Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org
108992|NCT00912925|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com
108994|NCT00913003|Northwestern University|Paul Fitzgerald|312-695- 1064|p-fitzgerald2@northwestern.edu
108995|NCT00915148|Stavanger UH|Torbjørn Moe Eggebø, phd|004792699433|tme@lyse.net
108996|NCT00915278|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
108997|NCT00915343|Shire|Study Physician|1866-842-5335|
108998|NCT00915356|AstraZeneca|Gerard Lynch||clinicalTrialTransparency@astrazeneca.com
108999|NCT00915473|Mayo Clinic|Dr. David Dodick|480-301-5797|dodick.david@mayo.edu
109000|NCT00915499|ResMed|June Mendoza|1-800-424-0737|june.mendoza@resmed.com
109001|NCT00915525|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
109002|NCT00915551|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com
109003|NCT00915590|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@meei.harvard.edu
109004|NCT00915603|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
109005|NCT00915655|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Medical Leader|+1 609 730-7548|
109006|NCT00915759|Warfighter Refractive Eye Surgery Program and Research Center at FT Belvoir|Principal Investigator|571-231-1600|rose.sia@us.army.mil
109007|NCT00915772|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
109008|NCT00915798|UC Irvine|Dr. Jean Gehricke|949-267-0404|jgehrick@uci.edu
109009|NCT00915876|University of Michigan|Amy Pai|7346470005|amypai@med.umich.edu
109010|NCT00915902|Nemours Alfred I. duPont Hospital for Children|Dr. Samuel Gidding|302-651-6607|sgidding@nemours.org
109011|NCT00916006|LEO Pharma|Dr. Torsten Skov|+4520736294|tosdk@leo-pharma.com
109013|NCT00916136|Vanderbilt|William Obremskey MD MPH|615-936-0112|william.obremskey@vanderbilt.edu
109014|NCT00916279|Lutonix Inc. a subsidiary of C.R. Bard|Chris Barry|763-445-2352|LutonixResearch@crbard.com
109015|NCT00916305|London School of Hygiene & Tropical Medicine|Clare Gilbert|+44 207 958 8332|clare.gilbert@lshtm.ac.uk
109016|NCT00916344|BIOTRONIK SE & Co.KG|Dr. Evelyn Diessel|+49 (0) 30 68905 ext 1231|evelyn.diessel@biotronik.com
109017|NCT00916357|Halozyme|Vice President, Endocrinology Clinical Development|858-794-8889|
109018|NCT00916370|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com
109019|NCT00916383|Teikoku Pharma USA, Inc.|Director of Clinical Trials|(408) 501-1821|
109020|NCT00916539|Massachusetts General Hospital|Taylor Pong, Research Coordinator|617-726-1569|tpong1@partners.org
109021|NCT00916617|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109022|NCT00916643|B. Braun Medical, Inc.|Kevin Minnich|610 596 2358|kevin.minnich@bbraun.com
109023|NCT00916721|Massachusetts General Hospital|A. Eden Evins, MD, MPH, Director Center for Addiction Medicine|617-643-4679|a_eden_evins@hms.harvard.edu
109024|NCT00916929|St Jude Medical|Tamara Shipman|408 522-6410|tshipman@sjm.com
109025|NCT00917124|University Hospital Center Zagreb|Zeljko Colak|00385915624189|zcolak2000@yahoo.com
109026|NCT00917267|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
109027|NCT00917384|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
109028|NCT00917501|University of Cincinnati|Dr. Robert McNamara|513-558-5601|robert.mcnamara@uc.edu
109029|NCT00917579|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
109030|NCT00917644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
109031|NCT00917735|University of Minnesota|Dr. Mindy Kurzer|612-624-9789|mkurzer@umn.edu
109032|NCT00917852|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com
109033|NCT00917865|Emory University|David Schuster, MD|404-712-4859|dschust@emory.edu
109034|NCT00920621|Brigham and Women's Hospital|Scott T. Weiss, MD, MS|617-525-2278|scott.weiss@channing.harvard.edu
109035|NCT00920647|Shire Human Genetic Therapies Medical Information|MedINfo|1-866-888-0660 ext 2|US_ShireHGT_Medicalinformation@shire.com
109036|NCT00920686|NeurAxon, Inc|Thomas Lategan, PhD|417 673 6697|tlategan@neuraxon.com
109037|NCT00920699|Johns Hopkins University|Christopher A. Ross M.D. Ph.D.|410-614-0011|caross@jhmi.edu
109038|NCT00920790|Kyowa Hakko Kirin|Project Management Department, Development Division||clinical.info@kyowa-kirin.co.jp
109039|NCT00920816|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109040|NCT00920855|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
109041|NCT00920907|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
109042|NCT00921024|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com
109043|NCT00921115|University of Kansas Cancer Center|Qamar Khan, MD|(913) 588-6029|QKHAN@kumc.edu
109044|NCT00921310|Washington University School of Medicine|Maria Baggstrom, M.D.|314-362-5737|mbaggstr@dom.wustl.edu
109045|NCT00921518|Wilkes University|Judith Kristeller|570-408-4272|judith.kristeller@wilkes.edu
109046|NCT00921557|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org
109047|NCT00921687|Louis Stokes Cleveland VA Medical Center|Paul Drawz, MD, MHS, MS|6126255423|draw0003@umn.edu
109048|NCT00921895|Rapid Pathogen Screening, Inc.|Robert Sambusky, MD|941-556-1853|sambursky@rpsdetectors.com
109049|NCT00921934|Department for Complementary and Alternative Medicine|Dr. med. Martin Schencking|+0049-2602-684-614|
109050|NCT00921947|VaxInnate|Dr. David N.Taylor|609-860-2260|david.taylor@vaxinnate.com
109051|NCT00922116|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
109052|NCT00922194|Sircar Diabetes Clinic|Dr. Amulya R Sircar|+ 91 (522) 2324747|arsircar@yahoo.com
109053|NCT00922207|HoffmannLa Roche|Medical Communications|800-821-8590|genentech@druginfo.com
109054|NCT00922233|FHI360|Dr. Vera Halpern|9195447040|vhalpern@fhi360.org
109055|NCT00922272|Shire Pharmaceutical|Study Physician|1-866-842-5335|
109056|NCT00922428|Pascoe pharmazeutische Präparate GmbH|Anja Braschoss|0049 641 7960100|KlinischeForschung@pascoe.de
109057|NCT00922623|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com
109058|NCT00922636|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
109059|NCT00922701|University G. D'Annunzio|Mario Bonomini, M.D.|+39 0871 540120|m.bonomini@nephro.unich.it
109060|NCT00922766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109061|NCT00922779|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
109062|NCT00913081|University of Pennsylvania|Richard L. Dunbar, MD, PI|609 413-1067|richard.dunbar@uphs.upenn.edu
109063|NCT00913133|Canyon Pharmaceuticals|Director of Clinical Trials|888-434-7003|info@canyonpharma.com
109064|NCT00913263|Dept. of Surgery, Tampere University Hospital, Tampere, Finland|Teuvo Tammela, Professor|+358-3-31164621|teuvo.tammela@uta.fi
109065|NCT00913380|Seoul National University Bundang Hospital|Kyoung Ho Lee|82-31-787-7607|kholeemail@gmail.com
109066|NCT00913458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109067|NCT00913510|Wellspect HealthCare|Dikran Shamoun|+46313764000|
109366|NCT00931918|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
109068|NCT00913523|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Senior Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com
109069|NCT00913692|National Institute of Allergy and Infectious Diseases, Laboratory of Infectious Diseases|Jeffrey I. Cohen, MD|(301) 496-5265|jcohen@niaid.nih.gov
109070|NCT00913744|ThromboGenics NV|Dr. Petra Kozma-Wiebe|+32 16 751 310|Petra.kozma@thrombogenics.com
109071|NCT00913770|Yale University|Gail D'Onofrio, MD, MS|203-785-4404|gail.donofrio@yale.edu
109072|NCT00913835|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
109073|NCT00913913|Dartmouth-Hitchcock Medical Center|Dr. Marc Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org
109074|NCT00914069|Bard Access Systems, Inc.|Gina Gilbert|407-489-0835|Gina.Gilbert@crbard.com
109075|NCT00914186|Taisho Pharmaceutical R&D Inc.|Fred Henry MS, MPH,|973-898-6200|F-Henry@taihso-rd.com
109076|NCT00914316|William Beaumont Hospital|Barbara Higgins, RN|248 551-1535|Barbara.Higgins@beaumont.org
109077|NCT00914459|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-­800­-718­-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109078|NCT00914485|Southeast Louisiana Veterans Health Care System|P. Adam Kelly, PhD, MBA|504-988-6630|peter.kelly@va.gov
109079|NCT00914589|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
109080|NCT00914810|Minneapolis VA Health Care System|Ken Kunisaki, M.D.|612-467-4400|kunis001@umn.edu
109081|NCT00914849|Washington University School of Medicine|John DiPersio, M.D., Ph.D.|314-454-8304|jdipersi@dom.wustl.edu
109082|NCT00914862|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
109083|NCT00914966|ViroPharma|Chief Scientific Officer|610-458-7300|
109084|NCT00922935|Straumann|Kristina Espemar Holst, Senior Clinical Trial Manager|+41 61 965 11 11|info@straumann.com
109085|NCT00922987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109086|NCT00923091|Daiichi Sankyo Europe, GmbH|Bettina Ammentorp|00498978080|bettina.ammentorp@daiichi-sankyo.eu
109087|NCT00923117|National Cancer Institute, National Institutes of Health|Dr. Teri Kreisl|301-402-3423|kreislt@mail.nih.gov
109088|NCT00923130|National Cancer Institute|Dr. Ravi Madan|301-496-3493|madanr@mail.nih.gov
109089|NCT00923156|Novartis Pharmaceuticals|Study Director|862-778-8300|
109090|NCT00923195|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov
109091|NCT00923247|National Cancer Institute|Dr. Ravi Madan|301-480-7168|madanr@mail.nih.gov
109092|NCT00923260|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Dr. Miguel F Herrera|(+52) 55 54870208|miguelfherrera@gmail.com
109093|NCT00923845|National Cancer Institute|Dr. Daniel Fowler|301-435-8641|fowlerda@mail.nih.gov
109094|NCT00923910|National Cancer Institute|Dr. Terry Fry|301-402-0215|fryt@mail.nih.gov
109095|NCT00923936|National Cancer Institute|Dr. Robert Yarchoan|301-496-0328|yarchoanr@pop.nci.nih.gov
109096|NCT00923949|National Cancer Institute|Giuseppe Giaccone M.D.|301-496-4916|giacconeg@mail.nih.gov
109097|NCT00923975|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com
109098|NCT00924001|National Cancer Institute, National Institutes of Health|Steven Rosenberg|301-496-4164|sar@mail.nih.gov
109099|NCT00924040|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitman@mail.nih.gov
109100|NCT00924053|Theracos, Inc|Yuan-Di Halvorsen|617 726-4236|yhalvorsen@ccib.mgh.harvard.edu
109101|NCT00924066|National Cancer Institute|Antonio Fojo, M.D.|301-496-2631|fojot@mail.nih.gov
109102|NCT00924118|Johns Hopkins Hospital|Steven P. Schulman, MD|4109557378 ext 410|sschulma@jhmi.edu
109103|NCT00924170|National Cancer Institute|Dr. Robert Kreitman|301-496-6947|Robert_Kreitman@nih.gov
109104|NCT00924209|National Cancer Institute, National Institutes of Health|Dr. Giuseppe Giaccone|301-402-3415|giacconeg@mail.nih.gov
109105|NCT00924287|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov
109106|NCT00924313|National Cancer Institute, National Institutes of Health|Dr. Peter L. Choyke|301-402-8409|pchoyke@mail.nih.gov
109107|NCT00924352|Vector Oncology (formerly Accelerated Community Oncology Research Network, Inc.)|Vice President of Scientific Affairs|901-435-5570|mwalker@vectoroncology.com
109108|NCT00924404|University of Iowa|Lakshmi Durairaj|319-353-7968|lakshmi-durairaj@uiowa.edu
109109|NCT00924443|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
109110|NCT00924469|Janssen Research & Development, LLC 10990 Wilshire Blvd, Suite 1200 Los Angeles, CA 90024|Senior Director, Clinical Research|(310) 914-2917|
109111|NCT00924482|University of California San Francisco|Arthur Wallace, M.D., Ph.D.|415-750-2069 ext 3732|wallacea@anesthesia.ucsf.edu
109112|NCT00924508|UCSF|John Koo, MD|415-476-6281|john.koo@ucsfmedctr.org
109113|NCT00924560|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
109114|NCT00924638|Medtronic, Inc.|Medtronic CRDM clinical trial manager|763-505-6000|medtronicCRMtrials@medtronic.com
109115|NCT00924651|University of Rochester Medical Center|Karen M. Mustian, PhD, MPH, Associate Professor|585-273-1796|Karen_Mustian@urmc.rochester.edu
109117|NCT00924781|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
109118|NCT00924807|St. Luke's Roosevelt Hospital Center|Seth Cohen, MD|212-523-7289|secohen@chpnet.org
109119|NCT00924833|Istituto Auxologico Italiano|Gianfranco Parati, Professor|+3961911 ext 2949|gianfranco.parati@unimib.it
109120|NCT00924898|The University of North Carolina|Dr. Cynthia Gay|919-843-2726|cynthia_gay@med.unc.edu
109121|NCT00924950|UCSF|Tina Bhutani|4154763396|tinabhutanimd@gmail.com
109122|NCT00925015|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109123|NCT00925132|University of Iowa|Mohammed Milhem|319-356-2324|
109124|NCT00925288|Johns Hopkins University|Dr. Brandon Brown|949-266-4401|bbrown@jhsph.edu
109125|NCT00925353|St. Luke's Mountain States Tumor and Medical Research Institute|Colleen K. Lambertz, MBA, MSN, FNP|208 463 6018|lambertc@slhs.org
109126|NCT00925522|St. Jude Medical|Nancy Ouch, Project Manager|949.769.5041|nouch@sjm.com
109127|NCT00925548|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
109128|NCT00925587|Amgen Inc.|Study Director|866-572-6436|
109129|NCT00925600|Amgen Inc.|Study Director|866-572-6436|
109130|NCT00925704|Shire Pharmaceutical|Gerald Tremblay, M.D.||gtremblay@shire.com
109131|NCT00925769|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
109132|NCT00925782|University of Kansas Medical Center|Omar Aljitawi, M.D., Assistant Professor of Medicine|913-588-6029|oaljitawi@kumc.edu
109133|NCT00925899|Bispebjerg Hospital|Lise Pedersen|004535312305|lise.pedersen.01@regionh.dk
109134|NCT00925938|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
109135|NCT00925990|Conatus Pharmaceuticals Inc.|Vice President, Clinical Development|858-457-7227|mhuyghe@conatuspharma.com
109136|NCT00926029|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com
109137|NCT00926185|Shire|Study Physician|1866-842-5335|
109138|NCT00926211|Restoration Robotics|Miguel Canales, M.D.|650-965-3612 ext 206|miguel@restorationrobotics.com
109139|NCT00926263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109140|NCT00926289|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
109141|NCT00918125|Duke University Medical Center|Dr. Kevin Thomas|919-668-7857|kevin.thomas@dm.duke.edu
109142|NCT00918138|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
109143|NCT00918203|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
109144|NCT00918255|Abbott|Global Medical Services|800-633-9110|
109145|NCT00918281|GE Healthcare|Matthew Miller|011-44-1494-543981|matthew.miller@ge.com
109146|NCT00918346|Santen Oy|Auli Ropo|+358405012416|auli.ropo@santen.fi
109147|NCT00918385|Duke University|Dr. Daniel George|(919) 668 4615|daniel.george@duke.edu
109148|NCT00918580|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109149|NCT00918671|NTNU|Professor Knut Hagen|+4772575080|knut.hagen@ntnu.no
109150|NCT00918684|Weill Cornell Medical College|Dr. George Alexopoulos, M.D.|914-997-5767|galexopoulos@med.cornell.edu
109151|NCT00918736|Veterans General Hospital, Kaohsiung, Taiwan|Shu-Fen Sun|886-73422121 ext 4210|sfsun.tw@yahoo.com.tw
109152|NCT00918749|Warner Chilcott|Grexan Wulff, Manager, Regulatory Affairs|973-442-3376|gwulff@wcrx.com
109153|NCT00918866|Lantheus Medical Imaging|Dana Washburn, M.D.|978-671-8686|dana.washburn@lantheus.com
109154|NCT00918879|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
109155|NCT00918931|Organization: The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org
109156|NCT00918957|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
109157|NCT00919035|Oncolgy Specialists, SC|Sigrun Hallmeyer, MD|847-268-8200|shallmeyer@oncmed.net
109158|NCT00919061|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa|646-888-4184|abou-alg@mskcc.org
109159|NCT00919113|Watson Laboratories, Inc.|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|801 588-6641|gary.hoel@watson.com
109160|NCT00919126|University Hospital Schleswig-Holstein|Prof. Dr. Med Berthold BEIN|+49(0)431-5973 739|bein@anasthesie.uni-kiel.de
109161|NCT00919191|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com
109162|NCT00919633|Medtronic, Inc.|Study Trial Manager|763-505-4594|sarah.mische@medtronic.com
109163|NCT00919711|Amgen Inc.|Study Director|866-572-6436|
109164|NCT00919724|Indiana University School of Medicine|Samir K. Gupta, MD, MS|317-274-7926|sgupta1@iu.edu
109165|NCT00919763|Galderma|Michael Graeber, MD, Head of Global Clinical Project Management and US Development|609-860-8201|michael.graeber@galderma.com
109166|NCT00919802|UAB|Timothy Ness|205-975-9643|tness@uabmc.edu
109167|NCT00919854|Janssen R&D US|Senior Director R&D|1 609 730-7548|
109168|NCT00919867|Shire Pharmaceutical|Gerald Tremblay, M.D.||gtremblay@shire.com
109169|NCT00919893|Clinic for urology and pediatric urology, JL-University, Giessen, Germany|Dr. F.M.E. Wagenlehner|0049 641 9944518|wagenlehner@AOL.com
109170|NCT00919932|University of Pittsburgh|Dr Han Liang|412-624-4141|liangh2@upmc.edu
109171|NCT00920023|Massachusetts General Hospital|Ralph Weissleder|6177268226|RWEISSLEDER@MGH.HARVARD.EDU
109172|NCT00920075|Medical University of South Carolina|Deborah A Bowlby, Asst.Professor, Pediatric Endocrinology|843-792-6807|bowlbyd@musc.edu
109173|NCT00920140|GlaxoSmithKline|GSK Response Center|866-435-7343|
109174|NCT00920231|Baltimore VA MC|Dr Cha-Min Tang|410 706-2347|ctang@som.umaryland.edu
109175|NCT00920309|Yale University School of Medicine|Dr. Neera Dahl|203-785-4184|neera.dahl@yale.edu
109176|NCT00920374|GlaxoSmithKline|GSK Response Center|866-435-7343|
109177|NCT00926328|Colgate Palmolive|William De Vizio, DMD|732-878-7901|William_Devizio@colpal.com
109178|NCT00926367|GlaxoSmithKline|GSK Response Center|866-435-7343|
109179|NCT00926393|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
109180|NCT00926497|Children's Hospital of Lucerne|Martin Stocker, MD|0041412051288|martin.stocker@ksl.ch
109181|NCT00926536|Stanford University|Dr Nishita Kothary|6504986020|kothary@stanford.edu
109182|NCT00926575|Soligenix, Inc.|Dhara Patel, Clinical Coordinator|609-538-8200|dpatel@soligenix.com
109183|NCT00926588|VA HSRD|Dr. Kurt Kroenke|317-988-3476|kkroenke@regenstrief.org
109184|NCT00927069|Innovaderm Research, Inc.|Annie Levesque|514 521 4285 ext 222|alevesque@innovaderm.ca
109185|NCT00927082|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
109186|NCT00927095|University of North Carolina at Chapel Hill|Dr. Susan Girdler|919-966-2179|susan_girdler@med.unc.edu
109187|NCT00927160|Icahn School of Medicine at Mount Sinai|Dr. William Hung|718-584-9000|william.hung@mssm.edu
109188|NCT00927186|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
109189|NCT00927251|Medtronic, Bakken Research Center|Model 4296 Left Ventricular (LV) Lead Study Sr. CRS|+31-43-3566602|margriet.kruijshoop@medtronic.com
109190|NCT00927264|Johns Hopkins University|Cynthia Rand, Ph.D.|410-550-0487|crand@jhmi.edu
109191|NCT00927355|Emory|Dr. George Beck|404-686-1000|gbeck@emory.edu
109192|NCT00927368|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org
109193|NCT00927394|Novartis Pharmaceuticals|Study Directors|862-778-8300|
109194|NCT00927472|Taro Pharmaceuticals U.S.A.,|Director, Clinical Research|914-345-9001|Natalie.Yantovskiy@Taro.com
109195|NCT00927563|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu
109196|NCT00927576|VANCHCS|Dr. David L. Woods|925-372-2571|dlwoods@ucdavis.edu
109197|NCT00927589|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
109198|NCT00927758|Sandoz|Study Director|609-627-8889|yaping.zhu@sandoz.com
109199|NCT00927823|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109200|NCT00927849|Mansoura university hospital|ayman elnakeeb|0020106752021|elnakeebayman@yahoo.com
109201|NCT00927862|Intermountain Healthcare|Dr. Jeffrey L. Anderson, Director of CV Research and Professor of Medicine|801-507-4704|jeffrey.anderson@imail.org
109202|NCT00927888|Stanford University|David Drover, MD|6507250364|ddrover@stanford.edu
109203|NCT00927901|Novartis Pharmaceuticals|Study Director|862 778-8300|
109204|NCT00927927|Novo Nordisk A/S|Public Access to Clinical Trials||RA-RNDUS-ClinTriDisc@ITS.JNJ.com
109205|NCT00927940|Medtronic Japan Co.,Ltd|Hiroko Okubo|+81-3-6430-7017|rs.medtroniccardiovascularclinicaltrials@medtronic.com
109206|NCT00927953|MacroGenics, Inc.|Medical Officer||info@macrogenics.com
109207|NCT00927992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109208|NCT00928018|Dana Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|parmand@partners.org
109209|NCT00928057|BD Medical, Medical Affairs|Kenneth Kassler-Taub, MD|201 847 6729|kenneth_kassler-taub@bd.com
109210|NCT00928070|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109211|NCT00928083|Medicines for Malaria Venture|Dr. Joerg Moehrle|+41 22 555 0330|moehrlej@mmv.org
109212|NCT00928174|The Queen's Medical Center|Sandi Kwee, Principal Investigator|808-691-5466|skwee@queens.org
109213|NCT00928187|UMI 233 IRD Montpellier|Dr Laura Ciaffi|00237 694926786|lauraciaffi2002@yahoo.fr
109214|NCT00928252|The Queen's Medical Center|Sandi Kwee, MD, PhD|8086915466|skwee@queens.org
109215|NCT00928304|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com
109216|NCT00928395|Uroplasty, Inc|Clinical Study Manager|952-426-6153|megan.otoole@uroplasty.com
109217|NCT00928408|Amgen Inc.|Study Director|866-572-6436|
109218|NCT00928421|BTG International Inc|David Wright MB FRCS|610-943-3513|david.wright@btgplc.com
109219|NCT00928434|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
109220|NCT00928486|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@celgene.com
109221|NCT00928512|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
109222|NCT00928642|Madigan Army Medical Center|COL David E. McCune, MD, MC|253-968-1155|david.e.mccune.mil@mail.mil
109223|NCT00928668|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
109224|NCT00928694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109225|NCT00928720|University of Virginia School of Nursing|Ann Gill Taylor, Professor Nursing|434-924-0113|agt@virginia.edu
109226|NCT00928746|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
109227|NCT00928772|VAMC|Grigory Chernyak, MD|405-326-1885|grigory.chernyak@va.gov
109228|NCT00928889|Novartis Pharmaceuticals|Study Director|862 778-8300|
109229|NCT00928954|Case Western Reserve University|R. John Leigh, M.D.|216-844-3190|rjl4@case.edu
109230|NCT00929071|Susan H. Weinkle, MD|Susan H. Weinkle, MD|941-794-5432|sweinkle@aol.com
109231|NCT00929110|Novartis Pharmaceuticals|Study Director|862 778-8300|
109232|NCT00929162|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
109233|NCT00929201|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109234|NCT00929240|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
109235|NCT00929305|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com
109236|NCT00929331|GlaxoSmithKline|GSK Response Center|866-435-7343|
109237|NCT00929344|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu
109238|NCT00929357|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109239|NCT00929383|Stryker Neurovascular|David Hess, Manager Clinical Affairs|1-510-413-2642|david.hess@stryker.com
109240|NCT00923273|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov
119381|NCT00666406|Baxter|Brigitt Abbühl, MD, Medical Director, Hematology/Hemophilia||brigitt_abbuehl@baxter.com
109242|NCT00923481|National Cancer Institute, National Institutes of Health|Dr. Shivaani Kummar|301-435-5402|kummars@mail.nih.gov
109243|NCT00929474|St. Jude Medical|Manager of Clinical Studies|818-493-2522|klee3@sjm.com
109245|NCT00929526|GlaxoSmithKline|GSK Response Center|866-435-7343|
109246|NCT00929578|Tufts Medical Center|Alice Gottlieb, MD PhD|617-636-7462|agottlieb@tuftsmedicalcenter.org
109247|NCT00929643|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109248|NCT00929656|Malcom Randall VAMC|Dr. Dorian Rose, Research Health Scientist|352-376-1611 ext 5238|Dorian.Rose@va.gov
109249|NCT00929695|Fred Hutchinson Cancer Research Center|Marco Mielcarek|206-667-2827|mmielcar@fhcrc.org
109250|NCT00929708|AstraZeneca|Carin Jorup, MSD||clinicaltrialtransparency@astrazeneca.com
109251|NCT00929734|University of Oslo|Professor Torbjørn Omland|+47 40107050|torbjorn.omland@medisin.uio.no
109252|NCT00929773|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com
119383|NCT00665444|University of Pittsburgh|Holly Swartz, MD|412-246-5588|swartzha@upmc.edu
109254|NCT00932165|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
109255|NCT00932282|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu
109256|NCT00932321|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
109257|NCT00932373|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com
109258|NCT00932399|Seattle Epidemiologic Research and Information Center|Alyson Littman|206-277-4182|alyson.littman@va.gov
109259|NCT00932425|University of California San Francisco|Wade Smith, MD, PhD|415-353-8897|smithw@neurology.ucsf.edu
109260|NCT00932451|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109261|NCT00932477|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
109262|NCT00932620|University of Ioannina|Prof Moses Elisaf|+302651007509|egepi@cc.uoi.gr
109263|NCT00932646|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
109264|NCT00932659|Duke University|Patrick Pun, MD, MHS|919-660-6865|patrick.pun@duke.edu
109265|NCT00932893|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109266|NCT00933166|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
109267|NCT00933244|University of Wisconsin - School of Medicine & Public Health|Dr. Karen E Hansen|608-265-8162|keh@medicine.wisc.edu
109268|NCT00933270|Abbott Vascular|Margo Zaugg|408-845-0576|margo.zaugg@av.abbott.com
109269|NCT00933335|GlaxoSmithKline|GSK Response Center|866-435-7343|
109270|NCT00933491|University of Michigan|Tae-Ju Oh|734-647-3320|taejuoh@umich.edu
109271|NCT00933543|Photocure|Project director Per Fuglerud|+47 22 06 16 54|pf@photocure.no
109272|NCT00933608|NYU School of Medicine|Lidia Glodzik|212.263.5698|Lidia.Glodzik@nyumc.org
109273|NCT00933686|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de
109274|NCT00933933|Abbott Diagnostic Division|Barbara Kaesdorf, Associate Director Clinical Affairs|847-937-8702|barbara.kaesdorf@abbott.com
109275|NCT00934050|Transition Therapeutics Ireland Limited and Transition Therapeutics USA Inc.|Susan Abushakra, MD, Chief Medical Officer|+1 650 425 6370|susan.abushakra@tthi.us
109276|NCT00934102|University of Waterloo|Craig Woods, PhD, FAAO / Research Manager|1-519-888-4742|cclr2@uwaterloo.ca
109277|NCT00934128|The University of Texas (UT) MD Anderson Cancer Center|David Hui, MD, MSc, FRCPC||HMoreno@mdanderson.org
109278|NCT00934141|University of Wisconsin - Madison|Dr. David H Gustafson|608-890-1436|dhgustaf@wisc.edu
109279|NCT00934180|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
109280|NCT00934362|University of North Carolina at Chapel Hill|Dr. Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu
109281|NCT00934375|Eisai Inc.|Anita Murthy, Study Director|201-692-1100|
109282|NCT00934440|University of Kansas Cancer Center|Dr. Peter Van Velduizen|(913) 945-5059|SWILLIAM@kumc.edu
109283|NCT00934544|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
109284|NCT00934596|Cardiothoracic Surgery, Skåne University Hospital Lund|Dr. Bansi Koul MD, PhD, Principal Investigator|+46 46 171649|bansi.koul@skane.se
109285|NCT00934622|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
109286|NCT00934635|Janssen Cilag|Medical Development Manager; Medical and Scientific Affairs|0049-2137-955-1240|
109287|NCT00926783|Biosense Webster EMEA|Ellen Harris, Sr. Clinical Research Associate, Clinical Operations|(800) 729-9010|eharris@its.jnj.com
109288|NCT00926796|University of Arkansas for Medical Sciences|Shelly Lensing|501-686-8203|sylensing@uams.edu
109289|NCT00926887|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com
109290|NCT00926952|Innovaderm Research Inc.|Annie Levesque|514-521-4285 ext 222|alevesque@innovaderm.ca
109291|NCT00934648|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
109292|NCT00934791|Mayo Clinic|Dr. Patrick G. Dean|507-266-6953|dean.patrick2@mayo.edu
109293|NCT00934843|Medical University of South Carolina|Dr. Eric Graham|843-792-8704|grahamem@musc.edu
109294|NCT00934856|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com
109295|NCT00934921|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
109297|NCT00935493|Yale University|Christopher van Dyck|203-764-8100|christopher.vandyck@yale.edu
109298|NCT00935532|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
109299|NCT00935584|VA san Diego Healthcare System|Dr. Zia Agha|8586421295|zia.agha@va.gov
109300|NCT00935649|PathoLase|David M Harris, PhD, Research Director|510-502-3345|bmcinc@comcast.net
109301|NCT00935701|Kennedy Krieger Institute|Lana Warren|4439239312|WarrenL@kennedykrieger.org
109302|NCT00935766|Denver Health Medical Center|Carlin Long, MD|303-602-3899|carlin.long@dhha.org
109303|NCT00935792|Mayo Clinic|Timothy Call, M.D.|5076682050|Call.Timothy@mayo.edu
109304|NCT00935818|Mayo Clinic|Dr. Jon Ebbert|507-284-4736|ebbert.jon@mayo.edu
109305|NCT00935857|Northwestern University|Rajesh N. Keswani|312-695-5620|raj-keswani@northwestern.edu
109306|NCT00935883|University of Miami Miller School of Medicine|Philip J Rosenfeld|305-326-6148|prosenfeld@med.miami.edu
109307|NCT00936065|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109308|NCT00936117|University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia Department|713-745-2723|CR_Study_Registration@mdanderson.org
109309|NCT00936208|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
109310|NCT00936221|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com
109311|NCT00936351|Roudebush VA Medical Center|Louanne W. Davis PsyD|317-988-4523|louanne.davis@va.gov
109312|NCT00936377|University of Colorado|Robert MacLaren|303 724-2622|rob.maclaren@ucdenver.edu
109313|NCT00936455|University of California San Diego|Dr Brett Meyer|619-543-7760|bcmeyer@ucsd.edu
109314|NCT00936481|Vanderbilt Universit|Kanika Bagai, MD, Assistant Professor|6153220283|kanika.bagai@vanderbilt.edu
109315|NCT00936585|National Institute of Allergy and Infectious Diseases|Michael Yao, MD|301-594-0593|yaomic@niaid.nih.gov
109316|NCT00936598|University of Pittsburgh|Professor|412-623-5965|bovbjergdh@upmc.edu
109317|NCT00936702|Mayo Clinic|Matthew P. Goetz, M.D.|507 284-2511|goetz.matthew@mayo.edu
109318|NCT00936715|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
109319|NCT00936741|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com
109320|NCT00936897|Amgen Inc.|Study Director|866-572-6436|
109322|NCT00936975|ECOG-ACRIN Cancer Research Group|Results Reporting Statistician|401-863-9188|bherman@stat.brown.edu
109323|NCT00937040|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136|
109324|NCT00937105|University Hospitals Eye Institute|Loretta Szczotka-Flynn OD, PhD|216-844-3609|loretta.szczotka@uhhospitals.org
109325|NCT00937118|Oregon Health & Science University|John Mayberry, MD|503-494-5300|mayberrj@ohsu.edu
109326|NCT00937157|Buffalo Neuroimaging Analysis Center|Robert Zivadinov, MD, PhD|716-859-7040|rzivadinov@bnac.net
109328|NCT00937391|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
109329|NCT00937495|University of Wisconsin|Steven Attia, D.O.||sa2@medicine.wisc.edu
109330|NCT00937521|Novartis Vaccines|Novartis Vaccines||RegistryContactVaccinesUS@novartis.com
109331|NCT00937547|Instituto de Oncología Dr. Luis Razetti, Caracas Venezuela|Dr. Jorge Sánchez-Lander Corresponding Author|582129870165|animamotrix@live.com
109333|NCT00937768|Mayo Clinic|Dr. R. Jeffrey Karnes|507 284-4430|Karnes.R@mayo.edu
109334|NCT00937794|Shire Development LLC|Study Physician|+1 866 842 5335|
109335|NCT00937833|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@CookBiotech.com
109336|NCT00929864|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
109337|NCT00929981|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109338|NCT00930176|Bio Products Laboratory|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk
109339|NCT00930293|University of Pittsburgh|Jill M. Cyranowski, PhD|412-246-5588|cyranowskijm@upmc.edu
109340|NCT00930553|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
109341|NCT00930644|NPS Pharmaceuticals|Executive Director, Clinical Development|+1 908-450-5300|info@npsp.com
109342|NCT00930722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109343|NCT00930761|Instituto de Puericultura e Pediatria Martagão Gesteira - UFRJ|Dr. Arnaldo Prata Barbosa|+55 21 25904891|arnaldoprata@globo.com
109344|NCT00930774|National Center for Rehabilitative Auditory Research, Portland VA Medical Center|Dr. Gabrielle H Saunders|503-220-8262 ext 56210|gabrielle.saunders@va.gov
109345|NCT00930787|LifeCell|Dr Michael Franz|908094701100|mfranz@lifecell.com
109346|NCT00930813|Lutonix Inc. a subsidiary of C.R. Bard|Chris Barry|763-445-2352|LutonixResearch@crbard.com
109347|NCT00930930|Vanderbilt-Ingram Cancer Center|Dr. Ingrid Mayer|615-936-2033|ingrid.mayer@vanderbilt.edu
109348|NCT00930969|Medtronic Cardiac Rhythm Disease Management|ST Detect Study Team|1-800-328-2518|medtronicCRMtrials@medtronic.com
109349|NCT00930982|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
109350|NCT00931164|University of Utah|Dr. Kathryn Swoboda|801-585-9717|taran@genetics.utah.edu
109351|NCT00931242|Tufts Medical Center|Alice B Gottlieb, MD, PhD|617 636 4802|agottlieb@tuftsmedicalcenter.org
109352|NCT00931268|Q-Med AB|Head of Clinical Development|+46 (0)18 4749000|reception.SEUPP@galderma.com
109353|NCT00931307|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
109354|NCT00931359|Miramar Labs|Kathy O'Shaughnessy, PhD|408-940-8700|kathyo@miramarlabs.com
109355|NCT00931385|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
109356|NCT00931411|Innovaderm Research|Annie Levesque|514-521-4285 ext 222|alevesque@innovaderm.ca
109357|NCT00931463|The Kirby Institute|Prof Sean Emery|+61293850900|semery@kirby.unsw.edu.au
109358|NCT00931489|University of California Davis, Department of Ophthalmology & Vision Science|Lawrence S. Morse, MD, PhD|916 734 6074|lsmorse@ucdavis.edu
109359|NCT00931515|Pioneer Surgical Technology|Director of Regulatory and Clinical Affairs|906-225-5602|emilydowns@pioneersurgical.com
109360|NCT00931528|NRG Onoclogy|Wendy Seiferheld||seiferheldw@nrg.oncology.org
109362|NCT00931710|Novartis Pharmaceuticals|Study Director|862-778-8300|
109363|NCT00931723|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
109364|NCT00931801|Community Research Initiative of New England|Calvin J. Cohen MD, MSc, Director of Research|617-502-1700|ccohen@crine.org
109365|NCT00931879|Eastern Virginia Medical School|Dr. Henri Parson|(757)446-7976|parsonhk@evms.edu
109367|NCT00931996|Ullinois|Dr. Jeffrey Bishop|312-413-3495|jbishop@uic.edu
109368|NCT00932022|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
109369|NCT00932035|City of Hope|Carolyn Behrendt, Ph.D.|(626)359-8111 ext 61148|Cbehrendt@coh.org
109370|NCT00932113|Tufts Medical Center|Nicole Dumont|617 636 7462|ndonovan1@tuftsmedicalcenter.org
109371|NCT00932126|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
119388|NCT00478933|Medtronic BRC|Margriet Kruijshoop, Clinical Research Manager|+31623910708|margriet.kruijshoop@medtronic.com
109373|NCT00937950|GlaxoSmithKline|GSK Response Center|866-435-7343|
109374|NCT00938015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109375|NCT00938041|GlaxoSmithKline|GSK Response Center|866-435-7343|
109376|NCT00940875|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
109378|NCT00940901|Johns Hopkins University, School of Medicine|Dr. Arthur L. Burnett, Director of Sexual Medicine Fellowship Program|410-614-3986|aburnett@jhmi.edu
109379|NCT00940927|Nemours Children's Clinic|Kathryn Blake, Pharm.D.|904 858 3806|kblake@nemours.org
109380|NCT00940992|Solgel|Ofra Levy-Hacham, Ph.D, VP of Quality Assurance|972-8-9313433 ext 3802|ofra.levy-hacham@sol-gel.com
109381|NCT00941031|Novartis Pharmaceuticals|Study Director|862-778-8300|
119389|NCT00466752|University of Washington / Seattle Cancer Care Alliance|Evan Yu|206-288-1152|evanyu@u.washington.edu
109383|NCT00941304|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
119390|NCT00421603|NYSPI|Daniel Brooks|212-740-3205|brooksd@nyspi.columbia.edu
109385|NCT00941603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109386|NCT00941655|National Cancer Institute, National Institutes of Health|Dr. Udo Rudloff|301-496-3098|Udo.Rudloff@nih.gov
109387|NCT00941668|Colgate Palmolive|Willliam DeVizio-DMD|732-878-7901|William_DeVizio@colpal.com
109388|NCT00941681|Cytokinetics, Inc.|Project Manager|650-624-2918|
109389|NCT00941720|CCCC|Dr. Ronald Sobecks|216-444-6833|sobeckr@ccf.org
109390|NCT00941733|Medtronic - CardioVascular|Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com
109391|NCT00941798|Novartis Pharmaceuticals|Study Director|862-778-8300|
109392|NCT00941863|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
109393|NCT00941889|Washington University|Steven Hunt, MD|314-454-7177|hunts@wudosis.wustl.edu
109394|NCT00941928|University of Texas MD Anderson Cancer Center|Anna Franklin, MD, Assistant Professor|713-792-3497|rnjackso@mdanderson.org
109395|NCT00941993|Acclarent|Clinical Director|650-687-5888|lenglan1@its.jnj.com
109396|NCT00942084|Duke Clinical Research Institute|P. Brian Smith, MD MPH MHS|919-668-8951|brian.smith@duke.edu
109397|NCT00942149|Duke University Medical Center|Brian Smith|9196688951|brian.smith@duke.edu
109398|NCT00942175|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
109399|NCT00942266|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
109400|NCT00942409|University of California, San Diego|Januario E Castro, MD|(858) 822-6600|jecastro@ucsd.edu
109401|NCT00942422|Barbara Ann Karmanos Cancer Institute|Jeffrey Zonder, M.D.|313-576-8732|zonderj@karmanos.org
109402|NCT00942448|IBSA Institut Biochimique|Barbara Gugliotta|+41 58 360 1000|barbara.gugliotta@ibsa.ch
109403|NCT00942604|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com
109404|NCT00942734|University of Texas (UT) MD Anderson Cancer Center|Vali Papadimitrakopoulou, MD||CR_Study_Registration@mdanderson.org
109405|NCT00942786|Department of Anesthesiology and Intensive Care Medicine, Medical University of Graz, Austria|Elisabeth Mahla, MD|++43316385 ext 13027|elisabeth.mahla@medunigraz.at
109406|NCT00942825|CanBas Co., Ltd.|Takumi Kawabe, MD, PhD|81559543666|takumi@canbas.co.jp
109407|NCT00942851|Office of the Clinical Director, NINDS, NIH|Codrin Lungu, MD|301-496-5295|lunguci@ninds.nih.gov
109408|NCT00942903|The Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5122550|f.hilgers@nki.nl
109409|NCT00942968|Pfizer, Inc.|Pfizer ClinicalTrials.gov|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109410|NCT00942994|Novartis Pharmaceuticals|Study Director|862-778-8300|
109411|NCT00943072|Regeneron Pharmaceuticals|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com
109412|NCT00943098|IBSA Institut Biochimique|Barbara Gugliotta, Clincial Research Manager|+41 58 360 10 00|barbara.gugliotta@ibsa.ch
109413|NCT00943111|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
109414|NCT00943124|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109415|NCT00943150|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com
109416|NCT00943202|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|freyse@slu.edu
109417|NCT00935064|University of Delaware/Christiana Care Health System|Dr. Raelene E. Maser|302-831-8400|rmaser@udel.edu
109418|NCT00935220|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
109419|NCT00935259|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109420|NCT00935272|Medicis Global Services|Heather M Corey|480-291-5981|hcorey@medicis.com
109421|NCT00935311|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
109422|NCT00943384|DePuy Synthes Clinical Affairs|Allyson Morris, PhD, CCRP, Staff Clinical Research Scientist|610-719-5298|morris.allyson@synthes.com
109423|NCT00943397|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
109424|NCT00943436|Healthy Eating and Activity Laboratory- University of Tenneessee|Emily Jokisch|865-974-0754|ejokisch@utk.edu
109425|NCT00943488|Carver College of Medicine, University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu
109426|NCT00943579|Children's Health Council|Glen R. Elliott, Ph.D., MD|650.688.3649|gelliott@chconline.org
109427|NCT00943592|University of Chicago|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu
109428|NCT00943605|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com
109429|NCT00943631|Center for Vaccine Development, University of Maryland|Karen Kotloff, MD|401-706-5328|kkotloff@medicine.umaryland.edu
109430|NCT00943670|Hoffman-LaRoche|Medical Communications|800-821-8590|
109431|NCT00943761|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109432|NCT00943787|University of Virginia|Mary Oliveri|434-982-0602|mc7m@virginia.edu
109433|NCT00943826|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
109434|NCT00943852|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
109435|NCT00943878|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|freyse@slu.edu
109436|NCT00943917|Intarcia Therapeutics, Inc|Michelle Baron MD|510-782-7800|clinicaltrials@intarcia.com
109437|NCT00944021|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212 227 7540|Dan.Everitt@tballiance.org
109438|NCT00944034|Novartis Vaccines|Posting Director|+39 0577 245863|anh.phung@novartis.com
109439|NCT00944073|Center for Vaccine Development, University of Maryland|Karen Kotloff, MD|401-706-5328|kkotloff@medicine.umaryland.edu
109440|NCT00944125|Aurora Health Care|Imran K. Niazi, MD|414-645-6070|imran.niazi@aurora.org
109441|NCT00944229|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu
109442|NCT00944450|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109443|NCT00944554|Johns Hopkins University|Maxine Stitzer, PhD|410-550-0042|mstitze1@jhmi.edu
109444|NCT00944645|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109445|NCT00944671|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
109446|NCT00944697|Mundipharma Research GmbH|Director of Medical Operations|44 01223424900|info@contact-clinical-trials.com
109447|NCT00944710|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org
109448|NCT00944749|National Heart Lung and Blood Institute|Dr Danielle Townsley|301-402-3477|townsleydm@nhlbi.nih.gov
109449|NCT00945035|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109450|NCT00945100|Jaeb Center for Health Research|Ray Kraker, M.S.P.H., Director of PEDIG Coordinating Center|(813) 975-8690|rkraker@jaeb.org
109451|NCT00945139|University of Vermont CC|Dr. Claire Verschraegen|802-656-5487|claire.verschraegen@vtmednet.org
119391|NCT00408902|Case Comprehensive Cancer Center|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org
109453|NCT00945256|University of Texas Medical Branch|Dr Melinda Sheffield-Moore, Professor of Medicine|409-772-8707|melmoore@utmb.edu
109454|NCT00945295|New Mexico VA Healthcare System|JoAnn Harnar, Research Nurse|505-256-5701|Joann.Harnar@va.gov
109455|NCT00945321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109456|NCT00945334|Cedars-Sinai Medical Center|Mark Pimentel|3104233792|chuak@cshs.org
109457|NCT00945477|Illinois CancerCare, P.C.|James Knost, M.D.|309-243-3000|jknost@illinoiscancercare.com
109458|NCT00945555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109459|NCT00945750|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109461|NCT00945854|Federico II University|Riccardi Gabriele|+390817462117|riccardi@unina.it
109462|NCT00945893|MedImmune, LLC|Raburn Mallory, MD Senior Director Clinical Development|301-398-0000|malloryr@medimmune.com
109463|NCT00945906|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
109464|NCT00945945|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
109465|NCT00945958|SPARC|Dr Shravanti Bhowmik||shravanti.bhowmik@sparcmail.com
109466|NCT00946088|Stanford University School of Medicine|Deirdre Lyell, MD|(650) 384-5107|deirdre.lyell@stanford.edu
109467|NCT00946101|MedImmune, LLC an affiliate of AstraZeneca AB|Elissa Malkin, D.O.|301-398-0000|malkine@medimmune.com
109468|NCT00946114|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109469|NCT00938366|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
109470|NCT00938392|GlaxoSmithKline|GSK Response Center|866-435-7343|
109471|NCT00938431|UCB|Study Director|+1877 822 9493|
109472|NCT00938457|Mayo Clinic|Dr. Robert C. Miller|507-284-2669|miller.robert@mayo.edu
109473|NCT00938470|Mayo Clinic|Steven R Alberts MD MPH|507-284-4918|alberts.steven@mayo.edu
109474|NCT00938548|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|Dr. So Yeon Kim|82-2-2227-3642|kimsy326@hanmail.net
109476|NCT00938704|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com
109477|NCT00938717|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com
109478|NCT00938782|Stanford University|Dr. David R Drover|650-725-0364|ddrover@stanford.edu
109479|NCT00938860|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
109480|NCT00938886|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu
109481|NCT00938964|Duke University Health System|Joseph Mathew, M.D|919-681-6646|joseph.mathew@duke.edu
109482|NCT00939003|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
109483|NCT00939029|Mayo Clinic|Dr. Jon Ebbert|507-284-4736|ebbert.jon@mayo.edu
109484|NCT00939055|EndoGastric Solutions|Senior Director Clinical Affairs|650-823-9093|gsahyun@endogastricsolutions.com
109485|NCT00939094|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
109486|NCT00939107|Back and Rehabilitation Center Copenhagen|Tom Petersen|+45 35304974|tom.petersen@suf.kk.dk
109487|NCT00939120|Research institute at Deaconess Clinic|Dr. Paul Siami|812-426-9548|paul.siami@deaconess.com
109488|NCT00939159|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org
109489|NCT00939185|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
109490|NCT00939211|AstraZeneca|Gerard Lynch|+441509645895|clinicaltrialtransparency@astrazeneca.com
109491|NCT00939341|AstraZeneca|Gerard Lynch|+44 1625 518062 ext 28062|aztrial_results_posting@astrazeneca.com
109494|NCT00939471|Acclarent, Inc.|Laura England, Manager-Clinical|650-687-4466|lenglan1@its.jnj.com
109495|NCT00939484|St. Jude Children's Research Hospital|Tong Lin (Biostatistician)|9015952048|Tong.Lin@stjude.org
109496|NCT00939510|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Robert Dreicer|216-445-4623|dreicer@ccf.org
109497|NCT00939536|Accutest Research Laboratories Pvt. Ltd.|Kedar Joshi|+91 22 27780718|
109498|NCT00939562|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
109500|NCT00939692|Gateway Medical Research, Inc.|Walter A Parham|(314) 663-4550|
109501|NCT00939705|Gateway Medical Research, Inc.|Walter A Parham|(314) 663-4550|
109502|NCT00939731|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109503|NCT00939783|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109504|NCT00939796|Acclarent|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com
109505|NCT00939809|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@nrgoncology.org
109506|NCT00939874|St Vincents Hospital|Professor Andrew Carr|+61 2 8382 3359|andrew.carr@svha.org.au
109507|NCT00939900|SeoulNUBH|Professor|82317877194|khkoo@snu.ac.kr
109508|NCT00939952|Albany College of Pharmacy and Health Sciences|Katie Cardone|518-694-7875|katie.cardone@acphs.edu
109509|NCT00939991|Duke University Medical Center|Katherine Peters, MD, PhD|919-684-3914|katherine.peters@dm.duke.edu
109510|NCT00940017|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
109512|NCT00940290|ITESM|Carlos A. Cuello-García|+52 (81)88882154|carlos.cuello@gmail.com, carlos.cuello@itesm.mx
109513|NCT00940485|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
109514|NCT00940537|Washington University School of Medicine|Gary Skolnick|314-362-5292|gskolnic@wustl.edu
109515|NCT00940576|University of Jena, Institute of Nutrition, Department of Nutritional Physiology Jena, Thuringia, Germany|Gerhard Jahreis, Prof. Dr.|+(49)3641/949610|gerhard.jahreis@uni-jena.de
109516|NCT00946296|UMass Medical School|Dr. Giles Whalen|508-334-5202|Giles.Whalen@umassmemorial.org
109517|NCT00946309|Fred Hutchinson Cancer Research Center|Dr. Daniel Lin|206-221-0797|dwlin@uw.edu
109518|NCT00946322|Trauma Recovery Center, Cincinnati VA Medical Center|Jeremiah A. Schumm, PhD, Associate Director|859-572-6717|Jeremiah.Schumm@va.gov
109519|NCT00946348|Geisel School of Medicine at Dartmouth|Alan I. Green, M.D.|603-650-7549|alan.i.green@dartmouth.edu
109520|NCT00946478|UCSD Dermatology|Dr. Tissa Hata|858-657-8390|ucsddermstudies@gmail.com
109521|NCT00946530|Stanford University|Jerome A. Yesavage, MD|650-493-5000 ext x64330|yesavage@stanford.edu
109522|NCT00948389|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com
109523|NCT00948441|University of Pittsburgh|Judith M. Martin, MD|412-692-7028|judy.martin@chp.edu
109524|NCT00948506|University of Pennsylvania|Joy Wan|2157466364|joy.wan@uphs.upenn.edu
119393|NCT00387751|University of Texas Health Science Center at San Antonio|Dr. John Sarantopoulos|210-450-1000|sarantopoulo@uthscsa.edu
109527|NCT00948688|Massachusetts General Hospital|Lawrence S. Blaszkowsky, M.D.|617-219-1230|lblaszkowsky@mgh.harvard.edu
109528|NCT00948766|Novartis Pharmaceuticals|Study Director|862 778-8300|
109529|NCT00948792|University of Oklahoma Health Sciences Center|Doug Dannaway|4052715215 ext 42048|douglas-dannaway@ouhsc.edu
109530|NCT00948818|Forest Research Institute|Paul F.C. Eng Ph.D Director, Clinical Development|201-427-8071|Paul.Eng@frx.com
109531|NCT00948857|Center for Human Reproduction|Dr. Norbert Gleicher|212-994-4400|ngleicher@thechr.com
109532|NCT00948896|University of California, San Francisco|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu
109533|NCT00949078|Johns Hopkins University School of Medicine|Professor Robert Wood, M.D.|rwood@jhmi.edu|rwood@jhmi.edu
109534|NCT00949117|SunCoast CCOP Research Base|Cristina Burroughs, Clinical Research Coordinator|(813) 396-9237|Cristina.Burroughs@epi.usf.edu
109535|NCT00949533|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
109536|NCT00949650|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
109537|NCT00949702|Hoffmann-La Roche|Medical Communications|800-821-8590|
109538|NCT00949715|Medtronic CRDM|Rachael Rose|763-526-2332|rachael.k.rose@medtronic.com
109539|NCT00949884|Daiichi Sankyo, Inc.|Robert Dubiel, PharmD|973-944-2963|bdubiel@dsi.com
109540|NCT00949910|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
109541|NCT00949975|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
109542|NCT00950183|OrthoCarolina|Dr. Robert B. Anderonson|704-323-2000|robert.anderson@orthocarolina.com
109543|NCT00950235|Kaiser Permanente Center for Health Research|Victor J. Stevens, PhD Principle Investigator|503 335 6751|victor.j.stevens@kpchr.org
109545|NCT00950352|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu
109546|NCT00950599|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
109547|NCT00950612|GlaxoSmithKline|GSK Response Center|866-435-7343|
109548|NCT00950651|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
109549|NCT00950664|Seoul National University Hospital|BS Jeon|+82220722876|brain@snu.ac.kr
109550|NCT00950690|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
109551|NCT00950729|Centre hospitalier universitaire de Sherbrooke (CHUS)|François Cabana|1-819-346-1110 ext 14233|francois.cabana@usherbrooke.ca
109552|NCT00950742|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
109553|NCT00950755|GlaxoSmithKline|GSK Response Center|866-435-7343|
109555|NCT00938314|Stem Cell Therapeutics Corp.|Chief Scientific Officer|403.245.5495 ext 226|adavidoff@stemcellthera.com
109556|NCT00938327|GlaxoSmithKline|GSK Response Center|866-435-7343|
109557|NCT00943683|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
119396|NCT00289536|Baxter Healthcare Corporation|Wing-Yen Wong, MD, Global Sr Medical Dir Hemophilia||wing_yen_wong@baxter.com
109559|NCT00943735|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109560|NCT00950833|GlaxoSmithKline|GSK Response Center|866-435-7343|
109561|NCT00950859|ViiV Healthcare|GSK Response Center|866-435-7343|
109562|NCT00950872|Covidien|Noreen Fahey, Director, Clinical Program Management|203-821-4716|noreen.fahey@covidien.com
109563|NCT00950911|Amgen Inc.|Study Director|866-572-6436|
109564|NCT00950937|Hospital de Clínicas de Porto Alegre|Pedro Dall'Ago|555133038751|pdallago@pq.cnpq.br
109565|NCT00950963|Denver Health|Raymond Estaico, MD|303-860-9900|Ray.Estacio@cpcmed.org
109566|NCT00951015|ViiV Healthcare|GSK Response Center|866-435-7343|
109567|NCT00951093|Clinica Gastrobese|Carlos AS Madalosso, Director of Department of Metabolic and Bariatric Surgery|+55(54)3045-4070|madalosso@gastrobese.com.br
109568|NCT00951275|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
109569|NCT00951379|University of Texas (UT) MD Anderson Cancer Center|University of Texas MD Anderson Phase I/II Prevention Consortium||CR_Study_Registration@mdanderson.org
109570|NCT00951483|Loyola University Chicago|Angelos Halaris, MD, PhD|708-216-3275|ahalaris@lumc.edu
109571|NCT00951509|Human Engineering Research Labs|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu
109572|NCT00951561|Another Way Products|Charles Tepper|917-538-6894|charles_tepper@yahoo.com
109573|NCT00951665|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
109574|NCT00951808|New England Research Institutes|Hae-Young Kim|617-972-3251|hkim@nerisicence.com
109575|NCT00951821|Brown University|Anthony Spirito|401-444-1929|anthony_spirito@brown.edu
109576|NCT00951899|Mayo Clinic|Dr. Adrian Vella|507-284-3289|vella.adrian@mayo.edu
109577|NCT00951912|the First Affiliated Hospital of Sun Yat-sen University|Dr. Yan-bin Ye|8620-87755766 ext 8179|yanbinye72@163.com
109578|NCT00952068|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
109579|NCT00952081|UMDNJ|Alex Bekker, MD, PhD|973-972-5007|bekkeray@umdnj.edu
109580|NCT00952120|University of Chicago|Lawrence Gottlieb|(773) 702-6302|lgottlie@surgery.bsd.uchicago.edu
109581|NCT00952133|NYU Langone Medical Center|Jeanna Blitz, MD|212-263 ext 0667|jeanna.viola@nyumc.org
109582|NCT00952211|UCSD|Dr. Joel Dimsdale||jdimsdale@ucsd.edu
109583|NCT00952276|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
109584|NCT00952289|Incyte Corporation|Study Director|855 463-3463|
119397|NCT00274287|Oncology Specialists, S.C.|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net
109586|NCT00952367|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109587|NCT00952393|University of Colorado|Dr. Robert Freedman|3037244940|Robert.Freedman@ucdenver.edu
109588|NCT00952419|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
109589|NCT00952484|Alexion Pharma GmbH|Alexion Pharma GmbH|(617) 494-1393|ClinicalTrials@alxn.com
109590|NCT00952523|Valeant Pharmaceuticals International Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com
109591|NCT00952588|AstraZeneca|James J. Armbrust||ClinicalTrialTransparency@astrazeneca.com
109592|NCT00952614|Duke University Medical Center|Glenn J. Jaffe, MD|919-684-4458|jaffe001@mc.duke.edu
109593|NCT00952653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109594|NCT00952705|MedImmune, LLC|JA Sliman, MD, MPH, Director, Clinical Development|301-398-0000|SlimanJ@medimmune.com
109595|NCT00952731|Northwestern University|Dr. Seema Khan|312-503-4236|s-khan2@northwestern.edu
109597|NCT00952848|Virginia Commonwealth University|Thomas J. Smith, MD, FACP|410-955-2091|tsmit136@jhmi.edu
109598|NCT00953017|Fort Belvoir Community Hospital|Dr. Michael Hjelkrem|531-231-2015|mhjelkrem@yahoo.com
109599|NCT00953043|Mayo Clinic|Dr. Michael Camilleri, Professor of Medicine and Physiology, Gastroenterology|507-266-2305|camilleri.michael@mayo.edu
109600|NCT00953056|Merck Sharp and Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
109601|NCT00953121|Preston Robert Tisch Brain Tumor Center at Duke University Medical Center|Dr. Annick Desjardins|919-684-1691|annick.desjardins@duke.edu
109603|NCT00953160|Cutera Inc.|Ayse Turley, Clinical Development Researcher|415-657-5665|aturley@cutera.com
109604|NCT00953199|Penn State Hershey Medical center|Abraham Mathew MD|717 531 3834|amathew@hmc.psu.edu
119398|NCT00272038|Oncology Specialists, S.C.|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD, FACP (PI)|847-268-8200|shallmeyer@oncmed.net
109606|NCT00953290|Cutera Inc.|Ayse Turley, Clinical Development Researcher|415-657-5665|aturley@cutera.com
109607|NCT00953329|DukeUMC|Shirley Blalock|919-668-0999|shirley.blalock@duke.edu
109608|NCT00953407|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
109609|NCT00953524|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
109610|NCT00953615|Mayo Clinic|Keith D. Lindor, M.D.|507-284-2969|lindor.keith@mayo.edu
109611|NCT00953654|The University of Georgia|Matthew P. Herring, PhD|706-542-4381|mph8@uga.edu
109612|NCT00953667|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu
109613|NCT00953680|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
109614|NCT00953706|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com
109615|NCT00953719|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|shimden@its.jnj.com
109616|NCT00946920|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
109617|NCT00946985|Ortho-McNeil Janssen Scientific Affairs, LLC|Clinical Project Scientist|609-730-3229|
109618|NCT00947011|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu
109619|NCT00947115|GlaxoSmithKline|GSK Response Center|866-435-7343|
109620|NCT00947154|Stanford Medical Center, Department of Psychiatry|Matthew White, M.D., clinical assistant professor|650 725-5598|mpwhite@stanford.edu
109621|NCT00947167|Stanford University School of Medicine|Pamela L. Kunz, MD, Leader GI Oncology Research Group|650-725-8738|pkunz@stanford.edu
109622|NCT00947219|Lexington International, LLC|David Michaels|561-417-0200|dm@hairmax.com
109623|NCT00947271|The Miriam Hospital|Dr. Michael Carey|401-793-8218|michael_carey@brown.edu
109624|NCT00947284|UCaliforniaSF|Jon Levine MD, PhD|415-476-5108|jon.levine@ucsf.edu
109625|NCT00947297|Hyperion Therapeutics|Craig James|650-745 7840|craig.james@hyperiontx.com
109626|NCT00947310|University of Rochester, Heart Research Follow-up Program|Dr. Arthur J. Moss|585-275-5391|arthur.moss@heart.rochester.edu
109627|NCT00947349|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
109628|NCT00947427|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org
109629|NCT00947505|Lexington International, LLC|David Michaels|561-417-0200|dm@hairmax.com
109630|NCT00947518|Department of Pediatrics, All India Institute of Medical Sciences, New Delhi|Mari Jeeva Sankar|+91-11-26594372|jeevasankar@gmail.com
109631|NCT00947531|Ebewe Neuro Pharma|Dr. Philipp Novak|+43 7665 8123 ext 733|philipp.novak@ebewe-neuro.com
109632|NCT00947544|Hyperion Therapeutics|Craig James-Associate Director, Clinical Operations|650-745-7840|craig.james@hyperiontx.com
109633|NCT00947661|Sun Pharma Advanced Research Company|Dr Shravanti Bhowmik||shravanti.bhowmik@sparcmail.com
109634|NCT00947752|Teva Neuroscience, Inc.|Thomas Smith, MD, VP, Medical Affairs|816-508-5000|tom.smith@tevapharm.com
109635|NCT00947765|Dr. Chetan Muralidhara Rao Dojode. Resident in Orthopaedics and Traumatology.|Dr. Chetan Muralidhara Rao Dojode, MBBS,MS(Ortho)|91 9844592532|docchetanmd@yahoo.co.in
109636|NCT00947791|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-6539|james.murrough@mssm.edu
109637|NCT00947856|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com
109638|NCT00947882|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
109639|NCT00948064|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia Department|713-745-3428|CR_Study_Registration@mdanderson.org
109640|NCT00948090|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
109641|NCT00948155|University of Pennsylvania|Andrew A. Strasser, Ph.D., Associate Professor|215 746 5788|strasse3@mail.med.upenn.edu
109642|NCT00948246|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com
109643|NCT00953849|Ralph H. Johnson VA Medical Center, Charleston, SC|M. Rita I. Young, Ph.D.|843-792-9953|rita.young@va.gov
109644|NCT00953862|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org
109645|NCT00953927|Aeras|Bernard Landry|301-547-2919|blandry@aeras.org
109646|NCT00954109|Harry S Truman Memorial VA Hospital and University of Missouri|John Thyfault, Associate Professor|573-814-6000 ext 53742|thyfaultj@health.missouri.edu
109647|NCT00954122|AstraZeneca|Gerard Lynch|4415 09645895|clinicaltrialtransparency@astrazeneca.com
109648|NCT00956943|University of Pennsylvania|Robert A. Schnoll, Ph.D.|215-746-7143|schnoll@mail.med.upenn.edu
109650|NCT00957021|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@Stryker.com
109651|NCT00957034|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
109652|NCT00957047|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com
109653|NCT00957242|University of Chicago Hospital|Imre Noth, MD, Associate Professor of Medicine|773-834-1832|inoth@medicine.bsd.uchicago.edu
109654|NCT00957268|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
109655|NCT00957333|WanFangH|Ruei-Ming Chen|02-27361661 ext 3222|rmchen@tmu.edu.tw
109656|NCT00957372|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com
109657|NCT00957424|Roswell Park Cancer Institute|Richard O'Connor|716-845-4517|richard.oconnor@roswellpark.org
109658|NCT00957528|The University of Texas Medical Branch at Galveston|Randall Urban, M.D., Professor of Medicine|409- 772-1176|rurban@utmb.edu
109659|NCT00957580|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
109660|NCT00957593|Lehigh Valley Health Netword|Joanne N. Quinones MD MSCE|6104021221|joanne_n.quinones@lvhn.org
109661|NCT00957658|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com
109662|NCT00957684|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com
119399|NCT00262223|The City College of New York|Denise A. Hien, Ph.D.|(212) 650-5666|dhien@ccny.cuny.edu
109664|NCT00957905|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman|646-422-4491|feldmand@mskcc.org
109665|NCT00957944|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
109666|NCT00957996|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302|
109667|NCT00958009|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|Fernando.dangond@emdserono.com
109668|NCT00958035|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
109669|NCT00958074|University of Washington|Dr. Andrei Shustov|206-288-6744|ashustov@uw.edu
109671|NCT00958165|CardioFocus, Inc|Burke T. Barrett|508 658-7200|bbarrett@cardiofocus.com
109672|NCT00958191|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com
109673|NCT00958217|VA San Diego Healthcare System/UCSD|Susan R. Tate, Ph.D., Clinical Psychologist|619-426-9402|srtate@ucsd.edu
109675|NCT00958256|University of Texas (UT) MD Anderson Cancer Center|Jorge Romaguera, MD/Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org
109676|NCT00958282|University of Minnesota|Dr. Marc Mooney|6129916875|moon0078@umn.edu
109677|NCT00958308|Bio-K+ International. Inc.|Dr. Serge Carrière|450-978-2465|scarriere@biokplus.com
109678|NCT00958334|Repros Therapeutics, Inc|Ronald Wiehle, PhD|281.719.3406|rwiehle@reprosrx.com
109679|NCT00958347|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com
109680|NCT00958360|Hines VA Blind Center|Joan Stelmack, O.D., M.P.H.|708-202-2124|joan.stelmack@va.gov
109681|NCT00958438|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com
109682|NCT00958477|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
109683|NCT00958568|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
109684|NCT00958776|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302|
109685|NCT00958789|Stryker Orthopaedics|Ellen Axelson, Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com
109686|NCT00958828|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
109687|NCT00958841|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
109688|NCT00958880|Southern Methodist University|Jasper Smits, Ph.D.|214-768-4310|jsmits@smu.edu
109689|NCT00958893|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com
109690|NCT00958919|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org
109691|NCT00959049|Seqirus|Clinical Program Director||Seqirus.ClinicalTrials@Seqirus.com
109692|NCT00959192|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109693|NCT00959374|Covidien|Amy Pollack M.D. Vice President Medical Affairs, STI|203-821-4719|amy.pollack@covidien.com
109694|NCT00951171|WIHRI|Andrew S Blazar, MD Principal Investigator|401-274-1122 ext 8461|ablazar@WIHRI.org
109695|NCT00959647|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com
109696|NCT00959699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
109697|NCT00959751|NeurAxon, Inc.|Thomas Lategan, PhD|417-673-6697|tlategan@neuraxon.com
109698|NCT00959764|Tarsa Theapeutics, Inc.|Dr. David Krause, Chief Medical Officer|1-267-273-7940|dkrause@tarsatherapeutics.com
109699|NCT00961116|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
109700|NCT00961181|University Medical Center, Freiburg i.Br., Germany|Prof. Dr. Christoph Hehrlein|+49 761 270 ext 6095|christoph.hehrlein@uniklinik-freiburg.de
109701|NCT00961220|Case Comprehensive Cancer Center|Dr. Kevin Cooper|216-844-3111|kevin.cooper@uhhospitals.org
109702|NCT00961233|University of North Carolina School of Medicine|Evan S. Dellon, MD MPH|919-966-2511|edellon@med.unc.edu
109703|NCT00961259|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
109704|NCT00961298|Allegheny General Hospital|Alicia Kaplan MD|412-330-4069|akaplan@wpahs.org
109705|NCT00961311|Medtronic Cardiovascular|K. Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com
109706|NCT00961350|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com
109707|NCT00961402|University of Minnesota|Beth Lewis|612-625-0756|blewis@umn.edu
109708|NCT00961415|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
109709|NCT00961441|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
109710|NCT00961532|Northwestern Medicine|Andrew M Naidech|312-503-3335|a-naidech@northwestern.edu
109711|NCT00961571|Georgetown University, Department of Medicine and Oncology|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu
109712|NCT00961636|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109713|NCT00961649|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com
109714|NCT00961662|University of Kentucky|Robert Lodder|859-955-0845|lodder@uky.edu
109715|NCT00961805|Federal University of Sao Paulo|Andreia S Baptista, PT|551155764239|deiasalvador1@yahoo.com.br
109716|NCT00961896|Novartis|Study Director|862-778-8300|
109717|NCT00962000|University of Louisville Kidney Disease Program|Richard A. Ward, Ph.D.|502-852-5757|richard.ward@louisville.edu
109718|NCT00962013|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com
109719|NCT00962065|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH|281-863-3000|
109720|NCT00962104|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
109721|NCT00962208|The Hong Kong Polytechnic University|Prof Pauline Cho|(852) 2766-6100|sopaulin@polyu.edu.hk
109722|NCT00962247|SUNY Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu
109723|NCT00962390|Ausio Pharmaceuticals, LLC|Rick Schwen, PhD, DABT, RAC / Vice President of Regulatory Affairs|513-731-0222|rick@ausiopharma.com
109724|NCT00962585|Ausio Pharmaceuticals, LLC|Rick Schwen, PhD, DABT, RAC / Vice President of Regulatory Affairs|513-731-0222|rick@ausiopharma.com
109725|NCT00962598|Icahn School of Medicine at Mount Sinai|Dr. Vilma Gabbay|212-659-1661|vilma.gabbay@mssm.edu
109726|NCT00962650|Ethicon Endo-Surgery, Inc.|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com
109727|NCT00962741|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109728|NCT00962754|Princess Amalia Children's Clinic, Isala Klinieken|Dr. J. Bekhof|0031-38-4245050|j.bekhof@isala.nl
109729|NCT00962780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109730|NCT00962871|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
109731|NCT00963157|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216|
109732|NCT00963235|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109733|NCT00963430|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216|
109734|NCT00963469|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109735|NCT00963482|Divsion Substance Use Disorder, Psychiatric Hospital of the Univeristy of Basel|M. Sc. S. Müller (Site-investigator) Prof. G. A. Wiesbeck (PI)|+41 61 325 53 33|sandra.mueller@upkbs.ch
109736|NCT00963508|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914 -345-9001|natalie.yantovskiy@taro.com
109737|NCT00963560|Alcon Research, Ltd.|Director of Alcon Clinical|888-451-3937; 817-568-6725|medinfo@alconlabs.com
109738|NCT00963599|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
109739|NCT00954447|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
109740|NCT00954512|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109741|NCT00954538|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109742|NCT00954681|NYSPI/Columbia University|John J. Mariani|6467746140 ext 646|john.mariani@nyspi.columbia.edu
109743|NCT00954707|Cordis Corporation, a Johnson & Johnson company|Amy Orlick, Associate Director|908-541-4347|aorlick@its.jnj.com
109744|NCT00954733|Northwestern University|Gildaasio De Oliveira, M.D.|312-472-3573|gjr@northwestern.edu
109745|NCT00954824|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu
109746|NCT00954915|MacroGenics, Inc.|Anastasia Daifotis, M.D.||info@macrogenics.com
109747|NCT00954941|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-794-5783|eharriso@mdanderson.org
109748|NCT00954993|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109749|NCT00955032|Center for Neurological Restoration Cleveland Clinic|Dr. Hubert Fernandez|(216) 445-1108|fernandez@neurology.ufl.edu
109750|NCT00955110|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
109751|NCT00955266|Brigham & Women's Hospital|Michael Nurok|617-899-5961|mnurok@gmail.com
109752|NCT00955279|Johnson & Johnson Pharmaceutical Research & Development|Senior Director||ClinicalTrialDisclosure@its.jnj.com
109753|NCT00955305|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|
109754|NCT00955357|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
109755|NCT00955474|Massachusetts General Hospital|John D. Matthews, MD|6177249144|jdmatthews@partners.org
109756|NCT00955487|University of Colorado School of Medicine/Children's Hospital Colorado|Dr. John Kinsella|(303) 724-2853|john.kinsella@ucdenver.edu
109757|NCT00955513|Novartis Consumer Health|Clinical Project Leader Pain category|+41223635528|
109758|NCT00955617|Guerbet|Emilie Huchet|+33 1 45 91 50 00 ext 7688|emilie.huchet@guerbet-group.com
109759|NCT00955721|University of Kentucky|Peter J. Hosein MD|859-323-6522|peter.hosein@uky.edu
109760|NCT00955747|University of Kentucky|Robert Lodder|859-955-0845|lodder@uky.edu
109761|NCT00955825|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com
109762|NCT00955903|Wake Forest School of Medicine|Jamy Ard, MD|3367169837|jard@wakehealth.edu
109763|NCT00955916|H. Lee Moffitt Cancer Center and Research Institute|Rami Komrokji, M.D.|813-745-4291|rami.komrokji@moffitt.org
109764|NCT00955955|Massachusetts General Hospital- Depression Clinical and Research Program|Dr. George Papakostas- Director of Treatment Resistant Depression Studies|617-726-6697|gpapakostas@partners.org
109765|NCT00956020|NYEEI Department of Otolaryngology|Anthony Sclafani, MD|212-979-4200|asclafani@nyee.edu
109766|NCT00956085|Stanford University|Carolyn Rodriguez, MD, PhD, Assistant Professor|6507236158|cr2163@stanford.edu
109767|NCT00956254|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602 910-2617|ldillaha@insysrx.com
109768|NCT00956293|Novartis Pharmaceuticals|Study Director|+1 (862) 778-1873|
109769|NCT00956540|Hospital Virgen de la Salud|Dr. Gonzalo Hernández|0034629625428|ghernandezm@telefonica.net
109770|NCT00956592|Oregon Health & Science University|Michael Aziz|503-494-5581|azizm@ohsu.edu
109771|NCT00956631|Vertos Medical|VP of Clinical, Regulatory and Quality|9493490008 ext 216|cmyers@vertosmed.com
109772|NCT00956657|NHS Greater Glasgow & Clyde|Gavin H. Taylor, Clinical Psychologist|0141 211 2134|gavin.taylor@ggc.scot.nhs.uk
109773|NCT00956709|CHU de Nantes|Dr Pham Dang|33 2 53 48 24 15|charles.phamdang@chu-nantes.fr
109774|NCT00956761|Novartis Vaccines and Diagnostics S.r.l|Posting Director||RegistryContactVaccinesUS@novartis.com
109775|NCT00956813|Mayo Clinic|Debra L. Barton, RN, PhD, AOCN||barton.debra@mayo.edu
109776|NCT00956839|Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow|Professor Eesh Bhatia|00915222494382|ebhatia@sgpgi.ac.in
109777|NCT00963638|William Beaumont Hospitals|Catherine Coleman, RN, BSN|248-655-5865|cjcoleman@beaumont.edu
109778|NCT00963677|The Second Xiangya Hospital of Central South University|Ru-Ping Dai, B.Sc(Med), PhD, Associate Professor|86-731-85295970|Ruping_dai@yahoo.com.cn
109779|NCT00963807|Washington University in St. Louis|John P Crandall|(314) 747 - 5561|jcrandall@wustl.edu
109780|NCT00963820|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
109781|NCT00963859|The University of Texas (UT) MD Anderson Cancer Center|John W. Davis, MD / Assistant Professor||CR_Study_Registration@mdanderson.org
109782|NCT00963872|University of Minnesota|Dr. Claudio Brunstein|612-625-3918|bruns072@umn.edu
109783|NCT00963924|Nathan Klein Institute for Psychiatric Research|Dr. Donald C Goff|646-754-4843|donald.goff@nyumc.org
109784|NCT00963937|GlaxoSmithKline|GSK Response Center|866-435-7343|
109785|NCT00964444|Pinnacle Health|David B. Peisner MD|717-231-8472|dpeisner@pinnaclehealth.org
109786|NCT00964496|Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine|Zhizheng Ge, MD. Ph.D. Director of the Clinical Trials|86-21-68383015|zhizhengge@yahoo.com.cn
109787|NCT00964548|UMASS Medical School|Susanne Muehlschlegel, MD, MPH, Principal Investigator|508-856-4667|susanne.muehlschlegel@umassmemorial.org
109788|NCT00964678|Virginia Commonwealth University Health System|Dan Grinnan, MD|804-828-9000|daniel.grinnan@vcuhealth.org
109789|NCT00964743|H. Lee Moffitt Cancer Center and Research Institute|Edward Pan, M.D.|813-745-3871|edward.pan@moffitt.org
109790|NCT00964795|Regeneron|Clinical Trials Administrator|9148475385|clinicaltrials@regeneron.com
109791|NCT00964860|Procter and Gamble|Holly Eynon|513-622-2920|eynon.ha@pg.com
109792|NCT00964886|VA San Diego Healthcare System|Joseph H. Atkinson MD|858 552 8585 ext 2568|joseph.atkinson@va.gov
109793|NCT00965081|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
109794|NCT00965094|Novartis Pharmaceuticals|Study Director|862-778-8300|
109797|NCT00965237|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
109798|NCT00965250|National Cancer Institute, National Institutes of Health|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov
109799|NCT00965341|The University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO / Assistant Professor|713-745-4192|HMoreno@mdanderson.org
119403|NCT00157157|Baxter Innovations GmbH|Brigitt Abbuehl, MD, Medical Director, Hematology/Hemophilia||brigitt_abbuehl@baxter.com
109801|NCT00965484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109802|NCT00965497|University of South Carolina School of Medicine|Meera Narasimhan, MD|803-434-1100|shardeman@uscmed.sc.edu
109803|NCT00965523|Eisai|Tatsuo Watanabe, Study Director|+81-3-3817-5252|
109804|NCT00965562|Donaghue Medical Research Foundation|Dr. Kimberly Yonkers|1-203-764-6621|Kimberly.Yonkers@yale.edu
109806|NCT00965731|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109807|NCT00965757|Eisai Co., Ltd.|Kota Nagai|+81-3-3817-5238|
109808|NCT00965848|Medical Affairs, Janssen-Cilag Ltd.,Thailand|Medical Affairs Director|662-792-7200|
109809|NCT00966186|Seoul National University Bundang Hospital|Jung-Won Hwang|82-31-787-7499|jungwon@snubh.org
109810|NCT00966238|VaxInnate|Dr. David N. Taylor|609-860-2260|david.taylor@vaxinnate.com
109811|NCT00966264|Helsinki University|Ritva Hurskainen|+23845872267|ritva.hurskainen@hus.fi
109812|NCT00966277|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org
109814|NCT00966550|Illinois Institute of Technology|Dr. Britt Burton-Freeman|312-567-5307|bburton@iit.edu
109815|NCT00966641|PLx Pharma|Ronald Zimmerman|1-713-842-1249 ext 205|ron.zimmerman@plxpharma.com
109816|NCT00966654|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu
109817|NCT00966823|Rhode Island Hospital|Francois I. Luks, MD, PhD|401-228-0556|Francois_Luks@brown.edu
109818|NCT00966875|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
109819|NCT00966940|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com
109820|NCT00966953|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com
109821|NCT00954187|Loma Linda University|Julio Narvaez, MD|9095589408|thamilton@llu.edu
109822|NCT00954356|Xenon Pharmaceuticals Inc.|Vice President Clinical|6044843300|pgoldberg@xenon-pharma.com
109823|NCT00954421|University of Florida|Dr. Kelly Foote|352-273-5550|foote@neurosurgery.ufl.edu
109824|NCT00959894|UNC School of Medicine|Michelle Floris-Moore, M.D., M.S.|919-966-2537|mfloris@med.unc.edu
109825|NCT00959907|CBED|Débora Zechmeister do Prado|55 51 30262633|cbed@cbed.org.br
109826|NCT00959920|Loyola University Medical Center|Dr. Sarita Massey|708-354-9250|smassey@lumc.edu
109827|NCT00959946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109828|NCT00959985|Massachusetts General Hospital|Dr. Alphonse G Taghian, MD PhD|617-726-6050 ext 24369|ataghian@partners.org
109829|NCT00960063|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109830|NCT00960076|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
109831|NCT00960115|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
109832|NCT00960141|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
109833|NCT00960154|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com
109834|NCT00960193|Mutual Pharmaceutical Company, Inc.|Medical Drector|215-697-1743|clinicaltrials@urlmutual.com
109835|NCT00960206|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com
109836|NCT00960297|Study Chair|David R. Spigel, M.D.|1-877-MY-1-SCRI|David.Spigel@scresearch.net
109837|NCT00960323|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
109838|NCT00960375|V Maryland Healthcare System|Dr. Melanie Bennett, Research Health Scientist|410-637-1859|Melanie.Bennett@va.gov
109839|NCT00960440|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109840|NCT00960531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109841|NCT00960570|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
109842|NCT00960622|St Luke's Roosevelt Hospital New York|Dr. Donald Phillip Kotler|212 523 3670|dkotler@chpnet.org
109843|NCT00960661|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
109844|NCT00960687|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
109845|NCT00960843|Ethicon Endo-Surgery Inc.|Michael Schwiers Principal Biostatistician|513-337-1172|mschwier@its.jnj.com
109846|NCT00960856|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clincialtrials@urlmutual.com
109847|NCT00960869|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com
109848|NCT00960934|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com
109849|NCT00960986|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
109850|NCT00960999|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org
109851|NCT00961051|Abbott Medical Optics|Eugenia Thomas, O.D.|714-247-8723|eugenia.thomas@amo.abbott.com
109852|NCT00966992|Washington University School of Medicine|Perry Grigsby, M.D.|314-362-8502|pgrigsby@radonc.wustl.edu
109853|NCT00967005|Yale University|Dr. Marc N. Potenza, M.D., Ph.D.|203-737-3553|marc.potenza@yale.edu
109854|NCT00967018|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
109855|NCT00967044|University of Texas MD Anderson Cancer Center|Yasuhiro Oki, MD / Assistant Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org
109856|NCT00967226|Childrens Research Institute|Nancy M. Bauman MD, Principle Investigator|2024764270|nbauman@cnmc.org
109857|NCT00967993|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-379|medicalinfo@keryx.com
109858|NCT00968019|Johnson and Johnson Medical Iberia|Mayda Lopez-Belmonte, PhD|+34 91 7228481|tlopezbe@its.jnj.com
109859|NCT00968032|pfm medical ag|Christof Schmeer|+49 6873 9011 ext 41|christof.schmeer@pfmmedical.com
109860|NCT00968071|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur M.D./Associate Proffesor|713-563-1586|eharriso@mdanderson.org
109861|NCT00968149|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
109862|NCT00968201|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
109863|NCT00968227|Washington University|Michael Diringer PI|314-362-2999|diringerm@wustl.edu
109864|NCT00968617|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
109865|NCT00968669|MedImmune|Joe Parker, MD|301-398-0000|parkerJ@medimmune.com
109866|NCT00968708|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com
109867|NCT00968799|Cantonal Hospital St.Gallen|Sascha Müller, MD|+41 71 494 1317|ulrich.beutner@kssg.ch
109868|NCT00968812|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736|
109869|NCT00968838|The University of Texas M D Anderson Cancer Center|Dr. Emil J. Freireich MD/Professor|713-792-2660|eharriso@mdanderson.org
109870|NCT00968890|GlaxoSmithKline|GSK Response Center|866-435-7343|
109871|NCT00968981|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
109872|NCT00969124|Avantis Medical Systems , Inc.|Jack Higgins, MD - Chief Medical Officer|4086367226|jhiggins@avantismedical.com
109873|NCT00969150|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000 ext 8124|carl.gommoll@frx.com
109874|NCT00969228|GlaxoSmithKline|GSK Response Center|866-435-7343|
109875|NCT00969280|Korea Institute of Oriental Medicine|Tae-Hun Kim, Researcher|82-10-6532-5524|rockandmineral@gmail.com
109876|NCT00969436|GlaxoSmithKline|GSK Response Center|866-435-7343|
109877|NCT00969501|Georgia Institute for Clinical Research, LLC|Arnold Weil, MD|770-421-2030|research@lowbackpain.com
109878|NCT00969540|Hologenix, LLC|Seth Casden|310-600-3673|seth.casden@celiant.com
109879|NCT00969618|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
109880|NCT00969709|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000 ext 8124|carl.gommoll@frx.com
109881|NCT00969878|Baylor|Thomas Kosten|7137947032|kosten@bcm.edu
109882|NCT00970216|Chang Gung Memorial Hospital|Chau-Ting Yeh|88633281200 ext 8121|chautingy@gmail.com
109883|NCT00964028|GlaxoSmithKline|GSK Response Center|866-435-7343|
109884|NCT00964119|University of Wisconsin - Madison|Dermatology Clinical Trials Administrator|608-287-2640|dbock@dermatology.wisc.edu
109885|NCT00964223|GlaxoSmithKline|GSK Response Center|866-435-7343|
109886|NCT00964366|GlaxoSmithKline|GSK Response Center|888-435-7343|
109887|NCT00964392|Biosense Webster, Inc.|Robert Stagg, Clinical Franchise|(800) 729-9010|RStagg@its.jnj.com
109888|NCT00964431|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com
109889|NCT00970268|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com
109890|NCT00970281|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
109891|NCT00970294|University of Kansas Medical Center|Patricia Kluding PT PhD|913-588-6918|pkluding@kumc.edu
109892|NCT00970307|GlaxoSmithKline|GSK Response Center|866-435-7343|
109893|NCT00970320|Ostfold Hospital Trust|Dr Hege Hølmo Johannessen|+4799721345|hege.holmo.johannessen@so-hf.no
109894|NCT00970359|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho|646-888-4235|hoa@mskcc.org
109895|NCT00970489|Harvard School of Public Health|Namasha Schelling|617-432-1734|nschelling@hsph.harvard.edu
109896|NCT00970502|Florida Radiation Oncology Group|Dr. Johnny Kao|813-661-6442|johnnykaomd@gmail.com
109897|NCT00970606|Vanderbilt University Medical Center|Gordon R. Bernard, MD, Associate Vice Chancellor for Research|615-343-0077|gordon.bernard@vanderbilt.edu
109898|NCT00970632|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
109899|NCT00970684|Case Comprehensive Cancer Center|Nathan Pennell MD|216-445-9285|penneln@ccf.org
109900|NCT00970736|University of Florida|Karen Hegland|352 359-1830|kwheeler@ufl.edu
109901|NCT00970814|NIAAA|Megan Ryan - Clinical Trials Project Manager|301-443-4225|mryan1@mail.nih.gov
109902|NCT00970853|Children's Hospital of Philadelphia|Dr. Jerilynn Radcliffe|215-590-7446|radcliffe@email.chop.edu
109903|NCT00970944|Spaulding Rehabilitation Hospital|Joseph T Giacino, PhD|617-573-2757|jgiacino@partners.org
109904|NCT00971048|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com
109905|NCT00971204|CardioFocus, Inc.|Burke Barrett, VP Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com
109906|NCT00971243|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
109907|NCT00971282|Galderma|Florence Paliargues|0033 4 92 95 29 57|Florence.Paliargues@Galderma.com
109908|NCT00971295|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
109909|NCT00971425|GlaxoSmithKline|GSK Response Center|866-435-7343|
109910|NCT00971620|National Cancer Institute|Dr. Edward Cowen|301-496-4299|cowene@mail.nih.gov
109911|NCT00971633|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|
109912|NCT00971750|Gundersen Lutheran Health System|Dr. Shanu Kothari|608-775-2331|snkothar@gundluth.org
109913|NCT00971789|National Cancer Institute, National Institutes of Health|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov
109914|NCT00971841|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
109915|NCT00971932|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
109916|NCT00971997|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
109917|NCT00972023|Barbara Ann Karmanos Cancer Institute|Elaina Gartner|800-527-6266|egartner@seagen.com
109918|NCT00972088|bikur holim hospital|samuel n adler md, director of clinical trial|972 2 6464206|nasnadler@gmail.com
109919|NCT00972153|Nimbic Systems|Sean Self|281-565-5715|self@nimbicsystems.com
109920|NCT00972205|National Cancer Institute (NCI), National Institutes of Health (NIH)|Susan S. Bates, M.D.|301-402-0984|Batess@mail.nih.gov
109921|NCT00972244|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com
109922|NCT00972283|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
109923|NCT00972322|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109924|NCT00972335|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
109925|NCT00972374|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
119405|NCT02871375|Alcon, A Novartis Division|Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com
109927|NCT00972504|GlaxoSmithKline|GSK Response Center|866-435-7343|
109928|NCT00972530|Department of Research and Development County Council of Gavleborg/Uppsala University|Dr Tomas Weitoft|+46 26 154388|tomas.weitoft@lg.se
109929|NCT00972543|Merck Serono S.A., a division of Merck KGaA|Medical Responsible|+49-6151-75-5200|service@merckgroup.com
109930|NCT00972595|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
109931|NCT00972621|Abbott Medical Optics, Inc.|Kendra Hileman, Ph.D., Head, Clinical Research & Development|714-247-8613|kendra.hileman@abbott.com
109932|NCT00972725|GlaxoSmithKline|GSK Response Center|866-435-7343|
109933|NCT00972738|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
109934|NCT00972777|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com
109935|NCT00972816|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com
109936|NCT00972959|Department of Clinical Therapeutics, University of Athens School of Medicine, “Alexandra” General Hospital of Athens,|Prof. M. A. Dimopoulos|0030 210 3381511|mdimop@med.uoa.gr
109937|NCT00967330|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
109938|NCT00967447|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
109939|NCT00967473|Alcon Research, Ltd.|Director of Alcon Clinical|888-451-3937; 817-568-6725|medinfo@alconlabs.com
109940|NCT00967486|Vascular center of excellence (CAMC medical staff-with admitting privileges)|Ali Fawazi AbuRahma MD|304-388-9973|
109941|NCT00967551|Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Bahia, Brasil|Hugo Costa-Ribeiro||hugocrj@ufba.br
109942|NCT00967668|VA Center for Clinical Management Research|Laura Damschroder|734-845-3603|laura.damschroder@va.gov
109943|NCT00967694|University of Utah Department of Anesthesiology|Dr. Eric Fox|775-340-0219|ericbfox@yahoo.com
109944|NCT00973349|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com
109945|NCT00973362|Hologic, Inc.|Vice President Clinical Affairs|858-410-8000|rainer.ziermann@hologic.com
109946|NCT00975975|IndianaU|Dr. Robert Nelson|317-944-0920|ronelson@iu.edu
109947|NCT00976027|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
109948|NCT00976183|Gynecologic Oncology Associates|John P. Micha, M.D.|949-642-5165|Research@gynoncology.com
109949|NCT00976209|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
109951|NCT00976274|Department of Family Medicine, Yonsei University College of Medicine|Dr. Jae-Yong Shim|(+82) 2-2019-3480|hope@yuhs.ac
109952|NCT00976339|Columbia University|Dr. Katherine Crew|212-305-1732|kd59@cumc.columbia.edu
109953|NCT00976391|GlaxoSmithKline|GSK Response Center|866-435-7343|
109954|NCT00976404|Northwestern University|Baiba Berzins, MPH|312-695-5012|baiba@northwestern.edu
109955|NCT00976456|Krankenhaus Martha-Maria Halle-Doelau gGmbH|Prof. Dr. Wolfgang Schuette|+49 345 5591440|wolfgang.schuette@martha-maria.de
109956|NCT00976482|ospedale S Orsola- Malpighi, Bologna, Italy|dr Mauro Biffi|+393337661449|mauro.biffi@aosp.bo.it
109957|NCT00976495|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com
109958|NCT00976508|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109959|NCT00976521|Atrium Medical Corporation|Leah Hollins, Director of Clinical Affairs|603-880-1433 ext 5365|lhollins@atriummed.com
109960|NCT00976573|Mayo Clinic|Robert R. McWilliams, MD|507/284-8432|mcwilliams.robert@mayo.edu
109961|NCT00976599|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109962|NCT00976664|National University of Health Sciences|Dr. Jerrilyn Cambron|630-889-6536|jcambron@nuhs.edu
109963|NCT00976677|ECOG Statistical Office|Study Statistician|617-632-3012|
109964|NCT00976703|Metrohealth Medical Center|Kelly S Gibson, MD|216-778-5498|kgibson@metrohealth.org
109965|NCT00976716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109966|NCT00976911|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
109967|NCT00976937|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
109968|NCT00976950|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
109969|NCT00976989|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
109970|NCT00977080|Abbott|Global Medical Services|800-633-9110|
109971|NCT00977106|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
109972|NCT00977171|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com
109973|NCT00977184|Department of Neurology, Centre Hospitalier Universitaire Vaudois|David H. Benninger, MD||David.Benninger@chuv.ch
109974|NCT00977197|Mayo Clinic|Yuri A. Saito Loftus, M.D.|507-284-2687|saito.yuri@mayo.edu
109975|NCT00977314|Sonitus Medical, Inc.|Clinical Trials Manager|8668162076|lily@sonitusmedical.com
109976|NCT00977379|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
109977|NCT00977470|Mass General Hospital Cancer Center|Maria Kempner|508-533-4132|mkempner@partners.org
109978|NCT00977548|H. Lee Moffitt Cancer Center and Research Institute|Rami Komrokji, Principal Investigator|813-745-4692|rami.komrokji@moffitt.org
109979|NCT00977561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
109980|NCT00977613|Beth Israel Cancer Center|Victoria Rosenwald|212 844-8285|vrosenwa@chpnet.org
109981|NCT00977665|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
109982|NCT00977704|Medicis R&D Clinical Research Department|Head of Clinical Trials||ClinicalTrialsQuery@Medicis.com
109983|NCT00977769|Oslo University Hospital|Professor Leiv Arne Rosseland|+4723070000|lrossela@ous-hf.no
109984|NCT00977808|University of Virginia|Boris Kovatchev, Ph.D./Principal Investigator|434-982-6479|pcm9b@virginia.edu
109985|NCT00977938|Harvard Clinical Research Institute|Priscilla Driscoll Shempp, Sr. Director Trial Design, Development and Strategy|617.307.5200|pdriscoll@hcri.harvard.edu
109986|NCT00978029|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
109987|NCT00978042|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
109988|NCT00978120|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
109989|NCT00978341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
109990|NCT00978380|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com
109991|NCT00978432|Duke University Medical Center|Anne Beaven, MD|919-684-8964|anne.beaven@duke.edu
109992|NCT00978445|Cleveland Clinic Foundation|Dr. Heather Gornik|216-445-3689|gornikh@ccf.org
109993|NCT00978562|OHSU KCI|Edward Neuwelt, MD|503-494-5626|huddlesa@ohsu.edu
109994|NCT00978627|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
109995|NCT00978731|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
109996|NCT00978757|Francisco C. Bonofiglio|MD|541149590200 ext 4949|francisco.bonofiglio@hospitalitaliano.org.ar
109997|NCT00979017|Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center|Katherine B. Peters, MD, PhD|(919) 684-6173|katherine.peters@duke.edu
109998|NCT00979069|Atlanta VAMC|Dr. Joe Nocera|404 321 6111 ext 6354|joe.nocera2@va.gov
109999|NCT00979121|ARDS Network|David A. Schoenfeld, PhD ARDSNet CCC PI|617-726-6111|dschoenfeld@mgh.harvard.edu
110000|NCT00979199|CNR Institute of Clinical Physiology, Pisa, Italy and Fondazione Toscana G. Monasterio, Pisa, Italy|Dr. Danilo Neglia|+390503152019 ext 2019|dneglia@ifc.cnr.it
110001|NCT00979212|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
110002|NCT00979420|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110003|NCT00979459|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110004|NCT00979576|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110006|NCT00979615|Alcon Research, Ltd.|Maria J. Tort, PhD|(817) 302-5968|Maria.Tort@alconlabs.com
110007|NCT00979628|EUSOM|Guillermo Umpierrez|4047781665|geumpie@emory.edu
110008|NCT00979654|MedImmune, LLC|Jerry Green|1-888-483-7729|rtpsafety@ppdi.com
110250|NCT00986245|Seoul National University Hospital|BS Jeon|82-2-2072-2876|brain@snu.ac.kr
110009|NCT00979875|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889|
110010|NCT00979901|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
110011|NCT00979940|Indiana University School of Medicine|Dr. Rolf Kreutz|3179620500|rkreutz@iu.edu
110012|NCT00979953|Cubist Pharmaceuticals|VP of Clinical Research|(781) 860-8660|
110013|NCT00979992|NRG Oncology Statistics and Data Management Center - Buffalo Office|Angela M. Kuras, Associate Director of Administration and Operations|716-845-5702|kurasa@nrgoncology.org
110014|NCT00980005|GlaxoSmithKline|GSK Response Center|866-435-7343|
110015|NCT00980044|University of Kentucky College of Medicine|Michelle Lofwall, MD, Associate Professor|8593239321|michelle.lofwall@uky.edu
110016|NCT00980148|University of Arkansas for Medical Sciences|Shelly Lensing, Statistician|501-686-8203|sylensing@uams.edu
110017|NCT00980174|Amgen Inc.|Study Director|866-572-6436|
110018|NCT00980200|GlaxoSmithKline|GSK Response Center|866-435-7343|
110019|NCT00980278|University of Michigan School of Dentistry|Dr. William Giannobile, Chair Department of Periodontics and Oral Medicine|734-763-2105|wgiannob@umich.edu
110020|NCT00980330|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com
110021|NCT00980343|Adult Brain Tumor Consortium (ABTC)|Charles J Nock, MD|410-955-8837|jfisher@jhmi.edu
110022|NCT00980590|Cleveland Clinic|Dr. Daniel Sessler|216-445-6500|sessled@ccf.org
110023|NCT00980642|Cleveland Clinic|Dr. Andrea Kurz|216 445-9924|KURZA@ccf.org
110024|NCT00980655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110025|NCT00980681|Guerbet|Pierre Desche, MD, Head of Clinical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com
110026|NCT00980746|BIAL – Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com
110027|NCT00980798|Janssen-Cilag Ireland|EMEA Medical Affairs Director Analgesia|0035 878 339174|
110028|NCT00980980|University of California, Irvine|Dr. Susan Huang|949-824-5073|sshuang@uci.edu
110029|NCT00981019|Max Planck Institute for Human Development, Harding Center for Risk Literacy|Dr. Odette Wegwarth|+49-30-82406 ext 695|wegwarth@mpib-berlin.mpg.de
110030|NCT00981045|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com
110031|NCT00981058|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110032|NCT00981084|University of Missouri - Kansas City|Dr. Jared Bruce|401-499-4043|brucejm@umkc.edu
110033|NCT00981175|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
110034|NCT00981214|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634|
110035|NCT00981227|Bial-Portela & Cª, S.A.|Head of Clinical Research Section|+351 22 986 6100|clinical.trials@bial.com
110036|NCT00981292|Northumbria university|Emma Wightman|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk
110037|NCT00981305|SeoulNUH|Myung Jae Jeon|82-2-2072-1916|jeonmj@snu.ac.kr
110038|NCT00981370|Childrens Hospital Los Angeles|Thomas Coates, MD|323-361-2352|tcoates@chla.usc.edu
110039|NCT00981409|GlaxoSmithKline|GSK Response Center|866-435-7343|
110040|NCT00981435|Stanford University|Clinical Research Coordinator|6507236995|mnunez1@stanford.edu
110041|NCT00981461|Lexington International, LLC|David Michaels|5614170200|dm@hairmax.com
110043|NCT00973622|University of Arkansas for Medical Sciences|Christine Sheffer, PhD|212 650 6860|csheffer@med.cuny.edu
110044|NCT00973700|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com
110045|NCT00973739|New York University Langone Medical Center|Matthias Karajannis, MD|212-263-8400|matthias.karajannis@nyumc.org
110046|NCT00973752|Massachusetts General Hospital|Dr. Amir Fathi|617-724-1124|afathi@partners.org
110047|NCT00973765|Washington Hospital Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com
110048|NCT00973921|Columbia University Medical Center|Giora Weisz MD|212-305 7060|gw2128@mail.cumc.columbia.edu
110049|NCT00974051|UColorado|Dr. H Peter Chase|303-724-2323|peter.chase@ucdenver.edu
110050|NCT00974090|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
110051|NCT00974220|Queen's University, Kingston, ON, Canada|Dr. Denis O'Donnell|1-613-548-2339|odonnell@queensu.ca
110052|NCT00974233|University of Wisconsin|Julie E. Chang, MD|608-262-3970|jc2@medicine.wisc.edu
110053|NCT00974246|Valley Medical Research|Meenakshi Patel, MD|937-208-8298|mpatelmd@ymail.com
110054|NCT00974311|Medivation, Inc.|Lynn Seely, MD, Chief Medical Officer|415-829-4106|lynn.seely@medivation.com
110055|NCT00974363|GlaxoSmithKline|GSK Response Center|866-435-7343|
110056|NCT00974376|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu
110057|NCT00974480|Innovaderm Research Inc|Annie Levesque|514-521-4285 ext 222|alevesque@innovaderm.ca
110058|NCT00974571|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110059|NCT00974675|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com
110060|NCT00974818|Memorial Slaon Kettering Cancer Center|Dr. Guido Dalbagni|646-422-4394|Dalbagng@mskcc.org
110061|NCT00974974|Impax Laboratories, Inc.|Michelle Landolfi, Director, Regulatory Affairs|510-240-6402|mlandolfi@impaxlabs.com
110062|NCT00975000|Amgen Inc.|Study Director|866-572-6436|
110063|NCT00975130|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
110064|NCT00975143|Cipher Pharmaceuticals Inc.|Julia Chan, RAC|905-602-5840 ext 326|jchan@cipherpharma.com
110065|NCT00975156|Mischer Neuroscience Institute, Memorial Hermann-TMC|Elizabeth Noser||elizabeth.noser@memorialhermann.org
110066|NCT00975195|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110067|NCT00975221|Amgen Inc.|Study Director|866-572-6436|
110068|NCT00975286|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
110069|NCT00975416|National Institute on Drug Abuse|Mary R. Lee, M.D.|301-825-0545|leemary@mail.nih.gov
110070|NCT00975481|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110071|NCT00975507|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110072|NCT00975585|Vistakon|Sheila Hickson-Curran, MCOptom/ Director, Medical Affairs|904-443-1754|
110073|NCT00975611|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org
110074|NCT00975637|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com
110075|NCT00975689|National Institute of Child Health and Human Development; NIH|Dr. Forbes D Porter, Senior Investigator|(301) 435-4432|fdporter@mail.nih.gov
110076|NCT00975715|Novartis|Study Director|41 61 324 1111|
110077|NCT00975780|Yale University School of Medicine|Vincent James Quagliarello MD, Professor of Medicine (Infectious Diseases); Clinical Chief, Infectio|(203) 785-7571|vincent.quagliarello@yale.edu
110078|NCT00975806|Celgene Corporation|Anne McClain,Senior Manager|1-888-260-1599|clinicaltrialsdisclosure@celgene.com
110079|NCT00975923|Vanderbilt University School of Medicine|Dr. Theodore Speroff|615-636-9476|ted.speroff@vanderbilt.edu
110080|NCT00981630|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
110081|NCT00981669|Instituto Butantan|Alexander Roberto Precioso|+5511-2627-9372 ext 9372|alexrp@butantan.gov.br
110082|NCT00981812|University of Cincinnati Medical Center|Mary Mahoney, MD|513-584-4396|mary.mahoney@uchealth.com
110083|NCT00981825|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com
110084|NCT00982735|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110085|NCT00982995|University of Michgan Comprehensive Cancer Center|Susan Urba|734-615-4762|surba@umich.edu
110086|NCT00983073|Grünenthal GmbH|Dr. Ilona Steigerwald|+49 241 569 3223|clinical-trials@grunenthal.com
110087|NCT00983216|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
110088|NCT00983242|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlpharma.com
110089|NCT00983281|University of Miami|Kenneth Proctor, PhD|305-243-4694|kproctor@med.miami.edu
110090|NCT00983294|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
110091|NCT00983346|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu
110092|NCT00983359|The Ohio State University Comprehensive Cancer Center|Mario Ammirati, MD|614-293-1970|Mario.Ammirati@osumc.edu
110093|NCT00983372|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
110094|NCT00983385|Grünenthal GmbH|Dr. Ilona Steigerwald|+49 241 569 3223|Clinical-Trials@grunenthal.com
110095|NCT00983437|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
110096|NCT00983476|VA Greater Los Angeles Healthcare System, Los Angeles, CA|Dr. Alexander S. Young|310-794-7219|alexander.young@va.gov
110097|NCT00983489|Deen Dayal Upadhaya Hospital, New Delhi|Dr Kanchan Sharma|919417938224|psaiims@yahoo.co.in
110098|NCT00983515|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clincialtrials@urlmutual.com
110099|NCT00983541|Huntsman Cancer Institute|Christopher Anker, MD|801-213-4241|candace.larson@hci.utah.edu
110100|NCT00983645|Loma Linda University Medical Center Transplantation Institute|Dr. Pedro Baron|909-558-3636 ext 36792|pbaron@llu.edu
110101|NCT00983749|Department of Emergency Medicine, University of California San Diego Health System|Kama Guluma, M.D.|619-543-6463|kguluma@ucsd.edu
110102|NCT00983801|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
110103|NCT00983827|University of Utah|Dr. Steven Edgley|801-581-4695|carma.hyde@hsc.utah.edu
110104|NCT00983853|Vertex Pharmaceuticals Incorporated|Medical Monitor|1-617-444-6777|medicalinfo@vrtx.com
110105|NCT00983892|Ann Arbor Veterans Administration|Maria J. Silveira MD MA MPH|734-763-4550|mariajs@med.umich.edu
110106|NCT00983905|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com
110107|NCT00983918|Baylor College of Medicine|Jaime Ortiz, MD|713-873-2860|jaimeo@bcm.edu
110108|NCT00983931|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
110109|NCT00983957|Bristol­Myers Squibb International Corporation|Bristol-Myers Squibb Study Director||clinical.trials@bms.com
110110|NCT00983983|Massachusetts General Hospital|Dr. Anne-Marie Wills|855-644-6387|awills@partners.org
110111|NCT00984009|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
110112|NCT00984022|Maricopa Integrated Health System|David Drachman|602-344-5161|david.drachman@mihs.org
110113|NCT00984061|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
110114|NCT00984126|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com
110115|NCT00984139|GlaxoSmithKline|GSK Response Center|866-435-7343|
110117|NCT00984204|St. Jude Medical|Nabil Kanaan|949-769-5000|nkanaan@sjm.com
110118|NCT00984256|US Army Medical Materiel Development Activity (USAMMDA)|Michelle Mathers|301-619-8061|Michelle.mathers@us.army.mil
110120|NCT00984295|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110121|NCT00984308|Department of Veterans Affairs|Dawn M. Bravata, MD|317-988-2676|dawn.bravata2@va.gov
110122|NCT00984334|S.L.A. Pharma UK Ltd|Dr C Jordan, Head of Clinical Operations|44 01923 681001|cjordan@slapharma.com
110123|NCT00984490|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu
110124|NCT00984542|Vanderbilt-Ingram Cancer Center|Leora Horn, MD|615-936-2033|leora.horn@vanderbilt.edu
110125|NCT00984568|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
110126|NCT00984594|RTI Biologics|Director, Clinical Projects|386-418-8888 ext 4172|rwaite@rtix.com
110429|NCT00996593|GlaxoSmithKline|GSK Response Center|866-435-7343|
110127|NCT00984620|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
119406|NCT02766400|University of Pittsburgh|Elizabeth R. Skidmore, PhD, OTR/L, FAOTA|(412) 383-6617|skidmore@pitt.edu
110129|NCT00984698|University of Arizona|Dr. Patricia Haynes, Assistant Professor|5206261855|thaynes@email.arizona.edu
110130|NCT00984815|Horizon Pharma|Amy Y. Grahn, MS|224-383-3012|agrahn@horizonpharma.com
110131|NCT00984867|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com
110132|NCT00985010|Materno-Perinatal Hospital of the State of Mexico|Hugo Mendieta Zerón|+52-722-2176605|mezh_74@yahoo.com
110133|NCT00985114|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3263|kwoessner@gidynamics.com
110134|NCT00985140|Stanford University Cancer Center|Richard T. Hoppe, MD Henry S. Kaplan Harry Lebeson Professor of Cancer Biology|(650) 723-5510|hoppe@stanford.edu
110135|NCT00985153|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
110136|NCT00985166|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110137|NCT00985192|UCLA GI Oncology Program, David Geffen School of Medicine at UCLA|Dr. Zev Wainberg|310 794-6500|zwainberg@mednet.ucla.edu
110138|NCT00985231|Bausch & Lomb Incorporated|William Reindel, OD, MS|(585) 338-8129|william.t.reindel@bausch.com
110139|NCT00985257|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com
110140|NCT00985439|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com
110141|NCT00985491|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3261|pkeating@gidynamics.com
110142|NCT00985504|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110143|NCT00988429|Bial - portela & Cª, S.A.|Head of Clinical Research|+351 22 986 6100|clinical.trials@bial.com
110144|NCT00988442|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 6283313|ACTGCT.Gov@s-3.com
110145|NCT00988533|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com
110146|NCT00988637|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Dierctor|817-961-5358|ron.gottschalk@galderma.com
110147|NCT00988832|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
110148|NCT00988858|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110149|NCT00988884|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110150|NCT00989014|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com
110151|NCT00989092|Amgen Inc.|Study Director|866-572-6436|
110152|NCT00989157|NRIFargo|Dr. James Roerig|701 365 4919|jroerig@nrifargo.com
110153|NCT00989196|Octapharma AG|Dr. Sigurd Knaub|+41 554512141|sigurd.knaub@octapharma.com
110154|NCT00989235|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
110155|NCT00989586|The Ohio State University Comprehensive Cancer Center|Beth Christian|614-293-8858|beth.christian@osumc.edu
110156|NCT00989664|GlaxoSmithKline|GSK Response Center|866-435-7343|
110157|NCT00989768|Brazilian Center for Studies in Dermatology|Juliana de Souza|+55 51 3026 2633|pesquisa@cebd.org.br
110158|NCT00989833|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
110159|NCT00989911|Ahamanson/UCLA ACHDC|Dr. Jamil Aboulhosn|3108255950|jaboulhosn@mednet.ucla.edu
110160|NCT00989950|CoxHealth|Arie Ashkenasi, MD|011 972 50 3007477|ashkenasi1@gmail.com
110161|NCT00989989|Novartis Pharmaceuticals|Study Director|41 61 324 1111|
110162|NCT00990093|Coloplast|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com
110163|NCT00990106|VA Puget Sound Health Care System|Murray Raskind, MD|206-277-3797|Murray.Raskind@va.gov
110164|NCT00990184|SIBCR|Steven E. Kahn|206-277-5515|skahn@u.washington.edu
110165|NCT00990340|Teva Neuroscience|Thomas Smith, MD, VP, Medical Affairs|816-508-5000|tom.smith@tevapharm.com
110166|NCT00990509|University of Arizona|Chelsea Kidwell, MD|(520) 626-7159|ckidwell@neurology.arizona.edu
110167|NCT00990561|UCSF|John Koo, Principle Investigator|415-476-4701|john.koo@ucsfmedctr.org
110168|NCT00990652|Northwestern University|Jeffrey Raizer, MD|312-503-4724|jraizer@nmff.org
110169|NCT00990704|Abbott|Global Medical Services|800-633-9110|
110170|NCT00990769|Duke University Medical Center|Dr. Heather Frederick|919-812-6204|heather.frederick@duke.edu
110171|NCT00990782|Cleveland Clinic|Dr. John Vargo|(216) 445-5012|vargoj@ccf.org
110172|NCT00990821|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110173|NCT00982007|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com
110174|NCT00982020|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
119407|NCT02622321|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
110176|NCT00982111|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110177|NCT00982137|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
110179|NCT00982228|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
110180|NCT00982280|Grünenthal GmbH|Dr. Ilona Steigerwald|+49 241 569 0|Clinical-Trials@grunenthal.com
110181|NCT00982345|Indiana University|Dr. Amit Anand|317-274-7422|aanand@iupui.edu
110182|NCT00982410|Ann Arbor Veteran Affairs|Dr. Mark Ilgen|(734) 845-3646|Mark.Ilgen@va.gov
110183|NCT00982423|Mayo Clinic|Dr. Horng Chen|507-538-2354|chen.horng@mayo.edu
110184|NCT00982488|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
110185|NCT00982553|Imperial College|Dr Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk
110186|NCT00982592|Perlmutter Cancer Center at NYU Langone|Deirdre Cohen, MD|212-731-5656|deirdre.cohen@nyumc.org
110187|NCT00982644|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
110188|NCT00982657|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110189|NCT00990964|Medtronic, Inc.|Attain Success Clinical Trial Leader|800-328-2518 ext 62864|medtronicCRMtrials@medtronic.com
110190|NCT00991081|Stanford University|Sean P. David, MD, SM, DPhil|650-498-4687|spdavid@stanford.edu
110191|NCT00991185|duke|brian smith|919668951|brian.smith@duke.edu
110192|NCT00991809|Johns Hopkins University, School of Medicine|Dr. D. Andrew Tompkins|410-550-5953|dtompki1@jhmi.edu
110193|NCT00991887|Carolinas Medical Center|Rachel Seymour, PhD|704-355-6969|Rachel.Seymour@carolinashealthcare.org
110194|NCT00991939|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-923-7747 ext 548|sassmann@neriscience.com
110195|NCT00991952|Memorial Sloan-Kettering Cancer Center|Dr. Yelena Janjigian|646-888-4186|janjigiy@mskcc.org
110196|NCT00992017|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|919-405-1429|mallen@fhi360.org
110197|NCT00992056|University of Miami|Richard A Preston MD MSPH MBA|305 243 5930|rpreston@med.miami.edu
110198|NCT00992108|UCLA Neurology|Marisa Chang, MD|310-794-1870|marisachang@mednet.ucla.edu
110199|NCT00992186|Centocor Research & Development, Inc., PA, USA|Senior Director, Early Clinical Development Global Leader|+1-908-927-3159|
119408|NCT02541864|Kaohsiung Veterans General Hospital|Dr. Feng-Woei Tsay|+886-7-3422121 ext 8233|fwchaie@vghks.gov.tw
110201|NCT00992394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110202|NCT00992407|R&D Clinical Research, Seoul KOREA|Clinical Research Director|+82 2 2094 -4518|
110203|NCT00992433|Baylor College of Medicine|Hana El Sahly, MD|713-798-2058|hanae@bcm.edu
110204|NCT00992446|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org
110205|NCT00992459|Hyperion Therapeutics|Bruce Scharschmidt, MD, SVP, Chief MedicaL & Development Officer|650-745-7851|bruce.scharschmidt@hyperiontx.com
110206|NCT00992589|Janssen R&D US|PORTFOLIO/CDT LEADER|1 609 730-2548|
110207|NCT00992602|University of Washington|Maciej M. Mrugala, MD, PhD, MPH|206-543-4069|mmrugala@uw.edu
110208|NCT00992719|Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, Duke University School of Medicine|Geeta K. Swamy, M.D.|919-681-5220|geeta.swamy@duke.edu
110209|NCT00992784|GlaxoSmithKline|GSK Response Center|866-435-7343|
110210|NCT00992836|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|919-405-1429|mallen@fhi360.org
110211|NCT00992927|Seoul National University Hospital|Sun Gun Chung/Professer|+82-2-2072-3954|suncg@snu.ac.kr
110212|NCT00992992|GlaxoSmithKline|GSK Response Center|866-435-7343|
110213|NCT00993044|Children's Hospital Los Angeles|Rajkumar Venkatramani|3233615504|rvenkatramani@chla.usc.edu
110214|NCT00993148|Northwestern University|Dr. Babafemi Taiwo|312-695-5085|b-taiwo@northwestern.edu
110215|NCT00993187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|
110216|NCT00993200|University of Utah|Robert Pendleton|801 581 7818|robert.pendleton@hsc.utah.edu
110217|NCT00993265|Yale University, Child Study Center|Dr. Michael Bloch, MD, MS|203-737-4809|michael.bloch@yale.edu
110218|NCT00993291|Vanderbilt University|Fenna Phibbs M.D.|615-936-2025|fenna.phibbs@vanderbilt.edu
110219|NCT00993317|Korea Otsuka Pharmaceutical|Eun Young Cho, Clinical Trial Manager|+82-2-3287-9233|hyerim@otsuka.co.kr
110220|NCT00993421|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110221|NCT00993447|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
110222|NCT00993473|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com
110223|NCT00993499|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110225|NCT00993655|Canadian Cancer Trials Group|Dr. Wendy Parulekar|6135336430|
110226|NCT00993668|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493|
110227|NCT00993824|International Diabetes Center|Roger Mazze PhD|952-993-3796|rmazze@aol.com
110228|NCT00993915|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110229|NCT00993928|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu
110230|NCT00993954|University of Alberta|Dr Andrew Dixon|780-492-3553|andrew.dixon@albertahealthservices.ca
110231|NCT00994110|Memorial Sloan Kettering Cancer Center|Dr. Peter Allen|212-639-5132|allenp@mskcc.org
110232|NCT00994123|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com
110233|NCT00994175|National Heart Lung and Blood Institute|Levine, Stewart|+1 301 402 1448|levines@nhlbi.nih.gov
110234|NCT00994214|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
110235|NCT00985543|St Stephens Centre, Chelsea and Westminster Hospital|Dr Marta Boffito|+44 2088 466 507|marta.boffito@chelwest.nhs.uk
110236|NCT00985673|GlaxoSmithKline|GSK Response Center|866-435-7343|
110237|NCT00985686|Canadian Institute of Natural and Integrative Medicine|Dr. John Toews|4032200022 ext 111|j.toews@cinim.org
110238|NCT00985712|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110239|NCT00985725|Shire Pharmaceutical|Study Physician|1 866-842-5335|
110240|NCT00985738|University of Colorado Hospital|Dr. Al Baha Barqawi|303-724-2722|AL.BARQAWI@UCDENVER.EDU
110241|NCT00985751|GlaxoSmithKline|GSK Response Center|866-435-7343|
110242|NCT00985790|GlaxoSmithKline|GSK Response Center|866-435-7343|
110243|NCT00985946|University of Wisconsin Carbone Cancer Center|Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu
110244|NCT00985959|Janssen Pharm KK Japan|Director|+81-3-4411-5801|
110245|NCT00985985|GlaxoSmithKline|GSK Response Center|866-435-7343|
110246|NCT00986102|Jan-Cil Singapore|VP MEDICAL AFFAIRS ASIA PACIFIC|+65 6827 6753|
110247|NCT00986154|Daiichi Sankyo, Inc.|Lee Schwocho, Sr. Director|732-590-5000|lschwocho@dsi.com
110248|NCT00986180|Janssen Pharmaceuticals|Vice President, Medical Affairs, Internal Medicine|1 908 218-7250|
110249|NCT00986232|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
119409|NCT02482805|University of Texas at Austin|Michelle Davis|214-470-1371|michelledavis@utexas.edu
110251|NCT00986258|Grünenthal GmbH|Dr. Ilona Steigerwald|+49 241 569 3223|clinical-trials@grunenthal.com
110252|NCT00986349|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com
110253|NCT00986362|ThromboGenics NV|Dr. Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com
110254|NCT00986401|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com
110255|NCT00986427|Columbia University Dept of Dermatology|Julian Mackay-Wiggan, MD|212-305-6953|jc299@columbia.edu
110256|NCT00986453|Medtronic Surgical Technologies|Robert Swain, PhD|+1 (603) 294-5428|robert.e.swain@medtronic.com
110257|NCT00986479|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com
110258|NCT00986544|Department of Surgery, Hospital “P. Colombo”, Via Orti Ginnetti 7, 00049 Velletri (Rome), Italy|Marcello Picchio|+39696102228|marcellopicchio@libero.it
110259|NCT00986570|Biolab Sanus Farmacêutica Ltda.|Priscilla Padilha, MD|55(11)35736335|ppadilha@biolabfarma.com.br
110260|NCT00986583|Cleveland Clinic|Alparslan Turan, M.D.|216-444-4000 ext 9857|turana@ccf.org
110261|NCT00986674|ECOG Statistical Office|Study Statistician|617-632-3012|
110262|NCT00986856|LEO Pharma|Anders Rhod Larsen, Scientific advisor|+45 72262990|anders.larsen@leo-pharma.com
110263|NCT00986921|Boston University Department of Obstetrics and Gynecology|Director of Clinical Research|617-414-5175|rstudy@bmc.org
110264|NCT00986947|Johns Hopkins University School of Medicine|Andrew Singer, MD|410-550-6484|registerclinicaltrials@jhmi.edu
110265|NCT00986960|Buffalo Neuroimaging Analysis Center|Dr. Robert Zivadinov|716-859-7031|rzivadinov@bnac.net
110266|NCT00986973|The Children's Hospital of Philadelphia|Dr. Can Ficicioglu|2155905876|ficicioglu@email.chop.edu
110267|NCT00986986|University of Hawaii at Manoa|Dominic Chow|(808)737-2751|dominicc@hawaii.edu
110268|NCT00986999|University of Hawaii|Cecilia M. Shikuma M.D.|808 692-1328|shikuma@hawaii.edu
110269|NCT00987337|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110270|NCT00987402|University Hospital, Geneva|Stephan Harbarth MD|+41-22-372.3357|stephan.harbarth@hcuge.ch
110271|NCT00987415|Duke University|Kevin Anstrom|919-668-8902|kevin.anstrom@dm.duke.edu
110272|NCT00987467|Johns Hopkins University, Wilmer Eye Institute|Dr.Esen Akpek, MD. Associate professor of ophthalmology Wilmer eye institute|410-955-5214|esakpek@jhmi.edu
110273|NCT00987558|Bial – Portela & Cª, S.A.|Head of Clinical Research||jose.rocha@bial.com
110274|NCT00987623|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
110275|NCT00987727|Allergan, Inc|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com
110276|NCT00987831|Oklahoma Medical Research Foundation|Joan T Merrill, M.D|405-271-7805|JTMmail@aol.com
110277|NCT00987935|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110278|NCT00987948|Hawaii Center for AIDS, University of Hawaii|Dr. Cecilia M Shikuma|8086921328|shikuma@hawaii.edu
110279|NCT00988065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
110280|NCT00988091|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
110281|NCT00988117|UCaliforniaSF|Dr. Bruce Miller|415-476-5569|bmiller@memory.ucsf.edu; kpossin@memory.ucsf.edu
110282|NCT00988143|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
110283|NCT00988156|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com
110284|NCT00988169|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org
110285|NCT00988208|Celgene Corporation|Senior Manager , Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
110286|NCT00988221|Hoffman-La Roche|Medical Communications|800 821-8590|
110287|NCT00988247|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
110288|NCT00988325|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
110289|NCT00988351|Malcom Randall VA|Dr. Richard B. Berry|3522621575|Richard.Berry@medicine.ufl.edu
110290|NCT00994240|University of Wisconsin-Madison|Clinical Research Administrator|608-287-2640|dbock@dermatology.wisc.edu
110291|NCT00994279|Wake Forest NCI NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu
110292|NCT00994318|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com
110293|NCT00994422|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com
110294|NCT00994448|UCLA|Keith Heinzerling MD|310-794-0619|KHeinzerling@mednet.ucla.edu
110295|NCT00994461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110296|NCT00996892|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
110297|NCT00996918|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110298|NCT00996931|Sutter Institute for Medical Research|Carol Parise, PhD|916-733-4413|PariseC@sutterhealth.org
110299|NCT00996944|GlaxoSmithKline|GSK Response Center|866-435-7343|
110300|NCT00996996|GlaxoSmithKline|GSK Response Center|866-435-7343|
110301|NCT00997035|University of California, San Francisco|Kathryn Ray|415-514-3227|kathryn.ray@ucsf.edu
110302|NCT00997113|Minneapolis Medical Reseach Foundation|James Miner|6128738791|miner015@umn.edu
110303|NCT00997126|MinneapolisMRF|James Miner|6128732493|miner015@umn.edu
110304|NCT00997139|Northwestern University Department of Dermatology|Clinical Trials Unit Coordinator|312-695-6829|mandybrowning2015@u.northwestern.edu
110305|NCT00997204|Shire Human Genetic Therapies, Inc|Alan Kimura, MD,PhD|781-482-0738|akimura@shire.com
110306|NCT00997243|Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center|Alison Walker, MD|614-293-3196|Alison.Walker@osumc.edu
110307|NCT00997321|MinneapolisMRF|James Miner|612-873-3000|miner015@umn.edu
110308|NCT00997334|Dana-Farber Cancer Institute|David M. Jackman, MD|617.632.3468|David_Jackman@dfci.harvard.edu
110309|NCT00997373|UC Davis|Lloyd H. Smith MD, PhD|916-734-6945|lhsmith@ucdavis.edu
110310|NCT00997425|James A. Haley VA Hospital, Tampa, FL|Dorothy H. Moore, PhD|813 558-3931|Dorothy.Moore4@va.gov
110311|NCT00997438|VA Portland Health Care System|Dr. Sonemany Salinthone|5032208262 ext 54394|salintho@ohsu.edu
110312|NCT00997503|Boston Scientific Corporation|Peter Maurer, Director of Clinical Trials|1-508-683-6678|Peter.Maurer@bsci.com
110313|NCT00997516|University of California, San Francisco|Jonathan T. Carter, MD, FACS|415-476-0974|jonathan.carter@ucsfmedctr.org
110314|NCT00997555|Hurley Medical Center|John Alfred Carr, MD|810-262-4993|heartandbones@yahoo.com
110315|NCT00997594|Mie University|Dr. Koichiro Yamakado|+81-59-231-5029 ext 5630|yama@clin.medic.mie-u.ac.jp
110316|NCT00997672|University Federico II, Naples, Italy|Dr. Francesco Saccà|3470734774 ext +39|francesco.sacca@unina.it
110317|NCT00997932|University of North Carolina School of Medicine|Dr. G Stuart|919-962-4880|gstuart@med.unc.edu
110318|NCT00997984|Shire Pharmaceutical|Jonathan Rubin, M.D.||jrubin@shire.com
110319|NCT00998023|University of Florida|J Mocco, M.D.|352-273-9000|jmocco@neurosurgery.ufl.edu
110320|NCT00998049|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu
110321|NCT00998205|University of Missouri-Columbia|Anand Chockalingam|573-882-2296|chockalingama@missouri.edu
110322|NCT00998296|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110323|NCT00998309|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110324|NCT00998335|University of Florida|Dr. Kenneth Cusi|352-273-7236|KCusi@ufl.edu
110325|NCT00998374|Lenox Hill Hospital|Dr. Mitchell Roslin|212-434-3285|MRoslin@NSHS.edu
110326|NCT00998426|Johns Hopkins Medicine|Kirti Shetty, MD|202 660 5555|kshetty1@jhmi.edu
110327|NCT00998517|Washington University in St. Louis|Indi Trehan|5039284634|itrehan@wustl.edu
110328|NCT00998582|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu
110329|NCT00998660|Medtronic, Inc.|Todd Weaver, PhD|763-526-8130|todd.weaver@medtronic.com
110330|NCT00998738|Mayo Clinic|Dr. Charles Loprinzi|507-266-6247|cloprinzi@mayo.edu
110331|NCT00998764|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110332|NCT00998868|Seoul National University Hospital|Tai Ryoon Han, MD, PhD./Professor|+82-2-2072-3218|tairyoon@snu.ac.kr
110333|NCT00998881|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
110334|NCT00998985|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110335|NCT00999037|University of California at Los Angeles|Katherine Wesseling-Perry|310-206-6987|kwesseling@mednet.ucla.edu
110336|NCT00999141|Baxter Innovations, GmbH|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com
110337|NCT00999167|Horizon Therapeutics, Inc.|Julia Egofske|224-383-3078|jegofske@horizonpharma.com
110338|NCT00985829|skin research center|Zohreh Tehranchi-nia, assist. prof|+989121029415|zohreh_tehranchi@yahoo.com
110339|NCT00991276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110340|NCT00991289|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
110341|NCT00991302|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
110342|NCT00991341|New England Research Institutes|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com
110343|NCT00991458|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
110344|NCT00991510|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
110345|NCT00999466|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
110346|NCT00999544|University of Kentucky|Dr. Sharon Walsh|859-257-6485|sharon.walsh@uky.edu
110347|NCT00999596|Philips Healthcare|Sarah Baxter or Linda Jalbert|425-487-7665 / 978-659-7434|sarah.baxter@philips.com, linda.jalbert@philips.com
110348|NCT01000610|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
110349|NCT01000649|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
110350|NCT01000662|NYU Langone Medical Center|Dr. Silvia Formenti, Chairman, Department of Radiation Oncology|(212) 731-5039|silvia.formenti@nyumc.org
110351|NCT01000727|GlaxoSmithKline|GSK Response Center|866-435-7343|
110352|NCT01000805|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110353|NCT01000818|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110354|NCT01000961|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com
110355|NCT01000974|GlaxoSmithKline|GSK Response Center|866-435-7343|
110356|NCT01001052|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
110357|NCT01001078|Maisonneuve-Rosemont Hospital|Nikola Joly, M.D.|+1 514 252 3426|nikola.joly@umontreal.ca
110358|NCT01001104|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110359|NCT01001169|GlaxoSmithKline|GSK Response Center|866-435-7343|
110360|NCT01001195|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
110361|NCT01001208|Amgen Inc.|Study Director|866-572-6436|
110362|NCT01001221|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com
110363|NCT01001234|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110364|NCT01001299|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
110365|NCT01001325|Mount Sinai Hospital|Dr. Brenda Coleman|416-586-4800 ext 4161|bcoleman@mtsinai.on.ca
110366|NCT01001377|Amgen Inc.|Study Director|866-572-6436|
110367|NCT01001390|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|866-966-5934|info@stjude.org
110368|NCT01001403|Seoul National University Hospital|CW Jung|82-2-2072-2467 ext 9|spss@snuh.org
110369|NCT01001429|Rutgers New Jersey Medical School|Anuradha Patel, MD|973 972-1886|patelan@njms.rutgers.edu
110370|NCT01001494|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com
110371|NCT01001520|University of Pennsylvania|Caryn Lerman, PhD|215-746-7141|clerman@mail.med.upenn.edu
110372|NCT01001546|Durham VA Medical Center - HSRD|Dr. Patrick S. Calhoun|919-286-0411 ext 7970|patrick.calhoun2@va.gov
110373|NCT01001559|Red Oak Psychiatry Associates|Dr. Lawrence Ginsberg|281-893-4111 ext 151|larrydg@earthlink.net
110374|NCT01001572|Novartis Pharmaceuticals|Study Director|862 778-8300|
110375|NCT01001702|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affair|800 562-3974|
110376|NCT01001767|University Hospitals Case Medical Center|Grace McComsey, MC|216-844-3607|mccomsey.grace@clevelandactu.org
110377|NCT01001806|Bucci Laser Vision|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com
110378|NCT01001832|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
119410|NCT02365519|Alcon, A Novartis Division|Ophthalmology & Medical Lead, Translational Medicine, NIBR|1-888-451-3937|alcon.medinfo@alcon.com
110380|NCT01002105|Shaar Menashe Mental Health Center|Prof. Alexander Grinshpoon|+972-4-6278719|alexander.grinshpoon@sm.health.gov.il
110381|NCT01002118|University of Iowa|Jennifer Robinson|319-384-1563|jennifer-g-robinson@uiowa.edu
110382|NCT01002287|Integra LifeSciences|Stefani Battaglia|44 7880 732691|stefani.battaglia@integralife.com
110383|NCT01002339|Hospital Universitario de Canarias. Universidad de La Laguna. Spain|Dr. Armando Torres Ramírez|+34630989515|atorres@ull.es
110384|NCT01002456|Dept. of Veterans Affairs|Dr. Madeline McCarren|708 786 7987|madeline.mccarren@va.gov
110385|NCT01002482|CH Chartres|Dr. Pierre Kalfon|003323730303073|pkalfon@ch-chartres.fr
110386|NCT01002573|Cumberland Pharmaceuticals Inc.|Senior Manager, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com
119411|NCT02356562|AbbVie|Global Medical Services|800-633-9110|
110388|NCT01002989|Hypertension Center, Third University Department of Medicine, Sotiria Hospital|George S. Stergiou, MD, FRCP, Associate Professor of Medicine|+30 2107763117|gstergi@med.uoa.gr
110389|NCT01003067|Hirslanden Bern|Prof. Christoph A. Maurer|+41 31 335 33 33|christoph.maurer@hin.ch
110390|NCT00994604|Johns Hokpins Medical Institutions|Dr. Robert Brown|410-614-5451|rbrown2@jhmi.edu
110392|NCT00994682|University of Florida|Dr. Kenneth Cusi|352-273-8662|kcusi@ufl.edu
110393|NCT00994760|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 ext 0|clinicaltrials@nycomed.com
110394|NCT00994929|The University of Pittsburgh|Margaret V. Ragni, MD, MPH|412-209-7288|ragni@pitt.edu
110395|NCT00995007|National Cancer Institute|Dr. Katherine E. Warren|301-435-4683|warrenk@box-w.nih.gov
110396|NCT00995020|Affiliation: Oswaldo Cruz Foundation|Investigator: MJCamargo [Camargo Maria José] Official Title: PHD|00552199777009|mariaj.camargo@hotmail.com
110397|NCT00995085|Alcobra Inc|Jonathan Rubin, MD, MBA|610-504-7814|jrubin@alcobra-pharma.com
110398|NCT00995345|ActivX Biosciences|Dr. Diane Plotkin, Sr. Director Clinical Development|858-558-5558|dianep@activx.com
110399|NCT00995371|Coastal Orthopedics & Sports Medicine|Lois A. Davis|941-782-1353|ldavis@coastalorthopedics.com
110400|NCT00995410|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com
110401|NCT00995436|ChestyerfieldNDRH|Jonathan Sandler|01246512106|JonSandler57@gmail.com
110402|NCT00995449|KaloBios Pharmaceuticals, Inc.|Nestor A. Molfino, MD., MSc|650-243-3103|nmolfino@kalobios.com
110403|NCT00995488|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain|734-647-8903|mahahuss@umich.edu
110404|NCT00995501|Cleveland clinic|Daniel Sessler, MD|216-445-4900|sesseld@ccf.org
110405|NCT00995553|Minneapolis VA Health Care System|Dr. Tasha Nienow|612-467-1004|Tasha.Nienow@va.gov
110406|NCT00995566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110407|NCT00995670|Zablocki VA Medical Center|Thomas J. Ebert, MD, PhD|414-384-2000 ext 42429|thomas.ebert@va.gov
110408|NCT00995709|Novartis Pharmaceuticals|Study Director|862-778-8300|
119412|NCT02301169|Tools4Patient|Study Director|+32 71 91 ext 94 00|alvaro.pereira@tools4patient.com
110410|NCT00995761|Gyeongsang National University Hospital|Gyeong-Won Lee M.D.Ph.D.|82-55-750-8066|brightree@lycos.co.kr
110411|NCT00995774|Washington DC Veterans Affairs Medical Center|Peter Lum, PhD|202-319-5181|lum@cua.edu
110412|NCT00995865|GE Healthcare- Life Sciences|Amanda Culliton|1-508-683-2232|Amanda.Culliton@ge.com
110413|NCT00995904|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com
110414|NCT00995930|Novartis Pharmaceuticals|Study Director|862-778-8300|
110415|NCT00996034|Yale University|Irina Esterlis, Ph.D.|203-932-5711 ext 3109|irina.esterlis@yale.edu
110416|NCT00996125|GlaxoSmithKline|GSK Response Center|866-435-7343|
110417|NCT00996164|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com
110418|NCT00996203|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
110419|NCT00996216|GlaxoSmithKline|GSK Response Center|866-435-7343|
119413|NCT02131064|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
119414|NCT02097992|University of Miami|Adam Wanner|(305)243-3045|awanner@med.miami.edu
110422|NCT00996333|Columbia University|Paul Oberstein|212-305-0592|po2178@cumc.columbia.edu
110423|NCT00996346|University of New Mexico Cancer Center|Monte Shaheen, MD / Study Principal Investigator|505-925-0404|MoShaheen@salud.unm.edu
110424|NCT00996372|Sprout Pharmaceuticals|VP, Clinical Development|9198820850|clinicaltrials@sproutpharma.com
110425|NCT00996437|Diabetic Retinopathy Clinical Research Network|Adam R. Glassman|813-975-8761|drcrstat4@jaeb.org
110426|NCT00996476|Janssen Pharmaceutical K.K., Japan|DIrector|81 3 44115639|
110427|NCT00996502|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu
110428|NCT00996580|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
119416|NCT01969565|Emory University|Jonathan Kaufman, MD|404-778-1900|jlkaufm@emory.edu
110430|NCT00996606|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
110431|NCT00996632|University of Trieste|Prof. Nicolò de Manzini|+390403994152|nicolo.demanzini@aots.sanita.fvg.it
110432|NCT00996658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110433|NCT00996736|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu
110434|NCT00996775|Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System|Michael A. Cucciare, Ph.D.|501-257-1068|michael.cucciare@va.gov
110435|NCT00996801|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clincaltrialsdisclosure@merck.com
110436|NCT01003080|Montefiore Medical Center|Dr. Sun Jin Kim|718-920-2060|sukim@montefiore.org
110437|NCT01003106|Wilmer Eye Institute, Johns Hopkins University School of Medicine|Peter A. Campochiaro, MD|(410) 955-5106|pcampo@jhmi.edu
110438|NCT01003184|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
110439|NCT01003210|University of Washington|Dr. James Taylor|206-6165-1206|uncjat@uw.edu
110440|NCT01003275|University of Washington|Ian H. de Boer, MD, MS, Associate Professor of Medicine|2066165403|deboer@u.washington.edu
110441|NCT01003288|University of Bergen|Professor Rebecca Cox|+4755974668|rebecca.cox@uib.no
110442|NCT01003301|Johns Hopkins University|Sarbjit S. Saini|410-550-2129|ssaini@jhmi.edu
110443|NCT01003886|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110444|NCT01003899|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110445|NCT01003938|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org
110446|NCT01003990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
119417|NCT01961323|Icahn School of Medicine at Mount Sinai|Dr. Partho Sengupta|212-659-8847|partho.sengupta@mountsinai.org
110448|NCT01004146|University of Texas at Houston Medical School / Dept. of Anesthesiology|Dr. Davide Cattano|713-500-6235|davide.cattano@uth.tmc.edu
110449|NCT01004159|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
110450|NCT01004172|Dana-Farber Cancer Institure|Nancy Lin, MD|617.632.2335|nlin@partners.org
110451|NCT01004185|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
110452|NCT01004250|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110453|NCT01004263|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
119418|NCT01942590|Duke University Health System|Dwight Koeberl, M.D., Ph.D.|919-684-2036|dwight.koeberl@duke.edu
110455|NCT01004393|Seirei Hamamatsu General Hospital|Masanori Mori, MD|81-53-474-2222|Masanori.Mori@sis.seirei.or.jp
110456|NCT01004432|Janssen Scientific Affairs, LLC|Study Director|215-325-4209|rdehorat@its.jnj.com
110457|NCT01004510|Rochester General Hospital|Todd Sheppard, MD|585-922-4409|todd.sheppard@rochestergeneral.org
110458|NCT01004614|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110459|NCT01004705|Ferrer Internacional S.A.|Natalia Oudovenko|+34 93 509 32 82|noudovenko-research@ferrergrupo.com
110460|NCT01004770|GE Healthcare|Rubin Sheng, MD|1-609-514-6899|rubin.sheng@ge.com
110461|NCT01004822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110462|NCT01004848|Icahn School of Medicine at Mount Sinai|Carol R. Horowitz, MD, MPH|212-659-9567|carol.horowitz@mountsinai.org
110463|NCT01004874|Duke University Medical Center|Dr. Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu
110464|NCT01004939|GlaxoSmithKline|GSK Response Center|866-435-7343|
110465|NCT01004991|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu
110466|NCT01005251|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
110467|NCT01005290|Ferrer Internacional S.A.|Natalia Oudovenko|+34 93 509 32 82|noudovenko-research@ferrergrupo.com
110468|NCT01005316|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
110469|NCT01005329|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@gmail.com
110470|NCT01005355|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
119419|NCT01828983|Memphis VA Medical Center|Dr. Linda Nichols|901 523-8990 ext 5082|linda.nichols@va.gov
110472|NCT01005602|University of Illinois at Chicago|Dr. Robert J. DiDomenico|(312) 413-4654|rdidom1@uic.edu
110473|NCT01005680|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110474|NCT01005706|Medical University of South Carolina|Charles F. Bratton, MD|843-792-4003|brattocf@musc.edu
110475|NCT01005719|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
110476|NCT01005732|University of Washington|Loren Engrav|206-744-3209|engrav@u.washington.edu
110477|NCT01005745|H. Lee Moffitt Cancer Center and Research Institute|Amod Sarnaik, M.D.|813-745-8581|amod.sarnaik@moffitt.org
110478|NCT01005875|University of Alabama at Birmingham|Dr. Kimberly Keene|2-5-934-5670|kkeene@uab.edu
110479|NCT01005888|ViroPharma|Chief Scientific Officer|610-458-7300|
110480|NCT01005901|Novartis Pharmaceuticals|Study Director|862-778-8300|
110481|NCT01005914|Oregon Health & Science University|Dr. Brandon Hayes-Lattin|503-494-1551|hayeslat@ohsu.edu
119420|NCT01751412|Massachusetts General Hospital|Thomas F. DeLaney, MD|617-726-6876|TDELANEY@mgh.harvard.edu
110483|NCT01006018|Emory University|Mary Rhee, M.D.|404-778-1666|mrhee@emory.edu
110484|NCT01006122|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110485|NCT01006135|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110486|NCT00999661|Ethicon Endo-Surgery, Inc.|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com
110487|NCT00999687|Chang Gung Memorial Hospital|Lin Yin-Ku MD.Ph.D.|886-2-24313131 ext 2127|lin1266@adm.cgmh.org.tw
110488|NCT00999804|Baylor College of Medicine|Dr. Mothaffar Rimawi|7137981311|rimawi@bcm.edu
110489|NCT00999830|HOPITAL DE PURPAN Service Hematologie|Dr Michel ATTAL|+33 (0)5.61.77.77.84|attal.m@chu-toulouse.fr
110490|NCT00999908|Novartis Pharmaceuticals|Study Director|862 778-8300|
110491|NCT00999921|Medical College and Hospital Kolkata|Md Tanveer Adil|0091-9830154566|tanveer.cmc@gmail.com
110492|NCT01000025|NCIC Clinical Trails Group|Dr. Keyue Ding|1-613-533-6000 ext 77705|kding@ctg.queensu.ca
110493|NCT01000064|Vanderbilt University Medical Center|Dr. Michael G. Tramontana|615-327-7144|Michael.Tramontana@Vanderbilt.Edu
110494|NCT01000155|Brigham&Women's Hospital|Maureen Okam, MD, MPH|617-732-5048|mokam@partners.org
110495|NCT01000285|Washington University School of Medicine|Lee Ratner, M.D., Ph.D.|314-362-8836|lratner@dom.wustl.edu
110496|NCT01000311|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
110497|NCT01000324|GlaxoSmithKline|GSK Response Center|866-435-7343|
110498|NCT01000337|Aretaieio Hospital, University of Athens|Argyro Fassoulaki|+30210 7286334|fassoula@aretaieio.uoa.gr
110499|NCT01000376|Eisai|Dr. Peter Tarassoff|888-422-4743|
110500|NCT01000480|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110501|NCT01000493|GlaxoSmithKline|GSK Response Center|866-435-7343|
119421|NCT01739361|LSU Health Sciences Center New Orleans|Dr. David R Janz, MD, MSc, Assistant Professor of Medicine|504-568-3167|djanz@lsuhsc.edu
110503|NCT01006291|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
110504|NCT01006356|Medical department / Korea|Medical Director|+82-2-2094-4518|
110505|NCT01006889|University of Florida|Dr. Kenneth Cusi|352-273-8661|kcusi@ufl.edu
110506|NCT01006980|Hoffman-LaRoche|Medical Communications|800-821-8590|
110507|NCT01007110|University of Kansas Medical Center|Kathleen Gustafson, Ph.D.|(913) 588-0065|kgustafson@kumc.edu
110508|NCT01007123|Albireo|Dr Mats Ekelund|+46 31 741 14 80|info@albireopharma.com
110509|NCT01007149|Novartis Pharmaceuticals|Study Director|862-778-8300|
110510|NCT01007253|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu
110511|NCT01007396|Samsung Medical Center|Won-Jung Koh|82-2-3410-3429|wjkoh@skku.edu
110512|NCT01007435|Hoffmann-La Roche|Medical Communications|800 821-8590|
110513|NCT01007552|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300 ext 847|groman@appliedstats.com
110514|NCT01007643|University of Manitoba|Dr Erika Persson|780-492-4752|epersson@ualberta.ca
110515|NCT01007656|PingTung Christian Hospital Ruiguang Branch|Dr. Choo-Aun Neoh|886-8-736-8686 ext 5310|neohca@gmail.com
110516|NCT01007812|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
110517|NCT01007838|UWalesBangor|Danielle Kirkman|00 44 1248 388254|pepa03@bangor.ac.uk
110518|NCT01007916|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
110519|NCT01007942|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
110520|NCT01008280|VISN 22 Network Office|Peter Hauser, MD, VISN 22 Mental Health Services Lead|562 826 8000 ext 2629|peter.hauser2@va.gov
110521|NCT01008449|UAB|Principal Investigator|205-934-3411|dana_figueroa_marzilli@hotmail.com
110522|NCT01008475|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
110523|NCT01008553|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387|
110524|NCT01008605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110525|NCT01008618|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387|
110526|NCT01008696|Medical Affairs, Seoul, Korea|Clinical Research Associate|82-2-2094-4835|
110527|NCT01008722|University of California, San Diego|Dr. Sanjiv Narayan (Professor of Medicine, Principal Investigator)|(650) 498-8161|sanjiv1@stanford.edu
110528|NCT01008904|Virginia Commonwealth University|Thomas J. Smith, MD|410-955-2091|tsmit136@jhmi.edu
110529|NCT01008943|Cook Medical|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com
110530|NCT01008969|University of California, San Francisco|Youngho Seo, PhD|415-353-9464|youngho.seo@ucsf.edu
110531|NCT01008995|Janssen R&D US|Director, Clinical Research|1 215-793-7646|
110532|NCT01009034|Maple Leaf Research|Tony Antoniou|4164657936|tantoniou@smh.toronto.on.ca
110533|NCT01009047|Janssen Research & Development, LLC|Senior Director, Clinical Leader|+1-609-730-2436|
119422|NCT01736475|Baxalta Innovations GmbH|Brigitt Abbuehl, MD||brigitt.abbuehl@baxalta.com
110535|NCT01009086|Janssen Research & Development, LLC|Director, Clinical Research|1-800-526-7736|
110536|NCT01009099|Edward Hines Jr., VA Hospital|Eileen Collins|708-202-3525|eileen.collins@va.gov
110537|NCT01009138|Research Institute of the Diabetes Academy Mergentheim|Dr. Bernhard Kulzer|+49 7931 ext 594151|kulzer@diabetes-zentrum.de
110538|NCT01009203|University of Pittsburgh Medical Center|Julie E. Bauman, MD|4126486507|baumanje@upmc.edu
110539|NCT01009333|Medtronic Neuromodulation|Maureen McGuire, Sr. Program Manager|763-526-8425|maureen.mcguire@medtronic.com
110540|NCT01009346|FDA|Shanthi Marur, MD|2404026373|shanthi.marur@fda.hhs.gov
110543|NCT01009554|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com
110544|NCT01009580|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
110545|NCT01012167|Maryland Psychiatric Research Center|William Carpenter, Jr.|410-402-7101|wcarpent@mprc.umaryland.edu
110546|NCT01012219|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110547|NCT01012245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
110548|NCT01012258|Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd.|Medical Responsible|+49-6151-72-5200|service@merckgroup.com
110549|NCT01012297|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Administration and Operations|(716) 845-5702|kurasa@nrgoncology.org
110550|NCT01012323|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com
110551|NCT01012336|Samsung Medical Center|Pf Duk-Soo Bae|82-2-3410-3519|huna0@naver.com
110552|NCT01012362|Masonic Cancer Center, University of Minnesota|Dr. Arkadiusz Dudek|651-254-3321|Arkadiusz.Z.Dudek@HealthPartners.com
110553|NCT01012388|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com
110554|NCT01012414|Thomas Jefferson University|David Whellan MD|215 955 5050|david.whellan@jefferson.edu
110555|NCT01012440|University of Chicago|Dr. Kirti Kulkarni|(773) 702-2781|kkulkarni@radiology.bsd.uchicago.edu
119424|NCT01651351|Baxter Healthcare Corporation|Leman Yel, MD, Medical Director, Biotherapeutics||leman_yel@baxter.com
110557|NCT01012622|Janssen Korea MAF, Korea|Clinical Research Associate|82-2-2094-4837|
110558|NCT01012661|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com
110559|NCT01012674|Guerbet|Dr Pierre Desché, MD - VP Head of Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com
110560|NCT01012713|University of California San Francisco|Dr. John Koo|4154764701|john.koo@ucsfmedctr.org
110561|NCT01012739|Novartis Pharmaceuticals|Study Director|862 778-8300|
110562|NCT01012765|Novartis Pharmaceuticals|Study Director|862-778-8300|
110563|NCT01012947|Ajou University|Dr. Kang Soo Lee|821087812077|kpsimon@hanmail.net, antiaging@ajou.ac.kr
110564|NCT01012973|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
110565|NCT01012999|University of Utah|Robert Stephen, MD|801-587-7653|rlstephen@comcast.net
110566|NCT01013194|ISMETT-UPMC|Dr Giada Pietrosi|+390912192111|gpietrosi@ismett.edu
110567|NCT01013207|ResMed Ltd|Alison Wimms|+61 8884 2583|alison.wimms@resmed.com.au
110568|NCT01013597|University of Wisconsin Carbone Cancer Center|Abigail Mapes, Thoracic Oncology Research Program Manager|608-262-8158|acmapes@medicine.wisc.edu
110569|NCT01013701|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu
110570|NCT01013740|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
110571|NCT01013753|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110572|NCT01013792|HCA Retreat Hospital, Institute of Plastic and Reconstructive Surgery|Joseph V. Boykin, Jr., MD|804-353-8100|joseph.boykin@HCAhealthcare.com
110573|NCT01013844|Northwestern University Department of Dermatology|June Robinson, MD|312-695-6624|june-robinson@northwestern.edu
110574|NCT01013870|Baylor College of Medicine|Claudia Robertson, MD|713-873-2792|claudiar@bcm.edu
110575|NCT01013883|Darlington Memorial Hospital|Dr Rajender singh|01325380100 ext 3444|drrsdogra@yahoo.com
110576|NCT01013961|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|
110577|NCT01014013|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
110578|NCT01014091|GlaxoSmithKline|GSK Response Center|866-435-7343|
110579|NCT01014143|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com
110580|NCT01014169|Boston University School of Medicine/Boston Medical Center|Dr Caroline Kistin|617-414-3642|caroline.kistin@bmc.org
110581|NCT01014208|GlaxoSmithKline|GSK Response Center|866-435-7343|
110582|NCT01014351|SCRI Development Innovations LLC|John D. Hainsworth, M.D.|615-329-7274|asksarah@scresearch.net
110583|NCT01014442|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
110584|NCT01014455|Mayo Clinic|David O. Warner MD|5072846277|warner.david@mayo.edu
110585|NCT01014585|Forest Research Institute, Inc., a subsidiary of Forest Laboratories, Inc.|Joel Trugman, MD|201-427-8681|joel.trugman@frx.com
110586|NCT01014624|Daiichi Sankyo, Inc.|Brian Baker|973-944-2712|bbaker@dsi.com
110587|NCT01006590|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
110588|NCT01006603|AstraZeneca|Boaz Hirshberg , MSD||ClinicalTrialTransparency@astrazeneca.com
110589|NCT01006616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110590|NCT01006629|Abbott|Global Medical Services|800-633-9110|
110591|NCT01006655|Rambam medical Center|Prof Lea Bentur|xx 972 4 854 3263 ext 0502062400|l_bentur@rambam.health.gov.il
110592|NCT01014689|Galderma|Florence Paliargues / CPM|+33492952957|florence.paliargues@galderma.com
110593|NCT01014728|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu
110594|NCT01014741|Icahn School of Medicine at Mount Sinai|Dr. Vivek Reddy|212-241-7114|vivek.reddy@mountsinai.org
110595|NCT01014871|Galderma|Florence Paliargues / CPM|+33492952957|florence.paliargues@galderma.com
110596|NCT01014910|Children's Mercy Hospital Kansas City|Dr. Russell McCulloh|816-234-3061|rmcculloh@cmh.edu
110597|NCT01014936|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
110598|NCT01016483|Merck Serono, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+496151725200|service@merckgroup.com
110599|NCT01016600|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu
110600|NCT01016652|Johnson & Johnson Vision Care|Thomas R. Karkkainen OD, MS, FAAO Senior Principal Research Optometrist|(904)443-3402|TKarkkai@its.jnj.com
110601|NCT01016678|Premiere Research Institute|Paul Winner, DO|561-845-0500 ext 102|pwinner777@aol.com
110602|NCT01016691|Vistakon|Brian Schwam MD|1-904-443-1482|bschwam@its.jnj.com
110603|NCT01016834|Zogenix|Judith Myers, Senior Director Clinical Operations|510-550-8300|jmyers@zogenix.com
110604|NCT01016847|Duke Asthma Allergy and Airway Center|Monica Kraft, M.D.|9194790719|denise.beaver@dm.duke.edu
110605|NCT01016873|Oraya Therapeutics Inc.|Denis O'Shaugnessy, Ph.D.|917-417-3974|doshaughnessy@orayainc.com
110606|NCT01016912|Bristol­Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com
110607|NCT01016938|Universtity of Maryland School of Medicine|Warren D'Souza, PhD, MBA|410-328-7159|wdsouza@umm.edu
110608|NCT01016964|Lexington International, LLC|David Michaels|5614170200|las@hairmax.com
110609|NCT01016977|GlaxoSmithKline|GSK Response Center|866-435-7343|
110610|NCT01017003|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
110611|NCT01017029|Pharmaceuticals|Novartis|+1(862)778-8300|
110612|NCT01017042|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
110613|NCT01017120|GlaxoSmithKline|GSK Response Center|866-435-7343|
110614|NCT01017146|GlaxoSmithKline|GSK Response Center|866-435-7343|
110615|NCT01017237|University of North Carolina School of Dentistry|Jay Anderson, DDS, MD|919-966-1126|janderson@aims.unc.edu
110616|NCT01017250|Duke University Radiation Oncology|John Kirkpatrick, MD, PhD|919 668-7342|robert.clough@dm.duke.edu
110617|NCT01017263|Duke UMC|Scott Kollins, PhD|9196810014|scott.kollins@dm.duke.edu
110618|NCT01017497|Duke University Medical Center|John Kirkpatrick MD|919 6687342|john.kirkpatrick@dm.duke.edu
110619|NCT01017536|Aeras|Bernard Landry|301-547-2900|blandry@aeras.org
110620|NCT01017549|iCAD, Inc. Xoft, Inc|Michael A. Patz MBA, RAC, Senior Director Clinical Affairs|603-882-5200 ext 7308|mpatz@icadmed.com
110621|NCT01017575|Bristol­Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com
110622|NCT01017601|Mayo Clinic|Julian Molina, M.D, Ph.D.|507-284-1328|Molina.julian@mayo.edu
110623|NCT01017653|Preston Robert Tisch Brain Tumor Center|Annick Desjardins||annick.desjardins@dm.duke.edu
110624|NCT01017731|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110625|NCT01017874|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110626|NCT01017952|GlaxoSmithKline|GSK Response Center|866-435-7343|
110627|NCT01018030|GlaxoSmithKline|GSK Response Center|866-435-7343|
110628|NCT01018056|Johns Hopkins University|Dr. Harvey S. Singer|410-955-7212|hsinger@jhmi.edu
110629|NCT01018095|Tulane University|Patricia Kissinger, PhD|5049887320|kissing@tulane.edu
110630|NCT01018134|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com
110631|NCT01018186|GlaxoSmithKline|GSK Response Center|866-435-7343|
110632|NCT01018264|University of South Florida|Theresa Zesiewicz, MD, Professor of Neurology|813-974-5909|tzesiewi@health.usf.edu
110633|NCT01018394|Mayo Clinic|Dr. Jon Ebbert|507-266-1944|nicotineresearch@mayo.edu
110634|NCT01018420|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
110635|NCT01018511|Astellas Pharma Europe B.V.|Medical Director, Global Medical Science||Astellas.resultsdisclosure@astellas.com
110636|NCT01018680|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110637|NCT01018732|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
110638|NCT01009762|Statens Serum Institut|Professor Anders Fomsgaard|+45-32683460|afo@ssi.dk
110639|NCT01009840|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974|
110640|NCT01009931|Rutgers Cancer Institute of New Jersey|Tatiana Zelinskaya|(732) 235-9837|zelinsta@cinj.rutgers.edu
110641|NCT01009983|Wake Forest University Health Sciences|Dr. Susan Melin|336-716-2839|smelin@wakehealth.edu
110642|NCT01010009|Northumbria university|Emma Wightman|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk
110645|NCT01010230|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|866-278-5833|kiri.ness@stjude.org
110646|NCT01010282|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
110647|NCT01010399|Franco Felizarta, MD|Franco Felizarta, MD|661-324-3128|felizarta@pol.net
110648|NCT01010477|Rutgers-Robert Wood Johnson Medical School|Jill Williams, MD, Principal Investigator|7322354341|Jill.williams@rutgers.edu
110649|NCT01010503|Hoffmann- LaRoche.|Medical Communications|800-821-8590|genentech@druginfo.com
110650|NCT01010555|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
110651|NCT01010568|Georgetown University Hospital|Bruce D. Cheson|202-444-1212|bdc4@georgetown.edu
110652|NCT01010633|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com
110653|NCT01010750|Shire Pharmaceutical|Gerald Tremblay, M.D.||gtremblay@shire.com
110654|NCT01010776|Jan-Cil Brazil|Medical Group Manager|55 11 3030-2770|
110655|NCT01010867|Columbia University Medical Center|Monica Bhatia, MD|2123055808|mb2476@cumc.columbia.edu
110656|NCT01010906|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110657|NCT01010932|Guerbet|Dr Pierre Desché, MD - VP Head of Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com
110658|NCT01010971|Sunovion|Respiratory Medical Director|1-866-503-6351|
110659|NCT01011049|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
110660|NCT01011075|University of Pittsburgh Cancer Institute|Julie E. Bauman, MD|412-648-6507|baumanje@upmc.edu
110661|NCT01011153|MELA Sciences, Inc.|Joanna Adrian, Director of Clinical Operatons and Medical Affairs|914-591-3783 ext 732|adrian@melasciences.com
110662|NCT01011179|The Hospital for Sick Children|Dr. Jennifer Stinson|416-813-7654 ext 304514|jennifer.stinson@sickkids.ca
110663|NCT01011283|Eisai Inc.|Erhan Berrack, M.D.|888-422-4743|
110664|NCT01011309|IDRI|Jill Ashman, MSc, Associate Director of Clinical Operations|206-858-6041|jill.ashman@idri.org
110665|NCT01011387|Mölnlycke Health Care AB|Jenny Thorell|0046 31 7223000|jenny.thorell@molnlycke.com
110666|NCT01011465|Harvard School of Public Health|Dr. Laura Kubzansky|617-432-3589|lkubzans@hsph.harvard.edu
110667|NCT01011556|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110668|NCT01011634|UCSF|Karen Meckstroth, MD|415 206-8713|meckstrothk@obgyn.ucsf.edu
110669|NCT01011673|Montefiore Medical Center, Albert Einstein College of Medicine|Benjamin Friedman, MD|718-920-6626|BEFRIEDM@montefiore.org
110670|NCT01011738|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
110671|NCT01011816|formerly Spinal Restoration, Inc|Jeff Doerzbacher||jdoerzbacher@renascentmed.com
110672|NCT01011829|University of California, Los Angeles|Steve Shoptaw PhD|310 794 0619 ext 225|sshoptaw@mednet.ucla.edu
110673|NCT01011868|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110674|NCT01011894|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens|212-639-7053|brentjer@mskcc.org
110675|NCT01011907|UCSF: EGCRC|Jennifer Mitchell, Clinical Project Director|510-985-3100|jmitchell@gallo.ucsf.edu
119425|NCT01612767|BIOTRONIK|Amy Culley, Director of Vascular Intervention|503-451-8034|amy.culley@biotronik.com
110677|NCT01011946|University of Chicago|Dr. Daniel Appelbaum|(773) 834-2012|dappelbaum@radiology.bsd.uchicago.edu
110678|NCT01012037|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110679|NCT01018810|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110680|NCT01018862|Meda Pharmaceuticals Inc|Sr.Director Medical Scientific Affairs|732 564 2200|David.ginsberg@meda.us
110681|NCT01018953|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
110682|NCT01018979|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072 ext 1211|cetsai@taigenbiotech.com
110683|NCT01018992|Emory University|Dr. Boadie Dunlop|404-727-8474|bdunlop@emory.edu
110684|NCT01022567|Turku University Hospital|Paulina Salminen|+358 2 313 0542|paulina.salminen@tyks.fi
110685|NCT01022762|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
110686|NCT01022996|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com
110687|NCT01023022|Institute of Cardiology|Prof. Hanna Szwed|48 22 343 46 00|hszwed@ikard.pl
110688|NCT01023035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110689|NCT01023061|University of Washington|Bruce Montgomery|206-598-0860|rbmontgo@uw.edu
110690|NCT01023074|Portland VA Medical Center|Robert Folmer, Ph.D.|503-220-8262 ext 51868|Robert.Folmer@va.gov
110691|NCT01023178|Stanford University|Sejal Shah MD|6507235791|sshah2@stanford.edu
110692|NCT01023217|Asan Medical Center|Professor Young-Suk Lim|+82-2-3010-5933|limys@amc.seoul.kr
110693|NCT01023256|MorphoSys|Roman Korolkiewicz|+498989927 ext 208|Roman.Korolkiewicz@morphosys.com
110694|NCT01023308|Novartis Pharmaceuticals|Study Director|862-778-8300|
110695|NCT01023516|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
110696|NCT01023568|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org
110697|NCT01023581|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
110698|NCT01023659|Centre for Addiction and Mental Heatlh|Dr. Peter Selby|416-535-8501 ext 74946|peter.selby@camh.ca
110699|NCT01023672|Mayo Clinic|Dr. Bradley F. Boeve|507-266-4106|bboeve@mayo.edu
110700|NCT01023711|University of Rochester|John Treanor, M.D.|585-275-5871|john_treanor@urmc.rochester.edu
110701|NCT01023724|Bucci Laser Visiosn|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com
110702|NCT01023776|University of Rochester|John Treanor< M.D.|585-275-5871|john_treanor@urmc.rochester.edu
110703|NCT01023815|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
110704|NCT01023841|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
110705|NCT01024036|Janssen R&D US|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com
110706|NCT01024244|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110707|NCT01024309|OrthoCarolina Research Institute|Dr. Susan Odum|704.323.2265|Susan.Odum@OrthoCarolina.com
110708|NCT01024335|NYS Psychiatric Institute|Adam Bisaga|646-774-6155|amb107@columbia.edu
110709|NCT01024465|ReShape Medical|Director of Clinical Operations|949-429-6680|lfong@reshapemedical.com
110710|NCT01024608|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
110711|NCT01024738|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com
110712|NCT01024751|Bausch & Lomb Incorporated|William Reindel, OD, MS|(585) 338-8129|william.reindel@bausch.com
110713|NCT01024855|Abbott Medical Optics, Inc.|Nick Tarantino, Head, Clinical Research and Development|714-247-8613|nicholas.tarantino@amo.abbott.com
110714|NCT01024946|Memorial Sloan Kettering Cancer Center|Dr. Lee Krug|646-888-4201|krugl@mskcc.org
110715|NCT01024959|Gen-Probe, Incorporated|Jennifer Reid, Director of Clinical Affairs|858-731-5985|jennifer.reid@hologic.com
110716|NCT01024972|University of Massachusetts Medical School|Dr. Susanne Muehlschlegel|508-421-5500|susanne.muehlschlegel@umassmemorial.org
110717|NCT01009619|Katholieke Universiteit Leuven and University Hospital Leuven|Prof. Dr. GM Verleden|+32 16 34 68 08|geert.verleden@uzleuven.be
110718|NCT01009645|Northwestern University|Kenzie Cameron, PhD, MPH|312-503-3910|kcameron@northwestern.edu
110719|NCT01014975|Grifols Therapeutics, Inc.|Henry Li, PhD|800-520-2807|henry.li@grifols.com
110720|NCT01014988|GlaxoSmithKline|GSK Response Center|866-435-7343|
119426|NCT01588418|University of Texas Health Science Center at San Antonio|Dr. Ralph DeFronzo|210-567-6691|defronzo@uthscsa.edu
110722|NCT01015131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110723|NCT01015170|Centre for Addiction and Mental Health|Dr. Peter Selby; Dr. Laurie Zawertailo Principal Investigator|416-535-8501 ext 77422|laurie.zawertailo@camh.ca
110724|NCT01015287|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110725|NCT01015326|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu
110726|NCT01015443|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
110845|NCT01033747|Novartis Pharmaceuticals|Study Director|862 778-8300|
110727|NCT01015534|Instituto Nacional de Cancerologia de Mexico|Carlos Gamboa Vignolle/ Radiation Oncologist|0155556280400 ext 441|cswgamboa@yahoo.com
110728|NCT01015560|SWOG Statistical Center|Study Statistician|206-667-4623|
110729|NCT01015638|GlaxoSmithKline|GSK Response Center|88-435-7343|
110730|NCT01015677|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110731|NCT01015703|BTG International Inc.|SVP Clinical Development|610-278-1660|angela.ogden@btgplc.com
110732|NCT01015781|VA RR&D, NCRAR|James A. Henry, Ph.D., Principal Investigator|5032208262 ext 57466|james.henry@va.gov
119427|NCT01572298|UTHSCSA Periodontics|Dr. Brian Mealey|210-567-3589|mealey@uthscsa.edu
110734|NCT01015820|Mayo Clinic|Dr. Michael B. Wallace|904-953-6970|wallace.michael@mayo.edu
110735|NCT01015976|University of North Dakota - Neuropsychiatric Research Institute|James L. Roerig PharmD, BCPP|701 365 4919|jroerig@nrifargo.com
110736|NCT01016015|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org
110737|NCT01016067|Medtronic Spinal|Clinical Department|1800-876-3133 ext 6068|msbkclinicalresearch@medtronic.com
110738|NCT01016106|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu
110739|NCT01016132|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
110740|NCT01025037|Tornier, Inc.|Manager of Clinical Operations|952-426-7674|serickson@tornier.com
110741|NCT01025076|Royal Alexandra Hospital/CAMIS|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca
110742|NCT01025154|The University of Texas MD Anderson Cancer Center|Stefan Faderl, MD / Associate Professor|713-745-4613|eharriso@mdanderson.org
110743|NCT01025193|Hospital of the University of Pennsylvania|Jennifer Trofe-Clark|215-614-4274|jennifer.trofe-clark@uphs.upenn.edu
110744|NCT01025232|Retinal Consultants of Houston|David M. Brown, MD Director of Clinical Research|713-394-7534|dmbmd@houstonretina.com
110745|NCT01025271|University of Pittsburgh|Karin Byers, MD|412-648-6553|dlp5@pitt.edu
119428|NCT01524887|Baxter Healthcare Corporation|Kathy Tobias, MD, Global Medical Dir, Biotherapeutics, Neurology||kathy_tobias@baxter.com
110747|NCT01026012|University of Maryland Cardiology|Dr. Scott Jerome|410-876-0086|sjerome@medicine.umaryland.edu
110748|NCT01026038|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110749|NCT01026103|Covidien|Noreen Fahey|203-821-4716|noreen.fahey@covidien.com
110750|NCT01026142|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
110751|NCT01026181|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca
110752|NCT01026194|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
110753|NCT01026220|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
110754|NCT01026324|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617-632-5053|stephen_hodi@dfci.harvard.edu
110755|NCT01026389|Guerbet|Post M. A. Clinical Unit Manager|+33 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com
110756|NCT01026402|AstraZeneca|Bryony Harrop|01625 582828|ClinicalTrialTransparency@astrazeneca.com
110757|NCT01026454|University of Washington|Connie Celum, MD, MPH|206-520-3800|ccelum@uw.edu
110758|NCT01026493|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
110759|NCT01026792|BC Cancer Agency, Vancouver Clinic, Vancouver, BC, Canada|Dr. Anna Tinker|604 877 6217|atinker@bccancer.bc.ca
110760|NCT01026805|Interlace Medical, Inc.|John Vozella, V.P. Clinical & Regulatory Affairs|508-875-1343 ext 112|john@interlacemedical.com
110761|NCT01026818|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110762|NCT01026831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110763|NCT01026844|Massachusetts General Hospital|Lecia Sequist, MD|617-724-4000|lvsequist@partners.org
110764|NCT01026909|Seattle Children's Hospital|Dr Klane White|206-987-5678|klane.white@seattlechildrens.org
110765|NCT01026948|University of Liverpool|Professor Zarko Alfirevic|00 44(1)51 702 ext 4100|zarko@liverpool.ac.uk
110766|NCT01026974|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
110767|NCT01027000|Dana Farber Cancer Institute|Edwin P. Alyea, MD||edwin_alyea@dfci.harvard.edu
110768|NCT01027195|The Cleveland Clinic|Wael K Barsoum, MD|216-444-7515|barsouw@ccf.org
110769|NCT01027273|Icahn School of Medicine at Mount Sinai|Carol R Horowitz, MD, MPH|212-659-9567|carol.horowitz@mountsinai.org
110770|NCT01027286|The Cleveland Clinic|Wael K Barsoum, MD|216-444-7515|barsouw@ccf.org
110771|NCT01027351|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
110772|NCT01027364|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
110773|NCT01027468|Medical University of Vienna|Assoc.Prof.PD.Dr.Stefan Sacu|+43404001 ext 7937|stefan.sacu@meduniwien.ac.at
110774|NCT01027598|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
110775|NCT01027650|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
110776|NCT01027780|University of Rochester|Dr. Jan Moynihan|585-275-4648|jan_moynihan@urmc.rochester.edu
110777|NCT01027819|Seoul National University Hospital|Dr. Dongwook Kim|821067395311|daljookim@gmail.com
110778|NCT01027884|University Hospital Leuven-Children Hospital|Dr Gunnar Buyse|+32 016343845|gunnar.buyse@uzleuven.be
110779|NCT01027897|Grady Health System|Prasad Abraham|404-616-3246|pabraham@gmh.edu
110780|NCT01027910|Massachusetts General Hospital|Dr. Edwin Choy|617-724-4000|echoy@mgh.harvard.edu
110781|NCT01028014|University of Alabama at Birmingham|Dr. William Jerod Greer|205-934-7874|wjgreer@uab.edu
110782|NCT01028027|Bausch & Lomb Incorporated|Tuyen Ong, MD|(973) 360-6389|tuyen.ong@bausch.com
110783|NCT01028053|GE Healthcare|Paul Sherwin M.D.|16095146820|Paul.Sherwin@ge.com
110784|NCT01028131|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu
110785|NCT01028222|Study Director|Novartis|862-778-8300|
110786|NCT01028300|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com
110787|NCT01028352|University of Michigan Comprehensive Cancer Center|Dr. Norah L. Henry|734-936-4991|norahh@umich.edu
110788|NCT01028378|Clinical Research Consultants, Inc.|Barbara S. Fant, Pharm.D.|513-961-8200|bsfant@crc-regulatory.com
110789|NCT01028391|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|
110790|NCT01019135|University Health Network & York University|Dr. Sherry L Grace|416.736.2100 ext 22364|sgrace@yorku.ca
110791|NCT01019317|University of Texas (UT) MD Anderson Cancer Center|Elias Joseph Jabbour MD/Assistant Professor|713-792-4764|eharriso@mdanderson.org
110792|NCT01019369|Baylor College of Medicine|Anitra Beasley, MD, MPH|832-826-7318|anitra.beasley@bcm.edu
110793|NCT01019486|University of Colorado, Denver|Robert A. Quaife M.D.|720-848-6562|robert.quaife@ucdenver.edu
110794|NCT01019694|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110795|NCT01019707|University of California Los Angeles|Edythe D London|310 825 0606|elondon@mednet.ucla.edu
110796|NCT01019928|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com
110797|NCT01019980|Novartis Pharmaceuticals|Study Director|862-778-8300|
110798|NCT01020006|Pharmacyclics|Dr. Laurence Elias|855-427-8846|pharmacyclics@medcomsol.com
110799|NCT01020123|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
110800|NCT01020305|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu
110801|NCT01020448|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
110802|NCT01020474|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110803|NCT01020487|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
110804|NCT01020526|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110805|NCT01020591|CDHA|Wendy Jardine|902 429 6218|wendymjardine@gmail.com
110806|NCT01020747|Massachusetts General Hospital|Monica Tettamanti|617-643-5696|mtettamanti@ccib.mgh.harvard.edu
110807|NCT01020773|Beijing Shijitan Hospital|Department of Respiratory Medicine|86-010-63926385|mayingmin@hotmail.com
110808|NCT01020786|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110809|NCT01020799|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
110810|NCT01020812|Stanford University|Daniel T Chang|650-723-6171|dtchang@stanford.edu
110811|NCT01020838|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com
110812|NCT01020877|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
110813|NCT01020903|Staten Island University Hospital|Michael Silverberg/Principal Investigator|718-226-6629|msilverberg@siuh.edu
110814|NCT01020981|VHA HSR&D|Marcia Valenstein, MD|7349453649|marcia.valenstein@va.gov
110815|NCT01021007|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com
110816|NCT01021020|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com
110817|NCT01021111|Stanford University|Professor Thomas P. Andriacchi|6507238024|tandriac@stanford.edu
110818|NCT01021215|University of Texas (UT) MD Anderson Cancer|Dr. Powel H. Brown, MD Anderson Phase I/II Prevention Consortium|(713) 745-3672|CR_Study_Registration@mdanderson.org
110819|NCT01021293|GlaxoSmithKline|GSK Response Center|866-435-7343|
110820|NCT01021306|Palmer Center for Chiropractic Research, Palmer College of Chiropractic|Dr. James DeVocht|563.884.5150|james.devocht@palmer.edu
110821|NCT01021332|Astellas Pharma Europe B.V.|Medical Director, Global Medical Science||astellas.resultsdisclosure@astellas.com
110822|NCT01021423|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
110823|NCT01021553|GlaxoSmithKline|GSK Response Center|866-435-7343|
110824|NCT01021618|Hartford Hospital|Gary V Heller, MD, PhD|860-545-5527|aahlber@harthosp.org
110825|NCT01021683|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879|
110826|NCT01021761|Bucci Laser Vision|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com
110827|NCT01021813|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110828|NCT01021852|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110829|NCT01021878|Pontifícia Universidade Católica do Paraná|Dr. Roberto Pecoits-Filho and Dr. Thyago P. Moraes|554132713150|r.pecoits@pucpr.br
110830|NCT01022073|San Francisco VA Medical Center|William J. Marks, Jr., M.D.|415-750-2100|William.Marks@va.gov
110831|NCT01022112|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
110832|NCT01022190|Radboud University Nijmegen Medical Centre|Study director|+31 24 36 13918|
110833|NCT01022203|Southeast Louisiana Veterans Health Care System (SLVHCS)|Frederic Sautter, Ph.D.|504-988-3026|Fsautter@tulane.edu
110834|NCT01022242|Uppsala University Hospital|Monica Wiig||monica.wiig@akademiska.se
110835|NCT01022307|VANCHCS|David L. Woods, Chief Clinical Neurophysiology|925-372-2571|David.Woods@va.gob
110836|NCT01022398|Creighton University|Cardiology Research Manager|402-280-4566|tammyburns@creighton.edu
110837|NCT01022502|Chang Gung Memorial Hospital|Yin-Ku Lin, MD. PhD.|886-2-24313131 ext 2127|lin1266@adm.cgmh.org.tw
110838|NCT01028651|United Therapeutics Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com
110839|NCT01028677|UNC_ChapelHill|Dr. Cort Pedersen|919 966-4447|cort_pedersen@med.unc.edu
110840|NCT01033383|Yale University|Dr. Manisha Juthani-Mehta|(203)785-7571|manisha.juthani@yale.edu
110841|NCT01033448|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
110842|NCT01033487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110843|NCT01033565|University of Nebraska|Howard Needelman MD|4025594097|hneedelm@unmc.edu
110844|NCT01033734|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
110847|NCT01033851|Massachusetts General Hospital|Dr. Elizabeth Hoge|6177240859|ehoge@partners.org
110848|NCT01033864|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
110849|NCT01033942|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com
110850|NCT01034111|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110851|NCT01034137|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
110852|NCT01034163|Novartis|Study Director|862-778-8300|
110853|NCT01034176|Brigham and Women's Hospital|Dr. Anil Chandraker|617-525-8203|achandraker@partners.org
110854|NCT01034306|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il
110855|NCT01034358|Mayo Clinic|Jeanne Tung, MD|507-266-0114|tung.jeanne@mayo.edu
110856|NCT01034397|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
110857|NCT01034462|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000 ext 8124|carl.gommoll@frx.com
110858|NCT01034540|Biofortis Clinical Research (formerly Provident)|Dr. Kevin Maki, Chief Science Officer|630-516-3800|kevin.maki@mxns.com
110859|NCT01034553|Mayo Clinic|Alexander Keith Stewart, M.B.CH.B|(480)301-4411|stewart.keith@mayo.edu
110860|NCT01034579|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
110861|NCT01034592|Stanford University Medical Center|Jason R Gotlib, MD, Professor of Medicine (Hematology)|650-867-2823|jason.gotlib@stanford.edu
110862|NCT01034631|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org
110863|NCT01034657|Novartis|Study Director|862-778-8300|
110864|NCT01034709|QIAGEN|Kevin Modarress, PhD Senior Manager Regulatory Affairs Operations NA, Regulatory Affairs|301-944-7103|kevin.modarress@qiagen.com
110866|NCT01035060|University of Florida|Dr. Thomas Buford|352-273-5918|tbuford@ufl.edu
110867|NCT01035138|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110868|NCT01035229|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
110869|NCT01035255|Novartis Pharmaceuticals|Study Director|862-778-8300|
110870|NCT01035333|Albany College of Pharmacy and Health Sciences|Dr Margaret Malone|518 694 7275|margaret.malone@acphs.edu
110871|NCT01035346|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110872|NCT01035658|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
110873|NCT01035749|GlaxoSmithKline|GSK Response Center|866-435-7343|
119429|NCT01451463|The Ohio State University|Sandra K Kostyk, MD, PhD|6142934969|sandra.kostyk@osumc.edu
110875|NCT01035905|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
110876|NCT01035944|HemCon Medical Technolgoies|Dr. Jody Oyama|503.245.0459|jody.oyama@hemcon.com
110877|NCT01020019|New York State Psychiatric Institute|Daniel Brooks|646-774-6171|brooksd@nyspi.columbia.edu
110878|NCT01025492|University of Utah|Scott Low|801-585-1380|scott.low@hsc.utah.edu
110879|NCT01025635|Bayer HealthCare Pharmaceuticals, Inc. (formerly Intendis GmbH)|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
110880|NCT01025817|Novartis|Study Director|+1 (862) 778-8300|
110881|NCT01025830|University of California Berkeley|Jayne Byakika Tusiime|1 510 219 7567|tusiimej@berkeley.edu
110882|NCT01025843|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
110883|NCT01036009|Benioff Children's Hospital at UCSF|Biljana Horn|415 476 2188|hornb@peds.ucsf.edu
110884|NCT01036022|GlaxoSmithKline|GSK Response Center|866-435-7343|
110885|NCT01036165|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|Fernando.dangond@emdserono.com
119430|NCT01434511|Baxter Healthcare Corporation|Heinrich Farin, MD||heinrich_farin@baxter.com
110887|NCT01036438|Molnlycke Health Care AB|Ann Larkö|+46 722 3338|ann.larko@molnlycke.com
110889|NCT01036529|Boston Scientific|Valerie Lucero-Cimmarusti|661-949-4745|Valerie.Lucero-Cimmarusti@bsci.com
110890|NCT01038128|McLean Hospital|Study Coordinator|617-855-2984|eryan@mclean.harvard.edu
110891|NCT01038323|Wake Forest|dennis ang|336-716-4209|dang@wakehealth.edu
110892|NCT01038336|VA RR&D National Center for Rehabilitative Auditory Research, Portland VA Medical Center|Gabrielle Saunders Ph.D.|503-220-2862 ext 56210|gabrielle.saunders@va.gov
110893|NCT01038609|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
110894|NCT01038635|The University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org
110895|NCT01038713|Dartmouth-Hitchcock Medical Center|Timothy Gardner|603-650-6472|timothy.b.gardner@hitchcock.org
110896|NCT01038752|Optimum Therapeutics|Dr. M. Guillaume Wientjes||gwientjes@optimumtx.com
110897|NCT01038869|DermResearch, PLLC|Leon Kircik, M.D.|502-451-9000|wedoderm@yahoo.com
110898|NCT01038921|Emory University|Dr. Abinav Goyal|404-727-8758|agoyal4@emory.edu
110899|NCT01039207|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org
110900|NCT01039376|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
110901|NCT01039428|KDL|Study Director|818058844243|toiawase@advance-cro.co.jp
110902|NCT01039519|Synta Pharmaceuticals|VP Clinical Research|781-541-7156|aoneill@syntapharma.com
110903|NCT01039584|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com
110905|NCT01039792|UCSF|Dr. Robert Hendren|415-502-3500|STAR@ucsf.edu
110906|NCT01040052|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
110907|NCT01040130|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110908|NCT01040169|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com
110909|NCT01040208|Sprout Pharmaceuticals|Krista Barbour|9198820850|kbarbour@sproutpharma.com
110910|NCT01040260|University of California, San Francisco|Dr. Timothy Carmody|(415) 221-4810 ext 6344|Timothy.Carmody@ucsf.edu
110911|NCT01028820|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu
110912|NCT01028911|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110913|NCT01029054|University of Michigan Hospital|Dr. Mark Kaminski, M.D.|734-936-5310|mkaminsk@umich.edu
110914|NCT01029262|Celgene Corporation|Anne McClain, Senior Study Manager|888-260-1588|clinicaltrialdisclosure@celgene.com
110915|NCT01029340|BAYER|Therapeutic Area Head||clinical-trial-contact@bayerhealthcare.com
119432|NCT01313884|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu
110917|NCT01029392|William Beaumont Hospital|Dr. Peter Gerrits|248-551-0487|peter.gerrits@beaumont.org
110918|NCT01029405|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110919|NCT01029535|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
110920|NCT01029652|Novartis Pharmaceuticals|Study Director|862 778-8300|
110921|NCT01029704|Theracos, Inc.|Yuan-Di C. Halvorsen, PhD|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu
110922|NCT01029730|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
110923|NCT01029795|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
110924|NCT01029886|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
110925|NCT01029925|University of California Los Angeles Jonsson Comprehensive Cancer Center|Edward Garon, MD|310 586 2098|egaron@mednet.ucla.edu
110926|NCT01030458|University of Leuven|Prof. Dr. Jan A Staessen|+32 16 34 7104|jan.staessen@med.kuleuven.be
110927|NCT01030653|University of Michigan|Manjuanth Pai|7346470006|amitpai@med.umich.edu
110928|NCT01030666|JWGUniversity|Prof. Dr. Peter Eickholz|+496963015642|eickholz@med.uni-frankfurt.de
110929|NCT01030718|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
110930|NCT01030757|University of New Mexico|Ben Liem, MD|505-272-0086|bliem@salud.unm.edu
110931|NCT01030822|GlaxoSmithKline|GSK Response Center|866-435-7343|
110932|NCT01030952|Novartis Pharmaceuticals|Study Director|+1-800-244-7668|
119433|NCT01174446|Baxter Innovations GmbH|Brigitt Abbuehl, MD, Global Medical Director, Hematology/Hemophilia||brigitt_abbuehl@baxter.com
110934|NCT01031004|Vistakon|John Buch/Principal Research Optometrist|904-443-1707|
110935|NCT01031043|Georgia Regents University|Gregory N. Postma MD|706-721-6100|gpostmat@gru.edu
110936|NCT01031095|Bursa Postgraduate Hospital|Dr.Hasan ARI|00902243605050 ext 1739|hasanari03@yahoo.com
110937|NCT01031134|Weill Cornell Medical College|Patrick Raue, Ph.D.|206-543-3807|praue@uw.edu
110938|NCT01031381|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu
110939|NCT01031446|Vanderbilt-Ingram Cancer Center|Ingrid A. Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu
110940|NCT01031498|UT MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org
110941|NCT01031550|UMDNJ|Yuriy Gubenko, MD|973 972-5007|yuriygubenko@yahoo.com
110942|NCT01031628|SARC|Research Project Manager|(734) 930-7600|sarc@sarctrials.org
110943|NCT01031680|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com
110944|NCT01031706|University of North Carolina at Chapel Hill|Dr. Scott H. Donaldson|919-966-9198|scott_donaldson@med.unc.edu
110945|NCT01031810|New York State Psychiatric Institute|Dr. Patrick J. McGrath|(646) 774-8076|mcgrath@nyspi.columbia.edu
110946|NCT01031914|Philips|Dr. David P. White|724 387 4554|Dr.DavidWhite@philips.com
110947|NCT01031953|Oregon Health & Science University|Dr. Joseph Bubalo|503-494-8007|bubaloj@ohsu.edu
110948|NCT01031979|Ralph H. Johnson VAMC|Dr. Peter Tuerk|(843) 789-6188|peter.tuerk@va.gov
110949|NCT01032018|Columbia University Medical Center|Karina W Davidson, PhD|212-342-4493|kd2124@cumc.columbia.edu
110950|NCT01032044|Mayo Clinic, Jacksonville, Florida, USA|Dr Michael B. Wallace|904 953-7630|wallace.michael@mayo.edu
110951|NCT01032070|Astellas Pharma Global Development, Inc|Senior Medical Director, Medical Oncology||ClinicalTrials.Disclosure@us.astellas.com
110952|NCT01032135|University of Pennsylvania|James McKay, PhD|215-746-7704|jimrache@mail.med.upenn.edu
110953|NCT01032174|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110955|NCT01032265|Umeå University, Umeå, Sweden|Dr. Eva Samuelsson|+46706966440|eva.samuelsson@jll.se
110956|NCT01032291|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
110957|NCT01032382|US Army Medical Materiel Development Activity (USAMMDA)|Director, Division of Regulated Activites and Compliance|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil
110958|NCT01032538|Martina Hansens Hospital|Tor Kjetil Nerhus|+47 93409934|kjnerhus@gmail.com
110959|NCT01032694|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110960|NCT01032733|University of Florida|Stephen Anton|352-273-7514|santon@ufl.edu
110961|NCT01032759|Duke University Medical Center|Dr. Ashraf Habib|9196686266|habib001@dm.duke.edu
110962|NCT01032837|Hoffman-LaRoche|Medical Communications|800-821-8590|
110963|NCT01032850|University of New Mexico Cancer Center|Dr. Yehuda Patt, MD|505-925-0405|yzpatt@salud.unm.edu
110964|NCT01032889|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com
110965|NCT01032915|Novartis|Study Director|862-778-8300|
110966|NCT01032928|Ralph H Johnson VA Medical Center|Dr. Bonnie Martin Harris|843-792-0879|Bonnie.Martin-Harris@va.gov
110967|NCT01032993|BIDMC|Catherine Buettner, MD MPH, Assistant Professor of Medicine|617-754-9600|cbuettne@bidmc.harvard.edu
110968|NCT01033019|Novartis|Study Director|862-778-8300|
110969|NCT01033032|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
110970|NCT01033071|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
119435|NCT00903396|Mayo Clinic|Michele Halyard, M.D.|4803014567|mhalyard@mayo.edu
110972|NCT01040351|Cairo university|Usama M.Fouda, M.D, PhD|+20123595106|umfrfouda@yahoo.com
110973|NCT01040403|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
110974|NCT01040624|University of Florida Health Proton Therapy Institute|Nancy P. Mendenhall, MD|904-588-1000|rtoton@floridaproton.org
110975|NCT01041859|Janssen Research&Development|Director, Clinical Leader|609-730-6777|
110976|NCT01041976|Edith Nourse Rogers Memorial VA|Lisa Mueller|781-687-3192|Lisa.Mueller@va.gov
110977|NCT01042093|Towson Orthopaedic Associates|David F. Dalury, MD|410-337-7900 ext 1221|ddalury@gmail.com
110978|NCT01042145|Washington University School of Medicine|Dr. Jane Garbutt|314-454-8613|jgarbutt@dom.wustl.edu
110979|NCT01042158|Johns Hopkins University|Paul Hassoun, MD|410-614-5158|phassoun@jhmi.edu
110980|NCT01042236|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
110981|NCT01042288|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
110982|NCT01042366|University of Pittsburgh|John Kirkwood, MD|(412) 623-7707|KirkwoodJM@upmc.edu
110983|NCT01042392|Novartis Pharmaceuticals|Study Director|862-778-8300|
110984|NCT01042496|Mayo Clinic|Dr. Mark A. Frye|507-284-6213|MFrye@mayo.edu
110985|NCT01042509|Hospital Universitario|Dr. David Gomez-Almaguer|5281-83488510|hematohu@yahoo.com
119436|NCT00822094|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|(215) 832-3750|
110987|NCT01042600|Albany Medical Center|Joaquim Pinheiro, MD, MPH|518-262-5421|pinheij@mail.amc.edu
110988|NCT01042613|St. Jude Children's Research Hospital|Luis Trujillo Huaccho, MD|1-866-278-5833|info@stjude.org
110989|NCT01042678|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
110990|NCT01042795|University of Michigan|Cheryl T. Lee|614-685-6666|cheryl.lee@osumc.edu
110991|NCT01042938|University of Rochester Medical Center|Julie L Ryan, PhD, MPH (PI)|585-276-3862|julie_ryan@urmc.rochester.edu
110992|NCT01042977|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com
110993|NCT01043094|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com
110994|NCT01043133|USUHS|Ronald W. Gimbel|301-295-3077|rgimbel@usuhs.mil
110995|NCT01043146|Corimmun, GmbH|Gary Peters, MD, Managing Director|001-215 628-5257|gpeters7@its.jnj.com
110996|NCT01043185|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
110997|NCT01043393|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com
110998|NCT01043432|Rocky Mountain MIRECC|Lisa A. Brenner|303-399-8020 ext 2571|lisa.brenner@va.gov
110999|NCT01043523|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
111000|NCT01043640|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu
111001|NCT01043653|VISN 5 MIRECC|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov
111002|NCT01043705|Medtronic plc|Lynn Landborg, Clinical Research Manager|763 526 2877|lynn.landborg@medtronic.com
111003|NCT01043874|Novartis Pharmaceuticals|Study Director|862-778-8300|
111004|NCT01043926|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111005|NCT01043939|Masonic Cancer Center, University of Minnesota|Cindy K. Blair, MPH|612-624-9668|blair016@umn.edu
111006|NCT01044030|Boston Children's Hospital|Louis Vernacchio, MD, MSc|617-919-4283|louis.vernacchio@childrens.harvard.edu
111007|NCT01044056|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111008|NCT01044212|University of Rochester|Gunhilde Buchsbaum, Division Director Urogynecology|585-273-3233|gunhilde_buchsbaum@urmc.rochester.edu
111009|NCT01044264|Perrigo Company|Manager|718-960-0119|jonathan.schwartz@perrigo.com
111010|NCT01036724|CTI Clinical Trials and Consulting|Dr. Tina Hunter, Consulting Statistician to Biosense Webster|513-619-5541|tinah@s2stats.com
111011|NCT01036763|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
111012|NCT01036802|University of North Carolina, Chapel Hill|Kenneth I. Ataga, MD|919-843-7708|kataga@med.unc.edu
111013|NCT01037088|UCaliforniaDavis|Dr. Barth Wilsey, MD|916-843-9082|blwilsey@ucdavis.edu
111014|NCT01037114|GlaxoSmithKline|GSK Response Center|866-435-7343|
111015|NCT01037127|GlaxoSmithKline|GSK Response Center|866-435-7343|
111016|NCT01037192|Fraser Health Authority|Anna Yuen, BSc. Pharm|604-520-4005|anna.yuen@fraserhealth.ca
111017|NCT01037218|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
111018|NCT01037244|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
111019|NCT01037309|Prosensa|Fiona Lawrence|+31(0)713322100|f.lawrence@prosensa.nl
111020|NCT01037452|Novartis|Head New Therapeutic Opportunities|973-503-8000|
111021|NCT01044290|HSRD, Durham VAMC|Karen Steinhauser, PhD|919 668-2148|karen.steinhauser@duke.edu
111022|NCT01044303|East Carolina University|Dr. Paul Bolin|252-744-3773|bolinp@ecu.edu
111023|NCT01044459|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com
111024|NCT01044498|Hoffmann-La Roche|Medical Communications|800 821-8590|
111025|NCT01044537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111026|NCT01044589|Cleveland Clinic|Dr. Massarat Zutshi|(216) 444-3540|zutshim@ccf.org
111027|NCT01045694|University of Missouri-Columbia|Stephen Colbert|573-882-2275|colberts@health.missouri.edu
111028|NCT01045707|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
111029|NCT01045798|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111030|NCT01045967|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
111031|NCT01045993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
111032|NCT01046084|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
111033|NCT01046110|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
111034|NCT01046136|Reckitt Benckiser Inc.|Gail Solomon, MS; Director Clinical Development|973-404-2752|gail.solomon@reckittbenckiser.com
111035|NCT01046253|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
111036|NCT01046396|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com
111037|NCT01046565|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com
111038|NCT01046643|The University of Michigan|Dr. Yolanda Smith|(734) 936-7401|ysmith@med.umich.edu
111039|NCT01046682|UHospitalsCleveland|Grace McComsey, MC|216-844-3607|mccomsey.grace@clevelandactu.org
111040|NCT01046695|Mayo Clinic|Deborah J. Engen, OT, CMT|507-255-5504|engen.deborah@mayo.edu
111041|NCT01046877|Acclarent|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com
111042|NCT01046903|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
121659|NCT00003474|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
111044|NCT01047241|Copenhagen University Hospital, Rigshospitalet|Sponsor's contact person Bettina Nygaard Nielsen|+45 35459546|bettina.nygaard.nielsen@regionh.dk
111045|NCT01047293|Huntsman Cancer Institute|Sunil Sharma|801-587-5559|sunil.sharma@hci.utah.edu
111046|NCT01047306|Shire Development LLC|Study Physician|+1 866 842 5335|
111047|NCT01047332|Brigham and Women’s Hospital|Dr. David L. Carr-Locke, MD, FRCP||dcarrlocke@chpnet.org
111048|NCT01047345|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111049|NCT01047358|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111050|NCT01047436|Xidea Solutions Limited|Dr D Bendel||daryl@xideasolutions.com
111051|NCT01047475|Microbio / Sophie Chang|Director of Clinical Trials|886-2-2570-5596 ext 556|sophie_chang@fountainmab.com
111052|NCT01047527|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu
111053|NCT01047553|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
111054|NCT01047709|University of Michigan|Devin Brown, MD|7349369075|devinb@umich.edu
111055|NCT01047839|Valneva Austria GmbH|Senior Scientist Clinical Research|+43 1 206 20 ext 1175|katrin.dubischar-kastner@valneva.com
111056|NCT01040689|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
111057|NCT01040728|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
111058|NCT01040780|Cancer Hospital, Chinese Academy of Medical Sciences|Yan Sun, M.D.|0086-010-87788519|zhangheping@csco.org.cn
111059|NCT01040793|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
111060|NCT01040819|Baylor College of Medicine|Dr. Yochai Birnbaum|713-798-0273|ybirnbau@bcm.edu
111061|NCT01040832|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
111062|NCT01040845|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
111063|NCT01040858|Portland VA Healthcare System|Dr. Daniel Storzbach|503-220-8262 ext 56497|Daniel.Storzbach@va.gov
111064|NCT01040871|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM
111065|NCT01041209|Hospital General de Niños Pedro de Elizalde|Dr. Fernando Torres|+54 11 43070140|slaip@intramed.net
111066|NCT01041287|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu
111067|NCT01041404|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
111068|NCT01041417|Emory University School of Medicine|Dr. Arshed Quyyumi|4047273655|aquyyum@emory.edu
111069|NCT01041573|Valneva Austria GmbH|Senior Manager Clinical Research|+43 1 206 20 ext 1175|katrin.dubischar-kastner@valneva.com
111070|NCT01041638|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
111071|NCT01048099|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
111072|NCT01048125|University of Missouri-Columbia|Dr. Anand Chockalingam|573/882-2296|chockalingama@health.missouri.edu
111073|NCT01048242|University of Pennsylvania|Nalaka Gooneratne|215 349 5938|ngoonera@mail.med.upenn.edu
111074|NCT01048333|Astra Zeneca|Gerard Lynch|+44 1509 645895|ClinicalTrialTransparency@astrazeneca.com
111075|NCT01048697|Texas Tech UHSC|Ronald Hall|214-654-9404|ronald.hall@ttuhsc.edu
111076|NCT01048723|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Zager, M.D.|813-745-1085|jonathan.zager@moffitt.org
111077|NCT01048788|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
111078|NCT01048866|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com
111079|NCT01048879|University of Michigan|Bruce A. Mueller|7346154578|muellerb@umich.edu
111080|NCT01048944|Southern Illinois University Carbondale|David G. Gilbert, Ph.D.|618-45303558|dgilbert@siu.edu
111081|NCT01049009|Emory University School of Medicine|Dr. Arshed A. Quyyumi|404-727-3655|aquyyum@emory.edu
111082|NCT01049217|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111084|NCT01049308|VA Loma Linda Healthcare System|Dr Helme Silvet|9095836097|helme.silvet@va.gov
111085|NCT01049334|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com
111086|NCT01049360|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com
121660|NCT00003456|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
111087|NCT01049373|PASCOE pharmazeutische Präparate GmbH|Dr. Gabriele Weiss|0049/641/7960-0|klinischeforschung@pascoe.de
111088|NCT01049503|Bauru Dental School/University of São Paulo|Dr. Marília Buzalaf|+55 14 32358346|mbuzalaf@fob.usp.br
111089|NCT01049581|ChangGungMH|Dr Chia- Ling Chen|886-3-3281200 ext 3846|clingchen@gmail.com
111090|NCT01049776|Illinois CancerCare, P.C.|Sachdev Thomas, M.D.|309-243-3000|sthomas@illinoiscancercare.com
111091|NCT01049802|The Rehabilitation Institute of Chicago|Richard L. Harvey, MD|312-238-1000|rharvey@ric.org
111092|NCT01049945|Mayo Clinic|Shaji K. Kumar, M.D.||kumar.shaji@mayo.edu
111093|NCT01049984|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
111094|NCT01050062|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
111095|NCT01050153|Denver Health Medical Center|Ernest E. Moore|303.602.1820|Ernest.Moore@dhha.org
111096|NCT01050205|University of Pittsburgh|Dr. Andrea Kriska|412-383-1286|aky@pitt.edu
111097|NCT01050218|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com
111098|NCT01050257|Hoffman-LaRoche|Medical Communications|800-821-8590|
111099|NCT01050530|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
111100|NCT01050543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
111101|NCT01050569|University of Minnesota|Dorothy Hatsukami|612 626-2121|hatsu001@umn.edu
111102|NCT01050582|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Clinical Leader|609-730-6581|
111103|NCT01050634|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111104|NCT01050660|Yale University|Dr. Orly Levit|203-688-2320|orly.levit@yale.edu
111105|NCT01050673|Northwestern Medical Faculty Foundation|Dr Robert D Galiano, Assistant Professor of Surgery|312-695-6022|rgaliano@nmh.org
111106|NCT01050764|Stanford University Medical Center|Everett H Meyer, MD, PhD; Assistant Professor of Medicine|650-725-5816|evmeyer@stanford.edu
111107|NCT01050790|Virginia Commonwealth University/Massey Cancer Center|Amir A. Toor, MD, Associate Professor of Medicine|804-828-4360|atoor@mcvh-vcu.edu
111108|NCT01050816|Eulji General Hospital|Lee Gyeong Tae|+82-11-214-3323|lkt2408@hanmail.net
111109|NCT01050946|Medical College of Wisconsin|Jeanne Palmer,MD|414-805-6800|jpalmer@mcw.edu
111110|NCT01050998|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com
111111|NCT01044693|Vanderbilt University|Italo Biaggioni MD|615-936-3420|italo.biaggioni@vanderbilt.edu
111112|NCT01044706|Kremers Urban Development Company|Bang Qian Xu, Ph.D., Director of Biopharmaceutics|812-523-5453|Bang.xu@ucb.com
111113|NCT01044732|Avantis Medical Systems|Jack Higgins, MD - Chief Medical Officer|6508239216|jhiggins@avantismedical.com
111114|NCT01044758|Johns Hopkins University School of Medicine|Gregory Krauss, M.D.|(410) 955-2822|gkrauss@jhmi.edu
111115|NCT01044771|Metropolis Medical|Dr. Fritz Bredeek|415 292 5477|fritz@doctor.com
111116|NCT01044862|Yale University|Heping Zhang, PhD|203-785-5185|heping.zhang@yale.edu
111117|NCT01045031|Health and Prevention Center, Sanatorium Hera, Vienna, Austria|Dr. Robert Winker|0043(1)-31350 ext 45666|robert.winker@hera.co.at
111118|NCT01045057|Atos Medical AB|Director of Clinical Affairs|+1 352 870 0872|Corina.van.As@atosmedical.com
111119|NCT01045096|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
111120|NCT01045122|University of Rochester Medical Center|Dr. Suzanne Karan|585-275-5161|Suzanne_Karan@urmc.rochester.edu
111121|NCT01045161|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com
111122|NCT01045187|Xoft, Inc.|Kelly W Elliott RN, MS|408-419-2428|Kelliott@xoftinc.com
111123|NCT01045265|Maple Leaf Research|Tony Antoniou|4164657936|tantoniou@smh.toronto.on.ca
111124|NCT01045421|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com
111125|NCT01045447|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
111126|NCT01045551|Columbia University Medical Center|Julian Mackay-Wiggan, MD, MS|212-305-6953|jc299@cumc.columbia.edu
111127|NCT01051323|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
111128|NCT01051440|Steward St. Elizabeth's Medical Center|Tara Lauriat|617-789-2404|tara.lauriat@steward.org
111129|NCT01051466|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111130|NCT01052116|ALA - ACRC|Robert A. Wise|(410) 550-0545|rwise@jhmi.edu
111131|NCT01052207|CHOA/Emory|Dr. Kiran Hebbar|404-785-6135|khebbar@emory.edu
111132|NCT01052272|University of Alabama at Birmingham|Louis . J. Dell'Italia, M.D|205-934-3969|Dell'Italia@PHYSIOLOGY.UAB.EDU
111133|NCT01052428|University of Alabama at Birmingham|Louis J. Dell'Italia, M.D.|205-934-0850|loudell@uab.edu
111134|NCT01052480|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov
111135|NCT01052545|Michael E. DeBakey VA Medical Center|Barbara Trautner, MD, PhD|713-440-4438|barbar.trautner@va.gov
111136|NCT01052662|University of Massachusetts Medical School|Gerardo Gonzalez, MD|508 856 6480|gerardo.gonzalez@umassmed.edu
111137|NCT01052701|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410) 614-8762|ejfuchs@jhmi.edu
111138|NCT01052714|Psychiatry Department at VA Greater Los Angeles Healthcare System|Dr. Donna Ames, Principal Investigator|310-478-3037|donna.ames@va.gov
111139|NCT01052831|University of Pennsylvania|Dr. Daniel Weintraub|12153498389|Daniel.Weintraub@uphs.upenn.edu
111140|NCT01052844|Faculdade de Medicina do ABC|Felipe Melo Cruz|+55+11+27595914|felipemcruz@yahoo.com.br
111141|NCT01052948|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111142|NCT01053000|Roger H. Stewart MD PA|Barry Galitzer MD|954-491-0510|barry@galitzer.com
111203|NCT01057121|AIDS Malignancy Consortium|AMC Statistical Center|501-526-6712|jylee@uams.edu
111144|NCT01053156|MIND Institute, University of California Davis Medical Center|Randi J. Hagerman MD, Medical Director of the MIND Institute|916-703-0247|randi.hagerman@ucdmc.ucdavis.edu
111145|NCT01053247|Fougera Pharmaceuticals Inc|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com
111146|NCT01053312|GE Healthcare|Paul Sherwin, MD|1-609-514-6820|paulsherwin@ge.com
111147|NCT01053429|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111148|NCT01053507|Clinvest/A Division of Banyan Group, Inc.|Dr. Roger K. Cady|417-841-3673|jtarrasch@clinvest.com
111149|NCT01053663|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
111150|NCT01053741|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410)614-8762|ejfuchs@jhmi.edu
111151|NCT01053819|University of Alabama at Birmingham|Boni Elewski, MD|205-502-9960|beelewski@gmail.com
111152|NCT01053897|Garnet BioTherapeutics, Inc.|Gerri Henwood, CEO|484-395-2440|ghenwood@garnetbio.com
111153|NCT01053988|GlaxoSmithKline|GSK Response Center|866-435-7343|
111154|NCT01054079|Comprehensive Cancer Center of Wake Forest University|Dr. K.C. Balaji|336-618-2272|kbalaji@wakehealth.edu
111155|NCT01054170|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
111156|NCT01054183|Akron Children's Hospital|Michael T. Bigham, MD|330-543-8639|MBigham@chmca.org
111157|NCT01054222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111158|NCT01054339|Applied Genetic Technologies Corp.|Jeffrey D. Chulay, MD|386-462-2204 ext 205|jchulay@agtc.com
111159|NCT01054404|Northwestern University|Dr. John F. Bebawy, Assistant Professor of Anesthesiology & Neurological Surgery|312-695-0061|j-bebawy@northwestern.edu
111160|NCT01054560|Covidien|Director of Clinical Affairs|9498373700|
111161|NCT01054573|Janssen Research & Development, LLC|Medical Leader|1 609 730-3174|
111162|NCT01048424|University of California, San Francisco|Alison Huang, MD|415-353-9751|ahuang@medicine.ucsf.edu
111163|NCT01048502|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu
111164|NCT01048541|Coloplast|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com
111165|NCT01048593|Icon Bioscience|VP, Clinical Development|408-492-9515|wendymurahashi@iconbioscience.com
111166|NCT01048606|Université de Sherbrooke|Pr Isabelle Dionne, Ph.D., vice-dean to research and graduate studies|1-819-821-8000 ext 63327|isabelle.dionne@usherbrooke.ca
111167|NCT01048658|Oregon Health & Science University|Dr. Rosenne Botha|503-494-3666|whru@ohsu.edu
111168|NCT01048671|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111169|NCT01054586|GlaxoSmithKline|GSK Response Center|866-435-7343|
111170|NCT01054599|VA New York Harbor Healthcare System, NYU|Beth Leeman-Markowski, MD|212-686-7500|beth.leeman-markowski@nyumc.org
111171|NCT01054625|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com
111172|NCT01054703|Acclarent|Laura England, Manager-Clinical Research|650-687-4466|lenglan1@its.jnj.com
111173|NCT01054729|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
111174|NCT01054742|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
111175|NCT01054820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111176|NCT01054846|Parkview Health|Thein Zhu|260-266-1279|thein.zhu@parkview.com
111178|NCT01054911|University of Alabama in Birmingham, Comprehensive Cancer Center|Dr. James Posey, MD|205-934-0916|jposey@uabmc.edu
111179|NCT01055769|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111180|NCT01055782|Specialist Doctors Rolighedsvej|Lene Hendel MD|+4545819090|lene@hendel.dk
111181|NCT01055834|Eisai Co., Ltd.|Kenya Nakai, Study Director|+81-3-3817-3865|k3-nakai@hhc.eisai.co.jp
111182|NCT01055886|VA Medical Center|Angela Kirby|919-286-0411 ext 5526|angela.kirby@va.gov
111183|NCT01056016|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|5136368296|jeff.epstein@cchmc.org
111184|NCT01056107|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu
111185|NCT01056198|Healthpoint Biotherapeutics|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com
111186|NCT01056263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111187|NCT01056276|Sarah Cannon Development Innovations|Charles Davis, RAC||charles.davis2@scri-innovations.com
111188|NCT01056289|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111189|NCT01056315|Grünenthal|Study Director|+49 (0)-241-569-3223|clinical-trials@grunenthal.com
111190|NCT01056328|St. Jude Medical|Nicole Glowacki, Clinical Project Manager|651-756-3432|NGlowacki@sjm.com
111191|NCT01056341|Pierre Fabre Dermatologie|Dr. Jean-Jacques VOISARD - General Manager -|+33 5 63 58 88 00|jean.jacques.voisard@pierre-fabre.com
111192|NCT01056380|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com
111193|NCT01056484|University of Wisconsin Madison|Aleksandra Zgierska, MD PhD|(608) 263-7882|aleksandra.zgierska@fammed.wisc.edu
111194|NCT01056510|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
111195|NCT01056523|Jewish General Hospital|Dr. Assouline|514-340-8222 ext 8434|sarit.assouline@mcgill.ca
111196|NCT01056601|Masonic Cancer Center, University of Minnesota|Arkaduisz Dudek, M.D.|612-624-0123|dudek002@umn.edu
111197|NCT01056640|Mayo Clinic|Dr. Paul Takahashi|507-284-2511|takahashi.paul@mayo.edu
111198|NCT01056653|University of Calgary, Faculty of Nursing|Dr. Karen Benzies|403-220-2294|benzies@ucalgary.ca
111199|NCT01056718|Mercy Hospital East Communities|Denise Janosik, MD|314-251-3920|Denise.Janosik@mercy.net
111200|NCT01056822|Pharmaceuticals|Novartis|+1 (862) 778-8300|
111201|NCT01056913|St John of God Hospital Vienna|Bernhard Dauser (MD)|+43121121 ext 5098|bernhard.dauser@gmail.com
111202|NCT01057017|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org
111205|NCT01057251|Forest Research Institute|Manfred Stapff, MD, PhD|201-427-8000 ext 8686|manfred.stapff@frx.com
111206|NCT01057277|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu
111207|NCT01057394|CardioFocus, Inc.|Burke Barrett, VP, Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com
111208|NCT01057433|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com
111209|NCT01057589|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111210|NCT01057693|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111211|NCT01057810|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
119437|NCT00818662|Baxter Healthcare Corporation|David Gelmont, MD, Global Medical Director, Head of Specialty Products TA, BioTherapeutics||david_gelmont@baxter.com
111213|NCT01057888|University of Rochester, Deparentment of Pediatrics|Dr. Peter Szilagyi|585 275-5798|peter_szilagyi@urmc.rochester.edu
111214|NCT01057901|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com
111215|NCT01058005|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com
111216|NCT01058070|Torax Medical, Inc.|VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com
111217|NCT01058096|Allergan, Inc.|Therapeutic Area Head|714-246-4500|
111219|NCT01051570|Barbara Ann Karmanos Cancer Institute|Ulka N. Vaishampayan, M.D.|313-576-8718|vaishamu@karmanos.org
111220|NCT01051739|Iowa City Veterans Administration Medical Center|Michael Wall, M.D.|319-3380581|michael-wall@uiowa.edu
111221|NCT01051778|Cairo university|Usama .M .Fouda|+20123595106|umfrfouda@yahoo.com
111222|NCT01051817|Novartis Pharmaceuticals|Study Director|862-778-8300|
111223|NCT01051856|Mayo Clinic|Florencia G. Que, MD|507-284-6178|que.florencia@mayo.edu
111224|NCT01051921|Conatus Pharmaceuticals Inc.|Vice President, Clinical Development|(858) 457- 7227|MHuyghe@conatuspharma.com
111225|NCT01051986|Seoul National University Hospital|Ki-Bong Kim|+82-2-2072-3482|kimkb@snu.ac.kr
111226|NCT01052038|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu
111227|NCT01052077|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
111228|NCT01058265|Mayo Clinic in Arizona|Larry Bergstrom, MD|480-301-7108|bergstrom.larry@mayo.edu
111229|NCT01058304|Health Services Research & Development, Durham VAMC|Kelli D. Allen|919-286-0411 ext 7090|kelli.allen@va.gov
111230|NCT01058356|Pharmbio Korea Co., Ltd.|Korea Association for the Study of Intestinal Disease (KASID)|82-2-587-2551|pharmbio@hotmail.com
111231|NCT01058421|University of Colorado|Dr. Marc Moss|303-724-6079|marc.moss@ucdenver.edu
111232|NCT01060072|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com
111233|NCT01060111|Medical Affairs / Janssen-Cil Korea|Clinical Research Associate|82-2-2094-4837|
111234|NCT01060124|Medical affairs, Janssen Korea, Ltd.|CRA|82220944835|
111235|NCT01060150|Medical Affairs / Janssen-Cil Korea|Clinical Research Director|82-2-2094-4518|
111236|NCT01060540|Durham VA Medical Center|Corrine Voils, PhD|919-286-0411 ext 5196|corrine.voils@va.gov
111237|NCT01060553|Veteran Affairs New Jersey Health Care System|Thomas W. Findley, MD, PhD|973-676-1000 ext 2713|thomas.findley@va.gov
111238|NCT01060592|Crospon|John O'Dea PhD|+353-91-519880|jodea@crospon.com
111239|NCT01060670|Integra LifeSciences, Inc.|Katie Bush, PhD- Manager, Global Medical Affairs- Tissue Technology|617-268-1616 ext 267|katie.bush@integralife.com
111240|NCT01061008|UWalesBangor|Dr. Jamie Macdonald|+441248383272|j.h.macdonald@bangor.ac.uk
111241|NCT01061034|Assaf Harofeh medical center|Dr. Keren Doenyas-Barak|972-57-7346651|kerendoenyas@gmail.com
111242|NCT01061177|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com
111243|NCT01061333|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111244|NCT01061359|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111245|NCT01061385|ReShape Medical|Director of Clinical Operations|949-429-6680|lfong@reshapemedical.com
111246|NCT01061476|Johns Hopkins University|Dr. Susheel Patil|410-550-0574|spatil@jhmi.edu
111247|NCT01061567|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
111248|NCT01061606|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org
111250|NCT01061710|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111251|NCT01061723|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
111252|NCT01061736|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
111253|NCT01061775|Children's Hospitals and Clinics of Minnesota|Dr. Jennifer Abuzzahab|651-220-6867|jennifer.abuzzahab@childrensmn.org
111254|NCT01061866|National Institute of Neurology and Neurosurgery of Mexico|Julio Sotelo|5255-5652-8285|jsotelo@unam.mx
111255|NCT01062061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111256|NCT01062074|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111257|NCT01062113|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
111258|NCT01062165|Texas Tech UHSC|Ronald Hall|214-654-9404|ronald.hall@ttuhsc.edu
111259|NCT01062230|Huntsman Cancer Institute at the University of Utah Medical Center|Maurizio Zangari, MD Principal Investigator|801-585-3229|
111260|NCT01062256|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com
111261|NCT01062269|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|Harold E. Bays, MD|502-515-5672|HBaysMD@aol.com
111498|NCT01076192|AbbVie|Global Medical Information|800-633-9110|
111262|NCT01062308|Christian Medical College and Hospital, Ludhiana, Punjab, India|Jeyaraj D Pandian|09915784750|jeyarajpandian@hotmail.com
119438|NCT00814320|Baxter Healthcare Corporation|Leman Yel, MD, Global Medical Director, BioTherapeutics||leman_yel@baxter.com
111264|NCT01054976|Jan-Cil Korea|Business Unit Director|82 2 2094-4537|
111265|NCT01055132|Johnson & Johnson Vision Care|Ross Franklin|1-904-443-1379|RFrankl1@its.jnj.com
111266|NCT01055171|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu
111267|NCT01055184|University of Rochester|Dr. John J. Treanor|585-275-5871|john_treanor@urmc.rochester.edu
111268|NCT01055197|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
111269|NCT01055223|GlaxoSmithKline|GSK Response Center|866-435-7343|
111270|NCT01055262|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com
111271|NCT01055314|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
111272|NCT01055457|Johson & Johnson Vision Care Inc.|Kristy Canavan, O.D.- PRINCIPAL RESEARCH OPTOMETRIST, Clin Ops|904-443-3500|KCANAVA2@its.jnj.com
111273|NCT01055613|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D.- Research Principle Optometrist|904-443-1290|BPALL@its.jnj.com
111274|NCT01055639|VA San Diego Healthcare System|Dr. Julie Wetherell|858-552-8585 ext 2752|jwetherell@ucsd.edu
111275|NCT01055704|Mayo Clinic|Dr Michael Camilleri|5072662305|camilleri.michael@mayo.edu
111276|NCT01062763|Dept. of Endocrinology, Odense University Hospital|Dr. Ib A. Jacobsen|+45 27203135|ib.abildgaard@rsyd.dk
111277|NCT01062841|University of Michigan|Lona Mody, MD, MSc|734-764-8942|lonamody@umich.edu
111278|NCT01065350|Mayo Clinic|Nathan J. Smischney, MD|507-255-6032|smischney.nathan@mayo.edu
111279|NCT01065428|Department of Critical Care Medicine, Nanjing Zhong-Da Hospital, Southeast University School of Medicine, China|Dr. Haibo Qiu; Dr. Christer Sinderby|008613951965301|haiboq2000@yahoo.com.cn
111281|NCT01065506|The University of Texas at Austin|Jasper Smits|512-475-8095|smits@utexas.edu
111282|NCT01065558|Psyadon Pharmaceuticals|Dr. Richard Chipkin|301-919-2020|rchipkin@psyadonrx.com
111283|NCT01065597|Department of Psychiatry, University of Maryland School of Medicine|William T. Regenold, MDCM|410-328-6511|wregenol@psych.umaryland.edu
111284|NCT01065714|DermResearch, PLLC|Leon Kircik, M.D.|502-451-9000|wedoderm@yahoo.com
111285|NCT01065766|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-888-577-8839|ClinicalTrialsDisclosure@merck.com
111286|NCT01065779|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
111287|NCT01065818|Columbia University|K.S. Clifford Chao, MD|212-305-9987|ksc2119@cumc.columbia.edu
119439|NCT00766753|University of Pittsburgh Cancer Institute|Frank Lieberman|(412) 648-6507|liebermanf@upmc.edu
111290|NCT01066039|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
111291|NCT01066104|MGH|Dr. Ellen Dutta|6177248256|edutta@mgh.harvard.edu
111292|NCT01066143|McLean|Igor Elman, PI|(800) 333-0338|ielman@partners.org
111293|NCT01066156|Cambridge Health Alliance|Igor Elman|(617) 665-1000|ielman@challiance.org
111294|NCT01066520|Biologische Heilmittel Heel GmbH|Dr. Istvan Zatik|+4972215013192|istvan.zatik@heel.com
111295|NCT01066546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111296|NCT01066585|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com
111297|NCT01066624|South Texas Veterans Health Care System|Juan J Toro|210-617-5300 ext 16777|juan.toro2@va.gov
111298|NCT01066780|Advanced Bionics, LLC|Kenneth Ripley, Director of Clinical Research|1.661.362.1400|clinical.research@advancedbionics.com
111299|NCT01066793|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
111300|NCT01066819|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
111301|NCT01066871|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
111302|NCT01066897|Stanford University|Dr. Jennifer Keller|650-724-0070|jkeller@stanford.edu
119440|NCT00666263|Baxter Healthcare Corporation|David Gelmont, MD, Head Clinical Research, Biotherapeutics||david_gelmont@baxter.com
111304|NCT01067105|Sunovion|Respiratory Medical Director|1-866-503-6351|
111305|NCT01067326|Mayo Clinic|Dr. Amir Lerman|507-255-4152|lerman.amir@mayo.edu
111306|NCT01067339|Mayo Clinic|Amir Lerman, MD|507-284-6429|lerman.amir@mayo.edu
111307|NCT01067352|Merck Serono S.p.A., Italy, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49-6151-72-5200|service@merckgroup.com
111308|NCT01067456|MGH|Dr. Udo Hoffmann|617-726-1255|uhoffmann@partners.org
111309|NCT01058642|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660|
111310|NCT01058655|Dana-Farber Cancer Institute|Brian M. Wolpin|617.632.6942|
111311|NCT01058668|Allergan, Inc.|Therapeutic Area Head|714-246-4500|
111312|NCT01058863|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
111313|NCT01058941|Oregon Health & Science University|Dr. Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu
111314|NCT01058993|University of Washington|David D. Dale, MD|206-543-7215|dcdale@u.washington.edu
111315|NCT01059071|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org
111316|NCT01059175|Medtronic|Latifa Foudali|+33 631992144|latifa.foudali@medtronic.com
111317|NCT01059305|The University of Texas (UT) MD Anderson Cancer Center|Bonnie Glisson, MD/Professor, Thoracic/Head & Neck Med Oncology|713-792-7734|CR_Study_Registration@mdanderson.org
111318|NCT01059344|The Role of Centralized Reading of Endoscopy in a Randomized Controlled Trial of Mesalamine for Ulcertive Colitis|Brian G. Feagan et al|Gastroenterology 2013; 145: ext 149-157|
111319|NCT01059526|Shire Development LLC|Study Physician|+1 866 842 5335|
111320|NCT01059565|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
111321|NCT01059617|GlaxoSmithKline|GSK Response Center|866-435-7343|
111323|NCT01059760|Intermountain Heart Institute|Benjamin D. Horne|8015074708|benjamin.horne@imail.org
111324|NCT01059773|Janssen-Cilag France|EMEA THERAPEUTIC AREA LEADER|+33 6 15167408|
111325|NCT01059799|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
111326|NCT01059812|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
111327|NCT01059825|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111328|NCT01059851|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111329|NCT01059864|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111330|NCT01059903|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
111331|NCT01059994|University of Texas Medical Branch|Dr. William Durham|4097728702|wjdurham@utmb.edu
111332|NCT01060007|Washington University School of Medicine|Parag Parikh, M.D.|314-362-9703|pparikh@radonc.wustl.edu
111333|NCT01060059|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
111334|NCT01067716|Abbott Medical Optics|Amelia Saliba|408-273-4158|amelia.saliba@amo.abbott.com
111335|NCT01067768|Hospital Pablo Tobón Uribe|Dr. María Victoria Restrepo|57-4-4459315|mrestrepo@hptu.org.co
111336|NCT01067781|Valneva Austria GmbH|Head Clinical Developement|0043120620 ext 0|info@valneva.com
111337|NCT01067846|Brain Imaging Research Center|Clint Kilts, PhD|526-8163|CDKilts@uams.edu
111338|NCT01068158|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com
111339|NCT01068262|Merck Sharp and Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111340|NCT01068418|Brigham and Women's Hospital, Harvard Medical School|Jonathan S. Williams|6177325666|jwilliams5@partners.org
111341|NCT01068509|PrimaBioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au
111342|NCT01068548|VANTHCS|Eric Mortensen, MD|214-857-1588|ericm.mortensen@va.gov
111343|NCT01068600|Novartis Pharmaceuticals|Study Director|862-778-8300|
111344|NCT01068626|University of Gothenburg|Kristjan Karason|+46 31 342 7554|kristjan.karason@gu.se
111345|NCT01068652|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
111346|NCT01068665|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
111347|NCT01068678|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
111348|NCT01068717|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
111349|NCT01068730|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
111350|NCT01068743|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
111351|NCT01068769|Dana-Farber Cancer Institute|Dr. Suzanne George|617-632-5204|sgeorge2@partners.org
111352|NCT01068821|Mayo Clinic, Florida|Dr. Mary Ellen Wechter|904 412 7351|wechter.mary@mayo.edu
111353|NCT01068860|Novartis Pharmaceuticals|Dr. Tom Thuren/Global Brand Medical Director|862-778-1828|tom.thuren@novartis.com
111354|NCT01068912|MediVector, Inc., managing member MDVI, LLC|Dr. Carol Epstein, Chief Medical Officer|617-439-4500|cepstein@medivector.com
111355|NCT01068964|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
111356|NCT01069003|Medtronic|Sidney Cohen, Sr. Clinical Medical Advisor|707-591-7277|sidney.a.cohen@medtonic.com
111357|NCT01069120|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com
111358|NCT01069172|AMO Development, LLC|Luis Atiles, Manager, Clinical Research|214 537-6784|luis.atiles@amo.abbott.com
111359|NCT01069185|Pablo Tobon Uribe Hospital|Dr.Jorge Donado Research Unit Chief|+574459753|jdonado@hptu.org.co
111360|NCT01069289|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
111361|NCT01069341|The University of Medicine and Dentistry of New Jersey|Dr. Neelakshi Bhagat|973-972-2032|bhagatne@umdnj.edu
111362|NCT01069419|UCB Clinical Trial Call Center|UCB (Study Director)|+1887 822 9493|
111363|NCT01069484|Norwegian School of Sport Sciences, Department of Sports Medicine, Oslo, Norway|Dr. Gunvor Hilde|+47 41366045|gunvor.hilde@gmail.com
111364|NCT01069523|University of Texas Health Science Center at San Antonio|Steven R.Pliszka MD|210-567-5475|pliszka@uthscsa.edu
111365|NCT01069562|Post Graduate Institute of Medical Education and Research|Puri GD|91-9914209509|gdpuri007@hotmail.com
111366|NCT01069627|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
111367|NCT01069861|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111368|NCT01069900|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
111369|NCT01069939|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
111370|NCT01070043|Novartis Pharmaceuticals|Study Director|862 - 778- 8300|
111371|NCT01070173|Tripler Army Medical Center|Dr. Jordan Pinsker|808-433-6338|jordan.pinsker@us.army.mil
111372|NCT01070303|Abbott|Global Medical Services|800-633-9110|
111373|NCT01070316|Cincinnati Children's Hospital Medical Center|Elizabeth Hoskins|(513) 803-7263|elizabeth.hoskins@cchmc.org
111374|NCT01070329|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111375|NCT01070381|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
111376|NCT01070394|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org
111377|NCT01063036|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
111378|NCT01063049|Gastroenterology Services|Dr. David Gerard|630 969 1167|davidpgerard@comcast.net
111379|NCT01063062|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
111380|NCT01063075|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111381|NCT01063153|Massachusetts General Hospital|Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD|(617)-724-0006|jbiederman@partners.org
111382|NCT01063348|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu
111383|NCT01063517|AstraZeneca|Anitra Fielding|+44 1625 517178|aztrial_results_posting@astrazeneca.com
111384|NCT01063595|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com
111385|NCT01063712|"Cardiology Medical Center Kardiozentrum"|Alexandra Heath MD Ph.D|005912 2785037|draheath@gmail.com
111386|NCT01063764|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
111387|NCT01063855|Janssen Research & Development, LLC|CDTL, Cardiovascular and Metabolism|1 908 704-4648|
111388|NCT01063868|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537|
111389|NCT01063881|Janssen Research & Development, LLC|Sr. Director CDTL, RA CVM Urology|1 908 704-4648|
111390|NCT01063907|Kyowa Hakko Kirin Pharma, Inc.|Senior VP Drug Development|609-919-1100|clinical.info@kyowa-kirin-pharma.com
111391|NCT01064076|Cameron Health, Inc. a subsidiary of Boston Scientific|Michael Husby, Clinical Studies Manager|312-402-1877|michael.husby@bsci.com
111392|NCT01064167|Cardiovascular Institute & Fuwai Hospital|Guyan Wang|86-10-88398377|guyanwang2006@163.com
111393|NCT01064284|"Centro Emofilia e Trombosi Angelo Bianchi Bonomi, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico di Milano"|Prof. Flora Peyvandi|0039 0255035414|flora.peyvandi@unimi.it
111394|NCT01064297|GlaxoSmithKline|GSK Response Center|866-435-7343|
111395|NCT01064310|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
111396|NCT01064323|Johns Hopkins University School of Medicine|Harry Silber, M.D., Ph.D. Assistant Professor of Medicine, Division of Cardiology|410-550-5717|hsilber@jhmi.edu
111397|NCT01064362|GlaxoSmithKline|GSK Response Center|866-435-7343|
111398|NCT01064401|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
111399|NCT01064414|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736|
111400|NCT01064622|University of Chicago|Hedy Kindler, MD|773-702-0360|hkindler@medicine.bsd.uchicago.edu
111401|NCT01064687|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111402|NCT01064739|Vanderbilt University|Dr. Emily Garland|615 936 1748|emily.garland@vanderbilt.edu
111403|NCT01064817|Promedior, Inc.|Elizabeth G. Trehu, MD|781-538-4203|btrehu@promedior.com
111404|NCT01064830|University of North carolina-Chapel Hill|Aida Lugo-Somolinos MD|919-843-9447|alugosom@med.unc.edu
111405|NCT01064856|AbbVie|Global Medical Services|800-633-9110|
111406|NCT01064882|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
111407|NCT01064947|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com
111408|NCT01065051|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
111409|NCT01070550|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
111410|NCT01070693|Helsinki University Central Hospital|Dr. Georgios Pierides|+358 9 4711|georgios.pierides@hus.fi
111411|NCT01070771|University Hospital Southampton NHS Foundation Trust|Professor Nick Curzen|+44 023 80777222|nick.curzen@uhs.nhs.uk
111412|NCT01070784|AstraZeneca|Goran Eckerwall, MSD||ClinicalTrialTransparency@astrazeneca.com
111413|NCT01070810|BIDMC|Michael W Donnino|617-754-2295|mdonnino@bidmc.harvard.edu
111414|NCT01071915|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
111416|NCT01072006|VANCHCS|Juliana Baldo|925-372-4649|juliana.baldo@va.gov
111417|NCT01072032|Baltimore Veterans Affairs|Dr. Ron Goodman|410-605-7000|ronald.goodman@va.gov
111418|NCT01072136|University of Arkansas for Medical Sciences|Shelly Lensing|501-686-8203|sylensing@uams.edu
119441|NCT00596934|University of Michigan|Dr. Elif A. Oral|734-615-7271|eliforal@med.umich.edu
111421|NCT01072188|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com
111422|NCT01072201|Colgate Palmolive Co|William De Vizio, DMD|732-878-7901|William_Devizio@colpal.com
111423|NCT01072331|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
111424|NCT01072344|Memorial Sloan Kettering Cancer Center|Dr. Jun Mao|646-888-0866|maoj@mskcc.org
111425|NCT01072357|Massachusetts Eye and Ear|Dr. Reza Dana|617-573-4431 ext 4431|Reza_Dana@meei.harvard.edu
111426|NCT01072396|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
111427|NCT01072409|University of Michigan|Teresa Zwolan, Ph.D.|(313) 618-9669|zwolan@umich.edu
111428|NCT01072448|Novartis Pharmaceuticals|Study Director|862 778-8300|
111429|NCT01072500|Wake Forest School of Medicine|Michael Miller|336-716-6837|mmiller@wakehealth.edu
111430|NCT01072526|University of Missouri|Lenworth Johnson, MD|573-882-8473|JohnsonLN@health.missouri.edu
111431|NCT01072539|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111432|NCT01072617|BIDMC|Alvaro Pascual-Leone|617-667-0203|apleone@bidmc.harvard.edu
111433|NCT01072630|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
111434|NCT01072643|The Children's Hospital of Philadelphia|Dr. Aruna T. Nathan|215-590-1858|nathan@email.chop.edu
111435|NCT01072656|Cleveland Clinic|Dr Andre Machado|216-444-4270|machada@ccf.org
111436|NCT01072669|Cleveland Clinic|Dr. Soumya Chatterjee|216-444-9945|chattes@ccf.org
111437|NCT01072773|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu
111438|NCT01072877|BTG International Inc|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com
111439|NCT01072929|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
111440|NCT01073163|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com
111441|NCT01073267|University of Texas (UT) MD Anderson Cancer Center|Bouthaina Dabaja, MD/Associate Professor, Radiation Oncology Department||CR_Study_Registration@mdanderson.org
111442|NCT01073293|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111443|NCT01073449|Dept. of Arrhythmology - Cliniche Humanitas Gavazzeni|Dr. Giosue Mascioli|+39 035 4204159|giosuemascioli@mac.com
111444|NCT01073462|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
111445|NCT01073566|Calibra Medical|Vice President Clinical Affairs|650-298-4750|ddreon@calibra.com
111446|NCT01073605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111447|NCT01073618|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111448|NCT01073631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111449|NCT01073657|Veterans Health Adminstration|Marsha Langer Ellison, Ph.D.|781 687 3401|Marsha.Ellison@va.gov
111450|NCT01073865|AstraZeneca|An Open Label Study of ZOLADEX in Pre-menopausal Women with ER Positive Advanced Breast Cancer|+44 1509 645895|clinicaltrialtransparency@astrazeneca.com
111451|NCT01073930|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
111452|NCT01073943|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
111453|NCT01074008|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
111454|NCT01074034|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com
111455|NCT01074047|Celgene|Anne McClain, Senior Manager Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com
111456|NCT01074099|Harvest Technologies|Director of Clinical Operations|508-732-7530|CLI2011communication@harvesttech.com
111457|NCT01074125|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com
111458|NCT01074164|Northwestern University Department of Dermatology|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu
111459|NCT01074216|Memorial Sloan Kettering Cancer Center|Dr. Barrie Cassileth|646-888-0801|Cassileth@mskcc.org
111460|NCT01074229|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu
111461|NCT01074242|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111462|NCT01074255|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111463|NCT01074268|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
111464|NCT01074307|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
111465|NCT01067976|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
111466|NCT01074437|Seattle childrens research institute|Jonathan Perkins, Prinicipal Investigator|206-987-1927|jonathan.perkins@seattlechildrens.org
111467|NCT01074450|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
111468|NCT01074463|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
111469|NCT01074502|UNC Chapel Hill|Aida Lugo-Somolinos MD-PI|919-843-9447|alugosom@med.unc.edu
111470|NCT01074554|Vanderbilt University School of Medicine|Dr. Wonder Drake|615-322-2035|wonder.drake@vanderbilt.edu
111472|NCT01075074|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu
111473|NCT01075087|Northwestern University|Gildasio De Oliveira MD,MS|312-472-3573|g-jr@northwestern.edu
111474|NCT01075100|US Oncology Research, McKesson Specialty Health|Dr. Cynthia Osborne|214-370-1057|Cynthia.Osborne@usoncology.com
111475|NCT01075152|University of Minnesota|Dr. David R Boulware|6126249996|boulw001@umn.edu
111476|NCT01075178|Abbott|Global Medical Services|800-633-9110|
111477|NCT01075191|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
111478|NCT01075204|Abbott|Esther Oppermann, Clinical Trial Manager|49 511 6750 3954|esther.oppermann@abbott.com
111479|NCT01075217|Bracco Diagnostics Inc|Usha Halemane|609.514.2578|Usha.Halemane@diag.bracco.com
111480|NCT01075243|GlaxoSmithKline|GSK Response Center|866-435-7343|
111481|NCT01075256|GlaxoSmithKline|GSK Response Center|866-435-7343|
111482|NCT01075282|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111483|NCT01075347|Natinal Taiwan University Hospital|We-Li Chen , MD|886-2-2356 ext 5206|chenweili@ntu.edu.tw
111484|NCT01075399|Certus International, Inc.|Edward M. Aten, MD, President|603.627.1212|eaten@certusintl.com
111485|NCT01075646|Department of Anesthesia, Reanimation Bellvitge University Hospital|Noelia Fustran|932607323|nfustran@bellvitgehospital.cat
111486|NCT01075685|Inpes|Juliette Guillemont|+331 49 33 22 55|juliette.guillemont@inpes.sante.fr
111487|NCT01075763|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
111488|NCT01075815|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
111489|NCT01075958|Northumbria University|Dr Philippa Jackson|+44 191 204 8818|philippa.jackson@northumbria.ac.uk
111490|NCT01075971|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com
121661|NCT00003471|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
111492|NCT01076036|Corindus, Inc|Michail M. Pankratov, MD, PhD, Vice President of Clinical & Regulatory Affairs|508-653-3335 ext 206|Michail.Pankratov@Corindus.com
111493|NCT01076075|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111494|NCT01076088|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111495|NCT01076153|Abbott|Global Medical Services|1-800-633-9110|
111496|NCT01076166|Abbott|Global Medical Services|1-800-633-9110|
111497|NCT01076179|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110|
121662|NCT00009945|NSABP Foundation, Inc.|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org
111499|NCT01076244|Center for Pain Relief|Timothy Deer|(304) 347-6144|Diana.tolentino@stfh.net
111500|NCT01076270|Fred Hutchinson Cancer Research Center|Dr. William Bensinger|206-667-4730|wbensing@fredhutch.org
111501|NCT01076283|Brown University|Lorenzo Leggio, MD|401-863-1000|lorenzoleggio@gmail.com
111502|NCT01076296|GE Healthcare|Anita Johnson|262-548-2825|Anita.Johnson@ge.com
111503|NCT01076335|The University of Texas (UT) MD Anderson Cancer Center|Lance Pagliaro, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org
111504|NCT01076348|Medtronic, Inc.|Stefanie Lorinser, Sr. Clinical Research Specialist|763-526-2742|stefanie.lorinser@medtronic.com
111505|NCT01076361|Medtronic|4968 Clinical Trial Leader||medtroniccrmtrials@medtronic.com
111506|NCT01076452|Hines Veterans Affairs Hospital Center for Management of Complex Chronic Care|Frances M. Weaver, Ph.D|708-202-8387 ext 25866|frances.weaver@va.gov
111507|NCT01076504|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
111508|NCT01076647|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
119442|NCT00546871|Baxter Healthcare Corporation|Richard Schiff, MD, PhD, Medical Director, Specialty Products TA, BioTherapeutics||richard_schiff@baxter.com
111510|NCT01076959|Abbott|Global Medical Services|800-633-9110|
111511|NCT01076972|Abbott|Global Medical Services|800-633-9110|
111512|NCT01076985|Abbott|Global Medical Services|800-633-9110|
111513|NCT01077024|University of Cincinnati Addiction Sciences Division|Dr. Theresa Winhusen|513-585-8227|winhust@ucmail.uc.edu
111514|NCT01077050|SciBase|Director of Clinical Operations|+46841062001|per.svedenhag@scibase.se
111515|NCT01077063|Sidney Kimmel Comprehensive Cancer Center at JHMI|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu
111516|NCT01077076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
111517|NCT01077128|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
111518|NCT01077193|Ethicon-Endo Surgery, Inc.|Michael L. Schwiers|513-337-1172|mschwier@its.jnj.com
111519|NCT01077258|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
111520|NCT01077271|Abbott|Global Medical Services|1-800-633-9110|
111521|NCT01077284|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
111522|NCT01077310|Yale School of Medicine|Principle Investigator|203-737-2883|sandra.springer@yale.edu
111523|NCT01077323|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
111524|NCT01077362|Janssen Research & Development, LLC|Senior Director, Clinical Research|1-800-526-7736|
111525|NCT01077375|Forest Research Institute|Allan Spera, Director, Clinical Development|(201) 427-8399|Allan.Spera@frx.com
111526|NCT01077401|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu
111527|NCT01070888|Boston Children's Hospital|Wanda Phipatanakul|857-218-5336|wanda.phipatanakul@childrens.harvard.edu
111528|NCT01070953|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111529|NCT01070966|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111530|NCT01070979|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
111531|NCT01071044|Rochester Center for Behavioral Medicine|Joel L. Young, MD|248-608-8800 ext 261|jyoung@rcbm.net
111532|NCT01071070|Abbott|Global Medical Services|800-633-9110|
111533|NCT01071083|Biogen Idec Inc|Biogen Idec Medical Director|1-617-679-2000|neurologyclinicaltrials@biogenidec.com
111534|NCT01071096|Clinvest|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com
111535|NCT01071200|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
111536|NCT01071252|Novartis Pharmaceuticals|Study Director|862-778-8300|
111537|NCT01071278|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111538|NCT01071395|Rush University of Medical Center|Dr. Christopher G. Goetz|312-942-8016|cgoetz@rush.edu
111540|NCT01071538|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu
111541|NCT01071798|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com
111542|NCT01077544|Novartis Pharmaceuticals|Study Director|82-778-8300|trialandresults.registries@novartis.com
111543|NCT01077596|GlaxoSmithKline|GSK Response Center|866-435-7343|
111544|NCT01077622|GlaxoSmithKline|GSK Response Center|866-435-7343|
111545|NCT01077713|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com
111546|NCT01077739|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
111547|NCT01077804|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
111548|NCT01077817|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111549|NCT01077830|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111550|NCT01077856|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111551|NCT01078441|ECOG Statistical Office|Study Statistician|617-632-3012|
111552|NCT01078454|ECOG Statistical Office|Study Statistician|617-632-3012|
111553|NCT01078545|Abbott|Global Medical Services|1-800-633-9110|
111554|NCT01078571|Abbott|Global Medical Services|1-800-633-9110|
111555|NCT01078584|Abbott|Global Medical Services|800-633-9110|
111556|NCT01078623|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com
111557|NCT01078662|AstraZeneca|Anitra Fielding|+44 1625 517178|aztrial_results_posting@astrazeneca.com
111558|NCT01078675|AstraZeneca, R&D, B&I|Niklas Berglind, GPS|+46317766310|niklas.berglind@astrazeneca.com
111559|NCT01078753|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
111560|NCT01078805|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111561|NCT01078844|Johns Hopkins University School of Medicine|Eric Samstad, MD|410-550-0171|esamsta1@jhmi.edu
119443|NCT00509002|The University of Texas (UT) MD Anderson Cancer Center|George R Blumenschein Jr, MD, Professor, Thoracic/Head & Neck Med. Oncology|713-792-7734|CR_Study_Registration@mdanderson.org
111563|NCT01078922|Oncology Specialists, SC|Research Manager|847-410-0658|ktolzien@oncmed.net
111564|NCT01078974|Dana-Farber Cancer Institute|Steven P. Treon|617-632-2681|steven_treon@dfci.harvard.edu
111565|NCT01079130|Novartis Pharmaceuticals|Study Director|862-778-8300|
111566|NCT01079143|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
111567|NCT01079182|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
111568|NCT01079195|Abbott|Global Medical Services|1-800-633-9110|
111569|NCT01079234|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
111570|NCT01079299|Center for Curative and Palliative Wound Care Calvary Hospital|Oscar M. Alvarez / Principal Investigator|718-518-2577|oalvarez@calvaryhospital.org
111571|NCT01079390|Mass General Hospital|Jian Kong|617-726-7893|kongj@nmr.mgh.harvard.edu
111572|NCT01079598|Medtronic|Stephanie Brucato, Principal Clinical Research Specialist|508-261-8000|stephanie.m.brucato@medtronic.com
119444|NCT00499122|UM/Sylvester Comprehensive Cancer Center|Alberto Montero MD|305-243-3771|amontero2@med.miami.edu
111574|NCT01079832|Case Comprehensive Cancer Center|Dr. Charles Kunos|330-375-4485|kunosc@summahealth.org
111575|NCT01079936|University of Texas (UT) MD Anderson Cancer Center|Muzaffar H. Qazilbash, Professor, Stem Cell Transplantation||CR_Study_Registration@mdanderson.org
111576|NCT01079949|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
111577|NCT01079962|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
111578|NCT01079988|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
111579|NCT01080118|Northwestern University Feinberg School of Medicine|Dr. Gildasio DeOliveira|312-472-3573|g-jr@northwestern.edu
111580|NCT01080131|Novartis Pharmaceuticals|Study Director|862 778-8300|
111581|NCT01080209|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
111582|NCT01080248|Washington University School of Medicine|Joel Picus, M.D.|314-362-5740|jpicus@dom.wustl.edu
111583|NCT01080261|Boston Scientific Corporation|Ruth Starzyk, Ph.D.|508-683-6577|ruth.starzyk@bsci.com
111584|NCT01080300|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com
111585|NCT01080326|Mayo Clinic|Juliane Bingener-Casey, M.D.|507-538-9007|BingenerCasey.Juliane@mayo.edu
111587|NCT01080625|SNUH|Chul-Woo Jung/ Assistant professor|82-2-2072-0640|spss@snuh.org
111588|NCT01080677|Stanford University School of Medicine|Professor of Neurology|650-723-5184|chos@stanford.edu
111589|NCT01080768|Novartis Pharmaceuticals|Study Director|862-778-8300|
111590|NCT01080794|Beth Israel Deaconess Medical Center|Dr. Alvaro Pascual-Leone|(617) 667-0203|apleone@bidmc.harvard.edu
111591|NCT01080807|Cephalon, Inc.|Vice President, Medical Affairs|610-727-6353|
111592|NCT01074931|Abbott|Global Medical Services|1-800-633-9110|
111593|NCT01074944|Sanofi|Trial Transparency Team||Contact­US@sanofi.com
111594|NCT01081041|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111595|NCT01081132|Shire Development LLC|Study Physician|+1 866 842 5335|
111596|NCT01081145|Shire Development LLC|Study Physician|+1 866 842 5335|
111597|NCT01081249|University of California, San Diego Medical Center, Department of Psychiatry|Dr. Kai MacDonald|619-203-7393|
111598|NCT01081301|University of Alberta|Dr. Wendy Duggleby|780-492-8660|wendy.duggleby@ualberta.ca
111599|NCT01081873|Abbott|Global Medical Services|800-633-9110|
111600|NCT01081886|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com
111601|NCT01081912|Zogenix|Kevin Romanko|(510) 550-8323|kromanko@zogenix.com
111602|NCT01081951|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
111603|NCT01082081|GlaxoSmithKline|GSK Response Center|866-435-7343|
111604|NCT01082159|Vertos Medical|VP Clinical Research|949-349-0008 ext 216|cmyers@vertosmed.com
111605|NCT01082211|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
111606|NCT01082328|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
111607|NCT01082367|Novartis|Study Director|862-778-8300|
111608|NCT01082380|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111609|NCT01082575|Covidien|Fran Haury Clinical Program Manager II|303 305-2314|fran.haury@covidien.com
111610|NCT01082588|Massachusetts General Hospital|Dr. David Henderson|617-912-7800|dchenderson@partners.org
111612|NCT01082640|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
111613|NCT01082874|Population Health Research Institute|P.J. Devereaux, MD, PhD, FRCPC|905-527-4322 ext 40654|philipj@mcmaster.ca
111614|NCT01082939|The University of Texas MD Anderson Cancer Center|William G. Wierda, MD, PhD, BS / Associate Professor|713-745-0428|eharriso@mdanderson.org
111615|NCT01082952|King Saud University|Dr. Rabih Halwani|00966551307134|rhalwani@ksu.edu.sa
111616|NCT01082965|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111617|NCT01083121|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
111618|NCT01083160|Abbott|Global Medical Services|1-800-633-9110|
111619|NCT01083173|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
111620|NCT01083186|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
111621|NCT01083199|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com
111622|NCT01083316|Boston Medical Center|Vaishali Sanchorawala|6176386521|vaishali.sanchorawala@bmc.org
111623|NCT01083472|LifeCell|Sandra VanGuldener|310612504695|svanguldener@lifecell.com
111624|NCT01083485|Mundipharma Research|Maggie Wilson|+ 4401223 424444 ext 2303|
111625|NCT01083576|US Army Medical Materiel Development Activity (USAMMDA)|Director, Division of Regulated Activites and Compliance|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil
111626|NCT01083602|Novartis Pharmaceuticals|Study Director|862-778-8300|
111627|NCT01083641|University of Wisconsin Carbone Cancer Center|Dr. Kari Wisinski|608-262-2876|kbwisinski@medicine.wisc.edu
111628|NCT01083654|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu
111629|NCT01083667|HSS/WCMC|Dale Lange|6467978917|langed@hss.edu
111630|NCT01083680|AbbVie|Global Medical Information|800-633-9110|
111631|NCT01083693|Abbott|Global Medical Services|1-800-633-9110|
111632|NCT01083706|Fred Hutchinson Cancer Research Center|Bart Scott|206-667-1990|bscott@fredhutch.org
111633|NCT01083732|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127 ext +1|clintriage.rdg@boehringer-ingelheim.com
111634|NCT01083758|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com
111635|NCT01083771|Brown University Oncology Research Group (BrUOG)|Anthony Mega, MD|4018633000|kayla_rosati@brown.edu
111636|NCT01083810|Abbott|Global Medical Services|1-800-633-9110|
111637|NCT01083849|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
111638|NCT01083901|University of Colorado Denver|Catherine M. Jankowski|303-724-7383|catherine.jankowski@ucdenver.edu
111639|NCT01083979|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu
111640|NCT01084005|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
111641|NCT01084083|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012|
111642|NCT01084135|Duke University Medical Center|Jane Ann Baker,MS, CGC|919-668-4576|janeann.mckillop@duke.edu
111643|NCT01084148|Orfagen|Clinical Project Manager|0033 5 34 50 64 62|caroline.miklaszewski@orfagen.com
111644|NCT01084174|Johns Hopkins University|Robert A. Wood, MD|410-955-5883|rwood@jhmi.edu
111645|NCT01084239|Massachusetts Genderal Hospital Biostatistics Center|Pearl Zakroysky|617 724 0309|pzakroysky@partners.org
111646|NCT01084265|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
119445|NCT00396006|Baxter Healthcare Corporation|David Gelmont, MD Global Medical Director, Head of Specialty Products TA, BioTherapeutics||david_gelmont@baxter.com
111648|NCT01077921|Duke University Medical Center|Laura De Castro, MD, MHSc|(412) 623-7026|laura.decastro@dm.duke.edu
111649|NCT01077960|EMD Serono|EMD Serono Medical Information|1-888-ASK-SERO (275-7376)|
111650|NCT01077973|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111651|NCT01078090|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
111652|NCT01078116|Abbott|Global Medical Services|1-800-633-9110|
111653|NCT01078155|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
111654|NCT01078207|Covidien|Fran Haury, RRT Research Coordinator, Clinical Affairs|303 305-2314|fran.haury@covidien.com
111655|NCT01078220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111656|NCT01078233|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111657|NCT01078246|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111658|NCT01078298|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111659|NCT01078363|Stanford University|William F. Fearon, M.D.|650 725-2621|wfearon@stanford.edu
111660|NCT01078376|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
111661|NCT01078389|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com
111662|NCT01078402|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
111663|NCT01084538|Abbott|Global Medical Services|1-800-633-9110|
111664|NCT01084551|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
111665|NCT01084603|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com
111666|NCT01084668|Abbott|Global Medical Services|800-633-9110|
111668|NCT01086410|GlaxoSmithKline|GSK Response Center|866-435-7343|
111669|NCT01086423|GlaxoSmithKline|GSK Response Center|866-435-7343|
111670|NCT01086475|Christian Sarkine Autism Treatment Center|Dr. Minshawi|317-944-8162|nminshaw@iupui.edu
111671|NCT01086605|Mayo Clinic|Alvaro Moreno-Asptia, M.D.|507/284-1159|morenoaspitia.alvaro@mayo.edu
111672|NCT01086761|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
111673|NCT01086852|Bio Products Laboratory|Miranda Norton|020 8 957 2661|miranda.norton@bpl.co.uk
111674|NCT01086969|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
111675|NCT01087489|Miami Veterans Affairs Medical Center|Dr. Ninel Gregori, MD|305-575-7000 ext 3081|ngregori@med.miami.edu
111676|NCT01087502|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
111677|NCT01087528|Givenimaging|Hilla Debby/Director of clinical affairs|972490977740 ext 77740|hila.debby@givenimaging.com
111678|NCT01087541|Jordi Gol i Gurina Foundation|Cecilia Borau|34 934824617|cborau@idiapjgol.org
111679|NCT01087723|The Medicines Company|Global Health Science Center|800-388-1183|
111680|NCT01087736|University of California, San Francisco|David L. Pennington, PhD (Research Psychologist II)|415-221-4810 ext 4504|david.pennington2@va.gov
111681|NCT01087762|Cares|UCB|+1887822 ext 9493|
111682|NCT01087788|Cares|UCB|+1877 822 ext 9493|
111683|NCT01087801|ChiRhoClin, Inc.|Edward Purich, Ph.D.|301-476-8388|mdoerr@chirhoclin.com
111684|NCT01087814|University of Minnesota|Ann Seguin|612-625-7472|segu0017@umn.edu
111685|NCT01087905|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.medicine.wisc.edu
111686|NCT01087918|UZurich|Hubertus van Hedel, PhD|+41 44 762 52 91|hubertus.vanhedel@kispi.uzh.ch
111687|NCT01087944|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
111688|NCT01087957|Innovative Neurotronics|Helen Rogers PT, PhD|512-721-1922|hrogers@ininc.us
111689|NCT01087970|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111690|NCT01087996|The EMMES Corporation|Adam Mendizabal|301 251 1161 ext 221|amendizabal@emmes.com
111691|NCT01088295|University of California, Los Angeles|Jordan E. Lake, M.D., M.Sc.|(310)557-1891|jlake@mednet.ucla.edu
111692|NCT01088399|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111693|NCT01088438|University of Illinois at Chicago|Dr. Alan Schwartz|312-996-2070|alansz@uic.edu
111694|NCT01088464|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111695|NCT01088503|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111696|NCT01088529|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com
111697|NCT01088646|Givenimaging|Hilla Debby/Director of clinical affairs|97249097774 ext 7774|hila.debby@givenimaging.com
111698|NCT01088672|Stryker NV|Amelia Saliba, AIS Clinical Program Manager|510-413-2500|aisstudies@stryker.com
111699|NCT01088711|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111700|NCT01081626|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
111701|NCT01081665|Abbott|Global Medical Services|1-800-633-9110|
111702|NCT01081769|Janssen-Cilag Germany|EMEA Medical Affairs Director Psychiatry||ClinicalTrialDisclosure@its.jnj.com
111703|NCT01081795|Janssen Pharmaceutical KK Japan|Group Manager|+81-3-4411-5072|
111704|NCT01081834|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736|
111705|NCT01088984|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com
111706|NCT01088997|Children's Hospital of Philadelphia|Haresh Kirpalani, MD, MSc|215-590-2455|kirpalanih@email.chop.edu
111707|NCT01089023|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
111708|NCT01089062|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com
111709|NCT01089127|Novartis Pharmaceuticals|Study Director|862 778-8300|
111710|NCT01090011|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
111711|NCT01090050|Clinvest/A Division of Banyan Group Inc.|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com
111712|NCT01090063|Tufts Medical Center|Dr. Alice Gottlieb|617-636-7462|Agottlieb@tuftsmedicalcenter.org
111713|NCT01090076|Changi General Hospital|Mr Alvin Wong|68504627|alvin_wong@cgh.com.sg
111714|NCT01090102|University of California, San Francisco|Dr. Ma Somsouk|415-206-6480|somsoukma@medsfgh.ucsf.edu
111715|NCT01090180|Veterans Affairs North Texas Health Care System|Alina Suris|817-715-0625|alina.suris@va.gov
111716|NCT01090310|Novartis|Study Director|862-778-8300|
111717|NCT01090323|Novartis Pharmaceuticals|Study Director|862-778-8300|
121663|NCT00003535|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
111719|NCT01090453|GlaxoSmithKline|GSK Response Center|866-435-7343|
111720|NCT01090479|Northwestern University|Michael Murray, MD|312-926-4444|m.murray8278@gmail.com
111721|NCT01090739|University of Michigan, Professor of Obstetrics and Gynecology|Dee Fenner, MD, Study Coordinating Investigator|734-647-5866|deef@med.umich.edu
111722|NCT01090752|University Hospital Geneva and Lausanne, Switzerland|Zanchi Anne, MD|0041213140775|azanchidel@hotmail.com
111723|NCT01090765|National Cancer Institute|Dr. William Dahut|301-496-4251|dahutw@mail.nih.gov
111724|NCT01090973|H. Lee Moffitt Cancer Center and Research Institute|Celeste Bello, M.D.|813-745-8623|celeste.bello@moffitt.org
111725|NCT01091103|Medivation, Inc.|Mohammad Hirmand, MD, VP, Clinical Development|415-829-4126|mohammad.hirmand@medivation.com
111726|NCT01091116|Menarini-Ricerche|Clinical Research Director|+39-055-56809990|
111727|NCT01091155|novoGI|Eran Choman, VP Clinical Affairs & Statistics|+972 9 8603000|eran.choman@novogi.com
111728|NCT01091246|MedImmune, LLC|Judy Falloon, MD/ Sr Director Clinical Development|301-398-0000|falloonj@medimmune.com
111729|NCT01091259|Perlmutter Cancer Center at NYU Lagone|Franco Muggia, MD|212-263-6485|Franco.Muggia@nyumc.org
111730|NCT01091454|Mayo Clinic|Alvaro Moreno-Aspitia MD|507-284-1159|morenoaspitia.alvaro@mayo.edu
111731|NCT01091519|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111732|NCT01091662|Sunovion Phamaceuticals Inc.|Eslicarbazepine acetate Medical Director|866-503-7813|clinicaltrialsdisclosure@sunovion.com
111733|NCT01091675|Unidad de Reumatología, Hospital Parc Tauli de Sabadell. Institut Universitari UAB|Dr. Jordi Gratacós Masmitjá|937.23.10.10|jgratacosmas@gmail.com
111734|NCT01091948|Cleveland Clinic Foundation|Dr. Basem Abdelmalak|216-444-3746|abdelmb@ccf.org
111735|NCT01091974|University of Rochester Medical Center|Joseph A. Roscoe Ph.D.|(585) 275-9962|Joseph_Roscoe@URMC.Rochester.edu
111736|NCT01092338|Children's Hospital of Philadephia|Virginia Stallings|215-590-1664|stallingsv@email.chop.edu
111737|NCT01084707|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com
111738|NCT01084759|SKCCC at Johns Hopkins|Dr. Samuel Denmeade|410-955-8875|denmesa@jhmi.edu
111739|NCT01085006|Tehran University of Medical Sciences|Dr. Laleh Eslamian|+982184902415|leslamian@tums.ac.ir
111740|NCT01085045|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com
111741|NCT01085136|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
111742|NCT01085201|BloodCenter of Wisconsin|Dr. Joshua J. Field|414-937-3848|joshua.field@bcw.edu
111743|NCT01085214|Massey Cancer Center, Virginia Commonwealth University|Steven Grant, M.D.|804-828-5211|stgrant@vcu.edu
111744|NCT01085318|EMD Serono, Inc.|Fernando Dangond, MD FAAN|781-681-2348|fernando.dangond@emdserono.com
111745|NCT01085331|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
111746|NCT01085357|Transcend Medical, Inc.|Vice President of Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com
111747|NCT01085500|Mayo Clinic|Benjamin Zendejas, MD|507-538-5413|zendejas.benjamin@mayo.edu
111748|NCT01085513|Given Imaging|director of clinical affairs|+972-4-9097774|Hila.debby@givenimaging.com
111749|NCT01085539|Covidien|Fran Haury, RRT Research Coordinator|303 305-2314|fran.haury@covidien.com
111750|NCT01085591|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660|
111751|NCT01085643|Cedars-Sinai Medical Center|Edy Soffer, MD|(310) 423-6143|edy.soffer@cshs.org
111752|NCT01085682|The Catholic University of Korea|Kun-Ho Yoon, professor|82-2-2258-8281|yoonk@catholic.ac.kr
111753|NCT01085734|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com
111754|NCT01085760|Mayo Clinic|Dr. Jayant A. Talwalkar|507-538--4877|talwalkar.jayant@mayo.edu
111755|NCT01085786|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|886-7-3462121 ext 8233|pihsu@isca.vghks.gov.tw
111756|NCT01085825|Planned Parenthood of NYC|Research Director|212-274-7255|cti@ppnyc.org
111757|NCT01085903|University of Arkansas for Medical Sciences|Mark Mennemeier, PhD|501 526 7773|msmennemeier@uams.edu
111758|NCT01085968|VA Overton Brooks|Elizabeth Disbrow|318-6757184|edisbr@lsuhsc.edu
111759|NCT01086033|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
111760|NCT01086215|Boston Scientific Corporation|DeeAnn Tinjum|763-450-8707|deeann.tinjum@bsci.com
111761|NCT01092416|Cardiovascular Systems, Inc.|Clinical Project Manager|6512591600|clinicaltrials_csi@csi360.com
111762|NCT01092442|CryoLife, Inc.|Scott B. Capps, MS|800-438-8285|clinicaltrialregistration@cryolife.com
111763|NCT01092507|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
111764|NCT01092546|GE Healthcare|Paul Sherwin, M.D.|609-514-6820|Paul.Sherwin@ge.com
111765|NCT01092559|GeNO, LLC|Director of Clinical Development|321-785-2613|matthew.rush@genollc.com
111766|NCT01092637|National Perinatal Epidemiology Unit, University of Oxford|Clinical Trials Unit|+44 1865 289700|ctu@npeu.ox.ac.uk
111767|NCT01092663|KineMed, Inc.|Carine Beysen, PhD|510-655-6525 ext 123|cbeysen@kinemed.com
111768|NCT01092702|Mayo Clinic|J Taylor Hays. MD|507-266-1944|nicotineresearch@mayo.edu
111769|NCT01095094|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org
111770|NCT01095250|Novartis Pharmaceuticals|Study Director|862-778-8300|
111771|NCT01095497|ViroPharma|Chief Scientific Officer|610-458-7300|
111772|NCT01095510|Shire|Jennifer Schranz, MD|484-595-8940|jschranz@shire.com
111773|NCT01095653|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com
111774|NCT01095666|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com
111775|NCT01095757|Winship Cancer Institute Emory University|Dr. Edmund Waller|404-727-4995|ewaller@emory.edu
111776|NCT01095796|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
111777|NCT01095835|Hoffmann-La Roche|Medical Communications|800-821-8590|
111778|NCT01095887|Mayo Clinic|Dr. Mark D. Stegall|507-266-2812|stegall.mark@mayo.edu
111779|NCT01095978|Abbott|Global Medical Services|1-800-633-9110|
111780|NCT01096017|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com
111781|NCT01096056|GlaxoSmithKline|GSK Response Center|866-435-7343|
111782|NCT01096186|Impax Laboratories, Inc.|Daven Mody, PharmD, MBA, Director, Regulatory Affairs|510-240-6073|dmody@impaxlabs.com
111783|NCT01096316|Dept Psychiatry & Behavioral Sciences University of Washington|Jurgen Unutzer MD MPH MA, Professor and Chair|206-543-3752|unutzer@uw.edu
111784|NCT01096342|Mayo Clinic Cancer Center|Shaji Kumar, M.D.||kumar.shaji@mayo.edu
111785|NCT01096446|OSF Saint Francis Medical Center|Dr. Kamlesh Macwan|309-624-0611|kamlesh.s.macwan@osfhealthcare.org
111786|NCT01096550|Friends Research Institute|Dr. Shannon Gwin Mitchell|410-837-3977 ext 238|smitchell@friendsresearch.org
111787|NCT01096589|Centre for Reasearch and Implementation of Clinical Practice (CRICP)|Prof. Christine Moffatt, Principal Investigator|+44 20 73 51 14 11|christine.moffatt@cricp.org.uk
111788|NCT01096680|Shire Pharmaceutical|Timothy Whitaker, MD||twhitaker@shire.com
111789|NCT01096771|Indiana University School of Medicine|Dr. William Carlos|3178807819|wcarlos@iu.edu
111790|NCT01096784|Shire|Study Physician||ClinicalTransparency@shire.com
111791|NCT01096810|Mount Sinai|Dr. Sundar Jagannath|2122417873|sundar.jagannath@mountsinai.org
111792|NCT01096823|Pediatric Pain and Palliative Care Program; University of California, Los Angeles|Dr. Lonnie K. Zeltzer, MD|(310) 825-0731|LZeltzer@mednet.ucla.edu
111793|NCT01096875|Ankara University Medical Faculty, Department of Cardiovascular Surgery|Prof. A. Ruchan Akar MD., FRCS(CTh).|+90 533 646 06 84|akarruchan@gmail.com
111794|NCT01097005|Mylan EPD Japan|Takao Miki, Medical Affairs||takao.miki@mylan.com
111795|NCT01097057|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org
121664|NCT00003472|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com
111798|NCT01097421|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
111799|NCT01097460|Merrimack Pharmaceuticals|Dr. Victor Moyo|1-617-441-1094|vmoyo@merrimackpharma.com
111800|NCT01089231|Leibniz Universität Hannover|M. Sc. Simone Schmidt|+49 (511) 762 5931|Schmidt@nutrition.uni-hannover.de
111801|NCT01089361|Beth Israel Deaconess Medical Center|Dr. Daniel Talmor|617-754-2675|dtalmor@bidmc.harvard.edu
111802|NCT01089413|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
111803|NCT01089504|University of Rochester|Ronnie Guillet|585-275-6209|ronnie_guillet@urmc.rochester.edu
111804|NCT01089517|Ophthotech|Jeffrey Nau|646-573-7045|jeff.nau@ophthotech.com
111805|NCT01089543|Eisai Inc.|Yoshiumi Okubo, Study Director|+81-3-3817-3908|y4-okubo@hhc.eisai.co.jp
111806|NCT01089556|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111807|NCT01089569|International Diabetes Center|Dr. Richard M. Bergenstal|952-993-1913|richard.bergenstal@parknicollet.com
111808|NCT01089582|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111809|NCT01089595|Fox Chase Cancer Center|Margaret von Mehren, Principal Investigator|215-728-4300|margaret.vonmehren@fccc.edu
111810|NCT01089608|Laboratoires Thea|Dr Pascale POULIQUEN|0473981436|p.pouliquen@laboratoires-thea.fr
111811|NCT01089751|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
111812|NCT01097616|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111813|NCT01097629|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111814|NCT01097655|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110|
111815|NCT01097668|Apitope Technology (Bristol) Ltd|Chief Executive Officer|+44(0)117 3707720|keith.martin@apitope.com
111816|NCT01097694|Brigham and Women's Hopsital|Elliot Israel, MD|617-732-8110|eisrael@partners.org
111817|NCT01097785|University of Missouri|Paul Fadel|1-573-884-5220|fadelp@health.missouri.edu
111818|NCT01097863|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com
111819|NCT01098032|Clinica Mediterranea|Dr. Carlo Briguori, Principal Investigator|+390817259 ext 764|carlobriguori@clinicamediterranea.it
111821|NCT01098097|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
111822|NCT01098110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111823|NCT01098162|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
111824|NCT01098240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111825|NCT01098253|University of Pennsylvania, Perelman School of Medicine|Dr. Hillary R Bogner|215-746-4181|hillary.bogner@uphs.upenn.edu
111826|NCT01098305|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu
111827|NCT01098318|University of Pennsylvania|Dr. Jun Mao, Associate Professor|215-746-2481|jun.mao@uphs.upenn.edu
111828|NCT01098461|GlaxoSmithKline|GSK Response Center|866-435-7343|
111829|NCT01098487|GlaxoSmithKline|GSK Response Center|866-435-7343|
111830|NCT01098500|GlaxoSmithKline|GSK Response Center|866-435-7343|
111831|NCT01098539|GlaxoSmithKline|GSK Response Center|866-435-7343|
111832|NCT01098578|Ottawa Hospital Research Institute|Dr. Shaun Kilty|613-798-5555 ext 18514|skilty@ottawahospital.on.ca
111833|NCT01098747|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111834|NCT01098812|Abbott Medical Optics|Kristen Featherstone|714-247-8621|kristen.featherstone@amo.abbott.com
111835|NCT01098851|Covidien|Fran Haury|303 305-2314|fran.haury@covidien.com
111836|NCT01099111|KFMC|Dr. Ahmed Al Omair|+96612889999 ext 8771|aalomair@kfmc.med.sa
111837|NCT01099202|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org
111838|NCT01099215|Shire Regenerative Medicine|Eric Goldberg, MD, Sr. Medical Director|(858) 754-5705|egoldberg@shire.com
111839|NCT01099267|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
111840|NCT01099358|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111841|NCT01099397|University of Florida|Mariellen Moore|352-273-6381|marielm@ufl.edu
111842|NCT01099475|Maastricht University Medical Centre|Dr. MAJ van den Broek, MD|31 43 3884502|m.vandenbroek@maastrichtuniversity.nl
111843|NCT01099579|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
111844|NCT01099618|Emory University SOM|Dawn Smiley|4047781665|dsmiley@emory.edu
111845|NCT01099709|Purdue Pharma LP|Stephen C. Harris, MD|203-588-7592|Stephen.Harris@pharma.com
111846|NCT01099761|Acceleron Pharma|Dr. Kenneth Attie|617-649-9200 ext 350|kattie@xlrn.com
111847|NCT01099774|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
111848|NCT01099917|Memorial Sloan Kettering Cancer Center|Dr. Barrie Cassileth|646-888-0801|Cassileth@mskcc.org
111849|NCT01100073|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
111850|NCT01100086|Purdue Pharma L.P.|Stephen Harris, M.D.|203-588-7592|Stephen.Harris@Pharma.com
111851|NCT01100112|Santarus, Inc.|Michael Huang, MD, Senior Medical Director, Clinical Research|8583145700|contact@santarus.com
111852|NCT01100242|University of New Mexico|Richard Lauer, MD|5052725837|rlauer@salud.unm.edu
111853|NCT01100255|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|6507236158|carolynrodriguez@stanford.edu
111854|NCT01100268|Columbia University Department of Psychiatry|Dr. Carolyn Rodriguez|(646) 774-8061|cr2163@columbia.edu
111855|NCT01100307|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111856|NCT01100320|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com
111857|NCT01100437|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111858|NCT01092728|The University of Texas (UT) MD Anderson Cancer Center|Kevin Kim, MD/Melanoma Medical Oncology|1-877-MDA-6789|CR_Study_Registration@mdanderson.org
111859|NCT01092767|Medtronic, Inc., Aortic and Peripheral Vascular|Laura Regan, MPH - Study Lead|707-591-2743|laura.e.regan@medtronic.com
111860|NCT01092780|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111861|NCT01092832|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111862|NCT01092910|Envoy Medical Corp.|Elizabeth Anderson, PhD|651-361-8080|landerson@envoymedical.com
111863|NCT01092923|Austin Health|Dr Phil Peyton|9496 5000 ext 5704|phil.peyton@austinhealth.org.au
111864|NCT01093014|University of Iowa / Iowa City VA Medical Center|Richard K. Shields PhD, PT|319-335-9791|richard-shields@uiowa.edu
111865|NCT01093027|Mayo Clinic|Virgilio Evidente MD|480-301-8000|evidente.virgilio@mayo.edu
111866|NCT01093222|SWOG|Study Statistician|206-667-4623|
111867|NCT01093417|University Hospitals Case Medical Center|Grace McComsey, MD|2168443607|gam9@case.edu
111868|NCT01093469|Wake Forest|Dr Alan Fleischer|336-716-3775|adclark@wakehalth.edu
111869|NCT01093521|University of Washington|A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients|206-543-3166|goss@u.washington.edu
119446|NCT00313144|Baxter Healthcare Corporation|David Gelmont, MD Global Medical Director, Head of Specialty Products TA, BioTherapeutics||david_gelmont@baxter.com
111871|NCT01093599|University of Wisconsin|James M. Davis MD, Assistant Professor, Duke University|608-217-9405|jjamesdavis@hotmail.com
111872|NCT01093625|Vistakon|Katherine E. Osborn||clinicalstudies@its.jnj.com
111873|NCT01093651|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu
111874|NCT01093690|Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University|Suthinee Ithimakin, MD|6624197000 ext 4489|aesi105@yahoo.co.th
111875|NCT01093755|Mayo Clinic|Prasad Iyer, MD|507-284-0970|Iyer.Prasad@mayo.edu
111876|NCT01093794|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
111877|NCT01093846|Novartis Pharmaceuticals|Study Director|862-778-8300|
111878|NCT01093976|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu
111879|NCT01094119|Cleveland Clinc|Daniel Sessler|216-444-4900|DS@OR.org
111880|NCT01094171|GlaxoSmithKline|GSK Response Center|866-435-7343|
111881|NCT01094522|Stanford University School of Medicine|Dr. Gregory Hammer|6507367359|ham@stanford.edu
111882|NCT01094548|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
111883|NCT01094561|Columbia University|Elizabeth Hecht, MD|(212)305-6510|eh2560@cumc.columbia.edu
111884|NCT01094574|Stanford School of Medicine|Martin Angst, MD, Professor, Dept. of Anesthesia, Stanford SOM|650-498-5109|ang@stanford.edu
111885|NCT01094704|UNC-Chapel Hill|Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu
111886|NCT01094730|Johnson & Johnson Vision Care|John R. Buch, O.D., M.S., F.A.A.O., Principal Research Optometrist|1-904-443-1707|jbuch@its.jnj.com
119447|NCT00307294|University of Pittsburgh|Rita Johnson RN BSN CCRC|412-647-8571|johnsonr1@upmc.edu
111888|NCT01094808|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu
111889|NCT01094886|Janssen Scientific Affairs, LLC|VP Medical Affairs, Internal Medicine|1 908 218-7250|
111890|NCT01100502|Seattle Genetics Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com
111891|NCT01100567|Boston Children's Hospital|Dr. Amy DiVasta, PI|6173553792|amy.divasta@childrens.harvard.edu
111892|NCT01100606|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634|
111893|NCT01100658|Masonic Cancer Center, University of Minnesota|Alicia Kunin-Batson|612-624-6931|kunin003@umn.edu
111894|NCT01100723|University of Colorado|Dr. David M. Spiegel|303-724-7797|david.spiegel@ucdenver.edu
111895|NCT01100762|University of Maryland, Baltimore|Gad Alon, PhD, PT|410-706-7733|galon@som.umaryland.edu
111896|NCT01101165|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com
111897|NCT01101178|Purdue Pharma L.P.|Clinical Leader|800-733-1333|
111898|NCT01101191|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com
111899|NCT01101308|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com
111900|NCT01101321|Purdue Pharma L.P.|Clinical Leader|800-733-1333|
111901|NCT01101464|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com
111902|NCT01101477|Chang Gung Memorial Hospital|Dr. Ting-Yu Lin|886 3 3281200 ext 5108|yuebaoyuebao@yahoo.com.tw
111903|NCT01101542|GlaxoSmithKline|GSK Response Center|866-435-7343|
111904|NCT01101841|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com
111906|NCT01101958|ThoraxKlinik, University of Heidelberg|Prof. Dr. F.J.F. Herth|650-216-0176|Felix.Herth@thoraxklinik-heidelberg.de
111907|NCT01101971|Queen's University|Dr. Robert Reid|6135332898 ext 32898|reidr@queensu.ca
111908|NCT01102140|University of Michigan|Dr. Jennifer Cowger|7345464911|jennifercowger@gmail.com
111909|NCT01102218|Fresenius Medical Care North America|Christina Kahn, Senior Manager of Clinical Trials|615-345-5542|christina.meng@fmc-na.com
111910|NCT01102257|Mount Sinai School of Medicine|Dr. Penny Asbell|(212) 241-7977|penny.asbell@mssm.edu
111911|NCT01102270|Brigham and Women's Hospital|Atul Malhotra|6177326488|amalhotra1@partners.org
111912|NCT01102374|University of Colorado School of Medicine|Adit Ginde, MD, MPH, Professor of Emergency Medicine|720-848-6777|adit.ginde@ucdenver.edu
111913|NCT01102413|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com
111914|NCT01102491|Joint Reconstruction Center, Seoul National University Bundang Hospital|TK Kim|82-31-787-7196|osktk@snubh.org
111915|NCT01102764|Medical University of South Carolina|Ron Acierno, PhD|843-792-2949|acierno@musc.edu
111916|NCT01102777|VA Ann Arbor Center for Clinical Management Research|Fatima Makki|+1 (734) 845-3623|Fatima.Makki@va.gov
111917|NCT01102803|Southern Methodist University|Dr. Jasper Smits|214-768-4125|jsmits@smu.edu
111918|NCT01102894|University of Minnesota|Dr. Joanne Slavin|612-624-7234|jslavin@umn.edu
111919|NCT01102972|ViiV Healthcare|GSK Response Center|866-435-7343|
111920|NCT01103063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111921|NCT01103141|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Affairs|765-463-7537|Scott.Snyder@CookMedical.com
111922|NCT01103232|Vakif Gureba Training and Research Hospital|ILHAN KARACAN|+ 90 212 4531700|ilhankaracan@hotmail.com
111923|NCT01103271|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-0838|mfava@partners.org
111924|NCT01103284|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com
111925|NCT01103323|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
111926|NCT01103362|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com
111927|NCT01103414|Mstabolic Solutions Company. LLC|Dr. Jerry Colca, President & CSO|269.343.6732|jcolca@msdrx.com
111928|NCT01103466|Coloplast A/S|Dr. Lis Hentze Poulsen|4549111111|dklhp@coloplast.com
111929|NCT01103479|Northwestern University|Kenzie A. Cameron|312-503-3910|k-cameron@northwestern.edu
111930|NCT01103492|University Hospitals Case Medical Center|Jeffrey Marks, MD|216-983-4930|Jeffrey.Marks@uhhospitals.org
111932|NCT01103713|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111933|NCT01104701|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTrasparency@astrazeneca.com
111934|NCT01104870|United Therapeutics, Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com
111935|NCT01105065|Massachusetts Eye and Ear Infirmary|Louis R. Pasquale, MD|617-573-4270|Louis_Pasquale@meei.harvard.edu
111936|NCT01105091|Actelion Pharmaceuticals, US|Wade Benton, PharmD, Director of Medical Affairs|650-808-6562|wade.benton@actelion.com
111937|NCT01105117|Actelion Pharmaceuticals, US|Wade Benton, PharmD, Director of Medical Affairs|650-808-6562|wade.benton@actelion.com
111938|NCT01105130|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu
111939|NCT01105247|Pharmacyclics|Danelle James|855-427-8846|medinfo@pcyc.com
111940|NCT01105312|Mayo Clinic|Winston Tan MD|507-284-1159|tan.winston@mayo.edu
111941|NCT01105377|Johns Hopkins Oncology Center|Nilofer S. Azad, M.D.||nazad2@jhmi.edu
111942|NCT01105533|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111943|NCT01105650|Masonic Cancer Center, University of Minnesota|Dr. Melissa Geller|612-626-3111|gelle005@umn.edu
111944|NCT01105702|Perlmutter Cancer Center at NYU Langone|Michael Gruber, MD|212-731-5577|michael.gruber@nyumc.org
111945|NCT01105754|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu
111946|NCT01105767|USUHS|LTC Michael Ellis|301-295-2254|Michael.Ellis@usuhs.edu
111947|NCT01105936|GlaxoSmithKline|GSK Response Center|866-435-7343|
111948|NCT01106014|Actelion Pharmaceuticals Ltd|Clinical trial disclosure desk||clinical-trials-disclosure@actelion.com
111949|NCT01106040|Navidea Biopharmaceuticals|Dr. Frederick Cope|614-793-7500 ext 140|fcope@navidea.com
111950|NCT01106092|GlaxoSmithKline|GSK Response Center|866-435-7343|
111951|NCT01106157|University of Florida|Michael J Haller|3522739264|hallemj@peds.ufl.edu
111952|NCT01106248|Eisai|Dr. Peter Tarassoff|888-422-4743|
111953|NCT01106287|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
111954|NCT01106326|University of Rochester|Maria Fagnano|5852758220|maria_fagnano@urmc.rochester.edu
111955|NCT01106352|Bayer|Therapeutic Area Head||Clinical-Trial-Disclosure@bayer.com
111956|NCT01106391|Cordis Corp.|Amy Berman, Associate Director Clinical Research|908-541-4347|AOrlick@its.jnj.com
111957|NCT01106404|Neuromodulation Emerging Therapy Clinical Research, Medtronic, Inc|Mark Sun, Senior Clinical Research Manager|763-526-8098|mark.sun@medtronic.com
111958|NCT01106430|Shire Development LLC|Study Physician|+1 866 842 5335|
111959|NCT01106456|The University of Kansas Medical Center|Dr. Won S. Choi|(913) 588-4742|wchoi@kumc.edu
111961|NCT01106586|Gilead Sciences, Inc|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
111962|NCT01106625|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736|
111963|NCT01106651|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise||ClinicalTrialDisclosure@its.jnj.com
111964|NCT01106677|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736|
111965|NCT01106690|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736|
111966|NCT01106846|Northwestern University|Shireen Ahmad, M.D.|321-472-3585|sah704@northwestern.edu
111967|NCT01106859|Purdue Pharma LP|Clinical Leader|800-733-1333|
111968|NCT01106911|University of Pittsburgh|Dr. Jules H. Sumkin|412-641-1976|jsumkin@upmc.edu
111969|NCT01106950|Masonic Cancer Center, University of Minnesota|Jeffrey S. Miller, M.D.|612-625-7409|mille011@umn.edu
111970|NCT01106976|VAAAHS|Nicolaas Bohnen|7349988400|Nicolaas.Bohnen@va.gov
111971|NCT01100853|University of Pennsylvania|Dr. Helen Pettinati|215-222-3200 ext 139|helenp@mail.med.upenn.edu
111972|NCT01100931|National Cancer Institute, National Institutes of Health|Dr. Giuseppe Giaccone|301-496-4916|giacconeg@mail.nih.gov
111973|NCT01100944|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov
111974|NCT01101022|Shire Pharmaceutical|Study Physician|1 866-842-5335|
111975|NCT01107197|Department of Clinical Nutrition and Dietetics, Azienda Ospedaliera “Maggiore della Carità”|Dr. Federico D'Andrea|+39 0321.373.3275|dietologia@maggioreosp.novara.it
111976|NCT01107353|Roxane Laboratories, Inc.|Anton (Tony) Amann, PhD., Executive Director, DRAMA|614-272-4785|tony.amann@boehringer-ingelheim.com
111977|NCT01107379|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com
111978|NCT01107392|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
111979|NCT01107405|Bausch & Lomb Incorporated|Tuyen Ong, MD MRCOphth|(973) 360-6389|tuyen.ong@bausch.com
111980|NCT01107418|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
111981|NCT01107457|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111982|NCT01107730|Attikon Hospital|Ioannis K. Toumpoulis|00306977243942|toumpoul@otenet.gr
111983|NCT01107743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
111984|NCT01107834|Washington University|William T. Cade|314-286-1432|tcade@wustl.edu
111985|NCT01107886|AstraZeneca LP|Boaz Hirshberg MD, MBA|1 302 885 4997|ClinicalTrialTransparency@astrazeneca.com
111986|NCT01107899|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111987|NCT01107912|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111988|NCT01107925|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
111989|NCT01108003|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
111990|NCT01108055|Stanford University|Sandy Srinivas, MD|650 498 6000|sandysri@stanford.edu
111991|NCT01108081|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov
111992|NCT01108185|Abbott|Global Medical Services|1-800-633-9110|
111993|NCT01108237|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|SHimden@its.jnj.com
111994|NCT01108263|Georgetown University|Dr. John Steinberg, Principal Investigator|202-444-0793|zr40@georgetown.edu
111995|NCT01108341|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
111996|NCT01108406|Sonitus Medical, Inc.|Lily Woodby, AuD|8668162076|lily@sonitusmedical.com
119448|NCT00242385|Baxter Healthcare Corporation|David Gelmont, MD, Global Medical Director, Head of Specialty Products TA, BioTherapeutics||david_gelmont@baxter.com
111998|NCT01108458|Stanford University Medical Center|George Albert Fisher, MD|650-725-9057|georgeaf@stanford.edu
111999|NCT01108510|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
112000|NCT01108523|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com
112001|NCT01108718|Beth Israel Medical Center|Diana Vu|212-844-6747|dvu@bethisraelny.org
112002|NCT01108731|Beth_IsraelMC|Dr Benjamin Natelson|212-844-6747|bnatelson@chpnet.org
112003|NCT01108796|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112004|NCT01108809|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112005|NCT01108835|The Chinese University of Hong Kong|Fanny Ko|85226323133|fannyko@cuhk.edu.hk
112006|NCT01109056|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
112007|NCT01109108|Boston Medical Center|Stephen I Pelton|617-414-5591|spelton@bu.edu
112008|NCT01109147|Hopital Sainte Marguerite - APHM - Service du Pr. Azorin|Dr. Eric Fakra||eric.fakra@ap-hm.fr
112009|NCT01109173|Alcon Research|Dana Sager, Clinical Manager Group Leader|1-817-551-8603|dana.sager@alconlabs.com
112010|NCT01109316|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112011|NCT01109381|Synergy Pharmaceuticals Pte Ltd|Medical Director|+64 9 522 4278|damian@pethica.net
112012|NCT01109524|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112013|NCT01109576|VHAPORHCS|Mitchel Turbin, PhD|503-220-8262|Bonnie.Becker@va.gov
112014|NCT01109602|Colorado State University, Department of Occupational Therapy|Arlene Schmid, PhD, OTR|970-491-7562|arlene.schmid@colostate.edu
112015|NCT01109849|Penn State College of Medicine|James Waxmonsky MD|7175318646|jwaxmonsky@pennstatehealth.psu.edu
112016|NCT01109979|Brigham and Women's Hospital|Ellen Seely, MD|617-732-5012|eseely@partners.org
112017|NCT01110005|Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu
112018|NCT01103934|University of Chicago|Robert M Naclerio, MD|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu
112019|NCT01103960|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112020|NCT01103973|Boston IVF|Alice D. Domar, PhD|781-434-6500|domar@domarcenter.com
112021|NCT01104103|The University of Texas Health Science Center at Houston|Dr. Richard Bradley|713-500-7878|Richard.N.Bradley@uth.tmc.edu
112022|NCT01104116|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu
112023|NCT01104155|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com
112024|NCT01104207|VA Portland Medical Center|Robert L. Folmer, Ph.D.|503-220-8262 ext 51868|Robert.Folmer@va.gov
112025|NCT01104246|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com
112026|NCT01104285|Maimonides Medical Center|Yizhak Kupfer MD|718-283-8380|ykupfer@maimonidesmed.org
112027|NCT01104311|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr
112028|NCT01104376|Indiana University|Zeruesenay Desta, PhD|317-630-8860|zdesta@iupui.edu
112029|NCT01104493|MedImmune, LLC|Dr. Robert Gasser|301-398-0000|gasserr@medimmune.com
112030|NCT01104558|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
112031|NCT01104584|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
112032|NCT01104636|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112033|NCT01104662|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660|
112034|NCT01110135|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org
112035|NCT01110187|University of Alabama at Birmingham|Jerzy P. Szaflarski, MD|205-934-3866|szaflaj@uab.edu
112037|NCT01110239|University Miami|Sebastian Koch|305 243-6733|skoch@med.miami.edu
112038|NCT01110252|Labcel|João Tadeu Ribeiro Paes|55 18 3302 5800 ext 5856|labcel.tronco@gmail.com
112039|NCT01110330|Jan-Cil Switzerland|Director Infectious Diseases|41 41 7673477|
112040|NCT01110382|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com
112041|NCT01110408|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com
112042|NCT01114945|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)
112043|NCT01114997|Cedars Sinai Medical Center|Dr. Roya Yumul|310-423-1682|Roya.Yumul@cshs.org
112044|NCT01115101|University of Rostock|Dr. Max Dieterich|+493814401 ext 4500|max.dieterich@uni-rostock.de
112045|NCT01115166|Department of Anaestesilogy and Intensive Care|Joachim Zdolsek|+46101030000|joachim.zdolsek@lio.se
112046|NCT01115452|GlaxoSmithKline|GSK Response Center|866-435-7343|
112047|NCT01115491|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
112048|NCT01115517|Robert Cizik Eye Clinic|Dr. Nan Wang|713-559-5200|nwang@cizikeye.org
112049|NCT01115556|Vitreous Retina Macula Consultants of New York|K. Bailey Freund, MD (or Galyna Ganieva, Research Manager)|212-861-9797 ext 6929|gganieva@vrmny.com
112050|NCT01115569|Zogenix|Kevin Romanko|(510) 550-8323|kromanko@zogenix.com
112051|NCT01115582|Retrophin, Inc.|Retrophin Medical Information|1-877-659 ext 5518|medinfo@retrophin.com
112052|NCT01115660|Wake Forest School of Medicine|Dr. Cheryl Bushnell|(336) 716-2357|cbushnel@wakehealth.edu
112053|NCT01115673|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com
112054|NCT01115699|Mayo Clinic|Michelle Skime, Supervisor - Senior Clinical Research Coordinator|507-255-0501|skime.michelle@mayo.edu
112055|NCT01115738|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112056|NCT01115855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112057|NCT01115933|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com
112058|NCT01115998|University of Oklahoma Health Sciences Cetner|Director of Sponsored Programs|405-271--2090|mary-cotter@ouhsc.edu
112059|NCT01116024|Medtronic, Inc.|Ryan Palmer, Principal Clinical Research Specialist|763-514-9732 ext 49732|ryan.j.palmer@medtronic.com
112060|NCT01116037|Medtronic|Ryan Palmer|+17635149732|ryan.j.palmer@medtronic.com
112061|NCT01116102|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com
112062|NCT01116232|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kadhimi, M.D.|313-576-8022|alkadhiz@karmanos.org
119449|NCT00208026|The Children's Hospital of Philadelphia|Albert C. Yan, M.D.|(215) 590-2158|Yana@email.chop.edu
112064|NCT01116466|Otto Bock Healthcare Products GmbH|Medical Affairs Manager|004315233786733|Milana.Mileusnic@ottobock.com
112065|NCT01116687|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org
112066|NCT01116882|Harvard Clinical Research Institute|Priscilla Driscoll-Shemp|617-307-5200|priscilla.driscoll-shempp@hcri.harvard.edu
112067|NCT01116921|Unviersity of Minnesota|Kari D. Roberts, MD|612-625--9577|rober694@umn.edu
112068|NCT01116934|JWGUniversity|Prof. Dr. Peter Eickholz|+49-69-6301 ext 5642|eickholz@med.uni-frankfurt.de
112069|NCT01116986|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu
112070|NCT01117012|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com
112071|NCT01117051|Movetis|Study Physician|+1 866 842 5335|
112072|NCT01117090|Medtronic Restorative Therapies Group - Targeted Drug Delivery|Restorative Therapies Group Clinical Trials||medtronicneurotrials@medtronic.com
112073|NCT01117181|Johns Hopkins|Anne Casper, MA|410-955-8183|ashankli@jhsph.edu
112074|NCT01117311|Mayo Clinic|Dr. Adrian Vella|507-284-3289|vella.adrian@mayo.edu
112075|NCT01117337|Moulana Hospital|Mohamed Ismail, Chief Consultant, Moulana Hospital, Perianthalmanna|0091-9447128511|drgargpankaj@yahoo.com, mdismail13@gmail.com
112076|NCT01117350|sanofi|Trial Transparency Team||Contact-us@sanofi.com
112077|NCT01117428|Symphogen A/S|Chief Scientific and Medical Officer|+45 8838 2600|info@symphogen.com
112078|NCT01107535|Abbott|Global Medical Services|1-800-633-9110|
112079|NCT01117454|Vanderbilt University Medical Center|Dr. Prince J. Kannankeril, MD, MSCI|615 322-7447|prince.kannankeril@vanderbilt.edu
112080|NCT01117480|AbbVie|Global Medical Information|800-633-9110|
112081|NCT01117623|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
112082|NCT01117727|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu
112083|NCT01117766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112084|NCT01119001|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu
112085|NCT01119040|University Hospitals Case Medical Center|Jeffrey Marks, MD/Principal Investigator|216-983-4930|jeffrey.marks@UHhospitals.org
112086|NCT01119118|University of Wisconsin Carbone Cancer Center|Dr. Glenn Liu|608-265-8689|gxl@medicine.wisc.edu
112087|NCT01119131|VA Portland Health Care System|Amie Hiller, MD|503.721.1091|peterami@ohsu.edu
112088|NCT01119222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112089|NCT01119287|Alcon Research|Head, Alcon Clinical|1-888-451-3937|
112090|NCT01119443|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112091|NCT01119625|GlaxoSmithKline|GSK Response Center|866-435-7343|
112092|NCT01119703|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
112093|NCT01119716|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
112094|NCT01119755|Hypertension Center, Third Department of Medicine, University of Athens, Greece|George S Stergiou, Associate Professor of Internal Medicine and Hypertension|+302107763117|gstergi@med.uoa.gr
112095|NCT01119768|AstraZeneca|Gerard Lynch||az_trials_posting@astrazeneca.com
112096|NCT01119794|Brown University Oncology Research Group (BrUOG)|Eric Winer, MD|4018633000|kayla_rosati@brown.edu
112097|NCT01119859|Hoffmann-La Roche|Medical Communications|800 821-8590|
112098|NCT01119937|Novartis Pharmaceuticals|Study Director|862-778-8300|
112099|NCT01119950|Novartis Pharmaceuticals|Study Director|41 61 324 1111|
112100|NCT01120067|VA Boston Healthcare System|John Otis|857-364-5740|john.otis@va.gov
112101|NCT01120093|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com
119450|NCT00167102|University of Minnesota|Dr. Maria Hordinsky|612-624-5721|hordi001@umn.edu
112279|NCT01128153|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com
112103|NCT01120197|Faculty of Health Sciences, Oslo University College, Oslo, Norway|Professor, Ph. D, Researcher. Astrid Bergland.|+4722452507|astrid.bergland@hf.hio.no
112104|NCT01120210|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director Translational Medicine|858.320.3408|wradzisz@its.jnj.com
112105|NCT01120223|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com
112106|NCT01120236|Department of Medicine, Division of Oncology, University of Washington|Evan Y. Yu, MD||evenyu@u.washington.edu
112107|NCT01120275|SWOG Statistical Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org
112108|NCT01120379|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com
112109|NCT01120405|Population Health Research Institute - Mc Master University, Hamilton CANADA|Yannick LE MANACH, MD, PhD|0012892606840|Yannick.Lemanach@phri.ca
112110|NCT01120626|Stanford University|Allan Reiss, MD|650-498-4538|reiss@stanford.edu
112111|NCT01120691|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
112112|NCT01120704|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu
112113|NCT01120717|Novartis Pharmaceuticals|Study Director|862 778-8300|
119451|NCT00003910|ECOG Statistical Office|Study Statistician|617-632-3012|
112115|NCT01120808|Stanford Department of Emergency Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu
112116|NCT01120834|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu
112117|NCT01120899|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov
112118|NCT01120990|Hypertension Center, Third University Department of Medicine, University of Athens|George S Stergiou, MD|+30 210 7763117|gstergi@med.uoa.gr
112119|NCT01121146|AORI|C. Anderson Engh, Jr., MD|703-619-4411|research@aori.org
112120|NCT01121172|4th Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki|Assimina Galli-Tsinopoulou, As.Professor of Pediatric Endocrinology|00302310991537|agalli@auth.gr
112121|NCT01121185|MassBiologics|Director Clinical Affairs|617-474-3000|MBLclinicaldirector@umassmed.edu
112122|NCT01121211|Massachusetts General Hospital|Dr. Anne Klibanski|6177263870|aklibanski@partners.org
112123|NCT01121263|Icahn School of Medicine at Mount Sinai|Deborah Ascheim, MD|212-659-9567|deborah.ascheim@mssm.edu
112124|NCT01121393|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112125|NCT01121406|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112126|NCT01110421|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com
112127|NCT01110499|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
112128|NCT01110915|Medtronic, Inc|Advisa MRI Clinical Research Specialist|800-328-2518 ext 62813|medtronicCRMtrials@medtronic.com
112129|NCT01110967|Medtronic Spinal & Biologics|Cristina Faria|+41 (0)21 802 70 00|cristina.faria@medtronic.com
112130|NCT01111110|University of Florida|Dr.Sreekala Prabhakaran. Clinical Assistant Professor Pediatrics|352-273-8381|sprabhakaran@peds.ufl.edu
112131|NCT01111123|Mount Siani School of Medicine Department of Dermatology|Jason Emer, MD|2122413288 ext 43288|jason.emer@mssm.edu
112132|NCT01111149|University of Minnesota|Dr. S. Hossein Fatemi|612-626-3633|fatem002@umn.edu
112133|NCT01111162|University of Pennsylvania|Pablo Tebas|2153498092|pablo.tebas@uphs.upenn.edu
112134|NCT01111240|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
112135|NCT01111292|Northwestern University|Dr. Seema Khan|(312) 503-4236|SKhan@nm.org
112137|NCT01111318|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112138|NCT01111331|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112139|NCT01111370|Dexcom, Inc|Andy Balo/Sr. VP|8582000203|abalo@dexcom.com
112140|NCT01111461|Eisai, Inc.|Eisai Medical Services|18884224743|esi_medinfo@eisai.com
112141|NCT01111526|H. Lee Moffitt Cancer Center and Research Institute|Dr. Lia Perez|813-745-3665|lia.perez@moffitt.org
112142|NCT01111838|Memorial Sloan Kettering Cancer Center|Dr. Andrea Cercek|646-888-4189|CercekA@mskcc.org
112143|NCT01111851|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
112144|NCT01112514|Massachusetts General Hospital|Andrew T. Chan|617 726 3212|achan@partners.org
112145|NCT01112579|Medtronic Cardiac Rhythm and Heart Failure|DEFEAT-HF Clinical Team|1-800-328-2518|MedtronicCRMtrials@medtronic.com
112146|NCT01112670|University of Colorado|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu
112147|NCT01112683|University of Colorado School of Medicine|Dr. Alberto Costa|303-724-6007|Alberto.Costa@ucdenver.edu
112149|NCT01112865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112150|NCT01112917|BRIGHT Research Partners|Andrea Fenton Abbs - Study Director|612-298-7460|andrea@brightresearchpartners.com
112151|NCT01113008|H Virgen de la Victoria|Dr Manuel Jiménez Navarro|951 032 354 ext 0034|jimeneznavarro@secardiologia.es
112152|NCT01113385|Children's National|Asha Moudgil MD, Professor of Pediatrics|202-476-5058|amoudgil@childrensnational.org
112153|NCT01113398|Duke University Medical Center|Katherine B. Peters, MD, PhD|919-684-6173|katy.peters@duke.edu
112154|NCT01113463|University of Texas MD Anderson Cancer Center|Charles A. Conrad, MD / Professor, Neuro Oncology|713-792-2883|CR_Study_Registration@mdanderson.org
112155|NCT01113541|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112157|NCT01113632|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
112158|NCT01113710|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
121247|NCT02116582|Astellas Pharma Europe B.V.|Executive Medical Director|+31 (0) 71 5455 050|Astellas.resultsdisclosure@astellas.com
112159|NCT01113723|Department of Anesthesiology, Cedars-Sinai Medical Center|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)
112160|NCT01113749|University of North Carolina Chapel Hill|Laura C. Hanson, MD, MPH|9199665945|lhanson@med.unc.edu
112161|NCT01113931|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
112162|NCT01114334|Denver Health and University of Colorado Denver|Dr. Robert D. Keeley|303-602-8270|robert.keeley@dhha.org
112163|NCT01114360|Emory University|Frederic Rahbari-Oskoui, Associate Professor of Medicine|404-727-2590|frahbar@emory.edu
112164|NCT01114373|Emory University|Frederic Rahbari-Oskoui, Associate Professor of Medicine|404-727-3425|frahbar@emory.edu
112165|NCT01114438|GI Dynamics|Clinical Affairs Manager|781.357.3263|kwoessner@gidynamics.com
112166|NCT01114503|GlaxoSmithKline|GSK Response Center|866-435-7343|
112167|NCT01114516|Northwestern University Feinberg School of Medicine|Dr. Emily Miller|3124724685|emily-miller-1@northwestern.edu
112168|NCT01114529|Novartis Pharmaceuticals|Study Director|+1(862)778-8300|trialandresults.registries@novartis.com
112170|NCT01114672|Winthrop University Hospital|Mary Schanler, Principal Investigator|5156639028|mschanler@winthrop.org
112172|NCT01114737|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com
112173|NCT01114828|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366|
112174|NCT01114880|Abbott|Global Medical Services|1-800-633-9110|
112175|NCT01114893|Alcon Research, Lt.d|Alcon Clinical|888.451.3937 ext 817.568.67|medinfo@alconlabs.com
112176|NCT01121484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112177|NCT01121536|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
112178|NCT01121549|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112179|NCT01121562|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112180|NCT01121575|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112181|NCT01121666|Five Office Ltd|Dr. Melanie Ruf|+41 44 9324132|clin@five.ch
112182|NCT01121757|Duke University Health Center|Anne Beaven, MD, Associate Professor|9196848964|anne.beaven@duke.edu
112183|NCT01123356|Medical University of South Carolina|Clinical Trials Network Manager|843-792-1753|adraleta@musc.edu
112184|NCT01123395|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
112185|NCT01123512|Benvenue Medical, Inc.|Barbara S. Lindsay, Vice President Clinical & Regulatory Affairs|408-454-9300|blindsay@benvenuemedical.com
112186|NCT01123642|VISN 17 Center of Excellence for Research on Returning War Veterans|Sandra B. Morissette, Ph.D.|254-297-5170|sandra.morissette@va.gov
112187|NCT01123850|Zimmer|Laura Herdrich|952-830-6224|laura.herdrich@zimmer.com
112188|NCT01123889|Loma Linda University Orthopaedic Surgery|Liz Clarke|909-558-5592|eaclarke@llu.edu
112189|NCT01123928|Zhongshan Ophthalmic Center|Dr. Nathan Congdon|13925056342|ncongdon1@gmail.com
112190|NCT01123941|Novartis Vaccines Institute for Global Health|Dr. Audino Podda, MD|+39 0577 243496|audino.podda@novartis.com
112191|NCT01123980|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
112192|NCT01124006|DePuy Synthes Spine|Mark Lotito|508-880-8045|Mlotito@its.jnj.com
112193|NCT01124045|Alcon Research, Ltd.|Pam Kaur, PhD|1-888-451-3937|alcon.medinfo@alcon.com
112194|NCT01124097|BIAL – Portela & Cª S.A.|Director R&D|+351-229866100|clinical.trials@bial.com
112195|NCT01124149|Shire Development LLC|Study Physician|+1 866 842 5335|
112196|NCT01124162|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
112197|NCT01124175|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
112198|NCT01124188|UPMC Late Life Depression|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu
112199|NCT01124292|Georgia Institute of Technology|Dr. Maysam Ghovanloo|404-385-7048|mgh@gatech.edu
112200|NCT01124305|AORI|Knee Project Director|7036194423|nparks@aori.org
112201|NCT01124370|Respicardia|Linda Nelson, VP Clinical Affairs|952-540-4479|lnelson@respicardia.com
112203|NCT01124448|Complutense University Madrid|Dr. Juan M Rodríguez|34 91 3943837|jmrodrig@vet.ucm.es
112204|NCT01124604|Neuroscience Department, Clinical Science Department, R&D in Janssen Japan Chiyodaku, Tokyo 101-0065 Japan|Manager|+81-3-4411-5509|
112205|NCT01124617|Neuroscience department, clinical science department, R&D in Janssen Japan, Chiyodaku, Tokyo 101-0065 Japan|Manager|+81-3-4411-5509|
112206|NCT01124643|Shire Development LLC|Study Physician|+1 866 842 5335|
112207|NCT01124786|Clovis Oncology, Inc.|VP Clinical Development|415-409-5440|clinicaltrialinfo@clovisoncology.com
112208|NCT01124838|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
112209|NCT01124864|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
112210|NCT01124916|Loyola University|Elizabeth Mueller, M.D.|708-216-2180|emuelle@lumc.edu
112211|NCT01124955|Federal University of São Paulo|Tatiana Molinas Hasegawa|55 115576 4239|tatianamolinas@hotmail.com
112212|NCT01125098|Department of Oncology Haematology and Respiratory Diseases|Leonardo Fabbri|+39 059422 ext 4227|leonardo.fabbri@unimore.it
112213|NCT01125189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
112214|NCT01125202|New York University School of Medicine|Mary Ann Sevick, ScD|6465012621 ext 646|mary.sevick@nyumc.org
112215|NCT01125514|Novartis Pharmaceuticals|Study Director|862-778-8300|
112216|NCT01125566|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112217|NCT01125605|Pascoe pharmazeutische Praeparate GmbH|Director of Clinical Trials|0049 641 7960100|klinische.forschung@pascoe.de
112218|NCT01125722|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com
112219|NCT01125748|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
112220|NCT01125774|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
112222|NCT01112241|Azienda Ospedaliera Universitaria San Martino, Genova, Italy|Dr. Giovanni Barisione, MD|+39 010 5553367|giovanni.barisione@hsanmartino.it
112223|NCT01112267|Janssen Korea/ Seoul|Therapeutic area Scientist|+82-2-2094-4802|
112224|NCT01117857|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org
112225|NCT01117870|McMaster University/ St. Joseph's Healthcare Hamilton|Dr. Harsha Shanthanna|905-522-1155|harshamd@gmail.com
112226|NCT01117948|JSW-Lifesciences|Director of Clinical Trials|0043316 258111 ext 310|office@jsw-lifesciences.com
112227|NCT01117987|Novartis Pharmaceuticals|Study Director|862-778-8300|Trialandresults.registries@novartis.com
112228|NCT01118013|Blood and Marrow Transplant Group of Georgia|Asad Bashey, MD, PhD||abashey@bmtga.com
112229|NCT01118091|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov
112231|NCT01118143|University of Tromsø|Professor Jan Bergdahl|+4777649122|jan.bergdahl@uit.no
112232|NCT01118221|MVAHS|Robert M Jackson, MD|305-575-3548|robert.jackson4@va.gov
112233|NCT01118273|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
112234|NCT01118312|Johns Hopkins University|Razan Yasin|443-287-5796|ryasin1@jhu.edu
112235|NCT01118325|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
112236|NCT01118377|Hoffmann-La Roche|Medical Communications|800 821-8590|
112237|NCT01118455|Cyberonics, Inc.|Mark Bunker, PharmD, Sr. Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com
112238|NCT01118624|Spectrum Pharmaceuticals|Pankaj Sharma, MD|949-743-9264|pankaj.sharma@sppirx.com
112239|NCT01118663|Cumberland Pharmaceuticals Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com
112240|NCT01118728|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
112242|NCT01118780|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112243|NCT01118845|Symbio Pharmaceuticals|Toshihiko Nagase|81-3-5472-1127|tnagase.331@symbiopharma.com
112244|NCT01118949|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
112245|NCT01118962|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
112246|NCT01118975|University of Maryland|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu
112247|NCT01118988|Pediatric Pain and Palliative Care Program; University of California, Los Angeles|Dr. Lonnie K. Zeltzer, MD|310-825-0731|LZeltzer@mednet.ucla.edu
112248|NCT01125800|Novartis Pharmaceuticals|Study Director|862 ­778 ­8300|
112249|NCT01125813|Octapharma AG|Dr Sigurd Knaub|41 55 451 21 41|sigurd.knaub@octapharma.ch
112250|NCT01125917|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333|
112251|NCT01125930|University of Michigan|Dr. Lisa Maier|734-936-4192|maierl@med.umich.edu
112252|NCT01126060|Samsung medical center|Dr. Man Ki Chung|82-2-3410-1845|manki.chung@samsung.com
112253|NCT01126099|VA Puget Sound|Lucy Wang|206-277-5089|wanglucy@u.washington.edu
112254|NCT01126359|Department of Orthopaedics|Dr. Erik Kubiak|801-587-5404|Erik.Kubiak@hsc.utah.edu
112256|NCT01126437|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112257|NCT01126541|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
112258|NCT01126580|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112259|NCT01126593|Orlando Orthopaedic Center|Dr. Randy Schwartzberg|(407) 254-2500|orlandosportsdoc@yahoo.com
112260|NCT01126619|Abbott|Global Medical Services|800-633-9110|
112261|NCT01126671|Boston Children's Hospital|Dr. Sarah Pitts|617-355-3732|sarah.pitts@childrens.harvard.edu
112262|NCT01126723|Institute for Aging Research, Hebrew SeniorLife|Dr. Lewis Lipsitz|617-971-5318|lipsitz@hsl.harvard.edu
112264|NCT01126957|University of Missouri-Columbia|Dr. David Henry|573/884-2582|henryda@missouri.edu
112265|NCT01127087|Mayo Clinic|Dr. John C. Lieske|507-266-7960|lieske.john@mayo.edu
112266|NCT01127139|Abbott|Global Medical Services|1-800-633-9110|
112267|NCT01127165|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com
112268|NCT01127256|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com
112269|NCT01127321|MedImmune, LLC.|David Close, Director, Clinical Development|301-398-0000|closeda@medimmune.com
112270|NCT01127438|Eisai Call Center|Eisai Inc.|888-422-4743|
112271|NCT01127581|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
112272|NCT01127607|Florida International University|Dr. James Waxmonsky|717 531 8646|jwaxmons@fiu.edu
112273|NCT01127646|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112274|NCT01127659|University of Buffalo|Paresh Dandona|716) 961-9900|pdandona@kaleidahealth.org
112275|NCT01127737|Northwestern University|June Robinson, MD|312-695-6624|june-robinson@northwestern.edu
112276|NCT01127763|Mt Sinai School of Medicine|Amy Tiersten, MD|212-249-3300|amy.tiersten@mssm.edu
112277|NCT01128049|University of Rochester Medical Center, Flaum Eye Institute|James Aquavella, MD|585-275-8944|James_Aquavella@URMC.Rochester.Edu
112278|NCT01128114|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com
112280|NCT01128179|Shire Development LLC|Study Physician|+1 866 842 5335|
112281|NCT01128192|Veterans Medical Research Foundation|Principal Investigator|858-552-8585|rrhenry@ucsd.edu
112282|NCT01128244|University of Florida|Dr. Jesse F. Gregory|(352) 392-1991 ext 225|jfgy@ufl.edu
112283|NCT01128270|University of Florida|Peter W. Stacpoole,MD|(352) 273-9023|pws@ufl.edu
112284|NCT01128296|UPMC CancerCenter|Herbert Zeh, MD|412-692-2852|zehxhx@upmc.edu
112285|NCT01128361|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|jburns2@kumc.edu
112286|NCT01128400|Washington University School of Medicine|M. Yanina Pepino|3143628113|ypepino@dom.wustl.edu
112287|NCT01128413|Washington University School of Medicine|Dr. Chris Holthaus|314-747-5994|holthauscv@wustl.edu
112288|NCT01128426|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112289|NCT01128543|GlaxoSmithKline|GSK Response Center|866-435-7343|
112290|NCT01128569|GlaxoSmithKline|GSK Response Center|866-435-7343|
112291|NCT01128595|GlaxoSmithKline|GSK Response Center|866-435-7343|
112292|NCT01128738|GlaxoSmithKline|GSK Response Center|866-435-7343|
112293|NCT01121900|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
112294|NCT01121913|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
112295|NCT01121926|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017|
112296|NCT01121939|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
112297|NCT01121991|EMD Serono Canada Inc., an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+1-888-737-6668 ext 5248|david.sciberras@emdserono.com
112298|NCT01122030|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp
112299|NCT01122108|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|Harold E. Bays, MD|502-515-5672|kschmitz@lmarc.com
112300|NCT01122160|USDA|Beverly Clevidence|301-504-8367|beverly.clevidence@ars.usda.gov
112301|NCT01122238|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu
112302|NCT01122264|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112303|NCT01122381|Vetarans Administration Pittsburgh Healthcare System|Kathy Gardner MD|(412) 360-6185|kathy.gardner@va.gov
112304|NCT01122394|VA New York Harbor Healthcare System|Jennifer Friedberg, Ph.D.|212-951-3314|jennifer.friedberg@va.gov
112305|NCT01122511|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
112306|NCT01122576|Bausch & Lomb Incorporated|Quintus Ngumah, OD, PhD|(973) 360-6450|Quintus.Ngumah@bausch.com
112307|NCT01122680|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112308|NCT01122862|GlaxoSmithKline|GSK Response Center|866-435-7343|
112309|NCT01122901|Adult Brain Tumor Consortium|David Peereboom, MD|410-955-8837|jfisher@jhmi.edu
112310|NCT01122927|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
112311|NCT01123083|GlaxoSmithKline|GSK Response Center|866-435-7343|
112312|NCT01123148|University of Michigan|Jane Huggins, PhD|734-936-7177|janeh@umich.edu
112313|NCT01123161|Cedars-Sinai Medical Center|Dr. Patrick Lyden|310-423-5166|lydenp@cshs.org
112314|NCT01123200|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu
112315|NCT01128829|Washington University School of Medicine|M. Yanina Pepino|3143628113|ypepino@dom.wustl.edu
112316|NCT01128894|GlaxoSmithKline|GSK Response Center|866-435-7343|
112317|NCT01128946|GlaxoSmithKline|GSK Response Center|866-435-7343|
112318|NCT01128959|Lundbeck LCC|Lundbeck LLC|+45 36301311|LundbeckClinicalTrials@lundbeck.com
112319|NCT01128972|GlaxoSmithKline|GSK Response Center|866-435-7343|
112320|NCT01129011|POZEN|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com
112321|NCT01129102|Nobelpharma|Department director of clinical development department 1|+81-5651-1177|murakami@nobelpharma.co.jp
112322|NCT01129115|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|kuamp@kumc.edu
112323|NCT01129128|University of Washington|James A Taylor, MD|206-616-1206|uncjat@uw.edu
112324|NCT01129141|NCRAR, VA RR&D|James A. Henry, Ph.D.|503.220.8262 ext 57466|james.henry@va.gov
112325|NCT01131884|University of Rochester|K.Rao Poduri, M.D., Chair of Physical Medicine & Rehab|585-275-6978|kr_poduri@urmc.rochester.edu
112326|NCT01132118|Brigham and Women's Hospital|Dr. Daniel H. Solomon|617-525-8127|dsolomon@partners.org
112327|NCT01132144|University of Sao Paulo|Dr. Wellington P Martins|55162231|wpmartins@gmail.com
112328|NCT01132313|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112329|NCT01132326|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com
112330|NCT01132378|Heekin Institute for Orthopaedic Research|R. David Heekin MD, FACS|904-634-0640|drheekin@heekinortho.com
112331|NCT01132495|St. Jude Medical|Sr. Director, Global Clinical Affairs|651-756-5586|jmifek@sjm.com
112332|NCT01132508|Synthes GmbH|Clinical Research Scientist|+41619656592|clinicalaffairs.emea@synthes.com
112333|NCT01132547|SunCoast CCOP Research Base at the University of South Florida|Angelina Fink, Research Base Administrator|813-396-9245|angelina.fink@epi.usf.edu
112334|NCT01132651|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu
112335|NCT01132664|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com
112336|NCT01132690|Protalix Biotherapeutics|Senior VP Development|+972-4-902-8100|einat@protalix.com
112337|NCT01132820|NRG Oncology /GOG|Linda Gedeon for Michael Sill, PhD|716 845-1169|lgedeon@gogstats.org
112338|NCT01132846|Duke University|Kevin Anstrom|919-668-8902|kevin.anstrom@dm.duke.edu
112339|NCT01133171|Department of Veterans Affairs|Dawn M. Bravata, MD|317-988-2676|dawn.bravata2@va.gov
112340|NCT01133275|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rami Komrokji|813-745-4692|rami.komrokji@moffitt.org
112341|NCT01133288|Kennedy Krieger Institute|Eric Levey, M.D.|443-923-9148|levey@kennedykrieger.org
112342|NCT01133379|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com
112343|NCT01133392|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112344|NCT01133418|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|5136368296|jeff.epstein@cchmc.org
112345|NCT01133522|Amgen Inc.|Study Director|866-572-6436|
112346|NCT01133626|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
112347|NCT01133665|The University of Chicago|Dr. Everett Vokes|773-702-9306|evokes@medicine.bsd.uchicago.edu
112348|NCT01133704|Dendreon Corporation|Kathleen Picha|206-265-4545|kpicha@dendreon.com
112349|NCT01133756|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com
112350|NCT01133821|University of Pittsburgh School of Medicine|Holly A. Swartz M.D.|412-246-5588|swartzha@upmc.edu
112351|NCT01133847|University of Texas Health Science Center Houston|Dr. Carolyn Denton|713-500-3891|carolyn.a.denton@uth.tmc.edu
112352|NCT01133860|IRCCS Policlinico San Matteo Foundation|Prof. Carlo Balduini|0039.0382.502580|c.balduini@smatteo.pv.it
112353|NCT01133977|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com
112354|NCT01134016|Golden Biotechnology Corp.|Dr. Howard Cheng, Director of clinical trials|886-2808-6006|howard@goldenbiotech.com.tw
112355|NCT01134042|GlaxoSmithKline|GSK Response Center|866-435-7343|
112356|NCT01134081|University of Michigan|Dr. William Giannobile|734 763 2105|wgiannob@umich.edu
112357|NCT01134107|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112358|NCT01126268|The University of Texas Health Science Center at Houston|Dr. Adelaide A Hebert|(713) 500-8339|Adelaide.A.Hebert@uth.tmc.edu
112359|NCT01134276|Seoul National University College of Medicine|Sun-Whe Kim|+82-2-2072-2315|sunkim@plaza.snu.ac.kr
112360|NCT01134315|AbbVie|Global Medical Services|800-633-9110|
112361|NCT01134328|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com
112362|NCT01134393|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112363|NCT01134510|Cedars-Sinai Medical Center|Stanely Jordan, MD|310-428-8186|stan.jordan@cshs.org
112364|NCT01135992|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
112365|NCT01136174|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112366|NCT01136226|Chesapeake Urology Research Associates|Heather Thomas, Administrator|443.471.5742|hthomas@cua.md
112367|NCT01136291|Department of Obstetrics and Gynecology - University of Campinas|Fernanda Garanhani de Castro Surita|+551935219304|surita@unicamp.br
112368|NCT01136356|Johns Hopkins University, School of Medicine|Eric C. Strain, MD|410-550-1191|estrain1@jhmi.edu
112369|NCT01136382|AstraZeneca|Geoff Gilmartin||ClinicalTrialTransparency@astrazeneca.com
112370|NCT01136408|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112371|NCT01136486|North Shore LIJ|Dr. Rosemarie Basile|718 226-6501|rbasile1@siuh.edu
112372|NCT01136655|AstraZeneca|Göran Eckerwall, MSD||ClinicalTrialTransparency@astrazeneca.com
112373|NCT01136746|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112374|NCT01136772|Columbia University|T. Scott Stroup|646-774-8435|stroups@nyspi.columbia.edu
112375|NCT01136785|The University of Chicago|Dr. Eve Van Cauter/Dr. Babak Mokhlesi|773-702-0169 or 773-702-2181|evcauter@medicine.bsd.uchicago.edu; bmokhles@medicine.bsd.uchicago.edu
112376|NCT01136876|Bracco Diagnostics Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com
112377|NCT01136915|Bracco Diagnostics, Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com
112378|NCT01136954|Eisai Call Center|Eisai Inc.|888-422-4743|
112379|NCT01136967|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com
112380|NCT01137032|Fougera Pharmaceuticals Inc.|Angela C. Kaplan, Associate Director Clinical Development|631-659-2256|angela.kaplan@sandoz.com
112381|NCT01137071|Recepta Biopharma|Director of Clinical Trials|55 11 3709-2140|recepta@receptabio.com.br
112382|NCT01137292|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112383|NCT01137370|Department of Medicine and Lung Institute, Seoul National University College of Medicine|Jae-Joon Yim|+82-2-2072-2059|yimjj@snu.ac.kr
112384|NCT01137396|Yale University|Peter Morgan|203-974-7560|peter.morgan@yale.edu
112385|NCT01137435|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
112386|NCT01137474|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
112387|NCT01137539|Michigan Institute of Women's Health|Salil Khandwala/Medical Director|313-982-0200|
112388|NCT01137578|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
112389|NCT01137604|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com
112390|NCT01137682|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
112391|NCT01137773|University Louisville|Rainer Lenhardt, MD|502-228-7517|rainer.lenhardt@louisville.edu
112392|NCT01137786|Bracco Diagnostics Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com
112393|NCT01137812|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736|
112394|NCT01137890|Johns Hopkins University|Dr. Annie Umbricht|410-550-1917|annieumbricht@jhu.edu
112395|NCT01138007|GlaxoSmithKline|GSK Response Center|866-435-7343|
112396|NCT01138046|GlaxoSmithKline|GSK Response Center|866-435-7343|
112397|NCT01138098|GlaxoSmithKline|GSK Response Center|866-435-7343|
112398|NCT01138111|Piramal Imaging|Juergen Hirschfeld, Senior Director Regulatory Affairs|+49 30 461 1246 15|juergen.hirschfeld@piramal.com
112399|NCT01138124|GlaxoSmithKline|GSK Response Center|866-435-7343|
112400|NCT01138150|The Johns Hopkins University School of Medicine|Dr. Lee Peterlin|410-550-5452|lpeterlin@jhmi.edu
112401|NCT01129206|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii Saab, MD|614-293-6529|Tanio.Saab@osumc.edu
112403|NCT01129284|Columbia University Medical Center|Dr. Andrew S. Bomback, MD, MPH|212-305-0320|asb68@columbia.edu
112404|NCT01129336|Novartis Pharmaceuticals|Study Director|862-778-8300|
112405|NCT01129531|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
112406|NCT01129557|Columbia University Medical Center, Division of Nephrology|Andrew Bomback, MD|212-305-5020|asb68@columbia.edu
112407|NCT01129583|Columbia University Medical Center|TTC research fellow|212-305-3912|ttc@gmail.com
112408|NCT01129622|Mount Sinai Hospital|Robert F Casper|416-972-0777|casper@lunenfeld.ca
112409|NCT01129765|Advanced Pediatrics|Mary Margaret Thorne|703-938-5555|mthorne@pop.powweb.com
112410|NCT01129778|Stanford University|W. Ray Kim, MD, Chief of Gastroenterology and Hepatology|650-725-6511|wrkim@stanford.edu
112411|NCT01129921|Napa Pain Institute|Eric Grigsby, MD|707-252-9660|egrig@aol.com
112412|NCT01129960|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com
112413|NCT01130051|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com
112414|NCT01130103|Research Foundation for Mental Hygiene|Franklin Schneier MD|212-543-5368|frs1@columbia.edu
112415|NCT01130168|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
112416|NCT01130337|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
112418|NCT01130532|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112419|NCT01130597|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com
112420|NCT01130740|Center for Health Services Reserach in Primary Care, Durham VAMC|Kelli D. Allen, PhD|919-286-0411 ext 7090|kelli.allen@va.gov
112421|NCT01130831|Shire Development LLC|Study Physician|+1 866 842 5335|
112422|NCT01130844|Shire Development LLC|Study Physician|+1 866 842 5335|
112423|NCT01130883|Abbott|Global Medical Services|1-800-633-9110|
112424|NCT01130974|Bausch & Lomb Inc.|Robert Steffen|(585) 338-6399|robert.steffens@bausch.com
112425|NCT01131052|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu
112426|NCT01131065|Instituto Grifols, S.A.|Michael Woodward, BSc, M.Sc|+34 935712200|michael.woodward@grifols.com
112427|NCT01131078|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
112428|NCT01131130|Bausch + Lomb|Dr. Robert Steffen|585-338-6399|robert.steffen@bausch.com
112430|NCT01131299|NIH NHLBI|Dr. Marcelo Amar|301-402-0521|mamar@mail.nih.gov
112431|NCT01131455|ColumbiaOG|Vicki L Jones, Research Coordinator|573-443-2402 ext 4391|v.jones@columbiaorthogroup.com
112432|NCT01131494|University Federal of Bahia|Natalie Argolo Ponte|55 31 3274 5579|natyargolo@hotmail.com
112433|NCT01131507|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634|
112435|NCT01131585|Novartis Pharmaceuticals|Study Director|41 61 324 1111|
112436|NCT01131676|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127 ext +1|clintriage.rdg@boehringer-ingelheim.com
112437|NCT01138475|William Beaumont Hospital|Kerstyn Zalesin|248-655-5900|Kerstyn.zalesin@beaumont.edu
112438|NCT01138501|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
112439|NCT01138514|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com
112440|NCT01138657|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
112441|NCT01138735|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com
112442|NCT01138826|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112443|NCT01138969|KaohsiungVGH|Dr. Ping-I Hsu|886-7-3462121 ext 8233|pihsu@isca.vghks.gov.tw
112444|NCT01138995|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com
112445|NCT01139008|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com
112446|NCT01139021|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
112447|NCT01139047|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com
112448|NCT01139125|Georgia Regents University|Peter F. Buckley, MD|706-721-2231|PBuckley@gru.edu
112449|NCT01139164|Medical University of South Carolina|Dr. Robert Stuart|843-792-4271|stuartrk@musc.edu
112450|NCT01139190|PLx Pharma LLC|Ronald Zimmerman, CEO & President|713-842-1249 ext 205|ron.zimmerman@plxpharma.com
112451|NCT01139294|Vanderbilt University Medical Center|Thomas Abramo, MD||tjabramo@uams.edu
112452|NCT01139411|Weight Control and Diabetes Research Center|Dr. Elissa Jelalian|(401) 793-9716|elissa_jelalian@brown.edu
112453|NCT01139450|Fougera Pharmaceuticals Inc.|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com
112454|NCT01139515|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112455|NCT01139580|GlaxoSmithKline|GSK Response Center|866-435-7343|
112456|NCT01139658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112457|NCT01139762|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112458|NCT01139814|Catheter Robotics, Inc.|Vice President, Clinical and Regulatory Affairs|973-426-0300|research@catheterrobotics.com
112459|NCT01139879|Wolcott and Associates|Randy Wolcott|806-793-8869|lisa@randallwolcott.com
112460|NCT01139996|Memorial University Medical Center|Imran Siddiqui, MD|912-350-8707|research2@memorialhealth.com
112461|NCT01140048|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
112522|NCT01143402|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646 888 4162|chapmanp@mskcc.org
112462|NCT01140061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
112463|NCT01140191|Walter Reed National Military Medical Center (WRNMMC)|COL Glenn W. Wortman|301-295-6400|glenn.wortmann@amedd.army.mil
112464|NCT01140295|The Children's Hospital of Philadelphia|Petar Mamula|215-590-9146|mamula@email.chop.edu
112465|NCT01140347|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112466|NCT01140360|Indiana University|Dr. Kent Robertson|317-944-4969|krobert@iu.edu
112467|NCT01140477|Bausch & Lomb, a division of Valeant Corporation|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com
112468|NCT01140503|Stanford University Department of Dermatology|David Fiorentino|650-721-7160|fiorentino@stanford.edu
112469|NCT01140646|Mayo Clinic|Dr. Amit Sood|507-284-1623|sood.amit@mayo.edu
112470|NCT01140815|AORI|Knee Research Director|7036194423|nancylparks@gmail.com
112471|NCT01140867|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com
112472|NCT01140880|Friends Research Institute, Inc.|Dr. Cathy J. Reback|323-463-1601|reback@friendsresearch.org
112473|NCT01140906|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
112474|NCT01141205|Statens Serum Institut|Dr Anders Fomsgaard|+45-32683460|afo@ssi.dk
112475|NCT01141283|Purdue Pharma LP|Clinical Leader, Medical Director|800-733-1333|
112476|NCT01134549|Amgen, Inc|Study Director|866-572-6436|
112477|NCT01134614|ECOG Statistical Office|Study Statistician|617-632-3012|
112478|NCT01134627|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
112479|NCT01134705|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
112480|NCT01134731|UAB|Dr. Richard Shelton|205-934-2484|rshelton@uab.edu
112481|NCT01134783|University of North Carolina, Chapel Hill|Dr. Leslie A. Lytle|919-843-8171|llytle@email.unc.edu
112482|NCT01134887|Veterans Administration Health Services Research and Development|Richard M. Frankel Ph.D.|317-988-4000|Richard.Frankel@VA.Gov
112483|NCT01134900|The University of Texas Health Science Center at Houston (UTHealth)|Allison B. McCoy, PhD|713-500-6931|allison.b.mccoy@uth.tmc.edu
112484|NCT01134939|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112485|NCT01134952|LondonHSC|Dr Vivian McAlister|5196632920|vmcalist@uwo.ca
112486|NCT01135017|Sanofi|Trial Transparency Team||Contact_US@sanofi.com
112487|NCT01135069|Spear Pharma|K.L. Spear M.D.|239-433-3442|spear@spearpharma.com
112488|NCT01135134|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
112489|NCT01135186|Stanford University|Dr. Linda Anh B. Nguyen|650-736-5555|nguyenlb@stanford.edu
112490|NCT01135368|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
112491|NCT01135381|University of California San Francisco (UCSF); University of Alabama at Birmingham (UAB)|Dr. Christine Ritchie|415-514-0605|christine.ritchie@ucsf.edu; critchie@uab.edu
112492|NCT01135420|Department of Veterans Afairs|Christine Timko|650-493-5000|Christine.Timko@va.gov
112493|NCT01135498|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
112494|NCT01135511|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112495|NCT01135524|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333|
112496|NCT01135914|Novartis Pharmaceuticals|Study Director|862-778-8300|
112497|NCT01141374|University of São Paulo|Leonice Fumiko Sato Kurebayashi|55-11-91126023|fumie_ibez@yahoo.com.br
112498|NCT01141491|MabVax Therapeutics, Inc.|Dave Hansen|858.259.9405 ext 301|dhansen@mabvax.com
112499|NCT01141569|BC Cancer Agency Vancouver Cancer Centre|Dr. Christian Kollmannsberger|604-877-6000|ckollmannsberger@bccancer.bc.ca
112500|NCT01141595|Arkansas Children's Hospital Reseach Insitute|Richard Frye|501-364-5465|REFrye@uams.edu
112501|NCT01141647|James A. Haley Veterans' Hospital|Lisa Ottomanelli, PhD|813-558-3917|lisa.ottomanelli-slone@va.gov
112502|NCT01142193|Upsher-Smith Laboratories, Inc.|Bob Anders, Sr. Director of Clinical Operations|763-315-2000|Bob.Anders@upsher-smith.com
112504|NCT01142323|University of Miami|Dr. Cynthia Levy|305-243-2147|clevy@med.miami.edu
112505|NCT01142336|University of Washington|Ge Li, MD, PhD|(206) 764-2485|gli@uw.edu
112506|NCT01142388|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|
112507|NCT01142466|Merck Serono GmbH, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49 6151 72 5200|service@merckgroup.com
112508|NCT01142596|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
112509|NCT01142661|Eisai Inc.|Prash Gopalakrishna|888-422-4743|
112510|NCT01142726|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
112511|NCT01142908|Veterans Administration HSRD, Durham COIN|Hayden B. Bosworth, PhD, Assoc Dir, Durham HSR&D COIN|919-286-0411 ext 6936|hayden.bosworth@va.gov
112512|NCT01143038|Amgen Inc.|Study Director|866-572-6436|
112513|NCT01143051|Amphastar Pharmaceuticals, Inc.|Stephen A. Campbell, Esq.|(909) 980-9484 ext 2016|stephenc@amphastar.com
112514|NCT01143077|Sunovion Pharmaceuticals|Medical Director, CNS|1-866-503-6351|
112515|NCT01143090|Sunovion Pharmaceuticals Inc|Medical Director, CNS|1-866-503-6351|
112516|NCT01143142|University of Colorado|Amanda Dempsey|303-724-6679|amanda.dempsey@ucdenver.edu
112517|NCT01143207|FHI 360|Vera Halpern, MD|919-54-7040 ext 11390|vhalpern@fhi360.org
112518|NCT01143259|Intermountain Healthcare|Matthew Peters RN MS|801-442-3703|matthew.peters@imail.org
112519|NCT01143272|Johns Hopkins Bloomberg School of Public Health|Stephan Ehrhardt|410-502-3872|sehrhard@jhsph.edu
112520|NCT01143324|MedtronicSpineECA|Christel Van Dam|+31433566523|christel.van.dam@medtronic.com
112521|NCT01143337|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
112523|NCT01143610|School of Dentistry at Bauru - USP|Adriana Campos Passanezi Sant'Ana|00 55 14 3235-8278|acpsantana@usp.br
112524|NCT01143636|Spaulding Rehabilitation Hospital, Boston, MA.|Dr. Felipe Fregni, Director of the Laboratory of Neuromodulation|617.952.6153|info@neuromodulationlab.org
112525|NCT01143649|Laboratory of Neuromodulation and Center of Clinical Research Training. Spaulding Rehabilitation Hospital.|Dr. Felipe Fregni|617.952.6153|info@neuromodulationlab.org
112526|NCT01143688|National Jewish Health|Michael E. Wechsler M.D.|617-285-4987|wechslerm@NJHealth.org
112527|NCT01143701|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|5136368296|jeff.epstein@cchmc.org
112528|NCT01143714|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com
112529|NCT01143727|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com
112530|NCT01143766|Indiana University|Gregory A. Cote|317-944-2740|gcote@iupui.edu
112531|NCT01143792|The Ohio State University|Natasha Slesnick|614 247-8469|slesnick.5@osu.edu
112532|NCT01143818|Abbott|Global Medical Services|800-633-9110|
112533|NCT01143883|University of South Florida|Jorge E. Marcet, M.D.|813-844-4545|jmateka@health.usf.edu
112534|NCT01143896|Michael E. DeBakey VA Medical Center|Fasiha Kanwal, MD, MSHS|(713) 440-4495|Fasiha.Kanwal@va.gov
112535|NCT01144026|Thymon LLC|Dr. Gideon Goldstein|(973) 467-9558|gidgold@gmail.com
112536|NCT01144052|Ospedale Civico|Claudio Globbi, Dr. med.|+41 91 811 6921|claudio.gobbi@eoc.ch
112537|NCT01144182|VA New York Harbor Healthcare System|Sundar Natarajan, MD, M.Sc.|212-951-3395|sundar.natarajan@va.gov
112538|NCT01144286|Privatni gynekologicka ambulance|Vladimir Dvorak|+420 542 221 661|ssgcr@ti.cz
112539|NCT01144299|GlaxoSmithKline|GSK Response Center|866-435-7343|
112540|NCT01144364|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
112541|NCT01144403|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
112543|NCT01144442|Masonic Cancer Center|Peter Argenta, MD|612-626-3111|argenta@umn.edu
112544|NCT01144598|Abbott|Global Medical Services|1-800-633-9110|
112545|NCT01144624|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com
112546|NCT01144715|Kinetic Muscles|James Koeneman, PhD|602-677-5256|jimkoeneman509@gmail.com
112547|NCT01144949|Watson Laboratories, Inc.|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|801 588-6641|gary.hoel@watson.com
112548|NCT01145352|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112549|NCT01145391|University of Colorado Denver School of Medicine|Amy Huebschmann|303-724-2268|amy.huebschmann@ucdenver.edu
112550|NCT01145417|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112551|NCT01145482|The University of Texas at Austin|Dr. Andreana Haley|512-232-0863|haley@psy.utexas.edu
112553|NCT01145508|ECOG Statistical Office|Study Statistician|617-632-3012|
112554|NCT01145547|Legacy Health System|W. Kenneth Ward|503-413-5171|kenward503@msn.com
112555|NCT01145560|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com
112556|NCT01145625|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|Study Director|(973) 385-3203|
112557|NCT01145638|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com
112558|NCT01145755|AstraZeneca|Gerard Lynch|645895 ext +44 1509|aztrial_results_posting@astrazeneca.com
112559|NCT01145898|Indiana University|Alon Harris|317-278-00177|alharris@indiana.edu
112560|NCT01146054|Stanford University Comprehensive Cancer Center|Albert C. Koong, M.D., Ph.D., Sue and Bob McCollum Professor, Associate Chair of Radiation Onocology|650-498-7703|akoong@stanford.edu
112561|NCT01146275|Q-Med AB|Head of Medical Affairs|+46 (0) 18 4749000|reception.SEUPP@galderma.com
112562|NCT01146288|Rabin Medical Center|Dr Boris Zingerman||borisz@clalit.org.il
112563|NCT01146379|Washington University School of Medicine|Dr. Catherine Lang|314-286-1945|langc@wustl.edu
112564|NCT01146418|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
112565|NCT01146457|BIDMC|Philip Hess|617-667-3353|phess@bidmc.harvard.edu
112567|NCT01146613|NIAAA|Megan Ryan, M.B.A.|301-443-4225|mryan1@mail.nih.gov
112568|NCT01146782|ApniCure, Inc.|Andrea Brown, Director, Clinical Affairs|650-361-9000 ext 122|abrown@apnicure.com
112569|NCT01146808|Columbia University Medical Center|Robert S. Brown Jr., MD, MPH|(212) 305-3839|tt2103@columbia.edu
112570|NCT01146860|ENT practice|Dr. Rainer Jund, Specialist in Otorhinolaryngology|+49 89 804880|RainerJund@gmx.de
112571|NCT01146873|Columbia University|Louise Kuhn, PhD|212-305-2398|lk24@cumc.columbia.edu
112572|NCT01146912|Columbia University|Melissa Stockwell, MD MPH|212-342-5372|mss2112@columbia.edu
112573|NCT01146951|Eisai Call Center|Eisai Inc.|888-422-4743|
112574|NCT01147042|NIH CC|Dr. John Gallin|301-827-5428|jgallin@cc.nih.gov
112575|NCT01147055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112576|NCT01147068|Protein Sciences Corporation|Dr. Ruvim Izikson, M.D.|203-599-6064 ext 163|rizikson@proteinsciences.com
112578|NCT01147250|Sanofi|Trail Transparency Team||Contact-US@sanofi.com
112579|NCT01147302|Shire Development LLC|Study Physician|+1 866 842 5335|
112580|NCT01147341|michael schiff|Michael schiff|303 773 8429|michael.schiff@me.com
112581|NCT01147380|University of Miami|Dr. Seigo Nishida|305-355-5760|snishida@med.miami.edu
112582|NCT01147393|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu
112583|NCT01147406|N30 Pharmaceuticals Inc.|Janice M Troha|720-945-7714|janice.troha@n30pharma.com
112584|NCT01147458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112585|NCT01147471|Virginia Commonwealth University|Ajai K Malhotra, MD|804-827-2409|akmalhot@mcvh-vcu.edu
112586|NCT01147497|Emory University|Eva Lathrop, MD, MPH|404-778-1379|elathro@emory.edu
112589|NCT01141725|FHCRC/UWMC|Elihu Estey, MD, Director of AML Program|206-288-7176|eestey@uw.edu
112590|NCT01142115|Clinical Regulatory Development, Global R&D|Trine Møller Kruse|+4549112174|dktrm@coloplast.com
112591|NCT01142128|University of Florida|Phillip Toskes, M.D.|352-273-9493|phillip.toskes@medicine.ufl.edu
112592|NCT01147601|Oregon Health & Science University|Dr. Alfons Krol|503-494-9993|krola@ohsu.edu
112593|NCT01147627|The Third Affiliated Hospital of Sun Yat-sen University|Dr. Jianping Weng|86-20-85253162|wjianp@mail.sysu.edu.cn
112594|NCT01147640|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com
112596|NCT01147744|GlaxoSmithKline|GSK Response Center|866-435-7343|
112597|NCT01147809|GlaxoSmithKline|GSK Response Center|866-435-7343|
112598|NCT01147822|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
112599|NCT01147848|GlaxoSmithKline|GSK Response Center|866-435-7343|
112600|NCT01147874|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112601|NCT01147900|GlaxoSmithKline|GSK Response Center|866-435-7343|
112602|NCT01147926|Shire|Study Physician|+1 866 842 5335|
112603|NCT01149057|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com
112604|NCT01149148|UmichiganHS|Dr. Wei C. Lau|734 9369479|weiclau@med.umich.edu
112605|NCT01149421|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112606|NCT01149434|Huntsman Cancer Institute Unversity of Utah|Sunil Sharma, MD|801-585-0255|sunil.sharma@hci.utah.edu
112607|NCT01149460|Teva Pharmaceuticals USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
112608|NCT01149473|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
112609|NCT01149486|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
112610|NCT01149512|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca
112611|NCT01149538|University of Minnesota|Jeffrey R. Wozniak, Ph.D.|612-273-9741|jwozniak@umn.edu
112612|NCT01149616|Beth Israel Deaconess Medical Center|Dr Lauren Fisher|6176671853|lauren_fisher@dmgaz.org
112613|NCT01149655|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
112614|NCT01149733|Teva Pharmaceuticals USA|Associate Director, Biopharmaceutics|866-384-5525|clinicaltrialqueries@tevausa.com
112615|NCT01149759|Rockefeller University|Emma Guttman Yassky, MD|212-327-8333|skhattri@rockefeller.edu
112616|NCT01149772|Michael E. DeBakey VA Medical Center|Dr. Jeffrey Cully|713-794-8526|Jeffrey.Cully@va.gov
112617|NCT01149785|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112618|NCT01149863|Emory University|Dr. Harvey|404-778-4381|rdharve@emory.edu
112619|NCT01149876|MGH|Dr. Molly Wanner|617-726-2914|harvardskinstudies@partners.org
112620|NCT01150097|Novartis Pharmaceuticals|Study Director|862-778-8300|
112621|NCT01150123|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com
112622|NCT01150357|Novartis Pharmaceuticals|Study Director|862 ­778 ­8300|
112623|NCT01150409|The Cleveland Clinic Foundation|Jorge Guzman MD|216-445-5765|guzmanj@ccf.org
112624|NCT01150461|Massachusetts General Hospital|Michael A. Fifer, MD|617 726-1832|mfifer@partners.org
112625|NCT01150474|Mayo Clinic|Dr. Kristina A. Butler|480-301-5934|butler.kristina@mayo.edu
112626|NCT01150500|Study Manager|Hiroko Ookubo|+81-3-6430-7017|hiroko.ookubo@medtronic.com
112627|NCT01150760|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
112628|NCT01150903|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112629|NCT01150981|University of Massachusetts Medical School|Samir Malkani, MD|5088563800|samir.malkani@umassmemorial.org
112630|NCT01151020|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com
112631|NCT01151046|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com
112632|NCT01151085|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112633|NCT01151098|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333 OR 800-745-7445|
112634|NCT01151137|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com
112635|NCT01151189|Aeras|Product Director; Bernard Landry|301-547-2919|blandry@aeras.org
112636|NCT01151215|Astrazeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com
112637|NCT01151280|Boston Scientific Corporation|Alexis James, Clinical Project Manager|508-683-4074|jamesa@bsci.com
112638|NCT01151345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112639|NCT01151371|Vistakon|Kathy Lorenz-Osborn, OD|+1 904 443-1032|kosborn@its.jnj.com
112640|NCT01151410|Novartis Pharmaceuticals|Study Director|862 ­778 ­8300|
112641|NCT01151436|Galderma|Ma May|+33 4 92 38 67 33|may.ma@galderma.com
112642|NCT01151449|Princess Margaret Cancer Centre|Dr. Srikala Sridhar|416-946-2662|srikala.sridhar@uhn.ca
112643|NCT01151553|Emory University|Dr. Heather Bloom|404-321-6111 ext 6391|heather.bloom@emory.edu
112644|NCT01145001|Yale University|Dana Cavallo, Assistant Professor|2039747607|dana.cavallo@yale.edu
112827|NCT01165047|Aurora Health Care|Katernie Slotke|414-649-2615|katherine.Slotke@aurora.org
112645|NCT01145053|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112646|NCT01151579|Genesys Regional Medical Center|Dr. Fahim Khorfan|810-606-7722|kbarber@genesys.org
112647|NCT01151761|Stanford University Cancer Center|Dr. Daniel Chang|650-724-3547|dtchang@stanford.edu
112648|NCT01151852|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr
112649|NCT01152697|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|2168442808|martha.sajatovic@uhhospitals.org
112650|NCT01152788|NCIC Clinical Trials Group|Dr. Janet Dancey|1-613-533-6430|jdancey@ctg.queensu.ca
112651|NCT01152814|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
112653|NCT01153009|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
112654|NCT01153269|Abbott|Global Medical Services|1-800-633-9110|
112655|NCT01153321|AstraZeneca|Anna Malmgren||ClinicalTrialTransparency@astrazeneca.com
112656|NCT01153347|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
112657|NCT01153425|University of Pennsylvania, Perelman School of Medicine|Felix W. Wehrli, Ph.D.|215-662-7951|wehrli@mail.med.upenn.edu
112658|NCT01153503|University of Texas Southwestern Medical Center|Irina Gasanova, MD, PhD|214-590-0064|Irina.Gasanova@UTSouthwestern.edu
112659|NCT01153581|Yale School of Medicine|Nina Stachenfeld|203-562-9901 ext 219|nina.stachenfeld@yale.edu
112660|NCT01153620|B. Braun Medical, Centre of Excellence|Medical Affairs Manager|+41 58 258 55 47|
112661|NCT01153633|B. Braun Medical AG|Medical Scientific Affairs Manager|+41 58 258 55 47|
112662|NCT01153672|University of Washington|Hannah M. Linden, MD|206-288-6989|hmlinden@u.washington.edu
112663|NCT01153685|GlaxoSmithKline|GSK Response Center|866-435-7343|
112664|NCT01153698|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112665|NCT01153711|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112666|NCT01153724|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112667|NCT01153763|GlaxoSmithKline|GSK Response Center|866-435-7343|
112668|NCT01153815|GlaxoSmithKline|GSK Response Center|866-435-7343|
112669|NCT01153841|GlaxoSmithKline|GSK Response Center|866-435-7343|
112670|NCT01153893|GlaxoSmithKline|GSK Response Center|866-435-7343|
112671|NCT01153958|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
112672|NCT01153971|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
112673|NCT01153984|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
112674|NCT01154010|Massachusetts Eye and Ear Infirmary|Director of the Ocular Immunology and Uveitis Service|617-573-5549|George_Papaliodis@meei.harvard.edu
112675|NCT01154036|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
112676|NCT01154127|Novartis Pharmaceuticals|Study Director|862-778-8300|
112677|NCT01154140|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112678|NCT01154153|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com
112679|NCT01154166|GlaxoSmithKline|GSK Response Center|866-435-7343|
112680|NCT01154218|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112681|NCT01154231|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112682|NCT01154283|UMichigan|Kirsten Gruis|7346041172|klgruis@gmail.com
112683|NCT01154296|Department of Sociomedical Sciences/Mailman School of Public Health/Columbia University|Lisa Metsch, PhD, Stephen Smith Professor and Chair of Sociomedical Sciences|212-305-3577|lm2892@columbia.edu
112684|NCT01154322|ResMed|June Mendoza|1-800-424-0737|june.mendoza@resmed.com
112685|NCT01154335|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
112686|NCT01154452|Memorial Sloan Kettering Cancer Center|Dr. Mrinal Gounder|646-888-4167|gounderm@mskcc.org
112687|NCT01154634|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com
112688|NCT01154673|University of Toronto|Mario Ostrowski, Principal Investigator, Professor of Medicine|416-946-5805|mario.ostrowski@gmail.com
112689|NCT01154699|University of California San Diego|Robert L. Owens|8586575258|rowens@ucsd.edu
112690|NCT01154751|Abbott Vascular|Margo Zaugg|408-845-0576|margo.zaugg@av.abbott.com
112692|NCT01154985|Mochida Pharmaceutical Company Ltd.|Hironori Sato, Director|+81-3-3225-6331|hnsato@mochida.co.jp
112693|NCT01155011|UCSD|Jacqueline Kerr|858-534-9305|jkerr@ucsd.edu
112694|NCT01155024|The Ohio Willow Wood Company|Applied Research Engineer|740-869-3377|mariag@owwco.com
112695|NCT01155063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112696|NCT01148017|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com
112697|NCT01148056|Mass General Hospital Cancer Center|Maria Kempner|508.533.4132|mkempner@partners.org
112698|NCT01148420|Harbor - UCLA Medical Center|Anita Nelson|310-222-3871|anitanelsonwhc@earthlink.net
112699|NCT01148511|Novartis Pharmaceuticals|Study Director|862 778-8300|
112700|NCT01148524|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
112701|NCT01148537|Purdue Pharma L.P.|Executive Medical Director|800-733-1333|
112702|NCT01148693|Tehran medical university of science|Dr. Rasoul sotoudehmanesh|(+98 21) 82414000 ext 82415000|r.sotudemanesh@gmail.com
112703|NCT01148745|Dialysis Clinic, Inc.|Dr. Toros Kapoian, M.D., F.A.C.P.|732-940-8368|Toros.Kapoian@dciinc.org
112763|NCT01160458|National Cancer Institute, National Institutes of Health|Dr. Raffit Hassan, M.D.|301-451-8742|hassanr@mail.nih.gov
112704|NCT01148771|Center for Anti-Infective Research and Development, Hartford Hospital|Joseph L. Kuti, Pharm.D. / Associate Director, Clinical and Economic Studies|860-545-3612|jkuti@harthosp.org
112705|NCT01148836|Cleveland Clinic|Jacqueline Sharp, CNP|216-636-0000|pylej@ccf.org
112706|NCT01148862|Medtronic|Thomas P Troub|818-576-3142|thomas.troub@medtronic.com
112707|NCT01148979|McLean Hospital|J. Alexander Bodkin, MD|617-855-3186|abodkin@mclean.harvard.edu
112708|NCT01155141|Stanford University|Dr. Richard Lafayette|650-498-6063|czar@stanford.edu
112709|NCT01155154|SUNY Downstate Medical Center|Shahriar Zehtabchi|718-245-2973|shahriar.zehtabchi@downstate.edu
112710|NCT01155167|UCSF|Andrew Boyle MD|4153533817|aboyle@medicne.ucsf.edu
112711|NCT01155180|Beth Israel Deaconess Medical Center|Dr. Christos Manztoros|617-667-8630|cmantzor@bidmc.harvard.edu
112712|NCT01155219|Laboratoires Thea|Dr Pascale Pouliquen|0473981436|p.pouliquen@laboratoires-thea.fr
112713|NCT01155284|Sanford Research|Kurt J. Griffin, PhD, MD, Director of Clinical Trials|6053126000|kurt.griffin@sanfordhealth.org
112714|NCT01155323|Johnson and Johnson K.K.|Wakana Katabami|81-34411-8040 ext 22025|wkatabam@its.jnj.com
112716|NCT01155726|Alcon Research|Director of Clinical Trials|1-800-241-7629|
112717|NCT01155830|University of Utah|Dr. Christian Yost|801/581-7052|christian.yost@hmbg.utah.edu
112718|NCT01155869|Providence VA Medical Center|Peter Friedmann|401-273-7100 ext 6240|peter.friedmann@va.gov
112719|NCT01155999|Laboratoires Thea|Pascale Pouliquen (Medical director)|0473963614|p.pouliquen@laboratoires-thea.fr
112720|NCT01156012|Laboratoires Théa|Dr Pascale Pouliquen - Medical Director|33 473 981 436|p.pouliquen@laboratoires-thea.fr
112721|NCT01156051|Children's Specialized Hospital|Thomas A Rugino MD|732-797-3826|trugino@childrens-specialized.org
112722|NCT01156116|University of Chicago|Esra Tasali|773-702-1497|etasali@medicine.bsd.uchicago.edu
112723|NCT01156142|Mayo Clinic|Robert C. Miller, M.D.|507/266-6247|Miller.Robert@mayo.edu
112724|NCT01156311|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
112725|NCT01156363|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
112726|NCT01156376|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com
112727|NCT01156480|NorthShore University HealthSystem|Dr. Brandy Frost|847-570-2033|bfrost@northshore.org
112728|NCT01156532|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
112729|NCT01156571|The Medicines Company|Meredith Todd - Sr. Director Program Management|+1.973.290.6088|meredith.todd@themedco.com
112730|NCT01156597|University of Miami Miller School of Medicine|Armando J. Mendez, Ph.D.|305-243-5342|a.mendez@miami.edu
112731|NCT01156701|GlaxoSmithKline|GSK Response Center|866-435-7343|
112732|NCT01156792|GlaxoSmithKline|GSK Response Center|866-435-7343|
112733|NCT01156844|Novartis Pharmaceuticals|Study Director|862-778-8300|
112734|NCT01156987|University of MN|Curt Corum|(612) 625-5000|corum003@umn.edu
112735|NCT01157065|Alcon Research, Ltd.|Mehdi Hosseini, Clinical Trial Manager|1-888-451-3937|alcon.medinfo@alcon.com
112736|NCT01157078|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
112737|NCT01157117|Ichan School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu
112738|NCT01157169|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
112739|NCT01157182|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
112740|NCT01157234|University of Florida|Alfonso H. Santos Jr, M,D,|352-273-6374|Alfonso.santos@medicine.ufl.edu
112741|NCT01157351|Janssen Research & Development|Director, Clinical Development||ClinicalTrialDisclosure@its.jnj.com
112742|NCT01157377|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
112743|NCT01157416|Tulane University School of Medicine|Dr. Michael Scheeringa|5046692322|mscheer@tulane.edu
112744|NCT01157429|Tulane University|Dr. Michael Scheeringa|5049882167|mscheer@tulane.edu
112745|NCT01157533|The University of Texas (UT) MD Anderson Cancer Center|Ara Vaporciyan, MD, BS/ Professor||CR_Study_Registration@mdanderson.org
112746|NCT01157845|Virginia Commonwealth University|R. Todd Stravitz|804-828-8514|rstravit@vcu.edu
112747|NCT01151904|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
112748|NCT01152112|Hologic, Inc.|Christina Mastandrea / Clinical Research manager|5082638772|christina.mastandrea@hologic.com
112749|NCT01152190|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112750|NCT01152294|Massachusetts General Hospital|Karen Sepucha, Ph.D.|617-724-3350|ksepucha@partners.org
112751|NCT01152307|Massachusetts General Hospital|Dr. Karen Sepucha|617-724-3350|ksepucha@partners.org
112752|NCT01152359|VA Medical Center|William S. Yancy, Jr.|919-286-0411 ext 7770|william.yancy2@va.gov
112753|NCT01152385|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com
112754|NCT01152437|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112755|NCT01152450|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112756|NCT01152554|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
112757|NCT01152580|Duquesne University|Dr. Paula Witt-Enderby, Professor of Pharmacology and Toxicology|412-396-4346|wittp@duq.edu
112758|NCT01158118|Washington University School of Medicine|Mark Schroeder, M.D.|314-454-8304|markschroeder@wustl.edu
112759|NCT01158261|Ethicon, Inc|Director of Clinical Development|908-218-2492|jbatill2@its.jnj.com
112760|NCT01158378|HyperBranch Medical Technology, Inc|Michael Carnahan, PhD|919-433-3329|michaelc@hyperbranch.com
112761|NCT01160380|Oncotherapeutics|Director of Clinical Operations|310-623-1200|lthulin@oncotherapeutics.com
112762|NCT01160445|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov
113479|NCT01209689|Hoffmann-La Roche|Medical Communications|800 821-8590|
112764|NCT01160484|Oncotherapeutics|Director, Clinical Operations|323-623-1200|lthulin@oncotherapeutics.com
112765|NCT01160614|Purdue Pharma L.P.|Medical Services|888-726-7535, option 1|
112766|NCT01160640|University of Pittsburgh|Dr. Harold Wiesenfeld|412-641-1403|wieshc@mail.magee.edu
112767|NCT01160744|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112768|NCT01160770|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com
112769|NCT01160822|Novartis Pharmaceuticals|Study Director|862-778-8300|
112770|NCT01160848|Photocure ASA|Project Director|+47 22062210|pf@photocure.no
112771|NCT01161121|St. Louis University|Dr. Michael Lim|314-268-7992|limmj@slu.edu
112772|NCT01161160|GlaxoSmithKline|GSK Response Center|866-435-7343|
112773|NCT01161173|Hoffman-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com
112774|NCT01161225|University of Rochester Medical Center|Hyekyun Rhee|5852763775|hyekyun_rhee@urmc.rochester.edu
112775|NCT01161329|UppsalaU|Karin Hellström|+46184714762|karin.hellstrom@neuro.uu.se
112776|NCT01161407|Purdue University|Kathleen M. Hill Gallant|765-494-0101|hillgallant@purdue.edu
112777|NCT01161420|Inspire Medical Systems|Quan Ni|763-205-7968|quanni@inspiresleep.com
112778|NCT01161446|University of Washington|Dr. David Katz|206-744-5877|dkatz7@u.washington.edu
112779|NCT01161472|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112780|NCT01161498|Amgen, Inc.|Study Director|866-572-6436|
112781|NCT01161537|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
112782|NCT01161563|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com
112783|NCT01161628|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD (Principal Investigator)|404-255-1930|ssolomon@bmtga.com
112784|NCT01161771|Allergan, Inc.|Vice President, Global Medical Affairs|714-246-4500|clinicaltrials@allergan.com
112785|NCT01162096|Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|neal.flomenberg@jefferson.edu
112786|NCT01162122|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
112787|NCT01162135|Thomas Jefferson University|Jianqing Lin, MD|215-955-8874|Jianqing.Lin@jefferson.edu
112788|NCT01162304|University of Rochester|Joel Kent, MD|585-273-2972|joel_kent@urmc.rochester.edu
112789|NCT01162317|Atlanta VAMC|Wei Huang (PI)|404-321-6111 ext 6517|wei.huang@va.gov
112790|NCT01162421|AbbVie|Global Medical Information|800-633-9110|
112791|NCT01162473|The Children's Hospital of Philadelphia|Rushani W. Saltzman MD|215-590-2549|allergyandimmunology@email.chop.edu
112793|NCT01162733|Christiana Care Health System|Deb Marco|302 733-4130|dmarco@christianacare.org
112794|NCT01155466|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
112795|NCT01155479|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
112796|NCT01155531|Theracos, Inc|Monica Tettamanti, MSc|617-643-5696|mtettamanti@ccib.mgh.harvard.edu
112797|NCT01155570|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
112798|NCT01162863|University of Michigan|Dr. Richard J Saad|734-936-4780|rsaad@umich.edu
112799|NCT01163032|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com
112800|NCT01163097|Swedish Orphan Biovitrum|Medical Program Director|+46 8 697 20 00|clinical@sobi.com
112801|NCT01163253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112802|NCT01163266|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
112803|NCT01163279|Baycrest Health Sciences|Dr. Deirdre Dawson|416-785-2500 ext 2136|ddawson@research.baycrest.org
112804|NCT01163292|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
112805|NCT01163318|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
112806|NCT01163461|VAMC Puget Sound|Dr. Diane Kendall (PI)|206-762-1010|diane.kendall@va.gov
112807|NCT01163474|Houston VA HSR&D|Donna Smith/Project Coordinator|(713)440-4423|Donna.Smithd19d7@va.gov
112808|NCT01163604|jinling hospital|xinfeng Liu|025-84801861|xfliu2@vip.163.com
112809|NCT01163617|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
112810|NCT01163656|The Children's Hospital of Philadelphia|John Fiadjoe, MD|215-590-3916|fiadjoej@email.chop.edu
112811|NCT01163721|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
112812|NCT01163747|Hoffman-LaRoche|Medical Communications|800-821-8590|
112813|NCT01163760|Vistakon|Kurt Moody OD, FAAO|904-443-3088|
112815|NCT01163916|Abbott|Global Medical Services|800-633-9110|
112816|NCT01163955|Glinn and Giordano Physical Therapy|W. Brian Monroe, Doctor of Physical Therapy|661-832-9737|tandbmonroe@hotmail.com
112817|NCT01164007|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
112818|NCT01164137|Westview Physician Collaborative|Allan Bailey, M.D.; Study Principal Investigator|(780)-975-1131|baileymd@telusplanet.net
112819|NCT01164475|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
112820|NCT01164501|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112821|NCT01164579|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112822|NCT01164644|University of Wisconsin School of Medicine and Public Health|Dr. Scott R. Chaiet|(608) 263-1092|scottchaiet@yahoo.com
112823|NCT01164722|AIDS Malignancy Consortium|Group Statistician|1-501-526-6712|jylee@uams.edu
112824|NCT01164865|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937|
112825|NCT01164891|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com
112826|NCT01165021|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112828|NCT01165112|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org
112829|NCT01165138|GlaxoSmithKline|GSK Response Center|866-435-7343|
112832|NCT01165216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
112833|NCT01165242|GlaxoSmithKline|GSK Response Center|866-435-7343|
112834|NCT01165281|Janssen Pharm KK Japan|Medical Director|＋81-3-5509|
112835|NCT01165307|Mayo Clinic|Dr. Abimbola O. Famuyide|507-284-7035|Famuyide.Abimbola@mayo.edu
112836|NCT01165320|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
112837|NCT01165424|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
112838|NCT01165450|University of Maryland School of Medicine|Bennie H. Jeng, MD, MS|667-214-1111|bjeng@som.umaryland.edu
112839|NCT01165541|Geisel School of Medicine At Dartmouth|Mary Brunette, MD|603-271-7642|mary.brunette@dartmouth.edu
112840|NCT01165554|GE Healthcare|Dr. Paul Sherwin|1-609-514-6820|paulsherwin@ge.com
112841|NCT01165684|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
112842|NCT01158534|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org
112843|NCT01158703|BROOKE ARMY MEDICAL CENTER|AHMAD M. SLIM, MD, LTC, MC|210-916-4717|AHMAD.SLIM@US.ARMY.MIL
112844|NCT01158716|Cardiovasular RS|Theodoros Zografos|+306956161001|theodoroszografos@gmail.com
112845|NCT01158924|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com
112846|NCT01159054|Brigham and Women's Hospital|Kambiz Zandi-Nejad|617-732-6660 ext 34769 page|kzandinejad@partners.org
112847|NCT01159171|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
112848|NCT01159262|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com
112849|NCT01159431|UCLA|Dr. Christopher DeGiorgio|310-206-3753|cmd@mednet.ucla.edu
112850|NCT01159535|University of Washington|Dr. Sarah Bowen|(206) 543-3452|swbowen@uw.edu
112851|NCT01159574|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu
112852|NCT01159600|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112853|NCT01159665|ThromboGenics|Dr. Petra Kozma-Wiebe|+32 16751310|Petra.kozma@thrombogenics.com
112854|NCT01159691|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
112855|NCT01159743|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
112856|NCT01159769|Alcon Research, Ltd.|Director of Medical Affairs|800-862-5266|medinfo@alconlabs.com
112858|NCT01159938|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112859|NCT01160237|GlaxoSmithKline|GSK Response Center|866-435-7343|
112860|NCT01165775|Stanford School of Medicine|Yasser El-Sayed, MD|(650) 723-3198|Yasser.el-sayed@stanford.edu
112862|NCT01165983|Beth Israel Deaconess Medical Center|Aristidis Veves, Research Director|617-632-7075|aveves@bidmc.harvard.edu
112863|NCT01165996|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Yogen Saunthararajah, MD|216-444-8170|saunthy@ccf.org
112864|NCT01166139|Hospital For Special Surgery|Annel Fernandez|212 774 2123|fernandeza@hss.edu
112865|NCT01166178|Novartis|Study Director|41 61 324 1111|
112866|NCT01166230|The University of Texas|H. Barton Grossman, MD|713-563-7456|hbgrossman@mdanderson.org
112867|NCT01166282|AbbVie|Global Medical Information|800-633-9110|
112868|NCT01166646|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com
112869|NCT01166659|Transcend Medical, Inc.|Vice President of Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com
112870|NCT01166724|Cleveland Clinic|Dr. Stuart Flechner|216 445-5772|FLECHNS@ccf.org
112871|NCT01166750|University of Kansas Medical Center|Michael A. Rapoff, PhD., Principal Investigator|913-588-6323|mrapoff@kumc.edu
112872|NCT01166763|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu
112873|NCT01166958|University of Wisconsin Osteoporosis Clinical Research Program|Neil Binkley, MD|608-265-6410|uwosteoporosis@gmail.com
112874|NCT01166971|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
112875|NCT01166997|EKOS Corporation|Lynn Allen|4254153100|Lynn.Allen@ekoscorp.com
112876|NCT01167023|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112877|NCT01167140|Myoscience|Francis Rogers Palmer III, MD|650-474-2600|thenry@myoscience.com
112878|NCT01167153|Novartis Pharmaceuticals|Study Director|862-778-8300|
112879|NCT01167192|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wustl.edu
112880|NCT01167257|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825 ext 2113|hck@tzuchi.com.tw
112881|NCT01167426|Teva Pharmaceuticals Medical Affairs|Thomas Smith, MD|816-508-5128|tom.smith@tevapharm.com
112883|NCT01167504|Institute of Food Research|Professor Peter Wilde|+441603255258|peter.wilde@ifr.ac.uk
112884|NCT01167582|Rutgers University|Jeffrey Carson|732-235-7122|jeffrey.carson@rutgers.edu
112885|NCT01167608|Rutgers-Robert Wood Johnson Medical School|Dr. Roseanne Dobkin, Associate Professor of Psychiatry|732-235-4051|dobkinro@rutgers.edu
112886|NCT01167634|University of Pennsylvania School of Medicine|Laurie Norton|2155738799 ext 215|lanorton@mail.med.upenn.edu
112887|NCT01167829|University of Washington, Dept. of Medicine|John Amory, MD|(206) 616-1727|jamory@u.washington.edu
112888|NCT01167881|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113480|NCT01209702|Hoffman-LaRoche|Medical Communications|800-821-8590|
112889|NCT01168024|Osprey Medical|VP Of Clinial Affairs|952-955-8230|mshepard@ospreymed.com
112890|NCT01168232|NRG Oncology Statistics and Data Management Center - Buffalo Office|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
112891|NCT01168349|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
112892|NCT01168427|Medtronic - CRDM|RIO Clinical Research Specialist.|1-800-328-2518 ext 63277|MedtronicCRMtrials@medtronic.com
112893|NCT01168596|University of Florida Center for Movement Disorders and Neurorestoration|Irene A. Malaty, MD|352-273-5550|Irene.Malaty@neurology.ufl.edu
112894|NCT01163149|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com
112895|NCT01163162|Indiana University|Dr. Rajiv Agarwal|317 988 2241|ragarwal@iu.edu
112896|NCT01163214|Mayo Clinic|Mark J. Spangehl, M.D.|480-342-2377|spangehl.mark@mayo.edu
112897|NCT01168674|Tufts Medical Center|Dr. Nassir Ghaemi|6176365735|nghaemi@tuftsmedicalcenter.org
112898|NCT01168687|Ernest Gallo Clinic and Research Center, UCSF|Jennifer Mitchell, Clinical Project Director|510-985-3100|jmitchell@gallo.ucsf.edu
112899|NCT01168726|University of Missouri|Dr. Matthew P. Martens, Professor; Division Executive Director|573-882-3382|martensmp@missouri.edu
112900|NCT01168856|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
112901|NCT01168934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112902|NCT01170364|NYPInstitute|Dr. Laurel Mayer|646-774-8067|lsm16@columbia.edu
112903|NCT01170390|Oregon Health & Science University|Dr. Alison Edelman|503.418.2585|edelmana@ohsu.edu
112904|NCT01170533|University of Florida-Jacksonville|Dominick J. Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu
112905|NCT01170546|Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital|Shih-Wei Chou, MD, PhD|88633281200 ext 3846|h0711@ms13.hinet.net
112906|NCT01170598|University Health Network|Sara O'Neill|416-597-3422 ext 7860|o'neill.sara@torontorehab.on.ca
112908|NCT01170754|Temple University|Frank Friedenberg, MD|215-707-9900|frank.friedenberg@temple.edu
112909|NCT01170884|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com
112910|NCT01170949|University Charité Berlin|Markus Magerl|+4930450618304|markus.magerl@charite.de
112911|NCT01170962|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
112912|NCT01171118|University of Rochester|Dr. Suzanne Karan|585-275-5161|suzanne_karan@urmc.rochester.edu
112913|NCT01171183|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu
112914|NCT01171521|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu
112915|NCT01171534|University of Missouri, Department of Orthopaedic Surgery|Gregory J. Della Rocca, MD, PhD, FACS|573-882-6562|dellaroccag@health.missouri.edu
112916|NCT01171612|Corporacion Sanitaria y Universitaria Parc Tauli|Anna Rodriguez-Pont|0034937231010 ext 21283|anna.r.pont@gmail.com
112917|NCT01171677|NYUMED|John Rotrosen|212 951 3294|john.rotrosen@nyumc.org
112918|NCT01171690|Mayo Clinic|Marius Stan, MD|507-284-2463|stan.marius@mayo.edu
112919|NCT01171794|Stanford University School of Medicine|Grant S Lipman ( PI)|4152909286|lipmangrant@gmail.com
112920|NCT01171820|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com
112921|NCT01171924|Curis, Inc.|Associate Director of Regulatory Affairs|(617) 503-6548|lsaunders@curis.com
112922|NCT01171963|GlaxoSmithKline|GSK Response Center|866-435-7343|
112923|NCT01171976|Novartis Pharmaceuticals|Study Director|862-778-8300|
112924|NCT01171989|GlaxoSmithKline|GSK Response Center|866-435-7343|
112925|NCT01172145|Brown University|Laura L. Frakey|401-729-3163|lfrakey@gmail.com
112926|NCT01172184|Kaohsiung veterans general hospital|Dr. Shih-Hung Hsiao|886-7-3422121 ext 1518|irb@vghks.gov.tw
112927|NCT01172288|Yale University- School of Medicine|Associate Professor|(203)737-4809|michael.bloch@yale.edu
112928|NCT01172353|Hospital Sao Lucas|Vitor Osório Gomes, MD, PhD|55 51 33203494|pesquisa@cardiarte.com.br
112930|NCT01172522|ConnecticutSC|Edward M. Lane|2033720009|EMLMD@msn.com
112931|NCT01172535|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org
112932|NCT01172600|Cleveland Clinic|Alparslan Turan, MD|216-445-9857|turana@ccf.org
112933|NCT01172808|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112934|NCT01172821|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112935|NCT01172847|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
112936|NCT01166126|H. Lee Moffitt Cancer Center and Research Institute|Ragini Kudchadkar, M.D.|813-745-8581|ragini.kudchadkar@moffitt.org
112937|NCT01172873|New York State Psychiatric Institute/Columbia University|Moira A. Rynn, M.D.|646-774-5805|RynnM@nyspi.columbia.edu
112938|NCT01172938|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|clinicaltrialdisclosure@celgene.com
112939|NCT01173029|Universidade Gama Filho|Paulo Robeto Benchimol Barbosa|+55-21-95320182|ecgar@yahoo.com
112941|NCT01173120|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
112942|NCT01175148|Mary Babb Randolph Cancer Center|Pam Bunner, Clinical Research Specialist|304-598-4511|bunnerp@wvuhealthcare.com
112944|NCT01175226|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com
112945|NCT01175317|Maastricht University Medical Center|Kostan Reisinger|0031433881494|k.reisinger@maastrichtuniversity.nl
112946|NCT01175343|Princess Margaret Cancer Centre|Dr. Amit M. Oza|416-946-2818|amit.oza@uhn.ca
112948|NCT01175369|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu
112949|NCT01175382|University of Alabama at Birmingham|Dr. Kathryn Burgio|205-558-7064|kburgio@uabmc.edu
112950|NCT01175395|University of Illinois at Chicago|Jennifer I Lim MD|312-413-0704|jennylim@uic.edu
112951|NCT01175434|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu
112952|NCT01175473|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
112953|NCT01175590|Bausch & Lomb Inc.|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com
112954|NCT01175668|Baystate Medical Center|Rachana Singh, MD|413-794-2400|rachana.singhmd@bhs.org
112955|NCT01175707|Cubist Pharmaceuticals|Vice President, Clinical Research|781-860-8318|
112956|NCT01175798|Icahn School of Medicine at Mount Sinai|Anita Mehrotra MD|2122415153|anita.mehrotra@mssm.edu
112957|NCT01175811|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112958|NCT01175824|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112959|NCT01175850|Medtronic - CardioVascular|Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com
112960|NCT01175902|Seoul St. Mary's Hospital|Chan Kee Park|82222586208|ckpark@catholic.ac.kr
112961|NCT01176032|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
112962|NCT01176058|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112963|NCT01176240|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com
112964|NCT01176292|Anderson Orthopaedic Research Institute|Dr. William Hamilton|703-619-4411|research@aori.org
112965|NCT01176448|University of Virginia Dept of Otolaryngology Head and Neck Surgery|J. Jared Christophel MD|434-243-9391|jjchristop@gmail.com
112966|NCT01176513|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|Paul.Gordon@ge.com
112967|NCT01176565|University of Minnesota|Adnan I. Qureshi, MD|612-624-2431|qureshai@gmail.com
112968|NCT01176773|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com
112969|NCT01176877|Northwestern University, Feinberg School of Medicine, Department of Dermatology|Dr. Steven Nwe, Clinical Research Fellow|312-695-4625|steven.nwe@northwestern.edu
112970|NCT01176955|Wake Forest Baptist Medical Center|Brad Yentzer|336-716-4735|byentzer@wakehealth.edu
112971|NCT01176968|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112972|NCT01177007|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu
112973|NCT01177098|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
112974|NCT01177228|Millennium Pharmaceuticals Inc|Medical Director|1-800-778-2860|clinicaltrialregistry@tpna.com
112975|NCT01177293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
112976|NCT01177384|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
112977|NCT01177410|Salix Pharmaceuticals, Inc.|Vice President of Clinical Operations|919-862-1000|enoch.bortey@salix.com
112978|NCT01168973|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
112979|NCT01168986|University of Florida|Joel Bialosky, PT, PhD|352-273-8636|jbialosky@phhp.ufl.edu
112980|NCT01168999|University of Florida|Dr. Joel Bialosky|352-273-8636|bialosky@phhp.ufl.edu
112981|NCT01169038|Vanderbilt University|Wonder Drake|615-322-2035|wonder.drake@vanderbilt.edu
112982|NCT01169064|Vanderbilt University Medical Ctr., Dept OB/GYN|Dr. Kelly Bennett; Director of Maternal Fetal Medicine|6153436275|kelly.a.bennett@vanderbilt.edu
112983|NCT01169103|Massachusetts General Hospital|Madhusmita Misra|617-724-5602|mmisra@partners.org
112984|NCT01169311|Covidien|Tam LaFleur|203-821-4744|tam.lafleur@covidien.com
112985|NCT01169467|Duke University Medical Center|Dr. Keith Dombrowski|(919)|keith.dombrowski@dm.duke.edu
112986|NCT01169493|Duke University Medical Center|Brett D. Atwater, MD|9196848111|brett.atwater@duke.edu
112987|NCT01169519|Duke University Medical Center|Dr. Kevin Hill|919-668-8305|kevin.hill@duke.edu
112988|NCT01169558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
112989|NCT01169610|Mayo Clinic|Mark A. Frye, MD|507-255-9391|mfrye@mayo.edu
112990|NCT01169649|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy-Lagunes|646-888-4185|reidyd@mskcc.org
112991|NCT01169675|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112992|NCT01169701|Novartis Pharmaceuticals|Study Director|862-778-8300|
112993|NCT01169753|University of Texas (UT) MD Anderson Cancer Center|Carmen Escalante, MD / Chair, General Internal Medicine||CR_Study_Registration@mdanderson.org
112994|NCT01169779|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
112995|NCT01169987|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
112996|NCT01170039|Emory University|Jennifer Christie|404-778-4594|jchris6@emory.edu
112997|NCT01170091|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
112998|NCT01170117|Columbia Center for Eating Disorders|Dr. Evelyn Attia|646-774-8085|ea12@cumc.columbia.edu
112999|NCT01170208|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com
113000|NCT01170221|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370 ext 241|Philippe.Prokocimer@cubist.com
113001|NCT01170247|University of Iowa|Brett Faine|319-310-8067|brett-faine@uiowa.edu
113002|NCT01170273|Miami VA Medical Center|Silvina Levis MD|305-575-3388|silvina.levis-dusseau@va.gov
113003|NCT01177553|University of South Florida|Research Coordinator|813-259-8680|obgynclinicalresearch@health.usf.edu
113004|NCT01177670|Hologic, Inc.|Edward Evantash, MD|508-263-8475|edward.evantash@hologic.com
113005|NCT01177709|Nathan Kline insistute for Psychiatric Research|Robert C smith MD|845-298-6531|rsmith@nki.rfmh.org
113006|NCT01177722|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
113008|NCT01177800|Beijing, China R&D|Senior Therapeutic Area Physician|+86 010 58218358|
113009|NCT01177813|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113010|NCT01179048|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com
113011|NCT01179113|Cedars Sinai Medical Center|Dr. Roya Yumu', Anesthesiology Program Director|310-423-1682|Roya.Yumul@cshs.org
113013|NCT01179217|Emmaus Medical, Inc|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com
113014|NCT01179334|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
113015|NCT01179347|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113016|NCT01179399|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
113017|NCT01179490|Symbio Pharmaceuticals|Toshihiko Nagase|81-3-5472-1127|tnagase.331@symbiopharma.com
113018|NCT01179516|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
113019|NCT01179568|Columbia School of Social Work|M. Katherine Shear, MD|212-851-2176|ks2394@columbia.edu
113020|NCT01179672|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
113021|NCT01179737|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
113022|NCT01179919|University of Michigan|Manjunath Pai|7346473466|amitpai@med.umich.edu
113023|NCT01179984|Bard Peripheral Vascular|Associate Director of Clinical Affairs|480-379-2838|josh.smale@crbard.com
113025|NCT01180127|Columbia University Medical Center, Division of Behavioral Medicine in Psychiatry|Richard Sloan|646-774-8940|rps7@cumc.columbia.edu
113026|NCT01180244|Department of Mechanical Engineering, Kettering University|Dr. Jeffrey B. Hargrove||jhargrov@kettering.edu
113027|NCT01180296|Fetal Medicine Foundation?USA|David McKenna|937-208-4005|dsmckenna@mvh.org
113028|NCT01180400|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
113029|NCT01180647|NYU School of Medicine|Joshua D. Lee|212-263-4242|joshua.lee@nyumc.org
113030|NCT01180660|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu
113031|NCT01180777|Johnson & Johnson Vision Care|Michael S. Mayers, O.D., FAAO|1-904-443-3252|MMayers@its.jnj.com
113032|NCT01180790|Achillion Pharmaceuticals, Inc.|Kevin Kucharski, VP Clinical Operations|203-624-7000|Kkucharski@achillion.com
113033|NCT01180894|Denver Health Hospital|Dr. Fredric Pieracci|303-436-4029|fredric.pieracci@dhha.org
113034|NCT01180985|Johnson & Johnson Vision Care|John Buch, OD, MS, FAAO|1 904 443-1707|jbuch@its.jnj.com
113035|NCT01180998|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|KOsborn@its.jnj.com
113036|NCT01181011|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257 ext Option 4|clintriage.rdg@boehringer-ingelheim.com
113037|NCT01181050|Novo Nordisk A/S|Public Access to Clinical Trials||RA-RNDUS-ClinTriDisc@ITS.JNJ.com
113038|NCT01181102|Daiichi Sankyo.,LTD|Kei Ibusuki, Associate Director|81-90-2732-9505|ibusuki.kei.tx@daiichisankyo.co.jp
113039|NCT01181128|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
113040|NCT01181141|Daiichi Sankyo.,LTD|Kenichi Sakakura, Manager|81-90-1885-0271|sakakura.kenichi.ef@daiichisankyo.co.jp
113041|NCT01181167|Daiichi Sankyo Co., Ltd.|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp
113042|NCT01181258|Masonic Cancer Center, University of Minnesota|Dr. Veronika Bachanova|612-625-5469|bach0173@umn.edu
113043|NCT01181271|Mass General Hospital|Yi-Bin Chen, MD|617-726-5765|ychen6@partners.org
113044|NCT01181323|Cincinnati Children’s Hospital Medical Center|Mark Steinhoff, MD|513-636-2791|Mark.steinhoff@cchmc.org
113045|NCT01181349|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
113046|NCT01173211|Baylor College of Medicine|Shital M. Patel, M.D.|713-798-3793|shitalp@bcm.edu
113047|NCT01173471|AstraZeneca|Stuart McIntosh||ClinicalTrialTransparency@astrazeneca.com
113048|NCT01173523|Dana-Farber Cancer Institute|David M. Jackman, MD|617.632.3468|
113049|NCT01173653|Vanderbilt University Emergency Medicine Department|Benjamin Heavrin, MD|615-936-0253-|benjamin.heavrin@vanderbilt.edu
113050|NCT01173679|Massachusetts General Hospital|Philip C. Amrein, M.D.|6177243456|pamrein@partners.org
113051|NCT01173718|W. L. Gore & Associates|Debby Pfile, Clinical Research Associate|623-234-5226|dpfile@wlgore.com
113052|NCT01173848|Cleveland Clinic|Dr. James Simon|216-445-4891|simonj2@ccf.org
113053|NCT01173874|New York State Psychiatric Institute|Dr. Joshua Kantrowitz|646-774-8436|mcarlson@nyspi.columbia.edu
113054|NCT01174004|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com
113055|NCT01174030|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com
113056|NCT01174043|IndianaU|Dr. Hamid Sayar|(317)278-6871|ssayar@iu.edu
113057|NCT01174160|Cardiome Pharma|Jonathan Mather, Director, Head of Regulatory Affairs|+44 (0)7581148916|jmather@cardiome.com
113058|NCT01174173|Northwestern University|Sanjiv J. Shah, MD|3129262926|sanjiv.shah@northwestern.edu
113059|NCT01174186|Silkeborg Regional Hospital|René Oestgaard|0045 78 41 50 00|ostgard@immunology.au.dk
113060|NCT01174264|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu
113061|NCT01174342|Meir Medical Center|Amit Meshi|+972523580222|amitmeshi@gmail.com
113063|NCT01174459|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113064|NCT01174550|Duke University Medical Center|Dr. Pamela Douglas|919-668-8700|pamela.douglas@duke.edu
113065|NCT01174576|Harokopio University|Dr. Mary Yannakoulia|00302109549175|myianna@hua.gr
113066|NCT01174784|Avinger Inc.|Patty Hevey|650.241.7900|phevey@avinger.com
113067|NCT01175005|Phoenixchildrens|Amanda Kasem|6025461910|akasem@phoenixchildrens.com
113068|NCT01175018|Virginia Commonwealth University|Antonio Abbate|804-828-0513|aabbate@mcvh-vcu.edu
113069|NCT01175031|Shanghai Jiao Tong University School of Medicine|Quing Yun Li, MD, PhD|86-21-64314162|liqingyun68@hotmail.com
113070|NCT01181492|Huazhong University of Science&Technology|Zhang Xianwei|027 83662853|ourpain@163.com
113071|NCT01181531|Amgen Inc.|Study Director|866-572-6436|
113072|NCT01181609|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
113073|NCT01182194|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
113074|NCT01182207|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
113075|NCT01182285|National Cancer Institute|Dr. Electron Kebebew|301-496-5049|kebebew@nih.gov
113076|NCT01182298|NIAID|Shyam Kottilil||Skottilil@niaid.nih.gov
113077|NCT01182337|DePuy Synthes Spine|Mark Lotito|508-880-8045|Mlotito@its.jnj.com
113078|NCT01182376|University of Utah|Clinical Research Manager|8015873889|christina.pacchia@hsc.utah.edu
113079|NCT01182428|Abbott Vascular|Ellen Travis, Clinical Science|408-845-3000|Ellen.Travis@av.abbott.com
113080|NCT01182480|Denver Health and Hospital Authority|Andrew W. Steele, MD, MPH, MSc|303-602-9773|andy.steele@dhha.org
113081|NCT01182493|CHU Caen|Prof. Yves Reznik|+33231064585|reznik-y@chu-caen.fr
113082|NCT01182610|Accelerated Community Oncology Research Network, Inc.|Vice Presidnet of Scientific Affairs||mwalker@acorncro.com
113084|NCT01182727|Maryland Psychiatric Research Center|Dr. Robert Buchanan, M.D.|410-402-7876|rwbuchanan@mprc.umaryland.edu
113085|NCT01182805|University of Michigan|Theodore J. Kolias, MD|(734) 615-4907|tkolias@umich.edu
113086|NCT01183013|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113087|NCT01183065|Memorial Sloan Kettering Cancer Center|Ho, Alan, MD, PhD (Assistant Attending)|+1646-888-4235|HoA@mskcc.org
113088|NCT01183104|Japan Association for Diabetes Education and Care|Prof. Yasuo Terauchi|+81-3-3514-1721|terauchi-tky@umin.ac.jp
113089|NCT01183169|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com
113090|NCT01183234|Shire Pharmaceutical|Patrick Martin, M.D.||pmartin@shire.com
113092|NCT01183390|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
113093|NCT01183468|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
113094|NCT01183481|Sunnybrook Health Sciences Centre|Dr. Edward Chow|416-480-4998|edward.chow@sunnybrook.ca
113095|NCT01183533|University of Texas Health Science Center at Houston|Sean I. Savitz, MD|713-500-7083|sean.i.savitz@uth.tmc.edu
113096|NCT01183546|Human Engineering Research Laboratories|Dr. Alicia Koontz|412-822-3700|alicia.koontz@va.gov
113097|NCT01183650|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
113098|NCT01183728|Instituto de Biología y Genética Molecular (IBGM)|Dr. Javier García-Sancho|+34 98 318 48 27|jgsancho@ibgm.uva.es
113099|NCT01183780|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
113100|NCT01183858|Hoffmann-La Roche|Medical Communications|800-821-8590|genetech@druginfo.com
113101|NCT01183975|Ethicon, Inc.|Birgit Temiz|+49 (0) 40 5297 3144|btemiz@its.jnj.com
113102|NCT01184014|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com
113103|NCT01184053|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
113104|NCT01184079|University of Pittsburgh Department of Family Medicine|Chyongchiou Jeng Lin, PhD|412/383-2360|cjlin@pitt.edu
113105|NCT01184118|UW Madison|Mihaela Teodorescu, MD|608-256-1901|mt3@medicine.wisc.edu
113106|NCT01184417|Alameda County Medical Center|Jonathan Rosenson MD|510-407-6743|jonrosenson@yahoo.com
113107|NCT01177943|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979|
113108|NCT01177956|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
113109|NCT01177969|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu
113110|NCT01178073|GlaxoSmithKline|GSK Response Center|866-435-7343|
113111|NCT01178099|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
113112|NCT01178125|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
113113|NCT01178138|University of Arkansas for Medical Sciences|W. Brooks Gentry, MD|501 686 6119|gentrywilliamb@uams.edu
113114|NCT01178268|Abbott Vascular|Dana Haudek|928-925-4054|dana.haudek@av.abbott.com
113115|NCT01178281|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com
113117|NCT01178333|New England Research Institutes|Dr. Susan Assmann, Principal Research Scientist|617-972-3048|sassmann@neriscience.com
113118|NCT01178385|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu
113119|NCT01178528|IRCCS San Raffaele|G Rosano|0652252309|giuseppe.rosano@sanraffaele.it
113120|NCT01178671|Research Foundation for Mental Hygiene|Franklin Schneier MD|6467748041|fschneier@nyspi.columbia.edu
113121|NCT01178762|National Taiwan University Hospital|Yan-Ming Chen / Yu-Chih Hou|886-2-2312-3456 ext 62131|louice1070@gmail.com
113122|NCT01178827|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
113123|NCT01178853|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com
113124|NCT01184755|Rutgers - Robert Wood Johnson Medical School|Lynn Clemow, PhD|732-235-6972|lynn.clemow@rutgers.edu
113125|NCT01184846|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
113126|NCT01184859|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
113127|NCT01184872|Novartis Pharmaceutical|Study Director|862 778 8300|
113128|NCT01184885|Thomas Jefferson University|Margaret Kasner, MD|215-955-8874|Margaret.Kasner@jefferson.edu
113129|NCT01184898|Thomas Jefferson University|Margaret Kasner, MD|215-955-8874|Margaret.Kasner@jefferson.edu
113130|NCT01184989|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113131|NCT01185834|Alcon Research, Ltd.|Sameena Haque-Khan, PhD, BSc(Hons)Optom, MCOptom, FAAO|1-800-241-7629|
113132|NCT01185964|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
113133|NCT01186250|Stanford University|Kiran K. Khush, MD|650-721-3241|kiran@stanford.edu
113134|NCT01186406|Duke University Medical Center|Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu
113135|NCT01186419|Shire Development LLC|Study Physician|1 866 842 5335|
113136|NCT01186458|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org
113137|NCT01186562|University of Minnesota|Melena D. Bellin|612-624-5409|bell0130@umn.edu
113139|NCT01186705|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org
113140|NCT01186744|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113141|NCT01186796|Mayo Clinic|Johannes. D. Veldhuis, M.D.|507-255-0902|Veldhuis.Johannes@mayo.edu
113142|NCT01186848|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu
113143|NCT01186939|Celgene Corporation|CL Beach||CLBeach@celgene.com
113144|NCT01187004|UTurin|Dr Daniela Pasero|00390116335511|daniela.pasero@unito.it
113145|NCT01187017|NIHNHLBI|Danielle Townsley, M.D.|301-402-3477|townsleydm@nhlbi.nih.gov
113146|NCT01187043|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com
113147|NCT01187355|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com
113148|NCT01187433|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
113149|NCT01187498|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu
113150|NCT01187511|National Institute on Alcohol Abuse and Alcoholism|Leggio, Lorenzo|+1 301 435 9398|lorenzo.leggio@nih.gov
113151|NCT01187550|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
113152|NCT01187771|University of Pittsburgh|Sanjay Patel|412-692-2035|patelsr2@upmc.edu
113153|NCT01187901|University of Utah|N. Jewel Samadder|801-213-4211|jewel.samadder@hsc.utah.edu
113154|NCT01187914|Arrhythmia Research Center, University of Utah|Dr. Kavitha Damal, Clinical research Manager|8012133775|kavitha.damal@carma.utah.edu
113155|NCT01187953|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com
113156|NCT01188109|Emory University|Shishir K. Maithel, MD|404-778-1900|smaithe@emory.edu
113157|NCT01188226|UCLA|Neal Garrett, MD||ngarrett@ucla.edu
113158|NCT01181726|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
113159|NCT01181778|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
113160|NCT01181804|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com
113162|NCT01181921|Jan-Cil Spain|COUNTRY MEDICAL DIRECTOR|+34 91 7228043|
113163|NCT01181947|St. Antonius Ziekenhuis|Dr. Robin Heijmen|0031306092047|r.heijmen@antoniusziekenhuis.nl
113164|NCT01181986|Phoenix VA Health Care System|Dr. Juraj Koska|602-277-5551 ext 7685|juraj.koska@va.gov
113165|NCT01182103|Kaohsiung Chang Gung Memorial Hospital|Tiao-Lai Huang|886-7-7317123 ext 8753|a540520@adm.cgmh.org.tw
113166|NCT01182181|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
113167|NCT01188343|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
113168|NCT01188421|Johns Hopkins University, School of Medicine|Eric C. Strain, MD|410-550-1191|estrain1@jhmi.edu
113169|NCT01188447|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555 ext 17012|cvaillancourt@ohri.ca
113170|NCT01188499|TetraLogic Pharmaceuticals|Vice President, Clinical Research|610-889-9900 ext 141|Jeffrey.Skolnik@tetralogicpharma.com
113171|NCT01188538|Galderma|Farzaneh SIDOU|00 33 4 93 95 70 51|farzaneh.sidou@galderma.com
113172|NCT01188551|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org
113173|NCT01188564|Pharming Technologies|Anurag Relan, Vice President Clinical Research and Medical Affairs||a.relan@pharming.com
113174|NCT01188577|Amphastar Pharmaceuticals, Inc.|Stephen A. Campbell, Esq.|(909) 980-9484 ext 2016|stephenc@amphastar.com
113175|NCT01190254|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113176|NCT01190267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113177|NCT01190306|Topcon Medical Systems|Robert Gibson|(201) 599-5121|RGIBSON@TOPCON.COM
113178|NCT01190436|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
113179|NCT01190514|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
113180|NCT01190527|University of Michigan Comprehensive Cancer Center|Dr. Shruti Jolly, M.D.|734-936-4300|shrutij@umich.edu
113181|NCT01190566|Seoul National University Hospital|Woo Kyung Moon|82-2-2072-2584|moonwk@snu.ac.kr
113182|NCT01190813|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org
113183|NCT01190839|Janssen Pharmaceuticals|Strategic Lead Gastroenterology||ClinicalTrialDisclosure@its.jnj.com
113184|NCT01190865|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com
113185|NCT01190878|InSite Vision|Director of Clinical Trials|510-747-1269|jhutcheson@insitevision.com
113186|NCT01190891|Madigan Army Medical Center|Troy Patience, Research Operations Service|(253) 968-1160|usarmy.jblm.medcom-mamc.mbx.dci@mail.mil
113187|NCT01191008|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113188|NCT01191086|Upsher-Smith Laboratories, Inc.|Bob Anders, Sr. Director of Clinical Operations|763-315-2000|bob.anders@upsher-smith.com
113189|NCT01191190|University of California, San Diego|Januario E Castro, MD|(858) 822-6600|jecastro@ucsd.edu
113190|NCT01191242|Intermountain Heart Institute|John Carlquist, PhD|8014081028 ext 74707|john.carlquist@imail.org
113191|NCT01191255|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com
113192|NCT01191268|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
113193|NCT01191320|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com
113194|NCT01191398|University of Texas Southwestern Dallas Medical Center|Craig J. Huang, MD|214-456-6371|craig.huang@utsouthwestern.edu
113195|NCT01191411|University of Texas Southwestern Medical Center|Keith E. Argenbright, MD|817-288-9898|keith.argenbright@utsouthwestern.edu
113196|NCT01191476|Abbott|Global Medical Services|800-633-9110|
113197|NCT01191723|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com
113198|NCT01191736|Maricopa Integrated Health System|David Drachman|602-344-5161|david.drachman@mihs.org
113199|NCT01191749|University of Texas (UT) MD Anderson Cancer Center|Tapan Kadia, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org
113200|NCT01191762|Kenneth R. Phelps, M.D.|Kenneth R. Phelps, M.D.|518-626-5641|kenneth.phelps@va.gov
113201|NCT01191788|RAND Corporation|Katherine Watkins|(310) 393-0411 ext 6509|kwatkins@rand.org
113202|NCT01191801|Sunesis Pharmaceuticals, Inc|Linda Neuman, Vice President, Clinical Development|(650) 266-3760|lneuman@sunesis.com
113203|NCT01191827|Denver VA Medical Center|Research Biologist|303-724-6232|jason.tregellas@va.gov
113204|NCT01191944|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113205|NCT01192022|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
113206|NCT01192126|Bausch & Lomb Incorporated|Dr. Robert Steffen OD|585-338-6399|robert.steffen@bausch.com
113207|NCT01192139|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
113208|NCT01192152|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
113209|NCT01192178|GlaxoSmithKline|GSK Response Center|866-435-7343|
113210|NCT01192191|GlaxoSmithKline|GSK Response Center|866-435-7343|
113211|NCT01192204|The Ohio State University|Susan R, Mallery DDS, PhD|614 292-5892|mallery.1@osu.edu
113212|NCT01192282|Groote Schurr Hospital / University of Cape Town|Dr Shahila Tayib|0060195773376|syarq@yahoo.com
113214|NCT01192347|Shire Development LLC|Study Physician|+1 866 842 5335|
113215|NCT01192412|St. George's, University of London|Dr. Laura A. Magee|+442086729944 ext 52621|LMagee@sgul.ac.uk
113216|NCT01192516|Veterans Affairs--Ann Arbor Health Care System|Research Health Science Specialist|734-936-2123|sumurphy@umich.edu
113217|NCT01192542|Johnson and Johnson Vision Care|Brian Pall, O.D., M.S. F.A.A.O. Principal Research Optometrist|1 904 443-1290|bpall@its.jnj.com
113218|NCT01192698|Carolinas Medical Center|Dr. Mark W. Russo|704-355-6649|mark.russo@carolinashealthcare.org
113219|NCT01185028|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov
113220|NCT01185080|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
113221|NCT01185249|Central DuPage Hospital|Dr. Alice Siehoff, Nurse Scientist|1-630-858-0260|asiehoffrn@msn.com
113222|NCT01185288|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
113223|NCT01185301|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
113224|NCT01185353|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
113225|NCT01185509|Dana-Farber Cancer Institute|Ian Krop, MD, PhD|617.632.6973|Ian_Krop@dfci.harvard.edu
113226|NCT01185522|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
113227|NCT01185561|Loyola University|Sue Penckofer, Ph.D.|708-216-9303|spencko@luc.edu
113228|NCT01185600|University of Miami|Wenche Jy, PhD, Research Associate Professor, Principal Investigator|305-243-6617|wjy@med.miami.edu
113229|NCT01185704|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
113230|NCT01185782|Merck Serono Co., Ltd., Japan, an affiliate of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
113231|NCT01192776|Wayne State University|Seetha Shankaran|(313) 745-1436|sshankar@med.wayne.edu
113232|NCT01193049|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113233|NCT01194219|Celgene Corporation|Anne McClain|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com
113234|NCT01194245|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889|
113235|NCT01194258|Halozyme Therapeutics|Vice President, Endocrinology Clinical Development|858-794-8889|
113236|NCT01194297|University of Rochester|Dr. Carl D'Angio|585-275-2972|carl_dangio@urmc.rochester.edu
113237|NCT01194414|Hoffman-LaRoche|Medical Communications|800-821-8590|
113238|NCT01194427|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu
113240|NCT01194453|Sun Yat-sen University Cancer Center|Dr. Li Zhang|87342288|zhangli6@mail.sysu.edu.cn
113241|NCT01194479|Department of Internal Medicine and Endocrinology, Yale University School of Medicine, New Haven, CT|Robert Sherwin, MD|(203) 785-3482|robert.sherwin@yale.edu
113242|NCT01194531|Natera (formerly Gene Security Network)|Nina Wemmer, MS,CGC, Study Coordinator|650-249-9090|nwemmer@natera.com
113243|NCT01194674|National Institutes of Health|H. Nida Sen, Principal Investigator, National Eye Institute|301-402-3254|senh@nei.nih.gov
113244|NCT01194830|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113245|NCT01194856|Cleveland Clinic|Marisa Tungsiripat|2164442037|tungsim@ccf.org
113246|NCT01194869|Emory University|Elisavet Paplomata, MD|404-778-1900|elisavet.paplomata@emory.edu
113247|NCT01194908|Emory University School of Medicine|Ruth O'Regan, MD|404-778-4824|roregan@emory.edu
113248|NCT01194973|Alexion Pharmaceuticals Inc|Alexion Pharmaceuticals Inc||clinicaltrials@alexion.com
113249|NCT01194999|Barrie Urology Associates - The Male/Female Health and Research Centre|Joseph A Zadra, MD CM FRCSC|705-727-0551|joezadra@rogers.com
113250|NCT01195025|University Hospital Linköping|Dr. Joachim Zdolsek|+46101030000|joachim.zdolsek@lio.se
113251|NCT01195090|Department of Internal Medicine, Mackay Memorial Hospital|Dr. Sung-Chen Liu|886-2-2543-3535 ext 2174|pine3.tw@yahoo.com.tw
113252|NCT01195103|Mayo Clinic|John B Leslie MD|480-301-8000|leslie.john@mayo.edu
113253|NCT01195116|University of Rochester|Dr. Suzanne Karan|5852751384|suzanne_karan@urmc.rochester.edu
113254|NCT01195272|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
113255|NCT01195363|UTHSCSA|Charles L Bowden, MD|210-567-5393|BowdenC@uthscsa.edu
113256|NCT01195415|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu
113257|NCT01195467|St Stephen's AIDS Trust|Dr Mark Nelson|02033 ext 155610|mark.nelson@chelwest.nhs.uk
113258|NCT01195584|General Hospital Amstetten|Wolfgang Senker, MD|+43 7472 6040 ext 6611|wolfgang.senker@aon.at
113259|NCT01195597|University of Catania|Prof Riccardo Polosa|0957436413 ext 0039|polosa@unict.it, p.caponnetto@unict.it
113260|NCT01195623|Uppsala UH|Lena Blomgren MD PhD|+46851774173|lena.blomgren@karolinska.se
113261|NCT01195636|Xenon Pharmaceuticals Inc.|Dr. Paul Goldberg, VP Clinical Development|604-484-3300|pgoldberg@xenon-pharma.com
113262|NCT01195662|ClinicalTrialTransparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
113263|NCT01195675|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113264|NCT01195701|TriHealth Hatton Research Institute|Academic Clinical Research Supervisor|513-862-2330|Angie_Fellner@trihealth.com
113265|NCT01195779|GlaxoSmithKline|GSK Response Center|866-435-7343|
113266|NCT01195831|Leo Pharma|Malin Jaernkrants|+4544945888|malin.jaernkrants@leo-pharma.com
113267|NCT01195844|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113269|NCT01195948|National Institutes of Health|Robert Nussenblatt, MD, MPH|301-496-3123|robert.nussenblatt@nih.gov
113270|NCT01196026|GlaxoSmithKline|GSK Response Center|866-435-7343|
113271|NCT01196052|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
113272|NCT01196078|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
113273|NCT01196104|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com
113274|NCT01196377|Vanderbilt University School of Medicine|Dr. Donald H Arnold|6155790516|don.arnold@vanderbilt.edu
113275|NCT01196429|NRG Oncology Statistics and Data Management Center - Buffalo|Linda Gedeon for William Brady PhD|716-845-5702|lgedeon@nrgoncology.org
113276|NCT01196442|Virginia Commonwealth University|Dr. Craig W. Swainey|804-828-9723|cswainey@mcvh-vcu.edu
113277|NCT01188603|Sprout Pharmaceuticals|Sprout Pharmaceuticals|1-919-882-0850|clinicaltrials@sproutpharma.com
113278|NCT01188655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113279|NCT01188668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113280|NCT01188681|Emergent BioSolutions|Scott C. Stromatt|206-859-6675|sstromatt@ebsi.com
113281|NCT01188694|University of Washington|Lori Zoellner|206 685-3617|zoellner@u.washington.edu
113282|NCT01188772|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
113283|NCT01188798|St. Jude Children's Research Hospital|Asha Pillai, MD|1-866-278-5833|info@stjude.org
113284|NCT01188811|Oregon Health & Science University|Rebecca Spain, MD, MSPH|503-494-5759|spainr@ohsu.edu
113285|NCT01188928|Leo Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com
113286|NCT01188967|Massachusetts General Hospital|Maurizio Fava M.D.|617-724-2513|mfava@partners.org
113287|NCT01189032|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp
113288|NCT01189071|University of Missouri-Columbia|Dr. Mark Wakefield|573-882-0496|wakefieldmr@health.nissouri.edu
113289|NCT01189110|VAMC St. Louis MO|Deborah Fritz FNP PhD|314-652-4100 ext 53692|deborah.fritz@va.gov
113290|NCT01189123|Vanderbilt University Medical Center|Dr. Keipp Talbot|6153222035|keipp.talbot@vanderbilt.edu
113291|NCT01189136|Women & Infants Hospital of Rhode Island|Charles R. Rardin, MD|401 453-7560|crardin@wihri.org
113292|NCT01189201|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113293|NCT01189227|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600|
113294|NCT01189240|Adult Brain Tumor Consortium (ABTC)|Dr. Edward Pan||Edward.Pan@UTSouthwestern.edu
113295|NCT01189279|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
113296|NCT01189292|Department of General, Abdominal and Transplant Surgery, University of Heidelberg|Dr. Ignazio Tarantino||ignazio.tarantino@med.uni-heidelberg.de
113297|NCT01189370|University of Kansas Cancer Center|Dr. Peter Van Velduizen|913-945-5059|SWILLIAM@kumc.edu
113298|NCT01189435|Memorial Sloan Kettering Cancer Center|Dr. Gregory Riely|646-888-4199|rielyg@mskcc.org
113299|NCT01189461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113300|NCT01189487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113301|NCT01189500|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113302|NCT01189604|Astrazeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
113303|NCT01189617|Johnson & Johsnon Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist|9285-277-0715|jhauze@its.jnj.com
113304|NCT01189747|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
113305|NCT01189760|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
113306|NCT01189812|Columbia Northwest Pharmaceuticals|Director of Clinical Operations|425.453.0404|jhobus@nwcrc.net
113307|NCT01189890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113308|NCT01190007|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113309|NCT01190085|Brown University|Dr. Lorenzo Leggio|401-863-1000|Lorenzo_Leggio@Brown.edu
113310|NCT01190098|Cleveland Clinic|Nancy Foldvary-Schaefer, DO, MS|216-445-2990|foldvan@ccf.org
113311|NCT01190124|Hospital de Santa Maria - Centro Hospitalar Lisboa Norte|Doroana, Maria Manuela, M.D.|351 217938043|manuela.doroana@hsm.min-saude.pt
113312|NCT01190150|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
113313|NCT01190215|GlaxoSmithKline|GSK Response Center|866-435-7343|
113314|NCT01196741|University of Glasgow|Prof Iain McNeish, Professor of Gynaecological Oncology|+44 (0)141 330 3968|iain.mcneish@glasgow.ac.uk
113315|NCT01196923|CardioFocus, Inc.|Burke Barrett, VP, Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com
113316|NCT01196975|GlaxoSmithKline|GSK Response Center|866-435-7343|
113317|NCT01196988|GlaxoSmithKline|GSK Response Center|866-435-7343|
113318|NCT01197898|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com
113319|NCT01197911|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
113320|NCT01198145|Mayo Clinic|Robert C. Miller, M.D., M.S.||miller.robert@mayo.edu
113321|NCT01198275|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|Dr. Savina Nodari|00390303996 ext 587|nodari@med.unibs.it
113322|NCT01198327|Wilmer Eye Institute|Peter Campocahiro|410-955-5106|pcampo@jhmi.edu
113323|NCT01198366|Aeras|Product Director|301-547-2919|blandry@aeras.org
113324|NCT01198509|New York University School of Medicine|Steven B. Abramson, MD|212-263-8003|StevenB.Abramson@nyumc.org
113325|NCT01198548|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
113326|NCT01198574|South East Asia Ministers of Education Organization, Regional Center for Food and Nutrition|Dr. Min Kyaw Htet, Township Health Officer, Ministry of Health, Myanmar|+62-857-27262672|kyawhtet@gmail.com
113327|NCT01198600|Alcon Research|R. Alan Landers, O.D., M.S., F.A.A.O.|1-800-241-7629|
113328|NCT01198691|TriHealth|Donna Lambers, MD|513-862-2828|donna_lambers@trihealth.com
113329|NCT01198756|GlaxoSmithKline|GSK Response Center|866-435-7343|
113330|NCT01198769|GlaxoSmithKline|GSK Response Center|866-435-7343|
113331|NCT01198795|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000 ext 58124|carl.gommoll@frx.com
113332|NCT01198873|Sanofi|Trial Transparency Team||Contact_US@sanofi.com
113333|NCT01198977|Rehabilitation Care Services; MS Center of Excellence (MSCOE), VA Puget Sound Health Care System|Aaron Turner, PhD, Director, Rehabilitation Psychology; Asst Director Research, MSCOE|206-277-6134|Aaron.Turner@med.va.gov
113334|NCT01199016|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113335|NCT01199042|Bethesda North Hospital|Dr. Shahrokh Javaheri|513-793-7378|shahrokhjavaheri@icloud.com
113336|NCT01199237|University of California, San Francisco|Rachel Eshima McKay|415-502-1715|eshimar@anesthesia.ucsf.edu
113337|NCT01199471|Abbott|Global Medical Services|800-633-9110|
113338|NCT01199601|Columbia University|Dr. Catherine Todd|212-305-4805|cst2121@columbia.edu
113339|NCT01199705|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com
113340|NCT01199744|GlaxoSmithKline|GSK Response Center|866-435-7343|
113341|NCT01199822|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
113342|NCT01199861|Novartis Pharmaceuticals|Study Director|862-778-8300|
113343|NCT01199926|Purdue University|Dr. Dorothy Teegarden|765-494-8791|teegarden@purdue.edu
113344|NCT01199939|Janssen Pharmaceuticals|SENIOR MEDICAL DIRECTOR|1 609 730-2931|
113345|NCT01199965|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com
113346|NCT01200069|Rutgers/New Jersey Medical School|Vasanti Tilak, MD|974 972-5254|tilakva@njms.rutgers.edu
113347|NCT01200160|Abbott Laboratories de México|Carlos A Gonzalez MD, PhD|(5255) 5809- ext 7576|carlos.gonzalez@abbott.com
113348|NCT01200342|UT MD Anderson Cancer Center|Sapna P. Patel, MD / Assistant Professor||CR_Study_Registration@mdanderson.org
113350|NCT01200368|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113351|NCT01193101|Novartis Pharmaceuticals|Study Director|+1 (862) 778-1873|
113352|NCT01193114|The Ohio State University|Dr. Natasha Slesnick|614 247-8469|slesnick.5@osu.edu
113353|NCT01193127|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com
113354|NCT01193153|Janssen Scientific Affairs, LLC, Titusville, NJ|Director of Clinical Development||ClinicalTrialDisclosure@its.jnj.com
113355|NCT01193218|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113356|NCT01193244|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
113357|NCT01193283|NIH NHLBI|Dr. Danielle Townsley|301-402-3477|townsleydm@nhlbi.nih.gov
113358|NCT01193335|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113359|NCT01193348|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|clinicaltrials@alxn.com|clinicaltrials@alxn.com
114127|NCT01256658|Novartis|Study Director|41 61 324 1111|
113360|NCT01193556|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com
113361|NCT01193582|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113362|NCT01193608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113363|NCT01193660|CHA Bundang Medical Center, CHA University|Minyoung Kim, MD, PhD|82-31-780-1872|kmin@cha.ac.kr
113364|NCT01193686|VA Puget Sound Health Care System|Rhonda Williams, Ph.D.|206-277-6290|Rhonda.Williams1@va.gov
113365|NCT01193868|The University of Texas MD Anderson Cancer Center|George Blumenschein, MD / Professor|713-792-2734|CR_Study_Registration@mdanderson.org
113366|NCT01193907|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com
113367|NCT01193920|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
113368|NCT01194089|Mayo Clinic|Dr. Toby N. Weingarten|507-255-1612|weingarten.toby@mayo.edu
113369|NCT01194154|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
113370|NCT01200433|Clevland Clinic Foundation|Ehab Farag, MD|216-444-9950|farage@ccf.org
113371|NCT01200498|The University of Texas MD Anderson Cancer Center|Alfonso Quintas-Cardama, MD/Assistant Professor|713-745-4009|eharriso@mdanderson.org
113372|NCT01200511|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com
113373|NCT01200524|AstraZeneca|Heather Bryson||clinicaltrialtransparency@astrazeneca.com
113374|NCT01200602|Mayo Clinic|Vilmarie Rodriguez, MD|507-284-2695|rodriguez.vilmarie@mayo.edu
113375|NCT01201486|StavangerUH|Torbjørn Moe Eggebø, phd|004792699433|tme@lyse.net
113376|NCT01201629|OKC VA Medical Center|Dr. Meheroz H. Rabadi|405-456-5298|meheroz.rabadi@va.gov
113377|NCT01201759|UNIVERSITY OF MIAMI- The Miami Project to Cure Paralysis|Dr. Mark S. Nash|(305) 243-3628|MNash@med.miami.edu
113378|NCT01201772|University of Florida|Dominick Angiolillo|904-244-3933|dominick.angiolillo@jax.ufl.edu
113379|NCT01201785|University of Florida-Jacksonville|Dominick J. Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu
113380|NCT01201798|Alcon Research, Ltd.|Head, Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com
113381|NCT01201811|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com
113382|NCT01201915|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com
113383|NCT01201967|Massachusetts General Hospital|Jeff C. Huffman, MD|6177242910|jhuffman@partners.org
113384|NCT01202071|Eisai Co., Ltd.|Masaharu Yokoyama, Director|+81-3-3817-3908|m-yokoyama@hhc.eisai.co.jp
113385|NCT01202110|Cedars-Sinai|Leah Silbert|310 423-3783|Leah.Silbert@cshs.org
113386|NCT01202162|Northwestern University|Gildasio De Oliveira, M.D.|312-926-8371|g-jr@northwestern.edu
113387|NCT01202188|Novartis Pharmaceuticals|Study Director|862-778-8300|
113388|NCT01202227|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113389|NCT01202253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113390|NCT01202279|Reckitt Benckiser Inc.|Gail Solomon,MS; Director Clinical Development|973-404-2752|gail.solomon@reckittbenckiser.com
113391|NCT01202565|AbbVie|Global Medical Services|800-633-9110|
113392|NCT01202578|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com
113393|NCT01202591|Astrazeneca|Richard Mather|+44 1763 263593|ClinicalTrialTransparency@astrazeneca.com
113394|NCT01202643|Center for Human Reproduction|Dr. David Barad|212 994-4400|dbarad@theCHR.com
113395|NCT01202656|Center for Human Reproduction|Dr. David Barad|212 994-4400|dbarad@theCHR.com
113396|NCT01202747|TearScience, Inc. (formerly Kolis Scientific)|Christy Stevens, OD|919-459-4815|cstevens@tearscience.com
113397|NCT01202877|The University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org
113398|NCT01202903|Novartis Pharmaceuticals|Study Director|862-778-8300|
113399|NCT01202955|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu
113400|NCT01203046|Dr. Silvia M. Pinango L|Dr. Silvia M. Pinango L.|+584169267988|pinangosilvia@yahoo.com
113401|NCT01203072|Daiichi Sankyo.,LTD|Kei Ibusuki, Associate Director|81-90-2732-9505|ibusuki.kei.tx@daiichisankyo.co.jp
113402|NCT01203098|Daiichi Sankyo.,LTD|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp
113403|NCT01203319|Jiangsu Provincial Center for Disease Control and Prevention|Fengcai Zhu|#86-25-83759418|jszfc@vip.sina.com
113404|NCT01203644|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com
113405|NCT01203787|UNIVERSITY OF FLORIDA|Roniel Cabrera, MD|352-273-9468|RONIEL.CABRERA@MEDICINE.UFL.EDU
113407|NCT01203852|University of Florida|Dr. Julie A. Johnson|(352) 273-6309|johnson@cop.ufl.edu
113408|NCT01203878|Tennessee Clinical Research Center|Medical Director|615-383-2400|jbiron@tnclinicalresearch.com
113409|NCT01203917|AstraZeneca|Haiyi Jiang|+86 21 60302408|aztrial_results_posting@astrazeneca.com
113410|NCT01203930|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
113411|NCT01197326|Philips Healthcare|Duane A Young-Kershaw RN, BSN, Clinical Researcher|508-817-7001|duane.young-kershaw@philips.com
113412|NCT01197417|Medical College of Wisconsin|David Brousseau MD, MS|414-266-2625|dbrousse@mcw.edu
113413|NCT01197495|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com
113414|NCT01197508|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
113415|NCT01197521|AstraZeneca|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
113416|NCT01197534|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
113417|NCT01197547|Boston Scientific|Meaghan Wilk|5086834113|wilkm@bsci.com
113418|NCT01197560|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com
113419|NCT01197755|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
113420|NCT01197794|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com
113421|NCT01197833|BTG International Inc|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com
113422|NCT01203956|Sleep Medicine Associates of Texas|Leon Rosenthal, MD|214-750-7776|LRosenthal@sleepmed.com
113423|NCT01204203|University of Alabama at Birmingham|Francisco Robert, MD|205-934-5077|pacorobertuab@cs.com
113425|NCT01205828|Georgetown University Medical Center|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu
113426|NCT01206101|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
113427|NCT01206140|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
113428|NCT01206322|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu
113429|NCT01206387|Taro Pharmaceuticals U.S.A., Inc|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com
113431|NCT01206452|University of Kansas Medical Center|Donita Atkins, RN, CCRC|(913) 588-9714|datkins2@kumc.edu
113432|NCT01206478|University of Kansas Medical Center|Ann M Davis, PI|913-588-6300|adavis6@kumc.edu
113433|NCT01206517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113434|NCT01206582|Mayo Clinic|Dr. Adil E. Bharucha|507-284-6439|bharucha.adil@mayo.edu
113435|NCT01206595|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com
113436|NCT01206608|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com
113437|NCT01206660|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com
113438|NCT01206738|University of Aberdeen|Prof Shaun Treweek||streweek@mac.com
113439|NCT01206777|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-688-7942|Jeffrey.Jones@osumc.edu
113440|NCT01207102|Duke University Medical Center|Dr Kimberly Blackwell|919-6681748|black034@mc.duke.edu
113441|NCT01207219|The Department of Psychiatry,HKU|Dr.Lin Jingxia|+85222553064|jingxia.lin@gmail.com
113442|NCT01207388|Amgen Inc.|Study Director|866-572-6436|
113443|NCT01207401|University of California, San Diego|Dr. Sheila Krishnan Mody|(619)543-6777|smody@ucsd.edu
113444|NCT01207414|Novartis Pharmaceuticals|Study Director|862-778-8300|
113445|NCT01207427|Cubist Pharmaceuticals|Vice President Clinical Research|(781) 860-8660|
113446|NCT01207453|Brigham and Women's Hospital|Yvonne C Lee, MD, MMSc|617-732-8736|ylee9@partners.org
113447|NCT01207466|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|joseph.rappon@cibavision.com
113448|NCT01207492|Dana-Farber Cancer Institute|Andrew Wagner, MD, PhD|617.632.5204|andrew_wagner@dfci.harvard.edu
113449|NCT01207570|The Hong Kong Polytechnic University|Dr. Marco Pang|85227667156|Marco.Pang@inet.polyu.edu.hk
113450|NCT01207583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113451|NCT01207596|International Clinical Research Institute|Srinivas Nalamachu|913-317-5300|nalamachu@yahoo.com
113452|NCT01207648|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
113453|NCT01207687|Johns Hopkins Comprehensive Neurofibromatosis Center|Dr. Jaishri Blakeley|410-614-3853|jblakel3@jhmi.edu
113454|NCT01207765|Tufts Medical Center|Andreas Klein, MD|617-636-8884|aklein2@tuftsmedicalcenter.org
113455|NCT01207934|Washington University School of Medicine|Samuel Klein, MD|3143628708|sklein@wustl.edu
113456|NCT01208181|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113457|NCT01208207|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113458|NCT01208220|LSUShreveport|Dr. Stanley McCallon|318-813-2996|smccal@lsushc.edu
113459|NCT01208233|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113460|NCT01200758|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com
113461|NCT01200797|Vanderbilt-Ingram Cancer Center|Marta A. Crispens, M.D.|615-322-8072|marta.crispens@Vanderbilt.Edu
113463|NCT01200875|Stanford University|Jason Dragoo, Associate Professor|(650) 721-3430|jdragoo@stanford.edu
113464|NCT01200992|Prometic Biosciences Inc.|Aline Hagerimana, MD, Senior Director Clinical Affairs|(514) 781-0115|a.hagerimana@prometic.com
113465|NCT01201265|Hoffmann-La Roche|Medical Communications|800-821-8590|
113466|NCT01201317|AstraZeneca|Heather Bryson||clinicaltrialtransparency@astrazeneca.com
113467|NCT01201343|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
113468|NCT01208337|University of Pittsburgh|Dr. Rakesh Sindhi|412-692-6110|rakesh.sindhi@chp.edu
113469|NCT01208402|Duke University Medical Center - Department of Anesthesiology|William White / Statistician|919-684-4081|white013@mc.duke.edu
113470|NCT01208415|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Affairs|765-463-7537|Scott.Snyder@CookMedical.com
113471|NCT01208870|SUNY Buffalo|Leonard H. Epstein, Ph.D.|716-829-3400|lhenet@buffalo.edu
113472|NCT01208961|AstraZeneca Pharmaceuticals|Torbjörn Lundström, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
113473|NCT01209143|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com
113474|NCT01209195|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com
113475|NCT01209260|University of California San Diego|Jonathan Hsu, MD, MAS|415-476-5706|jonathan.hsu@ucsd.edu
113476|NCT01209286|Amgen Inc.|Study Director|866-572-6436|
113477|NCT01209520|University of Miami|Ikechukwu Akunyili MD|305-243-6626|IAkunyili@med.miami.edu
113478|NCT01209624|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113481|NCT01209767|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu
113482|NCT01209780|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
113483|NCT01209949|Galderma Laboratories, L.P.|Norman Preston|817-961-5360|Norman.Preston@galderma.com
113484|NCT01210001|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113485|NCT01210079|School of Nursing, University of California, Los Angeles|Margaret (Peggy) Compton, RN PhD|(310) 206-2825|pcompton@sonnet.ucla.edu
113486|NCT01210118|Hellenic Anticancer Society|Professor Panagiotis Behrakis|00302106470056|pbehraki@hsph.harvard.edu
113487|NCT01210144|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
113489|NCT01210443|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113490|NCT01210495|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113491|NCT01210651|UCSF|Sudha Prathikanti, MD|415-516-3867|sudha.prathikanti@gmail.com
113492|NCT01210690|UCB|UCB Cares|+1 877 822 9493|
113493|NCT01210716|Fenwal, Inc|Sr. Mgr. Clinical Affairs|847-550-5620|carrie.pineda@fenwalinc.com
113494|NCT01210807|University Eye Clinic, Tubingen, Germany|PD Dr. med. Peter Szurman|49-7071-29-84915|peter.szurman@med.uni-tuebingen.de
113495|NCT01210820|AMO Development, LLC|Carrie Garufis|714-566-3728|carrie.garufis@amo.abbott.com
113496|NCT01211106|Cpl Micheal J Crescenz VA Medical Center|David Oslin, MD|215-823-5894|dave.oslin@va.gov
113497|NCT01204294|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113498|NCT01204398|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113499|NCT01204658|GlaxoSmithKline|GSK Response Center|866-435-7343|
113500|NCT01204671|GlaxoSmithKline|GSK Response Center|866-435-7343|
113501|NCT01204697|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
113502|NCT01204736|Rehabilitation Institute of Chicago|Dr. Wendy Murray|3122386965|w-murray@northwestern.edu
113503|NCT01204775|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484 ext 762 484|Eva.Johnsson@astrazeneca.com
113504|NCT01204788|University of Texas (UT) MD Anderson Cancer Center|Emil Freireich, MD, Professor, Department of Medical Education|713-745-2723|CR_Study_Registration@mdanderson.org
113505|NCT01204853|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113506|NCT01205035|Eye Center of Northern Colorado, PC|Dr. Arthur Korotkin, MD|970-221-2222|retina@eyecenternoco.com
113507|NCT01205126|Janssen Research & Development, LLC|Director, Established Products|+1 609 730 3387;|
113508|NCT01205230|GlaxoSmithKline|GSK Response Center|866-435-7343|
113509|NCT01205269|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
113510|NCT01205399|C. R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com
113511|NCT01205451|GlaxoSmithKline|GSK Response Center|866-435-7343|
113512|NCT01205503|Markey Cancer Center Biostatistics Shared Resource Facility|Emily Dressler, PhD|859 323-3076|emilydressler@uky.edu
113513|NCT01205581|St. Jude Children's Research Hospital|Jon McCullers, MD|866-278-5833|info@stjude.org
113515|NCT01205685|Vanderbilt-Ingram Cancer Center|Dr. Ingrid Mayer|615-936-2033|ingrid.mayer@vanderbilt.edu
113516|NCT01211145|AstraZeneca|Jamie Mullen, Medical Science Director|781-472-5032|jamie.mullen@astrazeneca.com
113517|NCT01211184|Södertälje Hospital|Robert Hahn|+46855024670 ext 4670|robert.hahn@sodertaljesjukhus.se
113518|NCT01211197|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113519|NCT01211340|University of Missouri|Debra Parker Oliver|573-884-5301|oliverdr@missouri.health.edu
113520|NCT01213576|University of Liverpool|Professor Neil French|+441517959630|french@liv.ac.uk
113521|NCT01213589|Medtronic|Richard Jonkers, PhD|800-217-1617 ext 3727|richard.jonkers@medtronic.com
113522|NCT01213706|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu
113523|NCT01213823|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113524|NCT01213836|Astra Zeneca|Gerard Lynch||ClinicalTrailTransparency@astrazeneca.com
113525|NCT01213966|Faculty of Tropical Medicine|Professor Sasithon Pukrittayakamee|(662) 354-9400-19 ext 1435|yon@tropmedres.ac
113526|NCT01214083|VA Connecticut Healthcare System|Gihyun Yoon, MD|203-932-5711 ext 7421|gihyun.yoon@va.gov
113527|NCT01214109|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113528|NCT01214161|Columbia University|Anne Davis, MD|212-305-4951|ard4@cumc.columbia.edu
113529|NCT01214174|Icon Bioscience, Inc.|Wendy Murahashi, MD|650-369-4049|wendymurahashi@iconbioscience.com
113530|NCT01214187|Brigham and Women's Hospital|Ivan Rosas, MD|617-278-0434|irosas@rics.bwh.harvard.edu
113531|NCT01214239|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113532|NCT01214252|Covidien|Annie Choi|781-839-1756|annie.choi@covidien.com
113533|NCT01214330|Mike O'Callaghan Federal Medical Center|Jill Clark, Clinical Research Manager|702-653-3298|jill.clark.3.ctr@us.af.mil
113534|NCT01214395|PathWest Laboratory Medicine WA|Dr Kerry Carson Trial Manager|+61 8 93464092|kerry.carson@uwa.edu.au
113535|NCT01214434|Promius Pharma, LLC|Medical Information Center|888 966-8766|product-complaints@promiuspharma.com
113536|NCT01214616|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113537|NCT01214720|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
113538|NCT01214759|The University of Texas Health Science Center at Houston|Dr. Karen Vigil|(713) 500-6703|Karen.J.Vigil@uth.tmc.edu
113539|NCT01214811|Molnlycke Health Care|Viktoria Ahlenius Körner|0046 31 7223000|viktoria.ahleniuskorner@molnlycke.com
113540|NCT01214824|Abbott Diabetes Care|Director Global Clinical and EMEA Regulatory Affairs|01993863164|joe.bugler@abbott.com
113543|NCT01214915|Shire Development LLC|Study Physician|+1 866 842 5335|
113544|NCT01214980|University South Florida|Dr. Lisa Gould|(410) 736-4646|lgould44@hotmail.com
113545|NCT01215032|Mass General Hospital Cancer Center|Maria Kempner|508.533.4132|mkempner@partners.org
113546|NCT01215097|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113547|NCT01215110|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org
113548|NCT01215123|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
113549|NCT01215227|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113550|NCT01215279|AstraZeneca|Anna Malmgren||ClinicalTrialTransparency@astrazeneca.com
113551|NCT01215292|University of Washington|Mara Roth, MD|206-221-0519|mylang@uw.edu
113552|NCT01215344|Vanderbilt-Ingram Cancer Center|Madan Jagasa, M.D.|(6150 936-8422|madan.jagasia@vanderbilt.edu
113553|NCT01215357|Psyadon Pharmaceuticals|Dr. Richard Chipkin|301-919-2020|rchipkin@psyadonrx.com
113554|NCT01215422|UNIVERSITY OF ALBERTA|DR. JOAN ROBINSON|780-248-5540|jr3@ualberta.ca
113555|NCT01215435|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
113556|NCT01215513|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
113557|NCT01215643|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com
113558|NCT01215695|University Louisville|Rainer Lenhardt, MD|502-228-7517|rainer.lenhardt@louisville.edu
113559|NCT01215721|UC Irvine|Thomas Ahlering, MD|714-456-6068|tahlerin@uci.edu
113560|NCT01215734|Vanderbilt University|Natasha Halasa, Associate Professor of Pediatrics|615-322-3346|natasha.halasa@vanderbilt.edu
113561|NCT01215786|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
113562|NCT01215851|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|dan.everitt@tballiance.org
113563|NCT01215929|UAMS|Michael J Mancino MD|501-526-8440|mjmancino@uams.edu
113564|NCT01215955|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
113565|NCT01215968|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
113566|NCT01215981|Masonic Cancer Center, University of Minnesota|Michael Verneris, M.D.|612-626-2961|verneris@umn.edu
113567|NCT01216072|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
113568|NCT01216943|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
113569|NCT01217073|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113570|NCT01217112|GW Research Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223266800|rp@gwpharm.com
113571|NCT01217229|Plexxikon Inc.|Medical Monitor|510-647-4000|info@plexxikon.com
113572|NCT01217411|University of Texas (UT) MD Anderson Cancer Center|Morris D. Groves, MD / Professor||CR_Study_Registration@mdanderson.org
113573|NCT01217463|Olympus France S.A.S|Mr. Akira Kondo, Manager, Clinical R&D|+33-1-4560-6849|akira.kondo@olympus.fr
113574|NCT01217476|Olympus France S.A.S|Mr. Akira Kondo, Manager, Clinical R&D|+33-1-4560-6849|akira.kondo@olympus.fr
113575|NCT01217515|S.L.A. Pharma UK Ltd|Dr C Jordan, Head of Clinical Operations|44 01923 681001|cjordan@slapharma.com
113576|NCT01217606|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
113577|NCT01217749|Pharmacyclics, Inc.|Dr. Jutta K. Neuenburg|877-877-3536|medinfo@pcyc.com
113578|NCT01217801|Par Pharmaceutical|Medical Affairs|800-828-9393|DrugInfo@strativapharma.com
113579|NCT01217814|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
113580|NCT01217827|VA Palo Alto HCS|Paul Heidenreich|650-849-1205|paul.heidenreich@va.gov
113582|NCT01217892|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com
113583|NCT01217944|Novartis Pharmaceuticals|Study Director|862-778-8300|
113584|NCT01217957|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
113585|NCT01218009|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com
113586|NCT01218087|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu
113587|NCT01218100|Forest Research Institute|Manfred Stapff, MD, PhD|201-427-8000|Manfred.stapff@frx.com
113588|NCT01218243|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|Zhishun Liu, Director of the study|8610-010-88001124|liuzhishun@yahoo.com.cn
113589|NCT01218308|GlaxoSmithKline|GSK Response Center|866-435-7343|
113590|NCT01218399|Astra Zeneca|Elena Pizzi|+1 302 885 2677|Elena.Pizzi@astrazeneca.com
113592|NCT01218477|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
113593|NCT01218594|Sun Yat-Sen University Cancer Center|Ming Chen|86-20-87343640|chenming@sysucc.org.cn
113594|NCT01218646|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
113595|NCT01218802|Case Western Reserve University|Grace McComsey, MD|2168442739|gam9@case.edu
113596|NCT01218867|National Cancer Institute|Dr. Steven Rosenberg|301- 496-4164|sar@mail.nih.gov
113597|NCT01218958|Alkermes, Inc.|Bernard L. Silverman, VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com
113598|NCT01218971|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|bernard.silverman@alkermes.com
113599|NCT01218984|Alkermes, Inc.|Bernard L. Silverman, VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com
113600|NCT01218997|Alkermes, Inc.|Bernard L. Silverman|781-609-6000|bernard.silverman@alkermes.com
113601|NCT01211535|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937|
113602|NCT01211613|University of Pittsburgh, Department of Physical Therapy`|Michael J Schneider, DC, PhD|412-383-6640|mjs5@pitt.edu
113603|NCT01211665|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com
113604|NCT01211730|Northwestern University Feinberg School of Medicine|Mark E. Molitch, M.D.|312 503-4130|molitch@northwestern.edu
113605|NCT01211769|UNIFESP|José Carlos Fernandes Galduróz|55 11 21490168|galduroz@psicobio.epm.br
113606|NCT01211873|Guerbet|Pierre Desché, MD - VP Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com
113607|NCT01212094|NINDS, NIH|Dr. Bibiana Bielekova, Prinicipal Investigator|301-402-4488|bibiana.bielekova@nih.gov
113608|NCT01212159|Temple University School of Medicine|Alfred A. Bove|215-707-9259|alfred.bove@tuhs.temple.edu
113609|NCT01212172|UC Irvine Dermatology Research Center|Christopher B. Zachary|949 824 7103|czachary@uci.edu
113610|NCT01212185|UNC_ChapelHill|Dr. Cort Pedersen|919-966-4447|cort_pedersen@med.unc.edu
113611|NCT01212302|Cardiology Dep, Ruhr-University Bochum|Dr Horst Neubauer|+49-234-509-2326|Horst.Neubauer@rub.de
113612|NCT01212445|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113613|NCT01212484|NYU Medical Center|Horacio Kaufmann, MD; director of Dysautonomia Center|212 263 7225|horacio.kaufmann@nyumc.org
113614|NCT01212627|Brown University Oncology Research Group (BrUOG)|Angela Taber, MD|4018633000|kayla_rosati@brown.edu
113615|NCT01212757|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
113618|NCT01212991|Medivation, Inc.|Phillip Cole, MD||phillip.cole@medivation.com
113619|NCT01213043|Grifols Therapeutics Inc.|Benjamin King, PhD||ben.king@grifols.com
113620|NCT01213173|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com
113621|NCT01213199|GALDERMA|Fabien AUDIBERT, CPM|+ 33 4 92 95 29 21|fabien.audibert@galderma.com
113622|NCT01213251|Medtronic plc|PRomPT Clinical Team|+1 800-328-2518|MedtronicCRMtrials@medtronic.com
113623|NCT01213264|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113624|NCT01213316|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113626|NCT01221272|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
113627|NCT01221285|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
113628|NCT01221298|AbbVie|Global Medical Services|800-633-9110|
113629|NCT01221311|Medical University of South Carolin|Gregory Cote|843-876-4261|cotea@musc.edu
113630|NCT01221350|Centro Universitario de Ciencias de la Salud, Mexico|Fernando R Siller Lopez, Ph.D.|523310585200 ext 33723|fsiller@cucs.udg.mx
113631|NCT01221363|Research Centre for Prevention and Health|Mette Aadahl|+45 38663359|mette.aadahl@regionh.dk
113632|NCT01221441|TissueGene, Inc|R. Ogden Copeland|(301) 921-6000 ext 122|ocopeland@tissuegene.com
113633|NCT01221597|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
113634|NCT01221623|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
113635|NCT01221727|Amgen Inc.|Study Director|866-572-6436|
113637|NCT01221948|Bostons Scientific Neuromodulation|Nic Van Dyck, Director International Clinical Operations|+31 43 3568328|vandyckn@bsci.com
113638|NCT01222078|GlaxoSmithKline|GSK Response Center|866-435-7343|
113639|NCT01222104|St Jude Medical|Andrew Campbell|651-756-5538|acampbell2@sjm.com
113640|NCT01222117|Grifols Therapeutics|Kimberly Steinmann, MD|919-308-5444|kimberly.steinmann@grifols.com
113641|NCT01222195|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org
113642|NCT01222234|University of Kansas Medical Center|Dr. Jason Stubbs|913-588-9252|jstubbs@kumc.edu
113643|NCT01222286|Innate Pharma|Dr Renaud Buffet|33 4 30 30 30 32|renaud.buffet@innate-pharma.fr
113644|NCT01222390|Northwestern University|John Y.S. Kim, MD|312-695-0208|jokim@nmh.org
113645|NCT01222403|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
113646|NCT01222416|Vanderbilt-Ingram Cancer Center|A Bapsi Chakravarthy, MD Program Director, Radiation Oncology|615-322-2555|babsi.chak@vanderbilt.edu
113647|NCT01222507|Washington University|Dr. Jay Piccirillo|314-362-7508|piccirilloj@ent.wustl.edu
113648|NCT01222520|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113649|NCT01222533|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113650|NCT01222572|Dana-Farber Cancer Institute/Brigham and Women's Hospital|Raymond Mak, MD|6177328651|rmak@partners.org
113651|NCT01222585|Duke Clinical Research Institute|Michael Cohen-Wolkowiez, MD|919668-8812|michael.cohenwolkowiez@dm.duke.edu
113652|NCT01222689|university of california san francisco|Dr. Andrew Ko, MD|415-353-7286|Andrew.Ko@ucsf.edu
113653|NCT01222715|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
113654|NCT01222832|SEMC|Peter catalano|617-789-5004|peter.catalano@steward.org
113655|NCT01222884|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com
113656|NCT01223001|The Rehabilitation Hospital of Indiana|Dr. Lance Trexler|(317)879-8940|lance.trexler@rhin.com
113657|NCT01223027|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com
113658|NCT01223196|UT Health Science Center San Antonio|Franco Folli, MD PhD/Professor|210-567-4826|FOLLI@uthscsa.edu
113660|NCT01223365|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
113661|NCT01223469|St. Jude Medical/Endosense|Hendrik Lambert PhD, VP of Clinical and Regulatory Affairs||Hendrik.Lambert@endosense.com
113662|NCT01223703|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|Dr Savina Nodari|00390303996 ext 587|nodari@med.unibs.it
113663|NCT01216163|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113664|NCT01216241|University of Rochester|Dr. Robert F. Betts|585-275-5871|robert_betts@urmc.rochester.edu
113665|NCT01216319|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com
113666|NCT01216397|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113667|NCT01216410|Duke University Medical Center|Ashraf Habib|919 668 6266|habib001@dm.duke.edu
113668|NCT01216631|University of Leeds|Professor Philip Conaghan|+44 113 3924884|p.conaghan@leeds.ac.uk
113669|NCT01216735|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu
113670|NCT01216748|University of Miami|Matthias Salathe, MD|(305)243-2568|msalathe@med.miami.edu
113671|NCT01216761|University of Michigan Health System|Laraine Washer, MD|734-936-5205|laraine@med.umich.edu
113672|NCT01223937|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
113673|NCT01224015|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
113674|NCT01224626|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113675|NCT01224639|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
113676|NCT01224782|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
113677|NCT01224821|GlaxoSmithKline|GSK Response Center|866-435-7343|
113678|NCT01225029|Icahn School of Medicine at Mount Sinai|Dr. Annemarie Stroustrup|212-241-6186|annemarie.stroustrup@mssm.edu
113679|NCT01225055|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu
113680|NCT01225068|Northwestern University Feinberg School of Medicine|Thomas J Schnitzer|3125032315|tjs@northwestern.edu
113681|NCT01225146|Retina Consultants of Houston|David M. Brown, MD|713-524-3434|dmbmd@houstonretina.com
113682|NCT01225159|Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand|Dr.Panthila Rujirojindakul, Staff|+66 74 45 1651|rpanthi@medicine.psu.ac.th
113683|NCT01225211|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
113684|NCT01225263|BIDMC|Catherine Buettner, MD MPH|617-754-9600|cbuettne@bidmc.harvard.edu
113685|NCT01225289|Tehran University of Medical Sciences|The Study of the Effects of Vitamin A Supplementation on Immune System and Th1/Th2 Balance in Patien|+98 912 2182815|sjafarirad@gmail.com
113686|NCT01225354|DeNova Research|Jack Arkins, Data Manager|312-335-2070|jack@drdayan.com
113687|NCT01225549|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
113688|NCT01225562|AstraZeneca AB|Anders Himmelmann, MD PhD|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com
113689|NCT01225731|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113690|NCT01225822|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113691|NCT01225835|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
113693|NCT01225926|Alcon Research, Ltd.|Manoj Venkiteshwar, Brand Lead, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com
113694|NCT01225952|Bausch & Lomb Incorporated|Omid Khodai, OD,RAC|(949) 521-7894|omid.khodai@bausch.com
113695|NCT01225991|University of California, Los Angeles|Dr. Helen Lavretsky,|310-794-4619|hlavretsky@mednet.ucla.edu
113696|NCT01226043|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
113697|NCT01226095|Abbott|Global Medical Services|800-633-9110|
113698|NCT01226121|Indiana Hand to Shoulder Center|F. Thomas D. Kaplan|3178759105|tdk@hand.md
113699|NCT01226420|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH, FRCP(C)|617-632-5946|cscutler@partners.org
113700|NCT01226459|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|Study Director|(973) 385-3203|
113701|NCT01226511|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
113702|NCT01226706|Gynecology, Regina Qu'Appelle Health Region|Dr. Corrine Jabs|(306) 586-3120|corrinejabs@hotmail.com
113703|NCT01226719|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
113704|NCT01226732|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net
113705|NCT01226745|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
113706|NCT01227005|University of Texas Health Science Center-Houston|Bryan A. Cotton, MD, MPH|713-500-7354|bryan.a.cotton@uth.tmc.edu
113707|NCT01227018|Vanderbilt-Ingram Cancer Center|Dr. Dana Cardin|615-936-8580|dana.cardin@vanderbilt.edu
113708|NCT01227057|VASDHS|Catherine Ayers|8585528585 ext 2976|catherine.ayers1@va.gov
113709|NCT01219673|University of Texas (UT) MD Anderson Cancer Center|Dr. David Rosenthal Professor, Radiation Oncology Department|713-792-7734|CR_Study_Registration@mdanderson.org
113710|NCT01219738|University of Miami|Eliana Mendes|(305) 243-2568|e.mendes@miami.edu
113711|NCT01219777|The Ohio State University Comprehensive Cancer Center|Ritu Salani, MD, MBA|614-293-3873|Ritu.Salani@osumc.edu
113712|NCT01219855|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com
113713|NCT01219881|The Ohio State University|Dr. Joseph Werner|614-293-8487|Joseph.Werner@osumc.edu
113714|NCT01219933|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
113715|NCT01219985|Centre Hospital-Universitaire d'Amiens|Pr. Marc-Etienne Meyer|+33 3 22 45 59 64|meyer.marc-etienne@chu-amiens.fr
113716|NCT01220128|GlaxoSmithKline|GSK Response Center|866-435-7343|
113717|NCT01220180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113718|NCT01220297|Stanford Univesity|Laura Johnston, MD|650-723-0822|laura.johnston@stanford.edu
113719|NCT01220401|University of Tulsa|Dr. Noelle Balliett|918-631-3976|noelle-balliett@utulsa.edu
113720|NCT01220466|Abbott Medical Optics|Amelia Saliba, Sr. Manager, Clinical Research|408-273-4158|amelia.saliba@amo.abbott.com
113721|NCT01220557|Forschungsinstitut der Diabetes Akademie Mergentheim|Norbert Hermanns, PhD|+49 7931 594 ext 553|hermanns@diabetes-zentrum.de
113723|NCT01220739|University of California, San Diego|Dr. Thomas Hemmen|858-657-7190|themmen@ucsd.edu
113724|NCT01220869|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
113725|NCT01221090|Scott & White Hospital|Dr. Samuel N. Forjuoh|(254) 771-7695|SFORJUOH@sw.org
113726|NCT01227265|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113727|NCT01227278|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com
113728|NCT01227382|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu
113729|NCT01227395|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113730|NCT01227421|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com
113731|NCT01227434|University of California San Francisco|Michael Prados, MD|4154767217|pradosm@neurosurg.ucsf.edu
113732|NCT01228591|Johnson & Johnson Vision Care|Brian Pall, O.D., M.S., F.A.A.O. Principal Research Optometrist|1 904 443-1290|bpall@its.jnj.com
113734|NCT01228747|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
113735|NCT01228903|University of Colorado|Diana Jalal|3037244867|diana.jalal@ucdenver.edu
113736|NCT01228929|University of Rochester|Dr. James V. Aquavella|585-275-8944|james_aquavella@urmc.rochester.edu
113737|NCT01228968|Washington University School of Medicine|Gary Skolnick|3143625292|gskolnic@wustl.edu
113738|NCT01229111|Case Comprehensive Cancer Center|Dr. Smitha Krishnamurthi|216-844-5234|smitha.krishnamurhti@uhhospitals.org
113739|NCT01229150|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov
113740|NCT01229176|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com
113741|NCT01229228|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com
113742|NCT01229254|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000|
113743|NCT01229371|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com
113744|NCT01229397|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com
113745|NCT01229410|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
113746|NCT01229423|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com
113747|NCT01229436|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113748|NCT01229462|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
113749|NCT01229527|Department of Anesthesia and Intensive Care|Dr. Massimo Agostoni|+39.02.2643.2656|agostoni.massimo@hsr.it
113750|NCT01229722|Dimagi Inc.|Dr. Vikram Kumar|6176492214|information@dimagi.com
113751|NCT01229735|UCB Pharma|UCB Clinical Trial Call Center|+1877 822 ext 9493|
113752|NCT01229891|National nutrition and food technology institute|T Neyestani|0982122376471|neytr@yahoo.com
113753|NCT01229943|Dana-Farber Cancer Institute|Matthew Kulke, MD, MMSc||matthew_kulke@dfci.harvard.edu
113754|NCT01230021|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
113755|NCT01230060|Bausch & Lomb Incorporated|Jon Hayashida|(949) 521-7876|jon.hayashida@bausch.com
113756|NCT01230177|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113757|NCT01230307|University of Michigan|Barry Bleske|734-763-3232|bbleske@umich.edu
113758|NCT01230424|Tufts Medical Center|Dr. Timothy McAlindon|6176365610|tmcalindon@tuftsmedicalcenter.org
113759|NCT01230502|University of Wisconsin|Professor William Burlingham, PhD|(608) 263-0119|BURLINGHAM@SURGERY.WISC.EDU
113760|NCT01230710|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
113761|NCT01230749|Janssen R&D US|Director, Translational Medicine|1 908 927-7881|
113762|NCT01230788|Emory University|Dr. Todd Cooper|404-785-3000|tmcoope@emory.edu
113763|NCT01230814|University of Arkansas for Medical Sciences|Shelly Lensing, MS|501-686-8203|sylensing@uams.edu
113764|NCT01230827|Johnson & Johnson Pharmaceutical Research & Development|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com
113765|NCT01230892|Emory University|Dr. Habib Samady|404-778-5299|hsamady@emory.edu
113766|NCT01224171|Millennium Pharmaceuticals Inc.|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com
113767|NCT01224236|University of Texas Health Science Center - Houston|Kathleen Kennedy|+1 (713) 500-5651|Kathleen.A.Kennedy@uth.tmc.edu
113768|NCT01224431|Phoenix Children's Hospital|Angelique Ferayorni|602-546-1910|aferayorni@phoenixchildrens.com
113769|NCT01224444|White River Junction VA|Heiko Pohl|802-295-9363 ext 5595|heiko.pohl@dartmouth.edu
113770|NCT01231230|University of Miami|Adam Wanner, MD|(305)243-2568|awanner@med.miami.edu
113771|NCT01231321|Abbott|Global Medical Services|800-633-9110|
113772|NCT01231334|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
113773|NCT01233232|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
113774|NCT01233258|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
113775|NCT01233284|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113776|NCT01233687|University of Pittsburgh|Ahmad Tarhini, MD|(412) 648-6578|tarhiniaa@upmc.edu
113777|NCT01233726|Intensive Care Unit, Hospital Clínico Universitario|Alfonso Mesejo|961 97 35 00|mesejo_alf@gva.es
113778|NCT01233817|Department of Physical Medicine and Rehabilitation, School of Medicine, University of Utah|Aga Lewelt MD, Principal Investigator|801-518-4572|aga@genetics.utah.edu
113779|NCT01233869|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113780|NCT01233921|Fred Hutchinson Cancer Research Cetner|Dr. Paul J. Martin|206-667-4798|pmartin@fhcrc.org
113781|NCT01233999|Emory University|Dr. Suephy Chen|404-778-3084|schen2@emory.edu
113782|NCT01234103|University of California, San Francisco|Cherrie B. Boyer, PhD|4154762184|Cherrie.Boyer@ucsf.edu
113783|NCT01234207|UCaliforniaBerkeley|Andrew D. Graham|510-643-9252|agraham@berkeley.edu
113785|NCT01234467|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
113786|NCT01234675|Cleveland Sleep Research Center|Mansoor Ahmed, MD|4402438044|sleepresearchcenter@yahoo.com
113787|NCT01234714|University of Zurich|Dr Dimitri Aristotle Raptis, Principal Investigator|+41442553300|dimitri.raptis@usz.ch
113789|NCT01234870|Northwestern University|Dr. James Carr|(312)695-4218|jcarr@northwestern.edu
113790|NCT01234883|Baxter Healthcare|Drew Jones, M.D.|224-270-2659|Drew_Jones@baxter.com
113791|NCT01234922|Wake Forest Baptist Health|William J. Petty, MD|336-716-3313|wpetty@wakehealth.edu
113792|NCT01235195|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113793|NCT01235234|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il
113794|NCT01235338|Shire Pharmaceutical|Patrick Martin, MD||pmartin@shire.com
113795|NCT01235377|Veterans Health Administration Pharmacy Benefits Management|Madeline McCarren, PhD|7087867987|madeline.mccarren@va.gov
113796|NCT01235403|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
113797|NCT01235442|Amgen Inc.|Study Director|866-572-6436|
113798|NCT01235507|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
113799|NCT01235546|University of Alabama at Birmingham, Maternal & Fetal Medicine|Alan Tita, MD|205-934-9616|atita@uab.edu
113800|NCT01235598|UCB|UCB Clinical Trials Call Center|+1 877 822 9493|
113801|NCT01227512|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
113802|NCT01227551|Viralytics|Mark Grose|1 647 821 7673|Mark.Grose@Viralytics.com
113803|NCT01227564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113804|NCT01227577|Novartis|Study Director|862-778-8300|
113805|NCT01227629|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113806|NCT01227655|Bial – Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com
113807|NCT01227668|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
113808|NCT01227681|Buddhist Tzu Chi General Hospital Hualien|Dr. Chen Shin-Yuan|+886-3-8561825 ext 2151|william.sychen@msa.hinet.net
113809|NCT01227707|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
113810|NCT01227785|Guidant, a Boston Scientific Company|Paji Vitoff, Senior Clinical Manager|651-582-5415|paji.vitoff@bsci.com
113811|NCT01227824|GlaxoSmithKline|GSK Response Center|866-435-7343|
113812|NCT01227889|GlaxoSmithKline|GSK Response Center|866-435-7343|
113813|NCT01227902|GlaxoSmithKline|GSK Response Center|866-435-7343|
113814|NCT01227928|GlaxoSmithKline|GSK Response Center|866-435-7343|
113815|NCT01227954|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
113816|NCT01227967|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov
113817|NCT01227980|National Institute on Alcohol Abuse and Alcoholism|Melanie Schwandt|301-451-6960|melanies@mail.nih.gov
113818|NCT01227993|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov
113819|NCT01228019|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113820|NCT01228071|Endo Pharmaceutical, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
113821|NCT01228084|Oregon Health & Science University, Knight Cancer Institute|Joshi Alumkal, MD|503-494-1091|
113822|NCT01228149|Dept. of Ophthalmology, University Medical Center Mainz|Dr. Dr. Katrin Lorenz|00496131174069|lorenz@augen.klinik.uni-mainz.de
113823|NCT01228175|The Mind Research Network|Dr. Kent Hutchison|50522725028|khutchison@mrn.org
113825|NCT01235715|Hospital for Special Surgery|Dr. Mark P. Figgie|212-606-1932|figgiem@hss.edu
113826|NCT01235728|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113827|NCT01235741|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
113828|NCT01235897|University of California, San Francisco|Jo Chien, MD|415-885-7577|crss@ucsf.edu
113830|NCT01235923|University of New Mexico|Robin Ohls|505-272-6410|rohls@salud.unm.edu
113831|NCT01235975|GlaxoSmithKline|GSK Response Center|866-435-7343|
113832|NCT01236001|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
113833|NCT01236300|University of Chicago Medical Center|Dr. Vani J.A. Konda|773-702-1460|vkonda@medicine.bsd.uchicago.edu
113834|NCT01236326|Weill Cornell Medical College|Meredith J. Aull, Pharm.D.|(212) 746-0727|mea9008@med.cornell.edu
113835|NCT01236339|W.L. Gore and Associates, Inc.|Arthur Scott / Clinical Study Manager|623.234.5263|artscott@wlgore.com
113836|NCT01236365|Nemours Children's Clinic|Nelly Mauras, MD|904-697-3674|nmauras@nemours.org
113837|NCT01236378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113838|NCT01236391|Pharmacyclics, Inc.|Dr. Darrin Beaupre|855-427-8846|medinfo@pcyc.com
113839|NCT01236534|University of Rochester|Andrew Goodman, MD|585-275-7854|andrew_goodman@urmc.rochester.edu
113840|NCT01236573|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov
113841|NCT01236768|Agile Therapeutics|Lisa Flood, Associate Director of Clinical Operations|609-683-1880|lflood@agiletherapeutics.com
113842|NCT01237054|National Cancer Institute|Dr. Peter Choyke|301-402-8409|pchoyke@mail.cc.nih.gov
113843|NCT01237080|Department of Anaesthesiology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark|Mogens Ydemann|+4531155995|clinicaltrials@ydemann.dk
113844|NCT01237197|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu
113845|NCT01237223|Novartis Pharmaceuticals|Study Director|862-778-8300|
113846|NCT01237301|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com
113847|NCT01237327|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113848|NCT01237340|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
113849|NCT01237353|University of California San Francisco|Dr. Leslie Benet|415-476-3853|leslie.benet@ucsf.edu
113850|NCT01237613|Orthopedic Foot and Ankle Center|Terrence M. Philbin, DO|614-895-8747 ext 111|ofacresearch@orthofootankle.com
113851|NCT01238211|The Ohio State University|Guido Marcucci, M.D.||Guido.Marcucci@osumc.edu
113852|NCT01238341|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu
113853|NCT01238471|Rambam Medical Center|Professor Imad Makhoul|972-4-8542219|makhoul@rambam.health.gov.il
113854|NCT01238575|Emory University|Lawrence Scahill, MSN, PhD||lawrence.scahill@emory.edu
113855|NCT01238588|Brigham and Women's Hospital|Kambiz Zandi-Nejad|617-732-5500 ext 34769|kzandinejad@partners.org
113856|NCT01238640|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhaue@its.jnj.com
113857|NCT01231373|BTG International Inc.|David Wright MBBS|610-278-1660|david.wright@btgplc.com
113858|NCT01231399|City of Hope|Paul Frankel, Ph.D.|(626) 218-5265|pfrankel@coh.org
113859|NCT01231464|GlaxoSmithKline|GSK Response Center|866-435-7343|
113860|NCT01231503|GlaxoSmithKline|GSK Response Center|866-435-7343|
113862|NCT01231581|GlaxoSmithKline|GSK Response Center|866-435-7343|
113863|NCT01231607|GlaxoSmithKline|GSK Response Center|866-435-7343|
113864|NCT01231646|North Shore-LIJ Health System|Connie Lau, MS, CCRC|516-325-7022|clau@nshs.edu
113865|NCT01231750|University of Cincinnati|Dr. Faisal Khan|513-558-4272|faisal.khan@uc.edu
113866|NCT01231841|Cleveland Clinic Foundation|Jaroslaw Maciejewski, MD PhD, Principal Investigator|216-445-5962|maciejj@ccf.org
113867|NCT01231984|Becton Dickinson|Laurence Hirsch, MD|201-847-6513|Laurence_Hirsch@bd.com
113868|NCT01232127|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
113869|NCT01232205|Dept Obstetrics Gynecology Indonesia University|Yuditiya Purwosunu|+44 753 870 6897|yudi@med.showa-u.ac.jp
113871|NCT01232296|Novartis Pharmaceuticals|Study Director|862-778-8300|
113872|NCT01232465|North Shore|Dennis Marchesi|516-562-1761|dmarches@nshs.edu
113873|NCT01232491|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
113874|NCT01232504|Department of Hematology, Shanghai Jiao Tong University Affiliated First People’s Hospital, China|Chun Wang||wangchun2@medmail.com.cn
113875|NCT01232569|Hoffmann-La Roche|Medical Communications|800 821-8590|
113876|NCT01232790|Yale University School of Medicine, Department of Psychiatry|Cenk Tek MD, Associate Professor of Psychiatry; Director, Psychosis Program, CMHC|(203) 974-7484|cenk.tek@yale.edu
113877|NCT01232829|University of Colorado Cancer Center|Dr. Wells Messersmith|303-724-3808|wells.messersmith@ucdenver.edu
113879|NCT01232894|Novartis|Study Director|41 61 324 1111|
113880|NCT01232920|Proctor Foundation, University of California San Francisco|Nisha Acharya|415-476-8131|nisha.acharya@ucsf.edu
113881|NCT01233050|Penn Medicine|Dr. Najjia Mahmoud, MD, Cheif of Colorectal Surgery|(215) 662-2078|najjia.mahmoud@uphs.upenn.edu
113882|NCT01233076|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|Joseph.Rappon@cibavision.com
113883|NCT01238822|Cincinnati Children's Hospital Medical Center|Jeff Epstein||jeff.epstein@cchmc.org
113884|NCT01238848|Hospital General de Niños Pedro de Elizalde|Maria I. Espelt, MD|541146136968|cespelt@fibertel.com.ar
113885|NCT01238861|MedImmune, LLC|Rene van der Merwe, MBChB, MFPM, Medical Officer|301-398-0000|vandermerwer@medimmune.com
113886|NCT01238900|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu
113887|NCT01238991|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113888|NCT01239680|Truman Medical Center|Charles W. Van Way, III, M.D.|816.235.2553|vanwayc@umkc.edu
113889|NCT01239732|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
113890|NCT01239745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113891|NCT01239797|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
113892|NCT01239992|University Munich|Klaus G. Parhofer|+49-89-7095-3010|klaus.parhofer@med.uni-muenchen.de
113893|NCT01240122|Abbott Medical Optics|Senior Manager, Clinical Research|714.247.8723|eugenia.kao@amo.abbott.com
113894|NCT01240135|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com
113895|NCT01240200|Emory University School of Medicine|Christopher Newton, MD|404-355-4393|cnewton@atlantadiabetes.com
113896|NCT01240330|Venous Health Systems, Inc.|Director of Quality Assurance & Operations|(650)646-3327 ext 104|rlaguna@venoushealth.com
113897|NCT01240356|The University of Texas Health Science Center at Houston|James C. Grotta, MD|+1 (713) 500-7088|james.c.grotta@uth.tmc.edu
113898|NCT01240382|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp
113899|NCT01240551|National Cancer Institute|Dr. Karen Kurdziel|301-443-0622|kurdziek@mail.nih.gov
113900|NCT01240590|National Cancer Institute|Dr. James Gulley|301-480-7164|gulleyj@mail.nih.gov
113901|NCT01240746|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
113902|NCT01240785|Department of Obstetrics and Gynecology, Turku University Central Hospital|Dr Kristiina Tertti|+358 2 3130000|kristiina.tertti@tyks.fi
113903|NCT01240811|University of Pittsburgh|Sharon Achilles, MD, PhD|412-641-1403|achisx@upmc.edu
113904|NCT01240863|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
113906|NCT01240915|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113907|NCT01241240|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
113908|NCT01241279|Valeant Pharmaceuticals/Bausch & Lomb|Johnson Varughese|908-927-1162|Johnson.Varughese@valeant.com
113909|NCT01241292|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
113910|NCT01241513|USARIEM|Charles S Fulco, PI|508 233-4893|charles.fulco@us.army.mil
113911|NCT01241539|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113912|NCT01241552|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113913|NCT01241565|Covidien|Noreen Fahey|203-821-4716|noreen.fahey@covidien.com
113914|NCT01241591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113915|NCT01241760|Janssen Infectious Diseases BVBA|Compound Development Team Leader|32 14 64 13 70|
113916|NCT01241903|University of Kentucky|Dr. Susan S. Smyth|(859) 323-2274|ssmyt2@uky.edu
113917|NCT01241916|Massachusetts General Hospital|Dr. David Ring|617-724-3953|dring@partners.org
113918|NCT01242020|Associate Dean for Clinical and Translational Research, College of Physicians and Surgeons|Muredach P. Reilly, MBBCh, MSCE|212-305-9453|mpr2144@cumc.columbia.edu
113919|NCT01236053|GlaxoSmithKline|GSK Response Center|866-435-7343|
113920|NCT01236105|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
113921|NCT01236118|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
113922|NCT01236170|VA Pittsburgh Healthcare System|Dr. Larissa Myaskovsky|4123602241|Larissa.Myaskovsky@va.gov
113923|NCT01236196|San Francisco VA Medical Center|Dr. Timothy Carmody|415-221-4810 ext 6344|Timothy.Carmody@va.gov
113924|NCT01242085|VA Palo Alto HCS|Steven T Woolson, MD|650-493-5000 ext 66101|steven.woolson@va.gov
113925|NCT01242111|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com
113926|NCT01242176|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113927|NCT01242371|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org
113928|NCT01243892|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
113929|NCT01243944|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com
113930|NCT01244061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113931|NCT01244126|Baylor College of Medicine, Department of Anesthesiology|Dr. Helena Karlberg Hippard|832-824-5800|hxkarlbe@texaschildrens.org; karlberg@bcm.edu
113932|NCT01244243|University of California, Irvine|Steve Cramer|7144566876|scramer@uci.edu
113933|NCT01244412|University of Rochester|David Kleinman, MD||david_kleinman@urmc.rochester.edu
113934|NCT01244425|BAXTER INNOVATIONS GmbH|Ildiko Szabo, MD, MBA Medical Director, Biosurgery||ildiko_szabo@baxter.com
113936|NCT01244490|Shire Development LLC|Study Physician|+1 866 842 5335|
113937|NCT01244503|Virginia Commonwealth University|Arun J Sanyal|804 828 6314|asanyal@mcvh-vcu.edu
113938|NCT01244516|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|KOsborn@its.jnj.com
113939|NCT01244529|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|kosborn@its.jnj.com
113940|NCT01244620|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113941|NCT01244633|Psyadon Pharmaceuticals|Dr. Richard Chipkin|3019192020|rchipkin@psyadonrx.com
113942|NCT01244711|Weill Cornell Medical College|james kocsis|212-746-5913|jhk2002@med.cornell.edu
113943|NCT01244724|Weill Cornell Medical College|James H. Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu
113944|NCT01244815|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113945|NCT01244828|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113946|NCT01244893|Johnson & Johnson Vision Care|Brian Pall, O.D., M.S., F.A.A.O. Senior Research Optometrist|(904) 443-1290|BPALL@its.jnj.com
113947|NCT01244906|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com
113948|NCT01244984|GlaxoSmithKline|GSK Response Center|866-435-7343|
113949|NCT01245049|GlaxoSmithKline|GSK Response Center|866-435-7343|
113951|NCT01245101|University of Miami|Rafael E. Campo|305-689-7030|rcampo@med.miami.edu
113952|NCT01245140|GlaxoSmithKline|GSK Response Center|866-435-7343|
113953|NCT01245270|University of Aberdeen Rowett Institute of Nutrition and Health|Dr Nigel Hoggard|[+44] (0) 1224 438700|N.Hoggard@abdn.ac.uk
113954|NCT01245283|UF&Shands Orthopaedics and Sports Medicine Institute|Kevin R. Vincent, M.D. Ph.D.|352-273-7458|vincekr@ortho.ufl.edu
113955|NCT01245374|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
113956|NCT01245387|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
113957|NCT01245413|Lægehuset, Skodsborg Strandvej 125A, 2942 Skodsborg, Denmark|Dr. Claus Hyldahl|4545801331|hyldahl@info.dk
113958|NCT01245439|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
113959|NCT01245595|Stanford University Medical Center|Dr. David M. Axelrod|650-723-7913|daxelrod@stanford.edu
113961|NCT01245738|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113962|NCT01245751|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113963|NCT01245764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
113965|NCT01246076|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu
113966|NCT01246206|Barbara Ann Karmanos Cancer Institute|Dr. Zaid Al-Kadhimi|800-527-6266|zalkadh@emory.edu
113967|NCT01246258|Imperial Health|Joanne Rimmer|0061402931120|rimmer.joanne@gmail.com
113969|NCT01239043|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
113970|NCT01239056|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu
113971|NCT01239121|James J. Peters VA Medical Center|Kenneth Boockvar|718-584-9000 ext 3807|kenneth.boockvar@va.gov
113972|NCT01239212|Cincinnati Children's Hospital Medical Center|Dr. Stephanie Merhar|513-636-4200|stephanie.merhar@cchmc.org
113973|NCT01239316|St. Jude Children's Research Hospital|Tong Lin (Biostatistician)|9015952048|Tong.Lin@stjude.org
113974|NCT01239342|The University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org
113975|NCT01239355|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
113978|NCT01239511|Sinphar Pharmaceutical Co., Ltd.|Melanie Huang|886-2-27603688 ext 2190|wthuang@sinphar.com.tw
113979|NCT01246401|Yale University|Dr. Sandra Springer||sandra.springer@yale.edu
113980|NCT01246479|Valneva Austria GmbH|Senior Scientist Clinical Research|+43120620 ext 0|katrin.dubischar-kastner@valneva.com
113981|NCT01246713|BIDMC|Michael Ganetsky, MD|6177542323|mganetsk@bidmc.harvard.edu
113982|NCT01247220|Retina Associates of Florida|Ivan J. Suner, MD|813-875-6373|ivansuner@gmail.com
113983|NCT01247272|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
113984|NCT01247285|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
113985|NCT01247298|University of Alabama at Birmingham (UAB)|Rojymon Jacob, MD|205-975-9704|rjacob@uabmc.edu
113987|NCT01247428|Micell Technologies|Dennis Donohoe, MD, Chief Medical Advisor|919-313-2102|ddonohoeconsult@gmail.com
113988|NCT01247571|NRG Oncology|Linda Gedeon for William Brady, PhD.|716-845-1169|lgedeon@gogstats.org
113989|NCT01247675|Ascendis Pharma A/S|Michael Beckert, MD|(+49) 172-155-2596|mb@ascendispharma.com
113990|NCT01247922|Astellas Pharma Global Development, Inc.|Sr. Medical Director||Astellas.resultsdisclosure@astellas.com
113991|NCT01247974|CorMatrix Cardiovascular|Director of Clinical Trials|6785662628|agreen@cormatrix.com
113992|NCT01248013|Mind-Body Digestive Center|Charles D. Gerson, M.D.|212 496 6161|cgerson@yahoo.com
113993|NCT01248065|Penn State University Dept. of Public Health Sciences|Tonya S. King, PhD|717-531-7178|tking@psu.edu
113995|NCT01248221|Mayo Clinic|Dr. Adil E. Bharucha|507-284-2687|bharucha.adil@mayo.edu
113996|NCT01248364|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
113997|NCT01248455|National Cancer Institute|Dr. Mark Roschewski|301-451-9021|roschewskimj@mail.nih.gov
113998|NCT01248468|Novartis Consumer Health|Clinical Project Leader|973-503-8000|
114000|NCT01248728|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-425-6220 ext 6005|eanagnostou@hollandbloorview.ca
114001|NCT01248780|Janssen Research & Development|Associate Director, Clinical Research|610-500-3369|
114002|NCT01248793|Janssen Research & Development|Associate Director, Clinical Research|610-500-3369|
114003|NCT01248884|GlaxoSmithKline|GSK Response Center|866-435-7343|
114004|NCT01248936|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
114005|NCT01248949|MedImmune, LLC|Mohammed Dar, MD|301-398-0000|information.center@astrazeneca.com
114006|NCT01249092|Cleveland Clinic|Claudia O. Zein, MD|216-444-0421|zeinc@ccf.org
114007|NCT01249118|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
114008|NCT01249131|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
114009|NCT01249157|Memorial Sloan Kettering|Dr. Maxine Jochelson|646-888-4507|JochelsM@mskcc.org
114010|NCT01249261|Warner Chilcott|Grexan J. Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com
114011|NCT01249274|Yale University|Kimberly A. Yonkers, M.D.|203-764-6621|kimberly.yonkers@yale.edu
114012|NCT01249417|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
114013|NCT01249651|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
114014|NCT01242514|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
114015|NCT01242527|AstraZeneca Pharmaceuticals|Torbjörn Lundström, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
114016|NCT01242748|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
114017|NCT01242813|Novartis Pharmaceuticals|Study Director|862-778-8300|
114018|NCT01243112|Scott & White Healthcare|James Collins, MD|254-724-7508 ext 0612|jbcollins@swmail.sw.org
114020|NCT01243242|Alcobra|Dr Yaron Daniely CEO|972-072-2204662|yaron@alcobra-pharma.com
114021|NCT01243294|Coloplast A/S|Pia Nordmand, Clinical Trial Manager|+4549113250|dkpialn@coloplast.com
114022|NCT01243320|University of Utah|Mark A. Munger, Pharm.D.|8015816165|mmunger@hsc.utah.edu
114023|NCT01243411|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
114024|NCT01243450|Cu-Tech, LLC|William J. Cunningham, MD|(973) 331-1620|wcunningham@cu-tech.com
114025|NCT01243567|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
114026|NCT01243619|Brigham and Women's Hospital / Dana Farber Cancer Institute|Harvey Mamon MD, PhD|617-732-8564|hmamon@lroc.harvard.edu
114027|NCT01243671|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
114028|NCT01243775|Chonnam National University Hwasun Hospital|Dr. Young-Chul Kim|82-61-379-7614|kyc0923@jnu.ac.kr
114029|NCT01249664|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
114030|NCT01249833|Trial Management Group Inc.|Joanne Morris, Clinical Research Quality Manager|4169297717|joanne@tmginvestigators.com
114031|NCT01249872|University Hospital Of Patras, Greece|Dr Anastasia Zotou|0026130603341|anzotou@hotmail.com
114032|NCT01251120|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
114033|NCT01251146|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
114035|NCT01251315|Charles R Drew University of Medicine and Science|Dr .Naureen Tareen|323-568-3359|aaant@aol.com
114036|NCT01251354|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
114037|NCT01251380|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
114038|NCT01251588|Vericel Corporation|Ann Remmers, Senior Director, Clinical Science|734-428-4526|aremmers@vcel.com
114039|NCT01251614|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110|
114040|NCT01251653|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114041|NCT01251757|Kaiser Permanente Center for Health Research|William M Vollmer, PhD|503-335-2400|william.vollmer@kpchr.org
114042|NCT01251770|Hospital General de Niños Pedro de Elizalde|Dr Facundo Jorro Barón|00541143632100 ext 2035|jorrobox@yahoo.com.ar
114043|NCT01251952|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kadhimi, M.D.|(313) 576-8022|alkadhiz@karmanos.org
114044|NCT01251978|New England Retina Associates|Leslie Hurst- study coordinator|203-288-2020|lhurst@retinamd.com
121252|NCT02074904|UPENN|Timothy Pond, MPH|215-746-1959|timpond@pennmedicine.upenn.edu
114046|NCT01252134|Alcon Research, Ltd.|Director of Medical Affairs|888.451.3937|medinfo@alconlabs.com
114047|NCT01252147|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
114048|NCT01252186|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
114049|NCT01252238|Brigham and Women's Hospital|Dr. Jonathan Williams|617-278-0882|jwilliams5@partners.org
114050|NCT01252251|Memorial Sloan Kettering Cancer Center|Dr. Michael Postow, MD|646-888-4589|PostowM@mskcc.org
114051|NCT01252277|University of Kansas Medical Center|Carol J. Fabian, M.D.|913-588-7791|cfabian@kumc.edu
114052|NCT01252290|University of Kansas Medical Center|Carol J. Fabian, MD; Professor|913-588-7791|cfabian@kumc.edu
114053|NCT01252355|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
114054|NCT01252810|GE Healthcare|Ruben Sheng, M.D.|609-514-6899|Rubin.Sheng@ge.com
114055|NCT01252940|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
114056|NCT01252966|University of Pennsylvania (Perelman School of Medicine)|Benjamin Albelda (Project Manager)|2157467173|albeldab@mail.med.upenn.edu
114057|NCT01253018|VA Maryland Health Care System|Dr. Christopher T. Bever, Jr. MD, MBA|(410) 605-7000 ext 7130|christopher.bever@va.gov
114058|NCT01253044|VA San Diego Healthcare System and UCSD|Dr. Ariel Lang|858-246-0631|ajlang@ucsd.edu
114059|NCT01253070|Washington University School of Medicine|Geoffrey Uy, MD||guy@dom.wustl.edu
114060|NCT01253135|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com
114061|NCT01253148|H. Lee Moffitt Cancer Center and Research Institute|Sarah Hoffe, M.D.|813-745-3814|sarah.hoffe@moffitt.org
114062|NCT01253174|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
114063|NCT01253187|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
114064|NCT01253265|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
114065|NCT01253304|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
114066|NCT01253317|Boston Children's Hospital|Walter E. Kaufmann, MD|617-355-5230|rettresearch@childrens.harvard.edu
114067|NCT01253343|Cincinnati Children's Hospital Medical Center|Dr. Drew Barzman|513-636-4788|drew.barzman@cchmc.org
114068|NCT01253369|Dana-Farber Cancer Institute|Leena Gandhi, MD, PhD|617.632.6049|Leena_Gandhi@dfci.harvard.edu
121253|NCT02060539|CooperVision|Cheryl McKinnon|925-251-2034|cmckinnon@coopervision.com
114069|NCT01253408|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu
114070|NCT01253447|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PHD / Professor||CR_Study_Registration@mdanderson.org
114071|NCT01253525|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
114072|NCT01253564|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com
114073|NCT01253577|Intersect ENT|James Stambaugh, Vice President Clinical Affairs|650-641-2103|jstambaugh@intersectent.com
114074|NCT01246791|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp
114075|NCT01246960|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
114076|NCT01246973|University of Rochester|Julie Ryan|585-276-3862|julie_ryan@urmc.rochester.edu
114077|NCT01246999|University of Rochester|John Treanor MD, Professor of Medicine|585-275-5871|John_Treanor@urmc.rochester.edu
114078|NCT01247064|Cincinnati Children's Hospital Medical Center|Todd Florin|513-636-7966|todd.florin@cchmc.org
114079|NCT01247090|Columbia University Medical Center|Anjali Ganda, MD - Principal Investigator|212-305-3273|ag355@columbia.edu
114080|NCT01253811|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
114081|NCT01253824|Nobelpharama|Department director of clinical development department 1|+81-23-5651-1177|murakami@nobelpharma.co.jp
114082|NCT01253902|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
114083|NCT01254292|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com
114084|NCT01254305|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000 ext 8124|carl.gommoll@frx.com
114085|NCT01254318|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114086|NCT01254331|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
114087|NCT01254344|Merck Sharp & Dohme (China) Ltd.|Naimi Missoum|+8621 2211 8546|naimi_missoum@merck.com
114088|NCT01254396|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114089|NCT01254409|Promedior, Inc.|Elizabeth G. Trehu, MD|781-538-4203|btrehu@promedior.com
114090|NCT01254565|Amgen, Inc|Study Director|866-572-6436|
114091|NCT01254604|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114092|NCT01254643|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114093|NCT01254656|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114094|NCT01254669|Boston Medical Center|Dr. Natalie Joseph|1-617-414-5202|napierre@bu.edu
114095|NCT01254721|SM&M Korea|Hui Jung Sin / Clinical Project Leader|82-2-2188-2165|ClinicalTrialTransparency@astrazeneca.com
114096|NCT01254747|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629|
114097|NCT01254760|Alcon Research, Ltd.|Director of Alcon Clinical|1-800-241-7629|
114098|NCT01254851|Loyola University Medical Center|Linda Brubaker|708-216-4033|lbrubaker@lumc.edu
114099|NCT01254890|University of Texas (UT) MD Anderson Cancer Center|Farhad Ravandi-Kashani, Professor, Leukemia Department||CR_Study_Registration@mdanderson.org
114100|NCT01255137|National Cancer Institute, National Institutes of Health|Dr. Tito Fojo|301-496-2631|FojoT@mail.nih.gov
114101|NCT01255306|"University Hospital Sestre milosrdnice"|Mia Zoric Geber, MD|+385 1 3787 354|mia.zoric-geber@zg.t-com.hr
114102|NCT01255423|Novartis Consumer Health|Clinical Project Leader|0041223635528|
114103|NCT01255436|University of the Philippines Manila|Dr. Lia M. Palileo|6325679740|liapalileo@gmail.com
114104|NCT01255449|IRCCS Azienda Ospedaliera Universitaria San Martino IST - Genova, Italy|Dr. Giovanni Barisione|+39010555 ext 3367|giovanni.barisione@hsanmartino.it
114105|NCT01255592|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
114106|NCT01255631|CUMC Plastic Surgery|Christine Rohde|212-342-3707|chr2111@cumc.columbia.edu
114107|NCT01255722|Section Head Interventional and Cardiac Radiology - Kantonsspital Lucerne, Spitalstrasse, 6006 Lucerne, Switzerland|Prof. Dr. med. Martin HOFFMANN|+41 41 205 4660|martin.hoffmann@luks.ch
114108|NCT01255761|UCB Clinical Trial Call Center|(UCB) Study Director|+1 887 822 9493|
114109|NCT01255787|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
114110|NCT01255904|Baylor College of Medicine|Jason Reynolds|(210) 704-2680|jmreynol@bcm.edu
114111|NCT01256008|Wenzhou Medical University|Director of Clinical Trials|+86 0577 55579363|hjc@wmu.edu.cn
114112|NCT01256034|Chiba University Graduate School of Medicine|Dr. Katsunori Furukawa|+81-43-226-2269|k-furukawa@umin.ac.jp
114113|NCT01256060|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca
114114|NCT01256086|University of Florida, Department of Pharmacotherapy and Tanslational Research, 100486 Gainesville, FL 32610|Prof. Dr. Leslie Hendeles|+1 352 279 ext 6027|hendeles@cop.ufl.edu
114115|NCT01256164|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com
114116|NCT01256177|AstraZeneca|Dhaval Desai (MSD, Seroquel)|+13028857643|aztrial_results_posting@astrazeneca.com
114117|NCT01256190|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com
114118|NCT01256281|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Glassberg|(212) 824-8056|jeffrey.glassberg@mountsinai.org
114119|NCT01256294|Novartis Pharmaceuticals|Study Director|862-778-8300|
114120|NCT01256385|University of Chicago|Dr. Tanguy Seiwert|(773) 702-2452|tseiwert@medicine.bsd.uchicago.edu
114121|NCT01256411|Novartis Pharmaceuticals|Study Director|862-778-8300|
114122|NCT01256424|Photocure|Vice President Research and Development|+47 22062210|ifh@photocure.no
114123|NCT01256450|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
114124|NCT01256476|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com
114126|NCT01256567|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
114128|NCT01256684|Endoceutics|Director of Data Analysis|418-653-0033 ext 215|celine.martel@endoceutics.com
114129|NCT01250002|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu
114130|NCT01250054|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|Joseph.Rappon@cibavision.com
114131|NCT01250119|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
114132|NCT01250145|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
114133|NCT01250171|Novartis Pharmaceuticals|Study Director|862 778-8300|
114134|NCT01250184|university of Antioquia, Research Group Rehabilitation in Health|Dr. Luz Helena Lugo, Head of Research Group Rehabilitation in Health|+57 4 2196475|luzh.lugo@gmail.com
114135|NCT01250379|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
114136|NCT01250418|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu
114137|NCT01250509|University of California, San Francisco|Jennifer Daubenmier, PhD|415-514-8601|jennifer.daubenmier@ucsf.edu
114138|NCT01250717|BIDMC|Glenn Bubley MD, Director of GU ONC|617-735-2062|gbubley@bidmc.harvard.edu
114139|NCT01250730|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114140|NCT01250756|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114141|NCT01250769|Philips Healthcare, Office of Medical and Health Affairs|Director of Clinical Operations|425 908-1208|wendy.jenkins@philips.com
114142|NCT01250834|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
114143|NCT01250899|University of California, Los Angeles|Dr Jordan Lake|310-557-2273|jlake@mednet.ucla.edu
114144|NCT01250925|Massachusetts Eye and Ear Infirmary|Dr. Pedram Hamrah|617-573-3313|cornea_research@meei.harvard.edu
114145|NCT01250990|University of Pennsylvania|Richard L Dunbar|215-662-9024|richard.dunbar@uphs.upenn.edu
114146|NCT01251042|Wellspect HealthCare|Emma Tällberg, Clinical Research Manager|+46313764000|
114147|NCT01256918|Dr. Ram Manohar Lohia Hospital|Dr. Praveen Kumar Malik|00919810405681|praveenk002@yahoo.com
114148|NCT01256944|Taipei Medical University - WanFang Hospital|Dr. Ming-I Hsu|886-2-2930-7930 ext 2508|hsumigni@yahoo.com.tw
114149|NCT01256983|University Hospital Zürich|Mrs. Hanna Burkahlter|0041 76 371 12 35|hanna.burkhalter@usz.ch
114150|NCT01258790|Cincinnati Children's Hospital Medical Center|Steve Wu, MD|513-636-4222|steve.wu@cchmc.org
114151|NCT01258803|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
114152|NCT01258985|Tufts Medical Center|chenchen wang|617-636-3251|cwang2@tuftsmedicalcenter.org
114153|NCT01258998|The University of Texas (UT) MD Anderson Cancer Center|Yasuhiro Oki, Assistant Professor, Lymphoma/Myeloma|713-792-7734|CR_Study_Registration@mdanderson.org
114154|NCT01259011|Emory University|Dr. Mi-Kyung Song|404-727-3134|mi-kyung.song@emory.edu
114155|NCT01259024|Washington University|Patricia Nieters, RN, BSN, Clinical Research Specialist|314-362-3371|nietersp@wustl.edu
114156|NCT01259102|Purdue Pharma L.P.|Executive Medical Director, Clinical Pharmacology|800-733-1333|
114157|NCT01259115|Purdue Pharma L.P.|Executive Medical Director, Clinical Pharmacology|800-733-1333|
114158|NCT01259245|Kwong Wah Hospital|Dr Lorna Ng|(852) 23322311|ngl@ha.org.hk
114159|NCT01259284|UT MD Anderson Cancer Center|Ara Vaporciyan, MD, BS / Professor||CR_Study_Registration@mdanderson.org
114160|NCT01259297|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
114161|NCT01259375|Huntsman Cancer Institute|Dr. Sunil Sharma|801-587-5559|sunil.sharma@hci.utah.edu
114162|NCT01259401|VA Greater Los Angeles Healthcare System|Dr. Jennifer Martin|818 891-7711 ext 9173|Jennifer.Martin@va.gov
114163|NCT01259427|VISN 5 MIRECC|Amy Drapalski|410-637-1855|amy.drapalski@va.gov
114164|NCT01259440|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov
114165|NCT01259466|Yale University School of Medicine|Dr. Marney A. White|203-785-4349|marney.white@yale.edu
114166|NCT01259492|Novartis Pharmaceuticals|Study Director|8627788300|
114168|NCT01259713|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
114169|NCT01259726|Shire|Study Physician|1 866-842-5335|
114170|NCT01260142|Eisai Call Center|Eisai Inc.|888-422-4743|
114171|NCT01260194|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
114172|NCT01260272|L-MARC Research center|Kathy Schmitz, Site Manager|502 214 3990|kschmitz@lmarc.com
114173|NCT01260311|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114174|NCT01260324|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114175|NCT01260350|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
114176|NCT01260454|University of Rochester|R. James White, MD, PhD|585-486-0869|jim_white@urmc.rochester.edu
114177|NCT01260467|University of Rochester Medical Center|Jennifer Serventi Research Associate|585-276-3971|jennifer_serventi@urmc.rochester.edu
114178|NCT01260493|Vårdalinstitute, University of Gothenburg|Professor Synneve Dahlin-Ivanoff ( Research leader)|+46 31 7865733|synneve.dahlin-ivanoff@gu.se
114179|NCT01260584|Daiichi Sankyo|Brian Baker|973-944-2712|bbaker@dsi.com
114180|NCT01260649|MGH|Dr. Cristina Cusin|617 726 64221|ccusin@mgh.harvard.edu
114181|NCT01260662|MinneapolisMRF|James Miner|612-873-3000|miner015@umn.edu
114182|NCT01260688|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca
114183|NCT01260701|SWOG Statistical Center|Study Statistician|206-667-4623|
114184|NCT01260883|Seattle Children's Hospital|Anne Lynn MD|206 987-2518|anne.lynn@seattlechildrens.org
114185|NCT01260896|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
114186|NCT01260922|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
114187|NCT01260948|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
114188|NCT01261000|Cedars-Sinai Medical Center|Vivian Hwe|424-315-4489|hwev@cshs.org
114189|NCT01261052|Legacy Health System|Dr. W Kenneth Ward|503-413-5171|kenward503@msn.com
114190|NCT01253980|Poisons Information Centre, Red Cross War Memorial Children's Hospital and University of Cape Town|Dr Kate Balme|+27 21 658 5308|kate.balme@uct.ac.za
114191|NCT01254045|Stanford University School of Medicine|Scott S. Hall, PhD|650-498-4799|hallss@stanford.edu
114192|NCT01254188|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
114193|NCT01254214|University of Minnesota|Cynthia Gross PhD|612-624-8676|gross002@umn.edu
114194|NCT01261325|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493|
114195|NCT01261390|Brigham and Women's Hospital|Dr. Susan Redline|617-732-5859|sredline1@rics.bwh.harvard.edu
114196|NCT01261507|Georgetown University Medical Center|Matthew T. Freedman, MD|4105429680|freedmmt@georgetown.edu
114198|NCT01264380|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
114199|NCT01264614|UNION COLLEGE|Cay Anderson-Hanley, PhD|518-388-6355|andersoc@union.edu
114200|NCT01264770|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
114201|NCT01264835|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com
114202|NCT01264887|Grünenthal GmbH|Director Clinical Trials|+49 241 569 ext 3223|clinical-trials@grunenthal.com
114203|NCT01264939|Genentech, Inc.|Medical Communications|800 821-8590|
114204|NCT01264952|Institute of Oncology Ljubljana|Gregor Sersa, PhD|+386 1 5879 434|gsersa@onko-i.si
114205|NCT01265056|The University of Iowa|Jennifer Lassner|319-335-2123|jennifer-lassner@uiowa.edu
114206|NCT01265394|GE Healthcare|Dr. Paul Sherwin|1-609-514-6820|paulsherwin@ge.com
114207|NCT01265420|Indiana Hand to Shoulder Center|F. Thomas D. Kaplan|317-875-9105|tdk@hand.md
114208|NCT01265446|Novartis Consumer Health, Nyon, Switzerland|Clinical Project Leader|+41223633279|Rowland.Furcha@novartis.com
114209|NCT01265459|Q-Med AB|Head of Medical Affairs|+46 (0) 18 4749000|reception.SEUPP@galderma.com
114210|NCT01265498|Johns Hopkins Data Coordinating Centers|Mark Van Natta|410-614-1362|mvannat1@jhu.edu
114211|NCT01265511|Scynexis|Katyna Borroto-Esoda|9192374431|katyna.borroto-esoda@scynexis.com
114212|NCT01265524|Sorbent Therapeutics|Howard Dittrich, MD FACC|858-405-1429|hdittrich@sorbent.com
114213|NCT01265563|VA- STVHCS|Dr. Shweta Bansal|2105674700|bansals3@uthscsa.edu
114214|NCT01265615|Ural Institute of Cardiology, Ural State Medical Academy|Dr. Alexander Kharlamov|+79638547663|drskharlamov@gmail.com
114215|NCT01265667|Can-Fite BioPharma Ltd|Zivit Harpaz|972-3-9241114|zivit@canfite.co.il
114216|NCT01265784|Tetraphase Pharmaceuticals, Inc.|Chief Medical Officer|+1.617.715.3600|
114217|NCT01265797|University of Toledo|Gretchen Tietjen, MD|419-383-3544|gretchen.tietjen@utoledo.edu
114218|NCT01265823|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
114219|NCT01265875|Dartmouth-Hitchcock Medical Center|Timothy Gardner, MD|603-650-6472|timothy.b.gardner@hitchcock.org
114220|NCT01265953|Oregon Health & Science University|Dr.Jackilen Shannon|503-418-9860|shannoja@ohsu.edu
114221|NCT01265966|Tripler Army Medical Center|Dr. Jordan Pinsker|808-433-6338|jordan.pinsker@us.army.mil
114222|NCT01265992|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
114223|NCT01266018|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org
114224|NCT01266031|National Cancer Institute|Dr. Mark Gilbert|301-402-6383|gilbertmr@mail.nih.gov
114225|NCT01266070|The University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org
114226|NCT01266122|Behavioral Medicine Service, Massachusetts General Hospital|Dr. Steven Safren|617-724-0817|ssafren@partners.org
114227|NCT01266148|Novartis Pharmaceuticals|Study director|862-778-8300|
114228|NCT01266265|United Therapeutics Corporation|Nicole Leedom|919-425-5870|nleedom@unither.com
114229|NCT01266291|University of Pennsylvania|John Pollard, MD|215-873-5909|john.pollard@uphs.upenn.edu
114230|NCT01266447|NRG Oncology|Linda Gedeon, Clinical Data Coordinator|716-845-1169|lgedeon@gogstats.org
114231|NCT01257204|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
114232|NCT01257217|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com
114233|NCT01257230|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114234|NCT01257347|Columbia University Medical Center|Ian Kronish, MD, MPH|2123421335|ik2293@columbia.edu
114235|NCT01257425|Ipsen|Director, Uro-oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
114236|NCT01257438|Bard Peripheral Vascular|Josh Smale, Associate Director Clinical Affairs|(480) 603-8140|Josh.Smale@crbard.com
114237|NCT01257503|University of Washington|James A Taylor|206-616-1206|uncjat@uw.edu
114239|NCT01257581|Massachusetts General Hospital|Nazem Atassi, MD|617-643-1807|natassi@partners.org
114241|NCT01257802|University of Michigan|W Joseph McCune MD Professor of Rheuntic Diseases University of Michigan|734 936 5560|jmccune@med.umich.edu
114242|NCT01257880|Swedish Medical Center|Jill T. Jesurum, Ph.D.|206-683-1505|jill.jesurum@swedish.org
114243|NCT01258049|Xidea Solutions Limited|Dr Daryl Bendel||daryl@xideasolutions.com
114244|NCT01258101|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
114245|NCT01258153|Menarini Ricerche|Dr. Angela Capriati|+39 05556809990|acapriati@menarini-ricerche.it
114246|NCT01258387|Acorda Therapeutics, Inc.|Anthony Caggiano, MD, PhD|914-347-4300 ext 5150|tcaggiano@acorda.com
114247|NCT01258504|University of Heidelberg|Prof. Dr. med. Gerd Mikus|4962215639197|gerd.mikus@med.uni-heidelberg.de
114248|NCT01258582|Massachusetts General Hospital|Rochelle P. Walensky, MD, MPH|(617) 724-8445|rwalensky@partners.org
114249|NCT01258595|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
114250|NCT01258660|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
114251|NCT01258738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114252|NCT01266824|Children's Hospital of Philadelphia|Dr. Amy Cohen|215-590-1000|cohenam@email.chop.edu
114253|NCT01266850|Vanderbilt University Medical Center|Kathryn M. Edwards, MD|615-322-3078|kathryn.edwards@vanderbilt.edu
114254|NCT01266876|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com
114255|NCT01266967|GlaxoSmithKline|GSK Response Center|866-435-7343|
114256|NCT01267019|VA Greater Los Angeles, VISN 22 MIRECC|Michael F. Green, PhD|(310) 268-3376|mgreen@ucla.edu
114257|NCT01267045|VA Puget Sound Health Care System|David J. Kearney, MD|206-277-1445|David.Kearney@VA.gov
114258|NCT01267266|University of Chicago|Walter M. Stadler|773-702-4150|wstadler@medicine.bsd.uchicago.edu
114259|NCT01267292|The University of Texas Health Science Center at Houston|Scott Lane, PhD|713-486-2535|Scott.D.Lane@uth.tmc.edu
114260|NCT01267422|Department of Ophthalmology, Tongji Hospital Tongji Medical College, Huazhong University of Science and Technology|Bin Li|+86-13638673626|libin-12@163.com
114261|NCT01267929|Postgraduate Studied Program, faculty of medicine, Thammasat University|Miss Namfon Mahasup|+66 867733596|namfon_pt@yahoo.com
114262|NCT01267994|North Shore-LIJ Health System|Andrea Vambutas, MD, FACS|718-470-7748|vambutas@nshs.edu
114263|NCT01268098|NPS Pharmaceuticals|Executive Director, Clinical Development|+1 908-450-5300|info@npsp.com
114264|NCT01268111|Mayo Clinic|A J Vinaya Simha|5072664321|simha.aj@mayo.edu
114265|NCT01268150|Eisai Inc.|Eisai Medical Services|1-888-422-4743|
114266|NCT01268189|USAISR|Leopoldo C. Cancio, COL, MC|210-916-3301|leopoldo.c.cancio.mil@mail.mil
114267|NCT01268267|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com
114268|NCT01268293|Eisai Co., Ltd.|Tatsuya Sasaki|81-3-3817-5252 ext 5252|
114269|NCT01268306|Arthur B. Epstein, OD|Dr. Arthur Epstein|424-226-2020|artepstein@yahoo.com
114270|NCT01268488|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|914-333-6280|carmine.greene@ascensia.com
114271|NCT01268501|Alcon Research, Ltd.|Director of Alcon Clinical|1-800-241-7629|
114272|NCT01268553|Los Angeles Biomedical research INst at Harbor-UCLA|Dr. Ronald Oudiz|310-222-3560 ext 310|roudiz@labiomed.org
114273|NCT01268566|MedImmune, LLC, an affiliate of AstraZeneca|A Phase 2 Study of MEDI-575 in Adult Subjects with Recurrent Glioblastoma Multiforme|1-877-240-9479|information.center@astrazeneca.com
114274|NCT01268683|Remedy Pharmaceuticals, Inc.|Sven Jacobson|212 586 2226 ext 225|sven@remedypharmaceuticals.com
114275|NCT01268891|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
114276|NCT01268943|Chinese Academic Medical Sciences|Dr. Jing Jin|010-87788503|tangyu.pumc@gmail.com
114277|NCT01269125|Dept. of Ob/Gyn, Patra University School of Medicine, Greece|Apostolos Kaponis, M.D.|+30-2610999569|kaponisapostolos@hotmail.com
114278|NCT01269346|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com
114279|NCT01269710|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu
114280|NCT01261975|Bausch & Lomb|Omid Khodai|(949) 521-7894|Omid.Khodai@bausch.com
114281|NCT01262027|The University of Texas (UT) MD Anderson Cancer Center|Vicente Valero, MD/Professor, Breast Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org
114282|NCT01262092|University of Arkansas for Medical Sciences|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu
114283|NCT01262105|Nimbic Systems|Sean Self|281-565-5700|self@nimbicsystems.com
114284|NCT01262118|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114285|NCT01262131|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303 795-3222|abraswell@pico-tesla.com
114286|NCT01262287|University of Connecticut School of Medicine|Dr. Jonathan Covault|860-679-7560|jocovault@uchc.edu
114287|NCT01262339|University of Wisconsin- Madison|Dermatology Clinical Trials Administrator|608-287-2640|dbock@dermatology.wisc.edu
114288|NCT01262352|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
114289|NCT01262456|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
114290|NCT01262547|Massachusetts General Hospital|Dr. Alexandra Kimball|617-726-5066|harvardskinstudies@partners.org
114291|NCT01262560|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
114292|NCT01262573|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org
114293|NCT01262599|Columbia University Medical Center|Dr. Christine Rohde|(212) 342-3707|chr2111@columbia.edu
114294|NCT01262755|Temple University|Frank Friedenberg, MD|215-707-9900|frank.friedenberg@temple.edu
114295|NCT01262820|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
114296|NCT01262846|University of Pennsylvania|Pablo Tebas|215-6626932|pablo.tebas@uphs.upenn.edu
114297|NCT01262872|GlaxoSmithKline|GSK Response Center|866-435-7343|
114298|NCT01262989|GlaxoSmithKline|GSK Response Center|866-435-7343|
114299|NCT01263015|GlaxoSmithKline|GSK Response Center|866-435-7343|
114300|NCT01263028|Kaiser Permanente|John J. Sim, MD||john.j.sim@kp.org
114301|NCT01263054|Halyard Health, Inc.|Mark Lavigne|508-837-1427|mark.lavigne@hyh.com
114302|NCT01263132|Merck S.A. de C.V., Mexico, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49-6151-72-5200|service@merckgroup.com
114303|NCT01263301|Mennonite Christian Hospital|Ling-Chih Wu MD|88638241234 ext 1810|lingchihwu@yahoo.com
114304|NCT01263444|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com
114305|NCT01263470|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com
114306|NCT01263483|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com
114307|NCT01263496|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com
114308|NCT01263509|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com
114309|NCT01263561|Department of Ophthalmology and Vision Sciences, University of Toronto|Dr Yvonne Buys|416-603-5682|y.buys@utoronto.ca
114310|NCT01263639|Vanderbilt Medical Center|Dr. Brent J. Morris Orthopaedic Resident|615-835-0699|brent.j.morris@vanderbilt.edu
114311|NCT01263665|W.L. Gore & Associates|Keli Sapp|9288643964|kesapp@wlgore.com
114312|NCT01263691|Emergent BioSolutions|Dr. Robert Hopkins|(301) 944-0136|hopkinsr@ebsi.com
114314|NCT01263873|University Hospitals of Cleveland|Brian Radesic|3309725175|radesic@uakron.edu
114315|NCT01263925|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
114316|NCT01264016|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com
114317|NCT01264081|National Cancer Institute|Dr. Udo Rudloff`|301-496-3098|rudloff@nih.gov
114318|NCT01269736|Yale University|Professor Marjorie Funk, PhD, RN|(203) 737-2346|marjorie.funk@yale.edu
114319|NCT01269801|AboutSkin|Joel L. Cohen, MD|303-756-7546|research@aboutskinderm.com
114320|NCT01269918|Cleveland Clinic|Daniel Sessler, MD|216-445-6500|sesslerd@ccf.org
114321|NCT01274429|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu
114322|NCT01274533|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu
114323|NCT01274559|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114324|NCT01274585|Massachusetts General Hospital|Does Percutaneous Tibial Nerve Stimulation (PTNS) Improve Outcomes in Patients|617-643-0541|lsavitt@partners.org
114325|NCT01274611|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu
114326|NCT01274637|Ottawa Hospital Research Institute|Dr. Marc Rodger|6137388899|mrodger@ohri.ca
114327|NCT01274715|Michael DeBakey VAMC|Aanand Naik, MD|713-794-8541|anaik@bcm.edu
114328|NCT01274897|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
114330|NCT01275066|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|(800) 983-4587|medinfo@bmrn.com
114331|NCT01275092|Columbia University Medical Center, New York, NY, 10032|Giora Weisz, MD; Director of Clinical Resarch Center for Interven tional Vascular Therapy|212-305-7060|gweisz@crf.org
114332|NCT01275131|Halozyme Therapeutics, Inc|Vice President, Endocrinology Clinical Development|(858)794-8889|
114333|NCT01275196|Novartis Pharmaceuticals|Study Director|862-778-8300|
114334|NCT01275313|University of Pittsburgh|David Brienza, Professor|412-624-6383|DBRIENZA@pitt.edu
114335|NCT01275430|Bard Access Systems, Inc.|Sharon Molotsky|856-266-1327|sharon.molotsky@crbard.com
114336|NCT01275586|Indiana University|Dr. Melissa Markel|317-944-4969|memarkel@iu.edu
114337|NCT01275625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114338|NCT01275755|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660|
114339|NCT01275833|Boston Scientific|Elke Sommerijns|+32479767156|elke.sommerijns@bsci.com
114340|NCT01276054|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|victoria.soto@med.usc.edu
114341|NCT01276106|TWi Biotechnology, Inc.|Medical Director|+886-2-26573350 ext 368|Carl.Brown@twipharma.com
114342|NCT01276171|University of Iowa Hospitals and Clinics|Dr. Kenichi Ueda|319-356-2633 ext 48517|kenichi-ueda@uiowa.edu
114343|NCT01276197|CHOIR|Dr. Thomas K. Houston|781-687-2884|thomas.houston2@va.gov
114344|NCT01276223|Alcon Research|Director of Alcon Clinical|1-888-451-3937|
114345|NCT01276288|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114346|NCT01276301|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114347|NCT01276327|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114348|NCT01276353|Clinical Development. JAC PCU. Eisai Co., Ltd.|Naoki Kubota|+81-3-3817-5245|
114349|NCT01276457|Novartis Pharmaceuticals|Study director|862 778-8300|
114351|NCT01276535|Westlake Dermatology|Gregory A. Nikolaidis, MD|512-328-3376|karen@westlakedermatology.com
114353|NCT01261624|Italfarmaco S.p.A.|Clinical R&D Director|026443 ext 2584|p.bettica@italfarmaco.com
114354|NCT01267136|Children's Hospitals and Clinics of Minnesota|Andrea Postier/Clinical Research Program Manager|612-813-6409|andrea.postier@childrensmn.org
114355|NCT01267175|Medtronic Diabetes|Harold Torunsky|(818) 576 5445|harold.torunsky@medtronic.com
114356|NCT01267201|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114357|NCT01267227|University of Mississippi|Dr. Daniel Riche|601-984-2640|driche@umc.edu
114358|NCT01267240|Princess Margaret Cancer Centre|Dr.Eric Chen, Principal Investigator|416-946-4501 ext 2263|eric.chen@uhn.ca
114359|NCT01267253|NRG Oncology|Linda Gedeon for Wei Deng,PhD|716-845-1169|lgedeon@gogstats.org
114360|NCT01276652|University of Iowa|Brian Gehlbach, MD|319-356-3603|brian-gehlbach@uiowa.edu
114361|NCT01276756|Cairo University|Dr. Hany Shehab|00201111111071|h.shehab@drshehab.com
114362|NCT01276821|Department of Child Health, Tribhuvan University Teaching Hospital, Institute of Medicine.|Dr. Aayush Khanal|977-1-4421532|aayush_khanal@yahoo.com
114363|NCT01276847|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114364|NCT01277822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114365|NCT01277861|University of Texas Southwestern Medical Center at Dallas|Girish P. Joshi, MD|214-590-7259|girish.joshi@utsouthwestern.edu
114366|NCT01278030|St. Jude Medical|John Gill|818-493-2609|jgill@sjm.com
114367|NCT01278160|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
114368|NCT01278173|Lundbeck|H||LundbeckClinicalTrials@Lundbeck.com
114369|NCT01278303|Johns Hopkins Hospital|Dr. Richard E. Ringel|410-614-6745|rringel@jhmi.edu
114370|NCT01278342|Novartis Pharmaceuticals|Study Director|862-778-8300|
114372|NCT01278407|Eisai Co., Ltd.|Masaki Nakagawa|+81-3-3817-5245 ext 5245|
114373|NCT01278485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114374|NCT01278615|University of Chicago|Dr. Sonali M. Smith|773-834-2895|smsmith@medicine.bsd.uchicago.edu
114375|NCT01278745|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
114376|NCT01278797|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114377|NCT01278927|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com
114378|NCT01278953|St Jude Medical|Nicole Glowacki|651-756-2000|nglowacki@sjm.com
114379|NCT01279044|San Francisco Department of Public Health|Dr. Phillip Coffin, Director of Substance Abuse Research Unit|(415) 437 6282|phillip.coffin@sfdph.org
114380|NCT01279070|Parc Sanitari Sant Joan de Déu|Dr. Aida Farreny|+34 936406350 ext 2373|afarreny@pssjd.org
114382|NCT01279200|University of Michigan|Senait Fisseha, MD, JD|734-763-4323|sfisseha@med.umich.edu
114383|NCT01279265|University of Texas Health Science Center at Houston|Dr. J. Marc Rhoads, Director, Pediatric Gastroenterology|713-500-7642|j.marc.rhoads@uth.tmc.edu
114384|NCT01279317|Maastricht University Medical Centre|Drs. Jan-Willem van Dijk|+31(0)433881394|janwillem.vandijk@maastrichtuniversity.nl
114385|NCT01279447|Northwestern|Lawrence Hsu, MD|312 9262000|larryphsu@gmail.com
114386|NCT01279564|Rambam Health Care Campus|Dr. Michal Barak|972 4 8542487|m_barak@rambam.health.gov.il
114387|NCT01280110|Departamento de Oftalmologia - Universidade Estadual de Campinas - Campinas - Brazil|Vital Paulino Costa|55-19-35217396|vp.costa@uol.com.br
114388|NCT01280123|Northwestern University|Tanya Simuni, MD||TSimuni@nm.org
114389|NCT01280266|Seoul National University|Dr. Eun Bong Lee|+82 2 2072-3944|leb7616@snu.ac.kr
114390|NCT01270126|Otto-von-Guericke University of Magdeburg, Medical Faculty, Institute of Medical Psychology, Magdeburg, Germany|Prof. Bernhard A. Sabel|0049 3916721800|bernhard.sabel@med.ovgu.de
114391|NCT01270139|Ural Institute of Cardiology|Dr. Alexander Kharlamov|0031627849118|drskharlamov@gmail.com
114392|NCT01270256|University of Chicago|Dr. Robert M Naclerio|773-702-0080|rnackeri@surgery.bsd.uchicago.edu
114393|NCT01270464|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
114394|NCT01270503|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
114395|NCT01270529|University of California, San Francisco|Dr. Kirsten Johansen|415-221-4810 ext 23598|kirsten.johansen@ucsf.edu
114396|NCT01270542|Doheny Eye Institute/USC/University of Iowa|Dr. Elliott Sohn|319-356-3185|elliott-sohn@uiowa.edu
114397|NCT01270555|Massachusetts General Hospital|Timothy Wilens, MD|617-503-1053|twilens@partners.org
114398|NCT01270581|Mount Sinai School of Medicine|Dr. Andrea Weintraub|212-241-6186|andrea.weintraub@mssm.edu
114399|NCT01270620|Stanford University School of Medicine|Dr. Pedro Tanaka|6507244066|ptanaka@stanford.edu
114401|NCT01271803|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
114402|NCT01271907|National Cancer Institute, National Institutes of Health|James Yang, M.D.|301-496-1574|jamesyang@mail.nih.gov
114403|NCT01271946|Arstasis|Debra Cogan, Director of Quality, Regulatory and Clinical|650-261-8073|dcogan@arstasis.com
114404|NCT01272011|Malcom Randall VAMC|Dr. Nicole Tester|352-376-1611 ext 7507|ntester@phhp.ufl.edu
114405|NCT01272076|TLC Eyecare and Laser Centers|Carmelina Gordon, MD|(517) 7821213|shellie.fuentes@tlcmi.com
114406|NCT01272141|Emory University School of Medicine|William Read, MD|1-888-946-7447|william.l.read@emory.edu
114407|NCT01272180|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com
114408|NCT01272193|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
114411|NCT01272284|Coloplast Corp|Clinical Trials Manager|612-302-4990|usdibe@coloplast.com
114412|NCT01272583|Academic Medical Center|Dr. Josefine E. Schopman|+31 20 5669111|j.e.schopman@amc.uva.nl
114413|NCT01272635|Penn State University|David Mauger|717-531-7178|dtm5@psu.edu
114414|NCT01272661|UHospitalsCleveland; Rainbow Babies and CHildren's Hospital|Lydia Furman MD, PI|216-844-8260|Lydia.Furman@uhhospitals.org
114415|NCT01272804|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114416|NCT01272869|Coloplast A/S|Director Medical Affairs|4549111111|dkbir@coloplast.com
114417|NCT01272882|ChristianaCHS|Gerard Fulda|302-733-4260|gfulda@christianacare.org
114418|NCT01272908|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
114419|NCT01272921|Northwestern University|Mark Kendall, M.D.|312-695-2528|m-kendall@northwestern.edu
114420|NCT01272934|Novartis Consumer Health|Clinical Project Leader|0041223635228|
114421|NCT01272947|Novartis Consumer Health S.A.|Clinical Project Leader|+41 22 3635528|
114422|NCT01273038|Coloplast A/S|Director of Medical Affairs|4549111111|dkbir@coloplast.com
114423|NCT01273064|Conatus Pharmaceuticals Inc.|MiRa Huyghe, Vice President, Clinical Development|(858) 457-7227|mhuyghe@conatuspharma.com
114424|NCT01273181|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov
114425|NCT01273519|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
114426|NCT01273597|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
114427|NCT01273623|Boston Scientific|Susanna Kennedy|763.494.2601|susanna.kennedy@bsci.com
114428|NCT01273766|Comprehensive Cancer Center of Wake Forest University|Dr. Mary Ann Knovich|336-716-7973|mknovich@wakehealth.edu
114429|NCT01273805|Dana-Farber Cancer Institute|Brian M. Wolpin|617.632.6942|Brian_Wolpin@dfci.harvard.edu
114430|NCT01273818|S.B.Ankara Diskapi Yildirim Beyazit Education and Teaching Hospital|Dr.Gaye Seker|+905323360618|gayeebru@superonline.com
114431|NCT01273857|Okayama University Hospital|Prof. Hidemasa Oh|+81-086-235-6506|hidemasa@md.okayama-u.ac.jp
114432|NCT01273883|Mayo Clinic|Dr. Michael J. Cevette|480-301-7020|mcevette@mayo.edu
114433|NCT01273896|Memorial Sloan Kettering Cancer Center|Modi, Shanu/Medicine (Assistant Attending)|+1646-888-4564|modis@mskcc.org
114434|NCT01280357|Monica Healthcare Ltd|Ian How|+44 (0)115912 ext 4540|ianhow@monicahealthcare.com
114435|NCT01280552|ImmunoCellular Therapeutics Ltd.|Anthony Gringeri, Ph.D. Senior Vice President Strategic Resources|818 264 2300|anthony.gringeri@imuc.com
114436|NCT01280591|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
114437|NCT01280604|Mercer University/ Kaiser Permanente|Kendra Manigault, PharmD, BCPS, BCACP, CDE|678-547-6216|manigault_kr@mercer.edu
114438|NCT01280955|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|mitchel.horwitz@duke.edu
114439|NCT01280968|Duke University Medical Center|Alexey G Mukhin, M.D., Ph.D.|Telephone: 919-668-5055|amukhin@duke.edu
114440|NCT01280981|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
114441|NCT01281007|EMS|Manager of Clinical Trials|+5501938877776|pesquisa.clinica@ems.com.br
114443|NCT01281202|National Institute on Drug Abuse|David McCann, Ph.D.|301-443-2999|dmccann@nida.nih.gov
114444|NCT01281306|Novartis|Study Director|862-778-8300|
114445|NCT01281475|Boston Children's Hospital|Wen-Hann Tan|617-355 6394|wen-hann.tan@childrens.harvard.edu
114446|NCT01281501|Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital.|Khrongwong Musikatavorn, MD|+662-256-4000 ext 4553-5|kmusikatavorn@yahoo.com
114447|NCT01281644|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu
114448|NCT01281839|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com
114449|NCT01281865|Memorial Sloan-Kettering Cancer Center|Dr. Mary Keohan|646-888-4160|keohanm@mskcc.org
114450|NCT01281917|University of Wisconsin Carbone Cancer Center|Lymphoma Disease Oriented Team|608-265-5542|neils@wisc.edu
114451|NCT01282086|Abbott (Ukraine)|Global Medical Services|1-800-633-9110|
114452|NCT01282138|Alcon Research|Head, Global Medical Affairs|1-800-862-5266|medinfo@alconlabs.com
114453|NCT01282164|Cleveland Clinic|Dr. Amir H. Hamrahian|216-445-8555|hamraha@ccf.org
114454|NCT01282203|AbbVie (prior sponsor Abbott)|Global Medical Services|1-800-633-9110|
114455|NCT01282229|Millenium Dental Technologies, Inc|Dr. David Harris|510-502-3345|dharris@LANAP.com
114456|NCT01282242|Massachusetts General Hospital|Lee H. Schwamm, MD|617-724-1597|lschwamm@mgh.harvard.edu
114457|NCT01282294|Synthes GmbH|Clinical Research Scientist|0041 32 720 44 65|clinicalaffairs.emea@synthes.com
114458|NCT01282372|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
114460|NCT01282476|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu
114461|NCT01282710|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com
114462|NCT01282723|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com
114463|NCT01282801|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
114464|NCT01282814|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
114465|NCT01282866|Laser & Skin Surgery Medical Group Inc.|Suzanne Kilmer, MD|916-456-0400|Study@skinlasers.com
114466|NCT01283022|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
114467|NCT01283035|DFCI|Joyce Liu, MD, MPH|617-632-5269|joyce_liu@dfci.harvard.edu
114468|NCT01283139|MedImmune, LLC|Gabor Illei, MD, Senior Director, Clinical Development|301-398-0000|IlleiG@Medimmune.com
114469|NCT01283152|Baylor University Medical Center|Robert S. Rahimi, M.D., M.S.C.R. Assistant Professor, Department of Medicine|214-820-8500|Robert.Rahimi@Baylorhealth.edu
114470|NCT01283282|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu
114471|NCT01283321|University of Maryland|Dr. Kenichi Tanaka|412-328-0205|ktanaka@anes.umm.edu
114472|NCT01283334|Emory University|Nabil F. Saba, MD|404-778-1900|nfsaba@emory.edu
114473|NCT01270659|University of Oklahoma Health Sciences Center Tulsa|Dr. Nasir Mushtaw|918/660-3680|Nasir-Mushtaq@ouhsc.edu
114474|NCT01270711|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114475|NCT01270802|Indiana University School of Medicine|Dr. Samir K. Gupta, Principal Investigator|317-274-7926|sgupta1@iu.edu
114476|NCT01270828|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114477|NCT01270841|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com
114478|NCT01270867|Concentric Medical / Stryker Neurovascular Inc|Paula Schmidt, Clinical Project Manager|510-413-2271|paula.schmidt@stryker.com
114543|NCT01289418|Laval University|Gaston De Serres|418-666-7000 ext 274|gaston.deserres@ssss.gouv.qc.ca
114479|NCT01270880|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath, M.D.|313-576-8715|heathe@karmanos.org
114480|NCT01270919|Stryker Orthopedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com
114481|NCT01270958|GlaxoSmithKline|GSK Response Center|866-435-7343|
114482|NCT01270971|Anacor Pharmaceuticals, Inc.|Sheryl Baldwin, RN/Associate Director|650-223-8597|clinicaltrials@anacor.com
114483|NCT01271036|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist|928-277-0715|jhauze@its.jnj.com
114484|NCT01271244|VA NEBRASKA WESTERN IOWA VA HEALTHCARE|SRIRAM RAMASWAMY MD|4029954712|SRIRAM.RAMASWAMY@VA.GOV
114485|NCT01271413|Johns Hopkins University School of Medicine|Dr. Miriam Mintzer|410 550-0529|mmintzer@jhmi.edu
114486|NCT01271452|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com
114487|NCT01271543|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu
114488|NCT01271686|University of California, San Diego|Dr. John Liu|858 534-7056|joliu@ucsd.edu
114489|NCT01277042|GlaxoSmithKline|GSK Response Center|866-435-7343|
114490|NCT01277081|GlaxoSmithKline|GSK Response Center|866-435-7343|
114491|NCT01277159|HSS|Dr. Yadeau|212.606.1206|YadeauJ@hss.edu
114492|NCT01277211|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114493|NCT01277302|Genentech, Inc.|Medical Communications|800 821-8590|
114494|NCT01277354|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu
114495|NCT01277510|Amgen Inc.|Study Director|866-572-6436|
114496|NCT01277523|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114497|NCT01277549|Terumo BCT|Jerome R Bill, M.D.|303-231-4729|jerry.bill@terumobct.com
114498|NCT01277601|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
114499|NCT01277666|GlaxoSmithKline|GSK Response Center|866-435-7343|
114500|NCT01277718|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
114501|NCT01277757|University of Texas (UT) MD Anderson Cancer Center|Funda Meric-Bernstam, MD/Chair, Investigational Cancer Therapeutics|713-563-4347|CR_Study_Registration@mdanderson.org
114502|NCT01283464|Johns Hopkins Dermatology|Dr. Anna L. Chien|4105027546|ctrep@jhmi.edu
114503|NCT01283516|Novartis Pharmaceuticals|Study Director|862-778-8300|
114504|NCT01283555|PATH|Jessica Cohen|206-285-3500|jcohen@path.org
114505|NCT01283581|Rib-X Pharmaceuticals|Dr. Eugene Sun||esun@Rib-x.com
114506|NCT01286805|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu
114507|NCT01286818|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
114508|NCT01287039|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
114509|NCT01287065|GlaxoSmithKline|GSK Response Center|866-435-7343|
114510|NCT01287117|Genentech, Inc.|Medical Communications|800 821-8590|
114511|NCT01287195|Brigham and Women’s Hospital|Scott B. Snapper, M.D., Ph.D.|617-919-4973|ssnapper@partners.org
114513|NCT01287221|Mayo Clinic|Dr. Phillip A. Low|507-284-3375|low@mayo.edu
114514|NCT01287364|Sunovion|Respiratory Medical Director|1-866-503-6351|
114515|NCT01287403|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, MD, PhD|+41217858054|maurice.beaumont@rdls.nestle.com
114516|NCT01287416|University of Manitoba|Shay-Lee Bolton|204-787-5082|sbolton@hsc.mb.ca
114517|NCT01287611|DrLutfi|Dr. Cem Turan|00905323513423|cemturan@gmail.com
114519|NCT01287754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
114520|NCT01287832|St. John Hospital and Medical Center|Leonard Johnson MD|3133438823|leonard.johnson@stjohn.org
114521|NCT01287897|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114522|NCT01288027|Sanofi|Trial Transparency Team||Contact-us@sanofi.com
114523|NCT01288079|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
114524|NCT01288209|Janssen Pharmaceutical K.K., Japan|Manager|81 3 44115639|
114525|NCT01288287|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)|
114526|NCT01288443|Sanofi|Trial Transparency Team||Contact ­-US@sanofi.com
114527|NCT01288469|Sanofi|Trial Transparency Team||Contact ­-US@sanofi.com
114529|NCT01288612|Mayo Clinic|Prasad G. Iyer|507-284-6469|iyer.prasad@mayo.edu
114530|NCT01288729|Stanford Childrens Health|Bruce Buckingham|650725-6549|buckingham@stanford.edu
114531|NCT01288781|UWalesBangor|Mr Justin Stevan Lawley|00441248382810|pepa16@bangor.ac.uk
114532|NCT01288859|University of Naples|Prof. Vincenzo Fogliano|+39 0812539356|fogliano@unina.it
114533|NCT01288911|Astellas Pharma Global Development, Inc. (APGD)|Executive Medical Director||Astellas.resultsdisclosure@astellas.com
114534|NCT01289015|Merz Pharmaceuticals, LLC|Stefan Plaum, MD Associate Medical Director|800-334-0514|clinicaltrials@merzusa.com
114535|NCT01289028|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
114536|NCT01289041|Novartis Pharmaceuticals|Study Director|862-778-8300|
114537|NCT01289080|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
114538|NCT01289119|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
114539|NCT01289210|VentiRx Pharmaceuticals Inc.|Kristi Manjarrez, Vice President, Clinical Affairs|206-689-2259|kmanjarrez@ventirx.com
114540|NCT01280656|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
114541|NCT01280695|Metabolic Solutions Development Company|Jerry Colca, PhD|269.343.6732|jcolca@msdrx.com
114542|NCT01289392|Associação Fundo de Incentivo à Pesquisa|Dr Teresa Cristina Barros Schutz|55-21-99868033|schutzferraz@gmail.com
121255|NCT02053610|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
121256|NCT02040779|Teva Branded Pharmaceutical Products R&D|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
114544|NCT01289522|Centre Antoine Lacassagne|Pr. Joël GUIGAY|+33492031000|joel.guigay@nice.unicancer.fr
114545|NCT01289548|Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology|Hua zheng|00862783663173|huaz1980@hotmail.com
114546|NCT01289574|AndroScience Corp|Charles CY Shih, PhD|(858) 638-7230|cyshih@androscience.com
114547|NCT01290224|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-2511|cloprinzi@mayo.edu
114548|NCT01290263|Dana-Farber Cancer Institute|David A. Reardon, MD|617-632-2166|dreardon3@partners.org
114549|NCT01290341|Merz Pharmaceuticals, LLC|Stefan Plaum, MD Associate Medical Director|800-334-0514|clinicaltrials@merzusa.com
114550|NCT01290484|Stanford University|Dr. Alfred Lane|650-721-7170|alfred.lane@stanford.edu
114551|NCT01290523|University of California San Francisco Department of Radiology|Dr Nicholas Fidelman|(415) 353-1300|Nicholas.Fidelman@ucsf.edu
114552|NCT01290536|University of California San Francisco|Nicholas Fidelman, MD|1-415-353-1300|Nicholas.Fidelman@ucsf.edu
114553|NCT01290614|University of Minnesota|Paul Drawz, MD|6126255423|draw0003@umn.edu
114554|NCT01290627|The University of Tennessee|Richard Komistek, Ph. D.|86598744159|rkomiste@utk.edu
114555|NCT01290640|The University of Tennessee|Dr. Richard Komistek, Professor|865-974-4159|rkomiste@utk.edu
114556|NCT01290666|University of California, Irvine|Michael J Stamos, MD|888-532-4123|
114557|NCT01290679|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com
114558|NCT01290718|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
114559|NCT01290731|Janssen Pharmaceutical K.K., Japan|Manager|81 3 44115639|
114560|NCT01290757|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114561|NCT01290796|Bard Medical Division|Jaime Ritter, MPH, CCRP, CIC|770-784-6437|jaime.ritter@crbard.com
114562|NCT01290822|Columbia University|Henry M. Spotnitz, MD|(212) 305-6191|hms2@columbia.edu
114563|NCT01290887|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
114564|NCT01290913|Boston Children's Hospital|Clinical Coordinator|6173556127|sara.little@childrens.harvard.edu
114565|NCT01290952|Azienda Ospedaliera Luigi Sacco|Dr. Massimo Lemma|0039 0239042876|lemma.massimo@hsacco.it
114566|NCT01290978|cyberDERM Clinical Studies|Dr. Gary Grove|610-325-0112|
114567|NCT01291017|University of Florida|Priya K Gopalan, MD|352-273-8699|gopalpk@ufl.edu
114568|NCT01291056|University of Utah Department of Obstetrics & Gynecology|Dr. Jessica Pittman|801-339-4103|jessica.pittman@hsc.utah.edu
114569|NCT01291108|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
114570|NCT01291160|Ogenix|S.Sarangapani|7817026732|ssarangapani@ogenix.com
114571|NCT01291173|Shire Development LLC|Study Physician|1 866-842-5335|
114572|NCT01291225|Center for Injury Research and Policy|Dr. Gary Smith|614-355-5850|Gary.Smith@Nationwidechildrens.org
114573|NCT01291264|University of California, San Francisco|Dr. Julius Schachter, Professor of Laboratory Medicine|415 824 5115|julius.schachter@ucsf.edu
114574|NCT01291277|Yale School of Medicine|Dr. Loren Laine|203-937-3462|loren.laine@yale.edu
114575|NCT01291498|Oxford University Hospitals NHS Trust|Mr Radu Mihai||radu.mihai@ouh.nhs.uk
114576|NCT01291784|Icahn School of Medicine at Mount Sinai|Dr. John O. Mascarenhas|212-241-6756|john.mascarenhas@mssm.edu
114577|NCT01292005|Mayo Clinic|Dr. Santhi Swaroop Vege|507-284-2175|vege.santhi@mayo.edu
114578|NCT01292057|Medical University of South Carolina|Joseph Schacht, Ph.D.|(843) 792-7497|schacht@musc.edu
114579|NCT01292070|Tunitas Therapeutics|Nolan Sigal, MD, PhD, CEO, Tunitas Therapeutics|(650) 887-4747|nsigal@tunitastherapeutics.com
114580|NCT01292135|Pharmacyclics|Thorsten Graef, MD|855.427.8846|medinfo@pcyc.com
114581|NCT01292187|Tarsa Therapeutics, Inc.|Dr. David Krause, Chief Medical Officer|1-267-273-7940|dkrause@tarsatherapeutics.com
114582|NCT01292226|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
114583|NCT01292239|Janssen Pharmaceutical K.K., Japan|Director|81 3 44115639|
114584|NCT01292265|UCB, Inc.|Study Director|+1 887 822 9493|
114585|NCT01292304|University of Florida|Giuseppe (Joseph) Morelli, MD|352-273-9508|giuseppe.morelli@medicine.ufl.edu
114586|NCT01292473|Genentech, Inc|Medical Communications|800 821-8590|
114587|NCT01292486|Terumo BCT|Jerome R Bill, M.D.|303-231-4729|jerry.bill@terumobct.com
114588|NCT01292538|Regulatory Insight, Inc.|Elvira Walls|615-712-9743|elvira@reginsight.com
114589|NCT01292603|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com
114590|NCT01292629|Hoya Surgical Optics, Inc.|Kees den Besten, Vice President Global Quality, Regulatory Affairs, and Clinical Research|+65 6681 0025|kees.denbesten@HOYA.com
114591|NCT01292642|McLean Hospital|Kevin P Hill, MD, MHS|617-855-4501|khill@mclean.harvard.edu
114592|NCT01284296|University of California, San Francisco|Ronald D. Miller|415 476-9034|millerr@anesthesia.ucsf.edu
114593|NCT01284361|Hollister Incorporated|Malford Cullum PhD/Sr Clin Res Scientist|847-918-3975|malford.cullum@hollister.com
114594|NCT01284426|Division of Allergy and Immunology, Department of Pediatrics, Siriraj Hospital, Mahidol University|Professor Orathai Jirapongsananuruk, Director of Clinical Trials|024197000|siojr@mahidol.ac.th
114595|NCT01284491|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com
114597|NCT01284517|Sunovion|Medical Director, CNS|1-866-503-6351|
114598|NCT01284621|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114599|NCT01284634|GW Research Ltd|Richard Potts|0044 1223 266800|rp@gwpharm.com
114600|NCT01284959|Chonbuk National University Hospital|Prof. Youngchul Chung|+82-63-250-2185|chungyc@chonbuk.ac.kr
114601|NCT01285024|Cleveland Clinic|President and CEO Cleveland Clinic Florida|216-444-7515|barsouw@ccf.org
114602|NCT01285050|Johns Hopkins University|David Thomas|410-502-6043|dthomas@jhmi.edu
114603|NCT01285076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114605|NCT01285323|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
114606|NCT01285401|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
114607|NCT01285427|Life Technologies|Deanna Vella, Staff Regulatory Engineer|760-918-3000|deanna.vella@lifetech.com
114608|NCT01285492|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
114609|NCT01285518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114611|NCT01285635|University of Michigan Cancer Center|Dr. Francis Worden, M.D.|734-936-0453|fworden@umich.edu
114613|NCT01285791|Hadassah Medical Organization|Dr Ido Mizrahi|+972-2-5844550|idomiz17@gmail.com
114614|NCT01285843|Medacta International|Ing. Elisa Bonacina, Clinical Data Manager|+41 91 696 60 60|bonacina@medacta.ch
114615|NCT01285908|National Institute of Neurological Disorders & Stroke|Dr. David S. Goldstein||david.goldstein1@nih.gov
114616|NCT01285947|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu
114618|NCT01286077|Janssen-Cilag Greece|EMEA Medical Affairs Director|+30 210 8090738|
114619|NCT01286129|IUCPQ|Louis-Philippe Boulet, principal investigator|418-656-4747|lpboulet@med.ulaval.ca
114620|NCT01286168|Mayo Clinic|Dr. Amy C. Degnim|507-284-6357|Degnim.Amy@mayo.edu
114621|NCT01286207|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
114622|NCT01286311|Northwestern University|Stephen D. Persell, MD MPH|312-503-6464|spersell@nmff.org
114624|NCT01286402|University of Texas Health Science Center at Houston|Angela Stotts, PhD, PI|713-500-7590|Angela.L.Stotts@uth.tmc.edu
114625|NCT01286454|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114626|NCT01286480|University of Alberta|Dr. Andrew Mackie|780-407-8361|andrew.mackie@ualberta.ca
114627|NCT01286493|Queen Saovabha Memorial Institute|Dr.Suda Sibunruang|+66 2 2520161 ext 125|sudapunrin@gmail.com
114628|NCT01286558|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114629|NCT01286740|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
114630|NCT01286753|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
114631|NCT01292746|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com
114632|NCT01292798|California Retina Consultants|Director of Research|8059631648 ext 3034|gabe@californiaretina.com
114633|NCT01292837|UCB|UCB Clinical Trial Call Center|++1 877 822 9493|
114634|NCT01292876|University of Pittsburgh|Maria Alexander, Office Manager|412-624-5308|alexanderm3@upmc.edu
114635|NCT01292928|Boston Scientific Corporation|Philip Ghizoni, Clinical Trial Manager|763-255-0036|Philip.Ghizoni@bsci.com
114636|NCT01293825|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|(216) 844-2808|martha.sajatovic@uhhospitals.org
114637|NCT01293968|Qazvin University of Medical Sciences|Dr.Katayun Borhanmojabi|09127841440|ka.mojabi@yahoo.com
114638|NCT01294046|Cleveland Clinic|Kathryn O'Connor||oconnok@ccf.org
114640|NCT01294163|Radboudumc, Department of Anaesthesiology|Dr. Jan HOFLAND|+31243611111 ext 3658|Jan.Hofland@radboudumc.nl
114641|NCT01294228|Alere San Diego|Director of Clinical Affairs|1-858-805-4808|william.arnold@alere.com
114642|NCT01294306|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
114643|NCT01294371|Abbvie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
114644|NCT01294384|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
114645|NCT01294397|Amgen Inc.|Study Director|866-572-6436|
114646|NCT01294423|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com
114647|NCT01294436|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com
114648|NCT01294449|University of Rochester Heart Research Follow-up Program|Dr. Arthur Moss|585-275-5291|Arthur.Moss@heart.rochester.edu
114649|NCT01294462|AstraZeneca|Judith Hsia||ClinicalTrialTransparency@astrazeneca.com
114650|NCT01294514|Covidien|Ulf Borg, Director of Clinical Affairs|303 305 2400|ulf.borg@covidien.com
114651|NCT01294553|GlaxoSmithKline|GSK Response Center|866-435-7343|
114652|NCT01294592|GlaxoSmithKline|GSK Response Center|866-435-7343|
114653|NCT01294644|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com
114654|NCT01294683|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114655|NCT01294696|Merck Sharp & Dohme Corp|Vice President, Late Stage Group Development Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114656|NCT01294709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114657|NCT01294748|Micell Technologies|Jeffrey Mifek, VP Clinical Affairs|919-313-2102|jmifek@micell.com
114658|NCT01294787|Novartis Pharmaceuticals|Study Director|41 61 324 1111|
114659|NCT01294800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114660|NCT01294917|Centre for Contact Lens Research|Clinical Scientist|519-888-4567 ext 36590|marc.schulze@uwaterloo.ca
114661|NCT01295034|Icahn School of Medicine at Mount Sinai|Andrea D. Branch PhD|212 659 8371|andrea.branch@mssm.edu
114837|NCT01302548|University of Florida|Richard F Petrik, MD|352-265-5911|rpetrik@ufl.edu
114662|NCT01295216|Institute of Nutrition of Central America and Panama|Manuel Ramirez-Zea|+502 24719913|mramirez@incap.int
114663|NCT01295281|Wellspect HealthCare|Dikran Shamoun|+46313764275|dikran.shamoun@wellspect.com
114665|NCT01295814|IC Study, LLC|Philip C. Bosch, MD|760-743-3135|pboschmd@gmail.com
114666|NCT01295840|Hospital Universitario Virgen de la Victoria|Dr Javier Alzueta|+34 952 64 15 50|jalzueta@telefonica.net
114667|NCT01295879|Brigham and Women's Hospital|David E. Leaf, M.D., Renal Fellow|617-732-5951|DELEAF@partners.org
114668|NCT01295905|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629|
114669|NCT01296035|Women & Infants Hospital|Director of Clinical Trials|401-274-1122|jmari@wihri.org
114670|NCT01296152|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
114671|NCT01283971|Hoffman-LaRoche|Medical Communications|800-821-8590|
114672|NCT01284062|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114673|NCT01284114|Division of Nephrology, Department of Internal Medicine, Jichi Medical University|Dr. Yoshiyuki Morishita|81-285-58-7346|ymori@jichi.ac.jp
114674|NCT01284244|Mount Sinai Hospital|Dr. Danny Lovatsis|416-586-4566|danny.lovatsis@sinaihealthsystem.ca
114675|NCT01289639|VA Puget Sound Health Care System|Kristina Utzschneider|206-277-3568 ext 6-3568|kutzschn@u.washington.edu
114676|NCT01289782|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com
114677|NCT01289821|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com
114678|NCT01289847|Bio Products Laboratory|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk
114679|NCT01289990|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdf@boehringer-ingelheim.com
114680|NCT01290029|Amgen Inc.|Study Director|866-572-6436|
114681|NCT01290068|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com
114682|NCT01290094|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
114683|NCT01296347|ImperialNHSTrust|Dr Gillian Chumbley|+44 203 311 1000 ext Bleep 5865|gillian.chumbley@imperial.nhs.uk
114684|NCT01296360|Valneva Austria GmbH|Senior Manager Clinical Research|+43 1 206 20 ext 1175|katrin.dubischar-kastner@valneva.com
114685|NCT01296412|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114686|NCT01299571|GlaxoSmithKline|GSK Response Center|866-435-7343|
114687|NCT01299584|GlaxoSmithKline|GSK Response Center|866-435-7343|
114688|NCT01299805|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
114689|NCT01299896|Vanderbilt University|Dr. Hilary A. Tindle|615-875-9726|hilary.tindle@vanderbilt.edu
114691|NCT01299961|UCLA|Veena K. Ranganath, MD, MS Assistant Clinical Professor|310-825-3061|vranganath@mednet.ucla.edu
114692|NCT01300052|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114693|NCT01300234|GlaxoSmithKline|GSK Response Center|866-435-7343|
114694|NCT01300247|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
114695|NCT01300260|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
114696|NCT01300286|Duke University Medical Center|Dr. Ian Welsby|919-668-2699|ian.welsby@duke.edu
114697|NCT01300338|Mayo Clinic|Dr. Frederick North|507-284-5164|North.Frederick@mayo.edu
114698|NCT01300351|AstraZeneca China|Guofei Dai|+86 21 60301242|guofei.dai@astrazeneca.com
114699|NCT01300455|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114700|NCT01300546|Clinvest/A Division of Banyan Group Inc.|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com
114701|NCT01300559|Duke University Medical Center|Steven E. Hill, M.D.|681-6614|hill0012@mc.duke.edu
114702|NCT01300624|Brain Rehabilitation Research Center, Malcom Randall VA, Gainesville, FL|Lisa Edmonds, PhD|352.262.4465|lisa.annamarie.edmonds@gmail.com
114704|NCT01300728|Sutter Neurology Medical Group|Shawn Kile, MD|(916) 454-6850|KileS@sutterhealth.org
114705|NCT01300741|Alcon Research|Director of Clinical Trials|1-800-241-7629|
114706|NCT01300767|Alcon Research|Director of Clinical Trials|1-800-241-7629|
114707|NCT01300819|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
114708|NCT01300923|Cincinnati Childrens Hospital|Craig Erickson|5136366265|craig.erickson@cchmc.org
114709|NCT01301027|University of Utah|Srinivansan Beddhu, M.D.|801-585-3810|srinivansan.beddhu@hsc.utah.edu
114710|NCT01301066|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@kowaus.com
114711|NCT01301079|Federal University of Sao Paulo|Plínio da Cunha Leal|55-98-8852-2021|pliniocunhaleal@hotmail.com
114712|NCT01301092|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
114713|NCT01301274|Intensive Care Unit - Hospital Pedro de Elizalde|Dr Facundo Jorro Barón|00541143632100 ext 2035|jorrobox@yahoo.com.ar
114714|NCT01301508|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114715|NCT01301729|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
114716|NCT01301742|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114717|NCT01301833|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
114718|NCT01301950|DePuy Synthes|Sam Himden, Clinical Portfolio Leader|574-372-7231|shimden@its.jnj.com
114719|NCT01301963|CCCC|Hien Duong, MD|216-445-5531|duongh@ccf.org
114720|NCT01302041|Astellas Pharma Global Devlopment, Inc.|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com
114721|NCT01293006|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114722|NCT01293032|Virginia Commonwealth University/Massey Cancer Center|Harry D Bear, MD, PhD|804-828-9325|harry.bear@vcuhealth.org
114723|NCT01293084|Johns Hopkins Univeristy|Beth Laube Professor|410-502-5791|blaube@jhmi.edu
114724|NCT01293240|Alcon Research|Peter Bergenske|1-800-241-7629|
114725|NCT01293539|Johns Hopkins|Monica Pearl, M.D.|410-955-8525|msmit135@jhmi.edu
114726|NCT01293695|Baylor University|Dr. Gary Elkins, Director of the Mind-Body Medicine Research Laboratory|254-296-0643|gary_elkins@baylor.edu
114727|NCT01302054|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114728|NCT01302067|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114729|NCT01302119|Anacor Pharmaceuticals, Inc.|Sheryl Baldwin, RN/Associate Director|650-223-8597|clinicaltrials@anacor.com
114730|NCT01302366|Perlmutter Cancer Center at NYU Langone|Amitabha Mazumder, MD|212-731-5757|amitabha.mazumder@nyumc.org
114731|NCT01302691|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114732|NCT01302743|Mike O'Callaghan Federal Medical Center|Jill M. Clark, MBA/HCM|702-653-3298|jill.clark.3.ctr@us.af.mil
114733|NCT01302860|Novartis Pharmaceuticals|Study Director|862 ­778 ­8300|
114734|NCT01302899|Novartis Pharmaceuticals|Study Director|862-778-8300|
114735|NCT01302938|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114736|NCT01303159|Weill Cornell Medical College|Michel Kahaleh|646-962-4797|mik9071@med.cornell.edu
114737|NCT01303224|Menarini Ricerche S.p.A.|Angela Capriati MD PhD, Corporate Director of Clinical Research|+39 055 5680 ext 9933|acapriati@menarini-ricerche.it
114738|NCT01303380|Novartis Pharmaceuticals|Study Director|862 ­778 ­8300|
114739|NCT01303406|National Hospital for Neurology and Neurosurgery|Dr Paola Giunti|020 3448 3141|violet.le-fevre@uclh.nhs.uk
114740|NCT01303445|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114741|NCT01303510|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com
114742|NCT01303627|Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital 1. Anesthesiology|Derya Özkan MD|0903125962553|derya_z@yahoo.com
114743|NCT01303744|Cerespir|Richard Margolin|(646) 202-2562|rmargolin@cerespir.com
114744|NCT01303835|Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center|Katherine B. Peters, MD, PhD|(919) 684-6173|katherine.peters@duke.edu
114745|NCT01303861|Duke University Medical Center - Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@dm.duke.edu
114746|NCT01304082|Massachusetts General Hospital|Brian Wainger|617-726-8810|bwainger@partners.org
114747|NCT01304147|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-7574|james.murrough@mssm.edu
114748|NCT01304238|GlaxoSmithKline|GSK Response Cente|866-435-7343|
114749|NCT01304277|Shire Development LLC|Study Physician|+1 866 842 5335|
114750|NCT01304316|University of Pennsylvania|Dr. Elliot V. Hersh|215-898-9686|evhersh@pobox.upenn.edu
114751|NCT01304329|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114752|NCT01304498|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114753|NCT01304589|University of Tennessee Health Science Center|Dr. Candace Brown|901-412-4341|csbrown@uthsc.edu
114754|NCT01304641|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114755|NCT01304693|Alcon Research, Ltd.|Georges Weissgerber, Executive Director, Novartis Pharma AG|1-888-451-3937|alcon.medinfo@alcon.com
114756|NCT01304706|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com
114757|NCT01304966|Queen Sirikit Nation Institute of Thailand|Dr.Pavinee Intakorn|06623548333 ext 2301|pintakorn@yahoo.com
114758|NCT01305044|Huntsman Cancer Institute|Anita Kinney, PhD, RN|801-585-1151|anita.kinney@hci.utah.edu
114759|NCT01296646|University of North Carolina at Chapel Hill|James C. Garbutt, M.D., Professor of Psychiatry|919-966-4652|jc_garbutt@med.unc.edu
114760|NCT01296672|UT Health|Jonathan Gelfond|210 567-0836|gelfondjal@uthscsa.edu
114761|NCT01296698|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com
114762|NCT01297062|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com
114763|NCT01297257|Clinical Research Director|Frank van Leeuwen, M.D.|+31433566622|frank.van.leeuwen@medtronic.com
114764|NCT01297270|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114765|NCT01297283|Medtronic|Latifa Foudali|+33 631992144|latifa.foudali@medtronic.com
114766|NCT01297322|Daniel & Daniel Consulting, LLC|Michael A. Daniel, Consulting VP Regulatory Affairs|7753922970|madaniel@clinregconsult.com
114767|NCT01297335|The Center for Clinical Research|Medical Director|3367656181|rrauck@ccrpain.com
114768|NCT01297348|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com
114769|NCT01297465|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
114770|NCT01297491|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
114771|NCT01297504|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
114772|NCT01297517|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com
114773|NCT01297595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114774|NCT01297920|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com
114775|NCT01298063|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114776|NCT01298128|Mount Sinai Hospital|Dr. Kimberly Liu|416-586-5367|kliu@mtsinai.on.ca
114777|NCT01298167|Yale University|David Leffell, MD|203 785 7999|david.leffell@yale.edu
114779|NCT01298362|Hellenic Society of Breast Surgeons|Christos J Markopoulos, MD, MPhil Professor of Surgery-Athens University Medical School|+30 210 6862527|cmarkop@hol.gr
114780|NCT01298492|Shire|Study Physician|1 866-842-5335|
114781|NCT01298518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114782|NCT01298531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114783|NCT01298544|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114784|NCT01298648|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
114785|NCT01298661|Universidade Federal de São Carlos|Juliano Ferreira Arcuri|+55 (16) 33518343|julianoarcuri@gmail.com
114787|NCT01299025|Region Örebro County|Dr Anette Forsberg|+46-19-6025788|anette.forsberg@regionorebrolan.se
114788|NCT01299077|Eisai China Inc.|Haibo Song|0086-21-24192864|songhaibo@eisai.com.cn
114789|NCT01299090|Moy, Fincher, Chipps Medical Group|Lisa Chipps, MD|(310) 274-5372|lchipps@ucla.com
114790|NCT01299103|Chicago Center for Facial Plastic Surgery|Dr. Steven Dayan|(312) 335-2070|sdayan@drdayan.com
114791|NCT01299285|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
114792|NCT01299376|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114793|NCT01299389|Janssen Pharmaceutical K.K|Medical director|+81-3-4411-5509|
114794|NCT01299454|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800-562-3974|
114795|NCT01299480|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114796|NCT01305200|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org
114798|NCT01305239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114799|NCT01305252|Stanford University School of Medicine|Roham Zamanian, MD, FCCP|650- 725-5495|zamanian@stanford.edu
114800|NCT01305265|Dept. of Anesthesia & Perioperative Care, UCSF San Francisco|Kolodzie, Kerstin M.D, PhD, Principal Investigator|4158853647|kolodziek@anesthesia.ucsf.edu
114801|NCT01305408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
114802|NCT01305473|C.R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com
114803|NCT01306214|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114804|NCT01306253|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com
114805|NCT01306292|Bracco Diagnostics Inc.|Dr. Maria Luigia Storto|609-514-2262|marialuigia.storto@diag.bracco.com
114806|NCT01306305|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com
114807|NCT01306617|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
114808|NCT01306643|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
114809|NCT01306877|Covidien|Tam LaFleur, Clinical Project Manager|203-821-4744|tam.lafleur@covidien.com
114810|NCT01306968|Uniformed Services University of Health Sciences|Dr. R. Scott Miller, M.D.|301-816-8424|robert.s.miller@us.army.mil
114811|NCT01307007|Luitpold Pharmaceuticals, Inc.|Sumita Chowdhury, MD, MPH, FACC, MBA|610-650-4200|SChowdhury@lpicrd.com
114812|NCT01307020|Menarini Ricerche S.p.A.|Dr Angela Capriati, Corporate Clinical Research Director|+39 055 5680 9933|acapriati@menarini-ricerche.it
114813|NCT01307033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114814|NCT01307046|Merch Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114815|NCT01307111|University of New Mexico|Eve Espey, MD, MPH, Principle Investigator|505-272-6372|eespey@salud.unm.edu
114816|NCT01307319|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
114817|NCT01307423|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com
114818|NCT01307462|FHCRC|Guang-Shing Cheng MD|206-667-7074|gcheng2@fhcrc.org
114819|NCT01307618|University of Chicago Comprehensive Cancer Center|Tomas Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu
114820|NCT01307631|Dana-Farber Cancer Institute|Jennifer Curtis, MS|617-582-7183|jennifer_curtis@dfci.harvard.edu
114821|NCT01307787|UMCG|G.Breedland||g.breedland@cvr.umcg.nl
114823|NCT01308424|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144|
114824|NCT01308450|BioBDx|Calvin R. Sumner, MD, CMO, Sr. VP for Clinical Development|978-431-5103|calvin_sumner@biobdx.com
114825|NCT01308463|Zimmer Biomet|Kelly Francher|574-371-9783|kelly.francher@zimmerbiomet.com
114826|NCT01308476|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114828|NCT01308580|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
114829|NCT01308619|Galderma Laboratories|Dr. Warren Winkelman|817-961-5494|warren.winkelman@galderma.com
114830|NCT01296763|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Thomas Brown|410-502-5328|tbrown55@jhmi.edu
114831|NCT01296815|Centro de Investigación en. Enfermedades Infecciosas|Gustavo Reyes-Teran|52 55 56667985|gustavo.reyesteran@gmail.com
114832|NCT01296841|VA Palo Alto|Roy Soetikno|650-493-5000 ext 64800|soetikno@earthlink.net
114833|NCT01302392|Amgen, Inc.|Study Director|866-572-6436|
114834|NCT01302418|QIAGEN|Tony Lam|301-944-7090|tony.lam@qiagen.com
114835|NCT01302444|Rhode Island Hospital|James R Klinger, MD||jklinger@lifespan.org
114836|NCT01302483|Department of Periodontics & Endodontics, School of Dental Medicine, University of Buffalo, SUNY|Dr. Sebastian Ciancio|(716) 829-3848|ciancio@buffalo.edu
114838|NCT01308736|Rutgers Robert Wood Johnson Medical School|Dr. Marc Steinberg|7322354341|marc.steinberg@rutgers.edu
114839|NCT01308749|Duke University Center for Autism and Brain Development|Linmarie Sikich, MD|9196810026|linmarie.sikich@duke.edu
114840|NCT01308762|Immodulon Therapeutics, The London Clinic Cancer Centre, London W1G 6JA,|Clinical Trials Co-ordinator|+44 (0)203 219 3568/3572|Ilda@immodulon.com
114841|NCT01308788|Indiana University|Alon Harris|3170278-0177|alharris@indiana.edu
114842|NCT01308814|University of North Carolina at Chapel Hill|Susan S. Girdler, Ph.D.|919-966-2179|susan_girdler@med.unc.edu
114843|NCT01308840|University of Rochester|Aram F Hezel|585-275-5823|aram_hezel@urmc.rochester.edu
114844|NCT01308918|Institut universitaire de cardiologie et de pneumologie de Quebec|Nathalie Gagne|418 656-8711 ext 2645|nathalie.gagne@criucpq.ulaval.ca
114845|NCT01309581|Mount Sinai School of Medicine|James Murrough|212 241 7574|James.Murrough@mssm.edu
114846|NCT01309646|GlaxoSmithKline|GSK Response Center|866-435-7343|
114847|NCT01309659|Duke University Medical Center|Harvey J Cohen, MD|919-660-7502|harvey.cohen@dm.duke.edu
114848|NCT01309672|University of Colorado, School of Medicine|Dr. Thomas W. Flaig, MD||Thomas.Flaig@ucdenver.edu
114850|NCT01309802|Southern Illinois University School of Medicine|Research Administrator|217-545-2531|surgeryresearch@siumed.edu
114851|NCT01309828|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
114852|NCT01309841|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com
114853|NCT01309880|Bausch & Lomb|Dr. Robert Steffen|585 338 6399|robert.steffen@bausch.com
114854|NCT01309893|Bausch & Lomb|Dr. Robert Steffen|585 338-6399|robert.steffen@bausch.com
114855|NCT01309919|Baystate Medical Center|Dr. Katharine White|413-794-5256|katharine.white@bhs.org
114856|NCT01309997|FHCRC|Stephanie J. Lee MD MPH|206-667-6190|sjlee@fhcrc.org
114857|NCT01310127|Discover Vision Centers|Melissa Toyos, MD|816-478-1230|mtoyos@discovervision.com
114858|NCT01310179|University of Alabama at Birmingham|Eben Rosenthal, MD|205-934-9713|erosenthal@uabmc.edu
114859|NCT01310400|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com
114860|NCT01310413|GlaxoSmithKline|GSK Response Center|866-435-7343|
114861|NCT01310582|Clinical Research Group|Kirtanaa Voralu, Associate Director Research Management|215-255-7878 ext 7878|kirtanaa.voralu@drexelmed.edu
114863|NCT01310777|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com
114864|NCT01310803|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
114865|NCT01310855|UCL and CTC Cancer Trials Centre|Mark Phillips|0207 679 9139|ctc.doric@ucl.ac.uk
114866|NCT01310868|University College London|GALA-5 Trial Coorinator|0207 679 9898|ctc.sponsor@ucl.ac.uk
114868|NCT01311102|Harbor-UCLA Medical Center|Dr. Anita Nelson|310-222-3871|anitanelsonwhc@earthlink.net
114869|NCT01311362|University of Heidelberg|Prof. Dr. med. Gerd Mikus|4966215639197|gerd.mikus@med.uni-heidelberg.de
114870|NCT01311505|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114871|NCT01311557|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
114872|NCT01311661|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114874|NCT01312038|Middle Ear Physiology Laboratory|Ellen Mandel, MD|412-692-6214|mandele@pitt.edu
114875|NCT01305564|Bard Peripheral Vascular|Ryan Melloy|480-350-6074|ryan.melloy@crbard.com
114876|NCT01305577|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com
114877|NCT01305655|NOPHO|Dr Jesper Heldrup|+46705172389|jesper.heldrup@skane.se
114878|NCT01305772|Duke University Medical Center|Neal Ready,MD|919-681-6932|neal.ready@dm.duke.edu
114879|NCT01305811|New England School of Acupuncture|Lisa Conboy|6175581788 ext 145|lconboy@nesa.edu
114880|NCT01306032|National Cancer Institute|Dr. Alice Chen|301-435-0517|chenali@mail.nih.gov
114881|NCT01306162|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114882|NCT01306175|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114883|NCT01306201|Covidien|Ulf Borg, Director of Clinical Affairs|303-305-2400|ulf.borg@covidien.com
114884|NCT01312129|The Mind Research Network|Kent Hutchison, Ph.D.|720-663-0745|khutchison@mrn.org
114885|NCT01312272|VISN 22 Mental Illness Research, Education, and Clinical Center|Dr. Michael C. Davis|3104783711 ext 49234|mcdavis@mednet.ucla.edu
114886|NCT01313624|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
114888|NCT01313650|GlaxoSmithKline|GSK Response Center|866-435-7343|
114889|NCT01313663|GlaxoSmithKline|GSK Response Center|866-435-7343|
114891|NCT01313689|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
114892|NCT01313728|Valeant Pharmaceuticals International Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com
114893|NCT01313780|Seoul Asan Hospital|Taewon Kim|82-2-3010-3910|twkimmd@amc.seoul.kr
114894|NCT01313858|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114896|NCT01313897|University of Arkansas for Medical Sciences|Frits van Rhee|501-526-6990|vanrheefrits@uams.edu
114897|NCT01313910|UCaliforniaDavis|David Asmuth, MD|9167348695|david.asmuth@ucdmc.ucdavis.edu
114898|NCT01313923|UC Irvine Dermatology Research Center|Sergei A. Grando, MD, PhD, DSc|9498242713|sgrando@uci.edu
114899|NCT01313936|UCSF Dept of Pediatrics|Steven DuBois, MD|415-476-3831|duboiss@peds.ucsf.ed
114900|NCT01314001|University of Pennsylvania|Paul M. Sanborn, M.S.|215-746-7150|sanborn@mail.med.upenn.edu
114901|NCT01314014|James P. Wilmot Cancer Center, University of Rochester|Paul M. Barr, MD|585-273-3258|Paul_Barr@urmc.rochester.edu
114902|NCT01314105|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114904|NCT01314261|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
114905|NCT01314417|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov
114906|NCT01314443|Ohio State University|Richard Bruno, PhD, RD|614-292-5522|bruno.27@osu.edu
114907|NCT01314703|CareFusion|Jennifer Raeder-Devens|847-454-4939|jennifer.raeder-devens@carefusion.com
114908|NCT01314716|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
114910|NCT01314872|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114911|NCT01315002|University Hospital Bonn, Department of Psychiatry and Psychotherapy|Prof. Dr. Michael Wagner|004922828716377|michael.wagner@uni-bonn.de
114912|NCT01315028|University of Glasgow|Professor Andrew Gumley|0044 141 211 3927|andrew.gumley@glasgow.ac.uk
114913|NCT01315145|Vertos Medical|VP of Clinical Affairs|9493490008|kdavis@vertosmed.com
114914|NCT01315158|Washington University School of Medicine|Faris Murad, M.D.||fmurad@northshore.org
114915|NCT01315249|Novartis|Study Director|41 61 324 1111|
114916|NCT01315574|Massachusetts Eye and Ear Infirmary|Dr. Pedram Hamrah|617-573-6060|ophthalmologyclinicalresearch@meei.harvard.edu
114917|NCT01315665|University Hospitals Cleveland Medical Center|James Chmiel|216-844-3267|James.Chmiel@uhhospitals.org
114918|NCT01315847|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
114919|NCT01316042|Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-8478|rlegro@hmc.psu.edu
114920|NCT01316055|Vice President - Clinical Development & Medical Affairs (CDMA)|Herbert Henney, PharmD|(914) 347-4300 ext 5138|hhenney@acorda.com
114921|NCT01309100|Bausch & Lomb|Dr. Robert Steffen|585 338 6399|robert.steffen@bausch.com
114922|NCT01309204|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com
114923|NCT01309243|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
114924|NCT01309269|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
114925|NCT01309282|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
114926|NCT01309308|Baskent University|Ayse Parlakgumus|00903224586868 ext 2102|ayseparlakgumus@yahoo.de
114927|NCT01309360|Helios-Kliniken Schwerin|Dr.med.Ronald Seidel|0049 (0)385 520-4251|ronald.seidel@helios-kliniken.de
114928|NCT01309386|Neuroscience department, Clinical science department, R&D in Janssen, Chiyodaku, Tokyo 101-0065, Japan|Manager|+81-3-4411-5509|
114929|NCT01309451|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com
114930|NCT01316224|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
114931|NCT01316263|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
114932|NCT01316302|The Medical Research Network, LLC|Michael R. Liebowitz, M.D.|(212) 595-5012|MLiebowitz@MedicalResearchNetwork.com
114933|NCT01316315|N30 Pharmaceuticals Inc.|Janice M. Troha|720-945-7714|janice.troha@n30pharma.com
114934|NCT01316341|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage@boehringer-ingelheim.com
114935|NCT01316380|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114936|NCT01316419|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
114937|NCT01318499|Alcon Research|Dana Sager, Clinical Manager Group Leader|1-817-551-8603|dana.sager@alconlabs.com
114938|NCT01318512|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
114939|NCT01318538|McLean Hospital|Shelly F. Greenfield, MD, MPH|617-855-2241|sgreenfield@mclean.harvard.edu
114940|NCT01318694|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com
114941|NCT01318733|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com
114942|NCT01318876|Laval University|Gaston De Serres|418-666-7000 ext 274|gaston.deserres@ssss.gouv.qc.ca
114945|NCT01318993|GlaxoSmithKline|GSK Response Center|866-435-7343|
114946|NCT01319045|UCLA|Jamil Aboulhosn|310-825-5950|jaboulhosn@mednet.ucla.edu
114947|NCT01319110|Beth Israel Deaconess Medical Center|Dr. Michael Cocchi||mcocchi@bidmc.harvard.edu
114948|NCT01319318|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
114949|NCT01319383|UNC Chapel Hill School of Medicine|Dr. David Margolis|919-966-6388|dmargo@med.unc.edu
114950|NCT01319396|BiancaMed Ltd|Paul Phillips|+353 1 716 3755|paul.phillips@biancamed.com
114951|NCT01319422|Yale University|Madhav Dhodapkar, M.D.|203-785-4144|madhav.dhodapkar@yale.edu
114952|NCT01319500|Center for Epidemiology and Health Research Berlin|Dr Juergen Dinger|+49 (0)30 945 10145|dinger@zeg-berlin.de
114953|NCT01319539|Columbia University Medical Center|Kevin Kalinsky, MD|212-305-1945|kk2693@cumc.columbia.edu
114954|NCT01319552|Columbia University|Dr. Steven Spitalnik|2123425648|eldad.hod@gmail.com
114955|NCT01319617|UCSD|Felipe Medeiros|858 82245-92|fmedeiros@glaucoma.ucsd.edu
114956|NCT01319721|State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University|Dr. Shiyou Zhou|+86-020-87331540|zhoushiy@mail.sysu.edu.cn
114957|NCT01319773|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
114958|NCT01319799|Sahlgrenska University Hospital,Cardiothoracic Anesthesia, 41345 Gothenburg ,SWEDEN|Dr Bjorn Reinsfelt|0046702954263|bjorn.reinsfelt@gu.se
114960|NCT01319851|Emory University|Dr. John Horan|404-785-1272|jthoran@emory.edu
114961|NCT01319877|Hoffmann-La Roche|Medical Communications|800-821-8590|
114963|NCT01320137|GlaxoSmithKline|GSK Response Center|866-435-7343|
114964|NCT01320202|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com
114965|NCT01320293|University of North Carolina|Aida Lugo-Somolinos MD|919-843-9447|alugosom@med.unc.edu
114966|NCT01320553|SPARC|Shravanti Bhowmik, MD||shravanti.bhowmik@sparcmail.com
114967|NCT01320683|City of Hope|Paul Frankel, Ph.D.|626-256-4673 ext 65265|pfrankel@coh.org
114968|NCT01320722|Brigham and Women's Hospital|John P Forman, MD||jforman@partners.org
114969|NCT01320735|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
114970|NCT01320826|University of Alberta|Dr. Michael Kolber|(780) 616-8411|mkolber@ualberta.ca
114972|NCT01312467|University of California, Irvine|Dr. Frank L. Meyskens, Jr.|714-456-6310|flmeyske@uci.edu
114973|NCT01312519|Vidacare Corporation|Senior Director of Science and Clinical|210-375-8500|thomas.philbeck@vidacare.com
114974|NCT01312766|IBSA Institut Biochimique SA|Dr. Barbara Cometti, Senior Clinical Research Manager, IBSA|+41 58 360 10 00|barbara.cometti@ibsa.ch
114975|NCT01312805|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu
114976|NCT01312818|University of Minnesota, Pediatric Hematology Dept.|Dr. Michael Burke, MD|612-672-7422|
114977|NCT01312844|Massachusetts General Hospital|Dr. John Matthews|617-643-9095|jmatthews@partners.org
114978|NCT01312948|ResMed Ltd|Alison Wimms|+6188842583|alison.wimms@resmed.com.au
114979|NCT01312961|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
114980|NCT01313039|University of Miami Sylvester Comprehensive Cancer Center|Judith Hurley MD|305-243-6462|JHurley@med.miami.edu
114981|NCT01313078|National Cancer Institute, National Institutes of Health|Elise Kohn, M.D.|301-496-9336|kohne@mail.nih.gov
114982|NCT01313117|Northwestern University|Jeffrey Allen M.D.|312-695-8636|jallen1@nmff.org
114983|NCT01313182|New York University School of Medicine|Dr. Michael Phillips|212 263 4316|michael.phillips@nyumc.org
114984|NCT01313208|Amgen Inc.|Study Director|866-572-6436|
114985|NCT01313221|Amgen Inc.|Study Director|866-572-6436|
114986|NCT01313273|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
114987|NCT01313299|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
114988|NCT01313312|Ipsen Innovation|Medical Director, Neurology.||clinical.trials@ipsen.com
114989|NCT01313494|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
114990|NCT01313507|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com
114991|NCT01313520|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com
114992|NCT01320943|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
114993|NCT01321008|University of Texas MD Anderson Cancer Center|Bouthaina Dabaja, MD / Associate Professor, Radiation Oncology|713-563-2300|CR_Study_Registration@mdanderson.org
114994|NCT01322594|MedImmune, Limited|Ed Piper|+44 (0) 1223 471 471|pipered@medimmune.com
114995|NCT01322607|Baltimore VA Medical Center (VAHMCS)|Research Specilist|410-605-7156|alyssa.stookey@va.gov
114996|NCT01322633|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
114997|NCT01322815|Ruesch Center at Georgetown Lombardi|John L Marshall|202.444.7064|marshalj@georgetown.edu
114998|NCT01322841|Indiana University School of Medicine|Aaron Carroll|3172789616|aaecarro@iu.edu
114999|NCT01322945|Barrow Neurological Institute|Andrew S. Little, MD|602-406-3181|heidi.jahnke@dignityhealth.org
115000|NCT01322971|Stanford University|Ruth Lathi||rlathi@stanford.edu
115001|NCT01323010|University of Sao Paulo|Dr Fabio Pereira Muchão|+5511 983835563|fabiomuchao@gmail.com
115002|NCT01323140|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com
115003|NCT01323192|Janssen Pharm KK Japan|Medical Director|+81-3-4411-5509|
115004|NCT01323270|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115006|NCT01323478|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
115007|NCT01323582|University of Florida|Baharak Moshiree MD|305-243-2515|bmoshiree@med.miami.edu
115009|NCT01323621|GlaxoSmithKline|GSK Response Center|866-435-7343|
115011|NCT01323647|GlaxoSmithKline|GSK Response Center|866-435-7343|
115012|NCT01323660|GlaxoSmithKline|GSK Response Center|866-435-7343|
115013|NCT01323673|GlaxoSmithKline|GSK Response Center|866-435-7343|
115014|NCT01323777|Alcon Japan, Ltd.|Group Manager, Surgical|1-888-451-3937|alcon.medinfo@alcon.com
115015|NCT01323790|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com
115195|NCT01335971|Johns Hopkins University School of Medicine|Alexis Rea|(443) 287-8496|area5@jhu.edu
115016|NCT01323855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115017|NCT01323920|Dana Farber Cancer Institute|Dr. John Koreth|617-632-2949|John_Koreth@dfci.harvard.edu
115018|NCT01323959|GlaxoSmithKline|GSK Response Center|866-435-7343|
115020|NCT01323998|GlaxoSmithKline|GSK Response Center|866-435-7343|
115021|NCT01324024|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu
115022|NCT01324102|VA Boston Healthcare System|Jennifer Moye|774-826-3721|jennifer.moye@va.gov
115023|NCT01324128|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com
115024|NCT01324271|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com
115025|NCT01324310|Celgene Corporation|Senior Manager|1-888-260-1599|clinicaltrialdisclosure@celgene.com
115026|NCT01324323|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com
115027|NCT01324349|Covidien|Vice President, Medical Affairs|203-500-4256|amy.pollack@covidien.com
115028|NCT01324388|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
115029|NCT01324401|Harvard Medical School / Massachusetts General Hospital|Wayne Shreffler|617-726-6147|wshreffler@mgh.harvard.edu
115030|NCT01324440|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115031|NCT01324570|Purdue Pharma L.P.|Clinical Leader|800-733-1333|stacy.baldridge@pharma.com
115033|NCT01324687|University of Rochester|Manish N. Shah|585-276-6565|manish_shah@urmc.rochester.edu
115035|NCT01324947|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com
115036|NCT01324999|University of North Carolina at Chapel Hill|H. James Ford, MD|(919) 966-2531|hjford@med.unc.edu
115037|NCT01316575|University of Saskatchewan|Dr. William McKay|306-655-1202|william.mckay@saskatoonhealthregion.ca
115038|NCT01316614|Washington University School of Medicine|Daniel K. Mullady, M.D.|314-362-8546|dmullady@dom.wustl.edu
115039|NCT01316692|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-875-8359|jeff.sosman@vanderbilt.edu
115042|NCT01316913|GlaxoSmithKline|GSK Response Center|866-435-7343|
115043|NCT01316926|GlaxoSmithKline|GSK Response Center|866-435-7343|
115044|NCT01316939|GlaxoSmithKline|GSK Response Center|866-435-7343|
115045|NCT01317004|Novartis Pharmaceuticals|Study Director|862-778-8300|
115046|NCT01317160|Karolinska university Hospital|Dr. Paul W. Ackermann|+46851770000|paul.ackermann@karolinska.se
115047|NCT01317615|Novartis|Study Director|862-778-8300|
115048|NCT01317641|Orion Pharma, Development, R&D|Head of Oncology|+358 10 4261|mika.mustonen@orionpharma.com
115049|NCT01317667|US Army Medical Research Institute of Infectious Diseases (USAMRIID)|Denise P Clizbe, RN, CCRC|301.619.6869|denise.p.clizbe.civ@mail.mil
115050|NCT01317797|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com
115051|NCT01317901|Aptevo Therapeutics|Scott C. Stromatt|206-859-6675|sstromatt@apvo.com
115052|NCT01318070|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com
115053|NCT01318083|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com
115054|NCT01318109|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com
115055|NCT01318122|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com
115056|NCT01318135|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com
115057|NCT01318278|Baylor College of Medicine|Dr. Danielle R. Rios|832-826-1380|drrios@texaschildrens.org
115058|NCT01318382|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
115059|NCT01318408|Drexel University College of Medicine|Carol Lippa, MD|215-762-7090|clippa@drexelmed.edu
115060|NCT01325181|Seoul National University Hospital|Jang Won Heo|82220720836|hjw68@snu.ac.kr
115061|NCT01325311|University of Wisconsin|Howard H. Bailey|608-263-8624|hhbailey@wisc.edu
115062|NCT01325337|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
115063|NCT01325350|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
115064|NCT01325714|Houston Center for Innovations in Quality, Effectiveness, and Safety|Mark Kunik, MD, MPH|713-794-8639|kunik.marke@va.gov
115065|NCT01325792|W. L. Gore & Associates, Inc., Sponsor|Lori Norton, PhD|800-437-8181|lnorton@wlgore.com
115066|NCT01325870|Advanced Circulatory|Clinical Research Associate|651-403-5606|nburkhart@advancedcirculatory.com
115067|NCT01326026|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
115068|NCT01326533|University of Pittsburgh|Frederico Toledo|412-692-2848|.toledofs@upmc.edu
115069|NCT01326845|Novartis Pharmaceuticals|Study Director|862-778-8300|
115070|NCT01326910|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist Clinical Quality Systems and Process|928-277-0715|jhauze@its.jnj.com
115071|NCT01326962|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
115072|NCT01327053|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
115073|NCT01327300|University of Florida|Dr. Baharak Moshiree|(352)273-8393|bmoshiree@med.miami.edu
115074|NCT01327313|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
115075|NCT01327339|GlaxoSmithKline|GSK Response Center|866-435-7343|
115076|NCT01327482|Massachusetts General Hospital|Dr. Caroline Mitchell|617-724-2182|caroline.mitchell@mgh.harvard.edu
115077|NCT01327495|University of Washington|Stephanie Page, MD, PhD|206-616-0483|page@uw.edu
115078|NCT01327508|Smith & Nephew, Inc.|Cathy Newbill|800-821-5700|cathy.newbill@smith-nephew.com
115080|NCT01327599|Alcon Research, Ltd.|Doug Hubatsch, Therapeutic Unit Head, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com
115081|NCT01327651|Fred Hutchinson Cancer Research Center|Maoji Li (Statistical Research Associate)|2066676035|mli2@fredhutch.org
115082|NCT01327677|Johns Hopkins University School of Medicine|Athir Morad, M.D.|4109552611|morada@jhmi.edu
115083|NCT01327703|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634|
115084|NCT01327885|Eisai Inc.|Eisai Medical Services|1-888-422-4743|
115085|NCT01327976|EnteroMedics|Director of Clinical Research|651-634-3209|mbroich@enteromedics.com
115086|NCT01327989|Medtronic|Manish Gupta, Sr. Director of Medical Affairs|949-837-3700|manish.gupta@medtronic.com
115087|NCT01328041|ViiV Healthcare|GSK Response Center|866-435-7343|
115088|NCT01328054|GlaxoSmithKline|GSK Response Center|866-435-7343|
115089|NCT01328080|Johns Hopkins Dermatology|Ginette Okoye, MD, Director of Ethnic Skin Program|410-502-7546|ctrep@jhmi.edu
115090|NCT01328158|AbbVie (prior sponsor, Abbott)|AbbVie Japan PMOS Desk|+81-3-4577-1125|abvj-pmos@abbvie.com
115091|NCT01328184|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
115092|NCT01321554|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com
115093|NCT01321697|University of Arkansas for Medical Sciences|Sandy Annis|5016868274|amannis@uams.edu
115094|NCT01321710|University of California, San Francisco|Kathryn Lee, RN, PhD|415-476-4442|kathryn.lee@nursing.ucsf.edu
115095|NCT01321723|Unigene Laboratories, Inc.|Nozer Mehta, PhD. Chief Scientific Officer|(973) 265-1100|nmehta@unigene.com
115096|NCT01321749|XuanWu Hospital, Capital Medical University|Xunming Ji, M.D.,Ph.D.|8683198127|jixm70@hotmail.com , Jixm@ccmu.edu.cn
115097|NCT01322009|University of Pittsburgh|Robert Clark|412-692-7260|clarkrs@ccm.upmc.edu
115098|NCT01322022|Children's Hospital of Pittsburgh/University of Pittsburgh|Dr. Cynthia Johnson|412-692-8404|cynthia.rheney.johnson@gmail.com
115099|NCT01322048|Vanderbilt University Medical Center|Mayur B. Patel|6153225000|mayur.b.patel@vanderbilt.edu
115100|NCT01322347|Rockwell Medical|Senior Director, Clinical Research & Development|248-960-9009|rd@rockwellmed.com
115101|NCT01322360|Roxane Laboratories, Inc|Anton (Tony) Amann, PhD, Executive Director, Drug Regulatory and Medical Affairs|614-272-4785|Tony.Amann@boehringer-ingelheim.com
115102|NCT01322386|Stanford University|Kenneth L Cox, MD / Principal Investigator|650-723-5070|KCox@stanfordchildrens.org
115103|NCT01328366|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110|
115104|NCT01328379|Acorda Therapeutics|Vice President - Clinical Development & Medical Affairs|(914) 347- 4300 ext 5138|hhenney@acorda.com
115105|NCT01328405|University of Wisconsin School of Medicine and Public Health|Dr. Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu
115106|NCT01328431|Yale University|Steven L. Bernstein, MD|203-737-3574|steven.bernstein@yale.edu
115108|NCT01328496|St. Jude Children's Research Hospital|Amr Qudeimat, MD|901-595-8342|amr.qudeimat@stjude.org
115109|NCT01328548|McMaster University|Dr. Mark Loeb|905 515 9140 ext 26679|loebm@mcmaster.ca
115110|NCT01328574|National Cancer Institute|Dr. Andrea Apolo|301-451-1984|apoloab@mail.nih.gov
115111|NCT01329185|University of Minnesota|Dr. Priya Verghese, Director of Pediatric Kidney Transplantation|6126262922 ext 0|pverghes@umn.edu
115112|NCT01329198|University of Florida Center for Movement Disorders & Neurorestoration|Assistant Director of Clinical Trials|352-294-5000|stacy.merritt@neurology.ufl.edu
115113|NCT01329263|University of Pennsylvania|Dr. Andrew Strasser|2157465788|strasse3@mail.med.upenn.edu
115114|NCT01329419|GlaxoSmithKline|GSK Response Center|866-435-7343|
115115|NCT01329549|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
115116|NCT01329562|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cady|417-890-7888|jtarrasch@clinvest.com
115117|NCT01329679|DavidGrant|Sachin Shah|707-423-3277|sshah@pacific.edu
115118|NCT01329848|Western University of Health Sciences|Dr. Chris Chase|909 706-3882|cchase@westernu.edu
115119|NCT01329939|North Shore - Long Island Jewish Health System; Hofstra North Shore-LIJ School of Medicine|Dr. Sherry Farzan, Attending Physician, Assistant Professor of Medicine and Pediatrics|5166225070|sfarzan@nshs.edu
115120|NCT01329978|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
115121|NCT01330017|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
115122|NCT01330030|Stanford University|Dr Joel D Killen|650-723-5895|jkillen@stanford.edu
115123|NCT01330043|Stanford University|Dr. Sean P. David|401-265-2275|spdavid@stanford.edu
115124|NCT01330108|University of Alabama at Birmingham|Robert C Bourge|205-934-3624|bbourge@uab.edu
115125|NCT01330290|UCB|UCB Clinical Trials Call Center|+1 877 822 9493|
115126|NCT01330303|GlaxoSmithKline|GSK Response Center|866-435-7343|
115127|NCT01330316|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
115128|NCT01330355|Valeant Pharmaceuticals|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com
115129|NCT01330381|Shire Development LLC|Study Physician|+1 866 842 5335|
115130|NCT01330394|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 7775-7337|emnpalacios@gmail.com
115132|NCT01330433|Loma Linda University, Dept of Cardiovascular and Thoracic Surgery|Research Coordinator|909-558-4355|vayermiller@llu.edu
115133|NCT01330628|Spectranetics|Amanda Johnson, VP of Regulatory & Medical Affairs|(719) 447-2000|amanda.johnson@spnc.com
115134|NCT01330914|San Francisco Veterans Affairs Medical Center|Dr. Anne Schafer|(415) 221-4810 ext 24895|anne.schafer@va.gov
115135|NCT01331005|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrnet@jaeb.org
115136|NCT01331109|Forest Research Institute|Robert Palmer, MD|1-201-427-8200 ext 8218|robert.palmer@frx.com
115138|NCT01331213|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu
115139|NCT01331291|Massachusetts General Hospital|Tracy T. Batchelor, MD|617-643-1938|tbatchelor@mgh.harvard.edu
115141|NCT01331681|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
115142|NCT01331694|GlaxoSmithKline|GSK Response Center|866-435-7343|
115143|NCT01325428|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com
115144|NCT01325493|Children's National Health System|Julia Finkel|2024764867|JFINKEL@childrensnational.org
115145|NCT01325532|Massachusetts General Hospital, Dept of Psychiatry|Dr David Mischoulon|617-724-5198|dmischoulon@partners.org
115146|NCT01325623|Cyberonics Europe BVBA|Wim Van Grunderbeek, Clinical Operations Manager Cyberonics Europe|+32 2 720 95 93 ext 312|wim.vangrunderbeek@cyberonics.com
115147|NCT01325701|Pharmacyclics, Inc.|Dr. Darrin Beaupre|855-427-8846|medinfo@pcyc.com
115148|NCT01331824|Icahn School of Medicine at Mount Sinai|Dr. Matthew D. Galsky|212-241-6756|matthew.galsky@mssm.edu
115149|NCT01331837|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
115150|NCT01332019|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
115151|NCT01333111|Novo Nordisk A/S|Global Clinical Regstry (GCR, 1452)||clinicaltrials@novonordisk.com
115152|NCT01333189|University of Colorado, Denver|Cory L Christiansen, PT, PhD|303-724-9101|cory.christiansen@ucdenver.edu
115153|NCT01333397|Ipsen|Medical Director|clinical.trials@ipsen.com|clinical.trials@ipsen.com
115154|NCT01333436|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115155|NCT01333475|National Cancer Institute|Dr. Shivaani Kummar|301-435-0517|kummars@mail.nih.gov
115156|NCT01333488|Memorial Healthcare System|Dr Greg Zorman|954 265 1840|csareli@mhs.net
115157|NCT01333501|Novartis Pharmaceuticals|Study Director|862-778-8300|
115158|NCT01333592|Kissei Pharmaceutical Co., Ltd|Clinical Development Division||rinsyousiken@pharm.kissei.co.jp
115159|NCT01333722|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
115160|NCT01333813|GlaxoSmithKline|GSK Response Center|866-435-7343|
115161|NCT01333865|Massachusetts General Hospital|Gagan Joshi, MD|617-724-2344|joshi.gagan@mgh.harvard.edu
115162|NCT01333956|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu
115163|NCT01334125|University of Massachusetts Medical School|Benjamin U. Nwosu, MD|5083347872|Benjamin.Nwosu@umassmemorial.org
115164|NCT01334216|Indiana University School of Medicine|Stephen M. Downs, MD, MS|3172780552 ext 317|stmdowns@iu.edu
115165|NCT01334229|Laval University|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca
115166|NCT01334515|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org
115167|NCT01334554|Vanderbilt University Medical Center|Cyndya A. Shibao|6159364584|cyndya.shibao@vanderbilt.edu
115168|NCT01334606|BD Medical - Diabetes Care|Laurence J. Hirsch. Medical Director|201-847-6513|laurence_hirsch@bd.com
115170|NCT01334723|GlaxoSmithKline|GSK Response Center|866-435-7343|
115171|NCT01334866|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com
115172|NCT01334918|Astellas Scientific and Medical Affairs, Inc. / Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Affairs||ClinicalTrials.Disclosure@us.astellas.com
115173|NCT01334944|Cumberland Pharmaceutical Inc.|Dr. Amy Rock|615-255-0068|arock@cumberlandpharma.com
115174|NCT01334957|Cumberland Pharmaceuticals Inc.|Dr. Amy Rock|615-255-0068|arock@cumberlandpharma.com
115175|NCT01335061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115176|NCT01335191|Thymon LLC|Dr. Gideon Goldstein|(973) 467-9558|gidgold@gmail.com
115177|NCT01335230|University of Cincinnati, Associate Prof., PI.|Mohamed Tarek M. shata|(513) 558-6110|mohamed.shata@uc.edu
115178|NCT01335308|University of Michigan|Ken Resnicow|734 647 0212|kresnic@umich.edu
115179|NCT01335464|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
115180|NCT01335477|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
115181|NCT01328717|Ascensia Diabetes Care|Dr. Daniel Brown|574-256-7754|daniel.brown@ascensia.com
115182|NCT01328756|Shire|Study Physician|1 866-842-5335|
115183|NCT01328769|University of Utah|Paul Hopkins|801-585-8139|paul.hopkins@utah.edu
115184|NCT01328782|Children's Hospital Colorado|Gaia Georgopoulos, MD|720-777-2588|Gaia.Georgopoulos@childrenscolorado.org
115185|NCT01328873|Northside Hospital|H. Kent Holland, MD|404-255-1930|kholland@bmtga.com
115186|NCT01328951|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
115187|NCT01328964|GlaxoSmithKline|GSK Response Center|866-435-7343|
115188|NCT01329029|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
115189|NCT01335542|Hospital for Special Surgery|Dr. Jacques YaDeau|2127742224|yadeauj@hss.edu
115191|NCT01335724|Novartis Consumer Health|Clinical project Leader|+41223635528|
115192|NCT01335750|Erdy/Searcy Group|Dr. Gary Andrasko, MS|(614) 459-3363|gandrask@columbus.rr.com
115193|NCT01335789|Medical University of South Carolina|Aimee McRae-Clark, Pharm.D., BCPP|843-792-5216|mcraeal@musc.edu
115194|NCT01335932|FHCRC|Dr.Michael Boeckh|206 667-6706|mboeckh@fredhutch.org
115196|NCT01335997|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115197|NCT01336023|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com
115198|NCT01336140|Rush University Medical center|Rami Doukky|312-942-4655|rami_doukky@rush.edu
115199|NCT01336205|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
115200|NCT01336296|UCincinnati|Research Associate Professor|5135852145|adele.rike@uc.edu
115201|NCT01336569|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Medical Affairs Leader, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com
115203|NCT01336647|Hatchtech Pty Ltd|Clinical Manager|+61 3 9092 0490|tahveninen@hatchtech.com.au
115204|NCT01336712|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD (Principal Investigator)|404-255-1930|ssolomon@bmtga.com
115205|NCT01336738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115206|NCT01336764|National Center for PTSD|Steven H. Woodward, PhD|650-493-5000 ext 22111|steve.woodward@va.gov
115207|NCT01336894|Boston Medical Center|Hiran C. Fernando, MD|617-638-5600|hiran.fernando@bmc.org
115208|NCT01336972|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974|
115209|NCT01337050|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115210|NCT01337076|Mayo Clinic, Rochester|Dr. Colin Driscoll|507 266 1965|driscoll.colin@mayo.edu
115211|NCT01337115|Centro Hospitalar do Porto|Dr Raul Carvalho|+351226176114|raul@meo.pt
115212|NCT01337167|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115213|NCT01337297|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 7775-7337|emnpalacios@gmail.com
115214|NCT01337336|GlaxoSmithKline|GSK Response Center|866-435-7343|
115215|NCT01337609|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-2513|mfava@partners.org
115216|NCT01337635|Medical College of Wisconsin|Yvonne Chiu, MD|414-955-2818|ychiu@mcw.edu
115217|NCT01337674|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115218|NCT01337739|Northwestern University|Paul Fitzgerald|312-472-3539|p-fitzgerald2@northwestern.edu
115219|NCT01337960|VA Maryland Health Care System|Larry Forrester, PhD|410-637-3241|Larry.Forrester@va.gov
115220|NCT01338012|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com
115221|NCT01338025|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org
115222|NCT01338493|Medtronic Spinal & Biologics|Cristina Faria|+41 (0)21 802 70 00|cristina.faria@medtronic.com
115223|NCT01332071|GlaxoSmithKline|GSK Response Center|866-435-7343|
115224|NCT01332123|university of pittsburgh|Goeran Fiedler|4126246475|gfiedler@pitt.edu
115225|NCT01332149|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115226|NCT01332188|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com
115227|NCT01332227|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
115228|NCT01332253|Senior Manager, Clinical Operations|Byron Kaelin|615-255-0068 ext 250|bkaelin@cumberlandpharma.com
115229|NCT01332292|GlaxoSmithKline|GSK Response Center|866-435-7343|
115230|NCT01332305|XenoPort, Inc.|XenoPort Call Center|877-936-6778|
115231|NCT01332318|XenoPort, Inc.|XenoPort Call Center|877-936-6778|
115232|NCT01332357|GlaxoSmithKline|GSK Response Center|866-435-7343|
115233|NCT01332435|GlaxoSmithKline|GSK Response Center|866-435-7343|
115234|NCT01332461|GlaxoSmithKline|GSK Response Center|866-435-7343|
115235|NCT01332487|GlaxoSmithKline|GSK Response Center|866-435-7343|
115236|NCT01332500|GlaxoSmithKline|GSK Response Center|866-435-7343|
115237|NCT01332578|GlaxoSmithKline|GSK Response Center|866-435-7343|
115238|NCT01332721|TRACON Pharmaceuticals|Dr Charles Theuer|8585500780 ext 233|ctheuer@traconpharma.com
115239|NCT01332968|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
115240|NCT01332981|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
115241|NCT01332994|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
115242|NCT01338610|Alcon Research, Ltd.|Christian Leisner|1-888-451-3937|alcon.medinfo@alcon.com
115243|NCT01338636|Brigham and Women’s Hospital Heart and Vascular Center|Aaron B. Waxman|617-525-9733|abwaxman@partners.org
115244|NCT01338649|Northwestern University|Aleksandar Videnovic|3126234033|aleksvidenovic@gmail.com
115245|NCT01338792|USC Norris Comprehensive Cancer Center|Jacek Pinski, MD|323-865-3900|pinski_j@ccnt.usc.edu
115246|NCT01338818|Novartis Pharmaceuticals|Study Director|8627788300|
115247|NCT01338857|New York University Langone Medical Center|Matthias A. Karajannis, MD|212-263-9630|matthias.karajannis@nyumc.org
115248|NCT01338870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115249|NCT01339247|GlaxoSmithKline|GSK Response Center|866-435-7343|
115250|NCT01339260|Helsinn Healthcare SA|Head of Clinical Development|+41 91 9852121|marco.palmas@helsinn.com
115251|NCT01339299|Fertility Clinic Regional Hospital Skive|Prof, M.D. Peter Humaidan|+45 78445760|peter.humaidan@viborg.rm.dk
115252|NCT01339390|Clement J. Zablocki VA Medical Center|Dr. Jeff Whittle|(414) 384-2000 ext 46444|jeffrey.whittle@va.gov
115253|NCT01339403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115254|NCT01339416|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115255|NCT01339429|Brigham and Women's Hospital|Dr. Gita Mody|617-921-8221|gmody@partners.org
115256|NCT01339832|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
115257|NCT01339897|N30 Pharmaceuticals Inc.|Janice M Troha|720-945-7714|janice.troha@n30pharma.com
115258|NCT01339923|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
115259|NCT01339936|Optometric Technology Group|Dr Michel Guillon|+44 2072224224|mguillon@otg.co.uk
115260|NCT01340014|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com
115261|NCT01340027|Astellas Pharma Europe, B.V.|Medical Director||Astellas.resultsdisclosure@astellas.com
115262|NCT01340066|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144|
115263|NCT01340144|Colorado Joint Replacement|Raymond Kim, MD|720-524-1367|raymondkim@ccentura.org
115264|NCT01340196|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
115265|NCT01340209|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
115267|NCT01340573|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
115268|NCT01340586|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
115269|NCT01340625|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
115270|NCT01340651|Incyte Corporation|Study Director|855 463-3463|
115271|NCT01340664|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 908 927-5775|
115272|NCT01340768|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115273|NCT01340794|Mayo Clinic Cancer Center|Keith Bible, M.D., Ph.D.||bible.keith@mayo.edu
115274|NCT01340937|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115275|NCT01341067|Rocky Mountain Diabetes and Osteoporosis Center|Mark Sulik, PharmD CCRP|208-528-9642|mark@idahomed.com
115276|NCT01341444|Medstar Georgetown University Hospital|Dr. Matthew Cooper|202-444-0753|Matthew.Cooper@gunet.georgetown.edu
115277|NCT01341600|University of Maryland School of Medicine|Richard Horenstein M.D., Associate Professor of Medicine|410-706-0154|rhorenst@medicine.umaryland.edu
115278|NCT01335867|University of Pennsylvania Treatment Research Center|Kyle M. Kampman, M.D.|2152223200 ext 109|kampman@mail.med.upenn.edu
115279|NCT01341782|Abbvie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
115280|NCT01341912|Octapharma|VP of Clinical Research and Development|+41 554512141|sigurd.knaub@octapharma.com
115281|NCT01341977|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
115282|NCT01342094|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp
115283|NCT01342107|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com
115284|NCT01342172|Icahn School of Medicine at Mount Sinai|Dr. Matthew Galsky|212-241-8816|matthew.glasky@mssme.edu
115285|NCT01342341|Ernest Gallo Clinic and Research Center|Dr. Jennifer Mitchell, Clinical Project Director|510-985-3921|jmitchell@gallo.ucsf.edu
115286|NCT01342445|University of Rhode Island|Dr. Lisa Weyandt|(401)874-2087|lisaweyandt@uri.edu
115287|NCT01342458|University of Sao Paulo|Dr. Francis Trombini-Souza|55 11 3091 8426|trombinisouza@usp.br
115288|NCT01342471|National Cancer Institute|Jeremy Steeves Ph.D.|(865)-308-3506|jeremy.steeves@nih.gov
115289|NCT01342484|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
115290|NCT01342510|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|Dr. Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu
115291|NCT01342523|University of Wisconsin|Stevens Smith, PhD|608-262-7563|sss@ctri.wisc.edu
115292|NCT01342549|Michael E. DeBakey VAMC|Dr. Ricardo Jorge|713-794-7010|ricardo.jorge@va.gov
115293|NCT01342640|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
115294|NCT01342666|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (INCMNSZ)|Favorable effect of tomato consumption on HDL-c serum levels|525555133891|shiverqks@hotmail.com
115297|NCT01342887|Fred Hutch Cancer Research Center|Roland B. Walter, MD, PhD, MS||rwalter@fredhutch.org
115298|NCT01342913|GlaxoSmithKline|GSK Response Center|866-435-7343|
115299|NCT01342926|GlaxoSmithKline|GSK Response Center|866-435-7343|
115300|NCT01342965|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
115301|NCT01343004|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com
115302|NCT01343056|University of Pittsburgh|Linda Siminerio, PhD|412-864-0158|simineriol@upmc.edu
115303|NCT01343082|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp
115304|NCT01343251|St John Hospital and Medical Center|Dr. Robert Provenzano|313-886-8787|Rprovenzano@scsp.net
115305|NCT01343277|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com
115307|NCT01343485|Planned Parenthood Federation of America|Zoe Unger, Research Program Coordinator|212-261-4702|zoe.unger@ppfa.org
115308|NCT01343667|W. L. Gore & Associates|Bryan Randall, Clinical Biostatistician|928-864-4832|BRandall@WLGore.com
115309|NCT01343823|Shire Development LLC|Study Physician|+1 866 842 5335|
115310|NCT01343888|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
115311|NCT01343901|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
115312|NCT01344057|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
115313|NCT01344161|Tehran University of Medical Sciences|Dr.Farzad Shidfar|09123082922|f-shidfar@tums.ac.ir
115314|NCT01344369|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
115315|NCT01344447|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
115316|NCT01344460|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
115317|NCT01344538|University of Michigan|Suzanna M Zick|734-998-9553|szick@umich.edu
115318|NCT01339000|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@mail.nih.gov
115319|NCT01339013|Region Skane, Lund University Hospital, Lund, Sweden|Dr Louise Walther Sturesson|+46 46 171953|louise.waltersturesson@skane.se
115321|NCT01339091|Durata Therapeutics|Michael Zelasky|203-871-4616|mzelasky@duratatherapeutics.com
115322|NCT01344616|PHCC LP|James G. Christian|7195468633|jim@phcclp.com
115323|NCT01344629|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
115324|NCT01344759|Cincinnati Children's Hosptial Medical Center|Dr. Mohamed Mahmoud|513-636-4408|Mohamed.Mahmoud@cchmc.org
115326|NCT01344876|Otsuka Pharmaceutical Co., Ltd|Leader of Department of “Small Global” Clinical Development|+81-3-6361-7366|
115327|NCT01345240|GlaxoSmithKline|GSK Response Center|866-435-7343|
115329|NCT01345292|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com
115330|NCT01345318|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115331|NCT01345591|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu
115332|NCT01345630|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115333|NCT01345682|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
115334|NCT01345721|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
115335|NCT01345786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
115336|NCT01345929|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com
115337|NCT01346059|Beaumont Health|Rose Callahan|248 551-5147|rose.callahan@beaumont.org
115338|NCT01346072|University of North Carolina Chapel Hill|Kirkwood F. Adams, Jr., MD|919-966-2877|kfa@med.unc.edu
115339|NCT01346085|Ospedale San Raffaele|Dr Lorenzo Piemonti|+390226432706|piemonti.lorenzo@hsr.it
115340|NCT01346176|University of Pennsylvania School of Medicine|Scott D. Halpern|215.573.9461|elcooney@exchange.upenn.edu
115341|NCT01346293|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
115342|NCT01346397|Boris Petrovsky research cener od surgery|Dr Michael Kaabak|+74992481344|kaabak@hotmail.com
115343|NCT01346475|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu
115344|NCT01346488|AbbVie|Global Medical Information|800-633-9110|
115345|NCT01346501|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|
115346|NCT01346514|VA Puget Sound|Carol Malte|206.277.3780|carol.malte@va.gov
115347|NCT01346592|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
115348|NCT01346774|University of Michigan|Betsy Foxman, Hunein F. and Hilda Maassab Professor of Epidemiology|734-764-5487|bfoxman@umich.edu
115349|NCT01346839|Michael E. DeBakey VA Medical Center and Baylor College of Medicine|Dr. Hardeep Singh|713-794-8515|hardeeps@bcm.edu
115350|NCT01346852|GlaxoSmithKline|GSK Response Center|866-435-7343|
115351|NCT01347008|Federal University of Sao Paulo|Fernando Villela Andrigueti, MD|+55 11 55764239|fernando.andrigueti@usp.br
115352|NCT01347034|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-3050|alberto.chiappori@moffitt.org
115353|NCT01347060|GlaxoSmithKline|GSK Response Center|866-435-7343|
115354|NCT01347073|Hyperion Therapeutics, Inc.|Craig James R.N. Associate Dir. UCD Clinical Operations|(650) 745- 7480|craig.james@hyperiontx.com
115355|NCT01347086|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
115356|NCT01347112|Mayo Clinic|Dr. Richard Hurt|507-284-7313|rhurt@mayo.edu
115357|NCT01347255|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com
115358|NCT01347554|Yonsei University Wonju College of Medicine|Dr. Seung-Hwan Lee|+82-33-741-0920|carshlee@yonsei.ac.kr
115359|NCT01347580|AstraZeneca|Dr Tomas Andersson MD|00 46 31 77 61966|tomas.lg.andersson@astrazeneca.com
115361|NCT01341990|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com
115362|NCT01342081|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp
115363|NCT01347710|Lantheus Medical Imaging|CMO|978-671-8544|c.orlandi@lantheus.com
115364|NCT01347788|Massachusetts General Hospital|Matthew R Smith, MDPhD|617-763-3748|smith.matthew@mgh.harvard.edu
115365|NCT01345058|Brigham and Women's Hospital|Jong Woo Lee, MD, PhD||JLEE38@BWH.HARVARD.EDU
115366|NCT01345123|Health Dialog|David R Veroff, MPP, SVP Analytic Development|617-406-5219|dveroff@healthdialog.com
115367|NCT01345162|IRCCS Policlinico S Matteo|Dr Massimo Allegri|00390382502627|massimo.allegri@unipv.it
115369|NCT02800213|San Antonio Uniformed Services Health Education Consortium|Dr. Michael D. April|2109160808 ext 210|Michael.D.April@post.harvard.edu
115375|NCT02600767|CDC|Alexandre Macedo de Oliveira|404 718 4751|acq7@cdc.gov
115378|NCT02551224|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
115379|NCT02524158|VA San Diego|Dr. Erik J. Groessl|858-552-8585 ext 6347|erik.groessl@va.gov
115383|NCT02374593|Riley Hospital for Children|Dr. Erica Eugster|317 944-3889|eeugster@iu.edu
115384|NCT02369341|GlaxoSmithKline|GSK Response Center|866-435-7343|
115387|NCT02256436|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115395|NCT01908829|Astellas Pharma Europe Ltd|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com
115396|NCT01884597|Retina Consultants of Hawaii, Inc.|Gregg Kokame, MD|(808) 487-8928|retinahi@aol.com
115399|NCT01767506|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu
115400|NCT01740297|Amgen Inc.|Study Director|866-572-6436|
115401|NCT01717209|Stanford University|Charles Hill|(650) 725-1930|chill1@stanford.edu
115403|NCT01693653|NYU Langone Medical Center, Center for Musculoskeletal Care|Yusuf Yazici|646-501-7400|yusuf.yazici@nyumc.org
115406|NCT01682044|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
115408|NCT01646177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
115412|NCT01576055|W.L. Gore & Associates|Thomas Sabin|928-864-3153|tsabin@wlgore.com
121258|NCT02023151|Johns Hopkins University|Sarbjit Saini|4105502191|ssaini@jhmi.edu
115416|NCT01465997|Cares|UCB|+1844 599 ext 2273|
115418|NCT01439165|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
115419|NCT01390948|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com
115420|NCT01383928|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
121261|NCT01998399|Vanderbilt University|Gordon Bernard, Professor of Medicine, Associate Vice Chancellor for Research|615-343-0077|gordon.bernard@Vanderbilt.Edu
121262|NCT01978314|University of Alabama, Birmingham|Dana Victor Rizk, M.D.||drizk@uab.edu
121266|NCT01957137|Pelvic Health and Gastric Therapies|Rachael McNamara / Clinical Research Specialist|763.526.8107|rachael.m.mcnamara@medtronic.com
115427|NCT01252095|Progen Pharmaceuticals Ltd|Director of Clinical Development|+61 7 32739133|
115428|NCT01244477|Michael E DeBakey VAMC|Wright Williams, PhD, ABPP|713-794-7629|wright.williams@va.gov
115429|NCT01225887|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org
121267|NCT01948310|Duke Medical Center|Leslie Willis|9196606782|leslie.willis@duke.edu
121269|NCT01937507|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com
115435|NCT00953225|Ralph H. Johnson VA Medical Center|Sebastiano Gattoni-Celli, M.D.|843-876-5103|gatttonis@musc.edu
115437|NCT00903409|GlaxoSmithKline|GSK Response Center|866-435-7343|
115438|NCT00892775|GlaxoSmithKline|GSK Response Center|866-435-7343|
115439|NCT00878709|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com
115441|NCT00848744|Northwestern University|Lori Asztalos|312-227-6486|masztalos@luriechildrens.org
115442|NCT00842153|GlaxoSmithKline|GSK Response Center|866-435-7343|
115443|NCT00833859|H. Lee Moffitt Cancer Center and Research Institute|Gregory Springett, M.D., Ph.D., via Moffitt Cancer Center|813-745-6898|gregory.springett@moffitt.org
115444|NCT00793611|University of New Mexico Health Sciences Center and CTSC|Yuko Komesu MD|505-925-4395|ykomesu@salud.unm.edu
115445|NCT00720096|H. Lee Moffitt Cancer Center and Research Institute|Robert Wenham, M.D., via Moffitt Cancer Center|813-745-4933|robert.wenham@moffitt.org
115446|NCT00718328|Johns Hopkins University SOM (former employer during the study)|Neeraj Naval|9042026290|neerajnaval@gmail.com
115447|NCT00703092|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu
115450|NCT00676052|GlaxoSmithKline|GSK Response Center|866-435-7343|
115455|NCT00575159|GlaxoSmithKline|GSK Response Center|866-435-7343|
115456|NCT00461591|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com
119602|NCT02570126|GlaxoSmithKline|GSK Response Center|866-435-7343|
115463|NCT03054077|Virginia Commonwealth University|Debra Shockey|804-828-3744|dpshockey@vcu.edu
115464|NCT02786927|GlaxoSmithKline|GSK Response Center|866-435-7343|
119608|NCT02411578|Jaeb Center for Health Research|Stephanie DuBose|813-975-8690|t1dstats2@jaeb.org
115466|NCT02686437|Sport and Spine Rehab Clinical Research Foundation|Jena Etnoyer-Slaski|301-251-2777 ext 838|jslaski@ssrehab.com
115467|NCT02681510|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu
115468|NCT02667821|Canadian Memorial Chiropractic College|Dr. Nicholas Moser|416-482-2340 ext 319|nmoser@cmcc.ca
115469|NCT02586506|GlaxoSmithKline|GSK Response Center|866-435-7343|
115471|NCT02401256|Indiana University School of Medicine|Dr. Zeruesenay Desta|3172742823|zdesta@iu.edu
115472|NCT02387996|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
115473|NCT02387749|Cairo university, faculty of medicine|Dina Mohammed Riad Ebrahim Abdelmagid|+201112052600|drdina_m@hotmail.com
115475|NCT02275052|GlaxoSmithKline|GSK Response Center|866-435-7343|
115476|NCT02236611|GlaxoSmithKline|GSK Response Center|866-435-7343|
115477|NCT02229487|Ramathibodii Hospital, Mahidol University|Sirimon Reutrakul|66922011647 ext 708|sreutrakul@yahoo.com
115482|NCT02164539|GlaxoSmithKline|GSK Response Center|866-435-7343|
115484|NCT02162979|Loma Linda University|Tonya Hamilton, reszearch Compliance Auditor|909-558-4908|thamilton@llu.edu
115485|NCT02091869|University of Arkansas for Medical Sciences|Dr. Tamara T. Perry|501-364-1538 ext 41538|perrytamarat@uams.edu
115486|NCT02068157|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org
115489|NCT01980888|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
119617|NCT02242643|GlaxoSmithKline|GSK Response Center|866-435-7343|
119627|NCT01857297|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com
119628|NCT01827839|GlaxoSmithKline|GSK Response Center|866-435-7343|
115504|NCT01685242|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com
115507|NCT01649856|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
115512|NCT01597791|Northwerstern University|Jeanette Bauchat, M.D.|312-472-3585|j-bauchat@northwestern.edu
115514|NCT01550757|US Department of Veterans Affairs|Thomas O'Toole, MD|(401) 273-7100 ext 6359|thomas.otoole@va.gov
115517|NCT01514760|University of Arkansas for Medical Sciences|Dr. Tamara T. Perry|501-364-3264 ext 43264|perrytamarat@uams.edu
115526|NCT01376323|GlaxoSmithKline|GSK Response Center|866-435-7343|
119644|NCT01591837|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com
115535|NCT01342211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115538|NCT01328444|GlaxoSmithKline|GSK Response Center|866-435-7343|
115539|NCT01313637|GlaxoSmithKline|GSK Response Center|866-435-7343|
119652|NCT01448707|Janssen Research & Development, LLC|EMEA Medical Affairs Program Lead||ClinicalTrialDisclosure@its.jnj.com
119656|NCT01366534|GlaxoSmithKline|GSK Response Center|866-435-7343|
119661|NCT01295320|GlaxoSmithKline|GSK Response Center|866-435-7343|
119667|NCT01165203|GlaxoSmithKline|GSK Response Center|866-435-7343|
119675|NCT00939367|Accutest Research Laboratories Pvt. Ltd.|Kedar Joshi|+91 22 27780718|
119676|NCT00940108|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com
119677|NCT00938639|CSL Limited|Clinical Trial Disclosure Manager|Use email contact|csl.clinicaltrials@csl.com.au
115561|NCT01086384|GlaxoSmithKline|GSK Response Center|866-435-7343|
115564|NCT01061671|University of Minnesota|Sarah Lindberg|612-626-9011|sharnden@ccbr.umn.edu
119683|NCT00888381|Seqirus|Clinical Study Disclosure Manager|Use email contact|Seqirus.ClinicalTrials@Seqirus.com
119687|NCT00829010|GlaxoSmithKline|GSK Response Center|866-435-7343|
119688|NCT00825162|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com
115578|NCT00936910|Children's Hospital of Pittburgh|Dr. William McGhee, Clinical Pharmacy Specialist, Transplant|412-692-5733|william.mcghee@chp.edu
119696|NCT00735475|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com
115587|NCT00858702|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com
119710|NCT00336232|Tufts University|Sarah Booth, PhD|617-556-3231|sarah.booth@tufts.edu
119715|NCT00314327|NSLIJ|Delbert Robinson, M.D.|718-470-8195|Drobinson@nshs.edu
121270|NCT01934192|GlaxoSmithKline|GSK Response Center|866-435-7343|
121273|NCT01922037|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
121277|NCT01896115|Boston Scientific|Stephen Carcieri, PhD|661-949-4756|Stephen.Carcieri@bsci.com
121278|NCT01890694|NYU Langone Medical Center|Office of Clinical Trials|646-754-7431|clinicaltrials@nyumc.org
121280|NCT01876784|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
121283|NCT01833169|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com
121284|NCT01819844|Massachusetts General Hospital|Steven J. Russell|617-726-8722|sjrussell@partners.org
121285|NCT01813474|AstraZeneca|Medical Director||ClinicalTrialTransparency@astrazeneca.com
121289|NCT01777334|GlaxoSmithKline|GSK Response Center|866-435-7343|
121290|NCT01771666|Stanford University|Dr. Irene Wapnir|650-724-1953|Wapnir@stanford.edu
121291|NCT01769456|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com
121293|NCT01765179|Clarus Therapeutics|Sr. VP Clinical and Medical Affairs|847-562-4300|tdanoff@clarustherapeutics.com
121294|NCT01753713|Case Comprehensive Cancer Center|Manmeet Ahluwalia, MD|216-844-5060|ahluwam@ccf.org
121296|NCT01713998|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com
121297|NCT01713933|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com
121298|NCT01713686|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com
121300|NCT01708525|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com
121301|NCT01705587|University of Pittsburgh|Susan Greenspan, MD|412-692-2477|greenspn@pitt.edu
121302|NCT01703208|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com
121305|NCT01685840|Duke University Health System|G. Michael Felker, M.D.|919-668-8919|michael.felker@duke.edu
121306|NCT01671839|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com
121307|NCT01669434|University of Nebraska Medical Center|Dr. Jason Shiffermiller|402-559-7299|jshiffermiller@unmc.edu
121309|NCT01656460|Brown University Oncology Research Group (BrUOG)|Thomas DiPetrillo, MD|4018633000|kayla_rosati@brown.edu
121310|NCT01655069|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 71 5455 050|Astellas.resultsdisclosure@astellas.com
121315|NCT01622348|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com
119728|NCT02690727|Algorithme Pharma Inc.|Dr. Eric Sicard|(514) 858-6077|esicard@algopharm.com
119729|NCT02683577|Ipsen Pharma|Medical Director||clinical.trials@ipsen.com
119731|NCT02657252|UPECLIN|Dr. Matheus Bertanha|+551438116305|matheus.fameca@ig.com.br
119734|NCT02532179|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
119735|NCT02474589|SIGA Technologies|Dennis E Hruby, PhD, Chief Scientific Officer|541-753-2000|dhruby@siga.com
115622|NCT00657709|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
119736|NCT02473471|Jordanian University of science and Technology|Dr.Amal Alkebsi|00966552358684|amalkibsi@gmail.com,aalkebsi13@den.just.edu.jo
115630|NCT00605839|Indiana University School of Medicine|Aaron E. Carroll|3172780552|aaecarro@iupui.edu
119746|NCT02260791|Fujifilm Kyowa Kirin Biologics Co., Ltd., EU Branch|Clinical Trial Information|+44 1896 668 173|Clinical-Trials@fk-b.com
119748|NCT02233101|Rush University Medical Center|Craig J. Della Valle, MD|312-432-2350|craigdellavalle@rushortho.com
119769|NCT01631656|WakeForest University Health Sciences|Dr Amy McMichael|336-716-3775|amcmicha@wakehealth.edu
119773|NCT01558661|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org
119776|NCT01500109|Loma Linda University|Chelan Nour, MD|909-558-8493|cnour@llu.edu
119779|NCT01385748|Onxeo|Berangere Vasseur, MD|+33 (0)1 45 58 76 00|b.vasseur@onxeo.com
119798|NCT00929669|University of Pennsylvania|Peter J. Snyder, MD|215-898-0208|pjs@mail.med.upenn.edu
115688|NCT00250484|Beth Israel Deaconess|Steven D. Freedman, MD Phd|631-667-2132|sfreedma@bidmc.harvard.edu
119807|NCT00796822|Indiana University School of Medicine|Dr. Samir K. Gupta|317-274-7926|sgupta1@iu.edu
119810|NCT00743730|Medical College of Wisconsin|Keri R. Hainsworth, PhD, Research Director|414-266-6306|khainswo@mcw.edu
119811|NCT00736645|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org
119812|NCT00675415|Cleveland Clinic|Dr. John Vargo|(216) 445-5012|vargoj@ccf.org
119816|NCT00526890|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
115706|NCT00083174|Massachusetts General Hospital|Dr. Paul Goss|617-724-3118|pgoss@partners.org
115709|NCT00066573|NCIC Clinical Trials Group|Dr. Wendy Parulekar|1-613-533-6430|wparulekar@ctg.queensu.ca
119819|NCT00470366|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman, MD|646-422-4491|feldmand@mskcc.org
119821|NCT00412360|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com
119822|NCT00381797|St. Jude Children's Research Hospital|Shengjie Wu|(901) 595-2859|shengjie.wu@stjude.org
119824|NCT00348309|GlaxoSmithKline|GSK Response Center|866-435-7343|
119830|NCT00262847|Gynecologic Oncology Group (GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org
119833|NCT00186628|Stanford University Medical Center|David Miklos, MD, PhD; Associate Professor of Medicine (Blood and Marrow Transplantation)|650-725-4626|dmiklos@stanford.edu
119836|NCT00075816|The EMMES Corporation|Adam Mendizabal|301-251-1161|amedizabal@EMMES.com
119838|NCT00053365|Gynecologic Oncology Group|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org
121316|NCT01615029|Janssen Research & Development, LLC|Senior Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com
121319|NCT01578239|Advanced Accelerator Applications|Paola Santoro, Ph.D., Senior Clinical Study Manager|917-854-1313|paola.santoro@adacap.com
121320|NCT01565941|Boston Children's Hospital|Dr. Michael Agus|617-355-5849|michael.agus@childrens.harvard.edu
121322|NCT01543178|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com
121324|NCT01540513|University of Wisconsin Carbone Cancer Center|Dr. Lance Hall|608-263-5585|lhall@uwhealth.org
121325|NCT01532362|Jonsson Comprehensive Cancer Center: University of California at Los Angeles|Dr. Jay Moon Lee|(310) 794-7333|jaymoonlee@mednet.ucla.edu
121326|NCT01519206|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com
121329|NCT01440816|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com
121330|NCT01439373|GlaxoSmithKline|GSK Response Center|866-435-7343|
121331|NCT01428219|University of Michigan Comprehensive Cancer Center|Dr. David C. Smith, M.D.|734-764-3066|dcsmith@umich.edu
121335|NCT01412710|Florida International University|Fatma G. Huffman|305-348-3877|huffmanf@fiu.edu
121336|NCT01412541|CR Bard|Angie Swenson, Assoc Dir, Clinical|7634452382|angie.swenson@crbard.com
121337|NCT01398943|Augusta University|Ryan Harris, Ph.D.|706-721-5998|ryharris@augusta.edu
121339|NCT01389596|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
121344|NCT01350102|Penn State Milton S. Hershey Medical Center|Nell Blake, DPM|(717) 531-5638|nblake@pennstatehealth.psu.edu
121345|NCT01342029|Cedars-Sinai Medical Center|C.Noel Bairey Merz, MD|310-423-9680|merz@cshs.org
121347|NCT01338415|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com
121348|NCT01319812|BIOTRONIK|Amy Culley, Director of Vascular Intervention|503-451-8034|amy.culley@biotronik.com
121349|NCT01314118|Janssen Services, LLC|Strategic Lead Oncology Tas||ClinicalTrialDisclosure@its.jnj.com
121350|NCT01287741|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
121352|NCT01271712|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
121353|NCT01253642|OHSU Knight Cancer Institute|Kristi Eilers|503-494-2897|eilersk@ohsu.edu
121354|NCT01249404|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com
121356|NCT01234337|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
119839|NCT02967354|Uppsala University Hospital|Dr Per-Ola Carlsson|+46184714425|per-ola.carlsson@mcb.uu.se
119850|NCT02410213|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200 ext 811|abutcher@lpicrd.com
119851|NCT02401022|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov
119852|NCT02377427|GlaxoSmithKline|GSK Response Center|866-435-7343|
119853|NCT02347189|Medtronic|Chad Harris, Sr. Clinical Research Specialist|763-514-9543|chad.m.harris@medtronic.com
119858|NCT02195986|Mylan Inc.|Abhijit Barve, Head of Global Clinical Research||abhijit.barve@mylan.com
119871|NCT01867580|KCI, an Acelity Company|Anthony Tate, RN, BSN|210-515-4060|anthony.tate@kci1.com
119874|NCT01799278|Weill Cornell Medical College|Dr. Himisha Beltran|(646) 962-2072|GUONC@med.cornell.edu
119893|NCT01572844|GW Medical Faculty Associates|Alison Ehrlich, MD, Chair of Department of Dermatology|202-741-2625|aehrlich@mfa.gwu.edu
119895|NCT01538199|Massachusetts General Hospital|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu
119898|NCT01429987|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020|
119899|NCT01381562|GlaxoSmithKline|GSK Response Center|866-435-7343|
119907|NCT01299909|University of Wisconsin|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu
119908|NCT01289275|UC San Diego, California Smokers' Helpline|Sharon Cummins, Ph.D.|8583001046|scummins@ucsd.edu
115832|NCT03073798|Johns Hopkins University|Nadia N Hansel, MD MPH|410-550-2935|nhansel@jhmi.edu
115842|NCT02294461|Astellas Pharma Inc|Clinical Trial Disclosure||astellas.resultsdisclosure@astellas.com
115843|NCT02218697|GlaxoSmithKline|GSK Response Center|866-435-7343|
115847|NCT02179892|Emory University|Dr. Colette Curtis|404-778-3900|ccurti3@emory.edu
115848|NCT02164929|Duke University Medical Center|Timothy Miller, MD||timothy.miller2@duke.edu
115849|NCT02164318|Duke University Medical Center|Dr. Jeffrey Lawson|919-681-2533|lawso006@mc.duke.edu
118144|NCT01661972|Duke University Medical Center|John Strickler, M.D.|919-668-1861|john.strickler@duke.edu
118145|NCT01649271|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
118149|NCT01618344|Hunstman Cancer Institute|Dr. Yelena Wu|801-213-5653|yelena.wu@utah.edu
118150|NCT01611558|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
118151|NCT01611259|AGMT|Public contact Daniela Wolkersdorfer|00436626404411|d.wolkersdorfer@agmt.at
118152|NCT01590875|Medical College of Wisconsin|Marcie Berger, MD|414-955-6806|mgberger@mcw.edu
118154|NCT01582971|Michigan State University|Dr. Gwen Wyatt|517-432-5511|gwyatt@msu.edu
118155|NCT01569022|VA Western New York|Ali El Solh|716-862-6525|ali.el-solh@va.gov
118156|NCT01553916|Washington University School of Medicine|Clifford Robinson, M.D.|314-362-4653|clifford.robinson@wustl.edu
118157|NCT01551056|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com
118158|NCT01544998|Mayo Clinic|Horng Chen, MD, Professor of Medicine|507-284-8846|chen.horng@mayo.edu
118160|NCT01510652|Institute of Cardiology, Univ. of Bologna, Bologna, Italy|Prof. Giuseppe Boriani||giuseppe.boriani@unibo.it
118161|NCT01491737|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
118163|NCT01480843|Joslin Diabetes Center|Medha Munshi, MD|617-309-4683|medha.munshi@joslin.harvard.edu
118164|NCT01475721|GlaxoSmithKline|GSK Response Center|866-435-7343|
118166|NCT01462344|GlaxoSmithKline|GSK Response Center|866-435-7343|
118167|NCT01443026|University of Illinois at Chicago|Dr. Peter Gann|312-355-3723|pgann@uic.edu
118168|NCT01429272|Laureate Institute for Brain Research|Jonathan Savitz; Principal Investigator|918 502 5104|jsavitz@laureateinstitute.org
118171|NCT01372410|GlaxoSmithKline|GSK Response Center|866-435-7343|
118173|NCT01369355|Janssen Research & Development, LLC|Vice President||ClinicalTrialDisclosure@its.jnj.com
118174|NCT01366092|Dana-Farber Cancer Institute|John Koreth, MBBS, DPhil|617-632-2949|JKoreth@partners.org
118175|NCT01362205|Denver Health Medical Center|Katie Overdier RN|303 602 1479|Katie.Overdier@dhha.org
118176|NCT01362140|Amgen Inc.|Study Director|866-572-6436|
118177|NCT01350141|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
118178|NCT01336608|GlaxoSmithKline|GSK Response Center|866-435-7343|
118180|NCT01323634|GlaxoSmithKline|GSK Response Center|866-435-7343|
118182|NCT01318967|Wake Forest School of Medicine|Michael Rocco, MD|336-716-4650|mrocco@wfubmc.edu
118183|NCT01316900|GlaxoSmithKline|GSK Response Center|866-435-7343|
118184|NCT01316887|GlaxoSmithKline|GSK Response Center|866-435-7343|
118186|NCT01301001|University of Tennessee Health Science Center|Dr. Candace Brown|9014124341|CSBROWN@TENNESSEE.EDU
118187|NCT01298778|Wake Forest School of Medicine|Dr. Jessica Booth|336-718-8278|jbooth@wakehealth.edu
118188|NCT01286324|University of Michigan|Suzanna M Zick|734-998-9553|szick@umich.edu
118189|NCT01281124|The Ohio State University Comprehensive Cancer Center|Greg Otterson|614-293-2887|Greg.Otterson@osumc.edu
118190|NCT01269749|University of Florida|Dr Scott Rivkees|352-273-9001|srivkees@ufl.edu
118191|NCT01264679|AMAG Pharmaceuticals, Inc.|Medical Information|+1-877-411-2510|amag@druginfo.com
118192|NCT01261780|University of Wisconsin Carbone Cancer Center|Toby Campbell|608-263-3962|tcc@medicine.wisc.edu
118193|NCT01256502|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
118195|NCT01248715|University Louisville|Dr. Paula Peyrani|502-852-3905|paula.peyrani@louisville.edu
118196|NCT01248130|Massachusetts General Hospital|Gagan Joshi, MD|617-726-4651|lkfeinberg@mgh.harvard.edu
119912|NCT01217840|Stanford University|Sejal Shah MD|6507211811|sshah2@stanford.edu
115854|NCT02046148|GlaxoSmithKline|GSK Response Center|866-435-7343|
115856|NCT01994629|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
115857|NCT01954251|GlaxoSmithKline|GSK Response Center|866-435-7343|
115858|NCT01903720|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
115859|NCT01867307|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
115860|NCT01867047|Duke University Medical Center|Michael Bolognesi, MD||michael.bolognesi@duke.edu
115863|NCT01804842|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com
115864|NCT01797094|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
115865|NCT01797081|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
115866|NCT01721746|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
115867|NCT01721759|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
115868|NCT01714024|UNC School of Dentistry|Steven Offenbacher, DDS, PhD, MMSc|919-537-3205|steven_offenbacher@unc.edu
115869|NCT01710046|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115871|NCT01680783|University of Chicago|John P. Kress|7737026790|jkress@medicine.bsd.uchicago.edu
115872|NCT01662440|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com
115874|NCT01621802|GlaxoSmithKline|GSK Response Center|866-435-7343|
115877|NCT01600716|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
115879|NCT01570192|University of Florida, Department of Medicine|Dr. George L. Drusano|407-313-7060|gdrusano@ufl.edu
115880|NCT01547299|Medivation, Inc.|William Novotny, MD, Sr. Director, Clinical Development|415- 983-3066|william.novotny@medivation.com
115883|NCT01466387|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
115884|NCT01453348|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
115885|NCT01439360|GlaxoSmithKline|GSK Response Center|866-435-7343|
115886|NCT01423253|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com
115887|NCT01422408|Knight Cancer Institute, Oregon Health & Science University|Emile Latour|503-418-9601|latour@ohsu.edu
115888|NCT01411852|Resuscitation Outcomes Consortium|Susanne May, PhD, Principal Investigator|206-685-1302|sjmay@uw.edu
115889|NCT01409096|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146466948|sherwood.brown@utsouthwestern.edu
115891|NCT01375374|UCB|UCB Clinical Trial Call Center|+1 877 822 9493|
115892|NCT01369342|Janssen Research & Development, LLC|Vice President||ClinicalTrialDisclosure@its.jnj.com
115893|NCT01369329|Janssen Research & Development, LLC|Vice President||ClinicalTrialDisclosure@its.jnj.com
115894|NCT01363479|Helsinn Healthcare SA|Marco Palmas MD, Head of Clinical Development|+41919852121|marco.palmas@helsinn.com
115896|NCT01354431|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
115897|NCT01350934|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115898|NCT01340300|Dana-Farber Cancer Institute|Meyerhardt, Jeffrey,M.D.,M.P.H.|617-632-6855|Jeffrey_Meyerhardt@dfci.harvard.edu
115899|NCT01331161|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu
115900|NCT01309737|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115901|NCT01276509|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115902|NCT01276639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115906|NCT01257542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115907|NCT01232868|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu
115909|NCT01214850|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
115910|NCT01214837|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
115912|NCT01179191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
118322|NCT02207088|AbbVie|Global Medical Services|800-633-9110|
118323|NCT02152605|GlaxoSmithKline|GSK Response Center|866-435-7343|
118324|NCT02138227|Temple University|Dr. Laura Siminoff|(215) 204-8726|lasiminoff@temple.edu
118325|NCT02105974|GlaxoSmithKline|GSK Response Center|866-435-7343|
118326|NCT01957163|GlaxoSmithKline|GSK Response Center|866-435-7343|
118327|NCT01940354|Hospital of the University of Pennsylvania|Scott Trerotola, MD|215-662-6983|scott.trerotola@uphs.upenn.edu
118330|NCT01881113|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com
118331|NCT01802632|AstraZeneca|Senior Medical Director, Tagrisso||ClinicalTrialTransparency@astrazeneca.com
118333|NCT01774591|University of Chicago|George L. Bakris, MD|773-702-7936|bbrisky@medicine.bsd.uchicago.edu
118334|NCT01772134|GlaxoSmithKline|GSK Response Center|866-435-7343|
118335|NCT01706328|GlaxoSmithKline|GSK Response Center|866-435-7343|
118336|NCT01686633|GlaxoSmithKline|GSK Response Center|866-435-7343|
115913|NCT01167452|Texas Tech University Health Sciences Center|Ronald Hall, PharmD, MSCS|214-358-9009|ronald.hall@ttuhsc.edu
115914|NCT01165840|Texas Tech University HSC|Ronald Hall|214-358-9009|ronald.hall@ttuhsc.edu
119914|NCT01210222|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org
115916|NCT01152996|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
115917|NCT01144416|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
115919|NCT01131182|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115920|NCT01126424|Astellas Pharma Europe Ltd.|Associate Medical Director Urology||clinicaltrials@us.astellas.com
115922|NCT01116427|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
115923|NCT01112059|UAB|Amit Gaggar, MD|934-5400|agaggar@uab.edu
115924|NCT01106534|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com
115925|NCT01093534|Astellas Pharma Europe Ltd.|Director Medical Affairs – Urology||clinicaltrials@us.astellas.com
115926|NCT01090427|Janssen Research & Development, LLC|VICE PRESIDENT IMMUNOLOGY||ClinicalTrialDisclosure@its.jnj.com
115927|NCT01084278|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
115928|NCT01076686|Pacira Pharmaceuticals|Executive Medical Director|203-837-6500|erolo@pacira.com
115930|NCT01025336|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115931|NCT01005966|GlaxoSmithKline|GSK Response Center|866-435-7343|
115932|NCT01001975|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
115933|NCT00996307|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
115934|NCT00996281|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
115935|NCT00995722|University Of Miami|Dr. Benatar|305-243-6480|MBenatar@med.miami.edu
119919|NCT01145495|Weill Cornell Medical College|Peter Martin, M.D.||pem9019@med.cornell.edu
115938|NCT00976248|Dana-Farber Cancer Institute|Steven P. Treon, MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu
115939|NCT00973479|Centocor, Inc.|Director Clinical Research|1-800-457-6399|
115941|NCT00965458|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
115942|NCT00952341|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115943|NCT00941330|Emory University|Jane Meisel, MD|404-778-1900|jane.l.meisel@emory.edu
115945|NCT00909870|Shire Regenerative Medicine|Mollie Carter, MD, Medical Director|(858) 754-5678|mcarter@shire.com
115948|NCT00891839|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
115949|NCT00887510|University of Florida|Rhonda M Cooper-DeHoff|352 273-6184|dehoff@cop.ufl.edu
115950|NCT00882557|Cubist Pharmaceuticals, Inc.|Ed Campanaro/Vice President, Clinical Operations|781-860-8318|ed.campanaro@cubist.com
115951|NCT00880698|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org
115953|NCT00874120|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
115954|NCT00868140|Virginia Commonwealth University|Dr. John Nestler|(804) 828-3389|john.nestler@vcuhealth.org
115955|NCT00856284|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com
115956|NCT00847912|Providence VA mendical Center|Martin Weinstock MD, PhD|401-457-3333|Martin.Weinstock@va.gov; Martin_Weinstock_MD@brown.edu
115958|NCT00819390|ACTG Network Coordinating Center, Social and Scientific Systems|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
115959|NCT00811928|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
115960|NCT00808405|University of Washington|Connie Celum, MD, MPH|206-520-3824|ccelum@uw.edu
115961|NCT00806351|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
115962|NCT00804843|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115963|NCT00804609|Stanford University|Brendan Carvalho|650-861-8607|bcarvalho@stanford.edu
115964|NCT00799617|University of Pennsylvania, Perelman School of Medicine|Peter J. Snyder, MD|215-898-0208|pjsnyder@upenn.edu
115965|NCT00793780|Yale University|Erin Sullivan|+1 (203) 974-7317|erin.reutenauer@yale.edu
115966|NCT00783263|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115967|NCT00771667|Janssen Research and Development, US|Director, Clinical Research|610-651-6554|
115968|NCT00770341|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@Merck.com
115969|NCT00761280|Isarna Therapeutics GmbH, formerly Antisense Pharma GmbH|Medical Officer|+49-89-890831 ext 0|info@isarna-therapeutics.com
115970|NCT00759109|Merck Sharp and Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com
115971|NCT00756938|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115972|NCT00755716|UConn Health|Dr. Cheryl Oncken|860-679-3425|oncken@uchc.edu
115973|NCT00752089|GlaxoSmithKline|GSK Response Center|866-435-7343|
115974|NCT00745823|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1- 800-672-6372|ClinicalTrialsDisclosure@merck.com
115975|NCT00738972|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
115976|NCT00737672|W.L. Gore and Associates, Inc.|Clinical Project Manager|928-864-3771|cavery@wlgore.com
115977|NCT00734539|Duke Univiersity Medical Center|Daniel K. Benjamin Jr|919-668-7081|danny.benjamin@dm.duke.edu
115979|NCT00708123|GlaxoSmithKline|GSK Response Center|866-435-7343|
115980|NCT00708097|GlaxoSmithKline|GSK Response Center|866-435-7343|
115981|NCT00708305|GlaxoSmithKline|GSK Response Center|866-435-7343|
115982|NCT00706446|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org
115983|NCT00705783|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974|
115984|NCT00700635|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
115985|NCT00686725|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
115987|NCT00674362|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493|
115990|NCT00646646|University of Alabama at Birmingham|Dr. Michael Froelich|205-934-4711|froelich@uab.edu
115991|NCT00645944|Yale University|Cenk Tek, M.D.|203-974-7484|cenk.tek@yale.edu
119926|NCT01001988|Sanofi Pasteur|Medical Director|800-633-1610|RegistryContactUS@sanofi.com
115993|NCT00643565|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
115994|NCT00623766|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
115995|NCT00612560|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
115996|NCT00611130|Catalyst Pharmaceutical Partners, Inc.|M Douglas Winship|305-529-2522 ext 12|dwinship@catalystpharma.com
115997|NCT00607126|DAvdi Geffen School of Medicine at UCLA|Barbara Giesser,MD|310-825-7313|bgiesser@mednet.ucla.edu
115998|NCT00604175|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301)-628-3313|ACTGCT.Gov@s-3.com
115999|NCT00603902|Arena Pharmaceuticals, Inc.|Associate Director, Clinical Operations|858-453-7200 ext 1602|sstubbe@arenapharm.com
116000|NCT00603291|Arena Pharmaceuticals, Inc.|Associate Director, Clinical Operations|858-453-7200 ext 1602|sstubbe@arenapharm.com
116002|NCT00582790|University of Wisconsin Carbone Cancer Center|Study coordinator|(608) 263-7107|uwcccgu@medicine.wisc.edu
116003|NCT00582010|University of Alabama at Birmingham|Rakesh Patel|205-934-3411|rakeshp@uab.edu
116004|NCT00580606|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov
116005|NCT00578448|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
116007|NCT00555893|Marshfield Clinic Research Foundation|Edward Belongia, MD|715-389-3783|belongia.edward@mcrf.mfldclin.edu
116008|NCT00555321|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
116009|NCT00552032|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
116010|NCT00550589|Statistical Center of AIDS Malignancy Consortium|Jeannette Lee|(501) 526-6712|jylee@uams.edu
116011|NCT00550459|Otsuka Pharmaceutical Development & Commercialization, Inc.|Frank Czerwiec, MD, PhD; Sr. Director, Global Clinical Development|(240) 683-3523|frank.czerwiec@otsuka.com
116012|NCT00545584|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
116013|NCT00537316|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
116014|NCT00527735|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com
116015|NCT00527488|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
116018|NCT00500682|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
116019|NCT00501046|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
116020|NCT00498628|NIAAA|Dr. Raye Litten|301-443-0636|
116021|NCT00496769|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
116022|NCT00488774|Janssen Research & Development|Senior Director|215-793-7540|
116023|NCT00488683|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
116024|NCT00487539|Janssen Research & Development|Senior Director|215-793-7540|
116026|NCT00474526|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com
116027|NCT00466817|University of Alabama in Birmingham|David Kimberlin, MD|205-934-2424|dkimberlin@peds.uab.edu
116028|NCT00465647|Purdue Pharma L.P.|Executive Medical Director|800-733-1333|
116029|NCT00462943|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
116030|NCT00457197|The University of Texas Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D., Professor|214-645-6950|sherwood.brown@utsouthwestern.edu
116031|NCT00455013|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
116032|NCT00453180|Cincinnati Childrens Hospital|Craig Erickson|513-636-6258|craig.erickson@cchmc.org
116033|NCT00452335|Sucampo Pharma Americas, Inc.|VP, Clinical Development|301-961-3400|info@sucampo.com
116034|NCT00445003|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|aglassman@jaeb.org
116036|NCT00436969|DePuy Mitek|Aileen Michael|508.828.3337|amichae2@its.jnj.com
116037|NCT00430950|Daiichi Sankyo|Global Clinical Leader|908-992-6400|DataSharing@dsi.com
116038|NCT00424554|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
116039|NCT00409539|Sunovion|Medical Director, Urology|1-866-503-6351|
116040|NCT00404547|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
116041|NCT00402168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
116043|NCT00395135|Arena Pharmaceuticals, Inc.|Associate Director, Clinical Operations|858-453-7200 ext 1602|sstubbe@arenapharm.com
116044|NCT00379821|Malaria Section, Center for Vaccine Development, University of Maryland School of Medicine|Christopher Plowe, MD, MPH|410-706-2491|cplowe@medicine.umaryland.edu
116045|NCT00375752|Novartis Pharmaceuticals|Study Director|862-778-8300|
116046|NCT00375219|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com
116047|NCT00374907|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
116048|NCT00355121|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
116049|NCT00354172|Masonic Cancer Center, University of Minnesota|Jeffrey Miller, M.D.|612-625-7409|mille011@umn.edu
116051|NCT00324896|UMDNJ - RWJMS|Matthew Menza, MD|732-235-4440|menza@umdnj.edu
116052|NCT00324155|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
116053|NCT00322465|University of Alabama at Birmingham|Jane R. Schwebke, MD|(205) 975-5665|schwebke@uab.edu
116054|NCT00306163|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
116057|NCT00256750|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
119932|NCT00888628|Massachusetts General Hospital|James F. Markmann, M.D. Ph.D - Chief, Division of Transplant Surgery|617-643-4087|kcrisalli@mgh.harvard.edu
116059|NCT00245037|Oregon Health and Science University|Richard T. Maziarz, MD|503-494-6345|maziarzr@ohsu.edu
116060|NCT00241839|University of Florida|Mark S. Segal, MD, PhD; Assistant Professor and Chief, Division of Nephrology|352-273-8821|Mark.Segal@medicine.ufl.edu
116061|NCT00238433|Oregon Health & Science University|Richard Maziarz, MD|503-494-6365|maziarzr@ohsu.edu
116062|NCT00219349|New York State Psychiatric Institute|Franklin Schneier MD|2125435368|fschneier@nyspi.columbia.edu
116064|NCT00205504|Virginia Commonwealth University|Kai Cheang, Principal Investigator|804-828-9698|kicheang@vcu.edu
116065|NCT00187889|University of Florida|Dr. Carl J. Pepine|352-273-9082|carl.pepine@medicine.ufl.edu
116066|NCT00163293|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com
116067|NCT00162123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
116068|NCT00157014|Astellas Pharma Canada, Inc|Associate Director, Scientific Affairs||clinicaltrials@us.astellas.com
116069|NCT00153816|Geisel School of Medicine at Dartmouth|Leila A. Mott, Statistical Analyst|603-650-3447|Leila.A.Mott@Dartmouth.EDU
116070|NCT00138424|Collaborative Antiviral Study Group|Penelope Jester, BSN,MPH,CCRC|(205) 877-975-7280|PJester@peds.uab.edu
116071|NCT00121641|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
116072|NCT00121667|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com
116073|NCT00117598|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
116074|NCT00114777|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
116075|NCT00100230|Retina Foundation of the Southwest|Dennis Hoffman, Ph.D., Sr. Research Scientist|214-363-3911 ext 125|dhoffman@retinafoundation.org
116076|NCT00073073|Georgetown University|Dr. Claudine Isaacs|(202)444-3677|isaacsc@georgetown.edu
116077|NCT00051363|Stanford University|Deborah A. Nichols|208-908-7364|dnichols@cableone.net
116078|NCT00044213|Mount Sinai Medical Center|Gervasio A. Lamas, M.D.|305-674-2162|Gervasio.Lamas@msmc.com
116079|NCT00031486|University of Alabama at Birmingham|Penny Jester|(877) 975-7280|pjester@peds.uab.edu
116081|NCT02907268|ICLS|Shantel Demay|905-842-2262|s.demay@icls.ca
116082|NCT02787564|University of Hohenheim|Prof. Dr. Nanette Ströbele-Benschop|+49711 459 24260 ext 24260|N.Stroebele@uni-hohenheim.de
116083|NCT02751320|GlaxoSmithKline|GSK Response Center|866-435-7343|
116084|NCT02730351|GlaxoSmithKline|GSK Response Center|866-435-7343|sarah.l.west@gsk.com
116085|NCT02724111|Korea University Guro Hospital|Dr Byung Gun Lim|82-2-2626-1437|bglim9205@korea.ac.kr
118396|NCT01769391|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
118398|NCT01709708|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cady|417-883-7889|rcady@banyangroupinc.com
116086|NCT02617901|Sheffield Children's NHS Foundation Trust|Dr Amaka C Offiah|0114 271 7557|a.offiah@sheffield.ac.uk
116087|NCT02524054|Beth Israel Deaconess Medical Center|Robert Banzett, PhD|6176670572|rbanzett@bidmc.harvard.edu
116088|NCT02336594|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com
116089|NCT02191137|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com
116090|NCT02187861|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
116091|NCT02128997|UPENN|Valerie Riis|2154989099 ext 215|valerie.armendariz@uphs.upenn.edu
116092|NCT02092285|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
116093|NCT02077140|Medtronic Spine and Biologics|Clinical Affairs|1800-876-3133 ext 6068|msbkclinicalresearch@medtronic.com
116094|NCT02049385|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov
116095|NCT02035696|Seqirus|Clinical Trial Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com
116096|NCT01807871|University of Vermont|Dr. John Hughes|802-656-1640|John.Hughes@med.uvm.edu
116097|NCT01683019|NeoSync, Inc.|Dr. Bill Phillips|949-333-2906|bill@neosync.com
116098|NCT01639040|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com
116100|NCT01610492|GlaxoSmithKline|GSK Response Center|866-435-7343|
116101|NCT01575106|Massachusetts General Hospital|Jian Kong|617-726-7893|JKONG2@mgh.harvard.edu
116102|NCT01539759|University of North Carolina|Erika Levi, MD and Gretchen Stuart, MD|(919) 843-5633|Erika.Levi@gmail.com
116103|NCT01506479|University of Pittsburgh|Dr. Charity G. Moore|412-383-6630|cgp22@pitt.edu
119934|NCT00858130|University of North Carolina at Chapel Hill|Dr. Stephan Moll, Professor of Hemology/Oncology|919-966-3311|stephan_moll@med.unc.edu
116105|NCT01257750|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@meei.harvard.edu
116106|NCT01256840|UCLA Department of Psychology|Dr. A. Janet Tomiyama|3102066875|tomiyama@psych.ucla.edu
116107|NCT01213329|Northwestern University|Dr. Lorenzo Gallon|312-695-8900|l-gallon@northwestern.edu
116108|NCT01154101|GlaxoSmithKline|GSK Response Center|866-435-7343|
116109|NCT01130493|Impax Laboratories, Inc.|Michelle Landolfi, Senior Director, Regulatory Affairs|(510) 240-6496|Michelle.Landolfi@impaxlabs.com
116110|NCT01118741|Johns Hopkins University|Michael Carducci, MD|410-614-3977|carducci@jhmi.edu
116111|NCT01057862|Yale University|Dr. Marc N Potenza|2037373553|marc.potenza@yale.edu
116112|NCT00992264|Group Health Research Institute|Jennifer McClure|206-287-2737|mcclure.j@ghc.org
116113|NCT00972478|SWOG|Study Statistician|206-667-4623|
119935|NCT00843518|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
116115|NCT00896441|Stanford University|Mike Greicius|650-723-8331|greicius@stanford.edu
116116|NCT00880048|GlaxoSmithKline|GSK Response Center|866-435-7343|
116117|NCT00685516|UCLA|Susanne Henning, Ph.D., Principal Investigator|310-825-9345|shenning@mednet.ucla.edu
116118|NCT00659230|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000 ext 3819|lori.davis@va.gov
119936|NCT00810810|Bloodworks Northwest (formerly Puget Sound Blood Center)|Karen Nelson, PhD., Vice President Laboratories|206-689-6549|knelson@bloodworksnw.org
116120|NCT00644995|Group Health Cooperative|Jennifer McClure, PhD|206-287-2737|mcclure.j@ghc.org
116121|NCT00602836|Mayo Clinic|Dr. Tait Shanafelt||shanafelt.tait@mayo.edu
116122|NCT00485953|University of Pittsburgh|Dr. Susan Greenspan|412-692-2476|greenspn@pitt.edu
116123|NCT00325819|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216|jackson.L@ghc.org
116124|NCT00287365|University of North Carolina at Chapel Hill|David B. Peden, MD, MS|919-966-0768|dpeden@med.unc.edu
116125|NCT00245518|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu
119956|NCT00477087|Stanford University Medical Center|Sandy Srinivas, MD; Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu
119961|NCT00334893|Memorial Sloan-Kettering Cancer Center|Dr. Martee L. Hensley|646-888-4222|hensleym@mskcc.org
119964|NCT00329797|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
119965|NCT00323063|Rutgers Cancer Institute of|Deborah Toppmeyer, MD|732-235-6789|toppmede@cinj.rutgers.edu
119966|NCT00291876|GlaxoSmithKline|GSK Response Center|866-435-7343|
119971|NCT00156013|Oncology Specialists|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net
121358|NCT01223352|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com
121359|NCT01205646|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org
121361|NCT01191840|Duke University Health System|Vance Fowler|919-668-8044|fowle003@mc.duke.edu
121364|NCT01185821|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com
121365|NCT01183312|Emory University School of Medicine|Dr. Lynn Marie Trotti|404-728-4752|lbecke2@emory.edu
121367|NCT01131520|Friends Research Institute|Robert Schwartz|410-837-3977|rschwartz@friendsresearch.org
121368|NCT01123382|MetroHealth Medical Center|Richard WIlson, MD|216-957-3559|rwilson@metrohealth.org
121372|NCT01112696|Medtronic|Scott Lee M.D.|818-576-4204|scott.w.lee@medtronic.com
121373|NCT01097343|St. Vincent Medical Group|Dr. Joseph S. Rossi|765 482 0656|jrossi@thecaregroup.com
121375|NCT01088243|National Jewish Health|Dr. Lisa A. Maier|303-398-1983|MaierL@NJHealth.org
121377|NCT01065844|The University of Iowa|John M. Buatti, M.D., Chair, Department of Radiation Oncology|319-356-2699|john-buatti@uiowa.edu
121378|NCT01057225|Mayo Clinic|Joseph Riad Mikhael, M.D.||Mikhael.Joseph@mayo.edu
121380|NCT01011335|Uniformed Services University of the Health Sciences|David Tribble, MD, DrPH|301-816-8404|dtribble@idcrp.org
121381|NCT01010061|Hoffman-LaRoche|Medical Communications|800-821-8590|
121383|NCT00990288|Hospital for Special Surgery|Mark P. Figgie MD|212-606-1932|figgiem@hss.edu
121384|NCT00985088|GlaxoSmithKline|GSK Response Center|866-435-7343|
121385|NCT00979602|GlaxoSmithKline|GSK Response Center|866-435-7343|
121386|NCT00976820|GlaxoSmithKline|GSK Response Center|866-435-7343|
121387|NCT00965263|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|6467746153|meg.haney@nyspi.columbia.edu
121388|NCT00965185|Massachusetts General Hospital|Dr. Steven K Grinspoon|617-724-9109|sgrinspoon@mgh.harvard.edu
121389|NCT00958581|NYU hospital for Joint Diseases|Dr. Thomas Errico (Chief of Spine), Dr. Kushagra Verma (Co-investigator)|212-598-6076|thomas.errico@nyumc.org; vermak01@gmail.com
121390|NCT00957723|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@Stryker.com
121391|NCT00957008|University of South Carolina|Project director|8037773881|msui@mailbox.sc.edu
121392|NCT00937937|SWOG Statistical Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org
121393|NCT00920218|GlaxoSmithKline|GSK Response Center|866-435-7343|
121394|NCT00912964|Astellas Pharma Global Development, Europe|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com
121395|NCT00884741|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
121398|NCT00843193|GlaxoSmithKline|GSK Response Center|866-435-7343|
121399|NCT00842296|Medtronic|Stephanie Brucato, Principal Clinical Research Specialist|508-261-8000|stephanie.m.brucato@medtronic.com
119976|NCT02777268|Simbec Research Limited|Dr Girish Sharma|+44 1443 690977|
119977|NCT02698423|Geneva University Hospitals|Dr Manuela Viviano|07955 32 272|manuela.viviano@hcuge.ch
119978|NCT02661594|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-875130|GabrielFox@acaciapharma.com
119979|NCT02599129|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|2122413288|giselle.singer@mssm.edu
119980|NCT02577107|Novartis Pharmaceuticals|Study Director|862-778-8300|
119981|NCT02534493|Pressure Profile Systems|Jae Son|3106418100|jaeson@pressureprofile.com
119982|NCT02497755|University of Washington|Dr. Amy Bauer|206.221.8385|abauer1@uw.edu
119983|NCT02466659|Indiana University|Daniel Neely|3172741214|deneely@iupui.edu
119984|NCT02429791|GlaxoSmithKline|GSK Response Center|866-435-7343|
119985|NCT02424357|University of Miami|Hilda Capo|305-326-6555|hcapo@med.miami.edu
119986|NCT02339506|Brigham and Women's Hospital|Dr. Gail Kurr Adler|(617) 732-8742|gadler@bwh.harvard.edu
119987|NCT02290691|PharmaJet, Inc|Tara Miller, MS, Clinical Affairs Manager|888-900-4321 ext 4163|tara.miller@pharmajet.com
119988|NCT02276040|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2260|susan.odum@orthocarolina.com
119989|NCT02238925|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency||tom.chmielewski@jazzpharma.com
119990|NCT02102490|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
119991|NCT02095106|Orthopaedic Institute for Children|Dr. Mauricio Silva|213-742-1109|msilva@mednet.ucla.edu
119992|NCT02071082|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
119993|NCT02039674|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
119994|NCT02030119|Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@upenn.edu
119995|NCT02029989|UMN, College of Pharmacy|Dr. Mark E. Schneiderhan|8452540458|meschnei@d.umn.edu
119996|NCT02022826|Medtronic|Michal Kedar-Datel|+972-4-9097952|michal.kedar-datel@medtronic.com
119997|NCT02002533|University of Rochester|Gary Morrow|585-275-9961|gary_morrow@urmc.rochester.edu
119998|NCT01956435|University of Texas at Austin Medical School and Seton Family of Hospitals|Ammar Ahmed, MD|512-504-0855|amahmed@seton.org
119999|NCT01938833|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Maysa Abu-Khalaf|215 503-4685|maysa.abu-khalaf@jefferson.edu
120000|NCT01896557|Heart Institute of University of Sao Paulo Medical School|Remo Holanda de Mendonca Furtado|+5511 26615058|remo_holanda@hotmail.com
120001|NCT01868334|University of Pittsburgh|Richard K. Zimmerman, MD, MPH, MA|412-383-2354|zimmer@pitt.edu
120002|NCT01806298|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
120003|NCT01800162|University of Pennsylvania|Dr. Kurt Barnhart|215-662-2974|KBarnhart@uphs.upenn.edu
120004|NCT01784770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
120005|NCT01775787|UConn Health|Dr. Cheryl Oncken|860-679-3425|oncken@uchc.edu
120006|NCT01770145|US WorldMeds|Regulatory Associate, Clinical Operations|5028158130|rgerlach@usworldmeds.com
120007|NCT01757821|University of Minnesota|James Carey|612-626-2746|carey007@umn.edu
120008|NCT01749501|William Beaumont Hospital|Dr. Martin Espinosa|248-898-0633|Martin.espinosa@beaumont.edu
120009|NCT01746979|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com
120010|NCT01729923|University of Washington|Dr. Stacey Cohen, Principal Investigator|206-606-6658|shiovitz@uw.edu
120011|NCT01722487|Pharmacyclics LLC|Dr. Lori Styles, Medical Monitor|+1 (408) 215-3770|lstyles@pcyc.com
120012|NCT01686828|University of Washington|Dr. Katya Rubinow|206-7543-3470|rubinow@uw.edu
120013|NCT01685372|University of Colorado School of Medicine|Donna Curtis, MD, MPH|720-777-6981|donna.curtis@childrenscolorado.org
120014|NCT01658813|Western Regional Medical Center|Heather Barilla|623-207-3649|heather.barilla@ctca-hope.com
120015|NCT01653028|Memorial Sloan Kettering Cancer Center|Mark Andrew Dickson M.D.|6468884164|dicksonm@mskcc.org
120016|NCT01639755|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
120017|NCT01639742|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com
120018|NCT01632683|Oregon Health & Science University|Michael Aziz, MD|503-494-5581|azizm@ohsu.edu
120019|NCT01625091|Unversity of Florida|Dr. Robert Cook|352-273-5869|cookrl@ufl.edu
120020|NCT01586156|Cleveland Clinic|Dr. Serpil Erzurum|216-445-6624|erzurus@ccf.org
116285|NCT02675634|Scientific and Regulatory affairs|Sara Gosk|+45 49113568|dksargo@coloplast.com
116286|NCT02651194|AbbVie|Global Medical Services|800-633-9110|
120021|NCT01578967|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
120022|NCT01545232|University of Texas Health Science Center - Houston|John Holcomb, M.D.|713-500-5493|John.Holcomb@uth.tmc.edu
120023|NCT01499147|University of Illinois Cancer Center|Damiano Rondelli, MD|312-996-6179|drond@uic.edu
120024|NCT01461707|University of California, San Francisco|JiWon Choi|415-514-2534|jiwon.choi@ucsf.edu
120025|NCT01364870|University of Iowa College of Nursing|Barbara Rakel, PhD, RN, FAAN|319-335-7036|barbara-rakel@uiowa.edu
120026|NCT01357512|Oulu University Hospital and Univeristy of Oulu|Chief urologist Markku Vaarala|+3588315 ext 2840|markku.vaarala@oulu.fi
116295|NCT02442284|AbbVie|Global Medical Services|800-633-9110|
120027|NCT01342757|Emory University School of Medicine|Jeffrey J. Olson, MD|404-778-3091|jolson@emory.edu
120028|NCT01324882|UConn Health Center|Joseph Anderson|8022959362 ext 6003|joseph.anderson@dartmouth.edu
116298|NCT02345642|Hospital for Special Surgery|Dr. Geoffrey Westrich|212-606-1510|ortizp@hss.edu
120029|NCT01318915|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
120030|NCT01313676|GlaxoSmithKline|GSK Response Center|866-435-7343|
116299|NCT02279082|Dr. Reddy's Laboratories|Clinical Operations Director|609-282-1476|kgulbronson@promiuspharma.com
116300|NCT02277769|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com
120031|NCT01300650|Virginia Commonwealth University|Benjamin Van Tassell|8049820997|bvantassell@vcu.edu
120032|NCT01272960|University of Alabama School of Medicine|Dr. Lorie Harper|205-975-0515|lmharper@uabmc.edu
120033|NCT01245647|University of Florida|Dr. Bob Cook|352-273-5869|cookrl@ufl.edu
116305|NCT02197247|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com
120034|NCT01233609|Foundation Fighting Blindness Clinical Research Institute|Chief Drug Development Officer|410 423 0581|pzilliox@blindness.org
116307|NCT02105688|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
120035|NCT01212874|Loma Linda University Anesthesiology|Patricia Moore|1-909-558-4475|pamoore@llu.edu
120036|NCT01206439|University of Cincinnati|Jack Rubinstein|513-558-3062|rubinsjk@ucmail.uc.edu
120037|NCT01200810|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|(732) 235-8675|steinmn@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu
116311|NCT02004236|BrainMech Foundation|Moises Aguilar president of Brainmech Foundation|+34 634548720|moises@brainmech.org
116312|NCT01995071|AbbVie|Global Medical Services|800-633-9110|
120038|NCT01182675|UCSF|Christopher C. Dvorak, MD|415-476-2188|dvorakc@peds.ucsf.edu
120039|NCT01147653|Duke University School of Medicine, Division of Pediatric Blood and Marrow Transplantation|Jesse Troy, PhD||cordbloodtherapyinfo@dm.duke.edu
116315|NCT01951963|Health Partners|Dr. Aaron Burnett|651-254-5304|Aaron.M.Burnett@HealthPartners.Com
120040|NCT01118052|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org
120041|NCT01082614|Loma Linda University|Tonya Hamilton|909-558-9408|thamilton@llu.edu
120042|NCT01075412|The University of Iowa|Sarah McGuire, PhD|214-645-7613|Sarah.McGuire@utsouthwestern.edu
120043|NCT01074658|Medronic Bakken Research Center|Hanne Gonnissen|+3143356 ext 6734|hanne.gonnissen@medtronic.com
116320|NCT01905423|Washington University in St Louis Medical School|Peter Fischer|+1 (314) 747-5198|pufischer@wustl.edu
116321|NCT01856686|Spanish Foundation for Neurometrics Development|Dr. Moises Aguilar|+34 634 54 87 20|moises.aguilar@gmail.com
120044|NCT01072175|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com
116323|NCT01847885|SPR Therapeutics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com
120045|NCT01053078|University of Minnesota|Elizabeth Seaquist|612 624 9176|seaqu001@umn.edu
116325|NCT01801449|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Montealegre, Gina|+1 301 761 7747|montealegrega@mail.nih.gov
120046|NCT00993031|University of California, San Francisco|Diane V Havlir, MD|01-415-476-4082 ext 400|dhavlir@php.ucsf.edu
120047|NCT00948610|UCLA|Michael R. Irwin|3108258281|mirwin1@ucla.edu
120049|NCT00923364|National Cancer Institute|Dr. Dennis Hickstein|301-594-1718|hicksted@mail.nih.gov
120050|NCT00889512|University Reproductive Associates|Dr. Peter G. McGovern|201-288-6330|mcgovepg@uranj.com
120051|NCT00861913|Karmanos Cancer Institute, Wayne State University|Amy M. Weise, D. O.|313-576-8952|
116332|NCT01646762|Mayo Clinic|Dr. Rafael Fonseca|480-301-4280|fonseca.rafael@mayo.edu
120052|NCT00802919|Nathan Kline Institute for Psychiatric Research|Robert C. Smith MD|845-398-6531|rsmith@nki.rfmh.org
120053|NCT00802854|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
116340|NCT01561976|GlaxoSmithKline|GSK Response Center|866-435-7343|
116341|NCT01535001|Aalborg University Hospital|Dr. Søren T. Skou|+4523708640|sots@rn.dk
116342|NCT01528592|Northwestern University|Darren Gitelman, MD|312-908-8266|d-gitelman@northwestern.edu
116343|NCT01470599|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
116344|NCT01462565|GlaxoSmithKline|GSK Response Center|866-435-7343|
116345|NCT01462292|GlaxoSmithKline|GSK Response Center|866-435-7343|
116346|NCT01435174|University of Michigan College of Pharmacy|Bruce A. Mueller|7346154578|muellerb@umich.edu
116347|NCT01410409|Aalborg University Hospital|Dr. Søren T. Skou|+4523708640|sots@rn.dk
116352|NCT01311024|head of Clinical Research Unit, National Institute for Health and Welfare|Arto Palmu, MD, PhD Research manager,|+358295247910|arto.palmu@thl.fi
116356|NCT01278394|Anacor Pharmaceuticals, Inc.|Sheryl Baldwin, RN/Associate Director|650-223-8597|clinicaltrials@anacor.com
116594|NCT01854710|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com
116596|NCT01819311|Florida International University|Jeremy W. Pettit (PI)|305-348-1671|jpettit@fiu.edu
116598|NCT01765530|Massachusetts General Hospital|Robert M Kacmarek PhD, RRT|617-724-4490|rkacmarek@partners.org
116605|NCT01732445|Mayo Clinic|Ruben A. Mesa, M.D.|480/301-8335|mesa.ruben@mayo.edu
116608|NCT01641042|GlaxoSmithKline|GSK Response Center|866-435-7343|
116612|NCT01611792|University of Vermont Medical Center, Burlington, VT|Dr. Sharon M. Henry|802 847-6733|Sharon.Henry@uvm.edu
116613|NCT01596283|Memorial Sloan Kettering Cancer Center|Dr. Mary Fischer MD|212-639-6745|fischerm@mskcc.org
116626|NCT01369641|Thomas Jefferson University|David Cognetti, MD|215-955-6670|David.Cognetti@jefferson.edu
120054|NCT00789724|VCU Pauley Heart Center|Antonio Abbate, MD, PhD|8048280513|aabbate@mcvh-vcu.edu
120055|NCT00770328|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu
120056|NCT00743106|Cleveland Clinic Foundation|Jerome O'Hara, MD|216-444-8278|oharaj@ccf.org
120057|NCT00667693|Cleveland Clinic Foundation|Daniel I Sessler, MD|216-445-8396|sesslerd@ccf.org
120058|NCT00664209|UCaliforniaLA|Jeff Bronstein MD, PhD|310 206-9799|jbronste@mednet.ucla.edu
120059|NCT00656019|StanfordU|Dr. Melinda Telli|650-724-9533|steinhau@stanford.edu
120060|NCT00637156|Medtronic Spine and biologics|Clinical Department|1800-876-3133 ext 6068|msbkclinicalresearch@medtronic.com
120061|NCT00628498|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|(215) 832-3750|
116367|NCT01128621|GlaxoSmithKline|GSK Response Center|866-435-7343|
120063|NCT00556374|Amgen Inc.|Study Director|866-572-6436|
120064|NCT00553969|University of Minnesota Medical School|Jay N. Cohn, M.D.|612.625.5646|cohnx001@umn.edu
120065|NCT00533273|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
116371|NCT01029691|University of Michigan|Louise O'Brien|734 647-9064|louiseo@med.umich.edu
120066|NCT00530218|City of Hope National Medical Center|Ricardo Spielberger, MD|626-359-8111 ext 65298|RSpielberger@coh.org
120067|NCT00528840|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
120068|NCT00528606|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
116375|NCT00984165|National Cancer Institute|Dr. Ronald E. Gress|301-496-1791|gressr@dc10a.nci.nih.gov
116377|NCT00943722|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
116378|NCT00887458|Johns Hopkins University|Dr. Michael Carducci|410-614-3977|carducci@jhmi.edu
120069|NCT00528424|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com
120070|NCT00498355|University of California San Francisco|Dr. Nisha Acharya|415-476-8131|nisha.acharya@ucsf.edu
120071|NCT00465894|University of Alabama at Birmingham|Dr. Holly E. Richter|205-934-1704|hrichter@uabmc.edu
116382|NCT00846651|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu
120072|NCT00434304|GlaxoSmithKline|GSK Response Center|866-435-7343|
120073|NCT00410904|Barbara Ann Karmanos Cancer Institute|Shirish M. Gadgeel, M.D.|313-576-8753|gadgeels@karmanos.org
120074|NCT00376688|The University of Chicago Comprehensive Cancer Center|Dr. Gini F. Fleming|773-702-6712|gfleming@medicine.bsd.uchicago.edu
120075|NCT00334633|University of Alabama at Birmingham|jane R Schwebke, MD|205-975-5665|schwebke@uab.edu
116387|NCT00739752|Indiana University|Dr. Gregory Zimet|317-274-8812|gzimet@iu.edu
116388|NCT00725764|GlaxoSmithKline|GSK Response Center|866-435-7343|
120076|NCT00332605|University of Chicago|Jon E. Grant|773-834-1325|jongrant@uchicago.edu
116390|NCT00715520|Emory University|Dr. Cathrin Buetefisch|4047121894|cathrin.buetefisch@emory.edu
120077|NCT00290693|University of Miami Sylvester Comprehensive Cancer Center|Caio Max Rocha Lima MD|305-243-7770|crocha@med.miami.edu
116392|NCT00692770|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
120078|NCT00201838|The Ohio State Unversity Comprehensive Cancer Center|Miguel Villalona-Calero, MD|614-293-5484|Miguel.Villalona@osumc.edu
116395|NCT00616200|UNC Center for Functional GI & Motility Disorders|Stephan R. Weinland, Ph.D.|9198437828|stephan_weinland@med.unc.edu
116396|NCT00612924|Terumo|Amanda Isula, Clinical Research Coordinator|800-262-3304 ext 5549|amanda.isula@terumomedical.com
120079|NCT00205374|University of Wisconsin-Madison|J. Scott McMurray, MD|608-262-7181|mcmurray@surgery.wisc.edu
120080|NCT00185731|Stanford University School of Medicine|Alice Fan, MD|650-725-6454|afan@stanford.edu
120081|NCT00094887|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com
120082|NCT00084409|University of Colorado Denver|Robert Keith, M.D.|303-399-8020 ext 3182|robert.keith@ucdenver.edu
116402|NCT00545844|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|
116403|NCT00534209|UM/Sylvester Comprehensive Cancer Center|Luis Raez MD|305-243-4909|lraez@med.miami.edu
120084|NCT00023712|Gynecologic Oncology Group(GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org
116405|NCT00494442|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
116406|NCT00218296|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu
116408|NCT00189540|AnGes|Director of Clinical Operations|240-780-9031|information@anges-mg.com
121401|NCT00837434|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
116410|NCT00151411|Penn State Hershey|Sandy Eyer|717-531-1540|seyer@hmc.psu.edu
116411|NCT00130728|Genentech, Inc.|Medical Communications Specialist|800-821-8590|
116412|NCT00113919|University of Arkansas for Medical Sciences|Nathan Petty|501-837-3894|pettynathanm@uams.edu
116413|NCT00105560|Massachusetts General Hospital|Dr. Nancy Tarbell, Pediatric Radiation Oncologist|617-724-1836|NTARBELL@mgh.harvard.edu
121402|NCT00832637|University of New Mexico|Yehuda Patt, MD|5059250405|yzpatt@salud.unm.edu
121403|NCT00831389|Medtronic Diabetes|Harry Clark|818-576-5653|bud.clark@medtronic.com
121404|NCT00807664|Coloplast|Dr Birte Petersen Jacobsen|004549110000 ext 1395|DKBIR@coloplast.com
121406|NCT00802464|GlaxoSmithKline|GSK Response Center|866-435-7343|
121407|NCT00802438|UW Madison|Gina Crisafi, BS|608-265-4554|gmc@medicine.wisc.edu
116419|NCT00054353|Fred Hutch|Marco Mielcarek, MD||mmielcar@fredhutch.org
116422|NCT00001596|National Human Genome Research Institute|Dr. William A. Gahl|301-402-2739|gahlw@mail.nih.gov
116423|NCT02847260|United Therapeutics Corporation|Leigh Peterson, Director, Product Development, Product Development & Global Clinical Operations|919-425-8165|lpeterson@unither.com
116427|NCT02596022|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu
116431|NCT02461966|Tanta university|Sherief Abd-Elsalam|00201095159522|sherif_tropical@yahoo.com
116435|NCT02359890|Biosense Webster|Robert Stagg|(800) 729-9010|RStagg@its.jnj.com
116441|NCT02260986|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com
116448|NCT02119650|Incyte Corporation|Study Director|855 463-3463|
116451|NCT02075255|AstraZeneca|Mitchell Goldman, Global Clinical Lead Benralizumab|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com
116453|NCT02015481|Bioblast Pharma|Warren Wasiewski|717-368-0780|Warren.wasiewski@bioblastpharma.com
116463|NCT01916941|University of New Mexico|Dr. Claire Wilcox|505-272-2333|cewilcox@salud.unm.edu
116476|NCT01658228|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu
116480|NCT01602016|University of Arkansas for Medical Sciences|Tracy Gatlin|501-686-6803|tlgatlin@uams.edu
116483|NCT01590394|Mayo Clinic|Christopher J. Gostout|507-284-7647|gostout.christopher@mayo.edu
116494|NCT01305941|UNC Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
116497|NCT01275053|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu
116507|NCT01147172|Anika Therapeutics|Adrian Orr, Director Clinical Affairs|781.457.9000|aorr@anikatherapeutics.com
116510|NCT01098071|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com
116513|NCT01033227|Children's Hospital Los Angeles|Dr. Thomas Coates|323 361 3841|TCoates@chla.usc.edu
116516|NCT00989781|UCSD|R. Jeffrey Chang, M.D.|858-534-8930|rjchang@ucsd.edu
116523|NCT00855413|The University of North Carolina|Dr. Cynthia Gay|9198432726|cynthia_gay@med.unc.edu
116749|NCT01285310|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com
116756|NCT01101880|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu
116758|NCT01079806|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
116759|NCT01062425|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
116762|NCT00932152|University of Pittsburgh|Ahmad Tarhini, MD|(412) 648-6578|tarhiniaa@upmc.edu
116763|NCT00923351|National Cancer Institute, National Institutes of Health|Dr. John Glod|301-451-0391|john.glod@nih.gov
116764|NCT00920439|GlaxoSmithKline|GSK Response Center|866-435-7343|
116771|NCT00689936|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com
116772|NCT00674583|GlaxoSmithKline|GSK Response Center|866-435-7343|
116773|NCT00651794|University of Texas HSC-Houston|Dr. Eric Thomas|713-500-7958|Eric.Thomas@uth.tmc.edu
116779|NCT00424047|Celgene Corporation|Anne McClain, Senior Manager|1-866-260-1599|ClinicalTrialDisclosure@celgene.com
116784|NCT00374140|University of Pittsburgh|Ahmad Tarhini, MD, PhD|(412) 648-6578|tarhiniaa@upmc.edu
116786|NCT00304187|New York State Psychiatric Institute|Dr. Michael Devlin|212-543-5748|mjd5@columbia.edu
116789|NCT00056160|Celgene Corporation|Robert Knight, M.D.|908-673-9749|rknight@celgene.com
116535|NCT00568178|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
116536|NCT00560755|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
116537|NCT00499746|Johns Hopkins University School of Medicine|Eric C. Strain, M.D.|410-550-1191|ecsgss@aol.com
116544|NCT00081939|The Myeloma Institute, University of Arkansas for Medical Sciences|Director of Clinical Trials and Regulatory Affairs|501-526-6990|npetty@uams.edu
116550|NCT00016718|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org
116553|NCT02609659|AbbVie|Global Medical Services|800-633-9110|
116558|NCT02475395|Sandstone Diagnostics|Cheif Science Officer|9253157246 ext 925|gsommer@sandstonedx.com
116559|NCT02450383|University of Iowa|Gustavo Avila-Ortiz|3193357241|gustavo-avila@uiowa.edu
116561|NCT02419521|Medtronic Coronary Structual Heart|Beth Moe, Clinical Study Manager||beth.moe@medtronic.com
116573|NCT02207803|Virginia Commonwealth University|Dr. Paul Perrin|8048273894|pperrin@vcu.edu
116578|NCT02102464|TearScience, Inc.|VP Clinical and Regulatory Affairs|919-467-4007|regulatory@tearscience.com
116585|NCT01986686|Stony Brook Medicine|Roberto Bergamaschi, MD, PhD|631-638-2215|roberto.bergamaschi@stonybrookmedicine.edu
116591|NCT01916967|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
116592|NCT01916980|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
116794|NCT02478632|GlaxoSmithKline|GSK Response Center|866-435-7343|
116796|NCT02317016|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com
116798|NCT02135848|GlaxoSmithKline|GSK Response Center|866-435-7343|
116799|NCT02108977|Health Services Research & Development, Durham VAMC|Dr. Santanu Datta, Health Sciences Research Specialist, HSR&D|(919) 286-0411 ext 7580|Santanu.Datta@va.gov
116800|NCT02105324|Massachusetts General Hospital|Dr. Steven J. Russell|617.726.1848|sjrussell@partners.org
116802|NCT02037607|Indiana University|Heather Cero, Research Nurse Manager|317-396-1298|hcero@iupui.edu
116803|NCT01939223|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com
116627|NCT01364090|Viral Hepatits Clinical Research Program - The Kirby Institute - UNSW Sydney|Dr. Jason Grebely|+61 2938 50957|Jgrebely@kirby.unsw.edu.au
116629|NCT01323387|Synthes Spine|Clinical Research Associate|610-719-5942|knappk@synthes.com
116630|NCT01295112|The Emmes Corporation|Traci Clemons|1-301-251-1161 ext 10212|tclemons@emmes.com
116632|NCT01256671|Endoceutics|Director of Data Analysis|418-653-0033 ext 215|celine.martel@endoceutics.com
116633|NCT01239394|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu
116635|NCT01212770|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com
116636|NCT01196416|Memorial Sloan Kettering Cancer Center|Dr. Mark Dickson|646-888-4164|DicksonM@mskcc.org
116637|NCT01192295|Purdue Pharma L.P.|Clinical Leader|800-733-1333|
116643|NCT01108757|Cleveland Clinic|Lynn Borzi|2164453158|borzil@ccf.org
116649|NCT01009515|University of New Mexico|Montaser Shaheen, MD, PhD|505-925-0404|MoShaheen@salud.unm.edu
116651|NCT00996840|GlaxoSmithKline|GSK Response Center|866-435-7343|
116661|NCT00832520|UNM Cancer Center|Nicole Stephens, PhD, CCRP, CRA|505-925-0350|nstepehens@salud.unm.edu
116665|NCT00722865|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu
116666|NCT00704496|milton s hershey medical center|timothy craig,|717-531-6525 ext 1|tcraig@psu.edu
116671|NCT00619112|UCSF|Nicholas Butowski|4153532966|Butowski@neurosurg.ucsf.edu
116686|NCT00194129|UHCMC Mood Disorders Program|David Kemp, MD|216-844-2865|David.Kemp@UHhospitals.org
116688|NCT00069238|National Cancer Institute|Dr. Wyndham WIlson|301-435-2415|wilsonw@mail.nih.gov
116689|NCT00064753|University of North Carolina at Chapel Hill|Dr. Myra Carpenter|9199429408|myra_carpenter@unc.edu
116691|NCT00045708|Johns Hopkins - Adult Brain Tumor Consortium (ABTC)|Director Adult Brain Tumor Consortium|410-955-8837|jfisher@jhmi.edu
116694|NCT02616250|GALDERMA|Fabien AUDIBERT, Sr CPM|+33 (0) 4 9238 3034|fabien.audibert@galderma.com
116699|NCT02447848|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com
116703|NCT02301364|Memorial Sloan Kettering Cancer Center|Christian Grommes, MD|212-639-4058|grommesc@mskcc.org
116704|NCT02287025|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com
116706|NCT02281773|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
116708|NCT02249065|Galderma Laboratories L.P.|Dr. Jean Philippe York|817-961-5468|jp.york@galderma.com
116710|NCT02207231|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com
116715|NCT02096081|Merz North America, Inc.|Michelle Widmann|919-582-8238|Michelle.Widmann@merz.com
116719|NCT02001714|Beaumont Health|Ananias C. Diokno, MD||ananias.diokno@beaumont.edu
116721|NCT01966003|Amgen Inc.|Study Director|866-572-6436|
116722|NCT01946529|St. Jude Children's Research Hospital|Sara Federico, MD|901-595-2220|sara.federico@stjude.org
116726|NCT01832090|Merz North America, Inc.|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com
116727|NCT01786902|Asan Medical Center|Dr. Hanwook Yoo|82-2-3010-3374|hwyoo@amc.seoul.kr
116733|NCT01732458|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
116734|NCT01703169|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu
121408|NCT00799643|Joslin Diabetes Center|Allison B.Goldfine|617-309-2400|allison.goldfine@joslin.harvard.edu
121409|NCT00794547|University of Michigan Comprehensive Cancer Center|Dr. Nithya Ramnath|734-647-1417|nithyar@umich.edu
121410|NCT00792948|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|(206) 667-4623|
121412|NCT00788697|Bracco Diagnostics Inc.|Maria Luigia Storto, MD Executive Director X-Ray and Ultrasound Medical Affairs|(609) 514-2200|MariaLuigia.Storto@diag.bracco.com
121413|NCT00782795|University of Michigan|Matthew DiMagno||mdimagno@umich.edu
121414|NCT00772668|UM/Sylvester Comprehensive Cancer|Denise Pereira MD|305-243-9127|dpereira2@med.miami.edu
116743|NCT01503164|Johns Hopkins University|Naresh Punjabi|410-550-6384|npunjabi@jhmi.edu
121415|NCT00764517|Knight Cancer Institute, Oregon Health & Science University|Dr. Stephen E. Spurgeon MD|503-494-4606|spurgeos@ohsu.edu
116791|NCT02730819|Mayo Clinic|Dr. Jason Sluzevich|904-953-9453|Sluzevich.Jason@mayo.edu
116793|NCT02480621|Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital|Dr. Adam Driesman|2033315938|Adam.Driesman@nyumc.org
116804|NCT01938573|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu
116807|NCT01748890|Massachusetts General Hospital|Anthony E. Samir|6178523241|asamir@partners.org
116808|NCT01748292|Retina Consultants of Houston|Charles C. Wykoff, MD, PhD|713-524-3434|ccwmd@houstonretina.com
116809|NCT01736397|Keryx Biopharmaceuticals|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com
116810|NCT01623739|UTHSCSA Periodontics|Guy Huynh-Ba|2105673569|huynhba@uthscsa.edu
116811|NCT01617460|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366|
116813|NCT01536197|Washington University School of Medicine|M. Yanina Pepino|3143628113|ypepino@dom.wustl.edu
116814|NCT01514357|Mayo Clinic|Dr. John C. Burnett|507-284-7932|burnett.john@mayo.edu
116816|NCT01336413|VHA Durham|Christine E. Marx, MD MA|9192860411 ext 3626|christine.marx@va.gov
116817|NCT01187381|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
116818|NCT01126801|Brigham & Women's Hospital|Dr. Hadine Joffe|617-732-4906|hjoffe@partners.org
116819|NCT01114724|Medtronic Inc., Aortic and Peripheral Vascular|Laura Regan, MPH - Study Lead|707-591-2743|laura.e.regan@medtronic.com
116820|NCT01094743|Johnson & Johnson Vision Care|Huan Sheng, MD, PhD|1-904-443-3440|HSheng2@its.jnj.com
116821|NCT01035606|VA Northern California|Anthony Chen, MD|925-372-2000|anthony.chen@ucsf.edu
116823|NCT00907218|MassGH|Dr. Timothy Wilens|617-724-5226|twilens@partners.org
116824|NCT00899847|Stanford University School of Med|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu
116827|NCT00790569|Butler Hospital|Dr. Michael Stein|401-455-6646|michael_stein@brown.ed
116828|NCT00625404|FHI 360|Jennifer Deese, Principal Investigator|919-544-7040 ext 11292|jdeese@fhi360.org
116829|NCT00601900|Memorial Sloan-Kettering Cancer Center|Maura Dickler, M.D.||dicklerm@mskcc.org
116830|NCT00573833|Memorial Sloan Kettering Cancer Center|Dr. Josh Yoshiya Yamada, Assistant Attending|+1212-639-2950|yamadaj@mskcc.org
116832|NCT00432159|Depuy Synthes|Lynn Wilson|508-880-8109|lwilso45@its.jnj.com
116833|NCT00414726|Massachusetts General Hospital|Aneesh B. Singhal, MD|617 726 8459|asinghal@partners.org
116834|NCT00409565|University of Pittsburgh Cancer Institute|Michael Gibson, MD|412-692-2600|gibsonmk@upmc.edu
116835|NCT00401817|Weill Cornell Medicine|John Leonard, MD|646.962.2064|amr2017@med.cornell.edu
116836|NCT00383760|Princess Margaret Cancer Centre|Dr. Malcolm Moore|416-945-2263|malcolm.moore@uhn.ca
116837|NCT00272844|Boston Children's Hospital|Dr. Mira Irons|617-355-2449|mira.irons@childrens.harvard.edu
116838|NCT00142506|MEMORIAL SLOAN KETTERING CANCER CENTER|MICHAEL J ZELEFSKY|+1212-639-6802|zelefskm@MSKCC.ORG
116839|NCT00006184|National Cancer Institute, National Institutes of Health|Dr, Claude Sportes, M.D.|301-435-5280|csportes@mail.nih.gov
120261|NCT03105518|Brigham and Women's Hospital/Harvard Medical School|Lawrence Tsen, MD|617.732.8216|ltsen@bwh.harvard.edu
120263|NCT03024112|University of Colorado, Denver|Dr. Jason Brainard|720-848-3257|Jason.Brainard@ucdenver.edu
120264|NCT02928380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com
120268|NCT02665455|Abbott Diabetes Care|Jolyon Bugler, Snr Director Clinical Development & Regulatory Affairs|+44 1993 863094|joe.bugler@abbott.com
120269|NCT02606279|Wake Forest University Health Sciences|Katherine Schafer, Assistant Professor Internal Medicine|13367166342 ext 336|kschafer@wakehealth.edu
120271|NCT02574858|University of Michigan|Dr. D. Kim Turgeon|734-764-6860|kturgeon@med.umich.edu
120272|NCT02487199|AbbVie|Global Medical Services|800-633-9110|
120273|NCT02476994|Baxter Healthcare|Clinical Trials Disclosure Group||joe_archer@baxter.com
120274|NCT02452892|Tal Medical|Dr. Atul Pande, MD, Chief Medical Officer||apande@talmedical.com
120275|NCT02452528|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400|
120277|NCT02390219|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
120278|NCT02359058|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
120280|NCT02345772|CTCA|Jessica L. Coats, RN|6232073899|jessica.coats@ctca-hope.com
120282|NCT02285777|GlaxoSmithKline|GSK Response Center|866-435-7343|
120283|NCT02271217|Acorda Therapeutics|Holly Roberts, Executive Medical Director|914-326-5000|hroberts@acorda.com
120284|NCT02265796|Malcom Randall VA Medical Center|Dr. Anthony Bavry|352-376-1611 ext 6325|anthony.bavry@va.gov
120285|NCT02251990|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
120286|NCT02247063|University of Michigan|Thiago Nascimento|734-615-9390|Nasci@umich.edu
120287|NCT02201394|Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai|Dr. Juan J. Badimon||Juan.Badimon@mssm.edu
120288|NCT02178696|University of Michigan|Jon-Kar Zubieta||JONKAR.ZUBIETA@hsc.utah.edu
120289|NCT02166476|The Medicines Company|Global Health Science Center|888-977-6326|medical.information@themedco.com
120290|NCT02151981|AstraZeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com
120291|NCT02140164|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov
120292|NCT02138825|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com
120293|NCT02132468|Mateon Therapeutics|Clinical Operations|6506357000|ca@mateon.com
120294|NCT02093520|Vertos Medical|VP of Clinical Affairs|9493490008|kdavis@vertosmed.com
120295|NCT02060890|University of California, San Francisco|Nicholas Butowski MD Professor of Neuro-Oncology|414-353-2966|Thelma.Munoz@ucsf.edu
120296|NCT02057068|Atlanta Department of Veterans Affairs Medical Center CVNR|Patricia C. Griffiths, PhD|6783615462|pcgriff@emory.edu
120297|NCT02042924|Masonic Cancer Center, University of Minnesota|Dr. Susanta Hui|626-218-0556|shui@coh.org
120298|NCT02037568|University of Colorado Denver|Mark L. Laudenslager, PhD|303-724-9277|biel@ucdenver.edu
120299|NCT02030080|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@upenn.edu
120300|NCT02023983|Municipal Hospital Ostrava|dr. Kamil Novobílský|+420 59 619 2660|k.novobilsky@mnof.cz
120301|NCT02013167|Amgen Inc.|Study Director|866-572-6436|
120302|NCT01975935|University of Michigan|Dr. Elif Oral|7346157271|eliforal@med.umich.edu
120303|NCT01942707|Universidade Federal de São Paulo|Dr. Heraldo Carlos Borges Inforzato|55-13-997112644|heraldo@litoral.com.br
120304|NCT01936974|CTCA|Jessica Coats, RN|6232073899|jessica.coats@ctca-hope.com
120306|NCT01933919|AbbVie|Global Medical Services|800-633-9110|
120309|NCT01910402|GlaxoSmithKline|GSK Response Center|866-435-7343|
120310|NCT01908803|Alcon Research, Ltd.|Sr Clinical Project Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com
120312|NCT01869439|WoundVision LLC|Dr. James G. Spahn, M.D.|(317) 775-6080|brett@woundvision.com
120313|NCT01860040|Western Regional Medical Center|Director of Clinical Research|6232073000|westerntrials@ctca-hope.com
116893|NCT02696317|Alcon, A Novartis Division|Sr. Brand Lead, Global Medical Affairs, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com
120314|NCT01851174|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com
116895|NCT02640482|AbbVie|Global Medical Services|800-633-9110|
116896|NCT02637804|CooperVision Inc.|Director, Professional Service|+81 3 5449 6619|Taku.Muraoka@jp.coopervision.com
116897|NCT02610634|Newcastle University|Professor Lynn Rochester|0191 208 1291|lynn.rochester@ncl.ac.uk
120315|NCT01848067|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Jianqing Lin|(215) 955-8874|jianqing.lin@jefferson.edu
116899|NCT02540356|Baxalta, now part of Shire|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com
116900|NCT02514473|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com
120316|NCT01819129|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com
116903|NCT02476032|University of Minnesota|Patricia Lenton Director of Oral Health Research Clinic||lento001@umn.edu
120319|NCT01773070|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110|
116907|NCT02410200|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com
120320|NCT01752712|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rwbuchanan@mprc.umaryland.edu
120321|NCT01740401|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu
116910|NCT02317692|Marquette University|Dr. Alyson Gerdes|414-288-6145|alyson.gerdes@mu.edu
120322|NCT01722929|Northwestern University|Murad Alam, MD|312-695-4761|m-alam@northwestern.edu
116912|NCT02283268|Baxalta US Inc.|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com
116915|NCT02210091|Baxalta US Inc.|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com
120325|NCT01702909|Western Regional Medical Center|Steffany Gayton|623-207-3778|Steffany.Gayton@ctca-hope.com
120326|NCT01687712|Fertility Biotech AG|Executive VP of Regulatory Affairs||maria.vazquez@fertilitybiotech.com
116919|NCT02071420|University of Iowa|Lucas Carr, PhD|319-353-5432|lucas-carr@uiowa.edu
120328|NCT01670292|Palmer Center for Chiropractic Research|Dr. Ting Xia|563-884-5161|ting.xia@palmer.edu
116921|NCT01989156|Philip Morris Products S.A.|Christelle Haziza, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com
116922|NCT01987908|Baxalta US Inc.|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com
120329|NCT01644500|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
120330|NCT01626092|Masonic Cancer Center, University of Minnesota|Weston P Miller, MD|612-626-2778|mill4991@umn.edu
120331|NCT01593670|Masonic Cancer Center, University of Minnesota|Dr. Erica Warlick|612-625-5467|ewarlick@umn.edu
120332|NCT01592240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
116930|NCT01790659|Instituto Conmemorativo Gorgas de Estudios de la Salud|Nestor Sosa, MD, FACP|507-527-4950|drnsosa@gmail.com
120333|NCT01588470|UT Health Science, San Antonio|Dr. Muhammad Abdul-Ghani, MD|210-567-6691|abdulghani@uthscsa.edu
116932|NCT01757405|Baxalta US Inc.|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com
120334|NCT01581619|Massachusetts General Hospital|Alphonse Taghian, MD, PhD|617-726-7559|ATAGHIAN@mgh.harvard.edu
116935|NCT01736579|Baxalta US Inc|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com
120335|NCT01552694|Washington University School of Medicine|Kevin Yarasheski, PhD|3143628173|key@wustl.edu
116941|NCT01614093|Morgan State University|Kimberly R. Warren, Ph.D.|443-885-3492|kimberly.warren@gmail.com
120339|NCT01435265|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-7740|sfeldman@wakehealth.edu
116944|NCT01508910|Baxalta US Inc.|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com
116945|NCT01507896|Baxalta US Inc|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com
120341|NCT01416584|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu
116947|NCT01488994|Baxalta US Inc|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com
116948|NCT01485796|Baxalta US Inc.|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com
120342|NCT01416389|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
120343|NCT01406860|University of Iowa Hospitals and Clinics|Brett Faine|3193108067|brett-faine@uiowa.edu
120344|NCT01401907|MGH|Jennifer Temel MD|617-724-4000|jtemel@partners.org
116955|NCT01308567|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
116956|NCT01305213|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org
120346|NCT01349933|Mayo Clinic|Brigette Buig-Yue Ma, MBBS, FRACP||brigette@clo.cuhk.edu.hk
120347|NCT01346189|University of Pennsylvania and Department of Veteran Affairs|Dr. Kevin G. Volpp||volpp70@wharton.upenn.edu
120350|NCT01343368|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-8094|smith719@umn.edu
116962|NCT01218438|Baxalta, now part of Shire|Leman Yel, Senior Medical Director||leman.yel@shire.com
120351|NCT01342770|Mayo Clinic|Dennis Wigle, M.D., Ph.D.|507-284-2511|wigle.dennis@mayo.edu
116964|NCT01178294|Baxalta US Inc.|Leonard A. Valentino, MD, Sr. Medical Director, Medical Affairs - Global Strategy Hemophilia||leonard.valentino@baxalta.com
116965|NCT01175213|Baxalta US Inc.|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com
116966|NCT01162499|Children's Hospital of Philadelphia|Diva De Leon, MD|267-426-5529|DELEON@email.chop.edu
116967|NCT01154816|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
120353|NCT01327547|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
116971|NCT01104402|Johns Hopkins University & University of Washington|Dr. Noah Lechtzin & Dr. Christopher Goss|410-502-7044|nlechtz@jhmi.edu
116972|NCT01101867|The Ohio State University|Dr. Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu
116974|NCT01015807|Univerisity of Washington|Dr. Laurent Bollag|+12063277328|bollag@uw.edu
120356|NCT01310699|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810 ext 94121|tonya.kaltenbach@va.gov
116976|NCT00939393|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com
120359|NCT01285713|New York University, Langone Medical Center|Dr. Kari Posner|212-263-7300|kariposner@gmail.com
116980|NCT00835731|Planned Parenthood League of Massachusetts|Principal Investigator|6176161600|
120361|NCT01261559|University of Washington|Dr. Claire Sandstrom|206-744-3561|cks13@uw.edu
116983|NCT00781898|University Of Pennsylvania|Charle P. O'Brien|215-222-3200|obrien@mail.med.upenn.edu
120362|NCT01243762|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
120363|NCT01235910|University of Colorado|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu
120365|NCT01231412|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org
120366|NCT01228435|Massachusetts General Hospital|Lecia Sequist|617-726-7812|lvsequist@partners.org
120367|NCT01221753|Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA02215|Robert Haddad, MD|617-632-3090|robert_haddad@dfci.harvard.edu
120368|NCT01209078|GlaxoSmithKline|GSK Response Center|866-435-7343|
120369|NCT01206062|Wake Forest University Health Sciences|David Reboussin|336-716-6844|drebouss@wakehealth.edu
120370|NCT01195922|University of California San Diego|D. J. Silvio Gutkind|(858) 534 5980|sgutkind@ucsd.edu
116995|NCT00570089|Cedars-Sinai Medical Center|C. Noel Bairey Merz, MD|310-423-9680|merz@cshs.org
116996|NCT00496964|Virginia Commonwealth University|Dr. Sheryl Finucane|804-628-3639|sfinucan@vcu.edu
120371|NCT01166438|RTI International|Dr. Marie Gantz|919-597-5110|mgantz@rti.org
116998|NCT00464568|GlaxoSmithKline|GSK Response Center|866-435-7343|
120372|NCT01144377|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
117002|NCT00357656|Baxalta US Inc|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com
120373|NCT01132612|Novartis Pharmaceuticals|Study Director|862-778-8300|
120374|NCT01120600|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
120375|NCT01111305|NIAID/NIH|Dr. Amy Klion|301-435-8903|aklion@niaid.nih.gov
120376|NCT01071993|University of Oklahoma|Mazen Abu-Fadel, MD|405-271-4742|mazen-abufadel@ouhsc.edu
120377|NCT01065454|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
120378|NCT01059643|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
120379|NCT01059630|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com
120380|NCT01051557|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley|212-639-5122|kaleyt@mskcc.org
120383|NCT01025284|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
120385|NCT01014533|University of Michigan|Kirk Brower||kbrower@med.umich.edu
120386|NCT01012492|Emory University School of Medicine|Leslie S Kean|404-376-0187|Leslie.kean@emory.edu
120387|NCT01010204|Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center|K.N. Roy Chengappa, Md|412-246-5006|chengappakn@upmc.edu
120388|NCT00984282|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
120389|NCT00965718|Yonsei university|Moonjae Chung, MD|82-2-2228-2274|MJCHUNG@yuhs.ac
117020|NCT02542072|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com
120390|NCT00940888|Saint Jude Medical|Grant Kim, Director Clinical Studies|818-493-3147|gkim@sjm.com
120391|NCT00931632|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com
120392|NCT00920426|ViiV Healthcare|GSK Response Center|866-435-7343|
117025|NCT02454608|Massachusetts Eye and Ear Infirmary|Benjamin Bleier|(617) 573-6966|Benjamin_Bleier@MEEI.HARVARD.EDU
120394|NCT00901901|BAYER|Therapeutic Area Head||clinical-trial-contact@bayerhealthcare.com
120395|NCT00888173|NRG Oncology|Linda Gedeon For Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org
120396|NCT00880360|University of Texas Health Science Center at San Antonio|Dr. Tyler Curiel|210-450-1000|curielt@uthscsa.edu
120397|NCT00880022|vanderbilt university|sheila h ridner|615-322-0831|Sheila.Ridner@Vanderbilt.edu
120398|NCT00878436|NYU Langone Medical Center|Fraustina Hsu|646 754 712|fraustina.hsu@nyumc.org
117031|NCT02302716|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
117032|NCT02255097|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
120399|NCT00869323|Masonic Cancer Center, University of Minnesota|Dr. Anne Blaes|612-626-8138|blaes004@umn.edu
117034|NCT02229396|AstraZeneca|Peter Ohman, MD|+1 301 398 0120|Peter.Ohman@astrazeneca.com
120400|NCT00867087|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
120401|NCT00863057|Center for Biostatistics in AIDS Research, Harvard School of Public Health|Clinicaltrials.gov Coordinator|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
117037|NCT02147184|Baylor College of Medicine|Dr. Chadi Calarge|832-824-4764|chadi.calarge@bcm.edu
117038|NCT02133508|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
120402|NCT00851591|Texas Tech University Health Sciences Center|Thomas Hale, PhD.|806-354-5528|thomas.hale@ttuhsc.edu
120405|NCT00825175|University of Michigan|Julia Looper|253 534 8499|jlooper@umich.edu
120406|NCT00821964|University of Washington|Principal Investigator||TrialTVG@medicine.washington.edu
120407|NCT00820898|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org
120408|NCT00818779|Texas Tech University Health Sciences Center School of Medicine|Gary Meyerrose|806-743-3150|gary.meyerrose@ttuhsc.edu
120411|NCT00783705|Mayo Clinic Rochester|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu
117049|NCT01788358|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com
120412|NCT00780026|University of Michigan|Subramanian Sathishkumar||ssatish@med.umich.edu
120413|NCT00775684|University of Pennsylvania|Associate Professor of Medicine. Director, Translational Research Center|215 746-0025|rickels@mail.med.upenn.edu
117053|NCT01692691|Western Regional Medical Center|Heather Barilla|623-207-3649|heather.barilla@ctca-hope.com
120415|NCT00753363|Baltimore VAMC|Dr. Alice Ryan|410-605-7851|aryan@grecc.umaryland.edu
120416|NCT00749957|Applied Genetic Technologies Corporation|Chief Medical Officer|386-462-2204 ext 7205|jchulay@agtc.com
120417|NCT00749606|SUNY Upstate Medical University|Ruth S. Weinstock MD PhD|315-464-5740|weinstor@upstate.edu
120418|NCT00737529|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialsdisclosure@celgene.com
117060|NCT01515189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
117061|NCT01495988|The Emmes Corporation|Damon Collie|301-251-1161|dcollie@emmes.com
117062|NCT01455519|Rehabilitation Institute of Chicago|Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org
117063|NCT01452529|Purdue Pharma L.P.|Clinical Leader|800-733-1333|
120420|NCT00733304|GlaxoSmithKline|GSK Response Center|866-435-7343|
117065|NCT01400139|Purdue Pharma L.P.|Clinical Leader|800-733-1333|
120421|NCT00718718|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com
117068|NCT01288534|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, M.D.|734-936-9630|sprattda@med.umich.edu
120423|NCT00710034|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu
120424|NCT00696449|Wake Forest University Health Sciences|Steven Feldman|3367167740|sfeldman@wakehealth.edu
120425|NCT00696488|Wake Forest University Health Sciences|Steve Feldman, MD|336-716-3775|sfeldman@wakehealth.edu
120426|NCT00693693|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wfubmc.edu
120427|NCT00690833|Wake Forest University Health Sciences|Dr Steve feldman|336-716-3775|sfeldman@wakehealth.edu
120430|NCT00681109|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|(617) 573-4331|Reza_Dana@meei.harvard.edu
120431|NCT00674661|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com
120432|NCT00661505|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com
120434|NCT00658112|Wake Forest University Health Sciences|Steve Feldman MD|336-716-3775|sfeldman@wakehealth.edu
117084|NCT00924729|Johns Hopkins University|Walter J. Stark, M.D./Professor of Ophthalmology|410-955-5490|wstark@jhmi.edu
120435|NCT00655824|GlaxoSmithKline|GSK Response Center|866-435-7343|
117086|NCT00853112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
120437|NCT00654355|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3885|sfeldman@wfubmc.edu
120438|NCT00647699|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com
120439|NCT00630955|Yale University|Dr. Suchitra Krishnan-Sarin, Associate Professor of Psychiatry|203-974-7595|suchitra.krishnan-sarin@yale.edu
120440|NCT00608530|VA San Diego Healthcare System|Joseph H. Atkinson MD, Principal Investigator|858 642 3775|joseph.atkinson@va.gov
120441|NCT00602459|Ohio State University|John Byrd, M.D.||john.byrd@osumc.edu
120442|NCT00587990|EMMES Corporation|Adam Mendizabal|301-251-1161 ext 221|amendizabal@emmes.com
120443|NCT00573872|University of Alabama at Birmingham|John Fiveash, MD|205-975-0224|jfiveash@uabmc.edu
120444|NCT00559988|Biotronik, Inc|Crystal Miller|503-451-8051|crystal.miller@biotronik.com
120445|NCT00556452|University of Michigan Cancer Center|Dr. John Magenau|734/936-8785|johnmage@umich.edu
120446|NCT00548886|Emory University|Dr. Peter Seth Fischbach|404-256-2593|pfischb@emory.edu
120447|NCT00538512|University of Michigan School of Public Health|Arnold S. Monto, MD|734-764-5453|asmonto@umich.edu
117100|NCT00596011|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D.|813-745-6885|nagi.kumar@moffitt.org
117102|NCT00575042|University of Miami|Dr. Cynthia Levy|305-243-2330|clevy@med.miami.edu
120450|NCT00527644|University of Missouri Health Care|Bruce Ramshaw, M.D.|5738841925|kadysj@health.missouri.edu
120451|NCT00521885|Lehigh Valley Health Network|Leslie Baga, Director of Research|610 402 1285|Leslie.Baga@lvhn.org
120452|NCT00500331|GlaxoSmithKline|GSK Response Center|866-435-7343|
117113|NCT00116428|Biosense Webster|Melissa Schultz, Project Manager, Regulatory Affairs|800-729-9010 ext 8787|mschult1@its.jnj.com
120453|NCT00499408|Comprehensive Cancer Center of Wake Forest University|K.C. Balaji, MD|336-716-5690|kbalaji@wakehealth.edu
120454|NCT00471497|Novartis Pharmaceuticals|Study Director|862-778-8300|
120455|NCT00463840|New York University Cancer Institute|Theresa Ryan, MD|212-731-5430|theresa.ryan@nyumc.org
120456|NCT00455312|Masonic Cancer Center, University of Minnesota|Dr. Jakub Tolar, MD||tolar003@umn.edu
120457|NCT00438490|Massachusetts General Hospital|Corrine Welt, MD|617-726-8437|cwelt@partners.org
117119|NCT00003659|Memorial-Sloan Kettering Cancer Center|Dr. David Scheinberg|646-888-2190|scheinbd@mskcc.org
117120|NCT00038727|George Washington University|Marinella Temprosa, PI of Coordinating Center|3018819260|ella@bsc.gwu.edu
117121|NCT03044431|Lung Institute|Melissa Rubio, PhD, APRN|214-504-2117|pidallas@lunginstitute.com
117122|NCT02798289|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
117123|NCT02750943|GlaxoSmithKline|GSK Response Center|866-435-7343|
120458|NCT00433966|Cardiovascular Research Foundation|Ori Ben-Yehuda, MD, Executive Director, Clinical Trials Center|646-434-4123|obenyehuda@crf.org
117126|NCT02642432|AbbVie|Global Medical Services|800-633-9110|
120459|NCT00429793|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org
120460|NCT00411086|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org
117129|NCT02513160|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com
117130|NCT02487771|University of Kansas Medical Center|Susan Carlson, PhD|(913) 588-5359|SCARLSON@kumc.edu
117131|NCT02478580|University Of Texas Southwestern Medical Center|Dr. Enas Kandil|214-590-8509|Enas.Kandil@UTSouthwestern.edu
117133|NCT02464163|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064 ext 153|ldunkle@proteinsciences.com
117134|NCT02434146|University of Wisconsin Carbone Cancer Center|Margo L Hoover-Regan|608-263-6200|mhooverregan@pediatrics.wisc.edu
117135|NCT02408692|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|whru@ohsu.edu
117136|NCT02395653|The Medicines Company|Global Health Science Center|1-888-977-6326|medical.information@themedco.com
120462|NCT00392951|Children's Hospital of Philadelphia|David T. Teachey, MD|267-426-5802|teacheyd@email.chop.edu
120463|NCT00376948|Barbara Ann Karmanos Cancer Institute|Almhanna Khaldoun, M.D.|313-576-8746|almhanna@karmanos.org
120464|NCT00362882|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
120465|NCT00352027|S.t Jude Children's Research Hospital|Monika Metzger, MD|901-595-4974|monika.metzger@stjude.org
120466|NCT00346775|GlaxoSmithKline|GSK Response Center|866-435-7343|
117145|NCT02149264|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
120467|NCT00305864|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org
120468|NCT00301964|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org
117148|NCT02076243|Icahn School of Medicine at Mount Sinai|Dr. Philip Friedlander|212-824-8584|philip.friedlander@mssm.edu
120469|NCT00283712|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
117150|NCT02035553|ACADIA Pharmaceuticals Inc.|James Youakim, Vice President, Clinical Development|609-250-6900|jyouakim@acadia-pharm.com
117151|NCT02019472|Janssen-Cilag International N.V.|Associate Director||ClinicalTrialDisclosure@its.jnj.com
117152|NCT01981057|Medical University of Vienna|Nadja Haiden M.D.|+4314040032320|nadja.haiden@meduniwien.ac.at
117153|NCT01972568|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
117154|NCT01944098|TeamHealth Anesthesia|Enrico Camporesi MD|813-844-7170|ecampore@health.usf.edu
120470|NCT00258206|Johns Hopkins University|Dr. Carol Ann Huff|410-955-8842|chuff1@jhmi.edu
120471|NCT00238420|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
120472|NCT00194675|VA Puget Sound Health Care System|Alvin M. Matsumoto, MD|(206) 764-2760|alvin.matsumoto@med.va.gov
117159|NCT01877564|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|BScanlan@uams.edu
117160|NCT01871805|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
120473|NCT00176839|University of Minnesota Masonic Cancer Center|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu
117163|NCT01744483|Oregon Health Science & Science University|Dr Miriam Treggiari|(503) 494-8311|treggiar@ohsu.edu
117164|NCT01741259|OB Anesthesia Associates|Christy Morgan, MD|314-469-6800|christylmorganmd@gmail.com
117165|NCT01709409|OHRI|Dr. Brigitte Lemyre|613-737-8899 ext 71882|blemyre@toh.on.ca
117167|NCT01665599|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
117168|NCT01655719|University of Michigan|Tim Muth|734-615-8914|tmuth@med.umich.edu
120474|NCT00176852|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu
117171|NCT01624233|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
120475|NCT00167180|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-625-7409|mille011@umn.edu
120476|NCT00149799|Rhode Island Hospital|Katharine A. Phillips, MD|401-444-1646|katharine_phillips@brown.edu
120477|NCT00127231|Johns Hopkins University School of Medicine|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu
117175|NCT01531374|Medtronic, Inc.|Hatice Bilgic Lim||rs.medtroniccardiovascularclinicaltrials@medtronic.com
120478|NCT00118157|Barbara Ann Karmanos Cancer Institute|Sayeh Lavasani, M.D.|(313) 576-8751|lavasans@karmanos.org
120479|NCT00101036|California Cancer Consortium|DCC Project Administrator|626-256-4673 ext 60094|CCCP@coh.org
117178|NCT01449929|GlaxoSmithKline|GSK Response Center|866-435-7343|
120481|NCT00096447|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
120483|NCT00075400|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
120484|NCT00057551|Weill Cornell Medical College|James H. Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu
117185|NCT01311687|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|
117186|NCT01307891|University of Alabama at Birmingham|Andres Forero, M.D.|205-934-7167|aforero@uab.edu
117188|NCT01264601|University of Michigan|Matthew Greenhawt, MD, MBA|734/936-5634|mgreenha@umich.edu
117189|NCT01247324|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
117190|NCT01245062|GlaxoSmithKline|GSK Response Center|866-435-7343|
117191|NCT01243177|UCB Cares|UCB (Study Director)|+1 887 822 9493|
117192|NCT01240902|Medtronic, Inc.|Hatice Bilgic Lim||rs.medtroniccardiovascularclinicaltrials@medtronic.com
117194|NCT01144455|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com
117196|NCT01129245|Oregon Health and Science University|Alison Edelman|503-494-5949|edelmana@ohsu.edu
120488|NCT00031551|NINR/NIH|Suzanne Wingate|301-827-0982|suzanne.wingate@nih.gov
121416|NCT00743119|New York State Psychiatric Institute|Dr. Ziva Cooper|646-774-6129|zc2160@cumc.columbia.edu
117199|NCT01071512|University of Chicago|Dr. Adil Javed|773.834.0558|ajaved@neurology.bsd.uchicago.edu
117201|NCT01004003|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
121418|NCT00726323|GlaxoSmithKline|GSK Response Center|866-435-7343|
121421|NCT00716976|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
121422|NCT00688688|Astellas Pharma Global Development, Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com
121423|NCT00689104|Astellas Pharma Europe B.V.|Director Medical Science||ClinicalTrials.Disclosure@us.astellas.com
117210|NCT00857220|Sunovion|CNS Medical Director|866-503-6357|
117211|NCT00811317|Massachusetts General Hospital|Steven Russell|6177261848|sjrussell@mgh.harvard.edu
117212|NCT00780715|University of Dundee|Professor Ewan Pearson|+44 (0) 1382 383387|e.z.pearson@dundee.ac.uk
117213|NCT00742963|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com
117214|NCT00742859|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000|
117215|NCT00740870|Medtronic|Susan Patterson|763.526.1544|susan.patterson@medtronic.com
117216|NCT00731731|Mayo Clinic|Evanthia Galanis, M.D.||galanis.evanthia@mayo.edu
117217|NCT00725322|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu
117218|NCT00699816|Seoul National University College of Medicine|Jung-Hwan Yoon, MD, PhD|+82-2-2072-2228|yoonjh@snu.ac.kr
117221|NCT00676715|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
117222|NCT00672204|University of Minnesota|Bernhard J. Hering, M.D.|612-626-5735|bhering@umn.edu
117223|NCT00658814|SWOG|Study Statistician|206-667-4623|
117224|NCT00616759|Loma Linda University|Ronald L. Warnell, M.D.|909-558-9551|rwarnell@llu.edu
117225|NCT00586339|GlaxoSmithKline|GSK Response Center|866-435-7343|
117229|NCT00392236|Feinstein Institute for Medical Research|Delbert Robinson, M.D.|718 470-8195|drobinso@nshs.edu
117230|NCT00390429|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu
117231|NCT00331409|Oregon Health and Science University|Christopher W. Ryan|503-494-1951|ryanc@ohsu.edu
120489|NCT03254602|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com
117234|NCT00310401|Vanderbilt University|Lorraine B. Ware M.D.|615 322 8614|lorraine.ware@vanderbilt.edu
120490|NCT03037541|Wake Forest University Health Sciences|Joseph Jorizzo, MD|336-716-3775|jjorizzo@wakehealth.edu
117236|NCT00249444|Columbia University|Dr Wilfrid Raby|212-923-3031|rabywil@nyspi.columbia.edu
117237|NCT00233324|University of Alabama|Waldemar A. Carlo, M.D|(205) 934-4680|wcarlo@peds.uab.edu
117242|NCT00095784|University of Chicago|Olatoyosi Odenike, MD|773-702-3354|todenike@medicine.bsd.uchicago.edu
117244|NCT00060528|National Cancer Instititute (NCI), National Institutes of Health (NIH)|James L. Gulley, M.D.|301-435-2956|gulleyj@mail.nih.gov
117245|NCT02647944|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu
117246|NCT02609672|McMaster University/University of Waterloo|Dr. Monica Maly|519-888-4567 ext 37916|mrmaly@uwaterloo.ca
117247|NCT02517515|AbbVie|Global Medical Services|800-633-9110|
117248|NCT02474082|Novartis Pharmaceuticals|Study Director|862 ­778­ 8300|
117249|NCT02312713|University of North Carolina at Chapel HIll|Kelli Allen|919-966-0558|kdallen@email.unc.edu
117250|NCT02302092|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
117251|NCT02285998|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064 ext 153|ldunkle@proteinsciences.com
117252|NCT02224846|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
117253|NCT02211534|Regenesis Biomedical|Heather Vander Ploeg|602-4287041|Heather.VanderPloeg@regenesisbio.com
117254|NCT02136004|Weill Cornell Medical College|S. Chiu Wong, MD|212-746-4644|scwong@med.cornell.edu
117255|NCT02108951|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com
117256|NCT02057952|Regenstried Institute|Daniel O. Clark, PhD|317-274-9292|daniclar@iu.edu
117257|NCT01943435|University of Pittsburgh|Michael Schneider, PhD, DC - Associate Professor and Principal Investigator|412-383-6640|mjs5@pitt.edu
117258|NCT01911169|Medical University of South Carolina|Dr. James Oates|843-789-6797|oatesjc@musc.edu
117259|NCT01905683|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de
117260|NCT01867710|Janssen Pharmaceutica N.V|Medical Affairs Director||ClinicalTrialDisclosure@its.jnj.com
117261|NCT01695239|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
117262|NCT01639443|West Los Angeles VA / Cedars-Sinai Medical Center|Jennifer Talley Soares|(310) 478-3711 ext 83240|jennifer.soares@va.gov
117263|NCT01618162|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com
117264|NCT01606124|Mayo Clinic|Frank A. Sinicrope, M.D.|507-284–2511|sinicrope.frank@mayo.edu
117265|NCT01544179|AstraZeneca|Haiyi Jiang/Asia Medical Director|+86 21 60302408|haiyi.jiang@astrazeneca.com
117266|NCT01512693|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
117267|NCT01468896|The Ohio State University Comprehensive Cancer Center|William Carson, MD|614-293-6306|William.Carson@osumc.edu
117268|NCT01437098|Medtronic|Hiroko Ookubo|81367760811|hiroko.ookubo@medtronic.com
117270|NCT01387282|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com
117271|NCT01387269|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com
117272|NCT01352221|Shield Therapeutics|Mark Sampson|+44 (0) 207 186 8500|msampson@shieldtx.com
117273|NCT01320072|Montefiore Medical Center|Dr. Elina Jerschow, attending physician|9173625291|ejerscho@montefiore.org
117274|NCT01286012|Rockwell Medical|Raymond Pratt, MD CMO|248 960 9009|rd@rockwellmed.com
117275|NCT01141712|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com
117276|NCT01120782|Johnson & Johnson Vision Care|Ross Franklin, OD|1-904-443-1379|RFrankl1@its.jnj.com
117278|NCT01042535|H. Lee Moffitt Cancer Center and Research Institute|Hatem Soliman, M.D.|813-745-4933|hatem.soliman@moffitt.org
117279|NCT01002742|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com
117280|NCT00912223|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com
117282|NCT00908388|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com
117283|NCT00864227|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com
117284|NCT00859040|Dana-Farber Cancer Institute / Brigham & Women's Hospital|Patrick Y. Wen, MD|617-632-2166|pwen@partners.org
117285|NCT00694551|H. Lee Moffitt Cancer Center and Research Institute|Mayer Fishman, M.D., Ph.D.|813-745-4398|mayer.fishman@moffitt.org
117286|NCT00678301|GlaxoSmithKline|GSK Response Center|866-435-7343|
117287|NCT00581308|W. L. Gore & Associates|Jay Donosky|(800) 437-8181|jdonosky@wlgore.com
117288|NCT00554515|Beth Israel Deaconess Medical Center|David F. McDermott, MD||dmcdermo@bidmc.harvard.edu
117289|NCT00483496|Orfagen|Clinical project manager|0033534506462|caroline.miklaszewski@orfagen.com
117290|NCT00326417|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com
117292|NCT00125762|BIDMC|Nezam Afdhal|6176321118|nafdhal@bidmc.harvard.edu
120494|NCT02811965|Lincoln Memorial University|Jennifer Savage, DNP, APN, FNP-BC||jennifer.savage@lmunet.edu
120496|NCT02763189|Wake Forest School of Medicine|Dr. Michael A. Olympio|3369182132|molympio@wakehealth.edu
120497|NCT02758613|Eli Lilly and Company|Chief Medical Officer|800-545-5079|
120500|NCT02581410|GlaxoSmithKline|GSK Response Center|866-435-7343|
120507|NCT02353299|Sleep Disorders and Research Center Henry Ford Hospital|Christopher L Drake|248-344-6672|cdrake1@hfhs.org
120510|NCT02332239|Department of Emergency Medicine, Alpert Medical School, Brown University|Megan L. Ranney, MD, MPH, FACEP|401-444-2557|megan_ranney@brown.edu
120518|NCT01936363|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
120519|NCT01920594|GlaxoSmithKline|GSK Response Center|866-435-7343|
117417|NCT01263717|Massachusetts General Hospital|Steven K. Grinspoon, MD|617-724-9109|sgrinspoon@partners.org
117421|NCT01142297|University of Texas Health Science Center at San Antonio|Thomas W. Oates|210-567-3590|oates@uthscsa.edu
117422|NCT01108445|Duke University Medical Center|Dr. Andrew J Armstrong|919-668-4615|andrew.armstrong@duke.edu
117424|NCT01036321|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D.|813-745-6885|nagi.kumar@moffitt.org
117426|NCT01000506|GlaxoSmithKline|GSK Response Center|866-435-7343|
117431|NCT00858494|University of Washington|James A Taylor|206-616-1206|uncjat@uw.edu
117494|NCT00868608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
117498|NCT00581256|University of Michigan Cancer Center|Dr. Lori Pierce, M.D.|734-764-9922|ljpierce@umich.edu
117499|NCT00581529|University of Michigan Comprehensive Cancer Center|Dr. Lori Pierce, M.D.|734-764-9922|ljpierce@umich.edu
117500|NCT00578331|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com
117501|NCT00537290|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu
117503|NCT00442611|Stanford University|Dr. Lorinda Chung|(650)493-5000 ext 6242|shauwai@stanford.edu
117504|NCT00425802|Memorial Sloan Kettering Cancer Center|Hugo Castro-Malaspina, MD|212-639-8197|castro-h@mskcc.org
117507|NCT00331344|Oakland Medical Center|Andrea Harzstark, M.D.|510-752-6789|andrea.l.harzstark@kp.org
117509|NCT00249470|Johns Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu
117511|NCT00005044|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
117526|NCT01454076|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com
117527|NCT01272232|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
117528|NCT01272219|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
117529|NCT01200355|Memorial Sloan Kettering Cancer Center|Dr. Genovefa Papanicolaou MD|212-639-8361|papanicg@mskcc.org
117530|NCT01078909|The Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu
117532|NCT00981149|ECU SODM|Sharon Gordon, DDS|2527377125|gordons@ecu.edu
117533|NCT00950300|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
117534|NCT00860743|Wayne State University and John D. Dingell VA Medical Center|Jason H. Mateika|313-576-4481|jmateika@med.wayne.edu
117535|NCT00845182|UTexas_SanAntonio|Devjit Tripathy|2105676691|tripathy@uthscsa.edu
117536|NCT00781937|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
117538|NCT00422058|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
117539|NCT00359736|Miami VAHS|Dr. Robert M Jackson, ACOS/R|305-575-3548|robert.jackson4@va.gov
117540|NCT00266864|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000 ext 5428|william.bauman@va.gov
117541|NCT00223795|VA Greater Los Angeles Healthcare System|Meika A. Fang, MD|310-268-4503|meika.fang@va.gov
120520|NCT01911546|Former: Cedars-Sinai Medical Center, Comprehensive Transplant Center|Dr. Joseph Kahwaji, MD, MPH|310-423-2641|joseph.m.kahwaji@kp.org
120521|NCT01874054|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com
120523|NCT01811316|Sunstar Americas, Inc.|Akane Takemura|+1-847-794-4276|akane.takemura@us.sunstar.com
120525|NCT01790594|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
120528|NCT01721057|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
120529|NCT01707043|Wake Forest|Steve Feldman, MD|336-716-3775|sfeldman@wakehalth.edu
120530|NCT01684748|Virginia Polytechnic Institute & State University|Elaina Marinik, Ph.D.|5402318299|emarinik@vt.edu
117374|NCT02507388|Alcon, A Novartis Division|Global Program Clinical Head, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com
120539|NCT01511081|UT MD Anderson Cancer Center|Joe Chang, MD/Professor, Radiation Oncology Department|713-792-7734|CR_Study_Registration@mdanderson.org
117377|NCT02480153|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
120540|NCT01510834|Pacific Health Research and Education Institute|Laurel King, PhD|808-564-5711|laurel.king@va.gov
120541|NCT01469767|Wake Forest University Health Sciences|Steve Feldman MD|336-716=3775|sfeldman@wakehealth.edu
120542|NCT01420926|Weill Medical College of Cornell University|Gail Roboz, M.D||gar2001@med.cornell.edu
117383|NCT02301975|GlaxoSmithKline|GSK Response Center|866-435-7343|
117384|NCT02229383|AstraZeneca|Peter Ohman, MD|+1 301 398 0120|Peter.Ohman@astrazeneca.com
120545|NCT01390389|McLean Hospital|Cara McCabe|617-855-2410|cfmccabe@partners.org
120547|NCT01345669|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
120548|NCT01345253|GlaxoSmithKline|GSK Response Center|866-435-7343|
120549|NCT01336634|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com
120550|NCT01324622|DePuy Synthes|Allyson Morris|610-719-5298|amorris5@its.jnj.com
120553|NCT01298323|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
120554|NCT01287208|Massachusetts General Hospital|Anne Thorndike, MD, MPH|617-724-4608|athorndike@partners.org
117396|NCT01732822|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00|kontakt@astrazeneca.com
120556|NCT01279109|Wake Forest School of Medicine|Dr. Sabina B. Gesell|336-713-8738|sgesell@wakehealth.edu
120558|NCT01235689|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110|
117401|NCT01641471|Cleveland Clinic - Section of Adult Reconstrution|Research Program Manager|216-444-4954|klikaa@ccf.org
117402|NCT01625182|Novartis Pharmaceuticals|Study Director|862-778-8300|
117404|NCT01607346|GlaxoSmithKline|GSK Response Center|866-435-7343|
120562|NCT01049243|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-1877|sfeldman@wfubmc.edu
117410|NCT01415232|UPittsburgh`|Dr. Manuel Vallejo|4126414260|vallejomc@anes.upmc.edu
120565|NCT01029912|MetroHealth Medical Center|Dr. Jayme Knutson|2167787342 ext 216|jsk12@case.edu
117412|NCT01344824|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
120566|NCT01015118|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
120567|NCT00910962|GlaxoSmithKline|GSK Response Center|866-435-7343|
120568|NCT00843466|Unilever|Jamie Regan|203-381-4448|Jamie.Regan@unilever.com
120569|NCT00841269|University of Utah|Dr. Douglas Kondo|(801) 587-1549|doug.kondo@hsc.utah.edu
117434|NCT00721409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
117435|NCT00719186|Yale University|Heping Zhang|203-785-5185|rmn-dcc@panlists.yale.edu
117436|NCT00690924|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org
120571|NCT00803062|NRG Oncology Statistics and Data Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
120573|NCT00754923|OSU|Miguel Villalona|614-366-5068|miguel.villalona@osumc.edu
117440|NCT00542425|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com
117443|NCT00495469|GlaxoSmithKline|GSK Response Center|866-435-7343|
120576|NCT00737464|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
120578|NCT00710684|GlaxoSmithKline|GSK Response Center|866-435-7343|
120579|NCT00689091|University of Michigan|Dr. George A Mashour|734-936-4280|gmashour@med.umich.edu
120580|NCT00688155|Wake Forest School of Medicine|Mark Espeland, PhD|336-761-2826 ext 336|mespelan@wakehealth.edu
120582|NCT00661427|Memorial Sloan Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org
120583|NCT00655564|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wakehealth.edu
120586|NCT00537095|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
120587|NCT00528645|Mayo Clinic|Julian R. Molina, M.D., Ph.D.|507-284-8318|molina.julian@mayo.edu
117456|NCT02526290|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com
117458|NCT02493855|AbbVie|Global Medical Services|800-633-9110|
117459|NCT02471326|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov
117463|NCT02340715|Medical College of Wisconsin|Ergun Ahunbay|4148057898|eahunbay@mcw.edu
117465|NCT02164916|SWOG Statistics & Data Management Center|SWOG Statistician|206-667-4408|smcdonou@fredhutch.org
117468|NCT01999322|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com
117469|NCT01999920|NYSPI|Franklin Schneier, MD|6464774-8041|fschneier@nyspi.columbia.edu
117470|NCT01994395|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org
117474|NCT01737268|Astellas Pharma Inc.|Vice-President, Japan-Asia Clinical Development Administration|+81-3-3244-0512|Astellas.resultsdisclosure@astellas.com
117477|NCT01684215|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
117478|NCT01668784|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
117479|NCT01615731|Stanford University|Dr. Kate Shaw|(650) 725-5986|kateshaw@stanford.edu
117482|NCT01496846|University of Michigan|Dr Tatiana Botero, Director of Postgraduate Program in Endodontics|734-936-2526|tbotero@umich.edu
117484|NCT01371110|Baylor College of Medicine (previously Icahn School of Medicine at Mount Sinai)|Wayne Goodman|713-798-4945|wayne.goodman@bcm.edu
117485|NCT01284504|Stanford University|Anthony Doufas, MD, PhD|1-650-498-7699|agdoufas@stanford.edu
117488|NCT01234831|Massachusetts General Hospital|Dr. Erica S. Shenoy|617-726-2036|eshenoy@partners.org
117512|NCT03109769|Riyadh Colleges of Dentistry and Pharmacy|Omar Alkadhi|966505154754|omar.alkadhi@riyadh.edu.sa
117513|NCT02706327|Eastern Mediterranean University|Yasin YURT|+905338724271|fzt.yasinyurt@gmail.com
117514|NCT02543398|UTHSCSA Periodontics|Guy Huynh-Ba|2105673569|huynhba@uthscsa.edu
117516|NCT02433483|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org
117519|NCT02116309|Johns Hopkins University|Dr. Vikesh Singh|4106146708|vakshin1@jhmi.edu
117520|NCT02099110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
117521|NCT01945021|OxOnc Development|Senior Director Clinical and Operational Science|6093157013|Allison.Kemner@oxfordoncology.com
117522|NCT01740427|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
117523|NCT01688921|PharmaJet, Inc.|Tara Miller, Clinical Affairs Manager|888-900-4321 ext 4163|tara.miller@pharmajet.com
117524|NCT01572389|Department of Veteran Affairs|Aanand, Naik, MD|713-794-8541|anaik@bcm.edu
117525|NCT01557166|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com
120591|NCT00410761|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
120599|NCT00098475|ECOG Statistical Office|Study Statistician|617-632-3012|
120600|NCT00093756|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|507/284- 9265|alex.adjei@roswellpark.org
120603|NCT00025233|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
120604|NCT00005803|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org
120605|NCT00025506|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
121428|NCT00662909|Astellas Pharma Global Development, Inc.|Medical Director, Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com
121431|NCT00650858|Johns Hopkins University|Daniel F. Hanley, MD|410-614-6996|dhanley@jhmi.edu
121433|NCT00635479|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu
121434|NCT00629122|Weill Cornell Medical College|Meredith J. Aull, Pharm.D.|(212) 746-8720|mea9008@med.cornell.edu
121436|NCT00624923|Joslin Diabetes Center|Dr. Allison Goldfine|617-309-2400|allison.goldfine@joslin.harvard.edu
121437|NCT00624013|Charles Drew University of Medicine and Science|Diana Echeverry, MD, Principal Investigator|3235634800|
121438|NCT00606554|Boston University School of Medicine|Allan Walkey, MD, MSc|617-638-4860|alwalkey@bu.edu
121439|NCT00604552|Medtronic Vascular|Angela Parsons|707-591-2293|angela.r.parsons@medtronic.com
121443|NCT00571324|Children's Hospital of Philadelphia|Diva De Leon, MD|267-426-5529|DELEON@email.chop.edu
121444|NCT00547378|Pelvic Health & Gastric Therapies|Shenita Bolstrom|763-526-8254|shenita.bolstrom@medtronic.com
121445|NCT00543400|Momenta Pharmaceuticals|Jim Roach, MD Chief Medical Officer|617-491-9700|jroach@momentpharma.com
121447|NCT00492349|University of Maryland|L. Elliot Hong, M.D.|410-402-6828|ehong@mprc.umaryland.edu
121448|NCT00467051|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
121451|NCT00459121|Barbara Ann Karmanos Cancer Institute|Shirish Gadgeel, M.D.|313-576-8753|sgadgeel@med.umich.edu
121452|NCT00450411|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
121455|NCT00420407|University of Texas Health Science Center at San Antonio|Stephen Cohn, M.D.|210-567-5724|mccarthyj@uthscsa.edu
121456|NCT00417989|Medtronic|Scott Lee, M.D.|8185764204|scott.w.lee@medtronic.com
121457|NCT00416598|The Ohio State University|William Blum, M.D.||William.Blum@osumc.edu
121459|NCT00408694|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org
121461|NCT00392678|Joslin Diabetes Center|Allison B. Goldfine, MD co-investigator|617-309-2643|allison.goldfine@joslin.harvard.edu
121463|NCT00389597|LDR Spine|Noah Bartsch, VP, Clinical,Regulatory,Quality|512-344-3319|noah.bartsch@ldrspine.com
121464|NCT00388414|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu
121465|NCT00379145|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org
121466|NCT00349778|Stanford University|Dr. Sally Arai|650-723-0822|sarai1@stanford.edu
121467|NCT00328783|Thomas Jefferson University|Rani Anne, MD|215-955-6045|Rani.Anne@jeffersonhospital.org
121468|NCT00321685|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|
120606|NCT02988622|Univeristy of Iowa, Hospitals and Clinics|Dr. Marta VanBeek|(319) 384-6012|marta-vanbeek@uiowa.edu
120607|NCT02966015|Clinical operations,Medical Affairs|Head of clinical operations|+45 49113267|dkphl@coloplast.com
120608|NCT02956460|CooperVision|Jose Vega, O.D., MSc., FAAO|925-621-3761|JVega2@coopervision.com
120611|NCT02806869|University of Michigan|Dr. Duxin Sun|734-615-8740|duxins@med.umich.edu
120613|NCT02642679|Brigham and Women's Hospital|Indranil Sinha, MD|617-732-5282|isinha@bwh.harvard.edu
120614|NCT02584790|Pamela Youde Nethersole Eastern Hospital|Dr Wong Kai Chuen|(852) 64600771|wkc568@ha.org.hk
120615|NCT02574832|Northwerstern University|Paloma Toledo, M.D.|312-472-3585|p-toledo@northwestern.edu
120617|NCT02494076|University Colorado School of Medicine, Chidren's Hospital Colorado|Nidhya Navanandan, MD|847-636-0817|nidhya.navanandan@childrenscolorado.org
120619|NCT02449915|TriHealth Inc.|Jennifer Yeung, DO|513-463-4300|Jennifer_Yeung@trihealth.com
120621|NCT02415127|Horizon Pharma Ireland, Ltd. Dublin, Ireland|Julie Ball, Executive Director Clinical Development & Operations||clinicaltrials@horizonpharma.com
120622|NCT02378935|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
120623|NCT02345252|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
120625|NCT02332590|Sanofi|Trial Transparency Team||Contact-US@sanofi.com
120626|NCT02297815|Children's Hospital of Philadelphia|Dr. Jeffrey Gerber|(267) 426-8775|gerberj@email.chop.edu
120627|NCT02247739|Pharming Group NV|VP Clinical Research & Medical Affairs||a.relan@pharming.com
120628|NCT02241720|Huntsman Cancer Institute|Kimberlee Taylor|801-213-5673|Kimberlee.Taylor@hci.utah.edu
120630|NCT02137226|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
120631|NCT02131662|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com
120632|NCT02111200|Baylor|Mahshid Azamian|832-822-1529|azamian@bcm.edu
120638|NCT02020304|Wake Forest School of Medicine|Vernon H Ross MD|336-718-8278|vhross@wakehealth.edu
120645|NCT01823510|Icahn School of Medicine at Mount Sinai|Dr. Juan Badimon|212-241-8484|juan.badimon@mssm.edu
120646|NCT01809639|Spartanburg Regional Healthcare System|John Lucas|423-309-5646|jlucas@srhs.com
120649|NCT01721460|University od Wisconsin - Madison|Dr. Aeyal Raz|608-263-8100|raz@wisc.edu
120650|NCT01720173|NRG Oncology|Angela Kuras on behalf of Wei Deng, PhD|716-845-5702|kurasa@nrgoncology.org
120658|NCT01631331|Stanford University|Dr. Gina Kwon|650-724-3859|gkwon@stanford.edu
120659|NCT01630811|Sutter Medical Group, Neurology|Michael Chez, MD|(916) 454-6667|ChezM@sutterhealth.org
120661|NCT01617629|PrimaBioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au
120663|NCT01579214|Massachusetts General Hospital|Dr. Mark Siedner|617-726-4686 ext 917|msiedner@mgh.harvard.edu
120665|NCT01567462|Emory University|Dr. Kenneth Ogan|404-778-3038|kogan@emory.edu
121471|NCT00285584|NYU School of Medicine|Michael Marmor, Ph.D.|212-263-6667|michael.marmor@nyumc.org
121472|NCT00278915|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com
121474|NCT00244751|GlaxoSmithKline|GSK Response Center|866-435-7343|
121475|NCT00231894|Nathan Kline Institute ofr Psychiatric research|Robert C. Smith MD|845-398-6531|rsmith@nki.rfmh.org
121477|NCT00227994|Washington University School of Medicine|Eric Lenze|314-362-1671|lenzee@wustl.edu
121478|NCT00201877|The Ohio State University Comprehensive Cancer Center|Kristie Blum, MD|614-293-4519|Kristie.Blum@osumc.edu
121479|NCT00181623|Massachusetts General Hospital|Corrine Welt, MD|617-716-8437|cwelt@partners.org
121481|NCT00126581|Dana-Farber Cancer Institute|Pasi Janne, MD, PhD||pjanne@partners.org
121482|NCT00114101|Roswell Park Cancer Institute|Philip McCarthy, MD||philip.mccarthy@roswellpark.org
121483|NCT00098839|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
121485|NCT00093795|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org
121486|NCT00082888|Mayo Clinic|Thomas E. Witzig, M.D.|507-266-2040|witzig@mayo.edu
121487|NCT00070499|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408|
121490|NCT00022659|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
121494|NCT00004054|NRG Oncology|Wendy Seiferheld||wseiferheld@nrgoncology.org
120667|NCT01564277|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
120668|NCT01545843|University of Michigan|Dr. J. Todd Arnedt|734-764-1234|tarnedt@med.umich.edu
120671|NCT01524783|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com
120674|NCT01413516|Stanford University|Judith Prochaska|6507243608|jodi.prochaska@stanford.edu
120677|NCT01392573|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com
120678|NCT01387139|Ucolorado|Keith Weisz|303-724-2592|keith.weisz@childrenscolorado.org
120680|NCT01323595|Weill Cornell Medical College|Chairman, Department of Urology|212 746-5491|pnschleg@med.cornell.edu
120681|NCT01315873|New York University School of Medicine|Michael Grossbard, MD|646 501 9305|Michael.Grossbard@nyumc.org
120684|NCT01279681|Mayo Clinic|Joleen M. Hubbard, M.D.|507 284-3121|hubbard.joleen@mayo.edu
120685|NCT01259596|Wake Forest School of Medicine|Gretchen A. Brenes, Ph.D.|336-716-4551|gbrenes@wakehealth.edu
120688|NCT01228734|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
120690|NCT01172418|University of Miami|George W. Burke, M.D.|305-355-5315|gburke@med.miami.edu
120691|NCT01167907|Wake Forest School of Medicine|Robert S. Weller, MD|336-716-7150|rweller@wakehealth.edu
120694|NCT01036490|Hines VA Hospiral|David J. Leehey, M.D.|(708)2022589|david.leehey@va.gov
120695|NCT01035047|Wake Forest Baptist Medical Center|Erin Harper|336-716-2059|erharper@wakehealth.edu
120706|NCT00810043|Medtronic|John Tillman|408-548-6518|tillmj1@mspexcng.medtronic.com
120713|NCT00752102|Joslin Diabetes Center|Dr. Sylvia Rosas|617-309-2477|sylvia.rosas@joslin.harvard.edu
120715|NCT00742183|Mölnlycke Health Care|Viktoria Ahlenius Körner|+46-31-722 32 46|viktoria.ahleniuskorner@molnlycke.com
120716|NCT00729378|University of Arizona|Dr. Scott Going, Ph.D.|520-626-3432|going@u.arizona.edu
120721|NCT00683696|Biotronik, Inc.|Kelly Mohr|800-547-0394|kelly.mohr@biotronik.com
120725|NCT00630344|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-8313|mary_taplin@dfci.harvard.edu
120728|NCT00592488|Vanderbilt University|Todd Rice, MD|615 322-3412|todd.rice@vanderbilt.edu
120730|NCT00502216|Yale University School of Medicine|Benjamin Toll, Ph.D.|203-974-5767|benjamin.toll@yale.edu
120733|NCT00443781|Medtronic Spine LLC|Zhimin Liu|901-399-3123|zhimin.liu@medtronic.com
120736|NCT00412841|NYULMC|Dr. H. Michael Belmont|212-598-6518|michael.belmont@nyumc.org
120741|NCT00365144|UCaliforniaSF|Andrew Ko, MD|415-353-9888|andrewko@medicine.ucsf.edu
120742|NCT00348816|The University of Texas Health Science Center at San Antonio, Department of Radiation Oncology|Gregory P. Swanson, MD|210-450-1103|swansong@uthscsa.edu
120743|NCT00345397|Medical College of Wisconsin and Zablocki VAMC Milwaukee, WI|Mary F. Otterson, MD; Professor of Surgery|414-384-2000 ext 4-1619|Motterso@mcw.edu
120750|NCT00226941|Stanford Cancer Institute, Stanford University|George Albert Fisher, Jr, MD, PhD; Colleen Haas Chair, School of Medicine|650-723-2990|georgeaf@stanford.edu
120751|NCT00211237|Medtronic Spine LLC|Zhimin Liu|901-399-3123|zhimin.liu@medtronic.com
120753|NCT00189423|Advanced Circulatory Systems, Inc.|Director of Clinical Trials|651-403-5600|csetum@advancedcirculatory.com
120757|NCT00114140|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
120760|NCT00060424|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org
120761|NCT00053352|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
121498|NCT03255655|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com
121499|NCT03191552|Department of Physical medicine and Rehabilitation, Marmara University School of Medicine, Istanbul,Turkey|Esra Giray|+90216624545 ext 6515|girayesra@hotmail.com
121500|NCT03128307|Zyppah|Jonathan Greenburg, DDS|(818) 414- 4817|jgreenburg@outlook.com
121501|NCT03035916|China-Japan Unit Hospital of Jilin University|Dr. Guoqing Zhao|0435-84995117|zhaogq65@126.com
121502|NCT03032965|University of Michigan|Hamid Ghanbari|734-963-7141|ghhamid@med.umich.edu
121503|NCT02987205|Prollenium Medical Technologies, Inc.|Ario Khoshbin, President|866-353-3015|
121504|NCT02951273|Rigshospitalet|Niels D. Olesen|004520262459|niels.damkjaer.olesen.01@regionh.dk
121505|NCT02923245|Brown University|Almaz Dessie, MD||almaz@brown.edu
121506|NCT02826551|Cedars-Sinai|Josh Page|3104233198|josh.page@cshs.org
121507|NCT02690935|ECSOR|Dr. Stephane Heijmans|3267444093|Jacques.Bruhwyler@ecsor.com
121508|NCT02632110|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|anna.houlihan@sunpharma.com
121509|NCT02626910|University of Pennsylvania|Dr. Hillary R. Bogner|215-746-4181|Hillary.Bogner@uphs.upenn.edu
121510|NCT02607735|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
121511|NCT02582632|AbbVie|Global Medical Services|800-633-9110|
121512|NCT02487030|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
121513|NCT02482298|AstraZeneca|Brilinta Global Clinical Leader|+46 31 776 10 00|
121514|NCT02446743|GlaxoSmithKline|GSK Response Center|866-435-7343|
121515|NCT02425826|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-800-260-1599|ClinicalTrialDisclosure@celgene.com
121516|NCT02420951|Brigham and Women's Hospital|Dr. Wolfgang Fitz|6177329501|wfitz@partners.org
121517|NCT02409459|Luitpold Pharmaceuticals, Inc.|Sumita Chowdhury, MD, MPH, FACC, MBA|610.650.4200|SChowdhury@lpicrd.com
121518|NCT02408068|Simbec Research Ltd|Dr G Sharma|0800 691995|contact@simbec.com
121519|NCT02404103|University Louisville|Nemr Eid, MD|502-852-3772|n.eid@louisville.edu
121520|NCT02395185|Shriners Hospital for Children|Rebecca Davis|859-268-5705|rfdavis@shrinenet.org
121521|NCT02353871|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com
121522|NCT02349295|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
121523|NCT02343003|Halyard Health|David Curd|470-448-5178|david.curd@hyh.com
121524|NCT02333045|Emory University|Anandi Sheth, MD|404-616-6240|ansheth@emory.edu
121525|NCT02299089|Camurus AB|Clinical Trial Manager|+46 46 2876 530|Info@Camurus.com
121526|NCT02296606|The University of Texas Southwestern Medical Center|DaiWai Olson|214-648-8946|Daiwai.Olson@UTSouthwestern.edu
121527|NCT02287883|University of California, Berkeley|Patricia Ramsay, Project Drector|(510)643-8063|pramsay@berkeley.edu
121528|NCT02240654|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
121529|NCT02230332|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.531.3584|dmauger@psu.edu
121530|NCT02197481|The Second Affiliated Hospital of Anhui Medical University|Dr.Jiang-ming Chen|15855518651 ext 86|chenjm10@126.com
121531|NCT02168309|Central Coast Perinatology|Kathryn Sharma|8058980258|katy.jones@gmail.com
121532|NCT02163187|Memorial Sloan Kettering Cancer Center|Dr. Martin Weister, MD|212-639-6698|weiser1@mskcc.org
121533|NCT02147899|Symbiomix Therapeutics|VP Clinical Operations|609-722-7250 ext 112|nadetoro@symbiomix.com
118047|NCT02851823|Izmir Katip Celebi University, Dentistry Faculty|Assoc.Prof.Dr. Mehmet Sağlam|+90 530 324 99 48|dtmehmetsaglam@gmail.com
118049|NCT02755805|University of Pittsburgh|Elizabeth R. Skidmore, PhD, OTR/L, FAOTA|(412) 383-6617|skidmore@pitt.edu
118050|NCT02732561|Wake Forest Health Sciences|Elizabeth Arnold, PhD|336-716-4551|earnold@wakehealth.edu
118051|NCT02724644|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquires@endo.com
118052|NCT02710630|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com
118053|NCT02696226|Cleveland Clinic|Dr. Douglas Johnston|216-444-5613|JOHNSTD3@ccf.org
118054|NCT02668822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118055|NCT02639247|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
118056|NCT02636907|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
118057|NCT02607800|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
118058|NCT02600845|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com
118059|NCT02596854|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com
118060|NCT02591290|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
118062|NCT02585245|ThedaCare|Lori Hartz MS, RDN Manager of Nutrition and Diabetes Education|920 831-5077|lori.hartz@thedacare.org
118063|NCT02577718|MD Anderson Cancer Center|Dr. A M Chaftari|7137923491|achaftar@mdanderson.org
118065|NCT02556632|University of Rochester|Julie Ryan Wolf, PhD, MPH; Associate Professor of Dermatology and Radiation Oncology|585-276-3862|julie_ryan@urmc.rochester.edu
118066|NCT02544074|The Ohio State University|Douglas Scharre, MD|614-293-4969|
118067|NCT02516306|Encore Vision, Inc|Jerry M. Stein, Ph.D.|817-292-6963|summercreekc@gmail.com
118070|NCT02451917|Endocrinology Division, University of São Paulo Medical School,|Marcia Silva Queiroz, MD, PhD|+ 5511 26616293|marcia.queiroz@hc.fm.usp.br
118071|NCT02423798|Medtronic Minimed|Odile O'Sullivan, Clinical Trial Manager|8184763319|odile.osullivan@medtronic.com
118072|NCT02422797|GlaxoSmithKline|GSK Response Center|866-435-7343|
118073|NCT02413918|University of Texas HEalth Science Center San Antonio|Charles Bowden, MD|210-567-5405|BowdenC@uthscsa.edu
118074|NCT02379585|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com
118075|NCT02335346|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
118076|NCT02319317|University of Pennsylvania|Catherine McDonald. PhD, RN|2157468355|mcdonalc@nursing.upenn.edu
118077|NCT02312882|Stanford University|Anthony E Oro, M.D., Ph.D.||oro@stanford.edu
118078|NCT02296931|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu
118079|NCT02295644|University at Buffalo, School of Dental Medicine, Oral Diagnostic Sciences|Dr. Willard D McCall|(716)829-3559|wdmccall@buffalo.edu
118080|NCT02288091|Massachusetts General Hospital|Sabrina Paganoni, MD, PhD|617-724-3914|spaganoni@mgh.harvard.edu
118081|NCT02262728|Janssen Research & Development, a division of Janssen Pharmaceutica NV|Medical Leader Hepatitis C, GCO ED&CP||ClinicalTrialDisclosure@its.jnj.com
118082|NCT02252939|Massachusetts General Hospital|Rachel Gottlieb, Research Coordinator|617-726-1569|rgottileb3@mgh.harvard.edu
118084|NCT02229214|VIVUS Inc.|Craig Peterson, Sr. Director, Clinical Research|650-934-5200|ClinicalTrials@vivus.com
118085|NCT02223338|Loma Linda University|Dr. David Sierpina|9095582154|dsierpina@llu.edu
118086|NCT02221947|Neurotrope BioScience, Inc|Vice President, Regulatory Affairs|973-826-5109|dcrockford@neurotropebioscience.com
118087|NCT02207244|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com
118089|NCT02202161|GlaxoSmithKline|GSK Response Center|866-435-7343|
118090|NCT02199795|MetroHealth Medical Center|Dr. Jayme Knutson|2169573557|jsk12@case.edu
118091|NCT02189837|Amgen Inc.|Study Director|866-572-6436|
118092|NCT02181387|Wake Forest School of Medicine|Peter H. Pan, MD, MSEE|336-718-8278|ppan@wakehealth.edu
118093|NCT02157935|AstraZeneca|Tor Skärby||tor.skarby@astrazeneca.com
118095|NCT02146482|Stanford University|Grant Ognibene|9518343465|grantog@stanford.edu
118096|NCT02143141|Wake Forest School of Medicine|Dr. Jessica Booth|3367188278|jbooth@wakehealth.edu
118097|NCT02139137|SDSU/UCSD Joint Doctoral Program in Clinical Psychology|Jessica Bomyea|8585528585 ext 3720|jbomyea@ucsd.edu
118098|NCT02138578|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, M.D.|734-936-4300|sprattda@med.umich.edu
118100|NCT02105636|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
118102|NCT02104505|Center for Environmental Medicine, Asthma and Lung Biology; University of North Carolina, Chapel Hill|Allison Burbank, MD|919-843-2714|allison_burbank@med.unc.edu
118103|NCT02094261|AstraZeneca|Senior Medical Director, Tagrisso||ClinicalTrialTransparency@astrazeneca.com
118104|NCT02093949|Saint joseph hospital|Dr Julien Seitz|+330491807044|jseitz@hopital-saint-joseph.fr
118106|NCT02040116|Wake Forest Baptist Medical Center|LeAnne Kennedy|336-713-3400|lakenned@wakehealth.edu
118107|NCT02034916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
118108|NCT02034552|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com
118110|NCT01945489|Allergan, Inc|Vice President Medical Affairs|1-877-277-8566|IR-CTRegistration@allergan.com
118116|NCT01887288|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com
118117|NCT01884571|Emory University|Jonathan Glass, MD|404-727-3507|jglas03@emory.edu
118119|NCT01879410|GlaxoSmithKline|GSK Response Center|866-435-7343|
118120|NCT01844518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
118121|NCT01844505|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
118122|NCT01835470|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
118123|NCT01835132|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov
118124|NCT01826227|Memorial Sloan Kettering Cancer Center|Dennis Chi, MD|212-639-5016|chid@mskcc.org
118125|NCT01817764|GlaxoSmithKline|GSK Response Center|866-435-7343|
118129|NCT01791517|Johnson & Johnson Vision Care, Inc.|Chantal Coles-Brennan, PRINCIPAL RESEARCH OPTOMETRIST, Global Med Affairs|904-443-3500 ext 3449|CColesb@ITS.JNJ.com
118130|NCT01782495|AbbVie|Global Medical Services|800-633-9110|
118131|NCT01780506|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
118135|NCT01735916|Medtronic|MIRACLE EF Study Manager|(763) 514-4000|medtroniccrmtrials@medtronic.com
118136|NCT01719744|Princess Margaret Cancer Centre|Dr. ALBIRUNI RAZAK|416-586-4800 ext 5371|Albiruni.Razak@uhn.ca
118139|NCT01688102|The Rockefeller University|Dr. Manish Ponda|212-327-7631|mponda@rockefeller.edu
118140|NCT01688037|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com
118197|NCT01239381|Massachusetts General Hospital|Theodore S Hong, MD, physician radiation oncology|617-726-6050|TSHONG1@mgh.harvard.edu
118198|NCT01236742|The Hong Kong Polytechnic University|Prof Pauline Cho|+852 2766 6100|pauline.cho@polyu.edu.hk
118199|NCT01232283|Celgene Corporation|Anne McClain|888-260-1599|ClinicalTrialDisclosure@celgene.com
118200|NCT01218204|GlaxoSmithKline|GSK Response Center|866-435-7343|
118202|NCT01194440|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|443-287-6489|HopkinsBreastTrials@jhmi.edu
118203|NCT01190228|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
118204|NCT01183260|Cleveland Clinic|Alison Klika, Research Program Manager|216-444-4954|klikaa@ccf.org
118205|NCT01181895|GlaxoSmithKline|GSK Response Center|866-435-7343|
118206|NCT01175356|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
118207|NCT01173055|University of Michigan|Daniel Clauw, MD|734-998-6901|dclauw@med.umich.edu
118209|NCT01163851|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
118211|NCT01155375|AMAG Pharmaceuticals, Inc.|Medical Information|+1-877-411-2510|amag@druginfo.com
118212|NCT01155388|AMAG Pharmaceuticals, Inc.|Medical Information|+1-877-411-2510|amag@druginfo.com
118213|NCT01155336|University of Rochester|Dr. Robert Block|585 275-3356|robert_block@urmc.rochester.edu
118214|NCT01146600|Emory University School of Medicine|Lynn Marie Trotti, MD, MSc|404-728-4752|lbecke2@emory.edu
118215|NCT01124422|GlaxoSmithKline|GSK Response Center|866-435-7343|
118216|NCT01120184|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
118217|NCT01114581|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com
118218|NCT01111825|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com
118219|NCT01110200|GlaxoSmithKline|GSK Response Center|866-435-7343|
118221|NCT01065480|New York State Psychiatric Institute|Edward V. Nunes, MD|646-774-6122|nunesed@nyspi.columbia.edu
118222|NCT01054885|GlaxoSmithKline|GSK Response Center|866-435-7343|
118223|NCT01047189|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wfubmc.edu
118224|NCT01039675|GlaxoSmithKline|GSK Response Center|866-435-7343|
118225|NCT01035788|Department of Veterans Affairs|Dr. Louanne Davis|317-988-4523|louanne.davis@va.gov
118226|NCT01030965|GlaxoSmithKline|GSK Response Center|866-435-7343|
118229|NCT01027702|PRA Health Sciences|Dr. Andrew Gilman|704-615-2744|gilmanandy@prahs.com
118230|NCT01009060|GlaxoSmithKline|GSK Response Center|866-435-7343|
118232|NCT01005459|Wake Forest School of Medicine-Anesthesiology|Peter H. Pan MD, MSEE|336-718-8278|ppan@wakehealth.edu
118233|NCT01004354|University of Massachusetts Medical School|Benjamin U Nwosu, MD|5083347872|benjamin.nwosu@umassmemorial.org
118234|NCT00984659|GlaxoSmithKline|GSK Response Center|866-435-7343|
118235|NCT00982397|Medtronic, plc|CRHF Clinical Research|800-328-2518|medtroniccrmtrials@medtronic.com
118236|NCT00982033|Wake Forest School of Medicine|Dalane W. Kitzman, M.D.|336-716-3274|dkitzman@wakehealth.edu
118237|NCT00968864|PRA Health Sciences|Dr. Andrew Gilman|704-615-2744|gilmanandy@prahs.com
118239|NCT00950807|GlaxoSmithKline|GSK Response Center|866-435-7343|
118240|NCT00945243|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com
118241|NCT00945815|SWOG Statistical Center|SWOG Leukemia Statistician|206-667-4408|
118242|NCT00937560|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com
118243|NCT00915018|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com
118245|NCT00891319|MetroHealth Medical Center|Dr. Jayme Knutson|2169573557 ext 216|jsk12@case.edu
118246|NCT00880906|Vanderbilt University|Michael Vaezi, MD, PhD|615-322-3739|michael.vaezi@vanderbilt.edu
118247|NCT00855335|Janssen Scientific Affairs, LLC|Medical Leader, Medical Department||ClinicalTrialDisclosure@its.jnj.com
118248|NCT00819780|Amgen Inc.|Study Director|866-572-6436|
118250|NCT00805766|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
118251|NCT00801892|University of Pittsburgh|E. Chasens, PhD|412-624-9380|chasense@pitt.edu
118253|NCT00779467|Wake Forest School of Medicine|Peter H. Pan, MD, MSEE|336-718-8278|ppan@wakehealth.edu
118254|NCT00779142|Wake Forest Baptist Health Eye Center|Dr. Shree Kurup|336-716-4091|skurup@wakehealth.edu
118259|NCT00725959|Colorado School of Public Health|Dr. Sheana Bull|303-724-1238|
118261|NCT00706329|Children's Hospital Boston and South Shore Hospital|Dr. Neil Feins|6173556915|
118262|NCT00696410|University of Michigan|Jennifer Cowger, MD, Assistant Professor|734 936-5265|jennmatt@med.umich.edu
118263|NCT00693160|Wake Forest School of Medicine|James C. Eisenach, M.D.|336-716-4498|jimeisenach@gmail.com
118264|NCT00686166|SWOG Statistical Center|SWOG Statistician|206-667-4408|
118266|NCT00667615|Memorial Sloan Kettering Cancer Center|David Straus MD|212-639-8365|strausd@mskcc.org
118267|NCT00655811|University of Miami|Gil Yosipovitch, MD, Professor|305-243-5121|gyosipovitch@med.miami.edu
118268|NCT00636168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
118270|NCT00621530|Wake Forest School of Medicine|Dr. James C. Eisenach|336-716-4498|jimeisenach@gmail.com
118271|NCT00619983|Wake Forest School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com
118272|NCT00619255|University of Washington|Doug Zatzick, MD|(206) 744-6701|dzatzick@uw.edu
118273|NCT00611455|GlaxoSmithKline|GSK Response Center|866-435-7343|
118274|NCT00602225|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu
118275|NCT00554463|NRG Onocology|Wendy Seiferheld||wseiferheld@nrgonology.org
118276|NCT00550420|GlaxoSmithKline|GSK Response Center|866-435-7343|
118277|NCT00540007|Washington University School of Medicine|Todd Fehniger, M.D., Ph.D.|314-747-1385|tfehnige@wustl.edu
118279|NCT00529035|Dana-Farber Cancer Institute|John Koreth, MBBS, D.Phil|(617) 632-2949|jkoreth@partners.org
118280|NCT00521339|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com
118281|NCT00490139|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|
118282|NCT00471237|GlaxoSmithKline|GSK Response Center|866-435-7343|
118285|NCT00445848|Swog Statistical Center|Lung Committee Statistican|2066674623|jmoon@fredhutch.org
118287|NCT00412867|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp
118288|NCT00410891|Stanford|Professor|6504984791|cta@stanford.edu
118289|NCT00400205|Emory University Winship Cancer Institute|Nabil Saba, MD|1-888-946-7447|nfsaba@emory.edu
118290|NCT00396019|AstraZeneca|Dr. Regina Jakacki||regina.jakacki@astrazeneca.com
118291|NCT00382018|SWOG|Breast Committee Statistician|2066675712|jmiao@fredhutch.org
118292|NCT00376961|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|
118294|NCT00350532|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4498|jimeisenach@gmail.com
118295|NCT00349921|Wake Forest University Health Sciences|Regina Curry, RN, CCRC|(336) 716-4294|recurry@wfubmc.edu
118297|NCT00348556|Mayo Clinic|Dr. Horng Chen|507-284-8846|chen.horng@mayo.edu
118298|NCT00321594|Department of Clinical Oncology, The Chinese University of Hong Kong|Professor Winnie Yeo|852-2632 ext 2118|winnieyeo@cuhk.edu.hk
118299|NCT00286949|Michael E. DeBakey VA Medical Center|Laura Marsh, M.D., Principal Investigator|713-794-8907|laura.marsh2@va.gov
118300|NCT00282672|University of north Carolina|Nicholas Shaheen|(919) 966-7047|nshaheen@med.unc.edu
118301|NCT00233987|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|
118302|NCT00206323|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu
118303|NCT00211081|Emory University|Dr. Willam Mahle|404-785-6000|wmahle@emory.edu
118304|NCT00206336|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu
118306|NCT00186069|Stanford University|Anna Girsen, Manager of Research Operations|(650) 725-5720|agirsen@stanford.edu
118307|NCT00178464|St. Christopher's Hospital for Children|Dr. Norma B. Lerner|215 427-5261|norma.lerner@drexelmed.edu
118308|NCT00127218|The Johns Hopkins Hospital, Department of Medicine, Division of Cardiology|Dr. Joao AC Lima|410-614-1284|jlima@jhmi.edu
118311|NCT00094328|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com
118312|NCT00088972|SWOG|Study Statistician|206-667-4623|
118313|NCT00070317|NRG Oncology|Linda Gedeon for Wei Deng, PhD.|716-845-1169|lgedeon@gogstats.org
118314|NCT00068367|SWOG Statistical Center|Study Statistician|206-667-4623|sarcoma@crab.org
118315|NCT00064337|SWOG Statistical Center|Study Statistician|206-667-4623|
118316|NCT03046212|Hospital de Clínicas de Porto Alegre|Graciele Sbruzzi|55 51 9423-9420|graciele.sbruzzi@ufrgs.br
118317|NCT02758210|Emory University|Mikhael El Chami, MD|404-686-2504|melcham@emory.edu
118318|NCT02586493|GlaxoSmithKline|GSK Response Center|866-435-7343|
118319|NCT02570165|GlaxoSmithKline|GSK Response Center|866-435-7343|
118320|NCT02472639|Cedars Sinai Medical Center|Karen Zaghiyan, MD|310-289-9224|kzaghiyan@yahoo.com
118321|NCT02234752|George Washington University, Washington, DC|Maju Koola|678-200-8613|majumkoola@gmail.com
118337|NCT01680666|Stanford University|Matias Bruzoni, MD|650-723-6439|mbruzoni@stanford.edu
118338|NCT01678443|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu
118339|NCT01630616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118340|NCT01627327|GlaxoSmithKline|GSK Response Center|866-435-7343|
118341|NCT01587898|GlaxoSmithKline|GSK Response Center|866-435-7343|
118342|NCT01519960|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com
118343|NCT01484496|GlaxoSmithKline|GSK Response Center|866-435-7343|
118344|NCT01387230|GlaxoSmithKline|GSK Response Center|866-435-7343|
118345|NCT01369108|3M Oral Care Solutions Division|Rolf Halvorson|651-733-3384|rhhalvorson@mmm.com
118346|NCT01323972|GlaxoSmithKline|GSK Response Center|866-435-7343|
118347|NCT01251367|Ipsen|Medical Director, Neurology,||clinical.trials@ipsen.com
118348|NCT01203826|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com
118349|NCT01165177|GlaxoSmithKline|GSK Response Center|866-435-7343|
118350|NCT01159912|GlaxoSmithKline|GSK Response Center|866-435-7343|
118351|NCT01072149|GlaxoSmithKline|GSK Response Center|866-435-7343|
118352|NCT01029366|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu
118353|NCT01009463|GlaxoSmithKline|GSK Response Center|866-435-7343|
118355|NCT00911820|Dana-Farber Cancer Insitute|Peter Enzinger, MD|617-632-6855|Peter_Enzinger@dfci.harvard.edu
118356|NCT00817063|GlaxoSmithKline|GSK Response Center|866-435-7343|
118357|NCT00791700|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
118358|NCT00777101|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com
118359|NCT00775593|GIMEMA|Edoardo La Sala|+39 06 70390524|e.lasala@gimema.it
118360|NCT00744211|University of South Carolina SOM|Francis G. Spinale|803-777-3964|cvctrc@uscmed.sc.edu
118361|NCT00741260|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com
118362|NCT00716820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
118363|NCT00675909|Seattle Children's Hospital|Eileen Klein, MD, MPH|206-987-2599|eileen.klein@seattlechildrens.org
118364|NCT00529802|The University of Chicago|Walter Stadler, MD|(773) 702-4150|wstadler@medicine.bsd.uchicago.edu
118367|NCT00374556|Johns Hopkins University School of Medicine|Michael Smith, PhD, Associate Professor of Psychiatry, Director of Behavioral Medicine|410-550-7000|msmith62@jhmi.edu
118368|NCT00201760|The Ohio State University Comprehensive Cancer Center|Kari Kendra, MD|614-293-7956|Kari.Kendra@osumc.edu
118369|NCT02760654|University of Michigan School of Nursing|Robert Knoerl, Doctoral Student|734-536-9369|rjknoerl@umich.edu
118371|NCT02667275|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com
118372|NCT02667236|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com
118373|NCT02601573|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118374|NCT02569086|Aarhus University Hospital, Department of infectious diseases|Dr. Kristina Öbrink-Hansen|+45 ext 78452845|krisoebr@rm.dk
118376|NCT02550288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118377|NCT02519855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118379|NCT02293395|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com
118380|NCT02286193|Group Health Research Institute|Clarissa Hsu, PhD|206-287-4276|hsu.c@ghc.org
118382|NCT02224508|Group Health Research Institute|Michael Von Korff, ScD|206-287-2874|vonkorff.m@ghc.org
118383|NCT02212834|Group Health Research Institute|Karen J. Wernli, PhD|206-287-2934|wernli.k@ghc.org
118384|NCT02186873|Johnson&Johnson|Senior Director Clinical Development, Immunology General||ClinicalTrialDisclosure@its.jnj.com
118385|NCT02158975|University of Michigan Comprehensive Cancer Center|Dr. Ryan Wilcox, M.D.|734-615-1482|rywilcox@umich.edu
118386|NCT02136498|Group Health Research Institute|Principle Investigator|206-287-2737|mcclure.j@ghc.org
118387|NCT02062385|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118389|NCT02036515|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118390|NCT02023866|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224- 383-3000|clinicaltrials@horizonpharma.com
118391|NCT02011490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118393|NCT01883999|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com
118394|NCT01797458|Preventive and Paediatric Dentistry Department of Greifswald University, Germany|Prof. Dr. Christian Splieth|+ 49 3834 867101|splieth@uni-greifswald.de
118400|NCT01587105|Seattle Children's Hospital|Rita Mangione-Smith, MD, MPH|2068848242|Rita.Mangione-Smith@seattlechildrens.org
118401|NCT01544153|Truth Initiative|Amanda L. Graham, PhD|202-454-5938|agraham@truthinitiative.org
118403|NCT01515306|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
118404|NCT01479010|Virginia Commonwealth University|Benjamin Van Tassell, PharmD|8048284583|bvantassell@vcu.edu
118405|NCT01472965|St. Jude Children's Research Hospital|Joshua Wolf, MBBS, BA|901-595-1475|joshua.wolf@stjude.org
118406|NCT01390428|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118407|NCT01331304|Massachusetts General Hospital|Dr. Andrew Nierenberg|617-724-0837|anierenberg@mgh.harvard.edu
118408|NCT01251276|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118409|NCT01141660|Eastern Virginia Medical School|Cristina Baldassari|7576689853|baldassc@yahoo.com
118412|NCT01075984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Cllinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118413|NCT01066923|University of Pittsburgh|Clifton Callaway|412-647-3078|callawaycw@upmc.edu
118415|NCT00948675|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
118417|NCT00816556|Mayo Clinic|Maire Brid MacBride MB BCh|507-538-2271|MacBride.Maire@mayo.edu
118418|NCT00771810|Tarix Pharmaceuticals|Elizabeth Wagner|6178760223|elizabeth.wagner@tarixpharma.com
118420|NCT00755235|Group Health Research Institute|Gregory Simon, Principal Investigator|206-287-2979|simon.g@ghc.org
118421|NCT00703326|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
118424|NCT00598806|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com
118425|NCT00584935|UAB Department of Dermatology|Wendy Cantrell, CRNP|205-502-9960|wcantrell@uabmc.edu
118426|NCT00570674|Dana-Farber Cancer Institute|Roy B. Tishler, MD|617.632.5734|RTISHLER@LROC.HARVARD.EDU
118427|NCT00543543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118429|NCT00490568|GlaxoSmithKline|GSK Response Center|866-435-7343|
118430|NCT00451321|GlaxoSmithKline|GSK Response Center|866-435-7343|
118431|NCT00432965|Acelity|Sr Director, Global Clinical Development|210-255-5595|jane.hart@kci1.com
118432|NCT00267774|Stanford University|William F. Fearon, MD|650 725-2621|wfearon@stanford.edu
118434|NCT00078754|The University of Chicago|Dr. Emil F. Coccaro, MD|773-834-4083|ecoccaro@yoda.bsd.uchicago.edu
118435|NCT00004259|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
118536|NCT02943213|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com
118537|NCT02736175|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com
118538|NCT02685202|University of North Carolina at Chapel Hill|Anne E. Sanders, PhD|919-537-3275|anne_sanders@unc.edu
118540|NCT02668783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118541|NCT02639338|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
118542|NCT02564042|GlaxoSmithKline|GSK Response Center|866-435-7343|
118543|NCT02556333|National Institutes of Health, National Institute of Allergy and Infectious Diseases|Alice Pau, Pharm.D., Staff Scientist (Clinical)|301-451-3740|apau@niaid.nih.gov
118544|NCT02355028|Alcon, A Novartis Division|Clinical Scientist, NIBR|1-888-451-3937|alcon.medinfo@alcon.com
118545|NCT02348723|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
118547|NCT02157883|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com
118548|NCT02100514|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
118549|NCT02010567|UNC Lineberger|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu
118550|NCT01977222|Boston Children's Hospital|Dr. Fred Wu|6173556508|fred.wu@cardio.chboston.org
118552|NCT01928797|Brigham and Women's Hospital|Dr. Bhavani Kodali|617-732-8220|BKODALI@BWH.HARVARD.EDU
118553|NCT01910181|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com
118554|NCT01853280|Massachusetts General Hospital|Dr. Craig Surman|617-726-8422|csurman@partners.org
118555|NCT01780545|Hoosier Cancer Research Network|Clinical Data Manager|3176345842 ext 41|hcrndm@hoosiercancer.org
118556|NCT01765673|James Madison University|Christy Ludlow|540-937-3007|ludlowcx@jmu.edu
118557|NCT01757678|HeartFlow|VP Clinical, Quality & Regulatory Affairs|650-241-1221|clinicalresearch@heartflow.com
118558|NCT01748162|University of Michigan|Dr. David J. Brown||davidjb@med.umich.edu
118559|NCT01632904|Incyte Corporation|Study Director|855 463-3463|
118560|NCT01587924|GlaxoSmithKline|GSK Response Center|866-435-7343|
118561|NCT01585428|National Cancer Institute|D. Steven Rosenberg|301-496-4164|sar@mail.nih.gov
118562|NCT01460940|The Ohio State University Comprehensive Cancer Center|Dr. Kristie Blum|614-293-4590|Kristie.Blum@osumc.edu
118563|NCT01406223|Duke University Medical Center|Principal Investigator|919-668-3987|francis.mcclernon@duke.edu
118564|NCT01371825|Alexion Pharmaceuticals|Mark Friedman, Medical Director|781-357-9953|mark.friedman@alxn.com
118565|NCT01282424|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com
118566|NCT01170663|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
118567|NCT01161862|Department of Biomedical Engineering, Boston University, Boston, Massachusetts.|Edward R. Damiano|(617) 353-9493|edamiano@bu.edu
118568|NCT01106027|Mayo Clinic|Dr. Mark Stegall|507-284-6275|Stegall.Mark@mayo.edu
118569|NCT01092364|Duke University Medical Center|Dr. Laura P. Svetkey|919-660-6626|laura.svetkey@dm.duke.edu
118570|NCT01066000|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com
118571|NCT00976560|GlaxoSmithKline|GSK Response Center|866-435-7343|
118572|NCT00937235|University of Pennsylvania|Dr. Edna Foa|2157463327|foa@mail.med.upenn.edu
118573|NCT00929500|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu
118574|NCT00903968|Dana-Farber Cancer Institute|Irene M. Ghobrial, MD|617-632-4198|Irene_Ghobrial@dfci.harvard.edu
118575|NCT00666978|University of Kansas Medical Center|Lisa Sanderson Cox|913-588-2643|lcox@kumc.edu
118577|NCT00622401|Beth Israel Deaconess Medical Center|David Avigan, MD|617-667-9920|davigan@bidmc.harvard.edu
118578|NCT00617409|H. Lee Moffitt Cancer Center and Research Institute|Dr. Scott Antonia|813-745-3883|scott.antonia@moffitt.org
118579|NCT00548470|Nathan Kline Institute for psychaitric Research|Robert C Smith MD|845-398-6531|rsmith@nki.rfmh.org
118580|NCT00512148|Tengion declared bankruptcy in 2014|Tengion declared bankruptcy and there is no results contact|There is no Tengion phone|
118582|NCT00344461|University of Maryland, Institute Of Human Virology|Charles E. Davis, Jr., MD|410-706-4608|cdavis@ihv.umaryland.edu
118583|NCT00278395|University of Texas Health Science Center at San Antonio|Dr. John Sarantopoulos|210-450-1000|sarantopoulo@uthscsa.edu
118584|NCT00252174|McLean Hospital at time of study|John H. Halpern, M.D.|6179065063|jhalpern@recoverycoa.com
118585|NCT00238108|Brigham and Women's Hospital|Dr. Frank Scheer|617-732-7014|fscheer@rics.bwh.harvard.edu
118595|NCT02675907|Recro Pharma, Inc.|Randall Mack|484-395-2470 ext 2406|rmack@recropharma.com
118596|NCT02667288|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com
118603|NCT02419937|United States Air Force|Dr. Matthew B. Carroll|228-376-3829|mcar100210@yahoo.com
118609|NCT02197130|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com
118610|NCT02196922|Northwell Health|Renee Pekmezaris, Ph.D., Vice President Community Health & Health Services Research|516 465-3161|rpekmeza@northwell.edu
118614|NCT02102204|Amgen Inc.|Study Director|866-572-6436|
118616|NCT02048241|New York State Psychiatric Institute|Stephen J. Donovan, MD|646-774-8078|sd45@columbia.edu
118618|NCT02040077|Johns Hopkins University School of Medicine|Kelly Dunn|410-550-2254|kdunn9@jhmi.edu
118620|NCT01984684|Melinta Therapeutics, Inc.|Sue Cammarata (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com
118621|NCT01978535|Mayo Clinic|Dr. Amie Jones|507-284-6063|Jones.Amie@mayo.edu
118622|NCT01972464|Yale School of Medicine|Ariadna Forray|2037648620|ariadna.forray@yale.edu
118623|NCT01959529|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com
118625|NCT01939197|AbbVie|Global Medical Services|800-633-9110|
118629|NCT01913600|Medtronic, Coronary & Structural Heart Clinical|Lisa Bousquette, Clinical Research Director|707-591-2967|rs.medtroniccardiovascularclinicaltrials@medtronic.com
118632|NCT01831791|GlaxoSmithKline|GSK Response Center|866-435-7343|
118634|NCT01808261|GlaxoSmithKline|GSK Response Center|866-435-7343|
118636|NCT01688843|Boston Scientific|Robert Shipley, Ph.D.|1-800-227-3422|robert.shipley@bsci.com
118640|NCT01466660|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
118653|NCT01246349|The Hospital for Sick Children|Beverly Walpole|416. 813 7654 ext 328363|bwalpole@uoguelph.ca
118655|NCT01205152|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com
118670|NCT00892099|Massachusetts General Hospital|Dr. Ishir Bhan|617-726-3934|ibhan@mgh.harvard.edu
118677|NCT00733980|GlaxoSmithKline|GSK Response Center|866-435-7343|
118680|NCT00634270|The Univ of Alabama at Birmingham|Bruce Korf, MD, PhD|205.934.5140|kcole@uab.edu
118681|NCT00625183|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
118684|NCT00463580|Emory University|Andrew H. Miller|404-727-8260|amill02@emory.edu
118685|NCT00398632|Stanford University Medical Center, Department of Psychiatry|Lorrin Koran, M.D., Professor of Psychiatry, Emeritus|650 498 5035|lkoran@stanford.edu
118689|NCT03255733|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com
118691|NCT03247985|Mayo Clinic|Dr. David R. Farley|507-284-7565|farley.david@mayo.edu
118696|NCT02579057|Johns Hopkins Hospital|Stuart Russell MD|4109555708|srusse14@jhmi.edu
118697|NCT02563899|GlaxoSmithKline|GSK Response Center|866-435-7343|
118702|NCT02281318|GlaxoSmithKline|GSK Response Center|866-435-7343|
118705|NCT02182115|University of Minnesota|Dr. Susan Kline|612-626-3662|kline003@umn.edu
118708|NCT02045797|GlaxoSmithKline|GSK Response Center|866-435-7343|
118710|NCT01949090|GlaxoSmithKline|GSK Response Center|866-435-7343|
118712|NCT01928186|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu
118713|NCT01921270|Emory University|Dr. Stewart Factor|404-728-4952|sfactor@emory.edu
118718|NCT01650350|Brown University Oncology Research Group|Maria Constantinou, MD|401-863-3000|Kayla_rosati@brown.edu
118719|NCT01637961|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
118722|NCT01463527|Yale University|Dr. Melissa Langhan|203-737-7413|melissa.langhan@yale.edu
118723|NCT01434290|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org
118724|NCT01428258|University of Wisconsin-Madison|Dr. Denise M Ney|608-262-4386|ney@nutrisci.wisc.edu
118726|NCT01394627|Brigham and Women's Hospital|Gail Adler|617-732-5661|gadler@partners.org
118731|NCT01262898|GlaxoSmithKline|GSK Response Center|866-435-7343|
118732|NCT01246011|Massachusetts General Hospital|Anne Philip, Data Manager|617 726 0423|alphilip@partners.org
118733|NCT01231555|ViiV Healthcare|GSK Response Center|866-435-7343|
118735|NCT01199731|ViiV Healthcare|GSK Response Center|866-435-7343|
118739|NCT01011933|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org
118740|NCT01007071|Stanford University|Dr. Laurence Katznelson|650-736-9551|katznels@stanford.edu
118743|NCT00966446|Perelman School of Medicine, University of Pennsylvania|Ebbing Lautenbach, MD, MPH, MSCE|215-898-6977|ebbing@mail.med.upenn.edu
118745|NCT00941070|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Charles Kunos|330-375-4485|kunosc@summahealth.org
118746|NCT00934947|UNC Department of Anesthesiology|Samuel McLean|919-966-7315|smclean@aims.unc.edu
118747|NCT00903201|GlaxoSmithKline|GSK Response Center|866-435-7343|
118750|NCT00834106|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
118752|NCT00825227|Cephalon, Inc.|Vice President, Clinical Research|1-800-896-5855|
118755|NCT00640224|Children's Hospital of Pittsburgh of UPMC|Dr. Silva Arslanian|412-692-6935|
118756|NCT00621777|Massachusetts General Hospital|A. Eden Evins, MD, MPH|6176434679|a_eden_evins@hms.harvard.edu
118757|NCT00590980|University of Illinois at Chicago|Sepideh Amin-Hanjani, MD|312-996-4842|hanjani@uic.edu
118758|NCT00270855|Penn State Hershey Medical Center|Dr. David Gater|7175314263|dgater@hmc.psu.edu
118759|NCT00089609|National Cancer Institute, National Institutes of Health|Ravi Madan, M.D.|301-480-7168|rm480i@nih.gov
118760|NCT00025155|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org
121534|NCT02142738|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
121535|NCT02137772|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
121536|NCT02136134|Janssen R&D US|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com
121537|NCT02135029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
121538|NCT02131233|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
121539|NCT02114203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
121540|NCT02109484|Chris Hani Baragwanath Academic Hospital|Michelle J. Groome, MD, PhD|+27 11 983 4283|groomem@rmpru.co.za
121541|NCT02104427|TaiGen Biotechnology Co., Ltd.|Li-Wen Chang|+886-2-8177-7072 ext 1227|lwchang@taigenbiotech.com
121542|NCT02093351|AstraZeneca Pharmaceuticals|Dr Carsten Goessl, Indication Lead||Carsten.Goessl@astrazeneca.com
121543|NCT02076178|GlaxoSmithKline|GSK Response Center|866-435-7343|
121544|NCT02072928|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com
121545|NCT02056171|Weill Cornell Medicine|Chani Traube|212-746-3056|chr9008@med.cornell.edu
121546|NCT02047500|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com
121547|NCT02033499|University of North Carolina at Chapel Hill|Dr. Katrina Donahue|919-966-5090|Katrina_Donahue@med.unc.edu
121548|NCT02003053|University of Kentucky|Dr. Peter Morris|8593235045|peter.morris@uky.edu
121549|NCT01998880|Hoffman-LaRoche|Medical Communications|800-821-8590|
121550|NCT01976806|Beth Israel Deaconess Medical Center|Dr. Kenneth Mukamal|617-754-1401|kmukamal@bidmc.harvard.edu
121551|NCT01969058|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com
121552|NCT01965561|USAISR|John Kragh, MD|210.539.2210|john.f.kragh.civ@mail.mil
121553|NCT01943539|Akili Interactive Labs|SVP of Medical Devices|617-456-0984|skellogg@akiliinteractive.com
121554|NCT01927419|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
121555|NCT01924975|University of Iowa Hopspital & Clinics|Satoshi Hanada/Clinical Assistant Professor|3193561219|satoshi-hanada@uiowa.edu
121556|NCT01911819|Loma Linda University|Prof. Joseph Kan|(909) 558-4980|jkan@llu.edu
121557|NCT01904864|Baylor College of Medicine|Jacquelyn M. Powers, MD||jacquelyn.powers@bcm.edu
121558|NCT01900444|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com
121559|NCT01877642|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7777|ClinicalTrialsInfo@alexza.com
121560|NCT01873950|U.S. Food and Drug Administration|David G Strauss, MD, PhD|301-796-6323|david.strauss@fda.hhs.gov
121561|NCT01872910|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com
121562|NCT01843374|AstraZeneca|Paul Stockman, MD, PhD|+44 162-523-1815|Paul.Stockman@astrazeneca.com
121563|NCT01816048|University of Wisconsin Carbone Cancer Center|Dr. Justine Bruce|608-262-4961|jybruce@medicine.wisc.edu
121564|NCT01813110|Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu
121565|NCT01806896|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
121566|NCT01798550|Emory University|Christine Kempton MD, MSc|404-778-1900|ckempto@emory.edu
121567|NCT01767935|Wake Forest University Health Sciences|Dr. David Childs|336-716-2471|dchilds@wakehealth.edu
121568|NCT01725126|GlaxoSmithKline|GSK Response Center|866-435-7343|
121569|NCT01719224|Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital|Matthias Eikermann, MD, PhD|617-643-7735|meikermann@partners.org
121570|NCT01710254|University of Utah, Dept. of Radiology Research|Edward DiBella, Ph.D.|801-585-5543|edward.dibella@hsc.utah.edu
121571|NCT01700439|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, HVT|949-250-2500 ext 1536|mary_edwards@edwards.com
121572|NCT01696942|Milton S. Hershey Medical Center|Dr. David Stewart|717-531-0003|dstewart@pennstatehealth.psu.edu
121573|NCT01664923|Medivation, Inc.|Medical Director, Clinical Development||TrialDisclosure@medivation.com
121574|NCT01657253|Laboratorios Sophia S.A. de C.V.|Leopoldo M Baiza-Duran MD, Director of Clinical Trials|52+ 33 30014200|leopoldo.baiza@sophia.com.mx
121575|NCT01651806|Rush University Medical Center|Brett Levine, MD|708.236.2664|levine.research@rushortho.com
121576|NCT01647282|UNMC College of Dentistry|Dr. Amy C. Killeen|402-202-7848|akilleen@unmc.edu
121577|NCT01632345|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
121578|NCT01625416|University of Washington|Dr. Douglas Zatzick|2067446701|dzatzick@uw.edu
121579|NCT01625104|University of Michigan|Eva Kline-Rogers MS, RN|734 9985909|evakline@med.umich.edu
121580|NCT01614210|Huntsman Cancer Institute|Mark Wade|8012135746|mark.wade@hci.utah.edu
121581|NCT01612351|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu
121582|NCT01557595|UAB|Dr. Rachel Fargason|205-934-5151|rfargason@uab.edu
121585|NCT01505673|University of Texas Southwestern Medical Center at Dallas|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu
121586|NCT01487265|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com
121587|NCT01469221|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com
121588|NCT01444027|University of Washington, School of Nursing|Dr. George Demiris|206-221-3866|gdemiris@uw.edu
121589|NCT01428128|The University of Texas Health Science Center at San Antonio, Department of Radiation Oncology|Chul S. Ha, MD, Professor and Chair|210-450-1109|hac@uthscsa.edu
121590|NCT01422538|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com
121591|NCT01414855|Genentech, Inc.|Medical Communications|800-821-8590|genetech@druginfo.com
121592|NCT01397422|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com
121593|NCT01368965|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com
121594|NCT01368900|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com
121595|NCT01368874|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com
121596|NCT01368835|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com
121597|NCT01339052|Dana-Farber Cancer Institute|Patrick Y. Wen, MD, Director, DFCI Center for Neuro-Oncology|617-632-2166|pwen@partners.org
121598|NCT01314742|Vanderbilt University Sch of Medicine|Dr. Beatrice Stefanescu|6159365933|beatrice.stefanescu@Vanderbilt.edu
121599|NCT01285609|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com
121600|NCT01238536|University of Washington|Janna Friedly M.D.|206-744-3664|friedlyj@uw.edu
121601|NCT01231516|GlaxoSmithKline|GSK Response Center|866-435-7343|
121602|NCT01223963|Q-Med AB|Chief Medical Officer|+46 18 4749000|reception.seupp@galderma.com
121603|NCT01198132|Merck KGaA|Title: Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com
121604|NCT01190475|Mereo BioPharma|Dr. Ian Hodgson|+44 333 0237300|enquiries@mereobiopharma.com
121605|NCT01186692|Medtronic|Susan Patterson|763.526.1544|susan.patterson@medtronic.com
121606|NCT01178944|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
121607|NCT01167179|Radboud University Nijmegen Medical Center|Jacqueline de Leeuw MSc|+31243614925|j.deleeuw@kno.umcn.nl
121608|NCT01115244|Vanderbilt University Medical Center|Mary Beth Cole|(615) 322-6485|
121609|NCT01114620|GlaxoSmithKline|GSK Response Center|866-435-7343|
121610|NCT01113801|Eli Lilly and Company|Chief Medical Officer|800-545-5979|
121611|NCT01097915|University of Cagliari|Iole Tomassini Barbarossa, Associate Professor|+390706754144|tomassin@unica.it
121612|NCT01096667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
121613|NCT01076400|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
121614|NCT01027416|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|
121615|NCT01005576|Washington University School of Medicine|Dr. Shalini Shenoy|314-454-6018|shalinishenoy@wustl.edu
121616|NCT00860171|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu
121617|NCT00855010|UT Southwestern Medical Center|Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu
121618|NCT00840307|UT Southwestern Medical Center|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu
121619|NCT00805194|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
121620|NCT00792909|GlaxoSmithKline|GSK Response Center|866-435-7343|
121621|NCT00740220|Wake Forest University|Arjun Chatterjee, MD, MS, FCCP|336.716.4649|achatter@wfubmc.edu
121622|NCT00735891|MS HERSHEY MC|Dr. Chandra Belani|717-531-1003|cbelani@psu.edu
121623|NCT00719576|Vericel Corporation|Ann Remmers, Senior Director, Clinical Science|734-428-4526|aremmers@vcel.com
121624|NCT00718094|University Louisville|Gerald Dryden, MD|502-852-0156|gwdryd01@louisville.edu
121625|NCT00693303|Shenandoah University|Deborah Marr ScD, OTR/L|540-678-4312|dmarr@su.edu
121626|NCT00688259|VA Greater Los Angeles Healthcare System at West Los Angeles|Shirley M. Glynn, Ph.D.|3102683939|shirley.glynn@va.gov
121627|NCT00683644|University of Iowa|richard tyler|319 356 2471|rich-tyler@uiowa.edu
121628|NCT00680823|Children's Hospital of Pittsburgh|Dr. Robert Hickey|412 692 7692|robert.hickey@chp.edu
121629|NCT00675506|Massachusetts General Hospital|Steven K. Grinspoon MD|617-726-3890|sgrinspoon@partners.org
121630|NCT00660049|Stanford University|Anne Chang, MD|(650) 721 7151|alschang@stanford.edu
121631|NCT00654615|Wake Forest University Health Sciences|Zhongyu Li, MD, PhD, Professor - Department of Orthopaedic Surgery|336-716-9520|zli@wakehealth.edu
121632|NCT00640653|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu
121633|NCT00626782|Wills Eye Hospital|Prinicipal Investigator|484-434-2700|mpro2020@yahoo.com
121634|NCT00597766|MetroHealth Medical Center|Dr. Richard Wilson|216-957-3529|rwilson@metrohealth.org
121635|NCT00590460|BAYLOR|Malcolm Brenner, MD|832-824-4663|mbrenner@bcm.edu
121636|NCT00585546|University of Michigan|Francis Pagani|734 647-2894|fpagani@med.umich.edu
121637|NCT00572533|University of Louisville|Adam E Gaweda|502-852-0766|adam.gaweda@louisville.edu
121638|NCT00541099|Barbara Ann Karmanos Cancer Institute|Shirish Gadgeel, M.D.|(313) 576-8753|sgadgeel@med.umich.edu
121639|NCT00525629|Beth Israel Deaconess Medical Center|Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu
121640|NCT00474266|GlaxoSmithKline|GSK Response Center|866-435-7343|
121641|NCT00461851|Yale University Yale Cancer Center|Dr Michael Hurwitz|2037371600|Hari.deshpande@yale.edu
121642|NCT00461097|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov
121643|NCT00441142|Dana-Farber Cancer Institute|Dr. Eudocia Quant Lee|617-632-2166|eqlee@partners.org
121644|NCT00438854|Massachusetts General Hospital|Philip C. Amrein, M.D.|617-726-8748|pamrein@partners.org
